gene_allele	cc_t_stat	cc_p_val	abun_t_stat	abun_p_val	Metadata_Bio_Batch	AUROC_BioRep1_Morph	AUROC_BioRep1_AGP	AUROC_BioRep1_GFP	AUROC_BioRep1_Mito	AUROC_BioRep1_DNA	AUROC_BioRep2_Morph	AUROC_BioRep2_AGP	AUROC_BioRep2_GFP	AUROC_BioRep2_Mito	AUROC_BioRep2_DNA	AUROC_Mean_Morph	AUROC_Mean_AGP	AUROC_Mean_GFP	AUROC_Mean_Mito	AUROC_Mean_DNA	Altered_95th_perc_Morph	Altered_95th_perc_AGP	Altered_95th_perc_GFP	Altered_95th_perc_Mito	Altered_95th_perc_DNA	Altered_99th_perc_Morph	Altered_99th_perc_AGP	Altered_99th_perc_GFP	Altered_99th_perc_Mito	Altered_99th_perc_DNA	Gene	symbol	ensembl_gene_id	orf_id	mut_id	ccsb_mutation_id	ccsb_allele_id	spdi	nt_change	aa_change	collection	entry_plate_orig	entry_well_orig	entry_plate_conso	entry_well_conso	entry_seq_pool	db_plate	db_well	n2h_plate	n2h_well	dualip_plate	dualip_well	mislocalization_plate	mislocalization_well	entry_sequenced	entry_sequence_confirmation_class	db_sequenced	db_sequence_confirmation_class	n2h_sequenced	n2h_sequence_confirmation_class	n2h_ref_sequence_confirmation_class	dualip_sequenced	dualip_sequence_confirmation_class	dualip_ref_sequence_confirmation_class	mislocalization_sequenced	mislocalization_sequence_confirmation_class	mislocalization_ref_sequence_confirmation_class	gene_variant	chr_num	nuc_loc	ref_allele	alt_allele	Chrom	node_type	nt_change_cdna	dest_well	dest_plate	imaging_well	imaging_plate_R1	imaging_plate_R2	seq_confirmed_wt_ppi	seq_confirmed_allele_ppi	seq_confirmed_final	varid	SomaticClinicalImpactLastEvaluated	CADD_raw_rankscore	Polyphen2_HDIV_score	aapos	gnomAD2.1.1_exomes_non_neuro_NFE_AC	gnomAD4.1_joint_ASJ_AC	gnomAD2.1.1_exomes_non_cancer_AFR_nhomalt	hg18_chr	hg19_pos(1-based)	AlternateAlleleVCF	gnomAD4.1_joint_AF	gnomAD2.1.1_exomes_controls_AMR_AC	Chromosome	clinvar_clnsig_clean	ChromosomeAccession	gnomAD4.1_joint_POPMAX_AC	clinvar_aa_change	gnomAD2.1.1_exomes_non_cancer_EAS_AC	CADD_phred	gnomAD2.1.1_exomes_controls_EAS_AC	ALFA_African_American_AC	gnomAD2.1.1_exomes_non_cancer_POPMAX_AF	MetaLR_pred	gnomAD4.1_joint_POPMAX_nhomalt	NumberSubmitters	TSL	gnomAD2.1.1_exomes_controls_NFE_AN	gnomAD2.1.1_exomes_non_cancer_AF	1000Gp3_AFR_AC	gnomAD2.1.1_exomes_non_cancer_SAS_AN	gnomAD2.1.1_exomes_controls_ASJ_AF	ALFA_Latin_American_2_AC	REVEL_rankscore	MANE	MetaLR_score	gnomAD2.1.1_exomes_non_cancer_POPMAX_AN	Polyphen2_HDIV_rankscore	gnomAD2.1.1_exomes_non_cancer_AMR_AC	1000Gp3_EAS_AF	DEOGEN2_pred	BayesDel_addAF_pred	gnomAD4.1_joint_FIN_AN	MPC_score	ALFA_African_American_AF	gnomAD4.1_joint_AFR_nhomalt	gnomAD2.1.1_exomes_non_cancer_ASJ_AF	gnomAD2.1.1_exomes_non_cancer_NFE_nhomalt	gnomAD2.1.1_exomes_non_cancer_POPMAX_nhomalt	PrimateAI_rankscore	gnomAD2.1.1_exomes_controls_AMR_AN	gnomAD4.1_joint_EAS_AN	gnomAD4.1_joint_SAS_AC	gnomAD2.1.1_exomes_non_neuro_EAS_AF	PROVEAN_converted_rankscore	gnomAD2.1.1_exomes_controls_NFE_AC	Aloft_prob_Dominant	VARITY_R_LOO_rankscore	phastCons17way_primate	1000Gp3_AFR_AF	MutationTaster_trees_benign	LIST-S2_score	GERP_91_mammals	MutationTaster_score	alt	Type	clinvar_hgvs	gnomAD4.1_joint_FIN_nhomalt	gnomAD2.1.1_exomes_non_neuro_FIN_AN	SubmitterCategories	VARITY_ER_LOO_score	gnomAD2.1.1_exomes_controls_AN	ALFA_South_Asian_AF	VARITY_R_score	ALFA_Asian_AF	alt_right	gnomAD2.1.1_exomes_non_neuro_AC	gnomAD2.1.1_exomes_non_cancer_AN	gnomAD2.1.1_exomes_controls_nhomalt	gnomAD2.1.1_exomes_controls_AFR_nhomalt	gnomAD2.1.1_exomes_non_cancer_EAS_AF	ALFA_Latin_American_1_AN	gnomAD2.1.1_exomes_controls_NFE_AF	ALFA_African_Others_AC	PhenotypeIDS	gnomAD2.1.1_exomes_controls_AC	gnomAD2.1.1_exomes_non_cancer_FIN_AC	gnomAD4.1_joint_AMI_AF	gnomAD4.1_joint_AMI_AC	MutationTaster_converted_rankscore	Polyphen2_HVAR_pred	VARITY_ER_rankscore	Polyphen2_HDIV_pred	MutationAssessor_pred	Eigen-phred_coding	gnomAD4.1_joint_AC	ChagyrskayaNeandertal	ALFA_African_Others_AN	ALFA_Other_AC	gnomAD2.1.1_exomes_controls_AFR_AN	gnomAD4.1_joint_AN	PhenotypeList	gnomAD2.1.1_exomes_non_neuro_AFR_AN	MetaSVM_rankscore	1000Gp3_AMR_AC	Aloft_prob_Tolerant	Guidelines	Start	gnomAD2.1.1_exomes_controls_POPMAX_AF	nsv/esv (dbVar)	phyloP470way_mammalian	gnomAD2.1.1_exomes_non_neuro_AFR_AC	MutScore_rankscore	gnomAD4.1_joint_ASJ_AN	ALFA_Latin_American_2_AF	gnomAD4.1_joint_POPMAX_AN	gnomAD2.1.1_exomes_non_neuro_EAS_AC	Origin	gnomAD4.1_joint_SAS_AN	MutPred_Top5features	MutPred_rankscore	Assembly	bStatistic	ReviewStatus	HGVSc_snpEff	gnomAD2.1.1_exomes_non_cancer_SAS_AF	GERP++_RS_rankscore	ALFA_Total_AC	gnomAD2.1.1_exomes_controls_AMR_nhomalt	gnomAD2.1.1_exomes_non_neuro_ASJ_AC	Interpro_domain	gnomAD2.1.1_exomes_non_neuro_FIN_AF	gnomAD2.1.1_exomes_controls_EAS_AN	AlphaMissense_pred	ALFA_East_Asian_AF	gnomAD4.1_joint_ASJ_AF	Name	StarStatus	gnomAD2.1.1_exomes_controls_EAS_nhomalt	Uniprot_entry	gnomAD2.1.1_exomes_non_cancer_AMR_nhomalt	MutationTaster_trees_deleterious	Eigen-raw_coding	gnomAD2.1.1_exomes_non_neuro_AMR_AC	LIST-S2_pred	AlphaMissense_rankscore	VARITY_R_LOO_score	cds_strand	gnomAD2.1.1_exomes_controls_AFR_AF	1000Gp3_SAS_AC	gnomad_af	gnomAD2.1.1_exomes_non_neuro_POPMAX_AC	gnomAD2.1.1_exomes_non_neuro_ASJ_AF	codon_degeneracy	gnomAD2.1.1_exomes_non_cancer_AMR_AN	clinvar_review	MutFormer_rankscore	gnomAD2.1.1_exomes_controls_AF	gnomAD4.1_joint_nhomalt	gnomAD2.1.1_exomes_controls_FIN_AF	gnomAD2.1.1_exomes_non_cancer_ASJ_nhomalt	gnomAD4.1_joint_AMR_AN	HGVSp_snpEff	gnomAD4.1_joint_MID_nhomalt	phyloP470way_mammalian_rankscore	Aloft_prob_Recessive	OriginSimple	gnomAD2.1.1_exomes_controls_POPMAX_AC	chr_pos_38	Ancestral_allele	LastEvaluated	gnomAD2.1.1_exomes_non_cancer_SAS_AC	VindijiaNeandertal	gnomAD2.1.1_exomes_non_neuro_nhomalt	gnomAD2.1.1_exomes_non_neuro_NFE_AN	phastCons100way_vertebrate	TestedInGTR	Cytogenetic	ALFA_European_AN	Aloft_Confidence	gnomAD2.1.1_exomes_non_neuro_AFR_AF	SCVsForAggregateGermlineClassification	clinvar_clnsig	gnomAD2.1.1_exomes_controls_FIN_AC	gnomAD2.1.1_exomes_non_cancer_ASJ_AC	aaalt_3	aaalt	SomaticClinicalImpact	gnomAD4.1_joint_AMI_AN	Ensembl_proteinid	Ensembl_transcriptid	gnomAD2.1.1_exomes_non_cancer_EAS_AN	SIFT_score	gnomAD2.1.1_exomes_non_neuro_EAS_AN	gnomAD2.1.1_exomes_non_cancer_nhomalt	phyloP17way_primate	ref	gnomAD2.1.1_exomes_non_neuro_FIN_nhomalt	CADD_raw	SIFT4G_converted_rankscore	fathmm-XF_coding_pred	SIFT4G_pred	SCVsForAggregateSomaticClinicalImpact	Eigen-PC-phred_coding	Aloft_pred	M-CAP_rankscore	ALFA_Latin_American_2_AN	gnomAD2.1.1_exomes_non_neuro_AMR_nhomalt	1000Gp3_EUR_AF	ClinPred_rankscore	ALFA_Asian_AC	pos(1-based)	GENCODE_basic	Reliability_index	ALFA_Latin_American_1_AF	gnomAD2.1.1_exomes_non_cancer_NFE_AN	gnomAD4.1_joint_MID_AF	Uniprot_acc	gnomAD2.1.1_exomes_controls_FIN_nhomalt	DEOGEN2_score	DANN_rankscore	ref_right	gnomAD2.1.1_exomes_controls_POPMAX_nhomalt	Polyphen2_HVAR_score	M-CAP_pred	gnomAD2.1.1_exomes_non_neuro_POPMAX_AN	VARITY_ER_score	gnomAD2.1.1_exomes_controls_POPMAX_AN	phastCons17way_primate_rankscore	GeneID	BayesDel_addAF_score	gnomAD4.1_joint_NFE_AC	PROVEAN_score	1000Gp3_SAS_AF	gnomAD4.1_joint_POPMAX_AF	SIFT_converted_rankscore	gnomAD2.1.1_exomes_controls_SAS_AF	gnomAD2.1.1_exomes_controls_NFE_nhomalt	gnomAD4.1_joint_AFR_AN	gnomAD2.1.1_exomes_controls_EAS_AF	gnomAD4.1_joint_MID_AN	gnomAD2.1.1_exomes_controls_AFR_AC	VARITY_ER_LOO_rankscore	#chr	genename	gnomAD4.1_joint_AFR_AF	ALFA_South_Asian_AC	aaref_3	ALFA_Total_AN	gnomAD2.1.1_exomes_non_neuro_NFE_AF	varid_right	clinvar_trait	gnomAD4.1_joint_ASJ_nhomalt	gnomAD2.1.1_exomes_non_cancer_NFE_AC	hg18_pos(1-based)	clinvar_var_source	fathmm-XF_coding_score	Eigen-raw_coding_rankscore	gnomAD4.1_joint_NFE_nhomalt	RCVaccession	MetaRNN_pred	gnomAD4.1_joint_EAS_nhomalt	gnomAD2.1.1_exomes_non_neuro_SAS_nhomalt	HGVSc_VEP	gnomAD2.1.1_exomes_non_cancer_SAS_nhomalt	gnomAD4.1_joint_EAS_AC	gnomAD4.1_joint_FIN_AC	BayesDel_addAF_rankscore	Denisova	rs_dbSNP	PositionVCF	gnomAD2.1.1_exomes_non_cancer_AFR_AN	ReferenceAlleleVCF	1000Gp3_AF	MutPred_protID	gnomAD2.1.1_exomes_controls_SAS_AN	VARITY_R_rankscore	gnomAD2.1.1_exomes_non_cancer_FIN_AF	phastCons470way_mammalian_rankscore	chr	gnomAD2.1.1_exomes_non_cancer_FIN_nhomalt	gnomAD2.1.1_exomes_non_neuro_NFE_nhomalt	gnomAD4.1_joint_EAS_AF	MutationAssessor_score	ALFA_African_Others_AF	ALFA_European_AC	TOPMed_frz8_AN	GERP++_RS	DEOGEN2_rankscore	ALFA_Asian_AN	ClinPred_pred	PrimateAI_pred	gnomAD2.1.1_exomes_non_cancer_AFR_AC	gnomAD2.1.1_exomes_non_neuro_AMR_AF	ALFA_Latin_American_1_AC	ALFA_Other_Asian_AN	gnomAD2.1.1_exomes_flag	gnomAD2.1.1_exomes_non_neuro_AFR_nhomalt	gnomAD2.1.1_exomes_non_neuro_FIN_AC	clinvar_Orphanet_id	clinvar_id	BayesDel_noAF_rankscore	MPC_rankscore	ClinPred_score	ALFA_African_AN	1000Gp3_AC	phastCons100way_vertebrate_rankscore	fathmm-XF_coding_rankscore	gnomAD2.1.1_exomes_non_cancer_AMR_AF	gnomAD2.1.1_exomes_non_neuro_POPMAX_AF	gnomAD4.1_joint_NFE_AN	phyloP100way_vertebrate	gnomAD2.1.1_exomes_non_neuro_AF	PROVEAN_pred	gnomAD2.1.1_exomes_controls_FIN_AN	gnomAD2.1.1_exomes_non_neuro_POPMAX_nhomalt	TOPMed_frz8_AF	ALFA_East_Asian_AC	clinvar_OMIM_id	phyloP100way_vertebrate_rankscore	hg19_chr	gnomAD2.1.1_exomes_non_cancer_AFR_AF	Ensembl_geneid	gnomAD4.1_joint_FIN_AF	ALFA_European_AF	gnomAD2.1.1_exomes_non_neuro_SAS_AC	ALFA_Other_Asian_AF	gMVP_score	codonpos	Polyphen2_HVAR_rankscore	bStatistic_converted_rankscore	gnomAD2.1.1_exomes_non_neuro_SAS_AN	TOPMed_frz8_AC	gnomAD2.1.1_exomes_non_cancer_NFE_AF	gnomAD4.1_joint_AMR_AF	Eigen-PC-raw_coding	VEP_canonical	gnomAD4.1_joint_SAS_AF	M-CAP_score	#AlleleID	HGNC_ID	MutationTaster_pred	gnomAD2.1.1_exomes_controls_SAS_nhomalt	MutationTaster_model	MutScore_score	gnomAD2.1.1_exomes_non_neuro_AN	Stop	refcodon	phastCons470way_mammalian	1000Gp3_EAS_AC	SCVsForAggregateOncogenicityClassification	ALFA_African_AF	MetaRNN_rankscore	gnomAD4.1_joint_NFE_AF	ALFA_African_AC	gnomAD4.1_joint_SAS_nhomalt	ClinicalSignificance	ESM1b_rankscore	gnomAD2.1.1_exomes_controls_SAS_AC	gnomAD4.1_joint_MID_AC	gnomAD4.1_joint_AMR_AC	OtherIDs	aaref	gnomAD2.1.1_exomes_non_neuro_EAS_nhomalt	MVP_score	OncogenicityLastEvaluated	MutPred_score	Oncogenicity	VEST4_rankscore	gnomAD2.1.1_exomes_non_cancer_AC	ALFA_Other_AN	gMVP_rankscore	PrimateAI_score	AlphaMissense_score	gnomAD4.1_joint_AMR_nhomalt	DANN_score	ALFA_South_Asian_AN	ReviewStatusOncogenicity	clinvar_nt_change	gnomAD2.1.1_exomes_non_cancer_POPMAX_AC	ALFA_Other_AF	clinvar_MedGen_id	gnomAD2.1.1_exomes_non_neuro_ASJ_nhomalt	gnomAD2.1.1_exomes_non_cancer_EAS_nhomalt	gnomAD2.1.1_exomes_controls_ASJ_AC	gnomAD2.1.1_exomes_controls_ASJ_nhomalt	RefSeq_mRNA	ReviewStatusClinicalImpact	1000Gp3_EUR_AC	1000Gp3_AMR_AF	ClinSigSimple	LIST-S2_rankscore	RS# (dbSNP)	gnomAD2.1.1_exomes_controls_ASJ_AN	ALFA_Total_AF	MVP_rankscore	Eigen-PC-raw_coding_rankscore	VEST4_score	SIFT4G_score	ALFA_African_American_AN	MutFormer_score	GERP++_NR	gnomAD4.1_joint_flag	Aloft_Fraction_transcripts_affected	gnomAD2.1.1_exomes_non_neuro_SAS_AF	BayesDel_noAF_score	PHACTboost_score	MutationAssessor_rankscore	MetaSVM_pred	ALFA_East_Asian_AN	gnomAD2.1.1_exomes_non_neuro_ASJ_AN	gnomAD2.1.1_exomes_non_cancer_ASJ_AN	MetaSVM_score	MetaLR_rankscore	HGVSp_VEP	ALFA_Other_Asian_AC	gnomAD4.1_joint_AMI_nhomalt	ESM1b_score	MetaRNN_score	gnomAD4.1_joint_AFR_AC	PHACTboost_rankscore	VariationID	ESM1b_pred	gnomAD2.1.1_exomes_non_neuro_AMR_AN	GeneSymbol	gnomAD2.1.1_exomes_controls_AMR_AF	BayesDel_noAF_pred	REVEL_score	gnomAD2.1.1_exomes_non_cancer_FIN_AN	MutPred_AAchange	SIFT_pred	GERP_91_mammals_rankscore	phyloP17way_primate_rankscore	AltaiNeandertal	APPRIS	""	ID	splice_measure	Interval 3 range	Published Date_ClinGen_repo	Combined LR (Odds for Causality)_PMID:31131967	Uuid_ClinGen_repo	Interval 6 name	Phenotype_detail	Personal and Family History LR (Combined)_PMID:34273903	Phenotype_measured	Interval 3 MaveDB class	Component_presumed_PMID:34273903	aa_ref	calculated_classification_PMID:31131967	transcript_pos	Dataset	ClinVar Variation Id_ClinGen_repo	Ensembl_transript_ID	Updated_Classification_ClinGen_repo	Interval 2 MaveDB class	Interval 5 range	SGR LR_PMID:34273903	Guideline_ClinGen_repo	Allele Registry Id_ClinGen_repo	Model_system	Reference Group*_presumed_PMID:34273903	Retracted_ClinGen_repo	Interval 4 name	Calculated_combined_LR_PMID:34273903	hgvs_p	Breast Tumor Pathology LR_PMID:34273903	pillar_tested	hgvs_c	Population Allele Frequency LR_PMID:34273903	Calculated_post_prob_PMID:34273903	Segregation LR_PMID:31131967	Interval 1 name	calculated_classification_PMID:34273903	HGNC_id	hg38_end	IGVF_produced	Assertion_ClinGen_repo	Gene_right	Case-Control LR_PMID:31131967	Flag	Interval 4 MaveDB class	Ref_seq_transcript_ID	Pathology LR_PMID:31131967	STRAND	MaveDB URN (score set)	BS2 LR_PMID:34273903	nucleotide_or_aa	Applied Evidence Codes (Met)_ClinGen_repo	transcript_alt	Interval 5 name	Co-occurrence LR_PMID:31131967	Interval 6 MaveDB class	Naive_prior_prob_PMID:34273903	Applied Evidence Codes (Not Met)_ClinGen_repo	hg19_pos	Summary of interpretation_ClinGen_repo	Mondo Id_ClinGen_repo	clinvar_star	auth_reported_rep_score	Mode of Inheritance_ClinGen_repo	Updated_Evidence Codes_ClinGen_repo	aa_change_pp	Evidence Repo Link_ClinGen_repo	Interval 2 name	Interval 6 range	Interval 1 range	Rationale_presumed_PMID:34273903	aa_alt	clinvar_date_last_reviewed	auth_transcript_id	Interval 2 range	Naive_prior_prob_PMID:31131967	Approval Date_ClinGen_repo	simplified_consequence	Expert Panel_ClinGen_repo	aa_pos	transcript_ref	Disease_ClinGen_repo	gnomad_MAF	auth_reported_score	Interval 1 MaveDB class	clinvar_sig	hg38_start	consequence	Interval 5 MaveDB class	REVEL	auth_reported_func_class	Interval 3 name	Family History LR_PMID:31131967	PubMed Articles_ClinGen_repo	Assay_type	Interval 4 range	Calcualted_post_prob_PMID:31131967	gene_variant_pp
BRIP1_Val76Ile	0.573151287218121	0.5988089065274734	-0.1501928285335794	0.3846004182179073	2025_01_Batch_13-14	0.8091988361109888	0.6844133981290228	0.6783701732387314	0.6731480580521042	0.7665337621531135	0.6712085747597284	0.6745958346966116	0.710337530479982	0.6764891815029795	0.644690981329773	0.7402037054353585	0.6795046164128171	0.6943538518593567	0.6748186197775419	0.7056123717414433	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRIP1	BRIP1		55128		CCSBVarC031290		NC_000017.11:61857211:C:T		Val76Ile																												BRIP1_Val76Ile	17	61857211	C	T	17	allele	226G>A	F12	527_CAVA_Array_P01	K23	B13A7A8P1_R1	B14A7A8P1_R2				17-61857211-C-T	-	0.0321	0.0	76	0	1	0	17	59934572	T	3.718360e-06	0	17	3_Conflicting	NC_000017.11	1	Val76Ile	0	0.53	0	0	6.710510e-05	T	0	5	1	42760	4.222690e-06	.	30522	0.000000e+00	0	0.34681	Select	0.1619	14902	0.02950	0	.	T	T	63982	0.129564647105	0	0	0.000000e+00	0	0	0.04436	17098	44880	0	0.000000e+00	0.06578	0	.	0.00820	0.003	.	97.0	.	-8.68	0.03	T	single nucleotide variant	NC_000017.11:g.61857211C>T	0	16726	2	0.01949408	109368	0	0.021931265	0		1	236816	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MedGen:C3661900	0	0	0.000000e+00	0	0.10877	B	0.00093	B	N	0.02929016	6	C/C	114	0	7164	1613616	Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia complementation group J|not provided	16218	0.36374	.	.	-	61857211	.	-	-0.247000	1	0.07179	29598	0	29598	0	germline	91058	Gain of loop (P = 0.1069)| Loss of disorder (P = 0.1257)| Gain of helix (P = 0.132)| Loss of catalytic residue at V76 (P = 0.1841)| Loss of phosphorylation at S77 (P = 0.1941)	0.46221	GRCh38	42	criteria provided, conflicting classifications	c.226G>A	0.000000e+00	0.09157	0	0	0	.	0.000000e+00	9038	B	0	3.378610e-05	NM_032043.3(BRIP1):c.226G>A (p.Val76Ile)	1	0	FANCJ_HUMAN	0	3.0	-1.75017022248378	0	.	0.01788	0.021931265	-	0.000000e+00	.		1	0.000000e+00	0	34242	criteria_provided,_conflicting_classifications	0.69646	0.000000e+00	0	0.000000e+00	0	59992	p.Val76Ile	0	0.10584	.	germline	.		C	Nov 10, 2024	0	C/C	0	89504	0.001	N	17q23.2	9690	.	6.165990e-05	SCV000547345|SCV000666205|SCV000911292|SCV002496263|SCV002531402	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	912	ENSP00000259008	ENST00000259008	17678	0.279	13400	0	-1.852	C	0	-0.178575	0.19614	N	T	-	0.05002578	.	0.58683	610	0	.	0.07741	0	61857211	Y	9	0	102668	0.000000e+00	Q9BX63	0	0.067288	0.05936		.	0.0	D	16218	0.01949408	.	0.0525	83990	-0.358382	3	0.03	.	3.378610e-05	0.15648	0.000000e+00	0	74908	0.000000e+00	6084	0	0.00093	17	BRIP1	2.669940e-05	0	Val	14050	0.000000e+00	17-61857211-C-T	Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Fanconi_anemia_complementation_group_J	0	0	57289354	ClinGen:CA16615534	0.021994	0.00673	0	RCV000562576|RCV000473938|RCV002056711	T	0	0	c.226G>A	0	0	0	0.04058	C/C	rs769573395	61857211	14902	C	.	Q9BX63	15688	0.00820	0.000000e+00	0.08389		0	0	0.000000e+00	0.55	0	0	264690	-1.16	0.32914	112	T	T	1	0.000000e+00	0	26	.	0	0	140162|227535|84	407851	0.15067	0.14353	0.064310478718449	2898	.	0.13799	0.01033	0.000000e+00	6.165990e-05	1179728	0.283	4.807000e-06	N	13386	0	1.51120175E-5	0	114480|609054	0.18669	17	6.710510e-05	ENSG00000136492	0.000000e+00	0	0	0	0.11234678450338882	1	0.01384	0.97870	30604	4	0.000000e+00	0.000000e+00	-1.70554440226488	YES	0.000000e+00	0.039492	402301	HGNC:20473	N	0	simple_aae	0.033	208030	61857211	GTA	0.000000	.	-	0	0.03935	2.542960e-06	0	0	Conflicting classifications of pathogenicity	0.17295	0	0	0	ClinGen:CA16615534	V	0	0.233150807113	-	0.421	-	0.08480	1	496	0.11014	0.25607085228	0.0643	0	0.57826123189942369	98	-	226G>A 	1	0	C0027672|C3661900|C0346153|C1836860	0	0	0	0	NM_032043.3	-	.	.	0	0.05921	769573395	2320	0	0.22520	0.01101	0.068	0.352	2784	0.13816178	5.24	.	.	0.000000e+00	-0.57104	0.000209254300804412	0.14367	T	86	6212	9570	-0.9732	0.49568	p.Val76Ile	0	0	-3.56	0.046871662	2	0.04287	407851	T	30504	BRIP1	0.000000e+00	T	0.127	21620	V76I	T	0.00559	0.00571	C/C	principal2																																																																																																				
BRIP1_His587Arg	1.584238978026326	0.18073804788590883	0.816068200765392	0.546285500107496	2025_01_Batch_13-14	0.7961700191551923	0.699855795832681	0.7171372516909297	0.6867968081920343	0.7478837190377782	0.6292249630555719	0.7365979805628727	0.7242945676845812	0.7098055259549884	0.6244217867226861	0.712697491105382	0.7182268881977769	0.7207159096877555	0.6983011670735113	0.6861527528802321	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRIP1	BRIP1		55128		CCSBVarC031376		NC_000017.11:61780874:T:C		His587Arg																												BRIP1_His587Arg	17	61780874	T	C	17	allele	1760A>G	E12	527_CAVA_Array_P01	I23	B13A7A8P1_R1	B14A7A8P1_R2				17-61780874-T-C	-	0.10931	0.004	587	.	0	.	17	59858235	C	6.195000e-07	.	17	3_Conflicting	NC_000017.11	1	His587Arg	.	7.579	.	.	.	T	0	3	.	.	.	.	.	.	.	0.14866	.	0.0418	.	0.12194	.	.	T	T	64024	.	.	0	.	.	.	0.03796	.	44880	0	.	0.51830	.	.	0.24247	0.993	.	.	.	-0.62	.	C	single nucleotide variant	NC_000017.11:g.61780874T>C	0	.	2	0.11949802	.	.	0.10351601	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	.	.	0.000000e+00	0	.	B	0.28773	B	L	0.8295734	1	T/T	.	.	.	1614206	Hereditary cancer-predisposing syndrome|Familial cancer of breast	.	0.19528	.	.	-	61780874	.	-	0.301000	.	0.33205	29602	.	1180040	.	germline;unknown	91078	Gain of MoRF binding (P = 0.0125)| Loss of methylation at K583 (P = 0.0639)| Loss of catalytic residue at L589 (P = 0.0953)| Gain of solvent accessibility (P = 0.1133)| Loss of loop (P = 0.1242)	0.57600	GRCh38	54	criteria provided, conflicting classifications	.	.	0.35749	.	.	.	.	.	.	.	.	0.000000e+00	NM_032043.3(BRIP1):c.1760A>G (p.His587Arg)	1	.	FANCJ_HUMAN	.	.	-0.689993184120315	.	.	0.07115	0.10351601	-	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.81192	.	0	.	.	60032	.	0	0.17048	.	germline	.		T	Jan 11, 2024	.	T/T	.	.	0.958	N	17q23.2	.	.	.	SCV001354344|SCV002716735|SCV005059286	Conflicting_classifications_of_pathogenicity	.	.	Arg	R	-	912	ENSP00000508303	ENST00000683039	.	.	.	.	-0.118	T	.	0.721728	0.15078	N	.	-	1.148141	.	0.12152	.	.	.	0.19868	.	61780874	Y	9	.	.	0.000000e+00	Q9BX63	.	0.210366	0.11955		.	0.002	T	.	0.11949802	.	0.69292	83990	-0.251719	1	.	.	8.474290e-07	0.14580	.	.	75066	.	6062	.	0.28773	17	BRIP1	0.000000e+00	.	His	.	.	17-61780874-T-C	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome	0	.	57213017	.	0.345304	0.16104	0	RCV001187524|RCV004570384	.	0	.	c.1760A>G	.	0	0	0.13623	T/T	rs876660646	61780874	.	T	.	Q9BX63	.	0.24247	.	0.31563		.	.	0.000000e+00	0.935	.	.	.	3.2	0.56871	.	T	T	.	.	.	.	.	.	.	227535|140162	925546	0.12601	0.22326	0.194684848189354	.	.	0.33576	0.43862	.	.	1180040	0.573	.	.	.	.	.	.	114480	0.23486	17	.	ENSG00000136492	0.000000e+00	.	.	.	.	2	0.06938	0.97580	.	.	.	0.000000e+00	-0.53367226512072	.	0.000000e+00	0.004931	914095	HGNC:20473	.	.	.	0.123	.	61780874	CAT	0.991000	.	-	.	0.24312	8.474290e-07	.	0	Conflicting classifications of pathogenicity	0.74039	.	0	0	ClinGen:CA400480314	H	.	.	-	0.491	-	0.37163	.	.	0.48927	0.250247567892	.	0	0.77167040114901508	.	-	1760A>G 	.	.	C0346153|C0027672	.	.	.	.	NM_032043.3	-	.	.	0	0.24645	876660646	.	.	0.09769	0.20931	.	.	.	0.46835166	5.42	.	.	.	-0.599353	0.00139744306121536	0.23470	T	.	.	.	-1.0328	0.17856	p.His587Arg	.	0	-10.008	.	0	0.11129	925546	D	.	BRIP1	.	T	.	.	H587R	.	0.17698	0.14421	T/T	principal2																																																																																																				
BRIP1_Ser520Thr	0.371993516515847	0.7214710962483611	0.7464293414885849	0.5681293449170272	2025_01_Batch_13-14	0.7296687083203656	0.6929974826337902	0.6576451968220566	0.6362999541312206	0.688999708379693	0.7470475012567772	0.7430743432933519	0.7208467243012086	0.7157303902993957	0.6802472179360314	0.7383581047885714	0.718035912963571	0.6892459605616326	0.6760151722153082	0.6846234631578623	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRIP1	BRIP1		55128		CCSBVarC031368		NC_000017.11:61784339:C:G		Ser520Thr																												BRIP1_Ser520Thr	17	61784339	C	G	17	allele	1559G>C	D12	527_CAVA_Array_P01	G23	B13A7A8P1_R1	B14A7A8P1_R2				17-61784339-C-G	-	0.56457	0.997	520	0	0	0	17	59861700	G	6.198990e-07	0	17	3_Conflicting	NC_000017.11	1	Ser520Thr	0	23.7	0	.	3.276750e-05	D	0	2	.	42764	4.222190e-06	.	30518	0.000000e+00	.	0.70117	.	0.5977	30518	0.70687	0	.	T	T	64020	.	.	0	0.000000e+00	0	0	0.51884	17106	44820	1	0.000000e+00	0.47017	0	.	0.55782	0.996	.	.	0.758424	.	.	G	single nucleotide variant	NC_000017.11:g.61784339C>G	0	16734	2	0.27921516	109392	.	0.33792168	.		1	236844	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84	0	0	0.000000e+00	0	.	D	0.53680	D	M	7.388994	1	C/C	.	.	7160	1613166	Hereditary breast ovarian cancer syndrome|Familial cancer of breast;Fanconi anemia complementation group J	16214	0.86105	.	.	-	61784339	.	-	4.818000	0	0.50735	29600	.	91054	0	germline	91054	Gain of loop (P = 0.0435)| Loss of helix (P = 0.079)| Gain of relative solvent accessibility (P = 0.09)| Loss of disorder (P = 0.099)| Gain of glycosylation at S520 (P = 0.1371)	0.37869	GRCh38	49	criteria provided, conflicting classifications	.	3.276750e-05	0.76916	.	0	0	.	0.000000e+00	9046	.	.	0.000000e+00	NM_032043.3(BRIP1):c.1559G>C (p.Ser520Thr)	1	0	FANCJ_HUMAN	0	.	0.718735528270629	0	T	0.17342	0.33792168	-	0.000000e+00	.		1	0.000000e+00	0	34244	criteria_provided,_single_submitter	0.92318	0.000000e+00	0	0.000000e+00	0	60006	.	0	0.45172	.	germline	.		C	Jan 20, 2025	1	C/C	0	89510	1.0	N	17q23.2	.	.	0.000000e+00	SCV002505035|SCV005863038	Likely_benign	0	0	Thr	T	-	912	ENSP00000506943	ENST00000682453	17692	.	13416	0	0.599	C	0	3.879663	0.25277	D	.	-	7.521477	.	0.88750	.	0	.	0.63403	.	61784339	Y	9	.	102680	0.000000e+00	Q9BX63	0	0.189817	0.74486		.	0.985	D	30600	0.27921516	.	0.76032	83990	-0.00666905	0	.	.	1.098250e-05	0.35312	0.000000e+00	0	74994	0.000000e+00	6032	0	0.53679	17	BRIP1	0.000000e+00	.	Ser	.	0.000000e+00	17-61784339-C-G	Hereditary_breast_ovarian_cancer_syndrome	0	0	57216482	.	0.663288	0.80755	0	RCV002226323|RCV005225570	.	0	0	c.1559G>C	0	0	0	0.50407	C/C	rs757629526	61784339	14898	C	.	Q9BX63	15688	0.55782	0.000000e+00	0.68239		0	0	0.000000e+00	2.77	.	.	.	5.37	0.54192	.	D	T	0	0.000000e+00	.	.	.	0	0	145	1679010	0.58913	0.43011	0.951732993125916	.	.	0.71675	0.63154	0.000000e+00	3.267970e-05	1179258	4.902	4.806400e-06	.	13394	0	.	.	.	0.63037	17	0.000000e+00	ENSG00000136492	0.000000e+00	.	1	.	.	2	0.76461	0.97674	30600	.	0.000000e+00	0.000000e+00	0.687325371777153	.	1.098250e-05	0.242835	1670804	HGNC:20473	.	0	.	0.238	208056	61784339	AGT	1.000000	.	-	.	0.52780	0.000000e+00	.	0	Conflicting classifications of pathogenicity	0.63781	0	0	0	ClinGen:CA8690715	S	0	.	-	0.37	-	0.33568	1	.	0.68862	0.593239068985	.	0	0.99605583092882555	.	-	1559G>C 	1	.	C0677776	0	0	0	0	NM_032043.3	-	.	.	0	0.38019	757629526	2320	.	0.88833	0.81314	.	.	.	0.92831135	5.37	.	.	3.267970e-05	-0.150502	0.273335049405932	0.80725	D	.	6212	9570	0.2150	0.85609	p.Ser520Thr	.	0	-8.391	.	0	0.53188	1679010	D	30508	BRIP1	0.000000e+00	T	.	21628	S520T	.	.	0.40292	C/C	principal2																																																																																																				
RAF1_Asp486Asn	0.45327533329345343	1.0	-3.1778243081480344	0.02572498582917983	2025_01_Batch_13-14	0.8739391265851165	0.9053125702290953	0.9058966866448821	0.9293565178076245	0.7916608191821694	0.7864937187645036	0.8715175779120291	0.8858534683267907	0.8838538667961265	0.6808674936830288	0.8302164226748101	0.8884150740705622	0.8958750774858364	0.9066051923018755	0.7362641564325991	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1	ENSG00000132155	732	213824	CCSBVarC003426	ALE00003426	NC_000003.12:12585761:C:T	1456G>A	Asp486Asn	CEGS2	CegsMutGDEh1014	G11	GDEhDisVCh_40029	D08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RAF1_Asp486Asn	3	12585761	C	T	3											3-12585761-C-T	-	0.92811	1.0	486	.	.	.	3	12627260	T	.	.	3	5_Others	NC_000003.12	.	Asp486Asn	.	33.0	.	.	.	D	.	1	.	.	.	.	.	.	.	0.97963	.	0.9946	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.93935	.	.	.	.	0.78079	.	.	0.95387	0.998	.	.	0.9975	5.35	.	T	single nucleotide variant	NC_000003.12:g.12585761C>T	.	.	1	0.8781777	.	.	0.94164735	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500	.	.	.	.	0.92286	D	0.94137	D	M	14.52467	.	C/C	.	.	.	.	Noonan syndrome with multiple lentigines	.	0.96265	.	.	-	12585761	.	-	7.684000	.	0.99826	.	.	.	.	unknown	.	Gain of MoRF binding (P = 0.0343)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K483 (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of ubiquitination at K483 (P = 0.1041)	0.99690	GRCh38	692	no classification provided	.	.	0.73443	.	.	.	Protein kinase domain|Protein kinase domain|Protein kinase domain	.	.	.	.	.	NM_002880.4(RAF1):c.1456G>A (p.Asp486Asn)		.	RAF1_HUMAN	.	.	1.01881719419438	.	D	0.98152	0.94205755	-	.	.		.	.	0	.	no_classification_provided	0.98129	.	.	.	.	.	.	.	0.65502	.	unknown	.		C	-	.	C/C	.	.	1.0	N	3p25.2	.	.	.	SCV000040957	not_provided	.	.	Asn	N	-	.	ENSP00000509968	ENST00000685653	.	.	.	.	0.599	C	.	5.650199	0.79703	D	.	-	15.28689	.	0.98643	.	.	.	0.93025	.	12585761	Y	9	.	.	.	P04049	.	0.949346	0.98788		.	0.998	D	.	0.889279	.	0.85369	5894	0.270705	.	.	.	.	0.78662	.	.	.	.	.	.	0.93345	3	RAF1	.	.	Asp	.	.	3-12585761-C-T	Noonan_syndrome_with_multiple_lentigines	.	.	12602260	ClinGen:CA341928|UniProtKB:P04049#VAR_037817	0.892841	0.96274	.	RCV000020506	.	.	.	c.1456G>A	.	.	.	0.80361	C/C	rs80338798	12585761	.	C	.	P04049	.	0.95344	.	0.68239		.	.	.	2.89	.	.	.	5.26	0.99250	.	D	D	.	.	.	.	.	.	.	500	21341	0.80106	0.97323	0.998047471046448	.	.	0.71675	0.82954	.	.	.	7.9	.	.	.	.	.	.	PS151100	0.86061	3	.	ENSG00000132155	.	.	.	.	.	1	0.88579	0.58673	.	.	.	.	0.933976822940601	.	.	0.825636	34193	HGNC:9829	.	.	.	0.995	.	12585761	GAT	1.000000	.	-	.	0.99202	.	.	.	not provided	0.93099	.	.	.	ClinGen:CA341928,UniProtKB:P04049#VAR_037817	D	.	.	-	0.968	-	0.99419	.	.	0.98776	0.879874408245	.	.	0.99921808742760565	.	-	1456G>A 	.	.	C0175704	.	.	.	.	NM_002880.4	-	.	.	0	0.98985	80338798	.	.	0.95330	0.96872	.	.	.	0.99668110	5.26	.	.	.	0.151072	0.99999342572825	0.83536	D	.	.	.	0.9420	0.99877	p.Asp486Asn	.	.	-14.009	.	.	0.99831	21341	D	.	RAF1	.	D	.	.	D486N	.	0.93259	0.40292	C/C	principal3																																																																																																				
RAF1_Asp486Asn	0.45327533329345343	1.0	-3.1778243081480344	0.02572498582917983	2025_01_Batch_13-14	0.8739391265851165	0.9053125702290953	0.9058966866448821	0.9293565178076245	0.7916608191821694	0.7864937187645036	0.8715175779120291	0.8858534683267907	0.8838538667961265	0.6808674936830288	0.8302164226748101	0.8884150740705622	0.8958750774858364	0.9066051923018755	0.7362641564325991	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008873		NC_000003.12:12590889:T:C		Asp486Asn																												RAF1_Asp486Asn	3	12590889	T	C	3	allele	1456G>A	A04	527_CAVA_Array_P05	A07	B13A7A8P2_R1	B14A7A8P2_R2				3-12590889-T-C	-	0.83076	1.0	427	.	.	.	3	12632388	C	.	.	3	1_Pathogenic	NC_000003.12	.	Ser427Gly	.	27.9	.	.	.	T	.	4	.	.	.	.	.	.	.	0.89880	.	0.2268	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.67068	.	.	.	.	0.71557	.	.	0.94866	0.998	.	.	.	5.35	.	C	single nucleotide variant	NC_000003.12:g.12590889T>C	.	.	2	0.8904818	.	.	0.93729275	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MedGen:CN230736|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.93300	D	0.94290	D	N	3.520768	.	T/T	.	.	.	.	not provided|Noonan syndrome and Noonan-related syndrome|Cardiovascular phenotype|RASopathy	.	0.77104	.	.	-	12590889	.	-	7.869000	.	0.78728	.	.	.	.	germline	.	Loss of ubiquitination at K431 (P = 0.0801)| Loss of stability (P = 0.2308)| Gain of catalytic residue at S427 (P = 0.2489)| Gain of methylation at K431 (P = 0.262)| Loss of disorder (P = 0.2717)	0.93292	GRCh38	690	criteria provided, multiple submitters, no conflicts	.	.	0.59904	.	.	.	Protein kinase domain|Protein kinase domain|Protein kinase domain	.	.	.	.	.	NM_002880.4(RAF1):c.1279A>G (p.Ser427Gly)	2	.	RAF1_HUMAN	.	.	0.247654629085886	.	.	0.65901	0.9370056	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.97958	.	.	.	.	.	.	.	0.71902	.	germline	.		T	Mar 26, 2024	.	T/T	.	.	1.0	N	3p25.2	.	.	.	SCV000209027|SCV002060957|SCV002228531|SCV005163541	Pathogenic/Likely_pathogenic	.	.	Gly	G	-	.	ENSP00000508763	ENST00000691899	.	.	.	.	0.665	T	.	5.003768	0.39532	D	.	-	3.906654	.	0.85398	.	.	.	0.86609	.	12590889	Y	10	.	.	.	P04049	.	0.897908	0.93824		.	0.999	D	.	0.8914141	.	0.85369	5894	0.30741	.	.	.	.	0.91343	.	.	.	.	.	.	0.94223	3	RAF1	.	.	Ser	.	.	3-12590889-T-C	not_provided|RASopathy|Noonan_syndrome_and_Noonan-related_syndrome|Cardiovascular_phenotype	.	.	12607388	ClinGen:CA297127	0.534511	0.53289	.	RCV000159084|RCV001813271|RCV004668748|RCV001852678	.	.	.	c.1279A>G	.	.	.	0.83430	T/T	rs730881002	12590889	.	T	.	P04049	.	0.94895	.	0.68239		.	.	.	-1.72	.	.	.	4.75	0.97955	.	D	T	.	.	.	.	.	.	.	536391|98733	40616	0.83214	0.96921	0.995037019252777	.	.	0.71675	0.55195	.	.	.	2.072	.	.	.	.	.	.	.	0.41239	3	.	ENSG00000132155	.	.	.	.	.	1	0.92348	0.58843	.	.	.	.	0.331680700016892	.	.	0.179624	49086	HGNC:9829	.	.	.	0.619	.	12590889	AGC	1.000000	.	-	.	0.70236	.	.	.	Pathogenic/Likely pathogenic	0.92018	.	.	.	ClinGen:CA297127	S	.	.	-	0.82	-	0.91505	.	.	0.97149	0.699861168861	.	.	0.99859374417457669	.	-	1279A>G 	.	.	C3661900|C5555857|C5681679|CN230736	.	.	.	.	NM_002880.4	-	.	.	1	0.92775	730881002	.	.	0.96743	0.57182	.	.	.	0.99608827	4.75	.	.	.	0.203797	0.999960555285628	0.00342	T	.	.	.	-0.2179	0.59002	p.Ser427Gly	.	.	-13.689	.	.	0.99297	40616	D	.	RAF1	.	D	.	.	S427G	.	0.93259	0.62996	T/T	principal3																																																																																																				
FARS2_Ile329Thr	-2.2456562230357777	1.0	-2.124393793498326	0.10954203012231531	2025_01_Batch_13-14	0.9497609191467175	0.8479652830539113	0.7922037280296529	0.8337499264828268	0.9429145177669562	0.8527071834718518	0.7411114826400237	0.6796648942929623	0.7992589702340727	0.8377677968078636	0.9012340513092847	0.7945383828469674	0.7359343111613076	0.8165044483584497	0.8903411572874099	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011924		NC_000006.12:5545261:T:C		Ile329Thr																												FARS2_Ile329Thr	6	5545261	T	C	6	allele	986T>C	B02	527_CAVA_Array_P03	D03	B13A7A8P1_R1	B14A7A8P1_R2				6-5545261-T-C	-	0.83025	1.0	329	3	0	0	6	5545494	C	1.858630e-06	0	6	1_Pathogenic	NC_000006.12	1	Ile329Thr	0	27.9	0	0	2.924030e-05	D	0	2	1	42768	1.267020e-05	.	30526	0.000000e+00	0	0.98190	Select	0.7276	102598	0.90580	0	.	D	D	64042	.	0	0	0.000000e+00	0	0	0.75288	17112	44882	0	0.000000e+00	0.80975	2	.	0.95948	0.99	.	3.0	0.994531	3.3	0.97	C	single nucleotide variant	NC_000006.12:g.5545261T>C	0	16734	3	0.88929117	109404	0	0.94993186	0		3	236776	0	0	0.000000e+00	0	4.676390e-05	0	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	2	0	0.000000e+00	0	0.96253	D	0.95310	D	H	12.80027	3	T/T	0	0	7164	1614088	Combined oxidative phosphorylation defect type 14	16218	0.93913	.	.	-	5545261	4.676390e-05	-	7.746000	0	0.99727	29604	0	64042	0	germline	91082	Loss of stability (P = 0.0021)| Gain of phosphorylation at I329 (P = 0.0509)| Loss of helix (P = 0.1299)| Gain of sheet (P = 0.1945)| Gain of loop (P = 0.2754)	0.89555	GRCh38	982	criteria provided, single submitter	c.986T>C	0.000000e+00	0.73761	0	0	0	Aminoacyl-tRNA synthetase, class II	0.000000e+00	9042	P	0	0.000000e+00	NM_006567.5(FARS2):c.986T>C (p.Ile329Thr)	1	0	SYFM_HUMAN	0	97.0	0.963131837071811	0	D	0.83150	0.9474884	+	0.000000e+00	.		3	0.000000e+00	0	34260	criteria_provided,_single_submitter	0.94918	1.828090e-05	0	0.000000e+00	0	60022	p.Ile329Thr	0	0.68123	.	germline	2		T	Jun 13, 2018	0	T/T	0	89552	1.0	N	6p25.1	78	.	0.000000e+00	SCV000845715	Likely_pathogenic	0	0	Thr	T	-	912	ENSP00000274680	ENST00000274680	17686	0.001	13410	0	0.665	T	0	5.001397	0.83643	D	D	-	11.98561	.	0.95867	0	0	.	0.95690	0	5545261	Y	10	0	102598	0.000000e+00	O95363	0	0.633828	0.94641		0	1.0	D	89552	0.90557504	42768	0.65338	10667	0.383	0	-4.83	.	1.561480e-05	0.78662	0.000000e+00	0	75056	0.000000e+00	6062	0	0.94138	6	FARS2	0.000000e+00	0	Ile	660	3.350010e-05	6-5545261-T-C	Combined_oxidative_phosphorylation_defect_type_14	0	3	5490493	ClinGen:CA130597|OMIM:611592.0002|UniProtKB:O95363#VAR_069488	0.907023	0.94462	0	RCV000033045	D	0	0	c.986T>C	0	0	1	0.88822	T/T	rs397514611	5545261	14902	T	.	O95363	15690	0.96200	0.000000e+00	0.68239		0	0	0.000000e+00	4.21	0	0	.	5.27	0.88570	34	D	T	0	0.000000e+00	0	0	.	0	0	319519	39825	0.91225	0.63719	0.998961210250854	434	.	0.71675	0.86001	0.000000e+00	3.350010e-05	1179922	7.646	1.441460e-05	D	13394	0	.	0	614946	0.82647	6	0.000000e+00	ENSG00000145982	1.561480e-05	0	0	0	.	2	0.97365	0.03399	30608	.	2.924030e-05	0.000000e+00	0.855816931618299	YES	0.000000e+00	0.551967	48424	HGNC:21062	A	0	simple_aae	0.992	208122	5545261	ATC	1.000000	.	-	0	0.95004	0.000000e+00	0	0	Likely pathogenic	0.91505	0	0	0	ClinGen:CA130597,UniProtKB:O95363#VAR_069488,OMIM:611592.0002	I	0	0.979357470534	-	0.769	-	0.97975	3	108	0.96169	0.75597679615	0.899	0	0.99868570309340743	6	-	986T>C 	3	0	C4755312	0	0	0	0	NM_006567.5	-	.	.	1	0.98201	397514611	2320	0	0.97892	0.93315	0.969	0.001	434	0.97331387	5.27	.	.	0.000000e+00	0.376023	0.999640102774092	0.97827	D	34	6212	9570	0.7613	0.90648	p.Ile329Thr	0	0	-13.546	0.9569025	0	0.97310	39825	D	30524	FARS2	0.000000e+00	D	0.926	21632	I329T	D	0.59857	0.62996	T/T	principal1																																																																																																				
FARS2_Ile329Thr	-2.2456562230357777	1.0	-2.124393793498326	0.10954203012231531	2025_01_Batch_13-14	0.9497609191467175	0.8479652830539113	0.7922037280296529	0.8337499264828268	0.9429145177669562	0.8527071834718518	0.7411114826400237	0.6796648942929623	0.7992589702340727	0.8377677968078636	0.9012340513092847	0.7945383828469674	0.7359343111613076	0.8165044483584497	0.8903411572874099	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2				CCSBVarC011924	ALE00012104	NC_000006.12:5545261:T:C	986T>C	Ile329Thr	CAVA																											FARS2_Ile329Thr	6	5545261	T	C	6								1	1	1	6-5545261-T-C	-	0.83025	1.0	329	3	0	0	6	5545494	C	1.858630e-06	0	6	1_Pathogenic	NC_000006.12	1	Ile329Thr	0	27.9	0	0	2.924030e-05	D	0	2	1	42768	1.267020e-05	.	30526	0.000000e+00	0	0.98190	Select	0.7276	102598	0.90580	0	.	D	D	64042	.	0	0	0.000000e+00	0	0	0.75288	17112	44882	0	0.000000e+00	0.80975	2	.	0.95948	0.99	.	3.0	0.994531	3.3	0.97	C	single nucleotide variant	NC_000006.12:g.5545261T>C	0	16734	3	0.88929117	109404	0	0.94993186	0		3	236776	0	0	0.000000e+00	0	4.676390e-05	0	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	2	0	0.000000e+00	0	0.96253	D	0.95310	D	H	12.80027	3	T/T	0	0	7164	1614088	Combined oxidative phosphorylation defect type 14	16218	0.93913	.	.	-	5545261	4.676390e-05	-	7.746000	0	0.99727	29604	0	64042	0	germline	91082	Loss of stability (P = 0.0021)| Gain of phosphorylation at I329 (P = 0.0509)| Loss of helix (P = 0.1299)| Gain of sheet (P = 0.1945)| Gain of loop (P = 0.2754)	0.89555	GRCh38	982	criteria provided, single submitter	c.986T>C	0.000000e+00	0.73761	0	0	0	Aminoacyl-tRNA synthetase, class II	0.000000e+00	9042	P	0	0.000000e+00	NM_006567.5(FARS2):c.986T>C (p.Ile329Thr)	1	0	SYFM_HUMAN	0	97.0	0.963131837071811	0	D	0.83150	0.9474884	+	0.000000e+00	.		3	0.000000e+00	0	34260	criteria_provided,_single_submitter	0.94918	1.828090e-05	0	0.000000e+00	0	60022	p.Ile329Thr	0	0.68123	.	germline	2		T	Jun 13, 2018	0	T/T	0	89552	1.0	N	6p25.1	78	.	0.000000e+00	SCV000845715	Likely_pathogenic	0	0	Thr	T	-	912	ENSP00000274680	ENST00000274680	17686	0.001	13410	0	0.665	T	0	5.001397	0.83643	D	D	-	11.98561	.	0.95867	0	0	.	0.95690	0	5545261	Y	10	0	102598	0.000000e+00	O95363	0	0.633828	0.94641		0	1.0	D	89552	0.90557504	42768	0.65338	10667	0.383	0	-4.83	.	1.561480e-05	0.78662	0.000000e+00	0	75056	0.000000e+00	6062	0	0.94138	6	FARS2	0.000000e+00	0	Ile	660	3.350010e-05	6-5545261-T-C	Combined_oxidative_phosphorylation_defect_type_14	0	3	5490493	ClinGen:CA130597|OMIM:611592.0002|UniProtKB:O95363#VAR_069488	0.907023	0.94462	0	RCV000033045	D	0	0	c.986T>C	0	0	1	0.88822	T/T	rs397514611	5545261	14902	T	.	O95363	15690	0.96200	0.000000e+00	0.68239		0	0	0.000000e+00	4.21	0	0	.	5.27	0.88570	34	D	T	0	0.000000e+00	0	0	.	0	0	319519	39825	0.91225	0.63719	0.998961210250854	434	.	0.71675	0.86001	0.000000e+00	3.350010e-05	1179922	7.646	1.441460e-05	D	13394	0	.	0	614946	0.82647	6	0.000000e+00	ENSG00000145982	1.561480e-05	0	0	0	.	2	0.97365	0.03399	30608	.	2.924030e-05	0.000000e+00	0.855816931618299	YES	0.000000e+00	0.551967	48424	HGNC:21062	A	0	simple_aae	0.992	208122	5545261	ATC	1.000000	.	-	0	0.95004	0.000000e+00	0	0	Likely pathogenic	0.91505	0	0	0	ClinGen:CA130597,UniProtKB:O95363#VAR_069488,OMIM:611592.0002	I	0	0.979357470534	-	0.769	-	0.97975	3	108	0.96169	0.75597679615	0.899	0	0.99868570309340743	6	-	986T>C 	3	0	C4755312	0	0	0	0	NM_006567.5	-	.	.	1	0.98201	397514611	2320	0	0.97892	0.93315	0.969	0.001	434	0.97331387	5.27	.	.	0.000000e+00	0.376023	0.999640102774092	0.97827	D	34	6212	9570	0.7613	0.90648	p.Ile329Thr	0	0	-13.546	0.9569025	0	0.97310	39825	D	30524	FARS2	0.000000e+00	D	0.926	21632	I329T	D	0.59857	0.62996	T/T	principal1																																																																																																				
SDHD_His102Arg	4.23284378127999	0.003902401439764406	-4.0992567991501385	0.052371008319831956	2025_01_Batch_13-14	0.7646330805473627	0.8300745460760569	0.7906816420510188	0.8447132748304026	0.731416119505325	0.6939391861387717	0.7733546771280568	0.7555159861396368	0.6844357460076645	0.6874179832524896	0.7292861333430671	0.8017146116020568	0.7730988140953278	0.7645745104190336	0.7094170513789073	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023323		NC_000011.10:112089002:A:G		His102Arg																												SDHD_His102Arg	11	112089002	A	G	11	allele	305A>G	D12	527_CAVA_Array_P05	G23	B13A7A8P2_R1	B14A7A8P2_R2				11-112089002-A-G	-	0.76234	0.999	102	1	0	0	11	111959726	G	3.097670e-06	0	11	1_Pathogenic	NC_000011.10	5	His102Arg	0	26.5	0	.	9.732740e-06	D	0	3	1	42768	4.220340e-06	.	30526	0.000000e+00	.	0.98152	Select	0.9986	102746	0.77914	0	.	D	D	64020	0.822716399301	.	0	0.000000e+00	0	0	0.55067	17112	44878	0	0.000000e+00	0.96333	0	.	0.94564	0.699	.	0.0	0.931507	.	1.0	G	single nucleotide variant	NC_000011.10:g.112089002A>G	0	16734	2	0.9051902	109408	.	0.95057625	.	G	1	236948	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072	0	0	0.000000e+00	0	0.99291	D	0.95540	D	H	6.639008	5	./.	.	.	7164	1614116	Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Paragangliomas 1	16218	0.94968	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112089002	.	-	9.318000	0	0.99760	29608	.	1180006	0	germline;unknown	91086	Gain of relative solvent accessibility (P = 0.1259)| Gain of solvent accessibility (P = 0.1319)| Loss of catalytic residue at L101 (P = 0.168)| Gain of loop (P = 0.2045)| Gain of MoRF binding (P = 0.3566)	0.99581	GRCh38	637	criteria provided, multiple submitters, no conflicts	c.305A>G	0.000000e+00	0.43622	.	0	0	.	0.000000e+00	9046	P	.	0.000000e+00	NM_003002.4(SDHD):c.305A>G (p.His102Arg)	2	0	DHSD_HUMAN	0	100.0	0.663599630439143	0	D	0.80800	0.93406326	+	0.000000e+00	.	3.42028e-6	1	0.000000e+00	0	34260	criteria_provided,_multiple_submitters,_no_conflicts	0.99288	0.000000e+00	0	0.000000e+00	0	60024	p.His102Arg	0	0.80050	.	germline	.	112089002	A	Dec 02, 2024	0	./.	0	89552	1.0	N	11q23.1	.	.	0.000000e+00	SCV000953725|SCV001179586|SCV004933595	Pathogenic/Likely_pathogenic	0	0	Arg	R	-	912	ENSP00000364699	ENST00000375549	17692	0.002	13416	0	0.691	A	0	4.730387	0.92967	D	D	-	5.184201	.	0.97228	.	0	.	0.86836	.	112089002	Y	10	.	102746	0.000000e+00	O14521	0	0.978249	0.73897	A	.	0.96	D	89552	0.9087782	.	0.34149	6392	0.565929	5	-7.95	.	4.237270e-06	0.91343	0.000000e+00	0	75020	0.000000e+00	6060	0	0.95282	11	SDHD	0.000000e+00	.	His	.	1.116670e-05	11-112089002-A-G	Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|Carney-Stratakis_syndrome|Cowden_syndrome_3|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss	0	1	111464936	.	0.960222	0.77127	0	RCV001018360|RCV002538159|RCV004028788	D	0	0	c.305A>G	0	0	0	0.96317	./.	rs104894302	112089002	14902	A	.	O14521	15690	0.96266	0.000000e+00	0.68239	11	0	0	0.000000e+00	3.58	.	.	.	3.86	0.99805	.	D	T	0	0.000000e+00	.	.	segdup	0	0	140162|29072|97286|201|29072	656860	0.96257	0.67041	0.995160043239594	.	.	0.71675	0.98087	0.000000e+00	1.116670e-05	1180006	8.712	4.804740e-06	D	13394	0	.	.	168000|606864|171300	0.9112	11	0.000000e+00	ENSG00000204370	0.000000e+00	.	0	.	0.9941230044772663	2	0.70309	0.64339	30608	.	9.732740e-06	0.000000e+00	0.502772132901211	YES	0.000000e+00	0.668847	639710	HGNC:10683	A	0	simple_aae	0.993	208128	112089002	CAT	1.000000	.	-	.	0.99869	4.237270e-06	.	0	Pathogenic/Likely pathogenic	0.83515	0	0	0	ClinGen:CA071040	H	0	0.99569366784	-	0.96	-	0.99987	1	.	0.99408	0.615795195103	0.8694	0	0.99595436499868495	.	-	305A>G 	1	.	C0027672|C3494181|C1847319|CN166604|C0031511|C1868633	0	0	0	0	NM_003002.4	-	.	.	1	0.74447	104894302	2320	.	0.99559	0.68002	0.981	0.005	.	0.99930870	5.04	.	.	0.000000e+00	0.575142	0.9963025324275	0.93458	D	.	6212	9572	0.8464	0.99961	p.His102Arg	.	0	-9.682	0.9932964	0	0.92025	656860	D	30524	SDHD	0.000000e+00	D	0.925	21632	H102R	D	.	0.84104	./.	principal1																																																																																																				
SDHD_His102Arg	4.23284378127999	0.003902401439764406	-4.0992567991501385	0.052371008319831956	2025_01_Batch_13-14	0.7646330805473627	0.8300745460760569	0.7906816420510188	0.8447132748304026	0.731416119505325	0.6939391861387717	0.7733546771280568	0.7555159861396368	0.6844357460076645	0.6874179832524896	0.7292861333430671	0.8017146116020568	0.7730988140953278	0.7645745104190336	0.7094170513789073	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023323	ALE00032062	NC_000011.10:112089002:A:G	305A>G	His102Arg	CAVA																											SDHD_His102Arg	11	112089002	A	G	11								1	1	1	11-112089002-A-G	-	0.76234	0.999	102	1	0	0	11	111959726	G	3.097670e-06	0	11	1_Pathogenic	NC_000011.10	5	His102Arg	0	26.5	0	.	9.732740e-06	D	0	3	1	42768	4.220340e-06	.	30526	0.000000e+00	.	0.98152	Select	0.9986	102746	0.77914	0	.	D	D	64020	0.822716399301	.	0	0.000000e+00	0	0	0.55067	17112	44878	0	0.000000e+00	0.96333	0	.	0.94564	0.699	.	0.0	0.931507	.	1.0	G	single nucleotide variant	NC_000011.10:g.112089002A>G	0	16734	2	0.9051902	109408	.	0.95057625	.	G	1	236948	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072	0	0	0.000000e+00	0	0.99291	D	0.95540	D	H	6.639008	5	./.	.	.	7164	1614116	Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Paragangliomas 1	16218	0.94968	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112089002	.	-	9.318000	0	0.99760	29608	.	1180006	0	germline;unknown	91086	Gain of relative solvent accessibility (P = 0.1259)| Gain of solvent accessibility (P = 0.1319)| Loss of catalytic residue at L101 (P = 0.168)| Gain of loop (P = 0.2045)| Gain of MoRF binding (P = 0.3566)	0.99581	GRCh38	637	criteria provided, multiple submitters, no conflicts	c.305A>G	0.000000e+00	0.43622	.	0	0	.	0.000000e+00	9046	P	.	0.000000e+00	NM_003002.4(SDHD):c.305A>G (p.His102Arg)	2	0	DHSD_HUMAN	0	100.0	0.663599630439143	0	D	0.80800	0.93406326	+	0.000000e+00	.	3.42028e-6	1	0.000000e+00	0	34260	criteria_provided,_multiple_submitters,_no_conflicts	0.99288	0.000000e+00	0	0.000000e+00	0	60024	p.His102Arg	0	0.80050	.	germline	.	112089002	A	Dec 02, 2024	0	./.	0	89552	1.0	N	11q23.1	.	.	0.000000e+00	SCV000953725|SCV001179586|SCV004933595	Pathogenic/Likely_pathogenic	0	0	Arg	R	-	912	ENSP00000364699	ENST00000375549	17692	0.002	13416	0	0.691	A	0	4.730387	0.92967	D	D	-	5.184201	.	0.97228	.	0	.	0.86836	.	112089002	Y	10	.	102746	0.000000e+00	O14521	0	0.978249	0.73897	A	.	0.96	D	89552	0.9087782	.	0.34149	6392	0.565929	5	-7.95	.	4.237270e-06	0.91343	0.000000e+00	0	75020	0.000000e+00	6060	0	0.95282	11	SDHD	0.000000e+00	.	His	.	1.116670e-05	11-112089002-A-G	Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|Carney-Stratakis_syndrome|Cowden_syndrome_3|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss	0	1	111464936	.	0.960222	0.77127	0	RCV001018360|RCV002538159|RCV004028788	D	0	0	c.305A>G	0	0	0	0.96317	./.	rs104894302	112089002	14902	A	.	O14521	15690	0.96266	0.000000e+00	0.68239	11	0	0	0.000000e+00	3.58	.	.	.	3.86	0.99805	.	D	T	0	0.000000e+00	.	.	segdup	0	0	140162|29072|97286|201|29072	656860	0.96257	0.67041	0.995160043239594	.	.	0.71675	0.98087	0.000000e+00	1.116670e-05	1180006	8.712	4.804740e-06	D	13394	0	.	.	168000|606864|171300	0.9112	11	0.000000e+00	ENSG00000204370	0.000000e+00	.	0	.	0.9941230044772663	2	0.70309	0.64339	30608	.	9.732740e-06	0.000000e+00	0.502772132901211	YES	0.000000e+00	0.668847	639710	HGNC:10683	A	0	simple_aae	0.993	208128	112089002	CAT	1.000000	.	-	.	0.99869	4.237270e-06	.	0	Pathogenic/Likely pathogenic	0.83515	0	0	0	ClinGen:CA071040	H	0	0.99569366784	-	0.96	-	0.99987	1	.	0.99408	0.615795195103	0.8694	0	0.99595436499868495	.	-	305A>G 	1	.	C0027672|C3494181|C1847319|CN166604|C0031511|C1868633	0	0	0	0	NM_003002.4	-	.	.	1	0.74447	104894302	2320	.	0.99559	0.68002	0.981	0.005	.	0.99930870	5.04	.	.	0.000000e+00	0.575142	0.9963025324275	0.93458	D	.	6212	9572	0.8464	0.99961	p.His102Arg	.	0	-9.682	0.9932964	0	0.92025	656860	D	30524	SDHD	0.000000e+00	D	0.925	21632	H102R	D	.	0.84104	./.	principal1																																																																																																				
SDHD_Ile31Val	4.150235795989882	0.009338842715277238	1.6670333692872967	0.13462103240313536	2025_01_Batch_13-14	0.8632571331477497	0.9092146244980089	0.8648443535593294	0.7855611845527318	0.759573299204002	0.751312878625422	0.8060784152900309	0.8239304512340127	0.788634996757791	0.7252208725648839	0.8072850058865858	0.85764651989402	0.8443874023966711	0.7870980906552614	0.7423970858844429	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023265		NC_000011.10:112087895:A:G		Ile31Val																												SDHD_Ile31Val	11	112087895	A	G	11	allele	91A>G	E01	527_CAVA_Array_P06	I02	B13A7A8P2_R1	B14A7A8P2_R2				11-112087895-A-G	-	0.05315	0.0	31	.	.	.	11	111958619	G	.	.	11	3_Conflicting	NC_000011.10	.	Ile31Val	.	1.791	.	.	.	T	.	4	1	.	.	.	.	.	.	0.76693	Select	0.4158	.	0.02950	.	.	T	D	.	0.15461328637	.	.	.	.	.	0.11802	.	.	.	.	0.05010	.	.	0.01119	0.663	.	92.0	0.533947	.	0.08	G	single nucleotide variant	NC_000011.10:g.112087895A>G	.	.	2	0.026847782	.	.	0.02366694	.		.	.	.	.	.	.	.	.	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	.	.	.	.	0.31989	B	0.00805	B	N	0.2106841	.	./.	.	.	.	.	Pheochromocytoma;Cowden syndrome 3;Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss|Hereditary cancer-predisposing syndrome|not specified|Hereditary pheochromocytoma-paraganglioma	.	0.66773	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112087895	.	-	2.708000	.	0.05809	.	.	.	.	germline	.	Gain of sheet (P = 0.1208)| Gain of methylation at R27 (P = 0.1334)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2754)| Gain of catalytic residue at I31 (P = 0.2808)	0.39663	GRCh38	635	criteria provided, conflicting classifications	c.91A>G	.	0.31620	.	.	.	.	.	.	B	.	.	NM_003002.4(SDHD):c.91A>G (p.Ile31Val)	1	.	DHSD_HUMAN	.	8.0	-1.22373084351358	.	T	0.12187	0.02366694	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.92192	.	.	.	.	.	p.Ile31Val	.	0.34295	.	germline	.		A	May 11, 2024	.	./.	.	.	0.37	N	11q23.1	.	.	.	SCV001231428|SCV002688111|SCV004822330	Conflicting_classifications_of_pathogenicity	.	.	Val	V	-	.	ENSP00000364699	ENST00000375549	.	1.0	.	.	-0.743	A	.	0.134814	0.03973	N	T	-	0.4109787	.	0.53719	.	.	.	0.02125	.	112087895	Y	10	.	.	.	O14521	.	0.146378	0.10972		.	0.0	D	.	0.026847782	.	0.33093	6392	0.0852895	.	0.18	.	.	0.00968	.	.	.	.	.	.	0.00805	11	SDHD	.	.	Ile	.	.	11-112087895-A-G	not_specified|Hereditary_pheochromocytoma-paraganglioma|Cowden_syndrome_3|Carney-Stratakis_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_cancer-predisposing_syndrome	.	.	111463829	.	0.118743	0.04605	.	RCV002240532|RCV002374977|RCV003151276|RCV004000160	T	.	.	c.91A>G	.	.	.	0.62390	./.	rs1865653068	112087895	.	A	.	O14521	.	0.01119	.	0.32271		.	.	.	-1.025	.	.	.	2.78	0.48116	.	T	T	.	.	.	.	.	.	.	29072|201|97286|29072|140162	860158	0.61922	0.17194	0.0309518799185753	.	.	0.26012	0.22993	.	.	.	0.472	.	N	.	.	.	.	606864|171300	0.21905	11	.	ENSG00000204370	.	.	.	.	0.43965305476109695	1	0.01384	0.64545	.	.	.	.	-1.06657851552802	YES	.	0.031946	837951	HGNC:10683	N	.	simple_aae	0.029	.	112087895	ATC	0.994000	.	-	.	0.04166	.	.	.	Conflicting classifications of pathogenicity	0.06038	.	.	.	ClinGen:CA382616974	I	.	0.786847784675	-	0.381	-	0.06176	.	.	0.43682	0.309365063906	0.0626	.	0.74706428750991605	.	-	91A>G 	.	.	CN169374|C1708353|CN166604|C1847319|C0031511|C1868633|C0027672	.	.	.	.	NM_003002.4	-	.	.	0	0.19158	1865653068	.	.	0.78318	0.08227	0.085	1.0	.	0.92538464	4.81	.	.	.	-0.115264	0.00494223008028627	0.01134	T	.	.	.	-0.5465	0.76166	p.Ile31Val	.	.	-2.33	0.04787895	.	0.18766	860158	T	.	SDHD	.	T	0.476	.	I31V	T	.	0.03658	./.	principal1																																																																																																				
SDHD_Ile31Val	4.150235795989882	0.009338842715277238	1.6670333692872967	0.13462103240313536	2025_01_Batch_13-14	0.8632571331477497	0.9092146244980089	0.8648443535593294	0.7855611845527318	0.759573299204002	0.751312878625422	0.8060784152900309	0.8239304512340127	0.788634996757791	0.7252208725648839	0.8072850058865858	0.85764651989402	0.8443874023966711	0.7870980906552614	0.7423970858844429	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023265	ALE00022446	NC_000011.10:112087895:A:G	91A>G	Ile31Val	CAVA																											SDHD_Ile31Val	11	112087895	A	G	11								1	1	1	11-112087895-A-G	-	0.05315	0.0	31	.	.	.	11	111958619	G	.	.	11	3_Conflicting	NC_000011.10	.	Ile31Val	.	1.791	.	.	.	T	.	4	1	.	.	.	.	.	.	0.76693	Select	0.4158	.	0.02950	.	.	T	D	.	0.15461328637	.	.	.	.	.	0.11802	.	.	.	.	0.05010	.	.	0.01119	0.663	.	92.0	0.533947	.	0.08	G	single nucleotide variant	NC_000011.10:g.112087895A>G	.	.	2	0.026847782	.	.	0.02366694	.		.	.	.	.	.	.	.	.	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	.	.	.	.	0.31989	B	0.00805	B	N	0.2106841	.	./.	.	.	.	.	Pheochromocytoma;Cowden syndrome 3;Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss|Hereditary cancer-predisposing syndrome|not specified|Hereditary pheochromocytoma-paraganglioma	.	0.66773	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112087895	.	-	2.708000	.	0.05809	.	.	.	.	germline	.	Gain of sheet (P = 0.1208)| Gain of methylation at R27 (P = 0.1334)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2754)| Gain of catalytic residue at I31 (P = 0.2808)	0.39663	GRCh38	635	criteria provided, conflicting classifications	c.91A>G	.	0.31620	.	.	.	.	.	.	B	.	.	NM_003002.4(SDHD):c.91A>G (p.Ile31Val)	1	.	DHSD_HUMAN	.	8.0	-1.22373084351358	.	T	0.12187	0.02366694	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.92192	.	.	.	.	.	p.Ile31Val	.	0.34295	.	germline	.		A	May 11, 2024	.	./.	.	.	0.37	N	11q23.1	.	.	.	SCV001231428|SCV002688111|SCV004822330	Conflicting_classifications_of_pathogenicity	.	.	Val	V	-	.	ENSP00000364699	ENST00000375549	.	1.0	.	.	-0.743	A	.	0.134814	0.03973	N	T	-	0.4109787	.	0.53719	.	.	.	0.02125	.	112087895	Y	10	.	.	.	O14521	.	0.146378	0.10972		.	0.0	D	.	0.026847782	.	0.33093	6392	0.0852895	.	0.18	.	.	0.00968	.	.	.	.	.	.	0.00805	11	SDHD	.	.	Ile	.	.	11-112087895-A-G	not_specified|Hereditary_pheochromocytoma-paraganglioma|Cowden_syndrome_3|Carney-Stratakis_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_cancer-predisposing_syndrome	.	.	111463829	.	0.118743	0.04605	.	RCV002240532|RCV002374977|RCV003151276|RCV004000160	T	.	.	c.91A>G	.	.	.	0.62390	./.	rs1865653068	112087895	.	A	.	O14521	.	0.01119	.	0.32271		.	.	.	-1.025	.	.	.	2.78	0.48116	.	T	T	.	.	.	.	.	.	.	29072|201|97286|29072|140162	860158	0.61922	0.17194	0.0309518799185753	.	.	0.26012	0.22993	.	.	.	0.472	.	N	.	.	.	.	606864|171300	0.21905	11	.	ENSG00000204370	.	.	.	.	0.43965305476109695	1	0.01384	0.64545	.	.	.	.	-1.06657851552802	YES	.	0.031946	837951	HGNC:10683	N	.	simple_aae	0.029	.	112087895	ATC	0.994000	.	-	.	0.04166	.	.	.	Conflicting classifications of pathogenicity	0.06038	.	.	.	ClinGen:CA382616974	I	.	0.786847784675	-	0.381	-	0.06176	.	.	0.43682	0.309365063906	0.0626	.	0.74706428750991605	.	-	91A>G 	.	.	CN169374|C1708353|CN166604|C1847319|C0031511|C1868633|C0027672	.	.	.	.	NM_003002.4	-	.	.	0	0.19158	1865653068	.	.	0.78318	0.08227	0.085	1.0	.	0.92538464	4.81	.	.	.	-0.115264	0.00494223008028627	0.01134	T	.	.	.	-0.5465	0.76166	p.Ile31Val	.	.	-2.33	0.04787895	.	0.18766	860158	T	.	SDHD	.	T	0.476	.	I31V	T	.	0.03658	./.	principal1																																																																																																				
RAF1_Cys95Trp	2.1174108905084634	0.25563446626635816	-1.491000957661587	0.23274383192261294	2025_01_Batch_13-14	0.6617335274570856	0.805767475717292	0.7057777209753036	0.7165035141792934	0.6139034617369616	0.9055479247847438	0.8463627931994039	0.8141494462461819	0.9072275184425841	0.8097659020203224	0.7836407261209146	0.826065134458348	0.7599635836107428	0.8118655163109387	0.7118346818786421	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008910		NC_000003.12:12611985:G:C		Cys95Trp																												RAF1_Cys95Trp	3	12611985	G	C	3	allele	285C>G	A05	527_CAVA_Array_P05	A09	B13A7A8P2_R1	B14A7A8P2_R2				3-12611985-G-C	-	0.79021	1.0	95	.	.	.	3	12653484	C	.	.	3	1_Pathogenic	NC_000003.12	.	Cys95Trp	.	27.0	.	.	.	D	.	1	.	.	.	.	.	.	.	0.91849	.	0.5496	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.92491	.	.	.	.	0.79947	.	.	0.90329	0.993	.	.	.	3.37	.	C	single nucleotide variant	NC_000003.12:g.12611985G>C	.	.	2	0.8686348	.	.	0.87996113	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	.	.	.	.	0.94956	D	0.88581	D	M	7.102922	.	G/G	.	.	.	.	Noonan syndrome	.	0.84874	.	.	-	12611985	.	-	6.510000	.	0.79193	.	.	.	.	germline	.	Gain of MoRF binding (P = 0.0301)| Gain of sheet (P = 0.0827)| Gain of catalytic residue at C96 (P = 0.2212)| Loss of loop (P = 0.2897)| Loss of stability (P = 0.5099)	0.88343	GRCh38	637	criteria provided, single submitter	.	.	0.58959	.	.	.	Raf-like Ras-binding|Raf-like Ras-binding|Raf-like Ras-binding	.	.	.	.	.	NM_002880.4(RAF1):c.285C>G (p.Cys95Trp)	1	.	RAF1_HUMAN	.	.	0.698857312374925	.	.	0.94636	0.8894862	-	.	.		.	.	2	.	criteria_provided,_single_submitter	0.93882	.	.	.	.	.	.	.	0.55873	.	germline	.		G	Aug 11, 2014	.	G/G	.	.	1.0	N	3p25.2	.	.	.	SCV000200051	Likely_pathogenic	.	.	Trp	W	-	.	ENSP00000508763	ENST00000691899	.	.	.	.	0.676	G	.	4.838956	0.38356	D	.	-	7.33289	.	0.82326	.	.	.	0.86028	.	12611985	Y	10	.	.	.	P04049	.	0.903854	0.58002		.	0.996	D	.	0.8072368	.	0.69292	5894	0.365418	.	.	.	.	0.68399	.	.	.	.	.	.	0.92675	3	RAF1	.	.	Cys	.	.	3-12611985-G-C	Noonan_syndrome	.	.	12628484	ClinGen:CA273221	0.756013	0.79444	.	RCV000151719	.	.	.	c.285C>G	.	.	.	0.87570	G/G	rs727503384	12611985	.	G	.	P04049	.	0.89519	.	0.68239		.	.	.	2.485	.	.	.	4.71	0.98115	.	D	D	.	.	.	.	.	.	.	648	165011	0.87410	0.87009	0.994695365428925	.	.	0.71675	0.69429	.	.	.	3.451	.	.	.	.	.	.	PS163950	0.52821	3	.	ENSG00000132155	.	.	.	.	.	3	0.84488	0.64339	.	.	.	.	0.676399396255758	.	.	0.141331	173887	HGNC:9829	.	.	.	0.627	.	12611985	TGC	1.000000	.	-	.	0.89682	.	.	.	Likely pathogenic	0.74995	.	.	.	ClinGen:CA273221	C	.	.	-	0.754	-	0.79136	.	.	0.85122	0.869541406631	.	.	0.99282249625692609	.	-	285C>G 	.	.	C0028326	.	.	.	.	NM_002880.4	-	.	.	1	0.92203	727503384	.	.	0.87322	0.80484	.	.	.	0.95872940	5.77	.	.	.	0.287121	0.999741413090409	0.72164	D	.	.	.	0.1432	0.83427	p.Cys95Trp	.	.	-10.122	.	.	0.97751	165011	D	.	RAF1	.	D	.	.	C95W	.	0.61085	0.76753	G/G	principal3																																																																																																				
SDHD_Asp92Gly	8.432612836805006	0.00007012093234778765	-4.98932153593171	0.027997159194273955	2025_01_Batch_13-14	0.8382648617100562	0.9018121459491316	0.894444117072103	0.9084642845176677	0.7545022585795033	0.8028092439799366	0.8158381311538452	0.8258595362843585	0.7671661805653115	0.7578092573793094	0.8205370528449965	0.8588251385514885	0.8601518266782308	0.8378152325414896	0.7561557579794063	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023312		NC_000011.10:112088972:A:G		Asp92Gly																												SDHD_Asp92Gly	11	112088972	A	G	11	allele	275A>G	B12	527_CAVA_Array_P05	C23	B13A7A8P2_R1	B14A7A8P2_R2				11-112088972-A-G	-	0.8714	1.0	92	.	.	.	11	111959696	G	.	.	11	1_Pathogenic	NC_000011.10	.	Asp92Gly	.	29.1	.	.	.	D	.	2	1	.	.	.	.	.	.	0.99783	Select	0.9872	.	0.90580	.	.	D	D	.	0.852731849783	.	.	.	.	.	0.60780	.	.	.	.	0.92923	.	.	0.99812	0.964	.	2.0	0.842116	.	0.98	G	single nucleotide variant	NC_000011.10:g.112088972A>G	.	.	3	0.97202027	.	.	0.9904235	.		.	.	.	.	.	.	.	.	MedGen:C3532243|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167	.	.	.	.	0.97926	D	0.99484	D	H	9.938285	.	./.	.	.	.	.	Fatal infantile mitochondrial cardiomyopathy|Mitochondrial complex 2 deficiency, nuclear type 3	.	0.97405	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112088972	.	-	9.300000	.	0.99892	.	.	.	.	germline	.	Loss of stability (P = 0.0632)| Gain of glycosylation at S89 (P = 0.0743)| Gain of catalytic residue at D92 (P = 0.078)| Gain of helix (P = 0.2294)| Gain of disorder (P = 0.6219)	0.99581	GRCh38	637	no assertion criteria provided	c.275A>G	.	0.67250	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.275A>G (p.Asp92Gly)		.	DHSD_HUMAN	.	98.0	0.854382185558375	.	T	0.82539	0.99101526	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99259	.	.	.	.	.	p.Asp92Gly	.	0.79897	.	germline	.		A	May 26, 2015	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV000196921|SCV000240203	Pathogenic	.	.	Gly	G	-	.	ENSP00000364699	ENST00000375549	.	0.0	.	.	0.691	A	.	5.193893	0.92967	D	D	-	9.494944	.	0.98618	.	.	.	0.98567	.	112088972	Y	10	.	.	.	O14521	.	0.980289	0.94461		.	1.0	D	.	0.970635	.	0.52647	6392	0.583575	.	-6.8	.	.	0.91343	.	.	.	.	.	.	0.99543	11	SDHD	.	.	Asp	.	.	11-112088972-A-G	Fatal_infantile_mitochondrial_cardiomyopathy|Mitochondrial_complex_2_deficiency,_nuclear_type_3	.	.	111464906	ClinGen:CA016709|OMIM:602690.0031|UniProtKB:O14521#VAR_074106	0.957097	0.89298	.	RCV000171136|RCV000186596	D	.	.	c.275A>G	.	.	.	0.97037	./.	rs786205436	112088972	.	A	.	O14521	.	0.99782	.	0.68239		.	.	.	3.9	.	.	.	5.04	0.99837	.	D	T	.	.	.	.	.	.	.	.	180590	0.96988	0.68423	0.999705016613007	.	.	0.71675	0.97598	.	.	.	8.791	.	D	.	.	.	.	619167	0.91503	11	.	ENSG00000204370	.	.	.	.	0.9625151340225994	2	0.97365	0.64339	.	.	.	.	0.777690480254967	YES	.	0.822633	178768	HGNC:10683	A	.	simple_aae	0.997	.	112088972	GAC	1.000000	.	-	.	0.99798	.	.	.	Pathogenic	0.85423	.	.	.	ClinGen:CA016709,UniProtKB:O14521#VAR_074106,OMIM:602690.0031	D	.	0.981310432533	-	0.96	-	0.99987	.	.	0.96216	0.656035840511	0.8975	.	0.99866692114947953	.	-	275A>G 	.	.	C3532243|C5436934	.	.	.	.	NM_003002.4	-	.	.	1	0.51695	786205436	.	.	0.98091	0.88139	0.998	0.0	.	0.99926764	5.04	.	.	.	0.600488	0.993190100922059	0.96054	D	.	.	.	1.0131	0.99622	p.Asp92Gly	.	.	-12.11	0.99263144	.	0.89912	180590	D	.	SDHD	.	D	0.976	.	D92G	D	.	0.84104	./.	principal1																																																																																																				
FARS2_Ser57Cys	1.8559224483749528	1.0	-0.6872432004263447	0.3026614585100301	2025_01_Batch_13-14	0.6962621920646235	0.6479026046562409	0.6005724849895941	0.6904932126070964	0.5069699651989267	0.425384013948535	0.6189456711032676	0.6607529821067415	0.6095850052596933	0.436106404793524	0.5608231030065792	0.6334241378797543	0.6306627335481678	0.6500391089333948	0.47153818499622535	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011870		NC_000006.12:5368740:C:G		Ser57Cys																												FARS2_Ser57Cys	6	5368740	C	G	6	allele	170C>G	F12	527_CAVA_Array_P02	K24	B13A7A8P1_R1	B14A7A8P1_R2				6-5368740-C-G	-	0.47684	0.533	57	18	0	4	6	5368973	G	1.509190e-03	56	6	2_Benign	NC_000006.12	1902	Ser57Cys	0	22.5	0	93	2.470130e-02	T	24	4	1	42758	2.114520e-03	37	30524	0.000000e+00	1	0.23465	.	0.0532	14898	0.37784	105	9.92063492063492E-4	T	T	64040	0.193570370082	0.022058823529411766	24	0.000000e+00	0	4	0.32723	17106	44870	4	0.000000e+00	0.58763	9	.	0.40151	0.985	0.02798789712556732	96.0	.	3.61	0.04	G	single nucleotide variant	NC_000006.12:g.5368740C>G	0	16732	2	0.09419375	109370	0	0.19544396	0		520	236460	1	1	0.000000e+00	794	2.104870e-04	9	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	257	0	0.000000e+00	0	0.13669	B	0.22449	P	L	2.253606	2436	C/C	174	16	7160	1614106	not specified|Combined oxidative phosphorylation defect type 14|not provided	16210	0.24757	3	.	-	5368740	2.653630e-02	-	4.823000	397	0.80521	29604	0.0010438413361169101	75000	0	germline	91074	.	.	GRCh38	944	criteria provided, multiple submitters, no conflicts	c.170C>G	6.552220e-05	0.79660	140	0	0	.	0.000000e+00	9032	LB	0	0.000000e+00	NM_006567.5(FARS2):c.170C>G (p.Ser57Cys)	2	0	SYFM_HUMAN	0	4.0	-0.0754966821653467	96	.	0.06880	0.18928379	+	2.653630e-02	0		397	0.000000e+00	0	34248	criteria_provided,_multiple_submitters,_no_conflicts	0.76416	2.349820e-03	25	0.000000e+00	0	60010	p.Ser57Cys	1	0.45211	.	germline	190		C	Jan 30, 2025	2	C/C	5	89426	0.001	N	6p25.1	92548	.	2.449110e-02	SCV000251367|SCV000652839|SCV000845669|SCV005222705	Benign/Likely_benign	0	0	Cys	C	-	912	ENSP00000316335	ENST00000324331	17666	0.02	13386	4	0.599	C	0	3.426274	0.55281	N	D	-	2.430867	.	.	958	0	0.0	0.01650	0	5368740	Y	10	0.007556675062972292	102338	9.897720e-04	O95363	0	0.255173	0.37846		1	0.062	.	16210	0.09490794	7160	0.61072	10667	-0.4711	181	-2.77	0.0	2.536000e-02	0.49772	6.374300e-05	0	75000	0.000000e+00	6062	190	0.22246	6	FARS2	2.536000e-02	0	Ser	110348	2.012840e-04	6-5368740-C-G	not_specified|Combined_oxidative_phosphorylation_defect_type_14	0	19	5313972	ClinGen:CA320525|UniProtKB:O95363#VAR_052642	0.207729	0.38198	0	RCV000196113|RCV000539812|RCV004705026	T	0	0	c.170C>G	0	0	0	0.00788	C/C	rs34382405	5368740	14898	C	0.008186900958466454	.	15688	0.41017	0.000000e+00	0.68239		0	0	0.000000e+00	1.625	0.05172413793103448	15	264690	5.45	0.62383	3332	T	T	368	3.146300e-03	6	656	.	5	0	319519	214327	0.29590	0.21414	0.0278036979532336	4390	41	0.13799	0.33177	3.065870e-03	2.449110e-02	1180024	1.388	2.500750e-03	D	13392	5	0.008719634	0	614946	0.34154	6	2.470130e-02	ENSG00000145982	0.000000e+00	1.620780567921511E-4	2	0	0.6181731990165388	2	0.26932	0.12756	30606	2308	1.856590e-04	3.549410e-03	0.0205336924994149	.	4.392030e-05	.	211248	HGNC:21062	N	0	simple_aae	0.65	207938	5368740	TCC	1.000000	1	-	0.023234624145785875	0.00155	1.533870e-04	102	0	Benign/Likely benign	0.63900	1	6	213	ClinGen:CA320525,UniProtKB:O95363#VAR_052642	S	0	0.650100694605	-	.	-	0.47612	500	8052	0.61574	0.456006199121	0.0774	0	0.98028766321917793	274	-	170C>G 	368	0.001987083954297069	CN169374|C4755312	0	0	0	0	NM_006567.5	-	0	0.004322766570605188	0	0.50927	34382405	2320	0.001268713524486171	0.64445	0.40378	0.439	0.028	4216	0.28674290	5.45	.	.	6.534670e-05	-0.429882	0.305673527694043	0.41446	T	2676	6208	9554	-1.0166	0.22381	p.Ser57Cys	0	0	-8.409	0.0069410205	1902	0.54432	214327	D	30512	FARS2	3.273710e-03	T	0.081	21626	.	D	0.66044	0.40292	C/C	principal1																																																																																																				
FARS2_Ser57Cys	1.8559224483749528	1.0	-0.6872432004263447	0.3026614585100301	2025_01_Batch_13-14	0.6962621920646235	0.6479026046562409	0.6005724849895941	0.6904932126070964	0.5069699651989267	0.425384013948535	0.6189456711032676	0.6607529821067415	0.6095850052596933	0.436106404793524	0.5608231030065792	0.6334241378797543	0.6306627335481678	0.6500391089333948	0.47153818499622535	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2				CCSBVarC011870	ALE00009031	NC_000006.12:5368740:C:G	170C>G	Ser57Cys	CAVA																											FARS2_Ser57Cys	6	5368740	C	G	6								1	1	1	6-5368740-C-G	-	0.47684	0.533	57	18	0	4	6	5368973	G	1.509190e-03	56	6	2_Benign	NC_000006.12	1902	Ser57Cys	0	22.5	0	93	2.470130e-02	T	24	4	1	42758	2.114520e-03	37	30524	0.000000e+00	1	0.23465	.	0.0532	14898	0.37784	105	9.92063492063492E-4	T	T	64040	0.193570370082	0.022058823529411766	24	0.000000e+00	0	4	0.32723	17106	44870	4	0.000000e+00	0.58763	9	.	0.40151	0.985	0.02798789712556732	96.0	.	3.61	0.04	G	single nucleotide variant	NC_000006.12:g.5368740C>G	0	16732	2	0.09419375	109370	0	0.19544396	0		520	236460	1	1	0.000000e+00	794	2.104870e-04	9	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	257	0	0.000000e+00	0	0.13669	B	0.22449	P	L	2.253606	2436	C/C	174	16	7160	1614106	not specified|Combined oxidative phosphorylation defect type 14|not provided	16210	0.24757	3	.	-	5368740	2.653630e-02	-	4.823000	397	0.80521	29604	0.0010438413361169101	75000	0	germline	91074	.	.	GRCh38	944	criteria provided, multiple submitters, no conflicts	c.170C>G	6.552220e-05	0.79660	140	0	0	.	0.000000e+00	9032	LB	0	0.000000e+00	NM_006567.5(FARS2):c.170C>G (p.Ser57Cys)	2	0	SYFM_HUMAN	0	4.0	-0.0754966821653467	96	.	0.06880	0.18928379	+	2.653630e-02	0		397	0.000000e+00	0	34248	criteria_provided,_multiple_submitters,_no_conflicts	0.76416	2.349820e-03	25	0.000000e+00	0	60010	p.Ser57Cys	1	0.45211	.	germline	190		C	Jan 30, 2025	2	C/C	5	89426	0.001	N	6p25.1	92548	.	2.449110e-02	SCV000251367|SCV000652839|SCV000845669|SCV005222705	Benign/Likely_benign	0	0	Cys	C	-	912	ENSP00000316335	ENST00000324331	17666	0.02	13386	4	0.599	C	0	3.426274	0.55281	N	D	-	2.430867	.	.	958	0	0.0	0.01650	0	5368740	Y	10	0.007556675062972292	102338	9.897720e-04	O95363	0	0.255173	0.37846		1	0.062	.	16210	0.09490794	7160	0.61072	10667	-0.4711	181	-2.77	0.0	2.536000e-02	0.49772	6.374300e-05	0	75000	0.000000e+00	6062	190	0.22246	6	FARS2	2.536000e-02	0	Ser	110348	2.012840e-04	6-5368740-C-G	not_specified|Combined_oxidative_phosphorylation_defect_type_14	0	19	5313972	ClinGen:CA320525|UniProtKB:O95363#VAR_052642	0.207729	0.38198	0	RCV000196113|RCV000539812|RCV004705026	T	0	0	c.170C>G	0	0	0	0.00788	C/C	rs34382405	5368740	14898	C	0.008186900958466454	.	15688	0.41017	0.000000e+00	0.68239		0	0	0.000000e+00	1.625	0.05172413793103448	15	264690	5.45	0.62383	3332	T	T	368	3.146300e-03	6	656	.	5	0	319519	214327	0.29590	0.21414	0.0278036979532336	4390	41	0.13799	0.33177	3.065870e-03	2.449110e-02	1180024	1.388	2.500750e-03	D	13392	5	0.008719634	0	614946	0.34154	6	2.470130e-02	ENSG00000145982	0.000000e+00	1.620780567921511E-4	2	0	0.6181731990165388	2	0.26932	0.12756	30606	2308	1.856590e-04	3.549410e-03	0.0205336924994149	.	4.392030e-05	.	211248	HGNC:21062	N	0	simple_aae	0.65	207938	5368740	TCC	1.000000	1	-	0.023234624145785875	0.00155	1.533870e-04	102	0	Benign/Likely benign	0.63900	1	6	213	ClinGen:CA320525,UniProtKB:O95363#VAR_052642	S	0	0.650100694605	-	.	-	0.47612	500	8052	0.61574	0.456006199121	0.0774	0	0.98028766321917793	274	-	170C>G 	368	0.001987083954297069	CN169374|C4755312	0	0	0	0	NM_006567.5	-	0	0.004322766570605188	0	0.50927	34382405	2320	0.001268713524486171	0.64445	0.40378	0.439	0.028	4216	0.28674290	5.45	.	.	6.534670e-05	-0.429882	0.305673527694043	0.41446	T	2676	6208	9554	-1.0166	0.22381	p.Ser57Cys	0	0	-8.409	0.0069410205	1902	0.54432	214327	D	30512	FARS2	3.273710e-03	T	0.081	21626	.	D	0.66044	0.40292	C/C	principal1																																																																																																				
RAF1_Asn140His	-0.04961800914186328	1.0	-0.26453384717819656	0.3404418495924471	2025_01_Batch_13-14	0.8768500439669253	0.8008637628205076	0.7526688883548288	0.8566458710111035	0.7498309272648557	0.7498700589060515	0.7908219336296483	0.7561533297498351	0.7553379890980602	0.6702817161096603	0.8133600514364885	0.7958428482250779	0.754411109052332	0.8059919300545818	0.710056321687258	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008912		NC_000003.12:12609238:T:G		Asn140His																												RAF1_Asn140His	3	12609238	T	G	3	allele	418A>C	B05	527_CAVA_Array_P05	C09	B13A7A8P2_R1	B14A7A8P2_R2				3-12609238-T-G	-	0.82606	1.0	140	.	.	.	3	12650737	G	.	.	3	1_Pathogenic	NC_000003.12	.	Asn140His	.	27.8	.	.	.	D	.	1	.	.	.	.	.	.	.	0.92184	.	0.8467	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.91719	.	.	.	.	0.72035	.	.	0.83820	0.998	.	.	.	5.35	.	G	single nucleotide variant	NC_000003.12:g.12609238T>G	.	.	2	0.7257919	.	.	0.7594829	.		.	.	.	.	.	.	.	.	MedGen:CN517202	.	.	.	.	0.76851	D	0.88218	D	L	7.773029	.	T/T	.	.	.	.	not provided	.	0.95294	.	.	-	12609238	.	-	7.876000	.	0.99076	.	.	.	.	germline	.	Loss of loop (P = 0.0374)| Loss of glycosylation at T138 (P = 0.0472)| Loss of catalytic residue at N140 (P = 0.0473)| Gain of sheet (P = 0.1208)| Gain of methylation at K144 (P = 0.1389)	0.60104	GRCh38	646	criteria provided, single submitter	.	.	0.93363	.	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	.	.	.	.	.	NM_002880.4(RAF1):c.418A>C (p.Asn140His)	1	.	RAF1_HUMAN	.	.	0.743491548643859	.	.	0.80100	0.8018196	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.93084	.	.	.	.	.	.	.	0.72273	.	germline	.		T	Oct 03, 2012	.	T/T	.	.	1.0	N	3p25.2	.	.	.	SCV000209037	Likely_pathogenic	.	.	His	H	-	.	ENSP00000508763	ENST00000691899	.	.	.	.	0.665	T	.	4.983822	0.50294	D	.	-	8.114436	.	0.94918	.	.	.	0.68540	.	12609238	Y	10	.	.	.	P04049	.	0.90447	0.71556		.	0.994	D	.	0.8015472	.	0.85369	5894	0.19048	.	.	.	.	0.72322	.	.	.	.	.	.	0.83611	3	RAF1	.	.	Asn	.	.	3-12609238-T-G	not_provided	.	.	12625737	ClinGen:CA297148	0.925488	0.82383	.	RCV000159094	.	.	.	c.418A>C	.	.	.	0.72806	T/T	rs730881009	12609238	.	T	.	P04049	.	0.81195	.	0.68239		.	.	.	1.78	.	.	.	5.84	0.98131	.	D	D	.	.	.	.	.	.	.	.	40590	0.72452	0.84295	0.969879031181335	.	.	0.71675	0.90478	.	.	.	8.012	.	.	.	.	.	.	.	0.88241	3	.	ENSG00000132155	.	.	.	.	.	1	0.82066	0.63408	.	.	.	.	0.718547825165139	.	.	0.486445	49060	HGNC:9829	.	.	.	0.975	.	12609238	AAC	1.000000	.	-	.	0.81918	.	.	.	Likely pathogenic	0.76444	.	.	.	ClinGen:CA297148	N	.	.	-	0.507	-	0.89342	.	.	0.78656	0.864215731621	.	.	0.99556719294456497	.	-	418A>C 	.	.	CN517202	.	.	.	.	NM_002880.4	-	.	.	1	0.92893	730881009	.	.	0.93906	0.83700	.	.	.	0.94453880	5.84	.	.	.	0.0358342	0.999536362008549	0.46014	D	.	.	.	0.8725	0.94874	p.Asn140His	.	.	-10.417	.	.	0.96903	40590	D	.	RAF1	.	D	.	.	N140H	.	0.93259	0.62996	T/T	principal3																																																																																																				
FARS2_His135Asp	2.635252319289227	1.0	-1.036882426271927	0.43180530628013897	2025_01_Batch_13-14	0.785308606661879	0.6754433308184951	0.664676040723288	0.8122260731565495	0.569307399872398	0.6404895598553312	0.6260270377742088	0.6013170955941902	0.6686704150526575	0.5496618618560352	0.7128990832586051	0.6507351842963519	0.6329965681587391	0.7404482441046034	0.5594846308642165	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011938		NC_000006.12:5368973:C:G		His135Asp																												FARS2_His135Asp	6	5368973	C	G	6	allele	403C>G	H12	527_CAVA_Array_P02	O24	B13A7A8P1_R1	B14A7A8P1_R2				6-5368973-C-G	-	0.80679	1.0	135	.	.	.	6	5369206	G	.	.	6	1_Pathogenic	NC_000006.12	.	His135Asp	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.96531	.	0.6251	.	0.90580	.	.	D	D	.	0.789096686981	.	.	.	.	.	0.58343	.	.	.	.	0.97166	.	.	0.95023	0.67	.	0.0	.	.	1.0	G	single nucleotide variant	NC_000006.12:g.5368973C>G	.	.	2	0.92687786	.	.	0.9517225	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	.	.	.	.	0.99291	D	0.97160	D	H	14.10817	.	C/C	.	.	.	.	Combined oxidative phosphorylation defect type 14	.	0.90933	.	.	-	5368973	.	-	7.594000	.	0.99209	.	.	.	.	germline	.	Gain of ubiquitination at K140 (P = 0.0395)| Gain of methylation at K140 (P = 0.0835)| Gain of phosphorylation at S137 (P = 0.1076)| Gain of disorder (P = 0.1088)| Gain of relative solvent accessibility (P = 0.1571)	0.98259	GRCh38	944	criteria provided, single submitter	c.403C>G	.	0.77246	.	.	.	Phenylalanyl-tRNA synthetase	.	.	LP	.	.	NM_006567.5(FARS2):c.403C>G (p.His135Asp)	1	.	SYFM_HUMAN	.	100.0	1.00590361464167	.	.	0.85478	0.93853235	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.95060	.	.	.	.	.	p.His135Asp	.	0.61402	.	germline	.		C	Jun 13, 2018	.	C/C	.	.	1.0	N	6p25.1	.	.	.	SCV000845706	Likely_pathogenic	.	.	Asp	D	-	.	ENSP00000316335	ENST00000324331	.	0.0	.	.	0.599	C	.	4.904405	0.92967	D	D	-	13.71825	.	0.92777	.	.	.	0.98192	.	5368973	Y	10	.	.	.	O95363	.	0.608311	0.62166		.	1.0	D	.	0.93154466	.	0.33292	10667	0.392218	.	-8.41	.	.	0.91343	.	.	.	.	.	.	0.96834	6	FARS2	.	.	His	.	.	6-5368973-C-G	Combined_oxidative_phosphorylation_defect_type_14	.	.	5314205	.	0.882442	0.95901	.	RCV000714939	D	.	.	c.403C>G	.	.	.	0.89385	C/C	rs1554169353	5368973	.	C	.	O95363	.	0.96384	.	0.68239		.	.	.	4.485	.	.	.	5.38	0.87433	.	D	T	.	.	.	.	.	.	.	319519	214339	0.89250	0.65457	0.999627828598022	.	.	0.71675	0.80986	.	.	.	7.564	.	D	.	.	.	.	614946	0.81354	6	.	ENSG00000145982	.	.	.	.	0.9676189548153906	1	0.97365	0.12756	.	.	.	.	0.89920352941961	.	.	0.373027	211250	HGNC:21062	A	.	simple_aae	0.978	.	5368973	CAC	1.000000	.	-	.	0.99321	.	.	.	Likely pathogenic	0.68288	.	.	.	ClinGen:CA321889	H	.	0.967068046118	-	0.912	-	0.96886	.	.	0.96731	0.638907074928	0.9357	.	0.99386437466063282	.	-	403C>G 	.	.	C4755312	.	.	.	.	NM_006567.5	-	.	.	1	0.69489	1554169353	.	.	0.96641	0.95512	0.959	0.0	.	0.97500426	5.38	.	.	.	0.325617	0.999854978671078	0.98910	D	.	.	.	0.5303	0.86770	p.His135Asp	.	.	-9.08	0.9888847	.	0.98365	214339	D	.	FARS2	.	D	0.882	.	H135D	D	.	0.40292	C/C	principal1																																																																																																				
FARS2_His135Asp	2.635252319289227	1.0	-1.036882426271927	0.43180530628013897	2025_01_Batch_13-14	0.785308606661879	0.6754433308184951	0.664676040723288	0.8122260731565495	0.569307399872398	0.6404895598553312	0.6260270377742088	0.6013170955941902	0.6686704150526575	0.5496618618560352	0.7128990832586051	0.6507351842963519	0.6329965681587391	0.7404482441046034	0.5594846308642165	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2				CCSBVarC011938	ALE00012867	NC_000006.12:5368973:C:G	403C>G	His135Asp	CAVA																											FARS2_His135Asp	6	5368973	C	G	6								1	1	1	6-5368973-C-G	-	0.80679	1.0	135	.	.	.	6	5369206	G	.	.	6	1_Pathogenic	NC_000006.12	.	His135Asp	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.96531	.	0.6251	.	0.90580	.	.	D	D	.	0.789096686981	.	.	.	.	.	0.58343	.	.	.	.	0.97166	.	.	0.95023	0.67	.	0.0	.	.	1.0	G	single nucleotide variant	NC_000006.12:g.5368973C>G	.	.	2	0.92687786	.	.	0.9517225	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	.	.	.	.	0.99291	D	0.97160	D	H	14.10817	.	C/C	.	.	.	.	Combined oxidative phosphorylation defect type 14	.	0.90933	.	.	-	5368973	.	-	7.594000	.	0.99209	.	.	.	.	germline	.	Gain of ubiquitination at K140 (P = 0.0395)| Gain of methylation at K140 (P = 0.0835)| Gain of phosphorylation at S137 (P = 0.1076)| Gain of disorder (P = 0.1088)| Gain of relative solvent accessibility (P = 0.1571)	0.98259	GRCh38	944	criteria provided, single submitter	c.403C>G	.	0.77246	.	.	.	Phenylalanyl-tRNA synthetase	.	.	LP	.	.	NM_006567.5(FARS2):c.403C>G (p.His135Asp)	1	.	SYFM_HUMAN	.	100.0	1.00590361464167	.	.	0.85478	0.93853235	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.95060	.	.	.	.	.	p.His135Asp	.	0.61402	.	germline	.		C	Jun 13, 2018	.	C/C	.	.	1.0	N	6p25.1	.	.	.	SCV000845706	Likely_pathogenic	.	.	Asp	D	-	.	ENSP00000316335	ENST00000324331	.	0.0	.	.	0.599	C	.	4.904405	0.92967	D	D	-	13.71825	.	0.92777	.	.	.	0.98192	.	5368973	Y	10	.	.	.	O95363	.	0.608311	0.62166		.	1.0	D	.	0.93154466	.	0.33292	10667	0.392218	.	-8.41	.	.	0.91343	.	.	.	.	.	.	0.96834	6	FARS2	.	.	His	.	.	6-5368973-C-G	Combined_oxidative_phosphorylation_defect_type_14	.	.	5314205	.	0.882442	0.95901	.	RCV000714939	D	.	.	c.403C>G	.	.	.	0.89385	C/C	rs1554169353	5368973	.	C	.	O95363	.	0.96384	.	0.68239		.	.	.	4.485	.	.	.	5.38	0.87433	.	D	T	.	.	.	.	.	.	.	319519	214339	0.89250	0.65457	0.999627828598022	.	.	0.71675	0.80986	.	.	.	7.564	.	D	.	.	.	.	614946	0.81354	6	.	ENSG00000145982	.	.	.	.	0.9676189548153906	1	0.97365	0.12756	.	.	.	.	0.89920352941961	.	.	0.373027	211250	HGNC:21062	A	.	simple_aae	0.978	.	5368973	CAC	1.000000	.	-	.	0.99321	.	.	.	Likely pathogenic	0.68288	.	.	.	ClinGen:CA321889	H	.	0.967068046118	-	0.912	-	0.96886	.	.	0.96731	0.638907074928	0.9357	.	0.99386437466063282	.	-	403C>G 	.	.	C4755312	.	.	.	.	NM_006567.5	-	.	.	1	0.69489	1554169353	.	.	0.96641	0.95512	0.959	0.0	.	0.97500426	5.38	.	.	.	0.325617	0.999854978671078	0.98910	D	.	.	.	0.5303	0.86770	p.His135Asp	.	.	-9.08	0.9888847	.	0.98365	214339	D	.	FARS2	.	D	0.882	.	H135D	D	.	0.40292	C/C	principal1																																																																																																				
RAF1_Leu603Pro	-1.790881684197182	1.0	-2.761223855400645	0.028913933298763714	2025_01_Batch_13-14	0.8072334686400157	0.9398959418348838	0.9632003901983831	0.9276792657133388	0.8371185622746348	0.7472667962186552	0.9145242728294307	0.9377890502524259	0.9052702480327363	0.7247164039514323	0.7772501324293355	0.9272101073321573	0.9504947202254045	0.9164747568730376	0.7809174831130336	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008861		NC_000003.12:12584653:A:G		Leu603Pro																												RAF1_Leu603Pro	3	12584653	A	G	3	allele	1808T>C	E04	527_CAVA_Array_P05	I07	B13A7A8P2_R1	B14A7A8P2_R2				3-12584653-A-G	-	0.84452	1.0	603	.	.	.	3	12626152	G	.	.	3	1_Pathogenic	NC_000003.12	.	Leu603Pro	.	28.3	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99942	Select	0.9820	.	0.90580	.	.	D	D	.	1.08258798955	.	.	.	.	.	0.94825	.	.	.	.	0.89120	.	.	0.99776	0.998	.	1.0	.	.	0.99	G	single nucleotide variant	NC_000003.12:g.12584653A>G	.	.	1	0.98532397	.	.	0.99187005	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014396,MedGen:C4014656,OMIM:615916,Orphanet:154	.	.	.	.	0.97926	D	0.99940	D	M	11.45292	.	A/A	.	.	.	.	Dilated cardiomyopathy 1NN	.	0.98251	.	.	-	12584653	.	-	11.190000	.	0.99559	.	.	.	.	germline	.	Gain of disorder (P = 0.017)| Gain of helix (P = 0.0325)| Gain of glycosylation at S604 (P = 0.0488)| Loss of loop (P = 0.0804)| Loss of stability (P = 0.1069)	0.91245	GRCh38	692	no assertion criteria provided	c.1808T>C	.	0.81744	.	.	.	Protein kinase domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_002880.4(RAF1):c.1808T>C (p.Leu603Pro)		.	RAF1_HUMAN	.	99.0	0.915325109665532	.	.	0.98761	0.9903099	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.99072	.	.	.	.	.	p.Leu603Pro	.	0.88645	.	germline	.		A	Jun 01, 2014	.	A/A	.	.	1.0	N	3p25.2	.	.	.	SCV000186308	Pathogenic	.	.	Pro	P	-	.	ENSP00000251849	ENST00000251849	.	0.001	.	.	0.756	A	.	5.064217	0.72530	D	D	-	12.28152	.	0.99287	.	.	.	0.96363	.	12584653	Y	10	.	.	.	P04049	.	0.932912	0.98168		.	0.999	D	.	0.9862118	.	0.85369	5894	0.575938	.	-5.94	.	.	0.78662	.	.	.	.	.	.	0.99928	3	RAF1	.	.	Leu	.	.	3-12584653-A-G	Dilated_cardiomyopathy_1NN	.	.	12601152	ClinGen:CA167980|OMIM:164760.0005|UniProtKB:P04049#VAR_071847	0.956235	0.92448	.	RCV000131334	D	.	.	c.1808T>C	.	.	.	0.96897	A/A	rs587777586	12584653	.	A	.	P04049	.	0.99851	.	0.68239		.	.	.	3.055	.	.	.	5.51	0.98867	.	D	D	.	.	.	.	.	.	.	154	142296	0.96846	0.77046	0.999162554740906	.	.	0.71675	0.97455	.	.	.	8.809	.	D	.	.	.	.	615916	0.91585	3	.	ENSG00000132155	.	.	.	.	.	2	0.92348	0.58673	.	.	.	.	0.863677081222081	YES	.	0.905219	152010	HGNC:9829	A	.	simple_aae	0.987	.	12584653	CTG	1.000000	.	-	.	0.94850	.	.	.	Pathogenic	0.90541	.	.	.	ClinGen:CA167980,UniProtKB:P04049#VAR_071847,OMIM:164760.0005	L	.	0.973766025508	-	0.791	-	0.97221	.	.	0.95923	0.886617004871	0.9993	.	0.99912388320110823	.	-	1808T>C 	.	.	C4014656	.	.	.	.	NM_002880.4	-	.	.	1	0.93270	587777586	.	.	0.97323	0.93754	0.954	0.006	.	0.99897957	5.51	.	.	.	0.589519	0.999902317115662	0.86694	D	.	.	.	1.0563	0.99448	p.Leu603Pro	.	.	-13.29	0.9554792	.	0.98723	142296	D	.	RAF1	.	D	0.986	.	L603P	D	.	0.943	A/A	principal3																																																																																																				
SDHD_Leu107Pro	0.2849529271708783	1.0	-2.0252207164999985	0.430332648190944	2025_01_Batch_13-14	0.8333986418202682	0.8569743213124418	0.8474656162013808	0.8993651620405937	0.7837756991153474	0.8327255249968093	0.821351088417951	0.8226978236124418	0.8458497429542634	0.7879415508181176	0.8330620834085387	0.8391627048651964	0.8350817199069114	0.8726074524974285	0.7858586249667325	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023335		NC_000011.10:112094810:T:C		Leu107Pro																												SDHD_Leu107Pro	11	112094810	T	C	11	allele	320T>C	G12	527_CAVA_Array_P05	M23	B13A7A8P2_R1	B14A7A8P2_R2				11-112094810-T-C	-	0.74806	0.989	107	.	.	.	11	111965534	C	.	.	11	1_Pathogenic	NC_000011.10	.	Leu107Pro	.	26.2	.	.	.	D	.	1	1	.	.	.	.	.	.	0.97963	Select	0.9673	.	0.62839	.	.	D	D	.	0.939674812069	.	.	.	.	.	0.33914	.	.	.	.	0.82724	.	.	0.96731	0.999	.	4.0	0.839116	.	0.96	C	single nucleotide variant	NC_000011.10:g.112094810T>C	.	.	2	0.9385074	.	.	0.9550924	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	.	.	0.95575	D	0.97635	D	.	8.434356	.	./.	.	.	.	.	Hereditary cancer-predisposing syndrome	.	0.99459	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094810	.	-	7.854000	.	0.99793	.	.	.	.	germline	.	Loss of stability (P = 0.0278)| Gain of sheet (P = 0.039)| Loss of helix (P = 0.079)| Loss of catalytic residue at L107 (P = 0.0817)| Gain of loop (P = 0.0851)	0.80417	GRCh38	638	criteria provided, single submitter	c.320T>C	.	0.54956	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.320T>C (p.Leu107Pro)	1	.	DHSD_HUMAN	.	96.0	0.781789244315126	.	T	0.78811	0.9550924	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99325	.	.	.	.	.	p.Leu107Pro	.	0.71149	.	germline	.		T	May 30, 2024	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV002609368	Likely_pathogenic	.	.	Pro	P	-	.	ENSP00000364699	ENST00000375549	.	0.002	.	.	0.661	T	.	4.675112	0.74454	D	D	-	7.934285	.	0.96886	.	.	.	0.74730	.	112094810	Y	10	.	.	.	O14521	.	0.966942	0.96515		.	0.926	D	.	0.9385074	.	0.91597	6392	0.510562	.	-5.05	.	.	0.72322	.	.	.	.	.	.	0.97635	11	SDHD	.	.	Leu	.	.	11-112094810-T-C	Hereditary_cancer-predisposing_syndrome	.	.	111470744	.	0.966134	0.84870	.	RCV002324587	D	.	.	c.320T>C	.	.	.	0.94567	./.	.	112094810	.	T	.	O14521	.	0.96731	.	0.68239		.	.	.	.	.	.	.	4.53	0.99610	.	D	T	.	.	.	.	.	.	.	140162	1728924	0.94487	0.72002	0.983124061519632	.	.	0.71675	0.98849	.	.	.	7.682	.	D	.	.	.	.	.	0.8343	11	.	ENSG00000204370	.	.	.	.	0.9866521081126458	2	0.66089	0.64247	.	.	.	.	0.709516226177353	YES	.	0.636512	1785214	HGNC:10683	D	.	simple_aae	0.994	.	112094810	CTT	1.000000	.	-	.	0.90660	.	.	.	Likely pathogenic	0.94089	.	.	.	ClinGen:CA382618744	L	.	0.93826696464	-	0.667	-	0.81497	.	.	0.98654	0.464732289314	0.8325	.	0.99891369030107691	.	-	320T>C 	.	.	C0027672	.	.	.	.	NM_003002.4	-	.	.	1	0.51220	-1	.	.	0.93714	0.83010	0.769	0.006	.	0.99935895	4.53	.	.	.	0.49561	0.995669802072404	.	D	.	.	.	1.0953	0.98959	p.Leu107Pro	.	.	-14.207	0.91400754	.	0.91503	1728924	D	.	SDHD	.	D	0.920	.	L107P	D	.	0.55789	./.	principal1																																																																																																				
FARS2_Ile388Ser	1.0162955675066876	1.0	-4.23530096770175	0.007658698829097526	2025_01_Batch_13-14	0.6256694420392738	0.7512853222117405	0.8307693779158166	0.7678373906321424	0.6186307284129027	0.44602811759794925	0.7229202849838836	0.8613571204353483	0.7762661569413991	0.43800721167840495	0.5358487798186116	0.737102803597812	0.8460632491755824	0.7720517737867707	0.5283189700456539	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011922		NC_000006.12:5613266:T:G		Ile388Ser																												FARS2_Ile388Ser	6	5613266	T	G	6	allele	1163T>G	D12	527_CAVA_Array_P02	G24	B13A7A8P1_R1	B14A7A8P1_R2				6-5613266-T-G	-	0.79869	0.714	388	.	.	.	6	5613499	G	.	.	6	1_Pathogenic	NC_000006.12	.	Ile388Ser	.	27.2	.	.	.	T	.	1	1	.	.	.	.	.	.	0.78922	Select	0.2675	.	0.42184	.	.	D	D	.	.	.	.	.	.	.	0.12779	.	.	.	.	0.82015	.	.	0.84016	0.903	.	.	0.978802	3.23	.	G	single nucleotide variant	NC_000006.12:g.5613266T>G	.	.	2	0.7604622	.	.	0.7625783	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	.	.	.	.	.	B	0.88169	P	M	4.392269	.	T/T	.	.	.	.	Combined oxidative phosphorylation defect type 14	.	0.70810	.	.	-	5613266	.	-	6.134000	.	0.99166	.	.	.	.	germline	.	Loss of stability (P = 0.0161)| Gain of disorder (P = 0.0363)| Gain of glycosylation at I388 (P = 0.0591)| Gain of helix (P = 0.0854)| Gain of relative solvent accessibility (P = 0.09)	0.67707	GRCh38	976	criteria provided, single submitter	c.1163T>G	.	0.82506	.	.	.	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	.	.	B	.	.	NM_006567.5(FARS2):c.1163T>G (p.Ile388Ser)	1	.	SYFM_HUMAN	.	.	0.407863502934099	.	D	0.49112	0.80483794	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.89259	.	.	.	.	.	p.Ile388Ser	.	0.54028	.	germline	.		T	Nov 15, 2017	.	T/T	.	.	0.997	N	6p25.1	.	.	.	SCV000680228	Likely_pathogenic	.	.	Ser	S	-	.	ENSP00000274680	ENST00000274680	.	0.002	.	.	0.665	T	.	4.872277	0.79703	D	D	-	4.833016	.	0.64640	.	.	.	0.72507	.	5613266	Y	10	.	.	.	O95363	.	0.571252	0.56442		.	0.367	D	.	0.80076313	.	0.43926	10667	0.0869603	.	-4.96	.	.	0.72322	.	.	.	.	.	.	0.85673	6	FARS2	.	.	Ile	.	.	6-5613266-T-G	Combined_oxidative_phosphorylation_defect_type_14	.	.	5558498	ClinGen:CA362736964	0.866864	0.61656	.	RCV000578458	D	.	.	c.1163T>G	.	.	.	0.62581	T/T	rs1407198979	5613266	.	T	.	O95363	.	0.81381	.	0.30284		.	.	.	2.125	.	.	.	5.53	0.85676	.	D	T	.	.	.	.	.	.	.	319519	488516	0.62116	0.44430	0.979173302650452	.	.	0.40243	0.78564	.	.	.	7.299	.	D	.	.	.	.	614946	0.78213	6	.	ENSG00000145982	.	.	.	.	.	2	0.43429	0.04721	.	.	.	.	0.462304649405172	YES	.	0.051707	481384	HGNC:21062	.	.	.	0.977	.	5613266	ATT	0.978000	.	-	.	0.81483	.	.	.	Likely pathogenic	0.90970	.	.	.	ClinGen:CA362736964	I	.	0.935486347505	-	0.559	-	0.83632	.	.	0.78077	0.315835446119	0.2564	.	0.99235441243343336	.	-	1163T>G 	.	.	C4755312	.	.	.	.	NM_006567.5	-	.	.	1	0.92613	1407198979	.	.	0.93431	0.65325	0.84	0.002	.	0.83609140	5.53	.	.	.	-0.112864	0.980686339579557	0.58867	T	.	.	.	-0.4338	0.63745	p.Ile388Ser	.	.	-13.402	0.8248781	.	0.85480	488516	D	.	FARS2	.	T	0.511	.	I388S	D	0.58548	0.62996	T/T	principal1																																																																																																				
BRIP1_Thr266Lys	2.4151939589858755	0.10172105859617687	-2.8097461543970716	0.1251885088372282	2025_01_Batch_13-14	0.7205994418325683	0.9278881751694511	0.9779481071676986	0.9367839182156471	0.9552154710492178	0.7507343851230628	0.90745197332534	0.9776304937469608	0.9504104860230399	0.9607925001991933	0.7356669134778155	0.9176700742473956	0.9777893004573297	0.9435972021193435	0.9580039856242055	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	BRIP1	BRIP1		55128		CCSBVarC031356		NC_000017.11:61808588:G:T		Thr266Lys																												BRIP1_Thr266Lys	17	61808588	G	T	17	allele	797C>A	C01	527_CAVA_Array_P02	E02	B13A7A8P1_R1	B14A7A8P1_R2				17-61808588-G-T	-	0.77458	1.0	266	.	.	.	17	59885949	T	.	.	17	1_Pathogenic	NC_000017.11	.	Thr266Lys	.	26.7	.	.	.	D	.	1	.	.	.	.	.	.	.	0.94975	.	0.6264	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.53597	.	.	.	.	0.85874	.	.	0.93728	0.878	.	.	0.90121	.	.	T	single nucleotide variant	NC_000017.11:g.61808588G>T	.	.	2	0.89155954	.	.	0.92582095	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0008170,MedGen:C1140680,OMIM:167000,Orphanet:213500	.	.	.	.	.	D	0.94301	D	H	11.84782	.	G/G	.	.	.	.	Ovarian cancer	.	0.89196	.	.	-	61808588	.	-	11.864000	.	0.87099	.	.	.	.	germline	.	Gain of MoRF binding (P = 0.0353)| Loss of phosphorylation at T266 (P = 0.0447)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1066)| Loss of glycosylation at S269 (P = 0.1314)	0.81610	GRCh38	46	criteria provided, single submitter	.	.	0.74394	.	.	.	.	.	.	.	.	.	NM_032043.3(BRIP1):c.797C>A (p.Thr266Lys)	1	.	FANCJ_HUMAN	.	.	0.929815744903823	.	D	0.87809	0.92582095	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.95833	.	.	.	.	.	.	.	0.98400	.	germline	.		G	Jan 01, 2022	.	G/G	.	.	1.0	N	17q23.2	.	.	.	SCV003843811	Likely_pathogenic	.	.	Lys	K	-	.	ENSP00000506943	ENST00000682453	.	.	.	.	0.618	G	.	4.777777	0.74454	D	.	-	12.64629	.	0.90215	.	.	.	0.97739	.	61808588	Y	9	.	.	.	Q9BX63	.	0.789212	0.60794		.	1.0	D	.	0.89155954	.	0.41977	83990	0.37424	.	.	.	.	0.72322	.	.	.	.	.	.	0.94301	17	BRIP1	.	.	Thr	.	.	17-61808588-G-T	Ovarian_cancer	.	.	57240731	.	0.906865	0.93103	.	RCV003154813	.	.	.	c.797C>A	.	.	.	0.88252	G/G	.	61808588	.	G	.	Q9BX63	.	0.93727	.	0.68239		.	.	.	4	.	.	.	5.29	0.94460	.	D	T	.	.	.	.	.	.	.	213500	2445403	0.88104	0.62958	0.999525785446167	.	.	0.71675	0.85967	.	.	.	9.212	.	.	.	.	.	.	167000	0.94247	17	.	ENSG00000136492	.	.	.	.	.	2	0.97365	0.97740	.	.	.	.	0.873075489682459	.	.	0.281209	2419129	HGNC:20473	.	.	.	0.767	.	61808588	ACG	1.000000	.	-	.	0.90945	.	.	.	Likely pathogenic	0.98525	.	.	.	ClinGen:CA400484892	T	.	.	-	0.679	-	0.91621	.	.	0.92109	0.605375230312	.	.	0.99354365820043622	.	-	797C>A 	.	.	C1140680	.	.	.	.	NM_032043.3	-	.	.	1	0.65586	-1	.	.	0.95729	0.94258	.	.	.	0.98299720	5.29	.	.	.	0.299793	0.982054469378051	0.96696	D	.	.	.	0.4095	0.86824	p.Thr266Lys	.	.	-16.593	.	.	0.85829	2445403	D	.	BRIP1	.	D	.	.	T266K	.	.	0.50684	G/G	principal2																																																																																																				
FARS2_Arg419Cys	1.6552138932581775	1.0	-1.2823493566133495	0.5033505994310011	2025_01_Batch_13-14	0.733208843842912	0.67991349779559	0.6942451587201367	0.6559214897792586	0.6525787544082512	0.6437794517662653	0.7353374141674315	0.7821620174284748	0.7692521210008939	0.45969014996277247	0.6884941478045886	0.7076254559815107	0.7382035880743057	0.7125868053900762	0.5561344521855118	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011932		NC_000006.12:5771328:C:T		Arg419Cys																												FARS2_Arg419Cys	6	5771328	C	T	6	allele	1255C>T	E12	527_CAVA_Array_P02	I24	B13A7A8P1_R1	B14A7A8P1_R2				6-5771328-C-T	-	0.94011	1.0	419	1	0	0	6	5771561	T	2.044500e-05	0	6	1_Pathogenic	NC_000006.12	28	Arg419Cys	0	33.0	0	0	3.276110e-05	D	0	4	1	42768	1.267890e-05	.	30524	0.000000e+00	0	0.98886	Select	0.7452	30524	0.90580	0	.	D	D	64038	.	0	0	0.000000e+00	0	0	0.64473	17112	44888	2	0.000000e+00	0.94393	1	.	0.93825	0.964	.	6.0	0.995867	.	0.94	T	single nucleotide variant	NC_000006.12:g.5771328C>T	0	16730	3	0.8879299	109402	0	0.9438368	0		2	236614	0	0	0.000000e+00	146	2.338200e-05	0	MedGen:C3661900|MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	2	0	0.000000e+00	0	0.94378	D	0.94697	D	H	13.17435	33	C/C	114	0	7164	1614088	not provided|Hereditary spastic paraplegia 77|Combined oxidative phosphorylation defect type 14	16218	0.92683	.	.	-	5771328	6.373490e-05	-	7.527000	0	0.99793	29604	0	1180044	0	germline	91084	Loss of MoRF binding (P = 5e-04)| Loss of disorder (P = 0.0261)| Gain of catalytic residue at E422 (P = 0.0714)| Gain of sheet (P = 0.0827)| Loss of phosphorylation at T417 (P = 0.1046)	0.85693	GRCh38	964	criteria provided, multiple submitters, no conflicts	c.1255C>T	3.276110e-05	0.92402	0	0	0	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	0.000000e+00	9044	B	0	0.000000e+00	NM_006567.5(FARS2):c.1255C>T (p.Arg419Cys)	2	0	SYFM_HUMAN	0	94.0	0.97565369231617	0	D	0.50506	0.92678815	+	0.000000e+00	.		1	0.000000e+00	0	34258	criteria_provided,_multiple_submitters,_no_conflicts	0.95306	1.828120e-05	0	0.000000e+00	0	60008	p.Arg419Cys	0	0.59919	.	germline	1		C	Jan 29, 2025	1	C/C	0	89280	1.0	N	6p25.1	9690	.	0.000000e+00	SCV000251376|SCV000845719|SCV001576048	Pathogenic/Likely_pathogenic	0	0	Cys	C	-	912	ENSP00000274680	ENST00000274680	17690	0.001	13414	0	0.599	C	0	5.901953	0.83643	D	D	-	14.4338	.	0.92219	610	0	.	0.95528	0	5771328	Y	10	0	102430	0.000000e+00	O95363	0	0.810547	0.99661		0	0.995	D	30606	0.897082	15690	0.52647	10667	0.348511	28	-7.26	.	2.372790e-05	0.78662	6.373490e-05	0	74938	0.000000e+00	6084	0	0.94041	6	FARS2	1.334440e-05	0	Arg	14050	1.120070e-05	6-5771328-C-T	Hereditary_spastic_paraplegia_77|not_provided|Combined_oxidative_phosphorylation_defect_type_14	0	2	5716560	ClinGen:CA321645|OMIM:611592.0006	0.856660	0.94917	0	RCV000197201|RCV000578139|RCV001378476	D	0	0	c.1255C>T	0	0	0	0.86306	C/C	rs775690041	5771328	14902	C	.	O95363	15690	0.95571	0.000000e+00	0.68239		0	0	0.000000e+00	3.715	0	0	264690	5.81	0.95222	112	D	T	0	0.000000e+00	0	26	.	0	0	466722|319519	214336	0.90625	0.65239	0.998910188674927	2898	.	0.71675	0.77309	0.000000e+00	3.267330e-05	1180044	6.805	9.622690e-06	D	13390	0	1.51120175E-5	0	617046|614946	0.75041	6	0.000000e+00	ENSG00000145982	0.000000e+00	0	1	0	.	1	0.83178	0.07711	30606	4	1.952550e-05	0.000000e+00	0.915579723915553	YES	2.195780e-05	0.349699	211261	HGNC:21062	A	0	simple_aae	0.994	207842	5771328	CGC	1.000000	.	-	0	0.92141	2.372790e-05	0	0	Pathogenic/Likely pathogenic	0.77122	1	0	0	ClinGen:CA321645,OMIM:611592.0006	R	0	0.955839850528	-	0.723	-	0.99026	3	496	0.77993	0.68183016777	0.2542	0	0.99937551864799379	98	-	1255C>T 	1	0	C5569007|C3661900|C4755312	0	0	0	0	NM_006567.5	-	.	.	1	0.98584	775690041	2320	0	0.95499	0.96194	0.932	0.001	2784	0.97777240	5.81	.	.	3.267330e-05	0.35969	0.98820251721525	0.94651	D	86	6208	9566	0.6632	0.91281	p.Arg419Cys	0	0	-10.535	0.928861	1	0.87710	214336	D	30524	FARS2	0.000000e+00	D	0.945	21628	R419C	D	.	0.40292	C/C	principal1																																																																																																				
RAF1_Thr491Ile	-3.8359287255680843	0.2755942932717806	2.583864682897168	0.271931931279114	2025_01_Batch_13-14	0.8142078548463356	0.7158286617781157	0.7556981684615444	0.7233804167785814	0.793730906544224	0.7370624431233321	0.6183580755393122	0.608405328162545	0.727770857023925	0.7185682600862653	0.7756351489848339	0.6670933686587139	0.6820517483120447	0.7255756369012532	0.7561495833152446	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC003427		NC_000003.12:12585745:G:C		Thr491Ile																												RAF1_Thr491Ile	3	12585745	G	C	3	allele	1472C>T	C04	527_CAVA_Array_P05	E07	B13A7A8P2_R1	B14A7A8P2_R2				3-12585745-G-C	-	0.90747	1.0	491	.	.	.	3	12627244	C	.	.	3	1_Pathogenic	NC_000003.12	.	Thr491Arg	.	31.0	.	.	.	T	.	3	1	.	.	.	.	.	.	0.92884	Select	0.4388	.	0.90580	.	.	D	D	.	2.53490677304	.	.	.	.	.	0.88882	.	.	.	.	0.84911	.	.	0.95828	0.994	.	2.0	.	.	0.98	C	single nucleotide variant	NC_000003.12:g.12585745G>C	.	.	3	0.90921533	.	.	0.9571182	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.99291	D	0.97656	D	N	6.199454	.	G/G	.	.	.	.	Noonan syndrome 5|not provided|RASopathy	.	0.84771	.	.	-	12585745	.	-	11.849000	.	0.99209	.	.	.	.	germline	.	Gain of MoRF binding (P = 0.0086)| Loss of ubiquitination at K493 (P = 0.0532)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K493 (P = 0.0976)| Gain of solvent accessibility (P = 0.1456)	0.88177	GRCh38	692	criteria provided, multiple submitters, no conflicts	c.1472C>G	.	0.73443	.	.	.	Protein kinase domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_002880.4(RAF1):c.1472C>G (p.Thr491Arg)	2	.	RAF1_HUMAN	.	98.0	0.626065396186754	.	.	0.92260	0.9463269	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98444	.	.	.	.	.	p.Thr491Arg	.	0.98025	.	germline	.		G	Sep 11, 2024	.	G/G	.	.	1.0	N	3p25.2	.	.	.	SCV000808247|SCV001401755	Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000251849	ENST00000251849	.	0.001	.	.	0.676	G	.	5.424006	0.40143	D	T	-	7.84486	.	0.88439	.	.	.	0.89353	.	12585745	Y	10	.	.	.	P04049	.	0.900422	0.64619		.	0.999	D	.	0.9388268	.	0.71086	5894	0.39866	.	-5.37	.	.	0.91343	.	.	.	.	.	.	0.95572	3	RAF1	.	.	Thr	.	.	3-12585745-G-C	RASopathy|not_provided|Noonan_syndrome_5	.	.	12602244	ClinGen:CA257064|OMIM:164760.0003|UniProtKB:P04049#VAR_037819	0.916990	0.74692	.	RCV000014988|RCV000680803|RCV001229313	D	.	.	c.1472C>G	.	.	.	0.89767	G/G	rs80338799	12585745	.	G	.	P04049	.	0.96940	.	0.68239		.	.	.	0.02	.	.	.	5.26	0.98022	.	D	D	.	.	.	.	.	.	.	536391|648	13959	0.89639	0.97794	0.996480882167816	.	.	0.71675	0.88355	.	.	.	9.996	.	D	.	.	.	.	611553	0.99292	3	.	ENSG00000132155	.	.	.	.	.	2	0.92348	0.58673	.	.	.	.	0.704879681503555	YES	.	0.235705	28998	HGNC:9829	A	.	simple_aae	0.978	.	12585745	ACA	1.000000	.	-	.	0.89196	.	.	.	Likely pathogenic	0.85499	.	.	.	ClinGen:CA257064,UniProtKB:P04049#VAR_037819,OMIM:164760.0003	T	.	0.974052792841	-	0.752	-	0.99191	.	.	0.85535	0.845280706882	0.9852	.	0.99437118353782505	.	-	1472C>G 	.	.	C5555857|C3661900|C1969057	.	.	.	.	NM_002880.4	-	.	.	1	0.92373	80338799	.	.	0.97352	0.82653	0.961	0.122	.	0.99762386	5.26	.	.	.	0.334871	0.999988562000968	0.07909	D	.	.	.	0.1373	0.77686	p.Thr491Arg	.	.	-12.126	0.899554	.	0.99579	13959	D	.	RAF1	.	D	0.786	.	T491R	D	.	0.76753	G/G	principal3																																																																																																				
SDHD_Ala90Glu	6.330677185442039	0.0003987614285506209	-0.886732719267612	0.05502190282117095	2025_01_Batch_13-14	0.8256721732844101	0.8309871723130089	0.7602068186207378	0.823567738429494	0.8256987354575871	0.7882412994273117	0.7970724451402329	0.7961394720416298	0.8272352207088102	0.7379069604992105	0.806956736355861	0.8140298087266209	0.7781731453311838	0.8254014795691521	0.7818028479783987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023305		NC_000011.10:112088966:C:A		Ala90Glu																												SDHD_Ala90Glu	11	112088966	C	A	11	allele	269C>A	H11	527_CAVA_Array_P05	O21	B13A7A8P2_R1	B14A7A8P2_R2				11-112088966-C-A	-	0.34286	0.932	90	0	0	0	11	111959690	A	1.301100e-05	0	11	3_Conflicting	NC_000011.10	21	Ala90Glu	11	19.57	3	0	6.218200e-04	D	0	4	1	42768	4.642760e-05	.	30526	0.000000e+00	0	0.89925	Select	0.9083	17690	0.52003	0	.	D	D	64032	0.56273454734	0	0	0.000000e+00	0	0	0.29793	17112	44888	0	8.945880e-04	0.67509	0	.	0.69074	0.993	.	.	0.662834	.	.	A	single nucleotide variant	NC_000011.10:g.112088966C>A	0	16734	2	0.7364212	109406	0	0.5395673	0		12	236928	0	0	6.218200e-04	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0000252,Human Phenotype Ontology:HP:0001366,Human Phenotype Ontology:HP:0005485,Human Phenotype Ontology:HP:0005489,Human Phenotype Ontology:HP:0005497,MONDO:MONDO:0001149,MedGen:C4551563|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:C3661900	3	0	0.000000e+00	0	.	P	0.84234	P	M	2.403878	21	./.	84	0	7164	1614014	Hereditary cancer-predisposing syndrome|Microcephaly|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3|not provided	16218	0.92564	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112088966	3.317120e-04	-	-0.210000	0	0.70339	29606	0	44888	12	germline	91090	Gain of solvent accessibility (P = 0.1185)| Gain of helix (P = 0.132)| Loss of glycosylation at S94 (P = 0.2235)| Loss of loop (P = 0.2237)| Gain of disorder (P = 0.2283)	0.78770	GRCh38	637	criteria provided, conflicting classifications	c.269C>A	0.000000e+00	0.22101	0	0	0	.	0.000000e+00	9044	A	0	0.000000e+00	NM_003002.4(SDHD):c.269C>A (p.Ala90Glu)	1	0	DHSD_HUMAN	0	.	-0.0306763802736097	0	T	0.71218	0.5395673	+	0.000000e+00	.		12	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.98376	2.742080e-05	0	0.000000e+00	0	60008	p.Ala90Glu	0	0.10908	.	germline	3		C	Oct 26, 2024	0	./.	0	89554	0.03	N	11q23.1	6962	.	0.000000e+00	SCV000554064|SCV001177292|SCV003933375	Conflicting_classifications_of_pathogenicity	0	0	Glu	E	-	912	ENSP00000364699	ENST00000375549	17690	0.007	13414	0	0.549	C	0	2.63182	0.52087	D	T	-	1.939294	.	0.87778	610	0	.	0.29737	0	112088966	Y	10	0	102728	0.000000e+00	O14521	0	0.882903	0.52353		0	0.57	D	13414	0.7364212	9044	0.69292	6392	0.147502	0	-3.44	.	4.678310e-04	0.65576	0.000000e+00	0	74936	3.317120e-04	6060	0	0.84235	11	SDHD	0.000000e+00	0	Ala	10680	0.000000e+00	11-112088966-C-A	not_provided|Hereditary_cancer-predisposing_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Microcephaly	0	0	111464900	ClinGen:CA070965	0.646940	0.40204	0	RCV001016345|RCV001252746|RCV002230664|RCV003235231	D	0	0	c.269C>A	0	21	0	0.68809	./.	rs200255724	112088966	14902	C	.	O14521	15690	0.69073	0.000000e+00	0.08389		0	0	4.678310e-04	2.42	0	0	.	1.52	0.97538	108	T	T	0	0.000000e+00	0	24	segdup	0	0	140162|97286|29072|201	412512	0.90010	0.52443	0.429612930299171	2294	.	0.20497	0.62094	0.000000e+00	8.945880e-04	1179998	0.348	5.765680e-05	D	13394	0	.	0	606864|171300	0.19856	11	0.000000e+00	ENSG00000204370	0.000000e+00	0	0	0	0.9025812371913887	2	0.49852	0.64339	30608	.	0.000000e+00	0.000000e+00	-0.139133932962987	YES	0.000000e+00	0.221482	398391	HGNC:10683	.	0	.	0.483	208128	112088966	GCG	0.000000	.	-	0	0.73260	0.000000e+00	0	0	Conflicting classifications of pathogenicity	0.80928	0	0	0	ClinGen:CA070965	A	0	0.994050821033	-	0.651	-	0.88119	11	466	0.90169	0.434535443783	0.5246	0	0.99093711970946219	94	-	269C>A 	11	0	C3661900|C0027672|C1868633|C1847319|C0031511|CN166604|C4551563	0	0	0	0	NM_003002.4	-	.	.	0	0.27239	200255724	2320	0	0.99390	0.33519	0.838	0.103	2210	0.99742990	5.04	.	.	0.000000e+00	0.344014	0.962673093571584	0.69809	D	84	6212	9572	0.6538	0.96954	p.Ala90Glu	0	0	-10.123	0.71854925	0	0.82104	412512	D	30524	SDHD	0.000000e+00	D	0.717	21632	A90E	D	.	0.27038	./.	principal1																																																																																																				
SDHD_Ala90Glu	6.330677185442039	0.0003987614285506209	-0.886732719267612	0.05502190282117095	2025_01_Batch_13-14	0.8256721732844101	0.8309871723130089	0.7602068186207378	0.823567738429494	0.8256987354575871	0.7882412994273117	0.7970724451402329	0.7961394720416298	0.8272352207088102	0.7379069604992105	0.806956736355861	0.8140298087266209	0.7781731453311838	0.8254014795691521	0.7818028479783987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023305	ALE00021471	NC_000011.10:112088966:C:A	269C>A	Ala90Glu	CAVA																											SDHD_Ala90Glu	11	112088966	C	A	11								1	1	1	11-112088966-C-A	-	0.34286	0.932	90	0	0	0	11	111959690	A	1.301100e-05	0	11	3_Conflicting	NC_000011.10	21	Ala90Glu	11	19.57	3	0	6.218200e-04	D	0	4	1	42768	4.642760e-05	.	30526	0.000000e+00	0	0.89925	Select	0.9083	17690	0.52003	0	.	D	D	64032	0.56273454734	0	0	0.000000e+00	0	0	0.29793	17112	44888	0	8.945880e-04	0.67509	0	.	0.69074	0.993	.	.	0.662834	.	.	A	single nucleotide variant	NC_000011.10:g.112088966C>A	0	16734	2	0.7364212	109406	0	0.5395673	0		12	236928	0	0	6.218200e-04	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0000252,Human Phenotype Ontology:HP:0001366,Human Phenotype Ontology:HP:0005485,Human Phenotype Ontology:HP:0005489,Human Phenotype Ontology:HP:0005497,MONDO:MONDO:0001149,MedGen:C4551563|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:C3661900	3	0	0.000000e+00	0	.	P	0.84234	P	M	2.403878	21	./.	84	0	7164	1614014	Hereditary cancer-predisposing syndrome|Microcephaly|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3|not provided	16218	0.92564	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112088966	3.317120e-04	-	-0.210000	0	0.70339	29606	0	44888	12	germline	91090	Gain of solvent accessibility (P = 0.1185)| Gain of helix (P = 0.132)| Loss of glycosylation at S94 (P = 0.2235)| Loss of loop (P = 0.2237)| Gain of disorder (P = 0.2283)	0.78770	GRCh38	637	criteria provided, conflicting classifications	c.269C>A	0.000000e+00	0.22101	0	0	0	.	0.000000e+00	9044	A	0	0.000000e+00	NM_003002.4(SDHD):c.269C>A (p.Ala90Glu)	1	0	DHSD_HUMAN	0	.	-0.0306763802736097	0	T	0.71218	0.5395673	+	0.000000e+00	.		12	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.98376	2.742080e-05	0	0.000000e+00	0	60008	p.Ala90Glu	0	0.10908	.	germline	3		C	Oct 26, 2024	0	./.	0	89554	0.03	N	11q23.1	6962	.	0.000000e+00	SCV000554064|SCV001177292|SCV003933375	Conflicting_classifications_of_pathogenicity	0	0	Glu	E	-	912	ENSP00000364699	ENST00000375549	17690	0.007	13414	0	0.549	C	0	2.63182	0.52087	D	T	-	1.939294	.	0.87778	610	0	.	0.29737	0	112088966	Y	10	0	102728	0.000000e+00	O14521	0	0.882903	0.52353		0	0.57	D	13414	0.7364212	9044	0.69292	6392	0.147502	0	-3.44	.	4.678310e-04	0.65576	0.000000e+00	0	74936	3.317120e-04	6060	0	0.84235	11	SDHD	0.000000e+00	0	Ala	10680	0.000000e+00	11-112088966-C-A	not_provided|Hereditary_cancer-predisposing_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Microcephaly	0	0	111464900	ClinGen:CA070965	0.646940	0.40204	0	RCV001016345|RCV001252746|RCV002230664|RCV003235231	D	0	0	c.269C>A	0	21	0	0.68809	./.	rs200255724	112088966	14902	C	.	O14521	15690	0.69073	0.000000e+00	0.08389		0	0	4.678310e-04	2.42	0	0	.	1.52	0.97538	108	T	T	0	0.000000e+00	0	24	segdup	0	0	140162|97286|29072|201	412512	0.90010	0.52443	0.429612930299171	2294	.	0.20497	0.62094	0.000000e+00	8.945880e-04	1179998	0.348	5.765680e-05	D	13394	0	.	0	606864|171300	0.19856	11	0.000000e+00	ENSG00000204370	0.000000e+00	0	0	0	0.9025812371913887	2	0.49852	0.64339	30608	.	0.000000e+00	0.000000e+00	-0.139133932962987	YES	0.000000e+00	0.221482	398391	HGNC:10683	.	0	.	0.483	208128	112088966	GCG	0.000000	.	-	0	0.73260	0.000000e+00	0	0	Conflicting classifications of pathogenicity	0.80928	0	0	0	ClinGen:CA070965	A	0	0.994050821033	-	0.651	-	0.88119	11	466	0.90169	0.434535443783	0.5246	0	0.99093711970946219	94	-	269C>A 	11	0	C3661900|C0027672|C1868633|C1847319|C0031511|CN166604|C4551563	0	0	0	0	NM_003002.4	-	.	.	0	0.27239	200255724	2320	0	0.99390	0.33519	0.838	0.103	2210	0.99742990	5.04	.	.	0.000000e+00	0.344014	0.962673093571584	0.69809	D	84	6212	9572	0.6538	0.96954	p.Ala90Glu	0	0	-10.123	0.71854925	0	0.82104	412512	D	30524	SDHD	0.000000e+00	D	0.717	21632	A90E	D	.	0.27038	./.	principal1																																																																																																				
SDHD_Ser68Gly	6.045343083600106	0.0007737129719721013	0.011366001524099723	0.07191885786144295	2025_01_Batch_13-14	0.8190385166900501	0.8837958005716589	0.8233262997117662	0.8905435213901371	0.7668257119115635	0.7747656332563093	0.8149245968509216	0.810321897022911	0.839414790220858	0.6861559920661408	0.7969020749731797	0.8493601987112902	0.8168240983673386	0.8649791558054976	0.7264908519888521	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023282		NC_000011.10:112088899:A:G		Ser68Gly																												SDHD_Ser68Gly	11	112088899	A	G	11	allele	202A>G	E11	527_CAVA_Array_P05	I21	B13A7A8P2_R1	B14A7A8P2_R2				11-112088899-A-G	-	0.1465	0.001	68	.	0	.	11	111959623	G	6.200900e-07	.	11	3_Conflicting	NC_000011.10	1	Ser68Gly	.	11.19	.	.	.	D	0	3	1	.	.	.	.	.	.	0.83500	Select	0.6363	.	0.07480	.	.	D	D	64046	0.171667858329	.	0	.	.	.	0.17562	.	44870	1	.	0.30311	.	.	0.06580	0.998	.	87.0	0.819918	.	0.13	G	single nucleotide variant	NC_000011.10:g.112088899A>G	0	.	2	0.04685765	.	.	0.04305329	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	.	.	0.000000e+00	0	0.33788	B	0.06638	B	N	0.4922996	1	./.	.	.	.	1612668	Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma	.	0.84642	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112088899	.	-	1.446000	.	0.37545	29606	.	91012	.	germline	91012	Loss of disorder (P = 0.1141)| Loss of stability (P = 0.2528)| Loss of phosphorylation at S68 (P = 0.2631)| Gain of catalytic residue at T67 (P = 0.2736)| Loss of loop (P = 0.2897)	0.30252	GRCh38	637	criteria provided, conflicting classifications	c.202A>G	.	0.02780	.	.	.	.	.	.	B	.	0.000000e+00	NM_003002.4(SDHD):c.202A>G (p.Ser68Gly)	1	.	DHSD_HUMAN	.	13.0	-0.922609032286981	.	T	0.00860	0.04305329	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.95218	.	0	.	.	60018	p.Ser68Gly	0	0.26652	.	germline	.		A	Apr 16, 2024	.	./.	.	.	0.885	N	11q23.1	.	.	.	SCV002527119|SCV004051962|SCV005424122	Conflicting_classifications_of_pathogenicity	.	.	Gly	G	-	912	ENSP00000364699	ENST00000375549	.	0.976	.	.	0.691	A	.	1.080037	0.07740	N	T	-	0.7649354	.	0.50323	.	.	.	0.14142	.	112088899	Y	10	.	.	0.000000e+00	O14521	.	0.705796	0.10342		.	0.001	D	.	0.04685765	.	0.85369	6392	0.153806	0	-1.06	.	1.098760e-05	0.05990	.	.	74984	.	4916	.	0.06637	11	SDHD	0.000000e+00	.	Ser	.	.	11-112088899-A-G	Hereditary_cancer-predisposing_syndrome	0	.	111464833	.	0.321938	0.10190	0	RCV002257333|RCV004804413	D	0	.	c.202A>G	.	0	0	0.69403	./.	rs2135269276	112088899	.	A	.	O14521	.	0.06580	.	0.29889		.	.	0.000000e+00	0.415	.	.	.	-5.0	0.91487	.	T	T	.	.	.	.	.	.	.	140162	1692740	0.69011	0.19059	0.118915073573589	.	.	0.31181	0.42266	.	.	1179934	0.898	.	N	.	.	.	.	.	0.2813	11	.	ENSG00000204370	0.000000e+00	.	.	.	0.6418887932230426	1	0.04348	0.64339	.	.	.	0.000000e+00	-0.794832955240867	YES	1.098760e-05	0.027744	1685180	HGNC:10683	N	.	simple_aae	0.145	.	112088899	AGC	0.972000	.	-	.	0.44975	0.000000e+00	.	0	Conflicting classifications of pathogenicity	0.38256	.	0	0	ClinGen:CA382617218	S	.	0.983747050717	-	0.323	-	0.34641	.	.	0.63954	0.347676306963	0.0495	0	0.73018468418494142	.	-	202A>G 	.	.	C0027672	.	.	.	.	NM_003002.4	-	.	.	0	0.49610	2135269276	.	.	0.98339	0.14373	0.309	0.707	.	0.97679627	5.04	.	.	.	-0.016845	0.109295900523767	0.12397	D	.	.	.	0.1300	0.87225	p.Ser68Gly	.	0	-1.587	0.27792534	0	0.44137	1692740	T	.	SDHD	.	D	0.589	.	S68G	T	.	0.84104	./.	principal1																																																																																																				
SDHD_Ser68Gly	6.045343083600106	0.0007737129719721013	0.011366001524099723	0.07191885786144295	2025_01_Batch_13-14	0.8190385166900501	0.8837958005716589	0.8233262997117662	0.8905435213901371	0.7668257119115635	0.7747656332563093	0.8149245968509216	0.810321897022911	0.839414790220858	0.6861559920661408	0.7969020749731797	0.8493601987112902	0.8168240983673386	0.8649791558054976	0.7264908519888521	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023282	ALE00034646	NC_000011.10:112088899:A:G	202A>G	Ser68Gly	CAVA																											SDHD_Ser68Gly	11	112088899	A	G	11								1	1	1	11-112088899-A-G	-	0.1465	0.001	68	.	0	.	11	111959623	G	6.200900e-07	.	11	3_Conflicting	NC_000011.10	1	Ser68Gly	.	11.19	.	.	.	D	0	3	1	.	.	.	.	.	.	0.83500	Select	0.6363	.	0.07480	.	.	D	D	64046	0.171667858329	.	0	.	.	.	0.17562	.	44870	1	.	0.30311	.	.	0.06580	0.998	.	87.0	0.819918	.	0.13	G	single nucleotide variant	NC_000011.10:g.112088899A>G	0	.	2	0.04685765	.	.	0.04305329	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	.	.	0.000000e+00	0	0.33788	B	0.06638	B	N	0.4922996	1	./.	.	.	.	1612668	Hereditary cancer-predisposing syndrome|Hereditary pheochromocytoma-paraganglioma	.	0.84642	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112088899	.	-	1.446000	.	0.37545	29606	.	91012	.	germline	91012	Loss of disorder (P = 0.1141)| Loss of stability (P = 0.2528)| Loss of phosphorylation at S68 (P = 0.2631)| Gain of catalytic residue at T67 (P = 0.2736)| Loss of loop (P = 0.2897)	0.30252	GRCh38	637	criteria provided, conflicting classifications	c.202A>G	.	0.02780	.	.	.	.	.	.	B	.	0.000000e+00	NM_003002.4(SDHD):c.202A>G (p.Ser68Gly)	1	.	DHSD_HUMAN	.	13.0	-0.922609032286981	.	T	0.00860	0.04305329	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.95218	.	0	.	.	60018	p.Ser68Gly	0	0.26652	.	germline	.		A	Apr 16, 2024	.	./.	.	.	0.885	N	11q23.1	.	.	.	SCV002527119|SCV004051962|SCV005424122	Conflicting_classifications_of_pathogenicity	.	.	Gly	G	-	912	ENSP00000364699	ENST00000375549	.	0.976	.	.	0.691	A	.	1.080037	0.07740	N	T	-	0.7649354	.	0.50323	.	.	.	0.14142	.	112088899	Y	10	.	.	0.000000e+00	O14521	.	0.705796	0.10342		.	0.001	D	.	0.04685765	.	0.85369	6392	0.153806	0	-1.06	.	1.098760e-05	0.05990	.	.	74984	.	4916	.	0.06637	11	SDHD	0.000000e+00	.	Ser	.	.	11-112088899-A-G	Hereditary_cancer-predisposing_syndrome	0	.	111464833	.	0.321938	0.10190	0	RCV002257333|RCV004804413	D	0	.	c.202A>G	.	0	0	0.69403	./.	rs2135269276	112088899	.	A	.	O14521	.	0.06580	.	0.29889		.	.	0.000000e+00	0.415	.	.	.	-5.0	0.91487	.	T	T	.	.	.	.	.	.	.	140162	1692740	0.69011	0.19059	0.118915073573589	.	.	0.31181	0.42266	.	.	1179934	0.898	.	N	.	.	.	.	.	0.2813	11	.	ENSG00000204370	0.000000e+00	.	.	.	0.6418887932230426	1	0.04348	0.64339	.	.	.	0.000000e+00	-0.794832955240867	YES	1.098760e-05	0.027744	1685180	HGNC:10683	N	.	simple_aae	0.145	.	112088899	AGC	0.972000	.	-	.	0.44975	0.000000e+00	.	0	Conflicting classifications of pathogenicity	0.38256	.	0	0	ClinGen:CA382617218	S	.	0.983747050717	-	0.323	-	0.34641	.	.	0.63954	0.347676306963	0.0495	0	0.73018468418494142	.	-	202A>G 	.	.	C0027672	.	.	.	.	NM_003002.4	-	.	.	0	0.49610	2135269276	.	.	0.98339	0.14373	0.309	0.707	.	0.97679627	5.04	.	.	.	-0.016845	0.109295900523767	0.12397	D	.	.	.	0.1300	0.87225	p.Ser68Gly	.	0	-1.587	0.27792534	0	0.44137	1692740	T	.	SDHD	.	D	0.589	.	S68G	T	.	0.84104	./.	principal1																																																																																																				
RAF1_Asn71Ser	0.6062636477246899	1.0	0.44825035148598597	0.12122549558823274	2025_01_Batch_13-14	0.5478643627268203	0.6137224913396894	0.6101961753365123	0.6191672504260337	0.5349339648391073	0.7201265609384727	0.7134220825236429	0.6426453264081347	0.7139488743137018	0.6168838101823942	0.6339954618326464	0.6635722869316661	0.6264207508723234	0.6665580623698677	0.5759088875107508	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008840		NC_000003.12:12612058:T:C		Asn71Ser																												RAF1_Asn71Ser	3	12612058	T	C	3	allele	212A>G	G04	527_CAVA_Array_P05	M07	B13A7A8P2_R1	B14A7A8P2_R2				3-12612058-T-C	-	0.31048	0.107	71	6	0	0	3	12653557	C	9.417990e-05	27	3	2_Benign	NC_000003.12	63	Asn71Ser	1	18.61	0	0	1.430240e-03	T	0	8	1	42768	2.532140e-04	0	30526	0.000000e+00	0	0.47225	Select	0.2684	34260	0.26097	49	0.0	D	T	64018	0.399458701232	0	0	0.000000e+00	0	0	0.77301	17112	44860	11	0.000000e+00	0.23101	3	.	0.59936	0.34	0.0	49.0	.	3.15	0.51	C	single nucleotide variant	NC_000003.12:g.12612058T>C	0	16734	2	0.16458307	109408	0	0.367634	0		57	236954	0	0	5.652270e-05	796	7.014590e-05	0	MedGen:CN169374||MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN230736	31	0	0.000000e+00	0	0.71892	B	0.32795	B	M	2.260626	152	T/T	352	1	7164	1613932	not specified|RAF1-related disorder|RASopathy|not provided|Cardiovascular phenotype	16218	0.60130	3	.	-	12612058	1.577840e-03	-	1.237000	1	0.48172	29602	0	60008	0	germline	91088	.	.	GRCh38	637	reviewed by expert panel	c.212A>G	6.551790e-05	0.57575	29	0	0	Raf-like Ras-binding|Raf-like Ras-binding|Raf-like Ras-binding	0.000000e+00	9046	B	0	0.000000e+00	NM_002880.4(RAF1):c.212A>G (p.Asn71Ser)	3	0	RAF1_HUMAN	0	51.0	-0.0733448836148503	48	.	0.33297	0.39323702	-	0.000000e+00	0		48	0.000000e+00	0	34260	reviewed_by_expert_panel	0.75518	2.833430e-04	0	0.000000e+00	0	60008	p.Asn71Ser	0	0.25166	.	germline	27		T	Apr 03, 2017	2	T/T	0	89556	1.0	N	3p25.2	178468	.	6.165990e-05	SCV000616420	Benign	0	0	Ser	S	-	912	ENSP00000251849	ENST00000251849	17692	0.466	13416	0	-0.188	T	0	2.411032	0.12752	D	T	-	2.553849	.	0.62660	968	0	0.0	0.01162	0	12612058	Y	10	0	102752	0.000000e+00	P04049	0	0.544649	0.30927		0	0.199	D	30524	0.13760614	17112	0.25482	5894	-0.441197	63	-0.85	0.0	1.049860e-03	0.08637	6.373490e-05	0	75034	0.000000e+00	6056	0	0.37996	3	RAF1	1.066180e-04	0	Asn	211164	6.699720e-05	3-12612058-T-C	not_specified|Cardiovascular_phenotype|RASopathy|not_provided|RAF1-related_disorder	0	7	12628557	ClinGen:CA134721	0.643219	0.38295	0	RCV000037686|RCV004532499|RCV000461248|RCV000586687|RCV000620637	T	0	0	c.212A>G	0	4	0	0.01189	T/T	rs184022679	12612058	14902	T	5.990415335463259E-4	.	15690	0.58081	0.000000e+00	0.29555		0	0	8.916630e-05	2.075	0	28	264690	4.65	0.84330	6294	T	T	1	1.572530e-03	0	1818	.	0	0	536391	40588	0.28238	0.40688	0.0241761773584133	9198	3	0.71675	0.61854	1.430240e-03	1.572530e-03	1179858	4.539	2.738650e-04	N	13394	0	1.813442E-4	0	.	0.60453	3	6.710510e-05	ENSG00000132155	0.000000e+00	1.5689087119259476E-4	2	0	.	2	0.36806	0.64339	30608	48	6.812520e-05	1.049860e-03	0.0541083710929102	YES	1.207620e-04	0.047179	49058	HGNC:9829	D	0	simple_aae	0.216	208132	12612058	AAT	0.965000	0	-	0	0.00618	5.339630e-05	0	0	Benign	0.40718	1	0	63	ClinGen:CA134721	N	0	0.700826663726	-	.	-	0.46496	60	15160	0.38507	0.769439399242	0.1357	0	0.96689436356771608	280	-	212A>G 	49	6.596306068601583E-5	CN169374|CN230736|C5555857|C3661900	0	0	0	0	NM_002880.4	-	0	0.004322766570605188	0	0.55502	184022679	2320	1.3733401526775396E-4	0.69587	0.41984	0.396	0.461	8846	0.26023328	5.81	.	.	6.534240e-05	-0.441903	0.847923193550861	0.56867	T	4476	6212	9572	-0.7029	0.63840	p.Asn71Ser	0	0	-5.34	0.023561597	8	0.73002	40588	T	30524	RAF1	1.577840e-03	T	0.194	21632	.	T	0.57234	0.09552	T/T	principal3																																																																																																				
FARS2_Asp142Tyr	-2.483576660753394	1.0	0.5392488168522181	0.19232098373943332	2025_01_Batch_13-14	0.5906016339396649	0.6769868661927881	0.6703108451762275	0.6554205626714743	0.532339517574178	0.5679488323067039	0.6936178877958527	0.6599759572345486	0.7143869657921782	0.5390523075029727	0.5792752331231844	0.6853023769943204	0.6651434012053881	0.6849037642318263	0.5356959125385754	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011914		NC_000006.12:5368994:G:T		Asp142Tyr																												FARS2_Asp142Tyr	6	5368994	G	T	6	allele	424G>T	B01	527_CAVA_Array_P03	D01	B13A7A8P1_R1	B14A7A8P1_R2				6-5368994-G-T	-	0.87485	1.0	142	0	0	0	6	5369227	T	6.195140e-07	0	6	1_Pathogenic	NC_000006.12	1	Asp142Tyr	1	29.2	0	.	5.653550e-05	D	0	3	1	42768	4.222300e-06	.	30526	0.000000e+00	.	0.93796	Select	0.6504	17688	0.90580	0	.	D	D	64038	.	.	0	0.000000e+00	0	0	0.79514	17112	44882	0	0.000000e+00	0.96618	0	.	0.96412	1.0	.	3.0	0.961304	2.52	0.97	T	single nucleotide variant	NC_000006.12:g.5368994G>T	0	16734	3	0.9112432	109406	.	0.9639511	.		0	236838	0	0	5.653550e-05	.	0.000000e+00	.	MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722	0	0	0.000000e+00	0	0.96253	D	0.94847	D	H	12.37248	1	G/G	.	.	7164	1614168	Hereditary spastic paraplegia 77	16212	0.91916	.	.	-	5368994	.	-	9.744000	0	0.99826	29604	.	44882	0	germline	91082	Loss of solvent accessibility (P = 0.0152)| Loss of relative solvent accessibility (P = 0.0186)| Loss of ubiquitination at K139 (P = 0.0246)| Loss of disorder (P = 0.0373)| Loss of phosphorylation at Y144 (P = 0.0593)	0.91245	GRCh38	944	criteria provided, single submitter	c.424G>T	0.000000e+00	0.54123	.	0	0	Phenylalanyl-tRNA synthetase	0.000000e+00	9044	P	.	0.000000e+00	NM_006567.5(FARS2):c.424G>T (p.Asp142Tyr)	1	0	SYFM_HUMAN	0	97.0	0.948429081889747	0	D	0.69372	0.95198554	+	0.000000e+00	.		.	0.000000e+00	0	34260	criteria_provided,_single_submitter	0.95052	0.000000e+00	0	0.000000e+00	0	60024	p.Asp142Tyr	0	0.81475	.	germline	.		G	Jun 13, 2018	0	G/G	0	89506	1.0	N	6p25.1	.	.	0.000000e+00	SCV000845707	Pathogenic	0	0	Tyr	Y	-	910	ENSP00000274680	ENST00000274680	17688	0.0	13406	0	0.676	G	0	5.212362	0.92967	D	D	-	11.68468	.	0.90164	.	0	.	0.97208	.	5368994	Y	10	.	102650	0.000000e+00	O95363	0	0.511236	0.72048		.	0.997	D	.	0.8991653	.	0.97202	10667	0.286301	0	-8.05	.	2.228060e-05	0.91343	0.000000e+00	0	75044	0.000000e+00	6062	0	0.95718	6	FARS2	0.000000e+00	.	Asp	.	0.000000e+00	6-5368994-G-T	Hereditary_spastic_paraplegia_77	0	0	5314226	ClinGen:CA10586223|OMIM:611592.0005|UniProtKB:O95363#VAR_077044	0.890111	0.93888	0	RCV000239526	D	0	0	c.424G>T	0	1	0	0.81716	G/G	rs145555213	5368994	14902	G	.	O95363	15690	0.97638	0.000000e+00	0.68239		0	0	2.228060e-05	4.425	.	.	.	4.49	0.82575	.	D	T	0	0.000000e+00	.	.	.	0	0	466722	253159	0.89952	0.62839	0.999397754669189	.	.	0.71675	0.82419	0.000000e+00	.	1180018	9.553	0.000000e+00	D	13394	.	.	.	617046	0.97226	6	0.000000e+00	ENSG00000145982	0.000000e+00	.	0	.	.	1	0.86259	0.12756	30608	.	0.000000e+00	0.000000e+00	0.847583306341376	YES	0.000000e+00	0.279745	247571	HGNC:21062	A	0	simple_aae	0.995	208056	5368994	GAC	1.000000	.	-	.	0.93109	0.000000e+00	.	0	Pathogenic	0.92263	0	0	0	ClinGen:CA10586223,UniProtKB:O95363#VAR_077044,OMIM:611592.0005	D	0	0.952766475807	-	0.791	-	0.98479	1	.	0.93477	0.784124493599	0.6133	0	0.99564433392369855	.	-	424G>T 	1	.	C5569007	0	0	0	0	NM_006567.5	-	.	.	1	0.85467	145555213	2320	.	0.95187	0.92834	0.974	0.0	.	0.97490570	5.38	.	.	0.000000e+00	0.342604	0.998275433556404	0.98710	D	.	6210	9568	0.6034	0.87777	p.Asp142Tyr	.	0	-13.759	0.93858135	0	0.94209	253159	D	30522	FARS2	0.000000e+00	D	0.809	21632	D142Y	D	0.46380	0.76753	G/G	principal1																																																																																																				
FARS2_Asp142Tyr	-2.483576660753394	1.0	0.5392488168522181	0.19232098373943332	2025_01_Batch_13-14	0.5906016339396649	0.6769868661927881	0.6703108451762275	0.6554205626714743	0.532339517574178	0.5679488323067039	0.6936178877958527	0.6599759572345486	0.7143869657921782	0.5390523075029727	0.5792752331231844	0.6853023769943204	0.6651434012053881	0.6849037642318263	0.5356959125385754	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2				CCSBVarC011914	ALE00013136	NC_000006.12:5368994:G:T	424G>T	Asp142Tyr	CAVA																											FARS2_Asp142Tyr	6	5368994	G	T	6								1	1	1	6-5368994-G-T	-	0.87485	1.0	142	0	0	0	6	5369227	T	6.195140e-07	0	6	1_Pathogenic	NC_000006.12	1	Asp142Tyr	1	29.2	0	.	5.653550e-05	D	0	3	1	42768	4.222300e-06	.	30526	0.000000e+00	.	0.93796	Select	0.6504	17688	0.90580	0	.	D	D	64038	.	.	0	0.000000e+00	0	0	0.79514	17112	44882	0	0.000000e+00	0.96618	0	.	0.96412	1.0	.	3.0	0.961304	2.52	0.97	T	single nucleotide variant	NC_000006.12:g.5368994G>T	0	16734	3	0.9112432	109406	.	0.9639511	.		0	236838	0	0	5.653550e-05	.	0.000000e+00	.	MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722	0	0	0.000000e+00	0	0.96253	D	0.94847	D	H	12.37248	1	G/G	.	.	7164	1614168	Hereditary spastic paraplegia 77	16212	0.91916	.	.	-	5368994	.	-	9.744000	0	0.99826	29604	.	44882	0	germline	91082	Loss of solvent accessibility (P = 0.0152)| Loss of relative solvent accessibility (P = 0.0186)| Loss of ubiquitination at K139 (P = 0.0246)| Loss of disorder (P = 0.0373)| Loss of phosphorylation at Y144 (P = 0.0593)	0.91245	GRCh38	944	criteria provided, single submitter	c.424G>T	0.000000e+00	0.54123	.	0	0	Phenylalanyl-tRNA synthetase	0.000000e+00	9044	P	.	0.000000e+00	NM_006567.5(FARS2):c.424G>T (p.Asp142Tyr)	1	0	SYFM_HUMAN	0	97.0	0.948429081889747	0	D	0.69372	0.95198554	+	0.000000e+00	.		.	0.000000e+00	0	34260	criteria_provided,_single_submitter	0.95052	0.000000e+00	0	0.000000e+00	0	60024	p.Asp142Tyr	0	0.81475	.	germline	.		G	Jun 13, 2018	0	G/G	0	89506	1.0	N	6p25.1	.	.	0.000000e+00	SCV000845707	Pathogenic	0	0	Tyr	Y	-	910	ENSP00000274680	ENST00000274680	17688	0.0	13406	0	0.676	G	0	5.212362	0.92967	D	D	-	11.68468	.	0.90164	.	0	.	0.97208	.	5368994	Y	10	.	102650	0.000000e+00	O95363	0	0.511236	0.72048		.	0.997	D	.	0.8991653	.	0.97202	10667	0.286301	0	-8.05	.	2.228060e-05	0.91343	0.000000e+00	0	75044	0.000000e+00	6062	0	0.95718	6	FARS2	0.000000e+00	.	Asp	.	0.000000e+00	6-5368994-G-T	Hereditary_spastic_paraplegia_77	0	0	5314226	ClinGen:CA10586223|OMIM:611592.0005|UniProtKB:O95363#VAR_077044	0.890111	0.93888	0	RCV000239526	D	0	0	c.424G>T	0	1	0	0.81716	G/G	rs145555213	5368994	14902	G	.	O95363	15690	0.97638	0.000000e+00	0.68239		0	0	2.228060e-05	4.425	.	.	.	4.49	0.82575	.	D	T	0	0.000000e+00	.	.	.	0	0	466722	253159	0.89952	0.62839	0.999397754669189	.	.	0.71675	0.82419	0.000000e+00	.	1180018	9.553	0.000000e+00	D	13394	.	.	.	617046	0.97226	6	0.000000e+00	ENSG00000145982	0.000000e+00	.	0	.	.	1	0.86259	0.12756	30608	.	0.000000e+00	0.000000e+00	0.847583306341376	YES	0.000000e+00	0.279745	247571	HGNC:21062	A	0	simple_aae	0.995	208056	5368994	GAC	1.000000	.	-	.	0.93109	0.000000e+00	.	0	Pathogenic	0.92263	0	0	0	ClinGen:CA10586223,UniProtKB:O95363#VAR_077044,OMIM:611592.0005	D	0	0.952766475807	-	0.791	-	0.98479	1	.	0.93477	0.784124493599	0.6133	0	0.99564433392369855	.	-	424G>T 	1	.	C5569007	0	0	0	0	NM_006567.5	-	.	.	1	0.85467	145555213	2320	.	0.95187	0.92834	0.974	0.0	.	0.97490570	5.38	.	.	0.000000e+00	0.342604	0.998275433556404	0.98710	D	.	6210	9568	0.6034	0.87777	p.Asp142Tyr	.	0	-13.759	0.93858135	0	0.94209	253159	D	30522	FARS2	0.000000e+00	D	0.809	21632	D142Y	D	0.46380	0.76753	G/G	principal1																																																																																																				
RAF1_Pro225Ser	0.045139855443872445	1.0	2.0699418157000897	0.035002026571959666	2025_01_Batch_13-14	0.6512782784969562	0.7999178543484294	0.8474914559883338	0.7688429176710421	0.6431031842912733	0.5939375746955838	0.7949831825516199	0.8322379078372641	0.7539172573256406	0.5492221396366254	0.6226079265962701	0.7974505184500247	0.839864681912799	0.7613800874983414	0.5961626619639493	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											
FARS2_Leu371Phe	0.24590492354475124	1.0	-2.718592944820778	0.042150746612175535	2025_01_Batch_13-14	0.6725393516295189	0.7424490977972589	0.7699201139117763	0.7909852528347302	0.5574119026468386	0.7225344402022017	0.7924054930913393	0.8017880222938175	0.8413800554305063	0.5634828091724872	0.6975368959158603	0.7674272954442991	0.7858540681027969	0.8161826541326183	0.5604473559096629	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011882		NC_000006.12:5613216:G:T		Leu371Phe																												FARS2_Leu371Phe	6	5613216	G	T	6	allele	1113G>T	C12	527_CAVA_Array_P02	E24	B13A7A8P1_R1	B14A7A8P1_R2				6-5613216-G-T	-	0.37026	0.984	371	.	.	.	6	5613449	T	.	.	6	1_Pathogenic	NC_000006.12	.	Leu371Phe	.	20.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.90105	Select	0.5146	.	0.60748	.	.	D	D	.	.	.	.	.	.	.	0.48064	.	.	.	.	0.65888	.	.	0.77329	0.996	.	2.0	0.949505	0.251	0.98	T	single nucleotide variant	NC_000006.12:g.5613216G>T	.	.	2	0.57329565	.	.	0.6913538	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	.	.	.	.	0.97016	P	0.75036	D	M	4.241475	.	G/G	.	.	.	.	Combined oxidative phosphorylation defect type 14	.	0.82548	.	.	-	5613216	.	-	0.741000	.	0.90063	.	.	.	.	germline	.	Loss of catalytic residue at L371 (P = 0.134)| Gain of sheet (P = 0.1451)| Loss of stability (P = 0.1495)| Gain of loop (P = 0.3485)| Gain of disorder (P = 0.4546)	0.78980	GRCh38	976	no assertion criteria provided	c.1113G>T	.	0.15396	.	.	.	Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain|Ferrodoxin-fold anticodon-binding domain	.	.	A	.	.	NM_006567.5(FARS2):c.1113G>T (p.Leu371Phe)		.	SYFM_HUMAN	.	98.0	0.383302004000591	.	D	0.62580	0.6913538	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.93179	.	.	.	.	.	p.Leu371Phe	.	0.21243	.	germline	.		G	Dec 12, 2019	.	G/G	.	.	0.99	N	6p25.1	.	.	.	SCV001424746	Pathogenic	.	.	Phe	F	-	.	ENSP00000274680	ENST00000274680	.	0.003	.	.	0.676	G	.	2.807945	0.72530	N	D	-	3.461171	.	0.79238	.	.	.	0.78021	.	5613216	Y	10	.	.	.	O95363	.	0.632922	0.93373		.	0.905	D	.	0.57329565	.	0.76032	10667	0.282506	.	-3.3	.	.	0.68399	.	.	.	.	.	.	0.75036	6	FARS2	.	.	Leu	.	.	6-5613216-G-T	Combined_oxidative_phosphorylation_defect_type_14	.	.	5558448	.	0.344351	0.60314	.	RCV001250395	D	.	.	c.1113G>T	.	.	.	0.81394	G/G	rs1204079767	5613216	.	G	.	O95363	.	0.77328	.	0.33331		.	.	.	3.49	.	.	.	0.378	0.88531	.	D	T	.	.	.	.	.	.	.	319519	973745	0.81155	0.59072	0.98774379491806	.	.	0.37076	0.43798	.	.	.	0.161	.	D	.	.	.	.	614946	0.16353	6	.	ENSG00000145982	.	.	.	.	.	3	0.64254	0.04721	.	.	.	.	0.254276606892227	YES	.	0.114229	962037	HGNC:21062	A	.	simple_aae	0.82	.	5613216	TTG	0.997000	.	-	.	0.86629	.	.	.	Pathogenic	0.71800	.	.	.	ClinGen:CA362736853	L	.	0.934491293691	-	0.653	-	0.82302	.	.	0.75719	0.566125333309	0.4567	.	0.99854701034997717	.	-	1113G>T 	.	.	C4755312	.	.	.	.	NM_006567.5	-	.	.	1	0.80529	1204079767	.	.	0.93330	0.52647	0.828	0.005	.	0.94634580	5.53	.	.	.	0.168024	0.937195805839724	0.92559	D	.	.	.	0.0185	0.81736	p.Leu371Phe	.	.	-9.639	0.87487864	.	0.79075	973745	D	.	FARS2	.	D	0.721	.	L371F	D	0.23301	0.76753	G/G	principal1																																																																																																				
ZC4H2_Val63Leu	-3.772508957351957	0.009520442136421024	-2.514597705164753	0.0010600427828077043	2025_01_Batch_13-14	0.6066181739777775	0.837648116185566	0.8783777829289516	0.8099086609881108	0.7024057124056164	0.6080136834909066	0.9321174949448261	0.9633767822285377	0.9443145016579653	0.673811281093341	0.607315928734342	0.884882805565196	0.9208772825787447	0.877111581323038	0.6881084967494787	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC005916		NC_000023.11:64921855:C:G		Val63Leu																												ZC4H2_Val63Leu	23	64921855	C	G	X	allele	187G>C	G03	527_CAVA_Array_P06	M06	B13A7A8P2_R1	B14A7A8P2_R2				X-64921855-C-G	-	0.66797	0.992	63	.	.	.	X	64141735	G	.	.	X	1_Pathogenic	NC_000023.11	.	Val63Leu	.	25.0	.	.	.	T	.	1	1	.	.	.	.	.	.	0.91077	Select	0.4181	.	0.64752	.	.	D	D	.	1.97721070638	.	.	.	.	.	0.95406	.	.	.	.	0.50191	.	.	0.87783	0.99	.	3.0	0.969003	4.31	0.97	G	single nucleotide variant	NC_000023.11:g.64921855C>G	.	.	1	0.87122726	.	.	0.85009694	.		.	.	.	.	.	.	.	.	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	.	.	.	.	0.96253	D	0.92856	D	M	.	.	C/C	.	.	.	.	Wieacker-Wolff syndrome	.	0.78440	.	.	-	64921855	.	-	5.916000	.	0.96717	.	.	.	.	germline	.	Gain of disorder (P = 0.0736)| Loss of ubiquitination at K59 (P = 0.0816)| Gain of stability (P = 0.1765)| Gain of glycosylation at K59 (P = 0.3702)| Gain of methylation at R67 (P = 0.5403)	0.85070	GRCh38	40	no assertion criteria provided	c.187G>C	.	0.83655	.	.	.	.	.	.	P	.	.	NM_018684.4(ZC4H2):c.187G>C (p.Val63Leu)		.	ZC4H2_HUMAN	.	97.0	.	.	D	0.99054	0.8581468	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.98543	.	.	.	.	.	p.Val63Leu	.	0.51166	.	germline	.		C	May 02, 2013	.	C/C	.	.	1.0	N	Xq11.2	.	.	.	SCV000071687	Pathogenic	.	.	Leu	L	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.599	C	.	4.346719	0.92967	.	T	-	.	.	0.86973	.	.	.	0.71437	.	64921855	Y	9	.	.	.	Q9NQZ6	.	0.512428	0.90510		.	0.983	D	.	0.87122726	.	0.65338	55906	0.470646	.	-2.24	.	.	0.91343	.	.	.	.	.	.	0.92856	X	ZC4H2	.	.	Val	.	.	X-64921855-C-G	Wieacker-Wolff_syndrome	.	.	64058460	ClinGen:CA143907|OMIM:300897.0001|UniProtKB:Q9NQZ6#VAR_069621	.	.	.	RCV000043676	D	.	.	c.187G>C	.	.	.	0.93309	C/C	rs398122938	64921855	.	C	.	Q9NQZ6	.	0.87173	.	0.68239		.	.	.	2.465	.	.	.	5.56	0.82640	.	D	D	.	.	.	.	.	.	.	3454|85283	50980	0.93226	0.93584	0.97698700428009	.	.	0.71675	.	.	.	.	7.641	.	N	.	.	.	.	314580	0.82558	X	.	ENSG00000126970	.	.	.	.	0.8373184595511529	1	0.75798	0.97963	.	.	.	.	.	YES	.	0.205808	65651	HGNC:24931	A	.	simple_aae	0.933	.	64921855	GTG	1.000000	.	-	.	0.83403	.	.	.	Pathogenic	0.54387	.	.	.	ClinGen:CA143907,UniProtKB:Q9NQZ6#VAR_069621,OMIM:300897.0001	V	.	0.884996165071	-	0.716	-	0.84047	.	.	0.83593	0.891219079494	0.9994	.	0.99821887779931795	.	-	187G>C 	.	.	C0796200	.	.	.	.	NM_018684.4	-	.	.	1	0.92268	398122938	.	.	0.88298	.	0.845	0.052	.	0.99788480	5.56	.	.	.	0.438274	0.996518372777224	0.71362	T	.	.	.	-0.1655	0.76324	p.Val63Leu	.	.	-7.039	0.84414655	.	0.92210	50980	T	.	ZC4H2	.	D	0.743	.	V63L	D	0.81542	0.40292	C/C	principal1																																																																																																				
ZC4H2_Val63Leu	-3.772508957351957	0.009520442136421024	-2.514597705164753	0.0010600427828077043	2025_01_Batch_13-14	0.6066181739777775	0.837648116185566	0.8783777829289516	0.8099086609881108	0.7024057124056164	0.6080136834909066	0.9321174949448261	0.9633767822285377	0.9443145016579653	0.673811281093341	0.607315928734342	0.884882805565196	0.9208772825787447	0.877111581323038	0.6881084967494787	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC005916		NC_000023.11:64921855:C:G		Val63Leu																												ZC4H2_Val63Leu	23	64921855	C	G	X	allele	187G>C	H03	527_CAVA_Array_P06	O06	B13A7A8P2_R1	B14A7A8P2_R2				X-64921855-C-G	-	0.66797	0.992	63	.	.	.	X	64141735	G	.	.	X	1_Pathogenic	NC_000023.11	.	Val63Leu	.	25.0	.	.	.	T	.	1	1	.	.	.	.	.	.	0.91077	Select	0.4181	.	0.64752	.	.	D	D	.	1.97721070638	.	.	.	.	.	0.95406	.	.	.	.	0.50191	.	.	0.87783	0.99	.	3.0	0.969003	4.31	0.97	G	single nucleotide variant	NC_000023.11:g.64921855C>G	.	.	1	0.87122726	.	.	0.85009694	.		.	.	.	.	.	.	.	.	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	.	.	.	.	0.96253	D	0.92856	D	M	.	.	C/C	.	.	.	.	Wieacker-Wolff syndrome	.	0.78440	.	.	-	64921855	.	-	5.916000	.	0.96717	.	.	.	.	germline	.	Gain of disorder (P = 0.0736)| Loss of ubiquitination at K59 (P = 0.0816)| Gain of stability (P = 0.1765)| Gain of glycosylation at K59 (P = 0.3702)| Gain of methylation at R67 (P = 0.5403)	0.85070	GRCh38	40	no assertion criteria provided	c.187G>C	.	0.83655	.	.	.	.	.	.	P	.	.	NM_018684.4(ZC4H2):c.187G>C (p.Val63Leu)		.	ZC4H2_HUMAN	.	97.0	.	.	D	0.99054	0.8581468	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.98543	.	.	.	.	.	p.Val63Leu	.	0.51166	.	germline	.		C	May 02, 2013	.	C/C	.	.	1.0	N	Xq11.2	.	.	.	SCV000071687	Pathogenic	.	.	Leu	L	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.599	C	.	4.346719	0.92967	.	T	-	.	.	0.86973	.	.	.	0.71437	.	64921855	Y	9	.	.	.	Q9NQZ6	.	0.512428	0.90510		.	0.983	D	.	0.87122726	.	0.65338	55906	0.470646	.	-2.24	.	.	0.91343	.	.	.	.	.	.	0.92856	X	ZC4H2	.	.	Val	.	.	X-64921855-C-G	Wieacker-Wolff_syndrome	.	.	64058460	ClinGen:CA143907|OMIM:300897.0001|UniProtKB:Q9NQZ6#VAR_069621	.	.	.	RCV000043676	D	.	.	c.187G>C	.	.	.	0.93309	C/C	rs398122938	64921855	.	C	.	Q9NQZ6	.	0.87173	.	0.68239		.	.	.	2.465	.	.	.	5.56	0.82640	.	D	D	.	.	.	.	.	.	.	3454|85283	50980	0.93226	0.93584	0.97698700428009	.	.	0.71675	.	.	.	.	7.641	.	N	.	.	.	.	314580	0.82558	X	.	ENSG00000126970	.	.	.	.	0.8373184595511529	1	0.75798	0.97963	.	.	.	.	.	YES	.	0.205808	65651	HGNC:24931	A	.	simple_aae	0.933	.	64921855	GTG	1.000000	.	-	.	0.83403	.	.	.	Pathogenic	0.54387	.	.	.	ClinGen:CA143907,UniProtKB:Q9NQZ6#VAR_069621,OMIM:300897.0001	V	.	0.884996165071	-	0.716	-	0.84047	.	.	0.83593	0.891219079494	0.9994	.	0.99821887779931795	.	-	187G>C 	.	.	C0796200	.	.	.	.	NM_018684.4	-	.	.	1	0.92268	398122938	.	.	0.88298	.	0.845	0.052	.	0.99788480	5.56	.	.	.	0.438274	0.996518372777224	0.71362	T	.	.	.	-0.1655	0.76324	p.Val63Leu	.	.	-7.039	0.84414655	.	0.92210	50980	T	.	ZC4H2	.	D	0.743	.	V63L	D	0.81542	0.40292	C/C	principal1																																																																																																				
RAF1_Asp381Asn	0.5714162180205059	1.0	0.5200707489892997	0.09902727176571031	2025_01_Batch_13-14	0.5916507293648501	0.554141112266058	0.603505251033311	0.5972816925458017	0.5882689811653663	0.6443114881687294	0.6776240956846027	0.6668260636089396	0.7245594930743811	0.5944293789710839	0.6179811087667897	0.6158826039753303	0.6351656573211253	0.6609205928100914	0.5913491800682251	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008844		NC_000003.12:12591760:C:T		Asp381Asn																												RAF1_Asp381Asn	3	12591760	C	T	3	allele	1141G>A	D03	527_CAVA_Array_P05	G05	B13A7A8P2_R1	B14A7A8P2_R2				3-12591760-C-T	-	0.24145	0.0	381	1	0	0	3	12633259	T	1.542630e-04	0	3	2_Benign	NC_000003.12	230	Asp381Asn	0	16.27	0	1	2.260370e-03	T	4	7	1	42768	2.955630e-04	0	30526	0.000000e+00	0	0.41991	Select	0.2621	30526	0.02950	0	0.0	D	T	64028	1.20632500761	3.061849357011635E-4	0	0.000000e+00	0	0	0.56847	17112	44880	230	0.000000e+00	0.42002	1	.	0.11702	0.034	0.0	91.0	.	0.329	0.09	T	single nucleotide variant	NC_000003.12:g.12591760C>T	0	16734	2	0.05158828	109408	0.009615384615384616	0.08191876	0		70	236836	0	0	0.000000e+00	146	2.338200e-05	0	MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:CN230736	31	0	0.000000e+00	0	0.26006	B	0.12728	B	N	0.6575577	249	C/C	114	0	7164	1614126	not specified|RASopathy|Noonan syndrome and Noonan-related syndrome|Noonan syndrome with multiple lentigines;Noonan syndrome|Cardiovascular phenotype	16218	0.54456	0	.	-	12591760	1.912050e-03	-	2.200000	0	0.57690	29608	0	91082	0	germline;unknown	91082	Gain of glycosylation at T383 (P = 0.0563)| Gain of MoRF binding (P = 0.0665)| Gain of methylation at K378 (P = 0.0678)| Gain of ubiquitination at K378 (P = 0.1989)| Gain of phosphorylation at T383 (P = 0.2411)	0.34294	GRCh38	685	reviewed by expert panel	c.1141G>A	2.260370e-03	0.28799	2	0	0	Protein kinase domain|Protein kinase domain|Protein kinase domain	0.000000e+00	9046	B	0	0.000000e+00	NM_002880.4(RAF1):c.1141G>A (p.Asp381Asn)	3	0	RAF1_HUMAN	0	9.0	-0.798101639362588	0	.	0.17894	0.058604848	-	0.000000e+00	3		69	0.000000e+00	0	34260	reviewed_by_expert_panel	0.86141	2.833430e-04	4	0.000000e+00	0	60020	p.Asp381Asn	0	0.31363	.	germline	30		c	Apr 18, 2017	69	C/C	0	89556	0.959	N	3p25.2	9902	.	0.000000e+00	SCV000616485	Benign	0	0	Asn	N	-	910	ENSP00000251849	ENST00000251849	17692	0.741	13416	0	-3.876	C	0	1.897587	0.07289	N	T	-	1.003532	.	.	610	0	0.0	0.01464	0	12591760	Y	10	0	102644	0.000000e+00	P04049	0	0.710307	0.09095		0	0.002	.	30608	0.063901514	15690	0.13647	5894	-0.470963	11	-1.58	0.003067484662576687	2.525200e-03	0.05469	1.912050e-03	0	75020	0.000000e+00	6062	0	0.08346	3	RAF1	0.000000e+00	1	Asp	15080	1.116620e-05	3-12591760-C-T	Cardiovascular_phenotype|RASopathy|not_specified|Noonan_syndrome|Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_and_Noonan-related_syndrome	0	1	12608259	ClinGen:CA297118	0.104954	0.13197	0	RCV000159079|RCV000522135|RCV001813412|RCV001261134|RCV002453552	T	0	0	c.1141G>A	0	0	0	0.00789	C/C	rs559632360	12591760	14902	C	5.990415335463259E-4	P04049	15690	0.18674	0.000000e+00	0.30138		0	0	0.000000e+00	0.725	0	0	264690	2.44	0.91654	146	T	T	0	0.000000e+00	0	26	.	0	0	536391|648|500|98733	181509	0.26743	0.80616	0.0264849085100513	3380	3	0.33632	0.20775	0.000000e+00	2.254310e-03	1180012	2.247	3.363280e-04	N	13394	0	2.2668026E-5	0	PS163950|PS151100	0.42906	3	0.000000e+00	ENSG00000132155	0.000000e+00	0	69	0	.	1	0.06938	0.5936	30608	6	9.742410e-06	1.666110e-05	-0.628625637051928	YES	2.525200e-03	.	179051	HGNC:9829	N	0	simple_aae	0.31	208130	12591760	GAC	0.976000	0	-	2.958579881656805E-4	0.00259	9.321940e-06	1	4	Benign	0.37036	30	0	1	ClinGen:CA297118	D	0	0.324009150485	-	0.348	-	0.15800	70	792	0.71714	0.628370404243	0.096	0	0.69381873695721796	104	-	1141G>A 	69	0	CN230736|C5555857|CN169374|C0028326|C0175704|C5681679	0	0	0	0	NM_002880.4	-	0	0.0	0	0.37334	559632360	2320	1.326259946949602E-4	0.31597	0.18464	0.141	0.631	3266	0.70292550	5.15	.	.	2.254310e-03	-0.45545	0.00775539406038167	0.18664	T	120	6210	9568	-0.8085	0.63163	p.Asp381Asn	0	0	-4.384	0.012194514	0	0.22004	181509	T	30524	RAF1	0.000000e+00	T	0.164	21630	D381N	T	0.23862	0.00054	C/C	principal3																																																																																																				
FARS2_His84Pro	-0.6685215350519559	1.0	-1.9143491804649417	0.11887068523584414	2025_01_Batch_13-14	0.6909273743374503	0.8085540786477744	0.9130441035248813	0.8066052962232809	0.7564985110978174	0.6083734781712353	0.7207950114303019	0.8816449178809973	0.797309862871002	0.6109844495301832	0.6496504262543428	0.7646745450390382	0.8973445107029393	0.8019575795471414	0.6837414803140003	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011910		NC_000006.12:5368821:A:C		His84Pro																												FARS2_His84Pro	6	5368821	A	C	6	allele	251A>C	G12	527_CAVA_Array_P02	M24	B13A7A8P1_R1	B14A7A8P1_R2				6-5368821-A-C	-	0.82771	1.0	84	.	.	.	6	5369054	C	.	.	6	1_Pathogenic	NC_000006.12	.	His84Pro	.	27.9	.	.	.	D	.	1	1	.	.	.	.	.	.	0.95012	Select	0.6119	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.42108	.	.	.	.	0.98237	.	.	0.97466	0.986	.	1.0	0.922108	3.49	0.99	C	single nucleotide variant	NC_000006.12:g.5368821A>C	.	.	2	0.9041385	.	.	0.9622549	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	.	.	.	.	0.97926	D	0.95204	D	H	15.34014	.	A/A	.	.	.	.	Combined oxidative phosphorylation defect type 14	.	0.91447	.	.	-	5368821	.	-	11.098000	.	0.97732	.	.	.	.	germline	.	Gain of catalytic residue at H84 (P = 0.0281)| Gain of glycosylation at H84 (P = 0.0433)| Loss of MoRF binding (P = 0.0679)| Loss of helix (P = 0.079)| Loss of disorder (P = 0.1597)	0.92954	GRCh38	944	no assertion criteria provided	c.251A>C	.	0.75646	.	.	.	Phenylalanyl-tRNA synthetase	.	.	P	.	.	NM_006567.5(FARS2):c.251A>C (p.His84Pro)		.	SYFM_HUMAN	.	99.0	1.04327041522056	.	D	0.77044	0.9622549	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.94359	.	.	.	.	.	p.His84Pro	.	0.86082	.	germline	.		A	Dec 12, 2019	.	A/A	.	.	1.0	N	6p25.1	.	.	.	SCV001424747	Pathogenic	.	.	Pro	P	-	.	ENSP00000274680	ENST00000274680	.	0.001	.	.	0.756	A	.	4.99072	0.79703	D	D	-	15.32305	.	0.91908	.	.	.	0.99780	.	5368821	Y	10	.	.	.	O95363	.	0.640816	0.47542		.	1.0	D	.	0.9041385	.	0.61779	10667	0.362787	.	-9.18	.	.	0.78662	.	.	.	.	.	.	0.95205	6	FARS2	.	.	His	.	.	6-5368821-A-C	Combined_oxidative_phosphorylation_defect_type_14	.	.	5314053	.	0.956935	0.96912	.	RCV001250396	D	.	.	c.251A>C	.	.	.	0.87376	A/A	rs1758844499	5368821	.	A	.	O95363	.	0.97466	.	0.68239		.	.	.	4.98	.	.	.	5.33	0.88872	.	D	T	.	.	.	.	.	.	.	319519	973746	0.87214	0.68072	0.999933004379272	.	.	0.71675	0.97572	.	.	.	8.916	.	D	.	.	.	.	614946	0.92352	6	.	ENSG00000145982	.	.	.	.	.	2	0.97365	0.12756	.	.	.	.	0.934733790292807	YES	.	0.337595	962036	HGNC:21062	A	.	simple_aae	0.95	.	5368821	CAC	1.000000	.	-	.	0.96682	.	.	.	Pathogenic	0.90296	.	.	.	ClinGen:CA362734878	H	.	0.958043335942	-	0.815	-	0.93495	.	.	0.96295	0.523846149445	0.7894	.	0.98859005853011162	.	-	251A>C 	.	.	C4755312	.	.	.	.	NM_006567.5	-	.	.	1	0.71602	1758844499	.	.	0.95723	0.96898	0.929	0.002	.	0.96594020	5.33	.	.	.	0.283342	0.999515333251888	0.99849	D	.	.	.	0.5682	0.86217	p.His84Pro	.	.	-13.227	0.97114253	.	0.96835	973746	D	.	FARS2	.	D	0.841	.	H84P	D	0.63201	0.943	A/A	principal1																																																																																																				
FARS2_His84Pro	-0.6685215350519559	1.0	-1.9143491804649417	0.11887068523584414	2025_01_Batch_13-14	0.6909273743374503	0.8085540786477744	0.9130441035248813	0.8066052962232809	0.7564985110978174	0.6083734781712353	0.7207950114303019	0.8816449178809973	0.797309862871002	0.6109844495301832	0.6496504262543428	0.7646745450390382	0.8973445107029393	0.8019575795471414	0.6837414803140003	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2				CCSBVarC011910	ALE00015564	NC_000006.12:5368821:A:C	251A>C	His84Pro	CAVA																											FARS2_His84Pro	6	5368821	A	C	6								1	1	1	6-5368821-A-C	-	0.82771	1.0	84	.	.	.	6	5369054	C	.	.	6	1_Pathogenic	NC_000006.12	.	His84Pro	.	27.9	.	.	.	D	.	1	1	.	.	.	.	.	.	0.95012	Select	0.6119	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.42108	.	.	.	.	0.98237	.	.	0.97466	0.986	.	1.0	0.922108	3.49	0.99	C	single nucleotide variant	NC_000006.12:g.5368821A>C	.	.	2	0.9041385	.	.	0.9622549	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	.	.	.	.	0.97926	D	0.95204	D	H	15.34014	.	A/A	.	.	.	.	Combined oxidative phosphorylation defect type 14	.	0.91447	.	.	-	5368821	.	-	11.098000	.	0.97732	.	.	.	.	germline	.	Gain of catalytic residue at H84 (P = 0.0281)| Gain of glycosylation at H84 (P = 0.0433)| Loss of MoRF binding (P = 0.0679)| Loss of helix (P = 0.079)| Loss of disorder (P = 0.1597)	0.92954	GRCh38	944	no assertion criteria provided	c.251A>C	.	0.75646	.	.	.	Phenylalanyl-tRNA synthetase	.	.	P	.	.	NM_006567.5(FARS2):c.251A>C (p.His84Pro)		.	SYFM_HUMAN	.	99.0	1.04327041522056	.	D	0.77044	0.9622549	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.94359	.	.	.	.	.	p.His84Pro	.	0.86082	.	germline	.		A	Dec 12, 2019	.	A/A	.	.	1.0	N	6p25.1	.	.	.	SCV001424747	Pathogenic	.	.	Pro	P	-	.	ENSP00000274680	ENST00000274680	.	0.001	.	.	0.756	A	.	4.99072	0.79703	D	D	-	15.32305	.	0.91908	.	.	.	0.99780	.	5368821	Y	10	.	.	.	O95363	.	0.640816	0.47542		.	1.0	D	.	0.9041385	.	0.61779	10667	0.362787	.	-9.18	.	.	0.78662	.	.	.	.	.	.	0.95205	6	FARS2	.	.	His	.	.	6-5368821-A-C	Combined_oxidative_phosphorylation_defect_type_14	.	.	5314053	.	0.956935	0.96912	.	RCV001250396	D	.	.	c.251A>C	.	.	.	0.87376	A/A	rs1758844499	5368821	.	A	.	O95363	.	0.97466	.	0.68239		.	.	.	4.98	.	.	.	5.33	0.88872	.	D	T	.	.	.	.	.	.	.	319519	973746	0.87214	0.68072	0.999933004379272	.	.	0.71675	0.97572	.	.	.	8.916	.	D	.	.	.	.	614946	0.92352	6	.	ENSG00000145982	.	.	.	.	.	2	0.97365	0.12756	.	.	.	.	0.934733790292807	YES	.	0.337595	962036	HGNC:21062	A	.	simple_aae	0.95	.	5368821	CAC	1.000000	.	-	.	0.96682	.	.	.	Pathogenic	0.90296	.	.	.	ClinGen:CA362734878	H	.	0.958043335942	-	0.815	-	0.93495	.	.	0.96295	0.523846149445	0.7894	.	0.98859005853011162	.	-	251A>C 	.	.	C4755312	.	.	.	.	NM_006567.5	-	.	.	1	0.71602	1758844499	.	.	0.95723	0.96898	0.929	0.002	.	0.96594020	5.33	.	.	.	0.283342	0.999515333251888	0.99849	D	.	.	.	0.5682	0.86217	p.His84Pro	.	.	-13.227	0.97114253	.	0.96835	973746	D	.	FARS2	.	D	0.841	.	H84P	D	0.63201	0.943	A/A	principal1																																																																																																				
FARS2_Asp325Tyr	-0.023869672948344745	1.0	-2.2000767192007293	0.07158255080772746	2025_01_Batch_13-14	0.7875315940839283	0.7224129475293346	0.7460618465562038	0.6805454834471193	0.7622528725017358	0.6455699269581424	0.7109054393595837	0.7144464645351264	0.7059632220054508	0.604386213000429	0.7165507605210353	0.7166591934444592	0.7302541555456651	0.6932543527262851	0.6833195427510824	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011942		NC_000006.12:5545248:G:T		Asp325Tyr																												FARS2_Asp325Tyr	6	5545248	G	T	6	allele	973G>T	A02	527_CAVA_Array_P03	B03	B13A7A8P1_R1	B14A7A8P1_R2				6-5545248-G-T	-	0.65565	0.997	325	.	.	.	6	5545481	T	.	.	6	1_Pathogenic	NC_000006.12	.	Asp325Tyr	.	24.8	.	.	.	T	.	2	1	.	.	.	.	.	.	0.68327	.	0.2879	.	0.70687	.	.	T	T	.	0.666257477821	.	.	.	.	.	0.36213	.	.	.	.	0.73078	.	.	0.82147	0.978	.	28.0	.	2.38	0.72	T	single nucleotide variant	NC_000006.12:g.5545248G>T	.	.	3	0.51400286	.	.	0.7669591	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	.	.	.	.	0.83457	P	0.73958	D	M	5.747102	.	G/G	.	.	.	.	Combined oxidative phosphorylation defect type 14	.	0.70898	.	.	-	5545248	.	-	2.441000	.	0.78377	.	.	.	.	germline	.	Loss of sheet (P = 0.0457)| Gain of helix (P = 0.1736)| Loss of relative solvent accessibility (P = 0.1903)| Loss of solvent accessibility (P = 0.2668)| Gain of loop (P = 0.2754)	0.66319	GRCh38	982	criteria provided, single submitter	c.973G>T	.	0.50124	.	.	.	Aminoacyl-tRNA synthetase, class II	.	.	LB	.	.	NM_006567.5(FARS2):c.973G>T (p.Asp325Tyr)	1	.	SYFM_HUMAN	.	72.0	0.582178761681802	.	.	0.51168	0.7752676	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.90056	.	.	.	.	.	p.Asp325Tyr	.	0.32855	.	germline	.		G	Jun 13, 2018	.	G/G	.	.	1.0	N	6p25.1	.	.	.	SCV000845714	Likely_pathogenic	.	.	Tyr	Y	-	.	ENSP00000316335	ENST00000324331	.	0.006	.	.	0.676	G	.	4.293796	0.59495	N	D	-	5.573649	.	0.91634	.	.	.	0.68326	.	5545248	Y	10	.	.	.	O95363	.	0.386013	0.67222		.	0.856	D	.	0.55408955	.	0.57275	10667	0.0497619	.	-3.91	.	.	0.61594	.	.	.	.	.	.	0.71661	6	FARS2	.	.	Asp	.	.	6-5545248-G-T	Combined_oxidative_phosphorylation_defect_type_14	.	.	5490480	ClinGen:CA10586222|OMIM:611592.0004	0.403449	0.71915	.	RCV000239485	D	.	.	c.973G>T	.	.	.	0.58021	G/G	rs764427452	5545248	.	G	.	O95363	.	0.81643	.	0.32549		.	.	.	2.89	.	.	.	4.28	0.74554	.	D	T	.	.	.	.	.	.	.	319519	253158	0.57486	0.58909	0.969270646572113	.	.	0.71675	0.47535	.	.	.	2.399	.	D	.	.	.	.	614946	0.4425	6	.	ENSG00000145982	.	.	.	.	0.818542452780431	1	0.60995	0.03399	.	.	.	.	0.542820554954507	.	.	0.327437	247570	HGNC:21062	A	.	simple_aae	0.613	.	5545248	GAC	0.995000	.	-	.	0.87061	.	.	.	Likely pathogenic	0.92217	.	.	.	ClinGen:CA10586222,OMIM:611592.0004	D	.	0.863127915216	-	0.549	-	0.89118	.	.	0.81703	0.481479197741	0.2762	.	0.99486466779059812	.	-	973G>T 	.	.	C4755312	.	.	.	.	NM_006567.5	-	.	.	1	0.94767	764427452	.	.	0.86073	0.70738	0.892	0.019	.	0.86435160	5.27	.	.	.	-0.166297	0.927914649263957	0.83536	T	.	.	.	-0.4312	0.65824	p.Asp325Tyr	.	.	-13.746	0.8789767	.	0.78214	253158	D	.	FARS2	.	T	0.365	.	D325Y	D	0.44324	0.76753	G/G	principal1																																																																																																				
FARS2_Asp325Tyr	-0.023869672948344745	1.0	-2.2000767192007293	0.07158255080772746	2025_01_Batch_13-14	0.7875315940839283	0.7224129475293346	0.7460618465562038	0.6805454834471193	0.7622528725017358	0.6455699269581424	0.7109054393595837	0.7144464645351264	0.7059632220054508	0.604386213000429	0.7165507605210353	0.7166591934444592	0.7302541555456651	0.6932543527262851	0.6833195427510824	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2				CCSBVarC011942	ALE00013134	NC_000006.12:5545248:G:T	973G>T	Asp325Tyr	CAVA																											FARS2_Asp325Tyr	6	5545248	G	T	6								1	1	1	6-5545248-G-T	-	0.65565	0.997	325	.	.	.	6	5545481	T	.	.	6	1_Pathogenic	NC_000006.12	.	Asp325Tyr	.	24.8	.	.	.	T	.	2	1	.	.	.	.	.	.	0.68327	.	0.2879	.	0.70687	.	.	T	T	.	0.666257477821	.	.	.	.	.	0.36213	.	.	.	.	0.73078	.	.	0.82147	0.978	.	28.0	.	2.38	0.72	T	single nucleotide variant	NC_000006.12:g.5545248G>T	.	.	3	0.51400286	.	.	0.7669591	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	.	.	.	.	0.83457	P	0.73958	D	M	5.747102	.	G/G	.	.	.	.	Combined oxidative phosphorylation defect type 14	.	0.70898	.	.	-	5545248	.	-	2.441000	.	0.78377	.	.	.	.	germline	.	Loss of sheet (P = 0.0457)| Gain of helix (P = 0.1736)| Loss of relative solvent accessibility (P = 0.1903)| Loss of solvent accessibility (P = 0.2668)| Gain of loop (P = 0.2754)	0.66319	GRCh38	982	criteria provided, single submitter	c.973G>T	.	0.50124	.	.	.	Aminoacyl-tRNA synthetase, class II	.	.	LB	.	.	NM_006567.5(FARS2):c.973G>T (p.Asp325Tyr)	1	.	SYFM_HUMAN	.	72.0	0.582178761681802	.	.	0.51168	0.7752676	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.90056	.	.	.	.	.	p.Asp325Tyr	.	0.32855	.	germline	.		G	Jun 13, 2018	.	G/G	.	.	1.0	N	6p25.1	.	.	.	SCV000845714	Likely_pathogenic	.	.	Tyr	Y	-	.	ENSP00000316335	ENST00000324331	.	0.006	.	.	0.676	G	.	4.293796	0.59495	N	D	-	5.573649	.	0.91634	.	.	.	0.68326	.	5545248	Y	10	.	.	.	O95363	.	0.386013	0.67222		.	0.856	D	.	0.55408955	.	0.57275	10667	0.0497619	.	-3.91	.	.	0.61594	.	.	.	.	.	.	0.71661	6	FARS2	.	.	Asp	.	.	6-5545248-G-T	Combined_oxidative_phosphorylation_defect_type_14	.	.	5490480	ClinGen:CA10586222|OMIM:611592.0004	0.403449	0.71915	.	RCV000239485	D	.	.	c.973G>T	.	.	.	0.58021	G/G	rs764427452	5545248	.	G	.	O95363	.	0.81643	.	0.32549		.	.	.	2.89	.	.	.	4.28	0.74554	.	D	T	.	.	.	.	.	.	.	319519	253158	0.57486	0.58909	0.969270646572113	.	.	0.71675	0.47535	.	.	.	2.399	.	D	.	.	.	.	614946	0.4425	6	.	ENSG00000145982	.	.	.	.	0.818542452780431	1	0.60995	0.03399	.	.	.	.	0.542820554954507	.	.	0.327437	247570	HGNC:21062	A	.	simple_aae	0.613	.	5545248	GAC	0.995000	.	-	.	0.87061	.	.	.	Likely pathogenic	0.92217	.	.	.	ClinGen:CA10586222,OMIM:611592.0004	D	.	0.863127915216	-	0.549	-	0.89118	.	.	0.81703	0.481479197741	0.2762	.	0.99486466779059812	.	-	973G>T 	.	.	C4755312	.	.	.	.	NM_006567.5	-	.	.	1	0.94767	764427452	.	.	0.86073	0.70738	0.892	0.019	.	0.86435160	5.27	.	.	.	-0.166297	0.927914649263957	0.83536	T	.	.	.	-0.4312	0.65824	p.Asp325Tyr	.	.	-13.746	0.8789767	.	0.78214	253158	D	.	FARS2	.	T	0.365	.	D325Y	D	0.44324	0.76753	G/G	principal1																																																																																																				
SDHD_Arg70Thr	6.934747073445434	0.00024459787473878774	-2.639814962822817	0.48151603696647616	2025_01_Batch_13-14	0.876907970433545	0.8712931700523606	0.837882280490174	0.890962358682571	0.8490884350443753	0.8022562630952143	0.8071245964094022	0.8143015360046635	0.804810928005952	0.6776231988824442	0.8395821167643795	0.8392088832308814	0.8260919082474187	0.8478866433442616	0.7633558169634097	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023288		NC_000011.10:112088906:G:C		Arg70Thr																												SDHD_Arg70Thr	11	112088906	G	C	11	allele	209G>C	G11	527_CAVA_Array_P05	M21	B13A7A8P2_R1	B14A7A8P2_R2				11-112088906-G-C	-	0.74309	1.0	70	.	.	.	11	111959630	C	.	.	11	3_Conflicting	NC_000011.10	.	Arg70Thr	.	26.1	.	.	.	D	.	3	1	.	.	.	.	.	.	0.99434	Select	0.9847	.	0.90580	.	.	D	D	.	0.91655607726	.	.	.	.	.	0.65485	.	.	.	.	0.88177	.	.	0.92543	0.998	.	1.0	0.946705	.	0.99	C	single nucleotide variant	NC_000011.10:g.112088906G>C	.	.	2	0.8970499	.	.	0.9203629	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286	.	.	.	.	0.97926	D	0.91973	D	H	8.704333	.	./.	.	.	.	.	Hereditary cancer-predisposing syndrome|not provided|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome	.	0.98128	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112088906	.	-	7.554000	.	0.98629	.	.	.	.	germline	.	Gain of catalytic residue at S73 (P = 0.146)| Loss of helix (P = 0.1706)| Loss of stability (P = 0.1869)| Loss of MoRF binding (P = 0.2156)| Gain of disorder (P = 0.2602)	0.99843	GRCh38	637	criteria provided, conflicting classifications	c.209G>C	.	0.47135	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.209G>C (p.Arg70Thr)	1	.	DHSD_HUMAN	.	99.0	0.796092789603072	.	D	0.82186	0.9137901	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99178	.	.	.	.	.	p.Arg70Thr	.	0.60397	.	germline	.		G	Feb 25, 2023	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV001175136|SCV001831914|SCV004570824	Conflicting_classifications_of_pathogenicity	.	.	Thr	T	-	.	ENSP00000364699	ENST00000375549	.	0.0	.	.	0.618	G	.	4.65578	0.74454	D	D	-	7.673905	.	0.97738	.	.	.	0.96363	.	112088906	Y	10	.	.	.	O14521	.	0.981408	0.42352		.	1.0	D	.	0.85851985	.	0.85369	6392	0.576146	.	-5.8	.	.	0.91343	.	.	.	.	.	.	0.94695	11	SDHD	.	.	Arg	.	.	11-112088906-G-C	Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Cowden_syndrome_3|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided	.	.	111464840	.	0.955196	0.85785	.	RCV001014432|RCV001597242|RCV003769463	D	.	.	c.209G>C	.	.	.	0.96900	./.	rs755047928	112088906	.	G	.	O14521	.	0.93183	.	0.68239		.	.	.	3.88	.	.	.	4.1	0.99854	.	D	T	.	.	.	.	.	.	.	29072|201|97286|140162	820714	0.96849	0.71085	0.999165654182434	.	.	0.71675	0.97277	.	.	.	7.535	.	D	.	.	.	.	171300|606864	0.80966	11	.	ENSG00000204370	.	.	.	.	0.9568632122871339	2	0.97365	0.64339	.	.	.	.	0.69577891730792	YES	.	0.720854	810762	HGNC:10683	A	.	simple_aae	0.966	.	112088906	AGG	1.000000	.	-	.	0.99772	.	.	.	Conflicting classifications of pathogenicity	0.91834	.	.	.	ClinGen:CA382617234	R	.	0.983230327024	-	0.984	-	0.96546	.	.	0.95645	0.688868284225	0.8906	.	0.98501578728992878	.	-	209G>C 	.	.	C1868633|C0031511|CN166604|C1847319|C0027672|C3661900	.	.	.	.	NM_003002.4	-	.	.	1	0.81107	755047928	.	.	0.98287	0.81957	0.956	0.004	.	0.99914825	5.04	.	.	.	0.589817	0.996839713185994	0.95915	D	.	.	.	1.0507	0.99536	p.Arg70Thr	.	.	-11.753	0.9923693	.	0.92509	820714	D	.	SDHD	.	D	0.962	.	R70T	D	.	0.50684	./.	principal1																																																																																																				
FARS2_Thr246Met	-0.10148333665327636	1.0	-2.3538191916275255	0.057290090602365104	2025_01_Batch_13-14	0.6804102176056458	0.7023703706038089	0.7528933762948292	0.7472986977081443	0.6146380679875117	0.6770292548089514	0.7112466396093987	0.7828756750691243	0.8243738879775552	0.4743863958826155	0.6787197362072985	0.7068085051066038	0.7678845256819767	0.7858362928428497	0.5445122319350636	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011873		NC_000006.12:5404666:C:T		Thr246Met																												FARS2_Thr246Met	6	5404666	C	T	6	allele	737C>T	E01	527_CAVA_Array_P03	J01	B13A7A8P1_R1	B14A7A8P1_R2				6-5404666-C-T	-	0.65479	0.996	246	636	15	0	6	5404899	T	6.621350e-03	39	6	2_Benign	NC_000006.12	9520	Thr246Met	0	24.8	0	25	6.838860e-03	T	43	8	1	42624	4.047300e-03	1	29896	8.658010e-04	1	0.63716	.	0.2289	102210	0.68795	84	0.0	T	T	63756	0.655512290444	0.002643824027072758	0	8.392780e-04	3	3	0.34256	16534	44762	320	0.000000e+00	0.74296	313	.	0.55255	0.533	7.564296520423601E-4	79.0	.	2.64	0.21	T	single nucleotide variant	NC_000006.12:g.5404666C>T	0	16722	2	0.26372668	108230	0	0.26475862	0		849	234230	2	0	0.000000e+00	804	7.343280e-03	0	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900	416	15	2.192980e-03	2	0.45549	D	0.54171	D	M	3.862512	10638	C/C	360	87	7116	1606620	not specified|Combined oxidative phosphorylation defect type 14|not provided	16112	0.57140	4	.	-	5404666	7.343280e-03	-	3.963000	23	0.45457	29462	0.001026694045174538	1175990	0	germline;unknown	89360	.	.	GRCh38	973	criteria provided, multiple submitters, no conflicts	c.737C>T	3.378380e-03	0.53107	1298	0	5	Aminoacyl-tRNA synthetase, class II	6.578160e-04	8992	LB	0	5.091300e-04	NM_006567.5(FARS2):c.737C>T (p.Thr246Met)	2	0	SYFM_HUMAN	0	21.0	0.315961225953202	62	.	0.35559	0.3314129	+	9.836990e-04	5		636	8.093230e-04	0	33134	criteria_provided,_multiple_submitters,_no_conflicts	0.86373	3.843670e-03	55	5.972820e-04	0	59598	p.Thr246Met	1	0.40843	.	germline	313		C	Jan 30, 2025	101	C/C	6	89182	1.0	N	6p25.1	178306	.	1.427510e-03	SCV000168422|SCV000652852|SCV000845689|SCV001137051|SCV001154616|SCV005222709|SCV005879797	Benign/Likely_benign	8	8	Met	M	-	912	ENSP00000316335	ENST00000324331	17536	0.027	13304	5	0.596	C	0	4.289772	0.48688	N	T	-	3.055297	.	0.46809	974	0	0.005964214711729622	0.00441	0	5404666	Y	10	0.0037313432835820895	102210	3.384090e-03	O95363	0	0.297402	0.85678		2	0.913	T	89182	0.2838555	42624	0.29823	10667	-0.321825	9520	-3.55	0.005112474437627812	8.095310e-03	0.46673	2.921320e-03	2	74778	0.000000e+00	5910	7	0.51982	6	FARS2	1.203560e-03	0	Thr	213974	7.131480e-03	6-5404666-C-T	not_specified|not_provided|Combined_oxidative_phosphorylation_defect_type_14	0	699	5349898	ClinGen:CA290843	0.131614	0.56747	43	RCV000124982|RCV000527403|RCV000677019	T	0	2	c.737C>T	2	1	70	0.06557	C/C	rs116567033	5404666	14796	C	0.003194888178913738	.	15404	0.49212	6.938660e-04	0.35501		0	4	2.234040e-05	2.83	0	1182	264690	4.44	0.66816	6352	T	T	22	2.107550e-03	3	1850	.	0	11	319519	137291	0.51677	0.58315	0.0169158800264063	9816	16	0.71675	0.24846	2.535160e-03	7.131480e-03	1175990	3.703	4.128250e-03	D	13394	4	0.004934074	0	614946	0.54631	6	1.486890e-03	ENSG00000145982	1.097940e-03	0.006629053425010936	102	0	0.7281157812391854	2	0.64880	0.05579	29978	1306	6.838860e-03	3.758520e-03	0.173260709396764	.	3.581020e-03	0.024038	140994	HGNC:21062	N	0	simple_aae	0.195	205656	5404666	ACG	0.999000	0	-	0.0025468622656886716	0.00254	8.095310e-03	25	5	Benign/Likely benign	0.69874	45	20	224	ClinGen:CA290843	T	0	0.819830007893	-	.	-	0.62419	948	17442	0.72612	0.467225492001	0.0974	3	0.99768528528554123	280	-	737C>T 	699	0.004987960096319229	CN169374|C3661900|C4755312	0	0	2	0	NM_006567.5	-	6	0.005763688760806916	0	0.91526	116567033	2310	0.006066157570545954	0.81670	0.48124	0.608	0.073	9456	0.71377310	5.32	.	.	3.402500e-03	-0.227665	0.64624273715353	0.82191	T	4502	6178	9532	-0.7616	0.59266	p.Thr246Met	0	0	-9.33	0.0118563175	90	0.65262	137291	D	29418	FARS2	2.358780e-03	T	0.317	21618	.	D	0.48287	0.33565	C/C	principal1																																																																																																				
RAF1_Leu613Val	-5.80016652158815	0.04739521026534352	5.723555823832908	0.0022460511579955496	2025_01_Batch_13-14	0.7624597863846476	0.7364161258611203	0.796199025654295	0.7788606988716829	0.6848428071283864											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008860		NC_000003.12:12584624:G:C		Leu613Val																												RAF1_Leu613Val	3	12584624	G	C	3	allele	1837C>G	F04	527_CAVA_Array_P05	K07	B13A7A8P2_R1	B14A7A8P2_R2				3-12584624-G-C	-	0.59191	0.135	613	.	.	.	3	12626123	C	.	.	3	1_Pathogenic	NC_000003.12	.	Leu613Val	.	24.1	.	.	.	T	.	11	1	.	.	.	.	.	.	0.82939	Select	0.4146	.	0.27320	.	.	D	D	.	0.394351984474	.	.	.	.	.	0.84115	.	.	.	.	0.56009	.	.	0.67095	0.995	.	21.0	.	4.17	0.79	C	single nucleotide variant	NC_000003.12:g.12584624G>C	.	.	3	0.22544135	.	.	0.5087415	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008647,MedGen:C3495498,OMIM:192600|	.	.	.	.	0.86984	B	0.47307	B	M	3.261897	.	G/G	.	.	.	.	Noonan syndrome 5|LEOPARD syndrome 2|Noonan syndrome with multiple lentigines|RASopathy|not provided|Noonan syndrome|Noonan syndrome with multiple lentigines;Noonan syndrome|Hypertrophic cardiomyopathy 1|RAF1-related disorder	.	0.80297	.	.	-	12584624	.	-	5.815000	.	0.91143	.	.	.	.	germline;unknown	.	Loss of catalytic residue at L613 (P = 0.0273)| Loss of glycosylation at K615 (P = 0.0453)| Gain of methylation at K615 (P = 0.0691)| Gain of ubiquitination at K615 (P = 0.1132)| Loss of stability (P = 0.1352)	0.92541	GRCh38	692	reviewed by expert panel	c.1837C>G	.	0.53511	.	.	.	.	.	.	A	.	.	NM_002880.4(RAF1):c.1837C>G (p.Leu613Val)	3	.	RAF1_HUMAN	.	79.0	0.1905950925256	.	.	0.64853	0.5052323	-	.	.		.	.	2	.	reviewed_by_expert_panel	0.96257	.	.	.	.	.	p.Leu613Val	.	0.50112	.	germline	.		G	Apr 03, 2017	.	G/G	.	.	1.0	N	3p25.2	.	.	.	SCV000616381	Pathogenic	.	.	Val	V	-	.	ENSP00000251849	ENST00000251849	.	0.019	.	.	0.676	G	.	4.008235	0.57928	D	D	-	3.75805	.	0.73737	.	.	.	0.68255	.	12584624	Y	9	.	.	.	P04049	.	0.760318	0.75865		.	0.252	D	.	0.225398	.	0.73271	5894	0.221088	.	-2.57	.	.	0.60085	.	.	.	.	.	.	0.47312	3	RAF1	.	.	Leu	.	.	3-12584624-G-C	not_provided|Hypertrophic_cardiomyopathy_1|Noonan_syndrome|RAF1-related_disorder|Noonan_syndrome_with_multiple_lentigines|RASopathy|Noonan_syndrome_5|LEOPARD_syndrome_2	.	.	12601123	ClinGen:CA257066|OMIM:164760.0004|UniProtKB:P04049#VAR_037821	0.504613	0.50505	.	RCV000014990|RCV000014989|RCV000020508|RCV000159089|RCV000254689|RCV000440827|RCV000824753|RCV001256891|RCV004532353	D	.	.	c.1837C>G	.	.	.	0.75698	G/G	rs80338797	12584624	.	G	.	P04049	.	0.67300	.	0.68239		.	.	.	2.485	.	.	.	4.46	0.93442	.	D	D	.	.	.	.	.	.	.	648|500|536391|648|500	13960	0.75382	0.40309	0.969073593616486	.	.	0.71675	0.53448	.	.	.	3.761	.	D	.	.	.	.	192600|PS163950|PS151100|611553|611554	0.55045	3	.	ENSG00000132155	.	.	.	.	.	1	0.39069	0.58673	.	.	.	.	0.307022034721395	YES	.	0.082094	28999	HGNC:9829	A	.	simple_aae	0.839	.	12584624	CTA	1.000000	.	-	.	0.83230	.	.	.	Pathogenic	0.70025	.	.	.	ClinGen:CA257066,UniProtKB:P04049#VAR_037821,OMIM:164760.0004	L	.	0.91975856692	-	0.809	-	0.59354	.	.	0.69748	0.81423997879	0.5072	.	0.99627613236244716	.	-	1837C>G 	.	.	C3661900|C3495498|C0028326|C0175704|C5555857|C1969057|C1969056	.	.	.	.	NM_002880.4	-	.	.	1	0.83110	80338797	.	.	0.91833	0.55718	0.568	0.022	.	0.98658720	5.41	.	.	.	0.0798012	0.993864972354477	0.72164	T	.	.	.	-0.0874	0.76085	p.Leu613Val	.	.	-9.343	0.8424604	.	0.90295	13960	D	.	RAF1	.	D	0.579	.	L613V	D	0.79380	0.76753	G/G	principal3																																																																																																				
RAF1_Leu613Val	-5.80016652158815	0.04739521026534352	5.723555823832908	0.0022460511579955496	2025_01_Batch_13-14	0.7624597863846476	0.7364161258611203	0.796199025654295	0.7788606988716829	0.6848428071283864											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1				CCSBVarC008860	ALE00011641	NC_000003.12:12584624:G:C	1837C>G	Leu613Val	CAVA																											RAF1_Leu613Val	3	12584624	G	C	3								1	1	1	3-12584624-G-C	-	0.59191	0.135	613	.	.	.	3	12626123	C	.	.	3	1_Pathogenic	NC_000003.12	.	Leu613Val	.	24.1	.	.	.	T	.	11	1	.	.	.	.	.	.	0.82939	Select	0.4146	.	0.27320	.	.	D	D	.	0.394351984474	.	.	.	.	.	0.84115	.	.	.	.	0.56009	.	.	0.67095	0.995	.	21.0	.	4.17	0.79	C	single nucleotide variant	NC_000003.12:g.12584624G>C	.	.	3	0.22544135	.	.	0.5087415	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008647,MedGen:C3495498,OMIM:192600|	.	.	.	.	0.86984	B	0.47307	B	M	3.261897	.	G/G	.	.	.	.	Noonan syndrome 5|LEOPARD syndrome 2|Noonan syndrome with multiple lentigines|RASopathy|not provided|Noonan syndrome|Noonan syndrome with multiple lentigines;Noonan syndrome|Hypertrophic cardiomyopathy 1|RAF1-related disorder	.	0.80297	.	.	-	12584624	.	-	5.815000	.	0.91143	.	.	.	.	germline;unknown	.	Loss of catalytic residue at L613 (P = 0.0273)| Loss of glycosylation at K615 (P = 0.0453)| Gain of methylation at K615 (P = 0.0691)| Gain of ubiquitination at K615 (P = 0.1132)| Loss of stability (P = 0.1352)	0.92541	GRCh38	692	reviewed by expert panel	c.1837C>G	.	0.53511	.	.	.	.	.	.	A	.	.	NM_002880.4(RAF1):c.1837C>G (p.Leu613Val)	3	.	RAF1_HUMAN	.	79.0	0.1905950925256	.	.	0.64853	0.5052323	-	.	.		.	.	2	.	reviewed_by_expert_panel	0.96257	.	.	.	.	.	p.Leu613Val	.	0.50112	.	germline	.		G	Apr 03, 2017	.	G/G	.	.	1.0	N	3p25.2	.	.	.	SCV000616381	Pathogenic	.	.	Val	V	-	.	ENSP00000251849	ENST00000251849	.	0.019	.	.	0.676	G	.	4.008235	0.57928	D	D	-	3.75805	.	0.73737	.	.	.	0.68255	.	12584624	Y	9	.	.	.	P04049	.	0.760318	0.75865		.	0.252	D	.	0.225398	.	0.73271	5894	0.221088	.	-2.57	.	.	0.60085	.	.	.	.	.	.	0.47312	3	RAF1	.	.	Leu	.	.	3-12584624-G-C	not_provided|Hypertrophic_cardiomyopathy_1|Noonan_syndrome|RAF1-related_disorder|Noonan_syndrome_with_multiple_lentigines|RASopathy|Noonan_syndrome_5|LEOPARD_syndrome_2	.	.	12601123	ClinGen:CA257066|OMIM:164760.0004|UniProtKB:P04049#VAR_037821	0.504613	0.50505	.	RCV000014990|RCV000014989|RCV000020508|RCV000159089|RCV000254689|RCV000440827|RCV000824753|RCV001256891|RCV004532353	D	.	.	c.1837C>G	.	.	.	0.75698	G/G	rs80338797	12584624	.	G	.	P04049	.	0.67300	.	0.68239		.	.	.	2.485	.	.	.	4.46	0.93442	.	D	D	.	.	.	.	.	.	.	648|500|536391|648|500	13960	0.75382	0.40309	0.969073593616486	.	.	0.71675	0.53448	.	.	.	3.761	.	D	.	.	.	.	192600|PS163950|PS151100|611553|611554	0.55045	3	.	ENSG00000132155	.	.	.	.	.	1	0.39069	0.58673	.	.	.	.	0.307022034721395	YES	.	0.082094	28999	HGNC:9829	A	.	simple_aae	0.839	.	12584624	CTA	1.000000	.	-	.	0.83230	.	.	.	Pathogenic	0.70025	.	.	.	ClinGen:CA257066,UniProtKB:P04049#VAR_037821,OMIM:164760.0004	L	.	0.91975856692	-	0.809	-	0.59354	.	.	0.69748	0.81423997879	0.5072	.	0.99627613236244716	.	-	1837C>G 	.	.	C3661900|C3495498|C0028326|C0175704|C5555857|C1969057|C1969056	.	.	.	.	NM_002880.4	-	.	.	1	0.83110	80338797	.	.	0.91833	0.55718	0.568	0.022	.	0.98658720	5.41	.	.	.	0.0798012	0.993864972354477	0.72164	T	.	.	.	-0.0874	0.76085	p.Leu613Val	.	.	-9.343	0.8424604	.	0.90295	13960	D	.	RAF1	.	D	0.579	.	L613V	D	0.79380	0.76753	G/G	principal3																																																																																																				
SDHD_His102Leu	10.438326676694441	0.000021211171344780724	4.685700930445011	0.010670406461331302	2025_01_Batch_13-14	0.831368025803328	0.947252744964598	0.9658088804128862	0.9381400157371114	0.8279097867431578	0.9522927559250102	0.9267390341730586	0.9620227410524386	0.9527092880084899	0.863479764578817	0.8918303908641692	0.9369958895688283	0.9639158107326624	0.9454246518728007	0.8456947756609874	0.0	1.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD	ENSG00000204370	5678	201957	CCSBVarC006160	ALE00006160	NC_000011.10:112089002:A:T	305A>T	His102Leu	CEGS2	CegsMutGDEh1014	D09	GDEhDisVCh_40066	F02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			SDHD_His102Leu	11	112089002	A	T	11											11-112089002-A-T	-	0.79446	0.999	102	.	.	.	11	111959726	T	.	.	11	1_Pathogenic	NC_000011.10	.	His102Leu	.	27.1	.	.	.	D	.	3	1	.	.	.	.	.	.	0.97545	Select	0.9985	.	0.77914	.	.	D	D	.	0.822681584721	.	.	.	.	.	0.50068	.	.	.	.	0.99269	.	.	0.86080	0.699	.	1.0	0.716128	.	0.99	T	single nucleotide variant	NC_000011.10:g.112089002A>T	.	.	3	0.7859342	.	.	0.8378367	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	.	.	.	.	0.99291	D	0.85055	D	H	6.522557	.	./.	.	.	.	.	Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	.	0.94493	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112089002	.	-	9.318000	.	0.99413	.	.	.	.	germline	.	Loss of catalytic residue at G103 (P = 0.0541)| Gain of helix (P = 0.2294)| Loss of disorder (P = 0.6187)| Gain of stability (P = 0.6318)| Gain of loop (P = 0.6993)	0.99876	GRCh38	637	criteria provided, multiple submitters, no conflicts	c.305A>T	.	0.43622	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.305A>T (p.His102Leu)	2	.	DHSD_HUMAN	.	99.0	0.654068949213661	.	T	0.78714	0.8351151	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99109	.	.	.	.	.	p.His102Leu	.	0.80050	.	germline	.		A	Apr 08, 2024	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV000664577|SCV000762668	Pathogenic	.	.	Leu	L	-	.	ENSP00000364699	ENST00000375549	.	0.001	.	.	0.691	A	.	4.855792	0.92967	D	D	-	5.122925	.	0.98395	.	.	.	0.99626	.	112089002	Y	9	.	.	.	O14521	.	0.976715	0.30834		.	0.928	D	.	0.7502163	.	0.34149	6392	0.566984	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.87236	11	SDHD	.	.	His	.	.	11-112089002-A-T	Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_1	.	.	111464936	ClinGen:CA016665|OMIM:602690.0005|UniProtKB:O14521#VAR_010040	0.948642	0.76505	.	RCV000007307|RCV000566289|RCV002228003	D	.	.	c.305A>T	.	.	.	0.96335	./.	rs104894302	112089002	.	A	.	O14521	.	0.86274	.	0.68239		.	.	.	3.925	.	.	.	3.86	0.99780	.	D	T	.	.	.	.	.	.	.	140162|201|29072|97286|29072	6898	0.96276	0.67039	0.999900341033936	.	.	0.71675	0.96033	.	.	.	8.712	.	D	.	.	.	.	171300|606864|168000	0.9112	11	.	ENSG00000204370	.	.	.	.	0.9890505541009824	2	0.66273	0.64339	.	.	.	.	0.496041743816457	YES	.	0.795712	21937	HGNC:10683	A	.	simple_aae	0.983	.	112089002	CAT	1.000000	.	-	.	0.99961	.	.	.	Pathogenic	0.80483	.	.	.	ClinGen:CA016665,UniProtKB:O14521#VAR_010040,OMIM:602690.0005	H	.	0.994554434502	-	0.988	-	0.98282	.	.	0.98896	0.580342292786	0.8306	.	0.96663677478836951	.	-	305A>T 	.	.	C0027672|CN166604|C1868633|C0031511|C1847319|C3494181	.	.	.	.	NM_003002.4	-	.	.	1	0.45817	104894302	.	.	0.99442	0.67552	0.946	0.002	.	0.99904233	5.04	.	.	.	0.576657	0.996540517566282	0.96220	D	.	.	.	0.8082	0.99959	p.His102Leu	.	.	-9.818	0.99472225	.	0.92238	6898	D	.	SDHD	.	D	0.909	.	H102L	D	.	0.84104	./.	principal1																																																																																																				
SDHD_His102Leu	10.438326676694441	0.000021211171344780724	4.685700930445011	0.010670406461331302	2025_01_Batch_13-14	0.831368025803328	0.947252744964598	0.9658088804128862	0.9381400157371114	0.8279097867431578	0.9522927559250102	0.9267390341730586	0.9620227410524386	0.9527092880084899	0.863479764578817	0.8918303908641692	0.9369958895688283	0.9639158107326624	0.9454246518728007	0.8456947756609874	0.0	1.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023325		NC_000011.10:112089002:A:T		His102Leu																												SDHD_His102Leu	11	112089002	A	T	11	allele	305A>T	E12	527_CAVA_Array_P05	I23	B13A7A8P2_R1	B14A7A8P2_R2				11-112089002-A-T	-	0.79446	0.999	102	.	.	.	11	111959726	T	.	.	11	1_Pathogenic	NC_000011.10	.	His102Leu	.	27.1	.	.	.	D	.	3	1	.	.	.	.	.	.	0.97545	Select	0.9985	.	0.77914	.	.	D	D	.	0.822681584721	.	.	.	.	.	0.50068	.	.	.	.	0.99269	.	.	0.86080	0.699	.	1.0	0.716128	.	0.99	T	single nucleotide variant	NC_000011.10:g.112089002A>T	.	.	3	0.7859342	.	.	0.8378367	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	.	.	.	.	0.99291	D	0.85055	D	H	6.522557	.	./.	.	.	.	.	Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	.	0.94493	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112089002	.	-	9.318000	.	0.99413	.	.	.	.	germline	.	Loss of catalytic residue at G103 (P = 0.0541)| Gain of helix (P = 0.2294)| Loss of disorder (P = 0.6187)| Gain of stability (P = 0.6318)| Gain of loop (P = 0.6993)	0.99876	GRCh38	637	criteria provided, multiple submitters, no conflicts	c.305A>T	.	0.43622	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.305A>T (p.His102Leu)	2	.	DHSD_HUMAN	.	99.0	0.654068949213661	.	T	0.78714	0.8351151	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99109	.	.	.	.	.	p.His102Leu	.	0.80050	.	germline	.		A	Apr 08, 2024	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV000664577|SCV000762668	Pathogenic	.	.	Leu	L	-	.	ENSP00000364699	ENST00000375549	.	0.001	.	.	0.691	A	.	4.855792	0.92967	D	D	-	5.122925	.	0.98395	.	.	.	0.99626	.	112089002	Y	9	.	.	.	O14521	.	0.976715	0.30834		.	0.928	D	.	0.7502163	.	0.34149	6392	0.566984	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.87236	11	SDHD	.	.	His	.	.	11-112089002-A-T	Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_1	.	.	111464936	ClinGen:CA016665|OMIM:602690.0005|UniProtKB:O14521#VAR_010040	0.948642	0.76505	.	RCV000007307|RCV000566289|RCV002228003	D	.	.	c.305A>T	.	.	.	0.96335	./.	rs104894302	112089002	.	A	.	O14521	.	0.86274	.	0.68239		.	.	.	3.925	.	.	.	3.86	0.99780	.	D	T	.	.	.	.	.	.	.	140162|201|29072|97286|29072	6898	0.96276	0.67039	0.999900341033936	.	.	0.71675	0.96033	.	.	.	8.712	.	D	.	.	.	.	171300|606864|168000	0.9112	11	.	ENSG00000204370	.	.	.	.	0.9890505541009824	2	0.66273	0.64339	.	.	.	.	0.496041743816457	YES	.	0.795712	21937	HGNC:10683	A	.	simple_aae	0.983	.	112089002	CAT	1.000000	.	-	.	0.99961	.	.	.	Pathogenic	0.80483	.	.	.	ClinGen:CA016665,UniProtKB:O14521#VAR_010040,OMIM:602690.0005	H	.	0.994554434502	-	0.988	-	0.98282	.	.	0.98896	0.580342292786	0.8306	.	0.96663677478836951	.	-	305A>T 	.	.	C0027672|CN166604|C1868633|C0031511|C1847319|C3494181	.	.	.	.	NM_003002.4	-	.	.	1	0.45817	104894302	.	.	0.99442	0.67552	0.946	0.002	.	0.99904233	5.04	.	.	.	0.576657	0.996540517566282	0.96220	D	.	.	.	0.8082	0.99959	p.His102Leu	.	.	-9.818	0.99472225	.	0.92238	6898	D	.	SDHD	.	D	0.909	.	H102L	D	.	0.84104	./.	principal1																																																																																																				
SDHD_His102Leu	10.438326676694441	0.000021211171344780724	4.685700930445011	0.010670406461331302	2025_01_Batch_13-14	0.831368025803328	0.947252744964598	0.9658088804128862	0.9381400157371114	0.8279097867431578	0.9522927559250102	0.9267390341730586	0.9620227410524386	0.9527092880084899	0.863479764578817	0.8918303908641692	0.9369958895688283	0.9639158107326624	0.9454246518728007	0.8456947756609874	0.0	1.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023325	ALE00034952	NC_000011.10:112089002:A:T	305A>T	His102Leu	CAVA																											SDHD_His102Leu	11	112089002	A	T	11								1	1	1	11-112089002-A-T	-	0.79446	0.999	102	.	.	.	11	111959726	T	.	.	11	1_Pathogenic	NC_000011.10	.	His102Leu	.	27.1	.	.	.	D	.	3	1	.	.	.	.	.	.	0.97545	Select	0.9985	.	0.77914	.	.	D	D	.	0.822681584721	.	.	.	.	.	0.50068	.	.	.	.	0.99269	.	.	0.86080	0.699	.	1.0	0.716128	.	0.99	T	single nucleotide variant	NC_000011.10:g.112089002A>T	.	.	3	0.7859342	.	.	0.8378367	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	.	.	.	.	0.99291	D	0.85055	D	H	6.522557	.	./.	.	.	.	.	Paragangliomas 1|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	.	0.94493	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112089002	.	-	9.318000	.	0.99413	.	.	.	.	germline	.	Loss of catalytic residue at G103 (P = 0.0541)| Gain of helix (P = 0.2294)| Loss of disorder (P = 0.6187)| Gain of stability (P = 0.6318)| Gain of loop (P = 0.6993)	0.99876	GRCh38	637	criteria provided, multiple submitters, no conflicts	c.305A>T	.	0.43622	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.305A>T (p.His102Leu)	2	.	DHSD_HUMAN	.	99.0	0.654068949213661	.	T	0.78714	0.8351151	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99109	.	.	.	.	.	p.His102Leu	.	0.80050	.	germline	.		A	Apr 08, 2024	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV000664577|SCV000762668	Pathogenic	.	.	Leu	L	-	.	ENSP00000364699	ENST00000375549	.	0.001	.	.	0.691	A	.	4.855792	0.92967	D	D	-	5.122925	.	0.98395	.	.	.	0.99626	.	112089002	Y	9	.	.	.	O14521	.	0.976715	0.30834		.	0.928	D	.	0.7502163	.	0.34149	6392	0.566984	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.87236	11	SDHD	.	.	His	.	.	11-112089002-A-T	Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_1	.	.	111464936	ClinGen:CA016665|OMIM:602690.0005|UniProtKB:O14521#VAR_010040	0.948642	0.76505	.	RCV000007307|RCV000566289|RCV002228003	D	.	.	c.305A>T	.	.	.	0.96335	./.	rs104894302	112089002	.	A	.	O14521	.	0.86274	.	0.68239		.	.	.	3.925	.	.	.	3.86	0.99780	.	D	T	.	.	.	.	.	.	.	140162|201|29072|97286|29072	6898	0.96276	0.67039	0.999900341033936	.	.	0.71675	0.96033	.	.	.	8.712	.	D	.	.	.	.	171300|606864|168000	0.9112	11	.	ENSG00000204370	.	.	.	.	0.9890505541009824	2	0.66273	0.64339	.	.	.	.	0.496041743816457	YES	.	0.795712	21937	HGNC:10683	A	.	simple_aae	0.983	.	112089002	CAT	1.000000	.	-	.	0.99961	.	.	.	Pathogenic	0.80483	.	.	.	ClinGen:CA016665,UniProtKB:O14521#VAR_010040,OMIM:602690.0005	H	.	0.994554434502	-	0.988	-	0.98282	.	.	0.98896	0.580342292786	0.8306	.	0.96663677478836951	.	-	305A>T 	.	.	C0027672|CN166604|C1868633|C0031511|C1847319|C3494181	.	.	.	.	NM_003002.4	-	.	.	1	0.45817	104894302	.	.	0.99442	0.67552	0.946	0.002	.	0.99904233	5.04	.	.	.	0.576657	0.996540517566282	0.96220	D	.	.	.	0.8082	0.99959	p.His102Leu	.	.	-9.818	0.99472225	.	0.92238	6898	D	.	SDHD	.	D	0.909	.	H102L	D	.	0.84104	./.	principal1																																																																																																				
SDHD_Leu139Arg	3.798682331808146	0.014136237819953438	3.6405640563005033	0.05718059390456844	2025_01_Batch_13-14	0.8235345660865708	0.8461560115031072	0.8174137578528592	0.7586154412052757	0.7453884050906837	0.8709498956187062	0.8359888050434786	0.8469426184661639	0.8497719666419139	0.7997680457440315	0.8472422308526385	0.8410724082732929	0.8321781881595116	0.8041937039235948	0.7725782254173577	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023371		NC_000011.10:112094906:T:G		Leu139Arg																												SDHD_Leu139Arg	11	112094906	T	G	11	allele	416T>G	D01	527_CAVA_Array_P06	G02	B13A7A8P2_R1	B14A7A8P2_R2				11-112094906-T-G	-	0.82116	1.0	139	.	.	.	11	111965630	G	.	.	11	1_Pathogenic	NC_000011.10	.	Leu139Arg	.	27.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99961	Select	0.9834	.	0.90580	.	.	D	D	.	0.916340064084	.	.	.	.	.	0.88307	.	.	.	.	0.85499	.	.	0.99491	0.999	.	.	0.929107	.	.	G	single nucleotide variant	NC_000011.10:g.112094906T>G	.	.	2	0.9717924	.	.	0.9855054	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633	.	.	.	.	.	D	0.99533	D	H	10.80072	.	./.	.	.	.	.	Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss	.	0.97910	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094906	.	-	7.853000	.	0.99793	.	.	.	.	germline	.	Gain of methylation at L139 (P = 0.0075)| Gain of sheet (P = 0.1208)| Gain of relative solvent accessibility (P = 0.1259)| Loss of helix (P = 0.1299)| Gain of solvent accessibility (P = 0.1319)	0.94573	GRCh38	638	criteria provided, single submitter	c.416T>G	.	0.62327	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.416T>G (p.Leu139Arg)	1	.	DHSD_HUMAN	.	.	0.890230994464423	.	D	0.84786	0.9855054	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99356	.	.	.	.	.	p.Leu139Arg	.	0.71102	.	germline	.		T	Jun 09, 2022	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV000823868	Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000364699	ENST00000375549	.	0.0	.	.	0.661	T	.	4.963449	0.92967	D	D	-	10.14829	.	0.98560	.	.	.	0.97327	.	112094906	Y	10	.	.	.	O14521	.	0.976158	0.84785		.	1.0	D	.	0.9717924	.	0.91597	6392	0.5783	.	-5.45	.	.	0.91343	.	.	.	.	.	.	0.99533	11	SDHD	.	.	Leu	.	.	11-112094906-T-G	Cowden_syndrome_3|Carney-Stratakis_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma	.	.	111470840	.	0.951878	0.91223	.	RCV002532294	D	.	.	c.416T>G	.	.	.	0.96940	./.	rs80338847	112094906	.	T	.	O14521	.	0.99491	.	0.68239		.	.	.	3.855	.	.	.	4.85	0.99771	.	D	D	.	.	.	.	.	.	.	201|97286|29072	573651	0.96890	0.71077	0.99942147731781	.	.	0.71675	0.96672	.	.	.	7.682	.	D	.	.	.	.	606864|171300	0.8343	11	.	ENSG00000204370	.	.	.	.	0.9940455699504791	2	0.97365	0.64247	.	.	.	.	0.800832412790881	YES	.	0.815524	564429	HGNC:10683	.	.	.	0.994	.	112094906	CTT	1.000000	.	-	.	0.97976	.	.	.	Likely pathogenic	0.98918	.	.	.	ClinGen:CA382619304	L	.	0.983425624168	-	0.84	-	0.99346	.	.	0.99400	0.841523647308	0.9277	.	0.99757144050314794	.	-	416T>G 	.	.	CN166604|C1847319|C1868633|C0031511	.	.	.	.	NM_003002.4	-	.	.	1	0.73846	80338847	.	.	0.98307	0.89794	0.982	0.001	.	0.99940443	4.85	.	.	.	0.592912	0.999298612534229	0.95736	D	.	.	.	1.0402	0.99493	p.Leu139Arg	.	.	-17.005	0.9803145	.	0.96182	573651	D	.	SDHD	.	D	0.988	.	L139R	D	.	0.55789	./.	principal1																																																																																																				
BRIP1_Leu195Pro	1.2668702182308096	0.27186458798147173	-1.898944257778324	0.3193129417034555	2025_01_Batch_13-14	0.7376117184704061	0.6595460545978806	0.6706831149265664	0.6998852237962895	0.6857644396183068	0.6639999428315029	0.7121556631762217	0.6922164654476003	0.7070030808612925	0.6409849852160716	0.7008058306509545	0.6858508588870511	0.6814497901870833	0.703444152328791	0.6633747124171891	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRIP1	BRIP1	ENSG00000136492	55128	28906	CCSBVarC002407	ALE00002407	NC_000017.11:61847144:A:G	584T>C	Leu195Pro	RC4	RC4_Mut_GDEh1031	G07	GDEhDisVCh_40040	B12	2	RC4_Mut_GDDh1031	G07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			BRIP1_Leu195Pro	17	61847144	A	G	17											17-61847144-A-G	-	0.08447	0.0	195	178	0	0	17	59924505	G	2.240180e-03	11	17	2_Benign	NC_000017.11	525	Leu195Pro	0	5.175	0	5	2.055370e-03	T	0	25	.	42762	1.972060e-03	0	30522	0.000000e+00	0	0.29213	.	0.1553	102658	0.02950	25	0.0	T	T	64018	.	5.304476978569913E-4	0	0.000000e+00	0	0	0.17890	17112	44838	39	0.000000e+00	0.08443	94	.	0.02528	0.001	0.0	.	.	-1.01	.	G	single nucleotide variant	NC_000017.11:g.61847144A>G	0	16718	2	0.03966814	109370	0	0.031770874	0	G	407	236808	1	0	0.000000e+00	794	2.198210e-03	0	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:C3661900|MedGen:CN221562|MedGen:CN239206|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	270	197	0.000000e+00	0	0.37131	B	0.01687	B	N	0.2952269	3615	A/A	360	28	7160	1613712	not specified|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group J|Ovarian neoplasm|Familial cancer of breast|not provided|Breast and/or ovarian cancer|BRIP1-related disorder|Fanconi anemia complementation group J;Familial cancer of breast	16212	0.45481	1	.	-	61847144	2.198210e-03	-	3.456000	8	0.02684	29594	0	64018	0	germline;unknown	91082	.	.	GRCh38	45	criteria provided, multiple submitters, no conflicts	.	4.259220e-04	0.13280	355	0	0	.	1.046780e-02	9038	.	0	0.000000e+00	NM_032043.3(BRIP1):c.584T>C (p.Leu195Pro)	2	0	FANCJ_HUMAN	1	.	-1.11276007648918	21	.	0.00668	0.029862495	-	2.793300e-04	2	0.00227726	178	0.000000e+00	0	34260	criteria_provided,_multiple_submitters,_no_conflicts	0.74722	2.468680e-03	7	1.113770e-02	0	60024	.	0	0.38560	.	germline	94	61847144	A	Mar 04, 2025	13	A/A	2	89524	0.393	N	17q23.2	198354	.	4.934620e-04	SCV000150071|SCV000166684|SCV000172953|SCV000489853|SCV000489854|SCV000699730|SCV000889221|SCV000910543|SCV001140793|SCV001157291|SCV001287318|SCV002043640|SCV002066143|SCV002533721|SCV002551206|SCV002819151|SCV004016923|SCV004145821|SCV005404126	Benign/Likely_benign	149	0	Pro	P	-	912	ENSP00000508303	ENST00000683039	17680	.	13404	2	-0.592	A	1	0.472332	0.15573	N	.	-	0.4800915	.	0.54133	964	1	9.940357852882703E-4	0.00012	0	61847144	Y	9	0	102658	0.000000e+00	Q9BX63	1	0.06698	0.00915	A	0	0.001	D	89524	0.031210301	42762	0.02614	83990	-0.505713	2836	.	0.002044989775051125	8.200820e-03	0.13823	5.099440e-04	0	75020	0.000000e+00	6056	2	0.04125	17	BRIP1	4.265530e-04	0	Leu	229246	1.988290e-03	17-61847144-A-G	BRIP1-related_disorder|Breast_and/or_ovarian_cancer|Fanconi_anemia_complementation_group_J|not_specified|Ovarian_neoplasm|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	0	211	57279287	ClinGen:CA157725	0.039188	0.06339	5	RCV000120407|RCV000116162|RCV000410203|RCV000411259|RCV000990029|RCV000589840|RCV001798361|RCV004528812|RCV001082551	.	0	0	c.584T>C	0	0	525	0.00508	A/A	rs4988347	61847144	14896	A	7.987220447284345E-4	.	15688	0.03049	9.113620e-03	0.35501	17	1	0	0.000000e+00	0.75	0	322	264690	-0.0114	0.32835	3400	T	T	8	6.879830e-04	0	672	.	0	175	84|140162|227535	128193	0.21493	0.28563	0.00119638136319552	9786	4	0.262	0.05557	7.297140e-04	1.988290e-03	1179684	0.364	1.956200e-03	.	13378	0	0.0012014054	0	609054|114480	0.20126	17	5.370570e-04	ENSG00000136492	8.200820e-03	0.001623360254897809	13	0	.	2	0.04348	0.97779	30604	318	2.055370e-03	9.329600e-04	-1.00712536356647	.	4.281860e-04	0.03251	133650	HGNC:20473	.	0	.	0.019	208056	61847144	CTC	0.999000	0	-	5.109339873288372E-4	0.00085	2.404030e-03	5	1	Benign/Likely benign	0.24602	8	0	56	ClinGen:CA157725	L	0	.	-	.	-	0.14123	467	15672	0.47148	0.3499096632	.	1	0.2264141844658854	276	-	584T>C 	211	0.0017866258295048494	CN239206|CN221562|C1836860|CN169374|C0919267|C0027672|C0346153|C3661900	0	0	0	0	NM_032043.3	-	1	0.001440922190201729	0	0.13035	4988347	2320	0.0015485548275651483	0.39799	0.09467	.	.	9426	0.23876125	5.26	.	.	4.247810e-04	-0.505056	0.00173275598557616	0.18917	T	2728	6208	9568	-0.9191	0.48453	p.Leu195Pro	0	0	-4.048	.	32	0.12269	128193	T	30524	BRIP1	6.428240e-04	T	.	21616	.	.	0.15704	0.0465	A/A	principal2																																																																																																				
BRIP1_Leu195Pro	1.2668702182308096	0.27186458798147173	-1.898944257778324	0.3193129417034555	2025_01_Batch_13-14	0.7376117184704061	0.6595460545978806	0.6706831149265664	0.6998852237962895	0.6857644396183068	0.6639999428315029	0.7121556631762217	0.6922164654476003	0.7070030808612925	0.6409849852160716	0.7008058306509545	0.6858508588870511	0.6814497901870833	0.703444152328791	0.6633747124171891	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRIP1	BRIP1		55128		CCSBVarC002407		NC_000017.11:61847144:A:G		Leu195Pro																												BRIP1_Leu195Pro	17	61847144	A	G	17	allele	584T>C	H12	527_CAVA_Array_P01	O23	B13A7A8P1_R1	B14A7A8P1_R2				17-61847144-A-G	-	0.08447	0.0	195	178	0	0	17	59924505	G	2.240180e-03	11	17	2_Benign	NC_000017.11	525	Leu195Pro	0	5.175	0	5	2.055370e-03	T	0	25	.	42762	1.972060e-03	0	30522	0.000000e+00	0	0.29213	.	0.1553	102658	0.02950	25	0.0	T	T	64018	.	5.304476978569913E-4	0	0.000000e+00	0	0	0.17890	17112	44838	39	0.000000e+00	0.08443	94	.	0.02528	0.001	0.0	.	.	-1.01	.	G	single nucleotide variant	NC_000017.11:g.61847144A>G	0	16718	2	0.03966814	109370	0	0.031770874	0	G	407	236808	1	0	0.000000e+00	794	2.198210e-03	0	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:C3661900|MedGen:CN221562|MedGen:CN239206|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	270	197	0.000000e+00	0	0.37131	B	0.01687	B	N	0.2952269	3615	A/A	360	28	7160	1613712	not specified|Hereditary cancer-predisposing syndrome|Fanconi anemia complementation group J|Ovarian neoplasm|Familial cancer of breast|not provided|Breast and/or ovarian cancer|BRIP1-related disorder|Fanconi anemia complementation group J;Familial cancer of breast	16212	0.45481	1	.	-	61847144	2.198210e-03	-	3.456000	8	0.02684	29594	0	64018	0	germline;unknown	91082	.	.	GRCh38	45	criteria provided, multiple submitters, no conflicts	.	4.259220e-04	0.13280	355	0	0	.	1.046780e-02	9038	.	0	0.000000e+00	NM_032043.3(BRIP1):c.584T>C (p.Leu195Pro)	2	0	FANCJ_HUMAN	1	.	-1.11276007648918	21	.	0.00668	0.029862495	-	2.793300e-04	2	0.00227726	178	0.000000e+00	0	34260	criteria_provided,_multiple_submitters,_no_conflicts	0.74722	2.468680e-03	7	1.113770e-02	0	60024	.	0	0.38560	.	germline	94	61847144	A	Mar 04, 2025	13	A/A	2	89524	0.393	N	17q23.2	198354	.	4.934620e-04	SCV000150071|SCV000166684|SCV000172953|SCV000489853|SCV000489854|SCV000699730|SCV000889221|SCV000910543|SCV001140793|SCV001157291|SCV001287318|SCV002043640|SCV002066143|SCV002533721|SCV002551206|SCV002819151|SCV004016923|SCV004145821|SCV005404126	Benign/Likely_benign	149	0	Pro	P	-	912	ENSP00000508303	ENST00000683039	17680	.	13404	2	-0.592	A	1	0.472332	0.15573	N	.	-	0.4800915	.	0.54133	964	1	9.940357852882703E-4	0.00012	0	61847144	Y	9	0	102658	0.000000e+00	Q9BX63	1	0.06698	0.00915	A	0	0.001	D	89524	0.031210301	42762	0.02614	83990	-0.505713	2836	.	0.002044989775051125	8.200820e-03	0.13823	5.099440e-04	0	75020	0.000000e+00	6056	2	0.04125	17	BRIP1	4.265530e-04	0	Leu	229246	1.988290e-03	17-61847144-A-G	BRIP1-related_disorder|Breast_and/or_ovarian_cancer|Fanconi_anemia_complementation_group_J|not_specified|Ovarian_neoplasm|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	0	211	57279287	ClinGen:CA157725	0.039188	0.06339	5	RCV000120407|RCV000116162|RCV000410203|RCV000411259|RCV000990029|RCV000589840|RCV001798361|RCV004528812|RCV001082551	.	0	0	c.584T>C	0	0	525	0.00508	A/A	rs4988347	61847144	14896	A	7.987220447284345E-4	.	15688	0.03049	9.113620e-03	0.35501	17	1	0	0.000000e+00	0.75	0	322	264690	-0.0114	0.32835	3400	T	T	8	6.879830e-04	0	672	.	0	175	84|140162|227535	128193	0.21493	0.28563	0.00119638136319552	9786	4	0.262	0.05557	7.297140e-04	1.988290e-03	1179684	0.364	1.956200e-03	.	13378	0	0.0012014054	0	609054|114480	0.20126	17	5.370570e-04	ENSG00000136492	8.200820e-03	0.001623360254897809	13	0	.	2	0.04348	0.97779	30604	318	2.055370e-03	9.329600e-04	-1.00712536356647	.	4.281860e-04	0.03251	133650	HGNC:20473	.	0	.	0.019	208056	61847144	CTC	0.999000	0	-	5.109339873288372E-4	0.00085	2.404030e-03	5	1	Benign/Likely benign	0.24602	8	0	56	ClinGen:CA157725	L	0	.	-	.	-	0.14123	467	15672	0.47148	0.3499096632	.	1	0.2264141844658854	276	-	584T>C 	211	0.0017866258295048494	CN239206|CN221562|C1836860|CN169374|C0919267|C0027672|C0346153|C3661900	0	0	0	0	NM_032043.3	-	1	0.001440922190201729	0	0.13035	4988347	2320	0.0015485548275651483	0.39799	0.09467	.	.	9426	0.23876125	5.26	.	.	4.247810e-04	-0.505056	0.00173275598557616	0.18917	T	2728	6208	9568	-0.9191	0.48453	p.Leu195Pro	0	0	-4.048	.	32	0.12269	128193	T	30524	BRIP1	6.428240e-04	T	.	21616	.	.	0.15704	0.0465	A/A	principal2																																																																																																				
FARS2_Ala166Thr	1.7169263893776356	1.0	-1.6391975750498469	0.2876744818638418	2025_01_Batch_13-14	0.4713106607706262	0.6370303960480233	0.6270861144226683	0.6699912261170724	0.41871075186739654	0.6308373155030829	0.6479839477667335	0.6696845627362428	0.7365212452649857	0.5198577825811788	0.5510739881368545	0.6425071719073784	0.6483853385794556	0.703256235691029	0.4692842672242876	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011877		NC_000006.12:5369066:G:A		Ala166Thr																												FARS2_Ala166Thr	6	5369066	G	A	6	allele	496G>A	D01	527_CAVA_Array_P03	H01	B13A7A8P1_R1	B14A7A8P1_R2				6-5369066-G-A	-	0.11648	0.789	166	2	0	0	6	5369299	A	1.115220e-05	2	6	3_Conflicting	NC_000006.12	3	Ala166Thr	0	8.215	0	0	5.837710e-05	T	0	2	1	42768	2.111930e-05	.	30526	0.000000e+00	0	0.17153	.	0.0493	34260	0.44584	2	.	T	T	63952	0.172407162635	0	0	0.000000e+00	0	0	0.21105	17112	44876	1	0.000000e+00	0.32965	0	.	0.19742	0.571	.	90.0	.	-0.754	0.1	A	single nucleotide variant	NC_000006.12:g.5369066G>A	0	16654	2	0.10970226	109328	0	0.06440483	0		4	236750	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	2	0	0.000000e+00	0	0.28107	B	0.24659	P	L	1.390813	18	G/G	114	0	7164	1614038	not specified|Combined oxidative phosphorylation defect type 14	16210	0.20841	.	.	-	5369066	1.168770e-04	-	2.603000	0	0.08577	29606	0	6062	0	germline	91064	Loss of helix (P = 0.0196)| Gain of loop (P = 0.069)| Loss of stability (P = 0.0942)| Loss of sheet (P = 0.302)| Gain of disorder (P = 0.3125)	0.34780	GRCh38	944	criteria provided, conflicting classifications	c.496G>A	0.000000e+00	0.21027	0	0	0	Phenylalanyl-tRNA synthetase	0.000000e+00	9046	LB	0	0.000000e+00	NM_006567.5(FARS2):c.496G>A (p.Ala166Thr)	1	0	SYFM_HUMAN	0	10.0	-0.396344597065005	2	.	0.12616	0.08581967	+	0.000000e+00	.		2	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.70784	1.829360e-05	0	0.000000e+00	0	60022	p.Ala166Thr	0	0.33615	.	germline	2		G	May 06, 2024	0	G/G	0	89522	0.339	N	6p25.1	9690	.	0.000000e+00	SCV000251368|SCV002217538	Conflicting_classifications_of_pathogenicity	0	0	Thr	T	-	912	ENSP00000316335	ENST00000324331	17692	0.349	13412	0	-0.675	G	0	0.792367	0.19439	N	T	-	1.27738	.	0.34468	610	0	.	0.17108	0	5369066	Y	10	0	102636	4.948860e-04	O95363	0	0.063676	0.63313		0	0.273	T	30522	0.10302442	17112	0.30719	10667	-0.340643	11	-1.32	.	4.948860e-04	0.12418	0.000000e+00	0	75018	0.000000e+00	6062	0	0.26384	6	FARS2	0.000000e+00	0	Ala	14050	2.234090e-05	6-5369066-G-A	Combined_oxidative_phosphorylation_defect_type_14|not_specified	0	3	5314298	ClinGen:CA322451	0.116843	0.25323	0	RCV000197977|RCV001853177	T	0	0	c.496G>A	0	0	0	0.05166	G/G	rs764932724	5369066	14902	G	.	O95363	15690	0.13537	0.000000e+00	0.34068		0	0	0.000000e+00	1.57	0	0	264690	1.35	0.31993	112	T	T	0	6.552650e-05	0	26	.	0	0	319519	214328	0.16906	0.19145	0.152796268463135	2898	.	0.25753	0.22702	5.837710e-05	6.552650e-05	1180016	0.428	1.923100e-05	N	13314	0	1.8890023E-5	0	614946	0.2119	6	0.000000e+00	ENSG00000145982	0.000000e+00	0	0	0	0.5003925295663422	1	0.40008	0.12756	30606	5	2.922950e-05	3.332110e-05	-0.454383794869487	.	1.098130e-05	0.014536	211251	HGNC:21062	N	0	simple_aae	0.037	207998	5369066	GCG	0.998000	.	-	0	0.24112	9.321910e-06	0	0	Conflicting classifications of pathogenicity	0.53619	0	3	2	ClinGen:CA322451	A	0	0.653491938199	-	0.351	-	0.28534	5	496	0.49766	0.372067689896	0.0898	0	0.99410883744534362	98	-	496G>A 	2	0	C4755312|CN169374	0	0	0	0	NM_006567.5	-	.	.	0	0.43452	764932724	2320	0	0.64789	0.23109	0.253	0.319	2784	0.15600365	5.68	.	.	0.000000e+00	-0.55124	0.20033392600971	0.39465	T	86	6210	9566	-1.0287	0.20874	p.Ala166Thr	0	0	-6.934	0.12830508	0	0.49936	214328	T	30522	FARS2	1.168770e-04	T	0.060	21552	A166T	T	0.16971	0.04283	G/G	principal1																																																																																																				
FARS2_Ala166Thr	1.7169263893776356	1.0	-1.6391975750498469	0.2876744818638418	2025_01_Batch_13-14	0.4713106607706262	0.6370303960480233	0.6270861144226683	0.6699912261170724	0.41871075186739654	0.6308373155030829	0.6479839477667335	0.6696845627362428	0.7365212452649857	0.5198577825811788	0.5510739881368545	0.6425071719073784	0.6483853385794556	0.703256235691029	0.4692842672242876	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2				CCSBVarC011877	ALE00009035	NC_000006.12:5369066:G:A	496G>A	Ala166Thr	CAVA																											FARS2_Ala166Thr	6	5369066	G	A	6								1	1	1	6-5369066-G-A	-	0.11648	0.789	166	2	0	0	6	5369299	A	1.115220e-05	2	6	3_Conflicting	NC_000006.12	3	Ala166Thr	0	8.215	0	0	5.837710e-05	T	0	2	1	42768	2.111930e-05	.	30526	0.000000e+00	0	0.17153	.	0.0493	34260	0.44584	2	.	T	T	63952	0.172407162635	0	0	0.000000e+00	0	0	0.21105	17112	44876	1	0.000000e+00	0.32965	0	.	0.19742	0.571	.	90.0	.	-0.754	0.1	A	single nucleotide variant	NC_000006.12:g.5369066G>A	0	16654	2	0.10970226	109328	0	0.06440483	0		4	236750	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:CN169374|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	2	0	0.000000e+00	0	0.28107	B	0.24659	P	L	1.390813	18	G/G	114	0	7164	1614038	not specified|Combined oxidative phosphorylation defect type 14	16210	0.20841	.	.	-	5369066	1.168770e-04	-	2.603000	0	0.08577	29606	0	6062	0	germline	91064	Loss of helix (P = 0.0196)| Gain of loop (P = 0.069)| Loss of stability (P = 0.0942)| Loss of sheet (P = 0.302)| Gain of disorder (P = 0.3125)	0.34780	GRCh38	944	criteria provided, conflicting classifications	c.496G>A	0.000000e+00	0.21027	0	0	0	Phenylalanyl-tRNA synthetase	0.000000e+00	9046	LB	0	0.000000e+00	NM_006567.5(FARS2):c.496G>A (p.Ala166Thr)	1	0	SYFM_HUMAN	0	10.0	-0.396344597065005	2	.	0.12616	0.08581967	+	0.000000e+00	.		2	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.70784	1.829360e-05	0	0.000000e+00	0	60022	p.Ala166Thr	0	0.33615	.	germline	2		G	May 06, 2024	0	G/G	0	89522	0.339	N	6p25.1	9690	.	0.000000e+00	SCV000251368|SCV002217538	Conflicting_classifications_of_pathogenicity	0	0	Thr	T	-	912	ENSP00000316335	ENST00000324331	17692	0.349	13412	0	-0.675	G	0	0.792367	0.19439	N	T	-	1.27738	.	0.34468	610	0	.	0.17108	0	5369066	Y	10	0	102636	4.948860e-04	O95363	0	0.063676	0.63313		0	0.273	T	30522	0.10302442	17112	0.30719	10667	-0.340643	11	-1.32	.	4.948860e-04	0.12418	0.000000e+00	0	75018	0.000000e+00	6062	0	0.26384	6	FARS2	0.000000e+00	0	Ala	14050	2.234090e-05	6-5369066-G-A	Combined_oxidative_phosphorylation_defect_type_14|not_specified	0	3	5314298	ClinGen:CA322451	0.116843	0.25323	0	RCV000197977|RCV001853177	T	0	0	c.496G>A	0	0	0	0.05166	G/G	rs764932724	5369066	14902	G	.	O95363	15690	0.13537	0.000000e+00	0.34068		0	0	0.000000e+00	1.57	0	0	264690	1.35	0.31993	112	T	T	0	6.552650e-05	0	26	.	0	0	319519	214328	0.16906	0.19145	0.152796268463135	2898	.	0.25753	0.22702	5.837710e-05	6.552650e-05	1180016	0.428	1.923100e-05	N	13314	0	1.8890023E-5	0	614946	0.2119	6	0.000000e+00	ENSG00000145982	0.000000e+00	0	0	0	0.5003925295663422	1	0.40008	0.12756	30606	5	2.922950e-05	3.332110e-05	-0.454383794869487	.	1.098130e-05	0.014536	211251	HGNC:21062	N	0	simple_aae	0.037	207998	5369066	GCG	0.998000	.	-	0	0.24112	9.321910e-06	0	0	Conflicting classifications of pathogenicity	0.53619	0	3	2	ClinGen:CA322451	A	0	0.653491938199	-	0.351	-	0.28534	5	496	0.49766	0.372067689896	0.0898	0	0.99410883744534362	98	-	496G>A 	2	0	C4755312|CN169374	0	0	0	0	NM_006567.5	-	.	.	0	0.43452	764932724	2320	0	0.64789	0.23109	0.253	0.319	2784	0.15600365	5.68	.	.	0.000000e+00	-0.55124	0.20033392600971	0.39465	T	86	6210	9566	-1.0287	0.20874	p.Ala166Thr	0	0	-6.934	0.12830508	0	0.49936	214328	T	30522	FARS2	1.168770e-04	T	0.060	21552	A166T	T	0.16971	0.04283	G/G	principal1																																																																																																				
SDHD_His102Pro	4.677318243891225	0.0025703667270182804	0.4759440939676418	0.00857286222204184	2025_01_Batch_13-14	0.9100589801042144	0.911754221775473	0.8796519729598896	0.9480011311043718	0.8233505215836364	0.9006813090782809	0.8844697790259992	0.8803163022913099	0.8962418338637648	0.7880721490532581	0.9053701445912476	0.8981120004007361	0.8799841376255997	0.9221214824840682	0.8057113353184473	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023321		NC_000011.10:112089002:A:C		His102Pro																												SDHD_His102Pro	11	112089002	A	C	11	allele	305A>C	C12	527_CAVA_Array_P05	E23	B13A7A8P2_R1	B14A7A8P2_R2				11-112089002-A-C	-	0.80073	0.999	102	.	.	.	11	111959726	C	.	.	11	1_Pathogenic	NC_000011.10	.	His102Pro	.	27.2	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98302	Select	0.9986	.	0.77914	.	.	D	D	.	0.94536333913	.	.	.	.	.	0.46655	.	.	.	.	0.98744	.	.	0.96900	0.699	.	0.0	0.911209	.	1.0	C	single nucleotide variant	NC_000011.10:g.112089002A>C	.	.	2	0.9501346	.	.	0.9729964	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072	.	.	.	.	0.99291	D	0.97654	D	H	6.736192	.	./.	.	.	.	.	Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma	.	0.94990	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112089002	.	-	9.318000	.	0.99450	.	.	.	.	germline	.	Loss of loop (P = 0.2237)| Loss of helix (P = 0.2271)| Loss of catalytic residue at L101 (P = 0.3531)| Loss of stability (P = 0.4934)| Gain of glycosylation at H102 (P = 0.6204)	0.99835	GRCh38	637	criteria provided, single submitter	c.305A>C	.	0.43622	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.305A>C (p.His102Pro)	1	.	DHSD_HUMAN	.	100.0	0.671343308934847	.	D	0.75321	0.9567221	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99252	.	.	.	.	.	p.His102Pro	.	0.80050	.	germline	.		A	May 06, 2021	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV001394789	Likely_pathogenic	.	.	Pro	P	-	.	ENSP00000364699	ENST00000375549	.	0.003	.	.	0.691	A	.	4.880315	0.92967	D	D	-	5.234679	.	0.97730	.	.	.	0.98821	.	112089002	Y	10	.	.	.	O14521	.	0.976804	0.27217		.	0.986	D	.	0.93879443	.	0.34149	6392	0.567998	.	-9.9	.	.	0.91343	.	.	.	.	.	.	0.98384	11	SDHD	.	.	His	.	.	11-112089002-A-C	Carney-Stratakis_syndrome|Cowden_syndrome_3|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss	.	.	111464936	.	0.982646	0.77635	.	RCV002241296	D	.	.	c.305A>C	.	.	.	0.96540	./.	rs104894302	112089002	.	A	.	O14521	.	0.98507	.	0.68239		.	.	.	3.925	.	.	.	3.86	0.99782	.	D	T	.	.	.	.	.	.	.	97286|201|29072	950869	0.96482	0.72230	0.99975723028183	.	.	0.71675	0.99906	.	.	.	8.712	.	D	.	.	.	.	606864|171300	0.9112	11	.	ENSG00000204370	.	.	.	.	0.994954265430575	2	0.76920	0.64339	.	.	.	.	0.508240574032574	YES	.	0.720051	926123	HGNC:10683	D	.	simple_aae	0.984	.	112089002	CAT	1.000000	.	-	.	0.99941	.	.	.	Likely pathogenic	0.92404	.	.	.	ClinGen:CA382617414	H	.	0.994429284596	-	0.983	-	0.99419	.	.	0.99492	0.556130588055	0.7574	.	0.95460008024022269	.	-	305A>C 	.	.	C1847319|CN166604|C0031511|C1868633	.	.	.	.	NM_003002.4	-	.	.	1	0.68451	104894302	.	.	0.99430	0.68372	0.974	0.006	.	0.99926025	5.04	.	.	.	0.578113	0.999806621831839	0.96220	D	.	.	.	0.8482	0.99961	p.His102Pro	.	.	-12.078	0.99432874	.	0.98063	950869	D	.	SDHD	.	D	0.929	.	H102P	D	.	0.84104	./.	principal1																																																																																																				
SDHD_His102Pro	4.677318243891225	0.0025703667270182804	0.4759440939676418	0.00857286222204184	2025_01_Batch_13-14	0.9100589801042144	0.911754221775473	0.8796519729598896	0.9480011311043718	0.8233505215836364	0.9006813090782809	0.8844697790259992	0.8803163022913099	0.8962418338637648	0.7880721490532581	0.9053701445912476	0.8981120004007361	0.8799841376255997	0.9221214824840682	0.8057113353184473	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023321	ALE00022517	NC_000011.10:112089002:A:C	305A>C	His102Pro	CAVA																											SDHD_His102Pro	11	112089002	A	C	11								1	1	1	11-112089002-A-C	-	0.80073	0.999	102	.	.	.	11	111959726	C	.	.	11	1_Pathogenic	NC_000011.10	.	His102Pro	.	27.2	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98302	Select	0.9986	.	0.77914	.	.	D	D	.	0.94536333913	.	.	.	.	.	0.46655	.	.	.	.	0.98744	.	.	0.96900	0.699	.	0.0	0.911209	.	1.0	C	single nucleotide variant	NC_000011.10:g.112089002A>C	.	.	2	0.9501346	.	.	0.9729964	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072	.	.	.	.	0.99291	D	0.97654	D	H	6.736192	.	./.	.	.	.	.	Carney-Stratakis syndrome;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Pheochromocytoma	.	0.94990	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112089002	.	-	9.318000	.	0.99450	.	.	.	.	germline	.	Loss of loop (P = 0.2237)| Loss of helix (P = 0.2271)| Loss of catalytic residue at L101 (P = 0.3531)| Loss of stability (P = 0.4934)| Gain of glycosylation at H102 (P = 0.6204)	0.99835	GRCh38	637	criteria provided, single submitter	c.305A>C	.	0.43622	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.305A>C (p.His102Pro)	1	.	DHSD_HUMAN	.	100.0	0.671343308934847	.	D	0.75321	0.9567221	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99252	.	.	.	.	.	p.His102Pro	.	0.80050	.	germline	.		A	May 06, 2021	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV001394789	Likely_pathogenic	.	.	Pro	P	-	.	ENSP00000364699	ENST00000375549	.	0.003	.	.	0.691	A	.	4.880315	0.92967	D	D	-	5.234679	.	0.97730	.	.	.	0.98821	.	112089002	Y	10	.	.	.	O14521	.	0.976804	0.27217		.	0.986	D	.	0.93879443	.	0.34149	6392	0.567998	.	-9.9	.	.	0.91343	.	.	.	.	.	.	0.98384	11	SDHD	.	.	His	.	.	11-112089002-A-C	Carney-Stratakis_syndrome|Cowden_syndrome_3|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss	.	.	111464936	.	0.982646	0.77635	.	RCV002241296	D	.	.	c.305A>C	.	.	.	0.96540	./.	rs104894302	112089002	.	A	.	O14521	.	0.98507	.	0.68239		.	.	.	3.925	.	.	.	3.86	0.99782	.	D	T	.	.	.	.	.	.	.	97286|201|29072	950869	0.96482	0.72230	0.99975723028183	.	.	0.71675	0.99906	.	.	.	8.712	.	D	.	.	.	.	606864|171300	0.9112	11	.	ENSG00000204370	.	.	.	.	0.994954265430575	2	0.76920	0.64339	.	.	.	.	0.508240574032574	YES	.	0.720051	926123	HGNC:10683	D	.	simple_aae	0.984	.	112089002	CAT	1.000000	.	-	.	0.99941	.	.	.	Likely pathogenic	0.92404	.	.	.	ClinGen:CA382617414	H	.	0.994429284596	-	0.983	-	0.99419	.	.	0.99492	0.556130588055	0.7574	.	0.95460008024022269	.	-	305A>C 	.	.	C1847319|CN166604|C0031511|C1868633	.	.	.	.	NM_003002.4	-	.	.	1	0.68451	104894302	.	.	0.99430	0.68372	0.974	0.006	.	0.99926025	5.04	.	.	.	0.578113	0.999806621831839	0.96220	D	.	.	.	0.8482	0.99961	p.His102Pro	.	.	-12.078	0.99432874	.	0.98063	950869	D	.	SDHD	.	D	0.929	.	H102P	D	.	0.84104	./.	principal1																																																																																																				
SDHD_Val111Ile	7.7451222208037676	0.00011337695822120214	-1.6891303326515856	0.34625416650385676	2025_01_Batch_13-14	0.6806283428302172	0.7903913226120411	0.7415580184685204	0.7197309821074369	0.6622642931221312	0.8362832234515796	0.8743478894614917	0.8712212938742474	0.8831303715286605	0.6754168939249733	0.7584557831408985	0.8323696060367665	0.8063896561713839	0.8014306768180487	0.6688405935235522	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023342		NC_000011.10:112094821:G:A		Val111Ile																												SDHD_Val111Ile	11	112094821	G	A	11	allele	331G>A	H12	527_CAVA_Array_P05	O23	B13A7A8P2_R1	B14A7A8P2_R2				11-112094821-G-A	-	0.27837	0.104	111	0	0	0	11	111965545	A	6.886730e-05	0	11	3_Conflicting	NC_000011.10	109	Val111Ile	2	17.58	1	0	1.130450e-04	D	0	5	1	42768	1.269850e-05	.	30524	0.000000e+00	0	0.82541	Select	0.7829	17692	0.25957	1	.	D	D	64020	0.181760226822	0	0	0.000000e+00	0	0	0.23094	17104	44898	0	1.490760e-04	0.09078	0	.	0.02032	1.0	.	10.0	0.852415	.	0.9	A	single nucleotide variant	NC_000011.10:g.112094821G>A	0	16734	2	0.051471613	109400	0	0.023600794	0		3	236248	0	0	1.130450e-04	146	0.000000e+00	0	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	1	0	0.000000e+00	0	0.92786	B	0.11338	B	.	1.842281	111	./.	114	0	7164	1611796	Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3|Paragangliomas 1|Mitochondrial complex 2 deficiency, nuclear type 3|Hereditary cancer-predisposing syndrome|not provided	16100	0.90098	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094821	1.105460e-04	-	3.805000	0	0.50061	29602	0	44898	2	germline;unknown	90990	Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Gain of phosphorylation at Y114 (P = 0.2011)| Gain of catalytic residue at V111 (P = 0.4375)| Loss of disorder (P = 0.6326)	0.96404	GRCh38	638	criteria provided, conflicting classifications	c.331G>A	0.000000e+00	0.32068	0	0	0	.	0.000000e+00	9046	B	0	0.000000e+00	NM_003002.4(SDHD):c.331G>A (p.Val111Ile)	1	0	DHSD_HUMAN	0	90.0	-0.212263563345696	1	D	0.08359	0.027904507	+	0.000000e+00	.		2	0.000000e+00	0	34244	criteria_provided,_conflicting_classifications	0.96548	9.140770e-06	0	0.000000e+00	0	59980	p.Val111Ile	0	0.39965	.	germline	1		G	Jan 21, 2025	0	./.	0	89376	1.0	N	11q23.1	9690	.	0.000000e+00	SCV000554067|SCV000675110|SCV001825380|SCV004031142|SCV004203107	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	912	ENSP00000364699	ENST00000375549	17692	0.26	13416	0	0.672	G	0	2.179907	0.15871	N	T	-	2.157289	.	0.63956	610	0	.	0.47946	0	112094821	Y	10	0	102210	0.000000e+00	O14521	0	0.505437	0.33813		0	0.055	D	13416	0.059936233	9046	0.97202	6392	0.180199	0	-0.14	.	2.427730e-03	0.16832	0.000000e+00	0	74848	1.105460e-04	4452	0	0.08303	11	SDHD	0.000000e+00	0	Val	14528	0.000000e+00	11-112094821-G-A	Hereditary_cancer-predisposing_syndrome|not_provided|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Mitochondrial_complex_2_deficiency,_nuclear_type_3|Paragangliomas_1	0	0	111470755	ClinGen:CA071246	0.151882	0.32351	0	RCV002230665|RCV003325203|RCV003476144|RCV000565076|RCV001591105	D	0	0	c.331G>A	0	109	0	0.71854	./.	rs201869798	112094821	14784	G	.	O14521	15690	0.01108	0.000000e+00	0.68239		0	0	2.427730e-03	.	0	0	264690	2.83	0.82256	112	D	T	0	3.277830e-05	0	26	segdup	0	0	140162|97286|29072|201|29072	412515	0.85364	0.20157	0.826030075550079	3324	.	0.71675	0.27431	2.920220e-05	1.490760e-04	1179800	1.908	1.443700e-05	N	13394	0	7.5560088E-6	0	606864|171300|619167|168000	0.39642	11	0.000000e+00	ENSG00000204370	0.000000e+00	0	0	0	0.7076145117288314	1	0.25997	0.64247	30606	2	0.000000e+00	3.334440e-05	-0.0625121141246808	YES	0.000000e+00	0.050089	398070	HGNC:10683	D	0	simple_aae	0.232	207800	112094821	GTT	1.000000	.	-	0	0.46306	0.000000e+00	0	0	Conflicting classifications of pathogenicity	0.10596	0	0	2	ClinGen:CA071246	V	0	0.97911266155	-	0.872	-	0.11434	3	548	0.70553	0.386111408472	0.081	0	0.97373826413851394	98	-	331G>A 	2	0	C0027672|C3661900|C1868633|C1847319|C0031511|CN166604|C5436934|C3494181	0	0	0	0	NM_003002.4	-	.	.	0	0.53609	201869798	2320	0	0.97867	0.36653	0.052	0.779	3210	0.98876506	4.85	.	.	0.000000e+00	0.246769	0.0132951746215333	.	D	86	6206	9566	0.4711	0.92608	p.Val111Ile	0	0	-2.495	0.2911021	0	0.26155	412515	T	30508	SDHD	0.000000e+00	D	0.572	21630	V111I	T	.	0.70176	./.	principal1																																																																																																				
SDHD_Val111Ile	7.7451222208037676	0.00011337695822120214	-1.6891303326515856	0.34625416650385676	2025_01_Batch_13-14	0.6806283428302172	0.7903913226120411	0.7415580184685204	0.7197309821074369	0.6622642931221312	0.8362832234515796	0.8743478894614917	0.8712212938742474	0.8831303715286605	0.6754168939249733	0.7584557831408985	0.8323696060367665	0.8063896561713839	0.8014306768180487	0.6688405935235522	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023342	ALE00021461	NC_000011.10:112094821:G:A	331G>A	Val111Ile	CAVA																											SDHD_Val111Ile	11	112094821	G	A	11								1	1	1	11-112094821-G-A	-	0.27837	0.104	111	0	0	0	11	111965545	A	6.886730e-05	0	11	3_Conflicting	NC_000011.10	109	Val111Ile	2	17.58	1	0	1.130450e-04	D	0	5	1	42768	1.269850e-05	.	30524	0.000000e+00	0	0.82541	Select	0.7829	17692	0.25957	1	.	D	D	64020	0.181760226822	0	0	0.000000e+00	0	0	0.23094	17104	44898	0	1.490760e-04	0.09078	0	.	0.02032	1.0	.	10.0	0.852415	.	0.9	A	single nucleotide variant	NC_000011.10:g.112094821G>A	0	16734	2	0.051471613	109400	0	0.023600794	0		3	236248	0	0	1.130450e-04	146	0.000000e+00	0	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	1	0	0.000000e+00	0	0.92786	B	0.11338	B	.	1.842281	111	./.	114	0	7164	1611796	Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3|Paragangliomas 1|Mitochondrial complex 2 deficiency, nuclear type 3|Hereditary cancer-predisposing syndrome|not provided	16100	0.90098	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094821	1.105460e-04	-	3.805000	0	0.50061	29602	0	44898	2	germline;unknown	90990	Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Gain of phosphorylation at Y114 (P = 0.2011)| Gain of catalytic residue at V111 (P = 0.4375)| Loss of disorder (P = 0.6326)	0.96404	GRCh38	638	criteria provided, conflicting classifications	c.331G>A	0.000000e+00	0.32068	0	0	0	.	0.000000e+00	9046	B	0	0.000000e+00	NM_003002.4(SDHD):c.331G>A (p.Val111Ile)	1	0	DHSD_HUMAN	0	90.0	-0.212263563345696	1	D	0.08359	0.027904507	+	0.000000e+00	.		2	0.000000e+00	0	34244	criteria_provided,_conflicting_classifications	0.96548	9.140770e-06	0	0.000000e+00	0	59980	p.Val111Ile	0	0.39965	.	germline	1		G	Jan 21, 2025	0	./.	0	89376	1.0	N	11q23.1	9690	.	0.000000e+00	SCV000554067|SCV000675110|SCV001825380|SCV004031142|SCV004203107	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	912	ENSP00000364699	ENST00000375549	17692	0.26	13416	0	0.672	G	0	2.179907	0.15871	N	T	-	2.157289	.	0.63956	610	0	.	0.47946	0	112094821	Y	10	0	102210	0.000000e+00	O14521	0	0.505437	0.33813		0	0.055	D	13416	0.059936233	9046	0.97202	6392	0.180199	0	-0.14	.	2.427730e-03	0.16832	0.000000e+00	0	74848	1.105460e-04	4452	0	0.08303	11	SDHD	0.000000e+00	0	Val	14528	0.000000e+00	11-112094821-G-A	Hereditary_cancer-predisposing_syndrome|not_provided|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Mitochondrial_complex_2_deficiency,_nuclear_type_3|Paragangliomas_1	0	0	111470755	ClinGen:CA071246	0.151882	0.32351	0	RCV002230665|RCV003325203|RCV003476144|RCV000565076|RCV001591105	D	0	0	c.331G>A	0	109	0	0.71854	./.	rs201869798	112094821	14784	G	.	O14521	15690	0.01108	0.000000e+00	0.68239		0	0	2.427730e-03	.	0	0	264690	2.83	0.82256	112	D	T	0	3.277830e-05	0	26	segdup	0	0	140162|97286|29072|201|29072	412515	0.85364	0.20157	0.826030075550079	3324	.	0.71675	0.27431	2.920220e-05	1.490760e-04	1179800	1.908	1.443700e-05	N	13394	0	7.5560088E-6	0	606864|171300|619167|168000	0.39642	11	0.000000e+00	ENSG00000204370	0.000000e+00	0	0	0	0.7076145117288314	1	0.25997	0.64247	30606	2	0.000000e+00	3.334440e-05	-0.0625121141246808	YES	0.000000e+00	0.050089	398070	HGNC:10683	D	0	simple_aae	0.232	207800	112094821	GTT	1.000000	.	-	0	0.46306	0.000000e+00	0	0	Conflicting classifications of pathogenicity	0.10596	0	0	2	ClinGen:CA071246	V	0	0.97911266155	-	0.872	-	0.11434	3	548	0.70553	0.386111408472	0.081	0	0.97373826413851394	98	-	331G>A 	2	0	C0027672|C3661900|C1868633|C1847319|C0031511|CN166604|C5436934|C3494181	0	0	0	0	NM_003002.4	-	.	.	0	0.53609	201869798	2320	0	0.97867	0.36653	0.052	0.779	3210	0.98876506	4.85	.	.	0.000000e+00	0.246769	0.0132951746215333	.	D	86	6206	9566	0.4711	0.92608	p.Val111Ile	0	0	-2.495	0.2911021	0	0.26155	412515	T	30508	SDHD	0.000000e+00	D	0.572	21630	V111I	T	.	0.70176	./.	principal1																																																																																																				
FARS2_Tyr144Cys	-0.31983357585618055	1.0	-0.9424771139167271	0.5205077242360756	2025_01_Batch_13-14	0.6419072422105627	0.7236909392375388	0.6679936181015709	0.7433070910902596	0.4927485261018876	0.751530142942959	0.6496685603276995	0.6400871597731469	0.782555014921668	0.6363712275656164	0.6967186925767608	0.6866797497826191	0.6540403889373589	0.7629310530059639	0.564559876833752	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011920		NC_000006.12:5369001:A:G		Tyr144Cys																												FARS2_Tyr144Cys	6	5369001	A	G	6	allele	431A>G	C01	527_CAVA_Array_P03	F01	B13A7A8P1_R1	B14A7A8P1_R2				6-5369001-A-G	-	0.73447	1.0	144	.	0	.	6	5369234	G	4.336650e-06	.	6	1_Pathogenic	NC_000006.12	1	Tyr144Cys	.	26.0	.	0	.	T	0	8	1	.	.	.	.	.	0	0.89285	.	0.4650	.	0.90580	.	.	D	D	64024	0.75116851782	0	0	.	.	.	0.81246	.	44878	2	.	0.96895	.	.	0.95835	0.995	.	3.0	.	2.35	0.97	G	single nucleotide variant	NC_000006.12:g.5369001A>G	0	.	3	0.72315854	.	0	0.9363221	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519|MedGen:C3661900|Human Phenotype Ontology:HP:0000754,Human Phenotype Ontology:HP:0001255,Human Phenotype Ontology:HP:0001263,Human Phenotype Ontology:HP:0001277,Human Phenotype Ontology:HP:0001292,Human Phenotype Ontology:HP:0002433,Human Phenotype Ontology:HP:0002473,Human Phenotype Ontology:HP:0002532,Human Phenotype Ontology:HP:0006793,Human Phenotype Ontology:HP:0006867,Human Phenotype Ontology:HP:0006885,Human Phenotype Ontology:HP:0006935,Human Phenotype Ontology:HP:0007005,Human Phenotype Ontology:HP:0007094,Human Phenotype Ontology:HP:0007106,Human Phenotype Ontology:HP:0007174,Human Phenotype Ontology:HP:0007224,Human Phenotype Ontology:HP:0007228,Human Phenotype Ontology:HP:0007342,Human Phenotype Ontology:HP:0025356,MedGen:C0557874;MONDO:MONDO:0004675,MedGen:C0162666	.	.	0.000000e+00	0	0.96253	D	0.86759	D	H	9.286241	7	A/A	84	0	.	1614150	Combined oxidative phosphorylation defect type 14|not provided|Global developmental delay;Mitochondrial encephalomyopathy	.	0.84306	.	.	-	5369001	.	-	7.903000	.	0.99985	29606	0	6062	.	germline;inherited	91080	Loss of phosphorylation at Y144 (P = 0.0287)| Loss of methylation at K140 (P = 0.0513)| Loss of disorder (P = 0.0822)| Loss of ubiquitination at K140 (P = 0.0949)| Loss of stability (P = 0.1997)	0.92954	GRCh38	944	criteria provided, multiple submitters, no conflicts	c.431A>G	.	0.48755	0	.	.	Phenylalanyl-tRNA synthetase	.	.	A	0	0.000000e+00	NM_006567.5(FARS2):c.431A>G (p.Tyr144Cys)	2	.	SYFM_HUMAN	.	97.0	0.824854143750858	.	.	0.66907	0.9463944	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.94252	.	0	.	.	60020	p.Tyr144Cys	0	0.73696	.	germline	.		A	Mar 25, 2024	.	A/A	.	.	1.0	N	6p25.1	7040	.	.	SCV000589666|SCV000845708|SCV001389842|SCV005038812	Pathogenic/Likely_pathogenic	.	.	Cys	C	-	912	ENSP00000316335	ENST00000324331	.	0.0	.	.	0.756	A	.	4.621909	0.92967	D	D	-	8.04306	.	0.81925	610	.	.	0.99082	0	5369001	Y	10	0	.	1.649620e-04	O95363	.	0.548925	0.92063		.	1.0	D	.	0.7782626	.	0.73271	10667	0.377045	1	-8.24	.	1.649620e-04	0.91343	.	.	75038	.	6062	.	0.83457	6	FARS2	0.000000e+00	0	Tyr	11340	.	6-5369001-A-G	Global_developmental_delay|Mitochondrial_encephalomyopathy|not_provided|Combined_oxidative_phosphorylation_defect_type_14	0	.	5314233	ClinGen:CA130596|OMIM:611592.0001|UniProtKB:O95363#VAR_069487	0.879351	0.87566	0	RCV000033044|RCV000497519|RCV000162158	D	0	.	c.431A>G	.	2	0	0.88436	A/A	rs397514610	5369001	.	A	.	O95363	.	0.94794	.	0.35501		.	.	4.456530e-05	4.145	0	0	.	4.2	0.84551	142	D	T	.	.	0	24	.	.	.	319519	39824	0.88290	0.63550	0.999801814556122	2728	.	0.71675	0.80452	.	.	1180020	7.079	.	D	.	.	.	0	614946	0.76566	6	.	ENSG00000145982	0.000000e+00	0	.	0	0.8535715990371623	2	0.97365	0.12756	.	.	.	0.000000e+00	0.715026058591333	.	2.195870e-05	0.137269	48423	HGNC:21062	A	.	simple_aae	1	.	5369001	TAT	0.999000	.	-	0	0.93464	8.474430e-07	0	0	Pathogenic/Likely pathogenic	0.80911	.	1	0	ClinGen:CA130596,UniProtKB:O95363#VAR_069487,OMIM:611592.0001	Y	.	0.912760158171	-	0.815	-	0.88450	.	574	0.85230	0.795505642891	0.5541	0	0.99840462098120319	100	-	431A>G 	.	0	C0557874|C0162666|C3661900|C4755312	.	.	.	.	NM_006567.5	-	.	.	1	0.88094	397514610	.	0	0.91122	0.83429	0.886	0.0	2644	0.96441020	5.38	.	.	.	0.303823	0.999742363997179	0.97505	D	118	.	.	0.1109	0.79239	p.Tyr144Cys	0	0	-11.22	0.94212466	0	0.97751	39824	D	.	FARS2	.	D	0.703	.	Y144C	D	0.43917	0.943	A/A	principal1																																																																																																				
SHOC2_Thr494Asn	-2.46768768795486	0.043748529350086024	6.245201442276201	0.0007634759552907376																											SHOC2	SHOC2		11602		CCSBVarC028085		NC_000010.11:111009771:C:A		Thr494Asn																												SHOC2_Thr494Asn	10	111009771	C	A	10	allele	1481C>A	A02	527_CAVA_Array_P06	A04	B13A7A8P2_R1	B14A7A8P2_R2				10-111009771-C-A	-	0.44047	0.163	494	0	0	0	10	112769529	A	2.355340e-05	0	10	3_Conflicting	NC_000010.11	37	Thr494Asn	0	21.8	0	0	4.259780e-04	T	0	2	.	42762	5.910760e-05	.	30518	0.000000e+00	0	0.20565	.	0.1329	30518	0.43673	0	.	T	T	64022	.	0	0	0.000000e+00	0	0	0.89704	17104	44814	37	0.000000e+00	0.40077	0	.	0.36792	0.992	.	.	0.943906	2.81	.	A	single nucleotide variant	NC_000010.11:g.111009771C>A	0	16734	2	0.14926983	109390	0	0.16714135	0		14	236856	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN169374	7	0	0.000000e+00	0	0.59775	B	0.35145	B	L	2.910648	38	C/C	84	0	7162	1613356	RASopathy|not specified	16216	0.36287	.	.	-	111009771	4.461440e-04	-	4.031000	0	0.25085	29586	0	91068	0	germline	91068	Gain of relative solvent accessibility (P = 0.1259)| Loss of helix (P = 0.1299)| Gain of disorder (P = 0.2132)| Gain of solvent accessibility (P = 0.2346)| Gain of loop (P = 0.2754)	0.29930	GRCh38	916	criteria provided, conflicting classifications	.	4.259780e-04	0.62077	0	0	0	.	0.000000e+00	9046	.	0	0.000000e+00	NM_007373.4(SHOC2):c.1481C>A (p.Thr494Asn)	1	0	SHOC2_HUMAN	0	.	0.106166022947134	0	D	0.30427	0.16714135	+	0.000000e+00	.		13	0.000000e+00	0	34252	criteria_provided,_conflicting_classifications	0.30927	6.399120e-05	0	0.000000e+00	0	59998	.	0	0.41417	.	germline	7		C	May 02, 2021	13	C/C	0	89512	1.0	N	10q25.2	6962	.	0.000000e+00	SCV001212736|SCV001623128	Conflicting_classifications_of_pathogenicity	0	0	Asn	N	-	912	ENSP00000510554	ENST00000689118	17692	.	13416	0	0.549	C	0	3.225538	0.43692	N	.	-	3.281369	.	0.31405	610	0	.	0.18523	0	111009771	Y	10	0	102688	0.000000e+00	Q9UQ13	0	0.235199	0.33955		0	0.157	T	30600	0.14926983	15690	0.67791	8036	-0.31296	0	.	.	4.062900e-04	0.28279	4.461440e-04	0	74886	0.000000e+00	6078	0	0.35144	10	SHOC2	0.000000e+00	0	Thr	10680	0.000000e+00	10-111009771-C-A	not_specified|RASopathy	0	0	112759519	.	0.331270	0.46496	0	RCV001048720|RCV001420775	.	0	0	c.1481C>A	0	0	0	0.07289	C/C	rs758241851	111009771	14900	C	.	Q9UQ13	15690	0.36793	0.000000e+00	0.68239		0	0	0.000000e+00	1.58	0	0	264690	4.84	0.60025	108	T	D	0	0.000000e+00	0	24	.	0	0	536391	845617	0.37770	0.80440	0.172610089051042	2294	.	0.71675	0.42914	0.000000e+00	4.248370e-04	1179528	3.316	6.728700e-05	.	13394	0	7.5560088E-6	0	.	0.51765	10	0.000000e+00	ENSG00000108061	0.000000e+00	0	13	0	.	2	0.42698	0.20739	30600	2	0.000000e+00	0.000000e+00	0.219752477088244	.	4.062900e-04	0.012795	836647	HGNC:15454	.	0	.	0.089	208064	111009771	ACT	1.000000	.	-	0	0.29167	0.000000e+00	0	0	Conflicting classifications of pathogenicity	0.51057	7	0	0	ClinGen:CA5689787	T	0	.	-	0.321	-	0.50808	14	466	0.54033	0.850702464581	.	0	0.97401986174303501	94	-	1481C>A 	13	0	CN169374|C5555857	0	0	0	0	NM_007373.4	-	.	.	0	0.78769	758241851	2320	0	0.34965	0.50689	.	.	2210	0.00410146	5.75	.	.	4.248370e-04	-0.359362	0.880875675876287	0.39613	T	84	6212	9570	-0.9736	0.44354	p.Thr494Asn	0	0	-6.592	.	0	0.74823	845617	T	30516	SHOC2	0.000000e+00	T	.	21626	T494N	.	0.51409	0.27038	C/C	principal1																																																																																																				
RAF1_Phe22Leu	0.9979103452561944	1.0	0.5106342537669916	0.10165419724841662	2025_01_Batch_13-14	0.6611114622240368	0.6959964161221559	0.6718233999906628	0.6634187249330441	0.6234668786162717	0.6575876991241759	0.7217617961169218	0.6471376378290921	0.686803693517124	0.6015017258743621	0.6593495806741063	0.7088791061195389	0.6594805189098774	0.675111209225084	0.6124843022453169	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008857		NC_000003.12:12618656:A:C		Phe22Leu																												RAF1_Phe22Leu	3	12618656	A	C	3	allele	66T>G	D05	527_CAVA_Array_P05	G09	B13A7A8P2_R1	B14A7A8P2_R2				3-12618656-A-C	-	0.2657	0.06	22	12	0	0	3	12660155	C	1.232870e-04	0	3	2_Benign	NC_000003.12	196	Phe22Leu	0	17.15	0	0	1.362610e-04	T	1	5	.	42768	5.908620e-05	.	30526	0.000000e+00	0	0.31809	.	0.2084	102744	0.23134	0	.	T	T	64042	.	0	0	0.000000e+00	0	0	0.84138	17112	44900	0	0.000000e+00	0.21370	5	.	0.32960	0.999	.	.	.	0.598	.	C	single nucleotide variant	NC_000003.12:g.12618656A>C	0	16732	2	0.14525777	109406	0	0.10763881	0		12	236942	0	0	0.000000e+00	500	1.169100e-04	0	|MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736	5	0	0.000000e+00	0	0.78586	B	0.29089	B	L	1.507842	199	A/A	122	1	7164	1614116	RAF1-related disorder|not specified|RASopathy|Cardiovascular phenotype	16218	0.46899	.	.	-	12618656	1.169100e-04	-	1.026000	0	0.75580	29608	0	1180052	0	germline	91094	Loss of sheet (P = 0.0181)| Gain of loop (P = 0.0312)| Loss of methylation at K18 (P = 0.0891)| Gain of relative solvent accessibility (P = 0.09)| Loss of ubiquitination at K18 (P = 0.1216)	0.38195	GRCh38	615	reviewed by expert panel	.	0.000000e+00	0.17595	4	0	0	.	0.000000e+00	9046	.	0	0.000000e+00	NM_002880.4(RAF1):c.66T>G (p.Phe22Leu)	3	0	RAF1_HUMAN	0	.	-0.344430833306449	0	.	0.68345	0.14490148	-	0.000000e+00	.		12	0.000000e+00	2	34258	reviewed_by_expert_panel	0.78477	4.570130e-05	1	0.000000e+00	0	60004	.	0	0.23526	.	germline	5		A	Apr 03, 2017	0	A/A	0	89554	1.0	N	3p25.2	37246	.	0.000000e+00	SCV000616418	Likely_benign	0	0	Leu	L	-	912	ENSP00000508763	ENST00000691899	17692	.	13416	0	0.756	A	0	2.085276	0.25352	N	.	-	1.759308	.	0.58315	628	0	.	0.15665	0	12618656	Y	10	0	102744	0.000000e+00	P04049	0	0.468965	0.90858		0	0.018	D	89554	0.120846346	42768	0.91597	5894	-0.176835	196	.	.	1.660940e-04	0.51407	0.000000e+00	0	74934	0.000000e+00	6084	0	0.34355	3	RAF1	0.000000e+00	0	Phe	49260	1.339970e-04	3-12618656-A-C	RASopathy|Cardiovascular_phenotype|not_specified|RAF1-related_disorder	0	14	12635155	ClinGen:CA134746	0.234715	0.27198	1	RCV004541061|RCV000037696|RCV000168020|RCV003362667	.	0	0	c.66T>G	0	0	0	0.23871	A/A	rs397516824	12618656	14902	A	.	P04049	15690	0.25223	0.000000e+00	0.31253		0	0	0.000000e+00	1.83	0	3	264690	0.769	0.80119	168	T	D	0	0.000000e+00	0	56	.	0	0	536391	40583	0.48980	0.85880	0.135316427567574	3560	.	0.71675	0.35536	0.000000e+00	1.339970e-04	1180052	1.009	5.765740e-05	.	13392	0	1.8890023E-5	0	.	0.29585	3	0.000000e+00	ENSG00000132155	0.000000e+00	8.054556193953713E-5	0	0	.	3	0.18486	0.66487	30608	5	1.362610e-04	0.000000e+00	-0.211098281217204	.	0.000000e+00	0.038866	49053	HGNC:9829	.	0	.	0.566	208126	12618656	TTT	0.989000	.	-	0	0.52770	1.660940e-04	0	0	Likely benign	0.05558	0	0	0	ClinGen:CA134746	F	0	.	-	0.372	-	0.61652	14	7060	0.36376	0.814390659332	.	0	0.99825905109529411	98	-	66T>G 	14	1.4164305949008498E-4	C5555857|CN230736|CN169374	0	0	0	0	NM_002880.4	-	.	.	0	0.44238	397516824	2320	8.120178643930166E-5	0.74448	0.30821	.	.	3438	0.35689947	6.03	.	.	0.000000e+00	-0.255119	0.900999158324285	0.47902	T	112	6212	9572	-0.9080	0.56595	p.Phe22Leu	0	0	-2.426	.	0	0.76121	40583	T	30522	RAF1	0.000000e+00	T	.	21630	F22L	.	0.25895	0.943	A/A	principal3																																																																																																				
RAF1_Phe22Leu	0.9979103452561944	1.0	0.5106342537669916	0.10165419724841662	2025_01_Batch_13-14	0.6611114622240368	0.6959964161221559	0.6718233999906628	0.6634187249330441	0.6234668786162717	0.6575876991241759	0.7217617961169218	0.6471376378290921	0.686803693517124	0.6015017258743621	0.6593495806741063	0.7088791061195389	0.6594805189098774	0.675111209225084	0.6124843022453169	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1				CCSBVarC008857	ALE00008509	NC_000003.12:12618656:A:C	66T>G	Phe22Leu	CAVA																											RAF1_Phe22Leu	3	12618656	A	C	3								1	1	1	3-12618656-A-C	-	0.2657	0.06	22	12	0	0	3	12660155	C	1.232870e-04	0	3	2_Benign	NC_000003.12	196	Phe22Leu	0	17.15	0	0	1.362610e-04	T	1	5	.	42768	5.908620e-05	.	30526	0.000000e+00	0	0.31809	.	0.2084	102744	0.23134	0	.	T	T	64042	.	0	0	0.000000e+00	0	0	0.84138	17112	44900	0	0.000000e+00	0.21370	5	.	0.32960	0.999	.	.	.	0.598	.	C	single nucleotide variant	NC_000003.12:g.12618656A>C	0	16732	2	0.14525777	109406	0	0.10763881	0		12	236942	0	0	0.000000e+00	500	1.169100e-04	0	|MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736	5	0	0.000000e+00	0	0.78586	B	0.29089	B	L	1.507842	199	A/A	122	1	7164	1614116	RAF1-related disorder|not specified|RASopathy|Cardiovascular phenotype	16218	0.46899	.	.	-	12618656	1.169100e-04	-	1.026000	0	0.75580	29608	0	1180052	0	germline	91094	Loss of sheet (P = 0.0181)| Gain of loop (P = 0.0312)| Loss of methylation at K18 (P = 0.0891)| Gain of relative solvent accessibility (P = 0.09)| Loss of ubiquitination at K18 (P = 0.1216)	0.38195	GRCh38	615	reviewed by expert panel	.	0.000000e+00	0.17595	4	0	0	.	0.000000e+00	9046	.	0	0.000000e+00	NM_002880.4(RAF1):c.66T>G (p.Phe22Leu)	3	0	RAF1_HUMAN	0	.	-0.344430833306449	0	.	0.68345	0.14490148	-	0.000000e+00	.		12	0.000000e+00	2	34258	reviewed_by_expert_panel	0.78477	4.570130e-05	1	0.000000e+00	0	60004	.	0	0.23526	.	germline	5		A	Apr 03, 2017	0	A/A	0	89554	1.0	N	3p25.2	37246	.	0.000000e+00	SCV000616418	Likely_benign	0	0	Leu	L	-	912	ENSP00000508763	ENST00000691899	17692	.	13416	0	0.756	A	0	2.085276	0.25352	N	.	-	1.759308	.	0.58315	628	0	.	0.15665	0	12618656	Y	10	0	102744	0.000000e+00	P04049	0	0.468965	0.90858		0	0.018	D	89554	0.120846346	42768	0.91597	5894	-0.176835	196	.	.	1.660940e-04	0.51407	0.000000e+00	0	74934	0.000000e+00	6084	0	0.34355	3	RAF1	0.000000e+00	0	Phe	49260	1.339970e-04	3-12618656-A-C	RASopathy|Cardiovascular_phenotype|not_specified|RAF1-related_disorder	0	14	12635155	ClinGen:CA134746	0.234715	0.27198	1	RCV004541061|RCV000037696|RCV000168020|RCV003362667	.	0	0	c.66T>G	0	0	0	0.23871	A/A	rs397516824	12618656	14902	A	.	P04049	15690	0.25223	0.000000e+00	0.31253		0	0	0.000000e+00	1.83	0	3	264690	0.769	0.80119	168	T	D	0	0.000000e+00	0	56	.	0	0	536391	40583	0.48980	0.85880	0.135316427567574	3560	.	0.71675	0.35536	0.000000e+00	1.339970e-04	1180052	1.009	5.765740e-05	.	13392	0	1.8890023E-5	0	.	0.29585	3	0.000000e+00	ENSG00000132155	0.000000e+00	8.054556193953713E-5	0	0	.	3	0.18486	0.66487	30608	5	1.362610e-04	0.000000e+00	-0.211098281217204	.	0.000000e+00	0.038866	49053	HGNC:9829	.	0	.	0.566	208126	12618656	TTT	0.989000	.	-	0	0.52770	1.660940e-04	0	0	Likely benign	0.05558	0	0	0	ClinGen:CA134746	F	0	.	-	0.372	-	0.61652	14	7060	0.36376	0.814390659332	.	0	0.99825905109529411	98	-	66T>G 	14	1.4164305949008498E-4	C5555857|CN230736|CN169374	0	0	0	0	NM_002880.4	-	.	.	0	0.44238	397516824	2320	8.120178643930166E-5	0.74448	0.30821	.	.	3438	0.35689947	6.03	.	.	0.000000e+00	-0.255119	0.900999158324285	0.47902	T	112	6212	9572	-0.9080	0.56595	p.Phe22Leu	0	0	-2.426	.	0	0.76121	40583	T	30522	RAF1	0.000000e+00	T	.	21630	F22L	.	0.25895	0.943	A/A	principal3																																																																																																				
RAF1_Gly361Ala	1.155499028633321	0.5403518469840319	-8.632887687864956	0.0425849344631385	2025_01_Batch_13-14	0.7595018226539966	0.9272565960609439		0.9780376829289873	0.7507258763780502	0.873767237649067	0.9215944194386212	0.9758176547108324	0.9389494908136753	0.8778551909175832	0.8166345301515319	0.9244255077497825		0.9584935868713313	0.8142905336478168	0.0	0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008862		NC_000003.12:12599717:C:G		Gly361Ala																												RAF1_Gly361Ala	3	12599717	C	G	3	allele	1082G>C	B03	527_CAVA_Array_P05	C05	B13A7A8P2_R1	B14A7A8P2_R2				3-12599717-C-G	-	0.9094	0.997	361	.	.	.	3	12641216	G	.	.	3	1_Pathogenic	NC_000003.12	.	Gly361Ala	.	32.0	.	.	.	D	.	8	.	.	.	.	.	.	.	0.97773	.	0.7939	.	0.70687	.	.	D	D	.	.	.	.	.	.	.	0.97002	.	.	.	.	0.87174	.	.	0.96139	0.999	.	.	.	.	.	G	single nucleotide variant	NC_000003.12:g.12599717C>G	.	.	2	0.9189513	.	.	0.9621787	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500	.	.	.	.	0.94956	D	0.96930	D	L	9.651506	.	C/C	.	.	.	.	Noonan syndrome|not provided|RASopathy|Noonan syndrome 5|LEOPARD syndrome 2	.	0.93289	.	.	-	12599717	.	-	7.697000	.	0.98682	.	.	.	.	germline;unknown	.	Gain of glycosylation at T362 (P = 0.0323)| Loss of methylation at K365 (P = 0.0936)| Gain of catalytic residue at G361 (P = 0.1011)| Gain of MoRF binding (P = 0.1018)| Loss of disorder (P = 0.134)	0.98955	GRCh38	677	reviewed by expert panel	.	.	0.82128	.	.	.	Protein kinase domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	.	.	.	.	.	NM_002880.4(RAF1):c.1082G>C (p.Gly361Ala)	3	.	RAF1_HUMAN	.	.	0.841710195614201	.	.	0.96519	0.9493423	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.98223	.	.	.	.	.	.	.	0.66139	.	germline	.		C	Apr 03, 2017	.	C/C	.	.	1.0	N	3p25.2	.	.	.	SCV000616425	Pathogenic	.	.	Ala	A	-	.	ENSP00000508763	ENST00000691899	.	.	.	.	0.596	C	.	5.440165	0.51463	D	.	-	11.27517	.	0.91439	.	.	.	0.89711	.	12599717	Y	10	.	.	.	P04049	.	0.939635	0.94371		.	0.977	D	.	0.92825574	.	0.91597	5894	0.455678	.	.	.	.	0.91343	.	.	.	.	.	.	0.96273	3	RAF1	.	.	Gly	.	.	3-12599717-C-G	not_provided|RASopathy|Noonan_syndrome|Noonan_syndrome_5|LEOPARD_syndrome_2	.	.	12616216	ClinGen:CA134687	0.911494	0.88569	.	RCV000037671|RCV000159081|RCV000473341|RCV001542563|RCV000987116	.	.	.	c.1082G>C	.	.	.	0.92679	C/C	rs397516813	12599717	.	C	.	P04049	.	0.97458	.	0.68239		.	.	.	1.905	.	.	.	5.52	0.99031	.	D	D	.	.	.	.	.	.	.	536391|648|648|500	40613	0.92588	0.97266	0.996657013893127	.	.	0.71675	0.87038	.	.	.	7.9	.	.	.	.	.	.	PS163950|611553|611554	0.86061	3	.	ENSG00000132155	.	.	.	.	.	2	0.73823	0.60231	.	.	.	.	0.835976326801195	.	.	0.320475	49083	HGNC:9829	.	.	.	0.967	.	12599717	GGA	1.000000	.	-	.	0.98222	.	.	.	Pathogenic	0.85279	.	.	.	ClinGen:CA134687	G	.	.	-	0.932	-	0.97765	.	.	0.94466	0.90528345108	.	.	0.99865175337036671	.	-	1082G>C 	.	.	C3661900|C5555857|C0028326|C1969057|C1969056	.	.	.	.	NM_002880.4	-	.	.	1	0.97197	397516813	.	.	0.98954	0.92127	.	.	.	0.99697757	5.52	.	.	.	0.416773	0.999868252519254	0.50677	D	.	.	.	0.7110	0.92997	p.Gly361Ala	.	.	-12.08	.	.	0.98431	40613	D	.	RAF1	.	D	.	.	G361A	.	.	0.33565	C/C	principal3																																																																																																				
RAF1_Gly361Ala	1.155499028633321	0.5403518469840319	-8.632887687864956	0.0425849344631385	2025_01_Batch_13-14	0.7595018226539966	0.9272565960609439		0.9780376829289873	0.7507258763780502	0.873767237649067	0.9215944194386212	0.9758176547108324	0.9389494908136753	0.8778551909175832	0.8166345301515319	0.9244255077497825		0.9584935868713313	0.8142905336478168	0.0	0.0		1.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1				CCSBVarC008862	ALE00012143	NC_000003.12:12599717:C:G	1082G>C	Gly361Ala	CAVA																											RAF1_Gly361Ala	3	12599717	C	G	3								1	1	1	3-12599717-C-G	-	0.9094	0.997	361	.	.	.	3	12641216	G	.	.	3	1_Pathogenic	NC_000003.12	.	Gly361Ala	.	32.0	.	.	.	D	.	8	.	.	.	.	.	.	.	0.97773	.	0.7939	.	0.70687	.	.	D	D	.	.	.	.	.	.	.	0.97002	.	.	.	.	0.87174	.	.	0.96139	0.999	.	.	.	.	.	G	single nucleotide variant	NC_000003.12:g.12599717C>G	.	.	2	0.9189513	.	.	0.9621787	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500	.	.	.	.	0.94956	D	0.96930	D	L	9.651506	.	C/C	.	.	.	.	Noonan syndrome|not provided|RASopathy|Noonan syndrome 5|LEOPARD syndrome 2	.	0.93289	.	.	-	12599717	.	-	7.697000	.	0.98682	.	.	.	.	germline;unknown	.	Gain of glycosylation at T362 (P = 0.0323)| Loss of methylation at K365 (P = 0.0936)| Gain of catalytic residue at G361 (P = 0.1011)| Gain of MoRF binding (P = 0.1018)| Loss of disorder (P = 0.134)	0.98955	GRCh38	677	reviewed by expert panel	.	.	0.82128	.	.	.	Protein kinase domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	.	.	.	.	.	NM_002880.4(RAF1):c.1082G>C (p.Gly361Ala)	3	.	RAF1_HUMAN	.	.	0.841710195614201	.	.	0.96519	0.9493423	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.98223	.	.	.	.	.	.	.	0.66139	.	germline	.		C	Apr 03, 2017	.	C/C	.	.	1.0	N	3p25.2	.	.	.	SCV000616425	Pathogenic	.	.	Ala	A	-	.	ENSP00000508763	ENST00000691899	.	.	.	.	0.596	C	.	5.440165	0.51463	D	.	-	11.27517	.	0.91439	.	.	.	0.89711	.	12599717	Y	10	.	.	.	P04049	.	0.939635	0.94371		.	0.977	D	.	0.92825574	.	0.91597	5894	0.455678	.	.	.	.	0.91343	.	.	.	.	.	.	0.96273	3	RAF1	.	.	Gly	.	.	3-12599717-C-G	not_provided|RASopathy|Noonan_syndrome|Noonan_syndrome_5|LEOPARD_syndrome_2	.	.	12616216	ClinGen:CA134687	0.911494	0.88569	.	RCV000037671|RCV000159081|RCV000473341|RCV001542563|RCV000987116	.	.	.	c.1082G>C	.	.	.	0.92679	C/C	rs397516813	12599717	.	C	.	P04049	.	0.97458	.	0.68239		.	.	.	1.905	.	.	.	5.52	0.99031	.	D	D	.	.	.	.	.	.	.	536391|648|648|500	40613	0.92588	0.97266	0.996657013893127	.	.	0.71675	0.87038	.	.	.	7.9	.	.	.	.	.	.	PS163950|611553|611554	0.86061	3	.	ENSG00000132155	.	.	.	.	.	2	0.73823	0.60231	.	.	.	.	0.835976326801195	.	.	0.320475	49083	HGNC:9829	.	.	.	0.967	.	12599717	GGA	1.000000	.	-	.	0.98222	.	.	.	Pathogenic	0.85279	.	.	.	ClinGen:CA134687	G	.	.	-	0.932	-	0.97765	.	.	0.94466	0.90528345108	.	.	0.99865175337036671	.	-	1082G>C 	.	.	C3661900|C5555857|C0028326|C1969057|C1969056	.	.	.	.	NM_002880.4	-	.	.	1	0.97197	397516813	.	.	0.98954	0.92127	.	.	.	0.99697757	5.52	.	.	.	0.416773	0.999868252519254	0.50677	D	.	.	.	0.7110	0.92997	p.Gly361Ala	.	.	-12.08	.	.	0.98431	40613	D	.	RAF1	.	D	.	.	G361A	.	.	0.33565	C/C	principal3																																																																																																				
SDHD_Gly138Val	4.8838800111042024	0.0027079461804252287	-12.876055682927626	0.00001379787718155587	2025_01_Batch_13-14	0.779727937404184	0.842939506578824	0.8372653544475047	0.8371611674748377	0.6466604887656755	0.8424335559451768	0.8643440041773732	0.9116431333101943	0.8722665348804463	0.696406868316711	0.8110807466746803	0.8536417553780986	0.8744542438788495	0.854713851177642	0.6715336785411932	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023367		NC_000011.10:112094903:G:T		Gly138Val																												SDHD_Gly138Val	11	112094903	G	T	11	allele	413G>T	C01	527_CAVA_Array_P06	E02	B13A7A8P2_R1	B14A7A8P2_R2				11-112094903-G-T	-	0.75179	1.0	138	.	.	.	11	111965627	T	.	.	11	3_Conflicting	NC_000011.10	.	Gly138Val	.	26.3	.	.	.	D	.	2	1	.	.	.	.	.	.	0.99718	Select	0.9890	.	0.90580	.	.	D	D	.	0.842846843757	.	.	.	.	.	0.88056	.	.	.	.	0.96234	.	.	0.99378	1.0	.	.	0.944306	.	.	T	single nucleotide variant	NC_000011.10:g.112094903G>T	.	.	2	0.979656	.	.	0.9838489	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	.	.	.	.	.	D	0.99806	D	H	13.73274	.	./.	.	.	.	.	Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss|Hereditary pheochromocytoma-paraganglioma	.	0.97172	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094903	.	-	11.775000	.	0.98576	.	.	.	.	germline	.	Loss of sheet (P = 0.0315)| Gain of helix (P = 0.062)| Gain of catalytic residue at G138 (P = 0.2062)| Loss of stability (P = 0.6621)| Gain of MoRF binding (P = 0.7378)	0.97537	GRCh38	638	criteria provided, conflicting classifications	c.413G>T	.	0.62327	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.413G>T (p.Gly138Val)	1	.	DHSD_HUMAN	.	.	0.993936175157801	.	D	0.75365	0.9838489	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99231	.	.	.	.	.	p.Gly138Val	.	0.95964	.	germline	.		G	Nov 24, 2024	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV000640163|SCV004830039	Conflicting_classifications_of_pathogenicity	.	.	Val	V	-	.	ENSP00000364699	ENST00000375549	.	0.0	.	.	0.672	G	.	4.689578	0.76775	D	D	-	14.27025	.	0.97162	.	.	.	0.98872	.	112094903	Y	10	.	.	.	O14521	.	0.976803	0.86358		.	0.999	D	.	0.979656	.	0.97202	6392	0.585153	.	-7.91	.	.	0.91343	.	.	.	.	.	.	0.99807	11	SDHD	.	.	Gly	.	.	11-112094903-G-T	Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_pheochromocytoma-paraganglioma	.	.	111470837	ClinGen:CA382619290	0.951372	0.95530	.	RCV002526127|RCV003999154	D	.	.	c.413G>T	.	.	.	0.97294	./.	rs1401695686	112094903	.	G	.	O14521	.	0.99378	.	0.68239		.	.	.	3.83	.	.	.	4.85	0.99782	.	D	D	.	.	.	.	.	.	.	97286|29072|201|29072	465238	0.97251	0.67951	0.999767601490021	.	.	0.71675	0.96574	.	.	.	9.578	.	D	.	.	.	.	606864|171300	0.97363	11	.	ENSG00000204370	.	.	.	.	0.986906335179873	2	0.92348	0.64247	.	.	.	.	0.911916477651707	YES	.	0.662484	461681	HGNC:10683	.	.	.	0.965	.	112094903	GGG	1.000000	.	-	.	0.99050	.	.	.	Conflicting classifications of pathogenicity	0.98253	.	.	.	ClinGen:CA382619290	G	.	0.994972793835	-	0.895	-	0.99026	.	.	0.98679	0.839876294136	0.7584	.	0.99775908092948307	.	-	413G>T 	.	.	C1847319|C0031511|CN166604|C1868633|C1708353	.	.	.	.	NM_003002.4	-	.	.	1	0.78902	1401695686	.	.	0.99485	0.96049	0.976	0.003	.	0.99923384	4.85	.	.	.	0.602755	0.999416088640572	0.95555	D	.	.	.	0.9995	0.99688	p.Gly138Val	.	.	-15.193	0.98711103	.	0.96520	465238	D	.	SDHD	.	D	0.973	.	G138V	D	.	0.70176	./.	principal1																																																																																																				
SDHD_Gly138Val	4.8838800111042024	0.0027079461804252287	-12.876055682927626	0.00001379787718155587	2025_01_Batch_13-14	0.779727937404184	0.842939506578824	0.8372653544475047	0.8371611674748377	0.6466604887656755	0.8424335559451768	0.8643440041773732	0.9116431333101943	0.8722665348804463	0.696406868316711	0.8110807466746803	0.8536417553780986	0.8744542438788495	0.854713851177642	0.6715336785411932	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023367	ALE00021764	NC_000011.10:112094903:G:T	413G>T	Gly138Val	CAVA																											SDHD_Gly138Val	11	112094903	G	T	11								1	1	1	11-112094903-G-T	-	0.75179	1.0	138	.	.	.	11	111965627	T	.	.	11	3_Conflicting	NC_000011.10	.	Gly138Val	.	26.3	.	.	.	D	.	2	1	.	.	.	.	.	.	0.99718	Select	0.9890	.	0.90580	.	.	D	D	.	0.842846843757	.	.	.	.	.	0.88056	.	.	.	.	0.96234	.	.	0.99378	1.0	.	.	0.944306	.	.	T	single nucleotide variant	NC_000011.10:g.112094903G>T	.	.	2	0.979656	.	.	0.9838489	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072	.	.	.	.	.	D	0.99806	D	H	13.73274	.	./.	.	.	.	.	Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma;Paragangliomas with sensorineural hearing loss|Hereditary pheochromocytoma-paraganglioma	.	0.97172	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094903	.	-	11.775000	.	0.98576	.	.	.	.	germline	.	Loss of sheet (P = 0.0315)| Gain of helix (P = 0.062)| Gain of catalytic residue at G138 (P = 0.2062)| Loss of stability (P = 0.6621)| Gain of MoRF binding (P = 0.7378)	0.97537	GRCh38	638	criteria provided, conflicting classifications	c.413G>T	.	0.62327	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.413G>T (p.Gly138Val)	1	.	DHSD_HUMAN	.	.	0.993936175157801	.	D	0.75365	0.9838489	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99231	.	.	.	.	.	p.Gly138Val	.	0.95964	.	germline	.		G	Nov 24, 2024	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV000640163|SCV004830039	Conflicting_classifications_of_pathogenicity	.	.	Val	V	-	.	ENSP00000364699	ENST00000375549	.	0.0	.	.	0.672	G	.	4.689578	0.76775	D	D	-	14.27025	.	0.97162	.	.	.	0.98872	.	112094903	Y	10	.	.	.	O14521	.	0.976803	0.86358		.	0.999	D	.	0.979656	.	0.97202	6392	0.585153	.	-7.91	.	.	0.91343	.	.	.	.	.	.	0.99807	11	SDHD	.	.	Gly	.	.	11-112094903-G-T	Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_pheochromocytoma-paraganglioma	.	.	111470837	ClinGen:CA382619290	0.951372	0.95530	.	RCV002526127|RCV003999154	D	.	.	c.413G>T	.	.	.	0.97294	./.	rs1401695686	112094903	.	G	.	O14521	.	0.99378	.	0.68239		.	.	.	3.83	.	.	.	4.85	0.99782	.	D	D	.	.	.	.	.	.	.	97286|29072|201|29072	465238	0.97251	0.67951	0.999767601490021	.	.	0.71675	0.96574	.	.	.	9.578	.	D	.	.	.	.	606864|171300	0.97363	11	.	ENSG00000204370	.	.	.	.	0.986906335179873	2	0.92348	0.64247	.	.	.	.	0.911916477651707	YES	.	0.662484	461681	HGNC:10683	.	.	.	0.965	.	112094903	GGG	1.000000	.	-	.	0.99050	.	.	.	Conflicting classifications of pathogenicity	0.98253	.	.	.	ClinGen:CA382619290	G	.	0.994972793835	-	0.895	-	0.99026	.	.	0.98679	0.839876294136	0.7584	.	0.99775908092948307	.	-	413G>T 	.	.	C1847319|C0031511|CN166604|C1868633|C1708353	.	.	.	.	NM_003002.4	-	.	.	1	0.78902	1401695686	.	.	0.99485	0.96049	0.976	0.003	.	0.99923384	4.85	.	.	.	0.602755	0.999416088640572	0.95555	D	.	.	.	0.9995	0.99688	p.Gly138Val	.	.	-15.193	0.98711103	.	0.96520	465238	D	.	SDHD	.	D	0.973	.	G138V	D	.	0.70176	./.	principal1																																																																																																				
SDHD_His50Arg	3.0284841744564357	0.020352148961914243	1.554229897751678	0.004899917361531291	2025_01_Batch_13-14	0.8487679862963862	0.8719928321814725	0.8172339674526357	0.8810832625909506	0.8441392336339028	0.7954797741243843	0.8378481675212374	0.7725825389706431	0.8202877514285964	0.7279689661472681	0.8221238802103852	0.8549204998513549	0.7949082532116394	0.8506855070097735	0.7860540998905854	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD	ENSG00000204370	5678	201953	CCSBVarC006156	ALE00006156	NC_000011.10:112087953:A:G	149A>G	His50Arg	CEGS2	CegsMutGDEh1012	G11	GDEhDisVCh_40066	B02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			SDHD_His50Arg	11	112087953	A	G	11											11-112087953-A-G	-	0.49453	0.985	50	811	260	0	11	111958677	G	7.349020e-03	126	11	2_Benign	NC_000011.10	15	His50Arg	0	22.8	0	21	9.352430e-03	D	1	24	1	42768	6.626600e-03	0	30526	7.758620e-03	9	0.88248	Select	0.7712	102754	0.61134	251	0.0	D	T	63988	0.366577337986	0.001901484969214053	0	8.357710e-03	4	4	0.40396	17112	44866	164	0.000000e+00	0.84629	408	.	0.36096	0.796	0.0	37.0	0.876112	.	0.63	G	single nucleotide variant	NC_000011.10:g.112087953A>G	2	16700	3	0.17666198	109374	0	0.17611195	3.1075201988812925E-4	G	1314	236924	4	0	0.000000e+00	1138	9.539840e-03	1	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0021533,MedGen:C0349535,OMIM:114900|MedGen:C3661900|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:CN169374|	699	138	1.644740e-02	15	0.78586	P	0.37087	D	M	4.96495	11829	./.	418	154	7164	1609602	Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carcinoid tumor of intestine|not provided|Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|not specified|SDHD-related disorder	16218	0.93046	14	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112087953	9.539840e-03	-	7.662000	24	0.66558	29574	0.008737864077669903	912	0	germline;unknown	91004	.	.	GRCh38	635	criteria provided, multiple submitters, no conflicts	c.149A>G	1.736220e-03	0.63598	1996	0	52	.	6.347310e-03	9046	B	2.1843599825251202E-4	8.791510e-03	NM_003002.4(SDHD):c.149A>G (p.His50Arg)	2	0	DHSD_HUMAN	1	63.0	0.49081428387198	212	D	0.49161	0.16287881	+	1.814630e-03	2	0.00740724	811	8.370900e-03	0	34260	criteria_provided,_multiple_submitters,_no_conflicts	0.97449	6.390920e-03	54	5.838320e-03	0	60020	p.His50Arg	0	0.64345	.	germline	408	112087953	A	Mar 04, 2025	53	./.	5	89556	1.0	N	11q23.1	206608	.	1.479840e-03	SCV000183872|SCV000261942|SCV000297095|SCV000367346|SCV000514602|SCV000574910|SCV000597000|SCV000605087|SCV000609650|SCV000698139|SCV000703621|SCV000888623|SCV001138593|SCV002527118|SCV004027251|SCV004362300|SCV005689605	Benign/Likely_benign	78	80	Arg	R	-	912	ENSP00000364699	ENST00000375549	17692	0.065	13416	5	0.756	A	0	3.521592	0.92967	D	T	-	4.534256	.	.	1030	0	0.016898608349900597	0.03481	2	112087953	Y	9	0.007908611599297012	102754	6.437770e-03	O14521	0	0.604841	0.75021	A	4	0.804	.	89556	0.159546	42768	0.37596	6392	0.00267657	9648	-1.91	0.002044989775051125	1.644740e-02	0.91343	1.657110e-03	4	74930	0.000000e+00	6058	13	0.40081	11	SDHD	1.801680e-03	0	His	247432	9.055790e-03	11-112087953-A-G	Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Paragangliomas_1|not_specified|not_provided|Carcinoid_tumor_of_intestine|SDHD-related_disorder	2	961	111463887	ClinGen:CA016777|OMIM:602690.0019|UniProtKB:O14521#VAR_017871	0.739987	0.66377	43	RCV000023207|RCV000129149|RCV000238643|RCV000007318|RCV000034696|RCV000988743|RCV005055437|RCV002228009|RCV000122007|RCV003924810	T	0	0	c.149A>G	0	0	430	0.51703	./.	rs11214077	112087953	14902	A	0.006589456869009584	.	15690	0.38200	6.389480e-03	0.68239	11	0	5	0.000000e+00	2.875	0.0023923444976076554	1800	264690	4.9	0.87272	6436	T	T	23	6.945350e-03	9	1858	segdup	0	106	29072|140162|201|97286|29072	6909	0.85234	0.37946	0.0389905626794946	11462	33	0.71675	0.68322	7.326330e-03	9.055790e-03	1175866	2.521	6.314270e-03	N	13360	5	0.0077600214	1	171300|606864|168000|114900	0.45325	11	1.543420e-03	ENSG00000204370	6.720010e-03	0.008712150545961434	53	5.382131324004305E-4	0.8321952904549407	2	0.58344	0.64545	30608	2054	9.352430e-03	1.011330e-02	0.424179265049854	YES	1.802120e-03	.	21948	HGNC:10683	D	0	simple_aae	0.427	208100	112087953	CAC	1.000000	0	-	0.0019193857965451055	0.00218	8.205020e-03	22	3	Benign/Likely benign	0.18161	26	39	607	ClinGen:CA016777,UniProtKB:O14521#VAR_017871,OMIM:602690.0019	H	0	0.949941544596	-	.	-	0.69591	1570	20432	0.83077	0.511648774147	0.134	2	0.99613682030186279	326	-	149A>G 	961	0.007537196554424432	C0031511|C0027672|CN166604|C1868633|C1847319|C3494181|CN169374|C3661900|C0349535	0	0	18	0	NM_003002.4	-	17	0.020172910662824207	0	0.58713	11214077	2320	0.008066862814833974	0.94900	0.62877	0.533	0.133	11044	0.99399060	4.9	.	.	1.731570e-03	0.244042	0.893627502624236	0.83215	D	4578	6212	9572	0.6916	0.92199	p.His50Arg	1	1	-3.62	0.00989148	135	0.75625	6909	T	30524	SDHD	7.363250e-03	D	0.681	21598	.	T	.	0.943	./.	principal1																																																																																																				
SDHD_His50Arg	3.0284841744564357	0.020352148961914243	1.554229897751678	0.004899917361531291	2025_01_Batch_13-14	0.8487679862963862	0.8719928321814725	0.8172339674526357	0.8810832625909506	0.8441392336339028	0.7954797741243843	0.8378481675212374	0.7725825389706431	0.8202877514285964	0.7279689661472681	0.8221238802103852	0.8549204998513549	0.7949082532116394	0.8506855070097735	0.7860540998905854	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023281		NC_000011.10:112087953:A:G		His50Arg																												SDHD_His50Arg	11	112087953	A	G	11	allele	149A>G	D11	527_CAVA_Array_P05	G21	B13A7A8P2_R1	B14A7A8P2_R2				11-112087953-A-G	-	0.49453	0.985	50	811	260	0	11	111958677	G	7.349020e-03	126	11	2_Benign	NC_000011.10	15	His50Arg	0	22.8	0	21	9.352430e-03	D	1	24	1	42768	6.626600e-03	0	30526	7.758620e-03	9	0.88248	Select	0.7712	102754	0.61134	251	0.0	D	T	63988	0.366577337986	0.001901484969214053	0	8.357710e-03	4	4	0.40396	17112	44866	164	0.000000e+00	0.84629	408	.	0.36096	0.796	0.0	37.0	0.876112	.	0.63	G	single nucleotide variant	NC_000011.10:g.112087953A>G	2	16700	3	0.17666198	109374	0	0.17611195	3.1075201988812925E-4	G	1314	236924	4	0	0.000000e+00	1138	9.539840e-03	1	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0021533,MedGen:C0349535,OMIM:114900|MedGen:C3661900|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:CN169374|	699	138	1.644740e-02	15	0.78586	P	0.37087	D	M	4.96495	11829	./.	418	154	7164	1609602	Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carcinoid tumor of intestine|not provided|Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|not specified|SDHD-related disorder	16218	0.93046	14	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112087953	9.539840e-03	-	7.662000	24	0.66558	29574	0.008737864077669903	912	0	germline;unknown	91004	.	.	GRCh38	635	criteria provided, multiple submitters, no conflicts	c.149A>G	1.736220e-03	0.63598	1996	0	52	.	6.347310e-03	9046	B	2.1843599825251202E-4	8.791510e-03	NM_003002.4(SDHD):c.149A>G (p.His50Arg)	2	0	DHSD_HUMAN	1	63.0	0.49081428387198	212	D	0.49161	0.16287881	+	1.814630e-03	2	0.00740724	811	8.370900e-03	0	34260	criteria_provided,_multiple_submitters,_no_conflicts	0.97449	6.390920e-03	54	5.838320e-03	0	60020	p.His50Arg	0	0.64345	.	germline	408	112087953	A	Mar 04, 2025	53	./.	5	89556	1.0	N	11q23.1	206608	.	1.479840e-03	SCV000183872|SCV000261942|SCV000297095|SCV000367346|SCV000514602|SCV000574910|SCV000597000|SCV000605087|SCV000609650|SCV000698139|SCV000703621|SCV000888623|SCV001138593|SCV002527118|SCV004027251|SCV004362300|SCV005689605	Benign/Likely_benign	78	80	Arg	R	-	912	ENSP00000364699	ENST00000375549	17692	0.065	13416	5	0.756	A	0	3.521592	0.92967	D	T	-	4.534256	.	.	1030	0	0.016898608349900597	0.03481	2	112087953	Y	9	0.007908611599297012	102754	6.437770e-03	O14521	0	0.604841	0.75021	A	4	0.804	.	89556	0.159546	42768	0.37596	6392	0.00267657	9648	-1.91	0.002044989775051125	1.644740e-02	0.91343	1.657110e-03	4	74930	0.000000e+00	6058	13	0.40081	11	SDHD	1.801680e-03	0	His	247432	9.055790e-03	11-112087953-A-G	Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Paragangliomas_1|not_specified|not_provided|Carcinoid_tumor_of_intestine|SDHD-related_disorder	2	961	111463887	ClinGen:CA016777|OMIM:602690.0019|UniProtKB:O14521#VAR_017871	0.739987	0.66377	43	RCV000023207|RCV000129149|RCV000238643|RCV000007318|RCV000034696|RCV000988743|RCV005055437|RCV002228009|RCV000122007|RCV003924810	T	0	0	c.149A>G	0	0	430	0.51703	./.	rs11214077	112087953	14902	A	0.006589456869009584	.	15690	0.38200	6.389480e-03	0.68239	11	0	5	0.000000e+00	2.875	0.0023923444976076554	1800	264690	4.9	0.87272	6436	T	T	23	6.945350e-03	9	1858	segdup	0	106	29072|140162|201|97286|29072	6909	0.85234	0.37946	0.0389905626794946	11462	33	0.71675	0.68322	7.326330e-03	9.055790e-03	1175866	2.521	6.314270e-03	N	13360	5	0.0077600214	1	171300|606864|168000|114900	0.45325	11	1.543420e-03	ENSG00000204370	6.720010e-03	0.008712150545961434	53	5.382131324004305E-4	0.8321952904549407	2	0.58344	0.64545	30608	2054	9.352430e-03	1.011330e-02	0.424179265049854	YES	1.802120e-03	.	21948	HGNC:10683	D	0	simple_aae	0.427	208100	112087953	CAC	1.000000	0	-	0.0019193857965451055	0.00218	8.205020e-03	22	3	Benign/Likely benign	0.18161	26	39	607	ClinGen:CA016777,UniProtKB:O14521#VAR_017871,OMIM:602690.0019	H	0	0.949941544596	-	.	-	0.69591	1570	20432	0.83077	0.511648774147	0.134	2	0.99613682030186279	326	-	149A>G 	961	0.007537196554424432	C0031511|C0027672|CN166604|C1868633|C1847319|C3494181|CN169374|C3661900|C0349535	0	0	18	0	NM_003002.4	-	17	0.020172910662824207	0	0.58713	11214077	2320	0.008066862814833974	0.94900	0.62877	0.533	0.133	11044	0.99399060	4.9	.	.	1.731570e-03	0.244042	0.893627502624236	0.83215	D	4578	6212	9572	0.6916	0.92199	p.His50Arg	1	1	-3.62	0.00989148	135	0.75625	6909	T	30524	SDHD	7.363250e-03	D	0.681	21598	.	T	.	0.943	./.	principal1																																																																																																				
SDHD_His50Arg	3.0284841744564357	0.020352148961914243	1.554229897751678	0.004899917361531291	2025_01_Batch_13-14	0.8487679862963862	0.8719928321814725	0.8172339674526357	0.8810832625909506	0.8441392336339028	0.7954797741243843	0.8378481675212374	0.7725825389706431	0.8202877514285964	0.7279689661472681	0.8221238802103852	0.8549204998513549	0.7949082532116394	0.8506855070097735	0.7860540998905854	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023281	ALE00037483	NC_000011.10:112087953:A:G	149A>G	His50Arg	CAVA																											SDHD_His50Arg	11	112087953	A	G	11								1	1	1	11-112087953-A-G	-	0.49453	0.985	50	811	260	0	11	111958677	G	7.349020e-03	126	11	2_Benign	NC_000011.10	15	His50Arg	0	22.8	0	21	9.352430e-03	D	1	24	1	42768	6.626600e-03	0	30526	7.758620e-03	9	0.88248	Select	0.7712	102754	0.61134	251	0.0	D	T	63988	0.366577337986	0.001901484969214053	0	8.357710e-03	4	4	0.40396	17112	44866	164	0.000000e+00	0.84629	408	.	0.36096	0.796	0.0	37.0	0.876112	.	0.63	G	single nucleotide variant	NC_000011.10:g.112087953A>G	2	16700	3	0.17666198	109374	0	0.17611195	3.1075201988812925E-4	G	1314	236924	4	0	0.000000e+00	1138	9.539840e-03	1	Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MONDO:MONDO:0021533,MedGen:C0349535,OMIM:114900|MedGen:C3661900|MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MedGen:CN169374|	699	138	1.644740e-02	15	0.78586	P	0.37087	D	M	4.96495	11829	./.	418	154	7164	1609602	Pheochromocytoma|Hereditary cancer-predisposing syndrome|Paragangliomas 1|Carcinoid tumor of intestine|not provided|Carney-Stratakis syndrome|Hereditary pheochromocytoma-paraganglioma|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|not specified|SDHD-related disorder	16218	0.93046	14	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112087953	9.539840e-03	-	7.662000	24	0.66558	29574	0.008737864077669903	912	0	germline;unknown	91004	.	.	GRCh38	635	criteria provided, multiple submitters, no conflicts	c.149A>G	1.736220e-03	0.63598	1996	0	52	.	6.347310e-03	9046	B	2.1843599825251202E-4	8.791510e-03	NM_003002.4(SDHD):c.149A>G (p.His50Arg)	2	0	DHSD_HUMAN	1	63.0	0.49081428387198	212	D	0.49161	0.16287881	+	1.814630e-03	2	0.00740724	811	8.370900e-03	0	34260	criteria_provided,_multiple_submitters,_no_conflicts	0.97449	6.390920e-03	54	5.838320e-03	0	60020	p.His50Arg	0	0.64345	.	germline	408	112087953	A	Mar 04, 2025	53	./.	5	89556	1.0	N	11q23.1	206608	.	1.479840e-03	SCV000183872|SCV000261942|SCV000297095|SCV000367346|SCV000514602|SCV000574910|SCV000597000|SCV000605087|SCV000609650|SCV000698139|SCV000703621|SCV000888623|SCV001138593|SCV002527118|SCV004027251|SCV004362300|SCV005689605	Benign/Likely_benign	78	80	Arg	R	-	912	ENSP00000364699	ENST00000375549	17692	0.065	13416	5	0.756	A	0	3.521592	0.92967	D	T	-	4.534256	.	.	1030	0	0.016898608349900597	0.03481	2	112087953	Y	9	0.007908611599297012	102754	6.437770e-03	O14521	0	0.604841	0.75021	A	4	0.804	.	89556	0.159546	42768	0.37596	6392	0.00267657	9648	-1.91	0.002044989775051125	1.644740e-02	0.91343	1.657110e-03	4	74930	0.000000e+00	6058	13	0.40081	11	SDHD	1.801680e-03	0	His	247432	9.055790e-03	11-112087953-A-G	Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Paragangliomas_1|not_specified|not_provided|Carcinoid_tumor_of_intestine|SDHD-related_disorder	2	961	111463887	ClinGen:CA016777|OMIM:602690.0019|UniProtKB:O14521#VAR_017871	0.739987	0.66377	43	RCV000023207|RCV000129149|RCV000238643|RCV000007318|RCV000034696|RCV000988743|RCV005055437|RCV002228009|RCV000122007|RCV003924810	T	0	0	c.149A>G	0	0	430	0.51703	./.	rs11214077	112087953	14902	A	0.006589456869009584	.	15690	0.38200	6.389480e-03	0.68239	11	0	5	0.000000e+00	2.875	0.0023923444976076554	1800	264690	4.9	0.87272	6436	T	T	23	6.945350e-03	9	1858	segdup	0	106	29072|140162|201|97286|29072	6909	0.85234	0.37946	0.0389905626794946	11462	33	0.71675	0.68322	7.326330e-03	9.055790e-03	1175866	2.521	6.314270e-03	N	13360	5	0.0077600214	1	171300|606864|168000|114900	0.45325	11	1.543420e-03	ENSG00000204370	6.720010e-03	0.008712150545961434	53	5.382131324004305E-4	0.8321952904549407	2	0.58344	0.64545	30608	2054	9.352430e-03	1.011330e-02	0.424179265049854	YES	1.802120e-03	.	21948	HGNC:10683	D	0	simple_aae	0.427	208100	112087953	CAC	1.000000	0	-	0.0019193857965451055	0.00218	8.205020e-03	22	3	Benign/Likely benign	0.18161	26	39	607	ClinGen:CA016777,UniProtKB:O14521#VAR_017871,OMIM:602690.0019	H	0	0.949941544596	-	.	-	0.69591	1570	20432	0.83077	0.511648774147	0.134	2	0.99613682030186279	326	-	149A>G 	961	0.007537196554424432	C0031511|C0027672|CN166604|C1868633|C1847319|C3494181|CN169374|C3661900|C0349535	0	0	18	0	NM_003002.4	-	17	0.020172910662824207	0	0.58713	11214077	2320	0.008066862814833974	0.94900	0.62877	0.533	0.133	11044	0.99399060	4.9	.	.	1.731570e-03	0.244042	0.893627502624236	0.83215	D	4578	6212	9572	0.6916	0.92199	p.His50Arg	1	1	-3.62	0.00989148	135	0.75625	6909	T	30524	SDHD	7.363250e-03	D	0.681	21598	.	T	.	0.943	./.	principal1																																																																																																				
SDHD_His50Asp	5.2045723369280035	0.003547308842902077	-5.489031542982944	0.11438868033215185	2025_01_Batch_13-14	0.9296084092898396	0.9341050188181299	0.9083678801835474	0.9562213211632515	0.8488139186065639	0.9026523425916128	0.8809122384551284	0.8614696514963278	0.9073025499216885	0.7856244238428094	0.9161303759407262	0.9075086286366292	0.8849187658399376	0.93176193554247	0.8172191712246866	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023279		NC_000011.10:112087952:C:G		His50Asp																												SDHD_His50Asp	11	112087952	C	G	11	allele	148C>G	C11	527_CAVA_Array_P05	E21	B13A7A8P2_R1	B14A7A8P2_R2				11-112087952-C-G	-	0.62924	1.0	50	1	.	0	11	111958676	G	.	0	11	3_Conflicting	NC_000011.10	.	His50Asp	0	24.5	0	.	.	D	.	5	1	42768	0.000000e+00	.	30526	0.000000e+00	.	0.91722	Select	0.8997	.	0.90580	0	.	D	D	.	0.67055262571	.	.	0.000000e+00	0	.	0.40377	17112	.	.	0.000000e+00	0.89554	0	.	0.61369	0.808	.	.	0.862614	.	.	G	single nucleotide variant	NC_000011.10:g.112087952C>G	.	16696	2	0.35787314	109370	.	0.41402334	.		1	236920	0	0	0.000000e+00	.	0.000000e+00	.	MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286	0	0	.	.	.	D	0.61034	D	M	6.303636	.	./.	.	.	7164	.	not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome	16218	0.96011	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112087952	.	-	5.674000	0	0.76062	.	.	.	0	germline	.	Loss of glycosylation at P53 (P = 0.0815)| Loss of sheet (P = 0.1398)| Loss of catalytic residue at S54 (P = 0.1704)| Gain of disorder (P = 0.1919)| Gain of relative solvent accessibility (P = 0.2363)	0.64172	GRCh38	635	criteria provided, conflicting classifications	c.148C>G	0.000000e+00	0.63598	.	0	0	.	0.000000e+00	9046	B	.	.	NM_003002.4(SDHD):c.148C>G (p.His50Asp)	1	0	DHSD_HUMAN	0	.	0.635376796190383	0	D	0.65739	0.41402334	+	0.000000e+00	.		1	0.000000e+00	0	34260	criteria_provided,_multiple_submitters,_no_conflicts	0.98169	0.000000e+00	.	0.000000e+00	0	.	p.His50Asp	.	0.49343	.	germline	.		C	Oct 04, 2024	0	./.	0	89556	0.999	N	11q23.1	.	.	0.000000e+00	SCV000589392|SCV000664535|SCV000762665|SCV005424120	Likely_pathogenic	0	0	Asp	D	-	.	ENSP00000364699	ENST00000375549	17692	0.018	13416	0	0.599	C	0	4.177101	0.92967	D	D	-	5.714621	.	0.94066	.	0	.	0.65639	.	112087952	Y	10	.	102754	.	O14521	0	0.704104	0.50938		.	0.99	D	89556	0.35787314	.	0.38116	6392	0.460795	.	-3.14	.	.	0.91343	0.000000e+00	0	.	0.000000e+00	.	0	0.61034	11	SDHD	.	.	His	.	1.116620e-05	11-112087952-C-G	Hereditary_cancer-predisposing_syndrome|Carney-Stratakis_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Cowden_syndrome_3|not_provided|Hereditary_pheochromocytoma-paraganglioma	.	0	111463886	ClinGen:CA382617089	0.784431	0.75292	.	RCV000497964|RCV000505346|RCV000569506|RCV002230973	D	.	0	c.148C>G	0	.	.	0.92907	./.	rs779249550	112087952	14902	C	.	O14521	15690	0.61368	0.000000e+00	0.68239		0	0	.	2.875	.	.	.	4.9	0.91424	.	D	T	0	0.000000e+00	.	.	segdup	0	0	140162|97286|29072|201|29072	431847	0.92818	0.59146	0.960621476173401	.	.	0.42732	0.71408	0.000000e+00	1.116620e-05	.	3.351	4.805470e-06	D	13356	0	.	.	606864|171300	0.52041	11	0.000000e+00	ENSG00000204370	.	.	0	.	0.9054445795321721	1	0.78943	0.64545	30608	.	0.000000e+00	.	0.556168196419146	YES	.	0.436238	425903	HGNC:10683	.	0	.	0.574	208096	112087952	CAC	1.000000	.	-	.	0.83639	.	.	.	Conflicting classifications of pathogenicity	0.12713	0	.	.	ClinGen:CA382617089	H	0	0.957064088694	-	0.534	-	0.76851	0	.	0.90457	0.511507630348	0.3169	.	0.99032993676936265	.	-	148C>G 	.	.	C0027672|C1847319|C0031511|C1868633|CN166604|C3661900|C1708353	0	0	0	0	NM_003002.4	-	.	.	1	0.55690	779249550	2320	.	0.95623	0.71674	0.772	0.008	.	0.99681085	4.9	.	.	0.000000e+00	0.424123	0.974774869969241	0.83215	D	.	6212	9572	0.9245	0.96666	p.His50Asp	.	.	-2.133	0.84643626	.	0.84170	431847	T	30524	SDHD	0.000000e+00	D	0.758	21594	H50D	D	.	0.40292	./.	principal1																																																																																																				
FARS2_Gly3Val	-2.1910901347520046	0.41370840506561246	-2.0289898882089776	0.1046229420390252	2025_01_Batch_13-14	0.6300724190845303	0.7579250535477255	0.7324038549786723	0.6785107013649005	0.613947755326278	0.6207307304139533	0.7254778234244152	0.7172547134442959	0.7504674270590193	0.48258131790836933	0.6254015747492419	0.7417014384860704	0.7248292842114841	0.7144890642119599	0.5482645366173237	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011880		NC_000006.12:5368578:G:T		Gly3Val																												FARS2_Gly3Val	6	5368578	G	T	6	allele	8G>T	G01	527_CAVA_Array_P03	N01	B13A7A8P1_R1	B14A7A8P1_R2				6-5368578-G-T	-	0.08506	0.0	3	.	0	.	6	5368811	T	1.865230e-06	.	6	2_Benign	NC_000006.12	3	Gly3Val	.	5.236	.	0	.	T	0	1	1	.	.	.	.	.	0	0.18106	Select	0.0490	.	0.02950	.	.	T	T	63832	.	0	0	.	.	.	0.18315	.	44808	0	.	0.03617	.	.	0.08549	0.033	.	.	0.706229	0.277	.	T	single nucleotide variant	NC_000006.12:g.5368578G>T	0	.	2	0.05854014	.	0	0.04899978	0		.	.	.	.	.	146	.	0	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	.	.	0.000000e+00	0	.	B	0.10844	B	N	0.1651864	3	G/G	108	0	.	1608378	Intellectual disability	.	0.24210	.	.	-	5368578	.	-	1.445000	.	0.28905	29148	0	1176546	.	inherited	90348	Gain of stability (P = 0.0417)| Gain of helix (P = 0.0425)| Loss of disorder (P = 0.0976)| Loss of loop (P = 0.1242)| Loss of methylation at R7 (P = 0.1536)	0.20839	GRCh38	944	no assertion criteria provided	c.8G>T	.	0.23089	0	.	.	.	.	.	B	0	0.000000e+00	NM_006567.5(FARS2):c.8G>T (p.Gly3Val)		.	SYFM_HUMAN	.	.	-1.29901716008698	.	T	0.19666	0.04899978	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.70290	.	0	.	.	59726	p.Gly3Val	0	0.26644	.	germline	.		G	Jan 01, 2019	.	G/G	.	.	0.0	N	6p25.1	7618	.	.	SCV001428242	Likely_benign	.	.	Val	V	-	912	ENSP00000274680	ENST00000274680	.	0.108	.	.	-0.779	G	.	0.478147	0.33996	N	T	-	0.2405891	.	0.29732	610	.	.	0.01420	0	5368578	Y	10	0	.	0.000000e+00	O95363	.	0.028576	0.10205		.	0.0	T	.	0.05854014	.	0.13527	10667	-0.160298	3	0.37	.	2.549840e-06	0.29555	.	.	74836	.	6032	.	0.10843	6	FARS2	0.000000e+00	0	Gly	11862	.	6-5368578-G-T	Intellectual_disability	0	.	5313810	.	0.048075	0.03647	0	RCV001252485	T	0	.	c.8G>T	.	0	0	0.26369	G/G	rs200380429	5368578	.	G	.	O95363	.	0.08549	.	0.18256		.	.	0.000000e+00	0.69	0	0	264690	1.67	0.20467	108	T	T	.	.	0	24	.	.	.	.	975692	0.25378	0.21965	0.0261529918185712	2816	.	0.06393	0.08031	.	.	1176546	0.253	.	N	.	.	3.7780044E-6	0	.	0.18128	6	.	ENSG00000145982	0.000000e+00	0	.	0	.	2	0.01384	0.12756	.	1	.	0.000000e+00	-1.25431266583447	YES	0.000000e+00	0.011909	963613	HGNC:21062	.	.	.	0.104	.	5368578	GGC	0.002000	.	-	0	0.08450	2.549840e-06	0	0	Likely benign	0.07480	.	0	0	ClinGen:CA3623578	G	.	0.533179623451	-	0.264	-	0.22970	.	470	0.50277	0.352800011635	0.0811	0	0.72636894617756464	94	-	8G>T 	.	0	C3714756	.	.	.	.	NM_006567.5	-	.	.	0	0.31439	200380429	.	0	0.52623	0.04988	0.201	0.173	2708	0.14797659	5.01	.	.	.	-0.468033	0.0342656122538894	0.16877	T	84	.	.	-1.0183	0.20756	p.Gly3Val	0	0	-2.72	0.06419563	0	0.33942	975692	T	.	FARS2	.	T	0.063	.	G3V	T	0.23484	0.0337	G/G	principal1																																																																																																				
FARS2_Gly3Val	-2.1910901347520046	0.41370840506561246	-2.0289898882089776	0.1046229420390252	2025_01_Batch_13-14	0.6300724190845303	0.7579250535477255	0.7324038549786723	0.6785107013649005	0.613947755326278	0.6207307304139533	0.7254778234244152	0.7172547134442959	0.7504674270590193	0.48258131790836933	0.6254015747492419	0.7417014384860704	0.7248292842114841	0.7144890642119599	0.5482645366173237	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2				CCSBVarC011880	ALE00010797	NC_000006.12:5368578:G:T	8G>T	Gly3Val	CAVA																											FARS2_Gly3Val	6	5368578	G	T	6								1	1	1	6-5368578-G-T	-	0.08506	0.0	3	.	0	.	6	5368811	T	1.865230e-06	.	6	2_Benign	NC_000006.12	3	Gly3Val	.	5.236	.	0	.	T	0	1	1	.	.	.	.	.	0	0.18106	Select	0.0490	.	0.02950	.	.	T	T	63832	.	0	0	.	.	.	0.18315	.	44808	0	.	0.03617	.	.	0.08549	0.033	.	.	0.706229	0.277	.	T	single nucleotide variant	NC_000006.12:g.5368578G>T	0	.	2	0.05854014	.	0	0.04899978	0		.	.	.	.	.	146	.	0	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	.	.	0.000000e+00	0	.	B	0.10844	B	N	0.1651864	3	G/G	108	0	.	1608378	Intellectual disability	.	0.24210	.	.	-	5368578	.	-	1.445000	.	0.28905	29148	0	1176546	.	inherited	90348	Gain of stability (P = 0.0417)| Gain of helix (P = 0.0425)| Loss of disorder (P = 0.0976)| Loss of loop (P = 0.1242)| Loss of methylation at R7 (P = 0.1536)	0.20839	GRCh38	944	no assertion criteria provided	c.8G>T	.	0.23089	0	.	.	.	.	.	B	0	0.000000e+00	NM_006567.5(FARS2):c.8G>T (p.Gly3Val)		.	SYFM_HUMAN	.	.	-1.29901716008698	.	T	0.19666	0.04899978	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.70290	.	0	.	.	59726	p.Gly3Val	0	0.26644	.	germline	.		G	Jan 01, 2019	.	G/G	.	.	0.0	N	6p25.1	7618	.	.	SCV001428242	Likely_benign	.	.	Val	V	-	912	ENSP00000274680	ENST00000274680	.	0.108	.	.	-0.779	G	.	0.478147	0.33996	N	T	-	0.2405891	.	0.29732	610	.	.	0.01420	0	5368578	Y	10	0	.	0.000000e+00	O95363	.	0.028576	0.10205		.	0.0	T	.	0.05854014	.	0.13527	10667	-0.160298	3	0.37	.	2.549840e-06	0.29555	.	.	74836	.	6032	.	0.10843	6	FARS2	0.000000e+00	0	Gly	11862	.	6-5368578-G-T	Intellectual_disability	0	.	5313810	.	0.048075	0.03647	0	RCV001252485	T	0	.	c.8G>T	.	0	0	0.26369	G/G	rs200380429	5368578	.	G	.	O95363	.	0.08549	.	0.18256		.	.	0.000000e+00	0.69	0	0	264690	1.67	0.20467	108	T	T	.	.	0	24	.	.	.	.	975692	0.25378	0.21965	0.0261529918185712	2816	.	0.06393	0.08031	.	.	1176546	0.253	.	N	.	.	3.7780044E-6	0	.	0.18128	6	.	ENSG00000145982	0.000000e+00	0	.	0	.	2	0.01384	0.12756	.	1	.	0.000000e+00	-1.25431266583447	YES	0.000000e+00	0.011909	963613	HGNC:21062	.	.	.	0.104	.	5368578	GGC	0.002000	.	-	0	0.08450	2.549840e-06	0	0	Likely benign	0.07480	.	0	0	ClinGen:CA3623578	G	.	0.533179623451	-	0.264	-	0.22970	.	470	0.50277	0.352800011635	0.0811	0	0.72636894617756464	94	-	8G>T 	.	0	C3714756	.	.	.	.	NM_006567.5	-	.	.	0	0.31439	200380429	.	0	0.52623	0.04988	0.201	0.173	2708	0.14797659	5.01	.	.	.	-0.468033	0.0342656122538894	0.16877	T	84	.	.	-1.0183	0.20756	p.Gly3Val	0	0	-2.72	0.06419563	0	0.33942	975692	T	.	FARS2	.	T	0.063	.	G3V	T	0.23484	0.0337	G/G	principal1																																																																																																				
SDHD_Glu69Lys	7.232879738605847	0.00017436415792478971	-4.077985550501284	0.2861293525491404	2025_01_Batch_13-14	0.8821027870189919	0.8894584643146449	0.8695156845974097	0.8899949431301525	0.8409505617727295	0.8785284667882031	0.8680985288630207	0.8556173956891031	0.8759832893674684	0.8231562566782767	0.8803156269035974	0.8787784965888328	0.8625665401432564	0.8829891162488104	0.8320534092255032	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023285		NC_000011.10:112088902:G:A		Glu69Lys																												SDHD_Glu69Lys	11	112088902	G	A	11	allele	205G>A	F11	527_CAVA_Array_P05	K21	B13A7A8P2_R1	B14A7A8P2_R2				11-112088902-G-A	-	0.9054	1.0	69	2	0	0	11	111959626	A	2.480210e-06	0	11	3_Conflicting	NC_000011.10	4	Glu69Lys	0	31.0	0	.	1.950500e-05	D	0	6	1	42768	8.448730e-06	.	30526	0.000000e+00	.	0.99981	Select	0.9843	102538	0.90580	0	.	D	D	64040	0.784672596276	.	0	0.000000e+00	0	0	0.71868	17112	44872	0	0.000000e+00	0.74082	1	.	0.99136	0.997	.	1.0	0.974503	.	0.99	A	single nucleotide variant	NC_000011.10:g.112088902G>A	0	16734	3	0.9438836	109406	.	0.98499125	.		2	236722	0	0	0.000000e+00	.	2.338200e-05	.	MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MedGen:C3661900|MONDO:MONDO:0100294,MedGen:C5700310,OMIM:252011,Orphanet:3208|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	1	0	0.000000e+00	0	0.97926	D	0.98647	D	H	12.90049	4	./.	.	.	7164	1612768	Mitochondrial complex 2 deficiency, nuclear type 3|not provided|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Hereditary cancer-predisposing syndrome|SDHD-related disorder	16216	0.97876	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112088902	2.338200e-05	-	11.792000	0	0.99892	29606	.	1179938	0	germline;inherited	91010	Gain of MoRF binding (P = 0.0031)| Gain of methylation at E69 (P = 0.0104)| Gain of ubiquitination at E69 (P = 0.0539)| Gain of relative solvent accessibility (P = 0.0999)| Gain of solvent accessibility (P = 0.1045)	0.99499	GRCh38	637	criteria provided, conflicting classifications	c.205G>A	0.000000e+00	0.67250	.	0	0	.	0.000000e+00	9044	P	.	0.000000e+00	NM_003002.4(SDHD):c.205G>A (p.Glu69Lys)	1	0	DHSD_HUMAN	0	99.0	0.966518903071094	0	D	0.78519	0.98053944	+	0.000000e+00	.		2	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.99205	9.140270e-06	0	0.000000e+00	0	60016	p.Glu69Lys	0	0.96405	.	germline	1		G	Jan 15, 2025	0	./.	0	89538	1.0	N	11q23.1	.	.	0.000000e+00	SCV000568557|SCV000825280|SCV002725594	Conflicting_classifications_of_pathogenicity	0	0	Lys	K	-	912	ENSP00000364699	ENST00000375549	17686	0.0	13410	0	0.618	G	0	5.407385	0.92967	D	D	-	13.28898	.	0.98097	.	0	.	0.98285	.	112088902	Y	10	.	102538	0.000000e+00	O14521	0	0.979582	0.99579		0	1.0	D	89538	0.95455986	42768	0.79771	6392	0.572592	4	-4.0	.	3.390010e-06	0.91343	0.000000e+00	0	74996	0.000000e+00	5002	0	0.97990	11	SDHD	0.000000e+00	.	Glu	.	2.233690e-05	11-112088902-G-A	Hereditary_cancer-predisposing_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Cowden_syndrome_3|Mitochondrial_complex_2_deficiency,_nuclear_type_3|not_provided|Mitochondrial_complex_II_deficiency,_nuclear_type_1	0	2	111464836	ClinGen:CA016681|OMIM:602690.0029|UniProtKB:O14521#VAR_074105	0.950494	0.94586	0	RCV000144171|RCV000484125|RCV001290090|RCV002515941|RCV002415627|RCV004748597	D	0	0	c.205G>A	0	0	0	0.96621	./.	rs202198133	112088902	14900	G	.	O14521	15690	0.99456	0.000000e+00	0.68239		0	0	0.000000e+00	3.83	.	.	.	5.04	0.99826	.	D	T	0	0.000000e+00	.	.	segdup	0	0	140162|29072|97286|201|3208	156153	0.96985	0.65221	0.999643564224243	.	.	0.71675	0.96405	0.000000e+00	2.233690e-05	1179938	9.348	9.610490e-06	D	13394	0	.	.	171300|606864|619167|252011	0.96472	11	0.000000e+00	ENSG00000204370	0.000000e+00	.	0	.	0.9609739073875347	1	0.97365	0.64339	30608	.	1.950500e-05	0.000000e+00	0.888994358309617	YES	0.000000e+00	0.760838	165952	HGNC:10683	A	0	simple_aae	0.997	208106	112088902	GAG	1.000000	.	-	.	0.99448	3.390010e-06	.	0	Conflicting classifications of pathogenicity	0.91228	0	0	0	ClinGen:CA016681,UniProtKB:O14521#VAR_074105,OMIM:602690.0029	E	0	0.972172681102	-	0.955	-	0.99956	2	.	0.96060	0.732807695866	0.8013	0	0.99935591763030651	.	-	205G>A 	2	.	C0027672|C0031511|C1868633|C1847319|CN166604|C5436934|C3661900|C5700310	0	0	0	0	NM_003002.4	-	.	.	1	0.92926	202198133	2320	.	0.97161	0.95048	0.996	0.004	.	0.99919051	5.04	.	.	0.000000e+00	0.600199	0.996962020332363	0.95555	D	.	6212	9572	1.0385	0.99522	p.Glu69Lys	.	0	-11.599	0.9897574	0	0.92637	156153	D	30524	SDHD	0.000000e+00	D	0.991	21632	E69K	D	.	0.50684	./.	principal1																																																																																																				
SDHD_Glu69Lys	7.232879738605847	0.00017436415792478971	-4.077985550501284	0.2861293525491404	2025_01_Batch_13-14	0.8821027870189919	0.8894584643146449	0.8695156845974097	0.8899949431301525	0.8409505617727295	0.8785284667882031	0.8680985288630207	0.8556173956891031	0.8759832893674684	0.8231562566782767	0.8803156269035974	0.8787784965888328	0.8625665401432564	0.8829891162488104	0.8320534092255032	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023285	ALE00029807	NC_000011.10:112088902:G:A	205G>A	Glu69Lys	CAVA																											SDHD_Glu69Lys	11	112088902	G	A	11								1	1	1	11-112088902-G-A	-	0.9054	1.0	69	2	0	0	11	111959626	A	2.480210e-06	0	11	3_Conflicting	NC_000011.10	4	Glu69Lys	0	31.0	0	.	1.950500e-05	D	0	6	1	42768	8.448730e-06	.	30526	0.000000e+00	.	0.99981	Select	0.9843	102538	0.90580	0	.	D	D	64040	0.784672596276	.	0	0.000000e+00	0	0	0.71868	17112	44872	0	0.000000e+00	0.74082	1	.	0.99136	0.997	.	1.0	0.974503	.	0.99	A	single nucleotide variant	NC_000011.10:g.112088902G>A	0	16734	3	0.9438836	109406	.	0.98499125	.		2	236722	0	0	0.000000e+00	.	2.338200e-05	.	MONDO:MONDO:0030937,MedGen:C5436934,OMIM:619167|MedGen:C3661900|MONDO:MONDO:0100294,MedGen:C5700310,OMIM:252011,Orphanet:3208|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	1	0	0.000000e+00	0	0.97926	D	0.98647	D	H	12.90049	4	./.	.	.	7164	1612768	Mitochondrial complex 2 deficiency, nuclear type 3|not provided|Mitochondrial complex II deficiency, nuclear type 1|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3|Hereditary cancer-predisposing syndrome|SDHD-related disorder	16216	0.97876	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112088902	2.338200e-05	-	11.792000	0	0.99892	29606	.	1179938	0	germline;inherited	91010	Gain of MoRF binding (P = 0.0031)| Gain of methylation at E69 (P = 0.0104)| Gain of ubiquitination at E69 (P = 0.0539)| Gain of relative solvent accessibility (P = 0.0999)| Gain of solvent accessibility (P = 0.1045)	0.99499	GRCh38	637	criteria provided, conflicting classifications	c.205G>A	0.000000e+00	0.67250	.	0	0	.	0.000000e+00	9044	P	.	0.000000e+00	NM_003002.4(SDHD):c.205G>A (p.Glu69Lys)	1	0	DHSD_HUMAN	0	99.0	0.966518903071094	0	D	0.78519	0.98053944	+	0.000000e+00	.		2	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.99205	9.140270e-06	0	0.000000e+00	0	60016	p.Glu69Lys	0	0.96405	.	germline	1		G	Jan 15, 2025	0	./.	0	89538	1.0	N	11q23.1	.	.	0.000000e+00	SCV000568557|SCV000825280|SCV002725594	Conflicting_classifications_of_pathogenicity	0	0	Lys	K	-	912	ENSP00000364699	ENST00000375549	17686	0.0	13410	0	0.618	G	0	5.407385	0.92967	D	D	-	13.28898	.	0.98097	.	0	.	0.98285	.	112088902	Y	10	.	102538	0.000000e+00	O14521	0	0.979582	0.99579		0	1.0	D	89538	0.95455986	42768	0.79771	6392	0.572592	4	-4.0	.	3.390010e-06	0.91343	0.000000e+00	0	74996	0.000000e+00	5002	0	0.97990	11	SDHD	0.000000e+00	.	Glu	.	2.233690e-05	11-112088902-G-A	Hereditary_cancer-predisposing_syndrome|Pheochromocytoma|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Cowden_syndrome_3|Mitochondrial_complex_2_deficiency,_nuclear_type_3|not_provided|Mitochondrial_complex_II_deficiency,_nuclear_type_1	0	2	111464836	ClinGen:CA016681|OMIM:602690.0029|UniProtKB:O14521#VAR_074105	0.950494	0.94586	0	RCV000144171|RCV000484125|RCV001290090|RCV002515941|RCV002415627|RCV004748597	D	0	0	c.205G>A	0	0	0	0.96621	./.	rs202198133	112088902	14900	G	.	O14521	15690	0.99456	0.000000e+00	0.68239		0	0	0.000000e+00	3.83	.	.	.	5.04	0.99826	.	D	T	0	0.000000e+00	.	.	segdup	0	0	140162|29072|97286|201|3208	156153	0.96985	0.65221	0.999643564224243	.	.	0.71675	0.96405	0.000000e+00	2.233690e-05	1179938	9.348	9.610490e-06	D	13394	0	.	.	171300|606864|619167|252011	0.96472	11	0.000000e+00	ENSG00000204370	0.000000e+00	.	0	.	0.9609739073875347	1	0.97365	0.64339	30608	.	1.950500e-05	0.000000e+00	0.888994358309617	YES	0.000000e+00	0.760838	165952	HGNC:10683	A	0	simple_aae	0.997	208106	112088902	GAG	1.000000	.	-	.	0.99448	3.390010e-06	.	0	Conflicting classifications of pathogenicity	0.91228	0	0	0	ClinGen:CA016681,UniProtKB:O14521#VAR_074105,OMIM:602690.0029	E	0	0.972172681102	-	0.955	-	0.99956	2	.	0.96060	0.732807695866	0.8013	0	0.99935591763030651	.	-	205G>A 	2	.	C0027672|C0031511|C1868633|C1847319|CN166604|C5436934|C3661900|C5700310	0	0	0	0	NM_003002.4	-	.	.	1	0.92926	202198133	2320	.	0.97161	0.95048	0.996	0.004	.	0.99919051	5.04	.	.	0.000000e+00	0.600199	0.996962020332363	0.95555	D	.	6212	9572	1.0385	0.99522	p.Glu69Lys	.	0	-11.599	0.9897574	0	0.92637	156153	D	30524	SDHD	0.000000e+00	D	0.991	21632	E69K	D	.	0.50684	./.	principal1																																																																																																				
FARS2_Asn280Ser	-1.5655811200139778	1.0	-0.6127928774573419	0.3383184701593376	2025_01_Batch_13-14	0.7753062704216714	0.8364156324435186	0.7536954439410324	0.7567184616927626	0.7212074588575044	0.8389461083420067	0.769635431082419	0.750969399987519	0.8430121171597668	0.6838882114343465	0.8071261893818391	0.8030255317629689	0.7523324219642757	0.7998652894262647	0.7025478351459254	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011867		NC_000006.12:5431107:A:G		Asn280Ser																												FARS2_Asn280Ser	6	5431107	A	G	6	allele	839A>G	F01	527_CAVA_Array_P03	L01	B13A7A8P1_R1	B14A7A8P1_R2				6-5431107-A-G	-	0.23297	0.001	280	16375	8354	49	6	5431340	G	1.910470e-01	4417	6	2_Benign	NC_000006.12	17868	Asn280Ser	8428	15.95	4291	734	4.768050e-01	T	3721	7	1	42760	2.234970e-01	73	30514	2.823280e-01	2175	0.12154	Select	0.0343	17676	0.07480	8942	0.4771825396825397	T	T	63978	.	0.06349480968858132	224	2.840720e-01	1743	2039	0.05267	17098	44846	24843	4.697060e-01	0.23101	7831	.	0.33047	0.997	0.05521936459909228	65.0	0.873413	3.86	0.35	G	single nucleotide variant	NC_000006.12:g.5431107A>G	749	16734	2	0.072034046	109368	0.26077752117013087	0.13583922	0.42604408352668216		45917	236782	3377	25	4.768050e-01	1244	1.831380e-01	18	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0014882,MedGen:C5569007,OMIM:617046,Orphanet:466722|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	24540	3422	3.135960e-01	286	0.59775	B	0.18565	B	N	1.164074	308230	A/A	410	4344	7162	1613374	not specified|not provided|Hereditary spastic paraplegia 77|Combined oxidative phosphorylation defect type 14	16216	0.09648	163	.	-	5431107	4.747730e-01	-	0.661000	1162	0.28905	29588	0.23853915332309716	44846	6295	germline;unknown	90970	.	.	GRCh38	957	criteria provided, multiple submitters, no conflicts	c.839A>G	2.769880e-01	0.35013	64323	595	1797	Aminoacyl-tRNA synthetase, class II	1.559100e-01	9038	B	0.4162261081740545	2.823440e-01	NM_006567.5(FARS2):c.839A>G (p.Asn280Ser)	2	1044	SYFM_HUMAN	1211	35.0	-0.50634435902713	8147	D	0.11803	0.14538196	+	6.632230e-02	299		6295	2.892790e-01	0	34234	criteria_provided,_multiple_submitters,_no_conflicts	0.42971	2.243800e-01	32055	1.576080e-01	370	59996	p.Asn280Ser	124	0.20583	.	germline	4291		A	Feb 04, 2025	8452	A/A	6059	89532	1.0	N	6p25.1	287826	.	7.165760e-02	SCV000168423|SCV000311536|SCV000845693|SCV001731157|SCV001933312|SCV001933313|SCV005091750	Benign	2111	2718	Ser	S	-	912	ENSP00000274680	ENST00000274680	17676	0.355	13402	7082	0.691	A	200	1.830349	0.17298	N	T	-	1.60963	.	.	9118	1117	0.1610337972166998	0.00059	2938	5431107	Y	9	0.11655948553054662	102644	1.898320e-01	O95363	164	0.039256	0.29640		1044	0.001	.	13402	0.081693865	9038	0.79771	10667	-0.686866	213144	-0.85	0.3057259713701431	3.984300e-01	0.12180	2.776430e-01	746	75004	4.747730e-01	6058	475	0.15483	6	FARS2	7.306280e-02	1355	Asn	340982	1.828960e-01	6-5431107-A-G	not_specified|Hereditary_spastic_paraplegia_77|Combined_oxidative_phosphorylation_defect_type_14|not_provided	1158	18713	5376339	ClinGen:CA290845|UniProtKB:O95363#VAR_052643	0.180003	0.21618	19229	RCV000124983|RCV000677020|RCV001701760|RCV000714927	T	3721	1279	c.839A>G	1276	17868	10087	0.00042	A/A	rs11243011	5431107	14900	A	0.23522364217252395	.	15682	0.31242	1.581920e-01	0.27860		262	1525	3.984300e-01	-1.405	0.04390243902439024	52614	264690	3.13	0.24861	6896	T	T	1054	2.670970e-01	145	1978	.	53	2609	466722|319519	137292	0.11282	0.13639	0.00545995115788096	11970	1178	0.71675	0.30517	2.612020e-01	4.697060e-01	1179548	3.397	2.206930e-01	N	13394	1503	0.17042956	2047	617046|614946	0.52411	6	7.073830e-02	ENSG00000145982	1.576640e-01	0.1827979404223385	8468	0.4504550050556117	.	2	0.04348	0.09723	30596	45111	1.823100e-01	2.378160e-01	-0.278242492394687	YES	2.730900e-01	.	140995	HGNC:21062	P	667	simple_aae	0.104	208058	5431107	AAC	0.887000	481	-	0.06282372598162071	0.00036	1.807000e-01	752	3623	Benign	0.32930	4354	1150	14268	ClinGen:CA290845,UniProtKB:O95363#VAR_052643	N	1503	.	-	.	-	0.02855	52920	18732	0.37527	0.263113975525	0.071	1793	0.96326186103365574	5196	-	839A>G 	8428	0.2319026265214606	CN169374|C5569007|C4755312|C3661900	257	2039	655	91	NM_006567.5	-	162	0.23487031700288186	0	0.59719	11243011	2320	0.1886404560944566	.	0.28498	0.057	0.358	11560	0.01150617	5.5	.	.	2.767680e-01	-0.615592	0.0760332499692323	0.00593	T	4918	6212	9568	-1.0690	0.14655	p.Asn280Ser	891	39	-4.658	0.0024745166	5480	0.40859	137292	T	30502	FARS2	2.583340e-01	T	0.045	21632	.	T	0.72457	0.84104	A/A	principal1																																																																																																				
SDHD_Tyr114Cys	4.506251060822262	0.004604751431917464	-8.333215389049078	0.004201518252758375	2025_01_Batch_13-14	0.8682120279262553	0.8812581055560494	0.8449747493825295	0.7870337879673006	0.788748895242953	0.7852056285483986	0.8303098099806919	0.7751751237961699	0.7336722800916803	0.7314659348476833	0.8267088282373269	0.8557839577683707	0.8100749365893497	0.7603530340294904	0.7601074150453182	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD	ENSG00000204370	5678	201959	CCSBVarC006161	ALE00006161	NC_000011.10:112094831:A:G	341A>G	Tyr114Cys	CEGS2	CegsMutGDEh1008	F02	GDEhDisVCh_40066	D01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			SDHD_Tyr114Cys	11	112094831	A	G	11											11-112094831-A-G	-	0.69299	0.964	114	.	.	.	11	111965555	G	.	.	11	1_Pathogenic	NC_000011.10	.	Tyr114Cys	.	25.3	.	0	.	D	.	11	1	.	.	.	.	.	0	0.98815	Select	0.9867	.	0.55869	.	.	D	D	.	0.746907957965	0	.	.	.	.	0.66847	.	.	.	.	0.94609	.	.	0.70631	0.992	.	13.0	0.867413	.	0.87	G	single nucleotide variant	NC_000011.10:g.112094831A>G	.	.	3	0.64086455	.	0	0.6309356	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	.	.	.	.	0.93829	P	0.73898	D	.	7.990596	.	./.	0	0	.	.	Paragangliomas 1|not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	.	0.97190	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094831	.	-	9.292000	.	0.88995	.	0	.	.	germline	.	Loss of phosphorylation at Y114 (P = 0.1741)| Loss of disorder (P = 0.1918)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2363)| Loss of helix (P = 0.2662)	0.99835	GRCh38	638	criteria provided, multiple submitters, no conflicts	c.341A>G	.	0.62327	0	.	.	.	.	.	P	0	.	NM_003002.4(SDHD):c.341A>G (p.Tyr114Cys)	2	.	DHSD_HUMAN	.	87.0	0.756609150763795	.	D	0.73951	0.56750697	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98698	.	.	.	.	.	p.Tyr114Cys	.	0.79831	.	germline	.		A	Mar 04, 2025	.	./.	.	.	1.0	N	11q23.1	78	.	.	SCV000205461|SCV000275206|SCV000823357|SCV001477811|SCV002527126|SCV002599968|SCV004814332|SCV005689607|SCV005872649	Pathogenic	.	.	Cys	C	-	.	ENSP00000364699	ENST00000375549	.	0.018	.	.	0.751	A	.	4.453053	0.45051	D	T	-	8.04602	.	0.96850	0	.	.	0.83880	0	112094831	Y	9	0	.	.	O14521	.	0.978102	0.26304		.	0.844	D	.	0.5530032	.	0.67791	6392	0.331545	.	-7.31	.	.	0.50835	.	.	.	.	.	.	0.78789	11	SDHD	.	0	Tyr	660	.	11-112094831-A-G	Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|not_provided|Hereditary_pheochromocytoma-paraganglioma	.	.	111470765	ClinGen:CA016797|OMIM:602690.0007|UniProtKB:O14521#VAR_017872	0.957666	0.83245	.	RCV000007309|RCV001810833|RCV000155750|RCV000221353|RCV002228004	D	.	.	c.341A>G	.	.	.	0.85161	./.	rs104894304	112094831	.	A	.	O14521	.	0.74072	.	0.68239		.	.	.	.	0	0	.	4.85	0.99803	34	D	T	.	.	0	0	.	.	.	201|29072|97286|140162|29072|29072	6900	0.84966	0.63330	0.993272423744202	434	.	0.71675	0.97690	.	.	.	8.931	.	D	.	.	.	0	171300|606864|168000	0.92428	11	.	ENSG00000204370	.	0	.	0	0.976168329744005	2	0.60367	0.64247	.	.	.	.	0.715173977717976	YES	.	0.633257	21939	HGNC:10683	A	.	simple_aae	0.801	.	112094831	TAT	1.000000	.	-	0	0.99992	.	0	.	Pathogenic	0.82441	.	.	.	OMIM:602690.0007,ClinGen:CA016797,UniProtKB:O14521#VAR_017872	Y	.	0.936232506373	-	0.983	-	0.98669	.	108	0.97594	0.698327541351	0.6697	.	0.95053500918197487	6	-	341A>G 	.	0	CN166604|C1868633|C0031511|C1847319|C0027672|C3494181|C3661900|C1708353	.	.	.	.	NM_003002.4	-	.	.	1	0.57053	104894304	.	0	0.93507	0.83441	0.976	0.065	434	0.99825233	4.85	.	.	.	0.238465	0.99848854137229	.	D	34	.	.	1.0006	0.99604	p.Tyr114Cys	0	.	-10.9	0.9957507	.	0.94531	6900	D	.	SDHD	.	D	0.943	.	Y114C	D	.	0.87726	./.	principal1																																																																																																				
SDHD_Tyr114Cys	4.506251060822262	0.004604751431917464	-8.333215389049078	0.004201518252758375	2025_01_Batch_13-14	0.8682120279262553	0.8812581055560494	0.8449747493825295	0.7870337879673006	0.788748895242953	0.7852056285483986	0.8303098099806919	0.7751751237961699	0.7336722800916803	0.7314659348476833	0.8267088282373269	0.8557839577683707	0.8100749365893497	0.7603530340294904	0.7601074150453182	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023361		NC_000011.10:112094831:A:G		Tyr114Cys																												SDHD_Tyr114Cys	11	112094831	A	G	11	allele	341A>G	B01	527_CAVA_Array_P06	C02	B13A7A8P2_R1	B14A7A8P2_R2				11-112094831-A-G	-	0.69299	0.964	114	.	.	.	11	111965555	G	.	.	11	1_Pathogenic	NC_000011.10	.	Tyr114Cys	.	25.3	.	0	.	D	.	11	1	.	.	.	.	.	0	0.98815	Select	0.9867	.	0.55869	.	.	D	D	.	0.746907957965	0	.	.	.	.	0.66847	.	.	.	.	0.94609	.	.	0.70631	0.992	.	13.0	0.867413	.	0.87	G	single nucleotide variant	NC_000011.10:g.112094831A>G	.	.	3	0.64086455	.	0	0.6309356	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	.	.	.	.	0.93829	P	0.73898	D	.	7.990596	.	./.	0	0	.	.	Paragangliomas 1|not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	.	0.97190	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094831	.	-	9.292000	.	0.88995	.	0	.	.	germline	.	Loss of phosphorylation at Y114 (P = 0.1741)| Loss of disorder (P = 0.1918)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2363)| Loss of helix (P = 0.2662)	0.99835	GRCh38	638	criteria provided, multiple submitters, no conflicts	c.341A>G	.	0.62327	0	.	.	.	.	.	P	0	.	NM_003002.4(SDHD):c.341A>G (p.Tyr114Cys)	2	.	DHSD_HUMAN	.	87.0	0.756609150763795	.	D	0.73951	0.56750697	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98698	.	.	.	.	.	p.Tyr114Cys	.	0.79831	.	germline	.		A	Mar 04, 2025	.	./.	.	.	1.0	N	11q23.1	78	.	.	SCV000205461|SCV000275206|SCV000823357|SCV001477811|SCV002527126|SCV002599968|SCV004814332|SCV005689607|SCV005872649	Pathogenic	.	.	Cys	C	-	.	ENSP00000364699	ENST00000375549	.	0.018	.	.	0.751	A	.	4.453053	0.45051	D	T	-	8.04602	.	0.96850	0	.	.	0.83880	0	112094831	Y	9	0	.	.	O14521	.	0.978102	0.26304		.	0.844	D	.	0.5530032	.	0.67791	6392	0.331545	.	-7.31	.	.	0.50835	.	.	.	.	.	.	0.78789	11	SDHD	.	0	Tyr	660	.	11-112094831-A-G	Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|not_provided|Hereditary_pheochromocytoma-paraganglioma	.	.	111470765	ClinGen:CA016797|OMIM:602690.0007|UniProtKB:O14521#VAR_017872	0.957666	0.83245	.	RCV000007309|RCV001810833|RCV000155750|RCV000221353|RCV002228004	D	.	.	c.341A>G	.	.	.	0.85161	./.	rs104894304	112094831	.	A	.	O14521	.	0.74072	.	0.68239		.	.	.	.	0	0	.	4.85	0.99803	34	D	T	.	.	0	0	.	.	.	201|29072|97286|140162|29072|29072	6900	0.84966	0.63330	0.993272423744202	434	.	0.71675	0.97690	.	.	.	8.931	.	D	.	.	.	0	171300|606864|168000	0.92428	11	.	ENSG00000204370	.	0	.	0	0.976168329744005	2	0.60367	0.64247	.	.	.	.	0.715173977717976	YES	.	0.633257	21939	HGNC:10683	A	.	simple_aae	0.801	.	112094831	TAT	1.000000	.	-	0	0.99992	.	0	.	Pathogenic	0.82441	.	.	.	OMIM:602690.0007,ClinGen:CA016797,UniProtKB:O14521#VAR_017872	Y	.	0.936232506373	-	0.983	-	0.98669	.	108	0.97594	0.698327541351	0.6697	.	0.95053500918197487	6	-	341A>G 	.	0	CN166604|C1868633|C0031511|C1847319|C0027672|C3494181|C3661900|C1708353	.	.	.	.	NM_003002.4	-	.	.	1	0.57053	104894304	.	0	0.93507	0.83441	0.976	0.065	434	0.99825233	4.85	.	.	.	0.238465	0.99848854137229	.	D	34	.	.	1.0006	0.99604	p.Tyr114Cys	0	.	-10.9	0.9957507	.	0.94531	6900	D	.	SDHD	.	D	0.943	.	Y114C	D	.	0.87726	./.	principal1																																																																																																				
SDHD_Tyr114Cys	4.506251060822262	0.004604751431917464	-8.333215389049078	0.004201518252758375	2025_01_Batch_13-14	0.8682120279262553	0.8812581055560494	0.8449747493825295	0.7870337879673006	0.788748895242953	0.7852056285483986	0.8303098099806919	0.7751751237961699	0.7336722800916803	0.7314659348476833	0.8267088282373269	0.8557839577683707	0.8100749365893497	0.7603530340294904	0.7601074150453182	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023361	ALE00034476	NC_000011.10:112094831:A:G	341A>G	Tyr114Cys	CAVA																											SDHD_Tyr114Cys	11	112094831	A	G	11								1	1	1	11-112094831-A-G	-	0.69299	0.964	114	.	.	.	11	111965555	G	.	.	11	1_Pathogenic	NC_000011.10	.	Tyr114Cys	.	25.3	.	0	.	D	.	11	1	.	.	.	.	.	0	0.98815	Select	0.9867	.	0.55869	.	.	D	D	.	0.746907957965	0	.	.	.	.	0.66847	.	.	.	.	0.94609	.	.	0.70631	0.992	.	13.0	0.867413	.	0.87	G	single nucleotide variant	NC_000011.10:g.112094831A>G	.	.	3	0.64086455	.	0	0.6309356	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C3661900|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C1868633;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	.	.	.	.	0.93829	P	0.73898	D	.	7.990596	.	./.	0	0	.	.	Paragangliomas 1|not provided|Hereditary pheochromocytoma-paraganglioma|Hereditary cancer-predisposing syndrome|Paragangliomas with sensorineural hearing loss;Pheochromocytoma;Carney-Stratakis syndrome;Cowden syndrome 3	.	0.97190	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094831	.	-	9.292000	.	0.88995	.	0	.	.	germline	.	Loss of phosphorylation at Y114 (P = 0.1741)| Loss of disorder (P = 0.1918)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2363)| Loss of helix (P = 0.2662)	0.99835	GRCh38	638	criteria provided, multiple submitters, no conflicts	c.341A>G	.	0.62327	0	.	.	.	.	.	P	0	.	NM_003002.4(SDHD):c.341A>G (p.Tyr114Cys)	2	.	DHSD_HUMAN	.	87.0	0.756609150763795	.	D	0.73951	0.56750697	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98698	.	.	.	.	.	p.Tyr114Cys	.	0.79831	.	germline	.		A	Mar 04, 2025	.	./.	.	.	1.0	N	11q23.1	78	.	.	SCV000205461|SCV000275206|SCV000823357|SCV001477811|SCV002527126|SCV002599968|SCV004814332|SCV005689607|SCV005872649	Pathogenic	.	.	Cys	C	-	.	ENSP00000364699	ENST00000375549	.	0.018	.	.	0.751	A	.	4.453053	0.45051	D	T	-	8.04602	.	0.96850	0	.	.	0.83880	0	112094831	Y	9	0	.	.	O14521	.	0.978102	0.26304		.	0.844	D	.	0.5530032	.	0.67791	6392	0.331545	.	-7.31	.	.	0.50835	.	.	.	.	.	.	0.78789	11	SDHD	.	0	Tyr	660	.	11-112094831-A-G	Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Pheochromocytoma|Carney-Stratakis_syndrome|Hereditary_cancer-predisposing_syndrome|Paragangliomas_1|not_provided|Hereditary_pheochromocytoma-paraganglioma	.	.	111470765	ClinGen:CA016797|OMIM:602690.0007|UniProtKB:O14521#VAR_017872	0.957666	0.83245	.	RCV000007309|RCV001810833|RCV000155750|RCV000221353|RCV002228004	D	.	.	c.341A>G	.	.	.	0.85161	./.	rs104894304	112094831	.	A	.	O14521	.	0.74072	.	0.68239		.	.	.	.	0	0	.	4.85	0.99803	34	D	T	.	.	0	0	.	.	.	201|29072|97286|140162|29072|29072	6900	0.84966	0.63330	0.993272423744202	434	.	0.71675	0.97690	.	.	.	8.931	.	D	.	.	.	0	171300|606864|168000	0.92428	11	.	ENSG00000204370	.	0	.	0	0.976168329744005	2	0.60367	0.64247	.	.	.	.	0.715173977717976	YES	.	0.633257	21939	HGNC:10683	A	.	simple_aae	0.801	.	112094831	TAT	1.000000	.	-	0	0.99992	.	0	.	Pathogenic	0.82441	.	.	.	OMIM:602690.0007,ClinGen:CA016797,UniProtKB:O14521#VAR_017872	Y	.	0.936232506373	-	0.983	-	0.98669	.	108	0.97594	0.698327541351	0.6697	.	0.95053500918197487	6	-	341A>G 	.	0	CN166604|C1868633|C0031511|C1847319|C0027672|C3494181|C3661900|C1708353	.	.	.	.	NM_003002.4	-	.	.	1	0.57053	104894304	.	0	0.93507	0.83441	0.976	0.065	434	0.99825233	4.85	.	.	.	0.238465	0.99848854137229	.	D	34	.	.	1.0006	0.99604	p.Tyr114Cys	0	.	-10.9	0.9957507	.	0.94531	6900	D	.	SDHD	.	D	0.943	.	Y114C	D	.	0.87726	./.	principal1																																																																																																				
RAF1_Thr491Arg	-5.242335541861087	0.17352561940663738	2.486225049163244	0.12982347958537951	2025_01_Batch_13-14	0.8035216812448265	0.7758778365355458	0.848415594617929	0.7156887829290858	0.7773362432954989	0.7092062608687455	0.6928103537942536	0.7052494097190242	0.7287510440410226	0.7004827463123123	0.756363971056786	0.7343440951648996	0.7768325021684765	0.7222199134850542	0.7389094948039057	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1	ENSG00000132155	732	213823	CCSBVarC003427	ALE00003427	NC_000003.12:12585745:G:C	1472C>G	Thr491Arg	CEGS2	CegsMutGDEh1015	G06	GDEhDisVCh_40029	F08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RAF1_Thr491Arg	3	12585745	G	C	3											3-12585745-G-C	-	0.90747	1.0	491	.	.	.	3	12627244	C	.	.	3	1_Pathogenic	NC_000003.12	.	Thr491Arg	.	31.0	.	.	.	T	.	3	1	.	.	.	.	.	.	0.92884	Select	0.4388	.	0.90580	.	.	D	D	.	2.53490677304	.	.	.	.	.	0.88882	.	.	.	.	0.84911	.	.	0.95828	0.994	.	2.0	.	.	0.98	C	single nucleotide variant	NC_000003.12:g.12585745G>C	.	.	3	0.90921533	.	.	0.9571182	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.99291	D	0.97656	D	N	6.199454	.	G/G	.	.	.	.	Noonan syndrome 5|not provided|RASopathy	.	0.84771	.	.	-	12585745	.	-	11.849000	.	0.99209	.	.	.	.	germline	.	Gain of MoRF binding (P = 0.0086)| Loss of ubiquitination at K493 (P = 0.0532)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K493 (P = 0.0976)| Gain of solvent accessibility (P = 0.1456)	0.88177	GRCh38	692	criteria provided, multiple submitters, no conflicts	c.1472C>G	.	0.73443	.	.	.	Protein kinase domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_002880.4(RAF1):c.1472C>G (p.Thr491Arg)	2	.	RAF1_HUMAN	.	98.0	0.626065396186754	.	.	0.92260	0.9463269	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98444	.	.	.	.	.	p.Thr491Arg	.	0.98025	.	germline	.		G	Sep 11, 2024	.	G/G	.	.	1.0	N	3p25.2	.	.	.	SCV000808247|SCV001401755	Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000251849	ENST00000251849	.	0.001	.	.	0.676	G	.	5.424006	0.40143	D	T	-	7.84486	.	0.88439	.	.	.	0.89353	.	12585745	Y	10	.	.	.	P04049	.	0.900422	0.64619		.	0.999	D	.	0.9388268	.	0.71086	5894	0.39866	.	-5.37	.	.	0.91343	.	.	.	.	.	.	0.95572	3	RAF1	.	.	Thr	.	.	3-12585745-G-C	RASopathy|not_provided|Noonan_syndrome_5	.	.	12602244	ClinGen:CA257064|OMIM:164760.0003|UniProtKB:P04049#VAR_037819	0.916990	0.74692	.	RCV000014988|RCV000680803|RCV001229313	D	.	.	c.1472C>G	.	.	.	0.89767	G/G	rs80338799	12585745	.	G	.	P04049	.	0.96940	.	0.68239		.	.	.	0.02	.	.	.	5.26	0.98022	.	D	D	.	.	.	.	.	.	.	536391|648	13959	0.89639	0.97794	0.996480882167816	.	.	0.71675	0.88355	.	.	.	9.996	.	D	.	.	.	.	611553	0.99292	3	.	ENSG00000132155	.	.	.	.	.	2	0.92348	0.58673	.	.	.	.	0.704879681503555	YES	.	0.235705	28998	HGNC:9829	A	.	simple_aae	0.978	.	12585745	ACA	1.000000	.	-	.	0.89196	.	.	.	Likely pathogenic	0.85499	.	.	.	ClinGen:CA257064,UniProtKB:P04049#VAR_037819,OMIM:164760.0003	T	.	0.974052792841	-	0.752	-	0.99191	.	.	0.85535	0.845280706882	0.9852	.	0.99437118353782505	.	-	1472C>G 	.	.	C5555857|C3661900|C1969057	.	.	.	.	NM_002880.4	-	.	.	1	0.92373	80338799	.	.	0.97352	0.82653	0.961	0.122	.	0.99762386	5.26	.	.	.	0.334871	0.999988562000968	0.07909	D	.	.	.	0.1373	0.77686	p.Thr491Arg	.	.	-12.126	0.899554	.	0.99579	13959	D	.	RAF1	.	D	0.786	.	T491R	D	.	0.76753	G/G	principal3																																																																																																				
RAF1_Thr491Arg	-5.242335541861087	0.17352561940663738	2.486225049163244	0.12982347958537951	2025_01_Batch_13-14	0.8035216812448265	0.7758778365355458	0.848415594617929	0.7156887829290858	0.7773362432954989	0.7092062608687455	0.6928103537942536	0.7052494097190242	0.7287510440410226	0.7004827463123123	0.756363971056786	0.7343440951648996	0.7768325021684765	0.7222199134850542	0.7389094948039057	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC003426		NC_000003.12:12585761:C:T		Thr491Arg																												RAF1_Thr491Arg	3	12585761	C	T	3	allele	1472C>G	B04	527_CAVA_Array_P05	C07	B13A7A8P2_R1	B14A7A8P2_R2				3-12585761-C-T	-	0.92811	1.0	486	.	.	.	3	12627260	T	.	.	3	5_Others	NC_000003.12	.	Asp486Asn	.	33.0	.	.	.	D	.	1	.	.	.	.	.	.	.	0.97963	.	0.9946	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.93935	.	.	.	.	0.78079	.	.	0.95387	0.998	.	.	0.9975	5.35	.	T	single nucleotide variant	NC_000003.12:g.12585761C>T	.	.	1	0.8781777	.	.	0.94164735	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500	.	.	.	.	0.92286	D	0.94137	D	M	14.52467	.	C/C	.	.	.	.	Noonan syndrome with multiple lentigines	.	0.96265	.	.	-	12585761	.	-	7.684000	.	0.99826	.	.	.	.	unknown	.	Gain of MoRF binding (P = 0.0343)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K483 (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of ubiquitination at K483 (P = 0.1041)	0.99690	GRCh38	692	no classification provided	.	.	0.73443	.	.	.	Protein kinase domain|Protein kinase domain|Protein kinase domain	.	.	.	.	.	NM_002880.4(RAF1):c.1456G>A (p.Asp486Asn)		.	RAF1_HUMAN	.	.	1.01881719419438	.	D	0.98152	0.94205755	-	.	.		.	.	0	.	no_classification_provided	0.98129	.	.	.	.	.	.	.	0.65502	.	unknown	.		C	-	.	C/C	.	.	1.0	N	3p25.2	.	.	.	SCV000040957	not_provided	.	.	Asn	N	-	.	ENSP00000509968	ENST00000685653	.	.	.	.	0.599	C	.	5.650199	0.79703	D	.	-	15.28689	.	0.98643	.	.	.	0.93025	.	12585761	Y	9	.	.	.	P04049	.	0.949346	0.98788		.	0.998	D	.	0.889279	.	0.85369	5894	0.270705	.	.	.	.	0.78662	.	.	.	.	.	.	0.93345	3	RAF1	.	.	Asp	.	.	3-12585761-C-T	Noonan_syndrome_with_multiple_lentigines	.	.	12602260	ClinGen:CA341928|UniProtKB:P04049#VAR_037817	0.892841	0.96274	.	RCV000020506	.	.	.	c.1456G>A	.	.	.	0.80361	C/C	rs80338798	12585761	.	C	.	P04049	.	0.95344	.	0.68239		.	.	.	2.89	.	.	.	5.26	0.99250	.	D	D	.	.	.	.	.	.	.	500	21341	0.80106	0.97323	0.998047471046448	.	.	0.71675	0.82954	.	.	.	7.9	.	.	.	.	.	.	PS151100	0.86061	3	.	ENSG00000132155	.	.	.	.	.	1	0.88579	0.58673	.	.	.	.	0.933976822940601	.	.	0.825636	34193	HGNC:9829	.	.	.	0.995	.	12585761	GAT	1.000000	.	-	.	0.99202	.	.	.	not provided	0.93099	.	.	.	ClinGen:CA341928,UniProtKB:P04049#VAR_037817	D	.	.	-	0.968	-	0.99419	.	.	0.98776	0.879874408245	.	.	0.99921808742760565	.	-	1456G>A 	.	.	C0175704	.	.	.	.	NM_002880.4	-	.	.	0	0.98985	80338798	.	.	0.95330	0.96872	.	.	.	0.99668110	5.26	.	.	.	0.151072	0.99999342572825	0.83536	D	.	.	.	0.9420	0.99877	p.Asp486Asn	.	.	-14.009	.	.	0.99831	21341	D	.	RAF1	.	D	.	.	D486N	.	0.93259	0.40292	C/C	principal3																																																																																																				
RAF1_Thr491Arg	-5.242335541861087	0.17352561940663738	2.486225049163244	0.12982347958537951	2025_01_Batch_13-14	0.8035216812448265	0.7758778365355458	0.848415594617929	0.7156887829290858	0.7773362432954989	0.7092062608687455	0.6928103537942536	0.7052494097190242	0.7287510440410226	0.7004827463123123	0.756363971056786	0.7343440951648996	0.7768325021684765	0.7222199134850542	0.7389094948039057	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1				CCSBVarC003427	ALE00003427	NC_000003.12:12585745:G:C	1472C>G	Thr491Arg	CAVA																											RAF1_Thr491Arg	3	12585745	G	C	3								1	1	1	3-12585745-G-C	-	0.90747	1.0	491	.	.	.	3	12627244	C	.	.	3	1_Pathogenic	NC_000003.12	.	Thr491Arg	.	31.0	.	.	.	T	.	3	1	.	.	.	.	.	.	0.92884	Select	0.4388	.	0.90580	.	.	D	D	.	2.53490677304	.	.	.	.	.	0.88882	.	.	.	.	0.84911	.	.	0.95828	0.994	.	2.0	.	.	0.98	C	single nucleotide variant	NC_000003.12:g.12585745G>C	.	.	3	0.90921533	.	.	0.9571182	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.99291	D	0.97656	D	N	6.199454	.	G/G	.	.	.	.	Noonan syndrome 5|not provided|RASopathy	.	0.84771	.	.	-	12585745	.	-	11.849000	.	0.99209	.	.	.	.	germline	.	Gain of MoRF binding (P = 0.0086)| Loss of ubiquitination at K493 (P = 0.0532)| Gain of glycosylation at T491 (P = 0.07)| Gain of methylation at K493 (P = 0.0976)| Gain of solvent accessibility (P = 0.1456)	0.88177	GRCh38	692	criteria provided, multiple submitters, no conflicts	c.1472C>G	.	0.73443	.	.	.	Protein kinase domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_002880.4(RAF1):c.1472C>G (p.Thr491Arg)	2	.	RAF1_HUMAN	.	98.0	0.626065396186754	.	.	0.92260	0.9463269	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98444	.	.	.	.	.	p.Thr491Arg	.	0.98025	.	germline	.		G	Sep 11, 2024	.	G/G	.	.	1.0	N	3p25.2	.	.	.	SCV000808247|SCV001401755	Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000251849	ENST00000251849	.	0.001	.	.	0.676	G	.	5.424006	0.40143	D	T	-	7.84486	.	0.88439	.	.	.	0.89353	.	12585745	Y	10	.	.	.	P04049	.	0.900422	0.64619		.	0.999	D	.	0.9388268	.	0.71086	5894	0.39866	.	-5.37	.	.	0.91343	.	.	.	.	.	.	0.95572	3	RAF1	.	.	Thr	.	.	3-12585745-G-C	RASopathy|not_provided|Noonan_syndrome_5	.	.	12602244	ClinGen:CA257064|OMIM:164760.0003|UniProtKB:P04049#VAR_037819	0.916990	0.74692	.	RCV000014988|RCV000680803|RCV001229313	D	.	.	c.1472C>G	.	.	.	0.89767	G/G	rs80338799	12585745	.	G	.	P04049	.	0.96940	.	0.68239		.	.	.	0.02	.	.	.	5.26	0.98022	.	D	D	.	.	.	.	.	.	.	536391|648	13959	0.89639	0.97794	0.996480882167816	.	.	0.71675	0.88355	.	.	.	9.996	.	D	.	.	.	.	611553	0.99292	3	.	ENSG00000132155	.	.	.	.	.	2	0.92348	0.58673	.	.	.	.	0.704879681503555	YES	.	0.235705	28998	HGNC:9829	A	.	simple_aae	0.978	.	12585745	ACA	1.000000	.	-	.	0.89196	.	.	.	Likely pathogenic	0.85499	.	.	.	ClinGen:CA257064,UniProtKB:P04049#VAR_037819,OMIM:164760.0003	T	.	0.974052792841	-	0.752	-	0.99191	.	.	0.85535	0.845280706882	0.9852	.	0.99437118353782505	.	-	1472C>G 	.	.	C5555857|C3661900|C1969057	.	.	.	.	NM_002880.4	-	.	.	1	0.92373	80338799	.	.	0.97352	0.82653	0.961	0.122	.	0.99762386	5.26	.	.	.	0.334871	0.999988562000968	0.07909	D	.	.	.	0.1373	0.77686	p.Thr491Arg	.	.	-12.126	0.899554	.	0.99579	13959	D	.	RAF1	.	D	0.786	.	T491R	D	.	0.76753	G/G	principal3																																																																																																				
RAF1_Ser427Gly	-5.857143473908194	0.08915991405016992	4.645910603471249	0.00992717572430983	2025_01_Batch_13-14	0.7927766062981189	0.8314193235226529	0.8219138734955567	0.8557426612183633	0.7318016857301761	0.8342764973325787	0.8421119023640624	0.7209446777313937	0.842479224161091	0.7298495481880614	0.8135265518153487	0.8367656129433576	0.7714292756134752	0.8491109426897272	0.7308256169591187	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008846		NC_000003.12:12618597:G:A		Ser427Gly																												RAF1_Ser427Gly	3	12618597	G	A	3	allele	1279A>G	H03	527_CAVA_Array_P05	O05	B13A7A8P2_R1	B14A7A8P2_R2				3-12618597-G-A	-	0.68134	0.44	42	32	47	0	3	12660096	A	2.168320e-04	10	3	2_Benign	NC_000003.12	47	Ala42Val	0	25.2	0	1	3.698440e-04	T	0	8	.	42768	3.334060e-04	.	30526	1.293100e-03	0	0.54847	.	0.2338	102746	0.35909	12	.	T	T	64030	.	1.2357884330202668E-4	0	2.298370e-03	0	0	0.47606	17112	44878	5	0.000000e+00	0.26593	10	.	0.35113	0.998	.	.	0.980702	.	.	A	single nucleotide variant	NC_000003.12:g.12618597G>A	0	16734	2	0.15447487	109408	0	0.14208941	0		67	236948	0	0	0.000000e+00	500	2.338200e-04	0	MONDO:MONDO:0012691,MedGen:C1969056,OMIM:611554,Orphanet:500|MONDO:MONDO:0012690,MedGen:C1969057,OMIM:611553,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733||MedGen:C3661900	26	0	0.000000e+00	0	0.63842	B	0.37602	B	L	3.129022	350	G/G	306	5	7164	1614154	LEOPARD syndrome 2|Noonan syndrome 5|RASopathy|Noonan syndrome and Noonan-related syndrome|RAF1-related disorder|not provided	16218	0.62631	.	.	-	12618597	5.843850e-04	-	11.846000	0	0.42719	29604	0	29604	0	germline	91090	.	.	GRCh38	615	reviewed by expert panel	.	6.551790e-05	0.74708	25	0	16	.	0.000000e+00	9046	.	0	1.587620e-03	NM_002880.4(RAF1):c.125C>T (p.Ala42Val)	3	0	RAF1_HUMAN	0	.	0.159595556076659	13	D	0.39554	0.15703622	-	0.000000e+00	.		13	2.575660e-03	0	34260	reviewed_by_expert_panel	0.78211	2.376430e-04	0	0.000000e+00	0	60022	.	0	0.97942	.	germline	10		G	Apr 18, 2017	2	G/G	0	89554	1.0	N	3p25.2	42874	.	0.000000e+00	SCV000616490	Likely_benign	0	22	Val	V	-	910	ENSP00000509968	ENST00000685653	17692	.	13416	0	0.676	G	0	4.404223	0.24339	D	.	-	3.89199	.	0.52764	628	0	.	0.01706	0	12618597	Y	10	0	102746	1.484660e-03	P04049	0	0.461137	0.91806		0	0.118	D	30524	0.16238137	17112	0.85369	5894	-0.248036	242	.	.	1.587620e-03	0.43552	6.373490e-05	0	75032	0.000000e+00	6062	0	0.36141	3	RAF1	1.332760e-05	0	Ala	61152	3.573260e-04	3-12618597-G-A	not_provided|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|Noonan_syndrome_5|LEOPARD_syndrome_2|RAF1-related_disorder	0	38	12635096	ClinGen:CA2259832	0.777693	0.49020	0	RCV000290750|RCV000398939|RCV000521407|RCV001813467|RCV004544638|RCV000981698	.	0	0	c.125C>T	0	0	0	0.14071	G/G	rs11549992	12618597	14902	G	.	.	15690	0.32435	0.000000e+00	0.68239		0	0	0.000000e+00	1.245	0	19	264690	5.3	0.79651	168	T	T	0	4.258940e-04	0	56	.	0	0	98733|536391|648|500	343103	0.46682	0.49126	0.0281786238071906	8398	.	0.71675	0.70936	3.502630e-04	4.258940e-04	1180026	7.408	3.219140e-04	.	13394	0	2.644603E-4	0	611553|611554	0.79314	3	0.000000e+00	ENSG00000132155	0.000000e+00	4.431590241171806E-4	2	0	.	2	0.32091	0.66487	30608	70	3.698440e-04	2.998900e-04	0.329305395729113	.	5.489080e-05	0.030693	289332	HGNC:9829	.	0	.	0.176	208130	12618597	GCA	1.000000	.	-	1.1907597046915932E-4	0.10650	2.050800e-04	1	0	Likely benign	0.46894	1	9	18	ClinGen:CA2259832	A	0	.	-	.	-	0.53299	79	8486	0.47139	0.562870502472	.	0	0.9983696088703764	98	-	125C>T 	38	5.892057506481263E-4	C3661900|C5681679|C5555857|C1969057|C1969056	0	0	3	0	NM_002880.4	-	.	.	0	0.93698	11549992	2320	4.088173731030874E-4	0.68373	0.57042	.	.	8092	0.34714562	6.17	.	.	6.534240e-05	-0.277907	0.93421742321215	0.31258	T	112	6212	9572	-0.6482	0.59872	p.Ala42Val	0	0	-5.939	.	1	0.78789	343103	T	30524	RAF1	5.843850e-04	T	.	21632	.	.	.	0.76753	G/G	principal3																																																																																																				
SDHD_Ala90Val	3.9356948777612146	0.00674516202223278	1.0316194490045085	0.014424673088470882	2025_01_Batch_13-14	0.7664720793721203	0.7787970486630793	0.7485959972249652	0.726195561365361	0.7396530881799547	0.641359679219435	0.7325650632500709	0.75415375541077	0.7141598576600099	0.6106354907409622	0.7039158792957776	0.7556810559565751	0.7513748763178676	0.7201777095126854	0.6751442894604585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023308		NC_000011.10:112088966:C:T		Ala90Val																												SDHD_Ala90Val	11	112088966	C	T	11	allele	269C>T	A12	527_CAVA_Array_P05	A23	B13A7A8P2_R1	B14A7A8P2_R2				11-112088966-C-T	-	0.20471	0.006	90	2	0	0	11	111959690	T	7.372920e-05	0	11	3_Conflicting	NC_000011.10	101	Ala90Val	0	14.75	0	0	9.172510e-04	D	1	5	1	42768	1.308410e-04	.	30526	0.000000e+00	0	0.80564	Select	0.7223	30526	0.13655	1	.	D	T	64032	0.186988364634	0	0	0.000000e+00	0	0	0.25620	17112	44888	101	7.454900e-05	0.18604	0	.	0.01422	0.993	.	87.0	0.778722	.	0.13	T	single nucleotide variant	NC_000011.10:g.112088966C>T	0	16734	2	0.04753903	109406	0	0.025199682	0		32	236928	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	17	0	0.000000e+00	0	0.45549	B	0.06884	B	N	0.7083525	119	./.	84	0	7164	1614014	Hereditary cancer-predisposing syndrome|not provided|not specified|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3	16218	0.81670	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112088966	1.083490e-03	-	-0.210000	0	0.17447	29606	0	91090	1	germline;unknown	91090	Gain of catalytic residue at A90 (P = 0.0619)| Loss of glycosylation at S94 (P = 0.2021)| Loss of helix (P = 0.3949)| Gain of solvent accessibility (P = 0.4304)| Loss of sheet (P = 0.5184)	0.67018	GRCh38	637	criteria provided, conflicting classifications	c.269C>T	9.172510e-04	0.22101	0	0	0	.	0.000000e+00	9044	B	0	0.000000e+00	NM_003002.4(SDHD):c.269C>T (p.Ala90Val)	1	0	DHSD_HUMAN	0	13.0	-0.764187358777515	1	T	0.13138	0.025199682	+	0.000000e+00	.		28	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.94571	1.553850e-04	1	0.000000e+00	0	60008	p.Ala90Val	0	0.10908	.	germline	17		C	Nov 06, 2024	28	./.	0	89554	0.03	N	11q23.1	6962	.	0.000000e+00	SCV000554063|SCV000675115|SCV001811695|SCV002065336|SCV002774237	Conflicting_classifications_of_pathogenicity	0	0	Val	V	-	912	ENSP00000364699	ENST00000375549	17690	0.458	13414	0	0.549	C	0	1.598506	0.17298	N	T	-	0.9755563	.	0.58532	610	0	.	0.07730	0	112088966	Y	10	0	102728	0.000000e+00	O14521	0	0.612815	0.31823		0	0.002	D	30608	0.04753903	15690	0.69292	6392	-0.096085	15	-0.49	.	1.108790e-03	0.15912	1.083490e-03	0	74936	0.000000e+00	6060	0	0.06884	11	SDHD	0.000000e+00	0	Ala	10680	2.233290e-05	11-112088966-C-T	Hereditary_cancer-predisposing_syndrome|not_provided|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|not_specified	0	2	111464900	ClinGen:CA070974	0.374914	0.14078	0	RCV000562410|RCV001584171|RCV001821298|RCV002230663	T	0	0	c.269C>T	0	0	0	0.36716	./.	rs200255724	112088966	14902	C	.	O14521	15690	0.01422	0.000000e+00	0.08389		0	0	0.000000e+00	-0.4	0	0	264690	1.52	0.87639	108	T	T	0	3.276110e-05	0	24	segdup	0	0	140162|97286|29072|201	412511	0.71444	0.20745	0.0642470002855991	2294	.	0.20497	0.45781	2.918860e-05	9.147940e-04	1179998	0.348	1.537520e-04	N	13394	0	3.7780044E-6	0	606864|171300	0.19856	11	0.000000e+00	ENSG00000204370	0.000000e+00	0	28	0	0.6562659735392878	2	0.06938	0.64339	30608	1	1.946890e-05	3.332890e-05	-0.647685205617222	YES	1.108790e-03	0.039239	398394	HGNC:10683	N	0	simple_aae	0.063	208128	112088966	GCG	0.000000	.	-	0	0.01525	1.271190e-05	0	1	Conflicting classifications of pathogenicity	0.23434	17	0	2	ClinGen:CA070974	A	0	0.97841390163	-	0.554	-	0.37474	31	466	0.65397	0.404172539711	0.063	0	0.96925041798389644	94	-	269C>T 	28	0	C0027672|C3661900|C1868633|C1847319|C0031511|CN166604|CN169374	0	0	0	0	NM_003002.4	-	.	.	0	0.41636	200255724	2320	0	0.97797	0.17985	0.325	1.0	2210	0.96888520	5.04	.	.	9.147940e-04	0.0203817	0.0286794542137332	0.02998	T	84	6212	9572	-0.0242	0.90456	p.Ala90Val	0	0	-3.974	0.033454627	0	0.32439	412511	T	30524	SDHD	0.000000e+00	D	0.538	21632	A90V	T	.	0.27038	./.	principal1																																																																																																				
SDHD_Ala90Val	3.9356948777612146	0.00674516202223278	1.0316194490045085	0.014424673088470882	2025_01_Batch_13-14	0.7664720793721203	0.7787970486630793	0.7485959972249652	0.726195561365361	0.7396530881799547	0.641359679219435	0.7325650632500709	0.75415375541077	0.7141598576600099	0.6106354907409622	0.7039158792957776	0.7556810559565751	0.7513748763178676	0.7201777095126854	0.6751442894604585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023308	ALE00021474	NC_000011.10:112088966:C:T	269C>T	Ala90Val	CAVA																											SDHD_Ala90Val	11	112088966	C	T	11								1	1	1	11-112088966-C-T	-	0.20471	0.006	90	2	0	0	11	111959690	T	7.372920e-05	0	11	3_Conflicting	NC_000011.10	101	Ala90Val	0	14.75	0	0	9.172510e-04	D	1	5	1	42768	1.308410e-04	.	30526	0.000000e+00	0	0.80564	Select	0.7223	30526	0.13655	1	.	D	T	64032	0.186988364634	0	0	0.000000e+00	0	0	0.25620	17112	44888	101	7.454900e-05	0.18604	0	.	0.01422	0.993	.	87.0	0.778722	.	0.13	T	single nucleotide variant	NC_000011.10:g.112088966C>T	0	16734	2	0.04753903	109406	0	0.025199682	0		32	236928	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MedGen:C1868633;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201	17	0	0.000000e+00	0	0.45549	B	0.06884	B	N	0.7083525	119	./.	84	0	7164	1614014	Hereditary cancer-predisposing syndrome|not provided|not specified|Pheochromocytoma;Paragangliomas with sensorineural hearing loss;Carney-Stratakis syndrome;Cowden syndrome 3	16218	0.81670	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112088966	1.083490e-03	-	-0.210000	0	0.17447	29606	0	91090	1	germline;unknown	91090	Gain of catalytic residue at A90 (P = 0.0619)| Loss of glycosylation at S94 (P = 0.2021)| Loss of helix (P = 0.3949)| Gain of solvent accessibility (P = 0.4304)| Loss of sheet (P = 0.5184)	0.67018	GRCh38	637	criteria provided, conflicting classifications	c.269C>T	9.172510e-04	0.22101	0	0	0	.	0.000000e+00	9044	B	0	0.000000e+00	NM_003002.4(SDHD):c.269C>T (p.Ala90Val)	1	0	DHSD_HUMAN	0	13.0	-0.764187358777515	1	T	0.13138	0.025199682	+	0.000000e+00	.		28	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.94571	1.553850e-04	1	0.000000e+00	0	60008	p.Ala90Val	0	0.10908	.	germline	17		C	Nov 06, 2024	28	./.	0	89554	0.03	N	11q23.1	6962	.	0.000000e+00	SCV000554063|SCV000675115|SCV001811695|SCV002065336|SCV002774237	Conflicting_classifications_of_pathogenicity	0	0	Val	V	-	912	ENSP00000364699	ENST00000375549	17690	0.458	13414	0	0.549	C	0	1.598506	0.17298	N	T	-	0.9755563	.	0.58532	610	0	.	0.07730	0	112088966	Y	10	0	102728	0.000000e+00	O14521	0	0.612815	0.31823		0	0.002	D	30608	0.04753903	15690	0.69292	6392	-0.096085	15	-0.49	.	1.108790e-03	0.15912	1.083490e-03	0	74936	0.000000e+00	6060	0	0.06884	11	SDHD	0.000000e+00	0	Ala	10680	2.233290e-05	11-112088966-C-T	Hereditary_cancer-predisposing_syndrome|not_provided|Paragangliomas_with_sensorineural_hearing_loss|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|not_specified	0	2	111464900	ClinGen:CA070974	0.374914	0.14078	0	RCV000562410|RCV001584171|RCV001821298|RCV002230663	T	0	0	c.269C>T	0	0	0	0.36716	./.	rs200255724	112088966	14902	C	.	O14521	15690	0.01422	0.000000e+00	0.08389		0	0	0.000000e+00	-0.4	0	0	264690	1.52	0.87639	108	T	T	0	3.276110e-05	0	24	segdup	0	0	140162|97286|29072|201	412511	0.71444	0.20745	0.0642470002855991	2294	.	0.20497	0.45781	2.918860e-05	9.147940e-04	1179998	0.348	1.537520e-04	N	13394	0	3.7780044E-6	0	606864|171300	0.19856	11	0.000000e+00	ENSG00000204370	0.000000e+00	0	28	0	0.6562659735392878	2	0.06938	0.64339	30608	1	1.946890e-05	3.332890e-05	-0.647685205617222	YES	1.108790e-03	0.039239	398394	HGNC:10683	N	0	simple_aae	0.063	208128	112088966	GCG	0.000000	.	-	0	0.01525	1.271190e-05	0	1	Conflicting classifications of pathogenicity	0.23434	17	0	2	ClinGen:CA070974	A	0	0.97841390163	-	0.554	-	0.37474	31	466	0.65397	0.404172539711	0.063	0	0.96925041798389644	94	-	269C>T 	28	0	C0027672|C3661900|C1868633|C1847319|C0031511|CN166604|CN169374	0	0	0	0	NM_003002.4	-	.	.	0	0.41636	200255724	2320	0	0.97797	0.17985	0.325	1.0	2210	0.96888520	5.04	.	.	9.147940e-04	0.0203817	0.0286794542137332	0.02998	T	84	6212	9572	-0.0242	0.90456	p.Ala90Val	0	0	-3.974	0.033454627	0	0.32439	412511	T	30524	SDHD	0.000000e+00	D	0.538	21632	A90V	T	.	0.27038	./.	principal1																																																																																																				
BRCA1_Ser611Arg	0.9435653387772786	1.0	3.4350690406883606	0.02202146477987949	2025_01_Batch_13-14	0.9553935623214184	0.9507932560196941	0.9084188437682514	0.949490270032494	0.883887929907112	0.9809933121913667	0.9396248586533601	0.9215061440810749	0.9789850450005839	0.889371169243643	0.9681934372563925	0.945209057336527	0.9149624939246632	0.964237657516539	0.8866295495753775	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	BRCA1	BRCA1		14613		CCSBVarC011835		NC_000017.11:43063881:G:C		Ser611Arg																												BRCA1_Ser611Arg	17	43063881	G	C	17	allele	1833C>G	F08	527_CAVA_Array_P01	K15	B13A7A8P1_R1	B14A7A8P1_R2				17-43063881-G-C	-	0.51985	0.064	1715	.	.	.	17	41215898	C	.	.	17	1_Pathogenic	NC_000017.11	.	Ser1715Arg	.	23.2	.	.	.	D	.	6	1	.	.	.	.	.	.	0.88582	.	0.6610	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.64025	.	.	.	.	0.74220	.	.	0.98504	0.998	.	.	.	4.33	.	C	single nucleotide variant	NC_000017.11:g.43063881G>C	.	.	2	0.7653877	.	.	0.9707088	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	.	.	.	.	0.99291	B	0.85672	B	M	6.719747	.	G/G	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	.	0.88675	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063881	.	-	4.969000	.	0.99727	.	.	.	.	germline;not applicable;unknown	.	.	.	GRCh38	549	criteria provided, multiple submitters, no conflicts	.	.	0.63341	.	.	.	BRCT domain|BRCT domain|BRCT domain	.	.	.	.	.	NM_007294.4(BRCA1):c.5145C>G (p.Ser1715Arg)	2	.	BRCA1_HUMAN	.	.	0.670045961903725	.	.	0.96584	0.97296304	-	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99835	.	.	.	.	.	.	.	0.46465	.	germline	.		G	Oct 16, 2024	.	G/G	.	.	1.0	N	17q21.31	.	.	.	SCV000326168|SCV002645244|SCV005058237|SCV005812863	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000419274	ENST00000470026	.	.	.	.	0.596	G	.	3.655532	0.92967	N	.	-	6.981316	.	0.94878	.	.	.	0.73434	.	43063881	Y	10	.	.	.	P38398	.	0.249441	0.91978		.	0.031	D	.	0.7604528	.	0.85369	672	0.397653	.	.	.	.	0.91343	.	.	.	.	.	.	0.85971	17	BRCA1	.	.	Ser	.	.	17-43063881-G-C	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38469424	ClinGen:CA003268|UniProtKB:P38398#VAR_063906	0.429032	0.77549	.	RCV000112509|RCV002336193|RCV005089439	.	.	.	c.5145C>G	.	.	.	0.89708	G/G	rs80357094	43063881	.	G	.	.	.	0.98298	.	0.68239		.	.	.	3.09	.	.	.	4.89	0.61729	.	D	T	.	.	.	.	.	.	.	140162|145	55418	0.89578	0.45682	0.98091846704483	.	.	0.71675	0.49057	.	.	.	2.013	.	.	.	.	.	.	604370	0.40665	17	.	ENSG00000012048	.	.	.	.	.	3	0.92348	0.72286	.	.	.	.	0.654600882003088	.	.	0.483874	70085	HGNC:1100	.	.	.	0.992	.	43063881	AGC	1.000000	.	-	.	0.79960	.	.	.	Pathogenic/Likely pathogenic	0.97410	.	.	.	ClinGen:CA003268,UniProtKB:P38398#VAR_063906	S	.	.	-	.	-	0.93850	.	.	0.92636	0.678713917732	.	.	0.99838730133180587	.	-	5145C>G 	.	.	C0027672|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.85294	80357094	.	.	0.91515	0.78837	.	.	.	0.99986792	6.04	.	.	.	0.333424	0.998593400129946	0.87301	D	.	.	.	0.3749	0.88183	p.Ser1715Arg	.	.	-15.775	.	.	0.94714	55418	D	.	BRCA1	.	D	.	.	.	.	0.81833	0.33565	G/G	principal2																																																																																																				
BRCA1_Ser611Arg	0.9435653387772786	1.0	3.4350690406883606	0.02202146477987949	2025_01_Batch_13-14	0.9553935623214184	0.9507932560196941	0.9084188437682514	0.949490270032494	0.883887929907112	0.9809933121913667	0.9396248586533601	0.9215061440810749	0.9789850450005839	0.889371169243643	0.9681934372563925	0.945209057336527	0.9149624939246632	0.964237657516539	0.8866295495753775	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	BRCA1	BRCA1		14613		CCSBVarC011847		NC_000017.11:43063883:T:G		Ser611Arg																												BRCA1_Ser611Arg	17	43063883	T	G	17	allele	1831A>C	C09	527_CAVA_Array_P01	E17	B13A7A8P1_R1	B14A7A8P1_R2				17-43063883-T-G	-	0.58299	0.064	1715	.	.	.	17	41215900	G	.	.	17	1_Pathogenic	NC_000017.11	.	Ser1715Arg	.	24.0	.	.	.	D	.	8	.	.	.	.	.	.	.	0.91164	.	0.6824	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.64025	.	.	.	.	0.74220	.	.	0.98504	0.999	.	.	.	.	.	G	single nucleotide variant	NC_000017.11:g.43063883T>G	.	.	2	0.7653877	.	.	0.96063316	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	.	.	.	.	0.99291	B	0.83331	B	M	7.683752	.	T/T	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not provided	.	0.90317	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063883	.	-	7.850000	.	0.99727	.	.	.	.	germline;not applicable	.	.	.	GRCh38	549	reviewed by expert panel	.	.	0.98023	.	.	.	BRCT domain|BRCT domain|BRCT domain	.	.	.	.	.	NM_007294.4(BRCA1):c.5143A>C (p.Ser1715Arg)	3	.	BRCA1_HUMAN	.	.	0.737909246897857	.	.	0.96584	0.97296304	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99835	.	.	.	.	.	.	.	0.70966	.	germline	.		T	Aug 10, 2015	.	T/T	.	.	1.0	N	17q21.31	.	.	.	SCV000244386	Pathogenic	.	.	Arg	R	-	.	ENSP00000518978	ENST00000713676	.	.	.	.	0.587	T	.	3.966832	0.92967	D	.	-	8.437762	.	0.96634	.	.	.	0.64367	.	43063883	Y	10	.	.	.	P38398	.	0.249441	0.93553		.	0.031	D	.	0.7210125	.	0.91597	672	0.403311	.	.	.	.	0.91343	.	.	.	.	.	.	0.85971	17	BRCA1	.	.	Ser	.	.	17-43063883-T-G	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_provided	.	.	38469426	BRCA1-HCI:BRCA1_00051|ClinGen:CA003264|UniProtKB:P38398#VAR_063906	0.773248	0.82017	.	RCV000112505|RCV001383430|RCV002267824	.	.	.	c.5143A>C	.	.	.	0.90034	T/T	rs80357222	43063883	.	T	.	.	.	0.97301	.	0.68239		.	.	.	3.09	.	.	.	6.04	0.61729	.	D	T	.	.	.	.	.	.	.	145|145	55414	0.89910	0.45682	0.955768585205078	.	.	0.71675	0.70624	.	.	.	3.389	.	.	.	.	.	.	604370	0.52349	17	.	ENSG00000012048	.	.	.	.	.	1	0.92348	0.72286	.	.	.	.	0.733918080214739	.	.	0.614101	70081	HGNC:1100	.	.	.	0.992	.	43063883	AGC	1.000000	.	-	.	0.84119	.	.	.	Pathogenic	0.97410	.	.	.	BRCA1-HCI:BRCA1_00051,ClinGen:CA003264,UniProtKB:P38398#VAR_063906	S	.	.	-	.	-	0.93850	.	.	0.92636	0.678713917732	.	.	0.99856366597217106	.	-	5143A>C 	.	.	C0677776|C2676676|C3661900	.	.	.	.	NM_007294.4	-	.	.	1	0.85294	80357222	.	.	0.93349	0.84867	.	.	.	0.99986720	6.04	.	.	.	0.341552	0.998593400129946	0.87301	D	.	.	.	0.4864	0.88985	p.Ser1715Arg	.	.	-15.775	.	.	0.94714	55414	D	.	BRCA1	.	D	.	.	.	.	.	0.31004	T/T	principal2																																																																																																				
RAF1_Thr145Pro	-6.387994716345845	0.1333777500132942	3.706074644344897	0.04897839094117087	2025_01_Batch_13-14	0.6948395624861297	0.7812129413187235	0.8303045437251851	0.7411965198648527	0.6776063686022727	0.7787636596227573	0.6949013084563911	0.5345638780487201	0.7831153912329918	0.6637667112505362	0.7368016110544435	0.7380571248875574	0.6824342108869526	0.7621559555489222	0.6706865399264045	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAF1	RAF1		732		CCSBVarC008929		NC_000003.12:12608914:T:G		Thr145Pro																												RAF1_Thr145Pro	3	12608914	T	G	3	allele	433A>C	C05	527_CAVA_Array_P05	E09	B13A7A8P2_R1	B14A7A8P2_R2				3-12608914-T-G	-	0.85379	0.884	145	.	.	.	3	12650413	G	.	.	3	1_Pathogenic	NC_000003.12	.	Thr145Pro	.	28.6	.	.	.	D	.	1	.	.	.	.	.	.	.	0.99189	.	0.9288	.	0.48632	.	.	D	D	.	.	.	.	.	.	.	0.89403	.	.	.	.	0.76607	.	.	0.98735	0.994	.	.	.	5.35	.	G	single nucleotide variant	NC_000003.12:g.12608914T>G	.	.	2	0.95809036	.	.	0.9750533	.		.	.	.	.	.	.	.	.	MedGen:CN517202	.	.	.	.	0.94378	P	0.97981	P	H	11.03838	.	T/T	.	.	.	.	not provided	.	0.99121	.	.	-	12608914	.	-	7.910000	.	0.99826	.	.	.	.	germline	.	Gain of glycosylation at T145 (P = 0.0599)| Gain of methylation at K144 (P = 0.1056)| Loss of MoRF binding (P = 0.1062)| Loss of ubiquitination at K144 (P = 0.1287)| Loss of stability (P = 0.1872)	0.86913	GRCh38	646	criteria provided, single submitter	.	.	0.85695	.	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	.	.	.	.	.	NM_002880.4(RAF1):c.433A>C (p.Thr145Pro)	1	.	RAF1_HUMAN	.	.	0.899566054000196	.	.	0.93458	0.97559345	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.95656	.	.	.	.	.	.	.	0.74019	.	germline	.		T	Nov 03, 2016	.	T/T	.	.	1.0	N	3p25.2	.	.	.	SCV000491591	Likely_pathogenic	.	.	Pro	P	-	.	ENSP00000508763	ENST00000691899	.	.	.	.	0.665	T	.	5.106479	0.79703	D	.	-	11.29401	.	0.98245	.	.	.	0.98238	.	12608914	Y	10	.	.	.	P04049	.	0.964761	0.62800		.	0.651	D	.	0.9437567	.	0.71086	5894	0.532258	.	.	.	.	0.78662	.	.	.	.	.	.	0.98851	3	RAF1	.	.	Thr	.	.	3-12608914-T-G	not_provided	.	.	12625413	ClinGen:CA16042457	0.965951	0.91692	.	RCV000414587	.	.	.	c.433A>C	.	.	.	0.95160	T/T	rs1057518155	12608914	.	T	.	P04049	.	0.98689	.	0.68239		.	.	.	3.94	.	.	.	5.62	0.99568	.	D	D	.	.	.	.	.	.	.	.	373032	0.95088	0.82338	0.999636769294739	.	.	0.71675	0.98828	.	.	.	8.012	.	.	.	.	.	.	.	0.88241	3	.	ENSG00000132155	.	.	.	.	.	1	0.52493	0.63408	.	.	.	.	0.836522703996796	.	.	0.77786	359447	HGNC:9829	.	.	.	0.995	.	12608914	ACG	1.000000	.	-	.	0.92727	.	.	.	Likely pathogenic	0.80472	.	.	.	ClinGen:CA16042457	T	.	.	-	0.737	-	0.66620	.	.	0.91688	0.8487200737	.	.	0.99400133114841904	.	-	433A>C 	.	.	CN517202	.	.	.	.	NM_002880.4	-	.	.	1	0.87265	1057518155	.	.	0.96289	0.92161	.	.	.	0.98135380	5.62	.	.	.	0.526776	0.999952511305676	0.96320	D	.	.	.	1.0870	0.97644	p.Thr145Pro	.	.	-11.037	.	.	0.99183	373032	D	.	RAF1	.	D	.	.	T145P	.	0.93259	0.62996	T/T	principal3																																																																																																				
SDHD_Gly106Val	3.3461453651413797	0.013103277931052443	-1.3929891888092012	0.003238229548318901	2025_01_Batch_13-14	0.7781633021684375	0.8343392162525063	0.7996012165652717	0.8582827131921871	0.6972959118318091	0.7551675962343357	0.8070916842991093	0.7695054555275767	0.7931835167663557	0.6723056539635265	0.7666654492013867	0.8207154502758078	0.7845533360464242	0.8257331149792714	0.6848007828976678	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023331		NC_000011.10:112094807:G:T		Gly106Val																												SDHD_Gly106Val	11	112094807	G	T	11	allele	317G>T	F12	527_CAVA_Array_P05	K23	B13A7A8P2_R1	B14A7A8P2_R2				11-112094807-G-T	-	0.66223	1.0	106	.	.	.	11	111965531	T	.	.	11	1_Pathogenic	NC_000011.10	.	Gly106Val	.	24.9	.	.	.	D	.	5	1	.	.	.	.	.	.	0.98302	Select	0.9966	.	0.90580	.	.	D	D	.	0.842846843757	.	.	.	.	.	0.46573	.	.	.	.	0.97150	.	.	0.97841	0.998	.	22.0	0.79822	.	0.78	T	single nucleotide variant	NC_000011.10:g.112094807G>T	.	.	2	0.9694429	.	.	0.94609135	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MedGen:C3661900|	.	.	.	.	0.86494	D	0.99168	D	.	11.78742	.	./.	.	.	.	.	Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma|not provided|SDHD-related disorder	.	0.95197	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094807	.	-	9.853000	.	0.99594	.	.	.	.	germline	.	Loss of sheet (P = 0.0817)| Gain of helix (P = 0.132)| Loss of catalytic residue at L107 (P = 0.1641)| Loss of loop (P = 0.2237)| Loss of relative solvent accessibility (P = 0.3219)	0.99827	GRCh38	638	criteria provided, multiple submitters, no conflicts	c.317G>T	.	0.54956	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.317G>T (p.Gly106Val)	2	.	DHSD_HUMAN	.	78.0	0.927619938196907	.	T	0.77749	0.9659864	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99371	.	.	.	.	.	p.Gly106Val	.	0.82031	.	germline	.		G	Sep 01, 2024	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV000664565|SCV000782286|SCV000961779|SCV004107262|SCV005434052	Pathogenic/Likely_pathogenic	.	.	Val	V	-	.	ENSP00000364699	ENST00000375549	.	0.0	.	.	0.672	G	.	4.321877	0.70891	D	D	-	11.67327	.	0.94454	.	.	.	0.83635	.	112094807	Y	10	.	.	.	O14521	.	0.980291	0.46791		.	0.99	D	.	0.9640038	.	0.85369	6392	0.324438	.	-8.4	.	.	0.91343	.	.	.	.	.	.	0.99432	11	SDHD	.	.	Gly	.	.	11-112094807-G-T	Paragangliomas_1|SDHD-related_disorder|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_cancer-predisposing_syndrome	.	.	111470741	ClinGen:CA382618730	0.966887	0.93007	.	RCV000561906|RCV000660262|RCV002232089|RCV004808786|RCV003420005	D	.	.	c.317G>T	.	.	.	0.84673	./.	rs1555187574	112094807	.	G	.	O14521	.	0.95803	.	0.68239		.	.	.	.	.	.	.	4.53	0.99837	.	D	T	.	.	.	.	.	.	.	29072|97286|29072|201|140162	480806	0.84473	0.67951	0.993092656135559	.	.	0.71675	0.98931	.	.	.	9.578	.	D	.	.	.	.	168000|606864|171300	0.97363	11	.	ENSG00000204370	.	.	.	.	0.98444967902886	2	0.78943	0.64247	.	.	.	.	0.847271321840749	YES	.	0.45813	476439	HGNC:10683	A	.	simple_aae	0.988	.	112094807	GGC	1.000000	.	-	.	0.99985	.	.	.	Pathogenic/Likely pathogenic	0.90765	.	.	.	ClinGen:CA382618730	G	.	0.957054369045	-	0.982	-	0.98575	.	.	0.98430	0.55555254221	0.8109	.	0.98815045644021704	.	-	317G>T 	.	.	C3494181|C1847319|C0031511|CN166604|C1868633|C0027672	.	.	.	.	NM_003002.4	-	.	.	1	0.47259	1555187574	.	.	0.95622	0.92817	0.975	0.006	.	0.99942360	4.53	.	.	.	0.228256	0.998577411365903	.	D	.	.	.	0.8648	0.99920	p.Gly106Val	.	.	-12.833	0.99544626	.	0.94680	480806	D	.	SDHD	.	D	0.929	.	G106V	D	.	0.70176	./.	principal1																																																																																																				
SDHD_Gly106Val	3.3461453651413797	0.013103277931052443	-1.3929891888092012	0.003238229548318901	2025_01_Batch_13-14	0.7781633021684375	0.8343392162525063	0.7996012165652717	0.8582827131921871	0.6972959118318091	0.7551675962343357	0.8070916842991093	0.7695054555275767	0.7931835167663557	0.6723056539635265	0.7666654492013867	0.8207154502758078	0.7845533360464242	0.8257331149792714	0.6848007828976678	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023331	ALE00031717	NC_000011.10:112094807:G:T	317G>T	Gly106Val	CAVA																											SDHD_Gly106Val	11	112094807	G	T	11								1	1	1	11-112094807-G-T	-	0.66223	1.0	106	.	.	.	11	111965531	T	.	.	11	1_Pathogenic	NC_000011.10	.	Gly106Val	.	24.9	.	.	.	D	.	5	1	.	.	.	.	.	.	0.98302	Select	0.9966	.	0.90580	.	.	D	D	.	0.842846843757	.	.	.	.	.	0.46573	.	.	.	.	0.97150	.	.	0.97841	0.998	.	22.0	0.79822	.	0.78	T	single nucleotide variant	NC_000011.10:g.112094807G>T	.	.	2	0.9694429	.	.	0.94609135	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MedGen:C3661900|	.	.	.	.	0.86494	D	0.99168	D	.	11.78742	.	./.	.	.	.	.	Hereditary cancer-predisposing syndrome|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma|not provided|SDHD-related disorder	.	0.95197	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112094807	.	-	9.853000	.	0.99594	.	.	.	.	germline	.	Loss of sheet (P = 0.0817)| Gain of helix (P = 0.132)| Loss of catalytic residue at L107 (P = 0.1641)| Loss of loop (P = 0.2237)| Loss of relative solvent accessibility (P = 0.3219)	0.99827	GRCh38	638	criteria provided, multiple submitters, no conflicts	c.317G>T	.	0.54956	.	.	.	.	.	.	P	.	.	NM_003002.4(SDHD):c.317G>T (p.Gly106Val)	2	.	DHSD_HUMAN	.	78.0	0.927619938196907	.	T	0.77749	0.9659864	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99371	.	.	.	.	.	p.Gly106Val	.	0.82031	.	germline	.		G	Sep 01, 2024	.	./.	.	.	1.0	N	11q23.1	.	.	.	SCV000664565|SCV000782286|SCV000961779|SCV004107262|SCV005434052	Pathogenic/Likely_pathogenic	.	.	Val	V	-	.	ENSP00000364699	ENST00000375549	.	0.0	.	.	0.672	G	.	4.321877	0.70891	D	D	-	11.67327	.	0.94454	.	.	.	0.83635	.	112094807	Y	10	.	.	.	O14521	.	0.980291	0.46791		.	0.99	D	.	0.9640038	.	0.85369	6392	0.324438	.	-8.4	.	.	0.91343	.	.	.	.	.	.	0.99432	11	SDHD	.	.	Gly	.	.	11-112094807-G-T	Paragangliomas_1|SDHD-related_disorder|Carney-Stratakis_syndrome|Pheochromocytoma|Cowden_syndrome_3|Paragangliomas_with_sensorineural_hearing_loss|Hereditary_cancer-predisposing_syndrome	.	.	111470741	ClinGen:CA382618730	0.966887	0.93007	.	RCV000561906|RCV000660262|RCV002232089|RCV004808786|RCV003420005	D	.	.	c.317G>T	.	.	.	0.84673	./.	rs1555187574	112094807	.	G	.	O14521	.	0.95803	.	0.68239		.	.	.	.	.	.	.	4.53	0.99837	.	D	T	.	.	.	.	.	.	.	29072|97286|29072|201|140162	480806	0.84473	0.67951	0.993092656135559	.	.	0.71675	0.98931	.	.	.	9.578	.	D	.	.	.	.	168000|606864|171300	0.97363	11	.	ENSG00000204370	.	.	.	.	0.98444967902886	2	0.78943	0.64247	.	.	.	.	0.847271321840749	YES	.	0.45813	476439	HGNC:10683	A	.	simple_aae	0.988	.	112094807	GGC	1.000000	.	-	.	0.99985	.	.	.	Pathogenic/Likely pathogenic	0.90765	.	.	.	ClinGen:CA382618730	G	.	0.957054369045	-	0.982	-	0.98575	.	.	0.98430	0.55555254221	0.8109	.	0.98815045644021704	.	-	317G>T 	.	.	C3494181|C1847319|C0031511|CN166604|C1868633|C0027672	.	.	.	.	NM_003002.4	-	.	.	1	0.47259	1555187574	.	.	0.95622	0.92817	0.975	0.006	.	0.99942360	4.53	.	.	.	0.228256	0.998577411365903	.	D	.	.	.	0.8648	0.99920	p.Gly106Val	.	.	-12.833	0.99544626	.	0.94680	480806	D	.	SDHD	.	D	0.929	.	G106V	D	.	0.70176	./.	principal1																																																																																																				
BRIP1_Arg848His	2.578571129238601	0.0754963461161795	-3.086811053904651	0.18383040953677723	2025_01_Batch_13-14	0.7587827823803478	0.7491731842366169	0.7311718734894977	0.7446874149976265	0.7116923345130145	0.7877104845651395	0.8487688359703991	0.7814650513637258	0.7920417222770307	0.7490619451894294	0.7732466334727437	0.798971010103508	0.7563184624266117	0.7683645686373286	0.730377139851222	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRIP1	BRIP1		55128		CCSBVarC031388		NC_000017.11:61693462:C:T		Arg848His																												BRIP1_Arg848His	17	61693462	C	T	17	allele	2543G>A	G12	527_CAVA_Array_P01	M23	B13A7A8P1_R1	B14A7A8P1_R2				17-61693462-C-T	-	0.90472	1.0	848	.	0	.	17	59770823	T	6.197680e-06	.	17	3_Conflicting	NC_000017.11	3	Arg848His	.	31.0	.	2	.	D	0	13	1	.	.	.	.	.	0	0.98414	Select	0.9696	.	0.90580	.	.	D	D	63978	0.750843833719	2.6961445133459155E-4	0	.	.	.	0.59114	.	44854	1	.	0.79008	.	.	0.96137	0.935	.	22.0	.	.	0.78	T	single nucleotide variant	NC_000017.11:g.61693462C>T	0	.	2	0.8188024	.	0	0.9493171	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MedGen:C3661900|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267;MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	.	.	0.000000e+00	0	0.86494	D	0.89326	D	H	12.5292	10	C/C	298	0	.	1613508	Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia complementation group J|not provided|Ovarian neoplasm;Fanconi anemia complementation group J|Fanconi anemia complementation group J|Hereditary breast ovarian cancer syndrome|Neurodevelopmental delay|Familial cancer of breast	.	0.99040	.	.	-	61693462	.	-	7.610000	.	0.80003	29590	0	74880	.	germline;unknown	91078	.	.	GRCh38	139	criteria provided, conflicting classifications	c.2543G>A	.	0.90056	2	.	.	.	.	.	P	0	0.000000e+00	NM_032043.3(BRIP1):c.2543G>A (p.Arg848His)	1	.	FANCJ_HUMAN	.	78.0	0.953849966561016	.	.	0.83733	0.9493171	-	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.98313	.	0	.	.	59990	p.Arg848His	0	0.61936	.	germline	.		C	Dec 22, 2024	.	C/C	.	.	1.0	N	17q23.2	19722	.	.	SCV000184883|SCV000786407|SCV000828254|SCV000896650|SCV000909762|SCV001777038|SCV002558935|SCV004217033|SCV005205363|SCV005373762|SCV005416787	Conflicting_classifications_of_pathogenicity	.	.	His	H	-	912	ENSP00000259008	ENST00000259008	.	0.0	.	.	0.549	C	.	5.402014	0.92967	D	D	-	12.44217	.	0.94645	610	.	.	0.98331	0	61693462	Y	9	0	.	0.000000e+00	Q9BX63	.	0.839083	0.99824		.	0.999	D	.	0.8188024	.	0.4738	83990	0.542959	6	-4.6	.	4.006410e-05	0.91343	.	.	74880	.	6082	.	0.89327	17	BRIP1	4.006410e-05	0	Arg	30326	.	17-61693462-C-T	Familial_cancer_of_breast|Neurodevelopmental_delay|Fanconi_anemia_complementation_group_J|Ovarian_neoplasm|not_provided|Hereditary_cancer-predisposing_syndrome	0	.	57125605	ClinGen:CA165626	0.731722	0.94104	0	RCV000130056|RCV000699539|RCV001194712|RCV000663220|RCV001255230|RCV004760390|RCV002273958|RCV003460909	D	0	.	c.2543G>A	.	0	0	0.95468	C/C	rs374334794	61693462	.	C	.	.	.	0.96137	.	0.68239		.	.	0.000000e+00	4.15	0	0	264690	5.74	0.96201	112	D	T	.	.	0	26	.	.	.	227535|84|140162	141499	0.95401	0.63531	0.999659895896912	7716	.	0.71675	0.67754	.	.	1179678	5.053	.	D	.	.	2.2668026E-5	0	114480|609054	0.6417	17	.	ENSG00000136492	0.000000e+00	0	.	0	0.8741008375185114	2	0.92348	0.94485	.	6	.	0.000000e+00	0.867844537858018	YES	1.097960e-05	0.469494	151213	HGNC:20473	D	.	simple_aae	0.641	.	61693462	CGC	1.000000	.	-	2.592016588906169E-4	0.93570	5.086130e-06	2	0	Conflicting classifications of pathogenicity	0.82941	.	0	0	ClinGen:CA165626	R	.	0.999184905289	-	.	-	0.99270	.	1922	0.87298	0.644317030907	0.8672	0	0.99942296316834778	98	-	2543G>A 	.	0	C0346153|C4022738|C1836860|C0919267|C3661900|C0027672	.	.	.	.	NM_032043.3	-	.	.	1	0.93863	374334794	.	6.595000989250148E-5	0.99916	0.93982	0.857	0.0	7418	0.99724770	5.74	.	.	.	0.542146	0.999253341147957	0.97531	D	86	.	.	1.0848	0.99037	p.Arg848His	0	0	-11.608	0.94317496	3	0.96077	141499	D	.	BRIP1	.	D	0.932	.	.	D	.	0.27038	C/C	principal2																																																																																																				
ZC4H2_Pro201Ser	-5.809680916000794	0.002975023338819346	3.658069769647808	0.034243655203901685	2025_01_Batch_13-14	0.6317258544338403	0.7175626828034266	0.7067604538877507	0.7237190711631107	0.6348000809610653	0.7814396132952472	0.8348792037272437	0.8978818081707663	0.8382258310191754	0.7005473768703887	0.7065827338645438	0.7762209432653351	0.8023211310292585	0.7809724510911431	0.6676737289157271	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2	ENSG00000126970	4320	215107	CCSBVarC005917	ALE00005917	NC_000023.11:64917857:G:A	601C>T	Pro201Ser	CEGS2	CegsMutGDEh1032	E08	GDEhDisVCh_40034	A12	2	CegsMutGDDh1032	E08	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			ZC4H2_Pro201Ser	23	64917857	G	A	X											X-64917857-G-A	-	0.79733	1.0	201	.	.	.	X	64137737	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro201Ser	.	27.2	.	0	.	T	.	2	1	.	.	.	.	.	0	0.99024	Select	0.4584	.	0.90580	.	.	D	D	.	3.14057088863	0	.	.	.	.	0.96691	.	.	.	.	0.93237	.	.	0.91852	0.999	.	4.0	0.959004	.	0.96	A	single nucleotide variant	NC_000023.11:g.64917857G>A	.	.	3	0.90109336	.	0	0.9243852	0		.	.	.	.	.	0	.	0	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	.	.	.	.	0.95575	D	0.96047	D	.	.	.	G/G	0	0	.	.	Wieacker-Wolff syndrome|Neurodevelopmental disorder	.	0.81829	.	.	-	64917857	.	-	11.614000	.	0.99892	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0359)| Gain of phosphorylation at P201 (P = 0.0595)| Loss of loop (P = 0.0603)| Loss of stability (P = 0.0799)| Gain of helix (P = 0.132)	0.68924	GRCh38	40	criteria provided, single submitter	c.601C>T	.	0.78637	0	.	.	Zinc finger C4H2-type	.	.	P	0	.	NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	1	.	ZC4H2_HUMAN	.	96.0	.	.	D	0.99952	0.90647143	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99084	.	.	.	.	.	p.Pro201Ser	.	0.93576	.	germline	.		G	Jun 24, 2020	.	G/G	.	.	1.0	N	Xq11.2	0	.	.	SCV001572190	Likely_pathogenic	.	.	Ser	S	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.676	G	.	4.866916	0.92967	.	D	-	.	.	0.99079	0	.	.	0.95336	0	64917857	Y	8	0	.	.	Q9NQZ6	.	0.841119	0.98918		.	0.998	D	.	0.9158107	.	0.91597	55906	0.579811	.	-6.88	.	.	0.91343	.	.	.	.	.	.	0.94986	X	ZC4H2	.	0	Pro	478	.	X-64917857-G-A	Wieacker-Wolff_syndrome|Neurodevelopmental_disorder	.	.	64054462	ClinGen:CA143908|OMIM:300897.0003|UniProtKB:Q9NQZ6#VAR_069623	.	.	.	RCV000043678|RCV001374903	D	.	.	c.601C>T	.	.	.	0.96963	G/G	rs398122939	64917857	.	G	.	Q9NQZ6	.	0.93582	.	0.68239		.	.	.	.	0	0	.	5.42	0.96267	0	D	D	.	.	0	0	.	.	.	3454|85283	50982	0.96914	0.99417	0.99885880947113	426	.	0.71675	.	.	.	.	9.224	.	D	.	.	.	0	314580	0.94382	X	.	ENSG00000126970	.	0	.	0	0.717222727726295	1	0.88579	0.97963	.	.	.	.	.	YES	.	0.879436	65653	HGNC:24931	A	.	simple_aae	0.997	.	64917857	CCT	1.000000	.	-	0	0.91983	.	0	.	Likely pathogenic	0.90166	.	.	.	ClinGen:CA143908,UniProtKB:Q9NQZ6#VAR_069623,OMIM:300897.0003	P	.	0.924160061229	-	0.568	-	0.93850	.	52	0.71518	0.90233540535	1.0	.	0.99923738092883418	0	-	601C>T 	.	0	C0796200|C1535926	.	.	.	.	NM_018684.4	-	.	.	1	0.85727	398122939	.	0	0.92281	.	0.933	0.0	426	0.99900264	5.42	.	.	.	0.595082	0.999295186201027	.	T	0	.	.	-0.0166	0.78867	p.Pro201Ser	0	.	-12.964	0.9272647	.	0.96182	50982	D	.	ZC4H2	.	D	0.949	.	P201S	D	.	0.76753	G/G	principal1																																																																																																				
ZC4H2_Pro201Ser	-5.809680916000794	0.002975023338819346	3.658069769647808	0.034243655203901685	2025_01_Batch_13-14	0.6317258544338403	0.7175626828034266	0.7067604538877507	0.7237190711631107	0.6348000809610653	0.7814396132952472	0.8348792037272437	0.8978818081707663	0.8382258310191754	0.7005473768703887	0.7065827338645438	0.7762209432653351	0.8023211310292585	0.7809724510911431	0.6676737289157271	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC005917		NC_000023.11:64917857:G:A		Pro201Ser																												ZC4H2_Pro201Ser	23	64917857	G	A	X	allele	601C>T	F03	527_CAVA_Array_P06	K06	B13A7A8P2_R1	B14A7A8P2_R2				X-64917857-G-A	-	0.79733	1.0	201	.	.	.	X	64137737	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro201Ser	.	27.2	.	0	.	T	.	2	1	.	.	.	.	.	0	0.99024	Select	0.4584	.	0.90580	.	.	D	D	.	3.14057088863	0	.	.	.	.	0.96691	.	.	.	.	0.93237	.	.	0.91852	0.999	.	4.0	0.959004	.	0.96	A	single nucleotide variant	NC_000023.11:g.64917857G>A	.	.	3	0.90109336	.	0	0.9243852	0		.	.	.	.	.	0	.	0	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	.	.	.	.	0.95575	D	0.96047	D	.	.	.	G/G	0	0	.	.	Wieacker-Wolff syndrome|Neurodevelopmental disorder	.	0.81829	.	.	-	64917857	.	-	11.614000	.	0.99892	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0359)| Gain of phosphorylation at P201 (P = 0.0595)| Loss of loop (P = 0.0603)| Loss of stability (P = 0.0799)| Gain of helix (P = 0.132)	0.68924	GRCh38	40	criteria provided, single submitter	c.601C>T	.	0.78637	0	.	.	Zinc finger C4H2-type	.	.	P	0	.	NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	1	.	ZC4H2_HUMAN	.	96.0	.	.	D	0.99952	0.90647143	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99084	.	.	.	.	.	p.Pro201Ser	.	0.93576	.	germline	.		G	Jun 24, 2020	.	G/G	.	.	1.0	N	Xq11.2	0	.	.	SCV001572190	Likely_pathogenic	.	.	Ser	S	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.676	G	.	4.866916	0.92967	.	D	-	.	.	0.99079	0	.	.	0.95336	0	64917857	Y	8	0	.	.	Q9NQZ6	.	0.841119	0.98918		.	0.998	D	.	0.9158107	.	0.91597	55906	0.579811	.	-6.88	.	.	0.91343	.	.	.	.	.	.	0.94986	X	ZC4H2	.	0	Pro	478	.	X-64917857-G-A	Wieacker-Wolff_syndrome|Neurodevelopmental_disorder	.	.	64054462	ClinGen:CA143908|OMIM:300897.0003|UniProtKB:Q9NQZ6#VAR_069623	.	.	.	RCV000043678|RCV001374903	D	.	.	c.601C>T	.	.	.	0.96963	G/G	rs398122939	64917857	.	G	.	Q9NQZ6	.	0.93582	.	0.68239		.	.	.	.	0	0	.	5.42	0.96267	0	D	D	.	.	0	0	.	.	.	3454|85283	50982	0.96914	0.99417	0.99885880947113	426	.	0.71675	.	.	.	.	9.224	.	D	.	.	.	0	314580	0.94382	X	.	ENSG00000126970	.	0	.	0	0.717222727726295	1	0.88579	0.97963	.	.	.	.	.	YES	.	0.879436	65653	HGNC:24931	A	.	simple_aae	0.997	.	64917857	CCT	1.000000	.	-	0	0.91983	.	0	.	Likely pathogenic	0.90166	.	.	.	ClinGen:CA143908,UniProtKB:Q9NQZ6#VAR_069623,OMIM:300897.0003	P	.	0.924160061229	-	0.568	-	0.93850	.	52	0.71518	0.90233540535	1.0	.	0.99923738092883418	0	-	601C>T 	.	0	C0796200|C1535926	.	.	.	.	NM_018684.4	-	.	.	1	0.85727	398122939	.	0	0.92281	.	0.933	0.0	426	0.99900264	5.42	.	.	.	0.595082	0.999295186201027	.	T	0	.	.	-0.0166	0.78867	p.Pro201Ser	0	.	-12.964	0.9272647	.	0.96182	50982	D	.	ZC4H2	.	D	0.949	.	P201S	D	.	0.76753	G/G	principal1																																																																																																				
ZC4H2_Pro201Ser	-5.809680916000794	0.002975023338819346	3.658069769647808	0.034243655203901685	2025_01_Batch_13-14	0.6317258544338403	0.7175626828034266	0.7067604538877507	0.7237190711631107	0.6348000809610653	0.7814396132952472	0.8348792037272437	0.8978818081707663	0.8382258310191754	0.7005473768703887	0.7065827338645438	0.7762209432653351	0.8023211310292585	0.7809724510911431	0.6676737289157271	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC005917		NC_000023.11:64917857:G:A		Pro201Ser																												ZC4H2_Pro201Ser	23	64917857	G	A	X	allele	601C>T	A04	527_CAVA_Array_P06	A08	B13A7A8P2_R1	B14A7A8P2_R2				X-64917857-G-A	-	0.79733	1.0	201	.	.	.	X	64137737	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro201Ser	.	27.2	.	0	.	T	.	2	1	.	.	.	.	.	0	0.99024	Select	0.4584	.	0.90580	.	.	D	D	.	3.14057088863	0	.	.	.	.	0.96691	.	.	.	.	0.93237	.	.	0.91852	0.999	.	4.0	0.959004	.	0.96	A	single nucleotide variant	NC_000023.11:g.64917857G>A	.	.	3	0.90109336	.	0	0.9243852	0		.	.	.	.	.	0	.	0	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	.	.	.	.	0.95575	D	0.96047	D	.	.	.	G/G	0	0	.	.	Wieacker-Wolff syndrome|Neurodevelopmental disorder	.	0.81829	.	.	-	64917857	.	-	11.614000	.	0.99892	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0359)| Gain of phosphorylation at P201 (P = 0.0595)| Loss of loop (P = 0.0603)| Loss of stability (P = 0.0799)| Gain of helix (P = 0.132)	0.68924	GRCh38	40	criteria provided, single submitter	c.601C>T	.	0.78637	0	.	.	Zinc finger C4H2-type	.	.	P	0	.	NM_018684.4(ZC4H2):c.601C>T (p.Pro201Ser)	1	.	ZC4H2_HUMAN	.	96.0	.	.	D	0.99952	0.90647143	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99084	.	.	.	.	.	p.Pro201Ser	.	0.93576	.	germline	.		G	Jun 24, 2020	.	G/G	.	.	1.0	N	Xq11.2	0	.	.	SCV001572190	Likely_pathogenic	.	.	Ser	S	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.676	G	.	4.866916	0.92967	.	D	-	.	.	0.99079	0	.	.	0.95336	0	64917857	Y	8	0	.	.	Q9NQZ6	.	0.841119	0.98918		.	0.998	D	.	0.9158107	.	0.91597	55906	0.579811	.	-6.88	.	.	0.91343	.	.	.	.	.	.	0.94986	X	ZC4H2	.	0	Pro	478	.	X-64917857-G-A	Wieacker-Wolff_syndrome|Neurodevelopmental_disorder	.	.	64054462	ClinGen:CA143908|OMIM:300897.0003|UniProtKB:Q9NQZ6#VAR_069623	.	.	.	RCV000043678|RCV001374903	D	.	.	c.601C>T	.	.	.	0.96963	G/G	rs398122939	64917857	.	G	.	Q9NQZ6	.	0.93582	.	0.68239		.	.	.	.	0	0	.	5.42	0.96267	0	D	D	.	.	0	0	.	.	.	3454|85283	50982	0.96914	0.99417	0.99885880947113	426	.	0.71675	.	.	.	.	9.224	.	D	.	.	.	0	314580	0.94382	X	.	ENSG00000126970	.	0	.	0	0.717222727726295	1	0.88579	0.97963	.	.	.	.	.	YES	.	0.879436	65653	HGNC:24931	A	.	simple_aae	0.997	.	64917857	CCT	1.000000	.	-	0	0.91983	.	0	.	Likely pathogenic	0.90166	.	.	.	ClinGen:CA143908,UniProtKB:Q9NQZ6#VAR_069623,OMIM:300897.0003	P	.	0.924160061229	-	0.568	-	0.93850	.	52	0.71518	0.90233540535	1.0	.	0.99923738092883418	0	-	601C>T 	.	0	C0796200|C1535926	.	.	.	.	NM_018684.4	-	.	.	1	0.85727	398122939	.	0	0.92281	.	0.933	0.0	426	0.99900264	5.42	.	.	.	0.595082	0.999295186201027	.	T	0	.	.	-0.0166	0.78867	p.Pro201Ser	0	.	-12.964	0.9272647	.	0.96182	50982	D	.	ZC4H2	.	D	0.949	.	P201S	D	.	0.76753	G/G	principal1																																																																																																				
SDHD_Phe34Cys	7.204566186715207	0.00017742529934530618	-1.9188547732241465	0.052251061085832565	2025_01_Batch_13-14	0.8930240841096873	0.9110751086339479	0.8882816334753623	0.9395293461461559	0.8243090951965234	0.8539948588305041	0.8535434769328026	0.8550420940281295	0.8552886373350626	0.7965256524057183	0.8735094714700957	0.8823092927833753	0.8716618637517459	0.8974089917406092	0.8104173738011209	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD		6363		CCSBVarC023269		NC_000011.10:112087905:T:G		Phe34Cys																												SDHD_Phe34Cys	11	112087905	T	G	11	allele	101T>G	B11	527_CAVA_Array_P05	C21	B13A7A8P2_R1	B14A7A8P2_R2				11-112087905-T-G	-	0.47109	0.953	34	0	0	0	11	111958629	G	2.726030e-05	2	11	3_Conflicting	NC_000011.10	38	Phe34Cys	0	22.4	0	2	4.026310e-04	D	0	7	1	42768	3.376300e-05	1	30526	0.000000e+00	0	0.88724	Select	0.6593	14902	0.54293	2	0.0	T	D	64038	0.662533756427	7.183908045977011E-4	0	0.000000e+00	0	0	0.41709	17112	44890	0	0.000000e+00	0.96333	0	.	0.18151	0.939	7.564296520423601E-4	87.0	0.860814	.	0.13	G	single nucleotide variant	NC_000011.10:g.112087905T>G	0	16724	2	0.07223325	109398	0	0.08004188	0		8	236946	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|	5	0	0.000000e+00	0	0.52324	B	0.15552	P	M	3.345592	44	./.	114	0	7164	1614066	not specified|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma|SDHD-related disorder	16218	0.86189	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112087905	4.187600e-04	-	5.897000	6	0.51065	29608	0	75038	0	germline	91088	.	.	GRCh38	635	criteria provided, conflicting classifications	c.101T>G	0.000000e+00	0.41042	2	0	0	.	0.000000e+00	9046	B	0	0.000000e+00	NM_003002.4(SDHD):c.101T>G (p.Phe34Cys)	1	0	DHSD_HUMAN	0	13.0	0.209532460011217	2	D	0.63627	0.08004188	+	4.187600e-04	0		6	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.96789	4.570470e-05	0	0.000000e+00	0	60030	p.Phe34Cys	0	0.50911	.	germline	3		T	Jan 23, 2025	0	./.	0	89558	1.0	N	11q23.1	9690	.	3.699590e-04	SCV000287810|SCV000675108|SCV001765234|SCV003928129|SCV004845023	Conflicting_classifications_of_pathogenicity	0	0	Cys	C	-	912	ENSP00000364699	ENST00000375549	17692	0.081	13416	0	0.665	T	0	3.395206	0.92967	D	T	-	3.443302	.	0.83237	610	0	0.0	0.13859	0	112087905	Y	10	0	102754	0.000000e+00	O14521	0	0.32663	0.57287		0	0.43	D	16218	0.07223325	7164	0.47934	6392	0.127906	0	-0.55	0.0	5.064100e-04	0.78662	0.000000e+00	0	75038	0.000000e+00	6060	3	0.15552	11	SDHD	5.064100e-04	0	Phe	14050	0.000000e+00	11-112087905-T-G	not_specified|Paragangliomas_1|not_provided|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Cowden_syndrome_3|Hereditary_pheochromocytoma-paraganglioma|Hereditary_cancer-predisposing_syndrome	0	0	111463839	ClinGen:CA016754	0.736750	0.51422	0	RCV000122008|RCV000569765|RCV001545828|RCV003230259|RCV002228410|RCV003997358|RCV004748588	D	0	0	c.101T>G	0	0	0	0.66920	./.	rs141802836	112087905	14902	T	1.9968051118210862E-4	.	15690	0.18151	0.000000e+00	0.68239		0	0	0.000000e+00	2.3	0	0	264690	3.66	0.69546	112	T	T	6	6.552220e-05	0	26	segdup	0	0	29072|29072|97286|201|29072|140162	135196	0.85611	0.58709	0.116020513204259	2898	1	0.71675	0.68100	5.837710e-05	3.699590e-04	1179892	2.022	3.843860e-05	N	13384	0	1.2089614E-4	0	168000|171300|606864	0.40755	11	4.026310e-04	ENSG00000204370	0.000000e+00	0	0	0	0.5560470912091142	2	0.45391	0.64545	30608	32	0.000000e+00	4.997500e-05	0.250926334821979	YES	0.000000e+00	0.151246	138935	HGNC:10683	N	0	simple_aae	0.241	208124	112087905	TTT	1.000000	0	-	6.901311249137336E-4	0.62974	0.000000e+00	2	0	Conflicting classifications of pathogenicity	0.23555	0	0	3	ClinGen:CA016754	F	0	0.931227753352	-	.	-	0.70120	8	496	0.55343	0.521012783051	0.1996	0	0.99261210856720172	98	-	101T>G 	6	0	CN169374|C3494181|C3661900|C0031511|C1847319|C1868633|CN166604|C1708353|C0027672	0	0	0	0	NM_003002.4	-	0	0.0	0	0.58949	141802836	2320	1.4234875444839857E-4	0.92998	0.52455	0.622	0.157	2784	0.99037120	4.81	.	.	0.000000e+00	0.251929	0.144711279699783	0.65510	D	86	6212	9572	0.2199	0.88119	p.Phe34Cys	0	0	-3.982	0.53285825	38	0.46760	135196	T	30524	SDHD	1.168770e-04	D	0.691	21622	.	T	.	0.62996	./.	principal1																																																																																																				
SDHD_Phe34Cys	7.204566186715207	0.00017742529934530618	-1.9188547732241465	0.052251061085832565	2025_01_Batch_13-14	0.8930240841096873	0.9110751086339479	0.8882816334753623	0.9395293461461559	0.8243090951965234	0.8539948588305041	0.8535434769328026	0.8550420940281295	0.8552886373350626	0.7965256524057183	0.8735094714700957	0.8823092927833753	0.8716618637517459	0.8974089917406092	0.8104173738011209	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SDHD	SDHD				CCSBVarC023269	ALE00029761	NC_000011.10:112087905:T:G	101T>G	Phe34Cys	CAVA																											SDHD_Phe34Cys	11	112087905	T	G	11								1	1	1	11-112087905-T-G	-	0.47109	0.953	34	0	0	0	11	111958629	G	2.726030e-05	2	11	3_Conflicting	NC_000011.10	38	Phe34Cys	0	22.4	0	2	4.026310e-04	D	0	7	1	42768	3.376300e-05	1	30526	0.000000e+00	0	0.88724	Select	0.6593	14902	0.54293	2	0.0	T	D	64038	0.662533756427	7.183908045977011E-4	0	0.000000e+00	0	0	0.41709	17112	44890	0	0.000000e+00	0.96333	0	.	0.18151	0.939	7.564296520423601E-4	87.0	0.860814	.	0.13	G	single nucleotide variant	NC_000011.10:g.112087905T>G	0	16724	2	0.07223325	109398	0	0.08004188	0		8	236946	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0008192,MedGen:C3494181,OMIM:168000,Orphanet:29072|MedGen:C1868633;MONDO:MONDO:0014045,MedGen:CN166604,Orphanet:201;MONDO:MONDO:0011740,MedGen:C1847319,OMIM:606864,Orphanet:97286;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017366,MedGen:C1708353,Orphanet:29072|	5	0	0.000000e+00	0	0.52324	B	0.15552	P	M	3.345592	44	./.	114	0	7164	1614066	not specified|Hereditary cancer-predisposing syndrome|not provided|Paragangliomas 1|Paragangliomas with sensorineural hearing loss;Cowden syndrome 3;Carney-Stratakis syndrome;Pheochromocytoma|Hereditary pheochromocytoma-paraganglioma|SDHD-related disorder	16218	0.86189	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	112087905	4.187600e-04	-	5.897000	6	0.51065	29608	0	75038	0	germline	91088	.	.	GRCh38	635	criteria provided, conflicting classifications	c.101T>G	0.000000e+00	0.41042	2	0	0	.	0.000000e+00	9046	B	0	0.000000e+00	NM_003002.4(SDHD):c.101T>G (p.Phe34Cys)	1	0	DHSD_HUMAN	0	13.0	0.209532460011217	2	D	0.63627	0.08004188	+	4.187600e-04	0		6	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.96789	4.570470e-05	0	0.000000e+00	0	60030	p.Phe34Cys	0	0.50911	.	germline	3		T	Jan 23, 2025	0	./.	0	89558	1.0	N	11q23.1	9690	.	3.699590e-04	SCV000287810|SCV000675108|SCV001765234|SCV003928129|SCV004845023	Conflicting_classifications_of_pathogenicity	0	0	Cys	C	-	912	ENSP00000364699	ENST00000375549	17692	0.081	13416	0	0.665	T	0	3.395206	0.92967	D	T	-	3.443302	.	0.83237	610	0	0.0	0.13859	0	112087905	Y	10	0	102754	0.000000e+00	O14521	0	0.32663	0.57287		0	0.43	D	16218	0.07223325	7164	0.47934	6392	0.127906	0	-0.55	0.0	5.064100e-04	0.78662	0.000000e+00	0	75038	0.000000e+00	6060	3	0.15552	11	SDHD	5.064100e-04	0	Phe	14050	0.000000e+00	11-112087905-T-G	not_specified|Paragangliomas_1|not_provided|Pheochromocytoma|Carney-Stratakis_syndrome|Paragangliomas_with_sensorineural_hearing_loss|Cowden_syndrome_3|Hereditary_pheochromocytoma-paraganglioma|Hereditary_cancer-predisposing_syndrome	0	0	111463839	ClinGen:CA016754	0.736750	0.51422	0	RCV000122008|RCV000569765|RCV001545828|RCV003230259|RCV002228410|RCV003997358|RCV004748588	D	0	0	c.101T>G	0	0	0	0.66920	./.	rs141802836	112087905	14902	T	1.9968051118210862E-4	.	15690	0.18151	0.000000e+00	0.68239		0	0	0.000000e+00	2.3	0	0	264690	3.66	0.69546	112	T	T	6	6.552220e-05	0	26	segdup	0	0	29072|29072|97286|201|29072|140162	135196	0.85611	0.58709	0.116020513204259	2898	1	0.71675	0.68100	5.837710e-05	3.699590e-04	1179892	2.022	3.843860e-05	N	13384	0	1.2089614E-4	0	168000|171300|606864	0.40755	11	4.026310e-04	ENSG00000204370	0.000000e+00	0	0	0	0.5560470912091142	2	0.45391	0.64545	30608	32	0.000000e+00	4.997500e-05	0.250926334821979	YES	0.000000e+00	0.151246	138935	HGNC:10683	N	0	simple_aae	0.241	208124	112087905	TTT	1.000000	0	-	6.901311249137336E-4	0.62974	0.000000e+00	2	0	Conflicting classifications of pathogenicity	0.23555	0	0	3	ClinGen:CA016754	F	0	0.931227753352	-	.	-	0.70120	8	496	0.55343	0.521012783051	0.1996	0	0.99261210856720172	98	-	101T>G 	6	0	CN169374|C3494181|C3661900|C0031511|C1847319|C1868633|CN166604|C1708353|C0027672	0	0	0	0	NM_003002.4	-	0	0.0	0	0.58949	141802836	2320	1.4234875444839857E-4	0.92998	0.52455	0.622	0.157	2784	0.99037120	4.81	.	.	0.000000e+00	0.251929	0.144711279699783	0.65510	D	86	6212	9572	0.2199	0.88119	p.Phe34Cys	0	0	-3.982	0.53285825	38	0.46760	135196	T	30524	SDHD	1.168770e-04	D	0.691	21622	.	T	.	0.62996	./.	principal1																																																																																																				
SHOC2_Thr126Ile	-3.8344663468001308	0.010115727076797684	5.1294871749893645	0.3169389179619709																											SHOC2	SHOC2		11602		CCSBVarC028024		NC_000010.11:110964735:C:T		Thr126Ile																												SHOC2_Thr126Ile	10	110964735	C	T	10	allele	377C>T	D02	527_CAVA_Array_P06	G04	B13A7A8P2_R1	B14A7A8P2_R2				10-110964735-C-T	-	0.58691	0.002	126	0	0	0	10	112724493	T	1.734860e-05	1	10	2_Benign	NC_000010.11	26	Thr126Ile	0	24.0	0	6	5.369850e-04	D	0	4	.	42760	3.806400e-05	.	30524	0.000000e+00	0	0.42174	.	0.6836	14898	0.30905	1	.	T	T	64028	.	7.633587786259542E-4	0	0.000000e+00	0	0	0.86861	17098	44902	0	0.000000e+00	0.38336	0	.	0.36888	1.0	.	.	.	3.68	.	T	single nucleotide variant	NC_000010.11:g.110964735C>T	0	16730	2	0.1808663	109374	0	0.19923036	0		12	236444	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN169374|MedGen:CN230736	6	0	0.000000e+00	0	0.57141	B	0.41202	B	L	3.185969	28	C/C	298	0	7162	1613964	RASopathy|not specified|Cardiovascular phenotype	16212	0.85548	.	.	-	110964735	6.981290e-04	-	7.666000	11	0.59514	29604	0	74908	0	germline	91078	.	.	GRCh38	915	reviewed by expert panel	.	0.000000e+00	0.97294	6	0	0	.	0.000000e+00	9040	.	0	0.000000e+00	NM_007373.4(SHOC2):c.377C>T (p.Thr126Ile)	3	0	SHOC2_HUMAN	0	.	0.173017913604129	1	.	0.55823	0.16773851	+	6.981290e-04	.		11	0.000000e+00	0	34222	reviewed_by_expert_panel	0.53096	5.485760e-05	0	0.000000e+00	0	59986	.	0	0.64570	.	germline	5		C	Apr 18, 2017	0	C/C	0	89526	1.0	N	10q25.2	19808	.	6.785100e-04	SCV000616494	Likely_benign	0	0	Ile	I	-	912	ENSP00000509273	ENST00000688928	17684	.	13408	0	0.596	C	0	3.985377	0.28516	D	.	-	3.905095	.	0.67575	610	0	.	0.05736	0	110964735	Y	10	0	102336	0.000000e+00	Q9UQ13	0	0.185472	0.59264		0	0.011	D	16212	0.18350416	7162	0.97202	8036	-0.141771	0	.	.	3.470920e-04	0.32128	0.000000e+00	0	74908	0.000000e+00	6084	5	0.40774	10	SHOC2	3.470920e-04	0	Thr	31004	0.000000e+00	10-110964735-C-T	not_specified|Cardiovascular_phenotype|RASopathy	0	0	112714483	ClinGen:CA5689584	0.754523	0.49661	0	RCV000523425|RCV001255488|RCV002367725	.	0	0	c.377C>T	0	0	0	0.29253	C/C	rs138375593	110964735	14898	C	.	.	15690	0.41537	0.000000e+00	0.68239		0	0	0.000000e+00	1.445	0	0	264690	5.99	0.53617	146	T	D	8	3.279760e-05	0	26	.	0	0	536391	448932	0.67954	0.69312	0.0516940710911475	8158	.	0.71675	0.69326	2.922100e-05	6.785100e-04	1179980	6.109	5.768070e-05	.	13392	0	1.0200612E-4	0	.	0.71273	10	5.369850e-04	ENSG00000108061	0.000000e+00	0	0	0	.	2	0.34016	0.20912	30606	27	0.000000e+00	3.334110e-05	0.331430484968046	.	0.000000e+00	0.059523	442529	HGNC:15454	.	0	.	0.332	208042	110964735	ACA	1.000000	.	-	7.354743809757293E-4	0.19890	0.000000e+00	6	0	Likely benign	0.74628	0	0	2	ClinGen:CA5689584	T	0	.	-	.	-	0.47056	9	2032	0.36382	0.832102060318	.	0	0.993162836398918	104	-	377C>T 	8	0	CN169374|CN230736|C5555857	0	0	0	0	NM_007373.4	-	.	.	0	0.76748	138375593	2320	1.9352341633337633E-4	0.49718	0.57169	.	.	7860	0.02778220	5.99	.	.	0.000000e+00	-0.0327684	0.861928913801726	0.36203	D	120	6210	9560	0.1822	0.89030	p.Thr126Ile	0	0	-10.107	.	26	0.73739	448932	D	30490	SHOC2	5.848640e-05	D	.	21628	.	.	0.67565	0.33565	C/C	principal1																																																																																																				
FARS2_Gly309Ser	0.9477119419492293	1.0	-3.676692343777721	0.008971916021034814	2025_01_Batch_13-14	0.8870193180070034	0.8998650905263066	0.9351462181651714	0.9057682218651986	0.7143682582373676	0.5686633110620103	0.7744023055282723	0.8854617174445364	0.7654933384954046	0.5584482783869892	0.7278413145345068	0.8371336980272894	0.9103039678048539	0.8356307801803016	0.6364082683121783	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2		12653		CCSBVarC011917		NC_000006.12:5545200:G:A		Gly309Ser																												FARS2_Gly309Ser	6	5545200	G	A	6	allele	925G>A	H01	527_CAVA_Array_P03	P01	B13A7A8P1_R1	B14A7A8P1_R2				6-5545200-G-A	-	0.87878	1.0	309	.	0	.	6	5545433	A	1.239360e-06	.	6	1_Pathogenic	NC_000006.12	1	Gly309Ser	.	29.4	.	.	.	D	0	4	1	.	.	.	.	.	.	0.96643	Select	0.5964	.	0.90580	.	.	T	D	64020	.	.	0	.	.	.	0.52451	.	44878	0	.	0.82599	.	.	0.87992	0.947	.	0.0	0.986551	.	1.0	A	single nucleotide variant	NC_000006.12:g.5545200G>A	0	.	2	0.7646657	.	.	0.8830356	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	.	.	0.000000e+00	0	0.99291	D	0.86915	D	H	9.876117	2	G/G	.	.	.	1613742	not provided|Combined oxidative phosphorylation defect type 14	.	0.88971	.	.	-	5545200	.	-	11.605000	.	0.92066	29600	.	75024	.	germline;unknown	91016	Loss of sheet (P = 0.0817)| Gain of disorder (P = 0.1887)| Gain of loop (P = 0.2045)| Loss of catalytic residue at L314 (P = 0.2562)| Gain of MoRF binding (P = 0.4653)	0.95637	GRCh38	982	criteria provided, multiple submitters, no conflicts	c.925G>A	.	0.73761	.	.	.	Aminoacyl-tRNA synthetase, class II	.	.	A	.	0.000000e+00	NM_006567.5(FARS2):c.925G>A (p.Gly309Ser)	2	.	SYFM_HUMAN	.	100.0	0.851669104685455	.	D	0.63025	0.86086655	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.94244	.	0	.	.	59968	p.Gly309Ser	0	0.93514	.	germline	.		G	Feb 23, 2023	.	G/G	.	.	1.0	N	6p25.1	.	.	.	SCV000845713|SCV001248521|SCV001582544|SCV003842096	Pathogenic/Likely_pathogenic	.	.	Ser	S	-	912	ENSP00000274680	ENST00000274680	.	0.006	.	.	0.676	G	.	5.233765	0.67073	D	D	-	8.543429	.	0.92707	.	.	.	0.94233	.	5545200	Y	10	.	.	0.000000e+00	O95363	.	0.449003	0.96592		.	1.0	D	.	0.78077585	.	0.4917	10667	0.390908	1	-5.03	.	1.332910e-05	0.61594	.	.	75024	.	6058	.	0.85927	6	FARS2	1.332910e-05	.	Gly	.	.	6-5545200-G-A	Combined_oxidative_phosphorylation_defect_type_14|not_provided	0	.	5490432	.	0.940941	0.89143	0	RCV001092144|RCV000714943	D	0	.	c.925G>A	.	0	0	0.89307	G/G	rs746746116	5545200	.	G	.	O95363	.	0.89777	.	0.68239		.	.	0.000000e+00	3.685	.	.	.	5.27	0.78909	.	D	T	.	.	.	.	.	.	.	319519	587672	0.89172	0.58884	0.998481690883636	.	.	0.71675	0.94336	.	.	1179784	9.507	.	D	.	.	.	.	614946	0.96998	6	.	ENSG00000145982	0.000000e+00	.	.	.	.	1	0.97365	0.03399	.	.	.	0.000000e+00	0.738735397986046	YES	0.000000e+00	0.369966	578624	HGNC:21062	A	.	simple_aae	0.855	.	5545200	GGC	1.000000	.	-	.	0.97630	8.476130e-07	.	0	Pathogenic/Likely pathogenic	0.74812	.	0	0	ClinGen:CA362736415	G	.	0.888883061527	-	0.858	-	0.95504	.	.	0.92879	0.59725445509	0.436	0	0.99892301299548369	.	-	925G>A 	.	.	C4755312|C3661900	.	.	.	.	NM_006567.5	-	.	.	1	0.95437	746746116	.	.	0.88693	0.85233	0.947	0.009	.	0.96428716	5.27	.	.	.	0.323736	0.990712134343876	0.94401	D	.	.	.	0.3946	0.85552	p.Gly309Ser	.	0	-10.138	0.9779998	1	0.88703	587672	D	.	FARS2	.	D	0.885	.	G309S	D	.	0.76753	G/G	principal1																																																																																																				
FARS2_Gly309Ser	0.9477119419492293	1.0	-3.676692343777721	0.008971916021034814	2025_01_Batch_13-14	0.8870193180070034	0.8998650905263066	0.9351462181651714	0.9057682218651986	0.7143682582373676	0.5686633110620103	0.7744023055282723	0.8854617174445364	0.7654933384954046	0.5584482783869892	0.7278413145345068	0.8371336980272894	0.9103039678048539	0.8356307801803016	0.6364082683121783	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FARS2	FARS2				CCSBVarC011917	ALE00014428	NC_000006.12:5545200:G:A	925G>A	Gly309Ser	CAVA																											FARS2_Gly309Ser	6	5545200	G	A	6								1	1	1	6-5545200-G-A	-	0.87878	1.0	309	.	0	.	6	5545433	A	1.239360e-06	.	6	1_Pathogenic	NC_000006.12	1	Gly309Ser	.	29.4	.	.	.	D	0	4	1	.	.	.	.	.	.	0.96643	Select	0.5964	.	0.90580	.	.	T	D	64020	.	.	0	.	.	.	0.52451	.	44878	0	.	0.82599	.	.	0.87992	0.947	.	0.0	0.986551	.	1.0	A	single nucleotide variant	NC_000006.12:g.5545200G>A	0	.	2	0.7646657	.	.	0.8830356	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0013986,MedGen:C4755312,OMIM:614946,Orphanet:319519	.	.	0.000000e+00	0	0.99291	D	0.86915	D	H	9.876117	2	G/G	.	.	.	1613742	not provided|Combined oxidative phosphorylation defect type 14	.	0.88971	.	.	-	5545200	.	-	11.605000	.	0.92066	29600	.	75024	.	germline;unknown	91016	Loss of sheet (P = 0.0817)| Gain of disorder (P = 0.1887)| Gain of loop (P = 0.2045)| Loss of catalytic residue at L314 (P = 0.2562)| Gain of MoRF binding (P = 0.4653)	0.95637	GRCh38	982	criteria provided, multiple submitters, no conflicts	c.925G>A	.	0.73761	.	.	.	Aminoacyl-tRNA synthetase, class II	.	.	A	.	0.000000e+00	NM_006567.5(FARS2):c.925G>A (p.Gly309Ser)	2	.	SYFM_HUMAN	.	100.0	0.851669104685455	.	D	0.63025	0.86086655	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.94244	.	0	.	.	59968	p.Gly309Ser	0	0.93514	.	germline	.		G	Feb 23, 2023	.	G/G	.	.	1.0	N	6p25.1	.	.	.	SCV000845713|SCV001248521|SCV001582544|SCV003842096	Pathogenic/Likely_pathogenic	.	.	Ser	S	-	912	ENSP00000274680	ENST00000274680	.	0.006	.	.	0.676	G	.	5.233765	0.67073	D	D	-	8.543429	.	0.92707	.	.	.	0.94233	.	5545200	Y	10	.	.	0.000000e+00	O95363	.	0.449003	0.96592		.	1.0	D	.	0.78077585	.	0.4917	10667	0.390908	1	-5.03	.	1.332910e-05	0.61594	.	.	75024	.	6058	.	0.85927	6	FARS2	1.332910e-05	.	Gly	.	.	6-5545200-G-A	Combined_oxidative_phosphorylation_defect_type_14|not_provided	0	.	5490432	.	0.940941	0.89143	0	RCV001092144|RCV000714943	D	0	.	c.925G>A	.	0	0	0.89307	G/G	rs746746116	5545200	.	G	.	O95363	.	0.89777	.	0.68239		.	.	0.000000e+00	3.685	.	.	.	5.27	0.78909	.	D	T	.	.	.	.	.	.	.	319519	587672	0.89172	0.58884	0.998481690883636	.	.	0.71675	0.94336	.	.	1179784	9.507	.	D	.	.	.	.	614946	0.96998	6	.	ENSG00000145982	0.000000e+00	.	.	.	.	1	0.97365	0.03399	.	.	.	0.000000e+00	0.738735397986046	YES	0.000000e+00	0.369966	578624	HGNC:21062	A	.	simple_aae	0.855	.	5545200	GGC	1.000000	.	-	.	0.97630	8.476130e-07	.	0	Pathogenic/Likely pathogenic	0.74812	.	0	0	ClinGen:CA362736415	G	.	0.888883061527	-	0.858	-	0.95504	.	.	0.92879	0.59725445509	0.436	0	0.99892301299548369	.	-	925G>A 	.	.	C4755312|C3661900	.	.	.	.	NM_006567.5	-	.	.	1	0.95437	746746116	.	.	0.88693	0.85233	0.947	0.009	.	0.96428716	5.27	.	.	.	0.323736	0.990712134343876	0.94401	D	.	.	.	0.3946	0.85552	p.Gly309Ser	.	0	-10.138	0.9779998	1	0.88703	587672	D	.	FARS2	.	D	0.885	.	G309S	D	.	0.76753	G/G	principal1																																																																																																				
BAP1_Arg59Pro	-2.590423379221777	0.037552604621238606	-6.724527061687109	0.0006642771727354712	2025_01_Batch_13-14	0.5309453839443147	0.7984598136944672	0.8843641487311844	0.8386750927350094	0.5029391190634009	0.7760629629165843	0.8643465275670094	0.9072409208963593	0.9068011608930485	0.6600366828700539	0.6535041734304494	0.8314031706307383	0.8958025348137719	0.872738126814029	0.5814879009667274	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009502		NC_000003.12:52408553:C:G		Arg59Pro																												BAP1_Arg59Pro	3	52408553	C	G	3	allele	176G>C	G02	527_CAVA_Array_P01	M03	B13A7A8P1_R1	B14A7A8P1_R2				3-52408553-C-G	-	0.91776	1.0	59	.	.	.	3	52442569	G	.	.	3	1_Pathogenic	NC_000003.12	.	Arg59Pro	.	32.0	.	.	.	T	.	1	1	.	.	.	.	.	.	0.79231	Select	0.3193	.	0.90580	.	.	T	D	.	3.06138964259	.	.	.	.	.	0.89405	.	.	.	.	0.91119	.	.	0.98358	0.98	.	.	0.983202	.	.	G	single nucleotide variant	NC_000003.12:g.52408553C>G	.	.	2	0.9540301	.	.	0.9713552	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926	.	.	.	.	.	D	0.98616	D	M	8.550095	.	C/C	.	.	.	.	Neurodevelopmental disorder	.	0.69867	.	.	-	52408553	.	-	7.674000	.	0.83697	.	.	.	.	de novo	.	Gain of glycosylation at S58 (P = 0.0035)| Loss of MoRF binding (P = 0.0099)| Gain of relative solvent accessibility (P = 0.0166)| Gain of loop (P = 0.0435)| Gain of ubiquitination at K61 (P = 0.0519)	0.49015	GRCh38	68	no assertion criteria provided	c.176G>C	.	0.78977	.	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	.	.	P	.	.	NM_004656.4(BAP1):c.176G>C (p.Arg59Pro)		.	BAP1_HUMAN	.	.	0.78803106441148	.	D	0.96455	0.9713552	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.99461	.	.	.	.	.	p.Arg59Pro	.	0.64997	.	germline	.		C	Jun 22, 2021	.	C/C	.	.	1.0	N	3p21.1	.	.	.	SCV001738371	Pathogenic	.	.	Pro	P	-	.	ENSP00000417132	ENST00000460680	.	0.033	.	.	0.599	C	.	5.519378	0.69466	D	D	-	9.704019	.	0.73409	.	.	.	0.72163	.	52408553	Y	10	.	.	.	Q92560	.	0.266761	0.90069		.	1.0	D	.	0.9540301	.	0.58201	8314	0.213371	.	-6.28	.	.	0.44516	.	.	.	.	.	.	0.98617	3	BAP1	.	.	Arg	.	.	3-52408553-C-G	Neurodevelopmental_disorder	.	.	52417609	.	0.969708	0.85268	.	RCV001797186	D	.	.	c.176G>C	.	.	.	0.74962	C/C	rs1298276806	52408553	.	C	.	Q92560	.	0.98358	.	0.68239		.	.	.	2.33	.	.	.	5.43	0.63670	.	D	D	.	.	.	.	.	.	.	.	1173080	0.74637	0.99302	0.978495126974096	.	.	0.71675	0.99205	.	.	.	7.867	.	D	.	.	.	.	.	0.85526	3	.	ENSG00000163930	.	.	.	.	0.8990698988239344	2	0.97365	0.97129	.	.	.	.	0.78537237783733	YES	.	0.080609	1162265	HGNC:950	.	.	.	0.706	.	52408553	CGG	1.000000	.	-	.	0.74462	.	.	.	Pathogenic	0.98086	.	.	.	ClinGen:CA353113466	R	.	0.836624110132	-	0.438	-	0.73344	.	.	0.89814	0.848732292652	0.9967	.	0.99817551053923181	.	-	176G>C 	.	.	C1535926	.	.	.	.	NM_004656.4	-	.	.	1	0.94307	1298276806	.	.	0.83377	0.88696	0.734	0.019	.	0.99953306	5.43	.	.	.	0.0687164	0.99866373685461	0.66629	T	.	.	.	-0.4620	0.68734	p.Arg59Pro	.	.	-16.228	0.73717695	.	0.94835	1173080	D	.	BAP1	.	D	0.516	.	R59P	D	.	0.40292	C/C	principal1																																																																																																				
BRIP1_Gln255His	0.732346824162546	0.5112396507139866	-0.835991169340316	0.2657296745339543	2025_01_Batch_13-14	0.7502156437554367	0.7841145318724635	0.8066482874246345	0.7927843692248923	0.6969966491731286	0.8171288577429178	0.8116297048057426	0.782100385457583	0.8591976244199683	0.7232732673439862	0.7836722507491772	0.7978721183391031	0.7943743364411087	0.8259909968224303	0.7101349582585574	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRIP1	BRIP1		55128		CCSBVarC031354		NC_000017.11:61808620:C:A		Gln255His																												BRIP1_Gln255His	17	61808620	C	A	17	allele	765G>T	B01	527_CAVA_Array_P02	C02	B13A7A8P1_R1	B14A7A8P1_R2				17-61808620-C-A	-	0.73515	1.0	255	.	.	.	17	59885981	A	.	.	17	1_Pathogenic	NC_000017.11	.	Gln255His	.	26.0	.	.	.	D	.	1	.	.	.	.	.	.	.	0.93600	.	0.6879	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.70000	.	.	.	.	0.79862	.	.	0.94071	0.999	.	.	0.918508	.	.	A	single nucleotide variant	NC_000017.11:g.61808620C>A	.	.	2	0.88003564	.	.	0.92846745	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0012187,MedGen:C1836860,OMIM:609054,Orphanet:84	.	.	.	.	0.90832	D	0.94458	D	H	10.51746	.	C/C	.	.	.	.	Fanconi anemia complementation group J	.	0.91558	.	.	-	61808620	.	-	5.995000	.	0.85485	.	.	.	.	germline	.	Gain of phosphorylation at T252 (P = 0.1383)| Gain of catalytic residue at K254 (P = 0.178)| Loss of methylation at K254 (P = 0.1938)| Loss of disorder (P = 0.2059)| Gain of helix (P = 0.2294)	0.98298	GRCh38	46	no assertion criteria provided	.	.	0.74394	.	.	.	.	.	.	.	.	.	NM_032043.3(BRIP1):c.765G>T (p.Gln255His)		.	FANCJ_HUMAN	.	.	0.878838601052151	.	D	0.97151	0.9292196	-	.	.		.	.	2	.	no_assertion_criteria_provided	0.96574	.	.	.	.	.	.	.	0.52465	.	germline	.		C	Feb 07, 2011	.	C/C	.	.	1.0	N	17q23.2	.	.	.	SCV001364483	Pathogenic	.	.	His	H	-	.	ENSP00000506943	ENST00000682453	.	.	.	.	0.549	C	.	4.62463	0.76775	D	.	-	9.820491	.	0.88077	.	.	.	0.96939	.	61808620	Y	9	.	.	.	Q9BX63	.	0.799612	0.85348		.	0.999	D	.	0.8937532	.	0.91597	83990	0.393787	.	.	.	.	0.91343	.	.	.	.	.	.	0.93477	17	BRIP1	.	.	Gln	.	.	17-61808620-C-A	Fanconi_anemia_complementation_group_J	.	.	57240763	.	0.713631	0.90632	.	RCV001194716	.	.	.	c.765G>T	.	.	.	0.89480	C/C	rs2078111971	61808620	.	C	.	Q9BX63	.	0.93994	.	0.68239		.	.	.	4.365	.	.	.	5.29	0.94832	.	D	T	.	.	.	.	.	.	.	84	929523	0.89348	0.58020	0.999322414398193	.	.	0.71675	0.66516	.	.	.	4.371	.	.	.	.	.	.	609054	0.5938	17	.	ENSG00000136492	.	.	.	.	.	3	0.92348	0.97740	.	.	.	.	0.789515383178468	.	.	0.227769	917865	HGNC:20473	.	.	.	0.738	.	61808620	CAG	1.000000	.	-	.	0.98250	.	.	.	Pathogenic	0.94021	.	.	.	ClinGen:CA400484955	Q	.	.	-	0.913	-	0.99419	.	.	0.96706	0.720037281513	.	.	0.99764672733639892	.	-	765G>T 	.	.	C1836860	.	.	.	.	NM_032043.3	-	.	.	1	0.70644	2078111971	.	.	0.97798	0.88995	.	.	.	0.98894000	5.29	.	.	.	0.327871	0.999870395781411	0.98493	D	.	.	.	0.5765	0.89189	p.Gln255His	.	.	-14.306	.	.	0.98499	929523	D	.	BRIP1	.	D	.	.	Q255H	.	.	0.27038	C/C	principal2																																																																																																				
SHOC2_Ile112Thr	-1.6941158363159368	0.13407053946967112	2.63387004383908	0.03372243975123364	2025_01_Batch_13-14	0.7843858644027072	0.8124825875291124	0.6855686887880554	0.720513982024652	0.7232494537137047	0.6900349759264535	0.7668552704562939	0.6730345003121042	0.8693878114030118	0.5810832363777728	0.7372104201645804	0.7896689289927031	0.6793015945500798	0.7949508967138319	0.6521663450457388	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											
BRAF_Lys499Asn	-4.944762682826767	0.0016661142958100037	5.574798126697147	0.0008377883870810507	2025_01_Batch_13-14	0.6633039561986507	0.6996246581318293	0.7713521227339928	0.7623872845325846	0.5442598720342052	0.6615102294809463	0.7097992368420202	0.7316570262664239	0.6880806223967423	0.5794403314132704	0.6624070928397985	0.7047119474869248	0.7515045745002084	0.7252339534646635	0.5618501017237378	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003166		NC_000007.14:140778011:T:G		Lys499Asn																												BRAF_Lys499Asn	7	140778011	T	G	7	allele	1497A>C	E04	527_CAVA_Array_P01	I07	B13A7A8P1_R1	B14A7A8P1_R2				7-140778011-T-G	-	0.69029	0.947	499	.	.	.	7	140477811	G	.	.	7	1_Pathogenic	NC_000007.14	.	Lys499Asn	.	25.3	.	.	.	D	.	3	.	.	.	.	.	.	.	0.88818	Select	0.5198	.	0.53490	.	.	D	D	.	.	.	.	.	.	.	0.97749	.	.	.	.	.	.	.	0.98171	1.0	.	.	0.958804	4.21	.	G	single nucleotide variant	NC_000007.14:g.140778011T>G	.	.	2	0.9186677	.	.	0.97060555	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	.	.	.	.	0.97926	P	0.96252	P	L	3.421713	.	T/T	.	.	.	.	not provided|Cardio-facio-cutaneous syndrome	.	0.84236	.	.	-	140778011	.	-	4.195000	.	0.99294	.	.	.	.	de novo;germline;unknown	.	Loss of methylation at K499 (P = 0.0305)| Loss of MoRF binding (P = 0.0517)| Loss of ubiquitination at K499 (P = 0.0546)| Gain of helix (P = 0.2059)| Gain of disorder (P = 0.292)	0.97257	GRCh38	776	criteria provided, multiple submitters, no conflicts	c.1497A>C	.	0.65108	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1497A>C (p.Lys499Asn)	2	.	BRAF_HUMAN	.	.	0.22632943565752	.	D	0.99393	0.9693646	-	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.97865	.	.	.	.	.	p.Lys499Asn	.	0.42508	.	germline	.		T	Jul 23, 2015	.	T/T	.	.	1.0	N	7q34	.	.	.	SCV000057218|SCV000263064	Pathogenic/Likely_pathogenic	.	.	Asn	N	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.605	T	.	4.441576	.	D	.	-	3.728117	.	0.80658	.	.	.	0.87648	.	140778011	Y	10	.	.	.	P15056	.	0.824469	0.94371		.	0.688	D	.	0.9186677	.	0.97202	673	0.110668	.	.	.	.	.	.	.	.	.	.	.	0.96252	7	BRAF	.	.	Lys	.	.	7-140778011-T-G	Cardio-facio-cutaneous_syndrome|not_provided	.	.	140124280	ClinGen:CA281974|UniProtKB:P15056#VAR_058625	0.620121	0.52240	.	RCV000207509|RCV001814021	D	.	.	c.1497A>C	.	.	.	0.65175	T/T	rs397507476	140778011	.	T	.	P15056	.	0.98288	.	0.68239		.	.	.	0.965	.	.	.	4.96	0.95710	.	D	D	.	.	.	.	.	.	.	1340	40371	0.64743	0.95599	0.9956134557724	.	.	0.71675	0.60389	.	.	.	3.119	.	.	.	.	.	.	PS115150	0.50212	7	.	ENSG00000157764	.	.	.	.	.	3	0.53696	0.48248	.	.	.	.	0.30192289424299	YES	.	0.1256	48841	HGNC:1097	.	.	.	0.98	.	140778011	AAA	1.000000	.	-	.	0.93596	.	.	.	Pathogenic/Likely pathogenic	0.89071	.	.	.	ClinGen:CA281974,UniProtKB:P15056#VAR_058625	K	.	.	-	0.889	-	.	.	.	0.87500	0.913059830666	0.9993	.	0.99865938726691972	.	-	1497A>C 	.	.	C1275081|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.84469	397507476	.	.	0.81448	0.55416	.	.	.	0.99575126	4.96	.	.	.	-0.078809	0.999246574469187	0.23851	D	.	.	.	0.1071	0.81988	p.Lys499Asn	.	.	-12.924	0.9434156	.	0.96052	40371	D	.	BRAF	.	T	.	.	K499N	.	0.80015	0.46302	T/T	principal4																																																																																																				
BAP1_Ser596Gly	0.351957833731541	0.7352272520962135	0.8767858936876382	0.40968206922602535	2025_01_Batch_13-14	0.5532073414376034	0.6796596792339478	0.5646293238417727	0.5627001908311333	0.5423182660052609	0.48790658287507727	0.5160948709558142	0.48137670979594915	0.4605114732564167	0.5044037424813426	0.5205569621563404	0.597877275094881	0.5230030168188609	0.5116058320437751	0.5233610042433017	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009473		NC_000003.12:52403242:T:C		Ser596Gly																												BAP1_Ser596Gly	3	52403242	T	C	3	allele	1786A>G	F01	527_CAVA_Array_P01	K01	B13A7A8P1_R1	B14A7A8P1_R2				3-52403242-T-C	-	0.12883	0.0	596	42	32	40	3	52437258	C	4.433240e-03	122	3	2_Benign	NC_000003.12	5750	Ser596Gly	0	9.376	0	681	7.435240e-02	T	242	14	1	42768	5.880120e-03	132	30526	1.293100e-03	9	0.12499	Select	0.0022	14902	0.02950	203	0.0	T	T	64004	0.342242573836	0.07073120066472788	242	1.567070e-03	0	40	0.07963	17112	44884	15	0.000000e+00	0.15507	20	.	0.02742	0.339	0.09984871406959153	98.0	0.556544	0.733	0.02	C	single nucleotide variant	NC_000003.12:g.52403242T>C	0	16712	2	0.042524464	109386	0	0.023078172	0		1445	236900	18	18	0.000000e+00	812	4.676390e-04	29	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0011696,MedGen:C1847723,OMIM:606661,Orphanet:39044|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MedGen:C3661900	683	0	0.000000e+00	0	0.08015	B	0.02755	B	L	0.3647541	7156	T/T	370	79	7164	1614170	not specified|Hereditary cancer-predisposing syndrome|Melanoma, uveal, susceptibility to, 2|BAP1-related tumor predisposition syndrome|not provided	16216	0.11740	2	.	-	52403242	7.467900e-02	-	0.443000	1203	0.04173	29608	0.008637236084452975	75034	0	germline;unknown	91084	.	.	GRCh38	68	criteria provided, multiple submitters, no conflicts	c.1786A>G	6.551790e-05	0.10740	894	0	7	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	0.000000e+00	9046	B	0	1.080790e-03	NM_004656.4(BAP1):c.1786A>G (p.Ser596Gly)	2	0	BAP1_HUMAN	0	2.0	-1.03807936463251	175	T	0.02645	0.030649683	-	7.467900e-02	0		1203	1.127210e-03	0	34250	criteria_provided,_multiple_submitters,_no_conflicts	0.96067	6.243940e-03	250	0.000000e+00	0	60032	p.Ser596Gly	0	0.18516	.	germline	535		T	Mar 04, 2025	2	T/T	43	89532	0.001	N	3p21.1	190482	.	7.418600e-02	SCV000310599|SCV000445464|SCV000518938|SCV000563727|SCV000602623|SCV000664595|SCV000682598|SCV002046889|SCV002537267|SCV002550709|SCV004016329|SCV005306435|SCV005404611	Benign	0	15	Gly	G	-	912	ENSP00000417132	ENST00000460680	17692	0.393	13416	40	-0.12	T	0	0.911982	0.14890	N	T	-	0.6318495	.	.	1042	0	9.940357852882703E-4	0.00003	0	52403242	Y	10	0.02586206896551724	102730	5.938630e-03	Q92560	0	0.019939	0.11964		18	0.0	.	16216	0.035254005	7164	0.25458	8314	-0.690695	484	0.01	0.0	7.663190e-02	0.10794	0.000000e+00	0	75034	0.000000e+00	6062	535	0.05097	3	BAP1	7.663190e-02	0	Ser	226930	4.691060e-04	3-52403242-T-C	not_specified|Hereditary_cancer-predisposing_syndrome|BAP1-related_tumor_predisposition_syndrome|Melanoma,_uveal,_susceptibility_to,_2|not_provided	0	50	52412298	ClinGen:CA157253	0.066346	0.07730	1	RCV000120192|RCV000569518|RCV003315731|RCV000396271|RCV003654201	T	0	0	c.1786A>G	0	1	0	0.00040	T/T	rs79014342	52403242	14902	T	0.026956869009584664	.	15690	0.01012	0.000000e+00	0.25517		0	0	2.227970e-05	1.39	0.07837837837837838	75	264690	-0.682	0.15680	6360	T	T	1108	5.735070e-03	21	1850	.	43	0	140162|289539|39044	133664	0.05120	0.35868	0.000335560480817249	9998	135	0.13799	0.12810	5.927010e-03	7.418600e-02	1180040	0.015	6.944710e-03	N	13372	43	0.02470815	0	614327|606661	0.13291	3	7.435240e-02	ENSG00000163930	0.000000e+00	3.937379909912748E-4	2	0	0.27734753240827054	1	0.01384	0.97129	30608	6540	4.867130e-04	6.979610e-03	-0.89131888610997	YES	1.646830e-04	.	137403	HGNC:950	P	0	simple_aae	0.024	208072	52403242	AGC	0.545000	0	-	0.07101420284056811	0.00018	4.101560e-04	710	0	Benign	0.24393	0	36	419	ClinGen:CA157253	S	0	0.40146981186	-	.	-	0.10867	1393	17940	0.27451	0.283363044262	0.0674	1	0.77187842073536805	296	-	1786A>G 	1108	0.004403567447045708	CN169374|C0027672|C3280492|C1847723|C3661900	0	0	3	0	NM_004656.4	-	1	0.002881844380403458	0	0.19051	79014342	2320	0.0039395408275679725	0.39360	0.12086	0.119	0.485	9628	0.98504820	5.94	.	.	6.534240e-05	-0.70984	0.0411517187189644	0.34781	T	4510	6210	9572	-1.0601	0.00700	p.Ser596Gly	0	0	-4.038	0.0015929043	5750	0.35503	133664	T	30514	BAP1	7.129500e-03	T	0.046	21610	.	T	0.26955	0.14111	T/T	principal1																																																																																																				
BRCA1_Val275Ile	-0.4219542876087648	0.6857151825709713	2.6645481179410244	0.03225365624269281	2025_01_Batch_13-14	0.7971938108459706	0.9154008456443704	0.7399972816189054	0.7702698951602724	0.6222736911823423	0.9934358013689744	0.9575499119286874	0.9609089410020877	0.9940636425450285	0.9210876525622533	0.8953148061074725	0.936475378786529	0.8504531113104965	0.8821667688526504	0.7716806718722978	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC013078		NC_000017.11:43090997:C:T		Val275Ile																												BRCA1_Val275Ile	17	43090997	C	T	17	allele	823G>A	H10	527_CAVA_Array_P01	O19	B13A7A8P1_R1	B14A7A8P1_R2				17-43090997-C-T	-	0.03572	0.001	1378	5	1	0	17	41243014	T	1.016910e-04	16	17	2_Benign	NC_000017.11	89	Val1378Ile	1	0.688	1	0	1.000180e-03	T	1	18	1	42360	1.747390e-04	.	30142	0.000000e+00	0	0.78048	Select	0.3134	33994	0.32504	34	.	T	T	63834	.	0	0	0.000000e+00	0	1	0.01019	16980	44890	5	7.476080e-05	0.09903	2	.	0.00205	0.529	.	99.0	.	-6.06	0.01	T	single nucleotide variant	NC_000017.11:g.43090997C>T	0	16568	2	0.02649676	108190	0	0.019548856	0		27	234636	0	0	5.666360e-05	498	4.721440e-05	0	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	19	0	0.000000e+00	0	0.13669	B	0.01070	B	N	0.1210794	164	C/C	114	0	6938	1612732	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|not provided|Malignant tumor of breast|BRCA1-related cancer predisposition	15900	0.59072	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43090997	9.422850e-04	-	0.284000	0	0.23719	29506	0	59814	1	germline;unknown	90788	.	.	GRCh38	519	reviewed by expert panel	c.4132G>A	6.635260e-05	0.14242	2	0	0	.	0.000000e+00	9016	B	0	3.389140e-05	NM_007294.4(BRCA1):c.4132G>A (p.Val1378Ile)	3	0	BRCA1_HUMAN	1	1.0	-1.3898584281667	18	.	0.07209	0.016553821	-	0.000000e+00	.		18	0.000000e+00	0	33994	reviewed_by_expert_panel	0.94286	1.756170e-04	1	0.000000e+00	0	59814	p.Val1378Ile	0	0.16868	.	germline	16		C	Jun 18, 2019	2	C/C	0	88838	0.0	N	17q21.31	26660	.	0.000000e+00	SCV001161590	Benign	0	0	Ile	I	-	912	ENSP00000350283	ENST00000357654	17648	0.214	13376	1	-2.609	C	0	-0.113362	0.32573	N	T	-	0.1960024	.	0.73121	628	0	.	0.00420	0	43090997	Y	10	0	101906	6.574620e-04	P38398	0	0.079098	0.11882		0	0.0	D	30256	0.028340364	16980	0.2973	672	-0.262208	61	-0.03	.	1.487950e-03	0.26644	0.000000e+00	0	74898	1.109140e-04	6084	0	0.00748	17	BRCA1	1.335150e-05	0	Val	36082	5.628220e-05	17-43090997-C-T	Malignant_tumor_of_breast|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	0	4	38496540	ClinGen:CA002653|UniProtKB:P38398#VAR_070487	0.095446	0.02705	0	RCV000048456|RCV000112269|RCV000130952|RCV000195345|RCV000735522|RCV000588834|RCV001353555|RCV004803994	T	0	0	c.4132G>A	0	1	0	0.12388	C/C	rs28897690	43090997	14596	C	.	.	15500	0.00487	0.000000e+00	0.21036		0	0	2.227670e-05	-0.69	0	2	264690	0.167	0.35782	146	T	T	0	5.949230e-04	0	26	.	0	0	145|145|140162	55111	0.53787	0.07277	0.0166096592434054	3350	.	0.06393	0.19078	1.000180e-03	5.949230e-04	1179578	-0.366	1.310290e-04	N	13288	0	4.873626E-4	0	604370	0.07635	17	0.000000e+00	ENSG00000012048	0.000000e+00	7.501875468867217E-5	2	0	.	1	0.18137	0.74474	30224	129	3.925190e-05	1.487950e-03	-1.32035774990261	YES	5.507340e-05	0.079338	69778	HGNC:1100	N	0	simple_aae	0.084	206062	43090997	GTC	0.024000	.	-	0	0.00272	5.171340e-05	0	0	Benign	0.23134	0	4	89	ClinGen:CA002653,UniProtKB:P38398#VAR_070487	V	0	0.158396225186	-	.	-	0.22590	41	4696	0.03344	0.214491963387	0.0686	1	0.76991446859715706	104	-	4132G>A 	34	0	C0006142|CN169374|C3661900|C0677776|CN221562|C2676676|C0027672	0	0	0	0	NM_007294.4	-	.	.	0	0.29041	28897690	2220	5.542929992794191E-5	0.15034	0.04105	0.195	0.235	3236	0.96491360	4.66	.	.	6.617260e-05	-0.205768	0.000385430296663524	0.01960	T	120	6090	9436	-0.7244	0.68210	p.Val1378Ile	0	0	-3.941	0.012888253	1	0.05956	55111	T	30256	BRCA1	9.422850e-04	T	0.497	21354	.	T	0.02993	0.00233	C/C	principal2																																																																																																				
RAD51D_Ile251Val	0.7776406398453396	0.4622488886013073	4.73346535387811	0.0021239643067238714	2025_01_Batch_13-14	0.9995217075101795	0.9534029604719589	0.931935185443018	0.942729026977195	0.9995249189219388	0.8034463122456237	0.9634776583088173	0.9860059425467218	0.9610438469712425	0.6815422778313502	0.9014840098779016	0.9584403093903882	0.9589705639948699	0.9518864369742187	0.8405335983766445	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024857		NC_000017.11:35101353:T:C		Ile251Val																												RAD51D_Ile251Val	17	35101353	T	C	17	allele	751A>G	B02	527_CAVA_Array_P05	C03	B13A7A8P2_R1	B14A7A8P2_R2				17-35101353-T-C	-	0.03972	0.0	251	1	0	0	17	33428372	C	4.337320e-06	0	17	3_Conflicting	NC_000017.11	1	Ile251Val	0	0.888	0	0	9.733310e-06	T	0	4	1	42762	4.226580e-06	.	30524	0.000000e+00	0	0.20265	Select	0.0599	102740	0.02950	0	.	T	T	63756	.	0	0	0.000000e+00	0	0	.	17110	44890	1	0.000000e+00	0.05782	0	.	0.00166	0.946	.	94.0	.	-5.59	0.06	C	single nucleotide variant	NC_000017.11:g.35101353T>C	0	16402	2	0.02370252	109058	0	0.015923232	0		1	236598	0	0	0.000000e+00	0	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	0	0	0.000000e+00	0	0.18971	B	0.00388	B	N	0.2220042	7	T/T	8	1	7158	1613900	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	16206	0.39436	.	.	-	35101353	.	-	-2.070000	0	0.01428	29608	0	6060	0	germline	91084	Gain of phosphorylation at T248 (P = 0.0936)| Gain of disorder (P = 0.0983)| Gain of MoRF binding (P = 0.1184)| Gain of methylation at R255 (P = 0.2396)| Loss of stability (P = 0.2941)	0.54885	GRCh38	911	criteria provided, conflicting classifications	c.751A>G	0.000000e+00	0.03894	1	0	0	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	0.000000e+00	9046	LB	0	0.000000e+00	NM_002878.4(RAD51D):c.751A>G (p.Ile251Val)	1	0	RA51D_HUMAN	0	6.0	-1.20699475414867	0	.	0.04993	0.015923232	-	0.000000e+00	.		1	0.000000e+00	0	34258	criteria_provided,_conflicting_classifications	0.74518	0.000000e+00	0	0.000000e+00	0	60020	p.Ile251Val	0	0.04280	.	germline	.		T	Jun 23, 2024	0	T/T	0	89534	0.881	N	17q12	6062	.	0.000000e+00	SCV000184576|SCV000293833|SCV000651777|SCV000904087	Conflicting_classifications_of_pathogenicity	0	0	Val	V	-	912	ENSP00000338790	ENST00000345365	17692	1.0	13414	0	0.665	T	0	-0.048466	0.03926	N	T	-	0.3294306	.	0.26052	0	0	.	0.02119	0	35101353	Y	10	0	102740	1.650170e-04	O75771	0	0.075571	0.13840		.	0.001	T	89534	0.02370252	.	0.49004	5892	-0.130246	4	0.1	.	1.650170e-04	0.00968	0.000000e+00	0	75054	0.000000e+00	6060	0	0.00387	17	RAD51D	0.000000e+00	0	Ile	8988	1.116890e-05	17-35101353-T-C	Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	1	30452485	ClinGen:CA165041	0.042627	0.04841	0	RCV000236753|RCV000542443|RCV000129767	T	0	0	c.751A>G	0	0	0	0.31098	T/T	rs540273429	35101353	14896	T	.	O75771	15688	0.00166	0.000000e+00	0.08389		0	0	0.000000e+00	-1.04	0	0	.	-3.91	0.34949	56	T	.	0	0.000000e+00	0	30	.	0	0	140162|145	141300	0.30159	0.31871	0.0309130971524996	594	.	0.31099	0.06525	0.000000e+00	1.116890e-05	1180012	0.337	4.813290e-06	N	13062	0	.	0	614291	0.19651	17	0.000000e+00	ENSG00000185379	0.000000e+00	0	0	0	.	1	0.04348	0.21960	30606	.	9.733310e-06	0.000000e+00	-1.14727300713446	YES	1.097890e-05	0.010139	151014	HGNC:9823	N	0	simple_aae	0.014	207758	35101353	ATA	0.000000	.	-	0	0.01956	3.389800e-06	0	0	Conflicting classifications of pathogenicity	0.00857	0	1	0	ClinGen:CA165041	I	0	0.388174495139	-	0.474	-	0.14965	1	2276	0.16030	.	0.0667	0	0.81310861979149396	0	-	751A>G 	1	4.393673110720562E-4	C0027672|C3661900|C3280345	0	0	0	0	NM_002878.4	-	.	.	0	0.39652	540273429	2320	1.1125945705384957E-4	0.38033	0.06706	0.105	1.0	586	0.23355223	4.86	.	.	0.000000e+00	-0.424866	1.1537049706086e-05	0.01100	T	26	6210	9570	-0.9577	0.24885	p.Ile251Val	0	0	-0.859	0.036506176	0	0.00991	141300	T	30522	RAD51D	0.000000e+00	T	0.070	21300	I251V	T	0.03621	0.62996	T/T	principal1	959712	RAD51D_unpublished_var153959	Yes						overall function		Cell survival			I		751	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Ile251Val		true	c.751A>G						9823.0	35101353.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				Ile251Val						V	Feb 27, 2024					missense_variant		251.0	A		4.3373195365e-6	-0.00741379		Conflicting classifications of pathogenicity	35101353.0	missense_variant		0.07	functionally_normal				Cell viability			RAD51D_Ile251Val
RAD51D_Ile251Val	0.7776406398453396	0.4622488886013073	4.73346535387811	0.0021239643067238714	2025_01_Batch_13-14	0.9995217075101795	0.9534029604719589	0.931935185443018	0.942729026977195	0.9995249189219388	0.8034463122456237	0.9634776583088173	0.9860059425467218	0.9610438469712425	0.6815422778313502	0.9014840098779016	0.9584403093903882	0.9589705639948699	0.9518864369742187	0.8405335983766445	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024857	ALE00029786	NC_000017.11:35101353:T:C	751A>G	Ile251Val	CAVA																											RAD51D_Ile251Val	17	35101353	T	C	17								1	1	1	17-35101353-T-C	-	0.03972	0.0	251	1	0	0	17	33428372	C	4.337320e-06	0	17	3_Conflicting	NC_000017.11	1	Ile251Val	0	0.888	0	0	9.733310e-06	T	0	4	1	42762	4.226580e-06	.	30524	0.000000e+00	0	0.20265	Select	0.0599	102740	0.02950	0	.	T	T	63756	.	0	0	0.000000e+00	0	0	.	17110	44890	1	0.000000e+00	0.05782	0	.	0.00166	0.946	.	94.0	.	-5.59	0.06	C	single nucleotide variant	NC_000017.11:g.35101353T>C	0	16402	2	0.02370252	109058	0	0.015923232	0		1	236598	0	0	0.000000e+00	0	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	0	0	0.000000e+00	0	0.18971	B	0.00388	B	N	0.2220042	7	T/T	8	1	7158	1613900	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	16206	0.39436	.	.	-	35101353	.	-	-2.070000	0	0.01428	29608	0	6060	0	germline	91084	Gain of phosphorylation at T248 (P = 0.0936)| Gain of disorder (P = 0.0983)| Gain of MoRF binding (P = 0.1184)| Gain of methylation at R255 (P = 0.2396)| Loss of stability (P = 0.2941)	0.54885	GRCh38	911	criteria provided, conflicting classifications	c.751A>G	0.000000e+00	0.03894	1	0	0	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	0.000000e+00	9046	LB	0	0.000000e+00	NM_002878.4(RAD51D):c.751A>G (p.Ile251Val)	1	0	RA51D_HUMAN	0	6.0	-1.20699475414867	0	.	0.04993	0.015923232	-	0.000000e+00	.		1	0.000000e+00	0	34258	criteria_provided,_conflicting_classifications	0.74518	0.000000e+00	0	0.000000e+00	0	60020	p.Ile251Val	0	0.04280	.	germline	.		T	Jun 23, 2024	0	T/T	0	89534	0.881	N	17q12	6062	.	0.000000e+00	SCV000184576|SCV000293833|SCV000651777|SCV000904087	Conflicting_classifications_of_pathogenicity	0	0	Val	V	-	912	ENSP00000338790	ENST00000345365	17692	1.0	13414	0	0.665	T	0	-0.048466	0.03926	N	T	-	0.3294306	.	0.26052	0	0	.	0.02119	0	35101353	Y	10	0	102740	1.650170e-04	O75771	0	0.075571	0.13840		.	0.001	T	89534	0.02370252	.	0.49004	5892	-0.130246	4	0.1	.	1.650170e-04	0.00968	0.000000e+00	0	75054	0.000000e+00	6060	0	0.00387	17	RAD51D	0.000000e+00	0	Ile	8988	1.116890e-05	17-35101353-T-C	Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	1	30452485	ClinGen:CA165041	0.042627	0.04841	0	RCV000236753|RCV000542443|RCV000129767	T	0	0	c.751A>G	0	0	0	0.31098	T/T	rs540273429	35101353	14896	T	.	O75771	15688	0.00166	0.000000e+00	0.08389		0	0	0.000000e+00	-1.04	0	0	.	-3.91	0.34949	56	T	.	0	0.000000e+00	0	30	.	0	0	140162|145	141300	0.30159	0.31871	0.0309130971524996	594	.	0.31099	0.06525	0.000000e+00	1.116890e-05	1180012	0.337	4.813290e-06	N	13062	0	.	0	614291	0.19651	17	0.000000e+00	ENSG00000185379	0.000000e+00	0	0	0	.	1	0.04348	0.21960	30606	.	9.733310e-06	0.000000e+00	-1.14727300713446	YES	1.097890e-05	0.010139	151014	HGNC:9823	N	0	simple_aae	0.014	207758	35101353	ATA	0.000000	.	-	0	0.01956	3.389800e-06	0	0	Conflicting classifications of pathogenicity	0.00857	0	1	0	ClinGen:CA165041	I	0	0.388174495139	-	0.474	-	0.14965	1	2276	0.16030	.	0.0667	0	0.81310861979149396	0	-	751A>G 	1	4.393673110720562E-4	C0027672|C3661900|C3280345	0	0	0	0	NM_002878.4	-	.	.	0	0.39652	540273429	2320	1.1125945705384957E-4	0.38033	0.06706	0.105	1.0	586	0.23355223	4.86	.	.	0.000000e+00	-0.424866	1.1537049706086e-05	0.01100	T	26	6210	9570	-0.9577	0.24885	p.Ile251Val	0	0	-0.859	0.036506176	0	0.00991	141300	T	30522	RAD51D	0.000000e+00	T	0.070	21300	I251V	T	0.03621	0.62996	T/T	principal1	959712	RAD51D_unpublished_var153959	Yes						overall function		Cell survival			I		751	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Ile251Val		true	c.751A>G						9823.0	35101353.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				Ile251Val						V	Feb 27, 2024					missense_variant		251.0	A		4.3373195365e-6	-0.00741379		Conflicting classifications of pathogenicity	35101353.0	missense_variant		0.07	functionally_normal				Cell viability			RAD51D_Ile251Val
SHOC2_Thr321Ala	-3.868653257477352	0.006142367602687363	0.8489421917934488	0.4239913700374366	2025_01_Batch_13-14	0.9944865255095497	0.9769409488992881	0.9579636104033097	0.984332074949247	0.9610009395064388	0.9226336864782333	0.6990133106060262	0.7001475754549954	0.7779270847526419	0.7449061871908219	0.9585601059938915	0.8379771297526571	0.8290555929291525	0.8811295798509444	0.8529535633486304	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											
RAD51D_Arg165Gln	2.2867183231461263	0.05607812764399085	7.454881373375606	0.0001426289433675745	2025_01_Batch_13-14	0.8167428149144147	0.8087444747462854	0.9222728431096141	0.8498909586148119	0.8059725835278194	0.9315934600653435	0.9206384594597057	0.9609246328766348	0.9448715878739475	0.8724392445842243	0.8741681374898791	0.8646914671029955	0.9415987379931244	0.8973812732443798	0.8392059140560219	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D	ENSG00000185379	7201	900197	CCSBVarC002917	ALE00002917	NC_000017.11:35106468:C:T	494G>A	Arg165Gln	RC4	NatVar_GDE_001	F05	GDEhDisVCh_40046	E03	2	NULL	NULL	NULL	NULL	VUSMutpDEST2_06	G01	VUSmut_GDEh12	E02	1	1	0		0			1	1	1	1	1	1	RAD51D_Arg165Gln	17	35106468	C	T	17											17-35106468-C-T	-	0.18765	0.0	165	12341	5762	9	17	33433487	T	1.387630e-01	5012	17	2_Benign	NC_000017.11	15964	Arg165Gln	815	13.9	413	636	2.954720e-01	T	2333	12	5	41956	1.569380e-01	18	29942	1.798720e-01	1955	0.34681	.	0.0001	33746	0.14667	9971	0.040674603174603176	T	T	63890	.	0.03983963918817339	55	1.897950e-01	990	1567	.	16850	44876	14721	4.213990e-02	0.63808	6003	.	0.02411	0.96	0.01361573373676248	99.0	0.740726	1.12	0.01	T	single nucleotide variant	NC_000017.11:g.35106468C>T	897	16654	2	0.048267353	107270	0.1653272101033295	0.029415702	0.04497278716700086	T	31945	232850	1699	1	4.613380e-02	1488	1.430780e-01	6	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	17045	3630	1.096490e-01	100	0.13669	B	0.07149	B	N	0.3368571	223574	C/C	594	3257	6652	1611192	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	15532	0.19845	153	.	-	35106468	2.974480e-01	-	0.032000	458	0.22017	29446	0.2698040298095501	59646	564	germline;unknown	90614	.	.	GRCh38	917	criteria provided, multiple submitters, no conflicts	c.494G>A	1.629480e-01	0.14768	54444	784	1134	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	1.697490e-01	9024	B	0.04287993617869964	1.956800e-01	NM_002878.4(RAD51D):c.494G>A (p.Arg165Gln)	2	8	RA51D_HUMAN	1567	1.0	-1.06674822980265	9035	T	0.00818	0.029415702	-	2.705950e-02	134	0.14061	9035	1.882470e-01	0	33746	criteria_provided,_multiple_submitters,_no_conflicts	0.51051	1.588980e-01	17336	1.710920e-01	174	59646	p.Arg165Gln	57	0.13801	.	germline	5012	35106468	C	Feb 04, 2025	4879	C/C	3152	88222	1.0	N	17q12	333254	.	2.948750e-02	SCV000185999|SCV000292088|SCV000309255|SCV000488799|SCV000884439|SCV001440195|SCV001717669|SCV001841070|SCV004044159|SCV005253873	Benign	2281	1778	Gln	Q	-	912	ENSP00000378090	ENST00000394589	17666	0.003	13384	3557	-0.169	C	255	1.452401	0.01173	N	T	-	0.7160679	.	.	7246	1451	0.12922465208747516	0.00085	314	35106468	Y	9	0.12231182795698925	100834	1.287180e-01	O75771	204	0.074496	0.20995	C	784	0.001	.	30024	0.048267353	16850	0.51684	5892	-0.647874	162928	-3.12	0.13701431492842536	2.676460e-01	0.68399	1.612710e-01	432	74974	4.576680e-02	6052	180	0.07148	17	RAD51D	3.041050e-02	864	Arg	394758	1.398860e-01	17-35106468-C-T	not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	582	14237	30457600	ClinGen:CA167606|UniProtKB:O75771#VAR_020561	0.077101	0.07176	11455	RCV000131069|RCV000245575|RCV000409134|RCV001705932	T	36	411	c.494G>A	407	1940	10732	0.00072	C/C	rs4796033	35106468	14258	C	0.0950479233226837	.	15384	0.02411	1.688840e-01	0.29478	17	330	860	4.323020e-02	-1.43	0.010101010101010102	47230	264690	0.253	0.34695	6982	T	.	409	3.009260e-01	182	1968	.	12	2827	145|140162	142159	0.16122	0.41278	0.00742585393685776	16558	476	0.71675	0.15335	2.954720e-01	3.009260e-01	1178350	1.179	1.560770e-01	D	13332	1451	0.119811855	215	614291	0.31705	17	2.868570e-02	ENSG00000185379	1.679760e-01	0.14172373024779897	4896	0.05030487804878049	.	2	0.04348	0.20141	30022	31713	1.411920e-01	2.676460e-01	-0.830017416971714	.	1.624580e-01	.	151873	HGNC:9823	P	210	simple_aae	0.078	204674	35106468	CGG	0.963000	41	-	0.03877279864717961	0.00033	1.382680e-01	642	1305	Benign	0.12431	2481	779	15964	ClinGen:CA167606,UniProtKB:O75771#VAR_020561	R	6	.	-	.	-	0.15800	36543	24004	0.04975	.	0.057	2333	0.91470505594779028	5226	-	494G>A 	9971	0.13568571904682553	CN169374|C3661900|C3280345|C0027672	111	15	395	42	NM_002878.4	-	130	0.22046109510086456	0	0.35767	4796033	2196	0.1379174076269512	.	0.13532	0.019	1.0	15964	0.02316738	4.96	.	.	1.630800e-01	-0.559582	2.61638337411342e-05	0.00575	T	5014	6024	9368	-1.0318	0.00038	p.Arg165Gln	99	6	3.206	0.0022848845	2280	0.01340	142159	T	30024	RAD51D	2.974480e-01	T	0.127	21494	.	D	0.30289	0.1135	C/C	principal1																																																																																																				
RAD51D_Arg165Gln	2.2867183231461263	0.05607812764399085	7.454881373375606	0.0001426289433675745	2025_01_Batch_13-14	0.8167428149144147	0.8087444747462854	0.9222728431096141	0.8498909586148119	0.8059725835278194	0.9315934600653435	0.9206384594597057	0.9609246328766348	0.9448715878739475	0.8724392445842243	0.8741681374898791	0.8646914671029955	0.9415987379931244	0.8973812732443798	0.8392059140560219	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC002917		NC_000017.11:35106468:C:T		Arg165Gln																												RAD51D_Arg165Gln	17	35106468	C	T	17	allele	494G>A	E01	527_CAVA_Array_P05	I01	B13A7A8P2_R1	B14A7A8P2_R2				17-35106468-C-T	-	0.18765	0.0	165	12341	5762	9	17	33433487	T	1.387630e-01	5012	17	2_Benign	NC_000017.11	15964	Arg165Gln	815	13.9	413	636	2.954720e-01	T	2333	12	5	41956	1.569380e-01	18	29942	1.798720e-01	1955	0.34681	.	0.0001	33746	0.14667	9971	0.040674603174603176	T	T	63890	.	0.03983963918817339	55	1.897950e-01	990	1567	.	16850	44876	14721	4.213990e-02	0.63808	6003	.	0.02411	0.96	0.01361573373676248	99.0	0.740726	1.12	0.01	T	single nucleotide variant	NC_000017.11:g.35106468C>T	897	16654	2	0.048267353	107270	0.1653272101033295	0.029415702	0.04497278716700086	T	31945	232850	1699	1	4.613380e-02	1488	1.430780e-01	6	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	17045	3630	1.096490e-01	100	0.13669	B	0.07149	B	N	0.3368571	223574	C/C	594	3257	6652	1611192	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	15532	0.19845	153	.	-	35106468	2.974480e-01	-	0.032000	458	0.22017	29446	0.2698040298095501	59646	564	germline;unknown	90614	.	.	GRCh38	917	criteria provided, multiple submitters, no conflicts	c.494G>A	1.629480e-01	0.14768	54444	784	1134	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	1.697490e-01	9024	B	0.04287993617869964	1.956800e-01	NM_002878.4(RAD51D):c.494G>A (p.Arg165Gln)	2	8	RA51D_HUMAN	1567	1.0	-1.06674822980265	9035	T	0.00818	0.029415702	-	2.705950e-02	134	0.14061	9035	1.882470e-01	0	33746	criteria_provided,_multiple_submitters,_no_conflicts	0.51051	1.588980e-01	17336	1.710920e-01	174	59646	p.Arg165Gln	57	0.13801	.	germline	5012	35106468	C	Feb 04, 2025	4879	C/C	3152	88222	1.0	N	17q12	333254	.	2.948750e-02	SCV000185999|SCV000292088|SCV000309255|SCV000488799|SCV000884439|SCV001440195|SCV001717669|SCV001841070|SCV004044159|SCV005253873	Benign	2281	1778	Gln	Q	-	912	ENSP00000378090	ENST00000394589	17666	0.003	13384	3557	-0.169	C	255	1.452401	0.01173	N	T	-	0.7160679	.	.	7246	1451	0.12922465208747516	0.00085	314	35106468	Y	9	0.12231182795698925	100834	1.287180e-01	O75771	204	0.074496	0.20995	C	784	0.001	.	30024	0.048267353	16850	0.51684	5892	-0.647874	162928	-3.12	0.13701431492842536	2.676460e-01	0.68399	1.612710e-01	432	74974	4.576680e-02	6052	180	0.07148	17	RAD51D	3.041050e-02	864	Arg	394758	1.398860e-01	17-35106468-C-T	not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	582	14237	30457600	ClinGen:CA167606|UniProtKB:O75771#VAR_020561	0.077101	0.07176	11455	RCV000131069|RCV000245575|RCV000409134|RCV001705932	T	36	411	c.494G>A	407	1940	10732	0.00072	C/C	rs4796033	35106468	14258	C	0.0950479233226837	.	15384	0.02411	1.688840e-01	0.29478	17	330	860	4.323020e-02	-1.43	0.010101010101010102	47230	264690	0.253	0.34695	6982	T	.	409	3.009260e-01	182	1968	.	12	2827	145|140162	142159	0.16122	0.41278	0.00742585393685776	16558	476	0.71675	0.15335	2.954720e-01	3.009260e-01	1178350	1.179	1.560770e-01	D	13332	1451	0.119811855	215	614291	0.31705	17	2.868570e-02	ENSG00000185379	1.679760e-01	0.14172373024779897	4896	0.05030487804878049	.	2	0.04348	0.20141	30022	31713	1.411920e-01	2.676460e-01	-0.830017416971714	.	1.624580e-01	.	151873	HGNC:9823	P	210	simple_aae	0.078	204674	35106468	CGG	0.963000	41	-	0.03877279864717961	0.00033	1.382680e-01	642	1305	Benign	0.12431	2481	779	15964	ClinGen:CA167606,UniProtKB:O75771#VAR_020561	R	6	.	-	.	-	0.15800	36543	24004	0.04975	.	0.057	2333	0.91470505594779028	5226	-	494G>A 	9971	0.13568571904682553	CN169374|C3661900|C3280345|C0027672	111	15	395	42	NM_002878.4	-	130	0.22046109510086456	0	0.35767	4796033	2196	0.1379174076269512	.	0.13532	0.019	1.0	15964	0.02316738	4.96	.	.	1.630800e-01	-0.559582	2.61638337411342e-05	0.00575	T	5014	6024	9368	-1.0318	0.00038	p.Arg165Gln	99	6	3.206	0.0022848845	2280	0.01340	142159	T	30024	RAD51D	2.974480e-01	T	0.127	21494	.	D	0.30289	0.1135	C/C	principal1																																																																																																				
BRCA1_Pro510Ser	1.2763374668476026	0.24254813146313225	4.261917325727006	0.003737738849101049	2025_01_Batch_13-14	0.9640036687223583	0.9118111337128814	0.9045387301347584	0.9339901222773391	0.9422400489874985	0.9842508167638084	0.9279514829560971	0.9366244489548248	0.9797877565913151	0.94228323593355	0.9741272427430834	0.9198813083344892	0.9205815895447915	0.9568889394343272	0.9422616424605242	1.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.0	1.0	BRCA1	BRCA1		14613		CCSBVarC013098		NC_000017.11:43071074:G:A		Pro510Ser																												BRCA1_Pro510Ser	17	43071074	G	A	17	allele	1528C>T	F11	527_CAVA_Array_P01	K21	B13A7A8P1_R1	B14A7A8P1_R2				17-43071074-G-A	-	0.05499	0.001	1614	1	0	0	17	41223091	A	1.102770e-04	1	17	2_Benign	NC_000017.11	156	Pro1614Ser	0	1.947	0	13	2.549990e-03	T	0	13	1	42768	1.815430e-04	1	30526	0.000000e+00	0	0.80920	Select	0.3747	14902	0.11208	4	0.0	T	T	64026	.	0.0013885921811578722	0	0.000000e+00	0	0	0.01370	17112	44892	0	0.000000e+00	0.49862	0	.	0.00033	0.008	7.564296520423601E-4	80.0	.	0.973	0.2	A	single nucleotide variant	NC_000017.11:g.43071074G>A	0	16734	2	0.035112027	109408	0	0.01818675	0		44	236858	0	0	0.000000e+00	442	0.000000e+00	0	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562	25	0	0.000000e+00	0	0.44282	B	0.02796	B	L	0.241072	178	G/G	360	1	7164	1614124	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer	16218	0.58992	1	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43071074	3.350080e-03	-	0.294000	41	0.24271	29602	0	75024	0	germline	91088	.	.	GRCh38	543	reviewed by expert panel	c.4840C>T	0.000000e+00	0.07233	14	0	0	.	0.000000e+00	9046	B	0	0.000000e+00	NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser)	3	0	BRCA1_HUMAN	0	20.0	-1.18046810113445	1	.	0.14859	0.012395442	-	3.350080e-03	0		41	0.000000e+00	0	34260	reviewed_by_expert_panel	0.97711	2.285020e-04	0	0.000000e+00	0	60006	p.Pro1614Ser	0	0.16973	.	germline	24		G	Aug 10, 2015	0	G/G	0	89552	0.0	N	17q21.31	163048	.	2.528060e-03	SCV000244370	Benign	0	0	Ser	S	-	910	ENSP00000350283	ENST00000357654	17692	0.074	13416	0	-0.106	G	0	0.15678	0.42259	N	T	-	0.2478793	.	0.73689	950	0	0.0	0.00022	0	43071074	Y	10	0	102658	0.000000e+00	P38398	0	0.118253	0.02973		0	0.001	D	16218	0.03539876	7164	0.08289	672	-0.292457	4	-1.13	0.0	2.079330e-03	0.34767	0.000000e+00	0	75024	0.000000e+00	6062	24	0.02713	17	BRCA1	2.079330e-03	0	Pro	193940	1.116670e-05	17-43071074-G-A	not_provided|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_and/or_ovarian_cancer	0	1	38476617	BRCA1-HCI:BRCA1_00089|ClinGen:CA003048	0.128273	0.05234	0	RCV000048676|RCV000112411|RCV000162988|RCV000167771|RCV001811342|RCV003492390	T	0	0	c.4840C>T	0	0	0	0.09169	G/G	rs70953660	43071074	14902	G	3.9936102236421724E-4	.	15690	0.00340	0.000000e+00	0.08389		0	0	0.000000e+00	1.245	0	0	264690	-1.9	0.43590	6350	T	T	38	3.276110e-05	0	1848	.	0	0	145|140162|145	55301	0.54546	0.10213	0.00209908424908425	9722	2	0.06393	0.24383	1.167540e-04	2.528060e-03	1180006	-0.1	2.114060e-04	N	13394	0	7.064868E-4	0	604370	0.10995	17	2.549990e-03	ENSG00000012048	0.000000e+00	0	0	0	.	1	0.11213	0.72771	30608	187	9.741080e-06	1.166550e-04	-1.24446342853677	YES	0.000000e+00	0.081866	69968	HGNC:1100	N	0	simple_aae	0.086	208130	43071074	CCA	0.000000	0	-	0.0013371734211067683	0.00282	3.389810e-06	13	0	Benign	0.09611	0	0	7	BRCA1-HCI:BRCA1_00089,ClinGen:CA003048	P	0	0.445007932271	-	.	-	0.28185	43	13148	0.22008	0.220991373062	0.0853	0	0.41163095527126975	280	-	4840C>T 	38	7.6057195010648E-5	C3661900|CN169374|C0677776|C0027672|C2676676|CN221562	0	0	0	0	NM_007294.4	-	0	0.001440922190201729	0	0.52390	70953660	2320	7.218727441476746E-5	0.43742	0.05132	0.197	0.331	9362	0.99514270	4.36	.	.	0.000000e+00	-0.197798	0.209477282755653	0.31258	T	4502	6212	9572	-0.7260	0.73191	p.Pro1614Ser	0	0	-2.617	0.013456136	156	0.50387	55301	T	30524	BRCA1	5.843850e-05	T	0.544	21632	.	T	0.28966	0.15547	G/G	principal2																																																																																																				
BAP1_Asn290Ser	-0.3729935111171861	0.7201914707181801	0.08966665608823118	0.9310637601032032	2025_01_Batch_13-14	0.5102749202430318	0.4980858979057414	0.5608719049035955	0.5879716163221951	0.5234867851259092	0.6559667095793311	0.652278002395132	0.6505931948512813	0.7551754642481316	0.5767050617784881	0.5831208149111815	0.5751819501504367	0.6057325498774384	0.6715735402851634	0.5500959234521987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009478		NC_000003.12:52405827:T:C		Asn290Ser																												BAP1_Asn290Ser	3	52405827	T	C	3	allele	869A>G	H01	527_CAVA_Array_P01	O01	B13A7A8P1_R1	B14A7A8P1_R2				3-52405827-T-C	-	0.15654	0.0	290	0	0	0	3	52439843	C	9.107980e-05	67	3	2_Benign	NC_000003.12	143	Asn290Ser	1	11.99	0	0	3.473640e-03	T	0	8	1	42766	5.149370e-04	.	30526	0.000000e+00	2	0.22615	Select	0.0329	34258	0.02950	119	.	T	T	64032	0.297888856719	0	0	0.000000e+00	0	0	0.02381	17112	44904	0	7.454900e-05	0.17141	0	.	0.01269	0.841	.	98.0	0.616438	-0.00352	0.02	C	single nucleotide variant	NC_000003.12:g.52405827T>C	0	16730	2	0.018665047	109402	0	0.020683967	0		118	236922	0	0	5.652270e-05	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MedGen:C3661900|	68	0	0.000000e+00	0	0.08015	B	0.00119	B	N	0.3046936	147	T/T	114	0	7164	1613970	Hereditary cancer-predisposing syndrome|BAP1-related tumor predisposition syndrome|not provided|BAP1-related disorder	16214	0.26903	.	.	-	52405827	3.915380e-03	-	2.762000	0	0.07179	29608	0.003278688524590164	60004	1	germline;unknown	91082	Gain of relative solvent accessibility (P = 0.0024)| Gain of glycosylation at S285 (P = 0.0098)| Gain of solvent accessibility (P = 0.012)| Loss of sheet (P = 0.0228)| Gain of loop (P = 0.0502)	0.35591	GRCh38	68	criteria provided, multiple submitters, no conflicts	c.869A>G	0.000000e+00	0.39700	2	0	0	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	0.000000e+00	9046	B	0	0.000000e+00	NM_004656.4(BAP1):c.869A>G (p.Asn290Ser)	2	0	BAP1_HUMAN	0	2.0	-1.10195154957138	115	T	0.00099	0.024449877	-	0.000000e+00	.		115	0.000000e+00	0	34258	criteria_provided,_multiple_submitters,_no_conflicts	0.93104	6.215610e-04	0	0.000000e+00	0	60004	p.Asn290Ser	0	0.34693	.	germline	67		T	Jan 31, 2025	0	T/T	0	89508	0.826	N	3p21.1	9690	.	0.000000e+00	SCV000651904|SCV000664731|SCV000910704|SCV000985789|SCV002537296|SCV004019766|SCV004221522	Benign/Likely_benign	0	0	Ser	S	-	912	ENSP00000417132	ENST00000460680	17692	1.0	13414	0	-1.018	T	0	1.173624	0.05881	N	T	-	0.6995833	.	0.13568	610	0	.	0.00323	0	52405827	Y	10	0	102730	0.000000e+00	Q92560	0	0.021852	0.11599		0	0.0	T	30522	0.020063097	17112	0.39729	8314	-0.644951	0	-0.57	.	2.383170e-03	0.00968	0.000000e+00	0	74936	0.000000e+00	5986	0	0.00063	3	BAP1	1.334470e-05	0	Asn	14050	0.000000e+00	3-52405827-T-C	Hereditary_cancer-predisposing_syndrome|not_provided|BAP1-related_disorder|BAP1-related_tumor_predisposition_syndrome	0	0	52414883	ClinGen:CA2436980	0.027530	0.06531	0	RCV000562577|RCV001079643|RCV000843751|RCV003952834	T	0	0	c.869A>G	0	0	0	0.00076	T/T	rs747079481	52405827	14898	T	.	Q92560	15690	0.00634	0.000000e+00	0.32549		0	0	0.000000e+00	-1.525	0	0	264690	3.55	0.16819	112	T	T	0	3.767770e-03	0	26	.	0	0	140162|289539	472716	0.05566	0.31871	0.0150392539939985	2898	.	0.30165	0.02227	3.473640e-03	3.767770e-03	1180038	0.83	5.671170e-04	N	13390	0	2.7201633E-4	0	614327	0.27208	3	0.000000e+00	ENSG00000163930	0.000000e+00	0	0	0	0.2007139702985778	2	0.01384	0.97129	30608	72	0.000000e+00	2.383170e-03	-0.841934346995282	YES	0.000000e+00	0.005388	453076	HGNC:950	N	0	simple_aae	0.033	208070	52405827	AAC	0.995000	.	-	0	0.00083	0.000000e+00	0	0	Benign/Likely benign	0.03355	0	0	143	ClinGen:CA2436980	N	0	0.328222422547	-	0.356	-	0.00817	122	496	0.19805	0.235256686807	0.048	0	0.76300458640983959	98	-	869A>G 	119	0	C0027672|C3661900|C3280492	0	0	0	0	NM_004656.4	-	.	.	0	0.23328	747079481	2320	1.4234875444839857E-4	0.32018	0.13249	0.027	0.697	2784	0.94490990	5.38	.	.	0.000000e+00	-0.70131	4.71611775438763e-05	0.00486	T	86	6212	9570	-1.0098	0.14050	p.Asn290Ser	0	0	-2.044	0.004228443	1	0.01873	472716	T	30522	BAP1	3.915380e-03	T	0.078	21628	N290S	T	0.21537	0.01749	T/T	principal1																																																																																																				
ZC4H2_Ala162Thr	-4.370447319580962	0.0032722768210010993	8.395631701605742	0.0000668881355903243	2025_01_Batch_13-14	0.6325524172812277	0.7885922907571303	0.8245184478802221	0.7413113322146364	0.6491819734900327	0.8502638266287432	0.8683484509498671	0.9436322625012543	0.9405561133731781	0.7059248170414719	0.7414081219549855	0.8284703708534987	0.8840753551907382	0.8409337227939073	0.6775533952657523	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC009153		NC_000023.11:64919119:C:T		Ala162Thr																												ZC4H2_Ala162Thr	23	64919119	C	T	X	allele	484G>A	B04	527_CAVA_Array_P06	C08	B13A7A8P2_R1	B14A7A8P2_R2				X-64919119-C-T	-	0.41235	0.253	162	1	.	0	X	64138999	T	.	6	X	2_Benign	NC_000023.11	.	Ala162Thr	0	21.3	0	0	6.513910e-04	T	.	3	1	29040	1.418930e-04	.	16843	0.000000e+00	0	0.32711	Select	0.1409	26098	0.31264	17	.	T	T	.	0.002779115915	0	.	0.000000e+00	0	0	0.72215	13184	.	.	0.000000e+00	0.20514	1	.	0.59709	0.996	.	98.0	0.921908	.	0.02	T	single nucleotide variant	NC_000023.11:g.64919119C>T	.	11828	2	0.37242544	76130	0	0.39003843	0		24	162094	0	0	0.000000e+00	146	3.443530e-05	0	MedGen:C3661900|MeSH:D030342,MedGen:C0950123	9	0	.	.	0.13669	B	0.62207	B	L	.	.	C/C	114	0	5609	.	not provided|Inborn genetic diseases	12852	0.38422	.	.	-	64919119	4.550970e-04	-	7.492000	0	0.56292	.	0	.	0	germline	.	Gain of glycosylation at A162 (P = 0.048)| Gain of phosphorylation at A162 (P = 0.0546)| Gain of MoRF binding (P = 0.1162)| Loss of stability (P = 0.5478)| Gain of catalytic residue at A162 (P = 0.5863)	0.48193	GRCh38	40	criteria provided, multiple submitters, no conflicts	c.484G>A	0.000000e+00	0.77927	0	0	0	.	0.000000e+00	6756	P	0	.	NM_018684.4(ZC4H2):c.484G>A (p.Ala162Thr)	2	0	ZC4H2_HUMAN	0	2.0	.	18	D	0.68255	0.39003843	-	0.000000e+00	.		18	0.000000e+00	0	26098	criteria_provided,_multiple_submitters,_no_conflicts	0.90918	1.182190e-04	.	0.000000e+00	0	.	p.Ala162Thr	.	0.59446	.	germline	6		C	Nov 21, 2024	0	C/C	0	60750	1.0	N	Xq11.2	9690	.	0.000000e+00	SCV001124496|SCV001875100|SCV003704074	Benign/Likely_benign	0	0	Thr	T	-	.	ENSP00000363972	ENST00000374839	12772	0.585	9768	0	0.599	C	0	3.063865	0.09609	.	T	-	.	.	0.90062	610	0	.	0.06045	0	64919119	Y	9	0	68992	.	Q9NQZ6	0	0.364445	0.53786		0	0.042	D	23519	0.37242544	13184	0.76032	55906	-0.170336	.	-0.73	.	.	0.05935	0.000000e+00	0	.	0.000000e+00	.	0	0.62207	X	ZC4H2	.	0	Ala	14050	1.646090e-05	X-64919119-C-T	Inborn_genetic_diseases|not_provided	.	1	64055724	.	.	.	.	RCV000976591|RCV002548407	T	.	0	c.484G>A	0	.	.	0.24842	C/C	rs763229158	64919119	11779	C	.	Q9NQZ6	8936	0.59709	0.000000e+00	0.68239		0	0	.	0.975	0	0	264690	5.4	0.72831	112	T	T	0	7.653390e-04	0	26	.	0	0	.	793408	0.59671	0.00229	0.0535271790125423	2898	.	0.71675	.	6.513910e-04	7.653390e-04	.	7.641	1.676900e-04	N	9673	0	4.533605E-5	0	.	0.82558	X	0.000000e+00	ENSG00000126970	.	0	0	0	0.7068802814843511	1	0.24116	0.97963	16908	12	1.449440e-05	.	.	YES	.	0.276816	786889	HGNC:24931	N	0	simple_aae	0.294	143121	64919119	GCC	1.000000	.	-	0	0.32362	.	0	.	Benign/Likely benign	0.38896	0	.	.	ClinGen:CA10433399	A	0	0.396617757867	-	0.433	-	0.59694	23	496	0.70480	0.73517537117	0.5862	.	0.99147030646255208	98	-	484G>A 	17	0	C0950123|C3661900	0	0	0	0	NM_018684.4	-	.	.	0	0.71557	763229158	1586	0	0.38874	.	0.563	0.549	2784	0.89157920	5.4	.	.	0.000000e+00	-0.141903	0.7151635813138	0.24371	T	86	4116	6264	-0.9631	0.45885	p.Ala162Thr	0	.	-5.158	0.17710975	.	0.67549	793408	T	23519	ZC4H2	4.550970e-04	T	0.118	15504	A162T	T	.	0.40292	C/C	principal1																																																																																																				
CTCF_Arg567Leu	1.1800602714906496	0.2765194233427633	2.874101838925229	0.023851750906581655	2025_01_Batch_13-14	0.5725732678815956	0.4704783921339683	0.5519199379916447	0.518320484133521	0.5643612753700188	0.5955774829893721	0.605650616489998	0.5849473574915652	0.5631671404073328	0.5993680619022184	0.5840753754354838	0.5380645043119832	0.568433647741605	0.5407438122704269	0.5818646686361186	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF		6173		CCSBVarC010820		NC_000016.10:67628551:G:T		Arg567Leu																												CTCF_Arg567Leu	16	67628551	G	T	16	allele	1700G>T	D02	527_CAVA_Array_P02	G04	B13A7A8P1_R1	B14A7A8P1_R2				16-67628551-G-T	-	0.89703	0.997	567	.	.	.	16	67662454	T	.	.	16	2_Benign	NC_000016.10	.	Arg567Leu	.	31.0	.	.	.	D	.	1	.	.	.	.	.	.	.	0.79046	.	0.5199	.	0.70687	.	.	D	D	.	.	.	.	.	.	.	0.98690	.	.	.	.	0.24626	.	.	0.65717	0.998	.	.	0.872913	4.59	.	T	single nucleotide variant	NC_000016.10:g.67628551G>T	.	.	2	0.3656615	.	.	0.48211032	.		.	.	.	.	.	.	.	.	MedGen:CN517202	.	.	.	.	0.94378	D	0.61669	D	L	4.67813	.	G/G	.	.	.	.	not provided	.	0.80295	.	.	-	67628551	.	-	11.725000	.	0.63130	.	.	.	.	germline	.	Loss of disorder (P = 0.0233)| Loss of glycosylation at T565 (P = 0.0575)| Loss of ubiquitination at K562 (P = 0.0666)| Loss of MoRF binding (P = 0.0734)| Loss of phosphorylation at T565 (P = 0.1284)	0.62092	GRCh38	53	criteria provided, single submitter	c.1700G>T	.	0.89363	.	.	.	.	.	.	P	.	.	NM_006565.4(CTCF):c.1700G>T (p.Arg567Leu)	1	.	CTCF_HUMAN	.	.	0.451229343520457	.	D	0.88385	0.48211032	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.93563	.	.	.	.	.	p.Arg567Leu	.	0.94893	.	germline	.		G	Dec 18, 2020	.	G/G	.	.	1.0	N	16q22.1	.	.	.	SCV000619177	Likely_benign	.	.	Leu	L	-	.	ENSP00000495348	ENST00000645699	.	.	.	.	0.676	G	.	5.346011	0.29853	D	.	-	5.949525	.	0.83108	.	.	.	0.49158	.	67628551	Y	10	.	.	.	P49711	.	0.711178	0.92149		.	0.993	D	.	0.3656615	.	0.85369	10664	0.317932	.	.	.	.	0.29555	.	.	.	.	.	.	0.61669	16	CTCF	.	.	Arg	.	.	16-67628551-G-T	not_provided	.	.	66219955	ClinGen:CA396321079	0.947009	0.64086	.	RCV000521064	D	.	.	c.1700G>T	.	.	.	0.84211	G/G	rs761621858	67628551	.	G	.	P49711	.	0.65717	.	0.68239		.	.	.	1.59	.	.	.	5.72	0.91685	.	D	D	.	.	.	.	.	.	.	.	450577	0.84006	0.96651	0.84126740694046	.	.	0.71675	0.95695	.	.	.	9.972	.	.	.	.	.	.	.	0.99137	16	.	ENSG00000102974	.	.	.	.	.	2	0.81117	0.97599	.	.	.	.	0.577215871047949	.	.	0.14978	445598	HGNC:13723	.	.	.	0.379	.	67628551	CGG	1.000000	.	-	.	0.66830	.	.	.	Likely benign	0.67536	.	.	.	ClinGen:CA396321079	R	.	.	-	0.52	-	0.90815	.	.	0.88570	0.925170183182	0.9523	.	0.99840494751249931	.	-	1700G>T 	.	.	CN517202	.	.	.	.	NM_006565.4	-	.	.	0	0.60159	761621858	.	.	0.92815	0.73164	.	.	.	0.95337390	5.72	.	.	.	0.218911	0.841414727856592	0.40152	T	.	.	.	-0.0875	0.81993	p.Arg567Leu	.	.	-8.963	0.6048416	.	0.72676	450577	D	.	CTCF	.	D	.	.	R567L	.	0.85410	0.76753	G/G	principal4																																																																																																				
KRAS_Phe156Leu	-2.8937598314972	0.023191472239177145	0.615722224711817	0.5575590131675932	2025_01_Batch_13-14	0.8904038053154149	0.9708217372426282	0.9918403133550269	0.9844276742428272	0.9781193592750286	0.9312549665502065	0.9614415292878467	0.9900235638764281	0.980567088137638	0.9803803461293565	0.9108293859328107	0.9661316332652374	0.9909319386157275	0.9824973811902327	0.9792498527021926	1.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	KRAS	KRAS	ENSG00000133703	3084	214497	CCSBVarC006103	ALE00006103	NC_000012.12:25209894:G:C	468C>G	Phe156Leu	CEGS2	CegsMutGDEh1042	A06	GDEhDisVCh_40061	D10	1	CegsMutGDDh1042	A06	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	1	0			0			0			KRAS_Phe156Leu	12	25209894	G	C	12											12-25209894-G-C	-	0.80384	.	131	.	.	.	12	25362828	C	.	.	12	1_Pathogenic	NC_000012.12	.		.	27.3	.	.	.	D	.	4	.	.	.	.	.	.	.	0.94600	.	0.5849	.	0.55569	.	.	.	D	.	.	.	.	.	.	.	.	.	.	.	.	0.84554	.	.	.	0.999	.	.	.	.	.	C	single nucleotide variant	NC_000012.12:g.25209894G>C	.	.	3	.	.	.	.	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|	.	.	.	.	0.90354	.	.	.	.	5.956009	.	G/G	.	.	.	.	Cardiofaciocutaneous syndrome 2|not provided|RASopathy|KRAS-related disorder	.	0.89890	.	.	-	25209894	.	-	6.589000	.	0.98576	.	.	.	.	germline	.	.	0.93225	GRCh38	874	criteria provided, multiple submitters, no conflicts	.	.	0.54956	.	.	.	.	.	.	.	.	.	NM_033360.4(KRAS):c.*22C>G	2	.	A0A8I5KQ21_HUMAN	.	.	0.603185148433657	.	.	0.98903	.	-	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.95342	.	.	.	.	.	.	.	0.56088	.	germline	.		G	Mar 29, 2023	.	G/G	.	.	1.0	N	12p12.1	.	.	.	SCV000207877|SCV001376927|SCV004121369	Pathogenic	.	.	Leu	L	-	.	ENSP00000509223	ENST00000693229	.	.	.	.	0.591	G	.	4.89283	0.83643	D	.	-	6.573638	.	0.91944	.	.	.	0.65634	.	25209894	Y	7	.	.	.	A0A8I5KQ21	.	.	0.68072		.	.	D	.	.	.	0.91597	3845	0.427055	.	.	.	.	0.78662	.	.	.	.	.	.	.	12	KRAS	.	.	Phe	.	.	12-25209894-G-C	Cardiofaciocutaneous_syndrome_2|not_provided|RASopathy|KRAS-related_disorder	.	.	25254095	ClinGen:CA279964|OMIM:190070.0018	0.705408	0.73232	.	RCV000013426|RCV000157942|RCV001205658|RCV004549359	.	.	.	c.393C>G	.	.	.	0.91321	G/G	rs104894362	25209894	.	G	.	.	.	.	.	0.68239		.	.	.	.	.	.	.	4.53	.	.	D	.	.	.	.	.	.	.	.	1340|536391	12595	0.91214	.	0.960605561733246	.	.	0.71675	0.65957	.	.	.	6.216	.	.	.	.	.	.	615278	0.72225	12	.	ENSG00000133703	.	.	.	.	.	3	0.53661	0.30573	.	.	.	.	0.626658052516122	.	.	0.338981	27634	HGNC:6407	.	.	.	0.965	.	25209894	TTC	1.000000	.	-	.	0.94504	.	.	.	Pathogenic	0.95241	.	.	.	ClinGen:CA279964,OMIM:190070.0018	F	.	.	-	.	-	0.87459	.	.	.	.	.	.	0.9950134605667188	.	-	*22C>G	.	.	C3809005|C3661900|C5555857	.	.	.	.	NM_033360.4	-	.	.	1	0.72066	104894362	.	.	0.97133	0.76756	.	.	.	0.97816370	5.43	.	.	.	0.375659	.	.	D	.	.	.	0.4565	0.85046	p.Phe131Leu	.	.	.	.	.	.	12595	.	.	KRAS	.	D	.	.	.	.	.	0.32125	G/G	.																																																																																																				
KRAS_Phe156Leu	-2.8937598314972	0.023191472239177145	0.615722224711817	0.5575590131675932	2025_01_Batch_13-14	0.8904038053154149	0.9708217372426282	0.9918403133550269	0.9844276742428272	0.9781193592750286	0.9312549665502065	0.9614415292878467	0.9900235638764281	0.980567088137638	0.9803803461293565	0.9108293859328107	0.9661316332652374	0.9909319386157275	0.9824973811902327	0.9792498527021926	1.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	KRAS	KRAS		3084		CCSBVarC006103		NC_000012.12:25209894:G:C		Phe156Leu																												KRAS_Phe156Leu	12	25209894	G	C	12	allele	468C>G	B09	527_CAVA_Array_P03	D17	B13A7A8P1_R1	B14A7A8P1_R2				12-25209894-G-C	-	0.80384	.	131	.	.	.	12	25362828	C	.	.	12	1_Pathogenic	NC_000012.12	.		.	27.3	.	.	.	D	.	4	.	.	.	.	.	.	.	0.94600	.	0.5849	.	0.55569	.	.	.	D	.	.	.	.	.	.	.	.	.	.	.	.	0.84554	.	.	.	0.999	.	.	.	.	.	C	single nucleotide variant	NC_000012.12:g.25209894G>C	.	.	3	.	.	.	.	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|	.	.	.	.	0.90354	.	.	.	.	5.956009	.	G/G	.	.	.	.	Cardiofaciocutaneous syndrome 2|not provided|RASopathy|KRAS-related disorder	.	0.89890	.	.	-	25209894	.	-	6.589000	.	0.98576	.	.	.	.	germline	.	.	0.93225	GRCh38	874	criteria provided, multiple submitters, no conflicts	.	.	0.54956	.	.	.	.	.	.	.	.	.	NM_033360.4(KRAS):c.*22C>G	2	.	A0A8I5KQ21_HUMAN	.	.	0.603185148433657	.	.	0.98903	.	-	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.95342	.	.	.	.	.	.	.	0.56088	.	germline	.		G	Mar 29, 2023	.	G/G	.	.	1.0	N	12p12.1	.	.	.	SCV000207877|SCV001376927|SCV004121369	Pathogenic	.	.	Leu	L	-	.	ENSP00000509223	ENST00000693229	.	.	.	.	0.591	G	.	4.89283	0.83643	D	.	-	6.573638	.	0.91944	.	.	.	0.65634	.	25209894	Y	7	.	.	.	A0A8I5KQ21	.	.	0.68072		.	.	D	.	.	.	0.91597	3845	0.427055	.	.	.	.	0.78662	.	.	.	.	.	.	.	12	KRAS	.	.	Phe	.	.	12-25209894-G-C	Cardiofaciocutaneous_syndrome_2|not_provided|RASopathy|KRAS-related_disorder	.	.	25254095	ClinGen:CA279964|OMIM:190070.0018	0.705408	0.73232	.	RCV000013426|RCV000157942|RCV001205658|RCV004549359	.	.	.	c.393C>G	.	.	.	0.91321	G/G	rs104894362	25209894	.	G	.	.	.	.	.	0.68239		.	.	.	.	.	.	.	4.53	.	.	D	.	.	.	.	.	.	.	.	1340|536391	12595	0.91214	.	0.960605561733246	.	.	0.71675	0.65957	.	.	.	6.216	.	.	.	.	.	.	615278	0.72225	12	.	ENSG00000133703	.	.	.	.	.	3	0.53661	0.30573	.	.	.	.	0.626658052516122	.	.	0.338981	27634	HGNC:6407	.	.	.	0.965	.	25209894	TTC	1.000000	.	-	.	0.94504	.	.	.	Pathogenic	0.95241	.	.	.	ClinGen:CA279964,OMIM:190070.0018	F	.	.	-	.	-	0.87459	.	.	.	.	.	.	0.9950134605667188	.	-	*22C>G	.	.	C3809005|C3661900|C5555857	.	.	.	.	NM_033360.4	-	.	.	1	0.72066	104894362	.	.	0.97133	0.76756	.	.	.	0.97816370	5.43	.	.	.	0.375659	.	.	D	.	.	.	0.4565	0.85046	p.Phe131Leu	.	.	.	.	.	.	12595	.	.	KRAS	.	D	.	.	.	.	.	0.32125	G/G	.																																																																																																				
F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	0.7099087143455147	0.7250776902536834	0.7300050971101899	0.7881197423438256	0.5947157080506009	0.49431238623440454	0.6747744992220248	0.7388275154040795	0.6853482336069867	0.47988743439077497	0.6021105502899596	0.699926094737854	0.7344163062571347	0.7367339879754062	0.5373015712206879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T		Pro175Ser																												F9_Pro175Ser	23	139551064	C	T	X	allele	523C>T	H07	527_CAVA_Array_P02	O14	B13A7A8P1_R1	B14A7A8P1_R2				X-139551064-C-T	-	0.47496	0.354	175	0	.	0	X	138633223	T	.	0	X	2_Benign	NC_000023.11	.	Pro175Ser	11	22.5	4	0	8.265700e-04	D	.	2	1	30931	6.410260e-05	.	18774	0.000000e+00	0	0.91637	Select	0.8615	13308	0.33728	0	.	D	T	.	1.6529612223	0	.	0.000000e+00	0	0	0.28604	13630	.	.	7.905140e-04	0.60697	0	.	0.60670	0.998	.	52.0	0.842116	.	0.48	T	single nucleotide variant	NC_000023.11:g.139551064C>T	.	12181	2	0.38183606	80161	0	0.40378746	0		8	171600	0	0	8.265700e-04	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	4	0	.	.	0.69764	B	0.62938	B	M	.	.	C/C	114	0	5698	.	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	13125	0.95250	.	.	-	139551064	5.787870e-04	-	4.861000	0	0.91893	.	0	.	8	germline	.	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.40807	GRCh38	924	criteria provided, single submitter	c.523C>T	0.000000e+00	0.69688	0	0	0	.	0.000000e+00	6911	B	0	.	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	1	0	FA9_HUMAN	0	48.0	.	0	T	0.35518	0.40378746	+	0.000000e+00	.		8	0.000000e+00	0	27098	criteria_provided,_single_submitter	0.99978	4.989960e-05	.	0.000000e+00	0	.	p.Pro175Ser	.	0.45547	.	germline	4		C	Dec 27, 2024	0	C/C	0	64445	1.0	N	Xq27.1	9690	.	0.000000e+00	SCV001009324	Benign	0	0	Ser	S	-	.	ENSP00000218099	ENST00000218099	13308	0.036	10120	0	0.599	C	0	3.416071	0.33883	.	T	-	.	.	0.88100	610	0	.	0.26526	0	139551064	Y	10	0	73207	.	P00740	0	0.697249	0.96821		0	0.086	D	10120	0.38183606	6911	0.85369	2158	0.0546764	.	-2.89	.	.	0.44852	0.000000e+00	0	.	5.787870e-04	.	0	0.62938	X	F9	.	0	Pro	14050	0.000000e+00	X-139551064-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	0	138460889	.	.	.	.	RCV000868038|RCV001825736	D	.	0	c.523C>T	0	.	.	0.58654	C/C	rs762986355	139551064	12057	C	.	P00740	9860	0.60670	0.000000e+00	0.68239		0	0	.	2.175	0	0	264690	5.13	0.91165	112	T	T	0	0.000000e+00	0	26	.	0	0	98879	700019	0.85025	0.89525	0.345082526519166	2898	.	0.71675	.	0.000000e+00	7.905140e-04	.	4.715	5.288590e-05	D	9927	0	5.6670066E-5	0	306900|300807	0.61684	X	0.000000e+00	ENSG00000101981	.	0	0	0	0.9703241368253629	1	0.29523	0.18019	18839	15	0.000000e+00	.	.	YES	.	0.228259	689353	HGNC:3551	N	0	simple_aae	0.852	151269	139551064	CCA	1.000000	.	-	0	0.41984	.	0	.	Benign	0.39483	0	.	.	ClinGen:CA10529810	P	0	0.975270461492	-	0.388	-	0.57301	11	496	0.97004	0.425827980042	0.1096	.	0.99894604001216725	98	-	523C>T 	11	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.51695	762986355	1757	0	0.97476	.	0.463	0.161	2784	0.99996960	5.13	.	.	0.000000e+00	0.239642	0.970189561557157	0.60790	D	86	4624	7059	0.8690	0.95381	p.Pro175Ser	0	.	-5.249	0.250471	.	0.83311	700019	T	24325	F9	0.000000e+00	D	0.756	15971	P175S	D	.	0.40292	C/C	principal1	216377	F9_Popp_2025_light_chain_var243710	No											P		523	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Pro175Ser		true	c.523C>T						3551.0	139551064.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Pro175Ser						S	Jan 19, 2024					missense_variant		175.0			0.000010769711264	1.0088200544671224		Benign	139551064.0	missense_variant,splice_region_variant		0.756					Reporter			F9_Pro175Ser
F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	0.7099087143455147	0.7250776902536834	0.7300050971101899	0.7881197423438256	0.5947157080506009	0.49431238623440454	0.6747744992220248	0.7388275154040795	0.6853482336069867	0.47988743439077497	0.6021105502899596	0.699926094737854	0.7344163062571347	0.7367339879754062	0.5373015712206879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T		Pro175Ser																												F9_Pro175Ser	23	139551064	C	T	X	allele	523C>T	H07	527_CAVA_Array_P02	O14	B13A7A8P1_R1	B14A7A8P1_R2				X-139551064-C-T	-	0.47496	0.354	175	0	.	0	X	138633223	T	.	0	X	2_Benign	NC_000023.11	.	Pro175Ser	11	22.5	4	0	8.265700e-04	D	.	2	1	30931	6.410260e-05	.	18774	0.000000e+00	0	0.91637	Select	0.8615	13308	0.33728	0	.	D	T	.	1.6529612223	0	.	0.000000e+00	0	0	0.28604	13630	.	.	7.905140e-04	0.60697	0	.	0.60670	0.998	.	52.0	0.842116	.	0.48	T	single nucleotide variant	NC_000023.11:g.139551064C>T	.	12181	2	0.38183606	80161	0	0.40378746	0		8	171600	0	0	8.265700e-04	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	4	0	.	.	0.69764	B	0.62938	B	M	.	.	C/C	114	0	5698	.	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	13125	0.95250	.	.	-	139551064	5.787870e-04	-	4.861000	0	0.91893	.	0	.	8	germline	.	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.40807	GRCh38	924	criteria provided, single submitter	c.523C>T	0.000000e+00	0.69688	0	0	0	.	0.000000e+00	6911	B	0	.	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	1	0	FA9_HUMAN	0	48.0	.	0	T	0.35518	0.40378746	+	0.000000e+00	.		8	0.000000e+00	0	27098	criteria_provided,_single_submitter	0.99978	4.989960e-05	.	0.000000e+00	0	.	p.Pro175Ser	.	0.45547	.	germline	4		C	Dec 27, 2024	0	C/C	0	64445	1.0	N	Xq27.1	9690	.	0.000000e+00	SCV001009324	Benign	0	0	Ser	S	-	.	ENSP00000218099	ENST00000218099	13308	0.036	10120	0	0.599	C	0	3.416071	0.33883	.	T	-	.	.	0.88100	610	0	.	0.26526	0	139551064	Y	10	0	73207	.	P00740	0	0.697249	0.96821		0	0.086	D	10120	0.38183606	6911	0.85369	2158	0.0546764	.	-2.89	.	.	0.44852	0.000000e+00	0	.	5.787870e-04	.	0	0.62938	X	F9	.	0	Pro	14050	0.000000e+00	X-139551064-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	0	138460889	.	.	.	.	RCV000868038|RCV001825736	D	.	0	c.523C>T	0	.	.	0.58654	C/C	rs762986355	139551064	12057	C	.	P00740	9860	0.60670	0.000000e+00	0.68239		0	0	.	2.175	0	0	264690	5.13	0.91165	112	T	T	0	0.000000e+00	0	26	.	0	0	98879	700019	0.85025	0.89525	0.345082526519166	2898	.	0.71675	.	0.000000e+00	7.905140e-04	.	4.715	5.288590e-05	D	9927	0	5.6670066E-5	0	306900|300807	0.61684	X	0.000000e+00	ENSG00000101981	.	0	0	0	0.9703241368253629	1	0.29523	0.18019	18839	15	0.000000e+00	.	.	YES	.	0.228259	689353	HGNC:3551	N	0	simple_aae	0.852	151269	139551064	CCA	1.000000	.	-	0	0.41984	.	0	.	Benign	0.39483	0	.	.	ClinGen:CA10529810	P	0	0.975270461492	-	0.388	-	0.57301	11	496	0.97004	0.425827980042	0.1096	.	0.99894604001216725	98	-	523C>T 	11	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.51695	762986355	1757	0	0.97476	.	0.463	0.161	2784	0.99996960	5.13	.	.	0.000000e+00	0.239642	0.970189561557157	0.60790	D	86	4624	7059	0.8690	0.95381	p.Pro175Ser	0	.	-5.249	0.250471	.	0.83311	700019	T	24325	F9	0.000000e+00	D	0.756	15971	P175S	D	.	0.40292	C/C	principal1	161345	F9_Popp_2025_carboxy_gla_motif_var253391	No											P		523	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Pro175Ser		true	c.523C>T						3551.0	139551064.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Pro175Ser						S	Jan 19, 2024					missense_variant		175.0			0.000010769711264	0.9867402763044592		Benign	139551064.0	missense_variant,splice_region_variant		0.756					Reporter			F9_Pro175Ser
F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	0.7099087143455147	0.7250776902536834	0.7300050971101899	0.7881197423438256	0.5947157080506009	0.49431238623440454	0.6747744992220248	0.7388275154040795	0.6853482336069867	0.47988743439077497	0.6021105502899596	0.699926094737854	0.7344163062571347	0.7367339879754062	0.5373015712206879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T		Pro175Ser																												F9_Pro175Ser	23	139551064	C	T	X	allele	523C>T	H07	527_CAVA_Array_P02	O14	B13A7A8P1_R1	B14A7A8P1_R2				X-139551064-C-T	-	0.47496	0.354	175	0	.	0	X	138633223	T	.	0	X	2_Benign	NC_000023.11	.	Pro175Ser	11	22.5	4	0	8.265700e-04	D	.	2	1	30931	6.410260e-05	.	18774	0.000000e+00	0	0.91637	Select	0.8615	13308	0.33728	0	.	D	T	.	1.6529612223	0	.	0.000000e+00	0	0	0.28604	13630	.	.	7.905140e-04	0.60697	0	.	0.60670	0.998	.	52.0	0.842116	.	0.48	T	single nucleotide variant	NC_000023.11:g.139551064C>T	.	12181	2	0.38183606	80161	0	0.40378746	0		8	171600	0	0	8.265700e-04	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	4	0	.	.	0.69764	B	0.62938	B	M	.	.	C/C	114	0	5698	.	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	13125	0.95250	.	.	-	139551064	5.787870e-04	-	4.861000	0	0.91893	.	0	.	8	germline	.	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.40807	GRCh38	924	criteria provided, single submitter	c.523C>T	0.000000e+00	0.69688	0	0	0	.	0.000000e+00	6911	B	0	.	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	1	0	FA9_HUMAN	0	48.0	.	0	T	0.35518	0.40378746	+	0.000000e+00	.		8	0.000000e+00	0	27098	criteria_provided,_single_submitter	0.99978	4.989960e-05	.	0.000000e+00	0	.	p.Pro175Ser	.	0.45547	.	germline	4		C	Dec 27, 2024	0	C/C	0	64445	1.0	N	Xq27.1	9690	.	0.000000e+00	SCV001009324	Benign	0	0	Ser	S	-	.	ENSP00000218099	ENST00000218099	13308	0.036	10120	0	0.599	C	0	3.416071	0.33883	.	T	-	.	.	0.88100	610	0	.	0.26526	0	139551064	Y	10	0	73207	.	P00740	0	0.697249	0.96821		0	0.086	D	10120	0.38183606	6911	0.85369	2158	0.0546764	.	-2.89	.	.	0.44852	0.000000e+00	0	.	5.787870e-04	.	0	0.62938	X	F9	.	0	Pro	14050	0.000000e+00	X-139551064-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	0	138460889	.	.	.	.	RCV000868038|RCV001825736	D	.	0	c.523C>T	0	.	.	0.58654	C/C	rs762986355	139551064	12057	C	.	P00740	9860	0.60670	0.000000e+00	0.68239		0	0	.	2.175	0	0	264690	5.13	0.91165	112	T	T	0	0.000000e+00	0	26	.	0	0	98879	700019	0.85025	0.89525	0.345082526519166	2898	.	0.71675	.	0.000000e+00	7.905140e-04	.	4.715	5.288590e-05	D	9927	0	5.6670066E-5	0	306900|300807	0.61684	X	0.000000e+00	ENSG00000101981	.	0	0	0	0.9703241368253629	1	0.29523	0.18019	18839	15	0.000000e+00	.	.	YES	.	0.228259	689353	HGNC:3551	N	0	simple_aae	0.852	151269	139551064	CCA	1.000000	.	-	0	0.41984	.	0	.	Benign	0.39483	0	.	.	ClinGen:CA10529810	P	0	0.975270461492	-	0.388	-	0.57301	11	496	0.97004	0.425827980042	0.1096	.	0.99894604001216725	98	-	523C>T 	11	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.51695	762986355	1757	0	0.97476	.	0.463	0.161	2784	0.99996960	5.13	.	.	0.000000e+00	0.239642	0.970189561557157	0.60790	D	86	4624	7059	0.8690	0.95381	p.Pro175Ser	0	.	-5.249	0.250471	.	0.83311	700019	T	24325	F9	0.000000e+00	D	0.756	15971	P175S	D	.	0.40292	C/C	principal1	243893	F9_Popp_2025_strep_2_var263072	No											P		523	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Pro175Ser		true	c.523C>T						3551.0	139551064.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Pro175Ser						S	Jan 19, 2024					missense_variant		175.0			0.000010769711264	1.0487967880316358		Benign	139551064.0	missense_variant,splice_region_variant		0.756					Reporter			F9_Pro175Ser
F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	0.7099087143455147	0.7250776902536834	0.7300050971101899	0.7881197423438256	0.5947157080506009	0.49431238623440454	0.6747744992220248	0.7388275154040795	0.6853482336069867	0.47988743439077497	0.6021105502899596	0.699926094737854	0.7344163062571347	0.7367339879754062	0.5373015712206879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T		Pro175Ser																												F9_Pro175Ser	23	139551064	C	T	X	allele	523C>T	H07	527_CAVA_Array_P02	O14	B13A7A8P1_R1	B14A7A8P1_R2				X-139551064-C-T	-	0.47496	0.354	175	0	.	0	X	138633223	T	.	0	X	2_Benign	NC_000023.11	.	Pro175Ser	11	22.5	4	0	8.265700e-04	D	.	2	1	30931	6.410260e-05	.	18774	0.000000e+00	0	0.91637	Select	0.8615	13308	0.33728	0	.	D	T	.	1.6529612223	0	.	0.000000e+00	0	0	0.28604	13630	.	.	7.905140e-04	0.60697	0	.	0.60670	0.998	.	52.0	0.842116	.	0.48	T	single nucleotide variant	NC_000023.11:g.139551064C>T	.	12181	2	0.38183606	80161	0	0.40378746	0		8	171600	0	0	8.265700e-04	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	4	0	.	.	0.69764	B	0.62938	B	M	.	.	C/C	114	0	5698	.	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	13125	0.95250	.	.	-	139551064	5.787870e-04	-	4.861000	0	0.91893	.	0	.	8	germline	.	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.40807	GRCh38	924	criteria provided, single submitter	c.523C>T	0.000000e+00	0.69688	0	0	0	.	0.000000e+00	6911	B	0	.	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	1	0	FA9_HUMAN	0	48.0	.	0	T	0.35518	0.40378746	+	0.000000e+00	.		8	0.000000e+00	0	27098	criteria_provided,_single_submitter	0.99978	4.989960e-05	.	0.000000e+00	0	.	p.Pro175Ser	.	0.45547	.	germline	4		C	Dec 27, 2024	0	C/C	0	64445	1.0	N	Xq27.1	9690	.	0.000000e+00	SCV001009324	Benign	0	0	Ser	S	-	.	ENSP00000218099	ENST00000218099	13308	0.036	10120	0	0.599	C	0	3.416071	0.33883	.	T	-	.	.	0.88100	610	0	.	0.26526	0	139551064	Y	10	0	73207	.	P00740	0	0.697249	0.96821		0	0.086	D	10120	0.38183606	6911	0.85369	2158	0.0546764	.	-2.89	.	.	0.44852	0.000000e+00	0	.	5.787870e-04	.	0	0.62938	X	F9	.	0	Pro	14050	0.000000e+00	X-139551064-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	0	138460889	.	.	.	.	RCV000868038|RCV001825736	D	.	0	c.523C>T	0	.	.	0.58654	C/C	rs762986355	139551064	12057	C	.	P00740	9860	0.60670	0.000000e+00	0.68239		0	0	.	2.175	0	0	264690	5.13	0.91165	112	T	T	0	0.000000e+00	0	26	.	0	0	98879	700019	0.85025	0.89525	0.345082526519166	2898	.	0.71675	.	0.000000e+00	7.905140e-04	.	4.715	5.288590e-05	D	9927	0	5.6670066E-5	0	306900|300807	0.61684	X	0.000000e+00	ENSG00000101981	.	0	0	0	0.9703241368253629	1	0.29523	0.18019	18839	15	0.000000e+00	.	.	YES	.	0.228259	689353	HGNC:3551	N	0	simple_aae	0.852	151269	139551064	CCA	1.000000	.	-	0	0.41984	.	0	.	Benign	0.39483	0	.	.	ClinGen:CA10529810	P	0	0.975270461492	-	0.388	-	0.57301	11	496	0.97004	0.425827980042	0.1096	.	0.99894604001216725	98	-	523C>T 	11	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.51695	762986355	1757	0	0.97476	.	0.463	0.161	2784	0.99996960	5.13	.	.	0.000000e+00	0.239642	0.970189561557157	0.60790	D	86	4624	7059	0.8690	0.95381	p.Pro175Ser	0	.	-5.249	0.250471	.	0.83311	700019	T	24325	F9	0.000000e+00	D	0.756	15971	P175S	D	.	0.40292	C/C	principal1	133829	F9_Popp_2025_carboxy_F9_specific_var224348	No											P		523	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Pro175Ser		true	c.523C>T						3551.0	139551064.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Pro175Ser						S	Jan 19, 2024					missense_variant		175.0			0.000010769711264	0.9735976624606066		Benign	139551064.0	missense_variant,splice_region_variant		0.756					Reporter			F9_Pro175Ser
F9_Pro175Ser	0.5239758224501593	0.6164710018454577	-1.8223377535932688	0.11118702752921403	2025_01_Batch_13-14	0.7099087143455147	0.7250776902536834	0.7300050971101899	0.7881197423438256	0.5947157080506009	0.49431238623440454	0.6747744992220248	0.7388275154040795	0.6853482336069867	0.47988743439077497	0.6021105502899596	0.699926094737854	0.7344163062571347	0.7367339879754062	0.5373015712206879	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030541		NC_000023.11:139551064:C:T		Pro175Ser																												F9_Pro175Ser	23	139551064	C	T	X	allele	523C>T	H07	527_CAVA_Array_P02	O14	B13A7A8P1_R1	B14A7A8P1_R2				X-139551064-C-T	-	0.47496	0.354	175	0	.	0	X	138633223	T	.	0	X	2_Benign	NC_000023.11	.	Pro175Ser	11	22.5	4	0	8.265700e-04	D	.	2	1	30931	6.410260e-05	.	18774	0.000000e+00	0	0.91637	Select	0.8615	13308	0.33728	0	.	D	T	.	1.6529612223	0	.	0.000000e+00	0	0	0.28604	13630	.	.	7.905140e-04	0.60697	0	.	0.60670	0.998	.	52.0	0.842116	.	0.48	T	single nucleotide variant	NC_000023.11:g.139551064C>T	.	12181	2	0.38183606	80161	0	0.40378746	0		8	171600	0	0	8.265700e-04	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	4	0	.	.	0.69764	B	0.62938	B	M	.	.	C/C	114	0	5698	.	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease	13125	0.95250	.	.	-	139551064	5.787870e-04	-	4.861000	0	0.91893	.	0	.	8	germline	.	Loss of catalytic residue at P175 (P = 0.0285)| Gain of relative solvent accessibility (P = 0.1571)| Gain of disorder (P = 0.1722)| Gain of solvent accessibility (P = 0.2987)| Gain of MoRF binding (P = 0.3343)	0.40807	GRCh38	924	criteria provided, single submitter	c.523C>T	0.000000e+00	0.69688	0	0	0	.	0.000000e+00	6911	B	0	.	NM_000133.4(F9):c.523C>T (p.Pro175Ser)	1	0	FA9_HUMAN	0	48.0	.	0	T	0.35518	0.40378746	+	0.000000e+00	.		8	0.000000e+00	0	27098	criteria_provided,_single_submitter	0.99978	4.989960e-05	.	0.000000e+00	0	.	p.Pro175Ser	.	0.45547	.	germline	4		C	Dec 27, 2024	0	C/C	0	64445	1.0	N	Xq27.1	9690	.	0.000000e+00	SCV001009324	Benign	0	0	Ser	S	-	.	ENSP00000218099	ENST00000218099	13308	0.036	10120	0	0.599	C	0	3.416071	0.33883	.	T	-	.	.	0.88100	610	0	.	0.26526	0	139551064	Y	10	0	73207	.	P00740	0	0.697249	0.96821		0	0.086	D	10120	0.38183606	6911	0.85369	2158	0.0546764	.	-2.89	.	.	0.44852	0.000000e+00	0	.	5.787870e-04	.	0	0.62938	X	F9	.	0	Pro	14050	0.000000e+00	X-139551064-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	0	138460889	.	.	.	.	RCV000868038|RCV001825736	D	.	0	c.523C>T	0	.	.	0.58654	C/C	rs762986355	139551064	12057	C	.	P00740	9860	0.60670	0.000000e+00	0.68239		0	0	.	2.175	0	0	264690	5.13	0.91165	112	T	T	0	0.000000e+00	0	26	.	0	0	98879	700019	0.85025	0.89525	0.345082526519166	2898	.	0.71675	.	0.000000e+00	7.905140e-04	.	4.715	5.288590e-05	D	9927	0	5.6670066E-5	0	306900|300807	0.61684	X	0.000000e+00	ENSG00000101981	.	0	0	0	0.9703241368253629	1	0.29523	0.18019	18839	15	0.000000e+00	.	.	YES	.	0.228259	689353	HGNC:3551	N	0	simple_aae	0.852	151269	139551064	CCA	1.000000	.	-	0	0.41984	.	0	.	Benign	0.39483	0	.	.	ClinGen:CA10529810	P	0	0.975270461492	-	0.388	-	0.57301	11	496	0.97004	0.425827980042	0.1096	.	0.99894604001216725	98	-	523C>T 	11	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.51695	762986355	1757	0	0.97476	.	0.463	0.161	2784	0.99996960	5.13	.	.	0.000000e+00	0.239642	0.970189561557157	0.60790	D	86	4624	7059	0.8690	0.95381	p.Pro175Ser	0	.	-5.249	0.250471	.	0.83311	700019	T	24325	F9	0.000000e+00	D	0.756	15971	P175S	D	.	0.40292	C/C	principal1	188861	F9_Popp_2025_heavy_chain_var234029	No											P		523	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Pro175Ser		true	c.523C>T						3551.0	139551064.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Pro175Ser						S	Jan 19, 2024					missense_variant		175.0			0.000010769711264	0.9909768733771436		Benign	139551064.0	missense_variant,splice_region_variant		0.756					Reporter			F9_Pro175Ser
KRAS_Pro34Leu	-1.422648105997645	0.1978359955775831	4.762868314287779	0.002052621330944476	2025_01_Batch_13-14	0.4738729661856484	0.6095449270752253	0.7513551264015575	0.6115574408962654	0.4367117374839895	0.950029664486399	0.8754404682474177	0.8875707014824106	0.9620546539726003	0.7794815559422359	0.7119513153360237	0.7424926976613215	0.819462913941984	0.7868060474344328	0.6080966467131127	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214481	CCSBVarC006093	ALE00006093	NC_000012.12:25245284:G:A	101C>T	Pro34Leu	CEGS2	CegsMutGDEh1035	F07	GDEhDisVCh_40061	H08	1	CegsMutGDDh1035	F07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Pro34Leu	12	25245284	G	A	12											12-25245284-G-A	-	0.90819	1.0	34	.	.	.	12	25398218	A	.	.	12	1_Pathogenic	NC_000012.12	.	Pro34Leu	.	31.0	.	.	.	D	.	7	1	.	.	.	.	.	.	0.95976	Plus_Clinical	0.8110	.	0.90580	.	.	D	D	.	2.72839044085	.	.	.	.	.	0.97821	.	.	.	.	0.98724	.	.	0.97281	1.0	.	2.0	0.906909	.	0.98	A	single nucleotide variant	NC_000012.12:g.25245284G>A	.	.	2	0.9655402	.	.	0.9735194	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	.	.	.	.	0.99291	D	0.97882	D	M	16.56095	.	./.	.	.	.	.	Noonan syndrome|RASopathy|Noonan syndrome 3|not provided|Noonan syndrome 1	.	0.95002	.	.	-	25245284	.	-	11.891000	.	0.99892	.	.	.	.	de novo;germline;unknown	.	Gain of catalytic residue at I36 (P = 0.0054)| Loss of disorder (P = 0.0163)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.1364)| Loss of relative solvent accessibility (P = 0.1807)	0.89476	GRCh38	707	reviewed by expert panel	c.101C>T	.	0.88004	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_004985.5(KRAS):c.101C>T (p.Pro34Leu)	3	.	RASK_HUMAN	.	98.0	1.07681546054986	.	D	0.97942	0.96042603	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99318	.	.	.	.	.	p.Pro34Leu	.	0.99094	.	germline	.		G	Sep 17, 2024	.	./.	.	.	1.0	N	12p12.1	.	.	.	SCV000616368	Pathogenic	.	.	Leu	L	-	.	ENSP00000256078	ENST00000256078	.	0.0	.	.	0.654	G	.	5.430283	0.92967	D	D	-	19.35518	.	0.90456	.	.	.	0.98005	.	25245284	Y	10	.	.	.	P01116	.	0.916481	0.94461		.	1.0	D	.	0.9422203	.	0.97202	3845	0.461598	.	-8.45	.	.	0.91343	.	.	.	.	.	.	0.99246	12	KRAS	.	.	Pro	.	.	12-25245284-G-A	Noonan_syndrome|RASopathy|Noonan_syndrome_1|not_provided|Noonan_syndrome_3	.	.	25289485	ClinGen:CA235301|UniProtKB:P01116#VAR_064852	0.907536	0.97667	.	RCV000150892|RCV000232330|RCV003152670|RCV000157668|RCV003450654	D	.	.	c.101C>T	.	.	.	0.92940	./.	rs104894366	25245284	.	G	.	P01116	.	0.98554	.	0.68239		.	.	.	3.155	.	.	.	5.68	0.98452	.	D	D	.	.	.	.	.	.	.	648|536391|648|648	40454	0.92852	0.98645	0.999580919742584	.	.	0.71675	0.86118	.	.	.	9.985	.	D	.	.	.	.	PS163950|163950|609942	0.99185	12	.	ENSG00000133703	.	.	.	.	0.9624586865523342	2	0.97365	0.56997	.	.	.	.	1.0082682822431	.	.	0.2884	48924	HGNC:6407	A	.	simple_aae	0.997	.	25245284	CCA	1.000000	.	-	.	0.92690	.	.	.	Pathogenic	0.98455	.	.	.	ClinGen:CA235301,UniProtKB:P01116#VAR_064852	P	.	0.993019268771	-	0.768	-	0.97658	.	.	0.96210	0.913879752159	0.9976	.	0.99866189682566164	.	-	101C>T 	.	.	C0028326|C5555857|C4551602|C3661900|C1860991	.	.	.	.	NM_004985.5	-	.	.	1	0.69125	104894366	.	.	0.99286	0.98773	0.966	0.0	.	0.99935130	5.68	.	.	.	0.425277	0.999893295116841	0.88323	D	.	.	.	0.8491	0.93606	p.Pro34Leu	.	.	-15.775	0.9343852	.	0.98645	40454	D	.	KRAS	.	D	0.867	.	P34L	D	.	0.53775	./.	alternative1																																																																																																				
KRAS_Pro34Leu	-1.422648105997645	0.1978359955775831	4.762868314287779	0.002052621330944476	2025_01_Batch_13-14	0.4738729661856484	0.6095449270752253	0.7513551264015575	0.6115574408962654	0.4367117374839895	0.950029664486399	0.8754404682474177	0.8875707014824106	0.9620546539726003	0.7794815559422359	0.7119513153360237	0.7424926976613215	0.819462913941984	0.7868060474344328	0.6080966467131127	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006093		NC_000012.12:25245284:G:A		Pro34Leu																												KRAS_Pro34Leu	12	25245284	G	A	12	allele	101C>T	C07	527_CAVA_Array_P03	F13	B13A7A8P1_R1	B14A7A8P1_R2				12-25245284-G-A	-	0.90819	1.0	34	.	.	.	12	25398218	A	.	.	12	1_Pathogenic	NC_000012.12	.	Pro34Leu	.	31.0	.	.	.	D	.	7	1	.	.	.	.	.	.	0.95976	Plus_Clinical	0.8110	.	0.90580	.	.	D	D	.	2.72839044085	.	.	.	.	.	0.97821	.	.	.	.	0.98724	.	.	0.97281	1.0	.	2.0	0.906909	.	0.98	A	single nucleotide variant	NC_000012.12:g.25245284G>A	.	.	2	0.9655402	.	.	0.9735194	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	.	.	.	.	0.99291	D	0.97882	D	M	16.56095	.	./.	.	.	.	.	Noonan syndrome|RASopathy|Noonan syndrome 3|not provided|Noonan syndrome 1	.	0.95002	.	.	-	25245284	.	-	11.891000	.	0.99892	.	.	.	.	de novo;germline;unknown	.	Gain of catalytic residue at I36 (P = 0.0054)| Loss of disorder (P = 0.0163)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.1364)| Loss of relative solvent accessibility (P = 0.1807)	0.89476	GRCh38	707	reviewed by expert panel	c.101C>T	.	0.88004	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_004985.5(KRAS):c.101C>T (p.Pro34Leu)	3	.	RASK_HUMAN	.	98.0	1.07681546054986	.	D	0.97942	0.96042603	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99318	.	.	.	.	.	p.Pro34Leu	.	0.99094	.	germline	.		G	Sep 17, 2024	.	./.	.	.	1.0	N	12p12.1	.	.	.	SCV000616368	Pathogenic	.	.	Leu	L	-	.	ENSP00000256078	ENST00000256078	.	0.0	.	.	0.654	G	.	5.430283	0.92967	D	D	-	19.35518	.	0.90456	.	.	.	0.98005	.	25245284	Y	10	.	.	.	P01116	.	0.916481	0.94461		.	1.0	D	.	0.9422203	.	0.97202	3845	0.461598	.	-8.45	.	.	0.91343	.	.	.	.	.	.	0.99246	12	KRAS	.	.	Pro	.	.	12-25245284-G-A	Noonan_syndrome|RASopathy|Noonan_syndrome_1|not_provided|Noonan_syndrome_3	.	.	25289485	ClinGen:CA235301|UniProtKB:P01116#VAR_064852	0.907536	0.97667	.	RCV000150892|RCV000232330|RCV003152670|RCV000157668|RCV003450654	D	.	.	c.101C>T	.	.	.	0.92940	./.	rs104894366	25245284	.	G	.	P01116	.	0.98554	.	0.68239		.	.	.	3.155	.	.	.	5.68	0.98452	.	D	D	.	.	.	.	.	.	.	648|536391|648|648	40454	0.92852	0.98645	0.999580919742584	.	.	0.71675	0.86118	.	.	.	9.985	.	D	.	.	.	.	PS163950|163950|609942	0.99185	12	.	ENSG00000133703	.	.	.	.	0.9624586865523342	2	0.97365	0.56997	.	.	.	.	1.0082682822431	.	.	0.2884	48924	HGNC:6407	A	.	simple_aae	0.997	.	25245284	CCA	1.000000	.	-	.	0.92690	.	.	.	Pathogenic	0.98455	.	.	.	ClinGen:CA235301,UniProtKB:P01116#VAR_064852	P	.	0.993019268771	-	0.768	-	0.97658	.	.	0.96210	0.913879752159	0.9976	.	0.99866189682566164	.	-	101C>T 	.	.	C0028326|C5555857|C4551602|C3661900|C1860991	.	.	.	.	NM_004985.5	-	.	.	1	0.69125	104894366	.	.	0.99286	0.98773	0.966	0.0	.	0.99935130	5.68	.	.	.	0.425277	0.999893295116841	0.88323	D	.	.	.	0.8491	0.93606	p.Pro34Leu	.	.	-15.775	0.9343852	.	0.98645	40454	D	.	KRAS	.	D	0.867	.	P34L	D	.	0.53775	./.	alternative1																																																																																																				
KRAS_Gly13Asp	-1.6558698671862377	0.1417194965294439	2.6206139205304035	0.03437849113816	2025_01_Batch_13-14	0.6073739488369176	0.8428727998723612	0.6736711985672156	0.6966658948865165	0.47154727380685507	0.8983153587583257	0.8690736096713144	0.8344384019008955	0.9277204216231002	0.6647689545354385	0.7528446537976217	0.8559732047718378	0.7540548002340555	0.8121931582548083	0.5681581141711468	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214486	CCSBVarC006091	ALE00006091	NC_000012.12:25245347:C:T	38G>A	Gly13Asp	CEGS2	CegsMutGDEh1039	E06	GDEhDisVCh_40061	E09	1	CegsMutGDDh1039	E06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Gly13Asp	12	25245347	C	T	12											12-25245347-C-T	-	0.82721	0.803	13	.	0	.	12	25398281	T	3.100210e-06	.	12	1_Pathogenic	NC_000012.12	5	Gly13Asp	.	27.9	.	0	.	D	0	15	1	.	.	.	.	.	0	0.94675	Plus_Clinical	0.6901	.	0.45147	.	.	D	D	63986	2.43727951051	0	0	.	.	.	0.98765	.	44868	0	.	0.92581	.	.	0.91352	0.999	.	0.0	0.853715	.	1.0	T	single nucleotide variant	NC_000012.12:g.25245347C>T	0	.	3	0.8511729	.	0	0.91416115	0	T	.	.	.	.	.	146	.	0	MONDO:MONDO:0004988,MedGen:C0858252||Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015278,MedGen:C2931038,OMIM:260350,Orphanet:1333|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114||MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396	.	.	0.000000e+00	0	0.99291	P	0.94268	P	M	6.423009	5	./.	108	0	.	1612796	Breast adenocarcinoma|OCULOECTODERMAL SYNDROME, SOMATIC|Nevus sebaceous|Neoplasm|RASopathy|Familial pancreatic carcinoma|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|KRAS-related disorder|not provided|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Encephalocraniocutaneous lipomatosis	.	0.91461	.	.	-	25245347	.	-	5.998000	.	0.99826	29526	0	1179366	.	germline;somatic;unknown	90796	Gain of catalytic residue at A11 (P = 0)| Gain of solvent accessibility (P = 0.0648)| Loss of ubiquitination at K16 (P = 0.1191)| Loss of methylation at K16 (P = 0.1236)| Gain of relative solvent accessibility (P = 0.1684)	0.85604	GRCh38	707	criteria provided, multiple submitters, no conflicts	c.38G>A	.	0.88004	0	.	.	Small GTP-binding domain	.	.	P	0	0.000000e+00	NM_004985.5(KRAS):c.38G>A (p.Gly13Asp)	2	.	RASK_HUMAN	.	100.0	0.645709001054705	.	D	0.98262	0.90101796	-	.	.	1.36928e-6	.	.	0	.	criteria_provided,_conflicting_classifications	0.98875	.	0	.	.	59938	p.Gly13Asp	0	0.52513	.	germline/somatic	.	25245347	C	Dec 18, 2024	.	./.	.	.	1.0	N	12p12.1	7618	.	.	SCV000061938|SCV001248878|SCV001444340|SCV001737088|SCV002016398|SCV002060774|SCV002117438|SCV005438357	Conflicting_classifications_of_pathogenicity	.	.	Asp	D	-	912	ENSP00000256078	ENST00000256078	.	0.032	.	.	0.58	C	.	4.988767	0.60671	D	D	-	7.528909	.	0.87991	610	.	.	0.84461	0	25245347	Y	10	0	.	0.000000e+00	P01116	.	0.897336	0.91720	C	.	0.506	D	.	0.8911059	.	0.91597	3845	0.43077	5	-5.4	.	4.239570e-06	0.54841	.	.	74896	.	6084	.	0.91471	12	KRAS	0.000000e+00	0	Gly	11862	.	12-25245347-C-T	Juvenile_myelomonocytic_leukemia|OCULOECTODERMAL_SYNDROME,_SOMATIC|Noonan_syndrome_and_Noonan-related_syndrome|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Inborn_genetic_diseases|Acute_myeloid_leukemia|not_provided|RASopathy|Breast_adenocarcinoma|Ovarian_neoplasm|Non-small_cell_lung_carcinoma|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|KRAS-related_disorder	0	.	25289548	ClinGen:CA122534|OMIM:190070.0003|UniProtKB:P01116#VAR_016029	0.894850	0.75963	0	RCV000013409|RCV000791297|RCV001526657|RCV004668723|RCV001857340|RCV004813034|RCV000038269|RCV000144967|RCV000144968|RCV004549358|RCV001092389|RCV001266168|RCV001813183|RCV001839444	D	0	.	c.38G>A	.	0	0	0.91511	./.	rs112445441	25245347	.	C	.	P01116	.	0.92578	.	0.68239	12	.	.	0.000000e+00	3.025	0	0	.	5.68	0.97939	108	D	D	.	.	0	24	.	.	.	86834|98733|2396|100087|519|536391|268114	12580	0.91406	0.97301	0.993683218955994	2816	.	0.71675	0.83365	.	.	1179366	7.892	.	D	.	.	.	0	607785|613001|601626|614470	0.85894	12	.	ENSG00000133703	0.000000e+00	0	.	0	0.9548591274127232	2	0.47822	0.56997	.	.	.	0.000000e+00	0.687742056596172	.	0.000000e+00	0.225927	27619	HGNC:6407	A	.	simple_aae	0.995	.	25245347	GGC	1.000000	.	SCV005094256	0	0.89322	4.239570e-06	0	0	Pathogenic	0.73003	.	0	0	ClinGen:CA122534,UniProtKB:P01116#VAR_016029,OMIM:190070.0003	G	.	0.974405323578	Mar 04, 2025	0.722	Oncogenic	0.98762	.	470	0.95442	0.92631560564	0.998	0	0.99835685265907259	94	criteria provided, single submitter	38G>A 	.	0	C0349639|C5681679|C0406612|C0009404|C0040136|C0950123|C0023467|C3661900|C5555857|C0858252|C0919267|C0007131|C2674723|C3854181	.	.	.	.	NM_004985.5	-	.	.	1	0.56129	112445441	.	0	0.97388	0.81343	0.977	0.023	2708	0.99862206	5.68	.	.	.	0.380995	0.999983137957112	0.86187	D	84	.	.	0.5692	0.89270	p.Gly13Asp	0	0	-9.831	0.9007832	0	0.99579	12580	D	.	KRAS	.	D	0.832	.	G13D	D	.	0.29757	./.	alternative1																																																																																																				
KRAS_Gly13Asp	-1.6558698671862377	0.1417194965294439	2.6206139205304035	0.03437849113816	2025_01_Batch_13-14	0.6073739488369176	0.8428727998723612	0.6736711985672156	0.6966658948865165	0.47154727380685507	0.8983153587583257	0.8690736096713144	0.8344384019008955	0.9277204216231002	0.6647689545354385	0.7528446537976217	0.8559732047718378	0.7540548002340555	0.8121931582548083	0.5681581141711468	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006091		NC_000012.12:25245347:C:T		Gly13Asp																												KRAS_Gly13Asp	12	25245347	C	T	12	allele	38G>A	G08	527_CAVA_Array_P03	N15	B13A7A8P1_R1	B14A7A8P1_R2				12-25245347-C-T	-	0.82721	0.803	13	.	0	.	12	25398281	T	3.100210e-06	.	12	1_Pathogenic	NC_000012.12	5	Gly13Asp	.	27.9	.	0	.	D	0	15	1	.	.	.	.	.	0	0.94675	Plus_Clinical	0.6901	.	0.45147	.	.	D	D	63986	2.43727951051	0	0	.	.	.	0.98765	.	44868	0	.	0.92581	.	.	0.91352	0.999	.	0.0	0.853715	.	1.0	T	single nucleotide variant	NC_000012.12:g.25245347C>T	0	.	3	0.8511729	.	0	0.91416115	0	T	.	.	.	.	.	146	.	0	MONDO:MONDO:0004988,MedGen:C0858252||Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015278,MedGen:C2931038,OMIM:260350,Orphanet:1333|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114||MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396	.	.	0.000000e+00	0	0.99291	P	0.94268	P	M	6.423009	5	./.	108	0	.	1612796	Breast adenocarcinoma|OCULOECTODERMAL SYNDROME, SOMATIC|Nevus sebaceous|Neoplasm|RASopathy|Familial pancreatic carcinoma|Non-small cell lung carcinoma|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|KRAS-related disorder|not provided|Inborn genetic diseases|Noonan syndrome and Noonan-related syndrome|Encephalocraniocutaneous lipomatosis	.	0.91461	.	.	-	25245347	.	-	5.998000	.	0.99826	29526	0	1179366	.	germline;somatic;unknown	90796	Gain of catalytic residue at A11 (P = 0)| Gain of solvent accessibility (P = 0.0648)| Loss of ubiquitination at K16 (P = 0.1191)| Loss of methylation at K16 (P = 0.1236)| Gain of relative solvent accessibility (P = 0.1684)	0.85604	GRCh38	707	criteria provided, multiple submitters, no conflicts	c.38G>A	.	0.88004	0	.	.	Small GTP-binding domain	.	.	P	0	0.000000e+00	NM_004985.5(KRAS):c.38G>A (p.Gly13Asp)	2	.	RASK_HUMAN	.	100.0	0.645709001054705	.	D	0.98262	0.90101796	-	.	.	1.36928e-6	.	.	0	.	criteria_provided,_conflicting_classifications	0.98875	.	0	.	.	59938	p.Gly13Asp	0	0.52513	.	germline/somatic	.	25245347	C	Dec 18, 2024	.	./.	.	.	1.0	N	12p12.1	7618	.	.	SCV000061938|SCV001248878|SCV001444340|SCV001737088|SCV002016398|SCV002060774|SCV002117438|SCV005438357	Conflicting_classifications_of_pathogenicity	.	.	Asp	D	-	912	ENSP00000256078	ENST00000256078	.	0.032	.	.	0.58	C	.	4.988767	0.60671	D	D	-	7.528909	.	0.87991	610	.	.	0.84461	0	25245347	Y	10	0	.	0.000000e+00	P01116	.	0.897336	0.91720	C	.	0.506	D	.	0.8911059	.	0.91597	3845	0.43077	5	-5.4	.	4.239570e-06	0.54841	.	.	74896	.	6084	.	0.91471	12	KRAS	0.000000e+00	0	Gly	11862	.	12-25245347-C-T	Juvenile_myelomonocytic_leukemia|OCULOECTODERMAL_SYNDROME,_SOMATIC|Noonan_syndrome_and_Noonan-related_syndrome|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Inborn_genetic_diseases|Acute_myeloid_leukemia|not_provided|RASopathy|Breast_adenocarcinoma|Ovarian_neoplasm|Non-small_cell_lung_carcinoma|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|KRAS-related_disorder	0	.	25289548	ClinGen:CA122534|OMIM:190070.0003|UniProtKB:P01116#VAR_016029	0.894850	0.75963	0	RCV000013409|RCV000791297|RCV001526657|RCV004668723|RCV001857340|RCV004813034|RCV000038269|RCV000144967|RCV000144968|RCV004549358|RCV001092389|RCV001266168|RCV001813183|RCV001839444	D	0	.	c.38G>A	.	0	0	0.91511	./.	rs112445441	25245347	.	C	.	P01116	.	0.92578	.	0.68239	12	.	.	0.000000e+00	3.025	0	0	.	5.68	0.97939	108	D	D	.	.	0	24	.	.	.	86834|98733|2396|100087|519|536391|268114	12580	0.91406	0.97301	0.993683218955994	2816	.	0.71675	0.83365	.	.	1179366	7.892	.	D	.	.	.	0	607785|613001|601626|614470	0.85894	12	.	ENSG00000133703	0.000000e+00	0	.	0	0.9548591274127232	2	0.47822	0.56997	.	.	.	0.000000e+00	0.687742056596172	.	0.000000e+00	0.225927	27619	HGNC:6407	A	.	simple_aae	0.995	.	25245347	GGC	1.000000	.	SCV005094256	0	0.89322	4.239570e-06	0	0	Pathogenic	0.73003	.	0	0	ClinGen:CA122534,UniProtKB:P01116#VAR_016029,OMIM:190070.0003	G	.	0.974405323578	Mar 04, 2025	0.722	Oncogenic	0.98762	.	470	0.95442	0.92631560564	0.998	0	0.99835685265907259	94	criteria provided, single submitter	38G>A 	.	0	C0349639|C5681679|C0406612|C0009404|C0040136|C0950123|C0023467|C3661900|C5555857|C0858252|C0919267|C0007131|C2674723|C3854181	.	.	.	.	NM_004985.5	-	.	.	1	0.56129	112445441	.	0	0.97388	0.81343	0.977	0.023	2708	0.99862206	5.68	.	.	.	0.380995	0.999983137957112	0.86187	D	84	.	.	0.5692	0.89270	p.Gly13Asp	0	0	-9.831	0.9007832	0	0.99579	12580	D	.	KRAS	.	D	0.832	.	G13D	D	.	0.29757	./.	alternative1																																																																																																				
RET_Val262Ala	-0.24949633256160386	0.8101398810197044	4.814403588905587	0.0019338869466561507	2025_01_Batch_13-14	0.8362120849218995	0.7781827768721448	0.9195076526268073	0.8840339082178769	0.7887272756339547	0.5811504652840943	0.7363850843844051	0.8692173993816996	0.7323775022120607	0.5632976111910845	0.7086812751029969	0.7572839306282749	0.8943625260042535	0.8082057052149687	0.6760124434125196	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET	ENSG00000165731	8858	202951	CCSBVarC006876	ALE00006874	NC_000010.11:43105111:T:C	785T>C	Val262Ala	CEGS2	CegsMutGDEh1029	C02	GDEhDisVCh_40066	C06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Val262Ala	10	43105111	T	C	10											10-43105111-T-C	-	0.88433	0.676	262	33	2	0	10	43600559	C	2.151970e-04	1	10	3_Conflicting	NC_000010.11	38	Val262Ala	0	29.6	0	1	4.267610e-04	D	2	17	5	42450	2.400570e-04	0	30462	0.000000e+00	0	0.91294	Select	0.6452	30462	0.41333	3	0.0	D	D	62808	1.39902537186	2.8968713789107763E-4	0	1.049760e-04	0	0	0.60534	17006	44818	34	0.000000e+00	0.53442	10	.	0.78674	0.946	0.0	40.0	0.812119	3.23	0.6	C	single nucleotide variant	NC_000010.11:g.43105111T>C	0	16134	2	0.51304674	108014	0	0.6398909	0	C	57	233278	0	0	0.000000e+00	498	2.355710e-04	0	MedGen:C3661900|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MedGen:CN169374|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|	21	2	1.096490e-03	1	0.76851	P	0.68880	P	M	3.331407	347	T/T	122	6	6988	1612474	not provided|Aganglionic megacolon|not specified|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Multiple endocrine neoplasia|RET-related disorder	15892	0.87004	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43105111	4.474560e-04	-	7.817000	1	0.70601	29562	0	6044	0	germline;unknown	91062	.	.	GRCh38	862	criteria provided, conflicting classifications	c.785T>C	4.267610e-04	0.40795	26	0	1	Cadherin-like	1.239620e-04	8944	P	0	6.765440e-05	NM_020975.6(RET):c.785T>C (p.Val262Ala)	1	0	RET_HUMAN	0	60.0	0.206366859142037	2	T	0.80456	0.7156541	+	0.000000e+00	0	0.000210916	13	1.629200e-04	0	34114	criteria_provided,_conflicting_classifications	0.99849	1.944190e-04	2	1.562500e-04	0	59988	p.Val262Ala	2	0.69666	.	germline	7	43105111	T	Feb 04, 2025	13	T/T	0	86794	1.0	N	10q11.21	38968	.	6.292470e-05	SCV000166634|SCV000279597|SCV000540171|SCV000664464|SCV000786544|SCV000822200|SCV000838371|SCV000891636|SCV001260709|SCV001260710|SCV001260711|SCV001261020|SCV002062909|SCV002068400|SCV002527924	Conflicting_classifications_of_pathogenicity	2	1	Ala	A	-	912	ENSP00000347942	ENST00000355710	17590	0.002	13250	0	0.663	T	0	5.265842	0.65108	D	D	-	3.284379	.	0.89793	628	0	9.940357852882703E-4	0.13282	0	43105111	Y	10	0	100690	6.287230e-03	P07949	0	0.747582	0.52036	T	0	0.568	D	30536	0.46798772	15644	0.49004	5979	0.147568	229	-2.44	0.0	6.287230e-03	0.72322	4.474560e-04	0	74994	0.000000e+00	6044	0	0.71604	10	RET	9.334080e-05	0	Val	51240	3.802110e-04	10-43105111-T-C	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon|RET-related_disorder|not_provided|not_specified|Pheochromocytoma	0	32	42920565	ClinGen:CA009350	0.704574	0.51267	0	RCV000034777|RCV000148775|RCV000223157|RCV000123327|RCV000663296|RCV001103896|RCV001103897|RCV001103898|RCV000573525|RCV001269367|RCV001104177|RCV004528165	T	0	0	c.785T>C	0	0	3	0.68816	T/T	rs139790943	43105111	14656	T	1.9968051118210862E-4	.	15644	0.74551	9.673050e-05	0.68239	10	0	0	0.000000e+00	2.325	0	19	264690	3.64	0.92993	168	T	T	1	6.588920e-05	0	56	.	0	2	411709|276161|653|140162|247698|653|388|388|29072	41845	0.87936	0.85084	0.110290273663753	3574	1	0.71675	0.65902	8.794040e-05	4.257270e-04	1179820	5.516	2.795600e-04	N	12800	0	2.531263E-4	0	191830|PS131100|171400|142623|PS142623|171300	0.66847	10	6.823140e-05	ENSG00000165731	4.776460e-05	4.87579552453295E-4	13	0	0.9449520661963712	2	0.49805	0.33096	30536	67	3.178070e-04	1.833700e-04	0.220349645155146	YES	3.733720e-04	0.269317	50284	HGNC:9967	D	0	simple_aae	0.487	203892	43105111	GTG	1.000000	0	-	2.797985450475658E-4	0.40642	1.940970e-04	1	0	Conflicting classifications of pathogenicity	0.84188	7	38	11	ClinGen:CA009350	V	0	0.986075961623	-	.	-	0.94561	56	7306	0.94443	0.654298603535	0.7004	0	0.99080146142778192	98	-	785T>C 	13	8.212428141253764E-4	C1619700|C0027662|C4048306|C0027672|C0006142|C0025268|C3888239|C0019569|C3661900|CN169374|C0031511	0	0	0	0	NM_020975.6	-	1	0.0	0	0.46196	139790943	2296	5.07416081186573E-4	0.98577	0.50723	0.4	0.011	3452	0.99988472	4.79	.	.	4.257270e-04	0.296161	0.998087980433202	0.66439	D	112	6138	9526	0.2692	0.87575	p.Val262Ala	0	0	-11.708	0.23900184	7	0.93939	41845	D	30354	RET	5.880280e-05	D	0.748	20676	.	D	0.58548	0.56753	T/T	principal4																																																																																																				
RET_Val262Ala	-0.24949633256160386	0.8101398810197044	4.814403588905587	0.0019338869466561507	2025_01_Batch_13-14	0.8362120849218995	0.7781827768721448	0.9195076526268073	0.8840339082178769	0.7887272756339547	0.5811504652840943	0.7363850843844051	0.8692173993816996	0.7323775022120607	0.5632976111910845	0.7086812751029969	0.7572839306282749	0.8943625260042535	0.8082057052149687	0.6760124434125196	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET		8858		CCSBVarC006876		NC_000010.11:43105111:T:C		Val262Ala																												RET_Val262Ala	10	43105111	T	C	10	allele	785T>C	F08	527_CAVA_Array_P05	K15	B13A7A8P2_R1	B14A7A8P2_R2				10-43105111-T-C	-	0.88433	0.676	262	33	2	0	10	43600559	C	2.151970e-04	1	10	3_Conflicting	NC_000010.11	38	Val262Ala	0	29.6	0	1	4.267610e-04	D	2	17	5	42450	2.400570e-04	0	30462	0.000000e+00	0	0.91294	Select	0.6452	30462	0.41333	3	0.0	D	D	62808	1.39902537186	2.8968713789107763E-4	0	1.049760e-04	0	0	0.60534	17006	44818	34	0.000000e+00	0.53442	10	.	0.78674	0.946	0.0	40.0	0.812119	3.23	0.6	C	single nucleotide variant	NC_000010.11:g.43105111T>C	0	16134	2	0.51304674	108014	0	0.6398909	0	C	57	233278	0	0	0.000000e+00	498	2.355710e-04	0	MedGen:C3661900|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MedGen:CN169374|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|	21	2	1.096490e-03	1	0.76851	P	0.68880	P	M	3.331407	347	T/T	122	6	6988	1612474	not provided|Aganglionic megacolon|not specified|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A|Hirschsprung disease, susceptibility to, 1|Pheochromocytoma|Renal hypodysplasia/aplasia 1|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Multiple endocrine neoplasia|RET-related disorder	15892	0.87004	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43105111	4.474560e-04	-	7.817000	1	0.70601	29562	0	6044	0	germline;unknown	91062	.	.	GRCh38	862	criteria provided, conflicting classifications	c.785T>C	4.267610e-04	0.40795	26	0	1	Cadherin-like	1.239620e-04	8944	P	0	6.765440e-05	NM_020975.6(RET):c.785T>C (p.Val262Ala)	1	0	RET_HUMAN	0	60.0	0.206366859142037	2	T	0.80456	0.7156541	+	0.000000e+00	0	0.000210916	13	1.629200e-04	0	34114	criteria_provided,_conflicting_classifications	0.99849	1.944190e-04	2	1.562500e-04	0	59988	p.Val262Ala	2	0.69666	.	germline	7	43105111	T	Feb 04, 2025	13	T/T	0	86794	1.0	N	10q11.21	38968	.	6.292470e-05	SCV000166634|SCV000279597|SCV000540171|SCV000664464|SCV000786544|SCV000822200|SCV000838371|SCV000891636|SCV001260709|SCV001260710|SCV001260711|SCV001261020|SCV002062909|SCV002068400|SCV002527924	Conflicting_classifications_of_pathogenicity	2	1	Ala	A	-	912	ENSP00000347942	ENST00000355710	17590	0.002	13250	0	0.663	T	0	5.265842	0.65108	D	D	-	3.284379	.	0.89793	628	0	9.940357852882703E-4	0.13282	0	43105111	Y	10	0	100690	6.287230e-03	P07949	0	0.747582	0.52036	T	0	0.568	D	30536	0.46798772	15644	0.49004	5979	0.147568	229	-2.44	0.0	6.287230e-03	0.72322	4.474560e-04	0	74994	0.000000e+00	6044	0	0.71604	10	RET	9.334080e-05	0	Val	51240	3.802110e-04	10-43105111-T-C	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon|RET-related_disorder|not_provided|not_specified|Pheochromocytoma	0	32	42920565	ClinGen:CA009350	0.704574	0.51267	0	RCV000034777|RCV000148775|RCV000223157|RCV000123327|RCV000663296|RCV001103896|RCV001103897|RCV001103898|RCV000573525|RCV001269367|RCV001104177|RCV004528165	T	0	0	c.785T>C	0	0	3	0.68816	T/T	rs139790943	43105111	14656	T	1.9968051118210862E-4	.	15644	0.74551	9.673050e-05	0.68239	10	0	0	0.000000e+00	2.325	0	19	264690	3.64	0.92993	168	T	T	1	6.588920e-05	0	56	.	0	2	411709|276161|653|140162|247698|653|388|388|29072	41845	0.87936	0.85084	0.110290273663753	3574	1	0.71675	0.65902	8.794040e-05	4.257270e-04	1179820	5.516	2.795600e-04	N	12800	0	2.531263E-4	0	191830|PS131100|171400|142623|PS142623|171300	0.66847	10	6.823140e-05	ENSG00000165731	4.776460e-05	4.87579552453295E-4	13	0	0.9449520661963712	2	0.49805	0.33096	30536	67	3.178070e-04	1.833700e-04	0.220349645155146	YES	3.733720e-04	0.269317	50284	HGNC:9967	D	0	simple_aae	0.487	203892	43105111	GTG	1.000000	0	-	2.797985450475658E-4	0.40642	1.940970e-04	1	0	Conflicting classifications of pathogenicity	0.84188	7	38	11	ClinGen:CA009350	V	0	0.986075961623	-	.	-	0.94561	56	7306	0.94443	0.654298603535	0.7004	0	0.99080146142778192	98	-	785T>C 	13	8.212428141253764E-4	C1619700|C0027662|C4048306|C0027672|C0006142|C0025268|C3888239|C0019569|C3661900|CN169374|C0031511	0	0	0	0	NM_020975.6	-	1	0.0	0	0.46196	139790943	2296	5.07416081186573E-4	0.98577	0.50723	0.4	0.011	3452	0.99988472	4.79	.	.	4.257270e-04	0.296161	0.998087980433202	0.66439	D	112	6138	9526	0.2692	0.87575	p.Val262Ala	0	0	-11.708	0.23900184	7	0.93939	41845	D	30354	RET	5.880280e-05	D	0.748	20676	.	D	0.58548	0.56753	T/T	principal4																																																																																																				
RAD51D_Glu307Lys	-3.404294044082903	0.011375795993745073	0.8497515553009464	0.4235704158061365	2025_01_Batch_13-14	0.9947048700755531	0.9590398418311258	0.9502312770001002	0.9765785759640803	0.9819097374301679	0.9298728681393036	0.9693014477509644	0.9842264895359032	0.9824305982077703	0.8783337045721995	0.9622888691074283	0.9641706447910451	0.9672288832680017	0.9795045870859254	0.9301217210011836	1.0	1.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	1.0	RAD51D	RAD51D		7201		CCSBVarC024889		NC_000017.11:35101021:C:T		Glu307Lys																												RAD51D_Glu307Lys	17	35101021	C	T	17	allele	919G>A	F02	527_CAVA_Array_P05	K03	B13A7A8P2_R1	B14A7A8P2_R2				17-35101021-C-T	-	0.36098	0.001	307	0	0	0	17	33428040	T	1.555340e-04	2	17	3_Conflicting	NC_000017.11	217	Glu307Lys	0	20.1	0	28	3.019730e-03	T	2	12	1	42768	2.363390e-04	3	30526	0.000000e+00	0	0.38573	Select	0.0695	14902	0.15546	9	0.0	T	T	64046	.	0.0031201248049922	2	0.000000e+00	0	0	.	17112	44888	0	0.000000e+00	0.33974	0	.	0.13031	0.789	0.0022692889561270802	96.0	.	1.06	0.04	T	single nucleotide variant	NC_000017.11:g.35101021C>T	0	16734	2	0.07841017	109408	0	0.06279154	0		55	236948	0	0	0.000000e+00	460	0.000000e+00	3	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562||MedGen:C1333600	20	0	0.000000e+00	0	0.16373	B	0.17544	B	L	1.273859	251	C/C	362	0	7164	1613792	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Malignant tumor of breast|Breast and/or ovarian cancer|RAD51D-related disorder|Hereditary cancer	16218	0.08363	0	.	-	35101021	2.372980e-03	-	4.830000	46	0.04173	29602	0	75054	0	germline;unknown	91070	.	.	GRCh38	913	criteria provided, conflicting classifications	c.919G>A	0.000000e+00	0.48586	32	0	0	.	0.000000e+00	9046	LB	0	0.000000e+00	NM_002878.4(RAD51D):c.919G>A (p.Glu307Lys)	1	0	RA51D_HUMAN	0	4.0	-0.451516097100692	8	.	0.48302	0.06279154	-	2.372980e-03	0		46	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.84992	1.828020e-04	2	0.000000e+00	0	60010	p.Glu307Lys	0	0.45268	.	germline	17		C	Feb 02, 2025	0	C/C	0	89556	1.0	N	17q12	167370	.	2.836350e-03	SCV000149730|SCV000185235|SCV000287733|SCV000602170|SCV000859940|SCV000910718|SCV000918142|SCV001140404|SCV002527051|SCV003838853	Conflicting_classifications_of_pathogenicity	0	0	Lys	K	-	912	ENSP00000338790	ENST00000345365	17692	0.178	13416	0	-0.187	C	0	2.74903	0.28071	N	T	-	1.572344	.	0.25268	1024	0	0.0	0.00910	0	35101021	Y	10	0	102744	0.000000e+00	O75771	0	0.12397	0.27048		0	0.003	T	16218	0.07841017	7164	0.37304	5892	-0.436555	3	-1.37	0.0	2.891250e-03	0.22252	0.000000e+00	0	75054	0.000000e+00	6062	17	0.17544	17	RAD51D	2.891250e-03	0	Glu	196172	0.000000e+00	17-35101021-C-T	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|RAD51D-related_disorder	0	0	30452153	ClinGen:CA287990	0.227759	0.23421	0	RCV000115821|RCV000212975|RCV000656966|RCV000989829|RCV001354385|RCV003149803|RCV003905100|RCV004700423	T	0	0	c.919G>A	0	0	0	0.01267	C/C	rs115031549	35101021	14902	C	5.990415335463259E-4	.	15690	0.13032	0.000000e+00	0.68239		0	0	0.000000e+00	0.975	0.008287292817679558	1	264690	4.19	0.44563	6308	T	.	45	2.620890e-04	0	1820	.	0	0	140162|145	127895	0.32684	0.10516	0.0220424253485093	9336	3	0.71675	0.34944	2.626970e-04	2.836350e-03	1179658	2.03	2.642530e-04	N	13394	0	8.9916505E-4	0	614291	0.40832	17	3.019730e-03	ENSG00000185379	0.000000e+00	5.9747864013861505E-6	0	0	.	1	0.17739	0.21155	30608	238	0.000000e+00	3.332780e-04	-0.296002730575465	YES	0.000000e+00	0.009794	133352	HGNC:9823	N	0	simple_aae	0.024	208134	35101021	GAG	1.000000	0	-	0.0033204798628963155	0.00128	2.543110e-06	31	0	Conflicting classifications of pathogenicity	0.19068	0	0	20	ClinGen:CA287990	E	0	0.607307720492	-	.	-	0.40913	56	11378	0.58340	.	0.2196	0	0.95388473665255458	296	-	919G>A 	45	0	C0027672|CN169374|C3661900|C3280345|C0006142|CN221562	0	0	0	0	NM_002878.4	-	0	0.0	0	0.44143	115031549	2320	1.6312215810615173E-4	0.60114	0.27912	0.183	1.0	8974	0.64807075	5.16	.	.	0.000000e+00	-0.402908	0.00210343958860793	0.24371	T	4488	6212	9572	-1.0750	0.28228	p.Glu307Lys	0	0	-3.296	0.005851954	217	0.13347	127895	T	30524	RAD51D	1.168770e-04	T	0.146	21632	.	T	0.29739	0.09644	C/C	principal1	959089	RAD51D_unpublished_var153336	Yes						overall function		Cell survival			E		919	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Glu307Lys		true	c.919G>A						9823.0	35101021.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		A									criteria provided, conflicting classifications				Glu307Lys						K	Sep 11, 2024					missense_variant		307.0	G		0.0001555342943824	-0.0106997		Conflicting classifications of pathogenicity	35101021.0	missense_variant		0.146	functionally_normal				Cell viability			RAD51D_Glu307Lys
RAD51D_Glu307Lys	-3.404294044082903	0.011375795993745073	0.8497515553009464	0.4235704158061365	2025_01_Batch_13-14	0.9947048700755531	0.9590398418311258	0.9502312770001002	0.9765785759640803	0.9819097374301679	0.9298728681393036	0.9693014477509644	0.9842264895359032	0.9824305982077703	0.8783337045721995	0.9622888691074283	0.9641706447910451	0.9672288832680017	0.9795045870859254	0.9301217210011836	1.0	1.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	1.0	RAD51D	RAD51D				CCSBVarC024889	ALE00029718	NC_000017.11:35101021:C:T	919G>A	Glu307Lys	CAVA																											RAD51D_Glu307Lys	17	35101021	C	T	17								1	1	1	17-35101021-C-T	-	0.36098	0.001	307	0	0	0	17	33428040	T	1.555340e-04	2	17	3_Conflicting	NC_000017.11	217	Glu307Lys	0	20.1	0	28	3.019730e-03	T	2	12	1	42768	2.363390e-04	3	30526	0.000000e+00	0	0.38573	Select	0.0695	14902	0.15546	9	0.0	T	T	64046	.	0.0031201248049922	2	0.000000e+00	0	0	.	17112	44888	0	0.000000e+00	0.33974	0	.	0.13031	0.789	0.0022692889561270802	96.0	.	1.06	0.04	T	single nucleotide variant	NC_000017.11:g.35101021C>T	0	16734	2	0.07841017	109408	0	0.06279154	0		55	236948	0	0	0.000000e+00	460	0.000000e+00	3	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562||MedGen:C1333600	20	0	0.000000e+00	0	0.16373	B	0.17544	B	L	1.273859	251	C/C	362	0	7164	1613792	Hereditary cancer-predisposing syndrome|not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Malignant tumor of breast|Breast and/or ovarian cancer|RAD51D-related disorder|Hereditary cancer	16218	0.08363	0	.	-	35101021	2.372980e-03	-	4.830000	46	0.04173	29602	0	75054	0	germline;unknown	91070	.	.	GRCh38	913	criteria provided, conflicting classifications	c.919G>A	0.000000e+00	0.48586	32	0	0	.	0.000000e+00	9046	LB	0	0.000000e+00	NM_002878.4(RAD51D):c.919G>A (p.Glu307Lys)	1	0	RA51D_HUMAN	0	4.0	-0.451516097100692	8	.	0.48302	0.06279154	-	2.372980e-03	0		46	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.84992	1.828020e-04	2	0.000000e+00	0	60010	p.Glu307Lys	0	0.45268	.	germline	17		C	Feb 02, 2025	0	C/C	0	89556	1.0	N	17q12	167370	.	2.836350e-03	SCV000149730|SCV000185235|SCV000287733|SCV000602170|SCV000859940|SCV000910718|SCV000918142|SCV001140404|SCV002527051|SCV003838853	Conflicting_classifications_of_pathogenicity	0	0	Lys	K	-	912	ENSP00000338790	ENST00000345365	17692	0.178	13416	0	-0.187	C	0	2.74903	0.28071	N	T	-	1.572344	.	0.25268	1024	0	0.0	0.00910	0	35101021	Y	10	0	102744	0.000000e+00	O75771	0	0.12397	0.27048		0	0.003	T	16218	0.07841017	7164	0.37304	5892	-0.436555	3	-1.37	0.0	2.891250e-03	0.22252	0.000000e+00	0	75054	0.000000e+00	6062	17	0.17544	17	RAD51D	2.891250e-03	0	Glu	196172	0.000000e+00	17-35101021-C-T	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|RAD51D-related_disorder	0	0	30452153	ClinGen:CA287990	0.227759	0.23421	0	RCV000115821|RCV000212975|RCV000656966|RCV000989829|RCV001354385|RCV003149803|RCV003905100|RCV004700423	T	0	0	c.919G>A	0	0	0	0.01267	C/C	rs115031549	35101021	14902	C	5.990415335463259E-4	.	15690	0.13032	0.000000e+00	0.68239		0	0	0.000000e+00	0.975	0.008287292817679558	1	264690	4.19	0.44563	6308	T	.	45	2.620890e-04	0	1820	.	0	0	140162|145	127895	0.32684	0.10516	0.0220424253485093	9336	3	0.71675	0.34944	2.626970e-04	2.836350e-03	1179658	2.03	2.642530e-04	N	13394	0	8.9916505E-4	0	614291	0.40832	17	3.019730e-03	ENSG00000185379	0.000000e+00	5.9747864013861505E-6	0	0	.	1	0.17739	0.21155	30608	238	0.000000e+00	3.332780e-04	-0.296002730575465	YES	0.000000e+00	0.009794	133352	HGNC:9823	N	0	simple_aae	0.024	208134	35101021	GAG	1.000000	0	-	0.0033204798628963155	0.00128	2.543110e-06	31	0	Conflicting classifications of pathogenicity	0.19068	0	0	20	ClinGen:CA287990	E	0	0.607307720492	-	.	-	0.40913	56	11378	0.58340	.	0.2196	0	0.95388473665255458	296	-	919G>A 	45	0	C0027672|CN169374|C3661900|C3280345|C0006142|CN221562	0	0	0	0	NM_002878.4	-	0	0.0	0	0.44143	115031549	2320	1.6312215810615173E-4	0.60114	0.27912	0.183	1.0	8974	0.64807075	5.16	.	.	0.000000e+00	-0.402908	0.00210343958860793	0.24371	T	4488	6212	9572	-1.0750	0.28228	p.Glu307Lys	0	0	-3.296	0.005851954	217	0.13347	127895	T	30524	RAD51D	1.168770e-04	T	0.146	21632	.	T	0.29739	0.09644	C/C	principal1	959089	RAD51D_unpublished_var153336	Yes						overall function		Cell survival			E		919	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Glu307Lys		true	c.919G>A						9823.0	35101021.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		A									criteria provided, conflicting classifications				Glu307Lys						K	Sep 11, 2024					missense_variant		307.0	G		0.0001555342943824	-0.0106997		Conflicting classifications of pathogenicity	35101021.0	missense_variant		0.146	functionally_normal				Cell viability			RAD51D_Glu307Lys
F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser411Ile	23	139561917	G	T	X											X-139561917-G-T	-	0.85044	1.0	411	.	.	.	X	138644076	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser411Ile	.	28.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99762	Select	0.9673	.	0.90580	.	.	D	D	.	1.79064612635	0	.	.	.	.	0.63863	.	.	.	.	0.89237	.	.	0.99994	0.991	.	3.0	0.975769	4.99	0.97	T	single nucleotide variant	NC_000023.11:g.139561917G>T	.	.	1	0.9916432	.	0	0.9967038	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.99991	D	H	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99132	.	.	-	139561917	.	-	11.888000	.	0.99985	.	0	.	.	germline	.	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.99665	GRCh38	924	no assertion criteria provided	c.1232G>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)		.	FA9_HUMAN	.	97.0	.	.	D	0.90387	0.9970585	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser411Ile	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	78	.	.	SCV000031627	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.091302	0.92967	.	D	-	.	.	0.99381	0	.	.	0.98421	0	139561917	Y	10	0	.	.	P00740	.	0.941744	0.77467		.	0.999	D	.	0.99245435	.	0.66489	2158	0.729601	.	-5.96	.	.	0.91343	.	.	.	.	.	.	0.99988	X	F9	.	0	Ser	660	.	X-139561917-G-T	Hereditary_factor_IX_deficiency_disease	.	.	138471742	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	.	.	.	RCV000011395	D	.	.	c.1232G>T	.	.	.	0.99956	G/G	rs137852276	139561917	.	G	.	P00740	.	0.99990	.	0.68239		.	.	.	3.86	0	0	.	5.66	0.99081	34	D	T	.	.	0	0	.	.	.	98879	10649	0.99956	0.91462	0.999679207801819	434	.	0.71675	.	.	.	.	9.93	.	D	.	.	.	0	306900	0.98824	X	.	ENSG00000101981	.	0	.	0	0.999860389252611	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.916627	25688	HGNC:3551	A	.	simple_aae	1	.	139561917	AGT	1.000000	.	-	0	0.99940	.	0	.	Pathogenic	0.90845	.	.	.	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	S	.	0.999417800528	-	0.966	-	0.99617	.	108	0.99986	0.677589416504	0.967	.	0.99652915189651026	6	-	1232G>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.91526	137852276	.	0	0.99939	.	0.931	0.001	434	0.99999240	5.66	.	.	.	0.810245	0.999849576725281	0.95772	D	34	.	.	1.0873	0.98959	p.Ser411Ile	0	.	-13.265	0.99438184	.	0.98301	10649	D	.	F9	.	D	0.975	.	S411I	D	0.89858	0.76753	G/G	principal1	175458	F9_Popp_2025_carboxy_gla_motif_var258341	No											S		1232	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ser411Ile		true	c.1232G>T						3551.0	139561917.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Ser411Ile						I	Mar 01, 1992					missense_variant		411.0				1.0822136685510857		Pathogenic	139561917.0	missense_variant		0.975					Reporter			F9_Ser411Ile
F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser411Ile	23	139561917	G	T	X											X-139561917-G-T	-	0.85044	1.0	411	.	.	.	X	138644076	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser411Ile	.	28.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99762	Select	0.9673	.	0.90580	.	.	D	D	.	1.79064612635	0	.	.	.	.	0.63863	.	.	.	.	0.89237	.	.	0.99994	0.991	.	3.0	0.975769	4.99	0.97	T	single nucleotide variant	NC_000023.11:g.139561917G>T	.	.	1	0.9916432	.	0	0.9967038	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.99991	D	H	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99132	.	.	-	139561917	.	-	11.888000	.	0.99985	.	0	.	.	germline	.	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.99665	GRCh38	924	no assertion criteria provided	c.1232G>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)		.	FA9_HUMAN	.	97.0	.	.	D	0.90387	0.9970585	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser411Ile	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	78	.	.	SCV000031627	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.091302	0.92967	.	D	-	.	.	0.99381	0	.	.	0.98421	0	139561917	Y	10	0	.	.	P00740	.	0.941744	0.77467		.	0.999	D	.	0.99245435	.	0.66489	2158	0.729601	.	-5.96	.	.	0.91343	.	.	.	.	.	.	0.99988	X	F9	.	0	Ser	660	.	X-139561917-G-T	Hereditary_factor_IX_deficiency_disease	.	.	138471742	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	.	.	.	RCV000011395	D	.	.	c.1232G>T	.	.	.	0.99956	G/G	rs137852276	139561917	.	G	.	P00740	.	0.99990	.	0.68239		.	.	.	3.86	0	0	.	5.66	0.99081	34	D	T	.	.	0	0	.	.	.	98879	10649	0.99956	0.91462	0.999679207801819	434	.	0.71675	.	.	.	.	9.93	.	D	.	.	.	0	306900	0.98824	X	.	ENSG00000101981	.	0	.	0	0.999860389252611	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.916627	25688	HGNC:3551	A	.	simple_aae	1	.	139561917	AGT	1.000000	.	-	0	0.99940	.	0	.	Pathogenic	0.90845	.	.	.	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	S	.	0.999417800528	-	0.966	-	0.99617	.	108	0.99986	0.677589416504	0.967	.	0.99652915189651026	6	-	1232G>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.91526	137852276	.	0	0.99939	.	0.931	0.001	434	0.99999240	5.66	.	.	.	0.810245	0.999849576725281	0.95772	D	34	.	.	1.0873	0.98959	p.Ser411Ile	0	.	-13.265	0.99438184	.	0.98301	10649	D	.	F9	.	D	0.975	.	S411I	D	0.89858	0.76753	G/G	principal1	202974	F9_Popp_2025_heavy_chain_var238979	No											S		1232	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ser411Ile		true	c.1232G>T						3551.0	139561917.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Ser411Ile						I	Mar 01, 1992					missense_variant		411.0				0.9778487977783746		Pathogenic	139561917.0	missense_variant		0.975					Reporter			F9_Ser411Ile
F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser411Ile	23	139561917	G	T	X											X-139561917-G-T	-	0.85044	1.0	411	.	.	.	X	138644076	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser411Ile	.	28.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99762	Select	0.9673	.	0.90580	.	.	D	D	.	1.79064612635	0	.	.	.	.	0.63863	.	.	.	.	0.89237	.	.	0.99994	0.991	.	3.0	0.975769	4.99	0.97	T	single nucleotide variant	NC_000023.11:g.139561917G>T	.	.	1	0.9916432	.	0	0.9967038	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.99991	D	H	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99132	.	.	-	139561917	.	-	11.888000	.	0.99985	.	0	.	.	germline	.	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.99665	GRCh38	924	no assertion criteria provided	c.1232G>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)		.	FA9_HUMAN	.	97.0	.	.	D	0.90387	0.9970585	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser411Ile	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	78	.	.	SCV000031627	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.091302	0.92967	.	D	-	.	.	0.99381	0	.	.	0.98421	0	139561917	Y	10	0	.	.	P00740	.	0.941744	0.77467		.	0.999	D	.	0.99245435	.	0.66489	2158	0.729601	.	-5.96	.	.	0.91343	.	.	.	.	.	.	0.99988	X	F9	.	0	Ser	660	.	X-139561917-G-T	Hereditary_factor_IX_deficiency_disease	.	.	138471742	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	.	.	.	RCV000011395	D	.	.	c.1232G>T	.	.	.	0.99956	G/G	rs137852276	139561917	.	G	.	P00740	.	0.99990	.	0.68239		.	.	.	3.86	0	0	.	5.66	0.99081	34	D	T	.	.	0	0	.	.	.	98879	10649	0.99956	0.91462	0.999679207801819	434	.	0.71675	.	.	.	.	9.93	.	D	.	.	.	0	306900	0.98824	X	.	ENSG00000101981	.	0	.	0	0.999860389252611	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.916627	25688	HGNC:3551	A	.	simple_aae	1	.	139561917	AGT	1.000000	.	-	0	0.99940	.	0	.	Pathogenic	0.90845	.	.	.	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	S	.	0.999417800528	-	0.966	-	0.99617	.	108	0.99986	0.677589416504	0.967	.	0.99652915189651026	6	-	1232G>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.91526	137852276	.	0	0.99939	.	0.931	0.001	434	0.99999240	5.66	.	.	.	0.810245	0.999849576725281	0.95772	D	34	.	.	1.0873	0.98959	p.Ser411Ile	0	.	-13.265	0.99438184	.	0.98301	10649	D	.	F9	.	D	0.975	.	S411I	D	0.89858	0.76753	G/G	principal1	147942	F9_Popp_2025_carboxy_F9_specific_var229298	No											S		1232	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ser411Ile		true	c.1232G>T						3551.0	139561917.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Ser411Ile						I	Mar 01, 1992					missense_variant		411.0				1.1096005759589982		Pathogenic	139561917.0	missense_variant		0.975					Reporter			F9_Ser411Ile
F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser411Ile	23	139561917	G	T	X											X-139561917-G-T	-	0.85044	1.0	411	.	.	.	X	138644076	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser411Ile	.	28.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99762	Select	0.9673	.	0.90580	.	.	D	D	.	1.79064612635	0	.	.	.	.	0.63863	.	.	.	.	0.89237	.	.	0.99994	0.991	.	3.0	0.975769	4.99	0.97	T	single nucleotide variant	NC_000023.11:g.139561917G>T	.	.	1	0.9916432	.	0	0.9967038	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.99991	D	H	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99132	.	.	-	139561917	.	-	11.888000	.	0.99985	.	0	.	.	germline	.	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.99665	GRCh38	924	no assertion criteria provided	c.1232G>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)		.	FA9_HUMAN	.	97.0	.	.	D	0.90387	0.9970585	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser411Ile	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	78	.	.	SCV000031627	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.091302	0.92967	.	D	-	.	.	0.99381	0	.	.	0.98421	0	139561917	Y	10	0	.	.	P00740	.	0.941744	0.77467		.	0.999	D	.	0.99245435	.	0.66489	2158	0.729601	.	-5.96	.	.	0.91343	.	.	.	.	.	.	0.99988	X	F9	.	0	Ser	660	.	X-139561917-G-T	Hereditary_factor_IX_deficiency_disease	.	.	138471742	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	.	.	.	RCV000011395	D	.	.	c.1232G>T	.	.	.	0.99956	G/G	rs137852276	139561917	.	G	.	P00740	.	0.99990	.	0.68239		.	.	.	3.86	0	0	.	5.66	0.99081	34	D	T	.	.	0	0	.	.	.	98879	10649	0.99956	0.91462	0.999679207801819	434	.	0.71675	.	.	.	.	9.93	.	D	.	.	.	0	306900	0.98824	X	.	ENSG00000101981	.	0	.	0	0.999860389252611	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.916627	25688	HGNC:3551	A	.	simple_aae	1	.	139561917	AGT	1.000000	.	-	0	0.99940	.	0	.	Pathogenic	0.90845	.	.	.	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	S	.	0.999417800528	-	0.966	-	0.99617	.	108	0.99986	0.677589416504	0.967	.	0.99652915189651026	6	-	1232G>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.91526	137852276	.	0	0.99939	.	0.931	0.001	434	0.99999240	5.66	.	.	.	0.810245	0.999849576725281	0.95772	D	34	.	.	1.0873	0.98959	p.Ser411Ile	0	.	-13.265	0.99438184	.	0.98301	10649	D	.	F9	.	D	0.975	.	S411I	D	0.89858	0.76753	G/G	principal1	258006	F9_Popp_2025_strep_2_var268022	No											S		1232	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ser411Ile		true	c.1232G>T						3551.0	139561917.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Ser411Ile						I	Mar 01, 1992					missense_variant		411.0				1.0706452008237304		Pathogenic	139561917.0	missense_variant		0.975					Reporter			F9_Ser411Ile
F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	NC_000023.11:139561917:G:T	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser411Ile	23	139561917	G	T	X											X-139561917-G-T	-	0.85044	1.0	411	.	.	.	X	138644076	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser411Ile	.	28.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99762	Select	0.9673	.	0.90580	.	.	D	D	.	1.79064612635	0	.	.	.	.	0.63863	.	.	.	.	0.89237	.	.	0.99994	0.991	.	3.0	0.975769	4.99	0.97	T	single nucleotide variant	NC_000023.11:g.139561917G>T	.	.	1	0.9916432	.	0	0.9967038	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.99991	D	H	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99132	.	.	-	139561917	.	-	11.888000	.	0.99985	.	0	.	.	germline	.	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.99665	GRCh38	924	no assertion criteria provided	c.1232G>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)		.	FA9_HUMAN	.	97.0	.	.	D	0.90387	0.9970585	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser411Ile	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	78	.	.	SCV000031627	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.091302	0.92967	.	D	-	.	.	0.99381	0	.	.	0.98421	0	139561917	Y	10	0	.	.	P00740	.	0.941744	0.77467		.	0.999	D	.	0.99245435	.	0.66489	2158	0.729601	.	-5.96	.	.	0.91343	.	.	.	.	.	.	0.99988	X	F9	.	0	Ser	660	.	X-139561917-G-T	Hereditary_factor_IX_deficiency_disease	.	.	138471742	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	.	.	.	RCV000011395	D	.	.	c.1232G>T	.	.	.	0.99956	G/G	rs137852276	139561917	.	G	.	P00740	.	0.99990	.	0.68239		.	.	.	3.86	0	0	.	5.66	0.99081	34	D	T	.	.	0	0	.	.	.	98879	10649	0.99956	0.91462	0.999679207801819	434	.	0.71675	.	.	.	.	9.93	.	D	.	.	.	0	306900	0.98824	X	.	ENSG00000101981	.	0	.	0	0.999860389252611	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.916627	25688	HGNC:3551	A	.	simple_aae	1	.	139561917	AGT	1.000000	.	-	0	0.99940	.	0	.	Pathogenic	0.90845	.	.	.	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	S	.	0.999417800528	-	0.966	-	0.99617	.	108	0.99986	0.677589416504	0.967	.	0.99652915189651026	6	-	1232G>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.91526	137852276	.	0	0.99939	.	0.931	0.001	434	0.99999240	5.66	.	.	.	0.810245	0.999849576725281	0.95772	D	34	.	.	1.0873	0.98959	p.Ser411Ile	0	.	-13.265	0.99438184	.	0.98301	10649	D	.	F9	.	D	0.975	.	S411I	D	0.89858	0.76753	G/G	principal1	230490	F9_Popp_2025_light_chain_var248660	No											S		1232	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ser411Ile		true	c.1232G>T						3551.0	139561917.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Ser411Ile						I	Mar 01, 1992					missense_variant		411.0				1.0517157228317906		Pathogenic	139561917.0	missense_variant		0.975					Reporter			F9_Ser411Ile
F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004395		NC_000023.11:139561917:G:T		Ser411Ile																												F9_Ser411Ile	23	139561917	G	T	X	allele	1232G>T	C05	527_CAVA_Array_P02	E10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561917-G-T	-	0.85044	1.0	411	.	.	.	X	138644076	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser411Ile	.	28.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99762	Select	0.9673	.	0.90580	.	.	D	D	.	1.79064612635	0	.	.	.	.	0.63863	.	.	.	.	0.89237	.	.	0.99994	0.991	.	3.0	0.975769	4.99	0.97	T	single nucleotide variant	NC_000023.11:g.139561917G>T	.	.	1	0.9916432	.	0	0.9967038	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.99991	D	H	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99132	.	.	-	139561917	.	-	11.888000	.	0.99985	.	0	.	.	germline	.	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.99665	GRCh38	924	no assertion criteria provided	c.1232G>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)		.	FA9_HUMAN	.	97.0	.	.	D	0.90387	0.9970585	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser411Ile	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	78	.	.	SCV000031627	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.091302	0.92967	.	D	-	.	.	0.99381	0	.	.	0.98421	0	139561917	Y	10	0	.	.	P00740	.	0.941744	0.77467		.	0.999	D	.	0.99245435	.	0.66489	2158	0.729601	.	-5.96	.	.	0.91343	.	.	.	.	.	.	0.99988	X	F9	.	0	Ser	660	.	X-139561917-G-T	Hereditary_factor_IX_deficiency_disease	.	.	138471742	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	.	.	.	RCV000011395	D	.	.	c.1232G>T	.	.	.	0.99956	G/G	rs137852276	139561917	.	G	.	P00740	.	0.99990	.	0.68239		.	.	.	3.86	0	0	.	5.66	0.99081	34	D	T	.	.	0	0	.	.	.	98879	10649	0.99956	0.91462	0.999679207801819	434	.	0.71675	.	.	.	.	9.93	.	D	.	.	.	0	306900	0.98824	X	.	ENSG00000101981	.	0	.	0	0.999860389252611	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.916627	25688	HGNC:3551	A	.	simple_aae	1	.	139561917	AGT	1.000000	.	-	0	0.99940	.	0	.	Pathogenic	0.90845	.	.	.	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	S	.	0.999417800528	-	0.966	-	0.99617	.	108	0.99986	0.677589416504	0.967	.	0.99652915189651026	6	-	1232G>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.91526	137852276	.	0	0.99939	.	0.931	0.001	434	0.99999240	5.66	.	.	.	0.810245	0.999849576725281	0.95772	D	34	.	.	1.0873	0.98959	p.Ser411Ile	0	.	-13.265	0.99438184	.	0.98301	10649	D	.	F9	.	D	0.975	.	S411I	D	0.89858	0.76753	G/G	principal1	175458	F9_Popp_2025_carboxy_gla_motif_var258341	No											S		1232	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ser411Ile		true	c.1232G>T						3551.0	139561917.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Ser411Ile						I	Mar 01, 1992					missense_variant		411.0				1.0822136685510857		Pathogenic	139561917.0	missense_variant		0.975					Reporter			F9_Ser411Ile
F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004395		NC_000023.11:139561917:G:T		Ser411Ile																												F9_Ser411Ile	23	139561917	G	T	X	allele	1232G>T	C05	527_CAVA_Array_P02	E10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561917-G-T	-	0.85044	1.0	411	.	.	.	X	138644076	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser411Ile	.	28.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99762	Select	0.9673	.	0.90580	.	.	D	D	.	1.79064612635	0	.	.	.	.	0.63863	.	.	.	.	0.89237	.	.	0.99994	0.991	.	3.0	0.975769	4.99	0.97	T	single nucleotide variant	NC_000023.11:g.139561917G>T	.	.	1	0.9916432	.	0	0.9967038	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.99991	D	H	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99132	.	.	-	139561917	.	-	11.888000	.	0.99985	.	0	.	.	germline	.	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.99665	GRCh38	924	no assertion criteria provided	c.1232G>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)		.	FA9_HUMAN	.	97.0	.	.	D	0.90387	0.9970585	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser411Ile	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	78	.	.	SCV000031627	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.091302	0.92967	.	D	-	.	.	0.99381	0	.	.	0.98421	0	139561917	Y	10	0	.	.	P00740	.	0.941744	0.77467		.	0.999	D	.	0.99245435	.	0.66489	2158	0.729601	.	-5.96	.	.	0.91343	.	.	.	.	.	.	0.99988	X	F9	.	0	Ser	660	.	X-139561917-G-T	Hereditary_factor_IX_deficiency_disease	.	.	138471742	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	.	.	.	RCV000011395	D	.	.	c.1232G>T	.	.	.	0.99956	G/G	rs137852276	139561917	.	G	.	P00740	.	0.99990	.	0.68239		.	.	.	3.86	0	0	.	5.66	0.99081	34	D	T	.	.	0	0	.	.	.	98879	10649	0.99956	0.91462	0.999679207801819	434	.	0.71675	.	.	.	.	9.93	.	D	.	.	.	0	306900	0.98824	X	.	ENSG00000101981	.	0	.	0	0.999860389252611	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.916627	25688	HGNC:3551	A	.	simple_aae	1	.	139561917	AGT	1.000000	.	-	0	0.99940	.	0	.	Pathogenic	0.90845	.	.	.	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	S	.	0.999417800528	-	0.966	-	0.99617	.	108	0.99986	0.677589416504	0.967	.	0.99652915189651026	6	-	1232G>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.91526	137852276	.	0	0.99939	.	0.931	0.001	434	0.99999240	5.66	.	.	.	0.810245	0.999849576725281	0.95772	D	34	.	.	1.0873	0.98959	p.Ser411Ile	0	.	-13.265	0.99438184	.	0.98301	10649	D	.	F9	.	D	0.975	.	S411I	D	0.89858	0.76753	G/G	principal1	202974	F9_Popp_2025_heavy_chain_var238979	No											S		1232	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ser411Ile		true	c.1232G>T						3551.0	139561917.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Ser411Ile						I	Mar 01, 1992					missense_variant		411.0				0.9778487977783746		Pathogenic	139561917.0	missense_variant		0.975					Reporter			F9_Ser411Ile
F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004395		NC_000023.11:139561917:G:T		Ser411Ile																												F9_Ser411Ile	23	139561917	G	T	X	allele	1232G>T	C05	527_CAVA_Array_P02	E10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561917-G-T	-	0.85044	1.0	411	.	.	.	X	138644076	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser411Ile	.	28.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99762	Select	0.9673	.	0.90580	.	.	D	D	.	1.79064612635	0	.	.	.	.	0.63863	.	.	.	.	0.89237	.	.	0.99994	0.991	.	3.0	0.975769	4.99	0.97	T	single nucleotide variant	NC_000023.11:g.139561917G>T	.	.	1	0.9916432	.	0	0.9967038	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.99991	D	H	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99132	.	.	-	139561917	.	-	11.888000	.	0.99985	.	0	.	.	germline	.	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.99665	GRCh38	924	no assertion criteria provided	c.1232G>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)		.	FA9_HUMAN	.	97.0	.	.	D	0.90387	0.9970585	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser411Ile	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	78	.	.	SCV000031627	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.091302	0.92967	.	D	-	.	.	0.99381	0	.	.	0.98421	0	139561917	Y	10	0	.	.	P00740	.	0.941744	0.77467		.	0.999	D	.	0.99245435	.	0.66489	2158	0.729601	.	-5.96	.	.	0.91343	.	.	.	.	.	.	0.99988	X	F9	.	0	Ser	660	.	X-139561917-G-T	Hereditary_factor_IX_deficiency_disease	.	.	138471742	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	.	.	.	RCV000011395	D	.	.	c.1232G>T	.	.	.	0.99956	G/G	rs137852276	139561917	.	G	.	P00740	.	0.99990	.	0.68239		.	.	.	3.86	0	0	.	5.66	0.99081	34	D	T	.	.	0	0	.	.	.	98879	10649	0.99956	0.91462	0.999679207801819	434	.	0.71675	.	.	.	.	9.93	.	D	.	.	.	0	306900	0.98824	X	.	ENSG00000101981	.	0	.	0	0.999860389252611	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.916627	25688	HGNC:3551	A	.	simple_aae	1	.	139561917	AGT	1.000000	.	-	0	0.99940	.	0	.	Pathogenic	0.90845	.	.	.	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	S	.	0.999417800528	-	0.966	-	0.99617	.	108	0.99986	0.677589416504	0.967	.	0.99652915189651026	6	-	1232G>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.91526	137852276	.	0	0.99939	.	0.931	0.001	434	0.99999240	5.66	.	.	.	0.810245	0.999849576725281	0.95772	D	34	.	.	1.0873	0.98959	p.Ser411Ile	0	.	-13.265	0.99438184	.	0.98301	10649	D	.	F9	.	D	0.975	.	S411I	D	0.89858	0.76753	G/G	principal1	147942	F9_Popp_2025_carboxy_F9_specific_var229298	No											S		1232	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ser411Ile		true	c.1232G>T						3551.0	139561917.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Ser411Ile						I	Mar 01, 1992					missense_variant		411.0				1.1096005759589982		Pathogenic	139561917.0	missense_variant		0.975					Reporter			F9_Ser411Ile
F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004395		NC_000023.11:139561917:G:T		Ser411Ile																												F9_Ser411Ile	23	139561917	G	T	X	allele	1232G>T	C05	527_CAVA_Array_P02	E10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561917-G-T	-	0.85044	1.0	411	.	.	.	X	138644076	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser411Ile	.	28.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99762	Select	0.9673	.	0.90580	.	.	D	D	.	1.79064612635	0	.	.	.	.	0.63863	.	.	.	.	0.89237	.	.	0.99994	0.991	.	3.0	0.975769	4.99	0.97	T	single nucleotide variant	NC_000023.11:g.139561917G>T	.	.	1	0.9916432	.	0	0.9967038	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.99991	D	H	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99132	.	.	-	139561917	.	-	11.888000	.	0.99985	.	0	.	.	germline	.	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.99665	GRCh38	924	no assertion criteria provided	c.1232G>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)		.	FA9_HUMAN	.	97.0	.	.	D	0.90387	0.9970585	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser411Ile	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	78	.	.	SCV000031627	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.091302	0.92967	.	D	-	.	.	0.99381	0	.	.	0.98421	0	139561917	Y	10	0	.	.	P00740	.	0.941744	0.77467		.	0.999	D	.	0.99245435	.	0.66489	2158	0.729601	.	-5.96	.	.	0.91343	.	.	.	.	.	.	0.99988	X	F9	.	0	Ser	660	.	X-139561917-G-T	Hereditary_factor_IX_deficiency_disease	.	.	138471742	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	.	.	.	RCV000011395	D	.	.	c.1232G>T	.	.	.	0.99956	G/G	rs137852276	139561917	.	G	.	P00740	.	0.99990	.	0.68239		.	.	.	3.86	0	0	.	5.66	0.99081	34	D	T	.	.	0	0	.	.	.	98879	10649	0.99956	0.91462	0.999679207801819	434	.	0.71675	.	.	.	.	9.93	.	D	.	.	.	0	306900	0.98824	X	.	ENSG00000101981	.	0	.	0	0.999860389252611	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.916627	25688	HGNC:3551	A	.	simple_aae	1	.	139561917	AGT	1.000000	.	-	0	0.99940	.	0	.	Pathogenic	0.90845	.	.	.	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	S	.	0.999417800528	-	0.966	-	0.99617	.	108	0.99986	0.677589416504	0.967	.	0.99652915189651026	6	-	1232G>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.91526	137852276	.	0	0.99939	.	0.931	0.001	434	0.99999240	5.66	.	.	.	0.810245	0.999849576725281	0.95772	D	34	.	.	1.0873	0.98959	p.Ser411Ile	0	.	-13.265	0.99438184	.	0.98301	10649	D	.	F9	.	D	0.975	.	S411I	D	0.89858	0.76753	G/G	principal1	258006	F9_Popp_2025_strep_2_var268022	No											S		1232	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ser411Ile		true	c.1232G>T						3551.0	139561917.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Ser411Ile						I	Mar 01, 1992					missense_variant		411.0				1.0706452008237304		Pathogenic	139561917.0	missense_variant		0.975					Reporter			F9_Ser411Ile
F9_Ser411Ile	1.2452466356035585	0.2531072668651517	3.4413497038332044	0.010817379207463796	2025_01_Batch_13-14	0.5792174404184528	0.568101870798119	0.5143703665717453	0.49912756256391044	0.5720512359304173	0.6908944882159987	0.6783313658562298	0.6592936561201292	0.6116093581473607	0.6679422758627646	0.6350559643172258	0.6232166183271743	0.5868320113459373	0.5553684603556356	0.6199967558965909	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004395		NC_000023.11:139561917:G:T		Ser411Ile																												F9_Ser411Ile	23	139561917	G	T	X	allele	1232G>T	C05	527_CAVA_Array_P02	E10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561917-G-T	-	0.85044	1.0	411	.	.	.	X	138644076	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser411Ile	.	28.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99762	Select	0.9673	.	0.90580	.	.	D	D	.	1.79064612635	0	.	.	.	.	0.63863	.	.	.	.	0.89237	.	.	0.99994	0.991	.	3.0	0.975769	4.99	0.97	T	single nucleotide variant	NC_000023.11:g.139561917G>T	.	.	1	0.9916432	.	0	0.9967038	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.99991	D	H	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99132	.	.	-	139561917	.	-	11.888000	.	0.99985	.	0	.	.	germline	.	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.99665	GRCh38	924	no assertion criteria provided	c.1232G>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)		.	FA9_HUMAN	.	97.0	.	.	D	0.90387	0.9970585	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser411Ile	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	78	.	.	SCV000031627	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.091302	0.92967	.	D	-	.	.	0.99381	0	.	.	0.98421	0	139561917	Y	10	0	.	.	P00740	.	0.941744	0.77467		.	0.999	D	.	0.99245435	.	0.66489	2158	0.729601	.	-5.96	.	.	0.91343	.	.	.	.	.	.	0.99988	X	F9	.	0	Ser	660	.	X-139561917-G-T	Hereditary_factor_IX_deficiency_disease	.	.	138471742	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	.	.	.	RCV000011395	D	.	.	c.1232G>T	.	.	.	0.99956	G/G	rs137852276	139561917	.	G	.	P00740	.	0.99990	.	0.68239		.	.	.	3.86	0	0	.	5.66	0.99081	34	D	T	.	.	0	0	.	.	.	98879	10649	0.99956	0.91462	0.999679207801819	434	.	0.71675	.	.	.	.	9.93	.	D	.	.	.	0	306900	0.98824	X	.	ENSG00000101981	.	0	.	0	0.999860389252611	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.916627	25688	HGNC:3551	A	.	simple_aae	1	.	139561917	AGT	1.000000	.	-	0	0.99940	.	0	.	Pathogenic	0.90845	.	.	.	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	S	.	0.999417800528	-	0.966	-	0.99617	.	108	0.99986	0.677589416504	0.967	.	0.99652915189651026	6	-	1232G>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.91526	137852276	.	0	0.99939	.	0.931	0.001	434	0.99999240	5.66	.	.	.	0.810245	0.999849576725281	0.95772	D	34	.	.	1.0873	0.98959	p.Ser411Ile	0	.	-13.265	0.99438184	.	0.98301	10649	D	.	F9	.	D	0.975	.	S411I	D	0.89858	0.76753	G/G	principal1	230490	F9_Popp_2025_light_chain_var248660	No											S		1232	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ser411Ile		true	c.1232G>T						3551.0	139561917.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Ser411Ile						I	Mar 01, 1992					missense_variant		411.0				1.0517157228317906		Pathogenic	139561917.0	missense_variant		0.975					Reporter			F9_Ser411Ile
G6PD_Gly378Ser	0.44980261220938383	0.6664511291342612	-4.885624293312452	0.001782128546597905	2025_01_Batch_13-14	0.40905820693214356	0.5162071505102306	0.6487625345346948	0.5846796562437677	0.4342564757227669	0.5350994019317835	0.604818612219922	0.7438736509912314	0.6463048748584876	0.5446064429274138	0.47207880443196354	0.5605128813650763	0.6963180927629631	0.6154922655511277	0.48943145932509036	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	G6PD	G6PD		4006		CCSBVarC021515		NC_000023.11:154532722:C:T		Gly378Ser																												G6PD_Gly378Ser	23	154532722	C	T	X	allele	1132G>A	G04	527_CAVA_Array_P03	N07	B13A7A8P1_R1	B14A7A8P1_R2				X-154532722-C-T	-	0.42085	1.0	378	2	0	0	X	153760937	T	9.910020e-06	0	X	3_Conflicting	NC_000023.11	1	Gly378Ser	0	21.5	0	0	1.373950e-05	D	0	3	.	30728	5.844400e-06	.	18893	0.000000e+00	0	0.92639	.	0.9601	72783	0.90580	0	.	D	D	46682	.	0	0	0.000000e+00	0	0	0.61595	13617	33786	0	0.000000e+00	0.80118	0	.	0.87700	0.232	.	.	0.913609	4.13	.	T	single nucleotide variant	NC_000023.11:g.154532722C>T	0	12156	2	0.76723653	79875	0	0.86035365	0		2	171104	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026|MedGen:C3661900	0	0	0.000000e+00	0	0.95575	D	0.88841	D	L	.	12	C/C	114	0	5668	1210896	Anemia, nonspherocytic hemolytic, due to G6PD deficiency|not provided	13060	0.99286	.	.	-	154532722	.	-	3.963000	0	0.95023	22045	0	46682	0	germline;unknown	56870	.	.	GRCh38	80	criteria provided, conflicting classifications	.	0.000000e+00	0.92730	0	0	0	Glucose-6-phosphate dehydrogenase, C-terminal	0.000000e+00	6853	.	0	0.000000e+00	NM_001360016.2(G6PD):c.1132G>A (p.Gly378Ser)	1	0	G6PD_HUMAN	0	.	.	0	D	0.57080	0.857077	-	0.000000e+00	.		2	0.000000e+00	0	27090	criteria_provided,_conflicting_classifications	0.98864	0.000000e+00	0	0.000000e+00	0	45931	.	0	0.40843	.	germline	.		C	Jan 16, 2025	0	C/C	0	64114	1.0	N	Xq28	9690	.	0.000000e+00	SCV002599268|SCV004299708|SCV005201601	Conflicting_classifications_of_pathogenicity	0	0	Ser	S	-	683	ENSP00000512625	ENST00000696430	13231	.	10047	0	0.585	C	0	3.113311	0.31345	.	.	-	.	.	0.97378	610	0	.	0.59158	0	154532722	Y	10	0	72783	0.000000e+00	P11413	0	0.964038	0.74605		.	0.983	D	64114	0.81130373	.	0.22834	2539	0.491478	11	.	.	2.142150e-05	0.20791	0.000000e+00	0	57586	0.000000e+00	4374	0	0.86083	X	G6PD	0.000000e+00	0	Gly	14050	3.119440e-05	X-154532722-C-T	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	0	1	153414131	.	.	.	0	RCV002305724|RCV004700721	.	0	0	c.1132G>A	0	0	1	0.93997	C/C	rs371489738	154532722	12003	C	.	.	9893	0.87950	0.000000e+00	0.35501		0	0	0.000000e+00	1.855	0	0	264690	5.82	0.99554	112	D	T	0	0.000000e+00	0	26	.	0	0	466026	1722614	0.94954	0.94444	0.929728746414185	2898	.	0.71675	.	0.000000e+00	3.119440e-05	895342	7.406	1.325650e-05	.	9912	0	3.7780044E-6	0	300908	0.79294	X	0.000000e+00	ENSG00000160211	2.142150e-05	0	0	0	.	1	0.75798	0.96675	18959	1	1.373950e-05	0.000000e+00	.	.	0.000000e+00	0.683657	1780130	HGNC:4057	.	0	.	0.905	150869	154532722	GGC	0.999000	.	-	0	0.90197	1.228580e-05	0	0	Conflicting classifications of pathogenicity	0.67258	0	0	0	ClinGen:CA10566075	G	0	.	-	.	-	0.69502	1	496	.	0.661729335785	.	0	0.99607459962891864	98	-	1132G>A 	1	0	C2720289	0	0	0	0	NM_001360016.2	-	.	.	1	0.69172	-1	1760	0	0.98330	.	.	.	2784	0.99859923	5.82	.	.	0.000000e+00	0.520035	0.987461282210342	0.48991	D	86	4622	7058	1.0912	0.98711	p.Gly378Ser	0	0	-8.453	.	0	0.87449	1722614	D	24309	G6PD	0.000000e+00	D	.	15912	.	.	0.78719	0.3052	C/C	principal4																																																																																																				
FANCC_Leu496Arg	-1.549280011711085	0.1652455454136042	-6.82618618656796	0.0002472608798740025	2025_01_Batch_13-14	0.6463386509857354	0.8060808157714119	0.8949602032890903	0.8497309349742465	0.8065596656809763	0.7440958622022515	0.9524697932812349	0.967628626732216	0.9287504020434858	0.8719891413627952	0.6952172565939935	0.8792753045263234	0.9312944150106531	0.8892406685088661	0.8392744035218858	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FANCC	FANCC	ENSG00000158169	7699	13989	CCSBVarC001230	ALE00001230	NC_000009.12:95107112:A:C	1487T>G	Leu496Arg	RC4	RC4_Mut_GDEh1009	C09	GDEhDisVCh_40044	F07	2	RC4_Mut_GDDh1009	C09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FANCC_Leu496Arg	9	95107112	A	C	9											9-95107112-A-C	-	0.51746	1.0	496	.	.	.	9	97869394	C	.	.	9	1_Pathogenic	NC_000009.12	.	Leu496Arg	.	23.1	.	0	.	T	.	1	1	.	.	.	.	.	0	0.79598	Select	0.3623	.	0.90580	.	.	D	D	.	0.400379318551	0	.	.	.	.	0.42681	.	.	.	.	0.82920	.	.	0.87667	0.023	.	26.0	.	5.03	0.74	C	single nucleotide variant	NC_000009.12:g.95107112A>C	.	.	1	0.77439195	.	0	0.87331074	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84	.	.	.	.	0.84487	D	0.87085	D	M	5.460852	.	A/A	0	0	.	.	Fanconi anemia complementation group C	.	0.80115	.	.	-	95107112	.	-	11.055000	.	0.89444	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0166)| Gain of methylation at L496 (P = 0.0294)| Gain of solvent accessibility (P = 0.0584)| Gain of relative solvent accessibility (P = 0.09)| Loss of stability (P = 0.101)	0.98955	GRCh38	167	no assertion criteria provided	c.1487T>G	.	0.64600	0	.	.	.	.	.	A	0	.	NM_000136.3(FANCC):c.1487T>G (p.Leu496Arg)		.	FANCC_HUMAN	.	74.0	0.551271328372298	.	.	0.65167	0.8566318	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.93950	.	.	.	.	.	p.Leu496Arg	.	0.85376	.	germline	.		A	Aug 01, 1999	.	A/A	.	.	1.0	N	9q22.32	0	.	.	SCV000033070	Pathogenic	.	.	Arg	R	-	.	ENSP00000289081	ENST00000289081	.	0.001	.	.	0.756	A	.	3.643055	0.83643	N	D	-	4.834584	.	0.59673	0	.	.	0.80281	0	95107112	Y	9	0	.	.	Q00597	.	0.502392	0.83280		.	0.99	D	.	0.7835274	.	0.12113	2176	0.30647	.	-5.08	.	.	0.78662	.	.	.	.	.	.	0.86521	9	FANCC	.	0	Leu	478	.	9-95107112-A-C	Fanconi_anemia_complementation_group_C	.	.	96909215	ClinGen:CA256207|OMIM:613899.0008|UniProtKB:Q00597#VAR_005232	0.455600	0.70000	.	RCV000012830	D	.	.	c.1487T>G	.	.	.	0.83356	A/A	rs121917785	95107112	.	A	.	Q00597	.	0.88974	.	0.68239		.	.	.	2.395	0	0	.	4.94	0.82079	0	D	T	.	.	0	0	.	.	.	84	12050	0.83141	0.40752	0.990214049816132	426	.	0.71675	0.50611	.	.	.	5.392	.	D	.	.	.	0	227645	0.66097	9	.	ENSG00000158169	.	0	.	0	0.7235648123959582	2	0.78943	0.93511	.	.	.	.	0.462495863549082	YES	.	0.041256	27089	HGNC:3584	A	.	simple_aae	0.809	.	95107112	CTC	1.000000	.	-	0	0.99622	.	0	.	Pathogenic	0.47446	.	.	.	ClinGen:CA256207,UniProtKB:Q00597#VAR_005232,OMIM:613899.0008	L	.	0.91854953846	-	0.932	-	0.95151	.	52	0.72155	0.527930855751	0.5133	.	0.99737588940490851	0	-	1487T>G 	.	0	C3468041	.	.	.	.	NM_000136.3	-	.	.	1	0.39699	121917785	.	0	0.91711	0.65336	0.944	0.001	426	0.95983505	4.94	.	.	.	0.202447	0.939888730715306	0.69015	T	0	.	.	-0.0954	0.72245	p.Leu496Arg	0	.	-6.134	0.9910704	.	0.79344	12050	T	.	FANCC	.	D	0.522	.	L496R	D	0.90264	0.943	A/A	principal1																																																																																																				
FANCC_Leu496Arg	-1.549280011711085	0.1652455454136042	-6.82618618656796	0.0002472608798740025	2025_01_Batch_13-14	0.6463386509857354	0.8060808157714119	0.8949602032890903	0.8497309349742465	0.8065596656809763	0.7440958622022515	0.9524697932812349	0.967628626732216	0.9287504020434858	0.8719891413627952	0.6952172565939935	0.8792753045263234	0.9312944150106531	0.8892406685088661	0.8392744035218858	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FANCC	FANCC		7699		CCSBVarC001230		NC_000009.12:95107112:A:C		Leu496Arg																												FANCC_Leu496Arg	9	95107112	A	C	9	allele	1487T>G	H11	527_CAVA_Array_P02	O22	B13A7A8P1_R1	B14A7A8P1_R2				9-95107112-A-C	-	0.51746	1.0	496	.	.	.	9	97869394	C	.	.	9	1_Pathogenic	NC_000009.12	.	Leu496Arg	.	23.1	.	0	.	T	.	1	1	.	.	.	.	.	0	0.79598	Select	0.3623	.	0.90580	.	.	D	D	.	0.400379318551	0	.	.	.	.	0.42681	.	.	.	.	0.82920	.	.	0.87667	0.023	.	26.0	.	5.03	0.74	C	single nucleotide variant	NC_000009.12:g.95107112A>C	.	.	1	0.77439195	.	0	0.87331074	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84	.	.	.	.	0.84487	D	0.87085	D	M	5.460852	.	A/A	0	0	.	.	Fanconi anemia complementation group C	.	0.80115	.	.	-	95107112	.	-	11.055000	.	0.89444	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0166)| Gain of methylation at L496 (P = 0.0294)| Gain of solvent accessibility (P = 0.0584)| Gain of relative solvent accessibility (P = 0.09)| Loss of stability (P = 0.101)	0.98955	GRCh38	167	no assertion criteria provided	c.1487T>G	.	0.64600	0	.	.	.	.	.	A	0	.	NM_000136.3(FANCC):c.1487T>G (p.Leu496Arg)		.	FANCC_HUMAN	.	74.0	0.551271328372298	.	.	0.65167	0.8566318	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.93950	.	.	.	.	.	p.Leu496Arg	.	0.85376	.	germline	.		A	Aug 01, 1999	.	A/A	.	.	1.0	N	9q22.32	0	.	.	SCV000033070	Pathogenic	.	.	Arg	R	-	.	ENSP00000289081	ENST00000289081	.	0.001	.	.	0.756	A	.	3.643055	0.83643	N	D	-	4.834584	.	0.59673	0	.	.	0.80281	0	95107112	Y	9	0	.	.	Q00597	.	0.502392	0.83280		.	0.99	D	.	0.7835274	.	0.12113	2176	0.30647	.	-5.08	.	.	0.78662	.	.	.	.	.	.	0.86521	9	FANCC	.	0	Leu	478	.	9-95107112-A-C	Fanconi_anemia_complementation_group_C	.	.	96909215	ClinGen:CA256207|OMIM:613899.0008|UniProtKB:Q00597#VAR_005232	0.455600	0.70000	.	RCV000012830	D	.	.	c.1487T>G	.	.	.	0.83356	A/A	rs121917785	95107112	.	A	.	Q00597	.	0.88974	.	0.68239		.	.	.	2.395	0	0	.	4.94	0.82079	0	D	T	.	.	0	0	.	.	.	84	12050	0.83141	0.40752	0.990214049816132	426	.	0.71675	0.50611	.	.	.	5.392	.	D	.	.	.	0	227645	0.66097	9	.	ENSG00000158169	.	0	.	0	0.7235648123959582	2	0.78943	0.93511	.	.	.	.	0.462495863549082	YES	.	0.041256	27089	HGNC:3584	A	.	simple_aae	0.809	.	95107112	CTC	1.000000	.	-	0	0.99622	.	0	.	Pathogenic	0.47446	.	.	.	ClinGen:CA256207,UniProtKB:Q00597#VAR_005232,OMIM:613899.0008	L	.	0.91854953846	-	0.932	-	0.95151	.	52	0.72155	0.527930855751	0.5133	.	0.99737588940490851	0	-	1487T>G 	.	0	C3468041	.	.	.	.	NM_000136.3	-	.	.	1	0.39699	121917785	.	0	0.91711	0.65336	0.944	0.001	426	0.95983505	4.94	.	.	.	0.202447	0.939888730715306	0.69015	T	0	.	.	-0.0954	0.72245	p.Leu496Arg	0	.	-6.134	0.9910704	.	0.79344	12050	T	.	FANCC	.	D	0.522	.	L496R	D	0.90264	0.943	A/A	principal1																																																																																																				
ZC4H2_Arg198Gln	-4.669579694535985	0.0022886216209041625	7.053550426742774	0.0002017525172681343	2025_01_Batch_13-14	0.6162865094081145	0.8397023423212076	0.8895967094541701	0.7860623351426326	0.5328589394680393	0.7964344290160212	0.8529203727580343	0.9367131200987617	0.9192406604177108	0.632008755500258	0.7063604692120679	0.846311357539621	0.9131549147764659	0.8526514977801717	0.5824338474841486	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC009191		NC_000023.11:64917865:C:T		Arg198Gln																												ZC4H2_Arg198Gln	23	64917865	C	T	X	allele	593G>A	B05	527_CAVA_Array_P06	C10	B13A7A8P2_R1	B14A7A8P2_R2				X-64917865-C-T	-	0.90114	0.998	198	.	.	.	X	64137745	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg198Gln	.	31.0	.	.	.	T	.	6	1	.	.	.	.	.	.	0.80683	Select	0.4448	.	0.73231	.	.	D	D	.	3.04366087562	.	.	.	.	.	0.91618	.	.	.	.	0.68915	.	.	0.88719	0.995	.	7.0	0.974003	.	0.93	T	single nucleotide variant	NC_000023.11:g.64917865C>T	.	.	3	0.84851253	.	.	0.8665144	.		.	.	.	.	.	.	.	.	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MedGen:C3661900|MONDO:MONDO:0026762,MedGen:C5393303,OMIM:301041	.	.	.	.	0.94378	D	0.91114	D	.	.	.	C/C	.	.	.	.	Wieacker-Wolff syndrome|not provided|Wieacker-Wolff syndrome, female-restricted	.	0.80920	.	.	-	64917865	.	-	7.539000	.	0.99661	.	.	.	.	germline;unknown	.	Loss of MoRF binding (P = 0.0352)| Loss of helix (P = 0.1299)| Gain of relative solvent accessibility (P = 0.1684)| Gain of catalytic residue at R198 (P = 0.2542)| Gain of loop (P = 0.3485)	0.67570	GRCh38	40	criteria provided, multiple submitters, no conflicts	c.593G>A	.	0.78637	.	.	.	Zinc finger C4H2-type	.	.	P	.	.	NM_018684.4(ZC4H2):c.593G>A (p.Arg198Gln)	2	.	ZC4H2_HUMAN	.	93.0	.	.	D	0.99795	0.8701332	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98429	.	.	.	.	.	p.Arg198Gln	.	0.60115	.	germline	.		C	May 27, 2023	.	C/C	.	.	1.0	N	Xq11.2	.	.	.	SCV000589376|SCV002011544|SCV002512603|SCV002521347|SCV004040963	Pathogenic	.	.	Gln	Q	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.599	C	.	5.374841	0.67073	.	D	-	.	.	0.99506	.	.	.	0.93976	.	64917865	Y	8	.	.	.	Q9NQZ6	.	0.861236	0.99969		.	0.988	D	.	0.84589994	.	0.73271	55906	0.619807	.	-3.56	.	.	0.91343	.	.	.	.	.	.	0.91292	X	ZC4H2	.	.	Arg	.	.	X-64917865-C-T	not_provided|Wieacker-Wolff_syndrome,_female-restricted|Wieacker-Wolff_syndrome	.	.	64054470	ClinGen:CA10575580|OMIM:300897.0002|UniProtKB:Q9NQZ6#VAR_069622	.	.	.	RCV000043677|RCV000498696|RCV001770066	D	.	.	c.593G>A	.	.	.	0.98328	C/C	rs879255235	64917865	.	C	.	Q9NQZ6	.	0.88431	.	0.68239		.	.	.	.	.	.	.	5.42	0.96898	.	D	D	.	.	.	.	.	.	.	3454|85283	50981	0.98300	0.99279	0.998395621776581	.	.	0.71675	.	.	.	.	7.301	.	D	.	.	.	.	301041|314580	0.78228	X	.	ENSG00000126970	.	.	.	.	0.6985962743898447	2	0.77983	0.97963	.	.	.	.	.	YES	.	0.931883	65652	HGNC:24931	A	.	simple_aae	0.99	.	64917865	CGG	1.000000	.	-	.	0.91026	.	.	.	Pathogenic	0.95182	.	.	.	ClinGen:CA10575580,UniProtKB:Q9NQZ6#VAR_069622,OMIM:300897.0002	R	.	0.896646558922	-	0.558	-	0.89118	.	.	0.69647	0.863531589508	0.9999	.	0.99954933178758143	.	-	593G>A 	.	.	CN517202|C5393303|C0796200	.	.	.	.	NM_018684.4	-	.	.	1	0.91550	879255235	.	.	0.89483	.	0.865	0.009	.	0.99758303	5.42	.	.	.	0.652534	0.999345122363188	.	T	.	.	.	-0.0594	0.78059	p.Arg198Gln	.	.	-14.555	0.91766816	.	0.96318	50981	D	.	ZC4H2	.	D	0.540	.	R198Q	D	.	0.40292	C/C	principal1																																																																																																				
KRAS_Phe156Ile	-1.3743464521347168	0.2117183578603233	4.60376764126087	0.0024731315942266253	2025_01_Batch_13-14	0.5339240086725837	0.676551602508837	0.8187287129941277	0.6553572596133344	0.46277101793242437	0.49694980554075857	0.5761139723485552	0.7003183642063119	0.5207223648655823	0.4641058591774421	0.5154369071066711	0.6263327874286961	0.7595235386002198	0.5880398122394583	0.4634384385549333	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006102		NC_000012.12:25209896:A:T		Phe156Ile																												KRAS_Phe156Ile	12	25209896	A	T	12	allele	466T>A	A09	527_CAVA_Array_P03	B17	B13A7A8P1_R1	B14A7A8P1_R2				12-25209896-A-T	-	0.82	.	131	.	.	.	12	25362830	T	.	.	12	1_Pathogenic	NC_000012.12	.	Phe156Ile	.	27.7	.	.	.	D	.	3	.	.	.	.	.	.	.	0.97054	.	0.7138	.	0.90580	.	.	.	D	.	.	.	.	.	.	.	.	.	.	.	.	0.84554	.	.	.	0.999	.	.	.	.	.	T	single nucleotide variant	NC_000012.12:g.25209896A>T	.	.	2	.	.	.	.	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:CN517202|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	.	.	.	.	0.95575	.	.	.	.	7.73527	.	A/A	.	.	.	.	Noonan syndrome;Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome 3	.	0.91524	.	.	-	25209896	.	-	11.233000	.	0.96958	.	.	.	.	germline	.	.	0.92541	GRCh38	874	criteria provided, multiple submitters, no conflicts	.	.	0.78977	.	.	.	.	.	.	.	.	.	NM_004985.5(KRAS):c.466T>A (p.Phe156Ile)	2	.	A0A8I5KQ21_HUMAN	.	.	0.741140742699006	.	.	0.95820	.	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.96023	.	.	.	.	.	.	.	0.90185	.	germline	.		A	Jan 05, 2022	.	A/A	.	.	1.0	N	12p12.1	.	.	.	SCV000198458|SCV000582867|SCV002061164	Pathogenic	.	.	Ile	I	-	.	ENSP00000509223	ENST00000693229	.	.	.	.	0.66	A	.	4.958659	0.92967	D	.	-	8.675262	.	0.93315	.	.	.	0.75739	.	25209896	Y	8	.	.	.	A0A8I5KQ21	.	.	0.49243		.	.	D	.	.	.	0.91597	3845	0.456603	.	.	.	.	0.91343	.	.	.	.	.	.	.	12	KRAS	.	.	Phe	.	.	12-25209896-A-T	Noonan_syndrome|Cardio-facio-cutaneous_syndrome|not_provided|Noonan_syndrome_3	.	.	25254097	ClinGen:CA273160	0.871179	0.82229	.	RCV000150884|RCV000493013|RCV001813760	.	.	.	c.391T>A	.	.	.	0.92716	A/A	rs397517042	25209896	.	A	.	.	.	.	.	0.68239		.	.	.	.	.	.	.	5.43	.	.	D	.	.	.	.	.	.	.	.	648|1340|648	163758	0.92627	.	0.984689116477966	.	.	0.71675	0.79169	.	.	.	8.891	.	.	.	.	.	.	PS163950|PS115150|609942	0.9215	12	.	ENSG00000133703	.	.	.	.	.	1	0.73823	0.30573	.	.	.	.	0.744583996035912	.	.	0.39769	175711	HGNC:6407	.	.	.	0.937	.	25209896	TTC	1.000000	.	-	.	0.88974	.	.	.	Pathogenic	0.98607	.	.	.	ClinGen:CA273160	F	.	.	-	.	-	0.86483	.	.	.	.	.	.	0.98951824215402029	.	-	466T>A 	.	.	C0028326|C1275081|CN517202|C1860991	.	.	.	.	NM_004985.5	-	.	.	1	0.88326	397517042	.	.	0.98060	0.85673	.	.	.	0.98468506	5.43	.	.	.	0.418102	.	.	D	.	.	.	0.5739	0.90143	p.Phe131Ile	.	.	.	.	.	.	163758	.	.	KRAS	.	D	.	.	.	.	.	0.55068	A/A	.																																																																																																				
LMNA_Ala43Thr	2.826701345748407	0.02552666596388305	-4.1903998369062005	0.004084025769311878	2025_01_Batch_13-14	0.9215057423653834	0.9396516603326881	0.8710391824484176	0.7509784047159569	0.9010626710007219	0.951718694174347	0.9133695378053251	0.8985854888870367	0.9623449079213537	0.8637866395999324	0.9366122182698652	0.9265105990690066	0.8848123356677271	0.8566616563186553	0.8824246553003272	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	LMNA	LMNA	ENSG00000160789	3903	201283	CCSBVarC003606	ALE00003606	NC_000001.11:156115045:G:A	127G>A	Ala43Thr	CEGS2	CegsMutGDEh1035	C03	GDEhDisVCh_40057	F08	1	CegsMutGDDh1035	C03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			LMNA_Ala43Thr	1	156115045	G	A	1											1-156115045-G-A	-	0.92707	1.0	43	.	0	.	1	156084836	A	6.261000e-07	.	1	3_Conflicting	NC_000001.11	1	Ala43Thr	.	32.0	.	.	.	D	0	4	.	.	.	.	.	.	.	0.99545	.	0.9299	.	0.90580	.	.	D	D	62534	.	.	0	.	.	.	0.75550	.	43966	0	.	0.67623	.	.	0.84994	0.999	.	.	.	.	.	A	single nucleotide variant	NC_000001.11:g.156115045G>A	0	.	2	0.751655	.	.	0.85589856	.	A	.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746	.	.	0.000000e+00	0	0.99291	D	0.86196	D	H	13.32298	1	G/G	.	.	.	1597190	not provided|Charcot-Marie-Tooth disease type 2	.	0.98653	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156115045	.	-	11.667000	.	0.99450	29200	.	1171998	.	germline	88354	Gain of phosphorylation at A43 (P = 0.0767)| Gain of disorder (P = 0.0918)| Gain of MoRF binding (P = 0.1749)| Loss of stability (P = 0.302)| Gain of solvent accessibility (P = 0.3819)	0.98699	GRCh38	420	criteria provided, conflicting classifications	.	.	0.60376	.	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	.	.	0.000000e+00	NM_170707.4(LMNA):c.127G>A (p.Ala43Thr)	1	.	LMNA_HUMAN	.	.	0.98056132522041	.	.	0.95185	0.819483	+	.	.	6.92112e-7	.	.	0	.	criteria_provided,_conflicting_classifications	0.99965	.	0	.	.	57712	.	0	0.94064	.	germline	.	156115045	G	Feb 26, 2024	.	G/G	.	.	1.0	N	1q22	.	.	.	SCV000293392|SCV000339872|SCV001397255	Conflicting_classifications_of_pathogenicity	.	.	Thr	T	-	912	ENSP00000502256	ENST00000675939	.	.	.	.	0.59	G	.	5.634268	0.60671	D	.	-	13.28456	.	0.97660	.	.	.	0.98769	.	156115045	Y	10	.	.	0.000000e+00	P02545	.	0.975701	0.97276	G	.	1.0	D	.	0.7691078	.	0.91597	4000	0.565194	1	.	.	8.532440e-07	0.91343	.	.	74668	.	6040	.	0.85142	1	LMNA	0.000000e+00	.	Ala	.	.	1-156115045-G-A	Charcot-Marie-Tooth_disease_type_2|not_provided	0	.	154351460	ClinGen:CA016942|UniProtKB:P02545#VAR_039753	0.964074	0.95089	0	RCV000057262|RCV001225020	.	0	.	c.127G>A	.	0	0	0.96303	G/G	rs60446065	156115045	.	G	.	P02545	.	0.87609	.	0.68239	1	.	.	0.000000e+00	4.8	.	.	.	4.77	0.99763	.	D	T	.	.	.	.	.	.	.	64746	66799	0.96243	0.94644	0.999742329120636	.	.	0.71675	0.98608	.	.	1171998	9.953	.	.	.	.	.	.	.	0.98981	1	.	ENSG00000160789	0.000000e+00	.	.	.	.	1	0.97365	0.81453	.	.	.	0.000000e+00	0.888889835448083	.	0.000000e+00	0.712602	77696	HGNC:6636	.	.	.	0.984	.	156115045	GCG	1.000000	.	-	.	0.99375	8.532440e-07	.	0	Conflicting classifications of pathogenicity	0.75805	.	0	0	ClinGen:CA016942,UniProtKB:P02545#VAR_039753	A	.	.	-	0.924	-	0.97975	.	.	0.99215	0.757743537426	.	0	0.99901205079885413	.	-	127G>A 	.	.	C0270914|C3661900	.	.	.	.	NM_170707.4	-	.	.	1	0.97858	60446065	.	.	0.98919	0.95043	.	.	.	0.99996510	4.77	.	.	.	0.574085	0.999479217996385	0.99640	D	.	.	.	1.0724	0.97681	p.Ala43Thr	.	0	-10.307	.	0	0.96705	66799	D	.	LMNA	.	D	.	.	A43T	.	.	0.31918	G/G	principal1																																																																																																				
LMNA_Ala43Thr	2.826701345748407	0.02552666596388305	-4.1903998369062005	0.004084025769311878	2025_01_Batch_13-14	0.9215057423653834	0.9396516603326881	0.8710391824484176	0.7509784047159569	0.9010626710007219	0.951718694174347	0.9133695378053251	0.8985854888870367	0.9623449079213537	0.8637866395999324	0.9366122182698652	0.9265105990690066	0.8848123356677271	0.8566616563186553	0.8824246553003272	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	LMNA	LMNA		3903		CCSBVarC003606		NC_000001.11:156115045:G:A		Ala43Thr																												LMNA_Ala43Thr	1	156115045	G	A	1	allele	127G>A	G09	527_CAVA_Array_P03	N17	B13A7A8P1_R1	B14A7A8P1_R2				1-156115045-G-A	-	0.92707	1.0	43	.	0	.	1	156084836	A	6.261000e-07	.	1	3_Conflicting	NC_000001.11	1	Ala43Thr	.	32.0	.	.	.	D	0	4	.	.	.	.	.	.	.	0.99545	.	0.9299	.	0.90580	.	.	D	D	62534	.	.	0	.	.	.	0.75550	.	43966	0	.	0.67623	.	.	0.84994	0.999	.	.	.	.	.	A	single nucleotide variant	NC_000001.11:g.156115045G>A	0	.	2	0.751655	.	.	0.85589856	.	A	.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746	.	.	0.000000e+00	0	0.99291	D	0.86196	D	H	13.32298	1	G/G	.	.	.	1597190	not provided|Charcot-Marie-Tooth disease type 2	.	0.98653	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156115045	.	-	11.667000	.	0.99450	29200	.	1171998	.	germline	88354	Gain of phosphorylation at A43 (P = 0.0767)| Gain of disorder (P = 0.0918)| Gain of MoRF binding (P = 0.1749)| Loss of stability (P = 0.302)| Gain of solvent accessibility (P = 0.3819)	0.98699	GRCh38	420	criteria provided, conflicting classifications	.	.	0.60376	.	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	.	.	0.000000e+00	NM_170707.4(LMNA):c.127G>A (p.Ala43Thr)	1	.	LMNA_HUMAN	.	.	0.98056132522041	.	.	0.95185	0.819483	+	.	.	6.92112e-7	.	.	0	.	criteria_provided,_conflicting_classifications	0.99965	.	0	.	.	57712	.	0	0.94064	.	germline	.	156115045	G	Feb 26, 2024	.	G/G	.	.	1.0	N	1q22	.	.	.	SCV000293392|SCV000339872|SCV001397255	Conflicting_classifications_of_pathogenicity	.	.	Thr	T	-	912	ENSP00000502256	ENST00000675939	.	.	.	.	0.59	G	.	5.634268	0.60671	D	.	-	13.28456	.	0.97660	.	.	.	0.98769	.	156115045	Y	10	.	.	0.000000e+00	P02545	.	0.975701	0.97276	G	.	1.0	D	.	0.7691078	.	0.91597	4000	0.565194	1	.	.	8.532440e-07	0.91343	.	.	74668	.	6040	.	0.85142	1	LMNA	0.000000e+00	.	Ala	.	.	1-156115045-G-A	Charcot-Marie-Tooth_disease_type_2|not_provided	0	.	154351460	ClinGen:CA016942|UniProtKB:P02545#VAR_039753	0.964074	0.95089	0	RCV000057262|RCV001225020	.	0	.	c.127G>A	.	0	0	0.96303	G/G	rs60446065	156115045	.	G	.	P02545	.	0.87609	.	0.68239	1	.	.	0.000000e+00	4.8	.	.	.	4.77	0.99763	.	D	T	.	.	.	.	.	.	.	64746	66799	0.96243	0.94644	0.999742329120636	.	.	0.71675	0.98608	.	.	1171998	9.953	.	.	.	.	.	.	.	0.98981	1	.	ENSG00000160789	0.000000e+00	.	.	.	.	1	0.97365	0.81453	.	.	.	0.000000e+00	0.888889835448083	.	0.000000e+00	0.712602	77696	HGNC:6636	.	.	.	0.984	.	156115045	GCG	1.000000	.	-	.	0.99375	8.532440e-07	.	0	Conflicting classifications of pathogenicity	0.75805	.	0	0	ClinGen:CA016942,UniProtKB:P02545#VAR_039753	A	.	.	-	0.924	-	0.97975	.	.	0.99215	0.757743537426	.	0	0.99901205079885413	.	-	127G>A 	.	.	C0270914|C3661900	.	.	.	.	NM_170707.4	-	.	.	1	0.97858	60446065	.	.	0.98919	0.95043	.	.	.	0.99996510	4.77	.	.	.	0.574085	0.999479217996385	0.99640	D	.	.	.	1.0724	0.97681	p.Ala43Thr	.	0	-10.307	.	0	0.96705	66799	D	.	LMNA	.	D	.	.	A43T	.	.	0.31918	G/G	principal1																																																																																																				
FH_Gln376Pro	4.964945865150239	0.0025396516076362347	-7.121042736745749	0.00019011851741779218	2025_01_Batch_13-14	0.4809332923956441	0.8970850884189809	0.9509859139522358	0.9209322629506538	0.7859056690255877	0.6954918151638652	0.8891893934119484	0.9588243952495716	0.9546566583557993	0.8556528408751934	0.5882125537797547	0.8931372409154646	0.9549051546009037	0.9377944606532265	0.8207792549503905	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH	ENSG00000091483	3408	214601	CCSBVarC004055	ALE00004055	NC_000001.11:241502552:T:G	1127A>C	Gln376Pro	CEGS2	CegsMutGDEh1042	C05	GDEhDisVCh_40065	B09	1	CegsMutGDDh1042	C05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_Gln376Pro	1	241502552	T	G	1											1-241502552-T-G	-	0.76664	1.0	376	10	0	0	1	241665852	G	4.646730e-05	0	1	3_Conflicting	NC_000001.11	10	Gln376Pro	0	26.5	0	1	1.168290e-04	D	0	12	1	42768	6.332210e-05	.	30524	0.000000e+00	0	0.99647	Select	0.9899	102714	0.90580	0	.	D	D	64034	1.08544749973	1.1366219595362583E-4	0	0.000000e+00	0	0	0.72804	17108	44886	0	0.000000e+00	0.89297	5	.	0.99956	0.998	.	2.0	0.989101	.	0.98	G	single nucleotide variant	NC_000001.11:g.241502552T>G	0	16734	3	0.97383636	109398	0	0.99478674	0	G	12	236884	0	0	0.000000e+00	796	1.169100e-04	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0001402,Human Phenotype Ontology:HP:0002899,Human Phenotype Ontology:HP:0003007,Human Phenotype Ontology:HP:0006750,MONDO:MONDO:0007256,MedGen:C2239176,OMIM:114550,Orphanet:88673|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	7	2	0.000000e+00	0	0.97016	D	0.99614	D	H	12.20484	75	./.	352	1	7164	1614038	Hereditary cancer-predisposing syndrome|not provided|Hepatocellular carcinoma|Fumarase deficiency|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	16218	0.96852	.	.	-	241502552	1.395870e-04	-	7.892000	1	0.99826	29600	0	64034	0	germline;unknown	91086	.	.	GRCh38	975	criteria provided, conflicting classifications	c.1127A>C	0.000000e+00	0.96689	20	0	0	Fumarate lyase, N-terminal	5.975860e-05	9042	P	0	0.000000e+00	NM_000143.4(FH):c.1127A>C (p.Gln376Pro)	1	0	FUMH_HUMAN	0	98.0	0.94256199435676	0	D	0.82051	0.99478674	-	1.395870e-04	.	0.0000465174	10	0.000000e+00	0	34238	criteria_provided,_conflicting_classifications	0.94214	6.398650e-05	0	7.466030e-05	0	59996	p.Gln376Pro	0	0.73146	.	germline	1	241502552	T	Jan 29, 2025	0	./.	0	89552	1.0	N	1q43	178358	.	6.165990e-05	SCV000214379|SCV000251429|SCV000632435|SCV001428576|SCV002022985|SCV003928116|SCV004197296|SCV005640073	Conflicting_classifications_of_pathogenicity	1	0	Pro	P	-	912	ENSP00000355518	ENST00000366560	17688	0.0	13412	0	0.665	T	0	4.747101	0.83643	D	D	-	11.80997	.	0.98288	968	0	.	0.88780	0	241502552	Y	10	0	102714	0.000000e+00	P07954	0	0.978282	0.80201	T	0	1.0	D	89552	0.97383636	7164	0.85369	2271	0.409114	62	-5.97	.	1.561670e-04	0.91343	0.000000e+00	0	74940	0.000000e+00	6084	1	0.99615	1	FH	2.668800e-05	0	Gln	206034	1.116670e-04	1-241502552-T-G	not_provided|Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|Hepatocellular_carcinoma|Hereditary_leiomyomatosis_and_renal_cell_cancer	0	12	239732475	ClinGen:CA189211	0.750574	0.93648	0	RCV000163798|RCV000199873|RCV002280864|RCV000034920|RCV004595492	D	0	0	c.1127A>C	0	0	10	0.90364	./.	rs200796606	241502552	14902	T	.	.	15688	0.99956	9.245560e-05	0.68239	1	0	0	0.000000e+00	4.55	0	18	264690	5.96	0.99806	3338	D	T	1	0.000000e+00	0	652	segdup	0	1	24|140162|88673|523	42094	0.95975	0.77132	0.996202170848846	9150	.	0.71675	0.69053	0.000000e+00	1.116670e-04	1180012	2.556	5.766510e-05	D	13394	0	7.178209E-5	0	606812|114550|150800	0.45625	1	6.710510e-05	ENSG00000091483	1.561670e-04	1.0092062032541293E-4	0	0	0.9931077487324933	2	0.97365	0.05314	30606	19	1.168290e-04	0.000000e+00	0.851050495351092	YES	0.000000e+00	0.783004	51260	HGNC:3700	A	0	simple_aae	0.995	208098	241502552	CAG	1.000000	.	-	1.092896174863388E-4	0.89206	5.254180e-05	1	0	Conflicting classifications of pathogenicity	0.96526	0	0	0	ClinGen:CA189211	Q	0	0.988874007372	-	.	-	0.60631	15	13144	0.99305	0.73917901516	0.89	0	0.99695009503082266	280	-	1127A>C 	12	7.608034083992696E-5	C3661900|C0342770|C0027672|C2239176|C1708350	0	0	0	0	NM_000143.4	-	.	.	1	0.96387	200796606	2320	9.707135715464438E-5	0.98862	0.93038	0.588	0.001	8798	0.96386050	5.96	.	.	0.000000e+00	0.565222	0.999990050804425	0.99107	D	2686	6210	9570	0.9801	0.99722	p.Gln376Pro	0	0	-15.301	0.89965594	2	0.99831	42094	D	30502	FH	0.000000e+00	D	0.970	21632	.	D	.	0.62996	./.	principal1																																																																																																				
FH_Gln376Pro	4.964945865150239	0.0025396516076362347	-7.121042736745749	0.00019011851741779218	2025_01_Batch_13-14	0.4809332923956441	0.8970850884189809	0.9509859139522358	0.9209322629506538	0.7859056690255877	0.6954918151638652	0.8891893934119484	0.9588243952495716	0.9546566583557993	0.8556528408751934	0.5882125537797547	0.8931372409154646	0.9549051546009037	0.9377944606532265	0.8207792549503905	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH		3408		CCSBVarC004055		NC_000001.11:241502552:T:G		Gln376Pro																												FH_Gln376Pro	1	241502552	T	G	1	allele	1127A>C	G02	527_CAVA_Array_P03	N03	B13A7A8P1_R1	B14A7A8P1_R2				1-241502552-T-G	-	0.76664	1.0	376	10	0	0	1	241665852	G	4.646730e-05	0	1	3_Conflicting	NC_000001.11	10	Gln376Pro	0	26.5	0	1	1.168290e-04	D	0	12	1	42768	6.332210e-05	.	30524	0.000000e+00	0	0.99647	Select	0.9899	102714	0.90580	0	.	D	D	64034	1.08544749973	1.1366219595362583E-4	0	0.000000e+00	0	0	0.72804	17108	44886	0	0.000000e+00	0.89297	5	.	0.99956	0.998	.	2.0	0.989101	.	0.98	G	single nucleotide variant	NC_000001.11:g.241502552T>G	0	16734	3	0.97383636	109398	0	0.99478674	0	G	12	236884	0	0	0.000000e+00	796	1.169100e-04	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0001402,Human Phenotype Ontology:HP:0002899,Human Phenotype Ontology:HP:0003007,Human Phenotype Ontology:HP:0006750,MONDO:MONDO:0007256,MedGen:C2239176,OMIM:114550,Orphanet:88673|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	7	2	0.000000e+00	0	0.97016	D	0.99614	D	H	12.20484	75	./.	352	1	7164	1614038	Hereditary cancer-predisposing syndrome|not provided|Hepatocellular carcinoma|Fumarase deficiency|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	16218	0.96852	.	.	-	241502552	1.395870e-04	-	7.892000	1	0.99826	29600	0	64034	0	germline;unknown	91086	.	.	GRCh38	975	criteria provided, conflicting classifications	c.1127A>C	0.000000e+00	0.96689	20	0	0	Fumarate lyase, N-terminal	5.975860e-05	9042	P	0	0.000000e+00	NM_000143.4(FH):c.1127A>C (p.Gln376Pro)	1	0	FUMH_HUMAN	0	98.0	0.94256199435676	0	D	0.82051	0.99478674	-	1.395870e-04	.	0.0000465174	10	0.000000e+00	0	34238	criteria_provided,_conflicting_classifications	0.94214	6.398650e-05	0	7.466030e-05	0	59996	p.Gln376Pro	0	0.73146	.	germline	1	241502552	T	Jan 29, 2025	0	./.	0	89552	1.0	N	1q43	178358	.	6.165990e-05	SCV000214379|SCV000251429|SCV000632435|SCV001428576|SCV002022985|SCV003928116|SCV004197296|SCV005640073	Conflicting_classifications_of_pathogenicity	1	0	Pro	P	-	912	ENSP00000355518	ENST00000366560	17688	0.0	13412	0	0.665	T	0	4.747101	0.83643	D	D	-	11.80997	.	0.98288	968	0	.	0.88780	0	241502552	Y	10	0	102714	0.000000e+00	P07954	0	0.978282	0.80201	T	0	1.0	D	89552	0.97383636	7164	0.85369	2271	0.409114	62	-5.97	.	1.561670e-04	0.91343	0.000000e+00	0	74940	0.000000e+00	6084	1	0.99615	1	FH	2.668800e-05	0	Gln	206034	1.116670e-04	1-241502552-T-G	not_provided|Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|Hepatocellular_carcinoma|Hereditary_leiomyomatosis_and_renal_cell_cancer	0	12	239732475	ClinGen:CA189211	0.750574	0.93648	0	RCV000163798|RCV000199873|RCV002280864|RCV000034920|RCV004595492	D	0	0	c.1127A>C	0	0	10	0.90364	./.	rs200796606	241502552	14902	T	.	.	15688	0.99956	9.245560e-05	0.68239	1	0	0	0.000000e+00	4.55	0	18	264690	5.96	0.99806	3338	D	T	1	0.000000e+00	0	652	segdup	0	1	24|140162|88673|523	42094	0.95975	0.77132	0.996202170848846	9150	.	0.71675	0.69053	0.000000e+00	1.116670e-04	1180012	2.556	5.766510e-05	D	13394	0	7.178209E-5	0	606812|114550|150800	0.45625	1	6.710510e-05	ENSG00000091483	1.561670e-04	1.0092062032541293E-4	0	0	0.9931077487324933	2	0.97365	0.05314	30606	19	1.168290e-04	0.000000e+00	0.851050495351092	YES	0.000000e+00	0.783004	51260	HGNC:3700	A	0	simple_aae	0.995	208098	241502552	CAG	1.000000	.	-	1.092896174863388E-4	0.89206	5.254180e-05	1	0	Conflicting classifications of pathogenicity	0.96526	0	0	0	ClinGen:CA189211	Q	0	0.988874007372	-	.	-	0.60631	15	13144	0.99305	0.73917901516	0.89	0	0.99695009503082266	280	-	1127A>C 	12	7.608034083992696E-5	C3661900|C0342770|C0027672|C2239176|C1708350	0	0	0	0	NM_000143.4	-	.	.	1	0.96387	200796606	2320	9.707135715464438E-5	0.98862	0.93038	0.588	0.001	8798	0.96386050	5.96	.	.	0.000000e+00	0.565222	0.999990050804425	0.99107	D	2686	6210	9570	0.9801	0.99722	p.Gln376Pro	0	0	-15.301	0.89965594	2	0.99831	42094	D	30502	FH	0.000000e+00	D	0.970	21632	.	D	.	0.62996	./.	principal1																																																																																																				
SOS2_Val869Ile	-1.6906881260572169	0.13473984727334107	24.562323565003886	4.723899389812003e-8	2025_01_Batch_13-14	0.660541002024487	0.9818388517981322	0.9961885034785765	0.9811042106268615	0.6985221185630515	0.7995106102292323	0.9874451617829887	0.9972769546312914	0.9931706805698124	0.7139928785959548	0.7300258061268596	0.9846420067905605	0.9967327290549339	0.9871374455983369	0.7062574985795032	0.0	1.0	1.0	1.0	0.0	0.0	1.0	1.0	0.0	0.0	SOS2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											
G6PD_Ile48Thr	-0.2620179732240577	0.8008506093363101	-5.13568429567412	0.0013451510736389762	2025_01_Batch_13-14	0.498102051673434	0.6773726472083663	0.8752138130416006	0.690890275113418	0.4686694704507386	0.9620209210586805	0.9095239752944728	0.9169525603244141	0.9731303464201745	0.8291248390927711	0.7300614863660573	0.7934483112514196	0.8960831866830073	0.8320103107667962	0.6488971547717548	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	G6PD	G6PD		4006		CCSBVarC021436		NC_000023.11:154536156:A:G		Ile48Thr																												G6PD_Ile48Thr	23	154536156	A	G	X	allele	143T>C	A05	527_CAVA_Array_P03	B09	B13A7A8P1_R1	B14A7A8P1_R2				X-154536156-A-G	-	0.67426	0.985	48	0	0	0	X	153764371	G	1.405040e-05	0	X	1_Pathogenic	NC_000023.11	10	Ile78Thr	2	25.1	1	0	1.501500e-04	D	0	16	5	30958	1.161600e-05	0	19010	0.000000e+00	0	0.93443	.	0.9334	13320	0.61134	0	0.0013089005235602095	D	D	46637	.	0	0	0.000000e+00	0	0	0.83546	13664	33749	0	1.974530e-04	0.66695	0	.	0.82164	0.998	0.0	1.0	.	.	0.99	G	single nucleotide variant	NC_000023.11:g.154536156A>G	0	12190	3	0.66341555	80339	0	0.83749527	0		2	172177	0	0	1.501500e-04	178	0.000000e+00	0	|MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026|MONDO:MONDO:0005775,MedGen:C2939465|MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026;MONDO:MONDO:0021024,MedGen:C1970028,OMIM:611162,Orphanet:673|MONDO:MONDO:0021024,MedGen:C1970028,OMIM:611162,Orphanet:673||MedGen:C3661900	1	0	0.000000e+00	0	0.97926	D	0.78580	D	L	.	17	A/A	122	0	5699	1209926	G6PD AURES|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency;Malaria, susceptibility to|Malaria, susceptibility to|G6PD-related disorder|not provided	13129	0.95840	0	.	-	154536156	1.445710e-04	-	9.206000	0	0.81095	22029	0	4355	2	germline;unknown	56799	Gain of disorder (P = 0.0198)| Loss of stability (P = 0.024)| Loss of catalytic residue at P50 (P = 0.0321)| Gain of glycosylation at P50 (P = 0.0902)| Loss of methylation at K47 (P = 0.1012)	0.99517	GRCh38	80	criteria provided, multiple submitters, no conflicts	c.143T>C	0.000000e+00	0.48586	0	0	0	Glucose-6-phosphate dehydrogenase, NAD-binding	0.000000e+00	6917	P	0	0.000000e+00	NM_000402.4(G6PD):c.233T>C (p.Ile78Thr)	2	0	G6PD_HUMAN	0	99.0	.	0	.	0.82620	0.7755391	-	0.000000e+00	0		2	0.000000e+00	0	27165	criteria_provided,_multiple_submitters,_no_conflicts	0.97879	1.244730e-05	0	0.000000e+00	0	45816	p.Ile48Thr	0	0.79242	.	germline	1		A	Dec 06, 2024	0	A/A	0	64662	1.0	N	Xq28	18236	.	0.000000e+00	SCV000280664|SCV000833043|SCV001142115|SCV001523185|SCV001793238|SCV002025185|SCV002038576|SCV002506148|SCV002599318|SCV002788373|SCV004195384|SCV004805193|SCV005186094|SCV005413462	Pathogenic/Likely_pathogenic	0	0	Thr	T	-	678	ENSP00000377194	ENST00000393564	13320	1.0	10129	0	0.751	A	0	4.373753	0.06347	.	T	-	.	.	0.85319	780	0	0.0	0.26859	0	154536156	Y	10	0	73427	2.296210e-03	P11413	0	0.864655	0.17599		0	0.964	D	10129	0.6371406	6917	0.85369	2539	0.423939	0	-3.37	0.0	2.296210e-03	0.06776	0.000000e+00	0	57219	1.445710e-04	4355	0	0.80049	X	G6PD	1.747670e-05	0	Ile	23470	0.000000e+00	X-154536156-A-G	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency|Malaria,_susceptibility_to|G6PD_AURES|G6PD_deficiency|not_provided	0	0	153417565	ClinGen:CA121021|OMIM:305900.0043	.	.	0	RCV000011145|RCV000704108|RCV001796957|RCV002482854|RCV003466850|RCV004748514|RCV000224890	D	0	0	c.143T>C	0	2	0	0.91161	A/A	rs76645461	154536156	12061	A	2.6490066225165563E-4	P11413	9952	0.86250	0.000000e+00	0.68239		0	0	5.926100e-05	1.365	0	0	264690	4.19	0.97001	400	T	D	0	0.000000e+00	0	58	.	0	0	466026|673	10402	0.97650	0.66127	0.353604669620596	3244	1	0.71675	.	0.000000e+00	1.974530e-04	895021	7.094	1.317120e-05	D	9932	0	1.51120175E-5	0	300908|611162	0.76658	X	0.000000e+00	ENSG00000160211	0.000000e+00	0	0	0	.	2	0.71005	0.96675	19075	4	0.000000e+00	0.000000e+00	.	.	0.000000e+00	0.178446	25441	HGNC:4057	A	0	simple_aae	0.66	151847	154536156	ATC	1.000000	1	-	0	0.91752	0.000000e+00	0	0	Pathogenic/Likely pathogenic	0.46017	0	10	0	ClinGen:CA121021,OMIM:305900.0043,ClinVar:1722711,ClinVar:1722739	I	0	0.999291972508	-	0.956	-	0.86268	2	516	.	0.810541808605	0.8079	0	0.87607992308164628	116	-	233T>C 	2	0	C2720289|C1970028|C2939465|C3661900	0	0	0	0	NM_000402.4	-	0	0.0	1	0.93807	76645461	1767	0	0.99927	.	0.796	0.771	3122	0.99580365	5.38	.	.	0.000000e+00	0.630861	0.998863967322053	0.34008	D	342	4649	7072	0.9127	0.97801	p.Ile48Thr	0	0	-5.158	0.9249425	1	0.95207	10402	T	24387	G6PD	0.000000e+00	D	0.800	15974	I48T	T	.	0.87726	A/A	principal4	274225	G6PD_unpublished_var123133	No						Protein stability		Fluorescence			I		143	G6PD_unpublished		ENST00000393562.10							immortalized human cells					p.Ile48Thr		true	c.143T>C						4057.0	154536156.0	Yes		G6PD				NM_001360016.2		-1.0			aa											criteria provided, multiple submitters, no conflicts	0.6796720223346846;-0.3441175263713626;0.6631703840089543			Ile48Thr						T	Aug 31, 2024					missense_variant		48.0			0.0000140504460603	0.3329082933240921		Pathogenic/Likely pathogenic	154536156.0	missense_variant		0.8					Reporter			G6PD_Ile48Thr
BRAF_Asp565Glu	-2.6309360210738006	0.0338665149617909	2.7720035823390834	0.027614311127530596	2025_01_Batch_13-14	0.552685161673155	0.6687514949660767	0.7068440226909102	0.6391403118674894	0.5217539669056006	0.5001272833154411	0.5939184049658881	0.6536136590776095	0.6767628059356723	0.5102262104531048	0.526406222494298	0.6313349499659824	0.6802288408842598	0.6579515589015809	0.5159900886793527	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220613	CCSBVarC003170	ALE00003170	NC_000007.14:140754233:A:C	1695T>G	Asp565Glu	CEGS2	CegsMutGDEh1012	F06	GDEhDisVCh_40058	F04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Asp565Glu	7	140754233	A	C	7											7-140754233-A-C	-	0.69197	0.008	565	.	.	.	7	140454033	C	.	.	7	1_Pathogenic	NC_000007.14	.	Asp565Glu	.	25.3	.	2	.	T	.	3	.	.	.	.	.	.	0	0.82085	Select	0.0795	.	0.14667	.	.	D	D	.	.	0.004694835680751174	.	.	.	.	0.95428	.	.	.	.	.	.	.	0.88657	1.0	.	.	0.918508	5.52	.	C	single nucleotide variant	NC_000007.14:g.140754233A>C	.	.	2	0.7036775	.	0	0.80036193	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733	.	.	.	.	0.76851	B	0.83912	B	N	4.271038	.	A/A	0	1	.	.	Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome and Noonan-related syndrome	.	0.11274	.	.	-	140754233	.	-	9.383000	.	0.82741	.	0	.	.	de novo;germline	.	Gain of catalytic residue at D565 (P = 0.0544)| Gain of ubiquitination at K570 (P = 0.1162)| Gain of methylation at K570 (P = 0.1449)| Gain of disorder (P = 0.2432)| Loss of helix (P = 0.3949)	0.92541	GRCh38	789	criteria provided, multiple submitters, no conflicts	c.1695T>G	.	0.47290	3	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	0	.	NM_004333.6(BRAF):c.1695T>G (p.Asp565Glu)	2	.	BRAF_HUMAN	.	.	0.388200223436253	.	D	0.94256	0.8693574	-	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98658	.	.	.	.	.	p.Asp565Glu	.	0.80559	.	germline	.		A	Dec 29, 2016	.	A/A	.	.	1.0	N	7q34	0	.	.	SCV000061591|SCV000263068|SCV002060706	Pathogenic/Likely_pathogenic	.	.	Glu	E	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.756	A	.	4.448549	.	D	.	-	4.588634	.	.	0	.	.	0.52308	0	140754233	Y	10	0	.	.	P15056	.	0.799272	0.58857		.	0.025	.	.	0.73096305	.	0.97202	673	0.275835	.	.	.	.	.	.	.	.	.	.	.	0.82332	7	BRAF	.	0	Asp	478	.	7-140754233-A-C	Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|not_provided	.	.	140100502	ClinGen:CA280016	0.621801	0.60579	.	RCV000037927|RCV000207514|RCV001813224	D	.	.	c.1695T>G	.	.	.	0.80817	A/A	rs397507480	140754233	.	A	.	P15056	.	0.83724	.	0.68239		.	.	.	-0.19	0	0	.	4.11	0.94819	0	D	D	.	.	0	0	.	.	.	1340|98733	40383	0.80570	0.71418	0.875816404819489	426	.	0.71675	0.60495	.	.	.	3.206	.	.	.	.	.	0	PS115150	0.50896	7	.	ENSG00000157764	.	0	.	0	.	3	0.20509	0.46282	.	.	.	.	0.431391921300296	YES	.	.	48853	HGNC:1097	.	.	.	0.689	.	140754233	GAT	1.000000	.	-	0.004694835680751174	0.85975	.	2	.	Pathogenic/Likely pathogenic	0.63492	.	.	.	ClinGen:CA280016	D	.	.	-	0.809	-	.	.	52	0.85572	0.891400456429	0.9665	.	0.99305136928065907	0	-	1695T>G 	.	0.019230769230769232	C1275081|C5681679|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.70644	397507480	.	0.006276150627615063	0.97114	0.63332	.	.	426	0.99816126	5.26	.	.	.	0.158442	0.983874848762311	0.04221	T	0	.	.	-1.0620	0.31365	p.Asp565Glu	0	.	-8.348	0.86869705	.	0.86325	40383	D	.	BRAF	.	D	.	.	D565E	.	0.94476	0.943	A/A	principal4																																																																																																				
BRAF_Asp565Glu	-2.6309360210738006	0.0338665149617909	2.7720035823390834	0.027614311127530596	2025_01_Batch_13-14	0.552685161673155	0.6687514949660767	0.7068440226909102	0.6391403118674894	0.5217539669056006	0.5001272833154411	0.5939184049658881	0.6536136590776095	0.6767628059356723	0.5102262104531048	0.526406222494298	0.6313349499659824	0.6802288408842598	0.6579515589015809	0.5159900886793527	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003170		NC_000007.14:140754233:A:C		Asp565Glu																												BRAF_Asp565Glu	7	140754233	A	C	7	allele	1695T>G	H04	527_CAVA_Array_P01	O07	B13A7A8P1_R1	B14A7A8P1_R2				7-140754233-A-C	-	0.69197	0.008	565	.	.	.	7	140454033	C	.	.	7	1_Pathogenic	NC_000007.14	.	Asp565Glu	.	25.3	.	2	.	T	.	3	.	.	.	.	.	.	0	0.82085	Select	0.0795	.	0.14667	.	.	D	D	.	.	0.004694835680751174	.	.	.	.	0.95428	.	.	.	.	.	.	.	0.88657	1.0	.	.	0.918508	5.52	.	C	single nucleotide variant	NC_000007.14:g.140754233A>C	.	.	2	0.7036775	.	0	0.80036193	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733	.	.	.	.	0.76851	B	0.83912	B	N	4.271038	.	A/A	0	1	.	.	Cardio-facio-cutaneous syndrome|not provided|Noonan syndrome and Noonan-related syndrome	.	0.11274	.	.	-	140754233	.	-	9.383000	.	0.82741	.	0	.	.	de novo;germline	.	Gain of catalytic residue at D565 (P = 0.0544)| Gain of ubiquitination at K570 (P = 0.1162)| Gain of methylation at K570 (P = 0.1449)| Gain of disorder (P = 0.2432)| Loss of helix (P = 0.3949)	0.92541	GRCh38	789	criteria provided, multiple submitters, no conflicts	c.1695T>G	.	0.47290	3	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	0	.	NM_004333.6(BRAF):c.1695T>G (p.Asp565Glu)	2	.	BRAF_HUMAN	.	.	0.388200223436253	.	D	0.94256	0.8693574	-	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98658	.	.	.	.	.	p.Asp565Glu	.	0.80559	.	germline	.		A	Dec 29, 2016	.	A/A	.	.	1.0	N	7q34	0	.	.	SCV000061591|SCV000263068|SCV002060706	Pathogenic/Likely_pathogenic	.	.	Glu	E	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.756	A	.	4.448549	.	D	.	-	4.588634	.	.	0	.	.	0.52308	0	140754233	Y	10	0	.	.	P15056	.	0.799272	0.58857		.	0.025	.	.	0.73096305	.	0.97202	673	0.275835	.	.	.	.	.	.	.	.	.	.	.	0.82332	7	BRAF	.	0	Asp	478	.	7-140754233-A-C	Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|not_provided	.	.	140100502	ClinGen:CA280016	0.621801	0.60579	.	RCV000037927|RCV000207514|RCV001813224	D	.	.	c.1695T>G	.	.	.	0.80817	A/A	rs397507480	140754233	.	A	.	P15056	.	0.83724	.	0.68239		.	.	.	-0.19	0	0	.	4.11	0.94819	0	D	D	.	.	0	0	.	.	.	1340|98733	40383	0.80570	0.71418	0.875816404819489	426	.	0.71675	0.60495	.	.	.	3.206	.	.	.	.	.	0	PS115150	0.50896	7	.	ENSG00000157764	.	0	.	0	.	3	0.20509	0.46282	.	.	.	.	0.431391921300296	YES	.	.	48853	HGNC:1097	.	.	.	0.689	.	140754233	GAT	1.000000	.	-	0.004694835680751174	0.85975	.	2	.	Pathogenic/Likely pathogenic	0.63492	.	.	.	ClinGen:CA280016	D	.	.	-	0.809	-	.	.	52	0.85572	0.891400456429	0.9665	.	0.99305136928065907	0	-	1695T>G 	.	0.019230769230769232	C1275081|C5681679|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.70644	397507480	.	0.006276150627615063	0.97114	0.63332	.	.	426	0.99816126	5.26	.	.	.	0.158442	0.983874848762311	0.04221	T	0	.	.	-1.0620	0.31365	p.Asp565Glu	0	.	-8.348	0.86869705	.	0.86325	40383	D	.	BRAF	.	D	.	.	D565E	.	0.94476	0.943	A/A	principal4																																																																																																				
F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser406Leu	23	139561902	C	T	X											X-139561902-C-T	-	0.79991	0.924	406	.	.	.	X	138644061	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser406Leu	.	27.2	.	0	.	D	.	1	1	.	.	.	.	.	0	0.95717	Select	0.8695	.	0.51298	.	.	D	D	.	1.42151595831	0	.	.	.	.	0.26982	.	.	.	.	0.68090	.	.	0.98169	0.998	.	28.0	0.835916	4.99	0.72	T	single nucleotide variant	NC_000023.11:g.139561902C>T	.	.	1	0.94676954	.	0	0.9734807	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.83457	P	0.99317	P	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.96061	.	.	-	139561902	.	-	7.708000	.	0.98885	.	0	.	.	germline	.	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.98766	GRCh38	924	no assertion criteria provided	c.1217C>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)		.	FA9_HUMAN	.	72.0	.	.	T	0.71593	0.9693402	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser406Leu	.	0.66701	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031595	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.599	C	.	4.877112	0.76775	.	D	-	.	.	0.99366	0	.	.	0.69295	0	139561902	Y	10	0	.	.	P00740	.	0.864181	0.97276		.	0.833	D	.	0.96699363	.	0.85369	2158	0.38613	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.98174	X	F9	.	0	Ser	660	.	X-139561902-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471727	ClinGen:CA255405|OMIM:300746.0061	.	.	.	RCV000011363	D	.	.	c.1217C>T	.	.	.	0.89021	C/C	rs137852263	139561902	.	C	.	P00740	.	0.98551	.	0.68239		.	.	.	2.22	0	0	.	5.66	0.96986	34	D	T	.	.	0	0	.	.	.	98879	10617	0.88883	0.85555	0.971914410591125	434	.	0.71675	.	.	.	.	7.879	.	D	.	.	.	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9949048274168517	2	0.59778	0.18019	.	.	.	.	.	YES	.	0.914868	25656	HGNC:3551	A	.	simple_aae	0.971	.	139561902	TCA	1.000000	.	-	0	0.98025	.	0	.	Pathogenic	0.91585	.	.	.	ClinGen:CA255405,OMIM:300746.0061	S	.	0.990085995164	-	0.926	-	0.81297	.	108	0.99487	0.414036989212	0.52	.	0.99900846572837232	6	-	1217C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.50543	137852263	.	0	0.98986	.	0.497	0.004	434	0.99998593	5.66	.	.	.	0.316873	0.999310278667129	0.62721	D	34	.	.	0.9280	0.95652	p.Ser406Leu	0	.	-13.568	0.98063314	.	0.96235	10617	D	.	F9	.	D	0.860	.	S406L	D	0.89858	0.40292	C/C	principal1	230185	F9_Popp_2025_light_chain_var248556	No											S		1217	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ser406Leu		true	c.1217C>T						3551.0	139561902.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Ser406Leu						L	Oct 09, 2017					missense_variant		406.0				1.0735200136724985		Pathogenic	139561902.0	missense_variant		0.86					Reporter			F9_Ser406Leu
F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser406Leu	23	139561902	C	T	X											X-139561902-C-T	-	0.79991	0.924	406	.	.	.	X	138644061	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser406Leu	.	27.2	.	0	.	D	.	1	1	.	.	.	.	.	0	0.95717	Select	0.8695	.	0.51298	.	.	D	D	.	1.42151595831	0	.	.	.	.	0.26982	.	.	.	.	0.68090	.	.	0.98169	0.998	.	28.0	0.835916	4.99	0.72	T	single nucleotide variant	NC_000023.11:g.139561902C>T	.	.	1	0.94676954	.	0	0.9734807	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.83457	P	0.99317	P	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.96061	.	.	-	139561902	.	-	7.708000	.	0.98885	.	0	.	.	germline	.	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.98766	GRCh38	924	no assertion criteria provided	c.1217C>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)		.	FA9_HUMAN	.	72.0	.	.	T	0.71593	0.9693402	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser406Leu	.	0.66701	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031595	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.599	C	.	4.877112	0.76775	.	D	-	.	.	0.99366	0	.	.	0.69295	0	139561902	Y	10	0	.	.	P00740	.	0.864181	0.97276		.	0.833	D	.	0.96699363	.	0.85369	2158	0.38613	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.98174	X	F9	.	0	Ser	660	.	X-139561902-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471727	ClinGen:CA255405|OMIM:300746.0061	.	.	.	RCV000011363	D	.	.	c.1217C>T	.	.	.	0.89021	C/C	rs137852263	139561902	.	C	.	P00740	.	0.98551	.	0.68239		.	.	.	2.22	0	0	.	5.66	0.96986	34	D	T	.	.	0	0	.	.	.	98879	10617	0.88883	0.85555	0.971914410591125	434	.	0.71675	.	.	.	.	7.879	.	D	.	.	.	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9949048274168517	2	0.59778	0.18019	.	.	.	.	.	YES	.	0.914868	25656	HGNC:3551	A	.	simple_aae	0.971	.	139561902	TCA	1.000000	.	-	0	0.98025	.	0	.	Pathogenic	0.91585	.	.	.	ClinGen:CA255405,OMIM:300746.0061	S	.	0.990085995164	-	0.926	-	0.81297	.	108	0.99487	0.414036989212	0.52	.	0.99900846572837232	6	-	1217C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.50543	137852263	.	0	0.98986	.	0.497	0.004	434	0.99998593	5.66	.	.	.	0.316873	0.999310278667129	0.62721	D	34	.	.	0.9280	0.95652	p.Ser406Leu	0	.	-13.568	0.98063314	.	0.96235	10617	D	.	F9	.	D	0.860	.	S406L	D	0.89858	0.40292	C/C	principal1	175153	F9_Popp_2025_carboxy_gla_motif_var258237	No											S		1217	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ser406Leu		true	c.1217C>T						3551.0	139561902.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Ser406Leu						L	Oct 09, 2017					missense_variant		406.0				1.0662084564629408		Pathogenic	139561902.0	missense_variant		0.86					Reporter			F9_Ser406Leu
F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser406Leu	23	139561902	C	T	X											X-139561902-C-T	-	0.79991	0.924	406	.	.	.	X	138644061	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser406Leu	.	27.2	.	0	.	D	.	1	1	.	.	.	.	.	0	0.95717	Select	0.8695	.	0.51298	.	.	D	D	.	1.42151595831	0	.	.	.	.	0.26982	.	.	.	.	0.68090	.	.	0.98169	0.998	.	28.0	0.835916	4.99	0.72	T	single nucleotide variant	NC_000023.11:g.139561902C>T	.	.	1	0.94676954	.	0	0.9734807	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.83457	P	0.99317	P	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.96061	.	.	-	139561902	.	-	7.708000	.	0.98885	.	0	.	.	germline	.	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.98766	GRCh38	924	no assertion criteria provided	c.1217C>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)		.	FA9_HUMAN	.	72.0	.	.	T	0.71593	0.9693402	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser406Leu	.	0.66701	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031595	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.599	C	.	4.877112	0.76775	.	D	-	.	.	0.99366	0	.	.	0.69295	0	139561902	Y	10	0	.	.	P00740	.	0.864181	0.97276		.	0.833	D	.	0.96699363	.	0.85369	2158	0.38613	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.98174	X	F9	.	0	Ser	660	.	X-139561902-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471727	ClinGen:CA255405|OMIM:300746.0061	.	.	.	RCV000011363	D	.	.	c.1217C>T	.	.	.	0.89021	C/C	rs137852263	139561902	.	C	.	P00740	.	0.98551	.	0.68239		.	.	.	2.22	0	0	.	5.66	0.96986	34	D	T	.	.	0	0	.	.	.	98879	10617	0.88883	0.85555	0.971914410591125	434	.	0.71675	.	.	.	.	7.879	.	D	.	.	.	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9949048274168517	2	0.59778	0.18019	.	.	.	.	.	YES	.	0.914868	25656	HGNC:3551	A	.	simple_aae	0.971	.	139561902	TCA	1.000000	.	-	0	0.98025	.	0	.	Pathogenic	0.91585	.	.	.	ClinGen:CA255405,OMIM:300746.0061	S	.	0.990085995164	-	0.926	-	0.81297	.	108	0.99487	0.414036989212	0.52	.	0.99900846572837232	6	-	1217C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.50543	137852263	.	0	0.98986	.	0.497	0.004	434	0.99998593	5.66	.	.	.	0.316873	0.999310278667129	0.62721	D	34	.	.	0.9280	0.95652	p.Ser406Leu	0	.	-13.568	0.98063314	.	0.96235	10617	D	.	F9	.	D	0.860	.	S406L	D	0.89858	0.40292	C/C	principal1	202669	F9_Popp_2025_heavy_chain_var238875	No											S		1217	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ser406Leu		true	c.1217C>T						3551.0	139561902.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Ser406Leu						L	Oct 09, 2017					missense_variant		406.0				1.0917705378443288		Pathogenic	139561902.0	missense_variant		0.86					Reporter			F9_Ser406Leu
F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser406Leu	23	139561902	C	T	X											X-139561902-C-T	-	0.79991	0.924	406	.	.	.	X	138644061	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser406Leu	.	27.2	.	0	.	D	.	1	1	.	.	.	.	.	0	0.95717	Select	0.8695	.	0.51298	.	.	D	D	.	1.42151595831	0	.	.	.	.	0.26982	.	.	.	.	0.68090	.	.	0.98169	0.998	.	28.0	0.835916	4.99	0.72	T	single nucleotide variant	NC_000023.11:g.139561902C>T	.	.	1	0.94676954	.	0	0.9734807	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.83457	P	0.99317	P	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.96061	.	.	-	139561902	.	-	7.708000	.	0.98885	.	0	.	.	germline	.	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.98766	GRCh38	924	no assertion criteria provided	c.1217C>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)		.	FA9_HUMAN	.	72.0	.	.	T	0.71593	0.9693402	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser406Leu	.	0.66701	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031595	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.599	C	.	4.877112	0.76775	.	D	-	.	.	0.99366	0	.	.	0.69295	0	139561902	Y	10	0	.	.	P00740	.	0.864181	0.97276		.	0.833	D	.	0.96699363	.	0.85369	2158	0.38613	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.98174	X	F9	.	0	Ser	660	.	X-139561902-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471727	ClinGen:CA255405|OMIM:300746.0061	.	.	.	RCV000011363	D	.	.	c.1217C>T	.	.	.	0.89021	C/C	rs137852263	139561902	.	C	.	P00740	.	0.98551	.	0.68239		.	.	.	2.22	0	0	.	5.66	0.96986	34	D	T	.	.	0	0	.	.	.	98879	10617	0.88883	0.85555	0.971914410591125	434	.	0.71675	.	.	.	.	7.879	.	D	.	.	.	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9949048274168517	2	0.59778	0.18019	.	.	.	.	.	YES	.	0.914868	25656	HGNC:3551	A	.	simple_aae	0.971	.	139561902	TCA	1.000000	.	-	0	0.98025	.	0	.	Pathogenic	0.91585	.	.	.	ClinGen:CA255405,OMIM:300746.0061	S	.	0.990085995164	-	0.926	-	0.81297	.	108	0.99487	0.414036989212	0.52	.	0.99900846572837232	6	-	1217C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.50543	137852263	.	0	0.98986	.	0.497	0.004	434	0.99998593	5.66	.	.	.	0.316873	0.999310278667129	0.62721	D	34	.	.	0.9280	0.95652	p.Ser406Leu	0	.	-13.568	0.98063314	.	0.96235	10617	D	.	F9	.	D	0.860	.	S406L	D	0.89858	0.40292	C/C	principal1	147637	F9_Popp_2025_carboxy_F9_specific_var229194	No											S		1217	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ser406Leu		true	c.1217C>T						3551.0	139561902.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Ser406Leu						L	Oct 09, 2017					missense_variant		406.0				1.0629815468074084		Pathogenic	139561902.0	missense_variant		0.86					Reporter			F9_Ser406Leu
F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	NC_000023.11:139561902:C:T	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ser406Leu	23	139561902	C	T	X											X-139561902-C-T	-	0.79991	0.924	406	.	.	.	X	138644061	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser406Leu	.	27.2	.	0	.	D	.	1	1	.	.	.	.	.	0	0.95717	Select	0.8695	.	0.51298	.	.	D	D	.	1.42151595831	0	.	.	.	.	0.26982	.	.	.	.	0.68090	.	.	0.98169	0.998	.	28.0	0.835916	4.99	0.72	T	single nucleotide variant	NC_000023.11:g.139561902C>T	.	.	1	0.94676954	.	0	0.9734807	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.83457	P	0.99317	P	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.96061	.	.	-	139561902	.	-	7.708000	.	0.98885	.	0	.	.	germline	.	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.98766	GRCh38	924	no assertion criteria provided	c.1217C>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)		.	FA9_HUMAN	.	72.0	.	.	T	0.71593	0.9693402	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser406Leu	.	0.66701	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031595	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.599	C	.	4.877112	0.76775	.	D	-	.	.	0.99366	0	.	.	0.69295	0	139561902	Y	10	0	.	.	P00740	.	0.864181	0.97276		.	0.833	D	.	0.96699363	.	0.85369	2158	0.38613	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.98174	X	F9	.	0	Ser	660	.	X-139561902-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471727	ClinGen:CA255405|OMIM:300746.0061	.	.	.	RCV000011363	D	.	.	c.1217C>T	.	.	.	0.89021	C/C	rs137852263	139561902	.	C	.	P00740	.	0.98551	.	0.68239		.	.	.	2.22	0	0	.	5.66	0.96986	34	D	T	.	.	0	0	.	.	.	98879	10617	0.88883	0.85555	0.971914410591125	434	.	0.71675	.	.	.	.	7.879	.	D	.	.	.	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9949048274168517	2	0.59778	0.18019	.	.	.	.	.	YES	.	0.914868	25656	HGNC:3551	A	.	simple_aae	0.971	.	139561902	TCA	1.000000	.	-	0	0.98025	.	0	.	Pathogenic	0.91585	.	.	.	ClinGen:CA255405,OMIM:300746.0061	S	.	0.990085995164	-	0.926	-	0.81297	.	108	0.99487	0.414036989212	0.52	.	0.99900846572837232	6	-	1217C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.50543	137852263	.	0	0.98986	.	0.497	0.004	434	0.99998593	5.66	.	.	.	0.316873	0.999310278667129	0.62721	D	34	.	.	0.9280	0.95652	p.Ser406Leu	0	.	-13.568	0.98063314	.	0.96235	10617	D	.	F9	.	D	0.860	.	S406L	D	0.89858	0.40292	C/C	principal1	257701	F9_Popp_2025_strep_2_var267918	No											S		1217	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ser406Leu		true	c.1217C>T						3551.0	139561902.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Ser406Leu						L	Oct 09, 2017					missense_variant		406.0				1.1617170228965867		Pathogenic	139561902.0	missense_variant		0.86					Reporter			F9_Ser406Leu
F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004393		NC_000023.11:139561902:C:T		Ser406Leu																												F9_Ser406Leu	23	139561902	C	T	X	allele	1217C>T	A05	527_CAVA_Array_P02	A10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561902-C-T	-	0.79991	0.924	406	.	.	.	X	138644061	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser406Leu	.	27.2	.	0	.	D	.	1	1	.	.	.	.	.	0	0.95717	Select	0.8695	.	0.51298	.	.	D	D	.	1.42151595831	0	.	.	.	.	0.26982	.	.	.	.	0.68090	.	.	0.98169	0.998	.	28.0	0.835916	4.99	0.72	T	single nucleotide variant	NC_000023.11:g.139561902C>T	.	.	1	0.94676954	.	0	0.9734807	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.83457	P	0.99317	P	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.96061	.	.	-	139561902	.	-	7.708000	.	0.98885	.	0	.	.	germline	.	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.98766	GRCh38	924	no assertion criteria provided	c.1217C>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)		.	FA9_HUMAN	.	72.0	.	.	T	0.71593	0.9693402	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser406Leu	.	0.66701	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031595	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.599	C	.	4.877112	0.76775	.	D	-	.	.	0.99366	0	.	.	0.69295	0	139561902	Y	10	0	.	.	P00740	.	0.864181	0.97276		.	0.833	D	.	0.96699363	.	0.85369	2158	0.38613	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.98174	X	F9	.	0	Ser	660	.	X-139561902-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471727	ClinGen:CA255405|OMIM:300746.0061	.	.	.	RCV000011363	D	.	.	c.1217C>T	.	.	.	0.89021	C/C	rs137852263	139561902	.	C	.	P00740	.	0.98551	.	0.68239		.	.	.	2.22	0	0	.	5.66	0.96986	34	D	T	.	.	0	0	.	.	.	98879	10617	0.88883	0.85555	0.971914410591125	434	.	0.71675	.	.	.	.	7.879	.	D	.	.	.	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9949048274168517	2	0.59778	0.18019	.	.	.	.	.	YES	.	0.914868	25656	HGNC:3551	A	.	simple_aae	0.971	.	139561902	TCA	1.000000	.	-	0	0.98025	.	0	.	Pathogenic	0.91585	.	.	.	ClinGen:CA255405,OMIM:300746.0061	S	.	0.990085995164	-	0.926	-	0.81297	.	108	0.99487	0.414036989212	0.52	.	0.99900846572837232	6	-	1217C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.50543	137852263	.	0	0.98986	.	0.497	0.004	434	0.99998593	5.66	.	.	.	0.316873	0.999310278667129	0.62721	D	34	.	.	0.9280	0.95652	p.Ser406Leu	0	.	-13.568	0.98063314	.	0.96235	10617	D	.	F9	.	D	0.860	.	S406L	D	0.89858	0.40292	C/C	principal1	230185	F9_Popp_2025_light_chain_var248556	No											S		1217	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ser406Leu		true	c.1217C>T						3551.0	139561902.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Ser406Leu						L	Oct 09, 2017					missense_variant		406.0				1.0735200136724985		Pathogenic	139561902.0	missense_variant		0.86					Reporter			F9_Ser406Leu
F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004393		NC_000023.11:139561902:C:T		Ser406Leu																												F9_Ser406Leu	23	139561902	C	T	X	allele	1217C>T	A05	527_CAVA_Array_P02	A10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561902-C-T	-	0.79991	0.924	406	.	.	.	X	138644061	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser406Leu	.	27.2	.	0	.	D	.	1	1	.	.	.	.	.	0	0.95717	Select	0.8695	.	0.51298	.	.	D	D	.	1.42151595831	0	.	.	.	.	0.26982	.	.	.	.	0.68090	.	.	0.98169	0.998	.	28.0	0.835916	4.99	0.72	T	single nucleotide variant	NC_000023.11:g.139561902C>T	.	.	1	0.94676954	.	0	0.9734807	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.83457	P	0.99317	P	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.96061	.	.	-	139561902	.	-	7.708000	.	0.98885	.	0	.	.	germline	.	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.98766	GRCh38	924	no assertion criteria provided	c.1217C>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)		.	FA9_HUMAN	.	72.0	.	.	T	0.71593	0.9693402	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser406Leu	.	0.66701	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031595	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.599	C	.	4.877112	0.76775	.	D	-	.	.	0.99366	0	.	.	0.69295	0	139561902	Y	10	0	.	.	P00740	.	0.864181	0.97276		.	0.833	D	.	0.96699363	.	0.85369	2158	0.38613	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.98174	X	F9	.	0	Ser	660	.	X-139561902-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471727	ClinGen:CA255405|OMIM:300746.0061	.	.	.	RCV000011363	D	.	.	c.1217C>T	.	.	.	0.89021	C/C	rs137852263	139561902	.	C	.	P00740	.	0.98551	.	0.68239		.	.	.	2.22	0	0	.	5.66	0.96986	34	D	T	.	.	0	0	.	.	.	98879	10617	0.88883	0.85555	0.971914410591125	434	.	0.71675	.	.	.	.	7.879	.	D	.	.	.	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9949048274168517	2	0.59778	0.18019	.	.	.	.	.	YES	.	0.914868	25656	HGNC:3551	A	.	simple_aae	0.971	.	139561902	TCA	1.000000	.	-	0	0.98025	.	0	.	Pathogenic	0.91585	.	.	.	ClinGen:CA255405,OMIM:300746.0061	S	.	0.990085995164	-	0.926	-	0.81297	.	108	0.99487	0.414036989212	0.52	.	0.99900846572837232	6	-	1217C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.50543	137852263	.	0	0.98986	.	0.497	0.004	434	0.99998593	5.66	.	.	.	0.316873	0.999310278667129	0.62721	D	34	.	.	0.9280	0.95652	p.Ser406Leu	0	.	-13.568	0.98063314	.	0.96235	10617	D	.	F9	.	D	0.860	.	S406L	D	0.89858	0.40292	C/C	principal1	175153	F9_Popp_2025_carboxy_gla_motif_var258237	No											S		1217	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ser406Leu		true	c.1217C>T						3551.0	139561902.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Ser406Leu						L	Oct 09, 2017					missense_variant		406.0				1.0662084564629408		Pathogenic	139561902.0	missense_variant		0.86					Reporter			F9_Ser406Leu
F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004393		NC_000023.11:139561902:C:T		Ser406Leu																												F9_Ser406Leu	23	139561902	C	T	X	allele	1217C>T	A05	527_CAVA_Array_P02	A10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561902-C-T	-	0.79991	0.924	406	.	.	.	X	138644061	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser406Leu	.	27.2	.	0	.	D	.	1	1	.	.	.	.	.	0	0.95717	Select	0.8695	.	0.51298	.	.	D	D	.	1.42151595831	0	.	.	.	.	0.26982	.	.	.	.	0.68090	.	.	0.98169	0.998	.	28.0	0.835916	4.99	0.72	T	single nucleotide variant	NC_000023.11:g.139561902C>T	.	.	1	0.94676954	.	0	0.9734807	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.83457	P	0.99317	P	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.96061	.	.	-	139561902	.	-	7.708000	.	0.98885	.	0	.	.	germline	.	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.98766	GRCh38	924	no assertion criteria provided	c.1217C>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)		.	FA9_HUMAN	.	72.0	.	.	T	0.71593	0.9693402	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser406Leu	.	0.66701	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031595	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.599	C	.	4.877112	0.76775	.	D	-	.	.	0.99366	0	.	.	0.69295	0	139561902	Y	10	0	.	.	P00740	.	0.864181	0.97276		.	0.833	D	.	0.96699363	.	0.85369	2158	0.38613	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.98174	X	F9	.	0	Ser	660	.	X-139561902-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471727	ClinGen:CA255405|OMIM:300746.0061	.	.	.	RCV000011363	D	.	.	c.1217C>T	.	.	.	0.89021	C/C	rs137852263	139561902	.	C	.	P00740	.	0.98551	.	0.68239		.	.	.	2.22	0	0	.	5.66	0.96986	34	D	T	.	.	0	0	.	.	.	98879	10617	0.88883	0.85555	0.971914410591125	434	.	0.71675	.	.	.	.	7.879	.	D	.	.	.	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9949048274168517	2	0.59778	0.18019	.	.	.	.	.	YES	.	0.914868	25656	HGNC:3551	A	.	simple_aae	0.971	.	139561902	TCA	1.000000	.	-	0	0.98025	.	0	.	Pathogenic	0.91585	.	.	.	ClinGen:CA255405,OMIM:300746.0061	S	.	0.990085995164	-	0.926	-	0.81297	.	108	0.99487	0.414036989212	0.52	.	0.99900846572837232	6	-	1217C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.50543	137852263	.	0	0.98986	.	0.497	0.004	434	0.99998593	5.66	.	.	.	0.316873	0.999310278667129	0.62721	D	34	.	.	0.9280	0.95652	p.Ser406Leu	0	.	-13.568	0.98063314	.	0.96235	10617	D	.	F9	.	D	0.860	.	S406L	D	0.89858	0.40292	C/C	principal1	202669	F9_Popp_2025_heavy_chain_var238875	No											S		1217	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ser406Leu		true	c.1217C>T						3551.0	139561902.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Ser406Leu						L	Oct 09, 2017					missense_variant		406.0				1.0917705378443288		Pathogenic	139561902.0	missense_variant		0.86					Reporter			F9_Ser406Leu
F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004393		NC_000023.11:139561902:C:T		Ser406Leu																												F9_Ser406Leu	23	139561902	C	T	X	allele	1217C>T	A05	527_CAVA_Array_P02	A10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561902-C-T	-	0.79991	0.924	406	.	.	.	X	138644061	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser406Leu	.	27.2	.	0	.	D	.	1	1	.	.	.	.	.	0	0.95717	Select	0.8695	.	0.51298	.	.	D	D	.	1.42151595831	0	.	.	.	.	0.26982	.	.	.	.	0.68090	.	.	0.98169	0.998	.	28.0	0.835916	4.99	0.72	T	single nucleotide variant	NC_000023.11:g.139561902C>T	.	.	1	0.94676954	.	0	0.9734807	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.83457	P	0.99317	P	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.96061	.	.	-	139561902	.	-	7.708000	.	0.98885	.	0	.	.	germline	.	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.98766	GRCh38	924	no assertion criteria provided	c.1217C>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)		.	FA9_HUMAN	.	72.0	.	.	T	0.71593	0.9693402	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser406Leu	.	0.66701	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031595	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.599	C	.	4.877112	0.76775	.	D	-	.	.	0.99366	0	.	.	0.69295	0	139561902	Y	10	0	.	.	P00740	.	0.864181	0.97276		.	0.833	D	.	0.96699363	.	0.85369	2158	0.38613	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.98174	X	F9	.	0	Ser	660	.	X-139561902-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471727	ClinGen:CA255405|OMIM:300746.0061	.	.	.	RCV000011363	D	.	.	c.1217C>T	.	.	.	0.89021	C/C	rs137852263	139561902	.	C	.	P00740	.	0.98551	.	0.68239		.	.	.	2.22	0	0	.	5.66	0.96986	34	D	T	.	.	0	0	.	.	.	98879	10617	0.88883	0.85555	0.971914410591125	434	.	0.71675	.	.	.	.	7.879	.	D	.	.	.	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9949048274168517	2	0.59778	0.18019	.	.	.	.	.	YES	.	0.914868	25656	HGNC:3551	A	.	simple_aae	0.971	.	139561902	TCA	1.000000	.	-	0	0.98025	.	0	.	Pathogenic	0.91585	.	.	.	ClinGen:CA255405,OMIM:300746.0061	S	.	0.990085995164	-	0.926	-	0.81297	.	108	0.99487	0.414036989212	0.52	.	0.99900846572837232	6	-	1217C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.50543	137852263	.	0	0.98986	.	0.497	0.004	434	0.99998593	5.66	.	.	.	0.316873	0.999310278667129	0.62721	D	34	.	.	0.9280	0.95652	p.Ser406Leu	0	.	-13.568	0.98063314	.	0.96235	10617	D	.	F9	.	D	0.860	.	S406L	D	0.89858	0.40292	C/C	principal1	147637	F9_Popp_2025_carboxy_F9_specific_var229194	No											S		1217	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ser406Leu		true	c.1217C>T						3551.0	139561902.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Ser406Leu						L	Oct 09, 2017					missense_variant		406.0				1.0629815468074084		Pathogenic	139561902.0	missense_variant		0.86					Reporter			F9_Ser406Leu
F9_Ser406Leu	-3.5650261072658345	0.009157638707403087	4.920567410383196	0.0017125353292463399	2025_01_Batch_13-14	0.8868635815796786	0.8405685454044737	0.8735975253877695	0.9218056487360786	0.6794363061150756	0.9457045820372267	0.8780270969461299	0.9096301699084473	0.937208202818066	0.916670473237063	0.9162840818084527	0.8592978211753017	0.8916138476481084	0.9295069257770723	0.7980533896760693	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004393		NC_000023.11:139561902:C:T		Ser406Leu																												F9_Ser406Leu	23	139561902	C	T	X	allele	1217C>T	A05	527_CAVA_Array_P02	A10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561902-C-T	-	0.79991	0.924	406	.	.	.	X	138644061	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ser406Leu	.	27.2	.	0	.	D	.	1	1	.	.	.	.	.	0	0.95717	Select	0.8695	.	0.51298	.	.	D	D	.	1.42151595831	0	.	.	.	.	0.26982	.	.	.	.	0.68090	.	.	0.98169	0.998	.	28.0	0.835916	4.99	0.72	T	single nucleotide variant	NC_000023.11:g.139561902C>T	.	.	1	0.94676954	.	0	0.9734807	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.83457	P	0.99317	P	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.96061	.	.	-	139561902	.	-	7.708000	.	0.98885	.	0	.	.	germline	.	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.98766	GRCh38	924	no assertion criteria provided	c.1217C>T	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)		.	FA9_HUMAN	.	72.0	.	.	T	0.71593	0.9693402	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ser406Leu	.	0.66701	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031595	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.599	C	.	4.877112	0.76775	.	D	-	.	.	0.99366	0	.	.	0.69295	0	139561902	Y	10	0	.	.	P00740	.	0.864181	0.97276		.	0.833	D	.	0.96699363	.	0.85369	2158	0.38613	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.98174	X	F9	.	0	Ser	660	.	X-139561902-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471727	ClinGen:CA255405|OMIM:300746.0061	.	.	.	RCV000011363	D	.	.	c.1217C>T	.	.	.	0.89021	C/C	rs137852263	139561902	.	C	.	P00740	.	0.98551	.	0.68239		.	.	.	2.22	0	0	.	5.66	0.96986	34	D	T	.	.	0	0	.	.	.	98879	10617	0.88883	0.85555	0.971914410591125	434	.	0.71675	.	.	.	.	7.879	.	D	.	.	.	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9949048274168517	2	0.59778	0.18019	.	.	.	.	.	YES	.	0.914868	25656	HGNC:3551	A	.	simple_aae	0.971	.	139561902	TCA	1.000000	.	-	0	0.98025	.	0	.	Pathogenic	0.91585	.	.	.	ClinGen:CA255405,OMIM:300746.0061	S	.	0.990085995164	-	0.926	-	0.81297	.	108	0.99487	0.414036989212	0.52	.	0.99900846572837232	6	-	1217C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.50543	137852263	.	0	0.98986	.	0.497	0.004	434	0.99998593	5.66	.	.	.	0.316873	0.999310278667129	0.62721	D	34	.	.	0.9280	0.95652	p.Ser406Leu	0	.	-13.568	0.98063314	.	0.96235	10617	D	.	F9	.	D	0.860	.	S406L	D	0.89858	0.40292	C/C	principal1	257701	F9_Popp_2025_strep_2_var267918	No											S		1217	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ser406Leu		true	c.1217C>T						3551.0	139561902.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Ser406Leu						L	Oct 09, 2017					missense_variant		406.0				1.1617170228965867		Pathogenic	139561902.0	missense_variant		0.86					Reporter			F9_Ser406Leu
AGXT_Asp201Asn	-6.42247425249429	0.000359522139449361	-4.292779848530696	0.003598374695788786																											AGXT	AGXT	ENSG00000172482	70497	3843	CCSBVarC008203	ALE00008189	NC_000002.12:240873983:G:A	601G>A	Asp201Asn	Edgotyping3	VUSMutGDEh004	A06	GDEhDisVCh_40002	H07	2	VUSMutGDDh004	A06	VUSN2Hmut_GDN2h_01	A08	VUSMutpDEST2_14	C07	VUSmut_GDEh01	A08	1	1	1	1	1	5	1	1	1	1	1	1	1	AGXT_Asp201Asn	2	240873983	G	A	2											2-240873983-G-A	-	0.77541	1.0	201	1	0	0	2	241813400	A	1.735380e-05	0	2	3_Conflicting	NC_000002.12	8	Asp201Asn	0	26.7	0	0	6.711410e-05	D	0	4	1	42754	8.450370e-06	.	30526	0.000000e+00	0	0.94675	Select	0.9528	14900	0.90580	0	.	D	D	63526	0.249302974152	0	0	0.000000e+00	0	0	0.45205	17098	44890	8	0.000000e+00	0.81381	0	.	0.96309	0.027	.	8.0	0.963304	.	0.92	A	single nucleotide variant	NC_000002.12:g.240873983G>A	0	16648	2	0.888501	109290	0	0.95099026	0	A	2	236676	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0009823,MedGen:C0268164,OMIM:259900,Orphanet:416,Orphanet:93598|MedGen:C3661900	0	0	0.000000e+00	0	0.93300	D	0.94081	D	.	5.895352	28	G/G	114	0	7162	1613476	Primary hyperoxaluria, type I|not provided	16204	0.99841	.	.	-	240873983	.	-	11.377000	1	0.99166	29608	0	91088	0	germline;unknown	91088	Loss of stability (P = 0.0893)| Loss of phosphorylation at Y204 (P = 0.1441)| Gain of sheet (P = 0.1451)| Gain of catalytic residue at D201 (P = 0.1703)| Gain of glycosylation at S205 (P = 0.2268)	0.99041	GRCh38	982	criteria provided, conflicting classifications	c.601G>A	0.000000e+00	0.47135	0	0	0	Aminotransferase class V domain|Aminotransferase class-V, pyridoxal-phosphate binding site	0.000000e+00	9046	P	0	0.000000e+00	NM_000030.3(AGXT):c.601G>A (p.Asp201Asn)	1	0	AGT1_HUMAN	0	92.0	0.597233602561017	0	D	0.74462	0.95099026	+	0.000000e+00	.	0.0000177924	1	0.000000e+00	0	34236	criteria_provided,_conflicting_classifications	0.79657	0.000000e+00	0	0.000000e+00	0	59998	p.Asp201Asn	0	0.92629	.	germline	.	240873983	G	Jan 28, 2025	0	G/G	0	89426	1.0	N	2q37.3	9690	.	6.171320e-05	SCV000429366|SCV002798210|SCV003449865|SCV004217810	Conflicting_classifications_of_pathogenicity	0	0	Asn	N	-	912	ENSP00000302620	ENST00000307503	17692	0.0	13404	0	0.602	G	0	4.781	0.70891	D	D	-	4.068939	.	0.99145	610	0	.	0.96469	0	240873983	Y	10	0	102600	0.000000e+00	P21549	0	0.964397	0.88915	G	.	1.0	D	16204	0.888501	.	0.12735	189	0.231496	10	-4.88	.	8.782720e-05	0.91343	0.000000e+00	0	74914	0.000000e+00	6084	0	0.94081	2	AGXT	4.004590e-05	0	Asp	14050	1.118240e-05	2-240873983-G-A	Primary_hyperoxaluria,_type_I|not_provided	0	1	241462073	ClinGen:CA10612912	0.958579	0.72858	0	RCV000268109|RCV002519959	D	0	0	c.601G>A	0	0	0	0.76689	G/G	rs886055840	240873983	14900	G	.	P21549	15690	0.96308	0.000000e+00	0.68239	2	0	0	0.000000e+00	.	0	0	.	4.1	0.99561	112	D	T	1	0.000000e+00	0	26	.	0	0	416|93598	335297	0.76386	0.27211	0.99919182062149	2898	.	0.71675	0.97837	0.000000e+00	6.171320e-05	1179980	7.07	9.621950e-06	D	13308	0	.	0	259900	0.7651	2	6.711410e-05	ENSG00000172482	0.000000e+00	0	0	0	0.9566660386156882	1	0.97365	0.03399	30608	.	9.746590e-06	0.000000e+00	0.35732007058197	YES	8.782720e-05	0.887607	285570	HGNC:341	D	0	simple_aae	0.977	207858	240873983	GAC	1.000000	.	-	0	0.99995	8.474720e-06	0	0	Conflicting classifications of pathogenicity	0.71776	0	0	0	ClinGen:CA10612912	D	0	0.982569718447	-	0.935	-	0.94798	2	496	0.95625	0.545840322971	0.7373	0	0.9980472094487004	98	-	601G>A 	1	0	C0268164|C3661900	0	0	0	0	NM_000030.3	-	.	.	1	0.86374	886055840	2320	0	0.98220	0.58731	0.941	0.006	2784	0.40280010	4.1	.	.	0.000000e+00	0.094751	0.999535002418938	.	D	86	6208	9560	1.1072	0.98463	p.Asp201Asn	0	0	-9.635	0.99594986	3	0.96903	335297	D	30504	AGXT	0.000000e+00	D	0.832	21546	D201N	D	.	0.45956	G/G	principal1																																																																																																				
F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg191His	23	139551113	G	A	X											X-139551113-G-A	-	0.38835	0.461	191	1	0	0	X	138633272	A	3.306930e-06	0	X	1_Pathogenic	NC_000023.11	4	Arg191His	0	20.8	0	1	1.361040e-05	D	0	8	1	30953	5.805520e-06	.	19004	0.000000e+00	0	0.90507	Select	0.8837	73473	0.36381	0	.	D	D	46533	1.82565083264	2.3969319271332693E-4	0	0.000000e+00	0	0	0.28775	13667	33770	0	0.000000e+00	0.49201	1	.	0.58804	0.055	.	71.0	0.872513	4.5	0.29	A	single nucleotide variant	NC_000023.11:g.139551113G>A	0	12191	3	0.20733581	80340	0	0.42576137	0	A	1	172250	0	0	0.000000e+00	436	3.230700e-05	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	1	0	0.000000e+00	0	0.82936	B	0.55303	P	M	.	4	G/G	176	0	5702	1209580	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	13134	0.97030	.	.	-	139551113	3.230700e-05	-	11.735000	0	0.84705	22034	0	894893	0	germline;unknown	56787	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.95637	GRCh38	924	reviewed by expert panel	c.572G>A	0.000000e+00	0.64600	1	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.572G>A (p.Arg191His)	3	0	FA9_HUMAN	0	29.0	.	0	D	0.40318	0.37745458	+	0.000000e+00	.	2.73283e-6	1	0.000000e+00	0	27168	reviewed_by_expert_panel	0.99989	1.244710e-05	0	0.000000e+00	0	45737	p.Arg191His	0	0.95080	.	germline	1	139551113	G	Feb 09, 2024	0	G/G	0	64663	0.997	N	Xq27.1	92674	.	0.000000e+00	SCV004363686	Pathogenic	0	0	His	H	-	688	ENSP00000218099	ENST00000218099	13319	0.038	10128	0	0.676	G	0	2.919779	0.48432	.	T	-	.	.	0.90955	928	0	.	0.43154	0	139551113	Y	10	0	73473	0.000000e+00	P00740	0	0.584288	0.96206	G	0	0.03	D	64663	0.29486942	30953	0.15632	2158	0.484746	4	-2.18	.	4.469810e-06	0.43243	0.000000e+00	0	57163	0.000000e+00	4373	0	0.44825	X	F9	0.000000e+00	0	Arg	105968	1.546480e-05	X-139551113-G-A	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	0	1	138460938	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	.	.	0	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	D	0	0	c.572G>A	0	0	0	0.93800	G/G	rs137852238	139551113	12064	G	.	P00740	9951	0.62152	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.175	0	0	.	4.94	0.86309	3330	D	T	0	0.000000e+00	0	656	.	0	0	98879|98878	10585	0.93722	0.91968	0.752935725469828	4348	.	0.40243	.	0.000000e+00	1.546480e-05	894893	4.306	6.585580e-06	N	9933	0	.	0	300807|306900|134500|306700	0.58997	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.97817949293013	2	0.21742	0.18019	19069	.	1.361040e-05	0.000000e+00	.	YES	0.000000e+00	0.304049	25624	HGNC:3551	A	0	simple_aae	0.724	151847	139551113	CGT	1.000000	.	-	2.2999080036798528E-4	0.94118	4.469810e-06	1	0	Pathogenic	0.29315	0	0	0	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	R	0	0.998451674901	-	0.858	-	0.68361	1	3978	0.97797	0.427083998919	0.1576	0	0.99887204579505651	274	-	572G>A 	1	0	C2749016|C0008533|C0019069|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.60210	137852238	1767	9.436811112788767E-6	0.99840	.	0.464	0.059	4172	0.99997842	4.94	.	.	0.000000e+00	0.458528	0.981076557386951	0.60790	D	2674	4647	7081	0.9910	0.96132	p.Arg191His	0	0	-4.38	0.94853324	0	0.85578	10585	T	24390	F9	0.000000e+00	D	0.730	15996	R191H	D	0.84251	0.76753	G/G	principal1	189871	F9_Popp_2025_heavy_chain_var234373	No		7/11/24		36190763-aaae-49d3-a95b-1e8f8f6199ab							R		572	F9_Popp_2025_heavy_chain	10585.0	ENST00000218099.7	Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255342	immortalized human cells		false			p.Arg191His		true	c.572G>A						3551.0	139551113.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa	PP4_Moderate,PM1_Strong,PS4,PP3						PM2,PS3_Supporting,PP1,PM5		The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM1_Strong,PS4	Arg191His	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	191.0		hemophilia B	3.306932985e-6	1.0142334797704238		Pathogenic	139551113.0	missense_variant		0.73				779,746,624,759,143	Reporter			F9_Arg191His
F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg191His	23	139551113	G	A	X											X-139551113-G-A	-	0.38835	0.461	191	1	0	0	X	138633272	A	3.306930e-06	0	X	1_Pathogenic	NC_000023.11	4	Arg191His	0	20.8	0	1	1.361040e-05	D	0	8	1	30953	5.805520e-06	.	19004	0.000000e+00	0	0.90507	Select	0.8837	73473	0.36381	0	.	D	D	46533	1.82565083264	2.3969319271332693E-4	0	0.000000e+00	0	0	0.28775	13667	33770	0	0.000000e+00	0.49201	1	.	0.58804	0.055	.	71.0	0.872513	4.5	0.29	A	single nucleotide variant	NC_000023.11:g.139551113G>A	0	12191	3	0.20733581	80340	0	0.42576137	0	A	1	172250	0	0	0.000000e+00	436	3.230700e-05	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	1	0	0.000000e+00	0	0.82936	B	0.55303	P	M	.	4	G/G	176	0	5702	1209580	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	13134	0.97030	.	.	-	139551113	3.230700e-05	-	11.735000	0	0.84705	22034	0	894893	0	germline;unknown	56787	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.95637	GRCh38	924	reviewed by expert panel	c.572G>A	0.000000e+00	0.64600	1	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.572G>A (p.Arg191His)	3	0	FA9_HUMAN	0	29.0	.	0	D	0.40318	0.37745458	+	0.000000e+00	.	2.73283e-6	1	0.000000e+00	0	27168	reviewed_by_expert_panel	0.99989	1.244710e-05	0	0.000000e+00	0	45737	p.Arg191His	0	0.95080	.	germline	1	139551113	G	Feb 09, 2024	0	G/G	0	64663	0.997	N	Xq27.1	92674	.	0.000000e+00	SCV004363686	Pathogenic	0	0	His	H	-	688	ENSP00000218099	ENST00000218099	13319	0.038	10128	0	0.676	G	0	2.919779	0.48432	.	T	-	.	.	0.90955	928	0	.	0.43154	0	139551113	Y	10	0	73473	0.000000e+00	P00740	0	0.584288	0.96206	G	0	0.03	D	64663	0.29486942	30953	0.15632	2158	0.484746	4	-2.18	.	4.469810e-06	0.43243	0.000000e+00	0	57163	0.000000e+00	4373	0	0.44825	X	F9	0.000000e+00	0	Arg	105968	1.546480e-05	X-139551113-G-A	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	0	1	138460938	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	.	.	0	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	D	0	0	c.572G>A	0	0	0	0.93800	G/G	rs137852238	139551113	12064	G	.	P00740	9951	0.62152	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.175	0	0	.	4.94	0.86309	3330	D	T	0	0.000000e+00	0	656	.	0	0	98879|98878	10585	0.93722	0.91968	0.752935725469828	4348	.	0.40243	.	0.000000e+00	1.546480e-05	894893	4.306	6.585580e-06	N	9933	0	.	0	300807|306900|134500|306700	0.58997	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.97817949293013	2	0.21742	0.18019	19069	.	1.361040e-05	0.000000e+00	.	YES	0.000000e+00	0.304049	25624	HGNC:3551	A	0	simple_aae	0.724	151847	139551113	CGT	1.000000	.	-	2.2999080036798528E-4	0.94118	4.469810e-06	1	0	Pathogenic	0.29315	0	0	0	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	R	0	0.998451674901	-	0.858	-	0.68361	1	3978	0.97797	0.427083998919	0.1576	0	0.99887204579505651	274	-	572G>A 	1	0	C2749016|C0008533|C0019069|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.60210	137852238	1767	9.436811112788767E-6	0.99840	.	0.464	0.059	4172	0.99997842	4.94	.	.	0.000000e+00	0.458528	0.981076557386951	0.60790	D	2674	4647	7081	0.9910	0.96132	p.Arg191His	0	0	-4.38	0.94853324	0	0.85578	10585	T	24390	F9	0.000000e+00	D	0.730	15996	R191H	D	0.84251	0.76753	G/G	principal1	134839	F9_Popp_2025_carboxy_F9_specific_var224692	No		7/11/24		36190763-aaae-49d3-a95b-1e8f8f6199ab							R		572	F9_Popp_2025_carboxy_F9_specific	10585.0	ENST00000218099.7	Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255342	immortalized human cells		false			p.Arg191His		true	c.572G>A						3551.0	139551113.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa	PP4_Moderate,PM1_Strong,PS4,PP3						PM2,PS3_Supporting,PP1,PM5		The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM1_Strong,PS4	Arg191His	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	191.0		hemophilia B	3.306932985e-6	0.7881751920285752		Pathogenic	139551113.0	missense_variant		0.73				779,746,624,759,143	Reporter			F9_Arg191His
F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg191His	23	139551113	G	A	X											X-139551113-G-A	-	0.38835	0.461	191	1	0	0	X	138633272	A	3.306930e-06	0	X	1_Pathogenic	NC_000023.11	4	Arg191His	0	20.8	0	1	1.361040e-05	D	0	8	1	30953	5.805520e-06	.	19004	0.000000e+00	0	0.90507	Select	0.8837	73473	0.36381	0	.	D	D	46533	1.82565083264	2.3969319271332693E-4	0	0.000000e+00	0	0	0.28775	13667	33770	0	0.000000e+00	0.49201	1	.	0.58804	0.055	.	71.0	0.872513	4.5	0.29	A	single nucleotide variant	NC_000023.11:g.139551113G>A	0	12191	3	0.20733581	80340	0	0.42576137	0	A	1	172250	0	0	0.000000e+00	436	3.230700e-05	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	1	0	0.000000e+00	0	0.82936	B	0.55303	P	M	.	4	G/G	176	0	5702	1209580	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	13134	0.97030	.	.	-	139551113	3.230700e-05	-	11.735000	0	0.84705	22034	0	894893	0	germline;unknown	56787	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.95637	GRCh38	924	reviewed by expert panel	c.572G>A	0.000000e+00	0.64600	1	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.572G>A (p.Arg191His)	3	0	FA9_HUMAN	0	29.0	.	0	D	0.40318	0.37745458	+	0.000000e+00	.	2.73283e-6	1	0.000000e+00	0	27168	reviewed_by_expert_panel	0.99989	1.244710e-05	0	0.000000e+00	0	45737	p.Arg191His	0	0.95080	.	germline	1	139551113	G	Feb 09, 2024	0	G/G	0	64663	0.997	N	Xq27.1	92674	.	0.000000e+00	SCV004363686	Pathogenic	0	0	His	H	-	688	ENSP00000218099	ENST00000218099	13319	0.038	10128	0	0.676	G	0	2.919779	0.48432	.	T	-	.	.	0.90955	928	0	.	0.43154	0	139551113	Y	10	0	73473	0.000000e+00	P00740	0	0.584288	0.96206	G	0	0.03	D	64663	0.29486942	30953	0.15632	2158	0.484746	4	-2.18	.	4.469810e-06	0.43243	0.000000e+00	0	57163	0.000000e+00	4373	0	0.44825	X	F9	0.000000e+00	0	Arg	105968	1.546480e-05	X-139551113-G-A	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	0	1	138460938	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	.	.	0	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	D	0	0	c.572G>A	0	0	0	0.93800	G/G	rs137852238	139551113	12064	G	.	P00740	9951	0.62152	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.175	0	0	.	4.94	0.86309	3330	D	T	0	0.000000e+00	0	656	.	0	0	98879|98878	10585	0.93722	0.91968	0.752935725469828	4348	.	0.40243	.	0.000000e+00	1.546480e-05	894893	4.306	6.585580e-06	N	9933	0	.	0	300807|306900|134500|306700	0.58997	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.97817949293013	2	0.21742	0.18019	19069	.	1.361040e-05	0.000000e+00	.	YES	0.000000e+00	0.304049	25624	HGNC:3551	A	0	simple_aae	0.724	151847	139551113	CGT	1.000000	.	-	2.2999080036798528E-4	0.94118	4.469810e-06	1	0	Pathogenic	0.29315	0	0	0	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	R	0	0.998451674901	-	0.858	-	0.68361	1	3978	0.97797	0.427083998919	0.1576	0	0.99887204579505651	274	-	572G>A 	1	0	C2749016|C0008533|C0019069|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.60210	137852238	1767	9.436811112788767E-6	0.99840	.	0.464	0.059	4172	0.99997842	4.94	.	.	0.000000e+00	0.458528	0.981076557386951	0.60790	D	2674	4647	7081	0.9910	0.96132	p.Arg191His	0	0	-4.38	0.94853324	0	0.85578	10585	T	24390	F9	0.000000e+00	D	0.730	15996	R191H	D	0.84251	0.76753	G/G	principal1	162355	F9_Popp_2025_carboxy_gla_motif_var253735	No		7/11/24		36190763-aaae-49d3-a95b-1e8f8f6199ab							R		572	F9_Popp_2025_carboxy_gla_motif	10585.0	ENST00000218099.7	Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255342	immortalized human cells		false			p.Arg191His		true	c.572G>A						3551.0	139551113.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa	PP4_Moderate,PM1_Strong,PS4,PP3						PM2,PS3_Supporting,PP1,PM5		The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM1_Strong,PS4	Arg191His	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	191.0		hemophilia B	3.306932985e-6	0.8607407016784892		Pathogenic	139551113.0	missense_variant		0.73				779,746,624,759,143	Reporter			F9_Arg191His
F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg191His	23	139551113	G	A	X											X-139551113-G-A	-	0.38835	0.461	191	1	0	0	X	138633272	A	3.306930e-06	0	X	1_Pathogenic	NC_000023.11	4	Arg191His	0	20.8	0	1	1.361040e-05	D	0	8	1	30953	5.805520e-06	.	19004	0.000000e+00	0	0.90507	Select	0.8837	73473	0.36381	0	.	D	D	46533	1.82565083264	2.3969319271332693E-4	0	0.000000e+00	0	0	0.28775	13667	33770	0	0.000000e+00	0.49201	1	.	0.58804	0.055	.	71.0	0.872513	4.5	0.29	A	single nucleotide variant	NC_000023.11:g.139551113G>A	0	12191	3	0.20733581	80340	0	0.42576137	0	A	1	172250	0	0	0.000000e+00	436	3.230700e-05	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	1	0	0.000000e+00	0	0.82936	B	0.55303	P	M	.	4	G/G	176	0	5702	1209580	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	13134	0.97030	.	.	-	139551113	3.230700e-05	-	11.735000	0	0.84705	22034	0	894893	0	germline;unknown	56787	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.95637	GRCh38	924	reviewed by expert panel	c.572G>A	0.000000e+00	0.64600	1	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.572G>A (p.Arg191His)	3	0	FA9_HUMAN	0	29.0	.	0	D	0.40318	0.37745458	+	0.000000e+00	.	2.73283e-6	1	0.000000e+00	0	27168	reviewed_by_expert_panel	0.99989	1.244710e-05	0	0.000000e+00	0	45737	p.Arg191His	0	0.95080	.	germline	1	139551113	G	Feb 09, 2024	0	G/G	0	64663	0.997	N	Xq27.1	92674	.	0.000000e+00	SCV004363686	Pathogenic	0	0	His	H	-	688	ENSP00000218099	ENST00000218099	13319	0.038	10128	0	0.676	G	0	2.919779	0.48432	.	T	-	.	.	0.90955	928	0	.	0.43154	0	139551113	Y	10	0	73473	0.000000e+00	P00740	0	0.584288	0.96206	G	0	0.03	D	64663	0.29486942	30953	0.15632	2158	0.484746	4	-2.18	.	4.469810e-06	0.43243	0.000000e+00	0	57163	0.000000e+00	4373	0	0.44825	X	F9	0.000000e+00	0	Arg	105968	1.546480e-05	X-139551113-G-A	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	0	1	138460938	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	.	.	0	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	D	0	0	c.572G>A	0	0	0	0.93800	G/G	rs137852238	139551113	12064	G	.	P00740	9951	0.62152	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.175	0	0	.	4.94	0.86309	3330	D	T	0	0.000000e+00	0	656	.	0	0	98879|98878	10585	0.93722	0.91968	0.752935725469828	4348	.	0.40243	.	0.000000e+00	1.546480e-05	894893	4.306	6.585580e-06	N	9933	0	.	0	300807|306900|134500|306700	0.58997	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.97817949293013	2	0.21742	0.18019	19069	.	1.361040e-05	0.000000e+00	.	YES	0.000000e+00	0.304049	25624	HGNC:3551	A	0	simple_aae	0.724	151847	139551113	CGT	1.000000	.	-	2.2999080036798528E-4	0.94118	4.469810e-06	1	0	Pathogenic	0.29315	0	0	0	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	R	0	0.998451674901	-	0.858	-	0.68361	1	3978	0.97797	0.427083998919	0.1576	0	0.99887204579505651	274	-	572G>A 	1	0	C2749016|C0008533|C0019069|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.60210	137852238	1767	9.436811112788767E-6	0.99840	.	0.464	0.059	4172	0.99997842	4.94	.	.	0.000000e+00	0.458528	0.981076557386951	0.60790	D	2674	4647	7081	0.9910	0.96132	p.Arg191His	0	0	-4.38	0.94853324	0	0.85578	10585	T	24390	F9	0.000000e+00	D	0.730	15996	R191H	D	0.84251	0.76753	G/G	principal1	217387	F9_Popp_2025_light_chain_var244054	No		7/11/24		36190763-aaae-49d3-a95b-1e8f8f6199ab							R		572	F9_Popp_2025_light_chain	10585.0	ENST00000218099.7	Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255342	immortalized human cells		false			p.Arg191His		true	c.572G>A						3551.0	139551113.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa	PP4_Moderate,PM1_Strong,PS4,PP3						PM2,PS3_Supporting,PP1,PM5		The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM1_Strong,PS4	Arg191His	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	191.0		hemophilia B	3.306932985e-6	0.9560010972432093		Pathogenic	139551113.0	missense_variant		0.73				779,746,624,759,143	Reporter			F9_Arg191His
F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	NC_000023.11:139551113:G:A	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg191His	23	139551113	G	A	X											X-139551113-G-A	-	0.38835	0.461	191	1	0	0	X	138633272	A	3.306930e-06	0	X	1_Pathogenic	NC_000023.11	4	Arg191His	0	20.8	0	1	1.361040e-05	D	0	8	1	30953	5.805520e-06	.	19004	0.000000e+00	0	0.90507	Select	0.8837	73473	0.36381	0	.	D	D	46533	1.82565083264	2.3969319271332693E-4	0	0.000000e+00	0	0	0.28775	13667	33770	0	0.000000e+00	0.49201	1	.	0.58804	0.055	.	71.0	0.872513	4.5	0.29	A	single nucleotide variant	NC_000023.11:g.139551113G>A	0	12191	3	0.20733581	80340	0	0.42576137	0	A	1	172250	0	0	0.000000e+00	436	3.230700e-05	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	1	0	0.000000e+00	0	0.82936	B	0.55303	P	M	.	4	G/G	176	0	5702	1209580	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	13134	0.97030	.	.	-	139551113	3.230700e-05	-	11.735000	0	0.84705	22034	0	894893	0	germline;unknown	56787	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.95637	GRCh38	924	reviewed by expert panel	c.572G>A	0.000000e+00	0.64600	1	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.572G>A (p.Arg191His)	3	0	FA9_HUMAN	0	29.0	.	0	D	0.40318	0.37745458	+	0.000000e+00	.	2.73283e-6	1	0.000000e+00	0	27168	reviewed_by_expert_panel	0.99989	1.244710e-05	0	0.000000e+00	0	45737	p.Arg191His	0	0.95080	.	germline	1	139551113	G	Feb 09, 2024	0	G/G	0	64663	0.997	N	Xq27.1	92674	.	0.000000e+00	SCV004363686	Pathogenic	0	0	His	H	-	688	ENSP00000218099	ENST00000218099	13319	0.038	10128	0	0.676	G	0	2.919779	0.48432	.	T	-	.	.	0.90955	928	0	.	0.43154	0	139551113	Y	10	0	73473	0.000000e+00	P00740	0	0.584288	0.96206	G	0	0.03	D	64663	0.29486942	30953	0.15632	2158	0.484746	4	-2.18	.	4.469810e-06	0.43243	0.000000e+00	0	57163	0.000000e+00	4373	0	0.44825	X	F9	0.000000e+00	0	Arg	105968	1.546480e-05	X-139551113-G-A	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	0	1	138460938	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	.	.	0	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	D	0	0	c.572G>A	0	0	0	0.93800	G/G	rs137852238	139551113	12064	G	.	P00740	9951	0.62152	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.175	0	0	.	4.94	0.86309	3330	D	T	0	0.000000e+00	0	656	.	0	0	98879|98878	10585	0.93722	0.91968	0.752935725469828	4348	.	0.40243	.	0.000000e+00	1.546480e-05	894893	4.306	6.585580e-06	N	9933	0	.	0	300807|306900|134500|306700	0.58997	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.97817949293013	2	0.21742	0.18019	19069	.	1.361040e-05	0.000000e+00	.	YES	0.000000e+00	0.304049	25624	HGNC:3551	A	0	simple_aae	0.724	151847	139551113	CGT	1.000000	.	-	2.2999080036798528E-4	0.94118	4.469810e-06	1	0	Pathogenic	0.29315	0	0	0	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	R	0	0.998451674901	-	0.858	-	0.68361	1	3978	0.97797	0.427083998919	0.1576	0	0.99887204579505651	274	-	572G>A 	1	0	C2749016|C0008533|C0019069|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.60210	137852238	1767	9.436811112788767E-6	0.99840	.	0.464	0.059	4172	0.99997842	4.94	.	.	0.000000e+00	0.458528	0.981076557386951	0.60790	D	2674	4647	7081	0.9910	0.96132	p.Arg191His	0	0	-4.38	0.94853324	0	0.85578	10585	T	24390	F9	0.000000e+00	D	0.730	15996	R191H	D	0.84251	0.76753	G/G	principal1	244903	F9_Popp_2025_strep_2_var263416	No		7/11/24		36190763-aaae-49d3-a95b-1e8f8f6199ab							R		572	F9_Popp_2025_strep_2	10585.0	ENST00000218099.7	Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255342	immortalized human cells		false			p.Arg191His		true	c.572G>A						3551.0	139551113.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa	PP4_Moderate,PM1_Strong,PS4,PP3						PM2,PS3_Supporting,PP1,PM5		The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM1_Strong,PS4	Arg191His	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	191.0		hemophilia B	3.306932985e-6	0.927009116		Pathogenic	139551113.0	missense_variant		0.73				779,746,624,759,143	Reporter			F9_Arg191His
F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004379		NC_000023.11:139551113:G:A		Arg191His																												F9_Arg191His	23	139551113	G	A	X	allele	572G>A	C08	527_CAVA_Array_P02	E16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551113-G-A	-	0.38835	0.461	191	1	0	0	X	138633272	A	3.306930e-06	0	X	1_Pathogenic	NC_000023.11	4	Arg191His	0	20.8	0	1	1.361040e-05	D	0	8	1	30953	5.805520e-06	.	19004	0.000000e+00	0	0.90507	Select	0.8837	73473	0.36381	0	.	D	D	46533	1.82565083264	2.3969319271332693E-4	0	0.000000e+00	0	0	0.28775	13667	33770	0	0.000000e+00	0.49201	1	.	0.58804	0.055	.	71.0	0.872513	4.5	0.29	A	single nucleotide variant	NC_000023.11:g.139551113G>A	0	12191	3	0.20733581	80340	0	0.42576137	0	A	1	172250	0	0	0.000000e+00	436	3.230700e-05	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	1	0	0.000000e+00	0	0.82936	B	0.55303	P	M	.	4	G/G	176	0	5702	1209580	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	13134	0.97030	.	.	-	139551113	3.230700e-05	-	11.735000	0	0.84705	22034	0	894893	0	germline;unknown	56787	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.95637	GRCh38	924	reviewed by expert panel	c.572G>A	0.000000e+00	0.64600	1	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.572G>A (p.Arg191His)	3	0	FA9_HUMAN	0	29.0	.	0	D	0.40318	0.37745458	+	0.000000e+00	.	2.73283e-6	1	0.000000e+00	0	27168	reviewed_by_expert_panel	0.99989	1.244710e-05	0	0.000000e+00	0	45737	p.Arg191His	0	0.95080	.	germline	1	139551113	G	Feb 09, 2024	0	G/G	0	64663	0.997	N	Xq27.1	92674	.	0.000000e+00	SCV004363686	Pathogenic	0	0	His	H	-	688	ENSP00000218099	ENST00000218099	13319	0.038	10128	0	0.676	G	0	2.919779	0.48432	.	T	-	.	.	0.90955	928	0	.	0.43154	0	139551113	Y	10	0	73473	0.000000e+00	P00740	0	0.584288	0.96206	G	0	0.03	D	64663	0.29486942	30953	0.15632	2158	0.484746	4	-2.18	.	4.469810e-06	0.43243	0.000000e+00	0	57163	0.000000e+00	4373	0	0.44825	X	F9	0.000000e+00	0	Arg	105968	1.546480e-05	X-139551113-G-A	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	0	1	138460938	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	.	.	0	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	D	0	0	c.572G>A	0	0	0	0.93800	G/G	rs137852238	139551113	12064	G	.	P00740	9951	0.62152	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.175	0	0	.	4.94	0.86309	3330	D	T	0	0.000000e+00	0	656	.	0	0	98879|98878	10585	0.93722	0.91968	0.752935725469828	4348	.	0.40243	.	0.000000e+00	1.546480e-05	894893	4.306	6.585580e-06	N	9933	0	.	0	300807|306900|134500|306700	0.58997	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.97817949293013	2	0.21742	0.18019	19069	.	1.361040e-05	0.000000e+00	.	YES	0.000000e+00	0.304049	25624	HGNC:3551	A	0	simple_aae	0.724	151847	139551113	CGT	1.000000	.	-	2.2999080036798528E-4	0.94118	4.469810e-06	1	0	Pathogenic	0.29315	0	0	0	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	R	0	0.998451674901	-	0.858	-	0.68361	1	3978	0.97797	0.427083998919	0.1576	0	0.99887204579505651	274	-	572G>A 	1	0	C2749016|C0008533|C0019069|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.60210	137852238	1767	9.436811112788767E-6	0.99840	.	0.464	0.059	4172	0.99997842	4.94	.	.	0.000000e+00	0.458528	0.981076557386951	0.60790	D	2674	4647	7081	0.9910	0.96132	p.Arg191His	0	0	-4.38	0.94853324	0	0.85578	10585	T	24390	F9	0.000000e+00	D	0.730	15996	R191H	D	0.84251	0.76753	G/G	principal1	189871	F9_Popp_2025_heavy_chain_var234373	No		7/11/24		36190763-aaae-49d3-a95b-1e8f8f6199ab							R		572	F9_Popp_2025_heavy_chain	10585.0	ENST00000218099.7	Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255342	immortalized human cells		false			p.Arg191His		true	c.572G>A						3551.0	139551113.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa	PP4_Moderate,PM1_Strong,PS4,PP3						PM2,PS3_Supporting,PP1,PM5		The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM1_Strong,PS4	Arg191His	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	191.0		hemophilia B	3.306932985e-6	1.0142334797704238		Pathogenic	139551113.0	missense_variant		0.73				779,746,624,759,143	Reporter			F9_Arg191His
F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004379		NC_000023.11:139551113:G:A		Arg191His																												F9_Arg191His	23	139551113	G	A	X	allele	572G>A	C08	527_CAVA_Array_P02	E16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551113-G-A	-	0.38835	0.461	191	1	0	0	X	138633272	A	3.306930e-06	0	X	1_Pathogenic	NC_000023.11	4	Arg191His	0	20.8	0	1	1.361040e-05	D	0	8	1	30953	5.805520e-06	.	19004	0.000000e+00	0	0.90507	Select	0.8837	73473	0.36381	0	.	D	D	46533	1.82565083264	2.3969319271332693E-4	0	0.000000e+00	0	0	0.28775	13667	33770	0	0.000000e+00	0.49201	1	.	0.58804	0.055	.	71.0	0.872513	4.5	0.29	A	single nucleotide variant	NC_000023.11:g.139551113G>A	0	12191	3	0.20733581	80340	0	0.42576137	0	A	1	172250	0	0	0.000000e+00	436	3.230700e-05	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	1	0	0.000000e+00	0	0.82936	B	0.55303	P	M	.	4	G/G	176	0	5702	1209580	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	13134	0.97030	.	.	-	139551113	3.230700e-05	-	11.735000	0	0.84705	22034	0	894893	0	germline;unknown	56787	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.95637	GRCh38	924	reviewed by expert panel	c.572G>A	0.000000e+00	0.64600	1	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.572G>A (p.Arg191His)	3	0	FA9_HUMAN	0	29.0	.	0	D	0.40318	0.37745458	+	0.000000e+00	.	2.73283e-6	1	0.000000e+00	0	27168	reviewed_by_expert_panel	0.99989	1.244710e-05	0	0.000000e+00	0	45737	p.Arg191His	0	0.95080	.	germline	1	139551113	G	Feb 09, 2024	0	G/G	0	64663	0.997	N	Xq27.1	92674	.	0.000000e+00	SCV004363686	Pathogenic	0	0	His	H	-	688	ENSP00000218099	ENST00000218099	13319	0.038	10128	0	0.676	G	0	2.919779	0.48432	.	T	-	.	.	0.90955	928	0	.	0.43154	0	139551113	Y	10	0	73473	0.000000e+00	P00740	0	0.584288	0.96206	G	0	0.03	D	64663	0.29486942	30953	0.15632	2158	0.484746	4	-2.18	.	4.469810e-06	0.43243	0.000000e+00	0	57163	0.000000e+00	4373	0	0.44825	X	F9	0.000000e+00	0	Arg	105968	1.546480e-05	X-139551113-G-A	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	0	1	138460938	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	.	.	0	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	D	0	0	c.572G>A	0	0	0	0.93800	G/G	rs137852238	139551113	12064	G	.	P00740	9951	0.62152	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.175	0	0	.	4.94	0.86309	3330	D	T	0	0.000000e+00	0	656	.	0	0	98879|98878	10585	0.93722	0.91968	0.752935725469828	4348	.	0.40243	.	0.000000e+00	1.546480e-05	894893	4.306	6.585580e-06	N	9933	0	.	0	300807|306900|134500|306700	0.58997	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.97817949293013	2	0.21742	0.18019	19069	.	1.361040e-05	0.000000e+00	.	YES	0.000000e+00	0.304049	25624	HGNC:3551	A	0	simple_aae	0.724	151847	139551113	CGT	1.000000	.	-	2.2999080036798528E-4	0.94118	4.469810e-06	1	0	Pathogenic	0.29315	0	0	0	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	R	0	0.998451674901	-	0.858	-	0.68361	1	3978	0.97797	0.427083998919	0.1576	0	0.99887204579505651	274	-	572G>A 	1	0	C2749016|C0008533|C0019069|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.60210	137852238	1767	9.436811112788767E-6	0.99840	.	0.464	0.059	4172	0.99997842	4.94	.	.	0.000000e+00	0.458528	0.981076557386951	0.60790	D	2674	4647	7081	0.9910	0.96132	p.Arg191His	0	0	-4.38	0.94853324	0	0.85578	10585	T	24390	F9	0.000000e+00	D	0.730	15996	R191H	D	0.84251	0.76753	G/G	principal1	134839	F9_Popp_2025_carboxy_F9_specific_var224692	No		7/11/24		36190763-aaae-49d3-a95b-1e8f8f6199ab							R		572	F9_Popp_2025_carboxy_F9_specific	10585.0	ENST00000218099.7	Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255342	immortalized human cells		false			p.Arg191His		true	c.572G>A						3551.0	139551113.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa	PP4_Moderate,PM1_Strong,PS4,PP3						PM2,PS3_Supporting,PP1,PM5		The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM1_Strong,PS4	Arg191His	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	191.0		hemophilia B	3.306932985e-6	0.7881751920285752		Pathogenic	139551113.0	missense_variant		0.73				779,746,624,759,143	Reporter			F9_Arg191His
F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004379		NC_000023.11:139551113:G:A		Arg191His																												F9_Arg191His	23	139551113	G	A	X	allele	572G>A	C08	527_CAVA_Array_P02	E16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551113-G-A	-	0.38835	0.461	191	1	0	0	X	138633272	A	3.306930e-06	0	X	1_Pathogenic	NC_000023.11	4	Arg191His	0	20.8	0	1	1.361040e-05	D	0	8	1	30953	5.805520e-06	.	19004	0.000000e+00	0	0.90507	Select	0.8837	73473	0.36381	0	.	D	D	46533	1.82565083264	2.3969319271332693E-4	0	0.000000e+00	0	0	0.28775	13667	33770	0	0.000000e+00	0.49201	1	.	0.58804	0.055	.	71.0	0.872513	4.5	0.29	A	single nucleotide variant	NC_000023.11:g.139551113G>A	0	12191	3	0.20733581	80340	0	0.42576137	0	A	1	172250	0	0	0.000000e+00	436	3.230700e-05	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	1	0	0.000000e+00	0	0.82936	B	0.55303	P	M	.	4	G/G	176	0	5702	1209580	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	13134	0.97030	.	.	-	139551113	3.230700e-05	-	11.735000	0	0.84705	22034	0	894893	0	germline;unknown	56787	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.95637	GRCh38	924	reviewed by expert panel	c.572G>A	0.000000e+00	0.64600	1	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.572G>A (p.Arg191His)	3	0	FA9_HUMAN	0	29.0	.	0	D	0.40318	0.37745458	+	0.000000e+00	.	2.73283e-6	1	0.000000e+00	0	27168	reviewed_by_expert_panel	0.99989	1.244710e-05	0	0.000000e+00	0	45737	p.Arg191His	0	0.95080	.	germline	1	139551113	G	Feb 09, 2024	0	G/G	0	64663	0.997	N	Xq27.1	92674	.	0.000000e+00	SCV004363686	Pathogenic	0	0	His	H	-	688	ENSP00000218099	ENST00000218099	13319	0.038	10128	0	0.676	G	0	2.919779	0.48432	.	T	-	.	.	0.90955	928	0	.	0.43154	0	139551113	Y	10	0	73473	0.000000e+00	P00740	0	0.584288	0.96206	G	0	0.03	D	64663	0.29486942	30953	0.15632	2158	0.484746	4	-2.18	.	4.469810e-06	0.43243	0.000000e+00	0	57163	0.000000e+00	4373	0	0.44825	X	F9	0.000000e+00	0	Arg	105968	1.546480e-05	X-139551113-G-A	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	0	1	138460938	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	.	.	0	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	D	0	0	c.572G>A	0	0	0	0.93800	G/G	rs137852238	139551113	12064	G	.	P00740	9951	0.62152	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.175	0	0	.	4.94	0.86309	3330	D	T	0	0.000000e+00	0	656	.	0	0	98879|98878	10585	0.93722	0.91968	0.752935725469828	4348	.	0.40243	.	0.000000e+00	1.546480e-05	894893	4.306	6.585580e-06	N	9933	0	.	0	300807|306900|134500|306700	0.58997	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.97817949293013	2	0.21742	0.18019	19069	.	1.361040e-05	0.000000e+00	.	YES	0.000000e+00	0.304049	25624	HGNC:3551	A	0	simple_aae	0.724	151847	139551113	CGT	1.000000	.	-	2.2999080036798528E-4	0.94118	4.469810e-06	1	0	Pathogenic	0.29315	0	0	0	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	R	0	0.998451674901	-	0.858	-	0.68361	1	3978	0.97797	0.427083998919	0.1576	0	0.99887204579505651	274	-	572G>A 	1	0	C2749016|C0008533|C0019069|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.60210	137852238	1767	9.436811112788767E-6	0.99840	.	0.464	0.059	4172	0.99997842	4.94	.	.	0.000000e+00	0.458528	0.981076557386951	0.60790	D	2674	4647	7081	0.9910	0.96132	p.Arg191His	0	0	-4.38	0.94853324	0	0.85578	10585	T	24390	F9	0.000000e+00	D	0.730	15996	R191H	D	0.84251	0.76753	G/G	principal1	162355	F9_Popp_2025_carboxy_gla_motif_var253735	No		7/11/24		36190763-aaae-49d3-a95b-1e8f8f6199ab							R		572	F9_Popp_2025_carboxy_gla_motif	10585.0	ENST00000218099.7	Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255342	immortalized human cells		false			p.Arg191His		true	c.572G>A						3551.0	139551113.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa	PP4_Moderate,PM1_Strong,PS4,PP3						PM2,PS3_Supporting,PP1,PM5		The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM1_Strong,PS4	Arg191His	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	191.0		hemophilia B	3.306932985e-6	0.8607407016784892		Pathogenic	139551113.0	missense_variant		0.73				779,746,624,759,143	Reporter			F9_Arg191His
F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004379		NC_000023.11:139551113:G:A		Arg191His																												F9_Arg191His	23	139551113	G	A	X	allele	572G>A	C08	527_CAVA_Array_P02	E16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551113-G-A	-	0.38835	0.461	191	1	0	0	X	138633272	A	3.306930e-06	0	X	1_Pathogenic	NC_000023.11	4	Arg191His	0	20.8	0	1	1.361040e-05	D	0	8	1	30953	5.805520e-06	.	19004	0.000000e+00	0	0.90507	Select	0.8837	73473	0.36381	0	.	D	D	46533	1.82565083264	2.3969319271332693E-4	0	0.000000e+00	0	0	0.28775	13667	33770	0	0.000000e+00	0.49201	1	.	0.58804	0.055	.	71.0	0.872513	4.5	0.29	A	single nucleotide variant	NC_000023.11:g.139551113G>A	0	12191	3	0.20733581	80340	0	0.42576137	0	A	1	172250	0	0	0.000000e+00	436	3.230700e-05	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	1	0	0.000000e+00	0	0.82936	B	0.55303	P	M	.	4	G/G	176	0	5702	1209580	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	13134	0.97030	.	.	-	139551113	3.230700e-05	-	11.735000	0	0.84705	22034	0	894893	0	germline;unknown	56787	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.95637	GRCh38	924	reviewed by expert panel	c.572G>A	0.000000e+00	0.64600	1	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.572G>A (p.Arg191His)	3	0	FA9_HUMAN	0	29.0	.	0	D	0.40318	0.37745458	+	0.000000e+00	.	2.73283e-6	1	0.000000e+00	0	27168	reviewed_by_expert_panel	0.99989	1.244710e-05	0	0.000000e+00	0	45737	p.Arg191His	0	0.95080	.	germline	1	139551113	G	Feb 09, 2024	0	G/G	0	64663	0.997	N	Xq27.1	92674	.	0.000000e+00	SCV004363686	Pathogenic	0	0	His	H	-	688	ENSP00000218099	ENST00000218099	13319	0.038	10128	0	0.676	G	0	2.919779	0.48432	.	T	-	.	.	0.90955	928	0	.	0.43154	0	139551113	Y	10	0	73473	0.000000e+00	P00740	0	0.584288	0.96206	G	0	0.03	D	64663	0.29486942	30953	0.15632	2158	0.484746	4	-2.18	.	4.469810e-06	0.43243	0.000000e+00	0	57163	0.000000e+00	4373	0	0.44825	X	F9	0.000000e+00	0	Arg	105968	1.546480e-05	X-139551113-G-A	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	0	1	138460938	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	.	.	0	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	D	0	0	c.572G>A	0	0	0	0.93800	G/G	rs137852238	139551113	12064	G	.	P00740	9951	0.62152	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.175	0	0	.	4.94	0.86309	3330	D	T	0	0.000000e+00	0	656	.	0	0	98879|98878	10585	0.93722	0.91968	0.752935725469828	4348	.	0.40243	.	0.000000e+00	1.546480e-05	894893	4.306	6.585580e-06	N	9933	0	.	0	300807|306900|134500|306700	0.58997	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.97817949293013	2	0.21742	0.18019	19069	.	1.361040e-05	0.000000e+00	.	YES	0.000000e+00	0.304049	25624	HGNC:3551	A	0	simple_aae	0.724	151847	139551113	CGT	1.000000	.	-	2.2999080036798528E-4	0.94118	4.469810e-06	1	0	Pathogenic	0.29315	0	0	0	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	R	0	0.998451674901	-	0.858	-	0.68361	1	3978	0.97797	0.427083998919	0.1576	0	0.99887204579505651	274	-	572G>A 	1	0	C2749016|C0008533|C0019069|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.60210	137852238	1767	9.436811112788767E-6	0.99840	.	0.464	0.059	4172	0.99997842	4.94	.	.	0.000000e+00	0.458528	0.981076557386951	0.60790	D	2674	4647	7081	0.9910	0.96132	p.Arg191His	0	0	-4.38	0.94853324	0	0.85578	10585	T	24390	F9	0.000000e+00	D	0.730	15996	R191H	D	0.84251	0.76753	G/G	principal1	217387	F9_Popp_2025_light_chain_var244054	No		7/11/24		36190763-aaae-49d3-a95b-1e8f8f6199ab							R		572	F9_Popp_2025_light_chain	10585.0	ENST00000218099.7	Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255342	immortalized human cells		false			p.Arg191His		true	c.572G>A						3551.0	139551113.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa	PP4_Moderate,PM1_Strong,PS4,PP3						PM2,PS3_Supporting,PP1,PM5		The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM1_Strong,PS4	Arg191His	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	191.0		hemophilia B	3.306932985e-6	0.9560010972432093		Pathogenic	139551113.0	missense_variant		0.73				779,746,624,759,143	Reporter			F9_Arg191His
F9_Arg191His	-2.575191626456613	0.03672882890207274	2.942357539772449	0.021640609484757076	2025_01_Batch_13-14	0.6651388699955143	0.7518339615445655	0.718484451067893	0.7258636421458928	0.5698504015309318	0.633158773386885	0.7863865595924778	0.7471014643468078	0.7796959713141005	0.5950374435545536	0.6491488216911996	0.7691102605685216	0.7327929577073504	0.7527798067299967	0.5824439225427427	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004379		NC_000023.11:139551113:G:A		Arg191His																												F9_Arg191His	23	139551113	G	A	X	allele	572G>A	C08	527_CAVA_Array_P02	E16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551113-G-A	-	0.38835	0.461	191	1	0	0	X	138633272	A	3.306930e-06	0	X	1_Pathogenic	NC_000023.11	4	Arg191His	0	20.8	0	1	1.361040e-05	D	0	8	1	30953	5.805520e-06	.	19004	0.000000e+00	0	0.90507	Select	0.8837	73473	0.36381	0	.	D	D	46533	1.82565083264	2.3969319271332693E-4	0	0.000000e+00	0	0	0.28775	13667	33770	0	0.000000e+00	0.49201	1	.	0.58804	0.055	.	71.0	0.872513	4.5	0.29	A	single nucleotide variant	NC_000023.11:g.139551113G>A	0	12191	3	0.20733581	80340	0	0.42576137	0	A	1	172250	0	0	0.000000e+00	436	3.230700e-05	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	1	0	0.000000e+00	0	0.82936	B	0.55303	P	M	.	4	G/G	176	0	5702	1209580	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	13134	0.97030	.	.	-	139551113	3.230700e-05	-	11.735000	0	0.84705	22034	0	894893	0	germline;unknown	56787	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.95637	GRCh38	924	reviewed by expert panel	c.572G>A	0.000000e+00	0.64600	1	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.572G>A (p.Arg191His)	3	0	FA9_HUMAN	0	29.0	.	0	D	0.40318	0.37745458	+	0.000000e+00	.	2.73283e-6	1	0.000000e+00	0	27168	reviewed_by_expert_panel	0.99989	1.244710e-05	0	0.000000e+00	0	45737	p.Arg191His	0	0.95080	.	germline	1	139551113	G	Feb 09, 2024	0	G/G	0	64663	0.997	N	Xq27.1	92674	.	0.000000e+00	SCV004363686	Pathogenic	0	0	His	H	-	688	ENSP00000218099	ENST00000218099	13319	0.038	10128	0	0.676	G	0	2.919779	0.48432	.	T	-	.	.	0.90955	928	0	.	0.43154	0	139551113	Y	10	0	73473	0.000000e+00	P00740	0	0.584288	0.96206	G	0	0.03	D	64663	0.29486942	30953	0.15632	2158	0.484746	4	-2.18	.	4.469810e-06	0.43243	0.000000e+00	0	57163	0.000000e+00	4373	0	0.44825	X	F9	0.000000e+00	0	Arg	105968	1.546480e-05	X-139551113-G-A	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	0	1	138460938	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	.	.	0	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	D	0	0	c.572G>A	0	0	0	0.93800	G/G	rs137852238	139551113	12064	G	.	P00740	9951	0.62152	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.175	0	0	.	4.94	0.86309	3330	D	T	0	0.000000e+00	0	656	.	0	0	98879|98878	10585	0.93722	0.91968	0.752935725469828	4348	.	0.40243	.	0.000000e+00	1.546480e-05	894893	4.306	6.585580e-06	N	9933	0	.	0	300807|306900|134500|306700	0.58997	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.97817949293013	2	0.21742	0.18019	19069	.	1.361040e-05	0.000000e+00	.	YES	0.000000e+00	0.304049	25624	HGNC:3551	A	0	simple_aae	0.724	151847	139551113	CGT	1.000000	.	-	2.2999080036798528E-4	0.94118	4.469810e-06	1	0	Pathogenic	0.29315	0	0	0	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	R	0	0.998451674901	-	0.858	-	0.68361	1	3978	0.97797	0.427083998919	0.1576	0	0.99887204579505651	274	-	572G>A 	1	0	C2749016|C0008533|C0019069|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.60210	137852238	1767	9.436811112788767E-6	0.99840	.	0.464	0.059	4172	0.99997842	4.94	.	.	0.000000e+00	0.458528	0.981076557386951	0.60790	D	2674	4647	7081	0.9910	0.96132	p.Arg191His	0	0	-4.38	0.94853324	0	0.85578	10585	T	24390	F9	0.000000e+00	D	0.730	15996	R191H	D	0.84251	0.76753	G/G	principal1	244903	F9_Popp_2025_strep_2_var263416	No		7/11/24		36190763-aaae-49d3-a95b-1e8f8f6199ab							R		572	F9_Popp_2025_strep_2	10585.0	ENST00000218099.7	Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255342	immortalized human cells		false			p.Arg191His		true	c.572G>A						3551.0	139551113.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa	PP4_Moderate,PM1_Strong,PS4,PP3						PM2,PS3_Supporting,PP1,PM5		The NM_000133.3(F9):c.572G>A predicts a missense change, Arg191His, at the activation residue. This residue is a site for cleavage by FXIa in order to activate FIX and therefore critical for protein function, which meets criteria for PM1_Strong. Over 100 patients meet the F9 phenotype criteria have been reported in the literature (selected PMIDs: 7873393,1972560, 26782891, 27865967, 24375831), meeting PS4_Very strong and PP4_Moderate. The variant has a REVEL score of 0.73 (threshold >0.6), meeting PP3. In summary, the variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency VCEP for F9: PS4_Very Strong, PM1_Strong, PP4_Moderate, PP3.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM1_Strong,PS4	Arg191His	https://erepo.genome.network/evrepo/ui/classification/36190763-aaae-49d3-a95b-1e8f8f6199ab					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	191.0		hemophilia B	3.306932985e-6	0.927009116		Pathogenic	139551113.0	missense_variant		0.73				779,746,624,759,143	Reporter			F9_Arg191His
F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	0.8052223116539097	0.770374504469749	0.8029166430497803	0.8380555280058175	0.688838888445426	0.730502955623894	0.6907037057543322	0.823181653805858	0.8214839805983268	0.618876714479806	0.7678626336389018	0.7305391051120406	0.8130491484278191	0.8297697543020721	0.653857801462616	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C		Cys134Ser																												F9_Cys134Ser	23	139548372	G	C	X	allele	401G>C	B07	527_CAVA_Array_P02	C14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548372-G-C	-	0.60976	1.0	134	.	.	.	X	138630531	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys134Ser	.	24.3	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98562	Select	0.9993	.	0.90580	.	.	D	D	.	3.32765753199	.	.	.	.	.	0.56360	.	.	.	.	0.94803	.	.	0.99850	0.685	.	2.0	0.773323	4.69	0.98	C	single nucleotide variant	NC_000023.11:g.139548372G>C	.	.	2	0.98336446	.	.	0.988561	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97016	D	0.99909	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96968	.	.	-	139548372	.	-	11.769000	.	0.99826	.	.	.	.	germline	.	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.99835	GRCh38	924	no assertion criteria provided	c.401G>C	.	0.64600	.	.	.	.	.	.	P	.	.	NM_000133.4(F9):c.401G>C (p.Cys134Ser)		.	FA9_HUMAN	.	98.0	.	.	T	0.95276	0.9918276	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys134Ser	.	0.95819	.	germline	.		G	Jun 01, 2019	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV001424902	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.618	G	.	4.089855	0.92967	.	D	-	.	.	0.94399	.	.	.	0.96610	.	139548372	Y	10	.	.	.	P00740	.	0.872264	0.41088		.	1.0	D	.	0.9841814	.	0.33728	2158	0.720984	.	-6.94	.	.	0.91343	.	.	.	.	.	.	0.99894	X	F9	.	.	Cys	.	.	X-139548372-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138458197	.	.	.	.	RCV001265104	D	.	.	c.401G>C	.	.	.	0.99946	G/G	rs1927764839	139548372	.	G	.	P00740	.	0.99681	.	0.68239		.	.	.	4.72	.	.	.	4.94	0.97227	.	D	T	.	.	.	.	.	.	.	98879	973818	0.99946	0.99614	0.999232292175293	.	.	0.71675	.	.	.	.	7.472	.	D	.	.	.	.	306900	0.80047	X	.	ENSG00000101981	.	.	.	.	0.9998499921215912	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.454898	962086	HGNC:3551	A	.	simple_aae	0.995	.	139548372	TGT	1.000000	.	-	.	0.99728	.	.	.	Pathogenic	0.65331	.	.	.	ClinGen:CA414438797	C	.	0.999909622329	-	0.983	-	0.94679	.	.	0.99985	0.624931335449	0.979	.	0.98390809585124928	.	-	401G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.40263	1927764839	.	.	0.99990	.	0.899	0.0	.	0.99999320	4.94	.	.	.	0.797867	0.99951099997631	0.99504	D	.	.	.	0.9872	0.99975	p.Cys134Ser	.	.	-7.378	0.9919677	.	0.96835	973818	T	.	F9	.	D	0.936	.	C134S	D	0.86632	0.50684	G/G	principal1	131369	F9_Popp_2025_carboxy_F9_specific_var223487	No											C		401	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys134Ser		true	c.401G>C						3551.0	139548372.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Cys134Ser						S	Jun 01, 2019					missense_variant		134.0				0.287122221128485		Pathogenic	139548372.0	missense_variant		0.936					Reporter			F9_Cys134Ser
F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	0.8052223116539097	0.770374504469749	0.8029166430497803	0.8380555280058175	0.688838888445426	0.730502955623894	0.6907037057543322	0.823181653805858	0.8214839805983268	0.618876714479806	0.7678626336389018	0.7305391051120406	0.8130491484278191	0.8297697543020721	0.653857801462616	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C		Cys134Ser																												F9_Cys134Ser	23	139548372	G	C	X	allele	401G>C	B07	527_CAVA_Array_P02	C14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548372-G-C	-	0.60976	1.0	134	.	.	.	X	138630531	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys134Ser	.	24.3	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98562	Select	0.9993	.	0.90580	.	.	D	D	.	3.32765753199	.	.	.	.	.	0.56360	.	.	.	.	0.94803	.	.	0.99850	0.685	.	2.0	0.773323	4.69	0.98	C	single nucleotide variant	NC_000023.11:g.139548372G>C	.	.	2	0.98336446	.	.	0.988561	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97016	D	0.99909	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96968	.	.	-	139548372	.	-	11.769000	.	0.99826	.	.	.	.	germline	.	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.99835	GRCh38	924	no assertion criteria provided	c.401G>C	.	0.64600	.	.	.	.	.	.	P	.	.	NM_000133.4(F9):c.401G>C (p.Cys134Ser)		.	FA9_HUMAN	.	98.0	.	.	T	0.95276	0.9918276	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys134Ser	.	0.95819	.	germline	.		G	Jun 01, 2019	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV001424902	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.618	G	.	4.089855	0.92967	.	D	-	.	.	0.94399	.	.	.	0.96610	.	139548372	Y	10	.	.	.	P00740	.	0.872264	0.41088		.	1.0	D	.	0.9841814	.	0.33728	2158	0.720984	.	-6.94	.	.	0.91343	.	.	.	.	.	.	0.99894	X	F9	.	.	Cys	.	.	X-139548372-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138458197	.	.	.	.	RCV001265104	D	.	.	c.401G>C	.	.	.	0.99946	G/G	rs1927764839	139548372	.	G	.	P00740	.	0.99681	.	0.68239		.	.	.	4.72	.	.	.	4.94	0.97227	.	D	T	.	.	.	.	.	.	.	98879	973818	0.99946	0.99614	0.999232292175293	.	.	0.71675	.	.	.	.	7.472	.	D	.	.	.	.	306900	0.80047	X	.	ENSG00000101981	.	.	.	.	0.9998499921215912	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.454898	962086	HGNC:3551	A	.	simple_aae	0.995	.	139548372	TGT	1.000000	.	-	.	0.99728	.	.	.	Pathogenic	0.65331	.	.	.	ClinGen:CA414438797	C	.	0.999909622329	-	0.983	-	0.94679	.	.	0.99985	0.624931335449	0.979	.	0.98390809585124928	.	-	401G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.40263	1927764839	.	.	0.99990	.	0.899	0.0	.	0.99999320	4.94	.	.	.	0.797867	0.99951099997631	0.99504	D	.	.	.	0.9872	0.99975	p.Cys134Ser	.	.	-7.378	0.9919677	.	0.96835	973818	T	.	F9	.	D	0.936	.	C134S	D	0.86632	0.50684	G/G	principal1	158885	F9_Popp_2025_carboxy_gla_motif_var252530	No											C		401	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys134Ser		true	c.401G>C						3551.0	139548372.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Cys134Ser						S	Jun 01, 2019					missense_variant		134.0				0.082006696		Pathogenic	139548372.0	missense_variant		0.936					Reporter			F9_Cys134Ser
F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	0.8052223116539097	0.770374504469749	0.8029166430497803	0.8380555280058175	0.688838888445426	0.730502955623894	0.6907037057543322	0.823181653805858	0.8214839805983268	0.618876714479806	0.7678626336389018	0.7305391051120406	0.8130491484278191	0.8297697543020721	0.653857801462616	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C		Cys134Ser																												F9_Cys134Ser	23	139548372	G	C	X	allele	401G>C	B07	527_CAVA_Array_P02	C14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548372-G-C	-	0.60976	1.0	134	.	.	.	X	138630531	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys134Ser	.	24.3	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98562	Select	0.9993	.	0.90580	.	.	D	D	.	3.32765753199	.	.	.	.	.	0.56360	.	.	.	.	0.94803	.	.	0.99850	0.685	.	2.0	0.773323	4.69	0.98	C	single nucleotide variant	NC_000023.11:g.139548372G>C	.	.	2	0.98336446	.	.	0.988561	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97016	D	0.99909	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96968	.	.	-	139548372	.	-	11.769000	.	0.99826	.	.	.	.	germline	.	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.99835	GRCh38	924	no assertion criteria provided	c.401G>C	.	0.64600	.	.	.	.	.	.	P	.	.	NM_000133.4(F9):c.401G>C (p.Cys134Ser)		.	FA9_HUMAN	.	98.0	.	.	T	0.95276	0.9918276	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys134Ser	.	0.95819	.	germline	.		G	Jun 01, 2019	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV001424902	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.618	G	.	4.089855	0.92967	.	D	-	.	.	0.94399	.	.	.	0.96610	.	139548372	Y	10	.	.	.	P00740	.	0.872264	0.41088		.	1.0	D	.	0.9841814	.	0.33728	2158	0.720984	.	-6.94	.	.	0.91343	.	.	.	.	.	.	0.99894	X	F9	.	.	Cys	.	.	X-139548372-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138458197	.	.	.	.	RCV001265104	D	.	.	c.401G>C	.	.	.	0.99946	G/G	rs1927764839	139548372	.	G	.	P00740	.	0.99681	.	0.68239		.	.	.	4.72	.	.	.	4.94	0.97227	.	D	T	.	.	.	.	.	.	.	98879	973818	0.99946	0.99614	0.999232292175293	.	.	0.71675	.	.	.	.	7.472	.	D	.	.	.	.	306900	0.80047	X	.	ENSG00000101981	.	.	.	.	0.9998499921215912	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.454898	962086	HGNC:3551	A	.	simple_aae	0.995	.	139548372	TGT	1.000000	.	-	.	0.99728	.	.	.	Pathogenic	0.65331	.	.	.	ClinGen:CA414438797	C	.	0.999909622329	-	0.983	-	0.94679	.	.	0.99985	0.624931335449	0.979	.	0.98390809585124928	.	-	401G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.40263	1927764839	.	.	0.99990	.	0.899	0.0	.	0.99999320	4.94	.	.	.	0.797867	0.99951099997631	0.99504	D	.	.	.	0.9872	0.99975	p.Cys134Ser	.	.	-7.378	0.9919677	.	0.96835	973818	T	.	F9	.	D	0.936	.	C134S	D	0.86632	0.50684	G/G	principal1	186401	F9_Popp_2025_heavy_chain_var233168	No											C		401	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys134Ser		true	c.401G>C						3551.0	139548372.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Cys134Ser						S	Jun 01, 2019					missense_variant		134.0				0.3701647117442558		Pathogenic	139548372.0	missense_variant		0.936					Reporter			F9_Cys134Ser
F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	0.8052223116539097	0.770374504469749	0.8029166430497803	0.8380555280058175	0.688838888445426	0.730502955623894	0.6907037057543322	0.823181653805858	0.8214839805983268	0.618876714479806	0.7678626336389018	0.7305391051120406	0.8130491484278191	0.8297697543020721	0.653857801462616	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C		Cys134Ser																												F9_Cys134Ser	23	139548372	G	C	X	allele	401G>C	B07	527_CAVA_Array_P02	C14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548372-G-C	-	0.60976	1.0	134	.	.	.	X	138630531	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys134Ser	.	24.3	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98562	Select	0.9993	.	0.90580	.	.	D	D	.	3.32765753199	.	.	.	.	.	0.56360	.	.	.	.	0.94803	.	.	0.99850	0.685	.	2.0	0.773323	4.69	0.98	C	single nucleotide variant	NC_000023.11:g.139548372G>C	.	.	2	0.98336446	.	.	0.988561	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97016	D	0.99909	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96968	.	.	-	139548372	.	-	11.769000	.	0.99826	.	.	.	.	germline	.	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.99835	GRCh38	924	no assertion criteria provided	c.401G>C	.	0.64600	.	.	.	.	.	.	P	.	.	NM_000133.4(F9):c.401G>C (p.Cys134Ser)		.	FA9_HUMAN	.	98.0	.	.	T	0.95276	0.9918276	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys134Ser	.	0.95819	.	germline	.		G	Jun 01, 2019	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV001424902	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.618	G	.	4.089855	0.92967	.	D	-	.	.	0.94399	.	.	.	0.96610	.	139548372	Y	10	.	.	.	P00740	.	0.872264	0.41088		.	1.0	D	.	0.9841814	.	0.33728	2158	0.720984	.	-6.94	.	.	0.91343	.	.	.	.	.	.	0.99894	X	F9	.	.	Cys	.	.	X-139548372-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138458197	.	.	.	.	RCV001265104	D	.	.	c.401G>C	.	.	.	0.99946	G/G	rs1927764839	139548372	.	G	.	P00740	.	0.99681	.	0.68239		.	.	.	4.72	.	.	.	4.94	0.97227	.	D	T	.	.	.	.	.	.	.	98879	973818	0.99946	0.99614	0.999232292175293	.	.	0.71675	.	.	.	.	7.472	.	D	.	.	.	.	306900	0.80047	X	.	ENSG00000101981	.	.	.	.	0.9998499921215912	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.454898	962086	HGNC:3551	A	.	simple_aae	0.995	.	139548372	TGT	1.000000	.	-	.	0.99728	.	.	.	Pathogenic	0.65331	.	.	.	ClinGen:CA414438797	C	.	0.999909622329	-	0.983	-	0.94679	.	.	0.99985	0.624931335449	0.979	.	0.98390809585124928	.	-	401G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.40263	1927764839	.	.	0.99990	.	0.899	0.0	.	0.99999320	4.94	.	.	.	0.797867	0.99951099997631	0.99504	D	.	.	.	0.9872	0.99975	p.Cys134Ser	.	.	-7.378	0.9919677	.	0.96835	973818	T	.	F9	.	D	0.936	.	C134S	D	0.86632	0.50684	G/G	principal1	241433	F9_Popp_2025_strep_2_var262211	No											C		401	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys134Ser		true	c.401G>C						3551.0	139548372.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Cys134Ser						S	Jun 01, 2019					missense_variant		134.0				0.4047348077825853		Pathogenic	139548372.0	missense_variant		0.936					Reporter			F9_Cys134Ser
F9_Cys134Ser	-3.3797959324717373	0.014861540864500467	2.68941056386725	0.03111228480786824	2025_01_Batch_13-14	0.8052223116539097	0.770374504469749	0.8029166430497803	0.8380555280058175	0.688838888445426	0.730502955623894	0.6907037057543322	0.823181653805858	0.8214839805983268	0.618876714479806	0.7678626336389018	0.7305391051120406	0.8130491484278191	0.8297697543020721	0.653857801462616	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030525		NC_000023.11:139548372:G:C		Cys134Ser																												F9_Cys134Ser	23	139548372	G	C	X	allele	401G>C	B07	527_CAVA_Array_P02	C14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548372-G-C	-	0.60976	1.0	134	.	.	.	X	138630531	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys134Ser	.	24.3	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98562	Select	0.9993	.	0.90580	.	.	D	D	.	3.32765753199	.	.	.	.	.	0.56360	.	.	.	.	0.94803	.	.	0.99850	0.685	.	2.0	0.773323	4.69	0.98	C	single nucleotide variant	NC_000023.11:g.139548372G>C	.	.	2	0.98336446	.	.	0.988561	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97016	D	0.99909	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96968	.	.	-	139548372	.	-	11.769000	.	0.99826	.	.	.	.	germline	.	Gain of disorder (P = 0.0388)| Gain of ubiquitination at K137 (P = 0.0725)| Loss of methylation at K137 (P = 0.0754)| Loss of stability (P = 0.1309)| Gain of relative solvent accessibility (P = 0.2629)	0.99835	GRCh38	924	no assertion criteria provided	c.401G>C	.	0.64600	.	.	.	.	.	.	P	.	.	NM_000133.4(F9):c.401G>C (p.Cys134Ser)		.	FA9_HUMAN	.	98.0	.	.	T	0.95276	0.9918276	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys134Ser	.	0.95819	.	germline	.		G	Jun 01, 2019	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV001424902	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.618	G	.	4.089855	0.92967	.	D	-	.	.	0.94399	.	.	.	0.96610	.	139548372	Y	10	.	.	.	P00740	.	0.872264	0.41088		.	1.0	D	.	0.9841814	.	0.33728	2158	0.720984	.	-6.94	.	.	0.91343	.	.	.	.	.	.	0.99894	X	F9	.	.	Cys	.	.	X-139548372-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138458197	.	.	.	.	RCV001265104	D	.	.	c.401G>C	.	.	.	0.99946	G/G	rs1927764839	139548372	.	G	.	P00740	.	0.99681	.	0.68239		.	.	.	4.72	.	.	.	4.94	0.97227	.	D	T	.	.	.	.	.	.	.	98879	973818	0.99946	0.99614	0.999232292175293	.	.	0.71675	.	.	.	.	7.472	.	D	.	.	.	.	306900	0.80047	X	.	ENSG00000101981	.	.	.	.	0.9998499921215912	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.454898	962086	HGNC:3551	A	.	simple_aae	0.995	.	139548372	TGT	1.000000	.	-	.	0.99728	.	.	.	Pathogenic	0.65331	.	.	.	ClinGen:CA414438797	C	.	0.999909622329	-	0.983	-	0.94679	.	.	0.99985	0.624931335449	0.979	.	0.98390809585124928	.	-	401G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.40263	1927764839	.	.	0.99990	.	0.899	0.0	.	0.99999320	4.94	.	.	.	0.797867	0.99951099997631	0.99504	D	.	.	.	0.9872	0.99975	p.Cys134Ser	.	.	-7.378	0.9919677	.	0.96835	973818	T	.	F9	.	D	0.936	.	C134S	D	0.86632	0.50684	G/G	principal1	213917	F9_Popp_2025_light_chain_var242849	No											C		401	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys134Ser		true	c.401G>C						3551.0	139548372.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Cys134Ser						S	Jun 01, 2019					missense_variant		134.0				0.3291742709468179		Pathogenic	139548372.0	missense_variant		0.936					Reporter			F9_Cys134Ser
ZC4H2_Ala157Thr	-10.081278927908906	0.00002028191414801023	9.593570090277995	0.000028105857841895354	2025_01_Batch_13-14	0.8225176987191085	0.8795583823130079	0.9207357200542785	0.9021636911526654	0.7383830096110535	0.7120837534108332	0.920207730610582	0.9760120806025069	0.9466316452432798	0.7105962662307128	0.7673007260649709	0.899883056461795	0.9483739003283926	0.9243976681979726	0.7244896379208832	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC009160		NC_000023.11:64919134:C:T		Ala157Thr																												ZC4H2_Ala157Thr	23	64919134	C	T	X	allele	469G>A	E04	527_CAVA_Array_P06	I08	B13A7A8P2_R1	B14A7A8P2_R2				X-64919134-C-T	-	0.52818	0.999	157	2	0	0	X	64139014	T	1.161620e-05	1	X	3_Conflicting	NC_000023.11	3	Ala157Thr	1	23.3	1	0	7.805790e-05	T	0	2	1	29771	2.429990e-05	.	17506	0.000000e+00	0	0.50121	Select	0.3458	12811	0.77914	1	.	T	D	46483	0.00654792661685	0	0	0.000000e+00	0	0	0.59234	13221	33605	0	1.015130e-04	0.10073	2	.	0.52822	0.966	.	93.0	0.927207	.	0.07	T	single nucleotide variant	NC_000023.11:g.64919134C>T	0	11944	2	0.3234439	77492	0	0.30280557	0		4	164610	0	0	7.805790e-05	146	6.717950e-05	0	MedGen:C3661900	4	0	0.000000e+00	0	0.44282	D	0.58049	D	L	.	14	./.	114	0	5627	1205217	not provided	12905	0.65140	.	.	-	64919134	1.472100e-04	-	7.554000	0	0.36230	21757	0	45240	1	germline	55969	.	.	GRCh38	40	criteria provided, conflicting classifications	c.469G>A	0.000000e+00	0.76590	0	0	0	.	0.000000e+00	6793	A	0	0.000000e+00	NM_018684.4(ZC4H2):c.469G>A (p.Ala157Thr)	1	0	ZC4H2_HUMAN	0	7.0	.	1	D	0.60657	0.30280557	-	0.000000e+00	.		1	0.000000e+00	0	26175	criteria_provided,_conflicting_classifications	0.95109	5.161820e-05	0	0.000000e+00	0	45240	p.Ala157Thr	0	0.60397	.	germline	1		C	Mar 01, 2023	0	./.	0	61889	1.0	N	Xq11.2	9690	.	0.000000e+00	SCV001796760|SCV004674635	Conflicting_classifications_of_pathogenicity	0	0	Thr	T	-	685	ENSP00000363972	ENST00000374839	12811	0.345	9851	0	0.595	C	0	3.698819	0.08074	.	T	-	.	.	0.85417	610	0	.	0.27756	0	64919134	Y	9	0	70182	0.000000e+00	Q9NQZ6	0	0.270772	0.87938		0	0.994	D	9851	0.3234439	6793	0.53174	55906	0.0837489	6	-0.2	.	6.631300e-05	0.12584	0.000000e+00	0	57025	1.472100e-04	4345	0	0.58048	X	ZC4H2	5.260850e-05	0	Ala	14050	3.231590e-05	X-64919134-C-T	not_provided	0	2	64055739	.	.	.	0	RCV001572168	D	0	0	c.469G>A	0	1	0	0.62210	./.	rs756615930	64919134	11834	C	.	.	9288	0.52822	0.000000e+00	0.35501		0	0	2.975750e-05	1.59	0	0	264690	5.36	0.64106	112	T	T	0	4.252790e-05	0	26	.	0	0	.	1205492	0.61741	0.00552	0.376825159565334	2898	.	0.71675	.	3.820440e-05	1.015130e-04	892775	7.638	2.751090e-05	N	9769	0	7.5560088E-6	0	.	0.82522	X	0.000000e+00	ENSG00000126970	0.000000e+00	0	0	0	0.696682045515307	1	0.82066	0.97963	17571	2	2.849730e-05	6.631300e-05	.	YES	0.000000e+00	0.179905	1195791	HGNC:24931	N	0	simple_aae	0.138	145397	64919134	GCT	0.999000	.	-	0	0.51923	6.720620e-06	0	0	Conflicting classifications of pathogenicity	0.44103	0	0	3	ClinGen:CA10433405	A	0	0.496162226526	-	.	-	0.58756	4	496	0.69455	0.645161211491	0.4207	0	0.99793533325966355	98	-	469G>A 	1	0	C3661900	0	0	0	0	NM_018684.4	-	.	.	0	0.73106	756615930	1650	0	0.48888	.	0.56	0.671	2784	0.97556907	5.36	.	.	0.000000e+00	-0.117477	0.690180673695841	0.40152	T	86	4286	6515	-0.5882	0.70954	p.Ala157Thr	0	0	-5.678	0.355225	3	0.66695	1205492	T	23514	ZC4H2	7.563720e-05	T	0.212	15672	.	T	.	0.32887	./.	principal1																																																																																																				
KRAS_Ile36Met	-3.4018910795778345	0.011413064402871407	6.974814863521124	0.00021634943402749327	2025_01_Batch_13-14	0.6809761632421119	0.8800282469012882	0.9480094506081909	0.8722517432348413	0.5789516080948736	0.9889391489111761	0.9881183579520308	0.9885898814965686	0.9935683429252101	0.9606665891969275	0.834957656076644	0.9340733024266595	0.9682996660523797	0.9329100430800257	0.7698090986459005	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214479	CCSBVarC006095	ALE00006095	NC_000012.12:25245277:T:C	108A>G	Ile36Met	CEGS2	CegsMutGDEh1040	D09	GDEhDisVCh_40061	G09	1	CegsMutGDDh1040	D09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Ile36Met	12	25245277	T	C	12											12-25245277-T-C	-	0.49383	0.999	36	.	.	.	12	25398211	C	.	.	12	1_Pathogenic	NC_000012.12	.	Ile36Met	.	22.8	.	.	.	D	.	11	1	.	.	.	.	.	.	0.95865	Plus_Clinical	0.7745	.	0.77914	.	.	D	D	.	2.38980543874	.	.	.	.	.	0.82287	.	.	.	.	0.60859	.	.	0.96352	0.998	.	17.0	0.819518	1.47	0.83	C	single nucleotide variant	NC_000012.12:g.25245277T>C	.	.	2	0.7634177	.	.	0.9472728	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:CN230736|	.	.	.	.	0.88920	D	0.90274	D	M	6.061257	.	./.	.	.	.	.	RASopathy|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|Cardiovascular phenotype|KRAS-related disorder	.	0.92922	.	.	-	25245277	.	-	2.363000	.	0.99252	.	.	.	.	germline;unknown	.	Gain of catalytic residue at E31 (P = 0.0146)| Gain of disorder (P = 0.0401)| Gain of phosphorylation at Y40 (P = 0.0722)| Gain of glycosylation at T35 (P = 0.271)| Loss of sheet (P = 0.302)	0.89476	GRCh38	707	criteria provided, multiple submitters, no conflicts	c.108A>G	.	0.54535	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_004985.5(KRAS):c.108A>G (p.Ile36Met)	2	.	RASK_HUMAN	.	83.0	0.613285447805062	.	T	0.92907	0.9514009	-	.	.		.	.	3	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98905	.	.	.	.	.	p.Ile36Met	.	0.32466	.	germline	.		T	Oct 23, 2024	.	./.	.	.	1.0	N	12p12.1	.	.	.	SCV000198471|SCV000329772|SCV000919564|SCV000927544|SCV000939441|SCV000999274|SCV002733242	Pathogenic/Likely_pathogenic	.	.	Met	M	-	.	ENSP00000256078	ENST00000256078	.	0.001	.	.	0.644	T	.	3.518299	0.92967	N	D	-	5.309093	.	0.89466	.	.	.	0.66744	.	25245277	Y	10	.	.	.	P01116	.	0.899405	0.70435		.	0.982	D	.	0.8332933	.	0.85369	3845	0.388059	.	-2.35	.	.	0.78662	.	.	.	.	.	.	0.85851	12	KRAS	.	.	Ile	.	.	12-25245277-T-C	Cardiovascular_phenotype|Cardiofaciocutaneous_syndrome_1|RASopathy|not_provided|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|KRAS-related_disorder	.	.	25289478	ClinGen:CA273162|UniProtKB:P01116#VAR_064854	0.242004	0.73875	.	RCV000150891|RCV000260877|RCV000844636|RCV000856729|RCV002444616|RCV004551310	D	.	.	c.108A>G	.	.	.	0.89138	./.	rs727503109	25245277	.	T	.	P01116	.	0.95925	.	0.68239		.	.	.	3.16	.	.	.	4.51	0.97995	.	D	T	.	.	.	.	.	.	.	1340|536391|648|1340	163768	0.89001	0.97077	0.964436054229736	.	.	0.71675	0.36148	.	.	.	0.81	.	N	.	.	.	.	115150|PS163950|PS115150	0.26933	12	.	ENSG00000133703	.	.	.	.	0.8805200537522034	3	0.75481	0.56997	.	.	.	.	0.51615875806198	.	.	0.260605	175716	HGNC:6407	A	.	simple_aae	0.979	.	25245277	ATA	1.000000	.	-	.	0.90066	.	.	.	Pathogenic/Likely pathogenic	0.93015	.	.	.	ClinGen:CA273162,UniProtKB:P01116#VAR_064854	I	.	0.957860125292	-	0.768	-	0.95970	.	.	0.87945	0.802328705788	0.9755	.	0.99539106627103746	.	-	108A>G 	.	.	CN230736|CN029449|C5555857|C3661900|C0028326|C1275081	.	.	.	.	NM_004985.5	-	.	.	1	0.90586	727503109	.	.	0.95704	0.68905	0.866	0.001	.	0.99868040	5.68	.	.	.	0.319644	0.999853564238121	0.88393	D	.	.	.	0.6818	0.92315	p.Ile36Met	.	.	-13.662	0.90810716	.	0.98365	163768	D	.	KRAS	.	D	0.864	.	I36M	D	0.33823	0.52462	./.	alternative1																																																																																																				
KRAS_Ile36Met	-3.4018910795778345	0.011413064402871407	6.974814863521124	0.00021634943402749327	2025_01_Batch_13-14	0.6809761632421119	0.8800282469012882	0.9480094506081909	0.8722517432348413	0.5789516080948736	0.9889391489111761	0.9881183579520308	0.9885898814965686	0.9935683429252101	0.9606665891969275	0.834957656076644	0.9340733024266595	0.9682996660523797	0.9329100430800257	0.7698090986459005	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006095		NC_000012.12:25245277:T:C		Ile36Met																												KRAS_Ile36Met	12	25245277	T	C	12	allele	108A>G	D07	527_CAVA_Array_P03	H13	B13A7A8P1_R1	B14A7A8P1_R2				12-25245277-T-C	-	0.49383	0.999	36	.	.	.	12	25398211	C	.	.	12	1_Pathogenic	NC_000012.12	.	Ile36Met	.	22.8	.	.	.	D	.	11	1	.	.	.	.	.	.	0.95865	Plus_Clinical	0.7745	.	0.77914	.	.	D	D	.	2.38980543874	.	.	.	.	.	0.82287	.	.	.	.	0.60859	.	.	0.96352	0.998	.	17.0	0.819518	1.47	0.83	C	single nucleotide variant	NC_000012.12:g.25245277T>C	.	.	2	0.7634177	.	.	0.9472728	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:CN230736|	.	.	.	.	0.88920	D	0.90274	D	M	6.061257	.	./.	.	.	.	.	RASopathy|not provided|Noonan syndrome;Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 1|Cardiovascular phenotype|KRAS-related disorder	.	0.92922	.	.	-	25245277	.	-	2.363000	.	0.99252	.	.	.	.	germline;unknown	.	Gain of catalytic residue at E31 (P = 0.0146)| Gain of disorder (P = 0.0401)| Gain of phosphorylation at Y40 (P = 0.0722)| Gain of glycosylation at T35 (P = 0.271)| Loss of sheet (P = 0.302)	0.89476	GRCh38	707	criteria provided, multiple submitters, no conflicts	c.108A>G	.	0.54535	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_004985.5(KRAS):c.108A>G (p.Ile36Met)	2	.	RASK_HUMAN	.	83.0	0.613285447805062	.	T	0.92907	0.9514009	-	.	.		.	.	3	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98905	.	.	.	.	.	p.Ile36Met	.	0.32466	.	germline	.		T	Oct 23, 2024	.	./.	.	.	1.0	N	12p12.1	.	.	.	SCV000198471|SCV000329772|SCV000919564|SCV000927544|SCV000939441|SCV000999274|SCV002733242	Pathogenic/Likely_pathogenic	.	.	Met	M	-	.	ENSP00000256078	ENST00000256078	.	0.001	.	.	0.644	T	.	3.518299	0.92967	N	D	-	5.309093	.	0.89466	.	.	.	0.66744	.	25245277	Y	10	.	.	.	P01116	.	0.899405	0.70435		.	0.982	D	.	0.8332933	.	0.85369	3845	0.388059	.	-2.35	.	.	0.78662	.	.	.	.	.	.	0.85851	12	KRAS	.	.	Ile	.	.	12-25245277-T-C	Cardiovascular_phenotype|Cardiofaciocutaneous_syndrome_1|RASopathy|not_provided|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|KRAS-related_disorder	.	.	25289478	ClinGen:CA273162|UniProtKB:P01116#VAR_064854	0.242004	0.73875	.	RCV000150891|RCV000260877|RCV000844636|RCV000856729|RCV002444616|RCV004551310	D	.	.	c.108A>G	.	.	.	0.89138	./.	rs727503109	25245277	.	T	.	P01116	.	0.95925	.	0.68239		.	.	.	3.16	.	.	.	4.51	0.97995	.	D	T	.	.	.	.	.	.	.	1340|536391|648|1340	163768	0.89001	0.97077	0.964436054229736	.	.	0.71675	0.36148	.	.	.	0.81	.	N	.	.	.	.	115150|PS163950|PS115150	0.26933	12	.	ENSG00000133703	.	.	.	.	0.8805200537522034	3	0.75481	0.56997	.	.	.	.	0.51615875806198	.	.	0.260605	175716	HGNC:6407	A	.	simple_aae	0.979	.	25245277	ATA	1.000000	.	-	.	0.90066	.	.	.	Pathogenic/Likely pathogenic	0.93015	.	.	.	ClinGen:CA273162,UniProtKB:P01116#VAR_064854	I	.	0.957860125292	-	0.768	-	0.95970	.	.	0.87945	0.802328705788	0.9755	.	0.99539106627103746	.	-	108A>G 	.	.	CN230736|CN029449|C5555857|C3661900|C0028326|C1275081	.	.	.	.	NM_004985.5	-	.	.	1	0.90586	727503109	.	.	0.95704	0.68905	0.866	0.001	.	0.99868040	5.68	.	.	.	0.319644	0.999853564238121	0.88393	D	.	.	.	0.6818	0.92315	p.Ile36Met	.	.	-13.662	0.90810716	.	0.98365	163768	D	.	KRAS	.	D	0.864	.	I36M	D	0.33823	0.52462	./.	alternative1																																																																																																				
BRCA1_Thr37Lys	-0.25728289233865603	0.80435939653231	4.817455604826412	0.0019270976461462776	2025_01_Batch_13-14	0.8174092776879838	0.9099221991247153	0.8751460309326402	0.8792001815247644	0.6670508282803029	0.9365262887156782	0.87455061964549	0.9119290812243445	0.9543367207758721	0.9395910456374548	0.876967783201831	0.8922364093851026	0.8935375560784924	0.9167684511503182	0.8033209369588789	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011837		NC_000017.11:43115750:G:T		Thr37Lys																												BRCA1_Thr37Lys	17	43115750	G	T	17	allele	110C>A	G08	527_CAVA_Array_P01	M15	B13A7A8P1_R1	B14A7A8P1_R2				17-43115750-G-T	-	0.82936	0.979	37	.	.	.	17	41267767	T	.	.	17	1_Pathogenic	NC_000017.11	.	Thr37Lys	.	27.9	.	.	.	D	.	7	1	.	.	.	.	.	.	0.94336	Select	0.9155	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.73798	.	.	.	.	0.87019	.	.	0.97946	0.998	.	1.0	.	.	0.99	T	single nucleotide variant	NC_000017.11:g.43115750G>T	.	.	2	0.84243727	.	.	0.9560325	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	.	.	0.99291	P	0.94327	D	M	13.43596	.	G/G	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	.	0.97975	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43115750	.	-	11.711000	.	0.98414	.	.	.	.	germline;not applicable;unknown	.	Gain of methylation at T37 (P = 0.0325)| Gain of disorder (P = 0.0355)| Gain of ubiquitination at T37 (P = 0.0369)| Loss of catalytic residue at T37 (P = 0.1105)| Loss of sheet (P = 0.1158)	0.99178	GRCh38	464	reviewed by expert panel	c.110C>A	.	0.96929	.	.	.	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	.	.	P	.	.	NM_007294.4(BRCA1):c.110C>A (p.Thr37Lys)	3	.	BRCA1_HUMAN	.	99.0	0.984277674482382	.	.	0.92484	0.96704304	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99611	.	.	.	.	.	p.Thr37Lys	.	0.94660	.	germline	.		G	Aug 10, 2015	.	G/G	.	.	1.0	N	17q21.31	.	.	.	SCV000244295	Pathogenic	.	.	Lys	K	-	.	ENSP00000350283	ENST00000357654	.	0.0	.	.	0.676	G	.	4.997611	0.92967	D	D	-	14.52852	.	0.96439	.	.	.	0.83032	.	43115750	Y	10	.	.	.	P38398	.	0.4401	0.58711		.	0.777	D	.	0.8919265	.	0.85369	672	0.478281	.	-0.91	.	.	0.91343	.	.	.	.	.	.	0.90882	17	BRCA1	.	.	Thr	.	.	17-43115750-G-T	Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	.	.	38521293	BRCA1-HCI:BRCA1_00112|ClinGen:CA000742	0.726971	0.95215	.	RCV000111781|RCV000763401|RCV001378528|RCV002433536	D	.	.	c.110C>A	.	.	.	0.93590	G/G	rs80356880	43115750	.	G	.	E9PFC7	.	0.96828	.	0.68239		.	.	.	2.54	.	.	.	5.97	0.88719	.	D	T	.	.	.	.	.	.	.	145|227535|145|1333|140162	54131	0.93510	0.46547	0.992633044719696	.	.	0.71675	0.67428	.	.	.	4.401	.	N	.	.	.	.	114480|617883|604370|614320	0.59561	17	.	ENSG00000012048	.	.	.	.	.	2	0.92348	0.78507	.	.	.	.	0.917667809072401	YES	.	0.597518	68798	HGNC:1100	A	.	simple_aae	0.962	.	43115750	ACA	1.000000	.	-	.	0.97988	.	.	.	Pathogenic	0.98159	.	.	.	BRCA1-HCI:BRCA1_00112,ClinGen:CA000742	T	.	0.980248173759	-	0.94	-	0.91390	.	.	0.87940	0.74592012167	0.9729	.	0.99301403670490562	.	-	110C>A 	.	.	C0677776|C0346153|C4554406|C2676676|C3280442|C0027672	.	.	.	.	NM_007294.4	-	.	.	1	0.77715	80356880	.	.	0.97984	0.96277	0.909	0.0	.	0.99969053	5.97	.	.	.	0.449241	0.992970792932514	0.73893	D	.	.	.	1.0434	0.97195	p.Thr37Lys	.	.	-15.301	0.9803947	.	0.89793	54131	D	.	BRCA1	.	D	0.823	.	T37K	D	.	0.76753	G/G	principal2																																																																																																				
RAD51D_Cys9Ser	-0.430044793701963	0.6800918575546037	5.4449101766361565	0.0009611984439907126	2025_01_Batch_13-14	0.632463571016932	0.8021323314471392	0.887076778154518	0.818850060236358	0.6706305219371522	0.9002881466248781	0.8716861670864113	0.9283657869044879	0.9291992671149147	0.8615728726581611	0.7663758588209051	0.8369092492667753	0.9077212825295029	0.8740246636756364	0.7661016972976566	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024707		NC_000017.11:35119588:C:G		Cys9Ser																												RAD51D_Cys9Ser	17	35119588	C	G	17	allele	26G>C	B01	527_CAVA_Array_P05	C01	B13A7A8P2_R1	B14A7A8P2_R2				17-35119588-C-G	-	0.78275	0.948	9	68	0	0	17	33446607	G	6.561480e-04	6	17	3_Conflicting	NC_000017.11	980	Cys9Ser	0	26.9	0	0	6.361450e-04	T	0	20	5	42712	3.469520e-04	.	30518	0.000000e+00	0	0.51046	.	0.3025	100606	0.77914	13	.	D	T	62412	.	0	0	0.000000e+00	0	0	.	17088	44872	0	0.000000e+00	0.91889	20	.	0.91745	0.842	.	100.0	0.89681	.	0.0	G	single nucleotide variant	NC_000017.11:g.35119588C>G	0	15538	2	0.9265354	108026	0	0.90909326	0		83	233462	1	0	0.000000e+00	772	4.682520e-04	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C1333600|MedGen:CN221562|	27	1	0.000000e+00	0	0.33788	P	0.95940	P	M	4.469254	1058	C/C	174	3	7118	1612440	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified|Malignant tumor of breast|Hereditary cancer|Breast and/or ovarian cancer|RAD51D-related disorder	16132	0.66187	.	.	-	35119588	4.682520e-04	-	7.405000	1	0.83023	29602	0	1179946	0	germline;unknown	91086	Gain of disorder (P = 0.0024)| Gain of phosphorylation at C9 (P = 0.0829)| Gain of methylation at R5 (P = 0.2031)| Gain of helix (P = 0.2294)| Gain of catalytic residue at G7 (P = 0.288)	0.88011	GRCh38	926	criteria provided, conflicting classifications	c.26G>C	0.000000e+00	0.54328	60	1	0	RAD51D, N-terminal domain	6.435830e-05	9008	P	0	0.000000e+00	NM_002878.4(RAD51D):c.26G>C (p.Cys9Ser)	1	0	RA51D_HUMAN	1	0.0	0.419960104252545	12	D	0.75474	0.9053122	-	0.000000e+00	.		68	0.000000e+00	0	34236	criteria_provided,_conflicting_classifications	0.95814	2.499400e-04	1	8.198070e-05	0	60030	p.Cys9Ser	0	0.58667	.	germline	20		C	Mar 04, 2025	0	C/C	1	87248	1.0	N	17q12	93168	.	6.198860e-05	SCV000149721|SCV000185831|SCV000287702|SCV000488471|SCV000537513|SCV000602155|SCV000698094|SCV000839205|SCV000861249|SCV001434312|SCV002010056|SCV002043216|SCV002071956|SCV002534788|SCV003799801|SCV004009783|SCV004017720|SCV004242788	Conflicting_classifications_of_pathogenicity	1	0	Ser	S	-	912	ENSP00000378090	ENST00000394589	17654	0.0	13354	1	0.599	C	0	4.809918	0.79703	D	D	-	4.315044	.	0.89798	946	1	.	0.14560	0	35119588	Y	10	0.0012953367875647669	100606	0.000000e+00	O75771	0	0.542336	0.51428		0	0.539	D	87248	0.91432685	42712	0.39783	5892	-0.0621782	980	-5.89	.	8.305460e-04	0.91343	0.000000e+00	0	75044	0.000000e+00	6062	0	0.96810	17	RAD51D	1.599060e-04	0	Cys	109968	7.793870e-04	17-35119588-C-G	Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided|RAD51D-related_disorder	0	64	30470720	ClinGen:CA287968	0.811646	0.62325	0	RCV000115812|RCV000231466|RCV000587404|RCV001175378|RCV001357793|RCV003492494|RCV001798342|RCV003389691	T	0	0	c.26G>C	0	0	2	0.42220	C/C	rs140825795	35119588	14856	C	.	O75771	15682	0.92096	4.893330e-05	0.68239		0	0	0.000000e+00	2.37	0	56	264690	4.5	0.84209	3330	T	.	1	3.935200e-04	1	656	.	0	1	145|140162	127886	0.75898	0.38233	0.123274603139513	4356	.	0.71675	0.73360	3.797170e-04	7.793870e-04	1179946	3.449	4.060940e-04	D	12198	0	4.231365E-4	0	614291	0.52806	17	6.731290e-05	ENSG00000185379	3.204510e-05	6.010647432594882E-4	0	0	.	2	0.82066	0.17784	30600	112	6.361450e-04	2.498750e-04	0.393835298150661	.	0.000000e+00	0.269442	133343	HGNC:9823	N	0	simple_aae	0.694	204386	35119588	TGC	1.000000	.	-	0	0.39578	8.305460e-04	0	0	Conflicting classifications of pathogenicity	0.92500	0	0	15	ClinGen:CA287968	C	0	0.89673440463	-	0.75	-	0.76382	81	7122	0.75662	.	0.7562	1	0.99055369264790372	274	-	26G>C 	64	4.2122999157540015E-4	C0006142|CN221562|C3280345|C1333600|CN169374|C0027672|C3661900	0	0	0	0	NM_002878.4	-	.	.	0	0.63880	140825795	2320	5.456132693147098E-4	0.89492	0.60976	0.767	0.005	4182	0.98283120	4.5	.	.	0.000000e+00	0.0874681	0.0197165020029777	0.68084	T	2674	6188	9562	-0.5618	0.67215	p.Cys9Ser	0	0	-13.828	0.23021111	12	0.29331	127886	D	30494	RAD51D	3.511240e-04	D	0.218	20436	C9S	D	.	0.40292	C/C	principal1	963127	RAD51D_unpublished_var157374	Yes						overall function		Cell survival			C		26	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Cys9Ser		true	c.26G>C						9823.0	35119588.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		C									criteria provided, conflicting classifications				Cys9Ser						S	Nov 18, 2024					missense_variant		9.0	G		0.0006561484458336	-0.00763888		Conflicting classifications of pathogenicity	35119588.0	missense_variant		0.218	functionally_normal				Cell viability			RAD51D_Cys9Ser
RAD51D_Cys9Ser	-0.430044793701963	0.6800918575546037	5.4449101766361565	0.0009611984439907126	2025_01_Batch_13-14	0.632463571016932	0.8021323314471392	0.887076778154518	0.818850060236358	0.6706305219371522	0.9002881466248781	0.8716861670864113	0.9283657869044879	0.9291992671149147	0.8615728726581611	0.7663758588209051	0.8369092492667753	0.9077212825295029	0.8740246636756364	0.7661016972976566	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024707	ALE00029715	NC_000017.11:35119588:C:G	26G>C	Cys9Ser	CAVA																											RAD51D_Cys9Ser	17	35119588	C	G	17								1	1	1	17-35119588-C-G	-	0.78275	0.948	9	68	0	0	17	33446607	G	6.561480e-04	6	17	3_Conflicting	NC_000017.11	980	Cys9Ser	0	26.9	0	0	6.361450e-04	T	0	20	5	42712	3.469520e-04	.	30518	0.000000e+00	0	0.51046	.	0.3025	100606	0.77914	13	.	D	T	62412	.	0	0	0.000000e+00	0	0	.	17088	44872	0	0.000000e+00	0.91889	20	.	0.91745	0.842	.	100.0	0.89681	.	0.0	G	single nucleotide variant	NC_000017.11:g.35119588C>G	0	15538	2	0.9265354	108026	0	0.90909326	0		83	233462	1	0	0.000000e+00	772	4.682520e-04	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C1333600|MedGen:CN221562|	27	1	0.000000e+00	0	0.33788	P	0.95940	P	M	4.469254	1058	C/C	174	3	7118	1612440	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified|Malignant tumor of breast|Hereditary cancer|Breast and/or ovarian cancer|RAD51D-related disorder	16132	0.66187	.	.	-	35119588	4.682520e-04	-	7.405000	1	0.83023	29602	0	1179946	0	germline;unknown	91086	Gain of disorder (P = 0.0024)| Gain of phosphorylation at C9 (P = 0.0829)| Gain of methylation at R5 (P = 0.2031)| Gain of helix (P = 0.2294)| Gain of catalytic residue at G7 (P = 0.288)	0.88011	GRCh38	926	criteria provided, conflicting classifications	c.26G>C	0.000000e+00	0.54328	60	1	0	RAD51D, N-terminal domain	6.435830e-05	9008	P	0	0.000000e+00	NM_002878.4(RAD51D):c.26G>C (p.Cys9Ser)	1	0	RA51D_HUMAN	1	0.0	0.419960104252545	12	D	0.75474	0.9053122	-	0.000000e+00	.		68	0.000000e+00	0	34236	criteria_provided,_conflicting_classifications	0.95814	2.499400e-04	1	8.198070e-05	0	60030	p.Cys9Ser	0	0.58667	.	germline	20		C	Mar 04, 2025	0	C/C	1	87248	1.0	N	17q12	93168	.	6.198860e-05	SCV000149721|SCV000185831|SCV000287702|SCV000488471|SCV000537513|SCV000602155|SCV000698094|SCV000839205|SCV000861249|SCV001434312|SCV002010056|SCV002043216|SCV002071956|SCV002534788|SCV003799801|SCV004009783|SCV004017720|SCV004242788	Conflicting_classifications_of_pathogenicity	1	0	Ser	S	-	912	ENSP00000378090	ENST00000394589	17654	0.0	13354	1	0.599	C	0	4.809918	0.79703	D	D	-	4.315044	.	0.89798	946	1	.	0.14560	0	35119588	Y	10	0.0012953367875647669	100606	0.000000e+00	O75771	0	0.542336	0.51428		0	0.539	D	87248	0.91432685	42712	0.39783	5892	-0.0621782	980	-5.89	.	8.305460e-04	0.91343	0.000000e+00	0	75044	0.000000e+00	6062	0	0.96810	17	RAD51D	1.599060e-04	0	Cys	109968	7.793870e-04	17-35119588-C-G	Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided|RAD51D-related_disorder	0	64	30470720	ClinGen:CA287968	0.811646	0.62325	0	RCV000115812|RCV000231466|RCV000587404|RCV001175378|RCV001357793|RCV003492494|RCV001798342|RCV003389691	T	0	0	c.26G>C	0	0	2	0.42220	C/C	rs140825795	35119588	14856	C	.	O75771	15682	0.92096	4.893330e-05	0.68239		0	0	0.000000e+00	2.37	0	56	264690	4.5	0.84209	3330	T	.	1	3.935200e-04	1	656	.	0	1	145|140162	127886	0.75898	0.38233	0.123274603139513	4356	.	0.71675	0.73360	3.797170e-04	7.793870e-04	1179946	3.449	4.060940e-04	D	12198	0	4.231365E-4	0	614291	0.52806	17	6.731290e-05	ENSG00000185379	3.204510e-05	6.010647432594882E-4	0	0	.	2	0.82066	0.17784	30600	112	6.361450e-04	2.498750e-04	0.393835298150661	.	0.000000e+00	0.269442	133343	HGNC:9823	N	0	simple_aae	0.694	204386	35119588	TGC	1.000000	.	-	0	0.39578	8.305460e-04	0	0	Conflicting classifications of pathogenicity	0.92500	0	0	15	ClinGen:CA287968	C	0	0.89673440463	-	0.75	-	0.76382	81	7122	0.75662	.	0.7562	1	0.99055369264790372	274	-	26G>C 	64	4.2122999157540015E-4	C0006142|CN221562|C3280345|C1333600|CN169374|C0027672|C3661900	0	0	0	0	NM_002878.4	-	.	.	0	0.63880	140825795	2320	5.456132693147098E-4	0.89492	0.60976	0.767	0.005	4182	0.98283120	4.5	.	.	0.000000e+00	0.0874681	0.0197165020029777	0.68084	T	2674	6188	9562	-0.5618	0.67215	p.Cys9Ser	0	0	-13.828	0.23021111	12	0.29331	127886	D	30494	RAD51D	3.511240e-04	D	0.218	20436	C9S	D	.	0.40292	C/C	principal1	963127	RAD51D_unpublished_var157374	Yes						overall function		Cell survival			C		26	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Cys9Ser		true	c.26G>C						9823.0	35119588.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		C									criteria provided, conflicting classifications				Cys9Ser						S	Nov 18, 2024					missense_variant		9.0	G		0.0006561484458336	-0.00763888		Conflicting classifications of pathogenicity	35119588.0	missense_variant		0.218	functionally_normal				Cell viability			RAD51D_Cys9Ser
SHOC2_Gly53Arg	-1.3521828512316285	0.21837236832015264	4.502630598472021	0.002789525522662503	2025_01_Batch_13-14	0.8216650233696959	0.8816101159079917	0.7569201111391481	0.7687754072288939	0.6632181990751883	0.750939423096193	0.8491425140558854	0.6718651200479084	0.8162824578848482	0.6992104773769182	0.7863022232329444	0.8653763149819385	0.7143926155935283	0.7925289325568711	0.6812143382260533	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2	SHOC2		11602		CCSBVarC028008		NC_000010.11:110964515:G:A		Gly53Arg																												SHOC2_Gly53Arg	10	110964515	G	A	10	allele	157G>A	B02	527_CAVA_Array_P06	C04	B13A7A8P2_R1	B14A7A8P2_R2				10-110964515-G-A	-	0.70599	0.982	53	.	.	.	10	112724273	A	.	.	10	1_Pathogenic	NC_000010.11	.	Gly53Arg	.	25.5	.	.	.	D	.	1	.	.	.	.	.	.	.	0.79415	.	0.8012	.	0.62839	.	.	T	D	.	.	.	.	.	.	.	0.93229	.	.	.	.	0.20730	.	.	0.52593	0.998	.	.	.	.	.	A	single nucleotide variant	NC_000010.11:g.110964515G>A	.	.	2	0.27641422	.	.	0.30022958	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701	.	.	.	.	0.88440	P	0.53380	D	L	7.305809	.	G/G	.	.	.	.	Noonan syndrome-like disorder with loose anagen hair 1	.	0.91770	.	.	-	110964515	.	-	9.913000	.	0.63863	.	.	.	.	de novo	.	Gain of MoRF binding (P = 0.0334)| Loss of ubiquitination at K55 (P = 0.0365)| Gain of methylation at K54 (P = 0.0787)| Gain of loop (P = 0.1069)| Loss of glycosylation at K54 (P = 0.1528)	0.11319	GRCh38	915	criteria provided, single submitter	.	.	0.97294	.	.	.	.	.	.	.	.	.	NM_007373.4(SHOC2):c.157G>A (p.Gly53Arg)	1	.	SHOC2_HUMAN	.	.	0.713091895322115	.	.	0.64318	0.30022958	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.70447	.	.	.	.	.	.	.	0.82471	.	germline	.		G	Jan 05, 2022	.	G/G	.	.	1.0	N	10q25.2	.	.	.	SCV002073494	Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000509754	ENST00000691369	.	.	.	.	0.672	G	.	4.506791	0.24765	D	.	-	9.229115	.	0.74238	.	.	.	0.55306	.	110964515	Y	10	.	.	.	Q9UQ13	.	0.259483	0.86015		.	0.785	D	.	0.27641422	.	0.85369	8036	0.335781	.	.	.	.	0.41793	.	.	.	.	.	.	0.53379	10	SHOC2	.	.	Gly	.	.	10-110964515-G-A	Noonan_syndrome-like_disorder_with_loose_anagen_hair_1	.	.	112714263	.	0.909199	0.80383	.	RCV002272501	.	.	.	c.157G>A	.	.	.	0.85447	G/G	rs2134121169	110964515	.	G	.	Q9UQ13	.	0.52593	.	0.68239		.	.	.	1.445	.	.	.	5.99	0.62867	.	D	D	.	.	.	.	.	.	.	2701	1339314	0.85257	0.67780	0.902562320232391	.	.	0.71675	0.86504	.	.	.	8.002	.	.	.	.	.	.	607721	0.8806	10	.	ENSG00000108061	.	.	.	.	.	1	0.63333	0.20912	.	.	.	.	0.767502526075403	.	.	0.084434	1330365	HGNC:15454	.	.	.	0.389	.	110964515	GGA	1.000000	.	-	.	0.60049	.	.	.	Likely pathogenic	0.38173	.	.	.	ClinGen:CA378381906	G	.	.	-	0.2	-	0.69502	.	.	0.19691	0.874739408493	.	.	0.99772429166242937	.	-	157G>A 	.	.	C4478716	.	.	.	.	NM_007373.4	-	.	.	1	0.60013	2134121169	.	.	0.65811	0.87388	.	.	.	0.15046370	5.99	.	.	.	0.24455	0.970648187277183	0.36203	D	.	.	.	0.5925	0.93256	p.Gly53Arg	.	.	-5.121	.	.	0.83393	1339314	T	.	SHOC2	.	D	.	.	G53R	.	.	0.70176	G/G	principal1																																																																																																				
F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Gly	23	139541127	A	G	X											X-139541127-A-G	-	0.75387	0.929	110	.	.	.	X	138623286	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Gly	.	26.3	.	1	.	D	.	1	1	.	.	.	.	.	0	0.98039	Select	0.9883	.	0.51703	.	.	D	D	.	3.4416008843	3.7821482602118004E-4	.	.	.	.	0.53261	.	.	.	.	0.88932	.	.	0.96828	0.979	.	6.0	0.946205	5.16	0.94	G	single nucleotide variant	NC_000023.11:g.139541127A>G	.	.	1	0.9480847	.	0	0.96431756	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.94378	P	0.99012	P	M	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97025	.	.	-	139541127	.	-	11.105000	.	0.97790	.	0	.	.	germline	.	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.98863	GRCh38	924	no assertion criteria provided	c.329A>G	.	0.92402	1	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	P	0	.	NM_000133.4(F9):c.329A>G (p.Asp110Gly)		.	FA9_HUMAN	.	94.0	.	.	D	0.73028	0.9560345	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp110Gly	.	0.86221	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031557	Pathogenic	.	.	Gly	G	-	.	ENSP00000218099	ENST00000218099	.	0.034	.	.	0.756	A	.	4.697825	0.55281	.	D	-	.	.	0.99615	610	.	.	0.84682	0	139541127	Y	10	0	.	.	P00740	.	0.959561	0.89981		.	0.905	D	.	0.9610434	.	0.57726	2158	0.665778	.	-5.91	.	.	0.44188	.	.	.	.	.	.	0.98257	X	F9	.	0	Asp	11340	.	X-139541127-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138450952	ClinGen:CA255331|OMIM:300746.0023	.	.	.	RCV000011326	D	.	.	c.329A>G	.	.	.	0.99899	A/A	rs137852234	139541127	.	A	.	P00740	.	0.97674	.	0.68239		.	.	.	2.635	0	0	.	5.81	0.99466	142	D	T	.	.	0	24	.	.	.	98879	10580	0.99898	0.99720	0.993830382823944	2728	.	0.71675	.	.	.	.	8.369	.	D	.	.	.	0	306900	0.90039	X	.	ENSG00000101981	.	0	.	0	0.9935189380505333	2	0.64254	0.18019	.	.	.	.	.	YES	.	0.945041	25619	HGNC:3551	A	.	simple_aae	0.951	.	139541127	GAT	1.000000	.	-	3.6656891495601173E-4	0.99786	.	1	.	Pathogenic	0.76039	.	.	.	ClinGen:CA255331,OMIM:300746.0023	D	.	0.999829378711	-	0.929	-	0.74808	.	574	0.99346	0.602996945381	0.703	.	0.99816010581735481	100	-	329A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79408	137852234	.	8.818342151675486E-5	0.99982	.	0.75	0.028	2644	0.99999225	5.81	.	.	.	0.718567	0.997306026786761	0.76933	D	118	.	.	0.9907	0.99662	p.Asp110Gly	0	.	-10.347	0.99250877	.	0.92990	10580	D	.	F9	.	D	0.922	.	D110G	D	0.91535	0.943	A/A	principal1	185013	F9_Popp_2025_heavy_chain_var232669	No											D		329	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Asp110Gly		true	c.329A>G						3551.0	139541127.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Asp110Gly						G	Apr 01, 1989					missense_variant		110.0				1.196362795		Pathogenic	139541127.0	missense_variant		0.922					Reporter			F9_Asp110Gly
F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Gly	23	139541127	A	G	X											X-139541127-A-G	-	0.75387	0.929	110	.	.	.	X	138623286	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Gly	.	26.3	.	1	.	D	.	1	1	.	.	.	.	.	0	0.98039	Select	0.9883	.	0.51703	.	.	D	D	.	3.4416008843	3.7821482602118004E-4	.	.	.	.	0.53261	.	.	.	.	0.88932	.	.	0.96828	0.979	.	6.0	0.946205	5.16	0.94	G	single nucleotide variant	NC_000023.11:g.139541127A>G	.	.	1	0.9480847	.	0	0.96431756	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.94378	P	0.99012	P	M	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97025	.	.	-	139541127	.	-	11.105000	.	0.97790	.	0	.	.	germline	.	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.98863	GRCh38	924	no assertion criteria provided	c.329A>G	.	0.92402	1	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	P	0	.	NM_000133.4(F9):c.329A>G (p.Asp110Gly)		.	FA9_HUMAN	.	94.0	.	.	D	0.73028	0.9560345	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp110Gly	.	0.86221	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031557	Pathogenic	.	.	Gly	G	-	.	ENSP00000218099	ENST00000218099	.	0.034	.	.	0.756	A	.	4.697825	0.55281	.	D	-	.	.	0.99615	610	.	.	0.84682	0	139541127	Y	10	0	.	.	P00740	.	0.959561	0.89981		.	0.905	D	.	0.9610434	.	0.57726	2158	0.665778	.	-5.91	.	.	0.44188	.	.	.	.	.	.	0.98257	X	F9	.	0	Asp	11340	.	X-139541127-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138450952	ClinGen:CA255331|OMIM:300746.0023	.	.	.	RCV000011326	D	.	.	c.329A>G	.	.	.	0.99899	A/A	rs137852234	139541127	.	A	.	P00740	.	0.97674	.	0.68239		.	.	.	2.635	0	0	.	5.81	0.99466	142	D	T	.	.	0	24	.	.	.	98879	10580	0.99898	0.99720	0.993830382823944	2728	.	0.71675	.	.	.	.	8.369	.	D	.	.	.	0	306900	0.90039	X	.	ENSG00000101981	.	0	.	0	0.9935189380505333	2	0.64254	0.18019	.	.	.	.	.	YES	.	0.945041	25619	HGNC:3551	A	.	simple_aae	0.951	.	139541127	GAT	1.000000	.	-	3.6656891495601173E-4	0.99786	.	1	.	Pathogenic	0.76039	.	.	.	ClinGen:CA255331,OMIM:300746.0023	D	.	0.999829378711	-	0.929	-	0.74808	.	574	0.99346	0.602996945381	0.703	.	0.99816010581735481	100	-	329A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79408	137852234	.	8.818342151675486E-5	0.99982	.	0.75	0.028	2644	0.99999225	5.81	.	.	.	0.718567	0.997306026786761	0.76933	D	118	.	.	0.9907	0.99662	p.Asp110Gly	0	.	-10.347	0.99250877	.	0.92990	10580	D	.	F9	.	D	0.922	.	D110G	D	0.91535	0.943	A/A	principal1	129981	F9_Popp_2025_carboxy_F9_specific_var222988	No											D		329	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Asp110Gly		true	c.329A>G						3551.0	139541127.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Asp110Gly						G	Apr 01, 1989					missense_variant		110.0				1.0137861421952827		Pathogenic	139541127.0	missense_variant		0.922					Reporter			F9_Asp110Gly
F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Gly	23	139541127	A	G	X											X-139541127-A-G	-	0.75387	0.929	110	.	.	.	X	138623286	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Gly	.	26.3	.	1	.	D	.	1	1	.	.	.	.	.	0	0.98039	Select	0.9883	.	0.51703	.	.	D	D	.	3.4416008843	3.7821482602118004E-4	.	.	.	.	0.53261	.	.	.	.	0.88932	.	.	0.96828	0.979	.	6.0	0.946205	5.16	0.94	G	single nucleotide variant	NC_000023.11:g.139541127A>G	.	.	1	0.9480847	.	0	0.96431756	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.94378	P	0.99012	P	M	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97025	.	.	-	139541127	.	-	11.105000	.	0.97790	.	0	.	.	germline	.	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.98863	GRCh38	924	no assertion criteria provided	c.329A>G	.	0.92402	1	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	P	0	.	NM_000133.4(F9):c.329A>G (p.Asp110Gly)		.	FA9_HUMAN	.	94.0	.	.	D	0.73028	0.9560345	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp110Gly	.	0.86221	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031557	Pathogenic	.	.	Gly	G	-	.	ENSP00000218099	ENST00000218099	.	0.034	.	.	0.756	A	.	4.697825	0.55281	.	D	-	.	.	0.99615	610	.	.	0.84682	0	139541127	Y	10	0	.	.	P00740	.	0.959561	0.89981		.	0.905	D	.	0.9610434	.	0.57726	2158	0.665778	.	-5.91	.	.	0.44188	.	.	.	.	.	.	0.98257	X	F9	.	0	Asp	11340	.	X-139541127-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138450952	ClinGen:CA255331|OMIM:300746.0023	.	.	.	RCV000011326	D	.	.	c.329A>G	.	.	.	0.99899	A/A	rs137852234	139541127	.	A	.	P00740	.	0.97674	.	0.68239		.	.	.	2.635	0	0	.	5.81	0.99466	142	D	T	.	.	0	24	.	.	.	98879	10580	0.99898	0.99720	0.993830382823944	2728	.	0.71675	.	.	.	.	8.369	.	D	.	.	.	0	306900	0.90039	X	.	ENSG00000101981	.	0	.	0	0.9935189380505333	2	0.64254	0.18019	.	.	.	.	.	YES	.	0.945041	25619	HGNC:3551	A	.	simple_aae	0.951	.	139541127	GAT	1.000000	.	-	3.6656891495601173E-4	0.99786	.	1	.	Pathogenic	0.76039	.	.	.	ClinGen:CA255331,OMIM:300746.0023	D	.	0.999829378711	-	0.929	-	0.74808	.	574	0.99346	0.602996945381	0.703	.	0.99816010581735481	100	-	329A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79408	137852234	.	8.818342151675486E-5	0.99982	.	0.75	0.028	2644	0.99999225	5.81	.	.	.	0.718567	0.997306026786761	0.76933	D	118	.	.	0.9907	0.99662	p.Asp110Gly	0	.	-10.347	0.99250877	.	0.92990	10580	D	.	F9	.	D	0.922	.	D110G	D	0.91535	0.943	A/A	principal1	240045	F9_Popp_2025_strep_2_var261712	No											D		329	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Asp110Gly		true	c.329A>G						3551.0	139541127.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Asp110Gly						G	Apr 01, 1989					missense_variant		110.0				1.35640675873924		Pathogenic	139541127.0	missense_variant		0.922					Reporter			F9_Asp110Gly
F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Gly	23	139541127	A	G	X											X-139541127-A-G	-	0.75387	0.929	110	.	.	.	X	138623286	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Gly	.	26.3	.	1	.	D	.	1	1	.	.	.	.	.	0	0.98039	Select	0.9883	.	0.51703	.	.	D	D	.	3.4416008843	3.7821482602118004E-4	.	.	.	.	0.53261	.	.	.	.	0.88932	.	.	0.96828	0.979	.	6.0	0.946205	5.16	0.94	G	single nucleotide variant	NC_000023.11:g.139541127A>G	.	.	1	0.9480847	.	0	0.96431756	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.94378	P	0.99012	P	M	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97025	.	.	-	139541127	.	-	11.105000	.	0.97790	.	0	.	.	germline	.	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.98863	GRCh38	924	no assertion criteria provided	c.329A>G	.	0.92402	1	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	P	0	.	NM_000133.4(F9):c.329A>G (p.Asp110Gly)		.	FA9_HUMAN	.	94.0	.	.	D	0.73028	0.9560345	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp110Gly	.	0.86221	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031557	Pathogenic	.	.	Gly	G	-	.	ENSP00000218099	ENST00000218099	.	0.034	.	.	0.756	A	.	4.697825	0.55281	.	D	-	.	.	0.99615	610	.	.	0.84682	0	139541127	Y	10	0	.	.	P00740	.	0.959561	0.89981		.	0.905	D	.	0.9610434	.	0.57726	2158	0.665778	.	-5.91	.	.	0.44188	.	.	.	.	.	.	0.98257	X	F9	.	0	Asp	11340	.	X-139541127-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138450952	ClinGen:CA255331|OMIM:300746.0023	.	.	.	RCV000011326	D	.	.	c.329A>G	.	.	.	0.99899	A/A	rs137852234	139541127	.	A	.	P00740	.	0.97674	.	0.68239		.	.	.	2.635	0	0	.	5.81	0.99466	142	D	T	.	.	0	24	.	.	.	98879	10580	0.99898	0.99720	0.993830382823944	2728	.	0.71675	.	.	.	.	8.369	.	D	.	.	.	0	306900	0.90039	X	.	ENSG00000101981	.	0	.	0	0.9935189380505333	2	0.64254	0.18019	.	.	.	.	.	YES	.	0.945041	25619	HGNC:3551	A	.	simple_aae	0.951	.	139541127	GAT	1.000000	.	-	3.6656891495601173E-4	0.99786	.	1	.	Pathogenic	0.76039	.	.	.	ClinGen:CA255331,OMIM:300746.0023	D	.	0.999829378711	-	0.929	-	0.74808	.	574	0.99346	0.602996945381	0.703	.	0.99816010581735481	100	-	329A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79408	137852234	.	8.818342151675486E-5	0.99982	.	0.75	0.028	2644	0.99999225	5.81	.	.	.	0.718567	0.997306026786761	0.76933	D	118	.	.	0.9907	0.99662	p.Asp110Gly	0	.	-10.347	0.99250877	.	0.92990	10580	D	.	F9	.	D	0.922	.	D110G	D	0.91535	0.943	A/A	principal1	212529	F9_Popp_2025_light_chain_var242350	No											D		329	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Asp110Gly		true	c.329A>G						3551.0	139541127.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Asp110Gly						G	Apr 01, 1989					missense_variant		110.0				1.0519859626998802		Pathogenic	139541127.0	missense_variant		0.922					Reporter			F9_Asp110Gly
F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	NC_000023.11:139541127:A:G	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Gly	23	139541127	A	G	X											X-139541127-A-G	-	0.75387	0.929	110	.	.	.	X	138623286	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Gly	.	26.3	.	1	.	D	.	1	1	.	.	.	.	.	0	0.98039	Select	0.9883	.	0.51703	.	.	D	D	.	3.4416008843	3.7821482602118004E-4	.	.	.	.	0.53261	.	.	.	.	0.88932	.	.	0.96828	0.979	.	6.0	0.946205	5.16	0.94	G	single nucleotide variant	NC_000023.11:g.139541127A>G	.	.	1	0.9480847	.	0	0.96431756	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.94378	P	0.99012	P	M	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97025	.	.	-	139541127	.	-	11.105000	.	0.97790	.	0	.	.	germline	.	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.98863	GRCh38	924	no assertion criteria provided	c.329A>G	.	0.92402	1	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	P	0	.	NM_000133.4(F9):c.329A>G (p.Asp110Gly)		.	FA9_HUMAN	.	94.0	.	.	D	0.73028	0.9560345	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp110Gly	.	0.86221	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031557	Pathogenic	.	.	Gly	G	-	.	ENSP00000218099	ENST00000218099	.	0.034	.	.	0.756	A	.	4.697825	0.55281	.	D	-	.	.	0.99615	610	.	.	0.84682	0	139541127	Y	10	0	.	.	P00740	.	0.959561	0.89981		.	0.905	D	.	0.9610434	.	0.57726	2158	0.665778	.	-5.91	.	.	0.44188	.	.	.	.	.	.	0.98257	X	F9	.	0	Asp	11340	.	X-139541127-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138450952	ClinGen:CA255331|OMIM:300746.0023	.	.	.	RCV000011326	D	.	.	c.329A>G	.	.	.	0.99899	A/A	rs137852234	139541127	.	A	.	P00740	.	0.97674	.	0.68239		.	.	.	2.635	0	0	.	5.81	0.99466	142	D	T	.	.	0	24	.	.	.	98879	10580	0.99898	0.99720	0.993830382823944	2728	.	0.71675	.	.	.	.	8.369	.	D	.	.	.	0	306900	0.90039	X	.	ENSG00000101981	.	0	.	0	0.9935189380505333	2	0.64254	0.18019	.	.	.	.	.	YES	.	0.945041	25619	HGNC:3551	A	.	simple_aae	0.951	.	139541127	GAT	1.000000	.	-	3.6656891495601173E-4	0.99786	.	1	.	Pathogenic	0.76039	.	.	.	ClinGen:CA255331,OMIM:300746.0023	D	.	0.999829378711	-	0.929	-	0.74808	.	574	0.99346	0.602996945381	0.703	.	0.99816010581735481	100	-	329A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79408	137852234	.	8.818342151675486E-5	0.99982	.	0.75	0.028	2644	0.99999225	5.81	.	.	.	0.718567	0.997306026786761	0.76933	D	118	.	.	0.9907	0.99662	p.Asp110Gly	0	.	-10.347	0.99250877	.	0.92990	10580	D	.	F9	.	D	0.922	.	D110G	D	0.91535	0.943	A/A	principal1	157497	F9_Popp_2025_carboxy_gla_motif_var252031	No											D		329	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Asp110Gly		true	c.329A>G						3551.0	139541127.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Asp110Gly						G	Apr 01, 1989					missense_variant		110.0				0.6820084491046996		Pathogenic	139541127.0	missense_variant		0.922					Reporter			F9_Asp110Gly
F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004377		NC_000023.11:139541127:A:G		Asp110Gly																												F9_Asp110Gly	23	139541127	A	G	X	allele	329A>G	A07	527_CAVA_Array_P02	A14	B13A7A8P1_R1	B14A7A8P1_R2				X-139541127-A-G	-	0.75387	0.929	110	.	.	.	X	138623286	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Gly	.	26.3	.	1	.	D	.	1	1	.	.	.	.	.	0	0.98039	Select	0.9883	.	0.51703	.	.	D	D	.	3.4416008843	3.7821482602118004E-4	.	.	.	.	0.53261	.	.	.	.	0.88932	.	.	0.96828	0.979	.	6.0	0.946205	5.16	0.94	G	single nucleotide variant	NC_000023.11:g.139541127A>G	.	.	1	0.9480847	.	0	0.96431756	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.94378	P	0.99012	P	M	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97025	.	.	-	139541127	.	-	11.105000	.	0.97790	.	0	.	.	germline	.	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.98863	GRCh38	924	no assertion criteria provided	c.329A>G	.	0.92402	1	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	P	0	.	NM_000133.4(F9):c.329A>G (p.Asp110Gly)		.	FA9_HUMAN	.	94.0	.	.	D	0.73028	0.9560345	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp110Gly	.	0.86221	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031557	Pathogenic	.	.	Gly	G	-	.	ENSP00000218099	ENST00000218099	.	0.034	.	.	0.756	A	.	4.697825	0.55281	.	D	-	.	.	0.99615	610	.	.	0.84682	0	139541127	Y	10	0	.	.	P00740	.	0.959561	0.89981		.	0.905	D	.	0.9610434	.	0.57726	2158	0.665778	.	-5.91	.	.	0.44188	.	.	.	.	.	.	0.98257	X	F9	.	0	Asp	11340	.	X-139541127-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138450952	ClinGen:CA255331|OMIM:300746.0023	.	.	.	RCV000011326	D	.	.	c.329A>G	.	.	.	0.99899	A/A	rs137852234	139541127	.	A	.	P00740	.	0.97674	.	0.68239		.	.	.	2.635	0	0	.	5.81	0.99466	142	D	T	.	.	0	24	.	.	.	98879	10580	0.99898	0.99720	0.993830382823944	2728	.	0.71675	.	.	.	.	8.369	.	D	.	.	.	0	306900	0.90039	X	.	ENSG00000101981	.	0	.	0	0.9935189380505333	2	0.64254	0.18019	.	.	.	.	.	YES	.	0.945041	25619	HGNC:3551	A	.	simple_aae	0.951	.	139541127	GAT	1.000000	.	-	3.6656891495601173E-4	0.99786	.	1	.	Pathogenic	0.76039	.	.	.	ClinGen:CA255331,OMIM:300746.0023	D	.	0.999829378711	-	0.929	-	0.74808	.	574	0.99346	0.602996945381	0.703	.	0.99816010581735481	100	-	329A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79408	137852234	.	8.818342151675486E-5	0.99982	.	0.75	0.028	2644	0.99999225	5.81	.	.	.	0.718567	0.997306026786761	0.76933	D	118	.	.	0.9907	0.99662	p.Asp110Gly	0	.	-10.347	0.99250877	.	0.92990	10580	D	.	F9	.	D	0.922	.	D110G	D	0.91535	0.943	A/A	principal1	185013	F9_Popp_2025_heavy_chain_var232669	No											D		329	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Asp110Gly		true	c.329A>G						3551.0	139541127.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Asp110Gly						G	Apr 01, 1989					missense_variant		110.0				1.196362795		Pathogenic	139541127.0	missense_variant		0.922					Reporter			F9_Asp110Gly
F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004377		NC_000023.11:139541127:A:G		Asp110Gly																												F9_Asp110Gly	23	139541127	A	G	X	allele	329A>G	A07	527_CAVA_Array_P02	A14	B13A7A8P1_R1	B14A7A8P1_R2				X-139541127-A-G	-	0.75387	0.929	110	.	.	.	X	138623286	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Gly	.	26.3	.	1	.	D	.	1	1	.	.	.	.	.	0	0.98039	Select	0.9883	.	0.51703	.	.	D	D	.	3.4416008843	3.7821482602118004E-4	.	.	.	.	0.53261	.	.	.	.	0.88932	.	.	0.96828	0.979	.	6.0	0.946205	5.16	0.94	G	single nucleotide variant	NC_000023.11:g.139541127A>G	.	.	1	0.9480847	.	0	0.96431756	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.94378	P	0.99012	P	M	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97025	.	.	-	139541127	.	-	11.105000	.	0.97790	.	0	.	.	germline	.	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.98863	GRCh38	924	no assertion criteria provided	c.329A>G	.	0.92402	1	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	P	0	.	NM_000133.4(F9):c.329A>G (p.Asp110Gly)		.	FA9_HUMAN	.	94.0	.	.	D	0.73028	0.9560345	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp110Gly	.	0.86221	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031557	Pathogenic	.	.	Gly	G	-	.	ENSP00000218099	ENST00000218099	.	0.034	.	.	0.756	A	.	4.697825	0.55281	.	D	-	.	.	0.99615	610	.	.	0.84682	0	139541127	Y	10	0	.	.	P00740	.	0.959561	0.89981		.	0.905	D	.	0.9610434	.	0.57726	2158	0.665778	.	-5.91	.	.	0.44188	.	.	.	.	.	.	0.98257	X	F9	.	0	Asp	11340	.	X-139541127-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138450952	ClinGen:CA255331|OMIM:300746.0023	.	.	.	RCV000011326	D	.	.	c.329A>G	.	.	.	0.99899	A/A	rs137852234	139541127	.	A	.	P00740	.	0.97674	.	0.68239		.	.	.	2.635	0	0	.	5.81	0.99466	142	D	T	.	.	0	24	.	.	.	98879	10580	0.99898	0.99720	0.993830382823944	2728	.	0.71675	.	.	.	.	8.369	.	D	.	.	.	0	306900	0.90039	X	.	ENSG00000101981	.	0	.	0	0.9935189380505333	2	0.64254	0.18019	.	.	.	.	.	YES	.	0.945041	25619	HGNC:3551	A	.	simple_aae	0.951	.	139541127	GAT	1.000000	.	-	3.6656891495601173E-4	0.99786	.	1	.	Pathogenic	0.76039	.	.	.	ClinGen:CA255331,OMIM:300746.0023	D	.	0.999829378711	-	0.929	-	0.74808	.	574	0.99346	0.602996945381	0.703	.	0.99816010581735481	100	-	329A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79408	137852234	.	8.818342151675486E-5	0.99982	.	0.75	0.028	2644	0.99999225	5.81	.	.	.	0.718567	0.997306026786761	0.76933	D	118	.	.	0.9907	0.99662	p.Asp110Gly	0	.	-10.347	0.99250877	.	0.92990	10580	D	.	F9	.	D	0.922	.	D110G	D	0.91535	0.943	A/A	principal1	129981	F9_Popp_2025_carboxy_F9_specific_var222988	No											D		329	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Asp110Gly		true	c.329A>G						3551.0	139541127.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Asp110Gly						G	Apr 01, 1989					missense_variant		110.0				1.0137861421952827		Pathogenic	139541127.0	missense_variant		0.922					Reporter			F9_Asp110Gly
F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004377		NC_000023.11:139541127:A:G		Asp110Gly																												F9_Asp110Gly	23	139541127	A	G	X	allele	329A>G	A07	527_CAVA_Array_P02	A14	B13A7A8P1_R1	B14A7A8P1_R2				X-139541127-A-G	-	0.75387	0.929	110	.	.	.	X	138623286	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Gly	.	26.3	.	1	.	D	.	1	1	.	.	.	.	.	0	0.98039	Select	0.9883	.	0.51703	.	.	D	D	.	3.4416008843	3.7821482602118004E-4	.	.	.	.	0.53261	.	.	.	.	0.88932	.	.	0.96828	0.979	.	6.0	0.946205	5.16	0.94	G	single nucleotide variant	NC_000023.11:g.139541127A>G	.	.	1	0.9480847	.	0	0.96431756	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.94378	P	0.99012	P	M	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97025	.	.	-	139541127	.	-	11.105000	.	0.97790	.	0	.	.	germline	.	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.98863	GRCh38	924	no assertion criteria provided	c.329A>G	.	0.92402	1	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	P	0	.	NM_000133.4(F9):c.329A>G (p.Asp110Gly)		.	FA9_HUMAN	.	94.0	.	.	D	0.73028	0.9560345	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp110Gly	.	0.86221	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031557	Pathogenic	.	.	Gly	G	-	.	ENSP00000218099	ENST00000218099	.	0.034	.	.	0.756	A	.	4.697825	0.55281	.	D	-	.	.	0.99615	610	.	.	0.84682	0	139541127	Y	10	0	.	.	P00740	.	0.959561	0.89981		.	0.905	D	.	0.9610434	.	0.57726	2158	0.665778	.	-5.91	.	.	0.44188	.	.	.	.	.	.	0.98257	X	F9	.	0	Asp	11340	.	X-139541127-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138450952	ClinGen:CA255331|OMIM:300746.0023	.	.	.	RCV000011326	D	.	.	c.329A>G	.	.	.	0.99899	A/A	rs137852234	139541127	.	A	.	P00740	.	0.97674	.	0.68239		.	.	.	2.635	0	0	.	5.81	0.99466	142	D	T	.	.	0	24	.	.	.	98879	10580	0.99898	0.99720	0.993830382823944	2728	.	0.71675	.	.	.	.	8.369	.	D	.	.	.	0	306900	0.90039	X	.	ENSG00000101981	.	0	.	0	0.9935189380505333	2	0.64254	0.18019	.	.	.	.	.	YES	.	0.945041	25619	HGNC:3551	A	.	simple_aae	0.951	.	139541127	GAT	1.000000	.	-	3.6656891495601173E-4	0.99786	.	1	.	Pathogenic	0.76039	.	.	.	ClinGen:CA255331,OMIM:300746.0023	D	.	0.999829378711	-	0.929	-	0.74808	.	574	0.99346	0.602996945381	0.703	.	0.99816010581735481	100	-	329A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79408	137852234	.	8.818342151675486E-5	0.99982	.	0.75	0.028	2644	0.99999225	5.81	.	.	.	0.718567	0.997306026786761	0.76933	D	118	.	.	0.9907	0.99662	p.Asp110Gly	0	.	-10.347	0.99250877	.	0.92990	10580	D	.	F9	.	D	0.922	.	D110G	D	0.91535	0.943	A/A	principal1	240045	F9_Popp_2025_strep_2_var261712	No											D		329	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Asp110Gly		true	c.329A>G						3551.0	139541127.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Asp110Gly						G	Apr 01, 1989					missense_variant		110.0				1.35640675873924		Pathogenic	139541127.0	missense_variant		0.922					Reporter			F9_Asp110Gly
F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004377		NC_000023.11:139541127:A:G		Asp110Gly																												F9_Asp110Gly	23	139541127	A	G	X	allele	329A>G	A07	527_CAVA_Array_P02	A14	B13A7A8P1_R1	B14A7A8P1_R2				X-139541127-A-G	-	0.75387	0.929	110	.	.	.	X	138623286	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Gly	.	26.3	.	1	.	D	.	1	1	.	.	.	.	.	0	0.98039	Select	0.9883	.	0.51703	.	.	D	D	.	3.4416008843	3.7821482602118004E-4	.	.	.	.	0.53261	.	.	.	.	0.88932	.	.	0.96828	0.979	.	6.0	0.946205	5.16	0.94	G	single nucleotide variant	NC_000023.11:g.139541127A>G	.	.	1	0.9480847	.	0	0.96431756	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.94378	P	0.99012	P	M	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97025	.	.	-	139541127	.	-	11.105000	.	0.97790	.	0	.	.	germline	.	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.98863	GRCh38	924	no assertion criteria provided	c.329A>G	.	0.92402	1	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	P	0	.	NM_000133.4(F9):c.329A>G (p.Asp110Gly)		.	FA9_HUMAN	.	94.0	.	.	D	0.73028	0.9560345	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp110Gly	.	0.86221	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031557	Pathogenic	.	.	Gly	G	-	.	ENSP00000218099	ENST00000218099	.	0.034	.	.	0.756	A	.	4.697825	0.55281	.	D	-	.	.	0.99615	610	.	.	0.84682	0	139541127	Y	10	0	.	.	P00740	.	0.959561	0.89981		.	0.905	D	.	0.9610434	.	0.57726	2158	0.665778	.	-5.91	.	.	0.44188	.	.	.	.	.	.	0.98257	X	F9	.	0	Asp	11340	.	X-139541127-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138450952	ClinGen:CA255331|OMIM:300746.0023	.	.	.	RCV000011326	D	.	.	c.329A>G	.	.	.	0.99899	A/A	rs137852234	139541127	.	A	.	P00740	.	0.97674	.	0.68239		.	.	.	2.635	0	0	.	5.81	0.99466	142	D	T	.	.	0	24	.	.	.	98879	10580	0.99898	0.99720	0.993830382823944	2728	.	0.71675	.	.	.	.	8.369	.	D	.	.	.	0	306900	0.90039	X	.	ENSG00000101981	.	0	.	0	0.9935189380505333	2	0.64254	0.18019	.	.	.	.	.	YES	.	0.945041	25619	HGNC:3551	A	.	simple_aae	0.951	.	139541127	GAT	1.000000	.	-	3.6656891495601173E-4	0.99786	.	1	.	Pathogenic	0.76039	.	.	.	ClinGen:CA255331,OMIM:300746.0023	D	.	0.999829378711	-	0.929	-	0.74808	.	574	0.99346	0.602996945381	0.703	.	0.99816010581735481	100	-	329A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79408	137852234	.	8.818342151675486E-5	0.99982	.	0.75	0.028	2644	0.99999225	5.81	.	.	.	0.718567	0.997306026786761	0.76933	D	118	.	.	0.9907	0.99662	p.Asp110Gly	0	.	-10.347	0.99250877	.	0.92990	10580	D	.	F9	.	D	0.922	.	D110G	D	0.91535	0.943	A/A	principal1	212529	F9_Popp_2025_light_chain_var242350	No											D		329	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Asp110Gly		true	c.329A>G						3551.0	139541127.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Asp110Gly						G	Apr 01, 1989					missense_variant		110.0				1.0519859626998802		Pathogenic	139541127.0	missense_variant		0.922					Reporter			F9_Asp110Gly
F9_Asp110Gly	-4.032269083219418	0.00498144213801118	3.4617750461748127	0.010522263831025634	2025_01_Batch_13-14	0.8686866330475287	0.8682703369041973	0.8697860864383293	0.9321126801043825	0.5143195256126359	0.8735341040387579	0.78482849321605	0.8306145051422102	0.924511179285112	0.7183294601493571	0.8711103685431433	0.8265494150601236	0.8502002957902698	0.9283119296947473	0.6163244928809966	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004377		NC_000023.11:139541127:A:G		Asp110Gly																												F9_Asp110Gly	23	139541127	A	G	X	allele	329A>G	A07	527_CAVA_Array_P02	A14	B13A7A8P1_R1	B14A7A8P1_R2				X-139541127-A-G	-	0.75387	0.929	110	.	.	.	X	138623286	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Gly	.	26.3	.	1	.	D	.	1	1	.	.	.	.	.	0	0.98039	Select	0.9883	.	0.51703	.	.	D	D	.	3.4416008843	3.7821482602118004E-4	.	.	.	.	0.53261	.	.	.	.	0.88932	.	.	0.96828	0.979	.	6.0	0.946205	5.16	0.94	G	single nucleotide variant	NC_000023.11:g.139541127A>G	.	.	1	0.9480847	.	0	0.96431756	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.94378	P	0.99012	P	M	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97025	.	.	-	139541127	.	-	11.105000	.	0.97790	.	0	.	.	germline	.	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.98863	GRCh38	924	no assertion criteria provided	c.329A>G	.	0.92402	1	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	P	0	.	NM_000133.4(F9):c.329A>G (p.Asp110Gly)		.	FA9_HUMAN	.	94.0	.	.	D	0.73028	0.9560345	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp110Gly	.	0.86221	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031557	Pathogenic	.	.	Gly	G	-	.	ENSP00000218099	ENST00000218099	.	0.034	.	.	0.756	A	.	4.697825	0.55281	.	D	-	.	.	0.99615	610	.	.	0.84682	0	139541127	Y	10	0	.	.	P00740	.	0.959561	0.89981		.	0.905	D	.	0.9610434	.	0.57726	2158	0.665778	.	-5.91	.	.	0.44188	.	.	.	.	.	.	0.98257	X	F9	.	0	Asp	11340	.	X-139541127-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138450952	ClinGen:CA255331|OMIM:300746.0023	.	.	.	RCV000011326	D	.	.	c.329A>G	.	.	.	0.99899	A/A	rs137852234	139541127	.	A	.	P00740	.	0.97674	.	0.68239		.	.	.	2.635	0	0	.	5.81	0.99466	142	D	T	.	.	0	24	.	.	.	98879	10580	0.99898	0.99720	0.993830382823944	2728	.	0.71675	.	.	.	.	8.369	.	D	.	.	.	0	306900	0.90039	X	.	ENSG00000101981	.	0	.	0	0.9935189380505333	2	0.64254	0.18019	.	.	.	.	.	YES	.	0.945041	25619	HGNC:3551	A	.	simple_aae	0.951	.	139541127	GAT	1.000000	.	-	3.6656891495601173E-4	0.99786	.	1	.	Pathogenic	0.76039	.	.	.	ClinGen:CA255331,OMIM:300746.0023	D	.	0.999829378711	-	0.929	-	0.74808	.	574	0.99346	0.602996945381	0.703	.	0.99816010581735481	100	-	329A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79408	137852234	.	8.818342151675486E-5	0.99982	.	0.75	0.028	2644	0.99999225	5.81	.	.	.	0.718567	0.997306026786761	0.76933	D	118	.	.	0.9907	0.99662	p.Asp110Gly	0	.	-10.347	0.99250877	.	0.92990	10580	D	.	F9	.	D	0.922	.	D110G	D	0.91535	0.943	A/A	principal1	157497	F9_Popp_2025_carboxy_gla_motif_var252031	No											D		329	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Asp110Gly		true	c.329A>G						3551.0	139541127.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Asp110Gly						G	Apr 01, 1989					missense_variant		110.0				0.6820084491046996		Pathogenic	139541127.0	missense_variant		0.922					Reporter			F9_Asp110Gly
BRCA1_Glu631Lys	1.0983392108185215	0.30839265196900983	1.9419342156297021	0.09326896956291159	2025_01_Batch_13-14	0.8653114532543542	0.8609513783183007	0.6786680870186188	0.7122638775895174	0.8390927652271518	0.9766476325556213	0.9213786545766204	0.9381547758252562	0.9808460116119835	0.9233140844072092	0.9209795429049877	0.8911650164474605	0.8084114314219375	0.8465549446007504	0.8812034248171805	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218448	CCSBVarC003307	ALE00003307	NC_000017.11:43057126:C:T	1891G>A	Glu631Lys	CEGS2	CegsMutGDEh1026	D09	GDEhDisVCh_40059	A09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Glu631Lys	17	43057126	C	T	17											17-43057126-C-T	-	0.74461	0.904	1735	.	.	.	17	41209143	T	.	.	17	5_Others	NC_000017.11	.	Glu1735Lys	.	26.2	.	.	.	D	.	2	1	.	.	.	.	.	.	0.94374	.	0.9540	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.54504	.	.	.	.	0.66115	.	.	0.85601	1.0	.	.	.	3.31	.	T	single nucleotide variant	NC_000017.11:g.43057126C>T	.	.	3	0.4636008	.	.	0.87069577	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	.	.	.	.	.	B	0.70717	P	H	9.046169	.	C/C	.	.	.	.	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	.	0.99062	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43057126	.	-	7.412000	.	0.96596	.	.	.	.	germline;not applicable	.	.	.	GRCh38	518	no classification provided	.	.	0.68064	.	.	.	BRCT domain	.	.	.	.	.	NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys)		.	BRCA1_HUMAN	.	.	0.813291850711605	.	.	0.86411	0.8283224	-	.	.		.	.	0	.	no_classification_provided	0.99849	.	.	.	.	.	.	.	0.58717	.	germline	.		C	-	.	C/C	.	.	1.0	N	17q21.31	.	.	.	SCV000679293|SCV001237915	not_provided	.	.	Lys	K	-	.	ENSP00000419274	ENST00000470026	.	.	.	.	0.593	C	.	4.661471	0.92967	D	.	-	8.829661	.	0.98236	.	.	.	0.82639	.	43057126	Y	10	.	.	.	P38398	.	0.384042	0.97503		.	0.17	D	.	0.49804372	.	0.97202	672	0.454957	.	.	.	.	0.91343	.	.	.	.	.	.	0.68604	17	BRCA1	.	.	Glu	.	.	17-43057126-C-T	Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38462669	ClinGen:CA003353|UniProtKB:P38398#VAR_070505	0.684509	0.86860	.	RCV000577367|RCV001072517	.	.	.	c.5203G>A	.	.	.	0.92647	C/C	rs397509238	43057126	.	C	.	.	.	0.88763	.	0.68239		.	.	.	3.64	.	.	.	5.07	0.81335	.	D	T	.	.	.	.	.	.	.	227535|145	55455	0.92557	0.10057	0.99232280254364	.	.	0.71675	0.64555	.	.	.	4.681	.	.	.	.	.	.	114480|604370	0.61438	17	.	ENSG00000012048	.	.	.	.	.	1	0.88579	0.74567	.	.	.	.	0.751252984158328	.	.	0.776902	70122	HGNC:1100	.	.	.	0.931	.	43057126	GAA	1.000000	.	-	.	0.91685	.	.	.	not provided	0.93916	.	.	.	ClinGen:CA003353,UniProtKB:P38398#VAR_070505	E	.	.	-	.	-	0.97441	.	.	0.86555	0.611799120903	.	.	0.99903481763990787	.	-	5203G>A 	.	.	C0346153|C2676676	.	.	.	.	NM_007294.4	-	.	.	0	0.97033	397509238	.	.	0.94343	0.86175	.	.	.	0.99988377	5.07	.	.	.	0.415738	0.997865992856704	0.94011	D	.	.	.	1.0854	0.98504	p.Glu1735Lys	.	.	-14.271	.	.	0.93647	55455	D	.	BRCA1	.	D	.	.	.	.	0.60027	0.32293	C/C	principal2																																																																																																				
BRCA1_Glu631Lys	1.0983392108185215	0.30839265196900983	1.9419342156297021	0.09326896956291159	2025_01_Batch_13-14	0.8653114532543542	0.8609513783183007	0.6786680870186188	0.7122638775895174	0.8390927652271518	0.9766476325556213	0.9213786545766204	0.9381547758252562	0.9808460116119835	0.9233140844072092	0.9209795429049877	0.8911650164474605	0.8084114314219375	0.8465549446007504	0.8812034248171805	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003307		NC_000017.11:43057126:C:T		Glu631Lys																												BRCA1_Glu631Lys	17	43057126	C	T	17	allele	1891G>A	H07	527_CAVA_Array_P01	O13	B13A7A8P1_R1	B14A7A8P1_R2				17-43057126-C-T	-	0.74461	0.904	1735	.	.	.	17	41209143	T	.	.	17	5_Others	NC_000017.11	.	Glu1735Lys	.	26.2	.	.	.	D	.	2	1	.	.	.	.	.	.	0.94374	.	0.9540	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.54504	.	.	.	.	0.66115	.	.	0.85601	1.0	.	.	.	3.31	.	T	single nucleotide variant	NC_000017.11:g.43057126C>T	.	.	3	0.4636008	.	.	0.87069577	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	.	.	.	.	.	B	0.70717	P	H	9.046169	.	C/C	.	.	.	.	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	.	0.99062	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43057126	.	-	7.412000	.	0.96596	.	.	.	.	germline;not applicable	.	.	.	GRCh38	518	no classification provided	.	.	0.68064	.	.	.	BRCT domain	.	.	.	.	.	NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys)		.	BRCA1_HUMAN	.	.	0.813291850711605	.	.	0.86411	0.8283224	-	.	.		.	.	0	.	no_classification_provided	0.99849	.	.	.	.	.	.	.	0.58717	.	germline	.		C	-	.	C/C	.	.	1.0	N	17q21.31	.	.	.	SCV000679293|SCV001237915	not_provided	.	.	Lys	K	-	.	ENSP00000419274	ENST00000470026	.	.	.	.	0.593	C	.	4.661471	0.92967	D	.	-	8.829661	.	0.98236	.	.	.	0.82639	.	43057126	Y	10	.	.	.	P38398	.	0.384042	0.97503		.	0.17	D	.	0.49804372	.	0.97202	672	0.454957	.	.	.	.	0.91343	.	.	.	.	.	.	0.68604	17	BRCA1	.	.	Glu	.	.	17-43057126-C-T	Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38462669	ClinGen:CA003353|UniProtKB:P38398#VAR_070505	0.684509	0.86860	.	RCV000577367|RCV001072517	.	.	.	c.5203G>A	.	.	.	0.92647	C/C	rs397509238	43057126	.	C	.	.	.	0.88763	.	0.68239		.	.	.	3.64	.	.	.	5.07	0.81335	.	D	T	.	.	.	.	.	.	.	227535|145	55455	0.92557	0.10057	0.99232280254364	.	.	0.71675	0.64555	.	.	.	4.681	.	.	.	.	.	.	114480|604370	0.61438	17	.	ENSG00000012048	.	.	.	.	.	1	0.88579	0.74567	.	.	.	.	0.751252984158328	.	.	0.776902	70122	HGNC:1100	.	.	.	0.931	.	43057126	GAA	1.000000	.	-	.	0.91685	.	.	.	not provided	0.93916	.	.	.	ClinGen:CA003353,UniProtKB:P38398#VAR_070505	E	.	.	-	.	-	0.97441	.	.	0.86555	0.611799120903	.	.	0.99903481763990787	.	-	5203G>A 	.	.	C0346153|C2676676	.	.	.	.	NM_007294.4	-	.	.	0	0.97033	397509238	.	.	0.94343	0.86175	.	.	.	0.99988377	5.07	.	.	.	0.415738	0.997865992856704	0.94011	D	.	.	.	1.0854	0.98504	p.Glu1735Lys	.	.	-14.271	.	.	0.93647	55455	D	.	BRCA1	.	D	.	.	.	.	0.60027	0.32293	C/C	principal2																																																																																																				
BRCA1_His239Arg	1.417428348829569	0.1992960548370097	3.0457234726586315	0.018695506167409243	2025_01_Batch_13-14	0.9834822561252834	0.9312856180684361	0.9240071908703403	0.9549275984709393	0.9457601553816197	0.9743999370205588	0.915422187205631	0.9399060371844637	0.9666856808301896	0.9119806747411504	0.978941096572921	0.9233539026370335	0.931956614027402	0.9608066396505645	0.9288704150613851	1.0	0.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	BRCA1	BRCA1		14613		CCSBVarC013119		NC_000017.11:43094815:T:C		His239Arg																												BRCA1_His239Arg	17	43094815	T	C	17	allele	716A>G	G11	527_CAVA_Array_P01	M21	B13A7A8P1_R1	B14A7A8P1_R2				17-43094815-T-C	-	0.04582	0.246	239	2	0	0	17	41246832	C	3.098440e-06	0	17	2_Benign	NC_000017.11	5	His239Arg	0	1.25	0	.	1.959170e-05	T	0	10	.	42666	8.497550e-06	.	30416	0.000000e+00	.	0.84105	.	0.1025	102084	0.31119	0	.	T	D	63992	.	.	0	0.000000e+00	0	0	0.07426	16994	44872	0	0.000000e+00	0.47184	1	.	0.04242	0.804	.	.	.	2.57E-4	.	C	single nucleotide variant	NC_000017.11:g.43094815T>C	0	16690	2	0.04520483	109054	.	0.035958365	.		2	235362	0	0	0.000000e+00	.	2.343790e-05	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|	1	0	0.000000e+00	0	0.37131	B	0.06439	B	L	1.040847	5	T/T	.	.	7154	1613714	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|BRCA1-related disorder	15854	0.39179	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43094815	2.343790e-05	-	-0.577000	0	0.17126	29590	.	1179908	0	germline;unknown	91010	Gain of helix (P = 0.0496)| Loss of loop (P = 0.0603)| Gain of phosphorylation at S242 (P = 0.0822)| Gain of catalytic residue at H239 (P = 0.1099)| Loss of glycosylation at S242 (P = 0.135)	0.01473	GRCh38	494	reviewed by expert panel	.	0.000000e+00	0.07559	.	0	0	.	0.000000e+00	9020	.	.	0.000000e+00	NM_007294.4(BRCA1):c.716A>G (p.His239Arg)	3	0	BRCA1_HUMAN	0	.	-0.571032691664479	0	.	0.10254	0.035795223	-	0.000000e+00	.		2	0.000000e+00	0	34032	reviewed_by_expert_panel	0.96756	9.169770e-06	0	0.000000e+00	0	59900	.	0	0.08433	.	germline	1		T	Jun 18, 2019	0	T/T	0	89080	0.004	N	17q21.31	.	.	0.000000e+00	SCV001161506	Benign	0	0	Arg	R	-	912	ENSP00000518978	ENST00000713676	17632	.	13376	0	0.609	T	0	0.040361	0.54888	N	.	-	0.8425785	.	0.75728	.	0	.	0.16733	.	43094815	Y	10	.	102084	0.000000e+00	P38398	0	0.185323	0.12881		0	0.088	D	89080	0.04630083	42666	0.3794	672	0.239413	5	.	.	4.237620e-06	0.32128	0.000000e+00	0	74988	0.000000e+00	6060	0	0.06046	17	BRCA1	0.000000e+00	.	His	.	2.245170e-05	17-43094815-T-C	not_provided|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	0	2	38500358	ClinGen:CA003832|UniProtKB:P38398#VAR_007760	0.152364	0.19588	0	RCV000112775|RCV000212160|RCV000509604|RCV001284302|RCV001339091|RCV004730865	.	0	0	c.716A>G	0	0	0	0.77438	T/T	rs80357396	43094815	14542	T	.	E9PFC7	15632	0.04291	0.000000e+00	0.17376		0	0	0.000000e+00	1.685	.	.	.	-1.76	0.53598	.	T	T	0	0.000000e+00	.	.	.	0	0	145|145|140162	55677	0.78181	0.28222	0.148020625114441	.	.	0.16649	0.27488	0.000000e+00	2.245170e-05	1179908	-0.794	9.671830e-06	.	13374	0	.	.	604370	0.04696	17	0.000000e+00	ENSG00000012048	0.000000e+00	.	0	.	.	2	0.29689	0.76469	30498	.	1.959170e-05	0.000000e+00	-0.739922874726497	.	0.000000e+00	0.091977	70344	HGNC:1100	.	0	.	0.062	206786	43094815	CAT	0.001000	.	-	.	0.21054	4.237620e-06	.	0	Benign	0.13969	0	0	0	ClinGen:CA003832,UniProtKB:P38398#VAR_007760	H	0	.	-	0.1	-	0.46309	2	.	0.23229	0.27954185009	.	0	0.79293829124576731	.	-	716A>G 	2	.	C3661900|CN169374|C0677776|C2676676|C0027672	0	0	0	0	NM_007294.4	-	.	.	0	0.43633	80357396	2310	.	0.84735	0.15702	.	.	.	0.99015945	4.64	.	.	0.000000e+00	0.12161	0.0751285277574732	0.43087	T	.	6190	9544	-0.9591	0.37609	p.His239Arg	.	0	-3.317	.	0	0.40751	55677	T	30300	BRCA1	0.000000e+00	D	.	21568	H239R	.	0.21563	0.47831	T/T	principal2																																																																																																				
SHOC2_Asn527Ser	2.1059774962464166	0.0732220540664537	0.2027614561326523	0.8450890466178025	2025_01_Batch_13-14	0.7940691263031118	0.8460453251256255	0.7756819177936045	0.7627699788022595	0.8104367508868358	0.8093247097913885	0.8177718096284736	0.7630117948880923	0.870882894271203	0.7309035102432322	0.8016969180472502	0.8319085673770495	0.7693468563408484	0.8168264365367313	0.770670130565034	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											
F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	0.8092956455580314	0.7482211894547589	0.8647586304094397	0.8421319766343551	0.6359506216068829	0.8460337062407786	0.7913699564039575	0.751983162581138	0.8371853003467626	0.7947090250643046	0.827664675899405	0.7697955729293582	0.8083708964952888	0.8396586384905589	0.7153298233355938	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G		His282Arg																												F9_His282Arg	23	139561530	A	G	X	allele	845A>G	A10	527_CAVA_Array_P02	A20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561530-A-G	-	0.31233	0.046	282	.	0	.	X	138643689	G	2.739590e-05	.	X	3_Conflicting	NC_000023.11	32	His282Arg	.	18.66	.	0	.	D	0	3	1	.	.	.	.	.	0	0.89469	Select	0.7468	.	0.21889	.	.	D	D	46844	1.73630748658	0	0	.	.	.	0.22147	.	33803	0	.	0.70711	.	.	0.88613	0.629	.	17.0	0.852415	4.79	0.83	G	single nucleotide variant	NC_000023.11:g.139561530A>G	0	.	2	0.81526446	.	0	0.84553546	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.90832	B	0.90237	B	M	.	33	A/A	114	0	.	1204562	Hereditary factor VIII deficiency disease|not provided	.	0.89093	.	.	-	139561530	.	-	9.394000	.	0.87544	21828	0	890491	.	germline;unknown	55876	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.99125	GRCh38	924	criteria provided, conflicting classifications	c.845A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.845A>G (p.His282Arg)	1	.	FA9_HUMAN	.	83.0	.	.	D	0.45138	0.8688038	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99989	.	0	.	.	45620	p.His282Arg	0	0.80629	.	germline	.		A	Feb 14, 2024	.	A/A	.	.	0.856	N	Xq27.1	9690	.	.	SCV000899963|SCV005079373|SCV005413446	Conflicting_classifications_of_pathogenicity	.	.	Arg	R	-	689	ENSP00000218099	ENST00000218099	.	0.601	.	.	0.691	A	.	2.423931	0.17349	.	T	-	.	.	0.97236	610	.	.	0.55065	0	139561530	Y	10	0	.	0.000000e+00	P00740	.	0.866353	0.22143		.	0.113	D	.	0.8327217	.	0.32173	2158	0.370769	32	-3.71	.	3.593520e-05	0.06521	.	.	57696	.	4331	.	0.89097	X	F9	0.000000e+00	0	His	14050	.	X-139561530-A-G	Hereditary_factor_VIII_deficiency_disease|not_provided	0	.	138471355	.	.	.	0	RCV000851898|RCV004588168	D	0	.	c.845A>G	.	0	0	0.88019	A/A	rs753654616	139561530	.	A	.	P00740	.	0.86834	.	0.35501		.	.	0.000000e+00	2.315	0	0	264690	5.42	0.97052	112	D	T	.	.	0	26	.	.	.	98878	627146	0.87868	0.90767	0.900605976581573	2898	.	0.30635	.	.	.	890491	4.839	.	D	.	.	7.5560088E-6	0	134500|306700	0.62586	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9970016739794073	2	0.31692	0.18019	.	2	.	0.000000e+00	.	YES	0.000000e+00	0.669559	615669	HGNC:3551	A	.	simple_aae	0.775	.	139561530	CAT	0.999000	.	-	0	0.94197	3.593520e-05	0	0	Conflicting classifications of pathogenicity	0.50934	.	0	0	ClinGen:CA336143030	H	.	0.999137776672	-	0.938	-	0.78847	.	496	0.99698	0.379394561052	0.1387	0	0.92464920108666138	98	-	845A>G 	.	0	C0019069|C3661900	.	.	.	.	NM_000133.4	-	.	.	1	0.53609	753654616	.	0	0.99911	.	0.405	0.379	2784	0.99998010	5.42	.	.	.	0.294808	0.98658244579304	0.66058	D	86	.	.	0.4026	0.91338	p.His282Arg	0	0	-6.135	0.9492965	0	0.87152	627146	T	.	F9	.	D	0.707	.	H282R	T	0.87757	0.84104	A/A	principal1	140280	F9_Popp_2025_carboxy_F9_specific_var226602	No											H		845	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.His282Arg		true	c.845A>G						3551.0	139561530.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, conflicting classifications				His282Arg						R	Feb 14, 2024					missense_variant		282.0			0.0000273958501098	0.8899825362811451		Conflicting classifications of pathogenicity	139561530.0	missense_variant		0.707					Reporter			F9_His282Arg
F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	0.8092956455580314	0.7482211894547589	0.8647586304094397	0.8421319766343551	0.6359506216068829	0.8460337062407786	0.7913699564039575	0.751983162581138	0.8371853003467626	0.7947090250643046	0.827664675899405	0.7697955729293582	0.8083708964952888	0.8396586384905589	0.7153298233355938	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G		His282Arg																												F9_His282Arg	23	139561530	A	G	X	allele	845A>G	A10	527_CAVA_Array_P02	A20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561530-A-G	-	0.31233	0.046	282	.	0	.	X	138643689	G	2.739590e-05	.	X	3_Conflicting	NC_000023.11	32	His282Arg	.	18.66	.	0	.	D	0	3	1	.	.	.	.	.	0	0.89469	Select	0.7468	.	0.21889	.	.	D	D	46844	1.73630748658	0	0	.	.	.	0.22147	.	33803	0	.	0.70711	.	.	0.88613	0.629	.	17.0	0.852415	4.79	0.83	G	single nucleotide variant	NC_000023.11:g.139561530A>G	0	.	2	0.81526446	.	0	0.84553546	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.90832	B	0.90237	B	M	.	33	A/A	114	0	.	1204562	Hereditary factor VIII deficiency disease|not provided	.	0.89093	.	.	-	139561530	.	-	9.394000	.	0.87544	21828	0	890491	.	germline;unknown	55876	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.99125	GRCh38	924	criteria provided, conflicting classifications	c.845A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.845A>G (p.His282Arg)	1	.	FA9_HUMAN	.	83.0	.	.	D	0.45138	0.8688038	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99989	.	0	.	.	45620	p.His282Arg	0	0.80629	.	germline	.		A	Feb 14, 2024	.	A/A	.	.	0.856	N	Xq27.1	9690	.	.	SCV000899963|SCV005079373|SCV005413446	Conflicting_classifications_of_pathogenicity	.	.	Arg	R	-	689	ENSP00000218099	ENST00000218099	.	0.601	.	.	0.691	A	.	2.423931	0.17349	.	T	-	.	.	0.97236	610	.	.	0.55065	0	139561530	Y	10	0	.	0.000000e+00	P00740	.	0.866353	0.22143		.	0.113	D	.	0.8327217	.	0.32173	2158	0.370769	32	-3.71	.	3.593520e-05	0.06521	.	.	57696	.	4331	.	0.89097	X	F9	0.000000e+00	0	His	14050	.	X-139561530-A-G	Hereditary_factor_VIII_deficiency_disease|not_provided	0	.	138471355	.	.	.	0	RCV000851898|RCV004588168	D	0	.	c.845A>G	.	0	0	0.88019	A/A	rs753654616	139561530	.	A	.	P00740	.	0.86834	.	0.35501		.	.	0.000000e+00	2.315	0	0	264690	5.42	0.97052	112	D	T	.	.	0	26	.	.	.	98878	627146	0.87868	0.90767	0.900605976581573	2898	.	0.30635	.	.	.	890491	4.839	.	D	.	.	7.5560088E-6	0	134500|306700	0.62586	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9970016739794073	2	0.31692	0.18019	.	2	.	0.000000e+00	.	YES	0.000000e+00	0.669559	615669	HGNC:3551	A	.	simple_aae	0.775	.	139561530	CAT	0.999000	.	-	0	0.94197	3.593520e-05	0	0	Conflicting classifications of pathogenicity	0.50934	.	0	0	ClinGen:CA336143030	H	.	0.999137776672	-	0.938	-	0.78847	.	496	0.99698	0.379394561052	0.1387	0	0.92464920108666138	98	-	845A>G 	.	0	C0019069|C3661900	.	.	.	.	NM_000133.4	-	.	.	1	0.53609	753654616	.	0	0.99911	.	0.405	0.379	2784	0.99998010	5.42	.	.	.	0.294808	0.98658244579304	0.66058	D	86	.	.	0.4026	0.91338	p.His282Arg	0	0	-6.135	0.9492965	0	0.87152	627146	T	.	F9	.	D	0.707	.	H282R	T	0.87757	0.84104	A/A	principal1	250344	F9_Popp_2025_strep_2_var265326	No											H		845	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.His282Arg		true	c.845A>G						3551.0	139561530.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, conflicting classifications				His282Arg						R	Feb 14, 2024					missense_variant		282.0			0.0000273958501098	0.8928388237393353		Conflicting classifications of pathogenicity	139561530.0	missense_variant		0.707					Reporter			F9_His282Arg
F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	0.8092956455580314	0.7482211894547589	0.8647586304094397	0.8421319766343551	0.6359506216068829	0.8460337062407786	0.7913699564039575	0.751983162581138	0.8371853003467626	0.7947090250643046	0.827664675899405	0.7697955729293582	0.8083708964952888	0.8396586384905589	0.7153298233355938	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G		His282Arg																												F9_His282Arg	23	139561530	A	G	X	allele	845A>G	A10	527_CAVA_Array_P02	A20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561530-A-G	-	0.31233	0.046	282	.	0	.	X	138643689	G	2.739590e-05	.	X	3_Conflicting	NC_000023.11	32	His282Arg	.	18.66	.	0	.	D	0	3	1	.	.	.	.	.	0	0.89469	Select	0.7468	.	0.21889	.	.	D	D	46844	1.73630748658	0	0	.	.	.	0.22147	.	33803	0	.	0.70711	.	.	0.88613	0.629	.	17.0	0.852415	4.79	0.83	G	single nucleotide variant	NC_000023.11:g.139561530A>G	0	.	2	0.81526446	.	0	0.84553546	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.90832	B	0.90237	B	M	.	33	A/A	114	0	.	1204562	Hereditary factor VIII deficiency disease|not provided	.	0.89093	.	.	-	139561530	.	-	9.394000	.	0.87544	21828	0	890491	.	germline;unknown	55876	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.99125	GRCh38	924	criteria provided, conflicting classifications	c.845A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.845A>G (p.His282Arg)	1	.	FA9_HUMAN	.	83.0	.	.	D	0.45138	0.8688038	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99989	.	0	.	.	45620	p.His282Arg	0	0.80629	.	germline	.		A	Feb 14, 2024	.	A/A	.	.	0.856	N	Xq27.1	9690	.	.	SCV000899963|SCV005079373|SCV005413446	Conflicting_classifications_of_pathogenicity	.	.	Arg	R	-	689	ENSP00000218099	ENST00000218099	.	0.601	.	.	0.691	A	.	2.423931	0.17349	.	T	-	.	.	0.97236	610	.	.	0.55065	0	139561530	Y	10	0	.	0.000000e+00	P00740	.	0.866353	0.22143		.	0.113	D	.	0.8327217	.	0.32173	2158	0.370769	32	-3.71	.	3.593520e-05	0.06521	.	.	57696	.	4331	.	0.89097	X	F9	0.000000e+00	0	His	14050	.	X-139561530-A-G	Hereditary_factor_VIII_deficiency_disease|not_provided	0	.	138471355	.	.	.	0	RCV000851898|RCV004588168	D	0	.	c.845A>G	.	0	0	0.88019	A/A	rs753654616	139561530	.	A	.	P00740	.	0.86834	.	0.35501		.	.	0.000000e+00	2.315	0	0	264690	5.42	0.97052	112	D	T	.	.	0	26	.	.	.	98878	627146	0.87868	0.90767	0.900605976581573	2898	.	0.30635	.	.	.	890491	4.839	.	D	.	.	7.5560088E-6	0	134500|306700	0.62586	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9970016739794073	2	0.31692	0.18019	.	2	.	0.000000e+00	.	YES	0.000000e+00	0.669559	615669	HGNC:3551	A	.	simple_aae	0.775	.	139561530	CAT	0.999000	.	-	0	0.94197	3.593520e-05	0	0	Conflicting classifications of pathogenicity	0.50934	.	0	0	ClinGen:CA336143030	H	.	0.999137776672	-	0.938	-	0.78847	.	496	0.99698	0.379394561052	0.1387	0	0.92464920108666138	98	-	845A>G 	.	0	C0019069|C3661900	.	.	.	.	NM_000133.4	-	.	.	1	0.53609	753654616	.	0	0.99911	.	0.405	0.379	2784	0.99998010	5.42	.	.	.	0.294808	0.98658244579304	0.66058	D	86	.	.	0.4026	0.91338	p.His282Arg	0	0	-6.135	0.9492965	0	0.87152	627146	T	.	F9	.	D	0.707	.	H282R	T	0.87757	0.84104	A/A	principal1	222828	F9_Popp_2025_light_chain_var245964	No											H		845	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.His282Arg		true	c.845A>G						3551.0	139561530.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, conflicting classifications				His282Arg						R	Feb 14, 2024					missense_variant		282.0			0.0000273958501098	0.9118857121513826		Conflicting classifications of pathogenicity	139561530.0	missense_variant		0.707					Reporter			F9_His282Arg
F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	0.8092956455580314	0.7482211894547589	0.8647586304094397	0.8421319766343551	0.6359506216068829	0.8460337062407786	0.7913699564039575	0.751983162581138	0.8371853003467626	0.7947090250643046	0.827664675899405	0.7697955729293582	0.8083708964952888	0.8396586384905589	0.7153298233355938	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G		His282Arg																												F9_His282Arg	23	139561530	A	G	X	allele	845A>G	A10	527_CAVA_Array_P02	A20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561530-A-G	-	0.31233	0.046	282	.	0	.	X	138643689	G	2.739590e-05	.	X	3_Conflicting	NC_000023.11	32	His282Arg	.	18.66	.	0	.	D	0	3	1	.	.	.	.	.	0	0.89469	Select	0.7468	.	0.21889	.	.	D	D	46844	1.73630748658	0	0	.	.	.	0.22147	.	33803	0	.	0.70711	.	.	0.88613	0.629	.	17.0	0.852415	4.79	0.83	G	single nucleotide variant	NC_000023.11:g.139561530A>G	0	.	2	0.81526446	.	0	0.84553546	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.90832	B	0.90237	B	M	.	33	A/A	114	0	.	1204562	Hereditary factor VIII deficiency disease|not provided	.	0.89093	.	.	-	139561530	.	-	9.394000	.	0.87544	21828	0	890491	.	germline;unknown	55876	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.99125	GRCh38	924	criteria provided, conflicting classifications	c.845A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.845A>G (p.His282Arg)	1	.	FA9_HUMAN	.	83.0	.	.	D	0.45138	0.8688038	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99989	.	0	.	.	45620	p.His282Arg	0	0.80629	.	germline	.		A	Feb 14, 2024	.	A/A	.	.	0.856	N	Xq27.1	9690	.	.	SCV000899963|SCV005079373|SCV005413446	Conflicting_classifications_of_pathogenicity	.	.	Arg	R	-	689	ENSP00000218099	ENST00000218099	.	0.601	.	.	0.691	A	.	2.423931	0.17349	.	T	-	.	.	0.97236	610	.	.	0.55065	0	139561530	Y	10	0	.	0.000000e+00	P00740	.	0.866353	0.22143		.	0.113	D	.	0.8327217	.	0.32173	2158	0.370769	32	-3.71	.	3.593520e-05	0.06521	.	.	57696	.	4331	.	0.89097	X	F9	0.000000e+00	0	His	14050	.	X-139561530-A-G	Hereditary_factor_VIII_deficiency_disease|not_provided	0	.	138471355	.	.	.	0	RCV000851898|RCV004588168	D	0	.	c.845A>G	.	0	0	0.88019	A/A	rs753654616	139561530	.	A	.	P00740	.	0.86834	.	0.35501		.	.	0.000000e+00	2.315	0	0	264690	5.42	0.97052	112	D	T	.	.	0	26	.	.	.	98878	627146	0.87868	0.90767	0.900605976581573	2898	.	0.30635	.	.	.	890491	4.839	.	D	.	.	7.5560088E-6	0	134500|306700	0.62586	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9970016739794073	2	0.31692	0.18019	.	2	.	0.000000e+00	.	YES	0.000000e+00	0.669559	615669	HGNC:3551	A	.	simple_aae	0.775	.	139561530	CAT	0.999000	.	-	0	0.94197	3.593520e-05	0	0	Conflicting classifications of pathogenicity	0.50934	.	0	0	ClinGen:CA336143030	H	.	0.999137776672	-	0.938	-	0.78847	.	496	0.99698	0.379394561052	0.1387	0	0.92464920108666138	98	-	845A>G 	.	0	C0019069|C3661900	.	.	.	.	NM_000133.4	-	.	.	1	0.53609	753654616	.	0	0.99911	.	0.405	0.379	2784	0.99998010	5.42	.	.	.	0.294808	0.98658244579304	0.66058	D	86	.	.	0.4026	0.91338	p.His282Arg	0	0	-6.135	0.9492965	0	0.87152	627146	T	.	F9	.	D	0.707	.	H282R	T	0.87757	0.84104	A/A	principal1	195312	F9_Popp_2025_heavy_chain_var236283	No											H		845	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.His282Arg		true	c.845A>G						3551.0	139561530.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, conflicting classifications				His282Arg						R	Feb 14, 2024					missense_variant		282.0			0.0000273958501098	0.9055978920969366		Conflicting classifications of pathogenicity	139561530.0	missense_variant		0.707					Reporter			F9_His282Arg
F9_His282Arg	-2.5485677847101242	0.038183352616759834	1.2929819666339708	0.23705255365323002	2025_01_Batch_13-14	0.8092956455580314	0.7482211894547589	0.8647586304094397	0.8421319766343551	0.6359506216068829	0.8460337062407786	0.7913699564039575	0.751983162581138	0.8371853003467626	0.7947090250643046	0.827664675899405	0.7697955729293582	0.8083708964952888	0.8396586384905589	0.7153298233355938	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030586		NC_000023.11:139561530:A:G		His282Arg																												F9_His282Arg	23	139561530	A	G	X	allele	845A>G	A10	527_CAVA_Array_P02	A20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561530-A-G	-	0.31233	0.046	282	.	0	.	X	138643689	G	2.739590e-05	.	X	3_Conflicting	NC_000023.11	32	His282Arg	.	18.66	.	0	.	D	0	3	1	.	.	.	.	.	0	0.89469	Select	0.7468	.	0.21889	.	.	D	D	46844	1.73630748658	0	0	.	.	.	0.22147	.	33803	0	.	0.70711	.	.	0.88613	0.629	.	17.0	0.852415	4.79	0.83	G	single nucleotide variant	NC_000023.11:g.139561530A>G	0	.	2	0.81526446	.	0	0.84553546	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.90832	B	0.90237	B	M	.	33	A/A	114	0	.	1204562	Hereditary factor VIII deficiency disease|not provided	.	0.89093	.	.	-	139561530	.	-	9.394000	.	0.87544	21828	0	890491	.	germline;unknown	55876	Loss of catalytic residue at N283 (P = 0.0495)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Loss of disorder (P = 0.236)| Gain of solvent accessibility (P = 0.2689)	0.99125	GRCh38	924	criteria provided, conflicting classifications	c.845A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.845A>G (p.His282Arg)	1	.	FA9_HUMAN	.	83.0	.	.	D	0.45138	0.8688038	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99989	.	0	.	.	45620	p.His282Arg	0	0.80629	.	germline	.		A	Feb 14, 2024	.	A/A	.	.	0.856	N	Xq27.1	9690	.	.	SCV000899963|SCV005079373|SCV005413446	Conflicting_classifications_of_pathogenicity	.	.	Arg	R	-	689	ENSP00000218099	ENST00000218099	.	0.601	.	.	0.691	A	.	2.423931	0.17349	.	T	-	.	.	0.97236	610	.	.	0.55065	0	139561530	Y	10	0	.	0.000000e+00	P00740	.	0.866353	0.22143		.	0.113	D	.	0.8327217	.	0.32173	2158	0.370769	32	-3.71	.	3.593520e-05	0.06521	.	.	57696	.	4331	.	0.89097	X	F9	0.000000e+00	0	His	14050	.	X-139561530-A-G	Hereditary_factor_VIII_deficiency_disease|not_provided	0	.	138471355	.	.	.	0	RCV000851898|RCV004588168	D	0	.	c.845A>G	.	0	0	0.88019	A/A	rs753654616	139561530	.	A	.	P00740	.	0.86834	.	0.35501		.	.	0.000000e+00	2.315	0	0	264690	5.42	0.97052	112	D	T	.	.	0	26	.	.	.	98878	627146	0.87868	0.90767	0.900605976581573	2898	.	0.30635	.	.	.	890491	4.839	.	D	.	.	7.5560088E-6	0	134500|306700	0.62586	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9970016739794073	2	0.31692	0.18019	.	2	.	0.000000e+00	.	YES	0.000000e+00	0.669559	615669	HGNC:3551	A	.	simple_aae	0.775	.	139561530	CAT	0.999000	.	-	0	0.94197	3.593520e-05	0	0	Conflicting classifications of pathogenicity	0.50934	.	0	0	ClinGen:CA336143030	H	.	0.999137776672	-	0.938	-	0.78847	.	496	0.99698	0.379394561052	0.1387	0	0.92464920108666138	98	-	845A>G 	.	0	C0019069|C3661900	.	.	.	.	NM_000133.4	-	.	.	1	0.53609	753654616	.	0	0.99911	.	0.405	0.379	2784	0.99998010	5.42	.	.	.	0.294808	0.98658244579304	0.66058	D	86	.	.	0.4026	0.91338	p.His282Arg	0	0	-6.135	0.9492965	0	0.87152	627146	T	.	F9	.	D	0.707	.	H282R	T	0.87757	0.84104	A/A	principal1	167796	F9_Popp_2025_carboxy_gla_motif_var255645	No											H		845	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.His282Arg		true	c.845A>G						3551.0	139561530.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, conflicting classifications				His282Arg						R	Feb 14, 2024					missense_variant		282.0			0.0000273958501098	0.9024192508494696		Conflicting classifications of pathogenicity	139561530.0	missense_variant		0.707					Reporter			F9_His282Arg
FH_Arg101Pro	4.936823787103087	0.0026122475521523467	-6.3120881858677516	0.00039949333367175175	2025_01_Batch_13-14	0.7591463818735216	0.8801537331098237	0.9445807184794202	0.9219469434032179	0.8487166714701131	0.8144788384306456	0.8936658580417775	0.9547278990487912	0.9332433100380673	0.8970774612096026	0.7868126101520836	0.8869097955758005	0.9496543087641056	0.9275951267206426	0.8728970663398579	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	FH	FH	ENSG00000091483	3408	214591	CCSBVarC004047	ALE00004047	NC_000001.11:241513679:C:G	302G>C	Arg101Pro	CEGS2	CegsMutGDEh1039	A01	GDEhDisVCh_40065	B08	1	CegsMutGDDh1039	A01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	2	0			0			0			FH_Arg101Pro	1	241513679	C	G	1											1-241513679-C-G	-	0.76136	0.953	101	.	.	.	1	241676979	G	.	.	1	1_Pathogenic	NC_000001.11	.	Arg101Pro	.	26.4	.	.	.	D	.	5	1	.	.	.	.	.	.	0.97205	Select	0.9706	.	0.54293	.	.	D	D	.	1.0454015372	.	.	.	.	.	0.49004	.	.	.	.	0.62369	.	.	0.99239	0.852	.	13.0	0.984402	.	0.87	G	single nucleotide variant	NC_000001.11:g.241513679C>G	.	.	3	0.8988987	.	.	0.98190993	.		.	.	.	.	.	.	.	.	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	.	.	.	.	0.90832	P	0.94827	P	M	5.235626	.	C/C	.	.	.	.	Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|not provided	.	0.98661	.	.	-	241513679	.	-	4.873000	.	0.91950	.	.	.	.	germline	.	Loss of MoRF binding (P = 0.0088)| Loss of methylation at R101 (P = 0.0316)| Gain of glycosylation at K100 (P = 0.1926)| Gain of ubiquitination at K100 (P = 0.3295)| Gain of disorder (P = 0.3433)	0.90945	GRCh38	965	criteria provided, multiple submitters, no conflicts	c.302G>C	.	0.64849	.	.	.	Fumarate lyase, N-terminal	.	.	P	.	.	NM_000143.4(FH):c.302G>C (p.Arg101Pro)	2	.	FUMH_HUMAN	.	87.0	0.524983923222637	.	D	0.92510	0.98190993	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.91792	.	.	.	.	.	p.Arg101Pro	.	0.45664	.	germline	.		C	Mar 20, 2024	.	C/C	.	.	1.0	N	1q43	.	.	.	SCV000576624|SCV002753171|SCV004292025	Pathogenic/Likely_pathogenic	.	.	Pro	P	-	.	ENSP00000355518	ENST00000366560	.	0.005	.	.	0.599	C	.	4.726614	0.72530	D	D	-	5.281088	.	0.96104	.	.	.	0.77268	.	241513679	Y	10	.	.	.	P07954	.	0.987676	0.84551		.	0.743	D	.	0.8988987	.	0.40339	2271	0.506134	.	-3.0	.	.	0.63383	.	.	.	.	.	.	0.94828	1	FH	.	.	Arg	.	.	1-241513679-C-G	Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer	.	.	239743602	ClinGen:CA341389|OMIM:136850.0009	0.799097	0.68407	.	RCV000017625|RCV002433458|RCV000489422	D	.	.	c.302G>C	.	.	.	0.94418	C/C	rs75086406	241513679	.	C	.	P07954	.	0.99239	.	0.68239		.	.	.	2.92	.	.	.	4.95	0.99933	.	D	T	.	.	.	.	.	.	.	140162|523	16238	0.94338	0.75799	0.986802875995636	.	.	0.71675	0.72445	.	.	.	1.844	.	D	.	.	.	.	150800	0.39015	1	.	ENSG00000091483	.	.	.	.	0.9653000365510797	2	0.55796	0.07233	.	.	.	.	0.513199196236598	YES	.	0.570217	31277	HGNC:3700	A	.	simple_aae	0.853	.	241513679	CGA	1.000000	.	-	.	0.96307	.	.	.	Pathogenic/Likely pathogenic	0.99132	.	.	.	ClinGen:CA341389,OMIM:136850.0009	R	.	0.975473075571	-	0.787	-	0.96546	.	.	0.96498	0.572783589363	0.9862	.	0.99754957809678579	.	-	302G>C 	.	.	C0027672|C3661900|C1708350	.	.	.	.	NM_000143.4	-	.	.	1	0.94657	75086406	.	.	0.97496	0.68706	0.956	0.005	.	0.91557670	5.85	.	.	.	0.48925	0.99935590898668	0.84163	D	.	.	.	1.0727	0.99071	p.Arg101Pro	.	.	-17.284	0.96818995	.	0.96346	16238	D	.	FH	.	D	0.900	.	R101P	D	.	0.40292	C/C	principal1																																																																																																				
FH_Arg101Pro	4.936823787103087	0.0026122475521523467	-6.3120881858677516	0.00039949333367175175	2025_01_Batch_13-14	0.7591463818735216	0.8801537331098237	0.9445807184794202	0.9219469434032179	0.8487166714701131	0.8144788384306456	0.8936658580417775	0.9547278990487912	0.9332433100380673	0.8970774612096026	0.7868126101520836	0.8869097955758005	0.9496543087641056	0.9275951267206426	0.8728970663398579	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	FH	FH		3408		CCSBVarC004047		NC_000001.11:241513679:C:G		Arg101Pro																												FH_Arg101Pro	1	241513679	C	G	1	allele	302G>C	F02	527_CAVA_Array_P03	L03	B13A7A8P1_R1	B14A7A8P1_R2				1-241513679-C-G	-	0.76136	0.953	101	.	.	.	1	241676979	G	.	.	1	1_Pathogenic	NC_000001.11	.	Arg101Pro	.	26.4	.	.	.	D	.	5	1	.	.	.	.	.	.	0.97205	Select	0.9706	.	0.54293	.	.	D	D	.	1.0454015372	.	.	.	.	.	0.49004	.	.	.	.	0.62369	.	.	0.99239	0.852	.	13.0	0.984402	.	0.87	G	single nucleotide variant	NC_000001.11:g.241513679C>G	.	.	3	0.8988987	.	.	0.98190993	.		.	.	.	.	.	.	.	.	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	.	.	.	.	0.90832	P	0.94827	P	M	5.235626	.	C/C	.	.	.	.	Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|not provided	.	0.98661	.	.	-	241513679	.	-	4.873000	.	0.91950	.	.	.	.	germline	.	Loss of MoRF binding (P = 0.0088)| Loss of methylation at R101 (P = 0.0316)| Gain of glycosylation at K100 (P = 0.1926)| Gain of ubiquitination at K100 (P = 0.3295)| Gain of disorder (P = 0.3433)	0.90945	GRCh38	965	criteria provided, multiple submitters, no conflicts	c.302G>C	.	0.64849	.	.	.	Fumarate lyase, N-terminal	.	.	P	.	.	NM_000143.4(FH):c.302G>C (p.Arg101Pro)	2	.	FUMH_HUMAN	.	87.0	0.524983923222637	.	D	0.92510	0.98190993	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.91792	.	.	.	.	.	p.Arg101Pro	.	0.45664	.	germline	.		C	Mar 20, 2024	.	C/C	.	.	1.0	N	1q43	.	.	.	SCV000576624|SCV002753171|SCV004292025	Pathogenic/Likely_pathogenic	.	.	Pro	P	-	.	ENSP00000355518	ENST00000366560	.	0.005	.	.	0.599	C	.	4.726614	0.72530	D	D	-	5.281088	.	0.96104	.	.	.	0.77268	.	241513679	Y	10	.	.	.	P07954	.	0.987676	0.84551		.	0.743	D	.	0.8988987	.	0.40339	2271	0.506134	.	-3.0	.	.	0.63383	.	.	.	.	.	.	0.94828	1	FH	.	.	Arg	.	.	1-241513679-C-G	Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer	.	.	239743602	ClinGen:CA341389|OMIM:136850.0009	0.799097	0.68407	.	RCV000017625|RCV002433458|RCV000489422	D	.	.	c.302G>C	.	.	.	0.94418	C/C	rs75086406	241513679	.	C	.	P07954	.	0.99239	.	0.68239		.	.	.	2.92	.	.	.	4.95	0.99933	.	D	T	.	.	.	.	.	.	.	140162|523	16238	0.94338	0.75799	0.986802875995636	.	.	0.71675	0.72445	.	.	.	1.844	.	D	.	.	.	.	150800	0.39015	1	.	ENSG00000091483	.	.	.	.	0.9653000365510797	2	0.55796	0.07233	.	.	.	.	0.513199196236598	YES	.	0.570217	31277	HGNC:3700	A	.	simple_aae	0.853	.	241513679	CGA	1.000000	.	-	.	0.96307	.	.	.	Pathogenic/Likely pathogenic	0.99132	.	.	.	ClinGen:CA341389,OMIM:136850.0009	R	.	0.975473075571	-	0.787	-	0.96546	.	.	0.96498	0.572783589363	0.9862	.	0.99754957809678579	.	-	302G>C 	.	.	C0027672|C3661900|C1708350	.	.	.	.	NM_000143.4	-	.	.	1	0.94657	75086406	.	.	0.97496	0.68706	0.956	0.005	.	0.91557670	5.85	.	.	.	0.48925	0.99935590898668	0.84163	D	.	.	.	1.0727	0.99071	p.Arg101Pro	.	.	-17.284	0.96818995	.	0.96346	16238	D	.	FH	.	D	0.900	.	R101P	D	.	0.40292	C/C	principal1																																																																																																				
ZC4H2_Arg18Lys	-6.340999360000492	0.00038856290197054536	7.618121131716513	0.00012439311242996078	2025_01_Batch_13-14	0.7503559799668514	0.9185601696203177	0.963587118979357	0.9064220148723456	0.7522493313481461	0.6601528287397939	0.9393200513331863	0.9789260946638219	0.931944116940673	0.6341990021331609	0.7052544043533227	0.9289401104767521	0.9712566068215894	0.9191830659065093	0.6932241667406536	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC009194		NC_000023.11:64976325:C:T		Arg18Lys																												ZC4H2_Arg18Lys	23	64976325	C	T	X	allele	53G>A	C05	527_CAVA_Array_P06	E10	B13A7A8P2_R1	B14A7A8P2_R2				X-64976325-C-T	-	0.92311	0.979	18	.	0	.	X	64196205	T	8.266660e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg18Lys	.	32.0	.	0	.	T	0	1	1	.	.	.	.	.	0	0.52992	Select	0.2792	.	0.59057	.	.	T	T	46659	1.62403551474	0	0	.	.	.	0.77960	.	33732	0	.	0.52471	.	.	0.76618	0.967	.	61.0	0.89491	4.0	0.39	T	single nucleotide variant	NC_000023.11:g.64976325C>T	0	.	1	0.41600963	.	0	0.6772347	0		.	.	.	.	.	146	.	0	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	.	.	0.000000e+00	0	0.63057	D	0.71097	D	L	.	1	C/C	84	0	.	1209679	Wieacker-Wolff syndrome	.	0.62892	.	.	-	64976325	.	-	7.412000	.	0.58615	22031	0	45815	.	germline	56759	Gain of methylation at R18 (P = 0.0377)| Gain of ubiquitination at K15 (P = 0.0632)| Loss of MoRF binding (P = 0.0922)| Loss of phosphorylation at T21 (P = 0.1157)| Loss of glycosylation at K15 (P = 0.2)	0.73845	GRCh38	45	no assertion criteria provided	c.53G>A	.	0.59435	0	.	.	.	.	.	P	0	0.000000e+00	NM_018684.4(ZC4H2):c.53G>A (p.Arg18Lys)		.	ZC4H2_HUMAN	.	39.0	.	.	D	0.75522	0.6783023	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.96797	.	0	.	.	45815	p.Arg18Lys	0	0.58717	.	germline	.		C	Mar 02, 2017	.	C/C	.	.	1.0	N	Xq11.2	6962	.	.	SCV000513398	Pathogenic	.	.	Lys	K	-	687	ENSP00000363972	ENST00000374839	.	0.162	.	.	0.549	C	.	5.580871	0.54507	.	T	-	.	.	0.38628	610	.	.	0.69797	0	64976325	Y	8	0	.	0.000000e+00	Q9NQZ6	.	0.486907	0.74191		.	0.973	T	.	0.5044407	.	0.53449	55906	0.0608247	0	-1.74	.	2.182690e-05	0.24024	.	.	57101	.	4372	.	0.65445	X	ZC4H2	0.000000e+00	0	Arg	10680	.	X-64976325-C-T	Wieacker-Wolff_syndrome	0	.	64112930	ClinGen:CA16609222|OMIM:300897.0007	.	.	0	RCV000426615	D	0	.	c.53G>A	.	0	0	0.59433	C/C	rs1057520299	64976325	.	C	.	Q9NQZ6	.	0.76559	.	0.68239		.	.	0.000000e+00	1.61	0	0	.	4.73	0.81174	108	D	T	.	.	0	24	.	.	.	3454|85283	378045	0.58921	0.89065	0.973198473453522	2294	.	0.71675	.	.	.	894933	5.226	.	N	.	.	.	0	314580	0.65208	X	.	ENSG00000126970	0.000000e+00	0	.	0	0.901597971559674	2	0.72925	0.97779	.	.	.	2.182690e-05	.	YES	0.000000e+00	0.017247	380137	HGNC:24931	A	.	simple_aae	0.321	.	64976325	AGG	1.000000	.	-	0	0.76724	0.000000e+00	0	0	Pathogenic	0.36534	.	0	1	ClinGen:CA16609222,OMIM:300897.0007	R	.	0.622178612725	-	0.607	-	0.86268	.	466	0.90069	0.773836612701	0.7363	0	0.99599773954017523	94	-	53G>A 	.	0	C0796200	.	.	.	.	NM_018684.4	-	.	.	1	0.63411	1057520299	.	0	0.61618	.	0.866	0.428	2210	0.99041635	4.73	.	.	.	-0.150406	0.99398228578285	0.40979	T	84	.	.	-0.6422	0.64962	p.Arg18Lys	0	0	-4.683	0.76925564	0	0.90367	378045	T	.	ZC4H2	.	T	0.231	.	R18K	T	0.76287	0.27038	C/C	principal1																																																																																																				
RAD51D_Met308Val	-1.5191507364824384	0.17252213344359443	14.967472002836823	1.4261030216509061e-6	2025_01_Batch_13-14	0.8740166193615838	0.9519753630441335	0.9903938708502005	0.9746801363316713	0.8196698329128753	0.960538673330112	0.9782166968374082	0.9876383851038141	0.987975692054751	0.9316261742150724	0.9172776463458479	0.9650960299407709	0.9890161279770073	0.9813279141932112	0.8756480035639739	0.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024892		NC_000017.11:35101018:T:C		Met308Val																												RAD51D_Met308Val	17	35101018	T	C	17	allele	922A>G	G02	527_CAVA_Array_P05	M03	B13A7A8P2_R1	B14A7A8P2_R2				17-35101018-T-C	-	0.11172	0.0	308	.	0	.	17	33428037	C	4.957860e-06	.	17	3_Conflicting	NC_000017.11	3	Met308Val	.	7.79	.	0	.	T	0	4	1	.	.	.	.	.	0	0.12499	Select	0.0836	.	0.09864	.	.	T	T	64022	.	0	0	.	.	.	.	.	44890	0	.	0.17975	.	.	0.21113	0.941	.	96.0	.	0.883	0.04	C	single nucleotide variant	NC_000017.11:g.35101018T>C	0	.	2	0.08494699	.	0	0.09098598	0		.	.	.	.	.	500	.	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	.	.	0.000000e+00	0	0.13669	B	0.19556	B	N	0.304481	8	T/T	114	0	.	1613598	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	.	0.43192	.	.	-	35101018	.	-	-0.511000	.	0.06489	29602	0	74880	.	germline	91062	Loss of disorder (P = 0.066)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T303 (P = 0.2109)| Loss of MoRF binding (P = 0.2269)| Gain of glycosylation at T313 (P = 0.247)	0.37543	GRCh38	913	criteria provided, conflicting classifications	c.922A>G	.	0.07985	1	.	.	.	.	.	LB	0	0.000000e+00	NM_002878.4(RAD51D):c.922A>G (p.Met308Val)	1	.	RA51D_HUMAN	.	4.0	-1.10219193532207	.	.	0.03206	0.09098598	-	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.77819	.	0	.	.	59998	p.Met308Val	0	0.08784	.	germline	.		T	Sep 23, 2024	.	T/T	.	.	0.007	N	17q12	26588	.	.	SCV000215164|SCV000771511|SCV000911462|SCV005394802	Conflicting_classifications_of_pathogenicity	.	.	Val	V	-	910	ENSP00000338790	ENST00000345365	.	0.274	.	.	0.665	T	.	0.745387	0.19266	N	T	-	0.4784977	.	0.18349	628	.	.	0.04499	0	35101018	Y	10	0	.	0.000000e+00	O75771	.	0.090794	0.15792		.	0.0	T	.	0.08494699	.	0.48226	5892	-0.22766	5	-0.61	.	4.006410e-05	0.15912	.	.	74880	.	6084	.	0.19555	17	RAD51D	4.006410e-05	0	Met	35432	.	17-35101018-T-C	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	.	30452150	ClinGen:CA191144	0.063394	0.06526	0	RCV000164512|RCV004782268|RCV000649679	T	0	.	c.922A>G	.	0	0	0.16671	T/T	rs786201961	35101018	.	T	.	O75771	.	0.21114	.	0.08389		.	.	0.000000e+00	0.72	0	1	264690	-1.59	0.38381	112	T	.	.	.	0	26	.	.	.	140162|145	185144	0.15640	0.09186	0.04466512799263	2918	.	0.17722	0.12075	.	.	1179678	-0.196	.	N	.	.	1.51120175E-5	0	614291	0.09562	17	.	ENSG00000185379	0.000000e+00	3.761095230931247E-5	.	0	.	1	0.06938	0.21155	.	4	.	0.000000e+00	-1.00842900774596	YES	0.000000e+00	0.00703	184803	HGNC:9823	N	.	simple_aae	0.031	.	35101018	ATG	0.000000	.	-	0	0.15785	4.238440e-06	0	0	Conflicting classifications of pathogenicity	0.04505	.	0	0	ClinGen:CA191144	M	.	0.445711490874	-	0.368	-	0.04065	.	4588	0.24814	.	0.0668	0	0.84883383379766109	98	-	922A>G 	.	0	C0027672|C3280345	.	.	.	.	NM_002878.4	-	.	.	0	0.22727	786201961	.	2.8223075186272295E-5	0.43808	0.09439	0.017	0.326	2804	0.33311860	5.16	.	.	.	-0.564795	0.000116984907820501	0.18616	T	86	.	.	-0.9351	0.32564	p.Met308Val	0	0	-2.125	0.091109514	3	0.03146	185144	T	.	RAD51D	.	T	0.046	.	M308V	T	0.28197	0.62996	T/T	principal1	959082	RAD51D_unpublished_var153329	Yes						overall function		Cell survival			M		922	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Met308Val		true	c.922A>G						9823.0	35101018.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				Met308Val						V	Sep 23, 2024					missense_variant		308.0	A		4.9578643503e-6	0.0243469		Conflicting classifications of pathogenicity	35101018.0	missense_variant		0.046	functionally_normal				Cell viability			RAD51D_Met308Val
RAD51D_Met308Val	-1.5191507364824384	0.17252213344359443	14.967472002836823	1.4261030216509061e-6	2025_01_Batch_13-14	0.8740166193615838	0.9519753630441335	0.9903938708502005	0.9746801363316713	0.8196698329128753	0.960538673330112	0.9782166968374082	0.9876383851038141	0.987975692054751	0.9316261742150724	0.9172776463458479	0.9650960299407709	0.9890161279770073	0.9813279141932112	0.8756480035639739	0.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024892	ALE00029928	NC_000017.11:35101018:T:C	922A>G	Met308Val	CAVA																											RAD51D_Met308Val	17	35101018	T	C	17								1	1	1	17-35101018-T-C	-	0.11172	0.0	308	.	0	.	17	33428037	C	4.957860e-06	.	17	3_Conflicting	NC_000017.11	3	Met308Val	.	7.79	.	0	.	T	0	4	1	.	.	.	.	.	0	0.12499	Select	0.0836	.	0.09864	.	.	T	T	64022	.	0	0	.	.	.	.	.	44890	0	.	0.17975	.	.	0.21113	0.941	.	96.0	.	0.883	0.04	C	single nucleotide variant	NC_000017.11:g.35101018T>C	0	.	2	0.08494699	.	0	0.09098598	0		.	.	.	.	.	500	.	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	.	.	0.000000e+00	0	0.13669	B	0.19556	B	N	0.304481	8	T/T	114	0	.	1613598	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4	.	0.43192	.	.	-	35101018	.	-	-0.511000	.	0.06489	29602	0	74880	.	germline	91062	Loss of disorder (P = 0.066)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T303 (P = 0.2109)| Loss of MoRF binding (P = 0.2269)| Gain of glycosylation at T313 (P = 0.247)	0.37543	GRCh38	913	criteria provided, conflicting classifications	c.922A>G	.	0.07985	1	.	.	.	.	.	LB	0	0.000000e+00	NM_002878.4(RAD51D):c.922A>G (p.Met308Val)	1	.	RA51D_HUMAN	.	4.0	-1.10219193532207	.	.	0.03206	0.09098598	-	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.77819	.	0	.	.	59998	p.Met308Val	0	0.08784	.	germline	.		T	Sep 23, 2024	.	T/T	.	.	0.007	N	17q12	26588	.	.	SCV000215164|SCV000771511|SCV000911462|SCV005394802	Conflicting_classifications_of_pathogenicity	.	.	Val	V	-	910	ENSP00000338790	ENST00000345365	.	0.274	.	.	0.665	T	.	0.745387	0.19266	N	T	-	0.4784977	.	0.18349	628	.	.	0.04499	0	35101018	Y	10	0	.	0.000000e+00	O75771	.	0.090794	0.15792		.	0.0	T	.	0.08494699	.	0.48226	5892	-0.22766	5	-0.61	.	4.006410e-05	0.15912	.	.	74880	.	6084	.	0.19555	17	RAD51D	4.006410e-05	0	Met	35432	.	17-35101018-T-C	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	.	30452150	ClinGen:CA191144	0.063394	0.06526	0	RCV000164512|RCV004782268|RCV000649679	T	0	.	c.922A>G	.	0	0	0.16671	T/T	rs786201961	35101018	.	T	.	O75771	.	0.21114	.	0.08389		.	.	0.000000e+00	0.72	0	1	264690	-1.59	0.38381	112	T	.	.	.	0	26	.	.	.	140162|145	185144	0.15640	0.09186	0.04466512799263	2918	.	0.17722	0.12075	.	.	1179678	-0.196	.	N	.	.	1.51120175E-5	0	614291	0.09562	17	.	ENSG00000185379	0.000000e+00	3.761095230931247E-5	.	0	.	1	0.06938	0.21155	.	4	.	0.000000e+00	-1.00842900774596	YES	0.000000e+00	0.00703	184803	HGNC:9823	N	.	simple_aae	0.031	.	35101018	ATG	0.000000	.	-	0	0.15785	4.238440e-06	0	0	Conflicting classifications of pathogenicity	0.04505	.	0	0	ClinGen:CA191144	M	.	0.445711490874	-	0.368	-	0.04065	.	4588	0.24814	.	0.0668	0	0.84883383379766109	98	-	922A>G 	.	0	C0027672|C3280345	.	.	.	.	NM_002878.4	-	.	.	0	0.22727	786201961	.	2.8223075186272295E-5	0.43808	0.09439	0.017	0.326	2804	0.33311860	5.16	.	.	.	-0.564795	0.000116984907820501	0.18616	T	86	.	.	-0.9351	0.32564	p.Met308Val	0	0	-2.125	0.091109514	3	0.03146	185144	T	.	RAD51D	.	T	0.046	.	M308V	T	0.28197	0.62996	T/T	principal1	959082	RAD51D_unpublished_var153329	Yes						overall function		Cell survival			M		922	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Met308Val		true	c.922A>G						9823.0	35101018.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				Met308Val						V	Sep 23, 2024					missense_variant		308.0	A		4.9578643503e-6	0.0243469		Conflicting classifications of pathogenicity	35101018.0	missense_variant		0.046	functionally_normal				Cell viability			RAD51D_Met308Val
F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	0.6833168035932747	0.7400107309035774	0.6656868709286089	0.673030648296955	0.6138560801947897	0.745046260152305	0.7648545841502495	0.6903987536292615	0.7052190866359288	0.6886297254222683	0.7141815318727899	0.7524326575269135	0.6780428122789353	0.6891248674664419	0.6512429028085289	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C		Ile136Thr																												F9_Ile136Thr	23	139548378	T	C	X	allele	407T>C	C07	527_CAVA_Array_P02	E14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548378-T-C	-	0.24009	0.007	136	.	.	.	X	138630537	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ile136Thr	.	16.22	.	.	.	D	.	2	1	.	.	.	.	.	.	0.85909	Select	0.6609	.	0.14196	.	.	D	D	.	1.94467123622	.	.	.	.	.	0.42531	.	.	.	.	0.42193	.	.	0.69365	0.912	.	18.0	0.725127	3.53	0.82	C	single nucleotide variant	NC_000023.11:g.139548378T>C	.	.	2	0.33303738	.	.	0.45117912	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.46839	B	L	.	.	T/T	.	.	.	.	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	.	0.82642	.	.	-	139548378	.	-	6.148000	.	0.85875	.	.	.	.	germline;unknown	.	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.95972	GRCh38	924	reviewed by expert panel	c.407T>C	.	0.42169	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	3	.	FA9_HUMAN	.	82.0	.	.	T	0.38457	0.54474115	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99953	.	.	.	.	.	p.Ile136Thr	.	0.54222	.	germline	.		T	Nov 01, 2024	.	T/T	.	.	0.759	N	Xq27.1	.	.	.	SCV005437143	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.184	.	.	0.609	T	.	1.886718	0.33327	.	T	-	.	.	0.87475	.	.	.	0.23290	.	139548378	Y	10	.	.	.	P00740	.	0.638754	0.21374		.	0.018	D	.	0.22186896	.	0.44761	2158	0.47971	.	-1.59	.	.	0.22252	.	.	.	.	.	.	0.58914	X	F9	.	.	Ile	.	.	X-139548378-T-C	Hereditary_factor_VIII_deficiency_disease	.	.	138458203	.	.	.	.	RCV000851938|RCV004812364	D	.	.	c.407T>C	.	.	.	0.93640	T/T	rs1603265481	139548378	.	T	.	P00740	.	0.63798	.	0.68239		.	.	.	0.92	.	.	.	3.75	0.88783	.	T	T	.	.	.	.	.	.	.	98878	627177	0.93561	0.93269	0.265829622745514	.	.	0.29323	.	.	.	.	1.274	.	N	.	.	.	.	134500|306700	0.32841	X	.	ENSG00000101981	.	.	.	.	0.9571971461018347	2	0.18486	0.18019	.	.	.	.	.	YES	.	0.215404	615665	HGNC:3551	A	.	simple_aae	0.745	.	139548378	ATT	1.000000	.	-	.	0.67284	.	.	.	Likely pathogenic	0.45201	.	.	.	ClinGen:CA414438824	I	.	0.999803421972	-	0.864	-	0.68623	.	.	0.95679	0.526858687401	0.1348	.	0.91815137977279504	.	-	407T>C 	.	.	C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.33926	1603265481	.	.	0.99980	.	0.323	0.145	.	0.99995446	4.94	.	.	.	0.451294	0.982214726841226	0.23286	D	.	.	.	0.0233	0.88180	p.Ile136Thr	.	.	-5.866	0.61334246	.	0.85871	627177	T	.	F9	.	D	0.634	.	I136T	T	0.64053	0.47831	T/T	principal1	159013	F9_Popp_2025_carboxy_gla_motif_var252573	No		11/1/24		42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c							I		407	F9_Popp_2025_carboxy_gla_motif	627177.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA414438824	immortalized human cells		false			p.Ile136Thr		true	c.407T>C						3551.0	139548378.0	No	Likely Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa	PM2_Supporting,PS4,PM1,PP3								NM_000133.4(F9):c.407T>C (p.Ile136Thr) missense variant has a REVEL score of 0.634, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). The variant occurs within exon 5, a region deemed critical for the encoded FIX protein by the CFD-VCEP, and meets criteria for PM1. The c.407T>C (p.Ile136Thr) variant is reported in at least two individuals with mild hemophilia B and two individuals with hemophilia B of unspecified severity (PMID: 8680410, 8091381, 31064749), meeting criteria for PS4. In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9 (Released 10/5/2023): PS4, PM1, PP3, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM2_Supporting,PS4,PM1	Ile136Thr	https://erepo.genome.network/evrepo/ui/classification/42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c					T	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	136.0		hemophilia B		0.4832918637154912		Likely pathogenic	139548378.0	missense_variant		0.634					Reporter			F9_Ile136Thr
F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	0.6833168035932747	0.7400107309035774	0.6656868709286089	0.673030648296955	0.6138560801947897	0.745046260152305	0.7648545841502495	0.6903987536292615	0.7052190866359288	0.6886297254222683	0.7141815318727899	0.7524326575269135	0.6780428122789353	0.6891248674664419	0.6512429028085289	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C		Ile136Thr																												F9_Ile136Thr	23	139548378	T	C	X	allele	407T>C	C07	527_CAVA_Array_P02	E14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548378-T-C	-	0.24009	0.007	136	.	.	.	X	138630537	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ile136Thr	.	16.22	.	.	.	D	.	2	1	.	.	.	.	.	.	0.85909	Select	0.6609	.	0.14196	.	.	D	D	.	1.94467123622	.	.	.	.	.	0.42531	.	.	.	.	0.42193	.	.	0.69365	0.912	.	18.0	0.725127	3.53	0.82	C	single nucleotide variant	NC_000023.11:g.139548378T>C	.	.	2	0.33303738	.	.	0.45117912	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.46839	B	L	.	.	T/T	.	.	.	.	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	.	0.82642	.	.	-	139548378	.	-	6.148000	.	0.85875	.	.	.	.	germline;unknown	.	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.95972	GRCh38	924	reviewed by expert panel	c.407T>C	.	0.42169	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	3	.	FA9_HUMAN	.	82.0	.	.	T	0.38457	0.54474115	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99953	.	.	.	.	.	p.Ile136Thr	.	0.54222	.	germline	.		T	Nov 01, 2024	.	T/T	.	.	0.759	N	Xq27.1	.	.	.	SCV005437143	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.184	.	.	0.609	T	.	1.886718	0.33327	.	T	-	.	.	0.87475	.	.	.	0.23290	.	139548378	Y	10	.	.	.	P00740	.	0.638754	0.21374		.	0.018	D	.	0.22186896	.	0.44761	2158	0.47971	.	-1.59	.	.	0.22252	.	.	.	.	.	.	0.58914	X	F9	.	.	Ile	.	.	X-139548378-T-C	Hereditary_factor_VIII_deficiency_disease	.	.	138458203	.	.	.	.	RCV000851938|RCV004812364	D	.	.	c.407T>C	.	.	.	0.93640	T/T	rs1603265481	139548378	.	T	.	P00740	.	0.63798	.	0.68239		.	.	.	0.92	.	.	.	3.75	0.88783	.	T	T	.	.	.	.	.	.	.	98878	627177	0.93561	0.93269	0.265829622745514	.	.	0.29323	.	.	.	.	1.274	.	N	.	.	.	.	134500|306700	0.32841	X	.	ENSG00000101981	.	.	.	.	0.9571971461018347	2	0.18486	0.18019	.	.	.	.	.	YES	.	0.215404	615665	HGNC:3551	A	.	simple_aae	0.745	.	139548378	ATT	1.000000	.	-	.	0.67284	.	.	.	Likely pathogenic	0.45201	.	.	.	ClinGen:CA414438824	I	.	0.999803421972	-	0.864	-	0.68623	.	.	0.95679	0.526858687401	0.1348	.	0.91815137977279504	.	-	407T>C 	.	.	C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.33926	1603265481	.	.	0.99980	.	0.323	0.145	.	0.99995446	4.94	.	.	.	0.451294	0.982214726841226	0.23286	D	.	.	.	0.0233	0.88180	p.Ile136Thr	.	.	-5.866	0.61334246	.	0.85871	627177	T	.	F9	.	D	0.634	.	I136T	T	0.64053	0.47831	T/T	principal1	241561	F9_Popp_2025_strep_2_var262254	No		11/1/24		42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c							I		407	F9_Popp_2025_strep_2	627177.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA414438824	immortalized human cells		false			p.Ile136Thr		true	c.407T>C						3551.0	139548378.0	No	Likely Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa	PM2_Supporting,PS4,PM1,PP3								NM_000133.4(F9):c.407T>C (p.Ile136Thr) missense variant has a REVEL score of 0.634, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). The variant occurs within exon 5, a region deemed critical for the encoded FIX protein by the CFD-VCEP, and meets criteria for PM1. The c.407T>C (p.Ile136Thr) variant is reported in at least two individuals with mild hemophilia B and two individuals with hemophilia B of unspecified severity (PMID: 8680410, 8091381, 31064749), meeting criteria for PS4. In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9 (Released 10/5/2023): PS4, PM1, PP3, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM2_Supporting,PS4,PM1	Ile136Thr	https://erepo.genome.network/evrepo/ui/classification/42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c					T	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	136.0		hemophilia B		0.6655233363014836		Likely pathogenic	139548378.0	missense_variant		0.634					Reporter			F9_Ile136Thr
F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	0.6833168035932747	0.7400107309035774	0.6656868709286089	0.673030648296955	0.6138560801947897	0.745046260152305	0.7648545841502495	0.6903987536292615	0.7052190866359288	0.6886297254222683	0.7141815318727899	0.7524326575269135	0.6780428122789353	0.6891248674664419	0.6512429028085289	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C		Ile136Thr																												F9_Ile136Thr	23	139548378	T	C	X	allele	407T>C	C07	527_CAVA_Array_P02	E14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548378-T-C	-	0.24009	0.007	136	.	.	.	X	138630537	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ile136Thr	.	16.22	.	.	.	D	.	2	1	.	.	.	.	.	.	0.85909	Select	0.6609	.	0.14196	.	.	D	D	.	1.94467123622	.	.	.	.	.	0.42531	.	.	.	.	0.42193	.	.	0.69365	0.912	.	18.0	0.725127	3.53	0.82	C	single nucleotide variant	NC_000023.11:g.139548378T>C	.	.	2	0.33303738	.	.	0.45117912	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.46839	B	L	.	.	T/T	.	.	.	.	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	.	0.82642	.	.	-	139548378	.	-	6.148000	.	0.85875	.	.	.	.	germline;unknown	.	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.95972	GRCh38	924	reviewed by expert panel	c.407T>C	.	0.42169	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	3	.	FA9_HUMAN	.	82.0	.	.	T	0.38457	0.54474115	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99953	.	.	.	.	.	p.Ile136Thr	.	0.54222	.	germline	.		T	Nov 01, 2024	.	T/T	.	.	0.759	N	Xq27.1	.	.	.	SCV005437143	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.184	.	.	0.609	T	.	1.886718	0.33327	.	T	-	.	.	0.87475	.	.	.	0.23290	.	139548378	Y	10	.	.	.	P00740	.	0.638754	0.21374		.	0.018	D	.	0.22186896	.	0.44761	2158	0.47971	.	-1.59	.	.	0.22252	.	.	.	.	.	.	0.58914	X	F9	.	.	Ile	.	.	X-139548378-T-C	Hereditary_factor_VIII_deficiency_disease	.	.	138458203	.	.	.	.	RCV000851938|RCV004812364	D	.	.	c.407T>C	.	.	.	0.93640	T/T	rs1603265481	139548378	.	T	.	P00740	.	0.63798	.	0.68239		.	.	.	0.92	.	.	.	3.75	0.88783	.	T	T	.	.	.	.	.	.	.	98878	627177	0.93561	0.93269	0.265829622745514	.	.	0.29323	.	.	.	.	1.274	.	N	.	.	.	.	134500|306700	0.32841	X	.	ENSG00000101981	.	.	.	.	0.9571971461018347	2	0.18486	0.18019	.	.	.	.	.	YES	.	0.215404	615665	HGNC:3551	A	.	simple_aae	0.745	.	139548378	ATT	1.000000	.	-	.	0.67284	.	.	.	Likely pathogenic	0.45201	.	.	.	ClinGen:CA414438824	I	.	0.999803421972	-	0.864	-	0.68623	.	.	0.95679	0.526858687401	0.1348	.	0.91815137977279504	.	-	407T>C 	.	.	C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.33926	1603265481	.	.	0.99980	.	0.323	0.145	.	0.99995446	4.94	.	.	.	0.451294	0.982214726841226	0.23286	D	.	.	.	0.0233	0.88180	p.Ile136Thr	.	.	-5.866	0.61334246	.	0.85871	627177	T	.	F9	.	D	0.634	.	I136T	T	0.64053	0.47831	T/T	principal1	214045	F9_Popp_2025_light_chain_var242892	No		11/1/24		42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c							I		407	F9_Popp_2025_light_chain	627177.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA414438824	immortalized human cells		false			p.Ile136Thr		true	c.407T>C						3551.0	139548378.0	No	Likely Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa	PM2_Supporting,PS4,PM1,PP3								NM_000133.4(F9):c.407T>C (p.Ile136Thr) missense variant has a REVEL score of 0.634, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). The variant occurs within exon 5, a region deemed critical for the encoded FIX protein by the CFD-VCEP, and meets criteria for PM1. The c.407T>C (p.Ile136Thr) variant is reported in at least two individuals with mild hemophilia B and two individuals with hemophilia B of unspecified severity (PMID: 8680410, 8091381, 31064749), meeting criteria for PS4. In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9 (Released 10/5/2023): PS4, PM1, PP3, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM2_Supporting,PS4,PM1	Ile136Thr	https://erepo.genome.network/evrepo/ui/classification/42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c					T	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	136.0		hemophilia B		0.6736284772469037		Likely pathogenic	139548378.0	missense_variant		0.634					Reporter			F9_Ile136Thr
F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	0.6833168035932747	0.7400107309035774	0.6656868709286089	0.673030648296955	0.6138560801947897	0.745046260152305	0.7648545841502495	0.6903987536292615	0.7052190866359288	0.6886297254222683	0.7141815318727899	0.7524326575269135	0.6780428122789353	0.6891248674664419	0.6512429028085289	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C		Ile136Thr																												F9_Ile136Thr	23	139548378	T	C	X	allele	407T>C	C07	527_CAVA_Array_P02	E14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548378-T-C	-	0.24009	0.007	136	.	.	.	X	138630537	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ile136Thr	.	16.22	.	.	.	D	.	2	1	.	.	.	.	.	.	0.85909	Select	0.6609	.	0.14196	.	.	D	D	.	1.94467123622	.	.	.	.	.	0.42531	.	.	.	.	0.42193	.	.	0.69365	0.912	.	18.0	0.725127	3.53	0.82	C	single nucleotide variant	NC_000023.11:g.139548378T>C	.	.	2	0.33303738	.	.	0.45117912	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.46839	B	L	.	.	T/T	.	.	.	.	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	.	0.82642	.	.	-	139548378	.	-	6.148000	.	0.85875	.	.	.	.	germline;unknown	.	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.95972	GRCh38	924	reviewed by expert panel	c.407T>C	.	0.42169	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	3	.	FA9_HUMAN	.	82.0	.	.	T	0.38457	0.54474115	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99953	.	.	.	.	.	p.Ile136Thr	.	0.54222	.	germline	.		T	Nov 01, 2024	.	T/T	.	.	0.759	N	Xq27.1	.	.	.	SCV005437143	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.184	.	.	0.609	T	.	1.886718	0.33327	.	T	-	.	.	0.87475	.	.	.	0.23290	.	139548378	Y	10	.	.	.	P00740	.	0.638754	0.21374		.	0.018	D	.	0.22186896	.	0.44761	2158	0.47971	.	-1.59	.	.	0.22252	.	.	.	.	.	.	0.58914	X	F9	.	.	Ile	.	.	X-139548378-T-C	Hereditary_factor_VIII_deficiency_disease	.	.	138458203	.	.	.	.	RCV000851938|RCV004812364	D	.	.	c.407T>C	.	.	.	0.93640	T/T	rs1603265481	139548378	.	T	.	P00740	.	0.63798	.	0.68239		.	.	.	0.92	.	.	.	3.75	0.88783	.	T	T	.	.	.	.	.	.	.	98878	627177	0.93561	0.93269	0.265829622745514	.	.	0.29323	.	.	.	.	1.274	.	N	.	.	.	.	134500|306700	0.32841	X	.	ENSG00000101981	.	.	.	.	0.9571971461018347	2	0.18486	0.18019	.	.	.	.	.	YES	.	0.215404	615665	HGNC:3551	A	.	simple_aae	0.745	.	139548378	ATT	1.000000	.	-	.	0.67284	.	.	.	Likely pathogenic	0.45201	.	.	.	ClinGen:CA414438824	I	.	0.999803421972	-	0.864	-	0.68623	.	.	0.95679	0.526858687401	0.1348	.	0.91815137977279504	.	-	407T>C 	.	.	C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.33926	1603265481	.	.	0.99980	.	0.323	0.145	.	0.99995446	4.94	.	.	.	0.451294	0.982214726841226	0.23286	D	.	.	.	0.0233	0.88180	p.Ile136Thr	.	.	-5.866	0.61334246	.	0.85871	627177	T	.	F9	.	D	0.634	.	I136T	T	0.64053	0.47831	T/T	principal1	131497	F9_Popp_2025_carboxy_F9_specific_var223530	No		11/1/24		42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c							I		407	F9_Popp_2025_carboxy_F9_specific	627177.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA414438824	immortalized human cells		false			p.Ile136Thr		true	c.407T>C						3551.0	139548378.0	No	Likely Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa	PM2_Supporting,PS4,PM1,PP3								NM_000133.4(F9):c.407T>C (p.Ile136Thr) missense variant has a REVEL score of 0.634, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). The variant occurs within exon 5, a region deemed critical for the encoded FIX protein by the CFD-VCEP, and meets criteria for PM1. The c.407T>C (p.Ile136Thr) variant is reported in at least two individuals with mild hemophilia B and two individuals with hemophilia B of unspecified severity (PMID: 8680410, 8091381, 31064749), meeting criteria for PS4. In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9 (Released 10/5/2023): PS4, PM1, PP3, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM2_Supporting,PS4,PM1	Ile136Thr	https://erepo.genome.network/evrepo/ui/classification/42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c					T	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	136.0		hemophilia B		0.5990003052119737		Likely pathogenic	139548378.0	missense_variant		0.634					Reporter			F9_Ile136Thr
F9_Ile136Thr	1.8596057282386111	0.10527238859817044	-2.234007194152328	0.060611432891231026	2025_01_Batch_13-14	0.6833168035932747	0.7400107309035774	0.6656868709286089	0.673030648296955	0.6138560801947897	0.745046260152305	0.7648545841502495	0.6903987536292615	0.7052190866359288	0.6886297254222683	0.7141815318727899	0.7524326575269135	0.6780428122789353	0.6891248674664419	0.6512429028085289	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030528		NC_000023.11:139548378:T:C		Ile136Thr																												F9_Ile136Thr	23	139548378	T	C	X	allele	407T>C	C07	527_CAVA_Array_P02	E14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548378-T-C	-	0.24009	0.007	136	.	.	.	X	138630537	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ile136Thr	.	16.22	.	.	.	D	.	2	1	.	.	.	.	.	.	0.85909	Select	0.6609	.	0.14196	.	.	D	D	.	1.94467123622	.	.	.	.	.	0.42531	.	.	.	.	0.42193	.	.	0.69365	0.912	.	18.0	0.725127	3.53	0.82	C	single nucleotide variant	NC_000023.11:g.139548378T>C	.	.	2	0.33303738	.	.	0.45117912	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.46839	B	L	.	.	T/T	.	.	.	.	Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease	.	0.82642	.	.	-	139548378	.	-	6.148000	.	0.85875	.	.	.	.	germline;unknown	.	Loss of stability (P = 0.0083)| Gain of disorder (P = 0.0126)| Loss of methylation at K137 (P = 0.0548)| Gain of ubiquitination at K137 (P = 0.068)| Gain of catalytic residue at I136 (P = 0.1884)	0.95972	GRCh38	924	reviewed by expert panel	c.407T>C	.	0.42169	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.407T>C (p.Ile136Thr)	3	.	FA9_HUMAN	.	82.0	.	.	T	0.38457	0.54474115	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99953	.	.	.	.	.	p.Ile136Thr	.	0.54222	.	germline	.		T	Nov 01, 2024	.	T/T	.	.	0.759	N	Xq27.1	.	.	.	SCV005437143	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.184	.	.	0.609	T	.	1.886718	0.33327	.	T	-	.	.	0.87475	.	.	.	0.23290	.	139548378	Y	10	.	.	.	P00740	.	0.638754	0.21374		.	0.018	D	.	0.22186896	.	0.44761	2158	0.47971	.	-1.59	.	.	0.22252	.	.	.	.	.	.	0.58914	X	F9	.	.	Ile	.	.	X-139548378-T-C	Hereditary_factor_VIII_deficiency_disease	.	.	138458203	.	.	.	.	RCV000851938|RCV004812364	D	.	.	c.407T>C	.	.	.	0.93640	T/T	rs1603265481	139548378	.	T	.	P00740	.	0.63798	.	0.68239		.	.	.	0.92	.	.	.	3.75	0.88783	.	T	T	.	.	.	.	.	.	.	98878	627177	0.93561	0.93269	0.265829622745514	.	.	0.29323	.	.	.	.	1.274	.	N	.	.	.	.	134500|306700	0.32841	X	.	ENSG00000101981	.	.	.	.	0.9571971461018347	2	0.18486	0.18019	.	.	.	.	.	YES	.	0.215404	615665	HGNC:3551	A	.	simple_aae	0.745	.	139548378	ATT	1.000000	.	-	.	0.67284	.	.	.	Likely pathogenic	0.45201	.	.	.	ClinGen:CA414438824	I	.	0.999803421972	-	0.864	-	0.68623	.	.	0.95679	0.526858687401	0.1348	.	0.91815137977279504	.	-	407T>C 	.	.	C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.33926	1603265481	.	.	0.99980	.	0.323	0.145	.	0.99995446	4.94	.	.	.	0.451294	0.982214726841226	0.23286	D	.	.	.	0.0233	0.88180	p.Ile136Thr	.	.	-5.866	0.61334246	.	0.85871	627177	T	.	F9	.	D	0.634	.	I136T	T	0.64053	0.47831	T/T	principal1	186529	F9_Popp_2025_heavy_chain_var233211	No		11/1/24		42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c							I		407	F9_Popp_2025_heavy_chain	627177.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA414438824	immortalized human cells		false			p.Ile136Thr		true	c.407T>C						3551.0	139548378.0	No	Likely Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa	PM2_Supporting,PS4,PM1,PP3								NM_000133.4(F9):c.407T>C (p.Ile136Thr) missense variant has a REVEL score of 0.634, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). The variant occurs within exon 5, a region deemed critical for the encoded FIX protein by the CFD-VCEP, and meets criteria for PM1. The c.407T>C (p.Ile136Thr) variant is reported in at least two individuals with mild hemophilia B and two individuals with hemophilia B of unspecified severity (PMID: 8680410, 8091381, 31064749), meeting criteria for PS4. In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9 (Released 10/5/2023): PS4, PM1, PP3, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PM2_Supporting,PS4,PM1	Ile136Thr	https://erepo.genome.network/evrepo/ui/classification/42c02c48-c3ed-4e7a-a05d-7d209d9c2d6c					T	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	136.0		hemophilia B		0.6038391908519662		Likely pathogenic	139548378.0	missense_variant		0.634					Reporter			F9_Ile136Thr
F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg226Gln	23	139551218	G	A	X											X-139551218-G-A	-	0.68339	0.998	226	.	.	.	X	138633377	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg226Gln	.	25.2	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93165	Select	0.8506	.	0.73231	.	.	D	D	.	1.74758098799	0	.	.	.	.	0.23489	.	.	.	.	0.66580	.	.	0.82601	0.94	.	23.0	0.737626	4.78	0.77	A	single nucleotide variant	NC_000023.11:g.139551218G>A	.	.	3	0.7921764	.	0	0.75372374	0		.	.	.	.	.	146	.	0	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	.	.	.	.	0.87956	P	0.89275	D	M	.	.	G/G	108	0	.	.	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	.	0.96137	.	.	-	139551218	.	-	11.788000	.	0.99413	.	0	.	.	germline	.	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.99445	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.677G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2	.	FA9_HUMAN	.	77.0	.	.	T	0.59270	0.782613	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Arg226Gln	.	0.96297	.	germline	.		G	Jun 21, 2024	.	G/G	.	.	0.988	N	Xq27.1	7618	.	.	SCV001976456|SCV005439229	Pathogenic	.	.	Gln	Q	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.412827	0.72530	.	D	-	.	.	0.98828	610	.	.	0.78004	0	139551218	Y	10	0	.	.	P00740	.	0.836803	0.99931		.	0.852	D	.	0.8180072	.	0.48078	2158	0.587764	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.87626	X	F9	.	0	Arg	11862	.	X-139551218-G-A	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	.	.	138461043	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	.	.	.	RCV000011337|RCV001727513|RCV004752695|RCV004814880	D	.	.	c.677G>A	.	.	.	0.97316	G/G	rs137852241	139551218	.	G	.	P00740	.	0.80855	.	0.68239		.	.	.	2.175	0	0	.	5.31	0.96127	108	D	T	.	.	0	24	.	.	.	98879	10591	0.97273	0.90920	0.987725436687469	2816	.	0.36621	.	.	.	.	5.361	.	D	.	.	.	0	306900	0.65922	X	.	ENSG00000101981	.	0	.	0	0.9984916172821304	2	0.60752	0.18019	.	.	.	.	.	YES	.	0.848427	25630	HGNC:3551	A	.	simple_aae	0.983	.	139551218	CGG	1.000000	.	-	0	0.99712	.	0	.	Pathogenic	0.78608	.	.	.	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	R	.	0.999946805639	-	0.952	-	0.90815	.	470	0.99848	0.388901472092	0.2674	.	0.99948969239605312	94	-	677G>A 	.	0	CN043453|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.35241	137852241	.	0	0.99994	.	0.864	0.005	2708	0.99998748	5.31	.	.	.	0.606506	0.999623815643521	0.60790	D	84	.	.	0.9333	0.95008	p.Arg226Gln	0	.	-10.798	0.9918215	.	0.97231	10591	D	.	F9	.	D	0.793	.	R226Q	D	0.87641	0.76753	G/G	principal1	136845	F9_Popp_2025_carboxy_F9_specific_var225422	No											R		677	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Arg226Gln		true	c.677G>A						3551.0	139551218.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				Arg226Gln						Q	Jun 21, 2024					missense_variant		226.0				1.078825764535242		Pathogenic	139551218.0	missense_variant		0.793					Reporter			F9_Arg226Gln
F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg226Gln	23	139551218	G	A	X											X-139551218-G-A	-	0.68339	0.998	226	.	.	.	X	138633377	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg226Gln	.	25.2	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93165	Select	0.8506	.	0.73231	.	.	D	D	.	1.74758098799	0	.	.	.	.	0.23489	.	.	.	.	0.66580	.	.	0.82601	0.94	.	23.0	0.737626	4.78	0.77	A	single nucleotide variant	NC_000023.11:g.139551218G>A	.	.	3	0.7921764	.	0	0.75372374	0		.	.	.	.	.	146	.	0	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	.	.	.	.	0.87956	P	0.89275	D	M	.	.	G/G	108	0	.	.	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	.	0.96137	.	.	-	139551218	.	-	11.788000	.	0.99413	.	0	.	.	germline	.	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.99445	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.677G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2	.	FA9_HUMAN	.	77.0	.	.	T	0.59270	0.782613	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Arg226Gln	.	0.96297	.	germline	.		G	Jun 21, 2024	.	G/G	.	.	0.988	N	Xq27.1	7618	.	.	SCV001976456|SCV005439229	Pathogenic	.	.	Gln	Q	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.412827	0.72530	.	D	-	.	.	0.98828	610	.	.	0.78004	0	139551218	Y	10	0	.	.	P00740	.	0.836803	0.99931		.	0.852	D	.	0.8180072	.	0.48078	2158	0.587764	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.87626	X	F9	.	0	Arg	11862	.	X-139551218-G-A	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	.	.	138461043	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	.	.	.	RCV000011337|RCV001727513|RCV004752695|RCV004814880	D	.	.	c.677G>A	.	.	.	0.97316	G/G	rs137852241	139551218	.	G	.	P00740	.	0.80855	.	0.68239		.	.	.	2.175	0	0	.	5.31	0.96127	108	D	T	.	.	0	24	.	.	.	98879	10591	0.97273	0.90920	0.987725436687469	2816	.	0.36621	.	.	.	.	5.361	.	D	.	.	.	0	306900	0.65922	X	.	ENSG00000101981	.	0	.	0	0.9984916172821304	2	0.60752	0.18019	.	.	.	.	.	YES	.	0.848427	25630	HGNC:3551	A	.	simple_aae	0.983	.	139551218	CGG	1.000000	.	-	0	0.99712	.	0	.	Pathogenic	0.78608	.	.	.	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	R	.	0.999946805639	-	0.952	-	0.90815	.	470	0.99848	0.388901472092	0.2674	.	0.99948969239605312	94	-	677G>A 	.	0	CN043453|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.35241	137852241	.	0	0.99994	.	0.864	0.005	2708	0.99998748	5.31	.	.	.	0.606506	0.999623815643521	0.60790	D	84	.	.	0.9333	0.95008	p.Arg226Gln	0	.	-10.798	0.9918215	.	0.97231	10591	D	.	F9	.	D	0.793	.	R226Q	D	0.87641	0.76753	G/G	principal1	246909	F9_Popp_2025_strep_2_var264146	No											R		677	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Arg226Gln		true	c.677G>A						3551.0	139551218.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				Arg226Gln						Q	Jun 21, 2024					missense_variant		226.0				0.757955943		Pathogenic	139551218.0	missense_variant		0.793					Reporter			F9_Arg226Gln
F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg226Gln	23	139551218	G	A	X											X-139551218-G-A	-	0.68339	0.998	226	.	.	.	X	138633377	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg226Gln	.	25.2	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93165	Select	0.8506	.	0.73231	.	.	D	D	.	1.74758098799	0	.	.	.	.	0.23489	.	.	.	.	0.66580	.	.	0.82601	0.94	.	23.0	0.737626	4.78	0.77	A	single nucleotide variant	NC_000023.11:g.139551218G>A	.	.	3	0.7921764	.	0	0.75372374	0		.	.	.	.	.	146	.	0	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	.	.	.	.	0.87956	P	0.89275	D	M	.	.	G/G	108	0	.	.	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	.	0.96137	.	.	-	139551218	.	-	11.788000	.	0.99413	.	0	.	.	germline	.	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.99445	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.677G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2	.	FA9_HUMAN	.	77.0	.	.	T	0.59270	0.782613	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Arg226Gln	.	0.96297	.	germline	.		G	Jun 21, 2024	.	G/G	.	.	0.988	N	Xq27.1	7618	.	.	SCV001976456|SCV005439229	Pathogenic	.	.	Gln	Q	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.412827	0.72530	.	D	-	.	.	0.98828	610	.	.	0.78004	0	139551218	Y	10	0	.	.	P00740	.	0.836803	0.99931		.	0.852	D	.	0.8180072	.	0.48078	2158	0.587764	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.87626	X	F9	.	0	Arg	11862	.	X-139551218-G-A	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	.	.	138461043	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	.	.	.	RCV000011337|RCV001727513|RCV004752695|RCV004814880	D	.	.	c.677G>A	.	.	.	0.97316	G/G	rs137852241	139551218	.	G	.	P00740	.	0.80855	.	0.68239		.	.	.	2.175	0	0	.	5.31	0.96127	108	D	T	.	.	0	24	.	.	.	98879	10591	0.97273	0.90920	0.987725436687469	2816	.	0.36621	.	.	.	.	5.361	.	D	.	.	.	0	306900	0.65922	X	.	ENSG00000101981	.	0	.	0	0.9984916172821304	2	0.60752	0.18019	.	.	.	.	.	YES	.	0.848427	25630	HGNC:3551	A	.	simple_aae	0.983	.	139551218	CGG	1.000000	.	-	0	0.99712	.	0	.	Pathogenic	0.78608	.	.	.	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	R	.	0.999946805639	-	0.952	-	0.90815	.	470	0.99848	0.388901472092	0.2674	.	0.99948969239605312	94	-	677G>A 	.	0	CN043453|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.35241	137852241	.	0	0.99994	.	0.864	0.005	2708	0.99998748	5.31	.	.	.	0.606506	0.999623815643521	0.60790	D	84	.	.	0.9333	0.95008	p.Arg226Gln	0	.	-10.798	0.9918215	.	0.97231	10591	D	.	F9	.	D	0.793	.	R226Q	D	0.87641	0.76753	G/G	principal1	164361	F9_Popp_2025_carboxy_gla_motif_var254465	No											R		677	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Arg226Gln		true	c.677G>A						3551.0	139551218.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				Arg226Gln						Q	Jun 21, 2024					missense_variant		226.0				1.0671888984333089		Pathogenic	139551218.0	missense_variant		0.793					Reporter			F9_Arg226Gln
F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg226Gln	23	139551218	G	A	X											X-139551218-G-A	-	0.68339	0.998	226	.	.	.	X	138633377	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg226Gln	.	25.2	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93165	Select	0.8506	.	0.73231	.	.	D	D	.	1.74758098799	0	.	.	.	.	0.23489	.	.	.	.	0.66580	.	.	0.82601	0.94	.	23.0	0.737626	4.78	0.77	A	single nucleotide variant	NC_000023.11:g.139551218G>A	.	.	3	0.7921764	.	0	0.75372374	0		.	.	.	.	.	146	.	0	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	.	.	.	.	0.87956	P	0.89275	D	M	.	.	G/G	108	0	.	.	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	.	0.96137	.	.	-	139551218	.	-	11.788000	.	0.99413	.	0	.	.	germline	.	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.99445	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.677G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2	.	FA9_HUMAN	.	77.0	.	.	T	0.59270	0.782613	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Arg226Gln	.	0.96297	.	germline	.		G	Jun 21, 2024	.	G/G	.	.	0.988	N	Xq27.1	7618	.	.	SCV001976456|SCV005439229	Pathogenic	.	.	Gln	Q	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.412827	0.72530	.	D	-	.	.	0.98828	610	.	.	0.78004	0	139551218	Y	10	0	.	.	P00740	.	0.836803	0.99931		.	0.852	D	.	0.8180072	.	0.48078	2158	0.587764	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.87626	X	F9	.	0	Arg	11862	.	X-139551218-G-A	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	.	.	138461043	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	.	.	.	RCV000011337|RCV001727513|RCV004752695|RCV004814880	D	.	.	c.677G>A	.	.	.	0.97316	G/G	rs137852241	139551218	.	G	.	P00740	.	0.80855	.	0.68239		.	.	.	2.175	0	0	.	5.31	0.96127	108	D	T	.	.	0	24	.	.	.	98879	10591	0.97273	0.90920	0.987725436687469	2816	.	0.36621	.	.	.	.	5.361	.	D	.	.	.	0	306900	0.65922	X	.	ENSG00000101981	.	0	.	0	0.9984916172821304	2	0.60752	0.18019	.	.	.	.	.	YES	.	0.848427	25630	HGNC:3551	A	.	simple_aae	0.983	.	139551218	CGG	1.000000	.	-	0	0.99712	.	0	.	Pathogenic	0.78608	.	.	.	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	R	.	0.999946805639	-	0.952	-	0.90815	.	470	0.99848	0.388901472092	0.2674	.	0.99948969239605312	94	-	677G>A 	.	0	CN043453|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.35241	137852241	.	0	0.99994	.	0.864	0.005	2708	0.99998748	5.31	.	.	.	0.606506	0.999623815643521	0.60790	D	84	.	.	0.9333	0.95008	p.Arg226Gln	0	.	-10.798	0.9918215	.	0.97231	10591	D	.	F9	.	D	0.793	.	R226Q	D	0.87641	0.76753	G/G	principal1	219393	F9_Popp_2025_light_chain_var244784	No											R		677	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Arg226Gln		true	c.677G>A						3551.0	139551218.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				Arg226Gln						Q	Jun 21, 2024					missense_variant		226.0				1.0828234546833777		Pathogenic	139551218.0	missense_variant		0.793					Reporter			F9_Arg226Gln
F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	NC_000023.11:139551218:G:A	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg226Gln	23	139551218	G	A	X											X-139551218-G-A	-	0.68339	0.998	226	.	.	.	X	138633377	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg226Gln	.	25.2	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93165	Select	0.8506	.	0.73231	.	.	D	D	.	1.74758098799	0	.	.	.	.	0.23489	.	.	.	.	0.66580	.	.	0.82601	0.94	.	23.0	0.737626	4.78	0.77	A	single nucleotide variant	NC_000023.11:g.139551218G>A	.	.	3	0.7921764	.	0	0.75372374	0		.	.	.	.	.	146	.	0	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	.	.	.	.	0.87956	P	0.89275	D	M	.	.	G/G	108	0	.	.	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	.	0.96137	.	.	-	139551218	.	-	11.788000	.	0.99413	.	0	.	.	germline	.	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.99445	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.677G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2	.	FA9_HUMAN	.	77.0	.	.	T	0.59270	0.782613	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Arg226Gln	.	0.96297	.	germline	.		G	Jun 21, 2024	.	G/G	.	.	0.988	N	Xq27.1	7618	.	.	SCV001976456|SCV005439229	Pathogenic	.	.	Gln	Q	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.412827	0.72530	.	D	-	.	.	0.98828	610	.	.	0.78004	0	139551218	Y	10	0	.	.	P00740	.	0.836803	0.99931		.	0.852	D	.	0.8180072	.	0.48078	2158	0.587764	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.87626	X	F9	.	0	Arg	11862	.	X-139551218-G-A	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	.	.	138461043	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	.	.	.	RCV000011337|RCV001727513|RCV004752695|RCV004814880	D	.	.	c.677G>A	.	.	.	0.97316	G/G	rs137852241	139551218	.	G	.	P00740	.	0.80855	.	0.68239		.	.	.	2.175	0	0	.	5.31	0.96127	108	D	T	.	.	0	24	.	.	.	98879	10591	0.97273	0.90920	0.987725436687469	2816	.	0.36621	.	.	.	.	5.361	.	D	.	.	.	0	306900	0.65922	X	.	ENSG00000101981	.	0	.	0	0.9984916172821304	2	0.60752	0.18019	.	.	.	.	.	YES	.	0.848427	25630	HGNC:3551	A	.	simple_aae	0.983	.	139551218	CGG	1.000000	.	-	0	0.99712	.	0	.	Pathogenic	0.78608	.	.	.	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	R	.	0.999946805639	-	0.952	-	0.90815	.	470	0.99848	0.388901472092	0.2674	.	0.99948969239605312	94	-	677G>A 	.	0	CN043453|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.35241	137852241	.	0	0.99994	.	0.864	0.005	2708	0.99998748	5.31	.	.	.	0.606506	0.999623815643521	0.60790	D	84	.	.	0.9333	0.95008	p.Arg226Gln	0	.	-10.798	0.9918215	.	0.97231	10591	D	.	F9	.	D	0.793	.	R226Q	D	0.87641	0.76753	G/G	principal1	191877	F9_Popp_2025_heavy_chain_var235103	No											R		677	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Arg226Gln		true	c.677G>A						3551.0	139551218.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				Arg226Gln						Q	Jun 21, 2024					missense_variant		226.0				0.943706481718542		Pathogenic	139551218.0	missense_variant		0.793					Reporter			F9_Arg226Gln
F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004380		NC_000023.11:139551218:G:A		Arg226Gln																												F9_Arg226Gln	23	139551218	G	A	X	allele	677G>A	A09	527_CAVA_Array_P02	A18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551218-G-A	-	0.68339	0.998	226	.	.	.	X	138633377	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg226Gln	.	25.2	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93165	Select	0.8506	.	0.73231	.	.	D	D	.	1.74758098799	0	.	.	.	.	0.23489	.	.	.	.	0.66580	.	.	0.82601	0.94	.	23.0	0.737626	4.78	0.77	A	single nucleotide variant	NC_000023.11:g.139551218G>A	.	.	3	0.7921764	.	0	0.75372374	0		.	.	.	.	.	146	.	0	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	.	.	.	.	0.87956	P	0.89275	D	M	.	.	G/G	108	0	.	.	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	.	0.96137	.	.	-	139551218	.	-	11.788000	.	0.99413	.	0	.	.	germline	.	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.99445	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.677G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2	.	FA9_HUMAN	.	77.0	.	.	T	0.59270	0.782613	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Arg226Gln	.	0.96297	.	germline	.		G	Jun 21, 2024	.	G/G	.	.	0.988	N	Xq27.1	7618	.	.	SCV001976456|SCV005439229	Pathogenic	.	.	Gln	Q	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.412827	0.72530	.	D	-	.	.	0.98828	610	.	.	0.78004	0	139551218	Y	10	0	.	.	P00740	.	0.836803	0.99931		.	0.852	D	.	0.8180072	.	0.48078	2158	0.587764	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.87626	X	F9	.	0	Arg	11862	.	X-139551218-G-A	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	.	.	138461043	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	.	.	.	RCV000011337|RCV001727513|RCV004752695|RCV004814880	D	.	.	c.677G>A	.	.	.	0.97316	G/G	rs137852241	139551218	.	G	.	P00740	.	0.80855	.	0.68239		.	.	.	2.175	0	0	.	5.31	0.96127	108	D	T	.	.	0	24	.	.	.	98879	10591	0.97273	0.90920	0.987725436687469	2816	.	0.36621	.	.	.	.	5.361	.	D	.	.	.	0	306900	0.65922	X	.	ENSG00000101981	.	0	.	0	0.9984916172821304	2	0.60752	0.18019	.	.	.	.	.	YES	.	0.848427	25630	HGNC:3551	A	.	simple_aae	0.983	.	139551218	CGG	1.000000	.	-	0	0.99712	.	0	.	Pathogenic	0.78608	.	.	.	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	R	.	0.999946805639	-	0.952	-	0.90815	.	470	0.99848	0.388901472092	0.2674	.	0.99948969239605312	94	-	677G>A 	.	0	CN043453|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.35241	137852241	.	0	0.99994	.	0.864	0.005	2708	0.99998748	5.31	.	.	.	0.606506	0.999623815643521	0.60790	D	84	.	.	0.9333	0.95008	p.Arg226Gln	0	.	-10.798	0.9918215	.	0.97231	10591	D	.	F9	.	D	0.793	.	R226Q	D	0.87641	0.76753	G/G	principal1	136845	F9_Popp_2025_carboxy_F9_specific_var225422	No											R		677	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Arg226Gln		true	c.677G>A						3551.0	139551218.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				Arg226Gln						Q	Jun 21, 2024					missense_variant		226.0				1.078825764535242		Pathogenic	139551218.0	missense_variant		0.793					Reporter			F9_Arg226Gln
F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004380		NC_000023.11:139551218:G:A		Arg226Gln																												F9_Arg226Gln	23	139551218	G	A	X	allele	677G>A	A09	527_CAVA_Array_P02	A18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551218-G-A	-	0.68339	0.998	226	.	.	.	X	138633377	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg226Gln	.	25.2	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93165	Select	0.8506	.	0.73231	.	.	D	D	.	1.74758098799	0	.	.	.	.	0.23489	.	.	.	.	0.66580	.	.	0.82601	0.94	.	23.0	0.737626	4.78	0.77	A	single nucleotide variant	NC_000023.11:g.139551218G>A	.	.	3	0.7921764	.	0	0.75372374	0		.	.	.	.	.	146	.	0	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	.	.	.	.	0.87956	P	0.89275	D	M	.	.	G/G	108	0	.	.	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	.	0.96137	.	.	-	139551218	.	-	11.788000	.	0.99413	.	0	.	.	germline	.	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.99445	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.677G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2	.	FA9_HUMAN	.	77.0	.	.	T	0.59270	0.782613	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Arg226Gln	.	0.96297	.	germline	.		G	Jun 21, 2024	.	G/G	.	.	0.988	N	Xq27.1	7618	.	.	SCV001976456|SCV005439229	Pathogenic	.	.	Gln	Q	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.412827	0.72530	.	D	-	.	.	0.98828	610	.	.	0.78004	0	139551218	Y	10	0	.	.	P00740	.	0.836803	0.99931		.	0.852	D	.	0.8180072	.	0.48078	2158	0.587764	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.87626	X	F9	.	0	Arg	11862	.	X-139551218-G-A	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	.	.	138461043	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	.	.	.	RCV000011337|RCV001727513|RCV004752695|RCV004814880	D	.	.	c.677G>A	.	.	.	0.97316	G/G	rs137852241	139551218	.	G	.	P00740	.	0.80855	.	0.68239		.	.	.	2.175	0	0	.	5.31	0.96127	108	D	T	.	.	0	24	.	.	.	98879	10591	0.97273	0.90920	0.987725436687469	2816	.	0.36621	.	.	.	.	5.361	.	D	.	.	.	0	306900	0.65922	X	.	ENSG00000101981	.	0	.	0	0.9984916172821304	2	0.60752	0.18019	.	.	.	.	.	YES	.	0.848427	25630	HGNC:3551	A	.	simple_aae	0.983	.	139551218	CGG	1.000000	.	-	0	0.99712	.	0	.	Pathogenic	0.78608	.	.	.	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	R	.	0.999946805639	-	0.952	-	0.90815	.	470	0.99848	0.388901472092	0.2674	.	0.99948969239605312	94	-	677G>A 	.	0	CN043453|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.35241	137852241	.	0	0.99994	.	0.864	0.005	2708	0.99998748	5.31	.	.	.	0.606506	0.999623815643521	0.60790	D	84	.	.	0.9333	0.95008	p.Arg226Gln	0	.	-10.798	0.9918215	.	0.97231	10591	D	.	F9	.	D	0.793	.	R226Q	D	0.87641	0.76753	G/G	principal1	246909	F9_Popp_2025_strep_2_var264146	No											R		677	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Arg226Gln		true	c.677G>A						3551.0	139551218.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				Arg226Gln						Q	Jun 21, 2024					missense_variant		226.0				0.757955943		Pathogenic	139551218.0	missense_variant		0.793					Reporter			F9_Arg226Gln
F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004380		NC_000023.11:139551218:G:A		Arg226Gln																												F9_Arg226Gln	23	139551218	G	A	X	allele	677G>A	A09	527_CAVA_Array_P02	A18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551218-G-A	-	0.68339	0.998	226	.	.	.	X	138633377	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg226Gln	.	25.2	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93165	Select	0.8506	.	0.73231	.	.	D	D	.	1.74758098799	0	.	.	.	.	0.23489	.	.	.	.	0.66580	.	.	0.82601	0.94	.	23.0	0.737626	4.78	0.77	A	single nucleotide variant	NC_000023.11:g.139551218G>A	.	.	3	0.7921764	.	0	0.75372374	0		.	.	.	.	.	146	.	0	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	.	.	.	.	0.87956	P	0.89275	D	M	.	.	G/G	108	0	.	.	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	.	0.96137	.	.	-	139551218	.	-	11.788000	.	0.99413	.	0	.	.	germline	.	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.99445	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.677G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2	.	FA9_HUMAN	.	77.0	.	.	T	0.59270	0.782613	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Arg226Gln	.	0.96297	.	germline	.		G	Jun 21, 2024	.	G/G	.	.	0.988	N	Xq27.1	7618	.	.	SCV001976456|SCV005439229	Pathogenic	.	.	Gln	Q	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.412827	0.72530	.	D	-	.	.	0.98828	610	.	.	0.78004	0	139551218	Y	10	0	.	.	P00740	.	0.836803	0.99931		.	0.852	D	.	0.8180072	.	0.48078	2158	0.587764	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.87626	X	F9	.	0	Arg	11862	.	X-139551218-G-A	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	.	.	138461043	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	.	.	.	RCV000011337|RCV001727513|RCV004752695|RCV004814880	D	.	.	c.677G>A	.	.	.	0.97316	G/G	rs137852241	139551218	.	G	.	P00740	.	0.80855	.	0.68239		.	.	.	2.175	0	0	.	5.31	0.96127	108	D	T	.	.	0	24	.	.	.	98879	10591	0.97273	0.90920	0.987725436687469	2816	.	0.36621	.	.	.	.	5.361	.	D	.	.	.	0	306900	0.65922	X	.	ENSG00000101981	.	0	.	0	0.9984916172821304	2	0.60752	0.18019	.	.	.	.	.	YES	.	0.848427	25630	HGNC:3551	A	.	simple_aae	0.983	.	139551218	CGG	1.000000	.	-	0	0.99712	.	0	.	Pathogenic	0.78608	.	.	.	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	R	.	0.999946805639	-	0.952	-	0.90815	.	470	0.99848	0.388901472092	0.2674	.	0.99948969239605312	94	-	677G>A 	.	0	CN043453|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.35241	137852241	.	0	0.99994	.	0.864	0.005	2708	0.99998748	5.31	.	.	.	0.606506	0.999623815643521	0.60790	D	84	.	.	0.9333	0.95008	p.Arg226Gln	0	.	-10.798	0.9918215	.	0.97231	10591	D	.	F9	.	D	0.793	.	R226Q	D	0.87641	0.76753	G/G	principal1	164361	F9_Popp_2025_carboxy_gla_motif_var254465	No											R		677	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Arg226Gln		true	c.677G>A						3551.0	139551218.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				Arg226Gln						Q	Jun 21, 2024					missense_variant		226.0				1.0671888984333089		Pathogenic	139551218.0	missense_variant		0.793					Reporter			F9_Arg226Gln
F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004380		NC_000023.11:139551218:G:A		Arg226Gln																												F9_Arg226Gln	23	139551218	G	A	X	allele	677G>A	A09	527_CAVA_Array_P02	A18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551218-G-A	-	0.68339	0.998	226	.	.	.	X	138633377	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg226Gln	.	25.2	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93165	Select	0.8506	.	0.73231	.	.	D	D	.	1.74758098799	0	.	.	.	.	0.23489	.	.	.	.	0.66580	.	.	0.82601	0.94	.	23.0	0.737626	4.78	0.77	A	single nucleotide variant	NC_000023.11:g.139551218G>A	.	.	3	0.7921764	.	0	0.75372374	0		.	.	.	.	.	146	.	0	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	.	.	.	.	0.87956	P	0.89275	D	M	.	.	G/G	108	0	.	.	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	.	0.96137	.	.	-	139551218	.	-	11.788000	.	0.99413	.	0	.	.	germline	.	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.99445	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.677G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2	.	FA9_HUMAN	.	77.0	.	.	T	0.59270	0.782613	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Arg226Gln	.	0.96297	.	germline	.		G	Jun 21, 2024	.	G/G	.	.	0.988	N	Xq27.1	7618	.	.	SCV001976456|SCV005439229	Pathogenic	.	.	Gln	Q	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.412827	0.72530	.	D	-	.	.	0.98828	610	.	.	0.78004	0	139551218	Y	10	0	.	.	P00740	.	0.836803	0.99931		.	0.852	D	.	0.8180072	.	0.48078	2158	0.587764	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.87626	X	F9	.	0	Arg	11862	.	X-139551218-G-A	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	.	.	138461043	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	.	.	.	RCV000011337|RCV001727513|RCV004752695|RCV004814880	D	.	.	c.677G>A	.	.	.	0.97316	G/G	rs137852241	139551218	.	G	.	P00740	.	0.80855	.	0.68239		.	.	.	2.175	0	0	.	5.31	0.96127	108	D	T	.	.	0	24	.	.	.	98879	10591	0.97273	0.90920	0.987725436687469	2816	.	0.36621	.	.	.	.	5.361	.	D	.	.	.	0	306900	0.65922	X	.	ENSG00000101981	.	0	.	0	0.9984916172821304	2	0.60752	0.18019	.	.	.	.	.	YES	.	0.848427	25630	HGNC:3551	A	.	simple_aae	0.983	.	139551218	CGG	1.000000	.	-	0	0.99712	.	0	.	Pathogenic	0.78608	.	.	.	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	R	.	0.999946805639	-	0.952	-	0.90815	.	470	0.99848	0.388901472092	0.2674	.	0.99948969239605312	94	-	677G>A 	.	0	CN043453|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.35241	137852241	.	0	0.99994	.	0.864	0.005	2708	0.99998748	5.31	.	.	.	0.606506	0.999623815643521	0.60790	D	84	.	.	0.9333	0.95008	p.Arg226Gln	0	.	-10.798	0.9918215	.	0.97231	10591	D	.	F9	.	D	0.793	.	R226Q	D	0.87641	0.76753	G/G	principal1	219393	F9_Popp_2025_light_chain_var244784	No											R		677	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Arg226Gln		true	c.677G>A						3551.0	139551218.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				Arg226Gln						Q	Jun 21, 2024					missense_variant		226.0				1.0828234546833777		Pathogenic	139551218.0	missense_variant		0.793					Reporter			F9_Arg226Gln
F9_Arg226Gln	-1.7008128767404025	0.1327719074838614	1.4556270843437564	0.18883087293195974	2025_01_Batch_13-14	0.6602951949209586	0.7706772275201149	0.7778306102934508	0.805557100309681	0.5015753048406917	0.8376591675240308	0.7238585015220481	0.7210425902782918	0.8706173757044446	0.7327212881923362	0.7489771812224947	0.7472678645210815	0.7494366002858712	0.8380872380070628	0.6171482965165139	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004380		NC_000023.11:139551218:G:A		Arg226Gln																												F9_Arg226Gln	23	139551218	G	A	X	allele	677G>A	A09	527_CAVA_Array_P02	A18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551218-G-A	-	0.68339	0.998	226	.	.	.	X	138633377	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg226Gln	.	25.2	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93165	Select	0.8506	.	0.73231	.	.	D	D	.	1.74758098799	0	.	.	.	.	0.23489	.	.	.	.	0.66580	.	.	0.82601	0.94	.	23.0	0.737626	4.78	0.77	A	single nucleotide variant	NC_000023.11:g.139551218G>A	.	.	3	0.7921764	.	0	0.75372374	0		.	.	.	.	.	146	.	0	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	.	.	.	.	0.87956	P	0.89275	D	M	.	.	G/G	108	0	.	.	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	.	0.96137	.	.	-	139551218	.	-	11.788000	.	0.99413	.	0	.	.	germline	.	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.99445	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.677G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2	.	FA9_HUMAN	.	77.0	.	.	T	0.59270	0.782613	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Arg226Gln	.	0.96297	.	germline	.		G	Jun 21, 2024	.	G/G	.	.	0.988	N	Xq27.1	7618	.	.	SCV001976456|SCV005439229	Pathogenic	.	.	Gln	Q	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.412827	0.72530	.	D	-	.	.	0.98828	610	.	.	0.78004	0	139551218	Y	10	0	.	.	P00740	.	0.836803	0.99931		.	0.852	D	.	0.8180072	.	0.48078	2158	0.587764	.	-3.36	.	.	0.72322	.	.	.	.	.	.	0.87626	X	F9	.	0	Arg	11862	.	X-139551218-G-A	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	.	.	138461043	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	.	.	.	RCV000011337|RCV001727513|RCV004752695|RCV004814880	D	.	.	c.677G>A	.	.	.	0.97316	G/G	rs137852241	139551218	.	G	.	P00740	.	0.80855	.	0.68239		.	.	.	2.175	0	0	.	5.31	0.96127	108	D	T	.	.	0	24	.	.	.	98879	10591	0.97273	0.90920	0.987725436687469	2816	.	0.36621	.	.	.	.	5.361	.	D	.	.	.	0	306900	0.65922	X	.	ENSG00000101981	.	0	.	0	0.9984916172821304	2	0.60752	0.18019	.	.	.	.	.	YES	.	0.848427	25630	HGNC:3551	A	.	simple_aae	0.983	.	139551218	CGG	1.000000	.	-	0	0.99712	.	0	.	Pathogenic	0.78608	.	.	.	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	R	.	0.999946805639	-	0.952	-	0.90815	.	470	0.99848	0.388901472092	0.2674	.	0.99948969239605312	94	-	677G>A 	.	0	CN043453|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.35241	137852241	.	0	0.99994	.	0.864	0.005	2708	0.99998748	5.31	.	.	.	0.606506	0.999623815643521	0.60790	D	84	.	.	0.9333	0.95008	p.Arg226Gln	0	.	-10.798	0.9918215	.	0.97231	10591	D	.	F9	.	D	0.793	.	R226Q	D	0.87641	0.76753	G/G	principal1	191877	F9_Popp_2025_heavy_chain_var235103	No											R		677	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Arg226Gln		true	c.677G>A						3551.0	139551218.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				Arg226Gln						Q	Jun 21, 2024					missense_variant		226.0				0.943706481718542		Pathogenic	139551218.0	missense_variant		0.793					Reporter			F9_Arg226Gln
RET_Val292Met	-6.302622328210597	0.00040314669841361	5.126137385468295	0.0013594595445485806	2025_01_Batch_13-14	0.5597747988299054	0.7418593421567587	0.8696012586804667	0.8053184200824319	0.6489271164433885	0.6522687131589785	0.7182645813064765	0.8402332581550437	0.7615852880624969	0.6873326960557387	0.606021755994442	0.7300619617316176	0.8549172584177551	0.7834518540724644	0.6681299062495636	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET	ENSG00000165731	8858	202956	CCSBVarC006880	ALE00006878	NC_000010.11:43106382:G:A	874G>A	Val292Met	CEGS2	CegsMutGDEh1026	H07	GDEhDisVCh_40066	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Val292Met	10	43106382	G	A	10											10-43106382-G-A	-	0.6527	1.0	292	5	2	0	10	43601830	A	2.266000e-04	2	10	3_Conflicting	NC_000010.11	199	Val292Met	123	24.8	65	0	6.970420e-03	D	2	15	5	42544	6.389530e-04	0	30434	0.000000e+00	0	0.71949	Select	0.5416	17646	0.90580	4	0.016865079365079364	T	T	61774	1.83343156079	0	0	0.000000e+00	0	0	0.47880	17040	44880	39	7.143930e-03	0.28250	3	.	0.45215	0.08	0.0	88.0	0.681032	2.99	0.12	A	single nucleotide variant	NC_000010.11:g.43106382G>A	0	15296	2	0.13554715	107468	0	0.17939073	0.003937007874015748	A	120	233194	0	0	6.970420e-03	1146	7.051520e-05	0	MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:C1333600	78	0	0.000000e+00	0	0.31989	D	0.31509	D	M	4.370004	365	G/G	242	10	7086	1610770	not provided|not specified|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hereditary cancer	15900	0.89300	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106382	7.222220e-03	-	6.639000	2	0.83697	29608	0	44880	95	germline;unknown	91004	.	.	GRCh38	862	criteria provided, conflicting classifications	c.874G>A	3.614380e-04	0.62577	51	0	0	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	0.000000e+00	9000	B	0.004443504020313161	6.754930e-05	NM_020975.6(RET):c.874G>A (p.Val292Met)	1	0	RET_HUMAN	0	12.0	0.404318965602062	4	T	0.33824	0.22824927	+	2.822470e-04	1	0.000211869	95	0.000000e+00	0	34166	criteria_provided,_conflicting_classifications	0.99806	7.257970e-04	5	0.000000e+00	0	60016	p.Val292Met	0	0.56245	.	germline	65	43106382	G	Jan 30, 2025	11	G/G	0	87600	0.998	N	10q11.21	159894	.	1.257860e-04	SCV000218577|SCV000362271|SCV000362272|SCV000362273|SCV000362274|SCV000609569|SCV000616852|SCV000674801|SCV000692679|SCV000807063|SCV000838372|SCV000883098|SCV002011440|SCV002527933|SCV002572022|SCV004220049	Conflicting_classifications_of_pathogenicity	0	0	Met	M	-	912	ENSP00000347942	ENST00000355710	17646	0.002	13298	0	-0.168	G	0	4.280368	0.53775	D	D	-	3.6522	.	.	1160	0	9.940357852882703E-4	0.07075	26	43106382	Y	10	0	101376	1.886790e-04	P07949	0	0.467186	0.84091	G	0	0.935	.	13298	0.13158411	9000	0.17286	5979	-0.0978649	73	-1.09	0.0010224948875255625	4.434050e-03	0.72322	3.838280e-04	0	75016	7.222220e-03	5300	2	0.32360	10	RET	9.331340e-05	0	Val	190862	5.707760e-05	10-43106382-G-A	Hereditary_cancer|Multiple_endocrine_neoplasia,_type_2|Hirschsprung_disease,_susceptibility_to,_1|not_provided|not_specified|Multiple_endocrine_neoplasia_type_2B|Pheochromocytoma|Multiple_endocrine_neoplasia|Hereditary_cancer-predisposing_syndrome|Renal_hypodysplasia/aplasia_1	0	6	42921836	ClinGen:CA009374|UniProtKB:P07949#VAR_041764	0.558315	0.61459	0	RCV000034779|RCV000121992|RCV000276548|RCV000333869|RCV000354891|RCV000755685|RCV000367517|RCV000565970|RCV001083006|RCV003492298	T	2	0	c.874G>A	0	199	1	0.36423	G/G	rs34682185	43106382	14664	G	0.0037939297124600637	.	15632	0.38700	0.000000e+00	0.68239	10	0	0	4.434050e-03	2.615	0	15	264690	4.86	0.80012	6604	T	T	2	1.315270e-04	0	1878	.	0	0	653|388|247709|653|29072|276161|140162|411709	24880	0.76187	0.92045	0.0599002876036932	6224	19	0.41403	0.56606	1.170750e-04	7.143930e-03	1179870	6.727	5.883740e-04	N	11960	0	3.0601837E-4	21	142623|162300|171300|PS131100|191830	0.74634	10	1.363880e-04	ENSG00000165731	1.618800e-05	9.381215054973921E-5	11	0.0026624068157614484	0.788903358267811	1	0.73565	0.33096	30514	81	5.918560e-05	6.664890e-05	0.288787131538424	YES	4.285530e-04	.	36221	HGNC:9967	N	0	simple_aae	0.706	203952	43106382	GTG	1.000000	17	-	0	0.00229	6.187120e-05	0	3	Conflicting classifications of pathogenicity	0.65784	6	1	4	ClinGen:CA009374,UniProtKB:P07949#VAR_041764	V	0	0.888871705788	-	.	-	0.60971	149	15512	0.78722	0.564820885658	0.1243	0	0.99748410528429388	322	-	874G>A 	123	6.446621970087674E-4	C1333600|C4048306|C3888239|C3661900|CN169374|C0025269|C0031511|C0027662|C0027672|C1619700	0	0	0	0	NM_020975.6	-	1	0.0	0	0.28743	34682185	2316	2.6720876863912143E-4	0.88692	0.54646	0.558	0.032	5982	0.99984658	4.86	.	.	3.604900e-04	0.0917746	0.936206762942958	0.76302	D	4726	6136	9544	0.4163	0.83044	p.Val292Met	5	0	-8.694	0.010467678	7	0.78979	24880	D	30412	RET	1.173710e-04	D	0.409	19796	.	D	0.54692	0.1142	G/G	principal4																																																																																																				
RET_Val292Met	-6.302622328210597	0.00040314669841361	5.126137385468295	0.0013594595445485806	2025_01_Batch_13-14	0.5597747988299054	0.7418593421567587	0.8696012586804667	0.8053184200824319	0.6489271164433885	0.6522687131589785	0.7182645813064765	0.8402332581550437	0.7615852880624969	0.6873326960557387	0.606021755994442	0.7300619617316176	0.8549172584177551	0.7834518540724644	0.6681299062495636	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET		8858		CCSBVarC006880		NC_000010.11:43106382:G:A		Val292Met																												RET_Val292Met	10	43106382	G	A	10	allele	874G>A	H08	527_CAVA_Array_P05	O15	B13A7A8P2_R1	B14A7A8P2_R2				10-43106382-G-A	-	0.6527	1.0	292	5	2	0	10	43601830	A	2.266000e-04	2	10	3_Conflicting	NC_000010.11	199	Val292Met	123	24.8	65	0	6.970420e-03	D	2	15	5	42544	6.389530e-04	0	30434	0.000000e+00	0	0.71949	Select	0.5416	17646	0.90580	4	0.016865079365079364	T	T	61774	1.83343156079	0	0	0.000000e+00	0	0	0.47880	17040	44880	39	7.143930e-03	0.28250	3	.	0.45215	0.08	0.0	88.0	0.681032	2.99	0.12	A	single nucleotide variant	NC_000010.11:g.43106382G>A	0	15296	2	0.13554715	107468	0	0.17939073	0.003937007874015748	A	120	233194	0	0	6.970420e-03	1146	7.051520e-05	0	MedGen:C3661900|MedGen:CN169374|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:C1333600	78	0	0.000000e+00	0	0.31989	D	0.31509	D	M	4.370004	365	G/G	242	10	7086	1610770	not provided|not specified|Pheochromocytoma|Hirschsprung disease, susceptibility to, 1|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia type 2B|Multiple endocrine neoplasia|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Hereditary cancer	15900	0.89300	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106382	7.222220e-03	-	6.639000	2	0.83697	29608	0	44880	95	germline;unknown	91004	.	.	GRCh38	862	criteria provided, conflicting classifications	c.874G>A	3.614380e-04	0.62577	51	0	0	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	0.000000e+00	9000	B	0.004443504020313161	6.754930e-05	NM_020975.6(RET):c.874G>A (p.Val292Met)	1	0	RET_HUMAN	0	12.0	0.404318965602062	4	T	0.33824	0.22824927	+	2.822470e-04	1	0.000211869	95	0.000000e+00	0	34166	criteria_provided,_conflicting_classifications	0.99806	7.257970e-04	5	0.000000e+00	0	60016	p.Val292Met	0	0.56245	.	germline	65	43106382	G	Jan 30, 2025	11	G/G	0	87600	0.998	N	10q11.21	159894	.	1.257860e-04	SCV000218577|SCV000362271|SCV000362272|SCV000362273|SCV000362274|SCV000609569|SCV000616852|SCV000674801|SCV000692679|SCV000807063|SCV000838372|SCV000883098|SCV002011440|SCV002527933|SCV002572022|SCV004220049	Conflicting_classifications_of_pathogenicity	0	0	Met	M	-	912	ENSP00000347942	ENST00000355710	17646	0.002	13298	0	-0.168	G	0	4.280368	0.53775	D	D	-	3.6522	.	.	1160	0	9.940357852882703E-4	0.07075	26	43106382	Y	10	0	101376	1.886790e-04	P07949	0	0.467186	0.84091	G	0	0.935	.	13298	0.13158411	9000	0.17286	5979	-0.0978649	73	-1.09	0.0010224948875255625	4.434050e-03	0.72322	3.838280e-04	0	75016	7.222220e-03	5300	2	0.32360	10	RET	9.331340e-05	0	Val	190862	5.707760e-05	10-43106382-G-A	Hereditary_cancer|Multiple_endocrine_neoplasia,_type_2|Hirschsprung_disease,_susceptibility_to,_1|not_provided|not_specified|Multiple_endocrine_neoplasia_type_2B|Pheochromocytoma|Multiple_endocrine_neoplasia|Hereditary_cancer-predisposing_syndrome|Renal_hypodysplasia/aplasia_1	0	6	42921836	ClinGen:CA009374|UniProtKB:P07949#VAR_041764	0.558315	0.61459	0	RCV000034779|RCV000121992|RCV000276548|RCV000333869|RCV000354891|RCV000755685|RCV000367517|RCV000565970|RCV001083006|RCV003492298	T	2	0	c.874G>A	0	199	1	0.36423	G/G	rs34682185	43106382	14664	G	0.0037939297124600637	.	15632	0.38700	0.000000e+00	0.68239	10	0	0	4.434050e-03	2.615	0	15	264690	4.86	0.80012	6604	T	T	2	1.315270e-04	0	1878	.	0	0	653|388|247709|653|29072|276161|140162|411709	24880	0.76187	0.92045	0.0599002876036932	6224	19	0.41403	0.56606	1.170750e-04	7.143930e-03	1179870	6.727	5.883740e-04	N	11960	0	3.0601837E-4	21	142623|162300|171300|PS131100|191830	0.74634	10	1.363880e-04	ENSG00000165731	1.618800e-05	9.381215054973921E-5	11	0.0026624068157614484	0.788903358267811	1	0.73565	0.33096	30514	81	5.918560e-05	6.664890e-05	0.288787131538424	YES	4.285530e-04	.	36221	HGNC:9967	N	0	simple_aae	0.706	203952	43106382	GTG	1.000000	17	-	0	0.00229	6.187120e-05	0	3	Conflicting classifications of pathogenicity	0.65784	6	1	4	ClinGen:CA009374,UniProtKB:P07949#VAR_041764	V	0	0.888871705788	-	.	-	0.60971	149	15512	0.78722	0.564820885658	0.1243	0	0.99748410528429388	322	-	874G>A 	123	6.446621970087674E-4	C1333600|C4048306|C3888239|C3661900|CN169374|C0025269|C0031511|C0027662|C0027672|C1619700	0	0	0	0	NM_020975.6	-	1	0.0	0	0.28743	34682185	2316	2.6720876863912143E-4	0.88692	0.54646	0.558	0.032	5982	0.99984658	4.86	.	.	3.604900e-04	0.0917746	0.936206762942958	0.76302	D	4726	6136	9544	0.4163	0.83044	p.Val292Met	5	0	-8.694	0.010467678	7	0.78979	24880	D	30412	RET	1.173710e-04	D	0.409	19796	.	D	0.54692	0.1142	G/G	principal4																																																																																																				
SHOC2_Glu25Gly	-1.292301105093803	0.23727522836829176	4.4494150343610945	0.002973737450232932	2025_01_Batch_13-14	0.6433044032860071	0.7750878643601726	0.6371818379286176	0.6228404341855232	0.5403685906557271	0.6224070740030938	0.7418334256889555	0.6435865191916832	0.7761029737935217	0.53295432120808	0.6328557386445505	0.7584606450245641	0.6403841785601504	0.6994717039895224	0.5366614559319035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											
LMNA_Arg377Leu	0.8303741991373911	0.4337309726645242	-1.7547994394249709	0.12273046621541059	2025_01_Batch_13-14	0.732651144476482	0.9809019974562119	0.9985181048778051	0.9899325537451653	0.9821100560733841	0.6803825019777638	0.9825461087800901	0.9985531629178768	0.992536651994558	0.989151297345318	0.706516823227123	0.981724053118151	0.998535633897841	0.9912346028698616	0.985630676709351	0.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	LMNA	LMNA	ENSG00000160789	3903	7292	CCSBVarC000580	ALE00000580	NC_000001.11:156136094:G:T	1130G>T	Arg377Leu	RC4	RC4_Mut_GDEh1027	B01	GDEhDisVCh_40057	F12	1	RC4_Mut_GDDh1027	B01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	99	0			0			0			LMNA_Arg377Leu	1	156136094	G	T	1											1-156136094-G-T	-	0.8857	1.0	377	.	0	.	1	156105885	T	1.239150e-06	.	1	1_Pathogenic	NC_000001.11	1	Arg377Leu	.	29.6	.	.	.	D	0	10	5	.	.	.	.	.	.	0.99671	.	0.9311	.	0.90580	.	.	D	D	63898	.	.	0	.	.	.	0.89686	.	44888	0	.	0.93423	.	.	0.96369	0.997	.	0.0	.	5.54	1.0	T	single nucleotide variant	NC_000001.11:g.156136094G>T	0	.	2	0.8996569	.	.	0.95186484	.	T	.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736|MONDO:MONDO:0013178,MedGen:C2750785,OMIM:613205,Orphanet:157973|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604	.	.	0.000000e+00	0	0.99291	D	0.96757	D	H	12.91139	2	./.	.	.	.	1614014	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype|Congenital muscular dystrophy due to LMNA mutation|Primary dilated cardiomyopathy	.	0.98647	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156136094	.	-	11.663000	.	0.99859	29604	.	59978	.	germline	91086	Gain of helix (P = 0.2059)| Loss of MoRF binding (P = 0.211)| Gain of ubiquitination at K378 (P = 0.2392)| Gain of phosphorylation at Y376 (P = 0.2452)| Loss of methylation at K378 (P = 0.3112)	0.94511	GRCh38	460	criteria provided, multiple submitters, no conflicts	c.1130G>T	.	0.74708	.	.	.	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	LP	.	0.000000e+00	NM_170707.4(LMNA):c.1130G>T (p.Arg377Leu)	2	.	LMNA_HUMAN	.	100.0	0.966889726849636	.	.	0.94839	0.9515742	+	.	.	1.36824e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	59978	p.Arg377Leu	0	0.94018	.	germline	.	156136094	G	Nov 11, 2024	.	./.	.	.	1.0	N	1q22	.	.	.	SCV000271921|SCV001410737|SCV002610638|SCV004176574|SCV004825165	Pathogenic/Likely_pathogenic	.	.	Leu	L	-	912	ENSP00000355292	ENST00000361308	.	0.0	.	.	0.676	G	.	5.27379	0.83643	D	D	-	13.57775	.	0.98215	.	.	.	0.94603	.	156136094	Y	10	.	.	0.000000e+00	P02545	.	0.98346	0.94906	G	.	0.999	D	.	0.92578965	.	0.79771	4000	0.551552	1	-6.93	.	1.667280e-05	0.91343	.	.	75048	.	6054	.	0.94882	1	LMNA	0.000000e+00	.	Arg	.	.	1-156136094-G-T	not_provided|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|Primary_dilated_cardiomyopathy	0	.	154372509	ClinGen:CA016657|UniProtKB:P02545#VAR_039777	0.977482	0.94600	0	RCV000057236|RCV001237945|RCV002321554|RCV003448256|RCV003996497	D	0	.	c.1130G>T	.	0	0	0.95787	./.	rs61672878	156136094	.	G	.	P02545	.	0.96399	.	0.68239	1	.	.	0.000000e+00	3.715	.	.	.	5.3	0.99884	.	D	D	.	.	.	.	.	.	.	157973|64746|217604	66778	0.95724	0.96642	0.998611927032471	.	.	0.71675	0.99724	.	.	1180036	8.119	.	D	.	.	.	.	613205	0.8947	1	.	ENSG00000160789	0.000000e+00	.	.	.	.	2	0.92348	0.78769	.	.	.	1.667280e-05	0.89589923552897	.	0.000000e+00	0.774445	77675	HGNC:6636	A	.	simple_aae	0.996	.	156136094	CGC	1.000000	.	-	.	0.96765	8.474320e-07	.	0	Pathogenic/Likely pathogenic	0.73069	.	0	1	ClinGen:CA016657,UniProtKB:P02545#VAR_039777	R	.	0.987595316139	-	0.839	-	0.99270	.	.	0.98530	0.850583195686	0.9926	0	0.99871771175567314	.	-	1130G>T 	.	.	C3661900|C2750785|C0270914|CN230736|C0007193	.	.	.	.	NM_170707.4	-	.	.	1	0.68071	61672878	.	.	0.98732	0.95367	0.951	0.002	.	0.99997818	5.3	.	.	.	0.55449	0.999965529954525	0.94651	D	.	.	.	1.0722	0.97722	p.Arg377Leu	.	0	-9.847	0.9717735	0	0.99297	66778	D	.	LMNA	.	D	0.971	.	R377L	D	0.94607	0.76753	./.	principal1																																																																																																				
LMNA_Arg377Leu	0.8303741991373911	0.4337309726645242	-1.7547994394249709	0.12273046621541059	2025_01_Batch_13-14	0.732651144476482	0.9809019974562119	0.9985181048778051	0.9899325537451653	0.9821100560733841	0.6803825019777638	0.9825461087800901	0.9985531629178768	0.992536651994558	0.989151297345318	0.706516823227123	0.981724053118151	0.998535633897841	0.9912346028698616	0.985630676709351	0.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	LMNA	LMNA		3903		CCSBVarC000580		NC_000001.11:156136094:G:T		Arg377Leu																												LMNA_Arg377Leu	1	156136094	G	T	1	allele	1130G>T	G12	527_CAVA_Array_P03	N23	B13A7A8P1_R1	B14A7A8P1_R2				1-156136094-G-T	-	0.8857	1.0	377	.	0	.	1	156105885	T	1.239150e-06	.	1	1_Pathogenic	NC_000001.11	1	Arg377Leu	.	29.6	.	.	.	D	0	10	5	.	.	.	.	.	.	0.99671	.	0.9311	.	0.90580	.	.	D	D	63898	.	.	0	.	.	.	0.89686	.	44888	0	.	0.93423	.	.	0.96369	0.997	.	0.0	.	5.54	1.0	T	single nucleotide variant	NC_000001.11:g.156136094G>T	0	.	2	0.8996569	.	.	0.95186484	.	T	.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736|MONDO:MONDO:0013178,MedGen:C2750785,OMIM:613205,Orphanet:157973|EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604	.	.	0.000000e+00	0	0.99291	D	0.96757	D	H	12.91139	2	./.	.	.	.	1614014	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype|Congenital muscular dystrophy due to LMNA mutation|Primary dilated cardiomyopathy	.	0.98647	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156136094	.	-	11.663000	.	0.99859	29604	.	59978	.	germline	91086	Gain of helix (P = 0.2059)| Loss of MoRF binding (P = 0.211)| Gain of ubiquitination at K378 (P = 0.2392)| Gain of phosphorylation at Y376 (P = 0.2452)| Loss of methylation at K378 (P = 0.3112)	0.94511	GRCh38	460	criteria provided, multiple submitters, no conflicts	c.1130G>T	.	0.74708	.	.	.	Intermediate filament, rod domain|Intermediate filament protein, conserved site|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	LP	.	0.000000e+00	NM_170707.4(LMNA):c.1130G>T (p.Arg377Leu)	2	.	LMNA_HUMAN	.	100.0	0.966889726849636	.	.	0.94839	0.9515742	+	.	.	1.36824e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	59978	p.Arg377Leu	0	0.94018	.	germline	.	156136094	G	Nov 11, 2024	.	./.	.	.	1.0	N	1q22	.	.	.	SCV000271921|SCV001410737|SCV002610638|SCV004176574|SCV004825165	Pathogenic/Likely_pathogenic	.	.	Leu	L	-	912	ENSP00000355292	ENST00000361308	.	0.0	.	.	0.676	G	.	5.27379	0.83643	D	D	-	13.57775	.	0.98215	.	.	.	0.94603	.	156136094	Y	10	.	.	0.000000e+00	P02545	.	0.98346	0.94906	G	.	0.999	D	.	0.92578965	.	0.79771	4000	0.551552	1	-6.93	.	1.667280e-05	0.91343	.	.	75048	.	6054	.	0.94882	1	LMNA	0.000000e+00	.	Arg	.	.	1-156136094-G-T	not_provided|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|Primary_dilated_cardiomyopathy	0	.	154372509	ClinGen:CA016657|UniProtKB:P02545#VAR_039777	0.977482	0.94600	0	RCV000057236|RCV001237945|RCV002321554|RCV003448256|RCV003996497	D	0	.	c.1130G>T	.	0	0	0.95787	./.	rs61672878	156136094	.	G	.	P02545	.	0.96399	.	0.68239	1	.	.	0.000000e+00	3.715	.	.	.	5.3	0.99884	.	D	D	.	.	.	.	.	.	.	157973|64746|217604	66778	0.95724	0.96642	0.998611927032471	.	.	0.71675	0.99724	.	.	1180036	8.119	.	D	.	.	.	.	613205	0.8947	1	.	ENSG00000160789	0.000000e+00	.	.	.	.	2	0.92348	0.78769	.	.	.	1.667280e-05	0.89589923552897	.	0.000000e+00	0.774445	77675	HGNC:6636	A	.	simple_aae	0.996	.	156136094	CGC	1.000000	.	-	.	0.96765	8.474320e-07	.	0	Pathogenic/Likely pathogenic	0.73069	.	0	1	ClinGen:CA016657,UniProtKB:P02545#VAR_039777	R	.	0.987595316139	-	0.839	-	0.99270	.	.	0.98530	0.850583195686	0.9926	0	0.99871771175567314	.	-	1130G>T 	.	.	C3661900|C2750785|C0270914|CN230736|C0007193	.	.	.	.	NM_170707.4	-	.	.	1	0.68071	61672878	.	.	0.98732	0.95367	0.951	0.002	.	0.99997818	5.3	.	.	.	0.55449	0.999965529954525	0.94651	D	.	.	.	1.0722	0.97722	p.Arg377Leu	.	0	-9.847	0.9717735	0	0.99297	66778	D	.	LMNA	.	D	0.971	.	R377L	D	0.94607	0.76753	./.	principal1																																																																																																				
BRAF_Gly469Glu	1.200036246927843	0.2691587309971123	-2.4349535695068565	0.04509157625446467	2025_01_Batch_13-14	0.7584429920405253	0.8194662027841655	0.8675298357279375	0.8787096855905449	0.6660433758168792	0.7701152582755086	0.9455754807623543	0.9343232747882235	0.9098661414429015	0.6535973522883113	0.764279125158017	0.88252084177326	0.9009265552580805	0.8942879135167232	0.6598203640525953	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003160		NC_000007.14:140781602:C:T		Gly469Glu																												BRAF_Gly469Glu	7	140781602	C	T	7	allele	1406G>A	H03	527_CAVA_Array_P01	O05	B13A7A8P1_R1	B14A7A8P1_R2				7-140781602-C-T	-	0.91667	0.999	469	.	.	.	7	140481402	T	.	.	7	1_Pathogenic	NC_000007.14	.	Gly469Glu	.	32.0	.	0	.	D	.	18	.	.	.	.	.	.	0	0.98001	Select	0.9172	.	0.77914	.	.	D	D	.	.	0	.	.	.	.	0.99500	.	.	.	.	.	.	.	0.99607	0.998	.	.	0.990601	.	.	T	single nucleotide variant	NC_000007.14:g.140781602C>T	.	.	3	0.98307276	.	0	0.99422306	0	T	.	.	.	.	.	146	.	0	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648	.	.	.	.	0.95575	D	0.99959	D	M	16.51806	.	./.	92	0	.	.	Cardiofaciocutaneous syndrome 1|RASopathy|Cardio-facio-cutaneous syndrome|not provided|not specified|Noonan syndrome 7|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1	.	0.98756	.	.	-	140781602	.	-	7.656000	.	0.99985	.	0	.	.	de novo;germline;unknown	.	Loss of MoRF binding (P = 0.0591)| Gain of catalytic residue at G469 (P = 0.1084)| Gain of methylation at K473 (P = 0.1128)| Gain of phosphorylation at Y472 (P = 0.1612)| Gain of ubiquitination at K473 (P = 0.1827)	0.99914	GRCh38	809	reviewed by expert panel	c.1406G>A	.	0.85695	0	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	.	.	P	0	.	NM_004333.6(BRAF):c.1406G>A (p.Gly469Glu)	3	.	BRAF_HUMAN	.	.	1.07569399882665	.	D	0.99952	0.9873307	-	.	.	0.0	.	.	0	.	reviewed_by_expert_panel	0.99211	.	.	.	.	.	p.Gly469Glu	.	0.64019	.	germline	.	140781602	C	Sep 17, 2024	.	./.	.	.	1.0	N	7q34	13024	.	.	SCV000616361	Pathogenic	.	.	Glu	E	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.549	C	.	5.508136	.	D	.	-	17.76874	.	0.96612	610	.	.	0.95854	0	140781602	Y	10	0	.	.	P15056	.	0.964899	0.88204	C	.	0.999	D	.	0.9877916	.	0.85369	673	0.481639	.	.	.	.	.	.	.	.	.	.	.	0.99888	7	BRAF	.	0	Gly	20146	.	7-140781602-C-T	not_specified|Squamous_cell_carcinoma_of_the_skin|Transitional_cell_carcinoma_of_the_bladder|Melanoma|Prostate_adenocarcinoma|Neoplasm_of_the_large_intestine|not_provided|Cardio-facio-cutaneous_syndrome|Malignant_melanoma_of_skin|Noonan_syndrome_1|Noonan_syndrome_and_Noonan-related_syndrome|Lung_adenocarcinoma|Cardiofaciocutaneous_syndrome_1|RASopathy|Noonan_syndrome_7|Multiple_myeloma|Squamous_cell_lung_carcinoma	.	.	140127871	ClinGen:CA279970|OMIM:164757.0014|UniProtKB:P15056#VAR_018621	0.905235	0.97644	.	RCV000015008|RCV000033307|RCV000211748|RCV000212152|RCV000506575|RCV002287336|RCV001813209|RCV003450641	D	.	.	c.1406G>A	.	.	.	0.93706	./.	rs121913355	140781602	.	C	.	P15056	.	0.99940	.	0.68239	7	.	.	.	3.445	0	0	.	5.62	0.99571	164	D	D	.	.	0	54	.	.	.	1340|648|98733|1340|536391|648|29073|85443	13974	0.93626	0.96811	0.999017953872681	3314	.	0.71675	0.85598	.	.	.	7.886	.	.	.	.	.	0	PS115150|163950|115150|613706|254500	0.85829	7	.	ENSG00000157764	.	0	.	0	.	2	0.92348	0.42973	.	.	.	.	0.981768342919213	YES	.	0.612203	29013	HGNC:1097	.	.	.	1	.	140781602	GGA	1.000000	.	-	0	0.99733	.	0	.	Pathogenic	0.91438	.	.	.	ClinGen:CA279970,UniProtKB:P15056#VAR_018621,OMIM:164757.0014	G	.	.	-	0.992	-	.	.	2794	0.97263	0.941216766834	1.0	.	0.99796911589266579	94	-	1406G>A 	.	0	CN169374|C0553723|C0279680|C0025202|C0007112|C0009404|C3661900|C1275081|C0151779|C4551602|C5681679|C0152013|CN029449|C5555857|C3150970|C0026764|C0149782	.	.	.	.	NM_004333.6	-	.	.	1	0.97084	121913355	.	0	0.97730	0.98233	.	.	3222	0.99919707	5.62	.	.	.	0.454064	0.999985580220805	0.92067	D	110	.	.	1.0760	0.97252	p.Gly469Glu	0	.	-13.528	0.992007	.	0.99579	13974	D	.	BRAF	.	D	.	.	G469E	.	.	0.27038	./.	principal4																																																																																																				
SHOC2_Ser403Gly	-3.861317166307788	0.006200919790985726	9.153768286343025	0.00003820144936004182	2025_01_Batch_13-14	0.8598607476040003	0.9190794412170451	0.802151747828081	0.8293676270278348	0.660643654159381	0.8621220845756798	0.8973053296396158	0.8203158873513924	0.8894980577124589	0.7536872859503306	0.8609914160898401	0.9081923854283305	0.8112338175897367	0.8594328423701469	0.7071654700548557	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2	SHOC2		11602		CCSBVarC028051		NC_000010.11:111007576:A:G		Ser403Gly																												SHOC2_Ser403Gly	10	111007576	A	G	10	allele	1207A>G	H01	527_CAVA_Array_P06	O02	B13A7A8P2_R1	B14A7A8P2_R2				10-111007576-A-G	-	0.65528	0.775	403	.	.	.	10	112767334	G	.	.	10	2_Benign	NC_000010.11	.	Ser403Gly	.	24.8	.	.	.	D	.	1	.	.	.	.	.	.	.	0.55539	.	0.6246	.	0.47335	.	.	D	D	.	.	.	.	.	.	.	0.89271	.	.	.	.	0.52959	.	.	0.57823	1.0	.	.	.	.	.	G	single nucleotide variant	NC_000010.11:g.111007576A>G	.	.	2	0.28831485	.	.	0.3641711	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648	.	.	.	.	.	B	0.54635	P	L	5.859629	.	A/A	.	.	.	.	Noonan syndrome	.	0.87567	.	.	-	111007576	.	-	11.099000	.	0.75882	.	.	.	.	paternal	.	Loss of sheet (P = 0.0817)| Loss of stability (P = 0.1306)| Loss of helix (P = 0.1706)| Gain of catalytic residue at T402 (P = 0.2032)| Loss of solvent accessibility (P = 0.4436)	0.56487	GRCh38	919	no assertion criteria provided	.	.	0.92730	.	.	.	.	.	.	.	.	.	NM_007373.4(SHOC2):c.1207A>G (p.Ser403Gly)		.	SHOC2_HUMAN	.	.	0.593668272867563	.	.	0.24834	0.3641711	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.56043	.	.	.	.	.	.	.	0.86103	.	germline	.		A	-	.	A/A	.	.	1.0	N	10q25.2	.	.	.	SCV001438561	Likely_benign	.	.	Gly	G	-	.	ENSP00000510639	ENST00000689300	.	.	.	.	0.756	A	.	4.291712	0.65108	D	.	-	7.154942	.	0.72413	.	.	.	0.57905	.	111007576	Y	10	.	.	.	Q9UQ13	.	0.621119	0.92408		.	0.184	D	.	0.28831485	.	0.97202	8036	0.15632	.	.	.	.	0.61594	.	.	.	.	.	.	0.54634	10	SHOC2	.	.	Ser	.	.	10-111007576-A-G	Noonan_syndrome	.	.	112757324	.	0.922270	0.72634	.	RCV001261152	.	.	.	c.1207A>G	.	.	.	0.69638	A/A	rs1564730663	111007576	.	A	.	Q9UQ13	.	0.57823	.	0.68239		.	.	.	1.495	.	.	.	5.82	0.88010	.	D	D	.	.	.	.	.	.	.	648	981611	0.69250	0.65897	0.921698868274689	.	.	0.71675	0.89662	.	.	.	9.271	.	.	.	.	.	.	PS163950	0.94934	10	.	ENSG00000108061	.	.	.	.	.	1	0.51811	0.19492	.	.	.	.	0.665622303315765	.	.	0.076346	969662	HGNC:15454	.	.	.	0.571	.	111007576	AGT	1.000000	.	-	.	0.73599	.	.	.	Likely benign	0.44926	.	.	.	ClinGen:CA378523403	S	.	.	-	0.484	-	0.78751	.	.	0.36956	0.847841501236	.	.	0.99843858264903962	.	-	1207A>G 	.	.	C0028326	.	.	.	.	NM_007373.4	-	.	.	0	0.86146	-1	.	.	0.74036	0.79668	.	.	.	0.03628605	5.82	.	.	.	-0.0132338	0.987016332867827	0.37283	D	.	.	.	0.3038	0.86749	p.Ser403Gly	.	.	-5.834	.	.	0.87295	981611	T	.	SHOC2	.	D	.	.	S403G	.	.	0.943	A/A	principal1																																																																																																				
F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	0.5280128373869296	0.46416947893294586	0.4610660797706094	0.3994524764064396	0.5252284119334957	0.5562734352083778	0.4760455283692873	0.59402811426185	0.5343461246836168	0.5509513100904082	0.5421431362976536	0.4701075036511166	0.5275470970162297	0.46689930054502815	0.538089861011952	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G		Lys39Arg																												F9_Lys39Arg	23	139537037	A	G	X	allele	116A>G	E04	527_CAVA_Array_P02	I08	B13A7A8P1_R1	B14A7A8P1_R2				X-139537037-A-G	-	0.42504	0.056	39	0	0	0	X	138619196	G	1.324680e-05	0	X	2_Benign	NC_000023.11	16	Lys39Arg	10	21.5	8	0	7.563150e-04	D	0	1	1	30817	5.928840e-05	0	17837	0.000000e+00	0	0.66405	Select	0.6381	13222	0.22821	0	0.007853403141361256	T	T	46597	0.19312899725	0	0	0.000000e+00	0	0	0.24181	13352	33690	0	1.292630e-03	0.18812	0	.	0.26523	0.997	0.0	99.0	0.0863914	1.14	0.01	G	single nucleotide variant	NC_000023.11:g.139537037A>G	0	12177	2	0.103917405	79213	0	0.113306604	0		13	168667	0	0	7.563150e-04	146	0.000000e+00	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	8	0	0.000000e+00	0	0.05039	B	0.24897	B	L	.	16	A/A	114	0	5673	1207839	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	12622	0.76067	0	.	-	139537037	1.162620e-03	-	9.182000	0	0.55009	21969	0	33690	13	germline	55963	.	.	GRCh38	924	criteria provided, single submitter	c.116A>G	0.000000e+00	0.45905	0	0	0	Gamma-carboxyglutamic acid-rich (GLA) domain	0.000000e+00	6881	B	0	0.000000e+00	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	1	0	FA9_HUMAN	0	1.0	.	0	T	0.06973	0.113306604	+	0.000000e+00	0		13	0.000000e+00	0	26591	criteria_provided,_single_submitter	0.99806	1.009940e-04	0	0.000000e+00	0	45673	p.Lys39Arg	0	0.79117	.	germline	8		A	Jan 30, 2024	0	A/A	0	63838	0.0	N	Xq27.1	9690	.	0.000000e+00	SCV001709323	Likely_benign	0	0	Arg	R	-	687	ENSP00000218099	ENST00000218099	13222	0.323	10057	0	0.756	A	0	3.13775	0.17147	.	T	-	.	.	0.83090	610	0	0.0	0.14653	0	139537037	Y	10	0	72498	0.000000e+00	P00740	0	0.357661	0.80679		0	0.032	D	10057	0.103917405	6881	0.79771	2158	-0.236865	0	-0.64	0.0	4.749180e-04	0.15597	0.000000e+00	0	57354	1.162620e-03	4334	0	0.24896	X	F9	0.000000e+00	0	Lys	14050	0.000000e+00	X-139537037-A-G	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	0	0	138446862	.	.	.	0	RCV001504446	T	0	0	c.116A>G	0	16	0	0.15471	A/A	rs200505648	139537037	11551	A	0.0015894039735099338	.	9392	0.26523	0.000000e+00	0.68239		0	0	4.749180e-04	1.92	0	0	264690	4.02	0.72262	112	T	T	0	0.000000e+00	0	26	.	0	0	98879	1160362	0.53563	0.21378	0.124255164463254	2898	6	0.06393	.	0.000000e+00	1.292630e-03	894043	1.162	8.749320e-05	N	9930	0	7.5560088E-6	0	300807|306900	0.31498	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.7314597189117038	2	0.22132	0.18019	17902	2	0.000000e+00	0.000000e+00	.	YES	0.000000e+00	0.149573	1150443	HGNC:3551	N	0	simple_aae	0.28	148583	139537037	AAA	1.000000	6	-	0	0.00300	0.000000e+00	0	0	Likely benign	0.26400	0	0	0	ClinGen:CA10529738	K	0	0.939239796073	-	.	-	0.37163	10	496	0.72948	0.393836945295	0.0743	0	0.99701738994094546	98	-	116A>G 	10	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	0	0.0	0	0.00987	200505648	1739	0	0.93813	.	0.312	0.417	2784	0.99985337	5.19	.	.	0.000000e+00	-0.208103	0.923986090574331	0.51123	T	86	4559	6965	-0.2568	0.87296	p.Lys39Arg	0	0	-4.174	0.014453173	0	0.77876	1160362	T	23895	F9	0.000000e+00	T	0.344	15966	.	T	0.30476	0.943	A/A	principal1	180865	F9_Popp_2025_heavy_chain_var231180	No											K		116	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Lys39Arg		true	c.116A>G						3551.0	139537037.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Lys39Arg						R	Jan 30, 2024					missense_variant		39.0			0.0000132467986213	1.0563088854352267		Likely benign	139537037.0	missense_variant		0.344					Reporter			F9_Lys39Arg
F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	0.5280128373869296	0.46416947893294586	0.4610660797706094	0.3994524764064396	0.5252284119334957	0.5562734352083778	0.4760455283692873	0.59402811426185	0.5343461246836168	0.5509513100904082	0.5421431362976536	0.4701075036511166	0.5275470970162297	0.46689930054502815	0.538089861011952	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G		Lys39Arg																												F9_Lys39Arg	23	139537037	A	G	X	allele	116A>G	E04	527_CAVA_Array_P02	I08	B13A7A8P1_R1	B14A7A8P1_R2				X-139537037-A-G	-	0.42504	0.056	39	0	0	0	X	138619196	G	1.324680e-05	0	X	2_Benign	NC_000023.11	16	Lys39Arg	10	21.5	8	0	7.563150e-04	D	0	1	1	30817	5.928840e-05	0	17837	0.000000e+00	0	0.66405	Select	0.6381	13222	0.22821	0	0.007853403141361256	T	T	46597	0.19312899725	0	0	0.000000e+00	0	0	0.24181	13352	33690	0	1.292630e-03	0.18812	0	.	0.26523	0.997	0.0	99.0	0.0863914	1.14	0.01	G	single nucleotide variant	NC_000023.11:g.139537037A>G	0	12177	2	0.103917405	79213	0	0.113306604	0		13	168667	0	0	7.563150e-04	146	0.000000e+00	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	8	0	0.000000e+00	0	0.05039	B	0.24897	B	L	.	16	A/A	114	0	5673	1207839	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	12622	0.76067	0	.	-	139537037	1.162620e-03	-	9.182000	0	0.55009	21969	0	33690	13	germline	55963	.	.	GRCh38	924	criteria provided, single submitter	c.116A>G	0.000000e+00	0.45905	0	0	0	Gamma-carboxyglutamic acid-rich (GLA) domain	0.000000e+00	6881	B	0	0.000000e+00	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	1	0	FA9_HUMAN	0	1.0	.	0	T	0.06973	0.113306604	+	0.000000e+00	0		13	0.000000e+00	0	26591	criteria_provided,_single_submitter	0.99806	1.009940e-04	0	0.000000e+00	0	45673	p.Lys39Arg	0	0.79117	.	germline	8		A	Jan 30, 2024	0	A/A	0	63838	0.0	N	Xq27.1	9690	.	0.000000e+00	SCV001709323	Likely_benign	0	0	Arg	R	-	687	ENSP00000218099	ENST00000218099	13222	0.323	10057	0	0.756	A	0	3.13775	0.17147	.	T	-	.	.	0.83090	610	0	0.0	0.14653	0	139537037	Y	10	0	72498	0.000000e+00	P00740	0	0.357661	0.80679		0	0.032	D	10057	0.103917405	6881	0.79771	2158	-0.236865	0	-0.64	0.0	4.749180e-04	0.15597	0.000000e+00	0	57354	1.162620e-03	4334	0	0.24896	X	F9	0.000000e+00	0	Lys	14050	0.000000e+00	X-139537037-A-G	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	0	0	138446862	.	.	.	0	RCV001504446	T	0	0	c.116A>G	0	16	0	0.15471	A/A	rs200505648	139537037	11551	A	0.0015894039735099338	.	9392	0.26523	0.000000e+00	0.68239		0	0	4.749180e-04	1.92	0	0	264690	4.02	0.72262	112	T	T	0	0.000000e+00	0	26	.	0	0	98879	1160362	0.53563	0.21378	0.124255164463254	2898	6	0.06393	.	0.000000e+00	1.292630e-03	894043	1.162	8.749320e-05	N	9930	0	7.5560088E-6	0	300807|306900	0.31498	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.7314597189117038	2	0.22132	0.18019	17902	2	0.000000e+00	0.000000e+00	.	YES	0.000000e+00	0.149573	1150443	HGNC:3551	N	0	simple_aae	0.28	148583	139537037	AAA	1.000000	6	-	0	0.00300	0.000000e+00	0	0	Likely benign	0.26400	0	0	0	ClinGen:CA10529738	K	0	0.939239796073	-	.	-	0.37163	10	496	0.72948	0.393836945295	0.0743	0	0.99701738994094546	98	-	116A>G 	10	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	0	0.0	0	0.00987	200505648	1739	0	0.93813	.	0.312	0.417	2784	0.99985337	5.19	.	.	0.000000e+00	-0.208103	0.923986090574331	0.51123	T	86	4559	6965	-0.2568	0.87296	p.Lys39Arg	0	0	-4.174	0.014453173	0	0.77876	1160362	T	23895	F9	0.000000e+00	T	0.344	15966	.	T	0.30476	0.943	A/A	principal1	153349	F9_Popp_2025_carboxy_gla_motif_var250542	No											K		116	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Lys39Arg		true	c.116A>G						3551.0	139537037.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Lys39Arg						R	Jan 30, 2024					missense_variant		39.0			0.0000132467986213	1.0317782090861911		Likely benign	139537037.0	missense_variant		0.344					Reporter			F9_Lys39Arg
F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	0.5280128373869296	0.46416947893294586	0.4610660797706094	0.3994524764064396	0.5252284119334957	0.5562734352083778	0.4760455283692873	0.59402811426185	0.5343461246836168	0.5509513100904082	0.5421431362976536	0.4701075036511166	0.5275470970162297	0.46689930054502815	0.538089861011952	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G		Lys39Arg																												F9_Lys39Arg	23	139537037	A	G	X	allele	116A>G	E04	527_CAVA_Array_P02	I08	B13A7A8P1_R1	B14A7A8P1_R2				X-139537037-A-G	-	0.42504	0.056	39	0	0	0	X	138619196	G	1.324680e-05	0	X	2_Benign	NC_000023.11	16	Lys39Arg	10	21.5	8	0	7.563150e-04	D	0	1	1	30817	5.928840e-05	0	17837	0.000000e+00	0	0.66405	Select	0.6381	13222	0.22821	0	0.007853403141361256	T	T	46597	0.19312899725	0	0	0.000000e+00	0	0	0.24181	13352	33690	0	1.292630e-03	0.18812	0	.	0.26523	0.997	0.0	99.0	0.0863914	1.14	0.01	G	single nucleotide variant	NC_000023.11:g.139537037A>G	0	12177	2	0.103917405	79213	0	0.113306604	0		13	168667	0	0	7.563150e-04	146	0.000000e+00	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	8	0	0.000000e+00	0	0.05039	B	0.24897	B	L	.	16	A/A	114	0	5673	1207839	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	12622	0.76067	0	.	-	139537037	1.162620e-03	-	9.182000	0	0.55009	21969	0	33690	13	germline	55963	.	.	GRCh38	924	criteria provided, single submitter	c.116A>G	0.000000e+00	0.45905	0	0	0	Gamma-carboxyglutamic acid-rich (GLA) domain	0.000000e+00	6881	B	0	0.000000e+00	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	1	0	FA9_HUMAN	0	1.0	.	0	T	0.06973	0.113306604	+	0.000000e+00	0		13	0.000000e+00	0	26591	criteria_provided,_single_submitter	0.99806	1.009940e-04	0	0.000000e+00	0	45673	p.Lys39Arg	0	0.79117	.	germline	8		A	Jan 30, 2024	0	A/A	0	63838	0.0	N	Xq27.1	9690	.	0.000000e+00	SCV001709323	Likely_benign	0	0	Arg	R	-	687	ENSP00000218099	ENST00000218099	13222	0.323	10057	0	0.756	A	0	3.13775	0.17147	.	T	-	.	.	0.83090	610	0	0.0	0.14653	0	139537037	Y	10	0	72498	0.000000e+00	P00740	0	0.357661	0.80679		0	0.032	D	10057	0.103917405	6881	0.79771	2158	-0.236865	0	-0.64	0.0	4.749180e-04	0.15597	0.000000e+00	0	57354	1.162620e-03	4334	0	0.24896	X	F9	0.000000e+00	0	Lys	14050	0.000000e+00	X-139537037-A-G	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	0	0	138446862	.	.	.	0	RCV001504446	T	0	0	c.116A>G	0	16	0	0.15471	A/A	rs200505648	139537037	11551	A	0.0015894039735099338	.	9392	0.26523	0.000000e+00	0.68239		0	0	4.749180e-04	1.92	0	0	264690	4.02	0.72262	112	T	T	0	0.000000e+00	0	26	.	0	0	98879	1160362	0.53563	0.21378	0.124255164463254	2898	6	0.06393	.	0.000000e+00	1.292630e-03	894043	1.162	8.749320e-05	N	9930	0	7.5560088E-6	0	300807|306900	0.31498	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.7314597189117038	2	0.22132	0.18019	17902	2	0.000000e+00	0.000000e+00	.	YES	0.000000e+00	0.149573	1150443	HGNC:3551	N	0	simple_aae	0.28	148583	139537037	AAA	1.000000	6	-	0	0.00300	0.000000e+00	0	0	Likely benign	0.26400	0	0	0	ClinGen:CA10529738	K	0	0.939239796073	-	.	-	0.37163	10	496	0.72948	0.393836945295	0.0743	0	0.99701738994094546	98	-	116A>G 	10	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	0	0.0	0	0.00987	200505648	1739	0	0.93813	.	0.312	0.417	2784	0.99985337	5.19	.	.	0.000000e+00	-0.208103	0.923986090574331	0.51123	T	86	4559	6965	-0.2568	0.87296	p.Lys39Arg	0	0	-4.174	0.014453173	0	0.77876	1160362	T	23895	F9	0.000000e+00	T	0.344	15966	.	T	0.30476	0.943	A/A	principal1	125833	F9_Popp_2025_carboxy_F9_specific_var221499	No											K		116	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Lys39Arg		true	c.116A>G						3551.0	139537037.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Lys39Arg						R	Jan 30, 2024					missense_variant		39.0			0.0000132467986213	1.0335224296642962		Likely benign	139537037.0	missense_variant		0.344					Reporter			F9_Lys39Arg
F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	0.5280128373869296	0.46416947893294586	0.4610660797706094	0.3994524764064396	0.5252284119334957	0.5562734352083778	0.4760455283692873	0.59402811426185	0.5343461246836168	0.5509513100904082	0.5421431362976536	0.4701075036511166	0.5275470970162297	0.46689930054502815	0.538089861011952	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G		Lys39Arg																												F9_Lys39Arg	23	139537037	A	G	X	allele	116A>G	E04	527_CAVA_Array_P02	I08	B13A7A8P1_R1	B14A7A8P1_R2				X-139537037-A-G	-	0.42504	0.056	39	0	0	0	X	138619196	G	1.324680e-05	0	X	2_Benign	NC_000023.11	16	Lys39Arg	10	21.5	8	0	7.563150e-04	D	0	1	1	30817	5.928840e-05	0	17837	0.000000e+00	0	0.66405	Select	0.6381	13222	0.22821	0	0.007853403141361256	T	T	46597	0.19312899725	0	0	0.000000e+00	0	0	0.24181	13352	33690	0	1.292630e-03	0.18812	0	.	0.26523	0.997	0.0	99.0	0.0863914	1.14	0.01	G	single nucleotide variant	NC_000023.11:g.139537037A>G	0	12177	2	0.103917405	79213	0	0.113306604	0		13	168667	0	0	7.563150e-04	146	0.000000e+00	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	8	0	0.000000e+00	0	0.05039	B	0.24897	B	L	.	16	A/A	114	0	5673	1207839	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	12622	0.76067	0	.	-	139537037	1.162620e-03	-	9.182000	0	0.55009	21969	0	33690	13	germline	55963	.	.	GRCh38	924	criteria provided, single submitter	c.116A>G	0.000000e+00	0.45905	0	0	0	Gamma-carboxyglutamic acid-rich (GLA) domain	0.000000e+00	6881	B	0	0.000000e+00	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	1	0	FA9_HUMAN	0	1.0	.	0	T	0.06973	0.113306604	+	0.000000e+00	0		13	0.000000e+00	0	26591	criteria_provided,_single_submitter	0.99806	1.009940e-04	0	0.000000e+00	0	45673	p.Lys39Arg	0	0.79117	.	germline	8		A	Jan 30, 2024	0	A/A	0	63838	0.0	N	Xq27.1	9690	.	0.000000e+00	SCV001709323	Likely_benign	0	0	Arg	R	-	687	ENSP00000218099	ENST00000218099	13222	0.323	10057	0	0.756	A	0	3.13775	0.17147	.	T	-	.	.	0.83090	610	0	0.0	0.14653	0	139537037	Y	10	0	72498	0.000000e+00	P00740	0	0.357661	0.80679		0	0.032	D	10057	0.103917405	6881	0.79771	2158	-0.236865	0	-0.64	0.0	4.749180e-04	0.15597	0.000000e+00	0	57354	1.162620e-03	4334	0	0.24896	X	F9	0.000000e+00	0	Lys	14050	0.000000e+00	X-139537037-A-G	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	0	0	138446862	.	.	.	0	RCV001504446	T	0	0	c.116A>G	0	16	0	0.15471	A/A	rs200505648	139537037	11551	A	0.0015894039735099338	.	9392	0.26523	0.000000e+00	0.68239		0	0	4.749180e-04	1.92	0	0	264690	4.02	0.72262	112	T	T	0	0.000000e+00	0	26	.	0	0	98879	1160362	0.53563	0.21378	0.124255164463254	2898	6	0.06393	.	0.000000e+00	1.292630e-03	894043	1.162	8.749320e-05	N	9930	0	7.5560088E-6	0	300807|306900	0.31498	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.7314597189117038	2	0.22132	0.18019	17902	2	0.000000e+00	0.000000e+00	.	YES	0.000000e+00	0.149573	1150443	HGNC:3551	N	0	simple_aae	0.28	148583	139537037	AAA	1.000000	6	-	0	0.00300	0.000000e+00	0	0	Likely benign	0.26400	0	0	0	ClinGen:CA10529738	K	0	0.939239796073	-	.	-	0.37163	10	496	0.72948	0.393836945295	0.0743	0	0.99701738994094546	98	-	116A>G 	10	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	0	0.0	0	0.00987	200505648	1739	0	0.93813	.	0.312	0.417	2784	0.99985337	5.19	.	.	0.000000e+00	-0.208103	0.923986090574331	0.51123	T	86	4559	6965	-0.2568	0.87296	p.Lys39Arg	0	0	-4.174	0.014453173	0	0.77876	1160362	T	23895	F9	0.000000e+00	T	0.344	15966	.	T	0.30476	0.943	A/A	principal1	208381	F9_Popp_2025_light_chain_var240861	No											K		116	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Lys39Arg		true	c.116A>G						3551.0	139537037.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Lys39Arg						R	Jan 30, 2024					missense_variant		39.0			0.0000132467986213	1.0395590160819106		Likely benign	139537037.0	missense_variant		0.344					Reporter			F9_Lys39Arg
F9_Lys39Arg	0.5834147239677604	0.5779189782041229	0.19849471444297212	0.8482998707084011	2025_01_Batch_13-14	0.5280128373869296	0.46416947893294586	0.4610660797706094	0.3994524764064396	0.5252284119334957	0.5562734352083778	0.4760455283692873	0.59402811426185	0.5343461246836168	0.5509513100904082	0.5421431362976536	0.4701075036511166	0.5275470970162297	0.46689930054502815	0.538089861011952	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030489		NC_000023.11:139537037:A:G		Lys39Arg																												F9_Lys39Arg	23	139537037	A	G	X	allele	116A>G	E04	527_CAVA_Array_P02	I08	B13A7A8P1_R1	B14A7A8P1_R2				X-139537037-A-G	-	0.42504	0.056	39	0	0	0	X	138619196	G	1.324680e-05	0	X	2_Benign	NC_000023.11	16	Lys39Arg	10	21.5	8	0	7.563150e-04	D	0	1	1	30817	5.928840e-05	0	17837	0.000000e+00	0	0.66405	Select	0.6381	13222	0.22821	0	0.007853403141361256	T	T	46597	0.19312899725	0	0	0.000000e+00	0	0	0.24181	13352	33690	0	1.292630e-03	0.18812	0	.	0.26523	0.997	0.0	99.0	0.0863914	1.14	0.01	G	single nucleotide variant	NC_000023.11:g.139537037A>G	0	12177	2	0.103917405	79213	0	0.113306604	0		13	168667	0	0	7.563150e-04	146	0.000000e+00	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	8	0	0.000000e+00	0	0.05039	B	0.24897	B	L	.	16	A/A	114	0	5673	1207839	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	12622	0.76067	0	.	-	139537037	1.162620e-03	-	9.182000	0	0.55009	21969	0	33690	13	germline	55963	.	.	GRCh38	924	criteria provided, single submitter	c.116A>G	0.000000e+00	0.45905	0	0	0	Gamma-carboxyglutamic acid-rich (GLA) domain	0.000000e+00	6881	B	0	0.000000e+00	NM_000133.4(F9):c.116A>G (p.Lys39Arg)	1	0	FA9_HUMAN	0	1.0	.	0	T	0.06973	0.113306604	+	0.000000e+00	0		13	0.000000e+00	0	26591	criteria_provided,_single_submitter	0.99806	1.009940e-04	0	0.000000e+00	0	45673	p.Lys39Arg	0	0.79117	.	germline	8		A	Jan 30, 2024	0	A/A	0	63838	0.0	N	Xq27.1	9690	.	0.000000e+00	SCV001709323	Likely_benign	0	0	Arg	R	-	687	ENSP00000218099	ENST00000218099	13222	0.323	10057	0	0.756	A	0	3.13775	0.17147	.	T	-	.	.	0.83090	610	0	0.0	0.14653	0	139537037	Y	10	0	72498	0.000000e+00	P00740	0	0.357661	0.80679		0	0.032	D	10057	0.103917405	6881	0.79771	2158	-0.236865	0	-0.64	0.0	4.749180e-04	0.15597	0.000000e+00	0	57354	1.162620e-03	4334	0	0.24896	X	F9	0.000000e+00	0	Lys	14050	0.000000e+00	X-139537037-A-G	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	0	0	138446862	.	.	.	0	RCV001504446	T	0	0	c.116A>G	0	16	0	0.15471	A/A	rs200505648	139537037	11551	A	0.0015894039735099338	.	9392	0.26523	0.000000e+00	0.68239		0	0	4.749180e-04	1.92	0	0	264690	4.02	0.72262	112	T	T	0	0.000000e+00	0	26	.	0	0	98879	1160362	0.53563	0.21378	0.124255164463254	2898	6	0.06393	.	0.000000e+00	1.292630e-03	894043	1.162	8.749320e-05	N	9930	0	7.5560088E-6	0	300807|306900	0.31498	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.7314597189117038	2	0.22132	0.18019	17902	2	0.000000e+00	0.000000e+00	.	YES	0.000000e+00	0.149573	1150443	HGNC:3551	N	0	simple_aae	0.28	148583	139537037	AAA	1.000000	6	-	0	0.00300	0.000000e+00	0	0	Likely benign	0.26400	0	0	0	ClinGen:CA10529738	K	0	0.939239796073	-	.	-	0.37163	10	496	0.72948	0.393836945295	0.0743	0	0.99701738994094546	98	-	116A>G 	10	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	0	0.0	0	0.00987	200505648	1739	0	0.93813	.	0.312	0.417	2784	0.99985337	5.19	.	.	0.000000e+00	-0.208103	0.923986090574331	0.51123	T	86	4559	6965	-0.2568	0.87296	p.Lys39Arg	0	0	-4.174	0.014453173	0	0.77876	1160362	T	23895	F9	0.000000e+00	T	0.344	15966	.	T	0.30476	0.943	A/A	principal1	235897	F9_Popp_2025_strep_2_var260223	No											K		116	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Lys39Arg		true	c.116A>G						3551.0	139537037.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Lys39Arg						R	Jan 30, 2024					missense_variant		39.0			0.0000132467986213	0.9412971589182256		Likely benign	139537037.0	missense_variant		0.344					Reporter			F9_Lys39Arg
RPS19_Val15Phe	-2.3726616409620696	0.0765985741724703	-5.512693220591865	0.0008944402490659259	2025_01_Batch_13-14	0.684109794739754	0.8354004220502114	0.9476236131613452	0.8981160057662907	0.6773948020766469	0.6498024481967875	0.8311746588573784	0.9456344669283709	0.9173255485788965	0.6438750406079519	0.6669561214682707	0.8332875404537949	0.946629040044858	0.9077207771725936	0.6606349213422994	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RPS19	RPS19	ENSG00000105372	3441	6053	CCSBVarC000466	ALE00000466	NC_000019.10:41860817:G:T	43G>T	Val15Phe	RC4	RC4_Mut_GDEh1010	E11	GDEhDisVCh_40042	B02	2	RC4_Mut_GDDh1010	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			RPS19_Val15Phe	19	41860817	G	T	19											19-41860817-G-T	-	0.87374	0.997	15	.	.	.	19	42364887	T	.	.	19	1_Pathogenic	NC_000019.10	.	Val15Phe	.	29.2	.	.	.	T	.	1	1	.	.	.	.	.	.	.	Select	0.3830	.	0.70687	.	.	D	D	.	1.80914359211	.	.	.	.	.	0.95692	.	.	.	.	.	.	.	0.98647	0.998	.	1.0	.	.	0.99	T	single nucleotide variant	NC_000019.10:g.41860817G>T	.	.	2	0.9133168	.	.	0.9801354	.		.	.	.	.	.	.	.	.	MedGen:C3661900	.	.	.	.	0.97926	D	0.96206	D	M	6.250244	.	./.	.	.	.	.	not provided	.	0.76366	.	.	-	41860817	.	-	11.663000	.	0.88659	.	.	.	.	germline	.	Loss of MoRF binding (P = 0.0787)| Loss of stability (P = 0.3828)| Loss of disorder (P = 0.4358)| Gain of methylation at R16 (P = 0.5521)| Loss of catalytic residue at F14 (P = 0.6366)	0.98139	GRCh38	758	criteria provided, single submitter	c.43G>T	.	0.38994	.	.	.	.	.	.	LP	.	.	NM_001022.4(RPS19):c.43G>T (p.Val15Phe)	1	.	RS19_HUMAN	.	99.0	0.630628753833532	.	.	0.91158	0.97457075	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99909	.	.	.	.	.	p.Val15Phe	.	0.94018	.	germline	.		G	Aug 03, 2015	.	./.	.	.	1.0	N	19q13.2	.	.	.	SCV000567615	Pathogenic	.	.	Phe	F	-	.	ENSP00000470972	ENST00000598742	.	.	.	.	0.662	G	.	5.206373	0.83643	D	D	-	5.654391	.	0.93389	.	.	.	0.74730	.	41860817	Y	9	.	.	.	P39019	.	0.984477	0.63408		.	0.961	D	.	0.91802967	.	0.85369	6223	0.554303	.	.	.	.	.	.	.	.	.	.	.	0.95867	19	RPS19	.	.	Val	.	.	19-41860817-G-T	not_provided	.	.	47056727	ClinGen:CA045535|OMIM:603474.0007|UniProtKB:P39019#VAR_018438	0.939381	0.74985	.	RCV000482973	D	.	.	c.43G>T	.	.	.	0.95835	./.	rs104894717	41860817	.	G	.	P39019	.	0.99104	.	0.68239		.	.	.	3.395	.	.	.	3.49	0.99897	.	D	D	.	.	.	.	.	.	.	.	242804	0.95771	0.91745	0.983127236366272	.	.	0.71675	0.93969	.	.	.	6.938	.	.	.	.	.	.	.	0.75774	19	.	ENSG00000105372	.	.	.	.	0.9614224850641426	1	0.70481	0.50788	.	.	.	.	0.550537727116612	YES	.	0.40126	21358	HGNC:10402	A	.	simple_aae	0.795	.	41860817	GTC	1.000000	.	-	.	0.97062	.	.	.	Pathogenic	0.90127	.	.	.	ClinVar:6319,ClinGen:CA045535,UniProtKB:P39019#VAR_018438,OMIM:603474.0007	V	.	0.991857985221	-	0.909	-	0.97658	.	.	0.96106	0.8935765028	0.9629	.	0.99412599951109681	.	-	43G>T 	.	.	C3661900	.	.	.	.	NM_001022.4	-	.	.	1	0.56568	104894717	.	.	0.99167	0.71277	0.966	0.002	.	0.99992170	4.53	.	.	.	0.558441	0.997229277562924	0.91508	T	.	.	.	-0.2458	0.73812	p.Val15Phe	.	.	-13.184	0.9739928	.	0.92904	242804	D	.	RPS19	.	D	.	.	V15F	.	.	0.56385	./.	principal1																																																																																																				
RPS19_Val15Phe	-2.3726616409620696	0.0765985741724703	-5.512693220591865	0.0008944402490659259	2025_01_Batch_13-14	0.684109794739754	0.8354004220502114	0.9476236131613452	0.8981160057662907	0.6773948020766469	0.6498024481967875	0.8311746588573784	0.9456344669283709	0.9173255485788965	0.6438750406079519	0.6669561214682707	0.8332875404537949	0.946629040044858	0.9077207771725936	0.6606349213422994	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RPS19	RPS19		3441		CCSBVarC000466		NC_000019.10:41860817:G:T		Val15Phe																												RPS19_Val15Phe	19	41860817	G	T	19	allele	43G>T	E10	527_CAVA_Array_P05	I19	B13A7A8P2_R1	B14A7A8P2_R2				19-41860817-G-T	-	0.87374	0.997	15	.	.	.	19	42364887	T	.	.	19	1_Pathogenic	NC_000019.10	.	Val15Phe	.	29.2	.	.	.	T	.	1	1	.	.	.	.	.	.	.	Select	0.3830	.	0.70687	.	.	D	D	.	1.80914359211	.	.	.	.	.	0.95692	.	.	.	.	.	.	.	0.98647	0.998	.	1.0	.	.	0.99	T	single nucleotide variant	NC_000019.10:g.41860817G>T	.	.	2	0.9133168	.	.	0.9801354	.		.	.	.	.	.	.	.	.	MedGen:C3661900	.	.	.	.	0.97926	D	0.96206	D	M	6.250244	.	./.	.	.	.	.	not provided	.	0.76366	.	.	-	41860817	.	-	11.663000	.	0.88659	.	.	.	.	germline	.	Loss of MoRF binding (P = 0.0787)| Loss of stability (P = 0.3828)| Loss of disorder (P = 0.4358)| Gain of methylation at R16 (P = 0.5521)| Loss of catalytic residue at F14 (P = 0.6366)	0.98139	GRCh38	758	criteria provided, single submitter	c.43G>T	.	0.38994	.	.	.	.	.	.	LP	.	.	NM_001022.4(RPS19):c.43G>T (p.Val15Phe)	1	.	RS19_HUMAN	.	99.0	0.630628753833532	.	.	0.91158	0.97457075	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99909	.	.	.	.	.	p.Val15Phe	.	0.94018	.	germline	.		G	Aug 03, 2015	.	./.	.	.	1.0	N	19q13.2	.	.	.	SCV000567615	Pathogenic	.	.	Phe	F	-	.	ENSP00000470972	ENST00000598742	.	.	.	.	0.662	G	.	5.206373	0.83643	D	D	-	5.654391	.	0.93389	.	.	.	0.74730	.	41860817	Y	9	.	.	.	P39019	.	0.984477	0.63408		.	0.961	D	.	0.91802967	.	0.85369	6223	0.554303	.	.	.	.	.	.	.	.	.	.	.	0.95867	19	RPS19	.	.	Val	.	.	19-41860817-G-T	not_provided	.	.	47056727	ClinGen:CA045535|OMIM:603474.0007|UniProtKB:P39019#VAR_018438	0.939381	0.74985	.	RCV000482973	D	.	.	c.43G>T	.	.	.	0.95835	./.	rs104894717	41860817	.	G	.	P39019	.	0.99104	.	0.68239		.	.	.	3.395	.	.	.	3.49	0.99897	.	D	D	.	.	.	.	.	.	.	.	242804	0.95771	0.91745	0.983127236366272	.	.	0.71675	0.93969	.	.	.	6.938	.	.	.	.	.	.	.	0.75774	19	.	ENSG00000105372	.	.	.	.	0.9614224850641426	1	0.70481	0.50788	.	.	.	.	0.550537727116612	YES	.	0.40126	21358	HGNC:10402	A	.	simple_aae	0.795	.	41860817	GTC	1.000000	.	-	.	0.97062	.	.	.	Pathogenic	0.90127	.	.	.	ClinVar:6319,ClinGen:CA045535,UniProtKB:P39019#VAR_018438,OMIM:603474.0007	V	.	0.991857985221	-	0.909	-	0.97658	.	.	0.96106	0.8935765028	0.9629	.	0.99412599951109681	.	-	43G>T 	.	.	C3661900	.	.	.	.	NM_001022.4	-	.	.	1	0.56568	104894717	.	.	0.99167	0.71277	0.966	0.002	.	0.99992170	4.53	.	.	.	0.558441	0.997229277562924	0.91508	T	.	.	.	-0.2458	0.73812	p.Val15Phe	.	.	-13.184	0.9739928	.	0.92904	242804	D	.	RPS19	.	D	.	.	V15F	.	.	0.56385	./.	principal1																																																																																																				
CTCF_Arg342Cys	4.0251147636350355	0.005026859283026853	3.3465906362055593	0.012308068398097118	2025_01_Batch_13-14	0.7323616410391203	0.7980792108414768	0.7414395687576792	0.6956161388840096	0.7051673427152019	0.643556593854874	0.6789145506292014	0.686227967227117	0.709388113297629	0.5442509671616682	0.6879591174469971	0.7384968807353391	0.7138337679923981	0.7025021260908193	0.624709154938435	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF		6173		CCSBVarC010851		NC_000016.10:67616816:C:T		Arg342Cys																												CTCF_Arg342Cys	16	67616816	C	T	16	allele	1024C>T	G01	527_CAVA_Array_P02	M02	B13A7A8P1_R1	B14A7A8P1_R2				16-67616816-C-T	-	0.91125	1.0	342	.	0	.	16	67650719	T	6.195260e-07	.	16	1_Pathogenic	NC_000016.10	1	Arg342Cys	.	32.0	.	0	.	T	0	5	.	.	.	.	.	.	0	0.81796	.	0.2195	.	0.90580	.	.	D	D	64030	.	0	0	.	.	.	0.99943	.	44890	0	.	0.94690	.	.	0.83088	0.995	.	.	.	.	.	T	single nucleotide variant	NC_000016.10:g.67616816C>T	0	.	2	0.75543875	.	0	0.8758145	0		.	.	.	.	.	146	.	0	MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|	.	.	0.000000e+00	0	0.91795	D	0.85523	D	M	10.37319	1	C/C	84	0	.	1614136	not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|CTCF-related disorder	.	0.66965	.	.	-	67616816	.	-	7.609000	.	0.91546	29608	0	1180010	.	de novo;germline	91086	Loss of MoRF binding (P = 0.0286)| Loss of disorder (P = 0.0417)| Gain of methylation at K344 (P = 0.0462)| Loss of loop (P = 0.0804)| Loss of solvent accessibility (P = 0.1077)	0.91830	GRCh38	55	criteria provided, multiple submitters, no conflicts	c.1024C>T	.	0.63341	0	.	.	.	.	.	LP	0	0.000000e+00	NM_006565.4(CTCF):c.1024C>T (p.Arg342Cys)	2	.	CTCF_HUMAN	.	.	0.872885598481848	.	.	0.95928	0.79036707	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.93745	.	0	.	.	60000	p.Arg342Cys	0	0.61899	.	germline	.		C	Aug 31, 2022	.	C/C	.	.	1.0	N	16q22.1	6962	.	.	SCV000581783|SCV001429134|SCV001449853|SCV004117060	Conflicting_classifications_of_pathogenicity	.	.	Cys	C	-	912	ENSP00000494408	ENST00000642819	.	.	.	.	0.599	C	.	5.456603	0.92967	D	.	-	10.28159	.	0.71478	610	.	.	0.94546	0	67616816	Y	10	0	.	0.000000e+00	P49711	.	0.874794	0.98096		.	0.996	D	.	0.75798017	.	0.73271	10664	0.243152	1	.	.	8.474500e-07	0.91343	.	.	75034	.	6062	.	0.85370	16	CTCF	0.000000e+00	0	Arg	10680	.	16-67616816-C-T	not_provided|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder	0	.	66208220	ClinGen:CA396312251	0.927208	0.90318	0	RCV000494182|RCV001253429|RCV004535549	D	0	.	c.1024C>T	.	0	0	0.77795	C/C	rs1131691283	67616816	.	C	.	P49711	.	0.89177	.	0.68239		.	.	0.000000e+00	2.925	0	0	264690	4.89	0.97303	108	D	D	.	.	0	24	.	.	.	363611	429261	0.77506	0.99749	0.998596012592316	2294	.	0.71675	0.90917	.	.	1180010	7.701	.	.	.	.	3.7780044E-6	0	615502	0.83585	16	.	ENSG00000102974	0.000000e+00	0	.	0	.	1	0.84488	0.97558	.	1	.	0.000000e+00	0.805277495105465	.	0.000000e+00	0.072612	422102	HGNC:13723	.	.	.	0.846	.	67616816	CGT	1.000000	.	-	0	0.90073	8.474500e-07	0	0	Pathogenic/Likely pathogenic	0.91976	.	0	0	ClinGen:CA396312251	R	.	.	-	0.799	-	0.66102	.	466	0.92611	0.963747024536	0.9958	0	0.99912080062961595	94	-	1024C>T 	.	0	C3661900|C3809686	.	.	.	.	NM_006565.4	-	.	.	1	0.91755	1131691283	.	0	0.78989	0.90104	.	.	2210	0.95648080	4.89	.	.	.	0.111494	0.999472519562105	0.84244	T	84	.	.	-0.5414	0.58068	p.Arg342Cys	0	0	-13.341	0.90816814	0	0.96705	429261	D	.	CTCF	.	D	.	.	R342C	.	.	0.40292	C/C	principal4	964318	CTCF_unpublished_var158565	Yes						overall function		Cell survival			R		1024	CTCF_unpublished		ENST00000264010.10							immortalized human cells					p.Arg342Cys		true	c.1024C>T						13723.0	67616816.0	Yes		CTCF				NM_006565.4		1.0			nucleotide		T									criteria provided, multiple submitters, no conflicts				Arg342Cys						C	Aug 31, 2022					missense_variant		342.0	C		6.195264835181174e-7	0.0968285		Pathogenic/Likely pathogenic	67616816.0	missense_variant		0.559	functionally_normal				Cell viability			CTCF_Arg342Cys
CTCF_Arg342Cys	4.0251147636350355	0.005026859283026853	3.3465906362055593	0.012308068398097118	2025_01_Batch_13-14	0.7323616410391203	0.7980792108414768	0.7414395687576792	0.6956161388840096	0.7051673427152019	0.643556593854874	0.6789145506292014	0.686227967227117	0.709388113297629	0.5442509671616682	0.6879591174469971	0.7384968807353391	0.7138337679923981	0.7025021260908193	0.624709154938435	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF				CCSBVarC010851	ALE00013946	NC_000016.10:67616816:C:T	1024C>T	Arg342Cys	CAVA																											CTCF_Arg342Cys	16	67616816	C	T	16								1	1	1	16-67616816-C-T	-	0.91125	1.0	342	.	0	.	16	67650719	T	6.195260e-07	.	16	1_Pathogenic	NC_000016.10	1	Arg342Cys	.	32.0	.	0	.	T	0	5	.	.	.	.	.	.	0	0.81796	.	0.2195	.	0.90580	.	.	D	D	64030	.	0	0	.	.	.	0.99943	.	44890	0	.	0.94690	.	.	0.83088	0.995	.	.	.	.	.	T	single nucleotide variant	NC_000016.10:g.67616816C>T	0	.	2	0.75543875	.	0	0.8758145	0		.	.	.	.	.	146	.	0	MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|	.	.	0.000000e+00	0	0.91795	D	0.85523	D	M	10.37319	1	C/C	84	0	.	1614136	not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|CTCF-related disorder	.	0.66965	.	.	-	67616816	.	-	7.609000	.	0.91546	29608	0	1180010	.	de novo;germline	91086	Loss of MoRF binding (P = 0.0286)| Loss of disorder (P = 0.0417)| Gain of methylation at K344 (P = 0.0462)| Loss of loop (P = 0.0804)| Loss of solvent accessibility (P = 0.1077)	0.91830	GRCh38	55	criteria provided, multiple submitters, no conflicts	c.1024C>T	.	0.63341	0	.	.	.	.	.	LP	0	0.000000e+00	NM_006565.4(CTCF):c.1024C>T (p.Arg342Cys)	2	.	CTCF_HUMAN	.	.	0.872885598481848	.	.	0.95928	0.79036707	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.93745	.	0	.	.	60000	p.Arg342Cys	0	0.61899	.	germline	.		C	Aug 31, 2022	.	C/C	.	.	1.0	N	16q22.1	6962	.	.	SCV000581783|SCV001429134|SCV001449853|SCV004117060	Conflicting_classifications_of_pathogenicity	.	.	Cys	C	-	912	ENSP00000494408	ENST00000642819	.	.	.	.	0.599	C	.	5.456603	0.92967	D	.	-	10.28159	.	0.71478	610	.	.	0.94546	0	67616816	Y	10	0	.	0.000000e+00	P49711	.	0.874794	0.98096		.	0.996	D	.	0.75798017	.	0.73271	10664	0.243152	1	.	.	8.474500e-07	0.91343	.	.	75034	.	6062	.	0.85370	16	CTCF	0.000000e+00	0	Arg	10680	.	16-67616816-C-T	not_provided|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder	0	.	66208220	ClinGen:CA396312251	0.927208	0.90318	0	RCV000494182|RCV001253429|RCV004535549	D	0	.	c.1024C>T	.	0	0	0.77795	C/C	rs1131691283	67616816	.	C	.	P49711	.	0.89177	.	0.68239		.	.	0.000000e+00	2.925	0	0	264690	4.89	0.97303	108	D	D	.	.	0	24	.	.	.	363611	429261	0.77506	0.99749	0.998596012592316	2294	.	0.71675	0.90917	.	.	1180010	7.701	.	.	.	.	3.7780044E-6	0	615502	0.83585	16	.	ENSG00000102974	0.000000e+00	0	.	0	.	1	0.84488	0.97558	.	1	.	0.000000e+00	0.805277495105465	.	0.000000e+00	0.072612	422102	HGNC:13723	.	.	.	0.846	.	67616816	CGT	1.000000	.	-	0	0.90073	8.474500e-07	0	0	Pathogenic/Likely pathogenic	0.91976	.	0	0	ClinGen:CA396312251	R	.	.	-	0.799	-	0.66102	.	466	0.92611	0.963747024536	0.9958	0	0.99912080062961595	94	-	1024C>T 	.	0	C3661900|C3809686	.	.	.	.	NM_006565.4	-	.	.	1	0.91755	1131691283	.	0	0.78989	0.90104	.	.	2210	0.95648080	4.89	.	.	.	0.111494	0.999472519562105	0.84244	T	84	.	.	-0.5414	0.58068	p.Arg342Cys	0	0	-13.341	0.90816814	0	0.96705	429261	D	.	CTCF	.	D	.	.	R342C	.	.	0.40292	C/C	principal4	964318	CTCF_unpublished_var158565	Yes						overall function		Cell survival			R		1024	CTCF_unpublished		ENST00000264010.10							immortalized human cells					p.Arg342Cys		true	c.1024C>T						13723.0	67616816.0	Yes		CTCF				NM_006565.4		1.0			nucleotide		T									criteria provided, multiple submitters, no conflicts				Arg342Cys						C	Aug 31, 2022					missense_variant		342.0	C		6.195264835181174e-7	0.0968285		Pathogenic/Likely pathogenic	67616816.0	missense_variant		0.559	functionally_normal				Cell viability			CTCF_Arg342Cys
F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444638	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520082	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu73Val	23	139537139	A	T	X											X-139537139-A-T	-	0.80612	1.0	73	.	.	.	X	138619298	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu73Val	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99783	Select	0.9947	.	0.90580	.	.	D	D	.	0.462158744156	.	.	.	.	.	0.46353	.	.	.	.	0.89056	.	.	0.97797	1.0	.	1.0	0.985426	5.06	0.99	T	single nucleotide variant	NC_000023.11:g.139537139A>T	.	.	1	0.9547829	.	.	0.9843717	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99195	D	H	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96095	.	.	-	139537139	.	-	11.053000	.	0.99559	.	.	.	.	germline	.	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.99735	GRCh38	924	no assertion criteria provided	c.218A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.218A>T (p.Glu73Val)		.	FA9_HUMAN	.	99.0	.	.	D	0.84530	0.9655434	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu73Val	.	0.85349	.	germline	.		A	Feb 19, 1990	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031548	Pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.901742	0.92967	.	D	-	.	.	0.99720	.	.	.	0.96829	.	139537139	Y	10	.	.	.	P00740	.	0.991043	0.58784		.	0.997	D	.	0.96451426	.	0.97202	2158	0.739945	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.98661	X	F9	.	.	Glu	.	.	X-139537139-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138446964	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	.	.	.	RCV000011317	D	.	.	c.218A>T	.	.	.	0.99969	A/A	rs137852226	139537139	.	A	.	P00740	.	0.99415	.	0.68239		.	.	.	3.8	.	.	.	5.19	0.99964	.	D	T	.	.	.	.	.	.	.	98879	10571	0.99969	0.45459	0.999292135238647	.	.	0.71675	.	.	.	.	8.504	.	D	.	.	.	.	306900	0.90364	X	.	ENSG00000101981	.	.	.	.	0.9910322472733558	2	0.86259	0.18019	.	.	.	.	.	YES	.	0.957945	25610	HGNC:3551	A	.	simple_aae	0.987	.	139537139	GAA	1.000000	.	-	.	0.99841	.	.	.	Pathogenic	0.94215	.	.	.	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	E	.	0.999812538853	-	0.972	-	0.91390	.	.	0.99096	0.553981482983	0.8952	.	0.99303529145021763	.	-	218A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.95006	137852226	.	.	0.99980	.	0.83	0.0	.	0.99999270	5.19	.	.	.	0.825103	0.999841268525741	0.95330	D	.	.	.	0.9304	0.99879	p.Glu73Val	.	.	-14.372	0.99308085	.	0.98301	10571	D	.	F9	.	D	0.976	.	E73V	D	0.90556	0.943	A/A	principal1	210285	F9_Popp_2025_light_chain_var241561	No											E		218	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Glu73Val		true	c.218A>T						3551.0	139537139.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Glu73Val						V	Feb 19, 1990					missense_variant		73.0				0.9295306653411096		Pathogenic	139537139.0	missense_variant		0.976					Reporter			F9_Glu73Val
F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444638	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520082	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu73Val	23	139537139	A	T	X											X-139537139-A-T	-	0.80612	1.0	73	.	.	.	X	138619298	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu73Val	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99783	Select	0.9947	.	0.90580	.	.	D	D	.	0.462158744156	.	.	.	.	.	0.46353	.	.	.	.	0.89056	.	.	0.97797	1.0	.	1.0	0.985426	5.06	0.99	T	single nucleotide variant	NC_000023.11:g.139537139A>T	.	.	1	0.9547829	.	.	0.9843717	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99195	D	H	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96095	.	.	-	139537139	.	-	11.053000	.	0.99559	.	.	.	.	germline	.	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.99735	GRCh38	924	no assertion criteria provided	c.218A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.218A>T (p.Glu73Val)		.	FA9_HUMAN	.	99.0	.	.	D	0.84530	0.9655434	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu73Val	.	0.85349	.	germline	.		A	Feb 19, 1990	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031548	Pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.901742	0.92967	.	D	-	.	.	0.99720	.	.	.	0.96829	.	139537139	Y	10	.	.	.	P00740	.	0.991043	0.58784		.	0.997	D	.	0.96451426	.	0.97202	2158	0.739945	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.98661	X	F9	.	.	Glu	.	.	X-139537139-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138446964	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	.	.	.	RCV000011317	D	.	.	c.218A>T	.	.	.	0.99969	A/A	rs137852226	139537139	.	A	.	P00740	.	0.99415	.	0.68239		.	.	.	3.8	.	.	.	5.19	0.99964	.	D	T	.	.	.	.	.	.	.	98879	10571	0.99969	0.45459	0.999292135238647	.	.	0.71675	.	.	.	.	8.504	.	D	.	.	.	.	306900	0.90364	X	.	ENSG00000101981	.	.	.	.	0.9910322472733558	2	0.86259	0.18019	.	.	.	.	.	YES	.	0.957945	25610	HGNC:3551	A	.	simple_aae	0.987	.	139537139	GAA	1.000000	.	-	.	0.99841	.	.	.	Pathogenic	0.94215	.	.	.	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	E	.	0.999812538853	-	0.972	-	0.91390	.	.	0.99096	0.553981482983	0.8952	.	0.99303529145021763	.	-	218A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.95006	137852226	.	.	0.99980	.	0.83	0.0	.	0.99999270	5.19	.	.	.	0.825103	0.999841268525741	0.95330	D	.	.	.	0.9304	0.99879	p.Glu73Val	.	.	-14.372	0.99308085	.	0.98301	10571	D	.	F9	.	D	0.976	.	E73V	D	0.90556	0.943	A/A	principal1	127737	F9_Popp_2025_carboxy_F9_specific_var222199	No											E		218	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Glu73Val		true	c.218A>T						3551.0	139537139.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Glu73Val						V	Feb 19, 1990					missense_variant		73.0				0.007236438		Pathogenic	139537139.0	missense_variant		0.976					Reporter			F9_Glu73Val
F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444638	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520082	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu73Val	23	139537139	A	T	X											X-139537139-A-T	-	0.80612	1.0	73	.	.	.	X	138619298	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu73Val	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99783	Select	0.9947	.	0.90580	.	.	D	D	.	0.462158744156	.	.	.	.	.	0.46353	.	.	.	.	0.89056	.	.	0.97797	1.0	.	1.0	0.985426	5.06	0.99	T	single nucleotide variant	NC_000023.11:g.139537139A>T	.	.	1	0.9547829	.	.	0.9843717	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99195	D	H	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96095	.	.	-	139537139	.	-	11.053000	.	0.99559	.	.	.	.	germline	.	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.99735	GRCh38	924	no assertion criteria provided	c.218A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.218A>T (p.Glu73Val)		.	FA9_HUMAN	.	99.0	.	.	D	0.84530	0.9655434	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu73Val	.	0.85349	.	germline	.		A	Feb 19, 1990	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031548	Pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.901742	0.92967	.	D	-	.	.	0.99720	.	.	.	0.96829	.	139537139	Y	10	.	.	.	P00740	.	0.991043	0.58784		.	0.997	D	.	0.96451426	.	0.97202	2158	0.739945	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.98661	X	F9	.	.	Glu	.	.	X-139537139-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138446964	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	.	.	.	RCV000011317	D	.	.	c.218A>T	.	.	.	0.99969	A/A	rs137852226	139537139	.	A	.	P00740	.	0.99415	.	0.68239		.	.	.	3.8	.	.	.	5.19	0.99964	.	D	T	.	.	.	.	.	.	.	98879	10571	0.99969	0.45459	0.999292135238647	.	.	0.71675	.	.	.	.	8.504	.	D	.	.	.	.	306900	0.90364	X	.	ENSG00000101981	.	.	.	.	0.9910322472733558	2	0.86259	0.18019	.	.	.	.	.	YES	.	0.957945	25610	HGNC:3551	A	.	simple_aae	0.987	.	139537139	GAA	1.000000	.	-	.	0.99841	.	.	.	Pathogenic	0.94215	.	.	.	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	E	.	0.999812538853	-	0.972	-	0.91390	.	.	0.99096	0.553981482983	0.8952	.	0.99303529145021763	.	-	218A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.95006	137852226	.	.	0.99980	.	0.83	0.0	.	0.99999270	5.19	.	.	.	0.825103	0.999841268525741	0.95330	D	.	.	.	0.9304	0.99879	p.Glu73Val	.	.	-14.372	0.99308085	.	0.98301	10571	D	.	F9	.	D	0.976	.	E73V	D	0.90556	0.943	A/A	principal1	155253	F9_Popp_2025_carboxy_gla_motif_var251242	No											E		218	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Glu73Val		true	c.218A>T						3551.0	139537139.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Glu73Val						V	Feb 19, 1990					missense_variant		73.0				0.9857232342018252		Pathogenic	139537139.0	missense_variant		0.976					Reporter			F9_Glu73Val
F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444638	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520082	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu73Val	23	139537139	A	T	X											X-139537139-A-T	-	0.80612	1.0	73	.	.	.	X	138619298	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu73Val	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99783	Select	0.9947	.	0.90580	.	.	D	D	.	0.462158744156	.	.	.	.	.	0.46353	.	.	.	.	0.89056	.	.	0.97797	1.0	.	1.0	0.985426	5.06	0.99	T	single nucleotide variant	NC_000023.11:g.139537139A>T	.	.	1	0.9547829	.	.	0.9843717	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99195	D	H	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96095	.	.	-	139537139	.	-	11.053000	.	0.99559	.	.	.	.	germline	.	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.99735	GRCh38	924	no assertion criteria provided	c.218A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.218A>T (p.Glu73Val)		.	FA9_HUMAN	.	99.0	.	.	D	0.84530	0.9655434	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu73Val	.	0.85349	.	germline	.		A	Feb 19, 1990	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031548	Pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.901742	0.92967	.	D	-	.	.	0.99720	.	.	.	0.96829	.	139537139	Y	10	.	.	.	P00740	.	0.991043	0.58784		.	0.997	D	.	0.96451426	.	0.97202	2158	0.739945	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.98661	X	F9	.	.	Glu	.	.	X-139537139-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138446964	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	.	.	.	RCV000011317	D	.	.	c.218A>T	.	.	.	0.99969	A/A	rs137852226	139537139	.	A	.	P00740	.	0.99415	.	0.68239		.	.	.	3.8	.	.	.	5.19	0.99964	.	D	T	.	.	.	.	.	.	.	98879	10571	0.99969	0.45459	0.999292135238647	.	.	0.71675	.	.	.	.	8.504	.	D	.	.	.	.	306900	0.90364	X	.	ENSG00000101981	.	.	.	.	0.9910322472733558	2	0.86259	0.18019	.	.	.	.	.	YES	.	0.957945	25610	HGNC:3551	A	.	simple_aae	0.987	.	139537139	GAA	1.000000	.	-	.	0.99841	.	.	.	Pathogenic	0.94215	.	.	.	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	E	.	0.999812538853	-	0.972	-	0.91390	.	.	0.99096	0.553981482983	0.8952	.	0.99303529145021763	.	-	218A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.95006	137852226	.	.	0.99980	.	0.83	0.0	.	0.99999270	5.19	.	.	.	0.825103	0.999841268525741	0.95330	D	.	.	.	0.9304	0.99879	p.Glu73Val	.	.	-14.372	0.99308085	.	0.98301	10571	D	.	F9	.	D	0.976	.	E73V	D	0.90556	0.943	A/A	principal1	237801	F9_Popp_2025_strep_2_var260923	No											E		218	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Glu73Val		true	c.218A>T						3551.0	139537139.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Glu73Val						V	Feb 19, 1990					missense_variant		73.0				1.190102844703168		Pathogenic	139537139.0	missense_variant		0.976					Reporter			F9_Glu73Val
F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444638	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520082	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	NC_000023.11:139537139:A:T	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu73Val	23	139537139	A	T	X											X-139537139-A-T	-	0.80612	1.0	73	.	.	.	X	138619298	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu73Val	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99783	Select	0.9947	.	0.90580	.	.	D	D	.	0.462158744156	.	.	.	.	.	0.46353	.	.	.	.	0.89056	.	.	0.97797	1.0	.	1.0	0.985426	5.06	0.99	T	single nucleotide variant	NC_000023.11:g.139537139A>T	.	.	1	0.9547829	.	.	0.9843717	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99195	D	H	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96095	.	.	-	139537139	.	-	11.053000	.	0.99559	.	.	.	.	germline	.	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.99735	GRCh38	924	no assertion criteria provided	c.218A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.218A>T (p.Glu73Val)		.	FA9_HUMAN	.	99.0	.	.	D	0.84530	0.9655434	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu73Val	.	0.85349	.	germline	.		A	Feb 19, 1990	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031548	Pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.901742	0.92967	.	D	-	.	.	0.99720	.	.	.	0.96829	.	139537139	Y	10	.	.	.	P00740	.	0.991043	0.58784		.	0.997	D	.	0.96451426	.	0.97202	2158	0.739945	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.98661	X	F9	.	.	Glu	.	.	X-139537139-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138446964	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	.	.	.	RCV000011317	D	.	.	c.218A>T	.	.	.	0.99969	A/A	rs137852226	139537139	.	A	.	P00740	.	0.99415	.	0.68239		.	.	.	3.8	.	.	.	5.19	0.99964	.	D	T	.	.	.	.	.	.	.	98879	10571	0.99969	0.45459	0.999292135238647	.	.	0.71675	.	.	.	.	8.504	.	D	.	.	.	.	306900	0.90364	X	.	ENSG00000101981	.	.	.	.	0.9910322472733558	2	0.86259	0.18019	.	.	.	.	.	YES	.	0.957945	25610	HGNC:3551	A	.	simple_aae	0.987	.	139537139	GAA	1.000000	.	-	.	0.99841	.	.	.	Pathogenic	0.94215	.	.	.	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	E	.	0.999812538853	-	0.972	-	0.91390	.	.	0.99096	0.553981482983	0.8952	.	0.99303529145021763	.	-	218A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.95006	137852226	.	.	0.99980	.	0.83	0.0	.	0.99999270	5.19	.	.	.	0.825103	0.999841268525741	0.95330	D	.	.	.	0.9304	0.99879	p.Glu73Val	.	.	-14.372	0.99308085	.	0.98301	10571	D	.	F9	.	D	0.976	.	E73V	D	0.90556	0.943	A/A	principal1	182769	F9_Popp_2025_heavy_chain_var231880	No											E		218	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Glu73Val		true	c.218A>T						3551.0	139537139.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Glu73Val						V	Feb 19, 1990					missense_variant		73.0				0.8639407670617942		Pathogenic	139537139.0	missense_variant		0.976					Reporter			F9_Glu73Val
F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444638	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520082	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004374		NC_000023.11:139537139:A:T		Glu73Val																												F9_Glu73Val	23	139537139	A	T	X	allele	218A>T	D06	527_CAVA_Array_P02	G12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537139-A-T	-	0.80612	1.0	73	.	.	.	X	138619298	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu73Val	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99783	Select	0.9947	.	0.90580	.	.	D	D	.	0.462158744156	.	.	.	.	.	0.46353	.	.	.	.	0.89056	.	.	0.97797	1.0	.	1.0	0.985426	5.06	0.99	T	single nucleotide variant	NC_000023.11:g.139537139A>T	.	.	1	0.9547829	.	.	0.9843717	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99195	D	H	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96095	.	.	-	139537139	.	-	11.053000	.	0.99559	.	.	.	.	germline	.	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.99735	GRCh38	924	no assertion criteria provided	c.218A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.218A>T (p.Glu73Val)		.	FA9_HUMAN	.	99.0	.	.	D	0.84530	0.9655434	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu73Val	.	0.85349	.	germline	.		A	Feb 19, 1990	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031548	Pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.901742	0.92967	.	D	-	.	.	0.99720	.	.	.	0.96829	.	139537139	Y	10	.	.	.	P00740	.	0.991043	0.58784		.	0.997	D	.	0.96451426	.	0.97202	2158	0.739945	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.98661	X	F9	.	.	Glu	.	.	X-139537139-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138446964	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	.	.	.	RCV000011317	D	.	.	c.218A>T	.	.	.	0.99969	A/A	rs137852226	139537139	.	A	.	P00740	.	0.99415	.	0.68239		.	.	.	3.8	.	.	.	5.19	0.99964	.	D	T	.	.	.	.	.	.	.	98879	10571	0.99969	0.45459	0.999292135238647	.	.	0.71675	.	.	.	.	8.504	.	D	.	.	.	.	306900	0.90364	X	.	ENSG00000101981	.	.	.	.	0.9910322472733558	2	0.86259	0.18019	.	.	.	.	.	YES	.	0.957945	25610	HGNC:3551	A	.	simple_aae	0.987	.	139537139	GAA	1.000000	.	-	.	0.99841	.	.	.	Pathogenic	0.94215	.	.	.	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	E	.	0.999812538853	-	0.972	-	0.91390	.	.	0.99096	0.553981482983	0.8952	.	0.99303529145021763	.	-	218A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.95006	137852226	.	.	0.99980	.	0.83	0.0	.	0.99999270	5.19	.	.	.	0.825103	0.999841268525741	0.95330	D	.	.	.	0.9304	0.99879	p.Glu73Val	.	.	-14.372	0.99308085	.	0.98301	10571	D	.	F9	.	D	0.976	.	E73V	D	0.90556	0.943	A/A	principal1	210285	F9_Popp_2025_light_chain_var241561	No											E		218	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Glu73Val		true	c.218A>T						3551.0	139537139.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Glu73Val						V	Feb 19, 1990					missense_variant		73.0				0.9295306653411096		Pathogenic	139537139.0	missense_variant		0.976					Reporter			F9_Glu73Val
F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444638	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520082	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004374		NC_000023.11:139537139:A:T		Glu73Val																												F9_Glu73Val	23	139537139	A	T	X	allele	218A>T	D06	527_CAVA_Array_P02	G12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537139-A-T	-	0.80612	1.0	73	.	.	.	X	138619298	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu73Val	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99783	Select	0.9947	.	0.90580	.	.	D	D	.	0.462158744156	.	.	.	.	.	0.46353	.	.	.	.	0.89056	.	.	0.97797	1.0	.	1.0	0.985426	5.06	0.99	T	single nucleotide variant	NC_000023.11:g.139537139A>T	.	.	1	0.9547829	.	.	0.9843717	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99195	D	H	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96095	.	.	-	139537139	.	-	11.053000	.	0.99559	.	.	.	.	germline	.	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.99735	GRCh38	924	no assertion criteria provided	c.218A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.218A>T (p.Glu73Val)		.	FA9_HUMAN	.	99.0	.	.	D	0.84530	0.9655434	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu73Val	.	0.85349	.	germline	.		A	Feb 19, 1990	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031548	Pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.901742	0.92967	.	D	-	.	.	0.99720	.	.	.	0.96829	.	139537139	Y	10	.	.	.	P00740	.	0.991043	0.58784		.	0.997	D	.	0.96451426	.	0.97202	2158	0.739945	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.98661	X	F9	.	.	Glu	.	.	X-139537139-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138446964	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	.	.	.	RCV000011317	D	.	.	c.218A>T	.	.	.	0.99969	A/A	rs137852226	139537139	.	A	.	P00740	.	0.99415	.	0.68239		.	.	.	3.8	.	.	.	5.19	0.99964	.	D	T	.	.	.	.	.	.	.	98879	10571	0.99969	0.45459	0.999292135238647	.	.	0.71675	.	.	.	.	8.504	.	D	.	.	.	.	306900	0.90364	X	.	ENSG00000101981	.	.	.	.	0.9910322472733558	2	0.86259	0.18019	.	.	.	.	.	YES	.	0.957945	25610	HGNC:3551	A	.	simple_aae	0.987	.	139537139	GAA	1.000000	.	-	.	0.99841	.	.	.	Pathogenic	0.94215	.	.	.	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	E	.	0.999812538853	-	0.972	-	0.91390	.	.	0.99096	0.553981482983	0.8952	.	0.99303529145021763	.	-	218A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.95006	137852226	.	.	0.99980	.	0.83	0.0	.	0.99999270	5.19	.	.	.	0.825103	0.999841268525741	0.95330	D	.	.	.	0.9304	0.99879	p.Glu73Val	.	.	-14.372	0.99308085	.	0.98301	10571	D	.	F9	.	D	0.976	.	E73V	D	0.90556	0.943	A/A	principal1	127737	F9_Popp_2025_carboxy_F9_specific_var222199	No											E		218	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Glu73Val		true	c.218A>T						3551.0	139537139.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Glu73Val						V	Feb 19, 1990					missense_variant		73.0				0.007236438		Pathogenic	139537139.0	missense_variant		0.976					Reporter			F9_Glu73Val
F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444638	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520082	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004374		NC_000023.11:139537139:A:T		Glu73Val																												F9_Glu73Val	23	139537139	A	T	X	allele	218A>T	D06	527_CAVA_Array_P02	G12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537139-A-T	-	0.80612	1.0	73	.	.	.	X	138619298	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu73Val	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99783	Select	0.9947	.	0.90580	.	.	D	D	.	0.462158744156	.	.	.	.	.	0.46353	.	.	.	.	0.89056	.	.	0.97797	1.0	.	1.0	0.985426	5.06	0.99	T	single nucleotide variant	NC_000023.11:g.139537139A>T	.	.	1	0.9547829	.	.	0.9843717	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99195	D	H	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96095	.	.	-	139537139	.	-	11.053000	.	0.99559	.	.	.	.	germline	.	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.99735	GRCh38	924	no assertion criteria provided	c.218A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.218A>T (p.Glu73Val)		.	FA9_HUMAN	.	99.0	.	.	D	0.84530	0.9655434	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu73Val	.	0.85349	.	germline	.		A	Feb 19, 1990	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031548	Pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.901742	0.92967	.	D	-	.	.	0.99720	.	.	.	0.96829	.	139537139	Y	10	.	.	.	P00740	.	0.991043	0.58784		.	0.997	D	.	0.96451426	.	0.97202	2158	0.739945	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.98661	X	F9	.	.	Glu	.	.	X-139537139-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138446964	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	.	.	.	RCV000011317	D	.	.	c.218A>T	.	.	.	0.99969	A/A	rs137852226	139537139	.	A	.	P00740	.	0.99415	.	0.68239		.	.	.	3.8	.	.	.	5.19	0.99964	.	D	T	.	.	.	.	.	.	.	98879	10571	0.99969	0.45459	0.999292135238647	.	.	0.71675	.	.	.	.	8.504	.	D	.	.	.	.	306900	0.90364	X	.	ENSG00000101981	.	.	.	.	0.9910322472733558	2	0.86259	0.18019	.	.	.	.	.	YES	.	0.957945	25610	HGNC:3551	A	.	simple_aae	0.987	.	139537139	GAA	1.000000	.	-	.	0.99841	.	.	.	Pathogenic	0.94215	.	.	.	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	E	.	0.999812538853	-	0.972	-	0.91390	.	.	0.99096	0.553981482983	0.8952	.	0.99303529145021763	.	-	218A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.95006	137852226	.	.	0.99980	.	0.83	0.0	.	0.99999270	5.19	.	.	.	0.825103	0.999841268525741	0.95330	D	.	.	.	0.9304	0.99879	p.Glu73Val	.	.	-14.372	0.99308085	.	0.98301	10571	D	.	F9	.	D	0.976	.	E73V	D	0.90556	0.943	A/A	principal1	155253	F9_Popp_2025_carboxy_gla_motif_var251242	No											E		218	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Glu73Val		true	c.218A>T						3551.0	139537139.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Glu73Val						V	Feb 19, 1990					missense_variant		73.0				0.9857232342018252		Pathogenic	139537139.0	missense_variant		0.976					Reporter			F9_Glu73Val
F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444638	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520082	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004374		NC_000023.11:139537139:A:T		Glu73Val																												F9_Glu73Val	23	139537139	A	T	X	allele	218A>T	D06	527_CAVA_Array_P02	G12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537139-A-T	-	0.80612	1.0	73	.	.	.	X	138619298	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu73Val	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99783	Select	0.9947	.	0.90580	.	.	D	D	.	0.462158744156	.	.	.	.	.	0.46353	.	.	.	.	0.89056	.	.	0.97797	1.0	.	1.0	0.985426	5.06	0.99	T	single nucleotide variant	NC_000023.11:g.139537139A>T	.	.	1	0.9547829	.	.	0.9843717	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99195	D	H	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96095	.	.	-	139537139	.	-	11.053000	.	0.99559	.	.	.	.	germline	.	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.99735	GRCh38	924	no assertion criteria provided	c.218A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.218A>T (p.Glu73Val)		.	FA9_HUMAN	.	99.0	.	.	D	0.84530	0.9655434	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu73Val	.	0.85349	.	germline	.		A	Feb 19, 1990	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031548	Pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.901742	0.92967	.	D	-	.	.	0.99720	.	.	.	0.96829	.	139537139	Y	10	.	.	.	P00740	.	0.991043	0.58784		.	0.997	D	.	0.96451426	.	0.97202	2158	0.739945	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.98661	X	F9	.	.	Glu	.	.	X-139537139-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138446964	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	.	.	.	RCV000011317	D	.	.	c.218A>T	.	.	.	0.99969	A/A	rs137852226	139537139	.	A	.	P00740	.	0.99415	.	0.68239		.	.	.	3.8	.	.	.	5.19	0.99964	.	D	T	.	.	.	.	.	.	.	98879	10571	0.99969	0.45459	0.999292135238647	.	.	0.71675	.	.	.	.	8.504	.	D	.	.	.	.	306900	0.90364	X	.	ENSG00000101981	.	.	.	.	0.9910322472733558	2	0.86259	0.18019	.	.	.	.	.	YES	.	0.957945	25610	HGNC:3551	A	.	simple_aae	0.987	.	139537139	GAA	1.000000	.	-	.	0.99841	.	.	.	Pathogenic	0.94215	.	.	.	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	E	.	0.999812538853	-	0.972	-	0.91390	.	.	0.99096	0.553981482983	0.8952	.	0.99303529145021763	.	-	218A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.95006	137852226	.	.	0.99980	.	0.83	0.0	.	0.99999270	5.19	.	.	.	0.825103	0.999841268525741	0.95330	D	.	.	.	0.9304	0.99879	p.Glu73Val	.	.	-14.372	0.99308085	.	0.98301	10571	D	.	F9	.	D	0.976	.	E73V	D	0.90556	0.943	A/A	principal1	237801	F9_Popp_2025_strep_2_var260923	No											E		218	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Glu73Val		true	c.218A>T						3551.0	139537139.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Glu73Val						V	Feb 19, 1990					missense_variant		73.0				1.190102844703168		Pathogenic	139537139.0	missense_variant		0.976					Reporter			F9_Glu73Val
F9_Glu73Val	-2.6225172420292235	0.03428348463706878	3.649068249307377	0.008188034318931552	2025_01_Batch_13-14	0.8364748256595527	0.6270908471789142	0.7480363250775551	0.7374140901317079	0.7358415374727499	0.7060483272444638	0.574556031562335	0.6756043739862669	0.6333586778794495	0.6713220829686419	0.7712615764520082	0.6008234393706247	0.7118203495319111	0.6853863840055787	0.7035818102206959	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004374		NC_000023.11:139537139:A:T		Glu73Val																												F9_Glu73Val	23	139537139	A	T	X	allele	218A>T	D06	527_CAVA_Array_P02	G12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537139-A-T	-	0.80612	1.0	73	.	.	.	X	138619298	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu73Val	.	27.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99783	Select	0.9947	.	0.90580	.	.	D	D	.	0.462158744156	.	.	.	.	.	0.46353	.	.	.	.	0.89056	.	.	0.97797	1.0	.	1.0	0.985426	5.06	0.99	T	single nucleotide variant	NC_000023.11:g.139537139A>T	.	.	1	0.9547829	.	.	0.9843717	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99195	D	H	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.96095	.	.	-	139537139	.	-	11.053000	.	0.99559	.	.	.	.	germline	.	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.99735	GRCh38	924	no assertion criteria provided	c.218A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.218A>T (p.Glu73Val)		.	FA9_HUMAN	.	99.0	.	.	D	0.84530	0.9655434	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu73Val	.	0.85349	.	germline	.		A	Feb 19, 1990	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031548	Pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.901742	0.92967	.	D	-	.	.	0.99720	.	.	.	0.96829	.	139537139	Y	10	.	.	.	P00740	.	0.991043	0.58784		.	0.997	D	.	0.96451426	.	0.97202	2158	0.739945	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.98661	X	F9	.	.	Glu	.	.	X-139537139-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138446964	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	.	.	.	RCV000011317	D	.	.	c.218A>T	.	.	.	0.99969	A/A	rs137852226	139537139	.	A	.	P00740	.	0.99415	.	0.68239		.	.	.	3.8	.	.	.	5.19	0.99964	.	D	T	.	.	.	.	.	.	.	98879	10571	0.99969	0.45459	0.999292135238647	.	.	0.71675	.	.	.	.	8.504	.	D	.	.	.	.	306900	0.90364	X	.	ENSG00000101981	.	.	.	.	0.9910322472733558	2	0.86259	0.18019	.	.	.	.	.	YES	.	0.957945	25610	HGNC:3551	A	.	simple_aae	0.987	.	139537139	GAA	1.000000	.	-	.	0.99841	.	.	.	Pathogenic	0.94215	.	.	.	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	E	.	0.999812538853	-	0.972	-	0.91390	.	.	0.99096	0.553981482983	0.8952	.	0.99303529145021763	.	-	218A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.95006	137852226	.	.	0.99980	.	0.83	0.0	.	0.99999270	5.19	.	.	.	0.825103	0.999841268525741	0.95330	D	.	.	.	0.9304	0.99879	p.Glu73Val	.	.	-14.372	0.99308085	.	0.98301	10571	D	.	F9	.	D	0.976	.	E73V	D	0.90556	0.943	A/A	principal1	182769	F9_Popp_2025_heavy_chain_var231880	No											E		218	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Glu73Val		true	c.218A>T						3551.0	139537139.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Glu73Val						V	Feb 19, 1990					missense_variant		73.0				0.8639407670617942		Pathogenic	139537139.0	missense_variant		0.976					Reporter			F9_Glu73Val
G6PD_Arg365His	-0.12537883577312148	0.9037485339254261	-0.030512229050507184	0.9765102707417327	2025_01_Batch_13-14	0.5453099664505856	0.740656644322949	0.6136202157862378	0.6880198318154094	0.49923219256387213	0.5049687799684487	0.504684733769262	0.5665028575772248	0.5254002764427956	0.5171809644275656	0.5251393732095171	0.6226706890461056	0.5900615366817313	0.6067100541291025	0.5082065784957188	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	G6PD	G6PD		4006		CCSBVarC021512		NC_000023.11:154532760:C:T		Arg365His																												G6PD_Arg365His	23	154532760	C	T	X	allele	1094G>A	F04	527_CAVA_Array_P03	L07	B13A7A8P1_R1	B14A7A8P1_R2				X-154532760-C-T	-	0.46204	0.535	365	.	0	.	X	153760975	T	8.261780e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg365His	.	22.2	.	0	.	D	0	1	1	.	.	.	.	.	0	0.93363	Select	0.9807	.	0.37823	.	.	D	D	46693	1.20514760124	0	0	.	.	.	0.87096	.	33766	0	.	0.75883	.	.	0.85245	0.906	.	13.0	.	.	0.87	T	single nucleotide variant	NC_000023.11:g.154532760C>T	0	.	2	0.6705637	.	0	0.8231586	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	.	.	0.000000e+00	0	0.91311	B	0.80452	P	M	.	1	C/C	114	0	.	1210393	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	.	0.97612	.	.	-	154532760	.	-	3.272000	.	0.97555	22013	0	45926	.	unknown	56740	Loss of solvent accessibility (P = 0.0364)| Loss of stability (P = 0.0369)| Gain of ubiquitination at K360 (P = 0.0542)| Loss of MoRF binding (P = 0.0803)| Loss of methylation at K360 (P = 0.1029)	0.73365	GRCh38	80	criteria provided, single submitter	c.1094G>A	.	0.62830	0	.	.	Glucose-6-phosphate dehydrogenase, C-terminal	.	.	A	0	0.000000e+00	NM_001360016.2(G6PD):c.1094G>A (p.Arg365His)	1	.	G6PD_HUMAN	.	87.0	.	.	.	0.69466	0.8231586	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.98559	.	0	.	.	45926	p.Arg365His	0	0.37248	.	unknown	.		C	Aug 12, 2022	.	C/C	.	.	1.0	N	Xq28	9690	.	.	SCV002599266	Likely_pathogenic	.	.	His	H	-	686	ENSP00000377192	ENST00000393562	.	.	.	.	0.535	C	.	3.345784	0.52739	.	.	-	.	.	0.96622	610	.	.	0.65842	0	154532760	Y	10	0	.	0.000000e+00	P11413	.	0.967016	0.89004		.	0.12	D	.	0.6705637	.	0.44196	2539	0.594247	0	.	.	2.177420e-05	0.48345	.	.	57896	.	4352	.	0.80453	X	G6PD	0.000000e+00	0	Arg	14050	.	X-154532760-C-T	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	0	.	153414169	.	.	.	0	RCV002305722	D	0	.	c.1094G>A	.	0	0	0.97356	C/C	rs781967767	154532760	.	C	.	P11413	.	0.85244	.	0.68239		.	.	0.000000e+00	3.26	0	0	264690	4.87	0.99611	112	D	D	.	.	0	26	.	.	.	466026	1722612	0.97313	0.80587	0.961354553699493	2898	.	0.71675	.	.	.	894734	5.68	.	.	.	.	1.51120175E-5	0	300908	0.67905	X	.	ENSG00000160211	0.000000e+00	0	.	0	.	2	0.32232	0.96675	.	4	.	2.177420e-05	.	YES	0.000000e+00	0.613028	1780128	HGNC:4057	D	.	simple_aae	0.947	.	154532760	CGC	1.000000	.	-	0	0.87196	0.000000e+00	0	0	Likely pathogenic	0.75018	.	0	1	ClinGen:CA10566079	R	.	0.998371958706	-	0.603	-	0.68273	.	496	.	0.833622932434	0.5174	0	0.99806085228496089	98	-	1094G>A 	.	0	C2720289	.	.	.	.	NM_001360016.2	-	.	.	1	0.95367	-1	.	0	0.99832	.	.	.	2784	0.99792010	5.73	.	.	.	0.615818	0.997402931741911	0.89820	D	86	.	.	1.0246	0.99405	p.Arg365His	0	0	-9.6	0.8802651	0	0.93099	1722612	D	.	G6PD	.	D	0.798	.	R365H	.	.	0.24985	C/C	principal4	285730	G6PD_unpublished_var126900	No						Protein stability		Fluorescence			R		1094	G6PD_unpublished		ENST00000393562.10							immortalized human cells					p.Arg365His		true	c.1094G>A						4057.0	154532760.0	Yes		G6PD				NM_001360016.2		-1.0			aa											criteria provided, single submitter	0.993865394126386;0.898221796809856;0.9672182436473086			Arg365His						H	Aug 12, 2022					missense_variant		365.0			8.26177943857904e-7	0.95310181152785		Likely pathogenic	154532760.0	missense_variant		0.798					Reporter			G6PD_Arg365His
LMNA_Leu162Pro	-3.3189154883621836	0.012784044679513561	-3.875594822687866	0.006087518771187429	2025_01_Batch_13-14	0.8736470722150931	0.8836403304174143	0.9295726105636404	0.88339887378602	0.8122503904346556	0.8129075240942252	0.8733994403773238	0.935861515387595	0.9231694847989189	0.7839253089672528	0.8432772981546591	0.878519885397369	0.9327170629756176	0.9032841792924695	0.7980878497009543	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	LMNA	LMNA	ENSG00000160789	3903	7240	CCSBVarC000579	ALE00000579	NC_000001.11:156130745:T:C	485T>C	Leu162Pro	RC4	RC4_Mut_GDEh1027	A01	GDEhDisVCh_40057	E12	1	RC4_Mut_GDDh1027	A01	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	7	0			0			0			LMNA_Leu162Pro	1	156130745	T	C	1											1-156130745-T-C	-	0.79131	0.899	162	.	.	.	1	156100536	C	.	.	1	1_Pathogenic	NC_000001.11	.	Leu162Pro	.	27.0	.	.	.	D	.	2	1	.	.	.	.	.	.	0.95533	Select	0.8568	.	0.66535	.	.	D	D	.	2.28727837	.	.	.	.	.	0.72764	.	.	.	.	0.78753	.	.	0.90622	0.286	.	0.0	0.922208	5.37	1.0	C	single nucleotide variant	NC_000001.11:g.156130745T>C	.	.	2	0.90807116	.	.	0.91780204	.		.	.	.	.	.	.	.	.	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900	.	.	.	.	0.99291	P	0.94044	P	H	7.971851	.	T/T	.	.	.	.	Primary dilated cardiomyopathy|not provided	.	0.96230	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156130745	.	-	7.897000	.	0.98576	.	.	.	.	germline	.	Loss of stability (P = 0.0302)| Loss of catalytic residue at L162 (P = 0.1798)| Loss of MoRF binding (P = 0.2541)| Gain of methylation at R166 (P = 0.2594)| Gain of glycosylation at L162 (P = 0.618)	0.96404	GRCh38	447	no assertion criteria provided	c.485T>C	.	0.84656	.	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	P	.	.	NM_170707.4(LMNA):c.485T>C (p.Leu162Pro)		.	LMNA_HUMAN	.	100.0	0.755506102375548	.	D	0.93613	0.89284736	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Leu162Pro	.	0.73388	.	germline	.		T	Apr 02, 2009	.	T/T	.	.	1.0	N	1q22	.	.	.	SCV000065045	Likely_pathogenic	.	.	Pro	P	-	.	ENSP00000357283	ENST00000368300	.	0.001	.	.	0.665	T	.	4.84313	0.70891	D	D	-	7.699593	.	0.97542	.	.	.	0.85750	.	156130745	Y	10	.	.	.	P02545	.	0.97322	0.97352		.	0.701	D	.	0.88798314	.	0.24211	4000	0.467231	.	-4.21	.	.	0.78662	.	.	.	.	.	.	0.95490	1	LMNA	.	.	Leu	.	.	1-156130745-T-C	not_provided|Primary_dilated_cardiomyopathy	.	.	154367160	ClinGen:CA018144	0.974602	0.83173	.	RCV000041352|RCV000057410	D	.	.	c.485T>C	.	.	.	0.93175	T/T	rs267607594	156130745	.	T	.	P02545	.	0.92932	.	0.68239		.	.	.	3.525	.	.	.	5.59	0.99722	.	D	T	.	.	.	.	.	.	.	217604	48068	0.93090	0.96349	0.994527041912079	.	.	0.71675	0.99567	.	.	.	6.268	.	D	.	.	.	.	.	0.72593	1	.	ENSG00000160789	.	.	.	.	0.9799140373469903	2	0.71005	0.79601	.	.	.	.	0.697166544701107	YES	.	0.700292	57232	HGNC:6636	A	.	simple_aae	0.965	.	156130745	CTG	1.000000	.	-	.	0.98945	.	.	.	Likely pathogenic	0.98755	.	.	.	ClinGen:CA018144	L	.	0.97668052646	-	0.872	-	0.88009	.	.	0.97973	0.738907754421	0.9901	.	0.99902297693059472	.	-	485T>C 	.	.	C3661900|C0007193	.	.	.	.	NM_170707.4	-	.	.	1	0.75543	267607594	.	.	0.97620	0.82066	0.649	0.033	.	0.99995673	5.59	.	.	.	0.433368	0.996923279603381	0.92921	D	.	.	.	0.9396	0.95221	p.Leu162Pro	.	.	-16.821	0.98645115	.	0.92597	48068	D	.	LMNA	.	D	0.855	.	L162P	D	0.93424	0.62996	T/T	principal1																																																																																																				
LMNA_Leu162Pro	-3.3189154883621836	0.012784044679513561	-3.875594822687866	0.006087518771187429	2025_01_Batch_13-14	0.8736470722150931	0.8836403304174143	0.9295726105636404	0.88339887378602	0.8122503904346556	0.8129075240942252	0.8733994403773238	0.935861515387595	0.9231694847989189	0.7839253089672528	0.8432772981546591	0.878519885397369	0.9327170629756176	0.9032841792924695	0.7980878497009543	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	LMNA	LMNA		3903		CCSBVarC000579		NC_000001.11:156130745:T:C		Leu162Pro																												LMNA_Leu162Pro	1	156130745	T	C	1	allele	485T>C	E11	527_CAVA_Array_P03	J21	B13A7A8P1_R1	B14A7A8P1_R2				1-156130745-T-C	-	0.79131	0.899	162	.	.	.	1	156100536	C	.	.	1	1_Pathogenic	NC_000001.11	.	Leu162Pro	.	27.0	.	.	.	D	.	2	1	.	.	.	.	.	.	0.95533	Select	0.8568	.	0.66535	.	.	D	D	.	2.28727837	.	.	.	.	.	0.72764	.	.	.	.	0.78753	.	.	0.90622	0.286	.	0.0	0.922208	5.37	1.0	C	single nucleotide variant	NC_000001.11:g.156130745T>C	.	.	2	0.90807116	.	.	0.91780204	.		.	.	.	.	.	.	.	.	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900	.	.	.	.	0.99291	P	0.94044	P	H	7.971851	.	T/T	.	.	.	.	Primary dilated cardiomyopathy|not provided	.	0.96230	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156130745	.	-	7.897000	.	0.98576	.	.	.	.	germline	.	Loss of stability (P = 0.0302)| Loss of catalytic residue at L162 (P = 0.1798)| Loss of MoRF binding (P = 0.2541)| Gain of methylation at R166 (P = 0.2594)| Gain of glycosylation at L162 (P = 0.618)	0.96404	GRCh38	447	no assertion criteria provided	c.485T>C	.	0.84656	.	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	P	.	.	NM_170707.4(LMNA):c.485T>C (p.Leu162Pro)		.	LMNA_HUMAN	.	100.0	0.755506102375548	.	D	0.93613	0.89284736	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Leu162Pro	.	0.73388	.	germline	.		T	Apr 02, 2009	.	T/T	.	.	1.0	N	1q22	.	.	.	SCV000065045	Likely_pathogenic	.	.	Pro	P	-	.	ENSP00000357283	ENST00000368300	.	0.001	.	.	0.665	T	.	4.84313	0.70891	D	D	-	7.699593	.	0.97542	.	.	.	0.85750	.	156130745	Y	10	.	.	.	P02545	.	0.97322	0.97352		.	0.701	D	.	0.88798314	.	0.24211	4000	0.467231	.	-4.21	.	.	0.78662	.	.	.	.	.	.	0.95490	1	LMNA	.	.	Leu	.	.	1-156130745-T-C	not_provided|Primary_dilated_cardiomyopathy	.	.	154367160	ClinGen:CA018144	0.974602	0.83173	.	RCV000041352|RCV000057410	D	.	.	c.485T>C	.	.	.	0.93175	T/T	rs267607594	156130745	.	T	.	P02545	.	0.92932	.	0.68239		.	.	.	3.525	.	.	.	5.59	0.99722	.	D	T	.	.	.	.	.	.	.	217604	48068	0.93090	0.96349	0.994527041912079	.	.	0.71675	0.99567	.	.	.	6.268	.	D	.	.	.	.	.	0.72593	1	.	ENSG00000160789	.	.	.	.	0.9799140373469903	2	0.71005	0.79601	.	.	.	.	0.697166544701107	YES	.	0.700292	57232	HGNC:6636	A	.	simple_aae	0.965	.	156130745	CTG	1.000000	.	-	.	0.98945	.	.	.	Likely pathogenic	0.98755	.	.	.	ClinGen:CA018144	L	.	0.97668052646	-	0.872	-	0.88009	.	.	0.97973	0.738907754421	0.9901	.	0.99902297693059472	.	-	485T>C 	.	.	C3661900|C0007193	.	.	.	.	NM_170707.4	-	.	.	1	0.75543	267607594	.	.	0.97620	0.82066	0.649	0.033	.	0.99995673	5.59	.	.	.	0.433368	0.996923279603381	0.92921	D	.	.	.	0.9396	0.95221	p.Leu162Pro	.	.	-16.821	0.98645115	.	0.92597	48068	D	.	LMNA	.	D	0.855	.	L162P	D	0.93424	0.62996	T/T	principal1																																																																																																				
F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys396Ser	23	139561872	G	C	X											X-139561872-G-C	-	0.82065	1.0	396	.	.	.	X	138644031	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys396Ser	.	27.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9645	.	0.90580	.	.	D	D	.	1.81973249962	0	.	.	.	.	0.65960	.	.	.	.	0.98771	.	.	0.99967	0.999	.	0.0	0.885211	4.99	1.0	C	single nucleotide variant	NC_000023.11:g.139561872G>C	.	.	1	0.9873635	.	0	0.9936732	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99991	D	H	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561872	.	-	11.888000	.	0.99985	.	0	.	.	unknown	.	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.99894	GRCh38	924	no assertion criteria provided	c.1187G>C	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)		.	FA9_HUMAN	.	100.0	.	.	D	0.97843	0.9952637	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys396Ser	.	0.99016	.	unknown	.		G	Jan 01, 1991	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV000031620	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.961018	0.92967	.	D	-	.	.	0.99337	610	.	.	0.99958	0	139561872	Y	10	0	.	.	P00740	.	0.973421	0.69200		.	1.0	D	.	0.99235654	.	0.91597	2158	0.731828	.	-9.94	.	.	0.91343	.	.	.	.	.	.	0.99955	X	F9	.	0	Cys	14050	.	X-139561872-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471697	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	.	.	.	RCV000011388	D	.	.	c.1187G>C	.	.	.	0.99958	G/G	rs137852273	139561872	.	G	.	P00740	.	0.99922	.	0.68239		.	.	.	4.565	0	0	264690	5.66	0.99725	112	D	T	.	.	0	26	.	.	.	98879	10642	0.99958	0.91881	0.999975085258484	2898	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.9999735596138305	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.911344	25681	HGNC:3551	A	.	simple_aae	1	.	139561872	TGT	1.000000	.	-	0	0.99985	.	0	.	Pathogenic	0.95156	.	.	.	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	C	.	0.999332245009	-	0.99	-	0.99987	.	496	0.99997	0.692160367966	0.9968	.	0.99520179590475488	98	-	1187G>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60899	137852273	.	0	0.99931	.	0.942	0.0	2784	0.99999356	5.66	.	.	.	0.813444	0.999926344739902	0.99150	D	86	.	.	1.0945	0.98863	p.Cys396Ser	0	.	-14.65	0.99544215	.	0.98892	10642	D	.	F9	.	D	0.971	.	C396S	D	0.89858	0.76753	G/G	principal1	147033	F9_Popp_2025_carboxy_F9_specific_var228989	No											C		1187	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys396Ser		true	c.1187G>C						3551.0	139561872.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Cys396Ser						S	Jan 01, 1991					missense_variant		396.0				0.038667062366221		Pathogenic	139561872.0	missense_variant		0.971					Reporter			F9_Cys396Ser
F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys396Ser	23	139561872	G	C	X											X-139561872-G-C	-	0.82065	1.0	396	.	.	.	X	138644031	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys396Ser	.	27.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9645	.	0.90580	.	.	D	D	.	1.81973249962	0	.	.	.	.	0.65960	.	.	.	.	0.98771	.	.	0.99967	0.999	.	0.0	0.885211	4.99	1.0	C	single nucleotide variant	NC_000023.11:g.139561872G>C	.	.	1	0.9873635	.	0	0.9936732	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99991	D	H	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561872	.	-	11.888000	.	0.99985	.	0	.	.	unknown	.	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.99894	GRCh38	924	no assertion criteria provided	c.1187G>C	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)		.	FA9_HUMAN	.	100.0	.	.	D	0.97843	0.9952637	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys396Ser	.	0.99016	.	unknown	.		G	Jan 01, 1991	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV000031620	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.961018	0.92967	.	D	-	.	.	0.99337	610	.	.	0.99958	0	139561872	Y	10	0	.	.	P00740	.	0.973421	0.69200		.	1.0	D	.	0.99235654	.	0.91597	2158	0.731828	.	-9.94	.	.	0.91343	.	.	.	.	.	.	0.99955	X	F9	.	0	Cys	14050	.	X-139561872-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471697	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	.	.	.	RCV000011388	D	.	.	c.1187G>C	.	.	.	0.99958	G/G	rs137852273	139561872	.	G	.	P00740	.	0.99922	.	0.68239		.	.	.	4.565	0	0	264690	5.66	0.99725	112	D	T	.	.	0	26	.	.	.	98879	10642	0.99958	0.91881	0.999975085258484	2898	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.9999735596138305	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.911344	25681	HGNC:3551	A	.	simple_aae	1	.	139561872	TGT	1.000000	.	-	0	0.99985	.	0	.	Pathogenic	0.95156	.	.	.	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	C	.	0.999332245009	-	0.99	-	0.99987	.	496	0.99997	0.692160367966	0.9968	.	0.99520179590475488	98	-	1187G>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60899	137852273	.	0	0.99931	.	0.942	0.0	2784	0.99999356	5.66	.	.	.	0.813444	0.999926344739902	0.99150	D	86	.	.	1.0945	0.98863	p.Cys396Ser	0	.	-14.65	0.99544215	.	0.98892	10642	D	.	F9	.	D	0.971	.	C396S	D	0.89858	0.76753	G/G	principal1	229581	F9_Popp_2025_light_chain_var248351	No											C		1187	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys396Ser		true	c.1187G>C						3551.0	139561872.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Cys396Ser						S	Jan 01, 1991					missense_variant		396.0				0.025590107		Pathogenic	139561872.0	missense_variant		0.971					Reporter			F9_Cys396Ser
F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys396Ser	23	139561872	G	C	X											X-139561872-G-C	-	0.82065	1.0	396	.	.	.	X	138644031	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys396Ser	.	27.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9645	.	0.90580	.	.	D	D	.	1.81973249962	0	.	.	.	.	0.65960	.	.	.	.	0.98771	.	.	0.99967	0.999	.	0.0	0.885211	4.99	1.0	C	single nucleotide variant	NC_000023.11:g.139561872G>C	.	.	1	0.9873635	.	0	0.9936732	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99991	D	H	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561872	.	-	11.888000	.	0.99985	.	0	.	.	unknown	.	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.99894	GRCh38	924	no assertion criteria provided	c.1187G>C	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)		.	FA9_HUMAN	.	100.0	.	.	D	0.97843	0.9952637	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys396Ser	.	0.99016	.	unknown	.		G	Jan 01, 1991	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV000031620	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.961018	0.92967	.	D	-	.	.	0.99337	610	.	.	0.99958	0	139561872	Y	10	0	.	.	P00740	.	0.973421	0.69200		.	1.0	D	.	0.99235654	.	0.91597	2158	0.731828	.	-9.94	.	.	0.91343	.	.	.	.	.	.	0.99955	X	F9	.	0	Cys	14050	.	X-139561872-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471697	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	.	.	.	RCV000011388	D	.	.	c.1187G>C	.	.	.	0.99958	G/G	rs137852273	139561872	.	G	.	P00740	.	0.99922	.	0.68239		.	.	.	4.565	0	0	264690	5.66	0.99725	112	D	T	.	.	0	26	.	.	.	98879	10642	0.99958	0.91881	0.999975085258484	2898	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.9999735596138305	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.911344	25681	HGNC:3551	A	.	simple_aae	1	.	139561872	TGT	1.000000	.	-	0	0.99985	.	0	.	Pathogenic	0.95156	.	.	.	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	C	.	0.999332245009	-	0.99	-	0.99987	.	496	0.99997	0.692160367966	0.9968	.	0.99520179590475488	98	-	1187G>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60899	137852273	.	0	0.99931	.	0.942	0.0	2784	0.99999356	5.66	.	.	.	0.813444	0.999926344739902	0.99150	D	86	.	.	1.0945	0.98863	p.Cys396Ser	0	.	-14.65	0.99544215	.	0.98892	10642	D	.	F9	.	D	0.971	.	C396S	D	0.89858	0.76753	G/G	principal1	257097	F9_Popp_2025_strep_2_var267713	No											C		1187	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys396Ser		true	c.1187G>C						3551.0	139561872.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Cys396Ser						S	Jan 01, 1991					missense_variant		396.0				0.14033838		Pathogenic	139561872.0	missense_variant		0.971					Reporter			F9_Cys396Ser
F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys396Ser	23	139561872	G	C	X											X-139561872-G-C	-	0.82065	1.0	396	.	.	.	X	138644031	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys396Ser	.	27.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9645	.	0.90580	.	.	D	D	.	1.81973249962	0	.	.	.	.	0.65960	.	.	.	.	0.98771	.	.	0.99967	0.999	.	0.0	0.885211	4.99	1.0	C	single nucleotide variant	NC_000023.11:g.139561872G>C	.	.	1	0.9873635	.	0	0.9936732	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99991	D	H	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561872	.	-	11.888000	.	0.99985	.	0	.	.	unknown	.	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.99894	GRCh38	924	no assertion criteria provided	c.1187G>C	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)		.	FA9_HUMAN	.	100.0	.	.	D	0.97843	0.9952637	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys396Ser	.	0.99016	.	unknown	.		G	Jan 01, 1991	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV000031620	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.961018	0.92967	.	D	-	.	.	0.99337	610	.	.	0.99958	0	139561872	Y	10	0	.	.	P00740	.	0.973421	0.69200		.	1.0	D	.	0.99235654	.	0.91597	2158	0.731828	.	-9.94	.	.	0.91343	.	.	.	.	.	.	0.99955	X	F9	.	0	Cys	14050	.	X-139561872-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471697	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	.	.	.	RCV000011388	D	.	.	c.1187G>C	.	.	.	0.99958	G/G	rs137852273	139561872	.	G	.	P00740	.	0.99922	.	0.68239		.	.	.	4.565	0	0	264690	5.66	0.99725	112	D	T	.	.	0	26	.	.	.	98879	10642	0.99958	0.91881	0.999975085258484	2898	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.9999735596138305	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.911344	25681	HGNC:3551	A	.	simple_aae	1	.	139561872	TGT	1.000000	.	-	0	0.99985	.	0	.	Pathogenic	0.95156	.	.	.	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	C	.	0.999332245009	-	0.99	-	0.99987	.	496	0.99997	0.692160367966	0.9968	.	0.99520179590475488	98	-	1187G>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60899	137852273	.	0	0.99931	.	0.942	0.0	2784	0.99999356	5.66	.	.	.	0.813444	0.999926344739902	0.99150	D	86	.	.	1.0945	0.98863	p.Cys396Ser	0	.	-14.65	0.99544215	.	0.98892	10642	D	.	F9	.	D	0.971	.	C396S	D	0.89858	0.76753	G/G	principal1	202065	F9_Popp_2025_heavy_chain_var238670	No											C		1187	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys396Ser		true	c.1187G>C						3551.0	139561872.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Cys396Ser						S	Jan 01, 1991					missense_variant		396.0				0.038435796		Pathogenic	139561872.0	missense_variant		0.971					Reporter			F9_Cys396Ser
F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	NC_000023.11:139561872:G:C	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys396Ser	23	139561872	G	C	X											X-139561872-G-C	-	0.82065	1.0	396	.	.	.	X	138644031	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys396Ser	.	27.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9645	.	0.90580	.	.	D	D	.	1.81973249962	0	.	.	.	.	0.65960	.	.	.	.	0.98771	.	.	0.99967	0.999	.	0.0	0.885211	4.99	1.0	C	single nucleotide variant	NC_000023.11:g.139561872G>C	.	.	1	0.9873635	.	0	0.9936732	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99991	D	H	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561872	.	-	11.888000	.	0.99985	.	0	.	.	unknown	.	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.99894	GRCh38	924	no assertion criteria provided	c.1187G>C	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)		.	FA9_HUMAN	.	100.0	.	.	D	0.97843	0.9952637	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys396Ser	.	0.99016	.	unknown	.		G	Jan 01, 1991	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV000031620	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.961018	0.92967	.	D	-	.	.	0.99337	610	.	.	0.99958	0	139561872	Y	10	0	.	.	P00740	.	0.973421	0.69200		.	1.0	D	.	0.99235654	.	0.91597	2158	0.731828	.	-9.94	.	.	0.91343	.	.	.	.	.	.	0.99955	X	F9	.	0	Cys	14050	.	X-139561872-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471697	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	.	.	.	RCV000011388	D	.	.	c.1187G>C	.	.	.	0.99958	G/G	rs137852273	139561872	.	G	.	P00740	.	0.99922	.	0.68239		.	.	.	4.565	0	0	264690	5.66	0.99725	112	D	T	.	.	0	26	.	.	.	98879	10642	0.99958	0.91881	0.999975085258484	2898	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.9999735596138305	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.911344	25681	HGNC:3551	A	.	simple_aae	1	.	139561872	TGT	1.000000	.	-	0	0.99985	.	0	.	Pathogenic	0.95156	.	.	.	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	C	.	0.999332245009	-	0.99	-	0.99987	.	496	0.99997	0.692160367966	0.9968	.	0.99520179590475488	98	-	1187G>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60899	137852273	.	0	0.99931	.	0.942	0.0	2784	0.99999356	5.66	.	.	.	0.813444	0.999926344739902	0.99150	D	86	.	.	1.0945	0.98863	p.Cys396Ser	0	.	-14.65	0.99544215	.	0.98892	10642	D	.	F9	.	D	0.971	.	C396S	D	0.89858	0.76753	G/G	principal1	174549	F9_Popp_2025_carboxy_gla_motif_var258032	No											C		1187	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys396Ser		true	c.1187G>C						3551.0	139561872.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Cys396Ser						S	Jan 01, 1991					missense_variant		396.0				0.0244746370917692		Pathogenic	139561872.0	missense_variant		0.971					Reporter			F9_Cys396Ser
F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004391		NC_000023.11:139561872:G:C		Cys396Ser																												F9_Cys396Ser	23	139561872	G	C	X	allele	1187G>C	G04	527_CAVA_Array_P02	M08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561872-G-C	-	0.82065	1.0	396	.	.	.	X	138644031	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys396Ser	.	27.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9645	.	0.90580	.	.	D	D	.	1.81973249962	0	.	.	.	.	0.65960	.	.	.	.	0.98771	.	.	0.99967	0.999	.	0.0	0.885211	4.99	1.0	C	single nucleotide variant	NC_000023.11:g.139561872G>C	.	.	1	0.9873635	.	0	0.9936732	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99991	D	H	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561872	.	-	11.888000	.	0.99985	.	0	.	.	unknown	.	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.99894	GRCh38	924	no assertion criteria provided	c.1187G>C	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)		.	FA9_HUMAN	.	100.0	.	.	D	0.97843	0.9952637	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys396Ser	.	0.99016	.	unknown	.		G	Jan 01, 1991	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV000031620	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.961018	0.92967	.	D	-	.	.	0.99337	610	.	.	0.99958	0	139561872	Y	10	0	.	.	P00740	.	0.973421	0.69200		.	1.0	D	.	0.99235654	.	0.91597	2158	0.731828	.	-9.94	.	.	0.91343	.	.	.	.	.	.	0.99955	X	F9	.	0	Cys	14050	.	X-139561872-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471697	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	.	.	.	RCV000011388	D	.	.	c.1187G>C	.	.	.	0.99958	G/G	rs137852273	139561872	.	G	.	P00740	.	0.99922	.	0.68239		.	.	.	4.565	0	0	264690	5.66	0.99725	112	D	T	.	.	0	26	.	.	.	98879	10642	0.99958	0.91881	0.999975085258484	2898	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.9999735596138305	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.911344	25681	HGNC:3551	A	.	simple_aae	1	.	139561872	TGT	1.000000	.	-	0	0.99985	.	0	.	Pathogenic	0.95156	.	.	.	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	C	.	0.999332245009	-	0.99	-	0.99987	.	496	0.99997	0.692160367966	0.9968	.	0.99520179590475488	98	-	1187G>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60899	137852273	.	0	0.99931	.	0.942	0.0	2784	0.99999356	5.66	.	.	.	0.813444	0.999926344739902	0.99150	D	86	.	.	1.0945	0.98863	p.Cys396Ser	0	.	-14.65	0.99544215	.	0.98892	10642	D	.	F9	.	D	0.971	.	C396S	D	0.89858	0.76753	G/G	principal1	147033	F9_Popp_2025_carboxy_F9_specific_var228989	No											C		1187	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys396Ser		true	c.1187G>C						3551.0	139561872.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Cys396Ser						S	Jan 01, 1991					missense_variant		396.0				0.038667062366221		Pathogenic	139561872.0	missense_variant		0.971					Reporter			F9_Cys396Ser
F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004391		NC_000023.11:139561872:G:C		Cys396Ser																												F9_Cys396Ser	23	139561872	G	C	X	allele	1187G>C	G04	527_CAVA_Array_P02	M08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561872-G-C	-	0.82065	1.0	396	.	.	.	X	138644031	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys396Ser	.	27.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9645	.	0.90580	.	.	D	D	.	1.81973249962	0	.	.	.	.	0.65960	.	.	.	.	0.98771	.	.	0.99967	0.999	.	0.0	0.885211	4.99	1.0	C	single nucleotide variant	NC_000023.11:g.139561872G>C	.	.	1	0.9873635	.	0	0.9936732	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99991	D	H	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561872	.	-	11.888000	.	0.99985	.	0	.	.	unknown	.	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.99894	GRCh38	924	no assertion criteria provided	c.1187G>C	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)		.	FA9_HUMAN	.	100.0	.	.	D	0.97843	0.9952637	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys396Ser	.	0.99016	.	unknown	.		G	Jan 01, 1991	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV000031620	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.961018	0.92967	.	D	-	.	.	0.99337	610	.	.	0.99958	0	139561872	Y	10	0	.	.	P00740	.	0.973421	0.69200		.	1.0	D	.	0.99235654	.	0.91597	2158	0.731828	.	-9.94	.	.	0.91343	.	.	.	.	.	.	0.99955	X	F9	.	0	Cys	14050	.	X-139561872-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471697	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	.	.	.	RCV000011388	D	.	.	c.1187G>C	.	.	.	0.99958	G/G	rs137852273	139561872	.	G	.	P00740	.	0.99922	.	0.68239		.	.	.	4.565	0	0	264690	5.66	0.99725	112	D	T	.	.	0	26	.	.	.	98879	10642	0.99958	0.91881	0.999975085258484	2898	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.9999735596138305	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.911344	25681	HGNC:3551	A	.	simple_aae	1	.	139561872	TGT	1.000000	.	-	0	0.99985	.	0	.	Pathogenic	0.95156	.	.	.	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	C	.	0.999332245009	-	0.99	-	0.99987	.	496	0.99997	0.692160367966	0.9968	.	0.99520179590475488	98	-	1187G>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60899	137852273	.	0	0.99931	.	0.942	0.0	2784	0.99999356	5.66	.	.	.	0.813444	0.999926344739902	0.99150	D	86	.	.	1.0945	0.98863	p.Cys396Ser	0	.	-14.65	0.99544215	.	0.98892	10642	D	.	F9	.	D	0.971	.	C396S	D	0.89858	0.76753	G/G	principal1	229581	F9_Popp_2025_light_chain_var248351	No											C		1187	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys396Ser		true	c.1187G>C						3551.0	139561872.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Cys396Ser						S	Jan 01, 1991					missense_variant		396.0				0.025590107		Pathogenic	139561872.0	missense_variant		0.971					Reporter			F9_Cys396Ser
F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004391		NC_000023.11:139561872:G:C		Cys396Ser																												F9_Cys396Ser	23	139561872	G	C	X	allele	1187G>C	G04	527_CAVA_Array_P02	M08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561872-G-C	-	0.82065	1.0	396	.	.	.	X	138644031	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys396Ser	.	27.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9645	.	0.90580	.	.	D	D	.	1.81973249962	0	.	.	.	.	0.65960	.	.	.	.	0.98771	.	.	0.99967	0.999	.	0.0	0.885211	4.99	1.0	C	single nucleotide variant	NC_000023.11:g.139561872G>C	.	.	1	0.9873635	.	0	0.9936732	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99991	D	H	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561872	.	-	11.888000	.	0.99985	.	0	.	.	unknown	.	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.99894	GRCh38	924	no assertion criteria provided	c.1187G>C	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)		.	FA9_HUMAN	.	100.0	.	.	D	0.97843	0.9952637	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys396Ser	.	0.99016	.	unknown	.		G	Jan 01, 1991	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV000031620	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.961018	0.92967	.	D	-	.	.	0.99337	610	.	.	0.99958	0	139561872	Y	10	0	.	.	P00740	.	0.973421	0.69200		.	1.0	D	.	0.99235654	.	0.91597	2158	0.731828	.	-9.94	.	.	0.91343	.	.	.	.	.	.	0.99955	X	F9	.	0	Cys	14050	.	X-139561872-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471697	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	.	.	.	RCV000011388	D	.	.	c.1187G>C	.	.	.	0.99958	G/G	rs137852273	139561872	.	G	.	P00740	.	0.99922	.	0.68239		.	.	.	4.565	0	0	264690	5.66	0.99725	112	D	T	.	.	0	26	.	.	.	98879	10642	0.99958	0.91881	0.999975085258484	2898	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.9999735596138305	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.911344	25681	HGNC:3551	A	.	simple_aae	1	.	139561872	TGT	1.000000	.	-	0	0.99985	.	0	.	Pathogenic	0.95156	.	.	.	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	C	.	0.999332245009	-	0.99	-	0.99987	.	496	0.99997	0.692160367966	0.9968	.	0.99520179590475488	98	-	1187G>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60899	137852273	.	0	0.99931	.	0.942	0.0	2784	0.99999356	5.66	.	.	.	0.813444	0.999926344739902	0.99150	D	86	.	.	1.0945	0.98863	p.Cys396Ser	0	.	-14.65	0.99544215	.	0.98892	10642	D	.	F9	.	D	0.971	.	C396S	D	0.89858	0.76753	G/G	principal1	257097	F9_Popp_2025_strep_2_var267713	No											C		1187	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys396Ser		true	c.1187G>C						3551.0	139561872.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Cys396Ser						S	Jan 01, 1991					missense_variant		396.0				0.14033838		Pathogenic	139561872.0	missense_variant		0.971					Reporter			F9_Cys396Ser
F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004391		NC_000023.11:139561872:G:C		Cys396Ser																												F9_Cys396Ser	23	139561872	G	C	X	allele	1187G>C	G04	527_CAVA_Array_P02	M08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561872-G-C	-	0.82065	1.0	396	.	.	.	X	138644031	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys396Ser	.	27.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9645	.	0.90580	.	.	D	D	.	1.81973249962	0	.	.	.	.	0.65960	.	.	.	.	0.98771	.	.	0.99967	0.999	.	0.0	0.885211	4.99	1.0	C	single nucleotide variant	NC_000023.11:g.139561872G>C	.	.	1	0.9873635	.	0	0.9936732	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99991	D	H	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561872	.	-	11.888000	.	0.99985	.	0	.	.	unknown	.	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.99894	GRCh38	924	no assertion criteria provided	c.1187G>C	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)		.	FA9_HUMAN	.	100.0	.	.	D	0.97843	0.9952637	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys396Ser	.	0.99016	.	unknown	.		G	Jan 01, 1991	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV000031620	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.961018	0.92967	.	D	-	.	.	0.99337	610	.	.	0.99958	0	139561872	Y	10	0	.	.	P00740	.	0.973421	0.69200		.	1.0	D	.	0.99235654	.	0.91597	2158	0.731828	.	-9.94	.	.	0.91343	.	.	.	.	.	.	0.99955	X	F9	.	0	Cys	14050	.	X-139561872-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471697	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	.	.	.	RCV000011388	D	.	.	c.1187G>C	.	.	.	0.99958	G/G	rs137852273	139561872	.	G	.	P00740	.	0.99922	.	0.68239		.	.	.	4.565	0	0	264690	5.66	0.99725	112	D	T	.	.	0	26	.	.	.	98879	10642	0.99958	0.91881	0.999975085258484	2898	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.9999735596138305	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.911344	25681	HGNC:3551	A	.	simple_aae	1	.	139561872	TGT	1.000000	.	-	0	0.99985	.	0	.	Pathogenic	0.95156	.	.	.	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	C	.	0.999332245009	-	0.99	-	0.99987	.	496	0.99997	0.692160367966	0.9968	.	0.99520179590475488	98	-	1187G>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60899	137852273	.	0	0.99931	.	0.942	0.0	2784	0.99999356	5.66	.	.	.	0.813444	0.999926344739902	0.99150	D	86	.	.	1.0945	0.98863	p.Cys396Ser	0	.	-14.65	0.99544215	.	0.98892	10642	D	.	F9	.	D	0.971	.	C396S	D	0.89858	0.76753	G/G	principal1	202065	F9_Popp_2025_heavy_chain_var238670	No											C		1187	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys396Ser		true	c.1187G>C						3551.0	139561872.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Cys396Ser						S	Jan 01, 1991					missense_variant		396.0				0.038435796		Pathogenic	139561872.0	missense_variant		0.971					Reporter			F9_Cys396Ser
F9_Cys396Ser	5.334346676148364	0.0010823425346290789	1.5614087607211882	0.16239678534293972	2025_01_Batch_13-14	0.4626556784325542	0.711744430069609	0.8568053473569524	0.7750108713714473	0.539562470786803	0.4252529456443782	0.834241491330143	0.9457166906087877	0.8542198494344126	0.5892729766405828	0.4439543120384662	0.772992960699876	0.90126101898287	0.81461536040293	0.5644177237136929	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004391		NC_000023.11:139561872:G:C		Cys396Ser																												F9_Cys396Ser	23	139561872	G	C	X	allele	1187G>C	G04	527_CAVA_Array_P02	M08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561872-G-C	-	0.82065	1.0	396	.	.	.	X	138644031	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys396Ser	.	27.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9645	.	0.90580	.	.	D	D	.	1.81973249962	0	.	.	.	.	0.65960	.	.	.	.	0.98771	.	.	0.99967	0.999	.	0.0	0.885211	4.99	1.0	C	single nucleotide variant	NC_000023.11:g.139561872G>C	.	.	1	0.9873635	.	0	0.9936732	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99991	D	H	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561872	.	-	11.888000	.	0.99985	.	0	.	.	unknown	.	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.99894	GRCh38	924	no assertion criteria provided	c.1187G>C	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)		.	FA9_HUMAN	.	100.0	.	.	D	0.97843	0.9952637	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys396Ser	.	0.99016	.	unknown	.		G	Jan 01, 1991	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV000031620	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.961018	0.92967	.	D	-	.	.	0.99337	610	.	.	0.99958	0	139561872	Y	10	0	.	.	P00740	.	0.973421	0.69200		.	1.0	D	.	0.99235654	.	0.91597	2158	0.731828	.	-9.94	.	.	0.91343	.	.	.	.	.	.	0.99955	X	F9	.	0	Cys	14050	.	X-139561872-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471697	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	.	.	.	RCV000011388	D	.	.	c.1187G>C	.	.	.	0.99958	G/G	rs137852273	139561872	.	G	.	P00740	.	0.99922	.	0.68239		.	.	.	4.565	0	0	264690	5.66	0.99725	112	D	T	.	.	0	26	.	.	.	98879	10642	0.99958	0.91881	0.999975085258484	2898	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.9999735596138305	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.911344	25681	HGNC:3551	A	.	simple_aae	1	.	139561872	TGT	1.000000	.	-	0	0.99985	.	0	.	Pathogenic	0.95156	.	.	.	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	C	.	0.999332245009	-	0.99	-	0.99987	.	496	0.99997	0.692160367966	0.9968	.	0.99520179590475488	98	-	1187G>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60899	137852273	.	0	0.99931	.	0.942	0.0	2784	0.99999356	5.66	.	.	.	0.813444	0.999926344739902	0.99150	D	86	.	.	1.0945	0.98863	p.Cys396Ser	0	.	-14.65	0.99544215	.	0.98892	10642	D	.	F9	.	D	0.971	.	C396S	D	0.89858	0.76753	G/G	principal1	174549	F9_Popp_2025_carboxy_gla_motif_var258032	No											C		1187	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys396Ser		true	c.1187G>C						3551.0	139561872.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Cys396Ser						S	Jan 01, 1991					missense_variant		396.0				0.0244746370917692		Pathogenic	139561872.0	missense_variant		0.971					Reporter			F9_Cys396Ser
BAP1_Glu31Lys	0.06824504354142172	0.9474990528833314	-2.0298025778770206	0.08193664202063412	2025_01_Batch_13-14	0.5646853145735389	0.5190594261515206	0.4923047687112512	0.5492657033647534	0.5517911511141563	0.7117206420996531	0.6011434644920295	0.5648586555852341	0.6718865866645662	0.6450377460662851	0.638202978336596	0.560101445321775	0.5285817121482426	0.6105761450146598	0.5984144485902207	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009499		NC_000003.12:52409585:C:T		Glu31Lys																												BAP1_Glu31Lys	3	52409585	C	T	3	allele	91G>A	F02	527_CAVA_Array_P01	K03	B13A7A8P1_R1	B14A7A8P1_R2				3-52409585-C-T	-	0.93179	1.0	31	.	.	.	3	52443601	T	.	.	3	3_Conflicting	NC_000003.12	.	Glu31Lys	.	33.0	.	.	.	D	.	3	1	.	.	.	.	.	.	0.88771	Select	0.5505	.	0.90580	.	.	D	D	.	2.56847412068	.	.	.	.	.	0.97064	.	.	.	.	0.72856	.	.	0.97067	0.999	.	.	0.989034	2.7	.	T	single nucleotide variant	NC_000003.12:g.52409585C>T	.	.	2	0.9142625	.	.	0.95834297	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	.	.	.	.	.	D	0.95935	D	H	13.50747	.	C/C	.	.	.	.	Neurodevelopmental disorder|not provided|BAP1-related tumor predisposition syndrome	.	0.89592	.	.	-	52409585	.	-	7.645000	.	0.94485	.	.	.	.	de novo;germline	.	Gain of glycosylation at Y33 (P = 0.0136)| Gain of ubiquitination at E31 (P = 0.0238)| Gain of methylation at E31 (P = 0.1374)| Loss of stability (P = 0.1598)| Loss of catalytic residue at E31 (P = 0.2264)	0.96082	GRCh38	68	criteria provided, conflicting classifications	c.91G>A	.	0.65374	.	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	.	.	P	.	.	NM_004656.4(BAP1):c.91G>A (p.Glu31Lys)	1	.	BAP1_HUMAN	.	.	0.986620787527088	.	D	0.99584	0.95834297	-	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99689	.	.	.	.	.	p.Glu31Lys	.	0.63450	.	germline	.		C	Jan 21, 2024	.	C/C	.	.	1.0	N	3p21.1	.	.	.	SCV002599838|SCV003525331	Conflicting_classifications_of_pathogenicity	.	.	Lys	K	-	.	ENSP00000417132	ENST00000460680	.	0.001	.	.	0.596	C	.	5.710604	0.92967	D	D	-	13.08669	.	0.91057	.	.	.	0.98923	.	52409585	Y	10	.	.	.	Q92560	.	0.595912	0.99439		.	1.0	D	.	0.9142625	.	0.91597	8314	0.379185	.	-3.77	.	.	0.78662	.	.	.	.	.	.	0.95936	3	BAP1	.	.	Glu	.	.	3-52409585-C-T	Neurodevelopmental_disorder|not_provided|BAP1-related_tumor_predisposition_syndrome	.	.	52418641	.	0.929216	0.95291	.	RCV001797184|RCV002305612|RCV002568139	D	.	.	c.91G>A	.	.	.	0.88575	C/C	rs2153228535	52409585	.	C	.	Q92560	.	0.97067	.	0.68239		.	.	.	4.045	.	.	.	4.97	0.86858	.	D	D	.	.	.	.	.	.	.	289539	1173078	0.88431	0.97995	0.999779880046844	.	.	0.71675	0.91432	.	.	.	7.695	.	D	.	.	.	.	614327	0.83532	3	.	ENSG00000163930	.	.	.	.	0.9484795993003543	1	0.97365	0.97129	.	.	.	.	0.884071350561727	YES	.	0.307408	1162267	HGNC:950	.	.	.	0.896	.	52409585	GAG	1.000000	.	-	.	0.95355	.	.	.	Conflicting classifications of pathogenicity	0.99558	.	.	.	ClinGen:CA353114656	E	.	0.862246886347	-	0.866	-	0.93495	.	.	0.94798	0.905887842178	0.9998	.	0.99932207852356958	.	-	91G>A 	.	.	C1535926|C3661900|C3280492	.	.	.	.	NM_004656.4	-	.	.	1	0.96357	2153228535	.	.	0.85983	0.94811	0.925	0.0	.	0.99976045	4.97	.	.	.	0.306897	0.986962859459876	0.96963	D	.	.	.	0.4363	0.83470	p.Glu31Lys	.	.	-18.084	0.9600752	.	0.87278	1173078	D	.	BAP1	.	D	0.692	.	E31K	D	0.49372	0.33565	C/C	principal1																																																																																																				
RHO_Arg135Trp	-17.38033735531913	5.133434051767988e-7	-16.193593012622983	8.332379341880668e-7	2025_01_Batch_13-14	0.848450778736868	0.9769099185317103	0.9995777144441768	0.997114828657089	0.9830374641219721	0.8289561051564006	0.9837335836904696	0.9998124136089	0.9982673769471616	0.9894353161315496	0.8387034419466344	0.98032175111109	0.9996950640265384	0.9976911028021254	0.9862363901267608	0.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	RHO	RHO		40080645		CCSBVarC013570		NC_000003.12:129530917:C:T		Arg135Trp																												RHO_Arg135Trp	3	129530917	C	T	3	allele	403C>T	G09	527_CAVA_Array_P05	M17	B13A7A8P2_R1	B14A7A8P2_R2				3-129530917-C-T	-	0.85113	1.0	135	.	0	.	3	129249760	T	1.238960e-06	.	3	1_Pathogenic	NC_000003.12	2	Arg135Trp	.	28.5	.	0	.	D	0	14	1	.	.	.	.	.	0	0.98376	Select	0.9723	.	0.90580	.	.	D	D	64044	0.882892313764	0	0	.	.	.	0.79846	.	44886	0	.	0.93600	.	.	0.99731	0.995	.	10.0	0.911709	2.8	0.9	T	single nucleotide variant	NC_000003.12:g.129530917C>T	0	.	3	0.9847179	.	0	0.98723143	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MONDO:MONDO:0018877,MedGen:C1405854,Orphanet:52427|MedGen:C3661900|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862|	.	.	0.000000e+00	0	0.92286	D	0.99913	D	H	6.480144	2	C/C	0	0	.	1614258	Retinitis pigmentosa 4|Retinitis punctata albescens|not provided|Retinitis pigmentosa|Retinal dystrophy|RHO-related disorder	.	0.98756	.	.	-	129530917	.	-	2.777000	.	0.97199	29608	0	1180052	.	germline;inherited;unknown	91088	Loss of sheet (P = 0.3635)| Loss of stability (P = 0.3899)| Loss of helix (P = 0.3949)| Gain of catalytic residue at R135 (P = 0.455)| Loss of MoRF binding (P = 0.548)	0.99713	GRCh38	511	criteria provided, multiple submitters, no conflicts	c.403C>T	.	0.25790	0	.	.	GPCR, rhodopsin-like, 7TM	.	.	P	0	0.000000e+00	NM_000539.3(RHO):c.403C>T (p.Arg135Trp)	2	.	OPSD_HUMAN	.	90.0	0.650539432728276	.	D	0.95008	0.98945296	+	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99953	.	0	.	.	60030	p.Arg135Trp	0	0.34791	.	germline	.		C	Feb 12, 2025	.	C/C	.	.	1.0	N	3q22.1	78	.	.	SCV000490772|SCV001234184|SCV001239845|SCV001443216|SCV002521615|SCV004030293|SCV004705655|SCV005073429|SCV005690572	Pathogenic	.	.	Trp	W	-	912	ENSP00000296271	ENST00000296271	.	0.0	.	.	0.599	C	.	5.094248	0.92967	D	D	-	4.890175	.	0.97240	0	.	.	0.96902	0	129530917	Y	9	0	.	0.000000e+00	P08100	.	0.923243	0.98380		.	1.0	D	.	0.9844158	.	0.73271	6010	0.558549	2	-6.98	.	1.694840e-06	0.91343	.	.	75066	.	6062	.	0.99918	3	RHO	0.000000e+00	0	Arg	660	.	3-129530917-C-T	Retinitis_punctata_albescens|Retinitis_pigmentosa_4|not_provided|Retinitis_pigmentosa|Retinal_dystrophy	0	.	130732450	ClinGen:CA122819|OMIM:180380.0012|UniProtKB:P08100#VAR_004797	0.715194	0.76276	0	RCV000013902|RCV000013903|RCV000413771|RCV000132597|RCV001074272|RCV004755734	D	0	.	c.403C>T	.	0	0	0.96030	C/C	rs104893775	129530917	.	C	.	P08100	.	0.99601	.	0.68239		.	.	0.000000e+00	4.615	0	0	.	2.05	0.98626	34	D	T	.	.	0	0	.	.	.	52427|791|791|71862	13028	0.95966	0.69650	0.99931013584137	434	.	0.71675	0.66623	.	.	1180052	1.284	.	D	.	.	.	0	613731|268000|PS268000	0.32959	3	.	ENSG00000163914	0.000000e+00	0	.	0	0.9895061687762009	1	0.97365	0.75154	.	.	.	0.000000e+00	0.469200349890802	YES	0.000000e+00	0.669966	28067	HGNC:10012	A	.	simple_aae	0.941	.	129530917	CGG	1.000000	.	-	0	0.99911	1.694840e-06	0	0	Pathogenic	0.92067	.	0	0	ClinGen:CA122819,UniProtKB:P08100#VAR_004797,OMIM:180380.0012	R	.	0.989048607444	-	0.97	-	0.98575	.	108	0.98942	0.786314368248	0.9939	0	0.99915472947634709	6	-	403C>T 	.	0	C1405854|C3151001|C3661900|C0035334|C0854723	.	.	.	.	NM_000539.3	-	.	.	1	0.68570	104893775	.	0	0.98880	0.65773	0.975	0.0	434	0.99994576	5.26	.	.	.	0.56454	0.99932078557985	0.99277	D	34	.	.	1.0760	0.99129	p.Arg135Trp	0	0	-13.703	0.99393994	0	0.96263	13028	D	.	RHO	.	D	0.931	.	R135W	D	0.51230	0.40292	C/C	principal1	999338	RHO_Wan_2019_var220545	No						cell surface expression		Fluorescence			R		403	RHO_Wan_2019		ENST00000296271.4							immortalized human cells					p.Arg135Trp		true	c.403C>T						10012.0	129530917.0	No		RHO				NM_000539.3		1.0	urn:mavedb:00000099-a-1		nucleotide		T									criteria provided, multiple submitters, no conflicts				Arg135Trp						W	Jan 08, 2024					missense_variant		135.0	C		1.2389593237e-6	0.3086407787092269		Pathogenic	129530917.0	missense_variant		0.931					Reporter			RHO_Arg135Trp
F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys28Arg	23	139530846	T	C	X											X-139530846-T-C	-	0.3059	0.002	28	.	.	.	X	138613005	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys28Arg	.	18.47	.	0	.	D	.	2	1	.	.	.	.	.	0	0.85231	Select	0.5835	.	0.09864	.	.	T	D	.	0.131800438695	0	.	.	.	.	0.47787	.	.	.	.	0.18812	.	.	0.66671	0.999	.	4.0	0.450155	.	0.96	C	single nucleotide variant	NC_000023.11:g.139530846T>C	.	.	3	0.38168523	.	0	0.67080367	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	B	0.68400	B	M	.	.	./.	84	0	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.79369	.	.	-	139530846	.	-	2.835000	.	0.78260	.	0	.	.	germline	.	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.97257	GRCh38	937	criteria provided, single submitter	c.82T>C	.	0.45610	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	B	0	.	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	1	.	FA9_HUMAN	.	96.0	.	.	T	0.53440	0.49801674	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99965	.	.	.	.	.	p.Cys28Arg	.	0.35126	.	germline	.		T	Feb 02, 2021	.	./.	.	.	1.0	N	Xq27.1	7040	.	.	SCV002126918	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.527	.	.	0.663	T	.	2.378924	0.13225	.	T	-	.	.	0.78694	610	.	.	0.20996	0	139530846	Y	10	0	.	.	P00740	.	0.440732	0.20170		.	0.005	D	.	0.4603896	.	0.91597	2158	0.449804	.	-0.6	.	.	0.07137	.	.	.	.	.	.	0.62926	X	F9	.	0	Cys	11340	.	X-139530846-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138440671	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	.	.	.	RCV000011402|RCV001851793	D	.	.	c.82T>C	.	.	.	0.92418	./.	rs387906481	139530846	.	T	.	P00740	.	0.76212	.	0.68239		.	.	.	2.05	0	0	264690	4.0	0.78393	142	T	T	.	.	0	24	.	.	.	98879	10657	0.92325	0.14606	0.215877322444314	2728	.	0.71675	.	.	.	.	1.529	.	N	.	.	7.5560088E-6	0	306900|300807	0.35708	X	.	ENSG00000101981	.	0	.	0	0.8743106529995943	1	0.11213	0.14592	.	2	.	.	.	YES	.	0.110281	25696	HGNC:3551	A	.	simple_aae	0.611	.	139530846	TGT	1.000000	.	-	0	0.92701	.	0	.	Pathogenic	0.49978	.	.	.	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	C	.	0.999672884819	-	0.889	-	0.76569	.	574	0.87320	0.564161062241	0.2472	.	0.90666156510274398	100	-	82T>C 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.16159	387906481	.	0	0.99966	.	0.677	0.497	2644	0.99995670	5.23	.	.	.	0.408336	0.991303745387021	0.56288	T	118	.	.	-0.1274	0.84984	p.Cys28Arg	0	.	-5.036	0.9344977	.	0.88967	10657	T	.	F9	.	D	0.621	.	C28R	T	.	0.56753	./.	principal1	125155	F9_Popp_2025_carboxy_F9_specific_var221268	No											C		82	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys28Arg		true	c.82T>C						3551.0	139530846.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Cys28Arg						R	Feb 02, 2021					missense_variant		28.0				0.2435717878896782		Pathogenic	139530846.0	missense_variant		0.621					Reporter			F9_Cys28Arg
F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys28Arg	23	139530846	T	C	X											X-139530846-T-C	-	0.3059	0.002	28	.	.	.	X	138613005	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys28Arg	.	18.47	.	0	.	D	.	2	1	.	.	.	.	.	0	0.85231	Select	0.5835	.	0.09864	.	.	T	D	.	0.131800438695	0	.	.	.	.	0.47787	.	.	.	.	0.18812	.	.	0.66671	0.999	.	4.0	0.450155	.	0.96	C	single nucleotide variant	NC_000023.11:g.139530846T>C	.	.	3	0.38168523	.	0	0.67080367	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	B	0.68400	B	M	.	.	./.	84	0	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.79369	.	.	-	139530846	.	-	2.835000	.	0.78260	.	0	.	.	germline	.	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.97257	GRCh38	937	criteria provided, single submitter	c.82T>C	.	0.45610	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	B	0	.	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	1	.	FA9_HUMAN	.	96.0	.	.	T	0.53440	0.49801674	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99965	.	.	.	.	.	p.Cys28Arg	.	0.35126	.	germline	.		T	Feb 02, 2021	.	./.	.	.	1.0	N	Xq27.1	7040	.	.	SCV002126918	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.527	.	.	0.663	T	.	2.378924	0.13225	.	T	-	.	.	0.78694	610	.	.	0.20996	0	139530846	Y	10	0	.	.	P00740	.	0.440732	0.20170		.	0.005	D	.	0.4603896	.	0.91597	2158	0.449804	.	-0.6	.	.	0.07137	.	.	.	.	.	.	0.62926	X	F9	.	0	Cys	11340	.	X-139530846-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138440671	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	.	.	.	RCV000011402|RCV001851793	D	.	.	c.82T>C	.	.	.	0.92418	./.	rs387906481	139530846	.	T	.	P00740	.	0.76212	.	0.68239		.	.	.	2.05	0	0	264690	4.0	0.78393	142	T	T	.	.	0	24	.	.	.	98879	10657	0.92325	0.14606	0.215877322444314	2728	.	0.71675	.	.	.	.	1.529	.	N	.	.	7.5560088E-6	0	306900|300807	0.35708	X	.	ENSG00000101981	.	0	.	0	0.8743106529995943	1	0.11213	0.14592	.	2	.	.	.	YES	.	0.110281	25696	HGNC:3551	A	.	simple_aae	0.611	.	139530846	TGT	1.000000	.	-	0	0.92701	.	0	.	Pathogenic	0.49978	.	.	.	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	C	.	0.999672884819	-	0.889	-	0.76569	.	574	0.87320	0.564161062241	0.2472	.	0.90666156510274398	100	-	82T>C 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.16159	387906481	.	0	0.99966	.	0.677	0.497	2644	0.99995670	5.23	.	.	.	0.408336	0.991303745387021	0.56288	T	118	.	.	-0.1274	0.84984	p.Cys28Arg	0	.	-5.036	0.9344977	.	0.88967	10657	T	.	F9	.	D	0.621	.	C28R	T	.	0.56753	./.	principal1	180187	F9_Popp_2025_heavy_chain_var230949	No											C		82	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys28Arg		true	c.82T>C						3551.0	139530846.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Cys28Arg						R	Feb 02, 2021					missense_variant		28.0				0.048946376		Pathogenic	139530846.0	missense_variant		0.621					Reporter			F9_Cys28Arg
F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys28Arg	23	139530846	T	C	X											X-139530846-T-C	-	0.3059	0.002	28	.	.	.	X	138613005	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys28Arg	.	18.47	.	0	.	D	.	2	1	.	.	.	.	.	0	0.85231	Select	0.5835	.	0.09864	.	.	T	D	.	0.131800438695	0	.	.	.	.	0.47787	.	.	.	.	0.18812	.	.	0.66671	0.999	.	4.0	0.450155	.	0.96	C	single nucleotide variant	NC_000023.11:g.139530846T>C	.	.	3	0.38168523	.	0	0.67080367	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	B	0.68400	B	M	.	.	./.	84	0	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.79369	.	.	-	139530846	.	-	2.835000	.	0.78260	.	0	.	.	germline	.	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.97257	GRCh38	937	criteria provided, single submitter	c.82T>C	.	0.45610	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	B	0	.	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	1	.	FA9_HUMAN	.	96.0	.	.	T	0.53440	0.49801674	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99965	.	.	.	.	.	p.Cys28Arg	.	0.35126	.	germline	.		T	Feb 02, 2021	.	./.	.	.	1.0	N	Xq27.1	7040	.	.	SCV002126918	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.527	.	.	0.663	T	.	2.378924	0.13225	.	T	-	.	.	0.78694	610	.	.	0.20996	0	139530846	Y	10	0	.	.	P00740	.	0.440732	0.20170		.	0.005	D	.	0.4603896	.	0.91597	2158	0.449804	.	-0.6	.	.	0.07137	.	.	.	.	.	.	0.62926	X	F9	.	0	Cys	11340	.	X-139530846-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138440671	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	.	.	.	RCV000011402|RCV001851793	D	.	.	c.82T>C	.	.	.	0.92418	./.	rs387906481	139530846	.	T	.	P00740	.	0.76212	.	0.68239		.	.	.	2.05	0	0	264690	4.0	0.78393	142	T	T	.	.	0	24	.	.	.	98879	10657	0.92325	0.14606	0.215877322444314	2728	.	0.71675	.	.	.	.	1.529	.	N	.	.	7.5560088E-6	0	306900|300807	0.35708	X	.	ENSG00000101981	.	0	.	0	0.8743106529995943	1	0.11213	0.14592	.	2	.	.	.	YES	.	0.110281	25696	HGNC:3551	A	.	simple_aae	0.611	.	139530846	TGT	1.000000	.	-	0	0.92701	.	0	.	Pathogenic	0.49978	.	.	.	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	C	.	0.999672884819	-	0.889	-	0.76569	.	574	0.87320	0.564161062241	0.2472	.	0.90666156510274398	100	-	82T>C 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.16159	387906481	.	0	0.99966	.	0.677	0.497	2644	0.99995670	5.23	.	.	.	0.408336	0.991303745387021	0.56288	T	118	.	.	-0.1274	0.84984	p.Cys28Arg	0	.	-5.036	0.9344977	.	0.88967	10657	T	.	F9	.	D	0.621	.	C28R	T	.	0.56753	./.	principal1	207703	F9_Popp_2025_light_chain_var240630	No											C		82	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys28Arg		true	c.82T>C						3551.0	139530846.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Cys28Arg						R	Feb 02, 2021					missense_variant		28.0				0.3029369390680045		Pathogenic	139530846.0	missense_variant		0.621					Reporter			F9_Cys28Arg
F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys28Arg	23	139530846	T	C	X											X-139530846-T-C	-	0.3059	0.002	28	.	.	.	X	138613005	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys28Arg	.	18.47	.	0	.	D	.	2	1	.	.	.	.	.	0	0.85231	Select	0.5835	.	0.09864	.	.	T	D	.	0.131800438695	0	.	.	.	.	0.47787	.	.	.	.	0.18812	.	.	0.66671	0.999	.	4.0	0.450155	.	0.96	C	single nucleotide variant	NC_000023.11:g.139530846T>C	.	.	3	0.38168523	.	0	0.67080367	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	B	0.68400	B	M	.	.	./.	84	0	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.79369	.	.	-	139530846	.	-	2.835000	.	0.78260	.	0	.	.	germline	.	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.97257	GRCh38	937	criteria provided, single submitter	c.82T>C	.	0.45610	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	B	0	.	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	1	.	FA9_HUMAN	.	96.0	.	.	T	0.53440	0.49801674	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99965	.	.	.	.	.	p.Cys28Arg	.	0.35126	.	germline	.		T	Feb 02, 2021	.	./.	.	.	1.0	N	Xq27.1	7040	.	.	SCV002126918	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.527	.	.	0.663	T	.	2.378924	0.13225	.	T	-	.	.	0.78694	610	.	.	0.20996	0	139530846	Y	10	0	.	.	P00740	.	0.440732	0.20170		.	0.005	D	.	0.4603896	.	0.91597	2158	0.449804	.	-0.6	.	.	0.07137	.	.	.	.	.	.	0.62926	X	F9	.	0	Cys	11340	.	X-139530846-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138440671	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	.	.	.	RCV000011402|RCV001851793	D	.	.	c.82T>C	.	.	.	0.92418	./.	rs387906481	139530846	.	T	.	P00740	.	0.76212	.	0.68239		.	.	.	2.05	0	0	264690	4.0	0.78393	142	T	T	.	.	0	24	.	.	.	98879	10657	0.92325	0.14606	0.215877322444314	2728	.	0.71675	.	.	.	.	1.529	.	N	.	.	7.5560088E-6	0	306900|300807	0.35708	X	.	ENSG00000101981	.	0	.	0	0.8743106529995943	1	0.11213	0.14592	.	2	.	.	.	YES	.	0.110281	25696	HGNC:3551	A	.	simple_aae	0.611	.	139530846	TGT	1.000000	.	-	0	0.92701	.	0	.	Pathogenic	0.49978	.	.	.	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	C	.	0.999672884819	-	0.889	-	0.76569	.	574	0.87320	0.564161062241	0.2472	.	0.90666156510274398	100	-	82T>C 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.16159	387906481	.	0	0.99966	.	0.677	0.497	2644	0.99995670	5.23	.	.	.	0.408336	0.991303745387021	0.56288	T	118	.	.	-0.1274	0.84984	p.Cys28Arg	0	.	-5.036	0.9344977	.	0.88967	10657	T	.	F9	.	D	0.621	.	C28R	T	.	0.56753	./.	principal1	235219	F9_Popp_2025_strep_2_var259992	No											C		82	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys28Arg		true	c.82T>C						3551.0	139530846.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Cys28Arg						R	Feb 02, 2021					missense_variant		28.0				0.030553486554471		Pathogenic	139530846.0	missense_variant		0.621					Reporter			F9_Cys28Arg
F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	NC_000023.11:139530846:T:C	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Cys28Arg	23	139530846	T	C	X											X-139530846-T-C	-	0.3059	0.002	28	.	.	.	X	138613005	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys28Arg	.	18.47	.	0	.	D	.	2	1	.	.	.	.	.	0	0.85231	Select	0.5835	.	0.09864	.	.	T	D	.	0.131800438695	0	.	.	.	.	0.47787	.	.	.	.	0.18812	.	.	0.66671	0.999	.	4.0	0.450155	.	0.96	C	single nucleotide variant	NC_000023.11:g.139530846T>C	.	.	3	0.38168523	.	0	0.67080367	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	B	0.68400	B	M	.	.	./.	84	0	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.79369	.	.	-	139530846	.	-	2.835000	.	0.78260	.	0	.	.	germline	.	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.97257	GRCh38	937	criteria provided, single submitter	c.82T>C	.	0.45610	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	B	0	.	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	1	.	FA9_HUMAN	.	96.0	.	.	T	0.53440	0.49801674	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99965	.	.	.	.	.	p.Cys28Arg	.	0.35126	.	germline	.		T	Feb 02, 2021	.	./.	.	.	1.0	N	Xq27.1	7040	.	.	SCV002126918	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.527	.	.	0.663	T	.	2.378924	0.13225	.	T	-	.	.	0.78694	610	.	.	0.20996	0	139530846	Y	10	0	.	.	P00740	.	0.440732	0.20170		.	0.005	D	.	0.4603896	.	0.91597	2158	0.449804	.	-0.6	.	.	0.07137	.	.	.	.	.	.	0.62926	X	F9	.	0	Cys	11340	.	X-139530846-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138440671	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	.	.	.	RCV000011402|RCV001851793	D	.	.	c.82T>C	.	.	.	0.92418	./.	rs387906481	139530846	.	T	.	P00740	.	0.76212	.	0.68239		.	.	.	2.05	0	0	264690	4.0	0.78393	142	T	T	.	.	0	24	.	.	.	98879	10657	0.92325	0.14606	0.215877322444314	2728	.	0.71675	.	.	.	.	1.529	.	N	.	.	7.5560088E-6	0	306900|300807	0.35708	X	.	ENSG00000101981	.	0	.	0	0.8743106529995943	1	0.11213	0.14592	.	2	.	.	.	YES	.	0.110281	25696	HGNC:3551	A	.	simple_aae	0.611	.	139530846	TGT	1.000000	.	-	0	0.92701	.	0	.	Pathogenic	0.49978	.	.	.	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	C	.	0.999672884819	-	0.889	-	0.76569	.	574	0.87320	0.564161062241	0.2472	.	0.90666156510274398	100	-	82T>C 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.16159	387906481	.	0	0.99966	.	0.677	0.497	2644	0.99995670	5.23	.	.	.	0.408336	0.991303745387021	0.56288	T	118	.	.	-0.1274	0.84984	p.Cys28Arg	0	.	-5.036	0.9344977	.	0.88967	10657	T	.	F9	.	D	0.621	.	C28R	T	.	0.56753	./.	principal1	152671	F9_Popp_2025_carboxy_gla_motif_var250311	No											C		82	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys28Arg		true	c.82T>C						3551.0	139530846.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Cys28Arg						R	Feb 02, 2021					missense_variant		28.0				0.087257991		Pathogenic	139530846.0	missense_variant		0.621					Reporter			F9_Cys28Arg
F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004373		NC_000023.11:139530846:T:C		Cys28Arg																												F9_Cys28Arg	23	139530846	T	C	X	allele	82T>C	G09	527_CAVA_Array_P02	M18	B13A7A8P1_R1	B14A7A8P1_R2				X-139530846-T-C	-	0.3059	0.002	28	.	.	.	X	138613005	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys28Arg	.	18.47	.	0	.	D	.	2	1	.	.	.	.	.	0	0.85231	Select	0.5835	.	0.09864	.	.	T	D	.	0.131800438695	0	.	.	.	.	0.47787	.	.	.	.	0.18812	.	.	0.66671	0.999	.	4.0	0.450155	.	0.96	C	single nucleotide variant	NC_000023.11:g.139530846T>C	.	.	3	0.38168523	.	0	0.67080367	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	B	0.68400	B	M	.	.	./.	84	0	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.79369	.	.	-	139530846	.	-	2.835000	.	0.78260	.	0	.	.	germline	.	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.97257	GRCh38	937	criteria provided, single submitter	c.82T>C	.	0.45610	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	B	0	.	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	1	.	FA9_HUMAN	.	96.0	.	.	T	0.53440	0.49801674	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99965	.	.	.	.	.	p.Cys28Arg	.	0.35126	.	germline	.		T	Feb 02, 2021	.	./.	.	.	1.0	N	Xq27.1	7040	.	.	SCV002126918	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.527	.	.	0.663	T	.	2.378924	0.13225	.	T	-	.	.	0.78694	610	.	.	0.20996	0	139530846	Y	10	0	.	.	P00740	.	0.440732	0.20170		.	0.005	D	.	0.4603896	.	0.91597	2158	0.449804	.	-0.6	.	.	0.07137	.	.	.	.	.	.	0.62926	X	F9	.	0	Cys	11340	.	X-139530846-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138440671	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	.	.	.	RCV000011402|RCV001851793	D	.	.	c.82T>C	.	.	.	0.92418	./.	rs387906481	139530846	.	T	.	P00740	.	0.76212	.	0.68239		.	.	.	2.05	0	0	264690	4.0	0.78393	142	T	T	.	.	0	24	.	.	.	98879	10657	0.92325	0.14606	0.215877322444314	2728	.	0.71675	.	.	.	.	1.529	.	N	.	.	7.5560088E-6	0	306900|300807	0.35708	X	.	ENSG00000101981	.	0	.	0	0.8743106529995943	1	0.11213	0.14592	.	2	.	.	.	YES	.	0.110281	25696	HGNC:3551	A	.	simple_aae	0.611	.	139530846	TGT	1.000000	.	-	0	0.92701	.	0	.	Pathogenic	0.49978	.	.	.	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	C	.	0.999672884819	-	0.889	-	0.76569	.	574	0.87320	0.564161062241	0.2472	.	0.90666156510274398	100	-	82T>C 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.16159	387906481	.	0	0.99966	.	0.677	0.497	2644	0.99995670	5.23	.	.	.	0.408336	0.991303745387021	0.56288	T	118	.	.	-0.1274	0.84984	p.Cys28Arg	0	.	-5.036	0.9344977	.	0.88967	10657	T	.	F9	.	D	0.621	.	C28R	T	.	0.56753	./.	principal1	125155	F9_Popp_2025_carboxy_F9_specific_var221268	No											C		82	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys28Arg		true	c.82T>C						3551.0	139530846.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Cys28Arg						R	Feb 02, 2021					missense_variant		28.0				0.2435717878896782		Pathogenic	139530846.0	missense_variant		0.621					Reporter			F9_Cys28Arg
F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004373		NC_000023.11:139530846:T:C		Cys28Arg																												F9_Cys28Arg	23	139530846	T	C	X	allele	82T>C	G09	527_CAVA_Array_P02	M18	B13A7A8P1_R1	B14A7A8P1_R2				X-139530846-T-C	-	0.3059	0.002	28	.	.	.	X	138613005	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys28Arg	.	18.47	.	0	.	D	.	2	1	.	.	.	.	.	0	0.85231	Select	0.5835	.	0.09864	.	.	T	D	.	0.131800438695	0	.	.	.	.	0.47787	.	.	.	.	0.18812	.	.	0.66671	0.999	.	4.0	0.450155	.	0.96	C	single nucleotide variant	NC_000023.11:g.139530846T>C	.	.	3	0.38168523	.	0	0.67080367	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	B	0.68400	B	M	.	.	./.	84	0	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.79369	.	.	-	139530846	.	-	2.835000	.	0.78260	.	0	.	.	germline	.	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.97257	GRCh38	937	criteria provided, single submitter	c.82T>C	.	0.45610	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	B	0	.	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	1	.	FA9_HUMAN	.	96.0	.	.	T	0.53440	0.49801674	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99965	.	.	.	.	.	p.Cys28Arg	.	0.35126	.	germline	.		T	Feb 02, 2021	.	./.	.	.	1.0	N	Xq27.1	7040	.	.	SCV002126918	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.527	.	.	0.663	T	.	2.378924	0.13225	.	T	-	.	.	0.78694	610	.	.	0.20996	0	139530846	Y	10	0	.	.	P00740	.	0.440732	0.20170		.	0.005	D	.	0.4603896	.	0.91597	2158	0.449804	.	-0.6	.	.	0.07137	.	.	.	.	.	.	0.62926	X	F9	.	0	Cys	11340	.	X-139530846-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138440671	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	.	.	.	RCV000011402|RCV001851793	D	.	.	c.82T>C	.	.	.	0.92418	./.	rs387906481	139530846	.	T	.	P00740	.	0.76212	.	0.68239		.	.	.	2.05	0	0	264690	4.0	0.78393	142	T	T	.	.	0	24	.	.	.	98879	10657	0.92325	0.14606	0.215877322444314	2728	.	0.71675	.	.	.	.	1.529	.	N	.	.	7.5560088E-6	0	306900|300807	0.35708	X	.	ENSG00000101981	.	0	.	0	0.8743106529995943	1	0.11213	0.14592	.	2	.	.	.	YES	.	0.110281	25696	HGNC:3551	A	.	simple_aae	0.611	.	139530846	TGT	1.000000	.	-	0	0.92701	.	0	.	Pathogenic	0.49978	.	.	.	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	C	.	0.999672884819	-	0.889	-	0.76569	.	574	0.87320	0.564161062241	0.2472	.	0.90666156510274398	100	-	82T>C 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.16159	387906481	.	0	0.99966	.	0.677	0.497	2644	0.99995670	5.23	.	.	.	0.408336	0.991303745387021	0.56288	T	118	.	.	-0.1274	0.84984	p.Cys28Arg	0	.	-5.036	0.9344977	.	0.88967	10657	T	.	F9	.	D	0.621	.	C28R	T	.	0.56753	./.	principal1	180187	F9_Popp_2025_heavy_chain_var230949	No											C		82	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys28Arg		true	c.82T>C						3551.0	139530846.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Cys28Arg						R	Feb 02, 2021					missense_variant		28.0				0.048946376		Pathogenic	139530846.0	missense_variant		0.621					Reporter			F9_Cys28Arg
F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004373		NC_000023.11:139530846:T:C		Cys28Arg																												F9_Cys28Arg	23	139530846	T	C	X	allele	82T>C	G09	527_CAVA_Array_P02	M18	B13A7A8P1_R1	B14A7A8P1_R2				X-139530846-T-C	-	0.3059	0.002	28	.	.	.	X	138613005	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys28Arg	.	18.47	.	0	.	D	.	2	1	.	.	.	.	.	0	0.85231	Select	0.5835	.	0.09864	.	.	T	D	.	0.131800438695	0	.	.	.	.	0.47787	.	.	.	.	0.18812	.	.	0.66671	0.999	.	4.0	0.450155	.	0.96	C	single nucleotide variant	NC_000023.11:g.139530846T>C	.	.	3	0.38168523	.	0	0.67080367	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	B	0.68400	B	M	.	.	./.	84	0	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.79369	.	.	-	139530846	.	-	2.835000	.	0.78260	.	0	.	.	germline	.	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.97257	GRCh38	937	criteria provided, single submitter	c.82T>C	.	0.45610	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	B	0	.	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	1	.	FA9_HUMAN	.	96.0	.	.	T	0.53440	0.49801674	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99965	.	.	.	.	.	p.Cys28Arg	.	0.35126	.	germline	.		T	Feb 02, 2021	.	./.	.	.	1.0	N	Xq27.1	7040	.	.	SCV002126918	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.527	.	.	0.663	T	.	2.378924	0.13225	.	T	-	.	.	0.78694	610	.	.	0.20996	0	139530846	Y	10	0	.	.	P00740	.	0.440732	0.20170		.	0.005	D	.	0.4603896	.	0.91597	2158	0.449804	.	-0.6	.	.	0.07137	.	.	.	.	.	.	0.62926	X	F9	.	0	Cys	11340	.	X-139530846-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138440671	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	.	.	.	RCV000011402|RCV001851793	D	.	.	c.82T>C	.	.	.	0.92418	./.	rs387906481	139530846	.	T	.	P00740	.	0.76212	.	0.68239		.	.	.	2.05	0	0	264690	4.0	0.78393	142	T	T	.	.	0	24	.	.	.	98879	10657	0.92325	0.14606	0.215877322444314	2728	.	0.71675	.	.	.	.	1.529	.	N	.	.	7.5560088E-6	0	306900|300807	0.35708	X	.	ENSG00000101981	.	0	.	0	0.8743106529995943	1	0.11213	0.14592	.	2	.	.	.	YES	.	0.110281	25696	HGNC:3551	A	.	simple_aae	0.611	.	139530846	TGT	1.000000	.	-	0	0.92701	.	0	.	Pathogenic	0.49978	.	.	.	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	C	.	0.999672884819	-	0.889	-	0.76569	.	574	0.87320	0.564161062241	0.2472	.	0.90666156510274398	100	-	82T>C 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.16159	387906481	.	0	0.99966	.	0.677	0.497	2644	0.99995670	5.23	.	.	.	0.408336	0.991303745387021	0.56288	T	118	.	.	-0.1274	0.84984	p.Cys28Arg	0	.	-5.036	0.9344977	.	0.88967	10657	T	.	F9	.	D	0.621	.	C28R	T	.	0.56753	./.	principal1	207703	F9_Popp_2025_light_chain_var240630	No											C		82	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys28Arg		true	c.82T>C						3551.0	139530846.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Cys28Arg						R	Feb 02, 2021					missense_variant		28.0				0.3029369390680045		Pathogenic	139530846.0	missense_variant		0.621					Reporter			F9_Cys28Arg
F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004373		NC_000023.11:139530846:T:C		Cys28Arg																												F9_Cys28Arg	23	139530846	T	C	X	allele	82T>C	G09	527_CAVA_Array_P02	M18	B13A7A8P1_R1	B14A7A8P1_R2				X-139530846-T-C	-	0.3059	0.002	28	.	.	.	X	138613005	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys28Arg	.	18.47	.	0	.	D	.	2	1	.	.	.	.	.	0	0.85231	Select	0.5835	.	0.09864	.	.	T	D	.	0.131800438695	0	.	.	.	.	0.47787	.	.	.	.	0.18812	.	.	0.66671	0.999	.	4.0	0.450155	.	0.96	C	single nucleotide variant	NC_000023.11:g.139530846T>C	.	.	3	0.38168523	.	0	0.67080367	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	B	0.68400	B	M	.	.	./.	84	0	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.79369	.	.	-	139530846	.	-	2.835000	.	0.78260	.	0	.	.	germline	.	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.97257	GRCh38	937	criteria provided, single submitter	c.82T>C	.	0.45610	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	B	0	.	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	1	.	FA9_HUMAN	.	96.0	.	.	T	0.53440	0.49801674	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99965	.	.	.	.	.	p.Cys28Arg	.	0.35126	.	germline	.		T	Feb 02, 2021	.	./.	.	.	1.0	N	Xq27.1	7040	.	.	SCV002126918	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.527	.	.	0.663	T	.	2.378924	0.13225	.	T	-	.	.	0.78694	610	.	.	0.20996	0	139530846	Y	10	0	.	.	P00740	.	0.440732	0.20170		.	0.005	D	.	0.4603896	.	0.91597	2158	0.449804	.	-0.6	.	.	0.07137	.	.	.	.	.	.	0.62926	X	F9	.	0	Cys	11340	.	X-139530846-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138440671	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	.	.	.	RCV000011402|RCV001851793	D	.	.	c.82T>C	.	.	.	0.92418	./.	rs387906481	139530846	.	T	.	P00740	.	0.76212	.	0.68239		.	.	.	2.05	0	0	264690	4.0	0.78393	142	T	T	.	.	0	24	.	.	.	98879	10657	0.92325	0.14606	0.215877322444314	2728	.	0.71675	.	.	.	.	1.529	.	N	.	.	7.5560088E-6	0	306900|300807	0.35708	X	.	ENSG00000101981	.	0	.	0	0.8743106529995943	1	0.11213	0.14592	.	2	.	.	.	YES	.	0.110281	25696	HGNC:3551	A	.	simple_aae	0.611	.	139530846	TGT	1.000000	.	-	0	0.92701	.	0	.	Pathogenic	0.49978	.	.	.	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	C	.	0.999672884819	-	0.889	-	0.76569	.	574	0.87320	0.564161062241	0.2472	.	0.90666156510274398	100	-	82T>C 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.16159	387906481	.	0	0.99966	.	0.677	0.497	2644	0.99995670	5.23	.	.	.	0.408336	0.991303745387021	0.56288	T	118	.	.	-0.1274	0.84984	p.Cys28Arg	0	.	-5.036	0.9344977	.	0.88967	10657	T	.	F9	.	D	0.621	.	C28R	T	.	0.56753	./.	principal1	235219	F9_Popp_2025_strep_2_var259992	No											C		82	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys28Arg		true	c.82T>C						3551.0	139530846.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Cys28Arg						R	Feb 02, 2021					missense_variant		28.0				0.030553486554471		Pathogenic	139530846.0	missense_variant		0.621					Reporter			F9_Cys28Arg
F9_Cys28Arg	2.152584623455668	0.06835226540196286	-15.200294562595731	1.2837247491940444e-6	2025_01_Batch_13-14	0.6277013178121026	0.9458264867789534	0.9785436051053813	0.960788624807321	0.6407207648505859	0.7363730507593718	0.9509372630088639	0.9855761971318318	0.9778662449863682	0.7301018054185299	0.6820371842857371	0.9483818748939087	0.9820599011186065	0.9693274348968446	0.685411285134558	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004373		NC_000023.11:139530846:T:C		Cys28Arg																												F9_Cys28Arg	23	139530846	T	C	X	allele	82T>C	G09	527_CAVA_Array_P02	M18	B13A7A8P1_R1	B14A7A8P1_R2				X-139530846-T-C	-	0.3059	0.002	28	.	.	.	X	138613005	C	.	.	X	1_Pathogenic	NC_000023.11	.	Cys28Arg	.	18.47	.	0	.	D	.	2	1	.	.	.	.	.	0	0.85231	Select	0.5835	.	0.09864	.	.	T	D	.	0.131800438695	0	.	.	.	.	0.47787	.	.	.	.	0.18812	.	.	0.66671	0.999	.	4.0	0.450155	.	0.96	C	single nucleotide variant	NC_000023.11:g.139530846T>C	.	.	3	0.38168523	.	0	0.67080367	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	B	0.68400	B	M	.	.	./.	84	0	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.79369	.	.	-	139530846	.	-	2.835000	.	0.78260	.	0	.	.	germline	.	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.97257	GRCh38	937	criteria provided, single submitter	c.82T>C	.	0.45610	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	B	0	.	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	1	.	FA9_HUMAN	.	96.0	.	.	T	0.53440	0.49801674	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99965	.	.	.	.	.	p.Cys28Arg	.	0.35126	.	germline	.		T	Feb 02, 2021	.	./.	.	.	1.0	N	Xq27.1	7040	.	.	SCV002126918	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.527	.	.	0.663	T	.	2.378924	0.13225	.	T	-	.	.	0.78694	610	.	.	0.20996	0	139530846	Y	10	0	.	.	P00740	.	0.440732	0.20170		.	0.005	D	.	0.4603896	.	0.91597	2158	0.449804	.	-0.6	.	.	0.07137	.	.	.	.	.	.	0.62926	X	F9	.	0	Cys	11340	.	X-139530846-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138440671	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	.	.	.	RCV000011402|RCV001851793	D	.	.	c.82T>C	.	.	.	0.92418	./.	rs387906481	139530846	.	T	.	P00740	.	0.76212	.	0.68239		.	.	.	2.05	0	0	264690	4.0	0.78393	142	T	T	.	.	0	24	.	.	.	98879	10657	0.92325	0.14606	0.215877322444314	2728	.	0.71675	.	.	.	.	1.529	.	N	.	.	7.5560088E-6	0	306900|300807	0.35708	X	.	ENSG00000101981	.	0	.	0	0.8743106529995943	1	0.11213	0.14592	.	2	.	.	.	YES	.	0.110281	25696	HGNC:3551	A	.	simple_aae	0.611	.	139530846	TGT	1.000000	.	-	0	0.92701	.	0	.	Pathogenic	0.49978	.	.	.	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	C	.	0.999672884819	-	0.889	-	0.76569	.	574	0.87320	0.564161062241	0.2472	.	0.90666156510274398	100	-	82T>C 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.16159	387906481	.	0	0.99966	.	0.677	0.497	2644	0.99995670	5.23	.	.	.	0.408336	0.991303745387021	0.56288	T	118	.	.	-0.1274	0.84984	p.Cys28Arg	0	.	-5.036	0.9344977	.	0.88967	10657	T	.	F9	.	D	0.621	.	C28R	T	.	0.56753	./.	principal1	152671	F9_Popp_2025_carboxy_gla_motif_var250311	No											C		82	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys28Arg		true	c.82T>C						3551.0	139530846.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Cys28Arg						R	Feb 02, 2021					missense_variant		28.0				0.087257991		Pathogenic	139530846.0	missense_variant		0.621					Reporter			F9_Cys28Arg
BRCA1_Asn132Lys	2.212585170847975	0.06255809591849197	2.057481779620184	0.0786569367910109	2025_01_Batch_13-14	0.989883589297884	0.9544798674417163	0.9515149578296669	0.9817695717721739	0.9685390552154329	0.979691614058316	0.9064612890411237	0.9102052356299227	0.9713533990828885	0.920053761064975	0.9847876016781	0.93047057824142	0.9308600967297949	0.9765614854275313	0.944296408140204	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	BRCA1	BRCA1		14613		CCSBVarC013093		NC_000017.11:43104167:G:T		Asn132Lys																												BRCA1_Asn132Lys	17	43104167	G	T	17	allele	396C>A	D11	527_CAVA_Array_P01	G21	B13A7A8P1_R1	B14A7A8P1_R2				17-43104167-G-T	-	0.18568	0.844	132	10	0	0	17	41256184	T	3.717640e-05	0	17	2_Benign	NC_000017.11	58	Asn132Lys	0	13.79	0	0	8.760830e-05	T	0	20	1	42766	3.799260e-05	.	30512	0.000000e+00	0	0.87273	Select	0.2504	102730	0.70687	0	.	T	D	64002	.	0	0	0.000000e+00	0	0	0.51867	17098	44890	0	0.000000e+00	0.74082	5	.	0.46959	0.941	.	52.0	.	1.8	0.48	T	single nucleotide variant	NC_000017.11:g.43104167G>T	0	16726	2	0.2039367	109376	0	0.22508949	0		10	236888	0	0	0.000000e+00	500	1.169150e-04	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	5	0	0.000000e+00	0	0.78014	B	0.42198	P	M	1.938592	60	G/G	114	0	7164	1613926	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	16218	0.57554	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43104167	1.169150e-04	-	0.730000	0	0.30556	29606	0	1179978	0	germline;unknown	91078	Gain of methylation at N132 (P = 0.0115)| Loss of ubiquitination at K135 (P = 0.027)| Gain of helix (P = 0.0325)| Gain of MoRF binding (P = 0.0503)| Loss of loop (P = 0.0804)	0.86654	GRCh38	462	reviewed by expert panel	c.396C>A	0.000000e+00	0.27660	2	0	0	.	0.000000e+00	9046	A	0	0.000000e+00	NM_007294.4(BRCA1):c.396C>A (p.Asn132Lys)	3	0	BRCA1_HUMAN	0	48.0	-0.178148358989986	0	.	0.66770	0.24349055	-	0.000000e+00	.		10	0.000000e+00	2	34238	reviewed_by_expert_panel	0.97691	4.571390e-05	0	0.000000e+00	0	59990	p.Asn132Lys	0	0.21161	.	germline	5		G	Aug 10, 2015	0	G/G	0	89540	1.0	N	17q21.31	31050	.	0.000000e+00	SCV000244350	Benign	0	0	Lys	K	-	912	ENSP00000350283	ENST00000357654	17692	0.001	13416	0	-0.727	G	0	1.435024	0.74454	D	D	-	1.893925	.	0.95677	628	0	.	0.21247	0	43104167	Y	10	0	102730	0.000000e+00	P38398	0	0.312083	0.74843		0	0.23	D	89540	0.18978201	42766	0.48226	672	0.105641	58	-0.84	.	4.915350e-05	0.91343	0.000000e+00	0	74908	0.000000e+00	6082	0	0.44334	17	BRCA1	1.334970e-05	0	Asn	39902	1.116820e-04	17-43104167-G-T	Hereditary_cancer-predisposing_syndrome|not_specified|Malignant_tumor_of_breast|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	0	9	38509710	BRCA1-HCI:BRCA1_00119|ClinGen:CA002545|UniProtKB:P38398#VAR_070462	0.533451	0.33768	0	RCV000083203|RCV000162966|RCV000212156|RCV000587325|RCV001083972|RCV001353495	D	0	0	c.396C>A	0	0	0	0.64645	G/G	rs80357413	43104167	14902	G	.	E9PFC7	15682	0.44837	0.000000e+00	0.34068		0	0	0.000000e+00	2.535	0	2	264690	2.3	0.68213	112	T	T	0	0.000000e+00	0	26	.	0	0	140162|145|145	55064	0.76727	0.14104	0.220903346759768	2918	.	0.71675	0.55132	0.000000e+00	1.116820e-04	1179978	1.172	4.805890e-05	N	13386	0	3.0224035E-5	0	604370	0.3162	17	0.000000e+00	ENSG00000012048	0.000000e+00	6.44122383252818E-5	0	0	.	3	0.76920	0.78630	30594	8	8.760830e-05	0.000000e+00	-0.156487260348686	YES	0.000000e+00	0.537965	69731	HGNC:1100	N	0	simple_aae	0.111	208078	43104167	AAC	0.998000	.	-	0	0.61126	4.915350e-05	0	0	Benign	0.01204	0	0	0	BRCA1-HCI:BRCA1_00119,ClinGen:CA002545,UniProtKB:P38398#VAR_070462	N	0	0.91044858891	-	0.734	-	0.84989	9	4596	0.38932	0.593114554882	0.5123	0	0.99611497861979004	98	-	396C>A 	9	0	C0027672|CN169374|C0006142|C0677776|C3661900|C2676676	0	0	0	0	NM_007294.4	-	.	.	0	0.79579	80357413	2320	5.0122800862112174E-5	0.90887	0.32848	0.728	0.014	2804	0.99506503	5.32	.	.	0.000000e+00	0.0998727	0.633096537117509	0.73728	T	86	6212	9572	-0.7539	0.61845	p.Asn132Lys	0	0	0.181	0.49917424	1	0.64846	55064	T	30508	BRCA1	0.000000e+00	D	0.661	21624	N132K	D	0.37395	0.03758	G/G	principal2																																																																																																				
BAP1_Thr93Ala	-0.6567658065858207	0.5323213743048774	-1.8287496773019911	0.11014705290189507	2025_01_Batch_13-14	0.6202397851478961	0.6362000012952241	0.7512034716753719	0.6892093396316892	0.6153877231073421	0.5360889193103129	0.5627802399760888	0.7323795754952047	0.6351488821939886	0.63413813268941	0.5781643522291045	0.5994901206356564	0.7417915235852883	0.6621791109128389	0.6247629278983761	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009507		NC_000003.12:52408056:T:C		Thr93Ala																												BAP1_Thr93Ala	3	52408056	T	C	3	allele	277A>G	H02	527_CAVA_Array_P01	O03	B13A7A8P1_R1	B14A7A8P1_R2				3-52408056-T-C	-	0.96116	0.999	93	0	.	0	3	52442072	C	.	0	3	4_VUS	NC_000003.12	.	Thr93Ala	1	35.0	0	0	5.711020e-05	D	.	3	1	41496	4.324700e-06	.	29584	0.000000e+00	0	0.94563	Select	0.5815	17510	0.77914	0	.	D	D	.	2.40817712881	0	.	0.000000e+00	0	0	0.87085	16808	.	.	0.000000e+00	0.80799	0	.	0.89125	0.995	.	0.0	0.994601	3.34	1.0	C	single nucleotide variant	NC_000003.12:g.52408056T>C	.	16576	3	0.8592254	106374	0	0.9059349	0		0	231230	0	0	5.711020e-05	146	0.000000e+00	0	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	0	0	.	.	0.99291	D	0.90693	D	H	12.5385	.	T/T	114	0	6610	.	BAP1-related tumor predisposition syndrome|Hereditary cancer-predisposing syndrome	15408	0.90073	.	.	-	52408056	.	-	7.827000	0	0.89950	.	0	.	0	germline	.	Gain of helix (P = 0.132)| Loss of glycosylation at T93 (P = 0.3182)| Loss of stability (P = 0.3249)| Loss of catalytic residue at N89 (P = 0.4948)| Gain of disorder (P = 0.6407)	0.96509	GRCh38	68	criteria provided, multiple submitters, no conflicts	c.277A>G	0.000000e+00	0.80997	0	0	0	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	0.000000e+00	8894	P	0	.	NM_004656.4(BAP1):c.277A>G (p.Thr93Ala)	2	0	BAP1_HUMAN	0	100.0	0.954170017245365	0	D	0.95276	0.8751512	-	0.000000e+00	.		.	0.000000e+00	0	33660	criteria_provided,_multiple_submitters,_no_conflicts	0.99571	0.000000e+00	.	0.000000e+00	0	.	p.Thr93Ala	.	0.70012	.	germline	.		T	Dec 03, 2022	0	T/T	0	87104	1.0	N	3p21.1	9690	.	0.000000e+00	SCV002746333|SCV004293103	Uncertain_significance	0	0	Ala	A	-	.	ENSP00000417132	ENST00000460680	17510	0.001	13312	0	0.665	T	0	7.074994	0.74454	D	D	-	12.37055	.	0.91452	610	0	.	0.88231	0	52408056	Y	10	0	100148	.	Q92560	0	0.577416	0.89183		.	0.989	D	.	0.8396252	.	0.73271	8314	0.251032	.	-4.56	.	.	0.78662	0.000000e+00	0	.	0.000000e+00	.	0	0.92021	3	BAP1	.	0	Thr	14528	0.000000e+00	3-52408056-T-C	BAP1-related_tumor_predisposition_syndrome|Hereditary_cancer-predisposing_syndrome	.	0	52417112	ClinGen:CA143983|OMIM:603089.0008	0.908893	0.94117	.	RCV000049290|RCV002433548	D	.	0	c.277A>G	0	.	.	0.78538	T/T	rs375129361	52408056	14150	T	.	Q92560	15212	0.91801	0.000000e+00	0.68239		0	0	.	4.105	0	0	.	5.49	0.85979	112	D	D	0	0.000000e+00	0	26	.	0	0	289539|140162	55879	0.87893	0.97198	0.995927274227142	3324	.	0.71675	0.86431	0.000000e+00	.	.	7.766	0.000000e+00	D	13292	.	.	0	614327	0.84189	3	0.000000e+00	ENSG00000163930	.	0	0	0	0.8901470396696406	1	0.78402	0.97129	29660	.	0.000000e+00	.	0.865996819397726	YES	.	0.320929	70527	HGNC:950	A	0	simple_aae	0.818	202728	52408056	ACT	1.000000	.	-	0	0.96665	.	0	.	Uncertain significance	0.95431	0	.	.	ClinGen:CA143983,OMIM:603089.0008	T	0	0.838735026799	-	0.874	-	0.99488	1	548	0.88915	0.833551824093	0.9945	.	0.99807720587773441	98	-	277A>G 	1	0	C3280492|C0027672	0	0	0	0	NM_004656.4	-	.	.	1	0.98251	375129361	2194	0	0.83592	0.93882	0.983	0.004	3210	0.99965429	5.49	.	.	0.000000e+00	0.295271	0.999630510295007	0.97294	D	86	5990	9380	0.4694	0.84895	p.Thr93Ala	0	.	-14.822	0.9710113	.	0.97271	55879	D	29904	BAP1	0.000000e+00	D	0.829	21264	T93A	D	0.60572	0.62996	T/T	principal1																																																																																																				
G6PD_Glu398Lys	-2.2270130039444096	0.061240193067420415	-0.8074387696543632	0.44597881965233355	2025_01_Batch_13-14	0.6375150811257665	0.6857507416320532	0.6899031274081147	0.754685069336219	0.5817260749943405	0.6490455450952126	0.6565875508067958	0.6259642270058572	0.6481168129234808	0.6344998491776213	0.6432803131104896	0.6711691462194245	0.6579336772069859	0.7014009411298499	0.6081129620859809	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	G6PD	G6PD		4006		CCSBVarC004025		NC_000023.11:154532662:C:T		Glu398Lys																												G6PD_Glu398Lys	23	154532662	C	T	X	allele	1192G>A	H04	527_CAVA_Array_P03	P07	B13A7A8P1_R1	B14A7A8P1_R2				X-154532662-C-T	-	0.71085	1.0	398	.	.	.	X	153760877	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu398Lys	.	25.6	.	.	.	D	.	3	.	.	.	.	.	.	.	0.97849	.	0.9960	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.84925	.	.	.	.	0.69872	.	.	0.98071	0.977	.	.	0.99725	3.01	.	T	single nucleotide variant	NC_000023.11:g.154532662C>T	.	.	2	0.90745586	.	.	0.95874125	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	.	.	.	.	0.94956	D	0.96951	D	H	.	.	C/C	.	.	.	.	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	.	0.95965	.	.	-	154532662	.	-	5.880000	.	0.99628	.	.	.	.	germline;maternal;unknown	.	Gain of MoRF binding (P = 0.0029)| Gain of methylation at E398 (P = 0.0073)| Loss of stability (P = 0.1334)| Gain of phosphorylation at T402 (P = 0.1773)| Loss of loop (P = 0.2237)	0.99385	GRCh38	80	criteria provided, multiple submitters, no conflicts	.	.	0.65108	.	.	.	Glucose-6-phosphate dehydrogenase, C-terminal	.	.	.	.	.	NM_001360016.2(G6PD):c.1192G>A (p.Glu398Lys)	2	.	G6PD_HUMAN	.	.	.	.	D	0.90566	0.9683203	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98976	.	.	.	.	.	.	.	0.50706	.	germline	.		C	May 20, 2023	.	C/C	.	.	1.0	N	Xq28	.	.	.	SCV001142103|SCV002599372|SCV005373641	Pathogenic	.	.	Lys	K	-	.	ENSP00000512625	ENST00000696430	.	.	.	.	0.585	C	.	4.526718	0.83643	.	.	-	.	.	0.98832	.	.	.	0.97827	.	154532662	Y	10	.	.	.	P11413	.	0.972763	0.98310		.	1.0	D	.	0.9285496	.	0.56847	2539	0.667932	.	.	.	.	0.78662	.	.	.	.	.	.	0.95445	X	G6PD	.	.	Glu	.	.	X-154532662-C-T	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	.	.	153414071	.	.	.	.	RCV000991012	.	.	.	c.1192G>A	.	.	.	0.99900	C/C	rs137852325	154532662	.	C	.	P11413	.	0.97108	.	0.68239		.	.	.	4.61	.	.	.	4.96	0.99714	.	D	D	.	.	.	.	.	.	.	466026	804134	0.99899	0.95480	0.999545991420746	.	.	0.71675	.	.	.	.	5.668	.	.	.	.	.	.	300908	0.67818	X	.	ENSG00000160211	.	.	.	.	.	1	0.97365	0.96675	.	.	.	.	.	.	.	0.848963	792173	HGNC:4057	.	.	.	0.989	.	154532662	GAG	1.000000	.	-	.	0.98957	.	.	.	Pathogenic	0.80418	.	.	.	ClinGen:CA337316269	E	.	.	-	0.949	-	0.73617	.	.	.	0.819497585297	.	.	0.99914936147112188	.	-	1192G>A 	.	.	C2720289	.	.	.	.	NM_001360016.2	-	.	.	1	0.98926	137852325	.	.	0.99692	.	.	.	.	0.99881110	5.82	.	.	.	0.721661	0.999990459212003	0.99266	D	.	.	.	0.9214	0.99908	p.Glu398Lys	.	.	-11.128	.	.	0.99831	804134	D	.	G6PD	.	D	.	.	E398K	.	0.55043	0.3052	C/C	principal4	266779	G6PD_unpublished_var120692	No						Protein stability		Fluorescence			E		1192	G6PD_unpublished		ENST00000393562.10							immortalized human cells					p.Glu398Glu		true	c.1192G>A						4057.0	154532662.0	Yes		G6PD				NM_001360016.2		-1.0			aa											criteria provided, multiple submitters, no conflicts	1.057171340117224;1.067244693361654;0.994831758572235			Glu398Glu						E	May 20, 2023					missense_variant		398.0				1.039749264017038		Pathogenic/Likely pathogenic	154532662.0	missense_variant							Reporter			G6PD_Glu398Glu
RAD51D_Glu233Gly	2.0151388056522266	0.08372864851161924	-22.26053493041938	9.334055407083976e-8	2025_01_Batch_13-14	0.6523177668682895	0.8737579764020821	0.9617439699350335	0.9066849961213046	0.7123528900241779	0.696707601081368	0.8967476179637639	0.9669006250473935	0.9315224387652209	0.6991962903503816	0.6745126839748288	0.8852527971829229	0.9643222974912136	0.9191037174432628	0.7057745901872797	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D	ENSG00000185379	7201	12776	CCSBVarC001140	ALE00001140	NC_000017.11:35103294:T:C	698A>G	Glu233Gly	RC4	RC4_Mut_GDEh1002	C07	GDEhDisVCh_40046	H04	2	RC4_Mut_GDDh1002	C07	NULL	NULL	VUSMutpDEST2_06	F01	VUSmut_GDEh12	G05	1	2	1	1	0			1	1	1	1	1	1	RAD51D_Glu233Gly	17	35103294	T	C	17											17-35103294-T-C	-	0.78468	0.973	233	1541	54	0	17	33430313	C	1.682330e-02	139	17	2_Benign	NC_000017.11	24903	Glu233Gly	0	26.9	0	38	1.658470e-02	T	286	20	5	41754	9.271140e-03	0	29798	8.984730e-04	12	0.46391	.	0.2448	100816	0.90580	242	0.0	T	T	63816	.	0.004023718763235917	0	1.697070e-03	18	18	.	16760	44820	335	0.000000e+00	0.66695	642	.	0.64786	0.998	0.0	99.0	0.918208	.	0.01	C	single nucleotide variant	NC_000017.11:g.35103294T>C	0	16462	2	0.5062009	106826	0	0.46690348	1.5673981191222572E-4	C	1989	232226	7	0	0.000000e+00	800	1.537580e-02	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	877	25	1.096490e-02	10	0.13669	P	0.71202	D	L	4.397588	27113	T/T	358	223	6852	1611638	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Malignant tumor of breast|not provided|Hereditary breast ovarian cancer syndrome	15672	0.66221	9	.	-	35103294	1.537580e-02	-	7.756000	54	0.56112	29510	0.012320328542094456	1179112	0	germline;unknown	90476	.	.	GRCh38	908	criteria provided, multiple submitters, no conflicts	c.698A>G	3.154570e-03	0.64102	3667	0	11	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	1.275670e-03	8848	A	0	1.829890e-03	NM_002878.4(RAD51D):c.698A>G (p.Glu233Gly)	2	0	RA51D_HUMAN	0	1.0	0.408714271726761	220	D	0.71170	0.46690348	-	2.481030e-03	2	0.0174388	1541	1.818780e-03	0	33624	criteria_provided,_multiple_submitters,_no_conflicts	0.90920	8.209610e-03	297	1.435260e-03	0	59646	p.Glu233Gly	1	0.68269	.	germline	642	35103294	T	Mar 04, 2025	94	T/T	19	87382	1.0	N	17q12	201918	.	3.445640e-03	SCV000171275|SCV000172849|SCV000262197|SCV000292107|SCV000488546|SCV000604996|SCV000698112|SCV000806585|SCV000859932|SCV000889832|SCV002550915|SCV004044167|SCV005214637	Benign/Likely_benign	19	16	Gly	G	-	912	ENSP00000378090	ENST00000394589	17460	.	13294	19	0.609	T	0	4.817542	0.68204	N	T	-	4.417963	.	.	974	0	0.010934393638170975	0.00877	1	35103294	Y	10	0.0075	100816	7.145230e-03	O75771	0	0.290868	0.36495	T	7	0.785	.	87382	0.5062009	41754	0.85369	5892	-0.22489	24903	.	0.002044989775051125	2.112010e-02	0.36459	3.013230e-03	7	74922	0.000000e+00	6018	17	0.71203	17	RAD51D	3.123250e-03	0	Glu	238800	1.763520e-02	17-35103294-T-C	not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast	0	1672	30454426	ClinGen:CA293923|UniProtKB:O75771#VAR_020564	0.450689	0.61704	286	RCV000128967|RCV000203773|RCV000212967|RCV001354814|RCV000588832|RCV001723701	T	0	0	c.698A>G	0	1	106	0.17038	T/T	rs28363284	35103294	14468	T	0.00439297124600639	.	15266	0.64786	1.186070e-03	0.68239	17	0	18	2.231150e-05	1.85	0	3387	264690	4.92	0.66175	6380	T	.	44	7.369690e-03	6	1850	.	0	21	140162|145|145	138873	0.64785	0.41897	0.021744398197262	9802	22	0.71675	0.50327	7.197240e-03	1.763520e-02	1179112	2.999	9.781940e-03	.	13238	18	0.010967547	0	614291	0.49258	17	3.041190e-03	ENSG00000185379	1.661030e-03	0.016774136035420318	94	5.405405405405405E-4	.	2	0.86259	0.22602	29872	2903	1.658470e-02	7.997180e-03	0.40833569100615	.	3.702640e-03	.	142576	HGNC:9823	N	0	simple_aae	0.292	203334	35103294	GAG	1.000000	0	-	0.0038767598449296063	0.00266	2.112010e-02	38	3	Benign/Likely benign	0.74324	46	43	477	ClinGen:CA293923,UniProtKB:O75771#VAR_020564	E	0	0.911308683432	-	.	-	0.63954	2153	18644	0.64516	.	0.4981	0	0.97842595494901574	282	-	698A>G 	1672	0.011960952585282129	C3661900|C0027672|CN169374|C0677776|C3280345|C0006142	0	0	2	0	NM_002878.4	-	11	0.012968299711815562	0	0.70530	28363284	2226	0.015355946398659967	0.90975	0.61877	0.562	0.451	9444	0.89164200	4.92	.	.	3.146760e-03	-0.07823	0.0150280587944397	0.48914	T	4530	6048	9428	-0.5609	0.61193	p.Glu233Gly	1	0	-7.244	0.012577295	234	0.27128	138873	T	29852	RAD51D	8.293560e-03	T	0.189	21078	.	.	.	0.47831	T/T	principal1	960095	RAD51D_unpublished_var154342	Yes						overall function		Cell survival			E		698	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Glu233Gly		true	c.698A>G						9823.0	35103294.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, multiple submitters, no conflicts				Glu233Gly						G	Feb 01, 2024					missense_variant		233.0	A		0.0168232568355921	0.018394		Benign/Likely benign	35103294.0	missense_variant		0.189	functionally_normal				Cell viability			RAD51D_Glu233Gly
RAD51D_Glu233Gly	2.0151388056522266	0.08372864851161924	-22.26053493041938	9.334055407083976e-8	2025_01_Batch_13-14	0.6523177668682895	0.8737579764020821	0.9617439699350335	0.9066849961213046	0.7123528900241779	0.696707601081368	0.8967476179637639	0.9669006250473935	0.9315224387652209	0.6991962903503816	0.6745126839748288	0.8852527971829229	0.9643222974912136	0.9191037174432628	0.7057745901872797	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC001140		NC_000017.11:35103294:T:C		Glu233Gly																												RAD51D_Glu233Gly	17	35103294	T	C	17	allele	698A>G	A02	527_CAVA_Array_P05	A03	B13A7A8P2_R1	B14A7A8P2_R2				17-35103294-T-C	-	0.78468	0.973	233	1541	54	0	17	33430313	C	1.682330e-02	139	17	2_Benign	NC_000017.11	24903	Glu233Gly	0	26.9	0	38	1.658470e-02	T	286	20	5	41754	9.271140e-03	0	29798	8.984730e-04	12	0.46391	.	0.2448	100816	0.90580	242	0.0	T	T	63816	.	0.004023718763235917	0	1.697070e-03	18	18	.	16760	44820	335	0.000000e+00	0.66695	642	.	0.64786	0.998	0.0	99.0	0.918208	.	0.01	C	single nucleotide variant	NC_000017.11:g.35103294T>C	0	16462	2	0.5062009	106826	0	0.46690348	1.5673981191222572E-4	C	1989	232226	7	0	0.000000e+00	800	1.537580e-02	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	877	25	1.096490e-02	10	0.13669	P	0.71202	D	L	4.397588	27113	T/T	358	223	6852	1611638	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Malignant tumor of breast|not provided|Hereditary breast ovarian cancer syndrome	15672	0.66221	9	.	-	35103294	1.537580e-02	-	7.756000	54	0.56112	29510	0.012320328542094456	1179112	0	germline;unknown	90476	.	.	GRCh38	908	criteria provided, multiple submitters, no conflicts	c.698A>G	3.154570e-03	0.64102	3667	0	11	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	1.275670e-03	8848	A	0	1.829890e-03	NM_002878.4(RAD51D):c.698A>G (p.Glu233Gly)	2	0	RA51D_HUMAN	0	1.0	0.408714271726761	220	D	0.71170	0.46690348	-	2.481030e-03	2	0.0174388	1541	1.818780e-03	0	33624	criteria_provided,_multiple_submitters,_no_conflicts	0.90920	8.209610e-03	297	1.435260e-03	0	59646	p.Glu233Gly	1	0.68269	.	germline	642	35103294	T	Mar 04, 2025	94	T/T	19	87382	1.0	N	17q12	201918	.	3.445640e-03	SCV000171275|SCV000172849|SCV000262197|SCV000292107|SCV000488546|SCV000604996|SCV000698112|SCV000806585|SCV000859932|SCV000889832|SCV002550915|SCV004044167|SCV005214637	Benign/Likely_benign	19	16	Gly	G	-	912	ENSP00000378090	ENST00000394589	17460	.	13294	19	0.609	T	0	4.817542	0.68204	N	T	-	4.417963	.	.	974	0	0.010934393638170975	0.00877	1	35103294	Y	10	0.0075	100816	7.145230e-03	O75771	0	0.290868	0.36495	T	7	0.785	.	87382	0.5062009	41754	0.85369	5892	-0.22489	24903	.	0.002044989775051125	2.112010e-02	0.36459	3.013230e-03	7	74922	0.000000e+00	6018	17	0.71203	17	RAD51D	3.123250e-03	0	Glu	238800	1.763520e-02	17-35103294-T-C	not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast	0	1672	30454426	ClinGen:CA293923|UniProtKB:O75771#VAR_020564	0.450689	0.61704	286	RCV000128967|RCV000203773|RCV000212967|RCV001354814|RCV000588832|RCV001723701	T	0	0	c.698A>G	0	1	106	0.17038	T/T	rs28363284	35103294	14468	T	0.00439297124600639	.	15266	0.64786	1.186070e-03	0.68239	17	0	18	2.231150e-05	1.85	0	3387	264690	4.92	0.66175	6380	T	.	44	7.369690e-03	6	1850	.	0	21	140162|145|145	138873	0.64785	0.41897	0.021744398197262	9802	22	0.71675	0.50327	7.197240e-03	1.763520e-02	1179112	2.999	9.781940e-03	.	13238	18	0.010967547	0	614291	0.49258	17	3.041190e-03	ENSG00000185379	1.661030e-03	0.016774136035420318	94	5.405405405405405E-4	.	2	0.86259	0.22602	29872	2903	1.658470e-02	7.997180e-03	0.40833569100615	.	3.702640e-03	.	142576	HGNC:9823	N	0	simple_aae	0.292	203334	35103294	GAG	1.000000	0	-	0.0038767598449296063	0.00266	2.112010e-02	38	3	Benign/Likely benign	0.74324	46	43	477	ClinGen:CA293923,UniProtKB:O75771#VAR_020564	E	0	0.911308683432	-	.	-	0.63954	2153	18644	0.64516	.	0.4981	0	0.97842595494901574	282	-	698A>G 	1672	0.011960952585282129	C3661900|C0027672|CN169374|C0677776|C3280345|C0006142	0	0	2	0	NM_002878.4	-	11	0.012968299711815562	0	0.70530	28363284	2226	0.015355946398659967	0.90975	0.61877	0.562	0.451	9444	0.89164200	4.92	.	.	3.146760e-03	-0.07823	0.0150280587944397	0.48914	T	4530	6048	9428	-0.5609	0.61193	p.Glu233Gly	1	0	-7.244	0.012577295	234	0.27128	138873	T	29852	RAD51D	8.293560e-03	T	0.189	21078	.	.	.	0.47831	T/T	principal1	960095	RAD51D_unpublished_var154342	Yes						overall function		Cell survival			E		698	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Glu233Gly		true	c.698A>G						9823.0	35103294.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, multiple submitters, no conflicts				Glu233Gly						G	Feb 01, 2024					missense_variant		233.0	A		0.0168232568355921	0.018394		Benign/Likely benign	35103294.0	missense_variant		0.189	functionally_normal				Cell viability			RAD51D_Glu233Gly
BRCA1_Arg71Gly	-1.183279693007538	0.275321882540562	5.634491429600972	0.000787086326597669	2025_01_Batch_13-14	0.9304760710892357	0.940321856870626	0.8585648206893093	0.9119236688191354	0.8374062887316356	0.9855224726609189	0.9404281751104907	0.9263130774563206	0.9809606129506918	0.9391781050206498	0.9579992718750773	0.9403750159905584	0.892438949072815	0.9464421408849136	0.8882921968761427	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011856		NC_000017.11:43106457:T:C		Arg71Gly																												BRCA1_Arg71Gly	17	43106457	T	C	17	allele	211A>G	F09	527_CAVA_Array_P01	K17	B13A7A8P1_R1	B14A7A8P1_R2				17-43106457-T-C	-	0.88579	0.956	71	1	0	0	17	41258474	C	1.265690e-06	0	17	1_Pathogenic	NC_000017.11	2	Arg71Gly	0	29.6	0	0	9.782630e-06	D	0	33	.	42620	4.250000e-06	.	30050	0.000000e+00	0	0.95939	.	0.8394	102222	0.59057	0	.	T	D	63918	.	0	0	0.000000e+00	0	0	0.45883	16894	44596	0	0.000000e+00	0.92366	0	.	0.74199	0.994	.	.	.	5.61	.	C	single nucleotide variant	NC_000017.11:g.43106457T>C	0	16704	3	0.31909144	108704	0	0.7237265	0		1	235294	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN169374||MONDO:MONDO:0700268,MedGen:CN377757	0	0	0.000000e+00	0	0.99291	B	0.58556	P	M	5.78522	2	T/T	84	0	7112	1580162	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1;Familial cancer of breast|not specified|BRCA1-related disorder|BRCA1-related cancer predisposition	16078	0.94843	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106457	.	-	7.857000	0	0.96596	29370	0	1150962	0	germline;not applicable;somatic;unknown	89324	Gain of ubiquitination at K70 (P = 0.0519)| Loss of solvent accessibility (P = 0.0807)| Loss of phosphorylation at T69 (P = 0.1027)| Gain of relative solvent accessibility (P = 0.1684)| Loss of disorder (P = 0.1823)	0.92541	GRCh38	459	reviewed by expert panel	.	0.000000e+00	0.57348	0	0	0	.	0.000000e+00	9040	.	0	0.000000e+00	NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly)	3	0	BRCA1_HUMAN	0	.	0.586117233560111	0	.	0.89378	0.63329226	-	0.000000e+00	.		1	0.000000e+00	2	33946	reviewed_by_expert_panel	0.99387	0.000000e+00	0	0.000000e+00	0	59768	.	0	0.71293	.	germline/somatic	.		T	Jun 18, 2019	0	T/T	0	89038	1.0	N	17q21.31	6962	.	0.000000e+00	SCV001161539	Pathogenic	0	0	Gly	G	-	912	ENSP00000518978	ENST00000713676	17632	.	13382	0	0.588	T	0	5.274462	0.83643	D	.	-	5.618586	.	0.98437	610	0	.	0.51486	0	43106457	Y	10	0	102222	0.000000e+00	P38398	0	0.325403	0.96206		.	0.444	D	89038	0.32902288	.	0.71086	672	0.464929	2	.	.	1.737680e-06	0.91343	0.000000e+00	0	74308	0.000000e+00	5674	0	0.57647	17	BRCA1	0.000000e+00	0	Arg	11158	1.123120e-05	17-43106457-T-C	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|not_specified|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Fanconi_anemia,_complementation_group_S|not_provided|Hereditary_breast_ovarian_cancer_syndrome	0	1	38512000	ClinGen:CA001398|OMIM:113705.0034	0.840976	0.72160	0	RCV000047713|RCV000131899|RCV000195359|RCV000019263|RCV000469732|RCV000763009|RCV000508177|RCV004758595|RCV004802945	.	0	0	c.211A>G	0	0	0	0.93082	T/T	rs80357382	43106457	14770	T	.	E9PFC7	15456	0.79126	0.000000e+00	0.68239		0	0	0.000000e+00	2.455	0	0	.	4.64	0.69435	108	D	T	0	0.000000e+00	0	24	.	0	0	145|140162|227535|1333|145	17693	0.92996	0.24793	0.867488086223602	2720	.	0.71675	0.75732	0.000000e+00	1.123120e-05	1150962	4.16	4.841540e-06	.	13388	0	.	0	604370|114480|614320|617883	0.58035	17	0.000000e+00	ENSG00000012048	0.000000e+00	0	0	0	.	1	0.68273	0.78836	30132	.	9.782630e-06	0.000000e+00	0.5471513750929	.	0.000000e+00	0.80066	32732	HGNC:1100	.	0	.	0.931	206546	43106457	AGG	1.000000	.	-	0	0.92374	1.737680e-06	0	0	Pathogenic	0.93673	0	0	0	ClinGen:CA001398,OMIM:113705.0034	R	0	.	-	0.809	-	0.86054	1	518	0.57140	0.550648927689	.	0	0.99887384451911465	94	-	211A>G 	1	0	C2676676|C0027672|CN169374|C0346153|C3280442|C4554406|C3661900|C0677776	0	0	0	0	NM_007294.4	-	.	.	1	0.86835	80357382	2294	0	0.93459	0.71040	.	.	2636	0.99944407	4.64	.	.	0.000000e+00	0.430062	0.999229197308064	0.71058	D	84	6166	9522	0.8364	0.94619	p.Arg71Gly	0	0	-13.862	.	0	0.96001	17693	D	30222	BRCA1	0.000000e+00	D	.	21592	R71G	.	0.95042	0.31377	T/T	principal2																																																																																																				
F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Val374Phe	23	139561805	G	T	X											X-139561805-G-T	-	0.56637	0.999	374	.	.	.	X	138643964	T	.	.	X	1_Pathogenic	NC_000023.11	.	Val374Phe	.	23.7	.	0	.	D	.	2	1	.	.	.	.	.	0	0.95347	Select	0.8565	.	0.77914	.	.	D	D	.	1.87575306562	0	.	.	.	.	0.31739	.	.	.	.	0.78505	.	.	0.97069	0.868	.	5.0	0.940906	.	0.95	T	single nucleotide variant	NC_000023.11:g.139561805G>T	.	.	3	0.8545136	.	0	0.945814	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94956	D	0.92378	D	M	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.95415	.	.	-	139561805	.	-	9.997000	.	0.99524	.	0	.	.	germline	.	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.99464	GRCh38	924	criteria provided, single submitter	c.1120G>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	1	.	FA9_HUMAN	.	95.0	.	.	D	0.73177	0.9583567	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Val374Phe	.	0.83047	.	germline	.		G	Dec 18, 2018	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV001158653	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	3.888037	0.79703	.	D	-	.	.	0.98905	610	.	.	0.88921	0	139561805	Y	10	0	.	.	P00740	.	0.917974	0.58247		.	0.979	D	.	0.8643849	.	0.4131	2158	0.54769	.	-4.54	.	.	0.78662	.	.	.	.	.	.	0.91699	X	F9	.	0	Val	14528	.	X-139561805-G-T	not_specified|Hereditary_factor_IX_deficiency_disease	.	.	138471630	ClinGen:CA255427|OMIM:300746.0083	.	.	.	RCV000011385|RCV001001418	D	.	.	c.1120G>T	.	.	.	0.95627	G/G	rs137852271	139561805	.	G	.	P00740	.	0.95774	.	0.68239		.	.	.	3.12	0	0	.	4.8	0.98491	112	D	T	.	.	0	26	.	.	.	98879	10639	0.95562	0.92526	0.996272087097168	3324	.	0.71675	.	.	.	.	3.673	.	D	.	.	.	0	306900	0.54417	X	.	ENSG00000101981	.	0	.	0	0.9979477165049676	1	0.74458	0.18019	.	.	.	.	.	YES	.	0.857905	25678	HGNC:3551	A	.	simple_aae	0.986	.	139561805	GTT	1.000000	.	-	0	0.99592	.	0	.	Pathogenic	0.69263	.	.	.	ClinGen:CA255427,OMIM:300746.0083	V	.	0.999932037799	-	0.953	-	0.93850	.	548	0.99793	0.448793083429	0.5066	.	0.99288949315307296	98	-	1120G>T 	.	0	CN169374|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.77818	137852271	.	0	0.99993	.	0.782	0.002	3210	0.99998975	5.66	.	.	.	0.548942	0.999660067107543	0.87775	D	86	.	.	0.8819	0.95211	p.Val374Phe	0	.	-9.205	0.99082434	.	0.97392	10639	D	.	F9	.	D	0.850	.	V374F	D	.	0.76753	G/G	principal1	173261	F9_Popp_2025_carboxy_gla_motif_var257567	No											V		1120	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Val374Phe		true	c.1120G>T						3551.0	139561805.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Val374Phe						F	Dec 18, 2018					missense_variant		374.0				0.060282288		Pathogenic	139561805.0	missense_variant		0.85					Reporter			F9_Val374Phe
F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Val374Phe	23	139561805	G	T	X											X-139561805-G-T	-	0.56637	0.999	374	.	.	.	X	138643964	T	.	.	X	1_Pathogenic	NC_000023.11	.	Val374Phe	.	23.7	.	0	.	D	.	2	1	.	.	.	.	.	0	0.95347	Select	0.8565	.	0.77914	.	.	D	D	.	1.87575306562	0	.	.	.	.	0.31739	.	.	.	.	0.78505	.	.	0.97069	0.868	.	5.0	0.940906	.	0.95	T	single nucleotide variant	NC_000023.11:g.139561805G>T	.	.	3	0.8545136	.	0	0.945814	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94956	D	0.92378	D	M	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.95415	.	.	-	139561805	.	-	9.997000	.	0.99524	.	0	.	.	germline	.	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.99464	GRCh38	924	criteria provided, single submitter	c.1120G>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	1	.	FA9_HUMAN	.	95.0	.	.	D	0.73177	0.9583567	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Val374Phe	.	0.83047	.	germline	.		G	Dec 18, 2018	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV001158653	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	3.888037	0.79703	.	D	-	.	.	0.98905	610	.	.	0.88921	0	139561805	Y	10	0	.	.	P00740	.	0.917974	0.58247		.	0.979	D	.	0.8643849	.	0.4131	2158	0.54769	.	-4.54	.	.	0.78662	.	.	.	.	.	.	0.91699	X	F9	.	0	Val	14528	.	X-139561805-G-T	not_specified|Hereditary_factor_IX_deficiency_disease	.	.	138471630	ClinGen:CA255427|OMIM:300746.0083	.	.	.	RCV000011385|RCV001001418	D	.	.	c.1120G>T	.	.	.	0.95627	G/G	rs137852271	139561805	.	G	.	P00740	.	0.95774	.	0.68239		.	.	.	3.12	0	0	.	4.8	0.98491	112	D	T	.	.	0	26	.	.	.	98879	10639	0.95562	0.92526	0.996272087097168	3324	.	0.71675	.	.	.	.	3.673	.	D	.	.	.	0	306900	0.54417	X	.	ENSG00000101981	.	0	.	0	0.9979477165049676	1	0.74458	0.18019	.	.	.	.	.	YES	.	0.857905	25678	HGNC:3551	A	.	simple_aae	0.986	.	139561805	GTT	1.000000	.	-	0	0.99592	.	0	.	Pathogenic	0.69263	.	.	.	ClinGen:CA255427,OMIM:300746.0083	V	.	0.999932037799	-	0.953	-	0.93850	.	548	0.99793	0.448793083429	0.5066	.	0.99288949315307296	98	-	1120G>T 	.	0	CN169374|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.77818	137852271	.	0	0.99993	.	0.782	0.002	3210	0.99998975	5.66	.	.	.	0.548942	0.999660067107543	0.87775	D	86	.	.	0.8819	0.95211	p.Val374Phe	0	.	-9.205	0.99082434	.	0.97392	10639	D	.	F9	.	D	0.850	.	V374F	D	.	0.76753	G/G	principal1	145745	F9_Popp_2025_carboxy_F9_specific_var228524	No											V		1120	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Val374Phe		true	c.1120G>T						3551.0	139561805.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Val374Phe						F	Dec 18, 2018					missense_variant		374.0				0.087066694		Pathogenic	139561805.0	missense_variant		0.85					Reporter			F9_Val374Phe
F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Val374Phe	23	139561805	G	T	X											X-139561805-G-T	-	0.56637	0.999	374	.	.	.	X	138643964	T	.	.	X	1_Pathogenic	NC_000023.11	.	Val374Phe	.	23.7	.	0	.	D	.	2	1	.	.	.	.	.	0	0.95347	Select	0.8565	.	0.77914	.	.	D	D	.	1.87575306562	0	.	.	.	.	0.31739	.	.	.	.	0.78505	.	.	0.97069	0.868	.	5.0	0.940906	.	0.95	T	single nucleotide variant	NC_000023.11:g.139561805G>T	.	.	3	0.8545136	.	0	0.945814	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94956	D	0.92378	D	M	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.95415	.	.	-	139561805	.	-	9.997000	.	0.99524	.	0	.	.	germline	.	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.99464	GRCh38	924	criteria provided, single submitter	c.1120G>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	1	.	FA9_HUMAN	.	95.0	.	.	D	0.73177	0.9583567	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Val374Phe	.	0.83047	.	germline	.		G	Dec 18, 2018	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV001158653	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	3.888037	0.79703	.	D	-	.	.	0.98905	610	.	.	0.88921	0	139561805	Y	10	0	.	.	P00740	.	0.917974	0.58247		.	0.979	D	.	0.8643849	.	0.4131	2158	0.54769	.	-4.54	.	.	0.78662	.	.	.	.	.	.	0.91699	X	F9	.	0	Val	14528	.	X-139561805-G-T	not_specified|Hereditary_factor_IX_deficiency_disease	.	.	138471630	ClinGen:CA255427|OMIM:300746.0083	.	.	.	RCV000011385|RCV001001418	D	.	.	c.1120G>T	.	.	.	0.95627	G/G	rs137852271	139561805	.	G	.	P00740	.	0.95774	.	0.68239		.	.	.	3.12	0	0	.	4.8	0.98491	112	D	T	.	.	0	26	.	.	.	98879	10639	0.95562	0.92526	0.996272087097168	3324	.	0.71675	.	.	.	.	3.673	.	D	.	.	.	0	306900	0.54417	X	.	ENSG00000101981	.	0	.	0	0.9979477165049676	1	0.74458	0.18019	.	.	.	.	.	YES	.	0.857905	25678	HGNC:3551	A	.	simple_aae	0.986	.	139561805	GTT	1.000000	.	-	0	0.99592	.	0	.	Pathogenic	0.69263	.	.	.	ClinGen:CA255427,OMIM:300746.0083	V	.	0.999932037799	-	0.953	-	0.93850	.	548	0.99793	0.448793083429	0.5066	.	0.99288949315307296	98	-	1120G>T 	.	0	CN169374|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.77818	137852271	.	0	0.99993	.	0.782	0.002	3210	0.99998975	5.66	.	.	.	0.548942	0.999660067107543	0.87775	D	86	.	.	0.8819	0.95211	p.Val374Phe	0	.	-9.205	0.99082434	.	0.97392	10639	D	.	F9	.	D	0.850	.	V374F	D	.	0.76753	G/G	principal1	228293	F9_Popp_2025_light_chain_var247886	No											V		1120	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Val374Phe		true	c.1120G>T						3551.0	139561805.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Val374Phe						F	Dec 18, 2018					missense_variant		374.0				0.0940726		Pathogenic	139561805.0	missense_variant		0.85					Reporter			F9_Val374Phe
F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Val374Phe	23	139561805	G	T	X											X-139561805-G-T	-	0.56637	0.999	374	.	.	.	X	138643964	T	.	.	X	1_Pathogenic	NC_000023.11	.	Val374Phe	.	23.7	.	0	.	D	.	2	1	.	.	.	.	.	0	0.95347	Select	0.8565	.	0.77914	.	.	D	D	.	1.87575306562	0	.	.	.	.	0.31739	.	.	.	.	0.78505	.	.	0.97069	0.868	.	5.0	0.940906	.	0.95	T	single nucleotide variant	NC_000023.11:g.139561805G>T	.	.	3	0.8545136	.	0	0.945814	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94956	D	0.92378	D	M	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.95415	.	.	-	139561805	.	-	9.997000	.	0.99524	.	0	.	.	germline	.	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.99464	GRCh38	924	criteria provided, single submitter	c.1120G>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	1	.	FA9_HUMAN	.	95.0	.	.	D	0.73177	0.9583567	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Val374Phe	.	0.83047	.	germline	.		G	Dec 18, 2018	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV001158653	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	3.888037	0.79703	.	D	-	.	.	0.98905	610	.	.	0.88921	0	139561805	Y	10	0	.	.	P00740	.	0.917974	0.58247		.	0.979	D	.	0.8643849	.	0.4131	2158	0.54769	.	-4.54	.	.	0.78662	.	.	.	.	.	.	0.91699	X	F9	.	0	Val	14528	.	X-139561805-G-T	not_specified|Hereditary_factor_IX_deficiency_disease	.	.	138471630	ClinGen:CA255427|OMIM:300746.0083	.	.	.	RCV000011385|RCV001001418	D	.	.	c.1120G>T	.	.	.	0.95627	G/G	rs137852271	139561805	.	G	.	P00740	.	0.95774	.	0.68239		.	.	.	3.12	0	0	.	4.8	0.98491	112	D	T	.	.	0	26	.	.	.	98879	10639	0.95562	0.92526	0.996272087097168	3324	.	0.71675	.	.	.	.	3.673	.	D	.	.	.	0	306900	0.54417	X	.	ENSG00000101981	.	0	.	0	0.9979477165049676	1	0.74458	0.18019	.	.	.	.	.	YES	.	0.857905	25678	HGNC:3551	A	.	simple_aae	0.986	.	139561805	GTT	1.000000	.	-	0	0.99592	.	0	.	Pathogenic	0.69263	.	.	.	ClinGen:CA255427,OMIM:300746.0083	V	.	0.999932037799	-	0.953	-	0.93850	.	548	0.99793	0.448793083429	0.5066	.	0.99288949315307296	98	-	1120G>T 	.	0	CN169374|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.77818	137852271	.	0	0.99993	.	0.782	0.002	3210	0.99998975	5.66	.	.	.	0.548942	0.999660067107543	0.87775	D	86	.	.	0.8819	0.95211	p.Val374Phe	0	.	-9.205	0.99082434	.	0.97392	10639	D	.	F9	.	D	0.850	.	V374F	D	.	0.76753	G/G	principal1	200777	F9_Popp_2025_heavy_chain_var238205	No											V		1120	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Val374Phe		true	c.1120G>T						3551.0	139561805.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Val374Phe						F	Dec 18, 2018					missense_variant		374.0				0.096591788		Pathogenic	139561805.0	missense_variant		0.85					Reporter			F9_Val374Phe
F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	NC_000023.11:139561805:G:T	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Val374Phe	23	139561805	G	T	X											X-139561805-G-T	-	0.56637	0.999	374	.	.	.	X	138643964	T	.	.	X	1_Pathogenic	NC_000023.11	.	Val374Phe	.	23.7	.	0	.	D	.	2	1	.	.	.	.	.	0	0.95347	Select	0.8565	.	0.77914	.	.	D	D	.	1.87575306562	0	.	.	.	.	0.31739	.	.	.	.	0.78505	.	.	0.97069	0.868	.	5.0	0.940906	.	0.95	T	single nucleotide variant	NC_000023.11:g.139561805G>T	.	.	3	0.8545136	.	0	0.945814	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94956	D	0.92378	D	M	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.95415	.	.	-	139561805	.	-	9.997000	.	0.99524	.	0	.	.	germline	.	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.99464	GRCh38	924	criteria provided, single submitter	c.1120G>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	1	.	FA9_HUMAN	.	95.0	.	.	D	0.73177	0.9583567	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Val374Phe	.	0.83047	.	germline	.		G	Dec 18, 2018	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV001158653	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	3.888037	0.79703	.	D	-	.	.	0.98905	610	.	.	0.88921	0	139561805	Y	10	0	.	.	P00740	.	0.917974	0.58247		.	0.979	D	.	0.8643849	.	0.4131	2158	0.54769	.	-4.54	.	.	0.78662	.	.	.	.	.	.	0.91699	X	F9	.	0	Val	14528	.	X-139561805-G-T	not_specified|Hereditary_factor_IX_deficiency_disease	.	.	138471630	ClinGen:CA255427|OMIM:300746.0083	.	.	.	RCV000011385|RCV001001418	D	.	.	c.1120G>T	.	.	.	0.95627	G/G	rs137852271	139561805	.	G	.	P00740	.	0.95774	.	0.68239		.	.	.	3.12	0	0	.	4.8	0.98491	112	D	T	.	.	0	26	.	.	.	98879	10639	0.95562	0.92526	0.996272087097168	3324	.	0.71675	.	.	.	.	3.673	.	D	.	.	.	0	306900	0.54417	X	.	ENSG00000101981	.	0	.	0	0.9979477165049676	1	0.74458	0.18019	.	.	.	.	.	YES	.	0.857905	25678	HGNC:3551	A	.	simple_aae	0.986	.	139561805	GTT	1.000000	.	-	0	0.99592	.	0	.	Pathogenic	0.69263	.	.	.	ClinGen:CA255427,OMIM:300746.0083	V	.	0.999932037799	-	0.953	-	0.93850	.	548	0.99793	0.448793083429	0.5066	.	0.99288949315307296	98	-	1120G>T 	.	0	CN169374|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.77818	137852271	.	0	0.99993	.	0.782	0.002	3210	0.99998975	5.66	.	.	.	0.548942	0.999660067107543	0.87775	D	86	.	.	0.8819	0.95211	p.Val374Phe	0	.	-9.205	0.99082434	.	0.97392	10639	D	.	F9	.	D	0.850	.	V374F	D	.	0.76753	G/G	principal1	255809	F9_Popp_2025_strep_2_var267248	No											V		1120	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Val374Phe		true	c.1120G>T						3551.0	139561805.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Val374Phe						F	Dec 18, 2018					missense_variant		374.0				0.3805148886610444		Pathogenic	139561805.0	missense_variant		0.85					Reporter			F9_Val374Phe
F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004387		NC_000023.11:139561805:G:T		Val374Phe																												F9_Val374Phe	23	139561805	G	T	X	allele	1120G>T	H03	527_CAVA_Array_P02	O06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561805-G-T	-	0.56637	0.999	374	.	.	.	X	138643964	T	.	.	X	1_Pathogenic	NC_000023.11	.	Val374Phe	.	23.7	.	0	.	D	.	2	1	.	.	.	.	.	0	0.95347	Select	0.8565	.	0.77914	.	.	D	D	.	1.87575306562	0	.	.	.	.	0.31739	.	.	.	.	0.78505	.	.	0.97069	0.868	.	5.0	0.940906	.	0.95	T	single nucleotide variant	NC_000023.11:g.139561805G>T	.	.	3	0.8545136	.	0	0.945814	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94956	D	0.92378	D	M	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.95415	.	.	-	139561805	.	-	9.997000	.	0.99524	.	0	.	.	germline	.	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.99464	GRCh38	924	criteria provided, single submitter	c.1120G>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	1	.	FA9_HUMAN	.	95.0	.	.	D	0.73177	0.9583567	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Val374Phe	.	0.83047	.	germline	.		G	Dec 18, 2018	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV001158653	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	3.888037	0.79703	.	D	-	.	.	0.98905	610	.	.	0.88921	0	139561805	Y	10	0	.	.	P00740	.	0.917974	0.58247		.	0.979	D	.	0.8643849	.	0.4131	2158	0.54769	.	-4.54	.	.	0.78662	.	.	.	.	.	.	0.91699	X	F9	.	0	Val	14528	.	X-139561805-G-T	not_specified|Hereditary_factor_IX_deficiency_disease	.	.	138471630	ClinGen:CA255427|OMIM:300746.0083	.	.	.	RCV000011385|RCV001001418	D	.	.	c.1120G>T	.	.	.	0.95627	G/G	rs137852271	139561805	.	G	.	P00740	.	0.95774	.	0.68239		.	.	.	3.12	0	0	.	4.8	0.98491	112	D	T	.	.	0	26	.	.	.	98879	10639	0.95562	0.92526	0.996272087097168	3324	.	0.71675	.	.	.	.	3.673	.	D	.	.	.	0	306900	0.54417	X	.	ENSG00000101981	.	0	.	0	0.9979477165049676	1	0.74458	0.18019	.	.	.	.	.	YES	.	0.857905	25678	HGNC:3551	A	.	simple_aae	0.986	.	139561805	GTT	1.000000	.	-	0	0.99592	.	0	.	Pathogenic	0.69263	.	.	.	ClinGen:CA255427,OMIM:300746.0083	V	.	0.999932037799	-	0.953	-	0.93850	.	548	0.99793	0.448793083429	0.5066	.	0.99288949315307296	98	-	1120G>T 	.	0	CN169374|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.77818	137852271	.	0	0.99993	.	0.782	0.002	3210	0.99998975	5.66	.	.	.	0.548942	0.999660067107543	0.87775	D	86	.	.	0.8819	0.95211	p.Val374Phe	0	.	-9.205	0.99082434	.	0.97392	10639	D	.	F9	.	D	0.850	.	V374F	D	.	0.76753	G/G	principal1	173261	F9_Popp_2025_carboxy_gla_motif_var257567	No											V		1120	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Val374Phe		true	c.1120G>T						3551.0	139561805.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Val374Phe						F	Dec 18, 2018					missense_variant		374.0				0.060282288		Pathogenic	139561805.0	missense_variant		0.85					Reporter			F9_Val374Phe
F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004387		NC_000023.11:139561805:G:T		Val374Phe																												F9_Val374Phe	23	139561805	G	T	X	allele	1120G>T	H03	527_CAVA_Array_P02	O06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561805-G-T	-	0.56637	0.999	374	.	.	.	X	138643964	T	.	.	X	1_Pathogenic	NC_000023.11	.	Val374Phe	.	23.7	.	0	.	D	.	2	1	.	.	.	.	.	0	0.95347	Select	0.8565	.	0.77914	.	.	D	D	.	1.87575306562	0	.	.	.	.	0.31739	.	.	.	.	0.78505	.	.	0.97069	0.868	.	5.0	0.940906	.	0.95	T	single nucleotide variant	NC_000023.11:g.139561805G>T	.	.	3	0.8545136	.	0	0.945814	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94956	D	0.92378	D	M	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.95415	.	.	-	139561805	.	-	9.997000	.	0.99524	.	0	.	.	germline	.	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.99464	GRCh38	924	criteria provided, single submitter	c.1120G>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	1	.	FA9_HUMAN	.	95.0	.	.	D	0.73177	0.9583567	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Val374Phe	.	0.83047	.	germline	.		G	Dec 18, 2018	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV001158653	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	3.888037	0.79703	.	D	-	.	.	0.98905	610	.	.	0.88921	0	139561805	Y	10	0	.	.	P00740	.	0.917974	0.58247		.	0.979	D	.	0.8643849	.	0.4131	2158	0.54769	.	-4.54	.	.	0.78662	.	.	.	.	.	.	0.91699	X	F9	.	0	Val	14528	.	X-139561805-G-T	not_specified|Hereditary_factor_IX_deficiency_disease	.	.	138471630	ClinGen:CA255427|OMIM:300746.0083	.	.	.	RCV000011385|RCV001001418	D	.	.	c.1120G>T	.	.	.	0.95627	G/G	rs137852271	139561805	.	G	.	P00740	.	0.95774	.	0.68239		.	.	.	3.12	0	0	.	4.8	0.98491	112	D	T	.	.	0	26	.	.	.	98879	10639	0.95562	0.92526	0.996272087097168	3324	.	0.71675	.	.	.	.	3.673	.	D	.	.	.	0	306900	0.54417	X	.	ENSG00000101981	.	0	.	0	0.9979477165049676	1	0.74458	0.18019	.	.	.	.	.	YES	.	0.857905	25678	HGNC:3551	A	.	simple_aae	0.986	.	139561805	GTT	1.000000	.	-	0	0.99592	.	0	.	Pathogenic	0.69263	.	.	.	ClinGen:CA255427,OMIM:300746.0083	V	.	0.999932037799	-	0.953	-	0.93850	.	548	0.99793	0.448793083429	0.5066	.	0.99288949315307296	98	-	1120G>T 	.	0	CN169374|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.77818	137852271	.	0	0.99993	.	0.782	0.002	3210	0.99998975	5.66	.	.	.	0.548942	0.999660067107543	0.87775	D	86	.	.	0.8819	0.95211	p.Val374Phe	0	.	-9.205	0.99082434	.	0.97392	10639	D	.	F9	.	D	0.850	.	V374F	D	.	0.76753	G/G	principal1	145745	F9_Popp_2025_carboxy_F9_specific_var228524	No											V		1120	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Val374Phe		true	c.1120G>T						3551.0	139561805.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Val374Phe						F	Dec 18, 2018					missense_variant		374.0				0.087066694		Pathogenic	139561805.0	missense_variant		0.85					Reporter			F9_Val374Phe
F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004387		NC_000023.11:139561805:G:T		Val374Phe																												F9_Val374Phe	23	139561805	G	T	X	allele	1120G>T	H03	527_CAVA_Array_P02	O06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561805-G-T	-	0.56637	0.999	374	.	.	.	X	138643964	T	.	.	X	1_Pathogenic	NC_000023.11	.	Val374Phe	.	23.7	.	0	.	D	.	2	1	.	.	.	.	.	0	0.95347	Select	0.8565	.	0.77914	.	.	D	D	.	1.87575306562	0	.	.	.	.	0.31739	.	.	.	.	0.78505	.	.	0.97069	0.868	.	5.0	0.940906	.	0.95	T	single nucleotide variant	NC_000023.11:g.139561805G>T	.	.	3	0.8545136	.	0	0.945814	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94956	D	0.92378	D	M	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.95415	.	.	-	139561805	.	-	9.997000	.	0.99524	.	0	.	.	germline	.	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.99464	GRCh38	924	criteria provided, single submitter	c.1120G>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	1	.	FA9_HUMAN	.	95.0	.	.	D	0.73177	0.9583567	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Val374Phe	.	0.83047	.	germline	.		G	Dec 18, 2018	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV001158653	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	3.888037	0.79703	.	D	-	.	.	0.98905	610	.	.	0.88921	0	139561805	Y	10	0	.	.	P00740	.	0.917974	0.58247		.	0.979	D	.	0.8643849	.	0.4131	2158	0.54769	.	-4.54	.	.	0.78662	.	.	.	.	.	.	0.91699	X	F9	.	0	Val	14528	.	X-139561805-G-T	not_specified|Hereditary_factor_IX_deficiency_disease	.	.	138471630	ClinGen:CA255427|OMIM:300746.0083	.	.	.	RCV000011385|RCV001001418	D	.	.	c.1120G>T	.	.	.	0.95627	G/G	rs137852271	139561805	.	G	.	P00740	.	0.95774	.	0.68239		.	.	.	3.12	0	0	.	4.8	0.98491	112	D	T	.	.	0	26	.	.	.	98879	10639	0.95562	0.92526	0.996272087097168	3324	.	0.71675	.	.	.	.	3.673	.	D	.	.	.	0	306900	0.54417	X	.	ENSG00000101981	.	0	.	0	0.9979477165049676	1	0.74458	0.18019	.	.	.	.	.	YES	.	0.857905	25678	HGNC:3551	A	.	simple_aae	0.986	.	139561805	GTT	1.000000	.	-	0	0.99592	.	0	.	Pathogenic	0.69263	.	.	.	ClinGen:CA255427,OMIM:300746.0083	V	.	0.999932037799	-	0.953	-	0.93850	.	548	0.99793	0.448793083429	0.5066	.	0.99288949315307296	98	-	1120G>T 	.	0	CN169374|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.77818	137852271	.	0	0.99993	.	0.782	0.002	3210	0.99998975	5.66	.	.	.	0.548942	0.999660067107543	0.87775	D	86	.	.	0.8819	0.95211	p.Val374Phe	0	.	-9.205	0.99082434	.	0.97392	10639	D	.	F9	.	D	0.850	.	V374F	D	.	0.76753	G/G	principal1	228293	F9_Popp_2025_light_chain_var247886	No											V		1120	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Val374Phe		true	c.1120G>T						3551.0	139561805.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Val374Phe						F	Dec 18, 2018					missense_variant		374.0				0.0940726		Pathogenic	139561805.0	missense_variant		0.85					Reporter			F9_Val374Phe
F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004387		NC_000023.11:139561805:G:T		Val374Phe																												F9_Val374Phe	23	139561805	G	T	X	allele	1120G>T	H03	527_CAVA_Array_P02	O06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561805-G-T	-	0.56637	0.999	374	.	.	.	X	138643964	T	.	.	X	1_Pathogenic	NC_000023.11	.	Val374Phe	.	23.7	.	0	.	D	.	2	1	.	.	.	.	.	0	0.95347	Select	0.8565	.	0.77914	.	.	D	D	.	1.87575306562	0	.	.	.	.	0.31739	.	.	.	.	0.78505	.	.	0.97069	0.868	.	5.0	0.940906	.	0.95	T	single nucleotide variant	NC_000023.11:g.139561805G>T	.	.	3	0.8545136	.	0	0.945814	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94956	D	0.92378	D	M	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.95415	.	.	-	139561805	.	-	9.997000	.	0.99524	.	0	.	.	germline	.	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.99464	GRCh38	924	criteria provided, single submitter	c.1120G>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	1	.	FA9_HUMAN	.	95.0	.	.	D	0.73177	0.9583567	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Val374Phe	.	0.83047	.	germline	.		G	Dec 18, 2018	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV001158653	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	3.888037	0.79703	.	D	-	.	.	0.98905	610	.	.	0.88921	0	139561805	Y	10	0	.	.	P00740	.	0.917974	0.58247		.	0.979	D	.	0.8643849	.	0.4131	2158	0.54769	.	-4.54	.	.	0.78662	.	.	.	.	.	.	0.91699	X	F9	.	0	Val	14528	.	X-139561805-G-T	not_specified|Hereditary_factor_IX_deficiency_disease	.	.	138471630	ClinGen:CA255427|OMIM:300746.0083	.	.	.	RCV000011385|RCV001001418	D	.	.	c.1120G>T	.	.	.	0.95627	G/G	rs137852271	139561805	.	G	.	P00740	.	0.95774	.	0.68239		.	.	.	3.12	0	0	.	4.8	0.98491	112	D	T	.	.	0	26	.	.	.	98879	10639	0.95562	0.92526	0.996272087097168	3324	.	0.71675	.	.	.	.	3.673	.	D	.	.	.	0	306900	0.54417	X	.	ENSG00000101981	.	0	.	0	0.9979477165049676	1	0.74458	0.18019	.	.	.	.	.	YES	.	0.857905	25678	HGNC:3551	A	.	simple_aae	0.986	.	139561805	GTT	1.000000	.	-	0	0.99592	.	0	.	Pathogenic	0.69263	.	.	.	ClinGen:CA255427,OMIM:300746.0083	V	.	0.999932037799	-	0.953	-	0.93850	.	548	0.99793	0.448793083429	0.5066	.	0.99288949315307296	98	-	1120G>T 	.	0	CN169374|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.77818	137852271	.	0	0.99993	.	0.782	0.002	3210	0.99998975	5.66	.	.	.	0.548942	0.999660067107543	0.87775	D	86	.	.	0.8819	0.95211	p.Val374Phe	0	.	-9.205	0.99082434	.	0.97392	10639	D	.	F9	.	D	0.850	.	V374F	D	.	0.76753	G/G	principal1	200777	F9_Popp_2025_heavy_chain_var238205	No											V		1120	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Val374Phe		true	c.1120G>T						3551.0	139561805.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Val374Phe						F	Dec 18, 2018					missense_variant		374.0				0.096591788		Pathogenic	139561805.0	missense_variant		0.85					Reporter			F9_Val374Phe
F9_Val374Phe	-5.504701111376828	0.0009020360212474599	1.574146257461855	0.15945387119897717	2025_01_Batch_13-14	0.6673805631651736	0.7320721929340855	0.8295208387386563	0.802352315962314	0.758954517487859	0.6166641471095112	0.7913960425636573	0.9219765812162496	0.8886092544634232	0.703312346421058	0.6420223551373424	0.7617341177488715	0.875748709977453	0.8454807852128686	0.7311334319544585	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004387		NC_000023.11:139561805:G:T		Val374Phe																												F9_Val374Phe	23	139561805	G	T	X	allele	1120G>T	H03	527_CAVA_Array_P02	O06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561805-G-T	-	0.56637	0.999	374	.	.	.	X	138643964	T	.	.	X	1_Pathogenic	NC_000023.11	.	Val374Phe	.	23.7	.	0	.	D	.	2	1	.	.	.	.	.	0	0.95347	Select	0.8565	.	0.77914	.	.	D	D	.	1.87575306562	0	.	.	.	.	0.31739	.	.	.	.	0.78505	.	.	0.97069	0.868	.	5.0	0.940906	.	0.95	T	single nucleotide variant	NC_000023.11:g.139561805G>T	.	.	3	0.8545136	.	0	0.945814	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94956	D	0.92378	D	M	.	.	G/G	114	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.95415	.	.	-	139561805	.	-	9.997000	.	0.99524	.	0	.	.	germline	.	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.99464	GRCh38	924	criteria provided, single submitter	c.1120G>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	A	0	.	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	1	.	FA9_HUMAN	.	95.0	.	.	D	0.73177	0.9583567	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Val374Phe	.	0.83047	.	germline	.		G	Dec 18, 2018	.	G/G	.	.	1.0	N	Xq27.1	9690	.	.	SCV001158653	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	3.888037	0.79703	.	D	-	.	.	0.98905	610	.	.	0.88921	0	139561805	Y	10	0	.	.	P00740	.	0.917974	0.58247		.	0.979	D	.	0.8643849	.	0.4131	2158	0.54769	.	-4.54	.	.	0.78662	.	.	.	.	.	.	0.91699	X	F9	.	0	Val	14528	.	X-139561805-G-T	not_specified|Hereditary_factor_IX_deficiency_disease	.	.	138471630	ClinGen:CA255427|OMIM:300746.0083	.	.	.	RCV000011385|RCV001001418	D	.	.	c.1120G>T	.	.	.	0.95627	G/G	rs137852271	139561805	.	G	.	P00740	.	0.95774	.	0.68239		.	.	.	3.12	0	0	.	4.8	0.98491	112	D	T	.	.	0	26	.	.	.	98879	10639	0.95562	0.92526	0.996272087097168	3324	.	0.71675	.	.	.	.	3.673	.	D	.	.	.	0	306900	0.54417	X	.	ENSG00000101981	.	0	.	0	0.9979477165049676	1	0.74458	0.18019	.	.	.	.	.	YES	.	0.857905	25678	HGNC:3551	A	.	simple_aae	0.986	.	139561805	GTT	1.000000	.	-	0	0.99592	.	0	.	Pathogenic	0.69263	.	.	.	ClinGen:CA255427,OMIM:300746.0083	V	.	0.999932037799	-	0.953	-	0.93850	.	548	0.99793	0.448793083429	0.5066	.	0.99288949315307296	98	-	1120G>T 	.	0	CN169374|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.77818	137852271	.	0	0.99993	.	0.782	0.002	3210	0.99998975	5.66	.	.	.	0.548942	0.999660067107543	0.87775	D	86	.	.	0.8819	0.95211	p.Val374Phe	0	.	-9.205	0.99082434	.	0.97392	10639	D	.	F9	.	D	0.850	.	V374F	D	.	0.76753	G/G	principal1	255809	F9_Popp_2025_strep_2_var267248	No											V		1120	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Val374Phe		true	c.1120G>T						3551.0	139561805.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Val374Phe						F	Dec 18, 2018					missense_variant		374.0				0.3805148886610444		Pathogenic	139561805.0	missense_variant		0.85					Reporter			F9_Val374Phe
BRAF_Glu501Val	0.06923700484882474	0.9467373185822208	0.8012197285196747	0.4493411824264216	2025_01_Batch_13-14	0.668419559676502	0.5162034704749344	0.6813451882258486	0.6066647733033534	0.6591434827390193	0.42454478615755165	0.5487894135502444	0.6491343945467217	0.5577070481243924	0.4399151595971117	0.5464821729170268	0.5324964420125894	0.6652397913862851	0.5821859107138729	0.5495293211680655	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220607	CCSBVarC003169	ALE00003169	NC_000007.14:140778006:T:A	1502A>T	Glu501Val	CEGS2	CegsMutGDEh1028	A12	GDEhDisVCh_40058	G10	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Glu501Val	7	140778006	T	A	7											7-140778006-T-A	-	0.94033	1.0	501	.	.	.	7	140477806	A	.	.	7	1_Pathogenic	NC_000007.14	.	Glu501Val	.	33.0	.	.	.	D	.	5	.	.	.	.	.	.	.	0.99995	Select	0.6087	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.97002	.	.	.	.	.	.	.	0.97241	0.999	.	.	0.984901	.	.	A	single nucleotide variant	NC_000007.14:g.140778006T>A	.	.	2	0.9024512	.	.	0.970521	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	.	.	.	.	0.97016	D	0.94611	D	M	5.957777	.	T/T	.	.	.	.	Cardio-facio-cutaneous syndrome|RASopathy|not provided|Cardiofaciocutaneous syndrome 1	.	0.90439	.	.	-	140778006	.	-	7.857000	.	0.99985	.	.	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.016)| Gain of methylation at K499 (P = 0.0368)| Gain of catalytic residue at Q496 (P = 0.0688)| Loss of disorder (P = 0.1462)| Loss of ubiquitination at K499 (P = 0.255)	0.99843	GRCh38	776	criteria provided, multiple submitters, no conflicts	c.1502A>T	.	0.65108	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1502A>T (p.Glu501Val)	2	.	BRAF_HUMAN	.	.	0.603356423307565	.	D	0.99795	0.9600396	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99310	.	.	.	.	.	p.Glu501Val	.	0.71293	.	germline	.		T	May 18, 2022	.	T/T	.	.	1.0	N	7q34	.	.	.	SCV000057223|SCV000061588|SCV002011970|SCV002233097	Pathogenic/Likely_pathogenic	.	.	Val	V	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.605	T	.	5.908522	.	D	.	-	6.077588	.	0.96172	.	.	.	0.96125	.	140778006	Y	10	.	.	.	P15056	.	0.959346	0.51225		.	1.0	D	.	0.8958858	.	0.91597	673	0.583525	.	.	.	.	.	.	.	.	.	.	.	0.95083	7	BRAF	.	.	Glu	.	.	7-140778006-T-A	Cardio-facio-cutaneous_syndrome|not_provided|RASopathy|Cardiofaciocutaneous_syndrome_1	.	.	140124275	ClinGen:CA280013	0.901308	0.73242	.	RCV000037924|RCV001852671|RCV000033318|RCV001775071	D	.	.	c.1502A>T	.	.	.	0.97036	T/T	rs180177039	140778006	.	T	.	P15056	.	0.98280	.	0.68239		.	.	.	3.175	.	.	.	4.96	0.99462	.	D	D	.	.	.	.	.	.	.	1340|536391|1340	40374	0.96988	0.96099	0.999093770980835	.	.	0.71675	0.84728	.	.	.	7.981	.	.	.	.	.	.	PS115150|115150	0.87756	7	.	ENSG00000157764	.	.	.	.	.	2	0.97365	0.48248	.	.	.	.	0.588108124975153	YES	.	0.575626	48844	HGNC:1097	.	.	.	1	.	140778006	GAA	1.000000	.	-	.	0.99356	.	.	.	Pathogenic/Likely pathogenic	0.92345	.	.	.	ClinGen:CA280013	E	.	.	-	0.984	-	.	.	.	0.97864	0.905288159847	0.9998	.	0.99046473600024798	.	-	1502A>T 	.	.	C1275081|C3661900|C5555857|CN029449	.	.	.	.	NM_004333.6	-	.	.	1	0.94804	180177039	.	.	0.99555	0.73943	.	.	.	0.99934202	4.96	.	.	.	0.600417	0.999948727464199	0.88626	D	.	.	.	0.4949	0.86082	p.Glu501Val	.	.	-13.783	0.9891212	.	0.99079	40374	D	.	BRAF	.	D	.	.	E501V	.	.	0.46302	T/T	principal4																																																																																																				
BRAF_Glu501Val	0.06923700484882474	0.9467373185822208	0.8012197285196747	0.4493411824264216	2025_01_Batch_13-14	0.668419559676502	0.5162034704749344	0.6813451882258486	0.6066647733033534	0.6591434827390193	0.42454478615755165	0.5487894135502444	0.6491343945467217	0.5577070481243924	0.4399151595971117	0.5464821729170268	0.5324964420125894	0.6652397913862851	0.5821859107138729	0.5495293211680655	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003169		NC_000007.14:140778006:T:A		Glu501Val																												BRAF_Glu501Val	7	140778006	T	A	7	allele	1502A>T	G04	527_CAVA_Array_P01	M07	B13A7A8P1_R1	B14A7A8P1_R2				7-140778006-T-A	-	0.94033	1.0	501	.	.	.	7	140477806	A	.	.	7	1_Pathogenic	NC_000007.14	.	Glu501Val	.	33.0	.	.	.	D	.	5	.	.	.	.	.	.	.	0.99995	Select	0.6087	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.97002	.	.	.	.	.	.	.	0.97241	0.999	.	.	0.984901	.	.	A	single nucleotide variant	NC_000007.14:g.140778006T>A	.	.	2	0.9024512	.	.	0.970521	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	.	.	.	.	0.97016	D	0.94611	D	M	5.957777	.	T/T	.	.	.	.	Cardio-facio-cutaneous syndrome|RASopathy|not provided|Cardiofaciocutaneous syndrome 1	.	0.90439	.	.	-	140778006	.	-	7.857000	.	0.99985	.	.	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.016)| Gain of methylation at K499 (P = 0.0368)| Gain of catalytic residue at Q496 (P = 0.0688)| Loss of disorder (P = 0.1462)| Loss of ubiquitination at K499 (P = 0.255)	0.99843	GRCh38	776	criteria provided, multiple submitters, no conflicts	c.1502A>T	.	0.65108	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1502A>T (p.Glu501Val)	2	.	BRAF_HUMAN	.	.	0.603356423307565	.	D	0.99795	0.9600396	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99310	.	.	.	.	.	p.Glu501Val	.	0.71293	.	germline	.		T	May 18, 2022	.	T/T	.	.	1.0	N	7q34	.	.	.	SCV000057223|SCV000061588|SCV002011970|SCV002233097	Pathogenic/Likely_pathogenic	.	.	Val	V	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.605	T	.	5.908522	.	D	.	-	6.077588	.	0.96172	.	.	.	0.96125	.	140778006	Y	10	.	.	.	P15056	.	0.959346	0.51225		.	1.0	D	.	0.8958858	.	0.91597	673	0.583525	.	.	.	.	.	.	.	.	.	.	.	0.95083	7	BRAF	.	.	Glu	.	.	7-140778006-T-A	Cardio-facio-cutaneous_syndrome|not_provided|RASopathy|Cardiofaciocutaneous_syndrome_1	.	.	140124275	ClinGen:CA280013	0.901308	0.73242	.	RCV000037924|RCV001852671|RCV000033318|RCV001775071	D	.	.	c.1502A>T	.	.	.	0.97036	T/T	rs180177039	140778006	.	T	.	P15056	.	0.98280	.	0.68239		.	.	.	3.175	.	.	.	4.96	0.99462	.	D	D	.	.	.	.	.	.	.	1340|536391|1340	40374	0.96988	0.96099	0.999093770980835	.	.	0.71675	0.84728	.	.	.	7.981	.	.	.	.	.	.	PS115150|115150	0.87756	7	.	ENSG00000157764	.	.	.	.	.	2	0.97365	0.48248	.	.	.	.	0.588108124975153	YES	.	0.575626	48844	HGNC:1097	.	.	.	1	.	140778006	GAA	1.000000	.	-	.	0.99356	.	.	.	Pathogenic/Likely pathogenic	0.92345	.	.	.	ClinGen:CA280013	E	.	.	-	0.984	-	.	.	.	0.97864	0.905288159847	0.9998	.	0.99046473600024798	.	-	1502A>T 	.	.	C1275081|C3661900|C5555857|CN029449	.	.	.	.	NM_004333.6	-	.	.	1	0.94804	180177039	.	.	0.99555	0.73943	.	.	.	0.99934202	4.96	.	.	.	0.600417	0.999948727464199	0.88626	D	.	.	.	0.4949	0.86082	p.Glu501Val	.	.	-13.783	0.9891212	.	0.99079	40374	D	.	BRAF	.	D	.	.	E501V	.	.	0.46302	T/T	principal4																																																																																																				
FH_Ser334Arg	0.5356287401458311	0.6114778201904933	-5.513451391166578	0.0008937233895488164	2025_01_Batch_13-14	0.8007347478615932	0.8589931606726063	0.8978571531593534	0.9153387714918513	0.7111055567943652	0.8033091007193875	0.838310274110057	0.9268423305735295	0.8967450792009897	0.7993948760244484	0.8020219242904904	0.8486517173913317	0.9123497418664415	0.9060419253464205	0.7552502164094068	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH	ENSG00000091483	3408	214599	CCSBVarC004053	ALE00004053	NC_000001.11:241504148:A:C	1002T>G	Ser334Arg	CEGS2	CegsMutGDEh1041	C09	GDEhDisVCh_40065	H08	1	CegsMutGDDh1041	C09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_Ser334Arg	1	241504148	A	C	1											1-241504148-A-C	-	0.55043	1.0	334	.	.	.	1	241667448	C	.	.	1	1_Pathogenic	NC_000001.11	.	Ser334Arg	.	23.6	.	.	.	D	.	1	1	.	.	.	.	.	.	0.97281	Select	0.9817	.	0.90580	.	.	D	D	.	1.03551510566	.	.	.	.	.	0.78796	.	.	.	.	0.81545	.	.	0.99652	0.999	.	3.0	0.991801	2.53	0.97	C	single nucleotide variant	NC_000001.11:g.241504148A>C	.	.	2	0.94546735	.	.	0.988074	.		.	.	.	.	.	.	.	.	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	.	.	.	.	0.96253	D	0.98092	D	H	5.94406	.	./.	.	.	.	.	Hereditary leiomyomatosis and renal cell cancer	.	0.99468	.	.	-	241504148	.	-	1.133000	.	0.98982	.	.	.	.	germline	.	Gain of MoRF binding (P = 0.012)| Gain of methylation at S334 (P = 0.1999)| Gain of catalytic residue at S334 (P = 0.2478)| Gain of ubiquitination at K337 (P = 0.2694)| Loss of helix (P = 0.3949)	0.89238	GRCh38	975	criteria provided, single submitter	c.1002T>G	.	0.38530	.	.	.	Fumarate lyase, N-terminal	.	.	P	.	.	NM_000143.4(FH):c.1002T>G (p.Ser334Arg)	1	.	FUMH_HUMAN	.	97.0	0.60202261948517	.	D	0.95185	0.988074	-	.	.		.	.	2	.	criteria_provided,_single_submitter	0.94587	.	.	.	.	.	p.Ser334Arg	.	0.24427	.	germline	.		A	May 22, 2023	.	./.	.	.	1.0	N	1q43	.	.	.	SCV003934314	Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000355518	ENST00000366560	.	0.0	.	.	0.756	A	.	3.81089	0.92967	D	D	-	5.219445	.	0.99481	.	.	.	0.88820	.	241504148	Y	10	.	.	.	P07954	.	0.968915	0.90858		.	1.0	D	.	0.94546735	.	0.91597	2271	0.540935	.	-4.9	.	.	0.91343	.	.	.	.	.	.	0.98092	1	FH	.	.	Ser	.	.	1-241504148-A-C	Hereditary_leiomyomatosis_and_renal_cell_cancer	.	.	239734071	.	0.530379	0.73159	.	RCV003236374	D	.	.	c.1002T>G	.	.	.	0.95434	./.	rs2147916185	241504148	.	A	.	P07954	.	0.99652	.	0.32271		.	.	.	3.55	.	.	.	3.45	0.99646	.	D	T	.	.	.	.	.	.	.	523	2506143	0.95366	0.75429	0.996222853660583	.	.	0.71675	0.54952	.	.	.	1.348	.	D	.	.	.	.	150800	0.33697	1	.	ENSG00000091483	.	.	.	.	0.991474710610662	3	0.97365	0.05314	.	.	.	.	0.506605376223128	YES	.	0.928795	1314676	HGNC:3700	D	.	simple_aae	0.973	.	241504148	AGT	0.994000	.	-	.	0.96080	.	.	.	Likely pathogenic	0.96286	.	.	.	ClinGen:CA345438245	S	.	0.986805441107	-	0.765	-	0.99270	.	.	0.99141	0.77938503027	0.9943	.	0.99825879520171334	.	-	1002T>G 	.	.	C1708350	.	.	.	.	NM_000143.4	-	.	.	1	0.97448	2147916185	.	.	0.98651	0.68262	0.983	0.0	.	0.96908960	5.73	.	.	.	0.539239	0.999937025252751	0.93172	D	.	.	.	1.0955	0.99438	p.Ser334Arg	.	.	-15.188	0.96632713	.	0.98982	2506143	D	.	FH	.	D	0.902	.	S334R	D	0.46530	0.943	./.	principal1																																																																																																				
FH_Ser334Arg	0.5356287401458311	0.6114778201904933	-5.513451391166578	0.0008937233895488164	2025_01_Batch_13-14	0.8007347478615932	0.8589931606726063	0.8978571531593534	0.9153387714918513	0.7111055567943652	0.8033091007193875	0.838310274110057	0.9268423305735295	0.8967450792009897	0.7993948760244484	0.8020219242904904	0.8486517173913317	0.9123497418664415	0.9060419253464205	0.7552502164094068	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH		3408		CCSBVarC004053		NC_000001.11:241504148:A:C		Ser334Arg																												FH_Ser334Arg	1	241504148	A	C	1	allele	1002T>G	H03	527_CAVA_Array_P03	P05	B13A7A8P1_R1	B14A7A8P1_R2				1-241504148-A-C	-	0.55043	1.0	334	.	.	.	1	241667448	C	.	.	1	1_Pathogenic	NC_000001.11	.	Ser334Arg	.	23.6	.	.	.	D	.	1	1	.	.	.	.	.	.	0.97281	Select	0.9817	.	0.90580	.	.	D	D	.	1.03551510566	.	.	.	.	.	0.78796	.	.	.	.	0.81545	.	.	0.99652	0.999	.	3.0	0.991801	2.53	0.97	C	single nucleotide variant	NC_000001.11:g.241504148A>C	.	.	2	0.94546735	.	.	0.988074	.		.	.	.	.	.	.	.	.	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	.	.	.	.	0.96253	D	0.98092	D	H	5.94406	.	./.	.	.	.	.	Hereditary leiomyomatosis and renal cell cancer	.	0.99468	.	.	-	241504148	.	-	1.133000	.	0.98982	.	.	.	.	germline	.	Gain of MoRF binding (P = 0.012)| Gain of methylation at S334 (P = 0.1999)| Gain of catalytic residue at S334 (P = 0.2478)| Gain of ubiquitination at K337 (P = 0.2694)| Loss of helix (P = 0.3949)	0.89238	GRCh38	975	criteria provided, single submitter	c.1002T>G	.	0.38530	.	.	.	Fumarate lyase, N-terminal	.	.	P	.	.	NM_000143.4(FH):c.1002T>G (p.Ser334Arg)	1	.	FUMH_HUMAN	.	97.0	0.60202261948517	.	D	0.95185	0.988074	-	.	.		.	.	2	.	criteria_provided,_single_submitter	0.94587	.	.	.	.	.	p.Ser334Arg	.	0.24427	.	germline	.		A	May 22, 2023	.	./.	.	.	1.0	N	1q43	.	.	.	SCV003934314	Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000355518	ENST00000366560	.	0.0	.	.	0.756	A	.	3.81089	0.92967	D	D	-	5.219445	.	0.99481	.	.	.	0.88820	.	241504148	Y	10	.	.	.	P07954	.	0.968915	0.90858		.	1.0	D	.	0.94546735	.	0.91597	2271	0.540935	.	-4.9	.	.	0.91343	.	.	.	.	.	.	0.98092	1	FH	.	.	Ser	.	.	1-241504148-A-C	Hereditary_leiomyomatosis_and_renal_cell_cancer	.	.	239734071	.	0.530379	0.73159	.	RCV003236374	D	.	.	c.1002T>G	.	.	.	0.95434	./.	rs2147916185	241504148	.	A	.	P07954	.	0.99652	.	0.32271		.	.	.	3.55	.	.	.	3.45	0.99646	.	D	T	.	.	.	.	.	.	.	523	2506143	0.95366	0.75429	0.996222853660583	.	.	0.71675	0.54952	.	.	.	1.348	.	D	.	.	.	.	150800	0.33697	1	.	ENSG00000091483	.	.	.	.	0.991474710610662	3	0.97365	0.05314	.	.	.	.	0.506605376223128	YES	.	0.928795	1314676	HGNC:3700	D	.	simple_aae	0.973	.	241504148	AGT	0.994000	.	-	.	0.96080	.	.	.	Likely pathogenic	0.96286	.	.	.	ClinGen:CA345438245	S	.	0.986805441107	-	0.765	-	0.99270	.	.	0.99141	0.77938503027	0.9943	.	0.99825879520171334	.	-	1002T>G 	.	.	C1708350	.	.	.	.	NM_000143.4	-	.	.	1	0.97448	2147916185	.	.	0.98651	0.68262	0.983	0.0	.	0.96908960	5.73	.	.	.	0.539239	0.999937025252751	0.93172	D	.	.	.	1.0955	0.99438	p.Ser334Arg	.	.	-15.188	0.96632713	.	0.98982	2506143	D	.	FH	.	D	0.902	.	S334R	D	0.46530	0.943	./.	principal1																																																																																																				
F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Leu	23	139561836	G	T	X											X-139561836-G-T	-	0.28896	0.002	384	.	.	.	X	138643995	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Leu	.	17.93	.	.	.	T	.	2	1	.	.	.	.	.	.	0.82199	Select	0.4357	.	0.09864	.	.	D	D	.	1.39186615189	.	.	.	.	.	0.16193	.	.	.	.	0.51338	.	.	0.74229	0.988	.	12.0	0.756624	3.27	0.88	T	single nucleotide variant	NC_000023.11:g.139561836G>T	.	.	1	0.30190954	.	.	0.62263954	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.93300	B	0.67459	B	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	.	0.66743	.	.	-	139561836	.	-	4.414000	.	0.82005	.	.	.	.	germline	.	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.94756	GRCh38	924	no assertion criteria provided	c.1151G>T	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	.	.	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)		.	FA9_HUMAN	.	88.0	.	.	T	0.53858	0.633839	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Arg384Leu	.	0.43370	.	germline	.		G	Oct 22, 2009	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031646	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.163	.	.	0.676	G	.	2.257674	0.15423	.	T	-	.	.	0.97820	.	.	.	0.29998	.	139561836	Y	10	.	.	.	P00740	.	0.838065	0.76047		.	0.005	D	.	0.44579682	.	0.63383	2158	0.262672	.	-2.31	.	.	0.23568	.	.	.	.	.	.	0.56005	X	F9	.	.	Arg	.	.	X-139561836-G-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	.	.	.	RCV000119810|RCV000011414	D	.	.	c.1151G>T	.	.	.	0.79628	G/G	rs137852283	139561836	.	G	.	P00740	.	0.73626	.	0.68239		.	.	.	0.955	.	.	.	2.91	0.96168	.	T	T	.	.	.	.	.	.	.	98879	10668	0.79364	0.84950	0.43669804930687	.	.	0.20792	.	.	.	.	1.5	.	N	.	.	.	.	300807|306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.960364883388395	2	0.11213	0.18019	.	.	.	.	.	YES	.	0.729767	25707	HGNC:3551	A	.	simple_aae	0.676	.	139561836	CGA	1.000000	.	-	.	0.90243	.	.	.	Pathogenic	0.33708	.	.	.	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	R	.	0.999777502907	-	0.843	-	0.85948	.	.	0.95999	0.338467955589	0.1582	.	0.99630479295637608	.	-	1151G>T 	.	.	C2749016|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.39747	137852283	.	.	0.99977	.	0.51	0.396	.	0.99994540	5.66	.	.	.	0.139533	0.974507408459896	0.23747	T	.	.	.	-0.5473	0.77488	p.Arg384Leu	.	.	-4.722	0.9098561	.	0.84116	10668	T	.	F9	.	D	0.566	.	R384L	T	0.59264	0.76753	G/G	principal1	173868	F9_Popp_2025_carboxy_gla_motif_var257775	No											R		1151	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Arg384Leu		true	c.1151G>T						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Arg384Leu						L	Oct 22, 2009					missense_variant		384.0				0.9398747041555362		Pathogenic	139561836.0	missense_variant		0.566					Reporter			F9_Arg384Leu
F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Leu	23	139561836	G	T	X											X-139561836-G-T	-	0.28896	0.002	384	.	.	.	X	138643995	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Leu	.	17.93	.	.	.	T	.	2	1	.	.	.	.	.	.	0.82199	Select	0.4357	.	0.09864	.	.	D	D	.	1.39186615189	.	.	.	.	.	0.16193	.	.	.	.	0.51338	.	.	0.74229	0.988	.	12.0	0.756624	3.27	0.88	T	single nucleotide variant	NC_000023.11:g.139561836G>T	.	.	1	0.30190954	.	.	0.62263954	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.93300	B	0.67459	B	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	.	0.66743	.	.	-	139561836	.	-	4.414000	.	0.82005	.	.	.	.	germline	.	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.94756	GRCh38	924	no assertion criteria provided	c.1151G>T	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	.	.	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)		.	FA9_HUMAN	.	88.0	.	.	T	0.53858	0.633839	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Arg384Leu	.	0.43370	.	germline	.		G	Oct 22, 2009	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031646	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.163	.	.	0.676	G	.	2.257674	0.15423	.	T	-	.	.	0.97820	.	.	.	0.29998	.	139561836	Y	10	.	.	.	P00740	.	0.838065	0.76047		.	0.005	D	.	0.44579682	.	0.63383	2158	0.262672	.	-2.31	.	.	0.23568	.	.	.	.	.	.	0.56005	X	F9	.	.	Arg	.	.	X-139561836-G-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	.	.	.	RCV000119810|RCV000011414	D	.	.	c.1151G>T	.	.	.	0.79628	G/G	rs137852283	139561836	.	G	.	P00740	.	0.73626	.	0.68239		.	.	.	0.955	.	.	.	2.91	0.96168	.	T	T	.	.	.	.	.	.	.	98879	10668	0.79364	0.84950	0.43669804930687	.	.	0.20792	.	.	.	.	1.5	.	N	.	.	.	.	300807|306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.960364883388395	2	0.11213	0.18019	.	.	.	.	.	YES	.	0.729767	25707	HGNC:3551	A	.	simple_aae	0.676	.	139561836	CGA	1.000000	.	-	.	0.90243	.	.	.	Pathogenic	0.33708	.	.	.	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	R	.	0.999777502907	-	0.843	-	0.85948	.	.	0.95999	0.338467955589	0.1582	.	0.99630479295637608	.	-	1151G>T 	.	.	C2749016|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.39747	137852283	.	.	0.99977	.	0.51	0.396	.	0.99994540	5.66	.	.	.	0.139533	0.974507408459896	0.23747	T	.	.	.	-0.5473	0.77488	p.Arg384Leu	.	.	-4.722	0.9098561	.	0.84116	10668	T	.	F9	.	D	0.566	.	R384L	T	0.59264	0.76753	G/G	principal1	146352	F9_Popp_2025_carboxy_F9_specific_var228732	No											R		1151	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Arg384Leu		true	c.1151G>T						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Arg384Leu						L	Oct 22, 2009					missense_variant		384.0				0.915564746657142		Pathogenic	139561836.0	missense_variant		0.566					Reporter			F9_Arg384Leu
F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Leu	23	139561836	G	T	X											X-139561836-G-T	-	0.28896	0.002	384	.	.	.	X	138643995	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Leu	.	17.93	.	.	.	T	.	2	1	.	.	.	.	.	.	0.82199	Select	0.4357	.	0.09864	.	.	D	D	.	1.39186615189	.	.	.	.	.	0.16193	.	.	.	.	0.51338	.	.	0.74229	0.988	.	12.0	0.756624	3.27	0.88	T	single nucleotide variant	NC_000023.11:g.139561836G>T	.	.	1	0.30190954	.	.	0.62263954	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.93300	B	0.67459	B	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	.	0.66743	.	.	-	139561836	.	-	4.414000	.	0.82005	.	.	.	.	germline	.	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.94756	GRCh38	924	no assertion criteria provided	c.1151G>T	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	.	.	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)		.	FA9_HUMAN	.	88.0	.	.	T	0.53858	0.633839	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Arg384Leu	.	0.43370	.	germline	.		G	Oct 22, 2009	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031646	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.163	.	.	0.676	G	.	2.257674	0.15423	.	T	-	.	.	0.97820	.	.	.	0.29998	.	139561836	Y	10	.	.	.	P00740	.	0.838065	0.76047		.	0.005	D	.	0.44579682	.	0.63383	2158	0.262672	.	-2.31	.	.	0.23568	.	.	.	.	.	.	0.56005	X	F9	.	.	Arg	.	.	X-139561836-G-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	.	.	.	RCV000119810|RCV000011414	D	.	.	c.1151G>T	.	.	.	0.79628	G/G	rs137852283	139561836	.	G	.	P00740	.	0.73626	.	0.68239		.	.	.	0.955	.	.	.	2.91	0.96168	.	T	T	.	.	.	.	.	.	.	98879	10668	0.79364	0.84950	0.43669804930687	.	.	0.20792	.	.	.	.	1.5	.	N	.	.	.	.	300807|306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.960364883388395	2	0.11213	0.18019	.	.	.	.	.	YES	.	0.729767	25707	HGNC:3551	A	.	simple_aae	0.676	.	139561836	CGA	1.000000	.	-	.	0.90243	.	.	.	Pathogenic	0.33708	.	.	.	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	R	.	0.999777502907	-	0.843	-	0.85948	.	.	0.95999	0.338467955589	0.1582	.	0.99630479295637608	.	-	1151G>T 	.	.	C2749016|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.39747	137852283	.	.	0.99977	.	0.51	0.396	.	0.99994540	5.66	.	.	.	0.139533	0.974507408459896	0.23747	T	.	.	.	-0.5473	0.77488	p.Arg384Leu	.	.	-4.722	0.9098561	.	0.84116	10668	T	.	F9	.	D	0.566	.	R384L	T	0.59264	0.76753	G/G	principal1	201384	F9_Popp_2025_heavy_chain_var238413	No											R		1151	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Arg384Leu		true	c.1151G>T						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Arg384Leu						L	Oct 22, 2009					missense_variant		384.0				0.8462483567545361		Pathogenic	139561836.0	missense_variant		0.566					Reporter			F9_Arg384Leu
F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Leu	23	139561836	G	T	X											X-139561836-G-T	-	0.28896	0.002	384	.	.	.	X	138643995	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Leu	.	17.93	.	.	.	T	.	2	1	.	.	.	.	.	.	0.82199	Select	0.4357	.	0.09864	.	.	D	D	.	1.39186615189	.	.	.	.	.	0.16193	.	.	.	.	0.51338	.	.	0.74229	0.988	.	12.0	0.756624	3.27	0.88	T	single nucleotide variant	NC_000023.11:g.139561836G>T	.	.	1	0.30190954	.	.	0.62263954	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.93300	B	0.67459	B	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	.	0.66743	.	.	-	139561836	.	-	4.414000	.	0.82005	.	.	.	.	germline	.	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.94756	GRCh38	924	no assertion criteria provided	c.1151G>T	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	.	.	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)		.	FA9_HUMAN	.	88.0	.	.	T	0.53858	0.633839	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Arg384Leu	.	0.43370	.	germline	.		G	Oct 22, 2009	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031646	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.163	.	.	0.676	G	.	2.257674	0.15423	.	T	-	.	.	0.97820	.	.	.	0.29998	.	139561836	Y	10	.	.	.	P00740	.	0.838065	0.76047		.	0.005	D	.	0.44579682	.	0.63383	2158	0.262672	.	-2.31	.	.	0.23568	.	.	.	.	.	.	0.56005	X	F9	.	.	Arg	.	.	X-139561836-G-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	.	.	.	RCV000119810|RCV000011414	D	.	.	c.1151G>T	.	.	.	0.79628	G/G	rs137852283	139561836	.	G	.	P00740	.	0.73626	.	0.68239		.	.	.	0.955	.	.	.	2.91	0.96168	.	T	T	.	.	.	.	.	.	.	98879	10668	0.79364	0.84950	0.43669804930687	.	.	0.20792	.	.	.	.	1.5	.	N	.	.	.	.	300807|306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.960364883388395	2	0.11213	0.18019	.	.	.	.	.	YES	.	0.729767	25707	HGNC:3551	A	.	simple_aae	0.676	.	139561836	CGA	1.000000	.	-	.	0.90243	.	.	.	Pathogenic	0.33708	.	.	.	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	R	.	0.999777502907	-	0.843	-	0.85948	.	.	0.95999	0.338467955589	0.1582	.	0.99630479295637608	.	-	1151G>T 	.	.	C2749016|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.39747	137852283	.	.	0.99977	.	0.51	0.396	.	0.99994540	5.66	.	.	.	0.139533	0.974507408459896	0.23747	T	.	.	.	-0.5473	0.77488	p.Arg384Leu	.	.	-4.722	0.9098561	.	0.84116	10668	T	.	F9	.	D	0.566	.	R384L	T	0.59264	0.76753	G/G	principal1	256416	F9_Popp_2025_strep_2_var267456	No											R		1151	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Arg384Leu		true	c.1151G>T						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Arg384Leu						L	Oct 22, 2009					missense_variant		384.0				1.0889826277544734		Pathogenic	139561836.0	missense_variant		0.566					Reporter			F9_Arg384Leu
F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	NC_000023.11:139561836:G:T	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Leu	23	139561836	G	T	X											X-139561836-G-T	-	0.28896	0.002	384	.	.	.	X	138643995	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Leu	.	17.93	.	.	.	T	.	2	1	.	.	.	.	.	.	0.82199	Select	0.4357	.	0.09864	.	.	D	D	.	1.39186615189	.	.	.	.	.	0.16193	.	.	.	.	0.51338	.	.	0.74229	0.988	.	12.0	0.756624	3.27	0.88	T	single nucleotide variant	NC_000023.11:g.139561836G>T	.	.	1	0.30190954	.	.	0.62263954	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.93300	B	0.67459	B	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	.	0.66743	.	.	-	139561836	.	-	4.414000	.	0.82005	.	.	.	.	germline	.	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.94756	GRCh38	924	no assertion criteria provided	c.1151G>T	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	.	.	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)		.	FA9_HUMAN	.	88.0	.	.	T	0.53858	0.633839	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Arg384Leu	.	0.43370	.	germline	.		G	Oct 22, 2009	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031646	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.163	.	.	0.676	G	.	2.257674	0.15423	.	T	-	.	.	0.97820	.	.	.	0.29998	.	139561836	Y	10	.	.	.	P00740	.	0.838065	0.76047		.	0.005	D	.	0.44579682	.	0.63383	2158	0.262672	.	-2.31	.	.	0.23568	.	.	.	.	.	.	0.56005	X	F9	.	.	Arg	.	.	X-139561836-G-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	.	.	.	RCV000119810|RCV000011414	D	.	.	c.1151G>T	.	.	.	0.79628	G/G	rs137852283	139561836	.	G	.	P00740	.	0.73626	.	0.68239		.	.	.	0.955	.	.	.	2.91	0.96168	.	T	T	.	.	.	.	.	.	.	98879	10668	0.79364	0.84950	0.43669804930687	.	.	0.20792	.	.	.	.	1.5	.	N	.	.	.	.	300807|306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.960364883388395	2	0.11213	0.18019	.	.	.	.	.	YES	.	0.729767	25707	HGNC:3551	A	.	simple_aae	0.676	.	139561836	CGA	1.000000	.	-	.	0.90243	.	.	.	Pathogenic	0.33708	.	.	.	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	R	.	0.999777502907	-	0.843	-	0.85948	.	.	0.95999	0.338467955589	0.1582	.	0.99630479295637608	.	-	1151G>T 	.	.	C2749016|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.39747	137852283	.	.	0.99977	.	0.51	0.396	.	0.99994540	5.66	.	.	.	0.139533	0.974507408459896	0.23747	T	.	.	.	-0.5473	0.77488	p.Arg384Leu	.	.	-4.722	0.9098561	.	0.84116	10668	T	.	F9	.	D	0.566	.	R384L	T	0.59264	0.76753	G/G	principal1	228900	F9_Popp_2025_light_chain_var248094	No											R		1151	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Arg384Leu		true	c.1151G>T						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Arg384Leu						L	Oct 22, 2009					missense_variant		384.0				0.9512012593519876		Pathogenic	139561836.0	missense_variant		0.566					Reporter			F9_Arg384Leu
F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004390		NC_000023.11:139561836:G:T		Arg384Leu																												F9_Arg384Leu	23	139561836	G	T	X	allele	1151G>T	C04	527_CAVA_Array_P02	E08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-T	-	0.28896	0.002	384	.	.	.	X	138643995	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Leu	.	17.93	.	.	.	T	.	2	1	.	.	.	.	.	.	0.82199	Select	0.4357	.	0.09864	.	.	D	D	.	1.39186615189	.	.	.	.	.	0.16193	.	.	.	.	0.51338	.	.	0.74229	0.988	.	12.0	0.756624	3.27	0.88	T	single nucleotide variant	NC_000023.11:g.139561836G>T	.	.	1	0.30190954	.	.	0.62263954	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.93300	B	0.67459	B	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	.	0.66743	.	.	-	139561836	.	-	4.414000	.	0.82005	.	.	.	.	germline	.	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.94756	GRCh38	924	no assertion criteria provided	c.1151G>T	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	.	.	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)		.	FA9_HUMAN	.	88.0	.	.	T	0.53858	0.633839	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Arg384Leu	.	0.43370	.	germline	.		G	Oct 22, 2009	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031646	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.163	.	.	0.676	G	.	2.257674	0.15423	.	T	-	.	.	0.97820	.	.	.	0.29998	.	139561836	Y	10	.	.	.	P00740	.	0.838065	0.76047		.	0.005	D	.	0.44579682	.	0.63383	2158	0.262672	.	-2.31	.	.	0.23568	.	.	.	.	.	.	0.56005	X	F9	.	.	Arg	.	.	X-139561836-G-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	.	.	.	RCV000119810|RCV000011414	D	.	.	c.1151G>T	.	.	.	0.79628	G/G	rs137852283	139561836	.	G	.	P00740	.	0.73626	.	0.68239		.	.	.	0.955	.	.	.	2.91	0.96168	.	T	T	.	.	.	.	.	.	.	98879	10668	0.79364	0.84950	0.43669804930687	.	.	0.20792	.	.	.	.	1.5	.	N	.	.	.	.	300807|306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.960364883388395	2	0.11213	0.18019	.	.	.	.	.	YES	.	0.729767	25707	HGNC:3551	A	.	simple_aae	0.676	.	139561836	CGA	1.000000	.	-	.	0.90243	.	.	.	Pathogenic	0.33708	.	.	.	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	R	.	0.999777502907	-	0.843	-	0.85948	.	.	0.95999	0.338467955589	0.1582	.	0.99630479295637608	.	-	1151G>T 	.	.	C2749016|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.39747	137852283	.	.	0.99977	.	0.51	0.396	.	0.99994540	5.66	.	.	.	0.139533	0.974507408459896	0.23747	T	.	.	.	-0.5473	0.77488	p.Arg384Leu	.	.	-4.722	0.9098561	.	0.84116	10668	T	.	F9	.	D	0.566	.	R384L	T	0.59264	0.76753	G/G	principal1	173868	F9_Popp_2025_carboxy_gla_motif_var257775	No											R		1151	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Arg384Leu		true	c.1151G>T						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Arg384Leu						L	Oct 22, 2009					missense_variant		384.0				0.9398747041555362		Pathogenic	139561836.0	missense_variant		0.566					Reporter			F9_Arg384Leu
F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004390		NC_000023.11:139561836:G:T		Arg384Leu																												F9_Arg384Leu	23	139561836	G	T	X	allele	1151G>T	C04	527_CAVA_Array_P02	E08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-T	-	0.28896	0.002	384	.	.	.	X	138643995	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Leu	.	17.93	.	.	.	T	.	2	1	.	.	.	.	.	.	0.82199	Select	0.4357	.	0.09864	.	.	D	D	.	1.39186615189	.	.	.	.	.	0.16193	.	.	.	.	0.51338	.	.	0.74229	0.988	.	12.0	0.756624	3.27	0.88	T	single nucleotide variant	NC_000023.11:g.139561836G>T	.	.	1	0.30190954	.	.	0.62263954	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.93300	B	0.67459	B	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	.	0.66743	.	.	-	139561836	.	-	4.414000	.	0.82005	.	.	.	.	germline	.	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.94756	GRCh38	924	no assertion criteria provided	c.1151G>T	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	.	.	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)		.	FA9_HUMAN	.	88.0	.	.	T	0.53858	0.633839	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Arg384Leu	.	0.43370	.	germline	.		G	Oct 22, 2009	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031646	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.163	.	.	0.676	G	.	2.257674	0.15423	.	T	-	.	.	0.97820	.	.	.	0.29998	.	139561836	Y	10	.	.	.	P00740	.	0.838065	0.76047		.	0.005	D	.	0.44579682	.	0.63383	2158	0.262672	.	-2.31	.	.	0.23568	.	.	.	.	.	.	0.56005	X	F9	.	.	Arg	.	.	X-139561836-G-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	.	.	.	RCV000119810|RCV000011414	D	.	.	c.1151G>T	.	.	.	0.79628	G/G	rs137852283	139561836	.	G	.	P00740	.	0.73626	.	0.68239		.	.	.	0.955	.	.	.	2.91	0.96168	.	T	T	.	.	.	.	.	.	.	98879	10668	0.79364	0.84950	0.43669804930687	.	.	0.20792	.	.	.	.	1.5	.	N	.	.	.	.	300807|306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.960364883388395	2	0.11213	0.18019	.	.	.	.	.	YES	.	0.729767	25707	HGNC:3551	A	.	simple_aae	0.676	.	139561836	CGA	1.000000	.	-	.	0.90243	.	.	.	Pathogenic	0.33708	.	.	.	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	R	.	0.999777502907	-	0.843	-	0.85948	.	.	0.95999	0.338467955589	0.1582	.	0.99630479295637608	.	-	1151G>T 	.	.	C2749016|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.39747	137852283	.	.	0.99977	.	0.51	0.396	.	0.99994540	5.66	.	.	.	0.139533	0.974507408459896	0.23747	T	.	.	.	-0.5473	0.77488	p.Arg384Leu	.	.	-4.722	0.9098561	.	0.84116	10668	T	.	F9	.	D	0.566	.	R384L	T	0.59264	0.76753	G/G	principal1	146352	F9_Popp_2025_carboxy_F9_specific_var228732	No											R		1151	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Arg384Leu		true	c.1151G>T						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Arg384Leu						L	Oct 22, 2009					missense_variant		384.0				0.915564746657142		Pathogenic	139561836.0	missense_variant		0.566					Reporter			F9_Arg384Leu
F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004390		NC_000023.11:139561836:G:T		Arg384Leu																												F9_Arg384Leu	23	139561836	G	T	X	allele	1151G>T	C04	527_CAVA_Array_P02	E08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-T	-	0.28896	0.002	384	.	.	.	X	138643995	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Leu	.	17.93	.	.	.	T	.	2	1	.	.	.	.	.	.	0.82199	Select	0.4357	.	0.09864	.	.	D	D	.	1.39186615189	.	.	.	.	.	0.16193	.	.	.	.	0.51338	.	.	0.74229	0.988	.	12.0	0.756624	3.27	0.88	T	single nucleotide variant	NC_000023.11:g.139561836G>T	.	.	1	0.30190954	.	.	0.62263954	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.93300	B	0.67459	B	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	.	0.66743	.	.	-	139561836	.	-	4.414000	.	0.82005	.	.	.	.	germline	.	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.94756	GRCh38	924	no assertion criteria provided	c.1151G>T	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	.	.	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)		.	FA9_HUMAN	.	88.0	.	.	T	0.53858	0.633839	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Arg384Leu	.	0.43370	.	germline	.		G	Oct 22, 2009	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031646	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.163	.	.	0.676	G	.	2.257674	0.15423	.	T	-	.	.	0.97820	.	.	.	0.29998	.	139561836	Y	10	.	.	.	P00740	.	0.838065	0.76047		.	0.005	D	.	0.44579682	.	0.63383	2158	0.262672	.	-2.31	.	.	0.23568	.	.	.	.	.	.	0.56005	X	F9	.	.	Arg	.	.	X-139561836-G-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	.	.	.	RCV000119810|RCV000011414	D	.	.	c.1151G>T	.	.	.	0.79628	G/G	rs137852283	139561836	.	G	.	P00740	.	0.73626	.	0.68239		.	.	.	0.955	.	.	.	2.91	0.96168	.	T	T	.	.	.	.	.	.	.	98879	10668	0.79364	0.84950	0.43669804930687	.	.	0.20792	.	.	.	.	1.5	.	N	.	.	.	.	300807|306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.960364883388395	2	0.11213	0.18019	.	.	.	.	.	YES	.	0.729767	25707	HGNC:3551	A	.	simple_aae	0.676	.	139561836	CGA	1.000000	.	-	.	0.90243	.	.	.	Pathogenic	0.33708	.	.	.	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	R	.	0.999777502907	-	0.843	-	0.85948	.	.	0.95999	0.338467955589	0.1582	.	0.99630479295637608	.	-	1151G>T 	.	.	C2749016|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.39747	137852283	.	.	0.99977	.	0.51	0.396	.	0.99994540	5.66	.	.	.	0.139533	0.974507408459896	0.23747	T	.	.	.	-0.5473	0.77488	p.Arg384Leu	.	.	-4.722	0.9098561	.	0.84116	10668	T	.	F9	.	D	0.566	.	R384L	T	0.59264	0.76753	G/G	principal1	201384	F9_Popp_2025_heavy_chain_var238413	No											R		1151	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Arg384Leu		true	c.1151G>T						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Arg384Leu						L	Oct 22, 2009					missense_variant		384.0				0.8462483567545361		Pathogenic	139561836.0	missense_variant		0.566					Reporter			F9_Arg384Leu
F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004390		NC_000023.11:139561836:G:T		Arg384Leu																												F9_Arg384Leu	23	139561836	G	T	X	allele	1151G>T	C04	527_CAVA_Array_P02	E08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-T	-	0.28896	0.002	384	.	.	.	X	138643995	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Leu	.	17.93	.	.	.	T	.	2	1	.	.	.	.	.	.	0.82199	Select	0.4357	.	0.09864	.	.	D	D	.	1.39186615189	.	.	.	.	.	0.16193	.	.	.	.	0.51338	.	.	0.74229	0.988	.	12.0	0.756624	3.27	0.88	T	single nucleotide variant	NC_000023.11:g.139561836G>T	.	.	1	0.30190954	.	.	0.62263954	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.93300	B	0.67459	B	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	.	0.66743	.	.	-	139561836	.	-	4.414000	.	0.82005	.	.	.	.	germline	.	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.94756	GRCh38	924	no assertion criteria provided	c.1151G>T	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	.	.	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)		.	FA9_HUMAN	.	88.0	.	.	T	0.53858	0.633839	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Arg384Leu	.	0.43370	.	germline	.		G	Oct 22, 2009	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031646	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.163	.	.	0.676	G	.	2.257674	0.15423	.	T	-	.	.	0.97820	.	.	.	0.29998	.	139561836	Y	10	.	.	.	P00740	.	0.838065	0.76047		.	0.005	D	.	0.44579682	.	0.63383	2158	0.262672	.	-2.31	.	.	0.23568	.	.	.	.	.	.	0.56005	X	F9	.	.	Arg	.	.	X-139561836-G-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	.	.	.	RCV000119810|RCV000011414	D	.	.	c.1151G>T	.	.	.	0.79628	G/G	rs137852283	139561836	.	G	.	P00740	.	0.73626	.	0.68239		.	.	.	0.955	.	.	.	2.91	0.96168	.	T	T	.	.	.	.	.	.	.	98879	10668	0.79364	0.84950	0.43669804930687	.	.	0.20792	.	.	.	.	1.5	.	N	.	.	.	.	300807|306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.960364883388395	2	0.11213	0.18019	.	.	.	.	.	YES	.	0.729767	25707	HGNC:3551	A	.	simple_aae	0.676	.	139561836	CGA	1.000000	.	-	.	0.90243	.	.	.	Pathogenic	0.33708	.	.	.	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	R	.	0.999777502907	-	0.843	-	0.85948	.	.	0.95999	0.338467955589	0.1582	.	0.99630479295637608	.	-	1151G>T 	.	.	C2749016|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.39747	137852283	.	.	0.99977	.	0.51	0.396	.	0.99994540	5.66	.	.	.	0.139533	0.974507408459896	0.23747	T	.	.	.	-0.5473	0.77488	p.Arg384Leu	.	.	-4.722	0.9098561	.	0.84116	10668	T	.	F9	.	D	0.566	.	R384L	T	0.59264	0.76753	G/G	principal1	256416	F9_Popp_2025_strep_2_var267456	No											R		1151	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Arg384Leu		true	c.1151G>T						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Arg384Leu						L	Oct 22, 2009					missense_variant		384.0				1.0889826277544734		Pathogenic	139561836.0	missense_variant		0.566					Reporter			F9_Arg384Leu
F9_Arg384Leu	-3.007334038146191	0.019736371292147295	2.8708323052481384	0.02396347802008087	2025_01_Batch_13-14	0.6391945424146871	0.5747914264922237	0.636436573822579	0.5799290743206506	0.6540329307427528	0.5629610377556141	0.6069151492582734	0.7002519616542973	0.6599662569399136	0.5983137089869622	0.6010777900851506	0.5908532878752486	0.6683442677384381	0.619947665630282	0.6261733198648576	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004390		NC_000023.11:139561836:G:T		Arg384Leu																												F9_Arg384Leu	23	139561836	G	T	X	allele	1151G>T	C04	527_CAVA_Array_P02	E08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-T	-	0.28896	0.002	384	.	.	.	X	138643995	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Leu	.	17.93	.	.	.	T	.	2	1	.	.	.	.	.	.	0.82199	Select	0.4357	.	0.09864	.	.	D	D	.	1.39186615189	.	.	.	.	.	0.16193	.	.	.	.	0.51338	.	.	0.74229	0.988	.	12.0	0.756624	3.27	0.88	T	single nucleotide variant	NC_000023.11:g.139561836G>T	.	.	1	0.30190954	.	.	0.62263954	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.93300	B	0.67459	B	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	.	0.66743	.	.	-	139561836	.	-	4.414000	.	0.82005	.	.	.	.	germline	.	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.94756	GRCh38	924	no assertion criteria provided	c.1151G>T	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	.	.	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)		.	FA9_HUMAN	.	88.0	.	.	T	0.53858	0.633839	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Arg384Leu	.	0.43370	.	germline	.		G	Oct 22, 2009	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031646	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.163	.	.	0.676	G	.	2.257674	0.15423	.	T	-	.	.	0.97820	.	.	.	0.29998	.	139561836	Y	10	.	.	.	P00740	.	0.838065	0.76047		.	0.005	D	.	0.44579682	.	0.63383	2158	0.262672	.	-2.31	.	.	0.23568	.	.	.	.	.	.	0.56005	X	F9	.	.	Arg	.	.	X-139561836-G-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	.	.	.	RCV000119810|RCV000011414	D	.	.	c.1151G>T	.	.	.	0.79628	G/G	rs137852283	139561836	.	G	.	P00740	.	0.73626	.	0.68239		.	.	.	0.955	.	.	.	2.91	0.96168	.	T	T	.	.	.	.	.	.	.	98879	10668	0.79364	0.84950	0.43669804930687	.	.	0.20792	.	.	.	.	1.5	.	N	.	.	.	.	300807|306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.960364883388395	2	0.11213	0.18019	.	.	.	.	.	YES	.	0.729767	25707	HGNC:3551	A	.	simple_aae	0.676	.	139561836	CGA	1.000000	.	-	.	0.90243	.	.	.	Pathogenic	0.33708	.	.	.	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	R	.	0.999777502907	-	0.843	-	0.85948	.	.	0.95999	0.338467955589	0.1582	.	0.99630479295637608	.	-	1151G>T 	.	.	C2749016|C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.39747	137852283	.	.	0.99977	.	0.51	0.396	.	0.99994540	5.66	.	.	.	0.139533	0.974507408459896	0.23747	T	.	.	.	-0.5473	0.77488	p.Arg384Leu	.	.	-4.722	0.9098561	.	0.84116	10668	T	.	F9	.	D	0.566	.	R384L	T	0.59264	0.76753	G/G	principal1	228900	F9_Popp_2025_light_chain_var248094	No											R		1151	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Arg384Leu		true	c.1151G>T						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Arg384Leu						L	Oct 22, 2009					missense_variant		384.0				0.9512012593519876		Pathogenic	139561836.0	missense_variant		0.566					Reporter			F9_Arg384Leu
F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	0.6355069577937184	0.6587303270483099	0.6652840299340169	0.6876251281328446	0.5374405565953059	0.5353478894172454	0.612348215915929	0.6559957532303466	0.7286489606287152	0.43369749675915864	0.585427423605482	0.6355392714821195	0.6606398915821818	0.70813704438078	0.48556902667723223	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A		Val257Ile																												F9_Val257Ile	23	139560786	G	A	X	allele	769G>A	E09	527_CAVA_Array_P02	I18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560786-G-A	-	0.00187	0.0	257	0	0	0	X	138642945	A	1.910530e-04	0	X	3_Conflicting	NC_000023.11	203	Val257Ile	21	0.003	8	0	1.576810e-03	T	1	5	1	30957	1.335350e-04	0	19007	0.000000e+00	0	0.77150	Select	0.2284	13318	0.02950	1	0.0013089005235602095	T	T	46494	0.51541283519	0	0	0.000000e+00	0	0	0.03692	13666	33751	0	1.974920e-03	0.01825	0	.	0.17469	0.82	0.0	93.0	0.808919	-10.4	0.07	A	single nucleotide variant	NC_000023.11:g.139560786G>A	0	12170	2	0.10740013	80322	0	0.050574146	0.00514216575922565		22	172240	0	0	1.576810e-03	436	0.000000e+00	1	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	8	1	0.000000e+00	0	0.21442	B	0.28024	B	N	.	231	G/G	168	0	5702	1209089	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13134	0.51428	0	.	-	139560786	1.156740e-03	-	-0.886000	0	0.19020	22020	0	33751	20	germline	56760	.	.	GRCh38	924	criteria provided, conflicting classifications	c.769G>A	0.000000e+00	0.02145	19	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.216930e-05	6916	B	0.006343283582089552	0.000000e+00	NM_000133.4(F9):c.769G>A (p.Val257Ile)	1	0	FA9_HUMAN	0	7.0	.	1	T	0.01289	0.07762356	+	0.000000e+00	0		20	0.000000e+00	0	27168	criteria_provided,_conflicting_classifications	0.99726	9.959910e-05	1	0.000000e+00	0	45735	p.Val257Ile	0	0.07077	.	germline	8		G	Aug 18, 2024	0	G/G	0	64682	0.0	N	Xq27.1	92828	.	0.000000e+00	SCV000267310|SCV000481885|SCV001003033	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	684	ENSP00000218099	ENST00000218099	13318	0.488	10127	0	-0.272	G	0	-1.717606	0.14754	.	T	-	.	.	0.70500	928	0	0.0	0.00712	17	139560786	Y	10	0	73479	2.298850e-04	P00740	0	0.385448	0.06705		0	0.0	D	10127	0.1163571	6916	0.3867	2158	-0.276942	8	0.81	0.0	6.014640e-03	0.08092	0.000000e+00	0	57201	1.156740e-03	4350	0	0.25799	X	F9	1.223750e-04	0	Val	104028	0.000000e+00	X-139560786-G-A	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138470611	ClinGen:CA10529834	.	.	0	RCV000862519|RCV000490374|RCV003917862	T	1	0	c.769G>A	0	203	4	0.10755	G/G	rs200608775	139560786	12064	G	2.6490066225165563E-4	.	9952	0.09073	6.259780e-05	0.08389		0	0	6.014640e-03	-1.135	0.005952380952380952	1	264690	-5.82	0.74512	3306	T	T	0	4.100040e-05	0	626	.	0	1	98879	225354	0.54792	0.49159	0.0201428491067639	4188	1	0.06393	.	3.680800e-05	1.974920e-03	894497	-0.992	1.448810e-04	N	9912	0	1.0578412E-4	17	306900|300807	0.03838	X	0.000000e+00	ENSG00000101981	8.603260e-05	1.0772611711983453E-5	0	0	0.8969268504407544	1	0.01384	0.18019	19072	28	0.000000e+00	4.373020e-05	.	YES	0.000000e+00	0.068982	227419	HGNC:3551	N	0	simple_aae	0.068	151849	139560786	GTT	0.000000	1	-	2.387774594078319E-4	0.00768	8.943570e-06	1	0	Conflicting classifications of pathogenicity	0.01014	0	1	2	ClinGen:CA10529834	V	0	0.975202009541	-	.	-	0.66533	23	2062	0.89598	0.24926649034	0.0601	0	0.61038201019498284	280	-	769G>A 	21	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	0	0.0	0	0.50832	200608775	1767	1.8264313454070057E-4	0.97469	.	0.396	0.41	4020	0.99979204	5.84	.	.	0.000000e+00	-0.195212	0.0165363210494945	0.00932	T	2680	4649	7083	-0.8550	0.59203	p.Val257Ile	0	0	-0.934	0.025891602	7	0.27901	225354	T	24390	F9	0.000000e+00	T	0.483	15975	.	T	0.00170	0.06718	G/G	principal1	166232	F9_Popp_2025_carboxy_gla_motif_var255107	No											V		769	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Val257Ile		true	c.769G>A						3551.0	139560786.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, conflicting classifications				Val257Ile						I	Jan 12, 2024					missense_variant		257.0			0.0001910529332414	0.6115191676603379		Conflicting classifications of pathogenicity	139560786.0	missense_variant		0.483					Reporter			F9_Val257Ile
F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	0.6355069577937184	0.6587303270483099	0.6652840299340169	0.6876251281328446	0.5374405565953059	0.5353478894172454	0.612348215915929	0.6559957532303466	0.7286489606287152	0.43369749675915864	0.585427423605482	0.6355392714821195	0.6606398915821818	0.70813704438078	0.48556902667723223	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A		Val257Ile																												F9_Val257Ile	23	139560786	G	A	X	allele	769G>A	E09	527_CAVA_Array_P02	I18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560786-G-A	-	0.00187	0.0	257	0	0	0	X	138642945	A	1.910530e-04	0	X	3_Conflicting	NC_000023.11	203	Val257Ile	21	0.003	8	0	1.576810e-03	T	1	5	1	30957	1.335350e-04	0	19007	0.000000e+00	0	0.77150	Select	0.2284	13318	0.02950	1	0.0013089005235602095	T	T	46494	0.51541283519	0	0	0.000000e+00	0	0	0.03692	13666	33751	0	1.974920e-03	0.01825	0	.	0.17469	0.82	0.0	93.0	0.808919	-10.4	0.07	A	single nucleotide variant	NC_000023.11:g.139560786G>A	0	12170	2	0.10740013	80322	0	0.050574146	0.00514216575922565		22	172240	0	0	1.576810e-03	436	0.000000e+00	1	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	8	1	0.000000e+00	0	0.21442	B	0.28024	B	N	.	231	G/G	168	0	5702	1209089	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13134	0.51428	0	.	-	139560786	1.156740e-03	-	-0.886000	0	0.19020	22020	0	33751	20	germline	56760	.	.	GRCh38	924	criteria provided, conflicting classifications	c.769G>A	0.000000e+00	0.02145	19	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.216930e-05	6916	B	0.006343283582089552	0.000000e+00	NM_000133.4(F9):c.769G>A (p.Val257Ile)	1	0	FA9_HUMAN	0	7.0	.	1	T	0.01289	0.07762356	+	0.000000e+00	0		20	0.000000e+00	0	27168	criteria_provided,_conflicting_classifications	0.99726	9.959910e-05	1	0.000000e+00	0	45735	p.Val257Ile	0	0.07077	.	germline	8		G	Aug 18, 2024	0	G/G	0	64682	0.0	N	Xq27.1	92828	.	0.000000e+00	SCV000267310|SCV000481885|SCV001003033	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	684	ENSP00000218099	ENST00000218099	13318	0.488	10127	0	-0.272	G	0	-1.717606	0.14754	.	T	-	.	.	0.70500	928	0	0.0	0.00712	17	139560786	Y	10	0	73479	2.298850e-04	P00740	0	0.385448	0.06705		0	0.0	D	10127	0.1163571	6916	0.3867	2158	-0.276942	8	0.81	0.0	6.014640e-03	0.08092	0.000000e+00	0	57201	1.156740e-03	4350	0	0.25799	X	F9	1.223750e-04	0	Val	104028	0.000000e+00	X-139560786-G-A	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138470611	ClinGen:CA10529834	.	.	0	RCV000862519|RCV000490374|RCV003917862	T	1	0	c.769G>A	0	203	4	0.10755	G/G	rs200608775	139560786	12064	G	2.6490066225165563E-4	.	9952	0.09073	6.259780e-05	0.08389		0	0	6.014640e-03	-1.135	0.005952380952380952	1	264690	-5.82	0.74512	3306	T	T	0	4.100040e-05	0	626	.	0	1	98879	225354	0.54792	0.49159	0.0201428491067639	4188	1	0.06393	.	3.680800e-05	1.974920e-03	894497	-0.992	1.448810e-04	N	9912	0	1.0578412E-4	17	306900|300807	0.03838	X	0.000000e+00	ENSG00000101981	8.603260e-05	1.0772611711983453E-5	0	0	0.8969268504407544	1	0.01384	0.18019	19072	28	0.000000e+00	4.373020e-05	.	YES	0.000000e+00	0.068982	227419	HGNC:3551	N	0	simple_aae	0.068	151849	139560786	GTT	0.000000	1	-	2.387774594078319E-4	0.00768	8.943570e-06	1	0	Conflicting classifications of pathogenicity	0.01014	0	1	2	ClinGen:CA10529834	V	0	0.975202009541	-	.	-	0.66533	23	2062	0.89598	0.24926649034	0.0601	0	0.61038201019498284	280	-	769G>A 	21	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	0	0.0	0	0.50832	200608775	1767	1.8264313454070057E-4	0.97469	.	0.396	0.41	4020	0.99979204	5.84	.	.	0.000000e+00	-0.195212	0.0165363210494945	0.00932	T	2680	4649	7083	-0.8550	0.59203	p.Val257Ile	0	0	-0.934	0.025891602	7	0.27901	225354	T	24390	F9	0.000000e+00	T	0.483	15975	.	T	0.00170	0.06718	G/G	principal1	248780	F9_Popp_2025_strep_2_var264788	No											V		769	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Val257Ile		true	c.769G>A						3551.0	139560786.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, conflicting classifications				Val257Ile						I	Jan 12, 2024					missense_variant		257.0			0.0001910529332414	0.8844402554633948		Conflicting classifications of pathogenicity	139560786.0	missense_variant		0.483					Reporter			F9_Val257Ile
F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	0.6355069577937184	0.6587303270483099	0.6652840299340169	0.6876251281328446	0.5374405565953059	0.5353478894172454	0.612348215915929	0.6559957532303466	0.7286489606287152	0.43369749675915864	0.585427423605482	0.6355392714821195	0.6606398915821818	0.70813704438078	0.48556902667723223	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A		Val257Ile																												F9_Val257Ile	23	139560786	G	A	X	allele	769G>A	E09	527_CAVA_Array_P02	I18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560786-G-A	-	0.00187	0.0	257	0	0	0	X	138642945	A	1.910530e-04	0	X	3_Conflicting	NC_000023.11	203	Val257Ile	21	0.003	8	0	1.576810e-03	T	1	5	1	30957	1.335350e-04	0	19007	0.000000e+00	0	0.77150	Select	0.2284	13318	0.02950	1	0.0013089005235602095	T	T	46494	0.51541283519	0	0	0.000000e+00	0	0	0.03692	13666	33751	0	1.974920e-03	0.01825	0	.	0.17469	0.82	0.0	93.0	0.808919	-10.4	0.07	A	single nucleotide variant	NC_000023.11:g.139560786G>A	0	12170	2	0.10740013	80322	0	0.050574146	0.00514216575922565		22	172240	0	0	1.576810e-03	436	0.000000e+00	1	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	8	1	0.000000e+00	0	0.21442	B	0.28024	B	N	.	231	G/G	168	0	5702	1209089	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13134	0.51428	0	.	-	139560786	1.156740e-03	-	-0.886000	0	0.19020	22020	0	33751	20	germline	56760	.	.	GRCh38	924	criteria provided, conflicting classifications	c.769G>A	0.000000e+00	0.02145	19	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.216930e-05	6916	B	0.006343283582089552	0.000000e+00	NM_000133.4(F9):c.769G>A (p.Val257Ile)	1	0	FA9_HUMAN	0	7.0	.	1	T	0.01289	0.07762356	+	0.000000e+00	0		20	0.000000e+00	0	27168	criteria_provided,_conflicting_classifications	0.99726	9.959910e-05	1	0.000000e+00	0	45735	p.Val257Ile	0	0.07077	.	germline	8		G	Aug 18, 2024	0	G/G	0	64682	0.0	N	Xq27.1	92828	.	0.000000e+00	SCV000267310|SCV000481885|SCV001003033	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	684	ENSP00000218099	ENST00000218099	13318	0.488	10127	0	-0.272	G	0	-1.717606	0.14754	.	T	-	.	.	0.70500	928	0	0.0	0.00712	17	139560786	Y	10	0	73479	2.298850e-04	P00740	0	0.385448	0.06705		0	0.0	D	10127	0.1163571	6916	0.3867	2158	-0.276942	8	0.81	0.0	6.014640e-03	0.08092	0.000000e+00	0	57201	1.156740e-03	4350	0	0.25799	X	F9	1.223750e-04	0	Val	104028	0.000000e+00	X-139560786-G-A	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138470611	ClinGen:CA10529834	.	.	0	RCV000862519|RCV000490374|RCV003917862	T	1	0	c.769G>A	0	203	4	0.10755	G/G	rs200608775	139560786	12064	G	2.6490066225165563E-4	.	9952	0.09073	6.259780e-05	0.08389		0	0	6.014640e-03	-1.135	0.005952380952380952	1	264690	-5.82	0.74512	3306	T	T	0	4.100040e-05	0	626	.	0	1	98879	225354	0.54792	0.49159	0.0201428491067639	4188	1	0.06393	.	3.680800e-05	1.974920e-03	894497	-0.992	1.448810e-04	N	9912	0	1.0578412E-4	17	306900|300807	0.03838	X	0.000000e+00	ENSG00000101981	8.603260e-05	1.0772611711983453E-5	0	0	0.8969268504407544	1	0.01384	0.18019	19072	28	0.000000e+00	4.373020e-05	.	YES	0.000000e+00	0.068982	227419	HGNC:3551	N	0	simple_aae	0.068	151849	139560786	GTT	0.000000	1	-	2.387774594078319E-4	0.00768	8.943570e-06	1	0	Conflicting classifications of pathogenicity	0.01014	0	1	2	ClinGen:CA10529834	V	0	0.975202009541	-	.	-	0.66533	23	2062	0.89598	0.24926649034	0.0601	0	0.61038201019498284	280	-	769G>A 	21	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	0	0.0	0	0.50832	200608775	1767	1.8264313454070057E-4	0.97469	.	0.396	0.41	4020	0.99979204	5.84	.	.	0.000000e+00	-0.195212	0.0165363210494945	0.00932	T	2680	4649	7083	-0.8550	0.59203	p.Val257Ile	0	0	-0.934	0.025891602	7	0.27901	225354	T	24390	F9	0.000000e+00	T	0.483	15975	.	T	0.00170	0.06718	G/G	principal1	193748	F9_Popp_2025_heavy_chain_var235745	No											V		769	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Val257Ile		true	c.769G>A						3551.0	139560786.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, conflicting classifications				Val257Ile						I	Jan 12, 2024					missense_variant		257.0			0.0001910529332414	0.6698528286308812		Conflicting classifications of pathogenicity	139560786.0	missense_variant		0.483					Reporter			F9_Val257Ile
F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	0.6355069577937184	0.6587303270483099	0.6652840299340169	0.6876251281328446	0.5374405565953059	0.5353478894172454	0.612348215915929	0.6559957532303466	0.7286489606287152	0.43369749675915864	0.585427423605482	0.6355392714821195	0.6606398915821818	0.70813704438078	0.48556902667723223	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A		Val257Ile																												F9_Val257Ile	23	139560786	G	A	X	allele	769G>A	E09	527_CAVA_Array_P02	I18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560786-G-A	-	0.00187	0.0	257	0	0	0	X	138642945	A	1.910530e-04	0	X	3_Conflicting	NC_000023.11	203	Val257Ile	21	0.003	8	0	1.576810e-03	T	1	5	1	30957	1.335350e-04	0	19007	0.000000e+00	0	0.77150	Select	0.2284	13318	0.02950	1	0.0013089005235602095	T	T	46494	0.51541283519	0	0	0.000000e+00	0	0	0.03692	13666	33751	0	1.974920e-03	0.01825	0	.	0.17469	0.82	0.0	93.0	0.808919	-10.4	0.07	A	single nucleotide variant	NC_000023.11:g.139560786G>A	0	12170	2	0.10740013	80322	0	0.050574146	0.00514216575922565		22	172240	0	0	1.576810e-03	436	0.000000e+00	1	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	8	1	0.000000e+00	0	0.21442	B	0.28024	B	N	.	231	G/G	168	0	5702	1209089	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13134	0.51428	0	.	-	139560786	1.156740e-03	-	-0.886000	0	0.19020	22020	0	33751	20	germline	56760	.	.	GRCh38	924	criteria provided, conflicting classifications	c.769G>A	0.000000e+00	0.02145	19	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.216930e-05	6916	B	0.006343283582089552	0.000000e+00	NM_000133.4(F9):c.769G>A (p.Val257Ile)	1	0	FA9_HUMAN	0	7.0	.	1	T	0.01289	0.07762356	+	0.000000e+00	0		20	0.000000e+00	0	27168	criteria_provided,_conflicting_classifications	0.99726	9.959910e-05	1	0.000000e+00	0	45735	p.Val257Ile	0	0.07077	.	germline	8		G	Aug 18, 2024	0	G/G	0	64682	0.0	N	Xq27.1	92828	.	0.000000e+00	SCV000267310|SCV000481885|SCV001003033	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	684	ENSP00000218099	ENST00000218099	13318	0.488	10127	0	-0.272	G	0	-1.717606	0.14754	.	T	-	.	.	0.70500	928	0	0.0	0.00712	17	139560786	Y	10	0	73479	2.298850e-04	P00740	0	0.385448	0.06705		0	0.0	D	10127	0.1163571	6916	0.3867	2158	-0.276942	8	0.81	0.0	6.014640e-03	0.08092	0.000000e+00	0	57201	1.156740e-03	4350	0	0.25799	X	F9	1.223750e-04	0	Val	104028	0.000000e+00	X-139560786-G-A	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138470611	ClinGen:CA10529834	.	.	0	RCV000862519|RCV000490374|RCV003917862	T	1	0	c.769G>A	0	203	4	0.10755	G/G	rs200608775	139560786	12064	G	2.6490066225165563E-4	.	9952	0.09073	6.259780e-05	0.08389		0	0	6.014640e-03	-1.135	0.005952380952380952	1	264690	-5.82	0.74512	3306	T	T	0	4.100040e-05	0	626	.	0	1	98879	225354	0.54792	0.49159	0.0201428491067639	4188	1	0.06393	.	3.680800e-05	1.974920e-03	894497	-0.992	1.448810e-04	N	9912	0	1.0578412E-4	17	306900|300807	0.03838	X	0.000000e+00	ENSG00000101981	8.603260e-05	1.0772611711983453E-5	0	0	0.8969268504407544	1	0.01384	0.18019	19072	28	0.000000e+00	4.373020e-05	.	YES	0.000000e+00	0.068982	227419	HGNC:3551	N	0	simple_aae	0.068	151849	139560786	GTT	0.000000	1	-	2.387774594078319E-4	0.00768	8.943570e-06	1	0	Conflicting classifications of pathogenicity	0.01014	0	1	2	ClinGen:CA10529834	V	0	0.975202009541	-	.	-	0.66533	23	2062	0.89598	0.24926649034	0.0601	0	0.61038201019498284	280	-	769G>A 	21	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	0	0.0	0	0.50832	200608775	1767	1.8264313454070057E-4	0.97469	.	0.396	0.41	4020	0.99979204	5.84	.	.	0.000000e+00	-0.195212	0.0165363210494945	0.00932	T	2680	4649	7083	-0.8550	0.59203	p.Val257Ile	0	0	-0.934	0.025891602	7	0.27901	225354	T	24390	F9	0.000000e+00	T	0.483	15975	.	T	0.00170	0.06718	G/G	principal1	138716	F9_Popp_2025_carboxy_F9_specific_var226064	No											V		769	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Val257Ile		true	c.769G>A						3551.0	139560786.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, conflicting classifications				Val257Ile						I	Jan 12, 2024					missense_variant		257.0			0.0001910529332414	0.5834863087702088		Conflicting classifications of pathogenicity	139560786.0	missense_variant		0.483					Reporter			F9_Val257Ile
F9_Val257Ile	-1.8257507063326923	0.11063229444803031	3.064324923319804	0.018212277955950307	2025_01_Batch_13-14	0.6355069577937184	0.6587303270483099	0.6652840299340169	0.6876251281328446	0.5374405565953059	0.5353478894172454	0.612348215915929	0.6559957532303466	0.7286489606287152	0.43369749675915864	0.585427423605482	0.6355392714821195	0.6606398915821818	0.70813704438078	0.48556902667723223	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030575		NC_000023.11:139560786:G:A		Val257Ile																												F9_Val257Ile	23	139560786	G	A	X	allele	769G>A	E09	527_CAVA_Array_P02	I18	B13A7A8P1_R1	B14A7A8P1_R2				X-139560786-G-A	-	0.00187	0.0	257	0	0	0	X	138642945	A	1.910530e-04	0	X	3_Conflicting	NC_000023.11	203	Val257Ile	21	0.003	8	0	1.576810e-03	T	1	5	1	30957	1.335350e-04	0	19007	0.000000e+00	0	0.77150	Select	0.2284	13318	0.02950	1	0.0013089005235602095	T	T	46494	0.51541283519	0	0	0.000000e+00	0	0	0.03692	13666	33751	0	1.974920e-03	0.01825	0	.	0.17469	0.82	0.0	93.0	0.808919	-10.4	0.07	A	single nucleotide variant	NC_000023.11:g.139560786G>A	0	12170	2	0.10740013	80322	0	0.050574146	0.00514216575922565		22	172240	0	0	1.576810e-03	436	0.000000e+00	1	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	8	1	0.000000e+00	0	0.21442	B	0.28024	B	N	.	231	G/G	168	0	5702	1209089	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13134	0.51428	0	.	-	139560786	1.156740e-03	-	-0.886000	0	0.19020	22020	0	33751	20	germline	56760	.	.	GRCh38	924	criteria provided, conflicting classifications	c.769G>A	0.000000e+00	0.02145	19	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.216930e-05	6916	B	0.006343283582089552	0.000000e+00	NM_000133.4(F9):c.769G>A (p.Val257Ile)	1	0	FA9_HUMAN	0	7.0	.	1	T	0.01289	0.07762356	+	0.000000e+00	0		20	0.000000e+00	0	27168	criteria_provided,_conflicting_classifications	0.99726	9.959910e-05	1	0.000000e+00	0	45735	p.Val257Ile	0	0.07077	.	germline	8		G	Aug 18, 2024	0	G/G	0	64682	0.0	N	Xq27.1	92828	.	0.000000e+00	SCV000267310|SCV000481885|SCV001003033	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	684	ENSP00000218099	ENST00000218099	13318	0.488	10127	0	-0.272	G	0	-1.717606	0.14754	.	T	-	.	.	0.70500	928	0	0.0	0.00712	17	139560786	Y	10	0	73479	2.298850e-04	P00740	0	0.385448	0.06705		0	0.0	D	10127	0.1163571	6916	0.3867	2158	-0.276942	8	0.81	0.0	6.014640e-03	0.08092	0.000000e+00	0	57201	1.156740e-03	4350	0	0.25799	X	F9	1.223750e-04	0	Val	104028	0.000000e+00	X-139560786-G-A	F9-related_disorder|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138470611	ClinGen:CA10529834	.	.	0	RCV000862519|RCV000490374|RCV003917862	T	1	0	c.769G>A	0	203	4	0.10755	G/G	rs200608775	139560786	12064	G	2.6490066225165563E-4	.	9952	0.09073	6.259780e-05	0.08389		0	0	6.014640e-03	-1.135	0.005952380952380952	1	264690	-5.82	0.74512	3306	T	T	0	4.100040e-05	0	626	.	0	1	98879	225354	0.54792	0.49159	0.0201428491067639	4188	1	0.06393	.	3.680800e-05	1.974920e-03	894497	-0.992	1.448810e-04	N	9912	0	1.0578412E-4	17	306900|300807	0.03838	X	0.000000e+00	ENSG00000101981	8.603260e-05	1.0772611711983453E-5	0	0	0.8969268504407544	1	0.01384	0.18019	19072	28	0.000000e+00	4.373020e-05	.	YES	0.000000e+00	0.068982	227419	HGNC:3551	N	0	simple_aae	0.068	151849	139560786	GTT	0.000000	1	-	2.387774594078319E-4	0.00768	8.943570e-06	1	0	Conflicting classifications of pathogenicity	0.01014	0	1	2	ClinGen:CA10529834	V	0	0.975202009541	-	.	-	0.66533	23	2062	0.89598	0.24926649034	0.0601	0	0.61038201019498284	280	-	769G>A 	21	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	0	0.0	0	0.50832	200608775	1767	1.8264313454070057E-4	0.97469	.	0.396	0.41	4020	0.99979204	5.84	.	.	0.000000e+00	-0.195212	0.0165363210494945	0.00932	T	2680	4649	7083	-0.8550	0.59203	p.Val257Ile	0	0	-0.934	0.025891602	7	0.27901	225354	T	24390	F9	0.000000e+00	T	0.483	15975	.	T	0.00170	0.06718	G/G	principal1	221264	F9_Popp_2025_light_chain_var245426	No											V		769	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Val257Ile		true	c.769G>A						3551.0	139560786.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, conflicting classifications				Val257Ile						I	Jan 12, 2024					missense_variant		257.0			0.0001910529332414	0.5500069180121129		Conflicting classifications of pathogenicity	139560786.0	missense_variant		0.483					Reporter			F9_Val257Ile
BRCA1_Cys44Tyr	-0.8137193508629426	0.4426010528135844	5.676268140463764	0.0007536407364486894	2025_01_Batch_13-14	0.831148627985987	0.9066524143661844	0.8216178034576009	0.8244578506765782	0.7124769240548263	0.9441987717219412	0.8729902762931168	0.9135044475399889	0.9649343906044164	0.860136022816206	0.887673699853964	0.8898213453296506	0.8675611254987949	0.8946961206404973	0.7863064734355162	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003296		NC_000017.11:43115729:C:T		Cys44Tyr																												BRCA1_Cys44Tyr	17	43115729	C	T	17	allele	131G>A	G06	527_CAVA_Array_P01	M11	B13A7A8P1_R1	B14A7A8P1_R2				17-43115729-C-T	-	0.85159	0.994	44	.	.	.	17	41267746	T	.	.	17	1_Pathogenic	NC_000017.11	.	Cys44Tyr	.	28.5	.	.	.	D	.	12	1	.	.	.	.	.	.	0.95458	.	0.9802	.	0.66535	.	.	T	D	.	.	.	.	.	.	.	0.71433	.	.	.	.	0.98949	.	.	0.92549	0.996	.	.	.	.	.	T	single nucleotide variant	NC_000017.11:g.43115729C>T	.	.	2	0.69650024	.	.	0.92106634	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	.	.	.	.	0.99291	P	0.78468	D	H	10.93124	.	C/C	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	.	0.98195	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43115729	.	-	7.600000	.	0.97139	.	.	.	.	germline;not applicable;unknown	.	Loss of disorder (P = 0.0407)| Loss of helix (P = 0.1299)| Loss of catalytic residue at I42 (P = 0.1404)| Loss of stability (P = 0.2362)| Loss of ubiquitination at K45 (P = 0.2592)	0.99894	GRCh38	464	reviewed by expert panel	c.131G>A	.	0.96929	.	.	.	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	.	.	LP	.	.	NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr)	3	.	BRCA1_HUMAN	.	.	0.895383086000917	.	.	0.97393	0.91385037	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99655	.	.	.	.	.	p.Cys44Tyr	.	0.61593	.	germline	.		C	Aug 10, 2015	.	C/C	.	.	1.0	N	17q21.31	.	.	.	SCV000244299	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000419103	ENST00000494123	.	0.016	.	.	0.599	C	.	5.096311	0.92967	D	D	-	11.33957	.	0.97758	.	.	.	0.77622	.	43115729	Y	10	.	.	.	P38398	.	0.47499	0.56189		.	0.84	D	.	0.6351263	.	0.76032	672	0.562886	.	-2.52	.	.	0.91343	.	.	.	.	.	.	0.81922	17	BRCA1	.	.	Cys	.	.	17-43115729-C-T	not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38521272	BRCA1-HCI:BRCA1_00114|ClinGen:CA000861	0.829447	0.91485	.	RCV000077486|RCV000235119|RCV000509871|RCV001386839	D	.	.	c.131G>A	.	.	.	0.96259	C/C	rs80357446	43115729	.	C	.	E9PFC7	.	0.93252	.	0.68239		.	.	.	4.005	.	.	.	5.97	0.93038	.	D	T	.	.	.	.	.	.	.	140162|145|145	54199	0.96199	0.18552	0.987259089946747	.	.	0.71675	0.74743	.	.	.	3.475	.	D	.	.	.	.	604370	0.52993	17	.	ENSG00000012048	.	.	.	.	.	2	0.60164	0.78507	.	.	.	.	0.837834818254792	.	.	0.72305	68866	HGNC:1100	.	.	.	0.94	.	43115729	TGC	1.000000	.	-	.	0.99802	.	.	.	Pathogenic	0.94506	.	.	.	BRCA1-HCI:BRCA1_00114,ClinGen:CA000861	C	.	0.998941922364	-	0.99	-	0.95504	.	.	0.91966	0.729841411114	0.9966	.	0.99228087188246783	.	-	131G>A 	.	.	C3661900|C0027672|C0677776|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.90786	80357446	.	.	0.99891	0.92242	.	0.0	.	0.99973255	5.97	.	.	.	0.57077	0.999496437666765	0.96727	D	.	.	.	1.0538	0.99389	p.Cys44Tyr	.	.	-13.581	0.99267334	.	0.96769	54199	D	.	BRCA1	.	D	0.853	.	C44Y	D	.	0.40292	C/C	principal2																																																																																																				
BRCA1_Arg391Met	0.12346703943560886	0.9052076336151375	-6.583652048919766	0.00030897140928174853	2025_01_Batch_13-14	0.9299075772210594	0.9497984108090004	0.9853237433825538	0.9866899917271708	0.7585291153116679	0.9306585284304987	0.9019704211817761	0.97806231864069	0.9773906371032913	0.7791421211298803	0.930283052825779	0.9258844159953883	0.9816930310116219	0.982040314415231	0.7688356182207741	1.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC002123		NC_000017.11:43076488:C:A		Arg391Met																												BRCA1_Arg391Met	17	43076488	C	A	17	allele	1172G>T	C06	527_CAVA_Array_P01	E11	B13A7A8P1_R1	B14A7A8P1_R2				17-43076488-C-A	-	0.83736	0.468	1495	1	0	0	17	41228505	A	2.479060e-06	0	17	1_Pathogenic	NC_000017.11	4	Arg1495Met	0	28.1	0	0	9.747730e-06	D	0	24	1	42760	4.225720e-06	.	30522	0.000000e+00	0	0.89238	.	0.7437	102588	0.63438	0	.	T	D	63812	.	0	0	0.000000e+00	0	0	0.09873	17108	44826	0	0.000000e+00	0.58927	1	.	0.30712	0.977	.	.	.	5.07	.	A	single nucleotide variant	NC_000017.11:g.43076488C>A	0	16632	2	0.09751014	109282	0	0.11150219	0	A	1	236646	0	0	0.000000e+00	146	2.338630e-05	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374	1	0	0.000000e+00	0	0.99291	B	0.24633	P	L	4.451626	4	C/C	114	0	7160	1613516	Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Hereditary breast ovarian cancer syndrome|not specified	16212	0.90684	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43076488	2.338630e-05	-	5.667000	0	0.95626	29594	0	1179796	0	germline;unknown	91068	.	.	GRCh38	527	criteria provided, multiple submitters, no conflicts	.	0.000000e+00	0.65374	0	0	0	.	0.000000e+00	9040	.	0	0.000000e+00	NM_007294.4(BRCA1):c.4484G>T (p.Arg1495Met)	2	0	BRCA1_HUMAN	0	.	0.417212491786565	0	.	0.37685	0.13314977	-	0.000000e+00	.	2.7372e-6	1	0.000000e+00	0	34254	criteria_provided,_multiple_submitters,_no_conflicts	0.99542	9.150640e-06	0	0.000000e+00	0	59986	.	0	0.49316	.	germline	1	43076488	C	Jan 23, 2025	0	C/C	0	89510	1.0	N	17q21.31	9690	.	0.000000e+00	SCV000076589|SCV000186941|SCV000210177|SCV000223754|SCV000296380|SCV000296803|SCV000325979|SCV000537652|SCV000540946|SCV000605750|SCV000699152|SCV000902222|SCV001140523|SCV002512513|SCV002515213|SCV002537753|SCV004215024|SCV004817666|SCV005647134	Pathogenic	0	0	Met	M	-	912	ENSP00000419274	ENST00000470026	17684	.	13408	0	0.599	C	0	5.032274	0.69466	D	.	-	4.450753	.	0.98644	610	0	.	0.49533	0	43076488	Y	9	0	102588	0.000000e+00	P38398	0	0.157106	0.28156	C	0	0.215	D	89510	0.10292555	42760	0.56847	672	0.355325	4	.	.	3.390420e-06	0.91343	0.000000e+00	0	74976	0.000000e+00	6058	0	0.23171	17	BRCA1	0.000000e+00	0	Arg	14528	1.117190e-05	17-43076488-C-A	Familial_cancer_of_breast|not_specified|Breast_and/or_ovarian_cancer|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome	0	1	38482031	Breast_Cancer_Information_Core_(BIC)_(BRCA1):4603&base_change%3DG_to_T|ClinGen:CA002876|UniProtKB:P38398#VAR_063900	0.813047	0.62173	0	RCV000131886|RCV000159992|RCV000770739|RCV005016310|RCV000031179|RCV000048576|RCV000462940|RCV001171414|RCV000238601	.	0	0	c.4484G>T	0	0	0	0.86796	C/C	rs80357389	43076488	14896	C	.	.	15688	0.26113	0.000000e+00	0.68239	17	0	0	0.000000e+00	1.895	0	0	264690	4.97	0.49694	112	D	T	0	0.000000e+00	0	26	.	0	0	227535|145|145|140162	37598	0.86624	0.18057	0.845764636993408	3324	.	0.71675	0.73465	0.000000e+00	1.117190e-05	1179796	3.879	4.808710e-06	.	13292	0	7.5560088E-6	0	114480|604370	0.55941	17	0.000000e+00	ENSG00000012048	0.000000e+00	0	0	0	.	2	0.73159	0.73883	30604	2	9.747730e-06	0.000000e+00	0.412864384325496	.	0.000000e+00	0.825771	46154	HGNC:1100	.	0	.	0.915	207956	43076488	AGG	1.000000	.	-	0	0.65625	3.390420e-06	0	0	Pathogenic	0.23826	0	0	0	Breast Cancer Information Core (BIC) (BRCA1):4603&base_change=G to T,ClinGen:CA002876,UniProtKB:P38398#VAR_063900	R	0	.	-	.	-	0.80306	1	548	0.29073	0.296483755112	.	0	0.95831755947551867	98	-	4484G>T 	1	0	C0346153|CN169374|CN221562|C3661900|C2676676|C0677776|C0027672	0	0	0	0	NM_007294.4	-	.	.	1	0.55938	80357389	2320	0	0.88343	0.62163	.	.	3210	0.99961948	4.97	.	.	0.000000e+00	0.272623	0.925453315994447	0.50187	D	86	6210	9564	0.5123	0.91227	p.Arg1495Met	0	0	-3.944	.	0	0.78001	37598	T	30518	BRCA1	0.000000e+00	D	.	21528	.	.	0.90660	0.40292	C/C	principal2																																																																																																				
BRCA1_Thr581Ala	0.0497091547769512	0.9617428060924307	4.326359069964326	0.003453197422548223	2025_01_Batch_13-14	0.9167490291041218	0.9030116271717452	0.903340193991352	0.9247672489714605	0.8009118765693297	0.8837938926005537	0.8520433324779236	0.8593154762600081	0.9488159897593582	0.7574468749360753	0.9002714608523378	0.8775274798248345	0.8813278351256801	0.9367916193654093	0.7791793757527026	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011843		NC_000017.11:43067629:T:C		Thr581Ala																												BRCA1_Thr581Ala	17	43067629	T	C	17	allele	1741A>G	B09	527_CAVA_Array_P01	C17	B13A7A8P1_R1	B14A7A8P1_R2				17-43067629-T-C	-	0.54478	0.53	1685	.	.	.	17	41219646	C	.	.	17	1_Pathogenic	NC_000017.11	.	Thr1685Ala	.	23.5	.	.	.	D	.	10	1	.	.	.	.	.	.	0.96531	Select	0.7785	.	0.77914	.	.	T	D	.	.	.	.	.	.	.	0.62862	.	.	.	.	0.74769	.	.	0.95639	0.983	.	9.0	.	3.42	0.91	C	single nucleotide variant	NC_000017.11:g.43067629T>C	.	.	2	0.6872717	.	.	0.96085334	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	.	.	.	.	0.99291	B	0.81474	P	M	6.379083	.	T/T	.	.	.	.	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided	.	0.93530	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43067629	.	-	7.873000	.	0.98629	.	.	.	.	germline;not applicable	.	.	.	GRCh38	545	reviewed by expert panel	c.5053A>G	.	0.72825	.	.	.	BRCT domain|BRCT domain|BRCT domain	.	.	A	.	.	NM_007294.4(BRCA1):c.5053A>G (p.Thr1685Ala)	3	.	BRCA1_HUMAN	.	91.0	0.641941303045784	.	.	0.76577	0.9444927	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99835	.	.	.	.	.	p.Thr1685Ala	.	0.72109	.	germline	.		T	Aug 10, 2015	.	T/T	.	.	1.0	N	17q21.31	.	.	.	SCV000244379	Pathogenic	.	.	Ala	A	-	.	ENSP00000350283	ENST00000357654	.	0.0	.	.	0.56	T	.	3.78294	0.92967	D	D	-	6.31232	.	0.98044	.	.	.	0.68797	.	43067629	Y	10	.	.	.	P38398	.	0.403358	0.86531		.	0.183	D	.	0.6886691	.	0.59808	672	0.418536	.	-0.82	.	.	0.91343	.	.	.	.	.	.	0.81396	17	BRCA1	.	.	Thr	.	.	17-43067629-T-C	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	.	.	38473172	BRCA1-HCI:BRCA1_00042|ClinGen:CA003174|UniProtKB:P38398#VAR_063902	0.717269	0.75718	.	RCV000048749|RCV000112475|RCV000163024|RCV000212192	D	.	.	c.5053A>G	.	.	.	0.90878	T/T	rs80356890	43067629	.	T	.	.	.	0.97324	.	0.68239		.	.	.	3.31	.	.	.	5.24	0.81781	.	D	T	.	.	.	.	.	.	.	145|145|140162	55364	0.90764	0.09116	0.970580279827118	.	.	0.71675	0.66764	.	.	.	4.786	.	N	.	.	.	.	604370	0.62201	17	.	ENSG00000012048	.	.	.	.	.	1	0.88579	0.72635	.	.	.	.	0.607013709110586	YES	.	0.754689	70031	HGNC:1100	A	.	simple_aae	0.966	.	43067629	ACT	1.000000	.	-	.	0.85903	.	.	.	Pathogenic	0.94593	.	.	.	BRCA1-HCI:BRCA1_00042,ClinGen:CA003174,UniProtKB:P38398#VAR_063902	T	.	0.952919659821	-	.	-	0.91505	.	.	0.86482	0.670587182045	0.523	.	0.99777731049735807	.	-	5053A>G 	.	.	C3661900|C0677776|C2676676|C0027672	.	.	.	.	NM_007294.4	-	.	.	1	0.76208	80356890	.	.	0.95202	0.75311	0.875	0.0	.	0.99986613	5.24	.	.	.	0.363421	0.979632873704045	0.90471	D	.	.	.	0.7304	0.92454	p.Thr1685Ala	.	.	-14.503	0.8680128	.	0.85227	55364	D	.	BRCA1	.	D	0.882	.	.	D	0.61925	0.28431	T/T	principal2																																																																																																				
KRAS_Asp153Val	-0.3822084358919264	0.7136459741761332	1.9062732019056778	0.09829495263619474	2025_01_Batch_13-14	0.9451762796566503	0.9568943207477909	0.9115073512637107	0.9461182286792507	0.8472461347940353	0.5368574535216379	0.6225225199673992	0.7053050140207169	0.70462617079029	0.45202930881121006	0.7410168665891441	0.789708420357595	0.8084061826422138	0.8253721997347703	0.6496377218026227	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214494	CCSBVarC006101	ALE00006101	NC_000012.12:25209904:T:A	458A>T	Asp153Val	CEGS2	CegsMutGDEh1042	B12	GDEhDisVCh_40061	E10	1	CegsMutGDDh1042	B12	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Asp153Val	12	25209904	T	A	12											12-25209904-T-A	-	0.82142	.	128	.	.	.	12	25362838	A	.	.	12	1_Pathogenic	NC_000012.12	.	Asp153Val	.	27.7	.	.	.	T	.	16	.	.	.	.	.	.	.	0.93084	.	0.4729	.	0.50195	.	.	.	D	.	.	.	.	.	.	.	.	.	.	.	.	0.82015	.	.	.	0.997	.	.	.	.	.	A	single nucleotide variant	NC_000012.12:g.25209904T>A	.	.	3	.	.	.	.	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN169374|11 conditions|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MedGen:CN230736	.	.	.	.	0.94378	.	.	.	.	5.592508	.	T/T	.	.	.	.	Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|RASopathy|not provided|not specified|11 conditions|Noonan syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 1|Cardiovascular phenotype	.	0.85920	.	.	-	25209904	.	-	7.901000	.	0.99694	.	.	.	.	de novo;germline;unknown	.	.	0.87760	GRCh38	874	reviewed by expert panel	.	.	0.94257	.	.	.	.	.	.	.	.	.	NM_004985.5(KRAS):c.458A>T (p.Asp153Val)	3	.	A0A8I5KQ21_HUMAN	.	.	0.565827697853449	.	.	0.91639	.	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.94579	.	.	.	.	.	.	.	0.73593	.	germline	.		T	Nov 15, 2018	.	T/T	.	.	1.0	N	12p12.1	.	.	.	SCV000616371	Pathogenic	.	.	Val	V	-	.	ENSP00000509223	ENST00000693229	.	.	.	.	0.583	T	.	4.964316	0.83643	D	.	-	6.639681	.	0.94056	.	.	.	0.64186	.	25209904	Y	7	.	.	.	A0A8I5KQ21	.	.	0.56347		.	.	D	.	.	.	0.79771	3845	0.432327	.	.	.	.	0.91343	.	.	.	.	.	.	.	12	KRAS	.	.	Asp	.	.	12-25209904-T-A	Acute_myeloid_leukemia|Autoimmune_lymphoproliferative_syndrome_type_4|Malignant_tumor_of_urinary_bladder|Lung_carcinoma|Cardiofaciocutaneous_syndrome_2|Carcinoma_of_pancreas|Hereditary_diffuse_gastric_adenocarcinoma|Linear_nevus_sebaceous_syndrome|Cerebral_arteriovenous_malformation|Noonan_syndrome_3|Familial_cancer_of_breast|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|not_provided|Cardiovascular_phenotype|RASopathy|Noonan_syndrome_1|not_specified	.	.	25254105	ClinGen:CA256478|OMIM:190070.0010|OMIM:190070.0015	0.867497	0.70896	.	RCV000013418|RCV000013417|RCV000157940|RCV000212501|RCV000507330|RCV000763307|RCV000523200|RCV000844634|RCV003450634|RCV004018621	.	.	.	c.383A>T	.	.	.	0.91589	T/T	rs104894360	25209904	.	T	.	.	.	.	.	0.68239		.	.	.	.	.	.	.	5.87	.	.	D	.	.	.	.	.	.	.	.	519|268114|157980|1340|1333|217074|26106|2612|46724|648|227535|1340|648|536391|648	12587	0.91485	.	0.955039322376251	.	.	0.71675	0.78650	.	.	.	7.628	.	.	.	.	.	.	601626|614470|109800|615278|137215|163200|108010|609942|114480|PS115150|PS163950|163950	0.82424	12	.	ENSG00000133703	.	.	.	.	.	2	0.47676	0.30573	.	.	.	.	0.631385021559758	.	.	0.435687	27626	HGNC:6407	.	.	.	0.991	.	25209904	GAT	1.000000	.	-	.	0.91672	.	.	.	Pathogenic	0.77191	.	.	.	ClinGen:CA256478,OMIM:190070.0010,OMIM:190070.0015	D	.	.	-	.	-	0.93732	.	.	.	.	.	.	0.99233185239291311	.	-	458A>T 	.	.	C0023467|C2674723|C0005684|C0684249|C3809005|C0235974|C1708349|C4552097|C0917804|C1860991|C0346153|C1275081|C0028326|C3661900|CN230736|C5555857|C4551602|CN169374	.	.	.	.	NM_004985.5	-	.	.	1	0.90939	104894360	.	.	0.92600	0.77104	.	.	.	0.96898425	5.87	.	.	.	0.383231	.	.	D	.	.	.	0.2042	0.79666	p.Asp128Val	.	.	.	.	.	.	12587	.	.	KRAS	.	D	.	.	.	.	.	0.30331	T/T	.																																																																																																				
KRAS_Asp153Val	-0.3822084358919264	0.7136459741761332	1.9062732019056778	0.09829495263619474	2025_01_Batch_13-14	0.9451762796566503	0.9568943207477909	0.9115073512637107	0.9461182286792507	0.8472461347940353	0.5368574535216379	0.6225225199673992	0.7053050140207169	0.70462617079029	0.45202930881121006	0.7410168665891441	0.789708420357595	0.8084061826422138	0.8253721997347703	0.6496377218026227	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006101		NC_000012.12:25209904:T:A		Asp153Val																												KRAS_Asp153Val	12	25209904	T	A	12	allele	458A>T	H08	527_CAVA_Array_P03	P15	B13A7A8P1_R1	B14A7A8P1_R2				12-25209904-T-A	-	0.82142	.	128	.	.	.	12	25362838	A	.	.	12	1_Pathogenic	NC_000012.12	.	Asp153Val	.	27.7	.	.	.	T	.	16	.	.	.	.	.	.	.	0.93084	.	0.4729	.	0.50195	.	.	.	D	.	.	.	.	.	.	.	.	.	.	.	.	0.82015	.	.	.	0.997	.	.	.	.	.	A	single nucleotide variant	NC_000012.12:g.25209904T>A	.	.	3	.	.	.	.	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MedGen:CN169374|11 conditions|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MedGen:CN230736	.	.	.	.	0.94378	.	.	.	.	5.592508	.	T/T	.	.	.	.	Noonan syndrome 3|Cardiofaciocutaneous syndrome 2|RASopathy|not provided|not specified|11 conditions|Noonan syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 1|Cardiovascular phenotype	.	0.85920	.	.	-	25209904	.	-	7.901000	.	0.99694	.	.	.	.	de novo;germline;unknown	.	.	0.87760	GRCh38	874	reviewed by expert panel	.	.	0.94257	.	.	.	.	.	.	.	.	.	NM_004985.5(KRAS):c.458A>T (p.Asp153Val)	3	.	A0A8I5KQ21_HUMAN	.	.	0.565827697853449	.	.	0.91639	.	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.94579	.	.	.	.	.	.	.	0.73593	.	germline	.		T	Nov 15, 2018	.	T/T	.	.	1.0	N	12p12.1	.	.	.	SCV000616371	Pathogenic	.	.	Val	V	-	.	ENSP00000509223	ENST00000693229	.	.	.	.	0.583	T	.	4.964316	0.83643	D	.	-	6.639681	.	0.94056	.	.	.	0.64186	.	25209904	Y	7	.	.	.	A0A8I5KQ21	.	.	0.56347		.	.	D	.	.	.	0.79771	3845	0.432327	.	.	.	.	0.91343	.	.	.	.	.	.	.	12	KRAS	.	.	Asp	.	.	12-25209904-T-A	Acute_myeloid_leukemia|Autoimmune_lymphoproliferative_syndrome_type_4|Malignant_tumor_of_urinary_bladder|Lung_carcinoma|Cardiofaciocutaneous_syndrome_2|Carcinoma_of_pancreas|Hereditary_diffuse_gastric_adenocarcinoma|Linear_nevus_sebaceous_syndrome|Cerebral_arteriovenous_malformation|Noonan_syndrome_3|Familial_cancer_of_breast|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|not_provided|Cardiovascular_phenotype|RASopathy|Noonan_syndrome_1|not_specified	.	.	25254105	ClinGen:CA256478|OMIM:190070.0010|OMIM:190070.0015	0.867497	0.70896	.	RCV000013418|RCV000013417|RCV000157940|RCV000212501|RCV000507330|RCV000763307|RCV000523200|RCV000844634|RCV003450634|RCV004018621	.	.	.	c.383A>T	.	.	.	0.91589	T/T	rs104894360	25209904	.	T	.	.	.	.	.	0.68239		.	.	.	.	.	.	.	5.87	.	.	D	.	.	.	.	.	.	.	.	519|268114|157980|1340|1333|217074|26106|2612|46724|648|227535|1340|648|536391|648	12587	0.91485	.	0.955039322376251	.	.	0.71675	0.78650	.	.	.	7.628	.	.	.	.	.	.	601626|614470|109800|615278|137215|163200|108010|609942|114480|PS115150|PS163950|163950	0.82424	12	.	ENSG00000133703	.	.	.	.	.	2	0.47676	0.30573	.	.	.	.	0.631385021559758	.	.	0.435687	27626	HGNC:6407	.	.	.	0.991	.	25209904	GAT	1.000000	.	-	.	0.91672	.	.	.	Pathogenic	0.77191	.	.	.	ClinGen:CA256478,OMIM:190070.0010,OMIM:190070.0015	D	.	.	-	.	-	0.93732	.	.	.	.	.	.	0.99233185239291311	.	-	458A>T 	.	.	C0023467|C2674723|C0005684|C0684249|C3809005|C0235974|C1708349|C4552097|C0917804|C1860991|C0346153|C1275081|C0028326|C3661900|CN230736|C5555857|C4551602|CN169374	.	.	.	.	NM_004985.5	-	.	.	1	0.90939	104894360	.	.	0.92600	0.77104	.	.	.	0.96898425	5.87	.	.	.	0.383231	.	.	D	.	.	.	0.2042	0.79666	p.Asp128Val	.	.	.	.	.	.	12587	.	.	KRAS	.	D	.	.	.	.	.	0.30331	T/T	.																																																																																																				
F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly357Arg	23	139561754	G	A	X											X-139561754-G-A	-	0.87068	1.0	357	.	.	.	X	138643913	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly357Arg	.	29.1	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99157	Select	0.9544	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.36509	.	.	.	.	0.96333	.	.	0.99944	1.0	.	0.0	0.921608	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561754G>A	.	.	3	0.9819979	.	0	0.9938451	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	.	.	.	.	0.99291	D	0.99892	D	H	.	.	G/G	108	0	.	.	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	.	0.98863	.	.	-	139561754	.	-	11.888000	.	0.99985	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.99859	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1069G>A	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2	.	FA9_HUMAN	.	100.0	.	.	D	0.93613	0.99436826	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Gly357Arg	.	0.99016	.	germline	.		G	Sep 01, 2022	.	G/G	.	.	1.0	N	Xq27.1	7696	.	.	SCV000899416|SCV002573125	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	5.190434	0.92967	.	D	-	.	.	0.99300	610	.	.	0.99466	0	139561754	Y	10	0	.	.	P00740	.	0.974572	0.98450		.	0.999	D	.	0.98331475	.	0.97202	2158	0.726137	.	-7.95	.	.	0.78662	.	.	.	.	.	.	0.99865	X	F9	.	0	Gly	12522	.	X-139561754-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	.	.	138471579	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	.	.	.	RCV000011357|RCV000851648	D	.	.	c.1069G>A	.	.	.	0.99952	G/G	rs137852257	139561754	.	G	.	P00740	.	0.99928	.	0.68239		.	.	.	4.18	0	0	264690	4.8	0.99744	142	D	T	.	.	0	24	.	.	.	98879|98878	10611	0.99952	0.91559	0.999871015548706	3250	.	0.71675	.	.	.	.	9.568	.	D	.	.	1.51120175E-5	0	306900|134500|306700	0.97322	X	.	ENSG00000101981	.	0	.	0	0.9982126436659727	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.906856	25650	HGNC:3551	A	.	simple_aae	1	.	139561754	GGA	1.000000	.	-	0	0.99977	.	0	.	Pathogenic/Likely pathogenic	0.95239	.	.	.	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	G	.	0.997918789465	-	0.986	-	0.99826	.	578	0.99820	0.483639627695	0.9808	.	0.99916914203747009	100	-	1069G>A 	.	0	C0008533|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.71470	137852257	.	0	0.99786	.	0.916	0.0	3142	0.99999261	5.66	.	.	.	0.805269	0.999911895729495	0.97682	D	118	.	.	1.0795	0.98518	p.Gly357Arg	0	.	-14.024	0.995182	.	0.98806	10611	D	.	F9	.	D	0.953	.	G357R	D	.	0.76753	G/G	principal1	144738	F9_Popp_2025_carboxy_F9_specific_var228177	No											G		1069	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Gly357Arg		true	c.1069G>A						3551.0	139561754.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				Gly357Arg						R	Sep 01, 2022					missense_variant		357.0				1.092139475		Pathogenic/Likely pathogenic	139561754.0	missense_variant		0.953					Reporter			F9_Gly357Arg
F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly357Arg	23	139561754	G	A	X											X-139561754-G-A	-	0.87068	1.0	357	.	.	.	X	138643913	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly357Arg	.	29.1	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99157	Select	0.9544	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.36509	.	.	.	.	0.96333	.	.	0.99944	1.0	.	0.0	0.921608	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561754G>A	.	.	3	0.9819979	.	0	0.9938451	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	.	.	.	.	0.99291	D	0.99892	D	H	.	.	G/G	108	0	.	.	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	.	0.98863	.	.	-	139561754	.	-	11.888000	.	0.99985	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.99859	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1069G>A	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2	.	FA9_HUMAN	.	100.0	.	.	D	0.93613	0.99436826	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Gly357Arg	.	0.99016	.	germline	.		G	Sep 01, 2022	.	G/G	.	.	1.0	N	Xq27.1	7696	.	.	SCV000899416|SCV002573125	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	5.190434	0.92967	.	D	-	.	.	0.99300	610	.	.	0.99466	0	139561754	Y	10	0	.	.	P00740	.	0.974572	0.98450		.	0.999	D	.	0.98331475	.	0.97202	2158	0.726137	.	-7.95	.	.	0.78662	.	.	.	.	.	.	0.99865	X	F9	.	0	Gly	12522	.	X-139561754-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	.	.	138471579	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	.	.	.	RCV000011357|RCV000851648	D	.	.	c.1069G>A	.	.	.	0.99952	G/G	rs137852257	139561754	.	G	.	P00740	.	0.99928	.	0.68239		.	.	.	4.18	0	0	264690	4.8	0.99744	142	D	T	.	.	0	24	.	.	.	98879|98878	10611	0.99952	0.91559	0.999871015548706	3250	.	0.71675	.	.	.	.	9.568	.	D	.	.	1.51120175E-5	0	306900|134500|306700	0.97322	X	.	ENSG00000101981	.	0	.	0	0.9982126436659727	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.906856	25650	HGNC:3551	A	.	simple_aae	1	.	139561754	GGA	1.000000	.	-	0	0.99977	.	0	.	Pathogenic/Likely pathogenic	0.95239	.	.	.	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	G	.	0.997918789465	-	0.986	-	0.99826	.	578	0.99820	0.483639627695	0.9808	.	0.99916914203747009	100	-	1069G>A 	.	0	C0008533|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.71470	137852257	.	0	0.99786	.	0.916	0.0	3142	0.99999261	5.66	.	.	.	0.805269	0.999911895729495	0.97682	D	118	.	.	1.0795	0.98518	p.Gly357Arg	0	.	-14.024	0.995182	.	0.98806	10611	D	.	F9	.	D	0.953	.	G357R	D	.	0.76753	G/G	principal1	227286	F9_Popp_2025_light_chain_var247539	No											G		1069	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Gly357Arg		true	c.1069G>A						3551.0	139561754.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				Gly357Arg						R	Sep 01, 2022					missense_variant		357.0				1.0929588609411258		Pathogenic/Likely pathogenic	139561754.0	missense_variant		0.953					Reporter			F9_Gly357Arg
F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly357Arg	23	139561754	G	A	X											X-139561754-G-A	-	0.87068	1.0	357	.	.	.	X	138643913	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly357Arg	.	29.1	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99157	Select	0.9544	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.36509	.	.	.	.	0.96333	.	.	0.99944	1.0	.	0.0	0.921608	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561754G>A	.	.	3	0.9819979	.	0	0.9938451	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	.	.	.	.	0.99291	D	0.99892	D	H	.	.	G/G	108	0	.	.	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	.	0.98863	.	.	-	139561754	.	-	11.888000	.	0.99985	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.99859	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1069G>A	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2	.	FA9_HUMAN	.	100.0	.	.	D	0.93613	0.99436826	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Gly357Arg	.	0.99016	.	germline	.		G	Sep 01, 2022	.	G/G	.	.	1.0	N	Xq27.1	7696	.	.	SCV000899416|SCV002573125	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	5.190434	0.92967	.	D	-	.	.	0.99300	610	.	.	0.99466	0	139561754	Y	10	0	.	.	P00740	.	0.974572	0.98450		.	0.999	D	.	0.98331475	.	0.97202	2158	0.726137	.	-7.95	.	.	0.78662	.	.	.	.	.	.	0.99865	X	F9	.	0	Gly	12522	.	X-139561754-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	.	.	138471579	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	.	.	.	RCV000011357|RCV000851648	D	.	.	c.1069G>A	.	.	.	0.99952	G/G	rs137852257	139561754	.	G	.	P00740	.	0.99928	.	0.68239		.	.	.	4.18	0	0	264690	4.8	0.99744	142	D	T	.	.	0	24	.	.	.	98879|98878	10611	0.99952	0.91559	0.999871015548706	3250	.	0.71675	.	.	.	.	9.568	.	D	.	.	1.51120175E-5	0	306900|134500|306700	0.97322	X	.	ENSG00000101981	.	0	.	0	0.9982126436659727	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.906856	25650	HGNC:3551	A	.	simple_aae	1	.	139561754	GGA	1.000000	.	-	0	0.99977	.	0	.	Pathogenic/Likely pathogenic	0.95239	.	.	.	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	G	.	0.997918789465	-	0.986	-	0.99826	.	578	0.99820	0.483639627695	0.9808	.	0.99916914203747009	100	-	1069G>A 	.	0	C0008533|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.71470	137852257	.	0	0.99786	.	0.916	0.0	3142	0.99999261	5.66	.	.	.	0.805269	0.999911895729495	0.97682	D	118	.	.	1.0795	0.98518	p.Gly357Arg	0	.	-14.024	0.995182	.	0.98806	10611	D	.	F9	.	D	0.953	.	G357R	D	.	0.76753	G/G	principal1	172254	F9_Popp_2025_carboxy_gla_motif_var257220	No											G		1069	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Gly357Arg		true	c.1069G>A						3551.0	139561754.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				Gly357Arg						R	Sep 01, 2022					missense_variant		357.0				1.090086830285221		Pathogenic/Likely pathogenic	139561754.0	missense_variant		0.953					Reporter			F9_Gly357Arg
F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly357Arg	23	139561754	G	A	X											X-139561754-G-A	-	0.87068	1.0	357	.	.	.	X	138643913	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly357Arg	.	29.1	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99157	Select	0.9544	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.36509	.	.	.	.	0.96333	.	.	0.99944	1.0	.	0.0	0.921608	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561754G>A	.	.	3	0.9819979	.	0	0.9938451	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	.	.	.	.	0.99291	D	0.99892	D	H	.	.	G/G	108	0	.	.	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	.	0.98863	.	.	-	139561754	.	-	11.888000	.	0.99985	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.99859	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1069G>A	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2	.	FA9_HUMAN	.	100.0	.	.	D	0.93613	0.99436826	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Gly357Arg	.	0.99016	.	germline	.		G	Sep 01, 2022	.	G/G	.	.	1.0	N	Xq27.1	7696	.	.	SCV000899416|SCV002573125	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	5.190434	0.92967	.	D	-	.	.	0.99300	610	.	.	0.99466	0	139561754	Y	10	0	.	.	P00740	.	0.974572	0.98450		.	0.999	D	.	0.98331475	.	0.97202	2158	0.726137	.	-7.95	.	.	0.78662	.	.	.	.	.	.	0.99865	X	F9	.	0	Gly	12522	.	X-139561754-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	.	.	138471579	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	.	.	.	RCV000011357|RCV000851648	D	.	.	c.1069G>A	.	.	.	0.99952	G/G	rs137852257	139561754	.	G	.	P00740	.	0.99928	.	0.68239		.	.	.	4.18	0	0	264690	4.8	0.99744	142	D	T	.	.	0	24	.	.	.	98879|98878	10611	0.99952	0.91559	0.999871015548706	3250	.	0.71675	.	.	.	.	9.568	.	D	.	.	1.51120175E-5	0	306900|134500|306700	0.97322	X	.	ENSG00000101981	.	0	.	0	0.9982126436659727	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.906856	25650	HGNC:3551	A	.	simple_aae	1	.	139561754	GGA	1.000000	.	-	0	0.99977	.	0	.	Pathogenic/Likely pathogenic	0.95239	.	.	.	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	G	.	0.997918789465	-	0.986	-	0.99826	.	578	0.99820	0.483639627695	0.9808	.	0.99916914203747009	100	-	1069G>A 	.	0	C0008533|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.71470	137852257	.	0	0.99786	.	0.916	0.0	3142	0.99999261	5.66	.	.	.	0.805269	0.999911895729495	0.97682	D	118	.	.	1.0795	0.98518	p.Gly357Arg	0	.	-14.024	0.995182	.	0.98806	10611	D	.	F9	.	D	0.953	.	G357R	D	.	0.76753	G/G	principal1	199770	F9_Popp_2025_heavy_chain_var237858	No											G		1069	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Gly357Arg		true	c.1069G>A						3551.0	139561754.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				Gly357Arg						R	Sep 01, 2022					missense_variant		357.0				1.0398613047454082		Pathogenic/Likely pathogenic	139561754.0	missense_variant		0.953					Reporter			F9_Gly357Arg
F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	NC_000023.11:139561754:G:A	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly357Arg	23	139561754	G	A	X											X-139561754-G-A	-	0.87068	1.0	357	.	.	.	X	138643913	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly357Arg	.	29.1	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99157	Select	0.9544	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.36509	.	.	.	.	0.96333	.	.	0.99944	1.0	.	0.0	0.921608	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561754G>A	.	.	3	0.9819979	.	0	0.9938451	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	.	.	.	.	0.99291	D	0.99892	D	H	.	.	G/G	108	0	.	.	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	.	0.98863	.	.	-	139561754	.	-	11.888000	.	0.99985	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.99859	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1069G>A	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2	.	FA9_HUMAN	.	100.0	.	.	D	0.93613	0.99436826	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Gly357Arg	.	0.99016	.	germline	.		G	Sep 01, 2022	.	G/G	.	.	1.0	N	Xq27.1	7696	.	.	SCV000899416|SCV002573125	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	5.190434	0.92967	.	D	-	.	.	0.99300	610	.	.	0.99466	0	139561754	Y	10	0	.	.	P00740	.	0.974572	0.98450		.	0.999	D	.	0.98331475	.	0.97202	2158	0.726137	.	-7.95	.	.	0.78662	.	.	.	.	.	.	0.99865	X	F9	.	0	Gly	12522	.	X-139561754-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	.	.	138471579	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	.	.	.	RCV000011357|RCV000851648	D	.	.	c.1069G>A	.	.	.	0.99952	G/G	rs137852257	139561754	.	G	.	P00740	.	0.99928	.	0.68239		.	.	.	4.18	0	0	264690	4.8	0.99744	142	D	T	.	.	0	24	.	.	.	98879|98878	10611	0.99952	0.91559	0.999871015548706	3250	.	0.71675	.	.	.	.	9.568	.	D	.	.	1.51120175E-5	0	306900|134500|306700	0.97322	X	.	ENSG00000101981	.	0	.	0	0.9982126436659727	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.906856	25650	HGNC:3551	A	.	simple_aae	1	.	139561754	GGA	1.000000	.	-	0	0.99977	.	0	.	Pathogenic/Likely pathogenic	0.95239	.	.	.	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	G	.	0.997918789465	-	0.986	-	0.99826	.	578	0.99820	0.483639627695	0.9808	.	0.99916914203747009	100	-	1069G>A 	.	0	C0008533|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.71470	137852257	.	0	0.99786	.	0.916	0.0	3142	0.99999261	5.66	.	.	.	0.805269	0.999911895729495	0.97682	D	118	.	.	1.0795	0.98518	p.Gly357Arg	0	.	-14.024	0.995182	.	0.98806	10611	D	.	F9	.	D	0.953	.	G357R	D	.	0.76753	G/G	principal1	254802	F9_Popp_2025_strep_2_var266901	No											G		1069	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Gly357Arg		true	c.1069G>A						3551.0	139561754.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				Gly357Arg						R	Sep 01, 2022					missense_variant		357.0				0.929428832801446		Pathogenic/Likely pathogenic	139561754.0	missense_variant		0.953					Reporter			F9_Gly357Arg
F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004386		NC_000023.11:139561754:G:A		Gly357Arg																												F9_Gly357Arg	23	139561754	G	A	X	allele	1069G>A	G03	527_CAVA_Array_P02	M06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561754-G-A	-	0.87068	1.0	357	.	.	.	X	138643913	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly357Arg	.	29.1	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99157	Select	0.9544	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.36509	.	.	.	.	0.96333	.	.	0.99944	1.0	.	0.0	0.921608	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561754G>A	.	.	3	0.9819979	.	0	0.9938451	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	.	.	.	.	0.99291	D	0.99892	D	H	.	.	G/G	108	0	.	.	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	.	0.98863	.	.	-	139561754	.	-	11.888000	.	0.99985	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.99859	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1069G>A	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2	.	FA9_HUMAN	.	100.0	.	.	D	0.93613	0.99436826	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Gly357Arg	.	0.99016	.	germline	.		G	Sep 01, 2022	.	G/G	.	.	1.0	N	Xq27.1	7696	.	.	SCV000899416|SCV002573125	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	5.190434	0.92967	.	D	-	.	.	0.99300	610	.	.	0.99466	0	139561754	Y	10	0	.	.	P00740	.	0.974572	0.98450		.	0.999	D	.	0.98331475	.	0.97202	2158	0.726137	.	-7.95	.	.	0.78662	.	.	.	.	.	.	0.99865	X	F9	.	0	Gly	12522	.	X-139561754-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	.	.	138471579	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	.	.	.	RCV000011357|RCV000851648	D	.	.	c.1069G>A	.	.	.	0.99952	G/G	rs137852257	139561754	.	G	.	P00740	.	0.99928	.	0.68239		.	.	.	4.18	0	0	264690	4.8	0.99744	142	D	T	.	.	0	24	.	.	.	98879|98878	10611	0.99952	0.91559	0.999871015548706	3250	.	0.71675	.	.	.	.	9.568	.	D	.	.	1.51120175E-5	0	306900|134500|306700	0.97322	X	.	ENSG00000101981	.	0	.	0	0.9982126436659727	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.906856	25650	HGNC:3551	A	.	simple_aae	1	.	139561754	GGA	1.000000	.	-	0	0.99977	.	0	.	Pathogenic/Likely pathogenic	0.95239	.	.	.	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	G	.	0.997918789465	-	0.986	-	0.99826	.	578	0.99820	0.483639627695	0.9808	.	0.99916914203747009	100	-	1069G>A 	.	0	C0008533|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.71470	137852257	.	0	0.99786	.	0.916	0.0	3142	0.99999261	5.66	.	.	.	0.805269	0.999911895729495	0.97682	D	118	.	.	1.0795	0.98518	p.Gly357Arg	0	.	-14.024	0.995182	.	0.98806	10611	D	.	F9	.	D	0.953	.	G357R	D	.	0.76753	G/G	principal1	144738	F9_Popp_2025_carboxy_F9_specific_var228177	No											G		1069	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Gly357Arg		true	c.1069G>A						3551.0	139561754.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				Gly357Arg						R	Sep 01, 2022					missense_variant		357.0				1.092139475		Pathogenic/Likely pathogenic	139561754.0	missense_variant		0.953					Reporter			F9_Gly357Arg
F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004386		NC_000023.11:139561754:G:A		Gly357Arg																												F9_Gly357Arg	23	139561754	G	A	X	allele	1069G>A	G03	527_CAVA_Array_P02	M06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561754-G-A	-	0.87068	1.0	357	.	.	.	X	138643913	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly357Arg	.	29.1	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99157	Select	0.9544	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.36509	.	.	.	.	0.96333	.	.	0.99944	1.0	.	0.0	0.921608	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561754G>A	.	.	3	0.9819979	.	0	0.9938451	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	.	.	.	.	0.99291	D	0.99892	D	H	.	.	G/G	108	0	.	.	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	.	0.98863	.	.	-	139561754	.	-	11.888000	.	0.99985	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.99859	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1069G>A	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2	.	FA9_HUMAN	.	100.0	.	.	D	0.93613	0.99436826	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Gly357Arg	.	0.99016	.	germline	.		G	Sep 01, 2022	.	G/G	.	.	1.0	N	Xq27.1	7696	.	.	SCV000899416|SCV002573125	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	5.190434	0.92967	.	D	-	.	.	0.99300	610	.	.	0.99466	0	139561754	Y	10	0	.	.	P00740	.	0.974572	0.98450		.	0.999	D	.	0.98331475	.	0.97202	2158	0.726137	.	-7.95	.	.	0.78662	.	.	.	.	.	.	0.99865	X	F9	.	0	Gly	12522	.	X-139561754-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	.	.	138471579	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	.	.	.	RCV000011357|RCV000851648	D	.	.	c.1069G>A	.	.	.	0.99952	G/G	rs137852257	139561754	.	G	.	P00740	.	0.99928	.	0.68239		.	.	.	4.18	0	0	264690	4.8	0.99744	142	D	T	.	.	0	24	.	.	.	98879|98878	10611	0.99952	0.91559	0.999871015548706	3250	.	0.71675	.	.	.	.	9.568	.	D	.	.	1.51120175E-5	0	306900|134500|306700	0.97322	X	.	ENSG00000101981	.	0	.	0	0.9982126436659727	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.906856	25650	HGNC:3551	A	.	simple_aae	1	.	139561754	GGA	1.000000	.	-	0	0.99977	.	0	.	Pathogenic/Likely pathogenic	0.95239	.	.	.	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	G	.	0.997918789465	-	0.986	-	0.99826	.	578	0.99820	0.483639627695	0.9808	.	0.99916914203747009	100	-	1069G>A 	.	0	C0008533|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.71470	137852257	.	0	0.99786	.	0.916	0.0	3142	0.99999261	5.66	.	.	.	0.805269	0.999911895729495	0.97682	D	118	.	.	1.0795	0.98518	p.Gly357Arg	0	.	-14.024	0.995182	.	0.98806	10611	D	.	F9	.	D	0.953	.	G357R	D	.	0.76753	G/G	principal1	227286	F9_Popp_2025_light_chain_var247539	No											G		1069	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Gly357Arg		true	c.1069G>A						3551.0	139561754.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				Gly357Arg						R	Sep 01, 2022					missense_variant		357.0				1.0929588609411258		Pathogenic/Likely pathogenic	139561754.0	missense_variant		0.953					Reporter			F9_Gly357Arg
F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004386		NC_000023.11:139561754:G:A		Gly357Arg																												F9_Gly357Arg	23	139561754	G	A	X	allele	1069G>A	G03	527_CAVA_Array_P02	M06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561754-G-A	-	0.87068	1.0	357	.	.	.	X	138643913	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly357Arg	.	29.1	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99157	Select	0.9544	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.36509	.	.	.	.	0.96333	.	.	0.99944	1.0	.	0.0	0.921608	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561754G>A	.	.	3	0.9819979	.	0	0.9938451	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	.	.	.	.	0.99291	D	0.99892	D	H	.	.	G/G	108	0	.	.	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	.	0.98863	.	.	-	139561754	.	-	11.888000	.	0.99985	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.99859	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1069G>A	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2	.	FA9_HUMAN	.	100.0	.	.	D	0.93613	0.99436826	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Gly357Arg	.	0.99016	.	germline	.		G	Sep 01, 2022	.	G/G	.	.	1.0	N	Xq27.1	7696	.	.	SCV000899416|SCV002573125	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	5.190434	0.92967	.	D	-	.	.	0.99300	610	.	.	0.99466	0	139561754	Y	10	0	.	.	P00740	.	0.974572	0.98450		.	0.999	D	.	0.98331475	.	0.97202	2158	0.726137	.	-7.95	.	.	0.78662	.	.	.	.	.	.	0.99865	X	F9	.	0	Gly	12522	.	X-139561754-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	.	.	138471579	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	.	.	.	RCV000011357|RCV000851648	D	.	.	c.1069G>A	.	.	.	0.99952	G/G	rs137852257	139561754	.	G	.	P00740	.	0.99928	.	0.68239		.	.	.	4.18	0	0	264690	4.8	0.99744	142	D	T	.	.	0	24	.	.	.	98879|98878	10611	0.99952	0.91559	0.999871015548706	3250	.	0.71675	.	.	.	.	9.568	.	D	.	.	1.51120175E-5	0	306900|134500|306700	0.97322	X	.	ENSG00000101981	.	0	.	0	0.9982126436659727	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.906856	25650	HGNC:3551	A	.	simple_aae	1	.	139561754	GGA	1.000000	.	-	0	0.99977	.	0	.	Pathogenic/Likely pathogenic	0.95239	.	.	.	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	G	.	0.997918789465	-	0.986	-	0.99826	.	578	0.99820	0.483639627695	0.9808	.	0.99916914203747009	100	-	1069G>A 	.	0	C0008533|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.71470	137852257	.	0	0.99786	.	0.916	0.0	3142	0.99999261	5.66	.	.	.	0.805269	0.999911895729495	0.97682	D	118	.	.	1.0795	0.98518	p.Gly357Arg	0	.	-14.024	0.995182	.	0.98806	10611	D	.	F9	.	D	0.953	.	G357R	D	.	0.76753	G/G	principal1	172254	F9_Popp_2025_carboxy_gla_motif_var257220	No											G		1069	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Gly357Arg		true	c.1069G>A						3551.0	139561754.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				Gly357Arg						R	Sep 01, 2022					missense_variant		357.0				1.090086830285221		Pathogenic/Likely pathogenic	139561754.0	missense_variant		0.953					Reporter			F9_Gly357Arg
F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004386		NC_000023.11:139561754:G:A		Gly357Arg																												F9_Gly357Arg	23	139561754	G	A	X	allele	1069G>A	G03	527_CAVA_Array_P02	M06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561754-G-A	-	0.87068	1.0	357	.	.	.	X	138643913	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly357Arg	.	29.1	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99157	Select	0.9544	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.36509	.	.	.	.	0.96333	.	.	0.99944	1.0	.	0.0	0.921608	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561754G>A	.	.	3	0.9819979	.	0	0.9938451	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	.	.	.	.	0.99291	D	0.99892	D	H	.	.	G/G	108	0	.	.	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	.	0.98863	.	.	-	139561754	.	-	11.888000	.	0.99985	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.99859	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1069G>A	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2	.	FA9_HUMAN	.	100.0	.	.	D	0.93613	0.99436826	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Gly357Arg	.	0.99016	.	germline	.		G	Sep 01, 2022	.	G/G	.	.	1.0	N	Xq27.1	7696	.	.	SCV000899416|SCV002573125	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	5.190434	0.92967	.	D	-	.	.	0.99300	610	.	.	0.99466	0	139561754	Y	10	0	.	.	P00740	.	0.974572	0.98450		.	0.999	D	.	0.98331475	.	0.97202	2158	0.726137	.	-7.95	.	.	0.78662	.	.	.	.	.	.	0.99865	X	F9	.	0	Gly	12522	.	X-139561754-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	.	.	138471579	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	.	.	.	RCV000011357|RCV000851648	D	.	.	c.1069G>A	.	.	.	0.99952	G/G	rs137852257	139561754	.	G	.	P00740	.	0.99928	.	0.68239		.	.	.	4.18	0	0	264690	4.8	0.99744	142	D	T	.	.	0	24	.	.	.	98879|98878	10611	0.99952	0.91559	0.999871015548706	3250	.	0.71675	.	.	.	.	9.568	.	D	.	.	1.51120175E-5	0	306900|134500|306700	0.97322	X	.	ENSG00000101981	.	0	.	0	0.9982126436659727	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.906856	25650	HGNC:3551	A	.	simple_aae	1	.	139561754	GGA	1.000000	.	-	0	0.99977	.	0	.	Pathogenic/Likely pathogenic	0.95239	.	.	.	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	G	.	0.997918789465	-	0.986	-	0.99826	.	578	0.99820	0.483639627695	0.9808	.	0.99916914203747009	100	-	1069G>A 	.	0	C0008533|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.71470	137852257	.	0	0.99786	.	0.916	0.0	3142	0.99999261	5.66	.	.	.	0.805269	0.999911895729495	0.97682	D	118	.	.	1.0795	0.98518	p.Gly357Arg	0	.	-14.024	0.995182	.	0.98806	10611	D	.	F9	.	D	0.953	.	G357R	D	.	0.76753	G/G	principal1	199770	F9_Popp_2025_heavy_chain_var237858	No											G		1069	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Gly357Arg		true	c.1069G>A						3551.0	139561754.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				Gly357Arg						R	Sep 01, 2022					missense_variant		357.0				1.0398613047454082		Pathogenic/Likely pathogenic	139561754.0	missense_variant		0.953					Reporter			F9_Gly357Arg
F9_Gly357Arg	-2.678554259182531	0.03160539804409802	-0.2649616421767047	0.7986717699292339	2025_01_Batch_13-14	0.5945518994223825	0.582100584468294	0.5316904259621111	0.5442982248196072	0.5778750828460288	0.6598582596464473	0.6290356888204685	0.665304093349328	0.7561075329904808	0.6407200859576836	0.6272050795344148	0.6055681366443812	0.5984972596557196	0.650202878905044	0.6092975844018562	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004386		NC_000023.11:139561754:G:A		Gly357Arg																												F9_Gly357Arg	23	139561754	G	A	X	allele	1069G>A	G03	527_CAVA_Array_P02	M06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561754-G-A	-	0.87068	1.0	357	.	.	.	X	138643913	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly357Arg	.	29.1	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99157	Select	0.9544	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.36509	.	.	.	.	0.96333	.	.	0.99944	1.0	.	0.0	0.921608	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561754G>A	.	.	3	0.9819979	.	0	0.9938451	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	.	.	.	.	0.99291	D	0.99892	D	H	.	.	G/G	108	0	.	.	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	.	0.98863	.	.	-	139561754	.	-	11.888000	.	0.99985	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.99859	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1069G>A	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2	.	FA9_HUMAN	.	100.0	.	.	D	0.93613	0.99436826	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Gly357Arg	.	0.99016	.	germline	.		G	Sep 01, 2022	.	G/G	.	.	1.0	N	Xq27.1	7696	.	.	SCV000899416|SCV002573125	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.676	G	.	5.190434	0.92967	.	D	-	.	.	0.99300	610	.	.	0.99466	0	139561754	Y	10	0	.	.	P00740	.	0.974572	0.98450		.	0.999	D	.	0.98331475	.	0.97202	2158	0.726137	.	-7.95	.	.	0.78662	.	.	.	.	.	.	0.99865	X	F9	.	0	Gly	12522	.	X-139561754-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	.	.	138471579	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	.	.	.	RCV000011357|RCV000851648	D	.	.	c.1069G>A	.	.	.	0.99952	G/G	rs137852257	139561754	.	G	.	P00740	.	0.99928	.	0.68239		.	.	.	4.18	0	0	264690	4.8	0.99744	142	D	T	.	.	0	24	.	.	.	98879|98878	10611	0.99952	0.91559	0.999871015548706	3250	.	0.71675	.	.	.	.	9.568	.	D	.	.	1.51120175E-5	0	306900|134500|306700	0.97322	X	.	ENSG00000101981	.	0	.	0	0.9982126436659727	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.906856	25650	HGNC:3551	A	.	simple_aae	1	.	139561754	GGA	1.000000	.	-	0	0.99977	.	0	.	Pathogenic/Likely pathogenic	0.95239	.	.	.	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	G	.	0.997918789465	-	0.986	-	0.99826	.	578	0.99820	0.483639627695	0.9808	.	0.99916914203747009	100	-	1069G>A 	.	0	C0008533|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.71470	137852257	.	0	0.99786	.	0.916	0.0	3142	0.99999261	5.66	.	.	.	0.805269	0.999911895729495	0.97682	D	118	.	.	1.0795	0.98518	p.Gly357Arg	0	.	-14.024	0.995182	.	0.98806	10611	D	.	F9	.	D	0.953	.	G357R	D	.	0.76753	G/G	principal1	254802	F9_Popp_2025_strep_2_var266901	No											G		1069	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Gly357Arg		true	c.1069G>A						3551.0	139561754.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				Gly357Arg						R	Sep 01, 2022					missense_variant		357.0				0.929428832801446		Pathogenic/Likely pathogenic	139561754.0	missense_variant		0.953					Reporter			F9_Gly357Arg
BCL10_Ala5Ser	-2.11002446113385	0.08861914220244649	-0.22462787367078096	0.8286849004700589	2025_01_Batch_13-14	0.8007408407158935	0.707528895168196	0.7844662272572069	0.7226784793589274	0.7541221803752104	0.7683806146572103	0.8285068625475089	0.7666484723157028	0.8121281617033118	0.541453049244701	0.7845607276865518	0.7680178788578524	0.7755573497864549	0.7674033205311196	0.6477876148099557	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BCL10	BCL10	ENSG00000142867	11832	20120	CCSBVarC001763	ALE00001763	NC_000001.11:85276340:C:A	13G>T	Ala5Ser	RC4	RC4_Mut_GDEh1005	H03	GDEhDisVCh_40010	D03	2	RC4_Mut_GDDh1005	H03	NULL	NULL	VUSMutpDEST2_09	F09	VUSmut_GDEh12	B07	1	1	1	1	0			1	1	1	1	1	1	BCL10_Ala5Ser	1	85276340	C	A	1											1-85276340-C-A	-	0.36089	0.0	5	2251	2701	0	1	85742023	A	2.458810e-02	320	1	2_Benign	NC_000001.11	2701	Ala5Ser	2112	20.1	1071	90	1.194160e-01	T	124	3	.	42754	2.998140e-02	0	30526	8.232760e-02	21	.	Select	0.0231	17686	0.02950	655	0.11706349206349206	T	T	64010	.	0.01	2	8.838910e-02	38	139	0.38062	17098	44842	1821	1.186610e-01	.	1026	.	0.26579	0.99	0.0	.	0.726327	2.73	.	A	single nucleotide variant	NC_000001.11:g.85276340C>A	1	16722	2	0.17036171	109350	0.01824817518248175	0.12828135	0.10230179028132992	A	5798	235746	98	0	1.194160e-01	786	2.399780e-02	1	MONDO:MONDO:0014491,MedGen:C4015195,OMIM:616098|MedGen:C3661900|	3040	98	6.030700e-02	55	.	B	0.38716	B	N	1.343174	39674	C/C	360	725	7152	1613546	Immunodeficiency 37|not provided|BCL10-related disorder	16198	0.26684	16	.	-	85276340	1.184470e-01	-	3.253000	67	0.33416	29582	0.021739130434782608	29582	1591	germline	91032	.	.	GRCh38	839	criteria provided, multiple submitters, no conflicts	c.13G>T	1.873810e-02	0.35642	6038	1	519	.	4.245900e-03	9042	B	0.0855530474040632	9.130550e-02	NM_003921.5(BCL10):c.13G>T (p.Ala5Ser)	2	70	BCL10_HUMAN	2	.	-0.418389870164214	551	T	0.11803	0.11355482	-	3.914990e-03	14	0.0247372	1591	8.368270e-02	0	34240	criteria_provided,_multiple_submitters,_no_conflicts	0.01318	2.780060e-02	780	4.110000e-03	32	59992	p.Ala5Ser	19	0.37120	.	germline	1071	85276340	C	Feb 03, 2025	572	C/C	191	88452	0.983	N	1p22.3	162754	.	4.136310e-03	SCV000655451|SCV005280959	Benign	55	845	Ser	S	-	912	ENSP00000498104	ENST00000648566	17686	.	13408	231	0.599	C	1	2.748674	0.07361	N	.	-	1.713435	.	.	966	1	0.0268389662027833	0.00357	640	85276340	Y	9	0.03689567430025445	101642	6.448410e-02	O95999	0	0.305241	0.68658	C	70	0.001	.	13408	0.16866185	9042	0.65338	8915	-0.689941	26788	.	0.014314928425357873	9.130550e-02	.	1.873800e-02	12	75002	1.184470e-01	6048	28	0.39010	1	BCL10	4.919870e-03	5	Ala	194788	2.544880e-02	1-85276340-C-A	BCL10-related_disorder|Immunodeficiency_37	124	2528	85514611	ClinGen:CA929838	0.140710	0.24553	305	RCV000532322|RCV004714073|RCV003915633	T	225	14	c.13G>T	14	3907	342	0.00041	C/C	rs12037217	85276340	14888	C	0.03494408945686901	.	15690	0.29734	4.538300e-03	0.68239	1	1	33	8.712810e-02	0.69	0.002777777777777778	4527	264690	3.19	0.67569	6256	T	T	61	1.806440e-02	29	1826	.	0	71	.	475271	0.07582	.	0.0156444791003721	9360	175	0.35756	0.26053	1.912970e-02	1.186610e-01	1179642	1.77	2.801590e-02	.	13382	114	0.02548264	379	616098	0.38267	1	4.097260e-03	ENSG00000142867	5.342920e-03	0.027814984577952	572	0.1429353778751369	.	1	0.04348	0.37627	30608	6745	2.487160e-02	2.206960e-02	-0.230976240330979	YES	2.000400e-02	.	448386	HGNC:989	.	7	.	0.124	206954	85276340	GCA	1.000000	118	-	0.009722222222222222	0.00018	2.270860e-02	91	41	Benign	0.06160	294	390	1324	ClinGen:CA929838	A	114	.	-	.	-	0.00874	7068	14392	.	0.494869709015	0.0874	15	0.99510976220833802	274	-	13G>T 	2112	0.05037520844913841	C4015195	23	139	191	7	NM_003921.5	-	27	0.023054755043227664	0	0.33844	12037217	2320	0.030997802739388465	.	0.30116	.	.	9000	0.00011795	5.12	.	.	1.868790e-02	-0.667112	0.00201335097249276	0.16877	T	4430	6202	9560	-1.0105	0.09750	p.Ala5Ser	261	2	-2.553	0.0015875101	369	0.13098	475271	T	30502	BCL10	1.871560e-02	T	.	21594	.	.	0.49939	0.40292	C/C	principal1																																																																																																				
BCL10_Ala5Ser	-2.11002446113385	0.08861914220244649	-0.22462787367078096	0.8286849004700589	2025_01_Batch_13-14	0.8007408407158935	0.707528895168196	0.7844662272572069	0.7226784793589274	0.7541221803752104	0.7683806146572103	0.8285068625475089	0.7666484723157028	0.8121281617033118	0.541453049244701	0.7845607276865518	0.7680178788578524	0.7755573497864549	0.7674033205311196	0.6477876148099557	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BCL10	BCL10		11832		CCSBVarC001763		NC_000001.11:85276340:C:A		Ala5Ser																												BCL10_Ala5Ser	1	85276340	C	A	1	allele	13G>T	B03	527_CAVA_Array_P01	C05	B13A7A8P1_R1	B14A7A8P1_R2				1-85276340-C-A	-	0.36089	0.0	5	2251	2701	0	1	85742023	A	2.458810e-02	320	1	2_Benign	NC_000001.11	2701	Ala5Ser	2112	20.1	1071	90	1.194160e-01	T	124	3	.	42754	2.998140e-02	0	30526	8.232760e-02	21	.	Select	0.0231	17686	0.02950	655	0.11706349206349206	T	T	64010	.	0.01	2	8.838910e-02	38	139	0.38062	17098	44842	1821	1.186610e-01	.	1026	.	0.26579	0.99	0.0	.	0.726327	2.73	.	A	single nucleotide variant	NC_000001.11:g.85276340C>A	1	16722	2	0.17036171	109350	0.01824817518248175	0.12828135	0.10230179028132992	A	5798	235746	98	0	1.194160e-01	786	2.399780e-02	1	MONDO:MONDO:0014491,MedGen:C4015195,OMIM:616098|MedGen:C3661900|	3040	98	6.030700e-02	55	.	B	0.38716	B	N	1.343174	39674	C/C	360	725	7152	1613546	Immunodeficiency 37|not provided|BCL10-related disorder	16198	0.26684	16	.	-	85276340	1.184470e-01	-	3.253000	67	0.33416	29582	0.021739130434782608	29582	1591	germline	91032	.	.	GRCh38	839	criteria provided, multiple submitters, no conflicts	c.13G>T	1.873810e-02	0.35642	6038	1	519	.	4.245900e-03	9042	B	0.0855530474040632	9.130550e-02	NM_003921.5(BCL10):c.13G>T (p.Ala5Ser)	2	70	BCL10_HUMAN	2	.	-0.418389870164214	551	T	0.11803	0.11355482	-	3.914990e-03	14	0.0247372	1591	8.368270e-02	0	34240	criteria_provided,_multiple_submitters,_no_conflicts	0.01318	2.780060e-02	780	4.110000e-03	32	59992	p.Ala5Ser	19	0.37120	.	germline	1071	85276340	C	Feb 03, 2025	572	C/C	191	88452	0.983	N	1p22.3	162754	.	4.136310e-03	SCV000655451|SCV005280959	Benign	55	845	Ser	S	-	912	ENSP00000498104	ENST00000648566	17686	.	13408	231	0.599	C	1	2.748674	0.07361	N	.	-	1.713435	.	.	966	1	0.0268389662027833	0.00357	640	85276340	Y	9	0.03689567430025445	101642	6.448410e-02	O95999	0	0.305241	0.68658	C	70	0.001	.	13408	0.16866185	9042	0.65338	8915	-0.689941	26788	.	0.014314928425357873	9.130550e-02	.	1.873800e-02	12	75002	1.184470e-01	6048	28	0.39010	1	BCL10	4.919870e-03	5	Ala	194788	2.544880e-02	1-85276340-C-A	BCL10-related_disorder|Immunodeficiency_37	124	2528	85514611	ClinGen:CA929838	0.140710	0.24553	305	RCV000532322|RCV004714073|RCV003915633	T	225	14	c.13G>T	14	3907	342	0.00041	C/C	rs12037217	85276340	14888	C	0.03494408945686901	.	15690	0.29734	4.538300e-03	0.68239	1	1	33	8.712810e-02	0.69	0.002777777777777778	4527	264690	3.19	0.67569	6256	T	T	61	1.806440e-02	29	1826	.	0	71	.	475271	0.07582	.	0.0156444791003721	9360	175	0.35756	0.26053	1.912970e-02	1.186610e-01	1179642	1.77	2.801590e-02	.	13382	114	0.02548264	379	616098	0.38267	1	4.097260e-03	ENSG00000142867	5.342920e-03	0.027814984577952	572	0.1429353778751369	.	1	0.04348	0.37627	30608	6745	2.487160e-02	2.206960e-02	-0.230976240330979	YES	2.000400e-02	.	448386	HGNC:989	.	7	.	0.124	206954	85276340	GCA	1.000000	118	-	0.009722222222222222	0.00018	2.270860e-02	91	41	Benign	0.06160	294	390	1324	ClinGen:CA929838	A	114	.	-	.	-	0.00874	7068	14392	.	0.494869709015	0.0874	15	0.99510976220833802	274	-	13G>T 	2112	0.05037520844913841	C4015195	23	139	191	7	NM_003921.5	-	27	0.023054755043227664	0	0.33844	12037217	2320	0.030997802739388465	.	0.30116	.	.	9000	0.00011795	5.12	.	.	1.868790e-02	-0.667112	0.00201335097249276	0.16877	T	4430	6202	9560	-1.0105	0.09750	p.Ala5Ser	261	2	-2.553	0.0015875101	369	0.13098	475271	T	30502	BCL10	1.871560e-02	T	.	21594	.	.	0.49939	0.40292	C/C	principal1																																																																																																				
ZC4H2_Ile7Val	-1.3973623365001806	0.20499887214456444	6.065888508703813	0.0005079045702971349	2025_01_Batch_13-14	0.7632383538736797	0.8936149046548247	0.8807897003645184	0.8389151966396824	0.6777458244127534	0.7312884995637602	0.9369051568891026	0.9621820633037574	0.8941139976864503	0.7038972819567935	0.7472634267187199	0.9152600307719636	0.9214858818341379	0.8665145971630663	0.6908215531847735	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC009155		NC_000023.11:64976359:T:C		Ile7Val																												ZC4H2_Ile7Val	23	64976359	T	C	X	allele	19A>G	C04	527_CAVA_Array_P06	E08	B13A7A8P2_R1	B14A7A8P2_R2				X-64976359-T-C	-	0.35125	0.002	7	22	0	0	X	64196239	C	5.428780e-04	0	X	2_Benign	NC_000023.11	630	Ile7Val	0	19.8	0	0	3.538670e-04	T	1	3	1	30957	1.567680e-04	.	19005	0.000000e+00	0	0.27216	Select	0.1320	73474	0.09864	0	.	T	T	46687	0.722628895279	0	0	0.000000e+00	0	0	0.77118	13663	33739	0	0.000000e+00	0.11844	13	.	0.40220	1.0	.	96.0	0.849515	4.0	0.04	C	single nucleotide variant	NC_000023.11:g.64976359T>C	0	12175	2	0.13270241	80322	0	0.18977433	0		23	172229	0	0	0.000000e+00	442	4.199370e-04	0	MedGen:C3661900|MeSH:D030342,MedGen:C0950123	13	0	0.000000e+00	0	0.13669	B	0.31751	B	L	.	657	T/T	168	4	5702	1210216	not provided|Inborn genetic diseases	13134	0.33106	.	.	-	64976359	4.199370e-04	-	7.617000	0	0.44051	22034	0	895221	0	germline	56809	.	.	GRCh38	45	criteria provided, multiple submitters, no conflicts	c.19A>G	0.000000e+00	0.64600	165	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_018684.4(ZC4H2):c.19A>G (p.Ile7Val)	2	0	ZC4H2_HUMAN	0	4.0	.	0	T	0.50035	0.18977433	-	0.000000e+00	.		22	0.000000e+00	0	27160	criteria_provided,_multiple_submitters,_no_conflicts	0.89902	1.618490e-04	1	0.000000e+00	0	45866	p.Ile7Val	0	0.62206	.	germline	13		T	May 31, 2024	0	T/T	0	64678	1.0	N	Xq11.2	146822	.	0.000000e+00	SCV001794764|SCV003484470|SCV003707394	Benign/Likely_benign	0	0	Val	V	-	685	ENSP00000363972	ENST00000374839	13319	0.351	10128	0	0.609	T	0	2.686521	0.12680	.	T	-	.	.	0.15489	950	0	.	0.08326	0	64976359	Y	9	0	73474	0.000000e+00	Q9NQZ6	0	0.032331	0.29591		0	0.001	T	64678	0.13270241	30957	0.97202	55906	-0.305108	630	-0.26	.	7.037370e-04	0.16776	0.000000e+00	0	57198	0.000000e+00	4373	0	0.31750	X	ZC4H2	8.741560e-05	0	Ile	163728	3.401470e-04	X-64976359-T-C	Inborn_genetic_diseases|not_provided	0	26	64112964	.	.	.	1	RCV001570468|RCV002570776	T	0	0	c.19A>G	0	0	0	0.07976	T/T	rs199516840	64976359	12064	T	.	.	9952	0.40220	0.000000e+00	0.68239		0	0	0.000000e+00	1.32	0	161	264690	4.94	0.22195	3338	T	T	0	0.000000e+00	0	652	.	0	0	.	1204188	0.37710	0.62047	0.0683943516306379	4292	.	0.71675	.	0.000000e+00	3.401470e-04	895221	5.297	1.514760e-04	N	9917	0	1.7378821E-4	0	.	0.65577	X	0.000000e+00	ENSG00000126970	0.000000e+00	0.001096565909741047	0	0	0.5398168254113483	1	0.04348	0.97779	19070	46	3.538670e-04	0.000000e+00	.	YES	0.000000e+00	0.006027	1195793	HGNC:24931	N	0	simple_aae	0.185	151839	64976359	ATC	1.000000	.	-	0	0.10648	7.037370e-04	0	0	Benign/Likely benign	0.20389	0	0	0	ClinGen:CA10433516	I	0	0.334371577756	-	.	-	0.34747	27	7604	0.53715	0.768219232559	0.1285	0	0.96312281054746651	280	-	19A>G 	26	5.260389268805891E-4	C0950123|C3661900	0	0	0	0	NM_018684.4	-	.	.	0	0.53108	199516840	1767	0.0010077689827030197	0.32629	.	0.31	0.678	4124	0.85911566	4.94	.	.	0.000000e+00	-0.359887	0.474340545313315	0.32853	T	2686	4649	7083	-0.9875	0.44177	p.Ile7Val	0	0	-3.754	0.07205117	5	0.60002	1204188	T	24382	ZC4H2	0.000000e+00	T	0.095	15980	.	T	0.76287	0.47831	T/T	principal1																																																																																																				
BRAF_Phe468Ser	-5.287701209677223	0.0011384771237647243	2.961834070476631	0.021050194197223714	2025_01_Batch_13-14	0.5879989123605611	0.6842041802629649	0.669575683879428	0.6931227660608306	0.54522477106327	0.5839173406709097	0.695054024771055	0.67664586718096	0.6993882351754044	0.5572598106102404	0.5859581265157354	0.68962910251701	0.6731107755301939	0.6962555006181175	0.5512422908367552	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220599	CCSBVarC003159	ALE00003159	NC_000007.14:140781605:A:G	1403T>C	Phe468Ser	CEGS2	CegsMutGDEh1010	E05	GDEhDisVCh_40058	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Phe468Ser	7	140781605	A	G	7											7-140781605-A-G	-	0.91162	0.474	468	1	.	0	7	140481405	G	.	0	7	1_Pathogenic	NC_000007.14	.	Phe468Ser	0	32.0	0	0	9.736150e-06	D	.	8	.	42766	4.221440e-06	.	30522	0.000000e+00	0	0.96308	Select	0.6181	102710	0.36638	0	.	D	D	.	.	0	.	0.000000e+00	0	0	0.96070	17110	.	.	0.000000e+00	.	1	.	0.98378	0.998	.	.	0.981002	.	.	G	single nucleotide variant	NC_000007.14:g.140781605A>G	.	16718	2	0.95852166	109386	0	0.9767253	0		1	236886	0	0	0.000000e+00	290	2.338310e-05	0	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||	1	0	.	.	0.99291	B	0.99444	P	L	4.318368	.	./.	54	0	7164	.	not provided|Cardio-facio-cutaneous syndrome|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1|RASopathy|BRAF-related disorder|See cases	16218	0.87139	.	.	-	140781605	2.338310e-05	-	11.190000	0	0.99892	.	0	.	0	de novo;germline	.	Gain of disorder (P = 0.003)| Gain of catalytic residue at F468 (P = 0.0093)| Gain of glycosylation at F468 (P = 0.0356)| Gain of methylation at K473 (P = 0.0485)| Gain of ubiquitination at K473 (P = 0.0682)	0.98057	GRCh38	809	criteria provided, multiple submitters, no conflicts	c.1403T>C	0.000000e+00	0.85695	0	0	0	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	0.000000e+00	9046	P	0	.	NM_004333.6(BRAF):c.1403T>C (p.Phe468Ser)	2	0	BRAF_HUMAN	0	.	0.395979229302215	0	D	0.99795	0.9715668	-	0.000000e+00	.		1	0.000000e+00	0	34254	criteria_provided,_multiple_submitters,_no_conflicts	0.99026	9.141940e-06	.	0.000000e+00	0	.	p.Phe468Ser	.	0.88645	.	germline	1		A	Feb 24, 2023	0	./.	0	89544	1.0	N	7q34	83130	.	0.000000e+00	SCV000057210|SCV000061579|SCV000937062|SCV001482525|SCV002060517|SCV002502773|SCV002523369|SCV004110177	Pathogenic/Likely_pathogenic	0	0	Ser	S	-	.	ENSP00000493543	ENST00000646891	17692	.	13416	0	0.691	A	0	5.459799	.	D	.	-	5.32187	.	0.92721	318	0	.	0.89024	0	140781605	Y	10	0	102710	.	P15056	0	0.8689	0.88648		0	0.333	D	89544	0.96972746	42766	0.85369	673	0.433457	.	.	.	.	.	0.000000e+00	0	.	0.000000e+00	.	0	0.98875	7	BRAF	.	0	Phe	89970	1.116770e-05	7-140781605-A-G	Cardiofaciocutaneous_syndrome_1|not_provided|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|See_cases|RASopathy|BRAF-related_disorder	.	1	140127874	ClinGen:CA280002|UniProtKB:P15056#VAR_035097	0.883596	0.61003	.	RCV000033305|RCV000037917|RCV001813222|RCV001293860|RCV000797502|RCV003407389|RCV002251944	D	.	0	c.1403T>C	0	.	.	0.91644	./.	rs397507473	140781605	14902	A	.	P15056	15688	0.98831	0.000000e+00	0.68239		0	0	.	1.375	0	0	.	5.62	0.97127	3196	D	D	0	0.000000e+00	0	600	segdup	0	0	1340|1340|98733|536391	40366	0.91542	0.97063	0.996321439743042	1288	.	0.71675	0.81195	0.000000e+00	1.116770e-05	.	9.302	4.805430e-06	.	13378	0	.	0	115150|PS115150	0.95273	7	0.000000e+00	ENSG00000157764	.	0	0	0	.	2	0.42166	0.42973	30604	.	9.736150e-06	.	0.517485622092491	YES	.	0.370597	48836	HGNC:1097	.	0	.	0.997	208098	140781605	TTT	1.000000	.	-	0	0.95979	.	0	.	Pathogenic/Likely pathogenic	0.89856	0	.	.	ClinGen:CA280002,UniProtKB:P15056#VAR_035097	F	0	.	-	0.907	-	.	1	1566	0.93588	0.896780073643	0.9997	.	0.99801327173541676	182	-	1403T>C 	1	0	CN029449|C3661900|C1275081|C5681679|C5555857	0	0	0	0	NM_004333.6	-	.	.	1	0.93472	397507473	2320	0	0.99561	0.68999	.	.	1234	0.99889910	5.62	.	.	0.000000e+00	0.384855	0.99997234991302	0.34130	D	2596	6212	9572	0.2775	0.86478	p.Phe468Ser	0	.	-13.116	0.9654888	.	0.99427	40366	D	30520	BRAF	0.000000e+00	D	.	21616	F468S	.	.	0.84104	./.	principal4																																																																																																				
BRAF_Phe468Ser	-5.287701209677223	0.0011384771237647243	2.961834070476631	0.021050194197223714	2025_01_Batch_13-14	0.5879989123605611	0.6842041802629649	0.669575683879428	0.6931227660608306	0.54522477106327	0.5839173406709097	0.695054024771055	0.67664586718096	0.6993882351754044	0.5572598106102404	0.5859581265157354	0.68962910251701	0.6731107755301939	0.6962555006181175	0.5512422908367552	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003159		NC_000007.14:140781605:A:G		Phe468Ser																												BRAF_Phe468Ser	7	140781605	A	G	7	allele	1403T>C	G03	527_CAVA_Array_P01	M05	B13A7A8P1_R1	B14A7A8P1_R2				7-140781605-A-G	-	0.91162	0.474	468	1	.	0	7	140481405	G	.	0	7	1_Pathogenic	NC_000007.14	.	Phe468Ser	0	32.0	0	0	9.736150e-06	D	.	8	.	42766	4.221440e-06	.	30522	0.000000e+00	0	0.96308	Select	0.6181	102710	0.36638	0	.	D	D	.	.	0	.	0.000000e+00	0	0	0.96070	17110	.	.	0.000000e+00	.	1	.	0.98378	0.998	.	.	0.981002	.	.	G	single nucleotide variant	NC_000007.14:g.140781605A>G	.	16718	2	0.95852166	109386	0	0.9767253	0		1	236886	0	0	0.000000e+00	290	2.338310e-05	0	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||	1	0	.	.	0.99291	B	0.99444	P	L	4.318368	.	./.	54	0	7164	.	not provided|Cardio-facio-cutaneous syndrome|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1|RASopathy|BRAF-related disorder|See cases	16218	0.87139	.	.	-	140781605	2.338310e-05	-	11.190000	0	0.99892	.	0	.	0	de novo;germline	.	Gain of disorder (P = 0.003)| Gain of catalytic residue at F468 (P = 0.0093)| Gain of glycosylation at F468 (P = 0.0356)| Gain of methylation at K473 (P = 0.0485)| Gain of ubiquitination at K473 (P = 0.0682)	0.98057	GRCh38	809	criteria provided, multiple submitters, no conflicts	c.1403T>C	0.000000e+00	0.85695	0	0	0	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	0.000000e+00	9046	P	0	.	NM_004333.6(BRAF):c.1403T>C (p.Phe468Ser)	2	0	BRAF_HUMAN	0	.	0.395979229302215	0	D	0.99795	0.9715668	-	0.000000e+00	.		1	0.000000e+00	0	34254	criteria_provided,_multiple_submitters,_no_conflicts	0.99026	9.141940e-06	.	0.000000e+00	0	.	p.Phe468Ser	.	0.88645	.	germline	1		A	Feb 24, 2023	0	./.	0	89544	1.0	N	7q34	83130	.	0.000000e+00	SCV000057210|SCV000061579|SCV000937062|SCV001482525|SCV002060517|SCV002502773|SCV002523369|SCV004110177	Pathogenic/Likely_pathogenic	0	0	Ser	S	-	.	ENSP00000493543	ENST00000646891	17692	.	13416	0	0.691	A	0	5.459799	.	D	.	-	5.32187	.	0.92721	318	0	.	0.89024	0	140781605	Y	10	0	102710	.	P15056	0	0.8689	0.88648		0	0.333	D	89544	0.96972746	42766	0.85369	673	0.433457	.	.	.	.	.	0.000000e+00	0	.	0.000000e+00	.	0	0.98875	7	BRAF	.	0	Phe	89970	1.116770e-05	7-140781605-A-G	Cardiofaciocutaneous_syndrome_1|not_provided|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_and_Noonan-related_syndrome|See_cases|RASopathy|BRAF-related_disorder	.	1	140127874	ClinGen:CA280002|UniProtKB:P15056#VAR_035097	0.883596	0.61003	.	RCV000033305|RCV000037917|RCV001813222|RCV001293860|RCV000797502|RCV003407389|RCV002251944	D	.	0	c.1403T>C	0	.	.	0.91644	./.	rs397507473	140781605	14902	A	.	P15056	15688	0.98831	0.000000e+00	0.68239		0	0	.	1.375	0	0	.	5.62	0.97127	3196	D	D	0	0.000000e+00	0	600	segdup	0	0	1340|1340|98733|536391	40366	0.91542	0.97063	0.996321439743042	1288	.	0.71675	0.81195	0.000000e+00	1.116770e-05	.	9.302	4.805430e-06	.	13378	0	.	0	115150|PS115150	0.95273	7	0.000000e+00	ENSG00000157764	.	0	0	0	.	2	0.42166	0.42973	30604	.	9.736150e-06	.	0.517485622092491	YES	.	0.370597	48836	HGNC:1097	.	0	.	0.997	208098	140781605	TTT	1.000000	.	-	0	0.95979	.	0	.	Pathogenic/Likely pathogenic	0.89856	0	.	.	ClinGen:CA280002,UniProtKB:P15056#VAR_035097	F	0	.	-	0.907	-	.	1	1566	0.93588	0.896780073643	0.9997	.	0.99801327173541676	182	-	1403T>C 	1	0	CN029449|C3661900|C1275081|C5681679|C5555857	0	0	0	0	NM_004333.6	-	.	.	1	0.93472	397507473	2320	0	0.99561	0.68999	.	.	1234	0.99889910	5.62	.	.	0.000000e+00	0.384855	0.99997234991302	0.34130	D	2596	6212	9572	0.2775	0.86478	p.Phe468Ser	0	.	-13.116	0.9654888	.	0.99427	40366	D	30520	BRAF	0.000000e+00	D	.	21616	F468S	.	.	0.84104	./.	principal4																																																																																																				
RET_Thr338Ile	-1.424602819963752	0.19729169514798545	2.2743462514220494	0.05711032904998553	2025_01_Batch_13-14	0.9174918166052234	0.7105123566417155	0.6594978765357586	0.5926499598947482	0.8981003866469992	0.9205314968803489	0.9027881067629824	0.8430259524063524	0.9205832086026784	0.8299564944318886	0.9190116567427862	0.806650231702349	0.7512619144710555	0.7566165842487134	0.8640284405394438	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	RET	RET	ENSG00000165731	8858	202954	CCSBVarC006878	ALE00006876	NC_000010.11:43106521:C:T	1013C>T	Thr338Ile	CEGS2	CegsMutGDEh1025	A12	GDEhDisVCh_40066	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Thr338Ile	10	43106521	C	T	10											10-43106521-C-T	-	0.32347	0.017	338	4	0	0	10	43601969	T	1.921050e-05	0	10	3_Conflicting	NC_000010.11	2	Thr338Ile	0	19.0	0	0	7.836070e-05	T	0	7	5	42620	3.395990e-05	.	30494	0.000000e+00	0	0.72027	Select	0.2905	102092	0.24484	0	.	T	D	63946	0.218286694533	0	0	0.000000e+00	0	0	0.36160	17042	44888	1	0.000000e+00	0.09401	6	.	0.23277	0.734	.	9.0	0.726327	4.24	0.91	T	single nucleotide variant	NC_000010.11:g.43106521C>T	0	16712	2	0.08741958	109044	0	0.14303645	0	T	4	235572	0	0	0.000000e+00	500	1.407790e-04	0	MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900	6	0	0.000000e+00	0	0.92786	B	0.19866	B	M	2.120756	31	C/C	114	1	7096	1613700	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Pheochromocytoma;Familial medullary thyroid carcinoma;Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|not provided	16044	0.53729	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106521	1.407790e-04	-	4.824000	0	0.18082	29596	0	6078	0	germline;unknown	91072	Loss of disorder (P = 0.0525)| Gain of catalytic residue at A342 (P = 0.1324)| Gain of sheet (P = 0.1945)| Gain of MoRF binding (P = 0.2848)| Loss of loop (P = 0.2897)	0.88426	GRCh38	862	criteria provided, conflicting classifications	c.1013C>T	0.000000e+00	0.75341	1	0	0	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	0.000000e+00	9024	B	0	0.000000e+00	NM_020975.6(RET):c.1013C>T (p.Thr338Ile)	1	0	RET_HUMAN	0	91.0	-0.117237538328119	0	T	0.55809	0.099525385	+	0.000000e+00	.	0.000018474	4	0.000000e+00	0	34164	criteria_provided,_conflicting_classifications	0.99419	5.502370e-05	0	0.000000e+00	0	59994	p.Thr338Ile	0	0.45219	.	germline	6	43106521	C	Jan 28, 2025	0	C/C	0	88828	0.974	N	10q11.21	26588	.	0.000000e+00	SCV000664515|SCV000838375|SCV001210484|SCV001440343|SCV005054176|SCV005201970|SCV005666584	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	912	ENSP00000347942	ENST00000355710	17668	0.478	13366	0	0.599	C	0	2.501402	0.24837	N	T	-	2.534287	.	0.50756	628	0	.	0.18506	0	43106521	Y	10	0	102092	3.290560e-04	P07949	0	0.376246	0.46629	C	0	0.007	D	88828	0.08598992	42620	0.35269	5979	0.151122	28	-0.16	.	3.290560e-04	0.08337	0.000000e+00	0	74914	0.000000e+00	6078	0	0.20292	10	RET	0.000000e+00	0	Thr	35910	4.503080e-05	10-43106521-C-T	Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hirschsprung_disease,_susceptibility_to,_1	0	8	42921975	ClinGen:CA007399	0.155931	0.36368	0	RCV000709106|RCV000570795|RCV001046577|RCV001262456|RCV005042101|RCV004566792|RCV004700294	D	0	0	c.1013C>T	0	0	0	0.69149	C/C	rs377767433	43106521	14776	C	.	P07949	15670	0.32613	0.000000e+00	0.68239	10	0	0	0.000000e+00	2.135	0	0	264690	5.32	0.73794	112	T	T	0	0.000000e+00	0	26	.	0	0	653|140162|247698|653|247709|653|388	38594	0.79109	0.24083	0.17234893143177	3344	.	0.34718	0.27906	0.000000e+00	4.503080e-05	1179836	1.993	1.932650e-05	N	13372	0	7.5560088E-6	0	171400|162300|142623	0.40471	10	0.000000e+00	ENSG00000165731	0.000000e+00	0	0	0	0.6790319585223052	2	0.19965	0.33096	30574	2	7.836070e-05	0.000000e+00	0.048901495971743	YES	1.098030e-05	0.028251	47198	HGNC:9967	D	0	simple_aae	0.065	206970	43106521	ACC	1.000000	.	-	0	0.45410	2.373210e-05	0	0	Conflicting classifications of pathogenicity	0.55945	0	2	0	ClinGen:CA007399	T	0	0.981789031089	-	0.755	-	0.30814	8	4640	0.67683	0.481091409922	0.3018	0	0.98805091438726533	98	-	1013C>T 	8	2.1551724137931034E-4	C4048306|C0027672|C0025268|C0025269|C3888239	0	0	0	0	NM_020975.6	-	.	.	0	0.33844	377767433	2312	2.78473962684489E-5	0.98140	0.41733	0.235	0.239	3230	0.99947983	5.32	.	.	0.000000e+00	0.135665	0.094241815648635	0.59336	T	86	6182	9550	-0.8203	0.66078	p.Thr338Ile	0	0	-7.255	0.2821769	0	0.42787	38594	T	30424	RET	0.000000e+00	D	0.410	21236	T338I	T	0.80495	0.40292	C/C	principal4																																																																																																				
RET_Thr338Ile	-1.424602819963752	0.19729169514798545	2.2743462514220494	0.05711032904998553	2025_01_Batch_13-14	0.9174918166052234	0.7105123566417155	0.6594978765357586	0.5926499598947482	0.8981003866469992	0.9205314968803489	0.9027881067629824	0.8430259524063524	0.9205832086026784	0.8299564944318886	0.9190116567427862	0.806650231702349	0.7512619144710555	0.7566165842487134	0.8640284405394438	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	RET	RET		8858		CCSBVarC006878		NC_000010.11:43106521:C:T		Thr338Ile																												RET_Thr338Ile	10	43106521	C	T	10	allele	1013C>T	A08	527_CAVA_Array_P05	A15	B13A7A8P2_R1	B14A7A8P2_R2				10-43106521-C-T	-	0.32347	0.017	338	4	0	0	10	43601969	T	1.921050e-05	0	10	3_Conflicting	NC_000010.11	2	Thr338Ile	0	19.0	0	0	7.836070e-05	T	0	7	5	42620	3.395990e-05	.	30494	0.000000e+00	0	0.72027	Select	0.2905	102092	0.24484	0	.	T	D	63946	0.218286694533	0	0	0.000000e+00	0	0	0.36160	17042	44888	1	0.000000e+00	0.09401	6	.	0.23277	0.734	.	9.0	0.726327	4.24	0.91	T	single nucleotide variant	NC_000010.11:g.43106521C>T	0	16712	2	0.08741958	109044	0	0.14303645	0	T	4	235572	0	0	0.000000e+00	500	1.407790e-04	0	MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900	6	0	0.000000e+00	0	0.92786	B	0.19866	B	M	2.120756	31	C/C	114	1	7096	1613700	Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Pheochromocytoma;Familial medullary thyroid carcinoma;Multiple endocrine neoplasia type 2B|Hirschsprung disease, susceptibility to, 1|not provided	16044	0.53729	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106521	1.407790e-04	-	4.824000	0	0.18082	29596	0	6078	0	germline;unknown	91072	Loss of disorder (P = 0.0525)| Gain of catalytic residue at A342 (P = 0.1324)| Gain of sheet (P = 0.1945)| Gain of MoRF binding (P = 0.2848)| Loss of loop (P = 0.2897)	0.88426	GRCh38	862	criteria provided, conflicting classifications	c.1013C>T	0.000000e+00	0.75341	1	0	0	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	0.000000e+00	9024	B	0	0.000000e+00	NM_020975.6(RET):c.1013C>T (p.Thr338Ile)	1	0	RET_HUMAN	0	91.0	-0.117237538328119	0	T	0.55809	0.099525385	+	0.000000e+00	.	0.000018474	4	0.000000e+00	0	34164	criteria_provided,_conflicting_classifications	0.99419	5.502370e-05	0	0.000000e+00	0	59994	p.Thr338Ile	0	0.45219	.	germline	6	43106521	C	Jan 28, 2025	0	C/C	0	88828	0.974	N	10q11.21	26588	.	0.000000e+00	SCV000664515|SCV000838375|SCV001210484|SCV001440343|SCV005054176|SCV005201970|SCV005666584	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	912	ENSP00000347942	ENST00000355710	17668	0.478	13366	0	0.599	C	0	2.501402	0.24837	N	T	-	2.534287	.	0.50756	628	0	.	0.18506	0	43106521	Y	10	0	102092	3.290560e-04	P07949	0	0.376246	0.46629	C	0	0.007	D	88828	0.08598992	42620	0.35269	5979	0.151122	28	-0.16	.	3.290560e-04	0.08337	0.000000e+00	0	74914	0.000000e+00	6078	0	0.20292	10	RET	0.000000e+00	0	Thr	35910	4.503080e-05	10-43106521-C-T	Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hirschsprung_disease,_susceptibility_to,_1	0	8	42921975	ClinGen:CA007399	0.155931	0.36368	0	RCV000709106|RCV000570795|RCV001046577|RCV001262456|RCV005042101|RCV004566792|RCV004700294	D	0	0	c.1013C>T	0	0	0	0.69149	C/C	rs377767433	43106521	14776	C	.	P07949	15670	0.32613	0.000000e+00	0.68239	10	0	0	0.000000e+00	2.135	0	0	264690	5.32	0.73794	112	T	T	0	0.000000e+00	0	26	.	0	0	653|140162|247698|653|247709|653|388	38594	0.79109	0.24083	0.17234893143177	3344	.	0.34718	0.27906	0.000000e+00	4.503080e-05	1179836	1.993	1.932650e-05	N	13372	0	7.5560088E-6	0	171400|162300|142623	0.40471	10	0.000000e+00	ENSG00000165731	0.000000e+00	0	0	0	0.6790319585223052	2	0.19965	0.33096	30574	2	7.836070e-05	0.000000e+00	0.048901495971743	YES	1.098030e-05	0.028251	47198	HGNC:9967	D	0	simple_aae	0.065	206970	43106521	ACC	1.000000	.	-	0	0.45410	2.373210e-05	0	0	Conflicting classifications of pathogenicity	0.55945	0	2	0	ClinGen:CA007399	T	0	0.981789031089	-	0.755	-	0.30814	8	4640	0.67683	0.481091409922	0.3018	0	0.98805091438726533	98	-	1013C>T 	8	2.1551724137931034E-4	C4048306|C0027672|C0025268|C0025269|C3888239	0	0	0	0	NM_020975.6	-	.	.	0	0.33844	377767433	2312	2.78473962684489E-5	0.98140	0.41733	0.235	0.239	3230	0.99947983	5.32	.	.	0.000000e+00	0.135665	0.094241815648635	0.59336	T	86	6182	9550	-0.8203	0.66078	p.Thr338Ile	0	0	-7.255	0.2821769	0	0.42787	38594	T	30424	RET	0.000000e+00	D	0.410	21236	T338I	T	0.80495	0.40292	C/C	principal4																																																																																																				
FH_Pro174Arg	10.162270857596216	0.000052836229120136614	-7.281739576538825	0.00016533890191996532	2025_01_Batch_13-14	0.6762706853155396	0.7848065989828991	0.8607648878207168	0.8843137993744704	0.5720850641276243											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH		3408		CCSBVarC004048		NC_000001.11:241512001:G:C		Pro174Arg																												FH_Pro174Arg	1	241512001	G	C	1	allele	521C>G	A03	527_CAVA_Array_P03	B05	B13A7A8P1_R1	B14A7A8P1_R2				1-241512001-G-C	-	0.85504	0.999	174	3	0	0	1	241675301	C	1.449970e-04	0	1	1_Pathogenic	NC_000001.11	230	Pro174Arg	0	28.6	0	1	4.872440e-05	D	0	19	1	42768	2.111770e-05	.	30526	0.000000e+00	0	0.99405	Select	0.9867	102618	0.77914	0	.	D	D	63972	0.978554424983	3.5919540229885057E-4	0	0.000000e+00	0	0	0.76405	17112	44872	0	0.000000e+00	0.95559	3	.	0.90959	0.993	.	40.0	0.976702	.	0.6	C	single nucleotide variant	NC_000001.11:g.241512001G>C	0	16694	3	0.89710534	109368	0	0.8966469	0	C	3	236768	0	0	0.000000e+00	146	7.014590e-05	0	MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523;MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	3	0	0.000000e+00	0	0.76851	D	0.94698	D	M	12.39802	234	G/G	114	0	7164	1613826	Fumarase deficiency|not provided|Hereditary cancer-predisposing syndrome|FH-related disorder|Hereditary leiomyomatosis and renal cell cancer;Fumarase deficiency	16216	0.97771	.	.	-	241512001	7.014590e-05	-	11.757000	0	0.99076	29598	0	1179928	0	germline;unknown	91076	.	.	GRCh38	968	criteria provided, multiple submitters, no conflicts	c.521C>G	0.000000e+00	0.72825	1	0	0	Fumarate lyase, N-terminal	0.000000e+00	9046	P	0	0.000000e+00	NM_000143.4(FH):c.521C>G (p.Pro174Arg)	2	0	FUMH_HUMAN	0	60.0	0.949310228068722	0	D	0.78770	0.8966469	-	0.000000e+00	.	0.000157353	3	0.000000e+00	0	34258	criteria_provided,_multiple_submitters,_no_conflicts	0.92291	2.743030e-05	0	0.000000e+00	0	60000	p.Pro174Arg	0	0.95546	.	germline	3	241512001	G	Jan 13, 2025	0	G/G	0	89538	1.0	N	1q43	9690	.	0.000000e+00	SCV000109987|SCV000283674|SCV000356713|SCV000516751|SCV000581681|SCV000992190|SCV002012378|SCV002048740|SCV004046437|SCV004197294|SCV004218884|SCV005184523|SCV005874269	Pathogenic/Likely_pathogenic	0	0	Arg	R	-	912	ENSP00000355518	ENST00000366560	17692	0.001	13416	0	0.676	G	0	5.112622	0.61305	D	D	-	13.5147	.	0.97710	610	0	.	0.57480	0	241512001	Y	10	0	102618	0.000000e+00	P07954	0	0.951848	0.89450	G	0	0.981	D	89538	0.89710534	42768	0.69292	2271	0.469226	230	-7.67	.	1.949270e-04	0.78662	0.000000e+00	0	74900	0.000000e+00	6082	0	0.94699	1	FH	0.000000e+00	0	Pro	14050	3.350530e-05	1-241512001-G-C	Fumarase_deficiency|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome|FH-related_disorder|not_provided	0	5	239741924	ClinGen:CA220381|OMIM:136850.0010	0.904483	0.93923	0	RCV000022554|RCV000078149|RCV000492836|RCV003335052|RCV003483435	D	0	0	c.521C>G	0	0	0	0.93253	G/G	rs199822819	241512001	14900	G	.	.	15690	0.90957	0.000000e+00	0.68239	1	0	0	0.000000e+00	2.505	0	0	264690	5.24	0.99304	112	D	T	0	0.000000e+00	0	26	.	0	0	24|523|140162	29705	0.96142	0.73484	0.918809771537781	2898	.	0.71675	0.85431	0.000000e+00	3.350530e-05	1179928	9.079	1.441810e-05	D	13354	0	3.0224035E-5	0	606812|150800	0.9345	1	0.000000e+00	ENSG00000091483	0.000000e+00	0	0	0	0.8682662705529591	2	0.75172	0.07020	30608	8	4.872440e-05	0.000000e+00	0.89439856430428	YES	0.000000e+00	0.717923	38660	HGNC:3700	A	0	simple_aae	0.975	208072	241512001	CCT	1.000000	.	-	3.450655624568668E-4	0.97191	1.949270e-04	1	0	Pathogenic/Likely pathogenic	0.91805	0	0	0	ClinGen:CA220381,OMIM:136850.0010	P	0	0.987495772737	-	.	-	0.97975	5	496	0.86710	0.763472080231	0.8317	0	0.9981003855289049	98	-	521C>G 	5	0	C0342770|C1708350|C0027672|C3661900	0	0	0	0	NM_000143.4	-	.	.	1	0.91928	199822819	2320	7.117437722419929E-5	0.98721	0.95298	0.969	0.016	2784	0.92770165	5.24	.	.	0.000000e+00	0.566685	0.969616269158006	0.72748	D	86	6212	9570	1.0331	0.99604	p.Pro174Arg	0	0	-13.629	0.9749284	0	0.83212	29705	D	30524	FH	0.000000e+00	D	0.961	21592	.	D	.	0.76753	G/G	principal1																																																																																																				
RAD51D_His23Arg	0.46032392122955723	0.6592416574464562	5.869166706727706	0.0006184625812000529	2025_01_Batch_13-14	0.7620934902533477	0.8807734751440904	0.9570207008826094	0.9040232974436648	0.7157911571535472	0.9203527373439884	0.9262859447299913	0.9635565017088441	0.9542859971134809	0.8925726472694465	0.8412231137986681	0.9035297099370408	0.9602886012957268	0.9291546472785729	0.8041819022114969	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024711		NC_000017.11:35119546:T:C		His23Arg																												RAD51D_His23Arg	17	35119546	T	C	17	allele	68A>G	G01	527_CAVA_Array_P05	M01	B13A7A8P2_R1	B14A7A8P2_R2				17-35119546-T-C	-	0.09313	0.0	23	1	0	0	17	33446565	C	6.202100e-07	0	17	3_Conflicting	NC_000017.11	1	His23Arg	0	6.069	0	0	9.961750e-06	T	0	3	5	42690	4.288530e-06	.	30514	0.000000e+00	0	0.03036	.	0.0244	100384	0.02950	0	.	T	T	62504	.	0	0	0.000000e+00	0	0	.	17080	44882	0	0.000000e+00	0.18393	0	.	0.05652	0.771	.	.	0.0435956	-3.41	.	C	single nucleotide variant	NC_000017.11:g.35119546T>C	0	15526	2	0.052508783	107948	0	0.040238965	0		1	233180	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	0	0	0.000000e+00	0	.	B	0.08678	B	N	0.1390257	1	T/T	108	0	7098	1612358	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	16112	0.31058	.	.	-	35119546	.	-	-1.240000	0	0.05473	29596	0	1179926	0	germline	91090	Loss of sheet (P = 0.003)| Gain of helix (P = 0.0034)| Gain of MoRF binding (P = 0.0286)| Gain of phosphorylation at S22 (P = 0.091)| Loss of ubiquitination at K26 (P = 0.1022)	0.46877	GRCh38	926	criteria provided, conflicting classifications	c.68A>G	0.000000e+00	0.08645	0	0	0	RAD51D, N-terminal domain	0.000000e+00	8998	B	0	0.000000e+00	NM_002878.4(RAD51D):c.68A>G (p.His23Arg)	1	0	RA51D_HUMAN	0	.	-1.35012510449794	0	T	0.02261	0.040238965	-	0.000000e+00	.		1	0.000000e+00	0	34228	criteria_provided,_conflicting_classifications	0.74091	0.000000e+00	0	0.000000e+00	0	59996	p.His23Arg	0	0.05963	.	germline	.		T	Feb 03, 2024	0	T/T	0	87036	0.0	N	17q12	7618	.	0.000000e+00	SCV000565901|SCV000651772|SCV000663810	Conflicting_classifications_of_pathogenicity	0	0	Arg	R	-	912	ENSP00000378090	ENST00000394589	17644	1.0	13344	0	-0.173	T	0	0.56021	0.05378	N	T	-	0.2407925	.	0.26860	610	0	.	0.05021	0	35119546	Y	10	0	100384	0.000000e+00	O75771	0	0.115945	0.09022		.	0.0	T	87036	0.052508783	.	0.36593	5892	-0.364518	1	-0.59	.	8.475110e-07	0.00968	0.000000e+00	0	74908	0.000000e+00	6084	0	0.08677	17	RAD51D	0.000000e+00	0	His	11862	1.148950e-05	17-35119546-T-C	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_provided|Hereditary_cancer-predisposing_syndrome	0	1	30470678	ClinGen:CA16620393	0.046472	0.03091	0	RCV000485429|RCV000547804|RCV000566071	T	0	0	c.68A>G	0	0	0	0.03721	T/T	rs990062370	35119546	14834	T	.	O75771	15678	0.05652	0.000000e+00	0.08389		0	0	0.000000e+00	-2.015	0	0	264690	-1.34	0.43190	108	T	.	0	0.000000e+00	0	24	.	0	0	145|140162	418673	0.02907	0.11066	0.0475806100992363	2816	.	0.06393	0.07594	0.000000e+00	1.148950e-05	1179926	-1.008	4.898980e-06	N	12186	0	1.1334013E-5	0	614291	0.03777	17	0.000000e+00	ENSG00000185379	0.000000e+00	0	0	0	.	2	0.01384	0.17784	30596	3	9.961750e-06	0.000000e+00	-1.25403651457861	.	0.000000e+00	0.010514	409908	HGNC:9823	.	0	.	0.028	204124	35119546	CAC	0.000000	.	-	0	0.01387	8.475110e-07	0	0	Conflicting classifications of pathogenicity	0.10376	0	0	0	ClinGen:CA16620393	H	0	0.319686207203	-	0.425	-	0.10018	1	470	0.34452	.	0.0613	0	0.69154575729474244	94	-	68A>G 	1	0	C3280345|C3661900|C0027672	0	0	0	0	NM_002878.4	-	.	.	0	0.00994	990062370	2320	0	0.31162	0.04992	0.064	0.792	2708	0.22299655	4.5	.	.	0.000000e+00	-0.761382	7.77047030966497e-07	0.00188	T	84	6182	9560	-0.9955	0.10333	p.His23Arg	0	0	-1.909	0.032363117	0	0.00398	418673	T	30490	RAD51D	0.000000e+00	T	0.018	20424	H23R	T	0.07546	0.11029	T/T	principal1	963001	RAD51D_unpublished_var157248	Yes						overall function		Cell survival			H		68	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.His23Arg		true	c.68A>G						9823.0	35119546.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				His23Arg						R	Oct 19, 2023					missense_variant		23.0	A		6.202096556720033e-7	-0.0128331		Conflicting classifications of pathogenicity	35119546.0	missense_variant		0.018	functionally_normal				Cell viability			RAD51D_His23Arg
RAD51D_His23Arg	0.46032392122955723	0.6592416574464562	5.869166706727706	0.0006184625812000529	2025_01_Batch_13-14	0.7620934902533477	0.8807734751440904	0.9570207008826094	0.9040232974436648	0.7157911571535472	0.9203527373439884	0.9262859447299913	0.9635565017088441	0.9542859971134809	0.8925726472694465	0.8412231137986681	0.9035297099370408	0.9602886012957268	0.9291546472785729	0.8041819022114969	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024711	ALE00031239	NC_000017.11:35119546:T:C	68A>G	His23Arg	CAVA																											RAD51D_His23Arg	17	35119546	T	C	17								1	1	1	17-35119546-T-C	-	0.09313	0.0	23	1	0	0	17	33446565	C	6.202100e-07	0	17	3_Conflicting	NC_000017.11	1	His23Arg	0	6.069	0	0	9.961750e-06	T	0	3	5	42690	4.288530e-06	.	30514	0.000000e+00	0	0.03036	.	0.0244	100384	0.02950	0	.	T	T	62504	.	0	0	0.000000e+00	0	0	.	17080	44882	0	0.000000e+00	0.18393	0	.	0.05652	0.771	.	.	0.0435956	-3.41	.	C	single nucleotide variant	NC_000017.11:g.35119546T>C	0	15526	2	0.052508783	107948	0	0.040238965	0		1	233180	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	0	0	0.000000e+00	0	.	B	0.08678	B	N	0.1390257	1	T/T	108	0	7098	1612358	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	16112	0.31058	.	.	-	35119546	.	-	-1.240000	0	0.05473	29596	0	1179926	0	germline	91090	Loss of sheet (P = 0.003)| Gain of helix (P = 0.0034)| Gain of MoRF binding (P = 0.0286)| Gain of phosphorylation at S22 (P = 0.091)| Loss of ubiquitination at K26 (P = 0.1022)	0.46877	GRCh38	926	criteria provided, conflicting classifications	c.68A>G	0.000000e+00	0.08645	0	0	0	RAD51D, N-terminal domain	0.000000e+00	8998	B	0	0.000000e+00	NM_002878.4(RAD51D):c.68A>G (p.His23Arg)	1	0	RA51D_HUMAN	0	.	-1.35012510449794	0	T	0.02261	0.040238965	-	0.000000e+00	.		1	0.000000e+00	0	34228	criteria_provided,_conflicting_classifications	0.74091	0.000000e+00	0	0.000000e+00	0	59996	p.His23Arg	0	0.05963	.	germline	.		T	Feb 03, 2024	0	T/T	0	87036	0.0	N	17q12	7618	.	0.000000e+00	SCV000565901|SCV000651772|SCV000663810	Conflicting_classifications_of_pathogenicity	0	0	Arg	R	-	912	ENSP00000378090	ENST00000394589	17644	1.0	13344	0	-0.173	T	0	0.56021	0.05378	N	T	-	0.2407925	.	0.26860	610	0	.	0.05021	0	35119546	Y	10	0	100384	0.000000e+00	O75771	0	0.115945	0.09022		.	0.0	T	87036	0.052508783	.	0.36593	5892	-0.364518	1	-0.59	.	8.475110e-07	0.00968	0.000000e+00	0	74908	0.000000e+00	6084	0	0.08677	17	RAD51D	0.000000e+00	0	His	11862	1.148950e-05	17-35119546-T-C	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_provided|Hereditary_cancer-predisposing_syndrome	0	1	30470678	ClinGen:CA16620393	0.046472	0.03091	0	RCV000485429|RCV000547804|RCV000566071	T	0	0	c.68A>G	0	0	0	0.03721	T/T	rs990062370	35119546	14834	T	.	O75771	15678	0.05652	0.000000e+00	0.08389		0	0	0.000000e+00	-2.015	0	0	264690	-1.34	0.43190	108	T	.	0	0.000000e+00	0	24	.	0	0	145|140162	418673	0.02907	0.11066	0.0475806100992363	2816	.	0.06393	0.07594	0.000000e+00	1.148950e-05	1179926	-1.008	4.898980e-06	N	12186	0	1.1334013E-5	0	614291	0.03777	17	0.000000e+00	ENSG00000185379	0.000000e+00	0	0	0	.	2	0.01384	0.17784	30596	3	9.961750e-06	0.000000e+00	-1.25403651457861	.	0.000000e+00	0.010514	409908	HGNC:9823	.	0	.	0.028	204124	35119546	CAC	0.000000	.	-	0	0.01387	8.475110e-07	0	0	Conflicting classifications of pathogenicity	0.10376	0	0	0	ClinGen:CA16620393	H	0	0.319686207203	-	0.425	-	0.10018	1	470	0.34452	.	0.0613	0	0.69154575729474244	94	-	68A>G 	1	0	C3280345|C3661900|C0027672	0	0	0	0	NM_002878.4	-	.	.	0	0.00994	990062370	2320	0	0.31162	0.04992	0.064	0.792	2708	0.22299655	4.5	.	.	0.000000e+00	-0.761382	7.77047030966497e-07	0.00188	T	84	6182	9560	-0.9955	0.10333	p.His23Arg	0	0	-1.909	0.032363117	0	0.00398	418673	T	30490	RAD51D	0.000000e+00	T	0.018	20424	H23R	T	0.07546	0.11029	T/T	principal1	963001	RAD51D_unpublished_var157248	Yes						overall function		Cell survival			H		68	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.His23Arg		true	c.68A>G						9823.0	35119546.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				His23Arg						R	Oct 19, 2023					missense_variant		23.0	A		6.202096556720033e-7	-0.0128331		Conflicting classifications of pathogenicity	35119546.0	missense_variant		0.018	functionally_normal				Cell viability			RAD51D_His23Arg
BRAF_Gln262Lys	-3.3290490377403623	0.012607505897050326	1.4713633473538252	0.18466553940209554	2025_01_Batch_13-14	0.7673606758750543	0.7418021366726815	0.7824119719135454	0.8146385969778781	0.656309645689469	0.4425712538927683	0.5478799800519032	0.6121320145426549	0.6069403394663526	0.4351602513534001	0.6049659648839113	0.6448410583622923	0.6972719932281002	0.7107894682221154	0.5457349485214346	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220594	CCSBVarC003157	ALE00003157	NC_000007.14:140801488:G:T	784C>A	Gln262Lys	CEGS2	CegsMutGDEh1017	C07	GDEhDisVCh_40058	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	2	0		0			0			0			BRAF_Gln262Lys	7	140801488	G	T	7											7-140801488-G-T	-	0.77833	0.476	262	.	.	.	7	140501288	T	.	.	7	1_Pathogenic	NC_000007.14	.	Gln262Lys	.	26.8	.	.	.	D	.	2	.	.	.	.	.	.	.	0.88724	Select	0.5754	.	0.36683	.	.	D	D	.	.	.	.	.	.	.	0.95311	.	.	.	.	0.39882	.	.	0.77646	0.996	.	.	0.972478	5.79	.	T	single nucleotide variant	NC_000007.14:g.140801488G>T	.	.	2	0.29162404	.	.	0.7150027	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.92786	B	0.61282	P	N	3.435949	.	./.	.	.	.	.	not provided|RASopathy	.	0.84883	.	.	-	140801488	.	-	11.707000	.	0.87990	.	.	.	.	germline	.	Gain of methylation at Q262 (P = 0.0013)| Gain of MoRF binding (P = 0.034)| Loss of sheet (P = 0.0457)| Gain of catalytic residue at Q262 (P = 0.0492)| Gain of helix (P = 0.0854)	0.95408	GRCh38	794	criteria provided, multiple submitters, no conflicts	c.784C>A	.	0.71966	.	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	.	.	P	.	.	NM_004333.6(BRAF):c.784C>A (p.Gln262Lys)	2	.	BRAF_HUMAN	.	.	0.229428578319334	.	D	0.91998	0.69711965	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.95809	.	.	.	.	.	p.Gln262Lys	.	0.94599	.	germline	.		G	Nov 22, 2024	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000057195|SCV001363182	Pathogenic/Likely_pathogenic	.	.	Lys	K	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.672	G	.	4.792683	0.25963	D	.	-	4.355617	.	0.79914	.	.	.	0.52474	.	140801488	Y	10	.	.	.	P15056	.	0.767013	0.69200		.	0.145	D	.	0.36088184	.	0.76032	673	0.433189	.	.	.	.	0.31974	.	.	.	.	.	.	0.54973	7	BRAF	.	.	Gln	.	.	7-140801488-G-T	not_provided|RASopathy	.	.	140147757	ClinGen:CA281957|UniProtKB:P15056#VAR_065172	0.875019	0.52393	.	RCV000033290|RCV001193980	D	.	.	c.784C>A	.	.	.	0.91632	./.	rs397507470	140801488	.	G	.	P15056	.	0.78637	.	0.68239		.	.	.	0.335	.	.	.	5.21	0.93678	.	D	D	.	.	.	.	.	.	.	536391	40352	0.91529	0.83165	0.877448976039886	.	.	0.71675	0.79748	.	.	.	9.943	.	.	.	.	.	.	.	0.9894	7	.	ENSG00000157764	.	.	.	.	.	1	0.33873	0.45529	.	.	.	.	0.399610595300935	YES	.	0.119437	48822	HGNC:1097	.	.	.	0.783	.	140801488	CAA	1.000000	.	-	.	0.90245	.	.	.	Pathogenic/Likely pathogenic	0.65895	.	.	.	UniProtKB:P15056#VAR_065172,ClinGen:CA281957	Q	.	.	-	0.854	-	0.92789	.	.	0.89159	0.890452325344	0.9841	.	0.99520084160858091	.	-	784C>A 	.	.	CN517202|C5555857	.	.	.	.	NM_004333.6	-	.	.	1	0.90100	397507470	.	.	0.99108	0.61333	.	.	.	0.98278390	5.21	.	.	.	0.384469	0.999639817524742	0.10354	D	.	.	.	0.1437	0.84624	p.Gln262Lys	.	.	-8.711	0.9098774	.	0.97271	40352	D	.	BRAF	.	D	.	.	Q262K	.	0.96129	0.70176	./.	principal4																																																																																																				
BRAF_Gln262Lys	-3.3290490377403623	0.012607505897050326	1.4713633473538252	0.18466553940209554	2025_01_Batch_13-14	0.7673606758750543	0.7418021366726815	0.7824119719135454	0.8146385969778781	0.656309645689469	0.4425712538927683	0.5478799800519032	0.6121320145426549	0.6069403394663526	0.4351602513534001	0.6049659648839113	0.6448410583622923	0.6972719932281002	0.7107894682221154	0.5457349485214346	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003157		NC_000007.14:140801488:G:T		Gln262Lys																												BRAF_Gln262Lys	7	140801488	G	T	7	allele	784C>A	H05	527_CAVA_Array_P01	O09	B13A7A8P1_R1	B14A7A8P1_R2				7-140801488-G-T	-	0.77833	0.476	262	.	.	.	7	140501288	T	.	.	7	1_Pathogenic	NC_000007.14	.	Gln262Lys	.	26.8	.	.	.	D	.	2	.	.	.	.	.	.	.	0.88724	Select	0.5754	.	0.36683	.	.	D	D	.	.	.	.	.	.	.	0.95311	.	.	.	.	0.39882	.	.	0.77646	0.996	.	.	0.972478	5.79	.	T	single nucleotide variant	NC_000007.14:g.140801488G>T	.	.	2	0.29162404	.	.	0.7150027	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.92786	B	0.61282	P	N	3.435949	.	./.	.	.	.	.	not provided|RASopathy	.	0.84883	.	.	-	140801488	.	-	11.707000	.	0.87990	.	.	.	.	germline	.	Gain of methylation at Q262 (P = 0.0013)| Gain of MoRF binding (P = 0.034)| Loss of sheet (P = 0.0457)| Gain of catalytic residue at Q262 (P = 0.0492)| Gain of helix (P = 0.0854)	0.95408	GRCh38	794	criteria provided, multiple submitters, no conflicts	c.784C>A	.	0.71966	.	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	.	.	P	.	.	NM_004333.6(BRAF):c.784C>A (p.Gln262Lys)	2	.	BRAF_HUMAN	.	.	0.229428578319334	.	D	0.91998	0.69711965	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.95809	.	.	.	.	.	p.Gln262Lys	.	0.94599	.	germline	.		G	Nov 22, 2024	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000057195|SCV001363182	Pathogenic/Likely_pathogenic	.	.	Lys	K	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.672	G	.	4.792683	0.25963	D	.	-	4.355617	.	0.79914	.	.	.	0.52474	.	140801488	Y	10	.	.	.	P15056	.	0.767013	0.69200		.	0.145	D	.	0.36088184	.	0.76032	673	0.433189	.	.	.	.	0.31974	.	.	.	.	.	.	0.54973	7	BRAF	.	.	Gln	.	.	7-140801488-G-T	not_provided|RASopathy	.	.	140147757	ClinGen:CA281957|UniProtKB:P15056#VAR_065172	0.875019	0.52393	.	RCV000033290|RCV001193980	D	.	.	c.784C>A	.	.	.	0.91632	./.	rs397507470	140801488	.	G	.	P15056	.	0.78637	.	0.68239		.	.	.	0.335	.	.	.	5.21	0.93678	.	D	D	.	.	.	.	.	.	.	536391	40352	0.91529	0.83165	0.877448976039886	.	.	0.71675	0.79748	.	.	.	9.943	.	.	.	.	.	.	.	0.9894	7	.	ENSG00000157764	.	.	.	.	.	1	0.33873	0.45529	.	.	.	.	0.399610595300935	YES	.	0.119437	48822	HGNC:1097	.	.	.	0.783	.	140801488	CAA	1.000000	.	-	.	0.90245	.	.	.	Pathogenic/Likely pathogenic	0.65895	.	.	.	UniProtKB:P15056#VAR_065172,ClinGen:CA281957	Q	.	.	-	0.854	-	0.92789	.	.	0.89159	0.890452325344	0.9841	.	0.99520084160858091	.	-	784C>A 	.	.	CN517202|C5555857	.	.	.	.	NM_004333.6	-	.	.	1	0.90100	397507470	.	.	0.99108	0.61333	.	.	.	0.98278390	5.21	.	.	.	0.384469	0.999639817524742	0.10354	D	.	.	.	0.1437	0.84624	p.Gln262Lys	.	.	-8.711	0.9098774	.	0.97271	40352	D	.	BRAF	.	D	.	.	Q262K	.	0.96129	0.70176	./.	principal4																																																																																																				
KRAS_Gly12Val	-5.955690773263131	0.0005668221876575696	7.386569839087916	0.00015114042618877112	2025_01_Batch_13-14	0.9194774110318478	0.9556724593463344	0.9016831345899275	0.8482163409955505	0.5948166390174948	0.9746819559282497	0.9458068604130303	0.9527695408005444	0.9781527555341658	0.9356989417028965	0.9470796834800488	0.9507396598796823	0.927226337695236	0.9131845482648582	0.7652577903601956	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214485	CCSBVarC006089	ALE00006089	NC_000012.12:25245350:C:A	35G>T	Gly12Val	CEGS2	CegsMutGDEh1035	A04	GDEhDisVCh_40061	G08	1	CegsMutGDDh1035	A04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Gly12Val	12	25245350	C	A	12											12-25245350-C-A	-	0.79528	0.999	12	.	0	.	12	25398284	A	6.200140e-07	.	12	1_Pathogenic	NC_000012.12	1	Gly12Val	.	27.1	.	.	.	D	0	12	1	.	.	.	.	.	.	0.97583	Plus_Clinical	0.6987	.	0.77914	.	.	D	D	63988	2.35052041495	.	0	.	.	.	0.96267	.	44856	0	.	0.97229	.	.	0.98906	1.0	.	0.0	0.366763	.	1.0	A	single nucleotide variant	NC_000012.12:g.25245350C>A	0	.	3	0.9436424	.	.	0.96866757	.	A	.	.	.	.	.	.	.	.	MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C3661900|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724|MONDO:MONDO:0006279,MedGen:C1708781|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|Human Phenotype Ontology:HP:0005506,Human Phenotype Ontology:HP:0005544,MONDO:MONDO:0011996,MeSH:D015464,MedGen:C0279543,OMIM:608232,Orphanet:521	.	.	0.000000e+00	0	0.99291	D	0.98397	D	L	12.35383	1	./.	.	.	.	1612866	Carcinoma of pancreas|not provided|Cerebral arteriovenous malformation|Lung sarcomatoid carcinoma|RASopathy|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Non-small cell lung carcinoma|Neoplasm|Chronic myelogenous leukemia, BCR-ABL1 positive	.	0.91106	.	.	-	25245350	.	-	7.698000	.	0.99892	29524	.	1179302	.	germline;somatic;unknown	90794	Gain of catalytic residue at V14 (P = 0)| Loss of ubiquitination at K16 (P = 0.1037)| Loss of methylation at K16 (P = 0.1785)| Loss of disorder (P = 0.1841)| Loss of sheet (P = 0.302)	0.89397	GRCh38	707	criteria provided, multiple submitters, no conflicts	c.35G>T	.	0.88004	.	.	.	Small GTP-binding domain	.	.	P	.	0.000000e+00	NM_004985.5(KRAS):c.35G>T (p.Gly12Val)	2	.	RASK_HUMAN	.	100.0	0.947784823501693	.	T	0.96393	0.9776439	-	.	.	6.84666e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99245	.	0	.	.	59958	p.Gly12Val	0	0.66189	.	germline/somatic	.	25245350	C	Oct 13, 2023	.	./.	.	.	1.0	N	12p12.1	.	.	.	SCV000198477|SCV000203917|SCV000207879|SCV001746133|SCV004176921|SCV004295856	Pathogenic	.	.	Val	V	-	912	ENSP00000256078	ENST00000256078	.	0.008	.	.	0.58	C	.	4.859019	0.83643	D	D	-	13.81752	.	0.85494	.	.	.	0.80423	.	25245350	Y	10	.	.	0.000000e+00	P01116	.	0.843047	0.87849	C	.	0.978	D	.	0.9503655	.	0.97202	3845	0.385769	1	-7.11	.	8.479590e-07	0.60085	.	.	75026	.	6062	.	0.97974	12	KRAS	0.000000e+00	.	Gly	.	.	12-25245350-C-A	Linear_nevus_sebaceous_syndrome|Nevus_sebaceous|not_provided|Non-small_cell_lung_carcinoma|Chronic_myelogenous_leukemia,_BCR-ABL1_positive|Carcinoma_of_pancreas|Lung_sarcomatoid_carcinoma|Acute_myeloid_leukemia|Juvenile_myelomonocytic_leukemia|Cerebral_arteriovenous_malformation|Thyroid_tumor|Ovarian_neoplasm|RASopathy|Neoplasm_of_the_large_intestine	0	.	25289551	COSMIC:520|ClinGen:CA122540|OMIM:190070.0006|OMIM:190070.0026|UniProtKB:P01116#VAR_006840	0.919073	0.93861	0	RCV000013413|RCV000157944|RCV000585801|RCV003322589|RCV003539760|RCV000029216|RCV003455987|RCV000150895|RCV000154262|RCV004668725|RCV002291496	D	0	.	c.35G>T	.	0	0	0.88997	./.	rs121913529	25245350	.	C	.	P01116	.	0.98104	.	0.68239	12	.	.	0.000000e+00	1.84	.	.	.	5.68	0.96328	.	D	D	.	.	.	.	.	.	.	2612|521|1333|217074|519|86834|46724|100087|536391	12583	0.88859	0.96801	0.990357935428619	.	.	0.71675	0.88866	.	.	1179302	7.892	.	D	.	.	.	.	163200|608232|601626|607785|108010	0.85894	12	.	ENSG00000133703	0.000000e+00	.	.	.	0.9781072363123009	2	0.74106	0.56997	.	.	.	0.000000e+00	0.901530992395951	.	0.000000e+00	0.181073	27622	HGNC:6407	A	.	simple_aae	0.997	.	25245350	GGT	1.000000	.	SCV005094259	.	0.91620	8.479590e-07	.	0	Pathogenic	0.98083	.	0	0	COSMIC:520,ClinGen:CA122540,UniProtKB:P01116#VAR_006840,OMIM:190070.0006,OMIM:190070.0026	G	.	0.988619423247	Mar 04, 2025	0.767	Oncogenic	0.94561	.	.	0.97790	0.898488461971	0.9949	0	0.99792542458718392	.	criteria provided, single submitter	35G>T 	.	.	C4552097|C3854181|C3661900|C0007131|C0279543|C0235974|C1708781|C0023467|C0349639|C0917804|C0040136|C0919267|C5555857|C0009404	.	.	.	.	NM_004985.5	-	.	.	1	0.56662	121913529	.	.	0.98836	0.95614	0.939	0.001	.	0.99924910	5.68	.	.	.	0.316354	0.999985518475673	0.48108	D	.	.	.	0.5429	0.89587	p.Gly12Val	.	0	-15.17	0.9236257	0	0.99579	12583	D	.	KRAS	.	D	0.910	.	G12V	D	.	0.29757	./.	alternative1																																																																																																				
KRAS_Gly12Val	-5.955690773263131	0.0005668221876575696	7.386569839087916	0.00015114042618877112	2025_01_Batch_13-14	0.9194774110318478	0.9556724593463344	0.9016831345899275	0.8482163409955505	0.5948166390174948	0.9746819559282497	0.9458068604130303	0.9527695408005444	0.9781527555341658	0.9356989417028965	0.9470796834800488	0.9507396598796823	0.927226337695236	0.9131845482648582	0.7652577903601956	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006089		NC_000012.12:25245350:C:A		Gly12Val																												KRAS_Gly12Val	12	25245350	C	A	12	allele	35G>T	F08	527_CAVA_Array_P03	L15	B13A7A8P1_R1	B14A7A8P1_R2				12-25245350-C-A	-	0.79528	0.999	12	.	0	.	12	25398284	A	6.200140e-07	.	12	1_Pathogenic	NC_000012.12	1	Gly12Val	.	27.1	.	.	.	D	0	12	1	.	.	.	.	.	.	0.97583	Plus_Clinical	0.6987	.	0.77914	.	.	D	D	63988	2.35052041495	.	0	.	.	.	0.96267	.	44856	0	.	0.97229	.	.	0.98906	1.0	.	0.0	0.366763	.	1.0	A	single nucleotide variant	NC_000012.12:g.25245350C>A	0	.	3	0.9436424	.	.	0.96866757	.	A	.	.	.	.	.	.	.	.	MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C3661900|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724|MONDO:MONDO:0006279,MedGen:C1708781|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|Human Phenotype Ontology:HP:0005506,Human Phenotype Ontology:HP:0005544,MONDO:MONDO:0011996,MeSH:D015464,MedGen:C0279543,OMIM:608232,Orphanet:521	.	.	0.000000e+00	0	0.99291	D	0.98397	D	L	12.35383	1	./.	.	.	.	1612866	Carcinoma of pancreas|not provided|Cerebral arteriovenous malformation|Lung sarcomatoid carcinoma|RASopathy|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Non-small cell lung carcinoma|Neoplasm|Chronic myelogenous leukemia, BCR-ABL1 positive	.	0.91106	.	.	-	25245350	.	-	7.698000	.	0.99892	29524	.	1179302	.	germline;somatic;unknown	90794	Gain of catalytic residue at V14 (P = 0)| Loss of ubiquitination at K16 (P = 0.1037)| Loss of methylation at K16 (P = 0.1785)| Loss of disorder (P = 0.1841)| Loss of sheet (P = 0.302)	0.89397	GRCh38	707	criteria provided, multiple submitters, no conflicts	c.35G>T	.	0.88004	.	.	.	Small GTP-binding domain	.	.	P	.	0.000000e+00	NM_004985.5(KRAS):c.35G>T (p.Gly12Val)	2	.	RASK_HUMAN	.	100.0	0.947784823501693	.	T	0.96393	0.9776439	-	.	.	6.84666e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99245	.	0	.	.	59958	p.Gly12Val	0	0.66189	.	germline/somatic	.	25245350	C	Oct 13, 2023	.	./.	.	.	1.0	N	12p12.1	.	.	.	SCV000198477|SCV000203917|SCV000207879|SCV001746133|SCV004176921|SCV004295856	Pathogenic	.	.	Val	V	-	912	ENSP00000256078	ENST00000256078	.	0.008	.	.	0.58	C	.	4.859019	0.83643	D	D	-	13.81752	.	0.85494	.	.	.	0.80423	.	25245350	Y	10	.	.	0.000000e+00	P01116	.	0.843047	0.87849	C	.	0.978	D	.	0.9503655	.	0.97202	3845	0.385769	1	-7.11	.	8.479590e-07	0.60085	.	.	75026	.	6062	.	0.97974	12	KRAS	0.000000e+00	.	Gly	.	.	12-25245350-C-A	Linear_nevus_sebaceous_syndrome|Nevus_sebaceous|not_provided|Non-small_cell_lung_carcinoma|Chronic_myelogenous_leukemia,_BCR-ABL1_positive|Carcinoma_of_pancreas|Lung_sarcomatoid_carcinoma|Acute_myeloid_leukemia|Juvenile_myelomonocytic_leukemia|Cerebral_arteriovenous_malformation|Thyroid_tumor|Ovarian_neoplasm|RASopathy|Neoplasm_of_the_large_intestine	0	.	25289551	COSMIC:520|ClinGen:CA122540|OMIM:190070.0006|OMIM:190070.0026|UniProtKB:P01116#VAR_006840	0.919073	0.93861	0	RCV000013413|RCV000157944|RCV000585801|RCV003322589|RCV003539760|RCV000029216|RCV003455987|RCV000150895|RCV000154262|RCV004668725|RCV002291496	D	0	.	c.35G>T	.	0	0	0.88997	./.	rs121913529	25245350	.	C	.	P01116	.	0.98104	.	0.68239	12	.	.	0.000000e+00	1.84	.	.	.	5.68	0.96328	.	D	D	.	.	.	.	.	.	.	2612|521|1333|217074|519|86834|46724|100087|536391	12583	0.88859	0.96801	0.990357935428619	.	.	0.71675	0.88866	.	.	1179302	7.892	.	D	.	.	.	.	163200|608232|601626|607785|108010	0.85894	12	.	ENSG00000133703	0.000000e+00	.	.	.	0.9781072363123009	2	0.74106	0.56997	.	.	.	0.000000e+00	0.901530992395951	.	0.000000e+00	0.181073	27622	HGNC:6407	A	.	simple_aae	0.997	.	25245350	GGT	1.000000	.	SCV005094259	.	0.91620	8.479590e-07	.	0	Pathogenic	0.98083	.	0	0	COSMIC:520,ClinGen:CA122540,UniProtKB:P01116#VAR_006840,OMIM:190070.0006,OMIM:190070.0026	G	.	0.988619423247	Mar 04, 2025	0.767	Oncogenic	0.94561	.	.	0.97790	0.898488461971	0.9949	0	0.99792542458718392	.	criteria provided, single submitter	35G>T 	.	.	C4552097|C3854181|C3661900|C0007131|C0279543|C0235974|C1708781|C0023467|C0349639|C0917804|C0040136|C0919267|C5555857|C0009404	.	.	.	.	NM_004985.5	-	.	.	1	0.56662	121913529	.	.	0.98836	0.95614	0.939	0.001	.	0.99924910	5.68	.	.	.	0.316354	0.999985518475673	0.48108	D	.	.	.	0.5429	0.89587	p.Gly12Val	.	0	-15.17	0.9236257	0	0.99579	12583	D	.	KRAS	.	D	0.910	.	G12V	D	.	0.29757	./.	alternative1																																																																																																				
RHO_Arg135Leu	-12.702939872581677	0.000014596173777115511	-16.56586795614291	7.132389771413138e-7																											RHO	RHO		40080645		CCSBVarC013572		NC_000003.12:129530918:G:T		Arg135Leu																												RHO_Arg135Leu	3	129530918	G	T	3	allele	404G>T	H09	527_CAVA_Array_P05	O17	B13A7A8P2_R1	B14A7A8P2_R2				3-129530918-G-T	-	0.93214	1.0	135	.	.	.	3	129249761	T	.	.	3	1_Pathogenic	NC_000003.12	.	Arg135Leu	.	33.0	.	0	.	D	.	4	1	.	.	.	.	.	0	0.99597	Select	0.9764	.	0.90580	.	.	D	D	.	0.96835728464	0	.	.	.	.	0.73104	.	.	.	.	0.90509	.	.	0.99966	0.996	.	9.0	0.987601	4.99	0.91	T	single nucleotide variant	NC_000003.12:g.129530918G>T	.	.	3	0.9928624	.	0	0.99405295	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900	.	.	.	.	0.92786	D	0.99984	D	H	18.32383	.	G/G	114	0	.	.	Retinitis pigmentosa 4|not provided	.	0.98119	.	.	-	129530918	.	-	11.810000	.	0.99985	.	0	.	.	germline	.	Loss of helix (P = 0.1299)| Loss of catalytic residue at R135 (P = 0.2691)| Loss of sheet (P = 0.3635)| Loss of MoRF binding (P = 0.5071)| Loss of methylation at R135 (P = 0.5619)	0.99756	GRCh38	511	criteria provided, multiple submitters, no conflicts	c.404G>T	.	0.73443	0	.	.	GPCR, rhodopsin-like, 7TM	.	.	P	0	.	NM_000539.3(RHO):c.404G>T (p.Arg135Leu)	2	.	OPSD_HUMAN	.	91.0	1.11802429763009	.	D	0.93677	0.9952068	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99939	.	.	.	.	.	p.Arg135Leu	.	0.96911	.	germline	.		G	Sep 26, 2022	.	G/G	.	.	1.0	N	3q22.1	9768	.	.	SCV000322377|SCV001573657|SCV001590839	Pathogenic	.	.	Leu	L	-	.	ENSP00000296271	ENST00000296271	.	0.0	.	.	0.676	G	.	5.717174	0.92967	D	D	-	18.48321	.	0.98765	610	.	.	0.99520	0	129530918	Y	9	0	.	.	P08100	.	0.917148	0.94097		.	1.0	D	.	0.990934	.	0.76032	6010	0.601351	.	-6.23	.	.	0.91343	.	.	.	.	.	.	0.99993	3	RHO	.	0	Arg	14710	.	3-129530918-G-T	not_provided|Retinitis_pigmentosa_4	.	.	130732451	ClinGen:CA256671|OMIM:180380.0011|UniProtKB:P08100#VAR_004796	0.913237	0.98445	.	RCV000013898|RCV000256085	D	.	.	c.404G>T	.	.	.	0.97648	G/G	rs104893774	129530918	.	G	.	P08100	.	0.99935	.	0.68239		.	.	.	4.615	0	0	.	5.26	0.98469	146	D	T	.	.	0	26	.	.	.	791	13024	0.97612	0.73109	0.999884724617004	3332	.	0.71675	0.87450	.	.	.	9.996	.	D	.	.	.	0	613731	0.99292	3	.	ENSG00000163914	.	0	.	0	0.9888686249646876	2	0.97365	0.75154	.	.	.	.	0.99406423223557	YES	.	0.840639	28063	HGNC:10012	A	.	simple_aae	1	.	129530918	CGG	1.000000	.	-	0	0.99965	.	0	.	Pathogenic	0.94464	.	.	.	ClinGen:CA256671,UniProtKB:P08100#VAR_004796,OMIM:180380.0011	R	.	0.98827829176	-	0.974	-	0.98079	.	604	0.98877	0.741208970547	0.9903	.	0.99862863388442769	104	-	404G>T 	.	0	C3661900|C3151001	.	.	.	.	NM_000539.3	-	.	.	1	0.95789	104893774	.	0	0.98802	0.98501	0.97	0.0	3218	0.99994111	5.26	.	.	.	0.626023	0.999591189859181	0.99277	D	120	.	.	1.0503	0.99265	p.Arg135Leu	0	.	-14.459	0.9948666	.	0.97117	13024	D	.	RHO	.	D	0.968	.	R135L	D	0.89858	0.76753	G/G	principal1	999340	RHO_Wan_2019_var220547	No						cell surface expression		Fluorescence			R		404	RHO_Wan_2019		ENST00000296271.4							immortalized human cells					p.Arg135Leu		true	c.404G>T						10012.0	129530918.0	No		RHO				NM_000539.3		1.0	urn:mavedb:00000099-a-1		nucleotide		T									criteria provided, multiple submitters, no conflicts				Arg135Leu						L	Sep 26, 2022					missense_variant		135.0	G			0.5848284926450827		Pathogenic	129530918.0	missense_variant		0.968					Reporter			RHO_Arg135Leu
CTCF_Tyr407Cys	2.2604531941423103	0.058292407096491645	5.642049992400373	0.0007809142606724553	2025_01_Batch_13-14	0.5832082165597294	0.8062520727072294	0.6881772674260671	0.6578961621597847	0.5755667279191388	0.7070470110384419	0.6614940913889276	0.6188088807723816	0.7503805460433652	0.6003427425011371	0.6451276137990857	0.7338730820480786	0.6534930740992244	0.704138354101575	0.587954735210138	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF		6173		CCSBVarC010870		NC_000016.10:67621454:A:G		Tyr407Cys																												CTCF_Tyr407Cys	16	67621454	A	G	16	allele	1220A>G	H01	527_CAVA_Array_P02	O02	B13A7A8P1_R1	B14A7A8P1_R2				16-67621454-A-G	-	0.90871	0.914	407	.	.	.	16	67655357	G	.	.	16	1_Pathogenic	NC_000016.10	.	Tyr407Cys	.	32.0	.	.	.	T	.	1	.	.	.	.	.	.	.	0.78861	.	0.1518	.	0.50540	.	.	D	D	.	.	.	.	.	.	.	0.99834	.	.	.	.	0.96158	.	.	0.85435	0.998	.	.	.	4.73	.	G	single nucleotide variant	NC_000016.10:g.67621454A>G	.	.	2	0.7453358	.	.	0.8909639	.		.	.	.	.	.	.	.	.	MedGen:C3661900	.	.	.	.	0.86984	P	0.81981	P	M	7.377784	.	A/A	.	.	.	.	not provided	.	0.57774	.	.	-	67621454	.	-	11.234000	.	0.94066	.	.	.	.	germline	.	Loss of phosphorylation at Y407 (P = 0.0811)| Gain of ubiquitination at K405 (P = 0.1079)| Gain of disorder (P = 0.1124)| Gain of glycosylation at K405 (P = 0.1594)| Loss of MoRF binding (P = 0.1621)	0.74786	GRCh38	54	criteria provided, single submitter	c.1220A>G	.	0.59198	.	.	.	.	.	.	.	.	.	NM_006565.4(CTCF):c.1220A>G (p.Tyr407Cys)	1	.	CTCF_HUMAN	.	.	0.717981494107391	.	.	0.96717	0.8259339	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.94734	.	.	.	.	.	p.Tyr407Cys	.	0.90219	.	germline	.		A	Jan 06, 2025	.	A/A	.	.	1.0	N	16q22.1	.	.	.	SCV000322502	Likely_pathogenic	.	.	Cys	C	-	.	ENSP00000493495	ENST00000644753	.	.	.	.	0.756	A	.	5.434312	0.92967	D	.	-	7.535864	.	0.74353	.	.	.	0.92450	.	67621454	Y	10	.	.	.	P49711	.	0.875329	0.85930		.	0.665	D	.	0.6975476	.	0.85369	10664	0.258403	.	.	.	.	0.78662	.	.	.	.	.	.	0.84765	16	CTCF	.	.	Tyr	.	.	16-67621454-A-G	not_provided	.	.	66212858	ClinGen:CA10588621	0.932506	0.80704	.	RCV000255519	D	.	.	c.1220A>G	.	.	.	0.79229	A/A	rs886039600	67621454	.	A	.	P49711	.	0.90456	.	0.68239		.	.	.	3.095	.	.	.	4.72	0.97318	.	D	D	.	.	.	.	.	.	.	.	265526	0.78960	0.99706	0.997824430465698	.	.	0.71675	0.92271	.	.	.	9.325	.	.	.	.	.	.	.	0.96016	16	.	ENSG00000102974	.	.	.	.	.	2	0.52957	0.97580	.	.	.	.	0.688130749716732	.	.	0.084978	260121	HGNC:13723	.	.	.	0.889	.	67621454	TAT	1.000000	.	-	.	0.83554	.	.	.	Likely pathogenic	0.98709	.	.	.	ClinGen:CA10588621	Y	.	.	-	0.615	-	0.77038	.	.	0.94871	0.954362869263	.	.	0.99770787246477033	.	-	1220A>G 	.	.	CN517202	.	.	.	.	NM_006565.4	-	.	.	1	0.93500	886039600	.	.	0.78538	0.81373	.	.	.	0.97100700	5.83	.	.	.	0.133401	0.999749203930458	0.87372	T	.	.	.	-0.7497	0.47848	p.Tyr407Cys	.	.	-16.773	0.84561706	.	0.97751	265526	D	.	CTCF	.	D	.	.	Y407C	.	0.87084	0.943	A/A	principal4	965455	CTCF_unpublished_var159702	Yes						overall function		Cell survival			Y		1220	CTCF_unpublished		ENST00000264010.10							immortalized human cells					p.Tyr407Cys		true	c.1220A>G						13723.0	67621454.0	Yes		CTCF				NM_006565.4		1.0			nucleotide		G									criteria provided, single submitter				Tyr407Cys						C	Jan 12, 2016					missense_variant		407.0	A			0.00170449		Likely pathogenic	67621454.0	missense_variant		0.51	functionally_normal				Cell viability			CTCF_Tyr407Cys
CTCF_Tyr407Cys	2.2604531941423103	0.058292407096491645	5.642049992400373	0.0007809142606724553	2025_01_Batch_13-14	0.5832082165597294	0.8062520727072294	0.6881772674260671	0.6578961621597847	0.5755667279191388	0.7070470110384419	0.6614940913889276	0.6188088807723816	0.7503805460433652	0.6003427425011371	0.6451276137990857	0.7338730820480786	0.6534930740992244	0.704138354101575	0.587954735210138	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF				CCSBVarC010870	ALE00013232	NC_000016.10:67621454:A:G	1220A>G	Tyr407Cys	CAVA																											CTCF_Tyr407Cys	16	67621454	A	G	16								1	1	1	16-67621454-A-G	-	0.90871	0.914	407	.	.	.	16	67655357	G	.	.	16	1_Pathogenic	NC_000016.10	.	Tyr407Cys	.	32.0	.	.	.	T	.	1	.	.	.	.	.	.	.	0.78861	.	0.1518	.	0.50540	.	.	D	D	.	.	.	.	.	.	.	0.99834	.	.	.	.	0.96158	.	.	0.85435	0.998	.	.	.	4.73	.	G	single nucleotide variant	NC_000016.10:g.67621454A>G	.	.	2	0.7453358	.	.	0.8909639	.		.	.	.	.	.	.	.	.	MedGen:C3661900	.	.	.	.	0.86984	P	0.81981	P	M	7.377784	.	A/A	.	.	.	.	not provided	.	0.57774	.	.	-	67621454	.	-	11.234000	.	0.94066	.	.	.	.	germline	.	Loss of phosphorylation at Y407 (P = 0.0811)| Gain of ubiquitination at K405 (P = 0.1079)| Gain of disorder (P = 0.1124)| Gain of glycosylation at K405 (P = 0.1594)| Loss of MoRF binding (P = 0.1621)	0.74786	GRCh38	54	criteria provided, single submitter	c.1220A>G	.	0.59198	.	.	.	.	.	.	.	.	.	NM_006565.4(CTCF):c.1220A>G (p.Tyr407Cys)	1	.	CTCF_HUMAN	.	.	0.717981494107391	.	.	0.96717	0.8259339	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.94734	.	.	.	.	.	p.Tyr407Cys	.	0.90219	.	germline	.		A	Jan 06, 2025	.	A/A	.	.	1.0	N	16q22.1	.	.	.	SCV000322502	Likely_pathogenic	.	.	Cys	C	-	.	ENSP00000493495	ENST00000644753	.	.	.	.	0.756	A	.	5.434312	0.92967	D	.	-	7.535864	.	0.74353	.	.	.	0.92450	.	67621454	Y	10	.	.	.	P49711	.	0.875329	0.85930		.	0.665	D	.	0.6975476	.	0.85369	10664	0.258403	.	.	.	.	0.78662	.	.	.	.	.	.	0.84765	16	CTCF	.	.	Tyr	.	.	16-67621454-A-G	not_provided	.	.	66212858	ClinGen:CA10588621	0.932506	0.80704	.	RCV000255519	D	.	.	c.1220A>G	.	.	.	0.79229	A/A	rs886039600	67621454	.	A	.	P49711	.	0.90456	.	0.68239		.	.	.	3.095	.	.	.	4.72	0.97318	.	D	D	.	.	.	.	.	.	.	.	265526	0.78960	0.99706	0.997824430465698	.	.	0.71675	0.92271	.	.	.	9.325	.	.	.	.	.	.	.	0.96016	16	.	ENSG00000102974	.	.	.	.	.	2	0.52957	0.97580	.	.	.	.	0.688130749716732	.	.	0.084978	260121	HGNC:13723	.	.	.	0.889	.	67621454	TAT	1.000000	.	-	.	0.83554	.	.	.	Likely pathogenic	0.98709	.	.	.	ClinGen:CA10588621	Y	.	.	-	0.615	-	0.77038	.	.	0.94871	0.954362869263	.	.	0.99770787246477033	.	-	1220A>G 	.	.	CN517202	.	.	.	.	NM_006565.4	-	.	.	1	0.93500	886039600	.	.	0.78538	0.81373	.	.	.	0.97100700	5.83	.	.	.	0.133401	0.999749203930458	0.87372	T	.	.	.	-0.7497	0.47848	p.Tyr407Cys	.	.	-16.773	0.84561706	.	0.97751	265526	D	.	CTCF	.	D	.	.	Y407C	.	0.87084	0.943	A/A	principal4	965455	CTCF_unpublished_var159702	Yes						overall function		Cell survival			Y		1220	CTCF_unpublished		ENST00000264010.10							immortalized human cells					p.Tyr407Cys		true	c.1220A>G						13723.0	67621454.0	Yes		CTCF				NM_006565.4		1.0			nucleotide		G									criteria provided, single submitter				Tyr407Cys						C	Jan 12, 2016					missense_variant		407.0	A			0.00170449		Likely pathogenic	67621454.0	missense_variant		0.51	functionally_normal				Cell viability			CTCF_Tyr407Cys
BRAF_Leu245Phe	-6.838409603080999	0.00024453937326696584	0.8416317444096693	0.4278071535265413	2025_01_Batch_13-14	0.854239827692258	0.8246017482336747	0.7947755656887654	0.8005495999829777	0.7756869324123206	0.638821106881982	0.749189433932763	0.7786162820182276	0.7664292422276268	0.6076022999835786	0.74653046728712	0.7868955910832189	0.7866959238534965	0.7834894211053023	0.6916446161979496	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220597	CCSBVarC003155	ALE00003155	NC_000007.14:140801537:T:A	735A>T	Leu245Phe	CEGS2	CegsMutGDEh1028	A06	GDEhDisVCh_40058	E10	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Leu245Phe	7	140801537	T	A	7											7-140801537-T-A	-	0.68734	0.817	245	.	.	.	7	140501337	A	.	.	7	1_Pathogenic	NC_000007.14	.	Leu245Phe	.	25.3	.	.	.	D	.	6	.	.	.	.	.	.	.	0.94750	Select	0.7689	.	0.45628	.	.	D	D	.	.	.	.	.	.	.	0.98407	.	.	.	.	0.59576	.	.	0.86525	1.0	.	.	0.982152	4.59	.	A	single nucleotide variant	NC_000007.14:g.140801537T>A	.	.	3	0.7422232	.	.	0.8534249	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	.	.	.	.	0.93829	P	0.82655	P	L	3.916485	.	./.	.	.	.	.	Noonan syndrome with multiple lentigines|Neurodevelopmental delay|RASopathy|not provided|Noonan syndrome and Noonan-related syndrome|Cardio-facio-cutaneous syndrome	.	0.90900	.	.	-	140801537	.	-	5.043000	.	0.99450	.	.	.	.	de novo;germline;unknown	.	Loss of ubiquitination at K240 (P = 0.1231)| Gain of MoRF binding (P = 0.2184)| Gain of methylation at K240 (P = 0.3546)| Loss of loop (P = 0.3664)| Loss of helix (P = 0.3949)	0.93817	GRCh38	794	reviewed by expert panel	c.735A>T	.	0.50124	.	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	.	.	P	.	.	NM_004333.6(BRAF):c.735A>T (p.Leu245Phe)	3	.	BRAF_HUMAN	.	.	0.326061389643417	.	D	0.96927	0.84129506	-	.	.		.	.	2	.	reviewed_by_expert_panel	0.96672	.	.	.	.	.	p.Leu245Phe	.	0.47004	.	germline	.		T	May 10, 2019	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000927044	Pathogenic	.	.	Phe	F	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.661	T	.	4.42959	0.74454	N	.	-	3.954269	.	0.93514	.	.	.	0.67355	.	140801537	Y	10	.	.	.	P15056	.	0.901578	0.96668		.	0.556	D	.	0.7093109	.	0.97202	673	0.430121	.	.	.	.	0.72322	.	.	.	.	.	.	0.84579	7	BRAF	.	.	Leu	.	.	7-140801537-T-A	Neurodevelopmental_delay|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|not_provided	.	.	140147806	ClinGen:CA280029|UniProtKB:P15056#VAR_058623	0.414992	0.57270	.	RCV000055897|RCV002273939|RCV000688777|RCV000033284|RCV000788012|RCV000037957	D	.	.	c.735A>T	.	.	.	0.91476	./.	rs397507466	140801537	.	T	.	P15056	.	0.87422	.	0.68239		.	.	.	1.93	.	.	.	4.28	0.98053	.	D	D	.	.	.	.	.	.	.	1340|500|98733|536391	40348	0.91371	0.95469	0.966380715370178	.	.	0.71675	0.48227	.	.	.	3.384	.	.	.	.	.	.	PS115150|PS151100	0.5231	7	.	ENSG00000157764	.	.	.	.	.	3	0.49409	0.45529	.	.	.	.	0.339330026637409	YES	.	0.407429	48818	HGNC:1097	.	.	.	0.984	.	140801537	TTA	1.000000	.	-	.	0.90783	.	.	.	Pathogenic	0.71025	.	.	.	ClinGen:CA280029,UniProtKB:P15056#VAR_058623	L	.	.	-	0.828	-	0.89792	.	.	0.87638	0.921125054359	0.9939	.	0.99892765569899233	.	-	735A>T 	.	.	C4022738|C1275081|C0175704|C5681679|C5555857|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.93952	397507466	.	.	0.99312	0.57643	.	.	.	0.98961290	5.43	.	.	.	0.380062	0.997428543660156	0.51259	D	.	.	.	0.5278	0.92118	p.Leu245Phe	.	.	-9.514	0.9152295	.	0.93122	40348	D	.	BRAF	.	D	.	.	L245F	.	0.85410	0.55789	./.	principal4																																																																																																				
BRAF_Leu245Phe	-6.838409603080999	0.00024453937326696584	0.8416317444096693	0.4278071535265413	2025_01_Batch_13-14	0.854239827692258	0.8246017482336747	0.7947755656887654	0.8005495999829777	0.7756869324123206	0.638821106881982	0.749189433932763	0.7786162820182276	0.7664292422276268	0.6076022999835786	0.74653046728712	0.7868955910832189	0.7866959238534965	0.7834894211053023	0.6916446161979496	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003155		NC_000007.14:140801537:T:A		Leu245Phe																												BRAF_Leu245Phe	7	140801537	T	A	7	allele	735A>T	F05	527_CAVA_Array_P01	K09	B13A7A8P1_R1	B14A7A8P1_R2				7-140801537-T-A	-	0.68734	0.817	245	.	.	.	7	140501337	A	.	.	7	1_Pathogenic	NC_000007.14	.	Leu245Phe	.	25.3	.	.	.	D	.	6	.	.	.	.	.	.	.	0.94750	Select	0.7689	.	0.45628	.	.	D	D	.	.	.	.	.	.	.	0.98407	.	.	.	.	0.59576	.	.	0.86525	1.0	.	.	0.982152	4.59	.	A	single nucleotide variant	NC_000007.14:g.140801537T>A	.	.	3	0.7422232	.	.	0.8534249	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007893,MedGen:C0175704,OMIM:PS151100,Orphanet:500|Human Phenotype Ontology:HP:0012758,MedGen:C4022738|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	.	.	.	.	0.93829	P	0.82655	P	L	3.916485	.	./.	.	.	.	.	Noonan syndrome with multiple lentigines|Neurodevelopmental delay|RASopathy|not provided|Noonan syndrome and Noonan-related syndrome|Cardio-facio-cutaneous syndrome	.	0.90900	.	.	-	140801537	.	-	5.043000	.	0.99450	.	.	.	.	de novo;germline;unknown	.	Loss of ubiquitination at K240 (P = 0.1231)| Gain of MoRF binding (P = 0.2184)| Gain of methylation at K240 (P = 0.3546)| Loss of loop (P = 0.3664)| Loss of helix (P = 0.3949)	0.93817	GRCh38	794	reviewed by expert panel	c.735A>T	.	0.50124	.	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	.	.	P	.	.	NM_004333.6(BRAF):c.735A>T (p.Leu245Phe)	3	.	BRAF_HUMAN	.	.	0.326061389643417	.	D	0.96927	0.84129506	-	.	.		.	.	2	.	reviewed_by_expert_panel	0.96672	.	.	.	.	.	p.Leu245Phe	.	0.47004	.	germline	.		T	May 10, 2019	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000927044	Pathogenic	.	.	Phe	F	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.661	T	.	4.42959	0.74454	N	.	-	3.954269	.	0.93514	.	.	.	0.67355	.	140801537	Y	10	.	.	.	P15056	.	0.901578	0.96668		.	0.556	D	.	0.7093109	.	0.97202	673	0.430121	.	.	.	.	0.72322	.	.	.	.	.	.	0.84579	7	BRAF	.	.	Leu	.	.	7-140801537-T-A	Neurodevelopmental_delay|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_with_multiple_lentigines|Noonan_syndrome_and_Noonan-related_syndrome|RASopathy|not_provided	.	.	140147806	ClinGen:CA280029|UniProtKB:P15056#VAR_058623	0.414992	0.57270	.	RCV000055897|RCV002273939|RCV000688777|RCV000033284|RCV000788012|RCV000037957	D	.	.	c.735A>T	.	.	.	0.91476	./.	rs397507466	140801537	.	T	.	P15056	.	0.87422	.	0.68239		.	.	.	1.93	.	.	.	4.28	0.98053	.	D	D	.	.	.	.	.	.	.	1340|500|98733|536391	40348	0.91371	0.95469	0.966380715370178	.	.	0.71675	0.48227	.	.	.	3.384	.	.	.	.	.	.	PS115150|PS151100	0.5231	7	.	ENSG00000157764	.	.	.	.	.	3	0.49409	0.45529	.	.	.	.	0.339330026637409	YES	.	0.407429	48818	HGNC:1097	.	.	.	0.984	.	140801537	TTA	1.000000	.	-	.	0.90783	.	.	.	Pathogenic	0.71025	.	.	.	ClinGen:CA280029,UniProtKB:P15056#VAR_058623	L	.	.	-	0.828	-	0.89792	.	.	0.87638	0.921125054359	0.9939	.	0.99892765569899233	.	-	735A>T 	.	.	C4022738|C1275081|C0175704|C5681679|C5555857|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.93952	397507466	.	.	0.99312	0.57643	.	.	.	0.98961290	5.43	.	.	.	0.380062	0.997428543660156	0.51259	D	.	.	.	0.5278	0.92118	p.Leu245Phe	.	.	-9.514	0.9152295	.	0.93122	40348	D	.	BRAF	.	D	.	.	L245F	.	0.85410	0.55789	./.	principal4																																																																																																				
FH_Leu507Pro	4.283741584521042	0.005184294876647455	-9.275306049641868	0.000035051027926109044	2025_01_Batch_13-14	0.9233232839906323	0.941708509775386	0.9910505348182328	0.9782635227503732	0.8190445976873685																0.0	0.0		0.0	0.0	FH	FH		3408		CCSBVarC000455		NC_000001.11:241497841:A:G		Leu507Pro																												FH_Leu507Pro	1	241497841	A	G	1	allele	1520T>C	H02	527_CAVA_Array_P03	P03	B13A7A8P1_R1	B14A7A8P1_R2				1-241497841-A-G	-	0.8524	1.0	507	.	0	.	1	241661141	G	1.864230e-06	.	1	1_Pathogenic	NC_000001.11	3	Leu507Pro	.	28.5	.	.	.	D	0	4	1	.	.	.	.	.	.	0.96123	Select	0.8489	.	0.90580	.	.	D	D	63920	1.25285983881	.	0	.	.	.	0.72042	.	44734	0	.	0.89738	.	.	0.99083	0.999	.	1.0	0.984202	5.2	0.99	G	single nucleotide variant	NC_000001.11:g.241497841A>G	0	.	2	0.9652735	.	.	0.9785105	.	G	.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	.	.	0.000000e+00	0	0.97926	D	0.98958	D	H	13.09385	3	./.	.	.	.	1609240	not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer	.	0.95672	.	.	-	241497841	.	-	10.988000	.	0.99029	29572	.	1178088	.	germline;unknown	90726	Gain of disorder (P = 0.0241)| Loss of stability (P = 0.0351)| Gain of ubiquitination at K502 (P = 0.0548)| Gain of glycosylation at L507 (P = 0.0656)| Loss of loop (P = 0.1258)	0.73245	GRCh38	973	criteria provided, multiple submitters, no conflicts	c.1520T>C	.	0.97555	.	.	.	Fumarase C, C-terminal	.	.	P	.	0.000000e+00	NM_000143.4(FH):c.1520T>C (p.Leu507Pro)	2	.	FUMH_HUMAN	.	99.0	0.97296511661057	.	D	0.81817	0.97985315	-	.	.	2.0591e-6	.	.	0	.	criteria_provided,_conflicting_classifications	0.92347	.	0	.	.	59480	p.Leu507Pro	0	0.84682	.	germline	.	241497841	A	Nov 07, 2023	.	./.	.	.	1.0	N	1q43	.	.	.	SCV001577113|SCV002705312|SCV004045439	Conflicting_classifications_of_pathogenicity	.	.	Pro	P	-	912	ENSP00000355518	ENST00000366560	.	0.0	.	.	0.751	A	.	5.100479	0.76775	D	D	-	15.19072	.	0.91822	.	.	.	0.97447	.	241497841	Y	10	.	.	0.000000e+00	P07954	.	0.828262	0.99334	A	.	0.999	D	.	0.96005136	.	0.91597	2271	0.476607	3	-6.03	.	2.546500e-06	0.91343	.	.	74882	.	4674	.	0.99233	1	FH	0.000000e+00	.	Leu	.	.	1-241497841-A-G	Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer	0	.	239727764	ClinGen:CA345450002	0.972825	0.94822	0	RCV000597494|RCV002395536|RCV003336091	D	0	.	c.1520T>C	.	0	0	0.93531	./.	rs1425094515	241497841	.	A	.	P07954	.	0.98976	.	0.68239	1	.	.	0.000000e+00	4.165	.	.	.	6.02	0.95840	.	D	T	.	.	.	.	.	.	.	140162|523	501651	0.93451	0.81756	0.999450027942657	.	.	0.71675	0.99451	.	.	1178088	7.047	.	D	.	.	.	.	150800	0.76373	1	.	ENSG00000091483	0.000000e+00	.	.	.	0.994625853800694	2	0.92348	0.05579	.	.	.	0.000000e+00	0.931949475285706	YES	0.000000e+00	0.334363	493075	HGNC:3700	D	.	simple_aae	0.974	.	241497841	CTG	1.000000	.	-	.	0.90077	2.546500e-06	.	0	Pathogenic/Likely pathogenic	0.90095	.	0	0	ClinGen:CA345450002	L	.	0.957075880139	-	0.602	-	0.89007	.	.	0.99458	0.733992934227	0.8863	0	0.99930446051084221	.	-	1520T>C 	.	.	C0027672|C3661900|C1708350	.	.	.	.	NM_000143.4	-	.	.	1	0.94624	1425094515	.	.	0.95625	0.96802	0.891	0.003	.	0.92898947	6.02	.	.	.	0.446837	0.999840444787748	0.97608	D	.	.	.	0.9009	0.94950	p.Leu507Pro	.	0	-13.176	0.9082073	0	0.98301	501651	D	.	FH	.	D	0.871	.	L507P	D	0.91904	0.87726	./.	principal1																																																																																																				
KRAS_Pro34Arg	-1.8765842108443014	0.10267990481406933	11.210462647469502	0.000010026137401729719	2025_01_Batch_13-14	0.676061446084069	0.7812795635760178	0.8548183969376422	0.7723692043021924	0.5994054833375623	0.7408775389714906	0.8291234575747858	0.8993292623961888	0.8900621488484681	0.548495579897181	0.7084694925277798	0.8052015105754018	0.8770738296669155	0.8312156765753302	0.5739505316173716	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214476	CCSBVarC006094	ALE00006094	NC_000012.12:25245284:G:C	101C>G	Pro34Arg	CEGS2	CegsMutGDEh1040	C02	GDEhDisVCh_40061	F09	1	CegsMutGDDh1040	C02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Pro34Arg	12	25245284	G	C	12											12-25245284-G-C	-	0.89486	1.0	34	.	.	.	12	25398218	C	.	.	12	1_Pathogenic	NC_000012.12	.	Pro34Arg	.	30.0	.	.	.	D	.	6	1	.	.	.	.	.	.	0.97394	Plus_Clinical	0.8174	.	0.90580	.	.	D	D	.	2.76950302636	.	.	.	.	.	0.97783	.	.	.	.	0.97924	.	.	0.99547	1.0	.	0.0	0.976402	.	1.0	C	single nucleotide variant	NC_000012.12:g.25245284G>C	.	.	3	0.978969	.	.	0.9888393	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519;MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648;MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114;MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.99291	D	0.99382	D	M	16.94078	.	./.	.	.	.	.	Cardiofaciocutaneous syndrome 2|not provided|Cardio-facio-cutaneous syndrome;Noonan syndrome|Acute myeloid leukemia;Noonan syndrome 3;Autoimmune lymphoproliferative syndrome type 4;Cardiofaciocutaneous syndrome 2|RASopathy	.	0.95298	.	.	-	25245284	.	-	11.891000	.	0.98836	.	.	.	.	germline;unknown	.	Gain of catalytic residue at I36 (P = 0.0042)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.0874)| Gain of solvent accessibility (P = 0.1708)| Loss of disorder (P = 0.1763)	0.91170	GRCh38	707	criteria provided, multiple submitters, no conflicts	c.101C>G	.	0.88004	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_004985.5(KRAS):c.101C>G (p.Pro34Arg)	2	.	RASK_HUMAN	.	100.0	1.08644740414511	.	D	0.97478	0.9863729	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99325	.	.	.	.	.	p.Pro34Arg	.	0.99094	.	germline	.		G	Jun 14, 2022	.	./.	.	.	1.0	N	12p12.1	.	.	.	SCV000061924|SCV000263050|SCV000329384|SCV000992785|SCV002159858	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000256078	ENST00000256078	.	0.0	.	.	0.654	G	.	5.331179	0.92967	D	D	-	19.75079	.	0.91490	.	.	.	0.97568	.	25245284	Y	9	.	.	.	P01116	.	0.919051	0.93107		.	1.0	D	.	0.96837485	.	0.97202	3845	0.468623	.	-7.6	.	.	0.91343	.	.	.	.	.	.	0.99788	12	KRAS	.	.	Pro	.	.	12-25245284-G-C	Cardio-facio-cutaneous_syndrome|Noonan_syndrome|RASopathy|not_provided|Acute_myeloid_leukemia|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2|Autoimmune_lymphoproliferative_syndrome_type_4	.	.	25289485	ClinGen:CA280040|OMIM:190070.0013|UniProtKB:P01116#VAR_026110	0.907375	0.97862	.	RCV000043674|RCV000207495|RCV000211723|RCV000850569|RCV001851825	D	.	.	c.101C>G	.	.	.	0.93232	./.	rs104894366	25245284	.	G	.	P01116	.	0.99697	.	0.68239		.	.	.	3.445	.	.	.	5.68	0.98519	.	D	D	.	.	.	.	.	.	.	1340|648|536391|519|648|1340|268114	12590	0.93147	0.98787	0.999483346939087	.	.	0.71675	0.86082	.	.	.	9.985	.	D	.	.	.	.	PS115150|PS163950|601626|609942|615278|614470	0.99185	12	.	ENSG00000133703	.	.	.	.	0.9765456698593341	2	0.97365	0.56997	.	.	.	.	1.01441952461028	.	.	0.322268	27629	HGNC:6407	A	.	simple_aae	0.97	.	25245284	CCA	1.000000	.	-	.	0.93391	.	.	.	Pathogenic/Likely pathogenic	0.99602	.	.	.	ClinGen:CA280040,UniProtKB:P01116#VAR_026110,OMIM:190070.0013	P	.	0.993217693452	-	0.79	-	0.98079	.	.	0.97632	0.913441181183	0.9972	.	0.99851702522609986	.	-	101C>G 	.	.	C1275081|C0028326|C5555857|C3661900|C0023467|C1860991|C3809005|C2674723	.	.	.	.	NM_004985.5	-	.	.	1	0.92683	104894366	.	.	0.99306	0.98880	0.961	0.0	.	0.99935538	5.68	.	.	.	0.435368	0.999953297071636	0.92067	D	.	.	.	0.8728	0.93837	p.Pro34Arg	.	.	-17.558	0.94139737	.	0.99183	12590	D	.	KRAS	.	D	0.905	.	P34R	D	.	0.53775	./.	alternative1																																																																																																				
KRAS_Pro34Arg	-1.8765842108443014	0.10267990481406933	11.210462647469502	0.000010026137401729719	2025_01_Batch_13-14	0.676061446084069	0.7812795635760178	0.8548183969376422	0.7723692043021924	0.5994054833375623	0.7408775389714906	0.8291234575747858	0.8993292623961888	0.8900621488484681	0.548495579897181	0.7084694925277798	0.8052015105754018	0.8770738296669155	0.8312156765753302	0.5739505316173716	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006094		NC_000012.12:25245284:G:C		Pro34Arg																												KRAS_Pro34Arg	12	25245284	G	C	12	allele	101C>G	B07	527_CAVA_Array_P03	D13	B13A7A8P1_R1	B14A7A8P1_R2				12-25245284-G-C	-	0.89486	1.0	34	.	.	.	12	25398218	C	.	.	12	1_Pathogenic	NC_000012.12	.	Pro34Arg	.	30.0	.	.	.	D	.	6	1	.	.	.	.	.	.	0.97394	Plus_Clinical	0.8174	.	0.90580	.	.	D	D	.	2.76950302636	.	.	.	.	.	0.97783	.	.	.	.	0.97924	.	.	0.99547	1.0	.	0.0	0.976402	.	1.0	C	single nucleotide variant	NC_000012.12:g.25245284G>C	.	.	3	0.978969	.	.	0.9888393	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519;MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648;MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114;MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.99291	D	0.99382	D	M	16.94078	.	./.	.	.	.	.	Cardiofaciocutaneous syndrome 2|not provided|Cardio-facio-cutaneous syndrome;Noonan syndrome|Acute myeloid leukemia;Noonan syndrome 3;Autoimmune lymphoproliferative syndrome type 4;Cardiofaciocutaneous syndrome 2|RASopathy	.	0.95298	.	.	-	25245284	.	-	11.891000	.	0.98836	.	.	.	.	germline;unknown	.	Gain of catalytic residue at I36 (P = 0.0042)| Loss of sheet (P = 0.0817)| Loss of glycosylation at T35 (P = 0.0874)| Gain of solvent accessibility (P = 0.1708)| Loss of disorder (P = 0.1763)	0.91170	GRCh38	707	criteria provided, multiple submitters, no conflicts	c.101C>G	.	0.88004	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_004985.5(KRAS):c.101C>G (p.Pro34Arg)	2	.	RASK_HUMAN	.	100.0	1.08644740414511	.	D	0.97478	0.9863729	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99325	.	.	.	.	.	p.Pro34Arg	.	0.99094	.	germline	.		G	Jun 14, 2022	.	./.	.	.	1.0	N	12p12.1	.	.	.	SCV000061924|SCV000263050|SCV000329384|SCV000992785|SCV002159858	Pathogenic/Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000256078	ENST00000256078	.	0.0	.	.	0.654	G	.	5.331179	0.92967	D	D	-	19.75079	.	0.91490	.	.	.	0.97568	.	25245284	Y	9	.	.	.	P01116	.	0.919051	0.93107		.	1.0	D	.	0.96837485	.	0.97202	3845	0.468623	.	-7.6	.	.	0.91343	.	.	.	.	.	.	0.99788	12	KRAS	.	.	Pro	.	.	12-25245284-G-C	Cardio-facio-cutaneous_syndrome|Noonan_syndrome|RASopathy|not_provided|Acute_myeloid_leukemia|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2|Autoimmune_lymphoproliferative_syndrome_type_4	.	.	25289485	ClinGen:CA280040|OMIM:190070.0013|UniProtKB:P01116#VAR_026110	0.907375	0.97862	.	RCV000043674|RCV000207495|RCV000211723|RCV000850569|RCV001851825	D	.	.	c.101C>G	.	.	.	0.93232	./.	rs104894366	25245284	.	G	.	P01116	.	0.99697	.	0.68239		.	.	.	3.445	.	.	.	5.68	0.98519	.	D	D	.	.	.	.	.	.	.	1340|648|536391|519|648|1340|268114	12590	0.93147	0.98787	0.999483346939087	.	.	0.71675	0.86082	.	.	.	9.985	.	D	.	.	.	.	PS115150|PS163950|601626|609942|615278|614470	0.99185	12	.	ENSG00000133703	.	.	.	.	0.9765456698593341	2	0.97365	0.56997	.	.	.	.	1.01441952461028	.	.	0.322268	27629	HGNC:6407	A	.	simple_aae	0.97	.	25245284	CCA	1.000000	.	-	.	0.93391	.	.	.	Pathogenic/Likely pathogenic	0.99602	.	.	.	ClinGen:CA280040,UniProtKB:P01116#VAR_026110,OMIM:190070.0013	P	.	0.993217693452	-	0.79	-	0.98079	.	.	0.97632	0.913441181183	0.9972	.	0.99851702522609986	.	-	101C>G 	.	.	C1275081|C0028326|C5555857|C3661900|C0023467|C1860991|C3809005|C2674723	.	.	.	.	NM_004985.5	-	.	.	1	0.92683	104894366	.	.	0.99306	0.98880	0.961	0.0	.	0.99935538	5.68	.	.	.	0.435368	0.999953297071636	0.92067	D	.	.	.	0.8728	0.93837	p.Pro34Arg	.	.	-17.558	0.94139737	.	0.99183	12590	D	.	KRAS	.	D	0.905	.	P34R	D	.	0.53775	./.	alternative1																																																																																																				
ZC4H2_Lys217Arg	-4.109348315318837	0.004519611248172494	-0.4673650531179407	0.6544384299817574	2025_01_Batch_13-14	0.5219040011392475	0.8915689837768885	0.9502369389311607	0.9120649636540208	0.863185593859517	0.4234407038208272	0.8677867382073803	0.9321519693497194	0.8982282622915231	0.8374510801141866	0.47267235248003736	0.8796778609921344	0.94119445414044	0.9051466129727719	0.8503183369868518	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC009181		NC_000023.11:64917808:T:C		Lys217Arg																												ZC4H2_Lys217Arg	23	64917808	T	C	X	allele	650A>G	G04	527_CAVA_Array_P06	M08	B13A7A8P2_R1	B14A7A8P2_R2				X-64917808-T-C	-	0.69648	0.941	217	.	.	.	X	64137688	C	.	.	X	1_Pathogenic	NC_000023.11	.	Lys217Arg	.	25.4	.	.	.	T	.	1	1	.	.	.	.	.	.	0.65341	Select	0.1423	.	0.52895	.	.	D	D	.	2.6112261011	.	.	.	.	.	0.86039	.	.	.	.	0.53442	.	.	0.80813	1.0	.	3.0	0.967303	.	0.97	C	single nucleotide variant	NC_000023.11:g.64917808T>C	.	.	1	0.7599174	.	.	0.75298744	.		.	.	.	.	.	.	.	.	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	.	.	.	.	0.96253	D	0.85640	P	.	.	.	T/T	.	.	.	.	Wieacker-Wolff syndrome	.	0.37756	.	.	-	64917808	.	-	7.742000	.	0.95990	.	.	.	.	germline	.	Loss of methylation at K217 (P = 0.007)| Loss of glycosylation at K217 (P = 0.0664)| Gain of helix (P = 0.1736)| Loss of ubiquitination at K217 (P = 0.2936)| Loss of solvent accessibility (P = 0.322)	0.49343	GRCh38	40	no assertion criteria provided	c.650A>G	.	0.78637	.	.	.	Zinc finger C4H2-type	.	.	B	.	.	NM_018684.4(ZC4H2):c.650A>G (p.Lys217Arg)		.	ZC4H2_HUMAN	.	97.0	.	.	D	0.49675	0.75298744	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.96976	.	.	.	.	.	p.Lys217Arg	.	0.68069	.	germline	.		T	Apr 09, 2020	.	T/T	.	.	1.0	N	Xq11.2	.	.	.	SCV001198008	Pathogenic	.	.	Arg	R	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.665	T	.	4.467578	0.92967	.	D	-	.	.	0.86022	.	.	.	0.85104	.	64917808	Y	8	.	.	.	Q9NQZ6	.	0.521062	0.96051		.	0.973	D	.	0.7599174	.	0.97202	55906	0.142269	.	-2.44	.	.	0.91343	.	.	.	.	.	.	0.85641	X	ZC4H2	.	.	Lys	.	.	X-64917808-T-C	Wieacker-Wolff_syndrome	.	.	64054413	OMIM:300897.0011	.	.	.	RCV001034718	D	.	.	c.650A>G	.	.	.	0.68312	T/T	rs1929002470	64917808	.	T	.	Q9NQZ6	.	0.80812	.	0.68239		.	.	.	.	.	.	.	5.42	0.83103	.	D	D	.	.	.	.	.	.	.	3454|85283	834097	0.67911	0.98235	0.994114935398102	.	.	0.71675	.	.	.	.	7.404	.	N	.	.	.	.	314580	0.79277	X	.	ENSG00000126970	.	.	.	.	0.5036670474541309	2	0.72925	0.97963	.	.	.	.	.	YES	.	0.189364	822347	HGNC:24931	A	.	simple_aae	0.921	.	64917808	AAG	1.000000	.	-	.	0.54427	.	.	.	Pathogenic	0.53810	.	.	.	OMIM:300897.0011,ClinGen:CA413411045	K	.	0.814197371498	-	0.44	-	0.51703	.	.	0.50093	0.826741635799	0.2619	.	0.9988496640312855	.	-	650A>G 	.	.	C0796200	.	.	.	.	NM_018684.4	-	.	.	1	0.88633	1929002470	.	.	0.81098	.	0.465	0.0	.	0.99151430	5.42	.	.	.	-0.033417	0.965892135885726	.	T	.	.	.	-0.9665	0.46144	p.Lys217Arg	.	.	-6.96	0.3894233	.	0.82597	834097	T	.	ZC4H2	.	D	0.333	.	K217R	D	.	0.62996	T/T	principal1																																																																																																				
F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	0.6170391164027158	0.6119787070567009	0.7108338645049038	0.7288431632537727	0.6132634122586127	0.6546947555220599	0.6182544835470235	0.5795864457237878	0.741698303827135	0.6483762804067048	0.6358669359623879	0.6151165953018622	0.6452101551143459	0.7352707335404538	0.6308198463326588	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T		Pro197Ser																												F9_Pro197Ser	23	139551130	C	T	X	allele	589C>T	G08	527_CAVA_Array_P02	M16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551130-C-T	-	0.00845	0.0	197	0	0	0	X	138633289	T	1.651560e-06	0	X	2_Benign	NC_000023.11	1	Pro197Ser	0	0.029	0	.	8.289120e-05	T	0	1	1	30955	5.804640e-06	.	19008	0.000000e+00	.	0.47720	Select	0.3717	12064	0.02950	0	.	T	T	46864	0.63775699092	.	0	0.000000e+00	0	0	0.11967	13666	33835	0	0.000000e+00	0.02246	0	.	0.02833	0.003	.	93.0	0.561944	-1.7	0.07	T	single nucleotide variant	NC_000023.11:g.139551130C>T	0	12192	2	0.06478413	80343	.	0.030987347	.		1	172276	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	0	0	0.000000e+00	0	0.26006	B	0.13037	B	N	.	2	C/C	.	.	5702	1210973	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13134	0.72190	.	.	-	139551130	.	-	-0.073000	1	0.22017	22039	.	57790	0	germline	56962	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.48357	GRCh38	924	criteria provided, single submitter	c.589C>T	0.000000e+00	0.06232	.	0	0	.	0.000000e+00	6917	B	.	0.000000e+00	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	1	0	FA9_HUMAN	0	7.0	.	0	T	0.01911	0.030987347	+	0.000000e+00	.		1	0.000000e+00	0	27167	criteria_provided,_single_submitter	0.98926	0.000000e+00	0	0.000000e+00	0	46015	p.Pro197Ser	0	0.12324	.	germline	.		C	Feb 03, 2024	0	C/C	0	64674	0.001	N	Xq27.1	.	.	7.613830e-05	SCV002992787	Likely_benign	0	0	Ser	S	-	688	ENSP00000218099	ENST00000218099	13319	1.0	10128	0	-1.556	C	0	-0.950913	0.02435	.	T	-	.	.	0.49836	.	0	.	0.00888	.	139551130	Y	10	.	73493	0.000000e+00	P00740	0	0.277936	0.00314		.	0.0	D	13134	0.06478413	.	0.0525	2158	-0.359869	1	0.67	.	1.730400e-05	0.00968	0.000000e+00	0	57790	0.000000e+00	4352	0	0.13037	X	F9	1.730400e-05	.	Pro	.	0.000000e+00	X-139551130-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138460955	.	.	.	0	RCV002710164	T	0	0	c.589C>T	0	0	0	0.03974	C/C	rs867548424	139551130	12064	C	.	P00740	9952	0.02834	0.000000e+00	0.18256		0	0	0.000000e+00	-1.845	.	.	.	-2.38	0.64861	.	T	T	1	0.000000e+00	.	.	.	0	0	98879	1959260	0.15863	0.57233	0.0218413153825192	.	.	0.13799	.	0.000000e+00	7.613830e-05	894804	-0.387	6.584840e-06	N	9934	0	.	.	306900|300807	0.07437	X	8.289120e-05	ENSG00000101981	0.000000e+00	.	0	.	0.9073591802246402	1	0.01384	0.18019	19073	.	0.000000e+00	0.000000e+00	.	YES	0.000000e+00	0.027201	2009495	HGNC:3551	N	0	simple_aae	0.078	151864	139551130	CCT	0.002000	.	-	.	0.01924	1.117560e-06	.	0	Likely benign	0.16375	0	0	0	ClinGen:CA336137425	P	0	0.445173020498	-	0.434	-	0.01414	1	.	0.90650	0.310453176498	0.0598	0	0.14416938963530473	.	-	589C>T 	1	.	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.19427	-1	1767	.	0.43755	.	0.041	1.0	.	0.99871650	4.94	.	.	0.000000e+00	-0.562367	0.0725587346858254	0.00268	T	.	4649	7084	-0.3909	0.72963	p.Pro197Ser	.	0	-3.242	0.036299646	1	0.40442	1959260	T	24389	F9	0.000000e+00	T	0.197	15996	P197S	T	0.12702	0.00956	C/C	principal1	245239	F9_Popp_2025_strep_2_var263534	No											P		589	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Pro197Ser		true	c.589C>T						3551.0	139551130.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Pro197Ser						S	Aug 30, 2022					missense_variant		197.0			1.6515644857e-6	0.9948666767593736		Likely benign	139551130.0	missense_variant		0.197					Reporter			F9_Pro197Ser
F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	0.6170391164027158	0.6119787070567009	0.7108338645049038	0.7288431632537727	0.6132634122586127	0.6546947555220599	0.6182544835470235	0.5795864457237878	0.741698303827135	0.6483762804067048	0.6358669359623879	0.6151165953018622	0.6452101551143459	0.7352707335404538	0.6308198463326588	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T		Pro197Ser																												F9_Pro197Ser	23	139551130	C	T	X	allele	589C>T	G08	527_CAVA_Array_P02	M16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551130-C-T	-	0.00845	0.0	197	0	0	0	X	138633289	T	1.651560e-06	0	X	2_Benign	NC_000023.11	1	Pro197Ser	0	0.029	0	.	8.289120e-05	T	0	1	1	30955	5.804640e-06	.	19008	0.000000e+00	.	0.47720	Select	0.3717	12064	0.02950	0	.	T	T	46864	0.63775699092	.	0	0.000000e+00	0	0	0.11967	13666	33835	0	0.000000e+00	0.02246	0	.	0.02833	0.003	.	93.0	0.561944	-1.7	0.07	T	single nucleotide variant	NC_000023.11:g.139551130C>T	0	12192	2	0.06478413	80343	.	0.030987347	.		1	172276	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	0	0	0.000000e+00	0	0.26006	B	0.13037	B	N	.	2	C/C	.	.	5702	1210973	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13134	0.72190	.	.	-	139551130	.	-	-0.073000	1	0.22017	22039	.	57790	0	germline	56962	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.48357	GRCh38	924	criteria provided, single submitter	c.589C>T	0.000000e+00	0.06232	.	0	0	.	0.000000e+00	6917	B	.	0.000000e+00	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	1	0	FA9_HUMAN	0	7.0	.	0	T	0.01911	0.030987347	+	0.000000e+00	.		1	0.000000e+00	0	27167	criteria_provided,_single_submitter	0.98926	0.000000e+00	0	0.000000e+00	0	46015	p.Pro197Ser	0	0.12324	.	germline	.		C	Feb 03, 2024	0	C/C	0	64674	0.001	N	Xq27.1	.	.	7.613830e-05	SCV002992787	Likely_benign	0	0	Ser	S	-	688	ENSP00000218099	ENST00000218099	13319	1.0	10128	0	-1.556	C	0	-0.950913	0.02435	.	T	-	.	.	0.49836	.	0	.	0.00888	.	139551130	Y	10	.	73493	0.000000e+00	P00740	0	0.277936	0.00314		.	0.0	D	13134	0.06478413	.	0.0525	2158	-0.359869	1	0.67	.	1.730400e-05	0.00968	0.000000e+00	0	57790	0.000000e+00	4352	0	0.13037	X	F9	1.730400e-05	.	Pro	.	0.000000e+00	X-139551130-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138460955	.	.	.	0	RCV002710164	T	0	0	c.589C>T	0	0	0	0.03974	C/C	rs867548424	139551130	12064	C	.	P00740	9952	0.02834	0.000000e+00	0.18256		0	0	0.000000e+00	-1.845	.	.	.	-2.38	0.64861	.	T	T	1	0.000000e+00	.	.	.	0	0	98879	1959260	0.15863	0.57233	0.0218413153825192	.	.	0.13799	.	0.000000e+00	7.613830e-05	894804	-0.387	6.584840e-06	N	9934	0	.	.	306900|300807	0.07437	X	8.289120e-05	ENSG00000101981	0.000000e+00	.	0	.	0.9073591802246402	1	0.01384	0.18019	19073	.	0.000000e+00	0.000000e+00	.	YES	0.000000e+00	0.027201	2009495	HGNC:3551	N	0	simple_aae	0.078	151864	139551130	CCT	0.002000	.	-	.	0.01924	1.117560e-06	.	0	Likely benign	0.16375	0	0	0	ClinGen:CA336137425	P	0	0.445173020498	-	0.434	-	0.01414	1	.	0.90650	0.310453176498	0.0598	0	0.14416938963530473	.	-	589C>T 	1	.	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.19427	-1	1767	.	0.43755	.	0.041	1.0	.	0.99871650	4.94	.	.	0.000000e+00	-0.562367	0.0725587346858254	0.00268	T	.	4649	7084	-0.3909	0.72963	p.Pro197Ser	.	0	-3.242	0.036299646	1	0.40442	1959260	T	24389	F9	0.000000e+00	T	0.197	15996	P197S	T	0.12702	0.00956	C/C	principal1	162691	F9_Popp_2025_carboxy_gla_motif_var253853	No											P		589	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Pro197Ser		true	c.589C>T						3551.0	139551130.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Pro197Ser						S	Aug 30, 2022					missense_variant		197.0			1.6515644857e-6	1.0472969167219943		Likely benign	139551130.0	missense_variant		0.197					Reporter			F9_Pro197Ser
F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	0.6170391164027158	0.6119787070567009	0.7108338645049038	0.7288431632537727	0.6132634122586127	0.6546947555220599	0.6182544835470235	0.5795864457237878	0.741698303827135	0.6483762804067048	0.6358669359623879	0.6151165953018622	0.6452101551143459	0.7352707335404538	0.6308198463326588	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T		Pro197Ser																												F9_Pro197Ser	23	139551130	C	T	X	allele	589C>T	G08	527_CAVA_Array_P02	M16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551130-C-T	-	0.00845	0.0	197	0	0	0	X	138633289	T	1.651560e-06	0	X	2_Benign	NC_000023.11	1	Pro197Ser	0	0.029	0	.	8.289120e-05	T	0	1	1	30955	5.804640e-06	.	19008	0.000000e+00	.	0.47720	Select	0.3717	12064	0.02950	0	.	T	T	46864	0.63775699092	.	0	0.000000e+00	0	0	0.11967	13666	33835	0	0.000000e+00	0.02246	0	.	0.02833	0.003	.	93.0	0.561944	-1.7	0.07	T	single nucleotide variant	NC_000023.11:g.139551130C>T	0	12192	2	0.06478413	80343	.	0.030987347	.		1	172276	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	0	0	0.000000e+00	0	0.26006	B	0.13037	B	N	.	2	C/C	.	.	5702	1210973	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13134	0.72190	.	.	-	139551130	.	-	-0.073000	1	0.22017	22039	.	57790	0	germline	56962	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.48357	GRCh38	924	criteria provided, single submitter	c.589C>T	0.000000e+00	0.06232	.	0	0	.	0.000000e+00	6917	B	.	0.000000e+00	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	1	0	FA9_HUMAN	0	7.0	.	0	T	0.01911	0.030987347	+	0.000000e+00	.		1	0.000000e+00	0	27167	criteria_provided,_single_submitter	0.98926	0.000000e+00	0	0.000000e+00	0	46015	p.Pro197Ser	0	0.12324	.	germline	.		C	Feb 03, 2024	0	C/C	0	64674	0.001	N	Xq27.1	.	.	7.613830e-05	SCV002992787	Likely_benign	0	0	Ser	S	-	688	ENSP00000218099	ENST00000218099	13319	1.0	10128	0	-1.556	C	0	-0.950913	0.02435	.	T	-	.	.	0.49836	.	0	.	0.00888	.	139551130	Y	10	.	73493	0.000000e+00	P00740	0	0.277936	0.00314		.	0.0	D	13134	0.06478413	.	0.0525	2158	-0.359869	1	0.67	.	1.730400e-05	0.00968	0.000000e+00	0	57790	0.000000e+00	4352	0	0.13037	X	F9	1.730400e-05	.	Pro	.	0.000000e+00	X-139551130-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138460955	.	.	.	0	RCV002710164	T	0	0	c.589C>T	0	0	0	0.03974	C/C	rs867548424	139551130	12064	C	.	P00740	9952	0.02834	0.000000e+00	0.18256		0	0	0.000000e+00	-1.845	.	.	.	-2.38	0.64861	.	T	T	1	0.000000e+00	.	.	.	0	0	98879	1959260	0.15863	0.57233	0.0218413153825192	.	.	0.13799	.	0.000000e+00	7.613830e-05	894804	-0.387	6.584840e-06	N	9934	0	.	.	306900|300807	0.07437	X	8.289120e-05	ENSG00000101981	0.000000e+00	.	0	.	0.9073591802246402	1	0.01384	0.18019	19073	.	0.000000e+00	0.000000e+00	.	YES	0.000000e+00	0.027201	2009495	HGNC:3551	N	0	simple_aae	0.078	151864	139551130	CCT	0.002000	.	-	.	0.01924	1.117560e-06	.	0	Likely benign	0.16375	0	0	0	ClinGen:CA336137425	P	0	0.445173020498	-	0.434	-	0.01414	1	.	0.90650	0.310453176498	0.0598	0	0.14416938963530473	.	-	589C>T 	1	.	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.19427	-1	1767	.	0.43755	.	0.041	1.0	.	0.99871650	4.94	.	.	0.000000e+00	-0.562367	0.0725587346858254	0.00268	T	.	4649	7084	-0.3909	0.72963	p.Pro197Ser	.	0	-3.242	0.036299646	1	0.40442	1959260	T	24389	F9	0.000000e+00	T	0.197	15996	P197S	T	0.12702	0.00956	C/C	principal1	190207	F9_Popp_2025_heavy_chain_var234491	No											P		589	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Pro197Ser		true	c.589C>T						3551.0	139551130.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Pro197Ser						S	Aug 30, 2022					missense_variant		197.0			1.6515644857e-6	1.042434873347617		Likely benign	139551130.0	missense_variant		0.197					Reporter			F9_Pro197Ser
F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	0.6170391164027158	0.6119787070567009	0.7108338645049038	0.7288431632537727	0.6132634122586127	0.6546947555220599	0.6182544835470235	0.5795864457237878	0.741698303827135	0.6483762804067048	0.6358669359623879	0.6151165953018622	0.6452101551143459	0.7352707335404538	0.6308198463326588	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T		Pro197Ser																												F9_Pro197Ser	23	139551130	C	T	X	allele	589C>T	G08	527_CAVA_Array_P02	M16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551130-C-T	-	0.00845	0.0	197	0	0	0	X	138633289	T	1.651560e-06	0	X	2_Benign	NC_000023.11	1	Pro197Ser	0	0.029	0	.	8.289120e-05	T	0	1	1	30955	5.804640e-06	.	19008	0.000000e+00	.	0.47720	Select	0.3717	12064	0.02950	0	.	T	T	46864	0.63775699092	.	0	0.000000e+00	0	0	0.11967	13666	33835	0	0.000000e+00	0.02246	0	.	0.02833	0.003	.	93.0	0.561944	-1.7	0.07	T	single nucleotide variant	NC_000023.11:g.139551130C>T	0	12192	2	0.06478413	80343	.	0.030987347	.		1	172276	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	0	0	0.000000e+00	0	0.26006	B	0.13037	B	N	.	2	C/C	.	.	5702	1210973	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13134	0.72190	.	.	-	139551130	.	-	-0.073000	1	0.22017	22039	.	57790	0	germline	56962	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.48357	GRCh38	924	criteria provided, single submitter	c.589C>T	0.000000e+00	0.06232	.	0	0	.	0.000000e+00	6917	B	.	0.000000e+00	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	1	0	FA9_HUMAN	0	7.0	.	0	T	0.01911	0.030987347	+	0.000000e+00	.		1	0.000000e+00	0	27167	criteria_provided,_single_submitter	0.98926	0.000000e+00	0	0.000000e+00	0	46015	p.Pro197Ser	0	0.12324	.	germline	.		C	Feb 03, 2024	0	C/C	0	64674	0.001	N	Xq27.1	.	.	7.613830e-05	SCV002992787	Likely_benign	0	0	Ser	S	-	688	ENSP00000218099	ENST00000218099	13319	1.0	10128	0	-1.556	C	0	-0.950913	0.02435	.	T	-	.	.	0.49836	.	0	.	0.00888	.	139551130	Y	10	.	73493	0.000000e+00	P00740	0	0.277936	0.00314		.	0.0	D	13134	0.06478413	.	0.0525	2158	-0.359869	1	0.67	.	1.730400e-05	0.00968	0.000000e+00	0	57790	0.000000e+00	4352	0	0.13037	X	F9	1.730400e-05	.	Pro	.	0.000000e+00	X-139551130-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138460955	.	.	.	0	RCV002710164	T	0	0	c.589C>T	0	0	0	0.03974	C/C	rs867548424	139551130	12064	C	.	P00740	9952	0.02834	0.000000e+00	0.18256		0	0	0.000000e+00	-1.845	.	.	.	-2.38	0.64861	.	T	T	1	0.000000e+00	.	.	.	0	0	98879	1959260	0.15863	0.57233	0.0218413153825192	.	.	0.13799	.	0.000000e+00	7.613830e-05	894804	-0.387	6.584840e-06	N	9934	0	.	.	306900|300807	0.07437	X	8.289120e-05	ENSG00000101981	0.000000e+00	.	0	.	0.9073591802246402	1	0.01384	0.18019	19073	.	0.000000e+00	0.000000e+00	.	YES	0.000000e+00	0.027201	2009495	HGNC:3551	N	0	simple_aae	0.078	151864	139551130	CCT	0.002000	.	-	.	0.01924	1.117560e-06	.	0	Likely benign	0.16375	0	0	0	ClinGen:CA336137425	P	0	0.445173020498	-	0.434	-	0.01414	1	.	0.90650	0.310453176498	0.0598	0	0.14416938963530473	.	-	589C>T 	1	.	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.19427	-1	1767	.	0.43755	.	0.041	1.0	.	0.99871650	4.94	.	.	0.000000e+00	-0.562367	0.0725587346858254	0.00268	T	.	4649	7084	-0.3909	0.72963	p.Pro197Ser	.	0	-3.242	0.036299646	1	0.40442	1959260	T	24389	F9	0.000000e+00	T	0.197	15996	P197S	T	0.12702	0.00956	C/C	principal1	217723	F9_Popp_2025_light_chain_var244172	No											P		589	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Pro197Ser		true	c.589C>T						3551.0	139551130.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Pro197Ser						S	Aug 30, 2022					missense_variant		197.0			1.6515644857e-6	1.0111500373664293		Likely benign	139551130.0	missense_variant		0.197					Reporter			F9_Pro197Ser
F9_Pro197Ser	-3.0775892024267777	0.017875819223215413	3.3939706402177365	0.011536838629607006	2025_01_Batch_13-14	0.6170391164027158	0.6119787070567009	0.7108338645049038	0.7288431632537727	0.6132634122586127	0.6546947555220599	0.6182544835470235	0.5795864457237878	0.741698303827135	0.6483762804067048	0.6358669359623879	0.6151165953018622	0.6452101551143459	0.7352707335404538	0.6308198463326588	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030562		NC_000023.11:139551130:C:T		Pro197Ser																												F9_Pro197Ser	23	139551130	C	T	X	allele	589C>T	G08	527_CAVA_Array_P02	M16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551130-C-T	-	0.00845	0.0	197	0	0	0	X	138633289	T	1.651560e-06	0	X	2_Benign	NC_000023.11	1	Pro197Ser	0	0.029	0	.	8.289120e-05	T	0	1	1	30955	5.804640e-06	.	19008	0.000000e+00	.	0.47720	Select	0.3717	12064	0.02950	0	.	T	T	46864	0.63775699092	.	0	0.000000e+00	0	0	0.11967	13666	33835	0	0.000000e+00	0.02246	0	.	0.02833	0.003	.	93.0	0.561944	-1.7	0.07	T	single nucleotide variant	NC_000023.11:g.139551130C>T	0	12192	2	0.06478413	80343	.	0.030987347	.		1	172276	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	0	0	0.000000e+00	0	0.26006	B	0.13037	B	N	.	2	C/C	.	.	5702	1210973	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13134	0.72190	.	.	-	139551130	.	-	-0.073000	1	0.22017	22039	.	57790	0	germline	56962	Loss of stability (P = 0.0486)| Gain of disorder (P = 0.1181)| Gain of phosphorylation at P197 (P = 0.1328)| Gain of glycosylation at P197 (P = 0.174)| Gain of MoRF binding (P = 0.4141)	0.48357	GRCh38	924	criteria provided, single submitter	c.589C>T	0.000000e+00	0.06232	.	0	0	.	0.000000e+00	6917	B	.	0.000000e+00	NM_000133.4(F9):c.589C>T (p.Pro197Ser)	1	0	FA9_HUMAN	0	7.0	.	0	T	0.01911	0.030987347	+	0.000000e+00	.		1	0.000000e+00	0	27167	criteria_provided,_single_submitter	0.98926	0.000000e+00	0	0.000000e+00	0	46015	p.Pro197Ser	0	0.12324	.	germline	.		C	Feb 03, 2024	0	C/C	0	64674	0.001	N	Xq27.1	.	.	7.613830e-05	SCV002992787	Likely_benign	0	0	Ser	S	-	688	ENSP00000218099	ENST00000218099	13319	1.0	10128	0	-1.556	C	0	-0.950913	0.02435	.	T	-	.	.	0.49836	.	0	.	0.00888	.	139551130	Y	10	.	73493	0.000000e+00	P00740	0	0.277936	0.00314		.	0.0	D	13134	0.06478413	.	0.0525	2158	-0.359869	1	0.67	.	1.730400e-05	0.00968	0.000000e+00	0	57790	0.000000e+00	4352	0	0.13037	X	F9	1.730400e-05	.	Pro	.	0.000000e+00	X-139551130-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138460955	.	.	.	0	RCV002710164	T	0	0	c.589C>T	0	0	0	0.03974	C/C	rs867548424	139551130	12064	C	.	P00740	9952	0.02834	0.000000e+00	0.18256		0	0	0.000000e+00	-1.845	.	.	.	-2.38	0.64861	.	T	T	1	0.000000e+00	.	.	.	0	0	98879	1959260	0.15863	0.57233	0.0218413153825192	.	.	0.13799	.	0.000000e+00	7.613830e-05	894804	-0.387	6.584840e-06	N	9934	0	.	.	306900|300807	0.07437	X	8.289120e-05	ENSG00000101981	0.000000e+00	.	0	.	0.9073591802246402	1	0.01384	0.18019	19073	.	0.000000e+00	0.000000e+00	.	YES	0.000000e+00	0.027201	2009495	HGNC:3551	N	0	simple_aae	0.078	151864	139551130	CCT	0.002000	.	-	.	0.01924	1.117560e-06	.	0	Likely benign	0.16375	0	0	0	ClinGen:CA336137425	P	0	0.445173020498	-	0.434	-	0.01414	1	.	0.90650	0.310453176498	0.0598	0	0.14416938963530473	.	-	589C>T 	1	.	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.19427	-1	1767	.	0.43755	.	0.041	1.0	.	0.99871650	4.94	.	.	0.000000e+00	-0.562367	0.0725587346858254	0.00268	T	.	4649	7084	-0.3909	0.72963	p.Pro197Ser	.	0	-3.242	0.036299646	1	0.40442	1959260	T	24389	F9	0.000000e+00	T	0.197	15996	P197S	T	0.12702	0.00956	C/C	principal1	135175	F9_Popp_2025_carboxy_F9_specific_var224810	No											P		589	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Pro197Ser		true	c.589C>T						3551.0	139551130.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Pro197Ser						S	Aug 30, 2022					missense_variant		197.0			1.6515644857e-6	1.010689335057021		Likely benign	139551130.0	missense_variant		0.197					Reporter			F9_Pro197Ser
BRCA1_Ala102Gly	-1.4050219512461604	0.20280504742642533	-6.386066195669309	0.00037218712893209217	2025_01_Batch_13-14	0.87910947777377	0.9080614217344603	0.9790875484839284	0.9649037055693481	0.8255454760853147	0.7179899562352263	0.8008915564922798	0.9556453157602098	0.9172671299391097	0.7462918151419493	0.7985497170044982	0.85447648911337	0.9673664321220692	0.9410854177542289	0.785918645613632	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC013080		NC_000017.11:43104258:G:C		Ala102Gly																												BRCA1_Ala102Gly	17	43104258	G	C	17	allele	305C>G	A11	527_CAVA_Array_P01	A21	B13A7A8P1_R1	B14A7A8P1_R2				17-43104258-G-C	-	0.36769	0.057	102	.	0	.	17	41256275	C	2.485640e-06	.	17	2_Benign	NC_000017.11	1	Ala102Gly	.	20.3	.	0	.	T	0	11	1	.	.	.	.	.	0	0.84430	.	0.1938	.	0.44237	.	.	T	D	63826	.	0	0	.	.	.	0.12270	.	44828	0	.	0.48535	.	.	0.29224	0.968	.	.	.	4.41	.	C	single nucleotide variant	NC_000017.11:g.43104258G>C	0	.	2	0.06543072	.	0	0.12579814	0.009259259259259259		.	.	.	.	.	146	.	0	MONDO:MONDO:0700268,MedGen:CN377757|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374	.	.	0.000000e+00	0	0.61445	B	0.13260	B	M	2.871031	4	G/G	84	0	.	1609246	BRCA1-related cancer predisposition|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified	.	0.49200	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43104258	.	-	6.237000	.	0.29145	29582	0	74900	.	germline;unknown	90756	Loss of stability (P = 0.0442)| Gain of relative solvent accessibility (P = 0.0999)| Gain of disorder (P = 0.157)| Gain of catalytic residue at S104 (P = 0.1636)| Loss of phosphorylation at Y101 (P = 0.2814)	0.55849	GRCh38	462	reviewed by expert panel	c.305C>G	.	0.36180	1	.	.	.	.	.	LB	0	0.000000e+00	NM_007294.4(BRCA1):c.305C>G (p.Ala102Gly)	3	.	BRCA1_HUMAN	.	.	0.0961423372559193	.	.	0.35034	0.12579814	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.96816	.	0	.	.	59924	p.Ala102Gly	0	0.55333	.	germline	.		G	Jun 11, 2024	.	G/G	.	.	1.0	N	17q21.31	6962	.	.	SCV004101421	Benign	.	.	Gly	G	-	912	ENSP00000419274	ENST00000470026	.	0.006	.	.	0.676	G	.	2.791559	0.48945	N	T	-	2.842934	.	0.79755	610	.	.	0.33015	1	43104258	Y	10	0	.	0.000000e+00	P38398	.	0.212967	0.60877		.	0.023	D	.	0.06543072	.	0.53734	672	0.262764	0	-0.52	.	1.335110e-05	0.68399	.	.	74900	.	6050	.	0.13260	17	BRCA1	1.335110e-05	0	Ala	10680	.	17-43104258-G-C	not_specified|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|BRCA1-related_cancer_predisposition|Hereditary_cancer-predisposing_syndrome	0	.	38509801	ClinGen:CA002009	0.328409	0.46027	0	RCV004566761|RCV001353922|RCV000166160|RCV000203639|RCV000031086|RCV000048062	D	0	.	c.305C>G	.	0	0	0.79636	G/G	rs80357190	43104258	.	G	.	E9PFC7	.	0.29224	.	0.68239		.	.	0.000000e+00	2.24	0	0	264690	3.24	0.57203	108	D	T	.	.	0	24	.	.	.	145|145|140162	37505	0.79372	0.20076	0.518966853618622	2294	.	0.71675	0.42717	.	.	1176114	1.516	.	N	.	.	3.7780044E-6	0	604370	0.35569	17	.	ENSG00000012048	0.000000e+00	0	.	0.041666666666666664	.	2	0.42592	0.78630	.	1	.	0.000000e+00	0.125822333913209	.	0.000000e+00	0.118185	46061	HGNC:1100	.	.	.	0.105	.	43104258	GCA	1.000000	.	-	0	0.50348	0.000000e+00	0	0	Benign	0.40366	.	0	0	ClinGen:CA002009	A	.	0.947690629548	-	0.48	-	0.53827	.	466	0.33795	0.312466681004	0.1268	0	0.99356524987265227	94	-	305C>G 	.	0	CN169374|C0677776|C3661900|C2676676|CN377757|C0027672	.	.	.	.	NM_007294.4	-	.	.	0	0.80632	80357190	.	9.363295880149813E-5	0.94671	0.45602	.	0.065	2210	0.99054370	5.32	.	.	.	0.139666	0.485608964919914	0.63167	T	84	.	.	-0.8845	0.54543	p.Ala102Gly	1	0	-4.128	0.33566126	1	0.60346	37505	T	.	BRCA1	.	D	0.606	.	A102G	D	0.82967	0.76753	G/G	principal2																																																																																																				
BAP1_Thr423Lys	-1.3565825611557805	0.21703700719903737	-4.239050177833455	0.003844822069613415	2025_01_Batch_13-14	0.5366318780047523	0.6153002905177806	0.7218464078878021	0.6202442813261588	0.5530089525647295	0.4178216284443667	0.4970009991935067	0.6379777085824948	0.607978353139027	0.4367129258942913	0.47722675322455954	0.5561506448556437	0.6799120582351484	0.6141113172325929	0.49486093922951035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009476		NC_000003.12:52403877:G:T		Thr423Lys																												BAP1_Thr423Lys	3	52403877	G	T	3	allele	1268C>A	G01	527_CAVA_Array_P01	M01	B13A7A8P1_R1	B14A7A8P1_R2				3-52403877-G-T	-	0.30551	0.002	423	1	0	0	3	52437893	T	2.645440e-04	8	3	2_Benign	NC_000003.12	363	Thr423Lys	0	18.46	0	32	5.032880e-03	T	3	9	1	42768	3.842450e-04	16	30526	0.000000e+00	0	0.15198	Select	0.0638	14902	0.09864	14	0.0	T	T	63940	0.453964407394	0.0033977489912932683	3	0.000000e+00	0	0	0.17586	17106	44890	0	0.000000e+00	0.27007	1	.	0.19931	0.994	0.012102874432677761	94.0	0.729627	3.9	0.06	T	single nucleotide variant	NC_000003.12:g.52403877G>T	0	16644	2	0.09277198	109312	0	0.07225229	0		93	236828	0	0	0.000000e+00	796	2.338200e-05	3	MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0011696,MedGen:C1847723,OMIM:606661,Orphanet:39044	52	0	0.000000e+00	0	0.18971	B	0.21201	B	N	2.029722	427	G/G	360	4	7164	1614100	BAP1-related tumor predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided|not specified|Melanoma, uveal, susceptibility to, 2	16212	0.22040	0	.	-	52403877	6.002230e-03	-	6.351000	79	0.25882	29598	0	75032	0	germline;unknown	91088	.	.	GRCh38	68	criteria provided, multiple submitters, no conflicts	c.1268C>A	0.000000e+00	0.68875	41	0	0	Peptidase C12, ubiquitin carboxyl-terminal hydrolase	0.000000e+00	9046	B	0	0.000000e+00	NM_004656.4(BAP1):c.1268C>A (p.Thr423Lys)	2	0	BAP1_HUMAN	0	6.0	-0.147163113713975	12	T	0.16120	0.0865195	-	6.002230e-03	0		79	0.000000e+00	0	34252	criteria_provided,_multiple_submitters,_no_conflicts	0.97351	4.757030e-04	3	0.000000e+00	0	60026	p.Thr423Lys	0	0.55560	.	germline	43		G	Feb 04, 2025	0	G/G	0	89508	0.94	N	3p21.1	173836	.	4.872930e-03	SCV000288737|SCV000445471|SCV000664594|SCV000682561|SCV000986622|SCV002064677|SCV002537251|SCV004016346|SCV005404632	Benign/Likely_benign	0	0	Lys	K	-	912	ENSP00000417132	ENST00000460680	17692	0.034	13414	0	0.676	G	0	2.376386	0.60671	N	D	-	2.686219	.	.	974	0	0.0	0.00125	0	52403877	Y	10	0.001256281407035176	102726	0.000000e+00	Q92560	0	0.024049	0.34277		0	0.002	.	16212	0.09052727	7164	0.71086	8314	-0.488477	11	-1.03	0.0	4.837940e-03	0.44516	0.000000e+00	0	75032	0.000000e+00	6062	43	0.21846	3	BAP1	4.837940e-03	0	Thr	209436	1.117220e-05	3-52403877-G-T	not_specified|BAP1-related_tumor_predisposition_syndrome|not_provided|Hereditary_cancer-predisposing_syndrome|Melanoma,_uveal,_susceptibility_to,_2	0	1	52412933	ClinGen:CA2436837	0.073686	0.35080	0	RCV000228893|RCV000563367|RCV000844571|RCV001818616|RCV003316284	T	0	0	c.1268C>A	0	0	0	0.00629	G/G	rs115109161	52403877	14902	G	0.003194888178913738	.	15690	0.15912	0.000000e+00	0.68239		0	0	0.000000e+00	0	0.008333333333333333	1	264690	5.1	0.18095	6354	T	T	75	3.932110e-04	1	1850	.	0	0	289539|140162|39044	240045	0.24913	0.44793	0.00967223067305719	9778	16	0.32731	0.14558	4.087350e-04	4.872930e-03	1180040	2.575	4.471580e-04	N	13304	0	0.001681212	0	614327|606661	0.4579	3	5.032880e-03	ENSG00000163930	0.000000e+00	5.752548378931867E-6	0	0	0.19555129210449032	2	0.06938	0.97129	30608	445	9.734630e-06	5.164430e-04	0.0881182991556912	YES	0.000000e+00	.	239268	HGNC:950	N	0	simple_aae	0.092	207980	52403877	ACA	1.000000	0	-	0.003579464103088566	0.00163	9.321720e-06	35	0	Benign/Likely benign	0.00535	0	0	31	ClinGen:CA2436837	T	0	0.671732637855	-	.	-	0.37371	91	17418	0.19291	0.347844183445	0.0922	0	0.974649564021286	280	-	1268C>A 	75	2.2964749110115972E-4	CN169374|C3280492|C3661900|C0027672|C1847723	0	0	0	0	NM_004656.4	-	0	0.0	0	0.34303	115109161	2320	1.9576386103630704E-4	0.66638	0.43669	0.324	0.017	9418	0.99352360	6.04	.	.	0.000000e+00	-0.472382	0.0551843815255829	0.06502	T	4504	6210	9568	-1.0250	0.26280	p.Thr423Lys	0	0	-0.415	0.007293403	363	0.38039	240045	T	30518	BAP1	4.676720e-04	T	0.054	21542	.	D	0.73887	0.76753	G/G	principal1																																																																																																				
CTCF_Tyr226Cys	-2.0081090165748017	0.08460141469372065	9.898022384502617	0.00002288890486814957	2025_01_Batch_13-14	0.7492800853906024	0.7696342836386185	0.7975981630763701	0.7179964404154167	0.6719436870404148	0.7548044068723039	0.706860760395464	0.8024246319711629	0.681781111840152	0.7348871972295691	0.7520422461314531	0.7382475220170412	0.8000113975237665	0.6998887761277843	0.703415442134992	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF		6173		CCSBVarC010845		NC_000016.10:67611509:A:G		Tyr226Cys																												CTCF_Tyr226Cys	16	67611509	A	G	16	allele	677A>G	G02	527_CAVA_Array_P02	M04	B13A7A8P1_R1	B14A7A8P1_R2				16-67611509-A-G	-	0.74309	0.999	226	.	0	.	16	67645412	G	6.194970e-07	.	16	1_Pathogenic	NC_000016.10	0	Tyr226Cys	.	26.1	.	.	.	T	0	2	.	.	.	.	.	.	.	0.68503	.	0.0480	.	0.77914	.	.	D	T	64044	.	.	0	.	.	.	0.98740	.	44890	0	.	0.63348	.	.	0.69472	0.991	.	.	.	6.5	.	G	single nucleotide variant	NC_000016.10:g.67611509A>G	0	.	2	0.56271493	.	.	0.5466574	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MedGen:C3661900	.	.	0.000000e+00	0	0.93300	D	0.74444	D	N	6.317652	1	A/A	.	.	.	1614212	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|not provided	.	0.03749	.	.	-	67611509	.	-	11.212000	.	0.82910	29604	.	75060	.	germline	91084	Loss of helix (P = 0.0123)| Loss of phosphorylation at Y226 (P = 0.0176)| Gain of loop (P = 0.0195)| Gain of sheet (P = 0.0507)| Loss of solvent accessibility (P = 0.1322)	0.26397	GRCh38	55	criteria provided, multiple submitters, no conflicts	c.677A>G	.	0.81360	.	.	.	.	.	.	.	.	0.000000e+00	NM_006565.4(CTCF):c.677A>G (p.Tyr226Cys)	2	.	CTCF_HUMAN	.	.	0.63659219199805	.	.	0.82640	0.5466574	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.91636	.	0	.	.	60020	p.Tyr226Cys	0	0.89448	.	germline	.		A	Sep 17, 2024	.	A/A	.	.	1.0	N	16q22.1	.	.	.	SCV001875117|SCV002767483	Pathogenic	.	.	Cys	C	-	912	ENSP00000493495	ENST00000644753	.	.	.	.	0.756	A	.	4.655767	0.57928	D	.	-	7.405549	.	0.43507	.	.	.	0.57406	.	67611509	Y	10	.	.	0.000000e+00	P49711	.	0.788068	0.87938		.	0.994	T	.	0.56271493	.	0.66489	10664	0.0396152	0	.	.	0.000000e+00	0.41793	.	.	75060	.	6062	.	0.74445	16	CTCF	0.000000e+00	.	Tyr	.	.	16-67611509-A-G	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|not_provided	0	.	66202913	.	0.923554	0.75371	0	RCV002471133|RCV001658992	D	0	.	c.677A>G	.	0	0	0.56698	A/A	rs2142826609	67611509	.	A	.	P49711	.	0.69471	.	0.68239		.	.	0.000000e+00	0	.	.	.	5.5	0.94419	.	D	D	.	.	.	.	.	.	.	363611	1254810	0.56141	0.84168	0.918294548988342	.	.	0.71675	0.89985	.	.	1180026	8.886	.	.	.	.	.	.	615502	0.92093	16	.	ENSG00000102974	0.000000e+00	.	.	.	.	2	0.82066	0.97558	.	.	.	0.000000e+00	0.680657746933852	.	0.000000e+00	0.02103	1244743	HGNC:13723	.	.	.	0.692	.	67611509	TAC	1.000000	.	-	.	0.63354	0.000000e+00	.	0	Pathogenic	0.31751	.	0	0	ClinGen:CA396307384	Y	.	.	-	0.299	-	0.82100	.	.	0.57532	0.925917685032	.	0	0.99793481628287251	.	-	677A>G 	.	.	C3809686|C3661900	.	.	.	.	NM_006565.4	-	.	.	1	0.94986	2142826609	.	.	0.57041	0.80807	.	.	.	0.91155195	5.5	.	.	.	-0.180872	0.983475363820255	0.06502	T	.	.	.	-1.1031	0.20364	p.Tyr226Cys	.	0	-4.564	0.539923	0	0.86213	1254810	T	.	CTCF	.	T	.	.	Y226C	.	0.99641	0.943	A/A	principal4																																																																																																				
RET_Pro64Leu	-1.201347931595469	0.2686812116504655	8.469985626960886	0.00006319510150519935	2025_01_Batch_13-14	0.9804880815822493	0.9530161642274781	0.9435651694351904	0.9760410272134588	0.9326239165240031	0.658728523687184	0.8366351888408243	0.8457080164261688	0.7596773926946224	0.6324477076733983	0.8196083026347167	0.8948256765341512	0.8946365929306797	0.8678592099540405	0.7825358120987007	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET	ENSG00000165731	8858	202947	CCSBVarC006874	ALE00006872	NC_000010.11:43100576:C:T	191C>T	Pro64Leu	CEGS2	CegsMutGDEh1028	E01	GDEhDisVCh_40066	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Pro64Leu	10	43100576	C	T	10											10-43100576-C-T	-	0.50649	0.959	64	.	.	.	10	43596024	T	.	.	10	4_VUS	NC_000010.11	.	Pro64Leu	.	23.0	.	.	.	D	.	3	5	.	.	.	.	.	.	0.87814	Select	0.5121	.	0.58322	.	.	D	D	.	0.905716289001	.	.	.	.	.	0.27167	.	.	.	.	0.64967	.	.	0.51970	0.839	.	24.0	0.863614	3.8	0.76	T	single nucleotide variant	NC_000010.11:g.43100576C>T	.	.	3	0.190038	.	.	0.24177787	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	.	.	.	.	0.87470	B	0.40264	D	M	5.233171	.	C/C	.	.	.	.	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	.	0.83683	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43100576	.	-	4.843000	.	0.72220	.	.	.	.	germline	.	Loss of disorder (P = 0.0168)| Gain of sheet (P = 0.0266)| Loss of loop (P = 0.0374)| Loss of catalytic residue at P64 (P = 0.301)| Gain of stability (P = 0.3098)	0.93158	GRCh38	862	criteria provided, multiple submitters, no conflicts	c.191C>T	.	0.81744	.	.	.	Ret, cadherin like domain 1	.	.	B	.	.	NM_020975.6(RET):c.191C>T (p.Pro64Leu)	2	.	RET_HUMAN	.	76.0	0.524681360864973	.	D	0.49988	0.2933445	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99561	.	.	.	.	.	p.Pro64Leu	.	0.45380	.	germline	.		C	Apr 09, 2024	.	C/C	.	.	1.0	N	10q11.21	.	.	.	SCV004294349|SCV004831371	Uncertain_significance	.	.	Leu	L	-	.	ENSP00000347942	ENST00000355710	.	0.004	.	.	0.599	C	.	3.585512	0.74454	N	D	-	5.553941	.	0.79794	.	.	.	0.66346	.	43100576	Y	10	.	.	.	P07949	.	0.721132	0.95413		.	0.411	D	.	0.1777569	.	0.39622	5979	0.22536	.	-3.22	.	.	0.65576	.	.	.	.	.	.	0.42237	10	RET	.	.	Pro	.	.	10-43100576-C-T	Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia,_type_2	.	.	42916030	ClinGen:CA008426|OMIM:164761.0019|UniProtKB:P07949#VAR_006296	0.312706	0.68387	.	RCV000014949|RCV003531901	D	.	.	c.191C>T	.	.	.	0.76106	C/C	rs77596424	43100576	.	C	.	P07949	.	0.46769	.	0.32869		.	.	.	2.67	.	.	.	5.51	0.92046	.	D	T	.	.	.	.	.	.	.	388|653	13924	0.75795	0.70658	0.963108539581299	.	.	0.71675	0.41613	.	.	.	2.831	.	D	.	.	.	.	142623	0.47943	10	.	ENSG00000165731	.	.	.	.	0.9054588325528415	2	0.51228	0.33096	.	.	.	.	0.540917518592382	YES	.	0.118491	28963	HGNC:9967	D	.	simple_aae	0.512	.	43100576	CCC	0.996000	.	-	.	0.88586	.	.	.	Uncertain significance	0.17366	.	.	.	ClinGen:CA008426,UniProtKB:P07949#VAR_006296,OMIM:164761.0019	P	.	0.926320950286	-	0.818	-	0.85733	.	.	0.90458	0.415368586779	0.2	.	0.99877806916319922	.	-	191C>T 	.	.	C3888239|C4048306	.	.	.	.	NM_020975.6	-	.	.	0	0.55862	77596424	.	.	0.92500	0.70609	0.536	0.004	.	0.99964368	5.51	.	.	.	0.0859375	0.356992193338291	0.77975	D	.	.	.	0.0771	0.81614	p.Pro64Leu	.	.	-3.563	0.89362335	.	0.56253	13924	T	.	RET	.	D	0.672	.	P64L	D	0.70283	0.40292	C/C	principal4																																																																																																				
RET_Pro64Leu	-1.201347931595469	0.2686812116504655	8.469985626960886	0.00006319510150519935	2025_01_Batch_13-14	0.9804880815822493	0.9530161642274781	0.9435651694351904	0.9760410272134588	0.9326239165240031	0.658728523687184	0.8366351888408243	0.8457080164261688	0.7596773926946224	0.6324477076733983	0.8196083026347167	0.8948256765341512	0.8946365929306797	0.8678592099540405	0.7825358120987007	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET		8858		CCSBVarC006874		NC_000010.11:43100576:C:T		Pro64Leu																												RET_Pro64Leu	10	43100576	C	T	10	allele	191C>T	C08	527_CAVA_Array_P05	E15	B13A7A8P2_R1	B14A7A8P2_R2				10-43100576-C-T	-	0.50649	0.959	64	.	.	.	10	43596024	T	.	.	10	4_VUS	NC_000010.11	.	Pro64Leu	.	23.0	.	.	.	D	.	3	5	.	.	.	.	.	.	0.87814	Select	0.5121	.	0.58322	.	.	D	D	.	0.905716289001	.	.	.	.	.	0.27167	.	.	.	.	0.64967	.	.	0.51970	0.839	.	24.0	0.863614	3.8	0.76	T	single nucleotide variant	NC_000010.11:g.43100576C>T	.	.	3	0.190038	.	.	0.24177787	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	.	.	.	.	0.87470	B	0.40264	D	M	5.233171	.	C/C	.	.	.	.	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia, type 2	.	0.83683	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43100576	.	-	4.843000	.	0.72220	.	.	.	.	germline	.	Loss of disorder (P = 0.0168)| Gain of sheet (P = 0.0266)| Loss of loop (P = 0.0374)| Loss of catalytic residue at P64 (P = 0.301)| Gain of stability (P = 0.3098)	0.93158	GRCh38	862	criteria provided, multiple submitters, no conflicts	c.191C>T	.	0.81744	.	.	.	Ret, cadherin like domain 1	.	.	B	.	.	NM_020975.6(RET):c.191C>T (p.Pro64Leu)	2	.	RET_HUMAN	.	76.0	0.524681360864973	.	D	0.49988	0.2933445	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99561	.	.	.	.	.	p.Pro64Leu	.	0.45380	.	germline	.		C	Apr 09, 2024	.	C/C	.	.	1.0	N	10q11.21	.	.	.	SCV004294349|SCV004831371	Uncertain_significance	.	.	Leu	L	-	.	ENSP00000347942	ENST00000355710	.	0.004	.	.	0.599	C	.	3.585512	0.74454	N	D	-	5.553941	.	0.79794	.	.	.	0.66346	.	43100576	Y	10	.	.	.	P07949	.	0.721132	0.95413		.	0.411	D	.	0.1777569	.	0.39622	5979	0.22536	.	-3.22	.	.	0.65576	.	.	.	.	.	.	0.42237	10	RET	.	.	Pro	.	.	10-43100576-C-T	Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia,_type_2	.	.	42916030	ClinGen:CA008426|OMIM:164761.0019|UniProtKB:P07949#VAR_006296	0.312706	0.68387	.	RCV000014949|RCV003531901	D	.	.	c.191C>T	.	.	.	0.76106	C/C	rs77596424	43100576	.	C	.	P07949	.	0.46769	.	0.32869		.	.	.	2.67	.	.	.	5.51	0.92046	.	D	T	.	.	.	.	.	.	.	388|653	13924	0.75795	0.70658	0.963108539581299	.	.	0.71675	0.41613	.	.	.	2.831	.	D	.	.	.	.	142623	0.47943	10	.	ENSG00000165731	.	.	.	.	0.9054588325528415	2	0.51228	0.33096	.	.	.	.	0.540917518592382	YES	.	0.118491	28963	HGNC:9967	D	.	simple_aae	0.512	.	43100576	CCC	0.996000	.	-	.	0.88586	.	.	.	Uncertain significance	0.17366	.	.	.	ClinGen:CA008426,UniProtKB:P07949#VAR_006296,OMIM:164761.0019	P	.	0.926320950286	-	0.818	-	0.85733	.	.	0.90458	0.415368586779	0.2	.	0.99877806916319922	.	-	191C>T 	.	.	C3888239|C4048306	.	.	.	.	NM_020975.6	-	.	.	0	0.55862	77596424	.	.	0.92500	0.70609	0.536	0.004	.	0.99964368	5.51	.	.	.	0.0859375	0.356992193338291	0.77975	D	.	.	.	0.0771	0.81614	p.Pro64Leu	.	.	-3.563	0.89362335	.	0.56253	13924	T	.	RET	.	D	0.672	.	P64L	D	0.70283	0.40292	C/C	principal4																																																																																																				
BRCA1_Gly602Ala	3.458879566726189	0.010563565807662701	0.5419560155120805	0.604663137301014	2025_01_Batch_13-14	0.8899492981161312	0.9204675782920699	0.9160276724904372	0.9268155515133806	0.784515980472033	0.9905934057415612	0.9357264373572229	0.9509726911567646	0.9853495651625582	0.9186595541595897	0.9402713519288461	0.9280970078246464	0.9335001818236008	0.9560825583379694	0.8515877673158113	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC013096		NC_000017.11:43063909:C:G		Gly602Ala																												BRCA1_Gly602Ala	17	43063909	C	G	17	allele	1805G>C	E11	527_CAVA_Array_P01	I21	B13A7A8P1_R1	B14A7A8P1_R2				17-43063909-C-G	-	0.59356	0.858	1706	5	0	0	17	41215926	G	4.646670e-05	0	17	2_Benign	NC_000017.11	4	Gly1706Ala	0	24.1	0	0	4.869120e-05	T	0	24	.	42758	4.222300e-05	0	30514	0.000000e+00	0	0.79354	.	0.4691	102688	0.90580	0	0.0	T	D	64028	.	0	0	0.000000e+00	0	0	0.80226	17106	44864	0	0.000000e+00	0.77997	1	.	0.84823	0.995	0.0	.	.	.	.	G	single nucleotide variant	NC_000017.11:g.43063909C>G	0	16734	2	0.6340818	109376	0	0.7676474	0		11	236838	0	0	0.000000e+00	500	2.338740e-05	0	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900	4	1	0.000000e+00	0	0.97016	B	0.67803	P	L	7.175777	75	C/C	114	1	7158	1614060	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|not provided	16206	0.80378	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063909	2.338740e-05	-	7.634000	0	0.85485	29604	0	6062	0	germline;not applicable;unknown	91072	.	.	GRCh38	549	reviewed by expert panel	.	0.000000e+00	0.93049	3	0	0	BRCT domain|BRCT domain|BRCT domain	5.975860e-05	9044	.	0	0.000000e+00	NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	3	0	BRCA1_HUMAN	0	.	0.704029495450117	1	.	0.77716	0.816965	-	0.000000e+00	0		5	0.000000e+00	0	34250	reviewed_by_expert_panel	0.99542	3.657110e-05	0	7.466030e-05	0	59998	.	0	0.62929	.	germline	1		C	Aug 10, 2015	0	C/C	0	89502	1.0	N	17q21.31	31050	.	0.000000e+00	SCV000244384	Benign	1	0	Ala	A	-	912	ENSP00000518978	ENST00000713676	17690	.	13414	0	0.53	C	0	4.015836	0.92967	D	.	-	8.254455	.	0.92864	628	0	9.940357852882703E-4	0.18632	0	43063909	Y	10	0	102688	6.598480e-04	P38398	0	0.144841	0.91463		0	0.415	D	89502	0.45108074	42758	0.73271	672	0.220015	48	.	0.0	6.598480e-04	0.91343	0.000000e+00	0	75038	0.000000e+00	6062	0	0.78412	17	BRCA1	0.000000e+00	0	Gly	39902	5.586470e-05	17-43063909-C-G	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Malignant_tumor_of_breast	0	5	38469452	BRCA1-HCI:BRCA1_00109|ClinGen:CA003250|UniProtKB:P38398#VAR_070502	0.783255	0.79789	0	RCV000048801|RCV000077598|RCV000162991|RCV001086320|RCV001353853|RCV000586262	.	0	0	c.5117G>C	0	0	8	0.75596	C/C	rs80356860	43063909	14892	C	1.9968051118210862E-4	.	15682	0.81684	4.623640e-05	0.68239		0	0	0.000000e+00	1.88	0	2	264690	5.83	0.58712	112	T	T	0	3.277180e-05	0	26	.	0	1	140162|145|145	55406	0.84783	0.41014	0.174270822478175	2918	1	0.71675	0.71325	0.000000e+00	5.586470e-05	1179976	4.855	5.287500e-05	.	13394	0	9.445011E-5	0	604370	0.62708	17	0.000000e+00	ENSG00000012048	1.249450e-04	6.44122383252818E-5	0	0	.	2	0.97365	0.72286	30596	25	4.869120e-05	6.666890e-05	0.72533764037511	.	0.000000e+00	0.376865	70073	HGNC:1100	.	0	.	0.738	208038	43063909	GGA	1.000000	0	-	0	0.52478	4.067880e-05	0	0	Benign	0.65921	0	4	4	BRCA1-HCI:BRCA1_00109,ClinGen:CA003250,UniProtKB:P38398#VAR_070502	G	0	.	-	.	-	0.83220	10	4596	0.86205	0.788811266422	.	0	0.99832727521296616	98	-	5117G>C 	5	2.175805047867711E-4	C0027672|CN169374|C3661900|C0677776|C2676676|C0006142	0	0	0	0	NM_007294.4	-	1	0.0	0	0.95417	80356860	2320	7.518420129316827E-5	0.85197	0.84214	.	.	2804	0.99961549	5.83	.	.	0.000000e+00	0.234626	0.953210802210829	0.49806	T	86	6212	9566	-0.0839	0.79463	p.Gly1706Ala	0	0	-8.619	.	0	0.80831	55406	D	30514	BRCA1	0.000000e+00	D	.	21628	.	.	.	0.24764	C/C	principal2	38225	BRCA1_Adamovich_2022_Cisplatin_var6405	No	[-0.729,-0.503]					Cisplatin resistance		Drug Resistance	Not specified		G		5117	BRCA1_Adamovich_2022_Cisplatin		ENST00000357654.9		Abnormal					immortalized human cells					p.Gly1706Ala		true	c.5117G>C				Functional		1100.0	43063909.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-0.234707235;-0.26220853;-0.180041867;-0.253091176			Gly1706Ala		LOF		(-0.503, Inf)		A	Aug 10, 2015		(-Inf, -0.729)			missense_variant		1706.0			0.0000464666741013	-0.232512202	Normal	Benign	43063909.0	missense_variant		0.518		Intermediate			Cell Viability			BRCA1_Gly1706Ala
BRCA1_Gly602Ala	3.458879566726189	0.010563565807662701	0.5419560155120805	0.604663137301014	2025_01_Batch_13-14	0.8899492981161312	0.9204675782920699	0.9160276724904372	0.9268155515133806	0.784515980472033	0.9905934057415612	0.9357264373572229	0.9509726911567646	0.9853495651625582	0.9186595541595897	0.9402713519288461	0.9280970078246464	0.9335001818236008	0.9560825583379694	0.8515877673158113	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC013096		NC_000017.11:43063909:C:G		Gly602Ala																												BRCA1_Gly602Ala	17	43063909	C	G	17	allele	1805G>C	E11	527_CAVA_Array_P01	I21	B13A7A8P1_R1	B14A7A8P1_R2				17-43063909-C-G	-	0.59356	0.858	1706	5	0	0	17	41215926	G	4.646670e-05	0	17	2_Benign	NC_000017.11	4	Gly1706Ala	0	24.1	0	0	4.869120e-05	T	0	24	.	42758	4.222300e-05	0	30514	0.000000e+00	0	0.79354	.	0.4691	102688	0.90580	0	0.0	T	D	64028	.	0	0	0.000000e+00	0	0	0.80226	17106	44864	0	0.000000e+00	0.77997	1	.	0.84823	0.995	0.0	.	.	.	.	G	single nucleotide variant	NC_000017.11:g.43063909C>G	0	16734	2	0.6340818	109376	0	0.7676474	0		11	236838	0	0	0.000000e+00	500	2.338740e-05	0	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900	4	1	0.000000e+00	0	0.97016	B	0.67803	P	L	7.175777	75	C/C	114	1	7158	1614060	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|not provided	16206	0.80378	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063909	2.338740e-05	-	7.634000	0	0.85485	29604	0	6062	0	germline;not applicable;unknown	91072	.	.	GRCh38	549	reviewed by expert panel	.	0.000000e+00	0.93049	3	0	0	BRCT domain|BRCT domain|BRCT domain	5.975860e-05	9044	.	0	0.000000e+00	NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	3	0	BRCA1_HUMAN	0	.	0.704029495450117	1	.	0.77716	0.816965	-	0.000000e+00	0		5	0.000000e+00	0	34250	reviewed_by_expert_panel	0.99542	3.657110e-05	0	7.466030e-05	0	59998	.	0	0.62929	.	germline	1		C	Aug 10, 2015	0	C/C	0	89502	1.0	N	17q21.31	31050	.	0.000000e+00	SCV000244384	Benign	1	0	Ala	A	-	912	ENSP00000518978	ENST00000713676	17690	.	13414	0	0.53	C	0	4.015836	0.92967	D	.	-	8.254455	.	0.92864	628	0	9.940357852882703E-4	0.18632	0	43063909	Y	10	0	102688	6.598480e-04	P38398	0	0.144841	0.91463		0	0.415	D	89502	0.45108074	42758	0.73271	672	0.220015	48	.	0.0	6.598480e-04	0.91343	0.000000e+00	0	75038	0.000000e+00	6062	0	0.78412	17	BRCA1	0.000000e+00	0	Gly	39902	5.586470e-05	17-43063909-C-G	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Malignant_tumor_of_breast	0	5	38469452	BRCA1-HCI:BRCA1_00109|ClinGen:CA003250|UniProtKB:P38398#VAR_070502	0.783255	0.79789	0	RCV000048801|RCV000077598|RCV000162991|RCV001086320|RCV001353853|RCV000586262	.	0	0	c.5117G>C	0	0	8	0.75596	C/C	rs80356860	43063909	14892	C	1.9968051118210862E-4	.	15682	0.81684	4.623640e-05	0.68239		0	0	0.000000e+00	1.88	0	2	264690	5.83	0.58712	112	T	T	0	3.277180e-05	0	26	.	0	1	140162|145|145	55406	0.84783	0.41014	0.174270822478175	2918	1	0.71675	0.71325	0.000000e+00	5.586470e-05	1179976	4.855	5.287500e-05	.	13394	0	9.445011E-5	0	604370	0.62708	17	0.000000e+00	ENSG00000012048	1.249450e-04	6.44122383252818E-5	0	0	.	2	0.97365	0.72286	30596	25	4.869120e-05	6.666890e-05	0.72533764037511	.	0.000000e+00	0.376865	70073	HGNC:1100	.	0	.	0.738	208038	43063909	GGA	1.000000	0	-	0	0.52478	4.067880e-05	0	0	Benign	0.65921	0	4	4	BRCA1-HCI:BRCA1_00109,ClinGen:CA003250,UniProtKB:P38398#VAR_070502	G	0	.	-	.	-	0.83220	10	4596	0.86205	0.788811266422	.	0	0.99832727521296616	98	-	5117G>C 	5	2.175805047867711E-4	C0027672|CN169374|C3661900|C0677776|C2676676|C0006142	0	0	0	0	NM_007294.4	-	1	0.0	0	0.95417	80356860	2320	7.518420129316827E-5	0.85197	0.84214	.	.	2804	0.99961549	5.83	.	.	0.000000e+00	0.234626	0.953210802210829	0.49806	T	86	6212	9566	-0.0839	0.79463	p.Gly1706Ala	0	0	-8.619	.	0	0.80831	55406	D	30514	BRCA1	0.000000e+00	D	.	21628	.	.	.	0.24764	C/C	principal2	46312	BRCA1_Adamovich_2022_HDR_var4960	No	[-0.562,-0.233]					Homology Directed Repair		Fluorescence	Not specified		G		5117	BRCA1_Adamovich_2022_HDR		ENST00000357654.9		Abnormal					immortalized human cells					p.Gly1706Ala		true	c.5117G>C				Functional		1100.0	43063909.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-0.229987392;0.333306695;-0.120197644;0.301608415			Gly1706Ala		LOF		(-0.233, Inf)		A	Aug 10, 2015		(-Inf, -0.562)			missense_variant		1706.0			0.0000464666741013	0.07118251875	Normal	Benign	43063909.0	missense_variant		0.518		Intermediate			Reporter			BRCA1_Gly1706Ala
RET_Arg67His	0.8659334758591015	0.4152170581728022	6.886187755373604	0.0002342201970283017	2025_01_Batch_13-14	0.9388740507962934	0.8188458712910882	0.7395946779055604	0.9125810420403285	0.7370609418645981	0.6316120613680205	0.6718183364343475	0.801327165044326	0.6547224220000333	0.6356580884512563	0.7852430560821569	0.7453321038627179	0.7704609214749432	0.7836517320201809	0.6863595151579271	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET	ENSG00000165731	8858	202945	CCSBVarC006873	ALE00006871	NC_000010.11:43100585:G:A	200G>A	Arg67His	CEGS2	CegsMutGDEh1027	E08	GDEhDisVCh_40066	H05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Arg67His	10	43100585	G	A	10											10-43100585-G-A	-	0.13006	0.002	67	15	0	0	10	43596033	A	4.002800e-04	1	10	2_Benign	NC_000010.11	377	Arg67His	218	9.492	110	0	1.232330e-02	T	3	12	5	42734	1.140570e-03	0	30522	0.000000e+00	0	0.34250	Select	0.1253	17690	0.13655	2	0.026785714285714284	T	T	63766	0.934419907037	0	0	0.000000e+00	0	0	0.02262	17100	44876	45	1.253170e-02	0.15106	9	.	0.06790	0.362	0.0	92.0	0.59724	-1.31	0.08	A	single nucleotide variant	NC_000010.11:g.43100585G>A	0	16708	2	0.026637115	109312	0	0.026211439	0.0074039067422810335	A	206	236724	0	0	1.232330e-02	796	2.106050e-04	0	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653	130	15	0.000000e+00	0	0.23785	B	0.01973	B	L	0.7503831	646	G/G	176	22	7156	1613870	not provided|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	16184	0.36417	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43100585	1.216280e-02	-	0.062000	0	0.03256	29604	0	44876	168	germline	91076	.	.	GRCh38	862	criteria provided, multiple submitters, no conflicts	c.200G>A	3.603960e-04	0.12496	85	0	0	Ret, cadherin like domain 1	4.189610e-04	9044	B	0.008666666666666666	0.000000e+00	NM_020975.6(RET):c.200G>A (p.Arg67His)	2	0	RET_HUMAN	0	8.0	-0.737658851988375	2	T	0.06414	0.043690175	+	0.000000e+00	1	0.000380405	168	0.000000e+00	0	34240	criteria_provided,_multiple_submitters,_no_conflicts	0.96462	1.189260e-03	6	2.992220e-04	0	60018	p.Arg67His	0	0.14201	.	germline	110	43100585	G	Feb 02, 2025	11	G/G	0	89320	0.899	N	10q11.21	174478	.	0.000000e+00	SCV000261427|SCV000362226|SCV000362227|SCV000362228|SCV000362229|SCV000610899|SCV000674752|SCV000807018|SCV000890954|SCV002067190|SCV002529960|SCV002572021|SCV004357215	Benign/Likely_benign	4	0	His	H	-	912	ENSP00000347942	ENST00000355710	17690	0.611	13406	0	-0.71	G	0	0.923631	0.29952	N	T	-	1.036945	.	.	968	0	0.0	0.00152	47	43100585	Y	10	0	102612	3.300330e-04	P07949	0	0.367069	0.12021	G	0	0.001	.	13406	0.032374926	9044	0.25981	5979	-0.494179	116	-0.47	0.0010224948875255625	8.400930e-03	0.05754	3.824580e-04	0	75036	1.216280e-02	6060	0	0.00770	10	RET	2.665390e-05	0	Arg	203840	1.679360e-04	10-43100585-G-A	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|not_provided|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Pheochromocytoma|not_specified	0	22	42916039	ClinGen:CA008548|UniProtKB:P07949#VAR_018153	0.064517	0.14788	0	RCV000034768|RCV000121986|RCV000271726|RCV000311573|RCV000368621|RCV000393823|RCV000563975|RCV001080638|RCV002307371	T	3	0	c.200G>A	0	377	53	0.00587	G/G	rs192489011	43100585	14884	G	0.005591054313099041	.	15688	0.01639	6.944440e-04	0.17376	10	0	0	8.400930e-03	0.905	0	16	264690	-0.21	0.73048	6348	T	T	0	6.557380e-05	0	1848	.	0	7	411709|276161|653|140162|247698|653|388|29072	41839	0.24820	0.71797	0.0107988245138953	4968	28	0.31494	0.12358	5.841120e-05	1.253170e-02	1180022	0.08	9.914620e-04	N	13368	0	5.2514265E-4	39	191830|PS131100|171400|142623|171300	0.14701	10	0.000000e+00	ENSG00000165731	8.311640e-04	9.170210570960235E-5	11	0.004329004329004329	0.5109484406135018	2	0.06938	0.33096	30604	139	2.144000e-04	1.332930e-04	-0.60610869746005	YES	4.940930e-04	.	50278	HGNC:9967	N	0	simple_aae	0.021	207774	43100585	CGC	0.001000	27	-	0	0.00152	9.830330e-05	0	3	Benign/Likely benign	0.31573	6	2	8	ClinGen:CA008548,UniProtKB:P07949#VAR_018153	R	0	0.47083157667	-	.	-	0.02855	270	16002	0.50823	0.233786687255	0.0675	0	0.77324054778089801	280	-	200G>A 	218	0.0013748281464816899	C1619700|C0027662|C4048306|C3661900|C0027672|C0025268|C3888239|C0031511|CN169374	0	0	0	0	NM_020975.6	-	0	0.0	0	0.21954	192489011	2310	4.1699372056514916E-4	0.46339	0.19037	0.028	0.58	4792	0.98813590	5.51	.	.	3.594300e-04	-0.473236	0.00636577096918478	0.23113	T	4500	6194	9558	-0.9730	0.42817	p.Arg67His	8	0	-4.548	0.0068158507	2	0.20556	41839	T	30500	RET	5.847950e-05	T	0.125	21600	.	T	0.14328	0.03958	G/G	principal4																																																																																																				
RET_Arg67His	0.8659334758591015	0.4152170581728022	6.886187755373604	0.0002342201970283017	2025_01_Batch_13-14	0.9388740507962934	0.8188458712910882	0.7395946779055604	0.9125810420403285	0.7370609418645981	0.6316120613680205	0.6718183364343475	0.801327165044326	0.6547224220000333	0.6356580884512563	0.7852430560821569	0.7453321038627179	0.7704609214749432	0.7836517320201809	0.6863595151579271	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET		8858		CCSBVarC006873		NC_000010.11:43100585:G:A		Arg67His																												RET_Arg67His	10	43100585	G	A	10	allele	200G>A	D08	527_CAVA_Array_P05	G15	B13A7A8P2_R1	B14A7A8P2_R2				10-43100585-G-A	-	0.13006	0.002	67	15	0	0	10	43596033	A	4.002800e-04	1	10	2_Benign	NC_000010.11	377	Arg67His	218	9.492	110	0	1.232330e-02	T	3	12	5	42734	1.140570e-03	0	30522	0.000000e+00	0	0.34250	Select	0.1253	17690	0.13655	2	0.026785714285714284	T	T	63766	0.934419907037	0	0	0.000000e+00	0	0	0.02262	17100	44876	45	1.253170e-02	0.15106	9	.	0.06790	0.362	0.0	92.0	0.59724	-1.31	0.08	A	single nucleotide variant	NC_000010.11:g.43100585G>A	0	16708	2	0.026637115	109312	0	0.026211439	0.0074039067422810335	A	206	236724	0	0	1.232330e-02	796	2.106050e-04	0	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653	130	15	0.000000e+00	0	0.23785	B	0.01973	B	L	0.7503831	646	G/G	176	22	7156	1613870	not provided|not specified|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia type 2A	16184	0.36417	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43100585	1.216280e-02	-	0.062000	0	0.03256	29604	0	44876	168	germline	91076	.	.	GRCh38	862	criteria provided, multiple submitters, no conflicts	c.200G>A	3.603960e-04	0.12496	85	0	0	Ret, cadherin like domain 1	4.189610e-04	9044	B	0.008666666666666666	0.000000e+00	NM_020975.6(RET):c.200G>A (p.Arg67His)	2	0	RET_HUMAN	0	8.0	-0.737658851988375	2	T	0.06414	0.043690175	+	0.000000e+00	1	0.000380405	168	0.000000e+00	0	34240	criteria_provided,_multiple_submitters,_no_conflicts	0.96462	1.189260e-03	6	2.992220e-04	0	60018	p.Arg67His	0	0.14201	.	germline	110	43100585	G	Feb 02, 2025	11	G/G	0	89320	0.899	N	10q11.21	174478	.	0.000000e+00	SCV000261427|SCV000362226|SCV000362227|SCV000362228|SCV000362229|SCV000610899|SCV000674752|SCV000807018|SCV000890954|SCV002067190|SCV002529960|SCV002572021|SCV004357215	Benign/Likely_benign	4	0	His	H	-	912	ENSP00000347942	ENST00000355710	17690	0.611	13406	0	-0.71	G	0	0.923631	0.29952	N	T	-	1.036945	.	.	968	0	0.0	0.00152	47	43100585	Y	10	0	102612	3.300330e-04	P07949	0	0.367069	0.12021	G	0	0.001	.	13406	0.032374926	9044	0.25981	5979	-0.494179	116	-0.47	0.0010224948875255625	8.400930e-03	0.05754	3.824580e-04	0	75036	1.216280e-02	6060	0	0.00770	10	RET	2.665390e-05	0	Arg	203840	1.679360e-04	10-43100585-G-A	Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|Multiple_endocrine_neoplasia,_type_2|not_provided|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Pheochromocytoma|not_specified	0	22	42916039	ClinGen:CA008548|UniProtKB:P07949#VAR_018153	0.064517	0.14788	0	RCV000034768|RCV000121986|RCV000271726|RCV000311573|RCV000368621|RCV000393823|RCV000563975|RCV001080638|RCV002307371	T	3	0	c.200G>A	0	377	53	0.00587	G/G	rs192489011	43100585	14884	G	0.005591054313099041	.	15688	0.01639	6.944440e-04	0.17376	10	0	0	8.400930e-03	0.905	0	16	264690	-0.21	0.73048	6348	T	T	0	6.557380e-05	0	1848	.	0	7	411709|276161|653|140162|247698|653|388|29072	41839	0.24820	0.71797	0.0107988245138953	4968	28	0.31494	0.12358	5.841120e-05	1.253170e-02	1180022	0.08	9.914620e-04	N	13368	0	5.2514265E-4	39	191830|PS131100|171400|142623|171300	0.14701	10	0.000000e+00	ENSG00000165731	8.311640e-04	9.170210570960235E-5	11	0.004329004329004329	0.5109484406135018	2	0.06938	0.33096	30604	139	2.144000e-04	1.332930e-04	-0.60610869746005	YES	4.940930e-04	.	50278	HGNC:9967	N	0	simple_aae	0.021	207774	43100585	CGC	0.001000	27	-	0	0.00152	9.830330e-05	0	3	Benign/Likely benign	0.31573	6	2	8	ClinGen:CA008548,UniProtKB:P07949#VAR_018153	R	0	0.47083157667	-	.	-	0.02855	270	16002	0.50823	0.233786687255	0.0675	0	0.77324054778089801	280	-	200G>A 	218	0.0013748281464816899	C1619700|C0027662|C4048306|C3661900|C0027672|C0025268|C3888239|C0031511|CN169374	0	0	0	0	NM_020975.6	-	0	0.0	0	0.21954	192489011	2310	4.1699372056514916E-4	0.46339	0.19037	0.028	0.58	4792	0.98813590	5.51	.	.	3.594300e-04	-0.473236	0.00636577096918478	0.23113	T	4500	6194	9558	-0.9730	0.42817	p.Arg67His	8	0	-4.548	0.0068158507	2	0.20556	41839	T	30500	RET	5.847950e-05	T	0.125	21600	.	T	0.14328	0.03958	G/G	principal4																																																																																																				
SHOC2_Ser4Arg	-2.115892778315492	0.07215780633141851	-0.3869856389427146	0.7102627631544374	2025_01_Batch_13-14	0.9179761181055074	0.9180943736465743	0.8794101522916892	0.9142199019956667	0.866539458520815	0.6755180544798177	0.8080985350876836	0.7424990989446605	0.7389737139587964	0.6404521495380249	0.7967470862926626	0.8630964543671289	0.8109546256181748	0.8265968079772316	0.75349580402942	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2	SHOC2		11602		CCSBVarC027999		NC_000010.11:110964368:A:C		Ser4Arg																												SHOC2_Ser4Arg	10	110964368	A	C	10	allele	10A>C	G01	527_CAVA_Array_P06	M02	B13A7A8P2_R1	B14A7A8P2_R2				10-110964368-A-C	-	0.52871	0.079	4	0	0	0	10	112724126	C	7.749220e-05	54	10	2_Benign	NC_000010.11	124	Ser4Arg	0	23.3	0	0	3.007780e-03	T	0	8	.	42570	4.450720e-04	.	30358	0.000000e+00	2	0.31580	.	0.0556	33912	0.24484	102	.	T	T	63988	.	0	0	0.000000e+00	0	0	0.53855	16920	44892	0	0.000000e+00	0.27215	0	.	0.55084	1.0	.	.	.	.	.	C	single nucleotide variant	NC_000010.11:g.110964368A>C	0	16712	2	0.33612105	108758	0	0.267935	0		101	233670	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:C3661900||MedGen:CN169374|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701	56	0	0.000000e+00	0	0.68318	B	0.55197	B	L	2.456036	125	A/A	114	0	7132	1613066	not provided|SHOC2-related disorder|not specified|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1	15362	0.07056	.	.	-	110964368	3.191490e-03	-	9.339000	0	0.51713	29586	0.003278688524590164	59742	0	germline;unknown	90932	Loss of phosphorylation at S4 (P = 9e-04)| Gain of MoRF binding (P = 0.0056)| Loss of sheet (P = 0.0315)| Gain of loop (P = 0.069)| Loss of ubiquitination at K7 (P = 0.0702)	0.37543	GRCh38	914	reviewed by expert panel	.	0.000000e+00	0.85695	2	0	0	.	0.000000e+00	8928	.	0	0.000000e+00	NM_007373.4(SHOC2):c.10A>C (p.Ser4Arg)	3	0	SHOC2_HUMAN	0	.	-0.0156583439103937	99	.	0.64952	0.32933065	+	0.000000e+00	.		99	0.000000e+00	0	33912	reviewed_by_expert_panel	0.30410	5.149050e-04	0	0.000000e+00	0	59742	.	0	0.80231	.	germline	54		A	Sep 17, 2024	0	A/A	0	88600	1.0	N	10q25.2	9768	.	0.000000e+00	SCV000616429	Benign	0	0	Arg	R	-	912	ENSP00000509273	ENST00000688928	17430	.	13368	0	0.751	A	0	3.701145	0.41419	D	.	-	3.276892	.	0.15489	610	0	.	0.09046	0	110964368	Y	10	0	101240	0.000000e+00	Q9UQ13	0	0.200839	0.67671		0	0.023	T	30182	0.2938221	16920	0.97202	8036	-0.417862	0	.	.	2.075590e-03	0.56615	0.000000e+00	0	74862	0.000000e+00	6080	0	0.59185	10	SHOC2	0.000000e+00	0	Ser	14710	0.000000e+00	10-110964368-A-C	SHOC2-related_disorder|not_provided|RASopathy|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|not_specified	0	0	112714116	ClinGen:CA136657	0.875239	0.40882	0	RCV000680308|RCV003914899|RCV000038777|RCV000518991|RCV001286384	.	0	0	c.10A>C	0	0	0	0.01658	A/A	rs397517231	110964368	14110	A	.	Q9UQ13	15610	0.49535	0.000000e+00	0.68239		0	0	0.000000e+00	1.39	0	0	264690	5.62	0.55638	146	T	T	0	3.280100e-03	0	26	.	0	0	536391|2701	40635	0.35750	0.52424	0.0736649466610808	3332	.	0.71675	0.79781	3.007780e-03	3.280100e-03	1179630	7.104	4.912790e-04	.	13386	0	1.7756621E-4	0	607721	0.76723	10	0.000000e+00	ENSG00000108061	0.000000e+00	0	0	0	.	1	0.19965	0.21043	30440	47	0.000000e+00	2.075590e-03	0.218876124825274	.	0.000000e+00	0.006028	49105	HGNC:15454	.	0	.	0.247	205586	110964368	AGT	1.000000	.	-	0	0.00200	0.000000e+00	0	0	Benign	0.18016	0	0	124	ClinGen:CA136657	S	0	.	-	0.368	-	0.39714	104	604	0.01051	0.607206702232	.	0	0.99493880126885215	104	-	10A>C 	102	0	C3661900|C5555857|C4478716|CN169374	0	0	0	0	NM_007373.4	-	.	.	0	0.74124	397517231	2310	1.3596193065941537E-4	0.13132	0.50640	.	.	3218	0.00392193	5.62	.	.	0.000000e+00	-0.376684	0.164860101419667	0.34781	T	120	6158	9530	-1.0816	0.23288	p.Ser4Arg	0	0	-3.61	.	0	0.48012	40635	T	30182	SHOC2	3.191490e-03	T	.	21590	S4R	.	.	0.87726	A/A	principal1																																																																																																				
F9_Glu27Lys	-1.2669475277184368	0.24569658941405892	0.15398402888899934	0.8819677098053768	2025_01_Batch_13-14	0.8211449773890915	0.6077626066331344	0.6538387561093866	0.733824328613967	0.7978611430742861	0.7108360461406398	0.5934040893585728	0.6491375949093524	0.670765353720995	0.6045048961910338	0.7659905117648657	0.6005833479958536	0.6514881755093695	0.702294841167481	0.7011830196326599	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Glu27Lys																												F9_Glu27Lys						allele	217G>A	E11	527_CAVA_Array_P02	I22	B13A7A8P1_R1	B14A7A8P1_R2					-	0.36471	0.035	27	.	.	.	X	138613002	A	.	.	X	4_VUS	NC_000023.11	.	Glu27Lys	.	20.2	.	0	.	D	.	2	1	.	.	.	.	.	0	0.79046	Select	0.6886	.	0.20628	.	.	T	D	.	0.323722222284	0	.	.	.	.	0.34035	.	.	.	.	0.28867	.	.	0.54850	1.0	.	8.0	0.79572	.	0.92	A	single nucleotide variant	NC_000023.11:g.139530843G>A	.	.	3	0.25482482	.	0	0.3950114	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94378	B	0.54650	B	M	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.86425	.	.	-	139530843	.	-	6.430000	.	0.84594	.	0	.	.	germline	.	Gain of methylation at E27 (P = 0.0092)| Gain of ubiquitination at E27 (P = 0.017)| Loss of stability (P = 0.0578)| Gain of catalytic residue at C28 (P = 0.3215)| Loss of loop (P = 0.3664)	0.66459	GRCh38	937	criteria provided, single submitter	c.79G>A	.	0.72532	0	.	.	.	.	.	B	0	.	NM_000133.4(F9):c.79G>A (p.Glu27Lys)	1	.	FA9_HUMAN	.	92.0	.	.	T	0.29425	0.3264995	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99909	.	.	.	.	.	p.Glu27Lys	.	0.55699	.	germline	.		G	May 06, 2024	.	./.	.	.	0.997	N	Xq27.1	78	.	.	SCV005185478	Uncertain_significance	.	.	Lys	K	-	.	ENSP00000218099	ENST00000218099	.	0.331	.	.	0.674	G	.	2.772725	0.05615	.	T	-	.	.	0.80167	0	.	.	0.52609	0	139530843	Y	10	0	.	.	P00740	.	0.439027	0.81162		.	0.027	D	.	0.2884549	.	0.97202	2158	0.151666	.	-1.12	.	.	0.13164	.	.	.	.	.	.	0.50959	X	F9	.	0	Glu	660	.	X-139530843-G-A	Hereditary_factor_IX_deficiency_disease|not_specified	.	.	138440668	ClinGen:CA255313|OMIM:300746.0013	.	.	.	RCV000011316|RCV004689413	D	.	.	c.79G>A	.	.	.	0.69201	./.	rs387906475	139530843	.	G	.	P00740	.	0.60060	.	0.68239		.	.	.	2.255	0	0	.	5.23	0.78286	34	D	T	.	.	0	0	.	.	.	98879	10570	0.68808	0.34238	0.87874972820282	434	.	0.40243	.	.	.	.	2.351	.	N	.	.	.	0	306900	0.43829	X	.	ENSG00000101981	.	0	.	0	0.7537842320718965	1	0.21085	0.14592	.	.	.	.	.	YES	.	0.12148	25609	HGNC:3551	A	.	simple_aae	0.722	.	139530843	GAA	1.000000	.	-	0	0.70037	.	0	.	Uncertain significance	0.34397	.	.	.	ClinGen:CA255313,OMIM:300746.0013	E	.	0.987605337173	-	0.55	-	0.62675	.	108	0.75191	0.465617716312	0.1087	.	0.9970874284767326	6	-	79G>A 	.	0	C0008533|CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.43678	387906475	.	0	0.98733	.	0.463	0.71	434	0.99992300	5.23	.	.	.	-0.0199194	0.969045974591162	0.63995	D	34	.	.	0.2342	0.89215	p.Glu27Lys	0	.	-4.78	0.66373074	.	0.83114	10570	T	.	F9	.	D	0.513	.	E27K	T	.	0.70877	./.	principal1																																																																																																				
F9_Glu27Lys	-1.2669475277184368	0.24569658941405892	0.15398402888899934	0.8819677098053768	2025_01_Batch_13-14	0.8211449773890915	0.6077626066331344	0.6538387561093866	0.733824328613967	0.7978611430742861	0.7108360461406398	0.5934040893585728	0.6491375949093524	0.670765353720995	0.6045048961910338	0.7659905117648657	0.6005833479958536	0.6514881755093695	0.702294841167481	0.7011830196326599	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Glu27Lys																												F9_Glu27Lys						allele	217G>A	E11	527_CAVA_Array_P02	I22	B13A7A8P1_R1	B14A7A8P1_R2					-	0.36471	0.035	27	.	.	.	X	138613002	A	.	.	X	4_VUS	NC_000023.11	.	Glu27Lys	.	20.2	.	0	.	D	.	2	1	.	.	.	.	.	0	0.79046	Select	0.6886	.	0.20628	.	.	T	D	.	0.323722222284	0	.	.	.	.	0.34035	.	.	.	.	0.28867	.	.	0.54850	1.0	.	8.0	0.79572	.	0.92	A	single nucleotide variant	NC_000023.11:g.139530843G>A	.	.	3	0.25482482	.	0	0.3950114	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94378	B	0.54650	B	M	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.86425	.	.	-	139530843	.	-	6.430000	.	0.84594	.	0	.	.	germline	.	Gain of methylation at E27 (P = 0.0092)| Gain of ubiquitination at E27 (P = 0.017)| Loss of stability (P = 0.0578)| Gain of catalytic residue at C28 (P = 0.3215)| Loss of loop (P = 0.3664)	0.66459	GRCh38	937	criteria provided, single submitter	c.79G>A	.	0.72532	0	.	.	.	.	.	B	0	.	NM_000133.4(F9):c.79G>A (p.Glu27Lys)	1	.	FA9_HUMAN	.	92.0	.	.	T	0.29425	0.3264995	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99909	.	.	.	.	.	p.Glu27Lys	.	0.55699	.	germline	.		G	May 06, 2024	.	./.	.	.	0.997	N	Xq27.1	78	.	.	SCV005185478	Uncertain_significance	.	.	Lys	K	-	.	ENSP00000218099	ENST00000218099	.	0.331	.	.	0.674	G	.	2.772725	0.05615	.	T	-	.	.	0.80167	0	.	.	0.52609	0	139530843	Y	10	0	.	.	P00740	.	0.439027	0.81162		.	0.027	D	.	0.2884549	.	0.97202	2158	0.151666	.	-1.12	.	.	0.13164	.	.	.	.	.	.	0.50959	X	F9	.	0	Glu	660	.	X-139530843-G-A	Hereditary_factor_IX_deficiency_disease|not_specified	.	.	138440668	ClinGen:CA255313|OMIM:300746.0013	.	.	.	RCV000011316|RCV004689413	D	.	.	c.79G>A	.	.	.	0.69201	./.	rs387906475	139530843	.	G	.	P00740	.	0.60060	.	0.68239		.	.	.	2.255	0	0	.	5.23	0.78286	34	D	T	.	.	0	0	.	.	.	98879	10570	0.68808	0.34238	0.87874972820282	434	.	0.40243	.	.	.	.	2.351	.	N	.	.	.	0	306900	0.43829	X	.	ENSG00000101981	.	0	.	0	0.7537842320718965	1	0.21085	0.14592	.	.	.	.	.	YES	.	0.12148	25609	HGNC:3551	A	.	simple_aae	0.722	.	139530843	GAA	1.000000	.	-	0	0.70037	.	0	.	Uncertain significance	0.34397	.	.	.	ClinGen:CA255313,OMIM:300746.0013	E	.	0.987605337173	-	0.55	-	0.62675	.	108	0.75191	0.465617716312	0.1087	.	0.9970874284767326	6	-	79G>A 	.	0	C0008533|CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.43678	387906475	.	0	0.98733	.	0.463	0.71	434	0.99992300	5.23	.	.	.	-0.0199194	0.969045974591162	0.63995	D	34	.	.	0.2342	0.89215	p.Glu27Lys	0	.	-4.78	0.66373074	.	0.83114	10570	T	.	F9	.	D	0.513	.	E27K	T	.	0.70877	./.	principal1	125099	F9_Popp_2025_carboxy_F9_specific_var221249	No											E		79	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Glu27Lys		true	c.79G>A						3551.0	139530843.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Glu27Lys						K	May 06, 2024					missense_variant		27.0				0.958364071		Uncertain significance	139530843.0	missense_variant		0.513					Reporter			
F9_Glu27Lys	-1.2669475277184368	0.24569658941405892	0.15398402888899934	0.8819677098053768	2025_01_Batch_13-14	0.8211449773890915	0.6077626066331344	0.6538387561093866	0.733824328613967	0.7978611430742861	0.7108360461406398	0.5934040893585728	0.6491375949093524	0.670765353720995	0.6045048961910338	0.7659905117648657	0.6005833479958536	0.6514881755093695	0.702294841167481	0.7011830196326599	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Glu27Lys																												F9_Glu27Lys						allele	217G>A	E11	527_CAVA_Array_P02	I22	B13A7A8P1_R1	B14A7A8P1_R2					-	0.36471	0.035	27	.	.	.	X	138613002	A	.	.	X	4_VUS	NC_000023.11	.	Glu27Lys	.	20.2	.	0	.	D	.	2	1	.	.	.	.	.	0	0.79046	Select	0.6886	.	0.20628	.	.	T	D	.	0.323722222284	0	.	.	.	.	0.34035	.	.	.	.	0.28867	.	.	0.54850	1.0	.	8.0	0.79572	.	0.92	A	single nucleotide variant	NC_000023.11:g.139530843G>A	.	.	3	0.25482482	.	0	0.3950114	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94378	B	0.54650	B	M	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.86425	.	.	-	139530843	.	-	6.430000	.	0.84594	.	0	.	.	germline	.	Gain of methylation at E27 (P = 0.0092)| Gain of ubiquitination at E27 (P = 0.017)| Loss of stability (P = 0.0578)| Gain of catalytic residue at C28 (P = 0.3215)| Loss of loop (P = 0.3664)	0.66459	GRCh38	937	criteria provided, single submitter	c.79G>A	.	0.72532	0	.	.	.	.	.	B	0	.	NM_000133.4(F9):c.79G>A (p.Glu27Lys)	1	.	FA9_HUMAN	.	92.0	.	.	T	0.29425	0.3264995	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99909	.	.	.	.	.	p.Glu27Lys	.	0.55699	.	germline	.		G	May 06, 2024	.	./.	.	.	0.997	N	Xq27.1	78	.	.	SCV005185478	Uncertain_significance	.	.	Lys	K	-	.	ENSP00000218099	ENST00000218099	.	0.331	.	.	0.674	G	.	2.772725	0.05615	.	T	-	.	.	0.80167	0	.	.	0.52609	0	139530843	Y	10	0	.	.	P00740	.	0.439027	0.81162		.	0.027	D	.	0.2884549	.	0.97202	2158	0.151666	.	-1.12	.	.	0.13164	.	.	.	.	.	.	0.50959	X	F9	.	0	Glu	660	.	X-139530843-G-A	Hereditary_factor_IX_deficiency_disease|not_specified	.	.	138440668	ClinGen:CA255313|OMIM:300746.0013	.	.	.	RCV000011316|RCV004689413	D	.	.	c.79G>A	.	.	.	0.69201	./.	rs387906475	139530843	.	G	.	P00740	.	0.60060	.	0.68239		.	.	.	2.255	0	0	.	5.23	0.78286	34	D	T	.	.	0	0	.	.	.	98879	10570	0.68808	0.34238	0.87874972820282	434	.	0.40243	.	.	.	.	2.351	.	N	.	.	.	0	306900	0.43829	X	.	ENSG00000101981	.	0	.	0	0.7537842320718965	1	0.21085	0.14592	.	.	.	.	.	YES	.	0.12148	25609	HGNC:3551	A	.	simple_aae	0.722	.	139530843	GAA	1.000000	.	-	0	0.70037	.	0	.	Uncertain significance	0.34397	.	.	.	ClinGen:CA255313,OMIM:300746.0013	E	.	0.987605337173	-	0.55	-	0.62675	.	108	0.75191	0.465617716312	0.1087	.	0.9970874284767326	6	-	79G>A 	.	0	C0008533|CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.43678	387906475	.	0	0.98733	.	0.463	0.71	434	0.99992300	5.23	.	.	.	-0.0199194	0.969045974591162	0.63995	D	34	.	.	0.2342	0.89215	p.Glu27Lys	0	.	-4.78	0.66373074	.	0.83114	10570	T	.	F9	.	D	0.513	.	E27K	T	.	0.70877	./.	principal1	235163	F9_Popp_2025_strep_2_var259973	No											E		79	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Glu27Lys		true	c.79G>A						3551.0	139530843.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Glu27Lys						K	May 06, 2024					missense_variant		27.0				0.6266992144460639		Uncertain significance	139530843.0	missense_variant		0.513					Reporter			
F9_Glu27Lys	-1.2669475277184368	0.24569658941405892	0.15398402888899934	0.8819677098053768	2025_01_Batch_13-14	0.8211449773890915	0.6077626066331344	0.6538387561093866	0.733824328613967	0.7978611430742861	0.7108360461406398	0.5934040893585728	0.6491375949093524	0.670765353720995	0.6045048961910338	0.7659905117648657	0.6005833479958536	0.6514881755093695	0.702294841167481	0.7011830196326599	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Glu27Lys																												F9_Glu27Lys						allele	217G>A	E11	527_CAVA_Array_P02	I22	B13A7A8P1_R1	B14A7A8P1_R2					-	0.36471	0.035	27	.	.	.	X	138613002	A	.	.	X	4_VUS	NC_000023.11	.	Glu27Lys	.	20.2	.	0	.	D	.	2	1	.	.	.	.	.	0	0.79046	Select	0.6886	.	0.20628	.	.	T	D	.	0.323722222284	0	.	.	.	.	0.34035	.	.	.	.	0.28867	.	.	0.54850	1.0	.	8.0	0.79572	.	0.92	A	single nucleotide variant	NC_000023.11:g.139530843G>A	.	.	3	0.25482482	.	0	0.3950114	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94378	B	0.54650	B	M	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.86425	.	.	-	139530843	.	-	6.430000	.	0.84594	.	0	.	.	germline	.	Gain of methylation at E27 (P = 0.0092)| Gain of ubiquitination at E27 (P = 0.017)| Loss of stability (P = 0.0578)| Gain of catalytic residue at C28 (P = 0.3215)| Loss of loop (P = 0.3664)	0.66459	GRCh38	937	criteria provided, single submitter	c.79G>A	.	0.72532	0	.	.	.	.	.	B	0	.	NM_000133.4(F9):c.79G>A (p.Glu27Lys)	1	.	FA9_HUMAN	.	92.0	.	.	T	0.29425	0.3264995	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99909	.	.	.	.	.	p.Glu27Lys	.	0.55699	.	germline	.		G	May 06, 2024	.	./.	.	.	0.997	N	Xq27.1	78	.	.	SCV005185478	Uncertain_significance	.	.	Lys	K	-	.	ENSP00000218099	ENST00000218099	.	0.331	.	.	0.674	G	.	2.772725	0.05615	.	T	-	.	.	0.80167	0	.	.	0.52609	0	139530843	Y	10	0	.	.	P00740	.	0.439027	0.81162		.	0.027	D	.	0.2884549	.	0.97202	2158	0.151666	.	-1.12	.	.	0.13164	.	.	.	.	.	.	0.50959	X	F9	.	0	Glu	660	.	X-139530843-G-A	Hereditary_factor_IX_deficiency_disease|not_specified	.	.	138440668	ClinGen:CA255313|OMIM:300746.0013	.	.	.	RCV000011316|RCV004689413	D	.	.	c.79G>A	.	.	.	0.69201	./.	rs387906475	139530843	.	G	.	P00740	.	0.60060	.	0.68239		.	.	.	2.255	0	0	.	5.23	0.78286	34	D	T	.	.	0	0	.	.	.	98879	10570	0.68808	0.34238	0.87874972820282	434	.	0.40243	.	.	.	.	2.351	.	N	.	.	.	0	306900	0.43829	X	.	ENSG00000101981	.	0	.	0	0.7537842320718965	1	0.21085	0.14592	.	.	.	.	.	YES	.	0.12148	25609	HGNC:3551	A	.	simple_aae	0.722	.	139530843	GAA	1.000000	.	-	0	0.70037	.	0	.	Uncertain significance	0.34397	.	.	.	ClinGen:CA255313,OMIM:300746.0013	E	.	0.987605337173	-	0.55	-	0.62675	.	108	0.75191	0.465617716312	0.1087	.	0.9970874284767326	6	-	79G>A 	.	0	C0008533|CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.43678	387906475	.	0	0.98733	.	0.463	0.71	434	0.99992300	5.23	.	.	.	-0.0199194	0.969045974591162	0.63995	D	34	.	.	0.2342	0.89215	p.Glu27Lys	0	.	-4.78	0.66373074	.	0.83114	10570	T	.	F9	.	D	0.513	.	E27K	T	.	0.70877	./.	principal1	180131	F9_Popp_2025_heavy_chain_var230930	No											E		79	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Glu27Lys		true	c.79G>A						3551.0	139530843.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Glu27Lys						K	May 06, 2024					missense_variant		27.0				0.7033171124942703		Uncertain significance	139530843.0	missense_variant		0.513					Reporter			
F9_Glu27Lys	-1.2669475277184368	0.24569658941405892	0.15398402888899934	0.8819677098053768	2025_01_Batch_13-14	0.8211449773890915	0.6077626066331344	0.6538387561093866	0.733824328613967	0.7978611430742861	0.7108360461406398	0.5934040893585728	0.6491375949093524	0.670765353720995	0.6045048961910338	0.7659905117648657	0.6005833479958536	0.6514881755093695	0.702294841167481	0.7011830196326599	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Glu27Lys																												F9_Glu27Lys						allele	217G>A	E11	527_CAVA_Array_P02	I22	B13A7A8P1_R1	B14A7A8P1_R2					-	0.36471	0.035	27	.	.	.	X	138613002	A	.	.	X	4_VUS	NC_000023.11	.	Glu27Lys	.	20.2	.	0	.	D	.	2	1	.	.	.	.	.	0	0.79046	Select	0.6886	.	0.20628	.	.	T	D	.	0.323722222284	0	.	.	.	.	0.34035	.	.	.	.	0.28867	.	.	0.54850	1.0	.	8.0	0.79572	.	0.92	A	single nucleotide variant	NC_000023.11:g.139530843G>A	.	.	3	0.25482482	.	0	0.3950114	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94378	B	0.54650	B	M	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.86425	.	.	-	139530843	.	-	6.430000	.	0.84594	.	0	.	.	germline	.	Gain of methylation at E27 (P = 0.0092)| Gain of ubiquitination at E27 (P = 0.017)| Loss of stability (P = 0.0578)| Gain of catalytic residue at C28 (P = 0.3215)| Loss of loop (P = 0.3664)	0.66459	GRCh38	937	criteria provided, single submitter	c.79G>A	.	0.72532	0	.	.	.	.	.	B	0	.	NM_000133.4(F9):c.79G>A (p.Glu27Lys)	1	.	FA9_HUMAN	.	92.0	.	.	T	0.29425	0.3264995	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99909	.	.	.	.	.	p.Glu27Lys	.	0.55699	.	germline	.		G	May 06, 2024	.	./.	.	.	0.997	N	Xq27.1	78	.	.	SCV005185478	Uncertain_significance	.	.	Lys	K	-	.	ENSP00000218099	ENST00000218099	.	0.331	.	.	0.674	G	.	2.772725	0.05615	.	T	-	.	.	0.80167	0	.	.	0.52609	0	139530843	Y	10	0	.	.	P00740	.	0.439027	0.81162		.	0.027	D	.	0.2884549	.	0.97202	2158	0.151666	.	-1.12	.	.	0.13164	.	.	.	.	.	.	0.50959	X	F9	.	0	Glu	660	.	X-139530843-G-A	Hereditary_factor_IX_deficiency_disease|not_specified	.	.	138440668	ClinGen:CA255313|OMIM:300746.0013	.	.	.	RCV000011316|RCV004689413	D	.	.	c.79G>A	.	.	.	0.69201	./.	rs387906475	139530843	.	G	.	P00740	.	0.60060	.	0.68239		.	.	.	2.255	0	0	.	5.23	0.78286	34	D	T	.	.	0	0	.	.	.	98879	10570	0.68808	0.34238	0.87874972820282	434	.	0.40243	.	.	.	.	2.351	.	N	.	.	.	0	306900	0.43829	X	.	ENSG00000101981	.	0	.	0	0.7537842320718965	1	0.21085	0.14592	.	.	.	.	.	YES	.	0.12148	25609	HGNC:3551	A	.	simple_aae	0.722	.	139530843	GAA	1.000000	.	-	0	0.70037	.	0	.	Uncertain significance	0.34397	.	.	.	ClinGen:CA255313,OMIM:300746.0013	E	.	0.987605337173	-	0.55	-	0.62675	.	108	0.75191	0.465617716312	0.1087	.	0.9970874284767326	6	-	79G>A 	.	0	C0008533|CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.43678	387906475	.	0	0.98733	.	0.463	0.71	434	0.99992300	5.23	.	.	.	-0.0199194	0.969045974591162	0.63995	D	34	.	.	0.2342	0.89215	p.Glu27Lys	0	.	-4.78	0.66373074	.	0.83114	10570	T	.	F9	.	D	0.513	.	E27K	T	.	0.70877	./.	principal1	207647	F9_Popp_2025_light_chain_var240611	No											E		79	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Glu27Lys		true	c.79G>A						3551.0	139530843.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Glu27Lys						K	May 06, 2024					missense_variant		27.0				0.7667209352939809		Uncertain significance	139530843.0	missense_variant		0.513					Reporter			
F9_Glu27Lys	-1.2669475277184368	0.24569658941405892	0.15398402888899934	0.8819677098053768	2025_01_Batch_13-14	0.8211449773890915	0.6077626066331344	0.6538387561093866	0.733824328613967	0.7978611430742861	0.7108360461406398	0.5934040893585728	0.6491375949093524	0.670765353720995	0.6045048961910338	0.7659905117648657	0.6005833479958536	0.6514881755093695	0.702294841167481	0.7011830196326599	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Glu27Lys																												F9_Glu27Lys						allele	217G>A	E11	527_CAVA_Array_P02	I22	B13A7A8P1_R1	B14A7A8P1_R2					-	0.36471	0.035	27	.	.	.	X	138613002	A	.	.	X	4_VUS	NC_000023.11	.	Glu27Lys	.	20.2	.	0	.	D	.	2	1	.	.	.	.	.	0	0.79046	Select	0.6886	.	0.20628	.	.	T	D	.	0.323722222284	0	.	.	.	.	0.34035	.	.	.	.	0.28867	.	.	0.54850	1.0	.	8.0	0.79572	.	0.92	A	single nucleotide variant	NC_000023.11:g.139530843G>A	.	.	3	0.25482482	.	0	0.3950114	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	.	.	.	.	0.94378	B	0.54650	B	M	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease|not specified	.	0.86425	.	.	-	139530843	.	-	6.430000	.	0.84594	.	0	.	.	germline	.	Gain of methylation at E27 (P = 0.0092)| Gain of ubiquitination at E27 (P = 0.017)| Loss of stability (P = 0.0578)| Gain of catalytic residue at C28 (P = 0.3215)| Loss of loop (P = 0.3664)	0.66459	GRCh38	937	criteria provided, single submitter	c.79G>A	.	0.72532	0	.	.	.	.	.	B	0	.	NM_000133.4(F9):c.79G>A (p.Glu27Lys)	1	.	FA9_HUMAN	.	92.0	.	.	T	0.29425	0.3264995	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99909	.	.	.	.	.	p.Glu27Lys	.	0.55699	.	germline	.		G	May 06, 2024	.	./.	.	.	0.997	N	Xq27.1	78	.	.	SCV005185478	Uncertain_significance	.	.	Lys	K	-	.	ENSP00000218099	ENST00000218099	.	0.331	.	.	0.674	G	.	2.772725	0.05615	.	T	-	.	.	0.80167	0	.	.	0.52609	0	139530843	Y	10	0	.	.	P00740	.	0.439027	0.81162		.	0.027	D	.	0.2884549	.	0.97202	2158	0.151666	.	-1.12	.	.	0.13164	.	.	.	.	.	.	0.50959	X	F9	.	0	Glu	660	.	X-139530843-G-A	Hereditary_factor_IX_deficiency_disease|not_specified	.	.	138440668	ClinGen:CA255313|OMIM:300746.0013	.	.	.	RCV000011316|RCV004689413	D	.	.	c.79G>A	.	.	.	0.69201	./.	rs387906475	139530843	.	G	.	P00740	.	0.60060	.	0.68239		.	.	.	2.255	0	0	.	5.23	0.78286	34	D	T	.	.	0	0	.	.	.	98879	10570	0.68808	0.34238	0.87874972820282	434	.	0.40243	.	.	.	.	2.351	.	N	.	.	.	0	306900	0.43829	X	.	ENSG00000101981	.	0	.	0	0.7537842320718965	1	0.21085	0.14592	.	.	.	.	.	YES	.	0.12148	25609	HGNC:3551	A	.	simple_aae	0.722	.	139530843	GAA	1.000000	.	-	0	0.70037	.	0	.	Uncertain significance	0.34397	.	.	.	ClinGen:CA255313,OMIM:300746.0013	E	.	0.987605337173	-	0.55	-	0.62675	.	108	0.75191	0.465617716312	0.1087	.	0.9970874284767326	6	-	79G>A 	.	0	C0008533|CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.43678	387906475	.	0	0.98733	.	0.463	0.71	434	0.99992300	5.23	.	.	.	-0.0199194	0.969045974591162	0.63995	D	34	.	.	0.2342	0.89215	p.Glu27Lys	0	.	-4.78	0.66373074	.	0.83114	10570	T	.	F9	.	D	0.513	.	E27K	T	.	0.70877	./.	principal1	152615	F9_Popp_2025_carboxy_gla_motif_var250292	No											E		79	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Glu27Lys		true	c.79G>A						3551.0	139530843.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Glu27Lys						K	May 06, 2024					missense_variant		27.0				0.7121030094296456		Uncertain significance	139530843.0	missense_variant		0.513					Reporter			
CTCF_Arg342Gly	6.0220837101592055	0.0005304623673855454	1.3306764800790363	0.22500413846281694	2025_01_Batch_13-14	0.6738743571694993	0.8386015774173865	0.9362891247658401	0.823922261253352	0.7704360005544952	0.6082543794760712	0.7681794064875938	0.9202075187399034	0.8076678706202	0.7252917962726947	0.6410643683227852	0.8033904919524901	0.9282483217528718	0.815795065936776	0.747863898413595	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF		6173		CCSBVarC010867		NC_000016.10:67616816:C:G		Arg342Gly																												CTCF_Arg342Gly	16	67616816	C	G	16	allele	1024C>G	F01	527_CAVA_Array_P02	K02	B13A7A8P1_R1	B14A7A8P1_R2				16-67616816-C-G	-	0.82886	0.997	342	.	.	.	16	67650719	G	.	.	16	1_Pathogenic	NC_000016.10	.	Arg342Gly	.	27.9	.	.	.	T	.	1	.	.	.	.	.	.	.	0.85178	.	0.1541	.	0.70687	.	.	D	D	.	.	.	.	.	.	.	0.99729	.	.	.	.	0.91330	.	.	0.91263	0.995	.	.	.	.	.	G	single nucleotide variant	NC_000016.10:g.67616816C>G	.	.	2	0.84071624	.	.	0.9000301	.		.	.	.	.	.	.	.	.	MedGen:C3661900	.	.	.	.	0.93829	D	0.90766	D	M	7.990627	.	C/C	.	.	.	.	not provided	.	0.49460	.	.	-	67616816	.	-	7.609000	.	0.92182	.	.	.	.	germline	.	Loss of stability (P = 0.0064)| Loss of MoRF binding (P = 0.0492)| Gain of methylation at K344 (P = 0.0961)| Gain of phosphorylation at Y343 (P = 0.1164)| Loss of disorder (P = 0.1303)	0.90945	GRCh38	55	criteria provided, single submitter	c.1024C>G	.	0.63341	.	.	.	.	.	.	.	.	.	NM_006565.4(CTCF):c.1024C>G (p.Arg342Gly)	1	.	CTCF_HUMAN	.	.	0.75661128044812	.	.	0.97655	0.9000301	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.94367	.	.	.	.	.	p.Arg342Gly	.	0.61899	.	germline	.		C	Feb 01, 2021	.	C/C	.	.	1.0	N	16q22.1	.	.	.	SCV001747837	Likely_pathogenic	.	.	Gly	G	-	.	ENSP00000493495	ENST00000644753	.	.	.	.	0.599	C	.	4.995947	0.79703	D	.	-	8.37291	.	0.62502	.	.	.	0.77291	.	67616816	Y	10	.	.	.	P49711	.	0.857179	0.80133		.	0.993	D	.	0.84071624	.	0.73271	10664	0.260551	.	.	.	.	0.78662	.	.	.	.	.	.	0.90766	16	CTCF	.	.	Arg	.	.	16-67616816-C-G	not_provided	.	.	66208220	.	0.947897	0.83245	.	RCV001532325	D	.	.	c.1024C>G	.	.	.	0.79429	C/C	rs1131691283	67616816	.	C	.	P49711	.	0.91262	.	0.68239		.	.	.	2.485	.	.	.	4.89	0.96774	.	D	D	.	.	.	.	.	.	.	.	1176667	0.79163	0.99365	0.986837384407801	.	.	0.71675	0.95882	.	.	.	7.701	.	.	.	.	.	.	.	0.83585	16	.	ENSG00000102974	.	.	.	.	.	1	0.81117	0.97558	.	.	.	.	0.730908088587966	.	.	0.046837	1166187	HGNC:13723	.	.	.	0.857	.	67616816	CGT	1.000000	.	-	.	0.89190	.	.	.	Likely pathogenic	0.96171	.	.	.	ClinGen:CA396312242	R	.	.	-	0.787	-	0.79815	.	.	0.96335	0.949047386646	.	.	0.99693360905744033	.	-	1024C>G 	.	.	C3661900	.	.	.	.	NM_006565.4	-	.	.	1	0.80202	1131691283	.	.	0.90579	0.84641	.	.	.	0.96604900	4.89	.	.	.	0.136487	0.999648397760086	0.72164	T	.	.	.	-0.8813	0.48246	p.Arg342Gly	.	.	-15.136	0.8994916	.	0.97310	1176667	D	.	CTCF	.	D	.	.	R342G	.	.	0.40292	C/C	principal4	964317	CTCF_unpublished_var158564	Yes						overall function		Cell survival			R		1024	CTCF_unpublished		ENST00000264010.10							immortalized human cells					p.Arg342Gly		true	c.1024C>G						13723.0	67616816.0	Yes		CTCF				NM_006565.4		1.0			nucleotide		G									criteria provided, single submitter				Arg342Gly						G	Feb 01, 2021					missense_variant		342.0	C			0.0775292		Likely pathogenic	67616816.0	missense_variant		0.62	functionally_normal				Cell viability			CTCF_Arg342Gly
F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg379Gln	23	139561821	G	A	X											X-139561821-G-A	-	0.50121	0.985	379	.	0	.	X	138643980	A	8.252830e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg379Gln	.	22.9	.	0	.	D	0	6	1	.	.	.	.	.	0	0.85753	Select	0.5944	.	0.61134	.	.	D	D	46886	1.44713708483	0	0	.	.	.	0.18333	.	33836	0	.	0.62369	.	.	0.82899	0.974	.	11.0	0.768423	4.99	0.89	A	single nucleotide variant	NC_000023.11:g.139561821G>A	0	.	3	0.5809159	.	0	0.80942816	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.91795	B	0.81875	D	N	.	1	G/G	114	0	.	1211705	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.85750	.	.	-	139561821	.	-	9.997000	.	0.94783	22040	0	895503	.	germline;unknown	56974	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.99425	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1136G>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2	.	FA9_HUMAN	.	89.0	.	.	T	0.53911	0.78737503	+	.	.	9.1059e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	46022	p.Arg379Gln	0	0.83047	.	germline	.	139561821	G	Nov 21, 2024	.	G/G	.	.	1.0	N	Xq27.1	9768	.	.	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	Pathogenic	.	.	Gln	Q	-	689	ENSP00000218099	ENST00000218099	.	0.052	.	.	0.676	G	.	3.557492	0.44850	.	T	-	.	.	0.96505	610	.	.	0.65052	0	139561821	Y	10	0	.	0.000000e+00	P00740	.	0.835829	0.99913	G	.	0.274	D	.	0.69568026	.	0.5568	2158	0.253373	1	-3.0	.	1.116690e-06	0.39251	.	.	57750	.	4354	.	0.75462	X	F9	0.000000e+00	0	Arg	14710	.	X-139561821-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	0	.	138471646	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	.	.	0	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	D	0	.	c.1136G>A	.	0	0	0.78760	G/G	rs137852259	139561821	.	G	.	P00740	.	0.84316	.	0.68239	X	.	.	0.000000e+00	0.15	0	0	264690	5.66	0.96094	146	D	T	.	.	0	26	.	.	.	98879|98878	10613	0.78484	0.86008	0.958440780639648	3332	.	0.71675	.	.	.	895503	5.168	.	D	.	.	7.556009E-5	0	306900|300807|134500|306700	0.64897	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9879215220694736	2	0.40038	0.18019	.	20	.	0.000000e+00	.	YES	0.000000e+00	0.603	25652	HGNC:3551	A	.	simple_aae	0.901	.	139561821	CGA	1.000000	.	-	0	0.92526	1.116690e-06	0	0	Pathogenic	0.13996	.	0	0	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	R	.	0.995206253788	-	0.951	-	0.73254	.	604	0.98782	0.352929472923	0.178	0	0.9994734402814196	104	-	1136G>A 	.	0	C0008533|C2749016|CN169374|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.39558	137852259	.	0	0.99508	.	0.313	0.067	3218	0.99996996	5.66	.	.	.	0.126177	0.983118799619526	0.08820	D	120	.	.	0.1942	0.85464	p.Arg379Gln	0	0	-3.268	0.93273604	0	0.86112	10613	T	.	F9	.	D	0.631	.	R379Q	T	0.89858	0.76753	G/G	principal1	173583	F9_Popp_2025_carboxy_gla_motif_var257678	No											R		1136	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Arg379Gln		true	c.1136G>A						3551.0	139561821.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				Arg379Gln						Q	Jun 05, 2024					missense_variant		379.0			8.252833816811848e-7	1.032095445118662		Pathogenic	139561821.0	missense_variant		0.631					Reporter			F9_Arg379Gln
F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg379Gln	23	139561821	G	A	X											X-139561821-G-A	-	0.50121	0.985	379	.	0	.	X	138643980	A	8.252830e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg379Gln	.	22.9	.	0	.	D	0	6	1	.	.	.	.	.	0	0.85753	Select	0.5944	.	0.61134	.	.	D	D	46886	1.44713708483	0	0	.	.	.	0.18333	.	33836	0	.	0.62369	.	.	0.82899	0.974	.	11.0	0.768423	4.99	0.89	A	single nucleotide variant	NC_000023.11:g.139561821G>A	0	.	3	0.5809159	.	0	0.80942816	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.91795	B	0.81875	D	N	.	1	G/G	114	0	.	1211705	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.85750	.	.	-	139561821	.	-	9.997000	.	0.94783	22040	0	895503	.	germline;unknown	56974	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.99425	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1136G>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2	.	FA9_HUMAN	.	89.0	.	.	T	0.53911	0.78737503	+	.	.	9.1059e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	46022	p.Arg379Gln	0	0.83047	.	germline	.	139561821	G	Nov 21, 2024	.	G/G	.	.	1.0	N	Xq27.1	9768	.	.	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	Pathogenic	.	.	Gln	Q	-	689	ENSP00000218099	ENST00000218099	.	0.052	.	.	0.676	G	.	3.557492	0.44850	.	T	-	.	.	0.96505	610	.	.	0.65052	0	139561821	Y	10	0	.	0.000000e+00	P00740	.	0.835829	0.99913	G	.	0.274	D	.	0.69568026	.	0.5568	2158	0.253373	1	-3.0	.	1.116690e-06	0.39251	.	.	57750	.	4354	.	0.75462	X	F9	0.000000e+00	0	Arg	14710	.	X-139561821-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	0	.	138471646	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	.	.	0	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	D	0	.	c.1136G>A	.	0	0	0.78760	G/G	rs137852259	139561821	.	G	.	P00740	.	0.84316	.	0.68239	X	.	.	0.000000e+00	0.15	0	0	264690	5.66	0.96094	146	D	T	.	.	0	26	.	.	.	98879|98878	10613	0.78484	0.86008	0.958440780639648	3332	.	0.71675	.	.	.	895503	5.168	.	D	.	.	7.556009E-5	0	306900|300807|134500|306700	0.64897	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9879215220694736	2	0.40038	0.18019	.	20	.	0.000000e+00	.	YES	0.000000e+00	0.603	25652	HGNC:3551	A	.	simple_aae	0.901	.	139561821	CGA	1.000000	.	-	0	0.92526	1.116690e-06	0	0	Pathogenic	0.13996	.	0	0	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	R	.	0.995206253788	-	0.951	-	0.73254	.	604	0.98782	0.352929472923	0.178	0	0.9994734402814196	104	-	1136G>A 	.	0	C0008533|C2749016|CN169374|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.39558	137852259	.	0	0.99508	.	0.313	0.067	3218	0.99996996	5.66	.	.	.	0.126177	0.983118799619526	0.08820	D	120	.	.	0.1942	0.85464	p.Arg379Gln	0	0	-3.268	0.93273604	0	0.86112	10613	T	.	F9	.	D	0.631	.	R379Q	T	0.89858	0.76753	G/G	principal1	228615	F9_Popp_2025_light_chain_var247997	No											R		1136	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Arg379Gln		true	c.1136G>A						3551.0	139561821.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				Arg379Gln						Q	Jun 05, 2024					missense_variant		379.0			8.252833816811848e-7	1.000491065611329		Pathogenic	139561821.0	missense_variant		0.631					Reporter			F9_Arg379Gln
F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg379Gln	23	139561821	G	A	X											X-139561821-G-A	-	0.50121	0.985	379	.	0	.	X	138643980	A	8.252830e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg379Gln	.	22.9	.	0	.	D	0	6	1	.	.	.	.	.	0	0.85753	Select	0.5944	.	0.61134	.	.	D	D	46886	1.44713708483	0	0	.	.	.	0.18333	.	33836	0	.	0.62369	.	.	0.82899	0.974	.	11.0	0.768423	4.99	0.89	A	single nucleotide variant	NC_000023.11:g.139561821G>A	0	.	3	0.5809159	.	0	0.80942816	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.91795	B	0.81875	D	N	.	1	G/G	114	0	.	1211705	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.85750	.	.	-	139561821	.	-	9.997000	.	0.94783	22040	0	895503	.	germline;unknown	56974	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.99425	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1136G>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2	.	FA9_HUMAN	.	89.0	.	.	T	0.53911	0.78737503	+	.	.	9.1059e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	46022	p.Arg379Gln	0	0.83047	.	germline	.	139561821	G	Nov 21, 2024	.	G/G	.	.	1.0	N	Xq27.1	9768	.	.	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	Pathogenic	.	.	Gln	Q	-	689	ENSP00000218099	ENST00000218099	.	0.052	.	.	0.676	G	.	3.557492	0.44850	.	T	-	.	.	0.96505	610	.	.	0.65052	0	139561821	Y	10	0	.	0.000000e+00	P00740	.	0.835829	0.99913	G	.	0.274	D	.	0.69568026	.	0.5568	2158	0.253373	1	-3.0	.	1.116690e-06	0.39251	.	.	57750	.	4354	.	0.75462	X	F9	0.000000e+00	0	Arg	14710	.	X-139561821-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	0	.	138471646	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	.	.	0	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	D	0	.	c.1136G>A	.	0	0	0.78760	G/G	rs137852259	139561821	.	G	.	P00740	.	0.84316	.	0.68239	X	.	.	0.000000e+00	0.15	0	0	264690	5.66	0.96094	146	D	T	.	.	0	26	.	.	.	98879|98878	10613	0.78484	0.86008	0.958440780639648	3332	.	0.71675	.	.	.	895503	5.168	.	D	.	.	7.556009E-5	0	306900|300807|134500|306700	0.64897	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9879215220694736	2	0.40038	0.18019	.	20	.	0.000000e+00	.	YES	0.000000e+00	0.603	25652	HGNC:3551	A	.	simple_aae	0.901	.	139561821	CGA	1.000000	.	-	0	0.92526	1.116690e-06	0	0	Pathogenic	0.13996	.	0	0	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	R	.	0.995206253788	-	0.951	-	0.73254	.	604	0.98782	0.352929472923	0.178	0	0.9994734402814196	104	-	1136G>A 	.	0	C0008533|C2749016|CN169374|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.39558	137852259	.	0	0.99508	.	0.313	0.067	3218	0.99996996	5.66	.	.	.	0.126177	0.983118799619526	0.08820	D	120	.	.	0.1942	0.85464	p.Arg379Gln	0	0	-3.268	0.93273604	0	0.86112	10613	T	.	F9	.	D	0.631	.	R379Q	T	0.89858	0.76753	G/G	principal1	146067	F9_Popp_2025_carboxy_F9_specific_var228635	No											R		1136	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Arg379Gln		true	c.1136G>A						3551.0	139561821.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				Arg379Gln						Q	Jun 05, 2024					missense_variant		379.0			8.252833816811848e-7	1.053306317400008		Pathogenic	139561821.0	missense_variant		0.631					Reporter			F9_Arg379Gln
F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg379Gln	23	139561821	G	A	X											X-139561821-G-A	-	0.50121	0.985	379	.	0	.	X	138643980	A	8.252830e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg379Gln	.	22.9	.	0	.	D	0	6	1	.	.	.	.	.	0	0.85753	Select	0.5944	.	0.61134	.	.	D	D	46886	1.44713708483	0	0	.	.	.	0.18333	.	33836	0	.	0.62369	.	.	0.82899	0.974	.	11.0	0.768423	4.99	0.89	A	single nucleotide variant	NC_000023.11:g.139561821G>A	0	.	3	0.5809159	.	0	0.80942816	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.91795	B	0.81875	D	N	.	1	G/G	114	0	.	1211705	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.85750	.	.	-	139561821	.	-	9.997000	.	0.94783	22040	0	895503	.	germline;unknown	56974	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.99425	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1136G>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2	.	FA9_HUMAN	.	89.0	.	.	T	0.53911	0.78737503	+	.	.	9.1059e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	46022	p.Arg379Gln	0	0.83047	.	germline	.	139561821	G	Nov 21, 2024	.	G/G	.	.	1.0	N	Xq27.1	9768	.	.	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	Pathogenic	.	.	Gln	Q	-	689	ENSP00000218099	ENST00000218099	.	0.052	.	.	0.676	G	.	3.557492	0.44850	.	T	-	.	.	0.96505	610	.	.	0.65052	0	139561821	Y	10	0	.	0.000000e+00	P00740	.	0.835829	0.99913	G	.	0.274	D	.	0.69568026	.	0.5568	2158	0.253373	1	-3.0	.	1.116690e-06	0.39251	.	.	57750	.	4354	.	0.75462	X	F9	0.000000e+00	0	Arg	14710	.	X-139561821-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	0	.	138471646	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	.	.	0	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	D	0	.	c.1136G>A	.	0	0	0.78760	G/G	rs137852259	139561821	.	G	.	P00740	.	0.84316	.	0.68239	X	.	.	0.000000e+00	0.15	0	0	264690	5.66	0.96094	146	D	T	.	.	0	26	.	.	.	98879|98878	10613	0.78484	0.86008	0.958440780639648	3332	.	0.71675	.	.	.	895503	5.168	.	D	.	.	7.556009E-5	0	306900|300807|134500|306700	0.64897	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9879215220694736	2	0.40038	0.18019	.	20	.	0.000000e+00	.	YES	0.000000e+00	0.603	25652	HGNC:3551	A	.	simple_aae	0.901	.	139561821	CGA	1.000000	.	-	0	0.92526	1.116690e-06	0	0	Pathogenic	0.13996	.	0	0	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	R	.	0.995206253788	-	0.951	-	0.73254	.	604	0.98782	0.352929472923	0.178	0	0.9994734402814196	104	-	1136G>A 	.	0	C0008533|C2749016|CN169374|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.39558	137852259	.	0	0.99508	.	0.313	0.067	3218	0.99996996	5.66	.	.	.	0.126177	0.983118799619526	0.08820	D	120	.	.	0.1942	0.85464	p.Arg379Gln	0	0	-3.268	0.93273604	0	0.86112	10613	T	.	F9	.	D	0.631	.	R379Q	T	0.89858	0.76753	G/G	principal1	256131	F9_Popp_2025_strep_2_var267359	No											R		1136	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Arg379Gln		true	c.1136G>A						3551.0	139561821.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				Arg379Gln						Q	Jun 05, 2024					missense_variant		379.0			8.252833816811848e-7	1.231034116272263		Pathogenic	139561821.0	missense_variant		0.631					Reporter			F9_Arg379Gln
F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	NC_000023.11:139561821:G:A	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg379Gln	23	139561821	G	A	X											X-139561821-G-A	-	0.50121	0.985	379	.	0	.	X	138643980	A	8.252830e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg379Gln	.	22.9	.	0	.	D	0	6	1	.	.	.	.	.	0	0.85753	Select	0.5944	.	0.61134	.	.	D	D	46886	1.44713708483	0	0	.	.	.	0.18333	.	33836	0	.	0.62369	.	.	0.82899	0.974	.	11.0	0.768423	4.99	0.89	A	single nucleotide variant	NC_000023.11:g.139561821G>A	0	.	3	0.5809159	.	0	0.80942816	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.91795	B	0.81875	D	N	.	1	G/G	114	0	.	1211705	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.85750	.	.	-	139561821	.	-	9.997000	.	0.94783	22040	0	895503	.	germline;unknown	56974	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.99425	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1136G>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2	.	FA9_HUMAN	.	89.0	.	.	T	0.53911	0.78737503	+	.	.	9.1059e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	46022	p.Arg379Gln	0	0.83047	.	germline	.	139561821	G	Nov 21, 2024	.	G/G	.	.	1.0	N	Xq27.1	9768	.	.	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	Pathogenic	.	.	Gln	Q	-	689	ENSP00000218099	ENST00000218099	.	0.052	.	.	0.676	G	.	3.557492	0.44850	.	T	-	.	.	0.96505	610	.	.	0.65052	0	139561821	Y	10	0	.	0.000000e+00	P00740	.	0.835829	0.99913	G	.	0.274	D	.	0.69568026	.	0.5568	2158	0.253373	1	-3.0	.	1.116690e-06	0.39251	.	.	57750	.	4354	.	0.75462	X	F9	0.000000e+00	0	Arg	14710	.	X-139561821-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	0	.	138471646	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	.	.	0	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	D	0	.	c.1136G>A	.	0	0	0.78760	G/G	rs137852259	139561821	.	G	.	P00740	.	0.84316	.	0.68239	X	.	.	0.000000e+00	0.15	0	0	264690	5.66	0.96094	146	D	T	.	.	0	26	.	.	.	98879|98878	10613	0.78484	0.86008	0.958440780639648	3332	.	0.71675	.	.	.	895503	5.168	.	D	.	.	7.556009E-5	0	306900|300807|134500|306700	0.64897	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9879215220694736	2	0.40038	0.18019	.	20	.	0.000000e+00	.	YES	0.000000e+00	0.603	25652	HGNC:3551	A	.	simple_aae	0.901	.	139561821	CGA	1.000000	.	-	0	0.92526	1.116690e-06	0	0	Pathogenic	0.13996	.	0	0	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	R	.	0.995206253788	-	0.951	-	0.73254	.	604	0.98782	0.352929472923	0.178	0	0.9994734402814196	104	-	1136G>A 	.	0	C0008533|C2749016|CN169374|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.39558	137852259	.	0	0.99508	.	0.313	0.067	3218	0.99996996	5.66	.	.	.	0.126177	0.983118799619526	0.08820	D	120	.	.	0.1942	0.85464	p.Arg379Gln	0	0	-3.268	0.93273604	0	0.86112	10613	T	.	F9	.	D	0.631	.	R379Q	T	0.89858	0.76753	G/G	principal1	201099	F9_Popp_2025_heavy_chain_var238316	No											R		1136	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Arg379Gln		true	c.1136G>A						3551.0	139561821.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				Arg379Gln						Q	Jun 05, 2024					missense_variant		379.0			8.252833816811848e-7	1.0869858322397092		Pathogenic	139561821.0	missense_variant		0.631					Reporter			F9_Arg379Gln
F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004388		NC_000023.11:139561821:G:A		Arg379Gln																												F9_Arg379Gln	23	139561821	G	A	X	allele	1136G>A	A04	527_CAVA_Array_P02	A08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561821-G-A	-	0.50121	0.985	379	.	0	.	X	138643980	A	8.252830e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg379Gln	.	22.9	.	0	.	D	0	6	1	.	.	.	.	.	0	0.85753	Select	0.5944	.	0.61134	.	.	D	D	46886	1.44713708483	0	0	.	.	.	0.18333	.	33836	0	.	0.62369	.	.	0.82899	0.974	.	11.0	0.768423	4.99	0.89	A	single nucleotide variant	NC_000023.11:g.139561821G>A	0	.	3	0.5809159	.	0	0.80942816	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.91795	B	0.81875	D	N	.	1	G/G	114	0	.	1211705	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.85750	.	.	-	139561821	.	-	9.997000	.	0.94783	22040	0	895503	.	germline;unknown	56974	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.99425	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1136G>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2	.	FA9_HUMAN	.	89.0	.	.	T	0.53911	0.78737503	+	.	.	9.1059e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	46022	p.Arg379Gln	0	0.83047	.	germline	.	139561821	G	Nov 21, 2024	.	G/G	.	.	1.0	N	Xq27.1	9768	.	.	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	Pathogenic	.	.	Gln	Q	-	689	ENSP00000218099	ENST00000218099	.	0.052	.	.	0.676	G	.	3.557492	0.44850	.	T	-	.	.	0.96505	610	.	.	0.65052	0	139561821	Y	10	0	.	0.000000e+00	P00740	.	0.835829	0.99913	G	.	0.274	D	.	0.69568026	.	0.5568	2158	0.253373	1	-3.0	.	1.116690e-06	0.39251	.	.	57750	.	4354	.	0.75462	X	F9	0.000000e+00	0	Arg	14710	.	X-139561821-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	0	.	138471646	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	.	.	0	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	D	0	.	c.1136G>A	.	0	0	0.78760	G/G	rs137852259	139561821	.	G	.	P00740	.	0.84316	.	0.68239	X	.	.	0.000000e+00	0.15	0	0	264690	5.66	0.96094	146	D	T	.	.	0	26	.	.	.	98879|98878	10613	0.78484	0.86008	0.958440780639648	3332	.	0.71675	.	.	.	895503	5.168	.	D	.	.	7.556009E-5	0	306900|300807|134500|306700	0.64897	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9879215220694736	2	0.40038	0.18019	.	20	.	0.000000e+00	.	YES	0.000000e+00	0.603	25652	HGNC:3551	A	.	simple_aae	0.901	.	139561821	CGA	1.000000	.	-	0	0.92526	1.116690e-06	0	0	Pathogenic	0.13996	.	0	0	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	R	.	0.995206253788	-	0.951	-	0.73254	.	604	0.98782	0.352929472923	0.178	0	0.9994734402814196	104	-	1136G>A 	.	0	C0008533|C2749016|CN169374|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.39558	137852259	.	0	0.99508	.	0.313	0.067	3218	0.99996996	5.66	.	.	.	0.126177	0.983118799619526	0.08820	D	120	.	.	0.1942	0.85464	p.Arg379Gln	0	0	-3.268	0.93273604	0	0.86112	10613	T	.	F9	.	D	0.631	.	R379Q	T	0.89858	0.76753	G/G	principal1	173583	F9_Popp_2025_carboxy_gla_motif_var257678	No											R		1136	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Arg379Gln		true	c.1136G>A						3551.0	139561821.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				Arg379Gln						Q	Jun 05, 2024					missense_variant		379.0			8.252833816811848e-7	1.032095445118662		Pathogenic	139561821.0	missense_variant		0.631					Reporter			F9_Arg379Gln
F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004388		NC_000023.11:139561821:G:A		Arg379Gln																												F9_Arg379Gln	23	139561821	G	A	X	allele	1136G>A	A04	527_CAVA_Array_P02	A08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561821-G-A	-	0.50121	0.985	379	.	0	.	X	138643980	A	8.252830e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg379Gln	.	22.9	.	0	.	D	0	6	1	.	.	.	.	.	0	0.85753	Select	0.5944	.	0.61134	.	.	D	D	46886	1.44713708483	0	0	.	.	.	0.18333	.	33836	0	.	0.62369	.	.	0.82899	0.974	.	11.0	0.768423	4.99	0.89	A	single nucleotide variant	NC_000023.11:g.139561821G>A	0	.	3	0.5809159	.	0	0.80942816	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.91795	B	0.81875	D	N	.	1	G/G	114	0	.	1211705	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.85750	.	.	-	139561821	.	-	9.997000	.	0.94783	22040	0	895503	.	germline;unknown	56974	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.99425	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1136G>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2	.	FA9_HUMAN	.	89.0	.	.	T	0.53911	0.78737503	+	.	.	9.1059e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	46022	p.Arg379Gln	0	0.83047	.	germline	.	139561821	G	Nov 21, 2024	.	G/G	.	.	1.0	N	Xq27.1	9768	.	.	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	Pathogenic	.	.	Gln	Q	-	689	ENSP00000218099	ENST00000218099	.	0.052	.	.	0.676	G	.	3.557492	0.44850	.	T	-	.	.	0.96505	610	.	.	0.65052	0	139561821	Y	10	0	.	0.000000e+00	P00740	.	0.835829	0.99913	G	.	0.274	D	.	0.69568026	.	0.5568	2158	0.253373	1	-3.0	.	1.116690e-06	0.39251	.	.	57750	.	4354	.	0.75462	X	F9	0.000000e+00	0	Arg	14710	.	X-139561821-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	0	.	138471646	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	.	.	0	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	D	0	.	c.1136G>A	.	0	0	0.78760	G/G	rs137852259	139561821	.	G	.	P00740	.	0.84316	.	0.68239	X	.	.	0.000000e+00	0.15	0	0	264690	5.66	0.96094	146	D	T	.	.	0	26	.	.	.	98879|98878	10613	0.78484	0.86008	0.958440780639648	3332	.	0.71675	.	.	.	895503	5.168	.	D	.	.	7.556009E-5	0	306900|300807|134500|306700	0.64897	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9879215220694736	2	0.40038	0.18019	.	20	.	0.000000e+00	.	YES	0.000000e+00	0.603	25652	HGNC:3551	A	.	simple_aae	0.901	.	139561821	CGA	1.000000	.	-	0	0.92526	1.116690e-06	0	0	Pathogenic	0.13996	.	0	0	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	R	.	0.995206253788	-	0.951	-	0.73254	.	604	0.98782	0.352929472923	0.178	0	0.9994734402814196	104	-	1136G>A 	.	0	C0008533|C2749016|CN169374|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.39558	137852259	.	0	0.99508	.	0.313	0.067	3218	0.99996996	5.66	.	.	.	0.126177	0.983118799619526	0.08820	D	120	.	.	0.1942	0.85464	p.Arg379Gln	0	0	-3.268	0.93273604	0	0.86112	10613	T	.	F9	.	D	0.631	.	R379Q	T	0.89858	0.76753	G/G	principal1	228615	F9_Popp_2025_light_chain_var247997	No											R		1136	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Arg379Gln		true	c.1136G>A						3551.0	139561821.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				Arg379Gln						Q	Jun 05, 2024					missense_variant		379.0			8.252833816811848e-7	1.000491065611329		Pathogenic	139561821.0	missense_variant		0.631					Reporter			F9_Arg379Gln
F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004388		NC_000023.11:139561821:G:A		Arg379Gln																												F9_Arg379Gln	23	139561821	G	A	X	allele	1136G>A	A04	527_CAVA_Array_P02	A08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561821-G-A	-	0.50121	0.985	379	.	0	.	X	138643980	A	8.252830e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg379Gln	.	22.9	.	0	.	D	0	6	1	.	.	.	.	.	0	0.85753	Select	0.5944	.	0.61134	.	.	D	D	46886	1.44713708483	0	0	.	.	.	0.18333	.	33836	0	.	0.62369	.	.	0.82899	0.974	.	11.0	0.768423	4.99	0.89	A	single nucleotide variant	NC_000023.11:g.139561821G>A	0	.	3	0.5809159	.	0	0.80942816	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.91795	B	0.81875	D	N	.	1	G/G	114	0	.	1211705	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.85750	.	.	-	139561821	.	-	9.997000	.	0.94783	22040	0	895503	.	germline;unknown	56974	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.99425	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1136G>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2	.	FA9_HUMAN	.	89.0	.	.	T	0.53911	0.78737503	+	.	.	9.1059e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	46022	p.Arg379Gln	0	0.83047	.	germline	.	139561821	G	Nov 21, 2024	.	G/G	.	.	1.0	N	Xq27.1	9768	.	.	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	Pathogenic	.	.	Gln	Q	-	689	ENSP00000218099	ENST00000218099	.	0.052	.	.	0.676	G	.	3.557492	0.44850	.	T	-	.	.	0.96505	610	.	.	0.65052	0	139561821	Y	10	0	.	0.000000e+00	P00740	.	0.835829	0.99913	G	.	0.274	D	.	0.69568026	.	0.5568	2158	0.253373	1	-3.0	.	1.116690e-06	0.39251	.	.	57750	.	4354	.	0.75462	X	F9	0.000000e+00	0	Arg	14710	.	X-139561821-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	0	.	138471646	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	.	.	0	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	D	0	.	c.1136G>A	.	0	0	0.78760	G/G	rs137852259	139561821	.	G	.	P00740	.	0.84316	.	0.68239	X	.	.	0.000000e+00	0.15	0	0	264690	5.66	0.96094	146	D	T	.	.	0	26	.	.	.	98879|98878	10613	0.78484	0.86008	0.958440780639648	3332	.	0.71675	.	.	.	895503	5.168	.	D	.	.	7.556009E-5	0	306900|300807|134500|306700	0.64897	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9879215220694736	2	0.40038	0.18019	.	20	.	0.000000e+00	.	YES	0.000000e+00	0.603	25652	HGNC:3551	A	.	simple_aae	0.901	.	139561821	CGA	1.000000	.	-	0	0.92526	1.116690e-06	0	0	Pathogenic	0.13996	.	0	0	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	R	.	0.995206253788	-	0.951	-	0.73254	.	604	0.98782	0.352929472923	0.178	0	0.9994734402814196	104	-	1136G>A 	.	0	C0008533|C2749016|CN169374|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.39558	137852259	.	0	0.99508	.	0.313	0.067	3218	0.99996996	5.66	.	.	.	0.126177	0.983118799619526	0.08820	D	120	.	.	0.1942	0.85464	p.Arg379Gln	0	0	-3.268	0.93273604	0	0.86112	10613	T	.	F9	.	D	0.631	.	R379Q	T	0.89858	0.76753	G/G	principal1	146067	F9_Popp_2025_carboxy_F9_specific_var228635	No											R		1136	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Arg379Gln		true	c.1136G>A						3551.0	139561821.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				Arg379Gln						Q	Jun 05, 2024					missense_variant		379.0			8.252833816811848e-7	1.053306317400008		Pathogenic	139561821.0	missense_variant		0.631					Reporter			F9_Arg379Gln
F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004388		NC_000023.11:139561821:G:A		Arg379Gln																												F9_Arg379Gln	23	139561821	G	A	X	allele	1136G>A	A04	527_CAVA_Array_P02	A08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561821-G-A	-	0.50121	0.985	379	.	0	.	X	138643980	A	8.252830e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg379Gln	.	22.9	.	0	.	D	0	6	1	.	.	.	.	.	0	0.85753	Select	0.5944	.	0.61134	.	.	D	D	46886	1.44713708483	0	0	.	.	.	0.18333	.	33836	0	.	0.62369	.	.	0.82899	0.974	.	11.0	0.768423	4.99	0.89	A	single nucleotide variant	NC_000023.11:g.139561821G>A	0	.	3	0.5809159	.	0	0.80942816	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.91795	B	0.81875	D	N	.	1	G/G	114	0	.	1211705	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.85750	.	.	-	139561821	.	-	9.997000	.	0.94783	22040	0	895503	.	germline;unknown	56974	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.99425	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1136G>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2	.	FA9_HUMAN	.	89.0	.	.	T	0.53911	0.78737503	+	.	.	9.1059e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	46022	p.Arg379Gln	0	0.83047	.	germline	.	139561821	G	Nov 21, 2024	.	G/G	.	.	1.0	N	Xq27.1	9768	.	.	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	Pathogenic	.	.	Gln	Q	-	689	ENSP00000218099	ENST00000218099	.	0.052	.	.	0.676	G	.	3.557492	0.44850	.	T	-	.	.	0.96505	610	.	.	0.65052	0	139561821	Y	10	0	.	0.000000e+00	P00740	.	0.835829	0.99913	G	.	0.274	D	.	0.69568026	.	0.5568	2158	0.253373	1	-3.0	.	1.116690e-06	0.39251	.	.	57750	.	4354	.	0.75462	X	F9	0.000000e+00	0	Arg	14710	.	X-139561821-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	0	.	138471646	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	.	.	0	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	D	0	.	c.1136G>A	.	0	0	0.78760	G/G	rs137852259	139561821	.	G	.	P00740	.	0.84316	.	0.68239	X	.	.	0.000000e+00	0.15	0	0	264690	5.66	0.96094	146	D	T	.	.	0	26	.	.	.	98879|98878	10613	0.78484	0.86008	0.958440780639648	3332	.	0.71675	.	.	.	895503	5.168	.	D	.	.	7.556009E-5	0	306900|300807|134500|306700	0.64897	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9879215220694736	2	0.40038	0.18019	.	20	.	0.000000e+00	.	YES	0.000000e+00	0.603	25652	HGNC:3551	A	.	simple_aae	0.901	.	139561821	CGA	1.000000	.	-	0	0.92526	1.116690e-06	0	0	Pathogenic	0.13996	.	0	0	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	R	.	0.995206253788	-	0.951	-	0.73254	.	604	0.98782	0.352929472923	0.178	0	0.9994734402814196	104	-	1136G>A 	.	0	C0008533|C2749016|CN169374|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.39558	137852259	.	0	0.99508	.	0.313	0.067	3218	0.99996996	5.66	.	.	.	0.126177	0.983118799619526	0.08820	D	120	.	.	0.1942	0.85464	p.Arg379Gln	0	0	-3.268	0.93273604	0	0.86112	10613	T	.	F9	.	D	0.631	.	R379Q	T	0.89858	0.76753	G/G	principal1	256131	F9_Popp_2025_strep_2_var267359	No											R		1136	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Arg379Gln		true	c.1136G>A						3551.0	139561821.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				Arg379Gln						Q	Jun 05, 2024					missense_variant		379.0			8.252833816811848e-7	1.231034116272263		Pathogenic	139561821.0	missense_variant		0.631					Reporter			F9_Arg379Gln
F9_Arg379Gln	-2.6628463076730364	0.03233336193180533	1.1488750909457108	0.28834551914610007	2025_01_Batch_13-14	0.6237540869814104	0.6095803779193913	0.6446597031932366	0.6912579747611411	0.5958214472974044	0.8948334662655197	0.8248786779480388	0.8321044689911908	0.9040200149061038	0.8125891344984355	0.7592937766234651	0.7172295279337151	0.7383820860922137	0.7976389948336224	0.7042052908979199	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004388		NC_000023.11:139561821:G:A		Arg379Gln																												F9_Arg379Gln	23	139561821	G	A	X	allele	1136G>A	A04	527_CAVA_Array_P02	A08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561821-G-A	-	0.50121	0.985	379	.	0	.	X	138643980	A	8.252830e-07	.	X	1_Pathogenic	NC_000023.11	1	Arg379Gln	.	22.9	.	0	.	D	0	6	1	.	.	.	.	.	0	0.85753	Select	0.5944	.	0.61134	.	.	D	D	46886	1.44713708483	0	0	.	.	.	0.18333	.	33836	0	.	0.62369	.	.	0.82899	0.974	.	11.0	0.768423	4.99	0.89	A	single nucleotide variant	NC_000023.11:g.139561821G>A	0	.	3	0.5809159	.	0	0.80942816	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.91795	B	0.81875	D	N	.	1	G/G	114	0	.	1211705	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.85750	.	.	-	139561821	.	-	9.997000	.	0.94783	22040	0	895503	.	germline;unknown	56974	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.99425	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1136G>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2	.	FA9_HUMAN	.	89.0	.	.	T	0.53911	0.78737503	+	.	.	9.1059e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	46022	p.Arg379Gln	0	0.83047	.	germline	.	139561821	G	Nov 21, 2024	.	G/G	.	.	1.0	N	Xq27.1	9768	.	.	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	Pathogenic	.	.	Gln	Q	-	689	ENSP00000218099	ENST00000218099	.	0.052	.	.	0.676	G	.	3.557492	0.44850	.	T	-	.	.	0.96505	610	.	.	0.65052	0	139561821	Y	10	0	.	0.000000e+00	P00740	.	0.835829	0.99913	G	.	0.274	D	.	0.69568026	.	0.5568	2158	0.253373	1	-3.0	.	1.116690e-06	0.39251	.	.	57750	.	4354	.	0.75462	X	F9	0.000000e+00	0	Arg	14710	.	X-139561821-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	0	.	138471646	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	.	.	0	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	D	0	.	c.1136G>A	.	0	0	0.78760	G/G	rs137852259	139561821	.	G	.	P00740	.	0.84316	.	0.68239	X	.	.	0.000000e+00	0.15	0	0	264690	5.66	0.96094	146	D	T	.	.	0	26	.	.	.	98879|98878	10613	0.78484	0.86008	0.958440780639648	3332	.	0.71675	.	.	.	895503	5.168	.	D	.	.	7.556009E-5	0	306900|300807|134500|306700	0.64897	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9879215220694736	2	0.40038	0.18019	.	20	.	0.000000e+00	.	YES	0.000000e+00	0.603	25652	HGNC:3551	A	.	simple_aae	0.901	.	139561821	CGA	1.000000	.	-	0	0.92526	1.116690e-06	0	0	Pathogenic	0.13996	.	0	0	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	R	.	0.995206253788	-	0.951	-	0.73254	.	604	0.98782	0.352929472923	0.178	0	0.9994734402814196	104	-	1136G>A 	.	0	C0008533|C2749016|CN169374|C0019069	.	.	.	.	NM_000133.4	-	.	.	1	0.39558	137852259	.	0	0.99508	.	0.313	0.067	3218	0.99996996	5.66	.	.	.	0.126177	0.983118799619526	0.08820	D	120	.	.	0.1942	0.85464	p.Arg379Gln	0	0	-3.268	0.93273604	0	0.86112	10613	T	.	F9	.	D	0.631	.	R379Q	T	0.89858	0.76753	G/G	principal1	201099	F9_Popp_2025_heavy_chain_var238316	No											R		1136	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Arg379Gln		true	c.1136G>A						3551.0	139561821.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				Arg379Gln						Q	Jun 05, 2024					missense_variant		379.0			8.252833816811848e-7	1.0869858322397092		Pathogenic	139561821.0	missense_variant		0.631					Reporter			F9_Arg379Gln
F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Asn	23	139541126	G	A	X											X-139541126-G-A	-	0.71019	0.997	110	.	.	.	X	138623285	A	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Asn	.	25.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.94182	Select	0.9866	.	0.70687	.	.	D	D	.	2.87732945386	0	.	.	.	.	0.57442	.	.	.	.	0.75805	.	.	0.88509	0.981	.	3.0	0.962504	.	0.97	A	single nucleotide variant	NC_000023.11:g.139541126G>A	.	.	1	0.8738812	.	0	0.8451415	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.94269	D	L	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97576	.	.	-	139541126	.	-	11.714000	.	0.99252	.	0	.	.	germline	.	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.98733	GRCh38	924	no assertion criteria provided	c.328G>A	.	0.92402	0	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	A	0	.	NM_000133.4(F9):c.328G>A (p.Asp110Asn)		.	FA9_HUMAN	.	97.0	.	.	D	0.59925	0.8674805	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Asp110Asn	.	0.94708	.	germline	.		G	Oct 09, 2017	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031621	Pathogenic	.	.	Asn	N	-	.	ENSP00000218099	ENST00000218099	.	0.006	.	.	0.676	G	.	4.524378	0.68204	.	D	-	.	.	0.99760	610	.	.	0.81689	0	139541126	Y	10	0	.	.	P00740	.	0.878352	0.99164		.	0.957	D	.	0.8911182	.	0.58703	2158	0.177508	.	-4.21	.	.	0.61594	.	.	.	.	.	.	0.93043	X	F9	.	0	Asp	11340	.	X-139541126-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138450951	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	.	.	.	RCV000011389	D	.	.	c.328G>A	.	.	.	0.71606	G/G	rs137852274	139541126	.	G	.	P00740	.	0.86805	.	0.68239		.	.	.	1.095	0	0	.	5.81	0.97407	142	D	T	.	.	0	24	.	.	.	98879	10643	0.71239	0.99059	0.991527616977692	2728	.	0.71675	.	.	.	.	5.823	.	D	.	.	.	0	306900	0.6903	X	.	ENSG00000101981	.	0	.	0	0.9787809428603149	1	0.69900	0.18019	.	.	.	.	.	YES	.	0.962922	25682	HGNC:3551	A	.	simple_aae	0.979	.	139541126	GAT	1.000000	.	-	0	0.99530	.	0	.	Pathogenic	0.55010	.	.	.	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	D	.	0.994855140868	-	0.925	-	0.65671	.	574	0.97859	0.632549464703	0.4071	.	0.99927164946011271	100	-	328G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.85963	137852274	.	0	0.99473	.	0.647	0.008	2644	0.99997795	5.81	.	.	.	0.0172016	0.991977909549927	0.27258	D	118	.	.	1.0226	0.99601	p.Asp110Asn	0	.	-7.125	0.99035263	.	0.89283	10643	T	.	F9	.	D	0.819	.	D110N	D	.	0.76753	G/G	principal1	240039	F9_Popp_2025_strep_2_var261709	No											D		328	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Asp110Asn		true	c.328G>A						3551.0	139541126.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Asp110Asn						N	Oct 09, 2017					missense_variant		110.0				1.200178129328389		Pathogenic	139541126.0	missense_variant		0.819					Reporter			F9_Asp110Asn
F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Asn	23	139541126	G	A	X											X-139541126-G-A	-	0.71019	0.997	110	.	.	.	X	138623285	A	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Asn	.	25.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.94182	Select	0.9866	.	0.70687	.	.	D	D	.	2.87732945386	0	.	.	.	.	0.57442	.	.	.	.	0.75805	.	.	0.88509	0.981	.	3.0	0.962504	.	0.97	A	single nucleotide variant	NC_000023.11:g.139541126G>A	.	.	1	0.8738812	.	0	0.8451415	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.94269	D	L	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97576	.	.	-	139541126	.	-	11.714000	.	0.99252	.	0	.	.	germline	.	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.98733	GRCh38	924	no assertion criteria provided	c.328G>A	.	0.92402	0	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	A	0	.	NM_000133.4(F9):c.328G>A (p.Asp110Asn)		.	FA9_HUMAN	.	97.0	.	.	D	0.59925	0.8674805	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Asp110Asn	.	0.94708	.	germline	.		G	Oct 09, 2017	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031621	Pathogenic	.	.	Asn	N	-	.	ENSP00000218099	ENST00000218099	.	0.006	.	.	0.676	G	.	4.524378	0.68204	.	D	-	.	.	0.99760	610	.	.	0.81689	0	139541126	Y	10	0	.	.	P00740	.	0.878352	0.99164		.	0.957	D	.	0.8911182	.	0.58703	2158	0.177508	.	-4.21	.	.	0.61594	.	.	.	.	.	.	0.93043	X	F9	.	0	Asp	11340	.	X-139541126-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138450951	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	.	.	.	RCV000011389	D	.	.	c.328G>A	.	.	.	0.71606	G/G	rs137852274	139541126	.	G	.	P00740	.	0.86805	.	0.68239		.	.	.	1.095	0	0	.	5.81	0.97407	142	D	T	.	.	0	24	.	.	.	98879	10643	0.71239	0.99059	0.991527616977692	2728	.	0.71675	.	.	.	.	5.823	.	D	.	.	.	0	306900	0.6903	X	.	ENSG00000101981	.	0	.	0	0.9787809428603149	1	0.69900	0.18019	.	.	.	.	.	YES	.	0.962922	25682	HGNC:3551	A	.	simple_aae	0.979	.	139541126	GAT	1.000000	.	-	0	0.99530	.	0	.	Pathogenic	0.55010	.	.	.	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	D	.	0.994855140868	-	0.925	-	0.65671	.	574	0.97859	0.632549464703	0.4071	.	0.99927164946011271	100	-	328G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.85963	137852274	.	0	0.99473	.	0.647	0.008	2644	0.99997795	5.81	.	.	.	0.0172016	0.991977909549927	0.27258	D	118	.	.	1.0226	0.99601	p.Asp110Asn	0	.	-7.125	0.99035263	.	0.89283	10643	T	.	F9	.	D	0.819	.	D110N	D	.	0.76753	G/G	principal1	129975	F9_Popp_2025_carboxy_F9_specific_var222985	No											D		328	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Asp110Asn		true	c.328G>A						3551.0	139541126.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Asp110Asn						N	Oct 09, 2017					missense_variant		110.0				1.051387770684173		Pathogenic	139541126.0	missense_variant		0.819					Reporter			F9_Asp110Asn
F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Asn	23	139541126	G	A	X											X-139541126-G-A	-	0.71019	0.997	110	.	.	.	X	138623285	A	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Asn	.	25.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.94182	Select	0.9866	.	0.70687	.	.	D	D	.	2.87732945386	0	.	.	.	.	0.57442	.	.	.	.	0.75805	.	.	0.88509	0.981	.	3.0	0.962504	.	0.97	A	single nucleotide variant	NC_000023.11:g.139541126G>A	.	.	1	0.8738812	.	0	0.8451415	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.94269	D	L	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97576	.	.	-	139541126	.	-	11.714000	.	0.99252	.	0	.	.	germline	.	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.98733	GRCh38	924	no assertion criteria provided	c.328G>A	.	0.92402	0	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	A	0	.	NM_000133.4(F9):c.328G>A (p.Asp110Asn)		.	FA9_HUMAN	.	97.0	.	.	D	0.59925	0.8674805	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Asp110Asn	.	0.94708	.	germline	.		G	Oct 09, 2017	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031621	Pathogenic	.	.	Asn	N	-	.	ENSP00000218099	ENST00000218099	.	0.006	.	.	0.676	G	.	4.524378	0.68204	.	D	-	.	.	0.99760	610	.	.	0.81689	0	139541126	Y	10	0	.	.	P00740	.	0.878352	0.99164		.	0.957	D	.	0.8911182	.	0.58703	2158	0.177508	.	-4.21	.	.	0.61594	.	.	.	.	.	.	0.93043	X	F9	.	0	Asp	11340	.	X-139541126-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138450951	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	.	.	.	RCV000011389	D	.	.	c.328G>A	.	.	.	0.71606	G/G	rs137852274	139541126	.	G	.	P00740	.	0.86805	.	0.68239		.	.	.	1.095	0	0	.	5.81	0.97407	142	D	T	.	.	0	24	.	.	.	98879	10643	0.71239	0.99059	0.991527616977692	2728	.	0.71675	.	.	.	.	5.823	.	D	.	.	.	0	306900	0.6903	X	.	ENSG00000101981	.	0	.	0	0.9787809428603149	1	0.69900	0.18019	.	.	.	.	.	YES	.	0.962922	25682	HGNC:3551	A	.	simple_aae	0.979	.	139541126	GAT	1.000000	.	-	0	0.99530	.	0	.	Pathogenic	0.55010	.	.	.	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	D	.	0.994855140868	-	0.925	-	0.65671	.	574	0.97859	0.632549464703	0.4071	.	0.99927164946011271	100	-	328G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.85963	137852274	.	0	0.99473	.	0.647	0.008	2644	0.99997795	5.81	.	.	.	0.0172016	0.991977909549927	0.27258	D	118	.	.	1.0226	0.99601	p.Asp110Asn	0	.	-7.125	0.99035263	.	0.89283	10643	T	.	F9	.	D	0.819	.	D110N	D	.	0.76753	G/G	principal1	157491	F9_Popp_2025_carboxy_gla_motif_var252028	No											D		328	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Asp110Asn		true	c.328G>A						3551.0	139541126.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Asp110Asn						N	Oct 09, 2017					missense_variant		110.0				0.9378215129456816		Pathogenic	139541126.0	missense_variant		0.819					Reporter			F9_Asp110Asn
F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Asn	23	139541126	G	A	X											X-139541126-G-A	-	0.71019	0.997	110	.	.	.	X	138623285	A	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Asn	.	25.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.94182	Select	0.9866	.	0.70687	.	.	D	D	.	2.87732945386	0	.	.	.	.	0.57442	.	.	.	.	0.75805	.	.	0.88509	0.981	.	3.0	0.962504	.	0.97	A	single nucleotide variant	NC_000023.11:g.139541126G>A	.	.	1	0.8738812	.	0	0.8451415	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.94269	D	L	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97576	.	.	-	139541126	.	-	11.714000	.	0.99252	.	0	.	.	germline	.	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.98733	GRCh38	924	no assertion criteria provided	c.328G>A	.	0.92402	0	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	A	0	.	NM_000133.4(F9):c.328G>A (p.Asp110Asn)		.	FA9_HUMAN	.	97.0	.	.	D	0.59925	0.8674805	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Asp110Asn	.	0.94708	.	germline	.		G	Oct 09, 2017	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031621	Pathogenic	.	.	Asn	N	-	.	ENSP00000218099	ENST00000218099	.	0.006	.	.	0.676	G	.	4.524378	0.68204	.	D	-	.	.	0.99760	610	.	.	0.81689	0	139541126	Y	10	0	.	.	P00740	.	0.878352	0.99164		.	0.957	D	.	0.8911182	.	0.58703	2158	0.177508	.	-4.21	.	.	0.61594	.	.	.	.	.	.	0.93043	X	F9	.	0	Asp	11340	.	X-139541126-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138450951	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	.	.	.	RCV000011389	D	.	.	c.328G>A	.	.	.	0.71606	G/G	rs137852274	139541126	.	G	.	P00740	.	0.86805	.	0.68239		.	.	.	1.095	0	0	.	5.81	0.97407	142	D	T	.	.	0	24	.	.	.	98879	10643	0.71239	0.99059	0.991527616977692	2728	.	0.71675	.	.	.	.	5.823	.	D	.	.	.	0	306900	0.6903	X	.	ENSG00000101981	.	0	.	0	0.9787809428603149	1	0.69900	0.18019	.	.	.	.	.	YES	.	0.962922	25682	HGNC:3551	A	.	simple_aae	0.979	.	139541126	GAT	1.000000	.	-	0	0.99530	.	0	.	Pathogenic	0.55010	.	.	.	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	D	.	0.994855140868	-	0.925	-	0.65671	.	574	0.97859	0.632549464703	0.4071	.	0.99927164946011271	100	-	328G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.85963	137852274	.	0	0.99473	.	0.647	0.008	2644	0.99997795	5.81	.	.	.	0.0172016	0.991977909549927	0.27258	D	118	.	.	1.0226	0.99601	p.Asp110Asn	0	.	-7.125	0.99035263	.	0.89283	10643	T	.	F9	.	D	0.819	.	D110N	D	.	0.76753	G/G	principal1	185007	F9_Popp_2025_heavy_chain_var232666	No											D		328	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Asp110Asn		true	c.328G>A						3551.0	139541126.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Asp110Asn						N	Oct 09, 2017					missense_variant		110.0				1.1413056500481331		Pathogenic	139541126.0	missense_variant		0.819					Reporter			F9_Asp110Asn
F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	NC_000023.11:139541126:G:A	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp110Asn	23	139541126	G	A	X											X-139541126-G-A	-	0.71019	0.997	110	.	.	.	X	138623285	A	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Asn	.	25.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.94182	Select	0.9866	.	0.70687	.	.	D	D	.	2.87732945386	0	.	.	.	.	0.57442	.	.	.	.	0.75805	.	.	0.88509	0.981	.	3.0	0.962504	.	0.97	A	single nucleotide variant	NC_000023.11:g.139541126G>A	.	.	1	0.8738812	.	0	0.8451415	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.94269	D	L	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97576	.	.	-	139541126	.	-	11.714000	.	0.99252	.	0	.	.	germline	.	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.98733	GRCh38	924	no assertion criteria provided	c.328G>A	.	0.92402	0	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	A	0	.	NM_000133.4(F9):c.328G>A (p.Asp110Asn)		.	FA9_HUMAN	.	97.0	.	.	D	0.59925	0.8674805	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Asp110Asn	.	0.94708	.	germline	.		G	Oct 09, 2017	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031621	Pathogenic	.	.	Asn	N	-	.	ENSP00000218099	ENST00000218099	.	0.006	.	.	0.676	G	.	4.524378	0.68204	.	D	-	.	.	0.99760	610	.	.	0.81689	0	139541126	Y	10	0	.	.	P00740	.	0.878352	0.99164		.	0.957	D	.	0.8911182	.	0.58703	2158	0.177508	.	-4.21	.	.	0.61594	.	.	.	.	.	.	0.93043	X	F9	.	0	Asp	11340	.	X-139541126-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138450951	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	.	.	.	RCV000011389	D	.	.	c.328G>A	.	.	.	0.71606	G/G	rs137852274	139541126	.	G	.	P00740	.	0.86805	.	0.68239		.	.	.	1.095	0	0	.	5.81	0.97407	142	D	T	.	.	0	24	.	.	.	98879	10643	0.71239	0.99059	0.991527616977692	2728	.	0.71675	.	.	.	.	5.823	.	D	.	.	.	0	306900	0.6903	X	.	ENSG00000101981	.	0	.	0	0.9787809428603149	1	0.69900	0.18019	.	.	.	.	.	YES	.	0.962922	25682	HGNC:3551	A	.	simple_aae	0.979	.	139541126	GAT	1.000000	.	-	0	0.99530	.	0	.	Pathogenic	0.55010	.	.	.	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	D	.	0.994855140868	-	0.925	-	0.65671	.	574	0.97859	0.632549464703	0.4071	.	0.99927164946011271	100	-	328G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.85963	137852274	.	0	0.99473	.	0.647	0.008	2644	0.99997795	5.81	.	.	.	0.0172016	0.991977909549927	0.27258	D	118	.	.	1.0226	0.99601	p.Asp110Asn	0	.	-7.125	0.99035263	.	0.89283	10643	T	.	F9	.	D	0.819	.	D110N	D	.	0.76753	G/G	principal1	212523	F9_Popp_2025_light_chain_var242347	No											D		328	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Asp110Asn		true	c.328G>A						3551.0	139541126.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Asp110Asn						N	Oct 09, 2017					missense_variant		110.0				1.0855410691429608		Pathogenic	139541126.0	missense_variant		0.819					Reporter			F9_Asp110Asn
F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004376		NC_000023.11:139541126:G:A		Asp110Asn																												F9_Asp110Asn	23	139541126	G	A	X	allele	328G>A	H06	527_CAVA_Array_P02	O12	B13A7A8P1_R1	B14A7A8P1_R2				X-139541126-G-A	-	0.71019	0.997	110	.	.	.	X	138623285	A	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Asn	.	25.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.94182	Select	0.9866	.	0.70687	.	.	D	D	.	2.87732945386	0	.	.	.	.	0.57442	.	.	.	.	0.75805	.	.	0.88509	0.981	.	3.0	0.962504	.	0.97	A	single nucleotide variant	NC_000023.11:g.139541126G>A	.	.	1	0.8738812	.	0	0.8451415	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.94269	D	L	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97576	.	.	-	139541126	.	-	11.714000	.	0.99252	.	0	.	.	germline	.	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.98733	GRCh38	924	no assertion criteria provided	c.328G>A	.	0.92402	0	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	A	0	.	NM_000133.4(F9):c.328G>A (p.Asp110Asn)		.	FA9_HUMAN	.	97.0	.	.	D	0.59925	0.8674805	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Asp110Asn	.	0.94708	.	germline	.		G	Oct 09, 2017	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031621	Pathogenic	.	.	Asn	N	-	.	ENSP00000218099	ENST00000218099	.	0.006	.	.	0.676	G	.	4.524378	0.68204	.	D	-	.	.	0.99760	610	.	.	0.81689	0	139541126	Y	10	0	.	.	P00740	.	0.878352	0.99164		.	0.957	D	.	0.8911182	.	0.58703	2158	0.177508	.	-4.21	.	.	0.61594	.	.	.	.	.	.	0.93043	X	F9	.	0	Asp	11340	.	X-139541126-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138450951	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	.	.	.	RCV000011389	D	.	.	c.328G>A	.	.	.	0.71606	G/G	rs137852274	139541126	.	G	.	P00740	.	0.86805	.	0.68239		.	.	.	1.095	0	0	.	5.81	0.97407	142	D	T	.	.	0	24	.	.	.	98879	10643	0.71239	0.99059	0.991527616977692	2728	.	0.71675	.	.	.	.	5.823	.	D	.	.	.	0	306900	0.6903	X	.	ENSG00000101981	.	0	.	0	0.9787809428603149	1	0.69900	0.18019	.	.	.	.	.	YES	.	0.962922	25682	HGNC:3551	A	.	simple_aae	0.979	.	139541126	GAT	1.000000	.	-	0	0.99530	.	0	.	Pathogenic	0.55010	.	.	.	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	D	.	0.994855140868	-	0.925	-	0.65671	.	574	0.97859	0.632549464703	0.4071	.	0.99927164946011271	100	-	328G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.85963	137852274	.	0	0.99473	.	0.647	0.008	2644	0.99997795	5.81	.	.	.	0.0172016	0.991977909549927	0.27258	D	118	.	.	1.0226	0.99601	p.Asp110Asn	0	.	-7.125	0.99035263	.	0.89283	10643	T	.	F9	.	D	0.819	.	D110N	D	.	0.76753	G/G	principal1	240039	F9_Popp_2025_strep_2_var261709	No											D		328	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Asp110Asn		true	c.328G>A						3551.0	139541126.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Asp110Asn						N	Oct 09, 2017					missense_variant		110.0				1.200178129328389		Pathogenic	139541126.0	missense_variant		0.819					Reporter			F9_Asp110Asn
F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004376		NC_000023.11:139541126:G:A		Asp110Asn																												F9_Asp110Asn	23	139541126	G	A	X	allele	328G>A	H06	527_CAVA_Array_P02	O12	B13A7A8P1_R1	B14A7A8P1_R2				X-139541126-G-A	-	0.71019	0.997	110	.	.	.	X	138623285	A	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Asn	.	25.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.94182	Select	0.9866	.	0.70687	.	.	D	D	.	2.87732945386	0	.	.	.	.	0.57442	.	.	.	.	0.75805	.	.	0.88509	0.981	.	3.0	0.962504	.	0.97	A	single nucleotide variant	NC_000023.11:g.139541126G>A	.	.	1	0.8738812	.	0	0.8451415	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.94269	D	L	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97576	.	.	-	139541126	.	-	11.714000	.	0.99252	.	0	.	.	germline	.	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.98733	GRCh38	924	no assertion criteria provided	c.328G>A	.	0.92402	0	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	A	0	.	NM_000133.4(F9):c.328G>A (p.Asp110Asn)		.	FA9_HUMAN	.	97.0	.	.	D	0.59925	0.8674805	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Asp110Asn	.	0.94708	.	germline	.		G	Oct 09, 2017	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031621	Pathogenic	.	.	Asn	N	-	.	ENSP00000218099	ENST00000218099	.	0.006	.	.	0.676	G	.	4.524378	0.68204	.	D	-	.	.	0.99760	610	.	.	0.81689	0	139541126	Y	10	0	.	.	P00740	.	0.878352	0.99164		.	0.957	D	.	0.8911182	.	0.58703	2158	0.177508	.	-4.21	.	.	0.61594	.	.	.	.	.	.	0.93043	X	F9	.	0	Asp	11340	.	X-139541126-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138450951	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	.	.	.	RCV000011389	D	.	.	c.328G>A	.	.	.	0.71606	G/G	rs137852274	139541126	.	G	.	P00740	.	0.86805	.	0.68239		.	.	.	1.095	0	0	.	5.81	0.97407	142	D	T	.	.	0	24	.	.	.	98879	10643	0.71239	0.99059	0.991527616977692	2728	.	0.71675	.	.	.	.	5.823	.	D	.	.	.	0	306900	0.6903	X	.	ENSG00000101981	.	0	.	0	0.9787809428603149	1	0.69900	0.18019	.	.	.	.	.	YES	.	0.962922	25682	HGNC:3551	A	.	simple_aae	0.979	.	139541126	GAT	1.000000	.	-	0	0.99530	.	0	.	Pathogenic	0.55010	.	.	.	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	D	.	0.994855140868	-	0.925	-	0.65671	.	574	0.97859	0.632549464703	0.4071	.	0.99927164946011271	100	-	328G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.85963	137852274	.	0	0.99473	.	0.647	0.008	2644	0.99997795	5.81	.	.	.	0.0172016	0.991977909549927	0.27258	D	118	.	.	1.0226	0.99601	p.Asp110Asn	0	.	-7.125	0.99035263	.	0.89283	10643	T	.	F9	.	D	0.819	.	D110N	D	.	0.76753	G/G	principal1	129975	F9_Popp_2025_carboxy_F9_specific_var222985	No											D		328	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Asp110Asn		true	c.328G>A						3551.0	139541126.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Asp110Asn						N	Oct 09, 2017					missense_variant		110.0				1.051387770684173		Pathogenic	139541126.0	missense_variant		0.819					Reporter			F9_Asp110Asn
F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004376		NC_000023.11:139541126:G:A		Asp110Asn																												F9_Asp110Asn	23	139541126	G	A	X	allele	328G>A	H06	527_CAVA_Array_P02	O12	B13A7A8P1_R1	B14A7A8P1_R2				X-139541126-G-A	-	0.71019	0.997	110	.	.	.	X	138623285	A	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Asn	.	25.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.94182	Select	0.9866	.	0.70687	.	.	D	D	.	2.87732945386	0	.	.	.	.	0.57442	.	.	.	.	0.75805	.	.	0.88509	0.981	.	3.0	0.962504	.	0.97	A	single nucleotide variant	NC_000023.11:g.139541126G>A	.	.	1	0.8738812	.	0	0.8451415	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.94269	D	L	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97576	.	.	-	139541126	.	-	11.714000	.	0.99252	.	0	.	.	germline	.	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.98733	GRCh38	924	no assertion criteria provided	c.328G>A	.	0.92402	0	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	A	0	.	NM_000133.4(F9):c.328G>A (p.Asp110Asn)		.	FA9_HUMAN	.	97.0	.	.	D	0.59925	0.8674805	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Asp110Asn	.	0.94708	.	germline	.		G	Oct 09, 2017	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031621	Pathogenic	.	.	Asn	N	-	.	ENSP00000218099	ENST00000218099	.	0.006	.	.	0.676	G	.	4.524378	0.68204	.	D	-	.	.	0.99760	610	.	.	0.81689	0	139541126	Y	10	0	.	.	P00740	.	0.878352	0.99164		.	0.957	D	.	0.8911182	.	0.58703	2158	0.177508	.	-4.21	.	.	0.61594	.	.	.	.	.	.	0.93043	X	F9	.	0	Asp	11340	.	X-139541126-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138450951	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	.	.	.	RCV000011389	D	.	.	c.328G>A	.	.	.	0.71606	G/G	rs137852274	139541126	.	G	.	P00740	.	0.86805	.	0.68239		.	.	.	1.095	0	0	.	5.81	0.97407	142	D	T	.	.	0	24	.	.	.	98879	10643	0.71239	0.99059	0.991527616977692	2728	.	0.71675	.	.	.	.	5.823	.	D	.	.	.	0	306900	0.6903	X	.	ENSG00000101981	.	0	.	0	0.9787809428603149	1	0.69900	0.18019	.	.	.	.	.	YES	.	0.962922	25682	HGNC:3551	A	.	simple_aae	0.979	.	139541126	GAT	1.000000	.	-	0	0.99530	.	0	.	Pathogenic	0.55010	.	.	.	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	D	.	0.994855140868	-	0.925	-	0.65671	.	574	0.97859	0.632549464703	0.4071	.	0.99927164946011271	100	-	328G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.85963	137852274	.	0	0.99473	.	0.647	0.008	2644	0.99997795	5.81	.	.	.	0.0172016	0.991977909549927	0.27258	D	118	.	.	1.0226	0.99601	p.Asp110Asn	0	.	-7.125	0.99035263	.	0.89283	10643	T	.	F9	.	D	0.819	.	D110N	D	.	0.76753	G/G	principal1	157491	F9_Popp_2025_carboxy_gla_motif_var252028	No											D		328	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Asp110Asn		true	c.328G>A						3551.0	139541126.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Asp110Asn						N	Oct 09, 2017					missense_variant		110.0				0.9378215129456816		Pathogenic	139541126.0	missense_variant		0.819					Reporter			F9_Asp110Asn
F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004376		NC_000023.11:139541126:G:A		Asp110Asn																												F9_Asp110Asn	23	139541126	G	A	X	allele	328G>A	H06	527_CAVA_Array_P02	O12	B13A7A8P1_R1	B14A7A8P1_R2				X-139541126-G-A	-	0.71019	0.997	110	.	.	.	X	138623285	A	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Asn	.	25.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.94182	Select	0.9866	.	0.70687	.	.	D	D	.	2.87732945386	0	.	.	.	.	0.57442	.	.	.	.	0.75805	.	.	0.88509	0.981	.	3.0	0.962504	.	0.97	A	single nucleotide variant	NC_000023.11:g.139541126G>A	.	.	1	0.8738812	.	0	0.8451415	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.94269	D	L	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97576	.	.	-	139541126	.	-	11.714000	.	0.99252	.	0	.	.	germline	.	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.98733	GRCh38	924	no assertion criteria provided	c.328G>A	.	0.92402	0	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	A	0	.	NM_000133.4(F9):c.328G>A (p.Asp110Asn)		.	FA9_HUMAN	.	97.0	.	.	D	0.59925	0.8674805	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Asp110Asn	.	0.94708	.	germline	.		G	Oct 09, 2017	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031621	Pathogenic	.	.	Asn	N	-	.	ENSP00000218099	ENST00000218099	.	0.006	.	.	0.676	G	.	4.524378	0.68204	.	D	-	.	.	0.99760	610	.	.	0.81689	0	139541126	Y	10	0	.	.	P00740	.	0.878352	0.99164		.	0.957	D	.	0.8911182	.	0.58703	2158	0.177508	.	-4.21	.	.	0.61594	.	.	.	.	.	.	0.93043	X	F9	.	0	Asp	11340	.	X-139541126-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138450951	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	.	.	.	RCV000011389	D	.	.	c.328G>A	.	.	.	0.71606	G/G	rs137852274	139541126	.	G	.	P00740	.	0.86805	.	0.68239		.	.	.	1.095	0	0	.	5.81	0.97407	142	D	T	.	.	0	24	.	.	.	98879	10643	0.71239	0.99059	0.991527616977692	2728	.	0.71675	.	.	.	.	5.823	.	D	.	.	.	0	306900	0.6903	X	.	ENSG00000101981	.	0	.	0	0.9787809428603149	1	0.69900	0.18019	.	.	.	.	.	YES	.	0.962922	25682	HGNC:3551	A	.	simple_aae	0.979	.	139541126	GAT	1.000000	.	-	0	0.99530	.	0	.	Pathogenic	0.55010	.	.	.	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	D	.	0.994855140868	-	0.925	-	0.65671	.	574	0.97859	0.632549464703	0.4071	.	0.99927164946011271	100	-	328G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.85963	137852274	.	0	0.99473	.	0.647	0.008	2644	0.99997795	5.81	.	.	.	0.0172016	0.991977909549927	0.27258	D	118	.	.	1.0226	0.99601	p.Asp110Asn	0	.	-7.125	0.99035263	.	0.89283	10643	T	.	F9	.	D	0.819	.	D110N	D	.	0.76753	G/G	principal1	185007	F9_Popp_2025_heavy_chain_var232666	No											D		328	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Asp110Asn		true	c.328G>A						3551.0	139541126.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Asp110Asn						N	Oct 09, 2017					missense_variant		110.0				1.1413056500481331		Pathogenic	139541126.0	missense_variant		0.819					Reporter			F9_Asp110Asn
F9_Asp110Asn	1.7930019133298674	0.11606692398250139	1.7599540493123675	0.12181047156624328	2025_01_Batch_13-14	0.8826315476452683	0.7436241295810764	0.7550144892876768	0.87815365726247	0.7278939020798749	0.6345242978723558	0.6972658323460702	0.6603216126081026	0.7560306095986086	0.5742916237205904	0.7585779227588121	0.7204449809635733	0.7076680509478896	0.8170921334305392	0.6510927629002327	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004376		NC_000023.11:139541126:G:A		Asp110Asn																												F9_Asp110Asn	23	139541126	G	A	X	allele	328G>A	H06	527_CAVA_Array_P02	O12	B13A7A8P1_R1	B14A7A8P1_R2				X-139541126-G-A	-	0.71019	0.997	110	.	.	.	X	138623285	A	.	.	X	1_Pathogenic	NC_000023.11	.	Asp110Asn	.	25.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.94182	Select	0.9866	.	0.70687	.	.	D	D	.	2.87732945386	0	.	.	.	.	0.57442	.	.	.	.	0.75805	.	.	0.88509	0.981	.	3.0	0.962504	.	0.97	A	single nucleotide variant	NC_000023.11:g.139541126G>A	.	.	1	0.8738812	.	0	0.8451415	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.96253	D	0.94269	D	L	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97576	.	.	-	139541126	.	-	11.714000	.	0.99252	.	0	.	.	germline	.	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.98733	GRCh38	924	no assertion criteria provided	c.328G>A	.	0.92402	0	.	.	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	.	.	A	0	.	NM_000133.4(F9):c.328G>A (p.Asp110Asn)		.	FA9_HUMAN	.	97.0	.	.	D	0.59925	0.8674805	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Asp110Asn	.	0.94708	.	germline	.		G	Oct 09, 2017	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031621	Pathogenic	.	.	Asn	N	-	.	ENSP00000218099	ENST00000218099	.	0.006	.	.	0.676	G	.	4.524378	0.68204	.	D	-	.	.	0.99760	610	.	.	0.81689	0	139541126	Y	10	0	.	.	P00740	.	0.878352	0.99164		.	0.957	D	.	0.8911182	.	0.58703	2158	0.177508	.	-4.21	.	.	0.61594	.	.	.	.	.	.	0.93043	X	F9	.	0	Asp	11340	.	X-139541126-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138450951	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	.	.	.	RCV000011389	D	.	.	c.328G>A	.	.	.	0.71606	G/G	rs137852274	139541126	.	G	.	P00740	.	0.86805	.	0.68239		.	.	.	1.095	0	0	.	5.81	0.97407	142	D	T	.	.	0	24	.	.	.	98879	10643	0.71239	0.99059	0.991527616977692	2728	.	0.71675	.	.	.	.	5.823	.	D	.	.	.	0	306900	0.6903	X	.	ENSG00000101981	.	0	.	0	0.9787809428603149	1	0.69900	0.18019	.	.	.	.	.	YES	.	0.962922	25682	HGNC:3551	A	.	simple_aae	0.979	.	139541126	GAT	1.000000	.	-	0	0.99530	.	0	.	Pathogenic	0.55010	.	.	.	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	D	.	0.994855140868	-	0.925	-	0.65671	.	574	0.97859	0.632549464703	0.4071	.	0.99927164946011271	100	-	328G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.85963	137852274	.	0	0.99473	.	0.647	0.008	2644	0.99997795	5.81	.	.	.	0.0172016	0.991977909549927	0.27258	D	118	.	.	1.0226	0.99601	p.Asp110Asn	0	.	-7.125	0.99035263	.	0.89283	10643	T	.	F9	.	D	0.819	.	D110N	D	.	0.76753	G/G	principal1	212523	F9_Popp_2025_light_chain_var242347	No											D		328	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Asp110Asn		true	c.328G>A						3551.0	139541126.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Asp110Asn						N	Oct 09, 2017					missense_variant		110.0				1.0855410691429608		Pathogenic	139541126.0	missense_variant		0.819					Reporter			F9_Asp110Asn
BAP1_Cys91Ser	0.5371858858067884	0.607783622798212	-2.6931062589231534	0.0309462574441354	2025_01_Batch_13-14	0.9333529871701809	0.7779180969243228	0.6547280169440957	0.7990596626902846	0.8911419451288887	0.6541532321800272	0.6325873153894371	0.6412806151140473	0.6604418906797691	0.6497839077167271	0.793753109675104	0.70525270615688	0.6480043160290715	0.7297507766850269	0.7704629264228079	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009484		NC_000003.12:52408061:C:G		Cys91Ser																												BAP1_Cys91Ser	3	52408061	C	G	3	allele	272G>C	B02	527_CAVA_Array_P01	C03	B13A7A8P1_R1	B14A7A8P1_R2				3-52408061-C-G	-	0.86714	1.0	91	.	.	.	3	52442077	G	.	.	3	1_Pathogenic	NC_000003.12	.	Cys91Ser	.	29.0	.	.	.	D	.	2	1	.	.	.	.	.	.	0.99434	Select	0.9489	.	0.90580	.	.	D	D	.	2.72839044085	.	.	.	.	.	0.91757	.	.	.	.	0.98771	.	.	0.95709	0.998	.	.	0.998731	.	.	G	single nucleotide variant	NC_000003.12:g.52408061C>G	.	.	2	0.93077695	.	.	0.94517225	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900	.	.	.	.	.	D	0.97107	D	H	14.66464	.	C/C	.	.	.	.	Neurodevelopmental disorder|not provided	.	0.99480	.	.	-	52408061	.	-	7.613000	.	0.92884	.	.	.	.	de novo;germline	.	Gain of disorder (P = 0.0084)| Loss of stability (P = 0.0799)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2045)| Loss of catalytic residue at T93 (P = 0.2182)	0.97974	GRCh38	68	criteria provided, single submitter	c.272G>C	.	0.80997	.	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	.	.	P	.	.	NM_004656.4(BAP1):c.272G>C (p.Cys91Ser)	1	.	BAP1_HUMAN	.	.	1.0231602614017	.	D	0.98761	0.94517225	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.99864	.	.	.	.	.	p.Cys91Ser	.	0.62049	.	germline	.		C	Apr 06, 2024	.	C/C	.	.	1.0	N	3p21.1	.	.	.	SCV005373284	Pathogenic	.	.	Ser	S	-	.	ENSP00000417132	ENST00000460680	.	0.002	.	.	0.599	C	.	5.171826	0.92967	D	D	-	15.33076	.	0.96431	.	.	.	0.99873	.	52408061	Y	10	.	.	.	Q92560	.	0.614019	0.63503		.	1.0	D	.	0.93077695	.	0.85369	8314	0.541235	.	-9.46	.	.	0.72322	.	.	.	.	.	.	0.97108	3	BAP1	.	.	Cys	.	.	3-52408061-C-G	Neurodevelopmental_disorder	.	.	52417117	.	0.954506	0.96393	.	RCV001797187|RCV004762154	D	.	.	c.272G>C	.	.	.	0.95439	C/C	rs1559591264	52408061	.	C	.	Q92560	.	0.95709	.	0.68239		.	.	.	4.145	.	.	.	5.49	0.87693	.	D	D	.	.	.	.	.	.	.	.	1173081	0.95371	0.98645	0.999951362609863	.	.	0.71675	0.97155	.	.	.	7.657	.	D	.	.	.	.	.	0.82777	3	.	ENSG00000163930	.	.	.	.	0.9595328650281908	2	0.97365	0.97129	.	.	.	.	0.934896275402238	YES	.	0.596811	1162263	HGNC:950	.	.	.	0.869	.	52408061	TGT	1.000000	.	-	.	0.99064	.	.	.	Pathogenic	0.85551	.	.	.	ClinGen:CA353112607	C	.	0.955221855794	-	0.905	-	0.96431	.	.	0.95915	0.864477872849	0.9993	.	0.99414808621726736	.	-	272G>C 	.	.	C1535926	.	.	.	.	NM_004656.4	-	.	.	1	0.99346	1559591264	.	.	0.95437	0.96904	0.955	0.0	.	0.99989426	5.49	.	.	.	0.53967	0.999965302743864	0.97505	D	.	.	.	1.0958	0.98331	p.Cys91Ser	.	.	-12.137	0.9872064	.	0.99297	1173081	D	.	BAP1	.	D	0.962	.	C91S	D	.	0.40292	C/C	principal1																																																																																																				
BAP1_Leu49Pro	1.5336173628501408	0.16899235826402517	-3.5941090630658135	0.008808725066084462	2025_01_Batch_13-14	0.6714650514021713	0.7249915388752513	0.7211160899220241	0.7357994038965971	0.6612148620052707	0.5927178557285544	0.6573221090769205	0.7233256814860385	0.7226002686637022	0.5611411472899007	0.6320914535653628	0.6911568239760859	0.7222208857040313	0.7291998362801497	0.6111780046475856	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009492		NC_000003.12:52408583:A:G		Leu49Pro																												BAP1_Leu49Pro	3	52408583	A	G	3	allele	146T>C	D02	527_CAVA_Array_P01	G03	B13A7A8P1_R1	B14A7A8P1_R2				3-52408583-A-G	-	0.92502	1.0	49	.	.	.	3	52442599	G	.	.	3	1_Pathogenic	NC_000003.12	.	Leu49Pro	.	32.0	.	.	.	D	.	2	1	.	.	.	.	.	.	0.94600	Select	0.5835	.	0.90580	.	.	D	D	.	3.28525368344	.	.	.	.	.	0.98162	.	.	.	.	0.91806	.	.	0.99618	0.995	.	.	0.998712	3.34	.	G	single nucleotide variant	NC_000003.12:g.52408583A>G	.	.	2	0.97671837	.	.	0.98750603	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MedGen:C3661900	.	.	.	.	.	D	0.99717	D	H	14.6051	.	A/A	.	.	.	.	Neurodevelopmental disorder|not provided	.	0.90127	.	.	-	52408583	.	-	9.358000	.	0.99252	.	.	.	.	de novo;germline	.	Loss of stability (P = 0.0111)| Gain of sheet (P = 0.0477)| Loss of MoRF binding (P = 0.0633)| Gain of disorder (P = 0.1336)| Gain of glycosylation at Y44 (P = 0.1882)	0.98220	GRCh38	68	criteria provided, single submitter	c.146T>C	.	0.78977	.	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	.	.	P	.	.	NM_004656.4(BAP1):c.146T>C (p.Leu49Pro)	1	.	BAP1_HUMAN	.	.	1.02132438138349	.	D	0.99584	0.98750603	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99778	.	.	.	.	.	p.Leu49Pro	.	0.80383	.	germline	.		A	Sep 28, 2022	.	A/A	.	.	1.0	N	3p21.1	.	.	.	SCV003915265	Likely_pathogenic	.	.	Pro	P	-	.	ENSP00000417132	ENST00000460680	.	0.0	.	.	0.756	A	.	5.605936	0.92967	D	D	-	15.15042	.	0.94573	.	.	.	0.99358	.	52408583	Y	10	.	.	.	Q92560	.	0.61312	0.97276		.	1.0	D	.	0.97671837	.	0.73271	8314	0.399268	.	-6.34	.	.	0.91343	.	.	.	.	.	.	0.99718	3	BAP1	.	.	Leu	.	.	3-52408583-A-G	Neurodevelopmental_disorder|not_provided	.	.	52417639	.	0.961659	0.96342	.	RCV001797185|RCV003161062	D	.	.	c.146T>C	.	.	.	0.89798	A/A	rs2153228340	52408583	.	A	.	Q92560	.	0.99618	.	0.68239		.	.	.	4.14	.	.	.	5.43	0.87653	.	D	D	.	.	.	.	.	.	.	.	1173079	0.89671	0.99563	0.999857425689697	.	.	0.71675	0.98292	.	.	.	9.279	.	D	.	.	.	.	.	0.94993	3	.	ENSG00000163930	.	.	.	.	0.9942708640742988	2	0.97365	0.97129	.	.	.	.	0.93110546969636	YES	.	0.465198	1162266	HGNC:950	.	.	.	0.979	.	52408583	CTG	1.000000	.	-	.	0.97974	.	.	.	Likely pathogenic	0.99425	.	.	.	ClinGen:CA353113658	L	.	0.919171306595	-	0.911	-	0.97441	.	.	0.99423	0.917951464653	0.9998	.	0.99900871002661273	.	-	146T>C 	.	.	C1535926|C3661900	.	.	.	.	NM_004656.4	-	.	.	1	0.99310	2153228340	.	.	0.91774	0.96774	0.964	0.0	.	0.99983054	5.43	.	.	.	0.335745	0.999944798679913	0.97479	D	.	.	.	0.4731	0.84984	p.Leu49Pro	.	.	-17.779	0.9803013	.	0.99079	1173079	D	.	BAP1	.	D	0.830	.	L49P	D	0.60572	0.943	A/A	principal1																																																																																																				
RAD51D_Val132Ile	1.1951833385138684	0.270931637294705	11.407170550504395	8.926785329176513e-6	2025_01_Batch_13-14	0.852293666669155	0.8857411452603304	0.958227488959117	0.9427350272896435	0.8044850193577774	0.8188471165112827	0.9182389071091395	0.9688289215325073	0.9283992779700836	0.7214189944707794	0.8355703915902188	0.9019900261847349	0.9635282052458122	0.9355671526298636	0.7629520069142783	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024822		NC_000017.11:35107074:C:T		Val132Ile																												RAD51D_Val132Ile	17	35107074	C	T	17	allele	394G>A	C01	527_CAVA_Array_P05	E01	B13A7A8P2_R1	B14A7A8P2_R2				17-35107074-C-T	-	0.17693	0.424	132	4	0	0	17	33434093	T	4.460840e-05	3	17	3_Conflicting	NC_000017.11	3	Val132Ile	0	13.3	0	1	2.684200e-04	T	0	15	5	42768	6.331200e-05	1	30526	0.000000e+00	0	0.52699	.	0.3597	14902	0.35468	5	0.0	T	T	64012	.	1.0656436487638534E-4	0	0.000000e+00	0	0	.	17112	44860	2	0.000000e+00	0.22672	0	.	0.18299	0.696	7.564296520423601E-4	95.0	0.738826	0.89	0.05	T	single nucleotide variant	NC_000017.11:g.35107074C>T	0	16728	2	0.09804036	109402	0	0.08056444	0		14	236922	0	0	0.000000e+00	796	0.000000e+00	0	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	6	1	0.000000e+00	0	0.18971	B	0.23318	B	M	0.9608728	72	C/C	360	0	7164	1614046	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	16218	0.72168	1	.	-	35107074	2.791740e-04	-	-0.207000	5	0.32993	29606	0	6060	0	germline;unknown	91086	.	.	GRCh38	921	criteria provided, conflicting classifications	c.394G>A	0.000000e+00	0.30590	13	0	0	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	5.978000e-05	9046	B	0	0.000000e+00	NM_002878.4(RAD51D):c.394G>A (p.Val132Ile)	1	0	RA51D_HUMAN	0	5.0	-0.614819935582183	4	T	0.17936	0.08056444	-	2.791740e-04	0		5	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.84609	5.484360e-05	0	7.469380e-05	0	60010	p.Val132Ile	0	0.10935	.	germline	2		C	Jan 19, 2025	0	C/C	0	89554	0.942	N	17q12	179916	.	3.082990e-04	SCV000215203|SCV000292678|SCV000551340|SCV000698100|SCV000784995|SCV000822177|SCV000886447|SCV000910748|SCV001470090|SCV002534813|SCV004017742|SCV004208066|SCV005374642	Conflicting_classifications_of_pathogenicity	1	0	Ile	I	-	912	ENSP00000378090	ENST00000394589	17692	.	13416	0	-0.939	C	0	1.358257	0.53076	N	D	-	0.9379878	.	0.71066	968	0	0.0	0.09324	0	35107074	Y	10	0	102724	4.950500e-04	O75771	0	0.15308	0.10230		0	0.382	D	16218	0.09804036	7164	0.34057	5892	-0.122049	42	.	0.0	4.950500e-04	0.44188	0.000000e+00	0	74988	0.000000e+00	6060	2	0.23318	17	RAD51D	1.066840e-04	0	Val	210506	4.466580e-05	17-35107074-C-T	not_provided|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	5	30458206	ClinGen:CA191240	0.067676	0.18271	0	RCV000458927|RCV000164547|RCV000588322|RCV004764772|RCV001356158	T	0	0	c.394G>A	0	4	1	0.32431	C/C	rs201141245	35107074	14902	C	3.9936102236421724E-4	.	15690	0.18299	4.624060e-05	0.08389		0	0	8.916630e-05	2.62	0	12	264690	2.66	0.49109	3394	T	.	4	1.310440e-04	0	682	.	0	1	140162|145	185178	0.62576	0.25574	0.0757847073892739	9744	2	0.32811	0.13137	1.459430e-04	3.082990e-04	1180002	1.984	6.726690e-05	.	13388	0	1.1334013E-4	0	614291	0.40383	17	2.684200e-04	ENSG00000185379	1.562210e-05	6.669779230307477E-5	0	0	.	1	0.43907	0.19236	30608	30	4.867410e-05	1.166470e-04	-0.673516161556329	.	2.195730e-05	0.071049	184833	HGNC:9823	N	0	simple_aae	0.122	208126	35107074	GTC	0.000000	0	-	1.0262725779967159E-4	0.20146	3.559320e-05	1	0	Conflicting classifications of pathogenicity	0.58592	0	3	7	ClinGen:CA191240	V	0	0.62430428174	-	.	-	0.24096	15	15410	0.37837	.	0.1016	0	0.72709087620192148	278	-	394G>A 	4	0	C3661900|C0027672|C0006142|C3280345	0	0	0	0	NM_002878.4	-	0	0.001440922190201729	0	0.35767	201141245	2320	6.175595945008693E-5	0.61834	0.17340	0.216	0.039	9384	0.62951803	4.65	.	.	0.000000e+00	-0.107115	0.000961144535626309	0.76477	T	2712	6212	9572	-0.3916	0.72046	p.Val132Ile	0	0	-7.63	0.109271616	8	0.09382	185178	D	30524	RAD51D	1.753160e-04	T	0.229	21626	.	.	0.28255	0.02107	C/C	principal1	961266	RAD51D_unpublished_var155513	Yes						overall function		Cell survival			V		394	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Val132Ile		true	c.394G>A						9823.0	35107074.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		A									criteria provided, conflicting classifications				Val132Ile						I	May 13, 2024					missense_variant		132.0	G		0.0000446083940606	0.00161802		Conflicting classifications of pathogenicity	35107074.0	missense_variant		0.229	functionally_normal				Cell viability			RAD51D_Val132Ile
RAD51D_Val132Ile	1.1951833385138684	0.270931637294705	11.407170550504395	8.926785329176513e-6	2025_01_Batch_13-14	0.852293666669155	0.8857411452603304	0.958227488959117	0.9427350272896435	0.8044850193577774	0.8188471165112827	0.9182389071091395	0.9688289215325073	0.9283992779700836	0.7214189944707794	0.8355703915902188	0.9019900261847349	0.9635282052458122	0.9355671526298636	0.7629520069142783	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024822	ALE00029930	NC_000017.11:35107074:C:T	394G>A	Val132Ile	CAVA																											RAD51D_Val132Ile	17	35107074	C	T	17								1	1	1	17-35107074-C-T	-	0.17693	0.424	132	4	0	0	17	33434093	T	4.460840e-05	3	17	3_Conflicting	NC_000017.11	3	Val132Ile	0	13.3	0	1	2.684200e-04	T	0	15	5	42768	6.331200e-05	1	30526	0.000000e+00	0	0.52699	.	0.3597	14902	0.35468	5	0.0	T	T	64012	.	1.0656436487638534E-4	0	0.000000e+00	0	0	.	17112	44860	2	0.000000e+00	0.22672	0	.	0.18299	0.696	7.564296520423601E-4	95.0	0.738826	0.89	0.05	T	single nucleotide variant	NC_000017.11:g.35107074C>T	0	16728	2	0.09804036	109402	0	0.08056444	0		14	236922	0	0	0.000000e+00	796	0.000000e+00	0	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142	6	1	0.000000e+00	0	0.18971	B	0.23318	B	M	0.9608728	72	C/C	360	0	7164	1614046	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast	16218	0.72168	1	.	-	35107074	2.791740e-04	-	-0.207000	5	0.32993	29606	0	6060	0	germline;unknown	91086	.	.	GRCh38	921	criteria provided, conflicting classifications	c.394G>A	0.000000e+00	0.30590	13	0	0	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	5.978000e-05	9046	B	0	0.000000e+00	NM_002878.4(RAD51D):c.394G>A (p.Val132Ile)	1	0	RA51D_HUMAN	0	5.0	-0.614819935582183	4	T	0.17936	0.08056444	-	2.791740e-04	0		5	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.84609	5.484360e-05	0	7.469380e-05	0	60010	p.Val132Ile	0	0.10935	.	germline	2		C	Jan 19, 2025	0	C/C	0	89554	0.942	N	17q12	179916	.	3.082990e-04	SCV000215203|SCV000292678|SCV000551340|SCV000698100|SCV000784995|SCV000822177|SCV000886447|SCV000910748|SCV001470090|SCV002534813|SCV004017742|SCV004208066|SCV005374642	Conflicting_classifications_of_pathogenicity	1	0	Ile	I	-	912	ENSP00000378090	ENST00000394589	17692	.	13416	0	-0.939	C	0	1.358257	0.53076	N	D	-	0.9379878	.	0.71066	968	0	0.0	0.09324	0	35107074	Y	10	0	102724	4.950500e-04	O75771	0	0.15308	0.10230		0	0.382	D	16218	0.09804036	7164	0.34057	5892	-0.122049	42	.	0.0	4.950500e-04	0.44188	0.000000e+00	0	74988	0.000000e+00	6060	2	0.23318	17	RAD51D	1.066840e-04	0	Val	210506	4.466580e-05	17-35107074-C-T	not_provided|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	5	30458206	ClinGen:CA191240	0.067676	0.18271	0	RCV000458927|RCV000164547|RCV000588322|RCV004764772|RCV001356158	T	0	0	c.394G>A	0	4	1	0.32431	C/C	rs201141245	35107074	14902	C	3.9936102236421724E-4	.	15690	0.18299	4.624060e-05	0.08389		0	0	8.916630e-05	2.62	0	12	264690	2.66	0.49109	3394	T	.	4	1.310440e-04	0	682	.	0	1	140162|145	185178	0.62576	0.25574	0.0757847073892739	9744	2	0.32811	0.13137	1.459430e-04	3.082990e-04	1180002	1.984	6.726690e-05	.	13388	0	1.1334013E-4	0	614291	0.40383	17	2.684200e-04	ENSG00000185379	1.562210e-05	6.669779230307477E-5	0	0	.	1	0.43907	0.19236	30608	30	4.867410e-05	1.166470e-04	-0.673516161556329	.	2.195730e-05	0.071049	184833	HGNC:9823	N	0	simple_aae	0.122	208126	35107074	GTC	0.000000	0	-	1.0262725779967159E-4	0.20146	3.559320e-05	1	0	Conflicting classifications of pathogenicity	0.58592	0	3	7	ClinGen:CA191240	V	0	0.62430428174	-	.	-	0.24096	15	15410	0.37837	.	0.1016	0	0.72709087620192148	278	-	394G>A 	4	0	C3661900|C0027672|C0006142|C3280345	0	0	0	0	NM_002878.4	-	0	0.001440922190201729	0	0.35767	201141245	2320	6.175595945008693E-5	0.61834	0.17340	0.216	0.039	9384	0.62951803	4.65	.	.	0.000000e+00	-0.107115	0.000961144535626309	0.76477	T	2712	6212	9572	-0.3916	0.72046	p.Val132Ile	0	0	-7.63	0.109271616	8	0.09382	185178	D	30524	RAD51D	1.753160e-04	T	0.229	21626	.	.	0.28255	0.02107	C/C	principal1	961266	RAD51D_unpublished_var155513	Yes						overall function		Cell survival			V		394	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Val132Ile		true	c.394G>A						9823.0	35107074.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		A									criteria provided, conflicting classifications				Val132Ile						I	May 13, 2024					missense_variant		132.0	G		0.0000446083940606	0.00161802		Conflicting classifications of pathogenicity	35107074.0	missense_variant		0.229	functionally_normal				Cell viability			RAD51D_Val132Ile
CTCF_Asp46Asn	-2.5556236375766055	0.04316233733910241	2.5264609447668644	0.039436363219745474	2025_01_Batch_13-14	0.8442630357834994	0.772836679383644	0.660723892135822	0.7164137896266487	0.8403217673680176	0.7477452984927581	0.7602714305498538	0.5915511730925458	0.6534449308500725	0.6714216910221661	0.7960041671381287	0.7665540549667489	0.6261375326141839	0.6849293602383606	0.7558717291950918	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF		6173		CCSBVarC010823		NC_000016.10:67610968:G:A		Asp46Asn																												CTCF_Asp46Asn	16	67610968	G	A	16	allele	136G>A	B02	527_CAVA_Array_P02	C04	B13A7A8P1_R1	B14A7A8P1_R2				16-67610968-G-A	-	0.60464	0.18	46	.	0	.	16	67644871	A	6.266630e-07	.	16	2_Benign	NC_000016.10	1	Asp46Asn	.	24.2	.	.	.	T	0	1	.	.	.	.	.	.	.	0.29456	.	0.0244	.	0.29064	.	.	T	T	63822	.	.	0	.	.	.	0.43488	.	44342	0	.	0.17556	.	.	0.32709	0.946	.	.	.	.	.	A	single nucleotide variant	NC_000016.10:g.67610968G>A	0	.	2	0.14724985	.	.	0.14355613	.		.	.	.	.	.	.	.	.	Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	.	.	0.000000e+00	0	0.23785	B	0.34752	B	L	3.18842	1	G/G	.	.	.	1595754	Intellectual disability	.	0.17573	.	.	-	67610968	.	-	11.831000	.	0.59995	29152	.	1165574	.	inherited	90282	Gain of loop (P = 0.069)| Loss of helix (P = 0.079)| Loss of catalytic residue at G48 (P = 0.1983)| Loss of sheet (P = 0.302)| Gain of MoRF binding (P = 0.4494)	0.14439	GRCh38	55	no assertion criteria provided	c.136G>A	.	0.71389	.	.	.	.	.	.	LB	.	0.000000e+00	NM_006565.4(CTCF):c.136G>A (p.Asp46Asn)		.	CTCF_HUMAN	.	.	0.173584497680614	.	.	0.24667	0.14355613	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.78355	.	0	.	.	59396	p.Asp46Asn	0	0.97527	.	germline	.		G	Jan 01, 2019	.	G/G	.	.	1.0	N	16q22.1	.	.	.	SCV001427963	Likely_benign	.	.	Asn	N	-	912	ENSP00000494408	ENST00000642819	.	.	.	.	0.676	G	.	4.066878	0.24550	D	.	-	4.110524	.	0.21016	.	.	.	0.40980	.	67610968	Y	10	.	.	0.000000e+00	P49711	.	0.37863	0.87230		.	0.057	T	.	0.14724985	.	0.49004	10664	-0.237905	1	.	.	8.579460e-07	0.68399	.	.	74694	.	5992	.	0.34751	16	CTCF	0.000000e+00	.	Asp	.	.	16-67610968-G-A	Intellectual_disability	0	.	66202372	.	0.903411	0.49687	0	RCV001252212	D	0	.	c.136G>A	.	0	0	0.15337	G/G	rs2052054114	67610968	.	G	.	P49711	.	0.32709	.	0.68239		.	.	0.000000e+00	1.1	.	.	.	5.19	0.73981	.	D	T	.	.	.	.	.	.	.	.	975529	0.14308	0.47360	0.711651020290767	.	.	0.71675	0.85191	.	.	1165574	8.296	.	.	.	.	.	.	.	0.89889	16	.	ENSG00000102974	0.000000e+00	.	.	.	.	1	0.26282	0.97558	.	.	.	0.000000e+00	0.363672439989046	.	0.000000e+00	0.008032	963811	HGNC:13723	.	.	.	0.338	.	67610968	GAT	1.000000	.	-	.	0.43135	8.579460e-07	.	0	Likely benign	0.34161	.	0	0	ClinGen:CA396302067	D	.	.	-	0.222	-	0.34213	.	.	0.33770	0.533664166927	0.1119	0	0.9978644389905249	.	-	136G>A 	.	.	C3714756	.	.	.	.	NM_006565.4	-	.	.	0	0.78261	2052054114	.	.	0.54510	0.59120	.	.	.	0.35239035	5.19	.	.	.	-0.579511	0.911406707488065	0.27864	T	.	.	.	-1.0391	0.10333	p.Asp46Asn	.	0	-4.76	0.26070982	0	0.76873	975529	T	.	CTCF	.	T	.	.	D46N	.	.	0.76753	G/G	principal4																																																																																																				
BRCA1_Met671Lys	2.267013845164269	0.05773114204962296	0.8349415031917329	0.43132063358320427	2025_01_Batch_13-14	0.9704484609385355	0.9116781681071608	0.9469280859184088	0.9403527782700145	0.9102883342188165	0.9505938449333811	0.8635539212999332	0.8959331127479064	0.9408515549566256	0.7977029247017272	0.9605211529359583	0.887616044703547	0.9214305993331576	0.9406021666133201	0.8539956294602719	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011871		NC_000017.11:43051071:A:T		Met671Lys																												BRCA1_Met671Lys	17	43051071	A	T	17	allele	2012T>A	B10	527_CAVA_Array_P01	C19	B13A7A8P1_R1	B14A7A8P1_R2				17-43051071-A-T	-	0.54208	0.99	1775	.	.	.	17	41203088	T	.	.	17	1_Pathogenic	NC_000017.11	.	Met1775Lys	.	23.4	.	.	.	D	.	10	1	.	.	.	.	.	.	0.90683	Select	0.7837	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.47621	.	.	.	.	0.77340	.	.	0.97787	0.997	.	5.0	.	.	0.95	T	single nucleotide variant	NC_000017.11:g.43051071A>T	.	.	3	0.735878	.	.	0.9531011	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	.	.	0.99291	P	0.88742	D	M	7.028289	.	A/A	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	.	0.93053	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43051071	.	-	11.142000	.	0.98136	.	.	.	.	germline;not applicable	.	.	.	GRCh38	449	reviewed by expert panel	c.5324T>A	.	0.71966	.	.	.	.	.	.	P	.	.	NM_007294.4(BRCA1):c.5324T>A (p.Met1775Lys)	3	.	BRCA1_HUMAN	.	95.0	0.693440170392724	.	.	0.86232	0.9654434	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99879	.	.	.	.	.	p.Met1775Lys	.	0.87118	.	germline	.		A	Aug 10, 2015	.	A/A	.	.	1.0	N	17q21.31	.	.	.	SCV000244397	Pathogenic	.	.	Lys	K	-	.	ENSP00000350283	ENST00000357654	.	0.0	.	.	0.756	A	.	3.769401	0.92967	D	D	-	7.165023	.	0.98472	.	.	.	0.81018	.	43051071	Y	10	.	.	.	P38398	.	0.234774	0.43068		.	0.798	D	.	0.80974793	.	0.79771	672	0.436191	.	-1.1	.	.	0.91343	.	.	.	.	.	.	0.84203	17	BRCA1	.	.	Met	.	.	17-43051071-A-T	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome	.	.	38456614	BRCA1-HCI:BRCA1_00110|ClinGen:CA003476|OMIM:113705.0036|UniProtKB:P38398#VAR_063212	0.719653	0.79088	.	RCV000019265|RCV000496817|RCV001526335	D	.	.	c.5324T>A	.	.	.	0.91778	A/A	rs41293463	43051071	.	A	.	.	.	0.96527	.	0.68239		.	.	.	2.33	.	.	.	5.21	0.59973	.	D	T	.	.	.	.	.	.	.	145|140162|145	17695	0.91677	0.52277	0.990923941135406	.	.	0.71675	0.66927	.	.	.	5.026	.	N	.	.	.	.	604370	0.63961	17	.	ENSG00000012048	.	.	.	.	.	2	0.86259	0.79449	.	.	.	.	0.666244745644706	YES	.	0.804846	32734	HGNC:1100	A	.	simple_aae	0.957	.	43051071	ATG	1.000000	.	-	.	0.89121	.	.	.	Pathogenic	0.89812	.	.	.	BRCA1-HCI:BRCA1_00110,ClinGen:CA003476,UniProtKB:P38398#VAR_063212,OMIM:113705.0036	M	.	0.963482532597	-	.	-	0.98669	.	.	0.86847	0.562978863716	0.8787	.	0.98558459070339721	.	-	5324T>A 	.	.	C2676676|C0027672|C0677776	.	.	.	.	NM_007294.4	-	.	.	1	0.83947	41293463	.	.	0.96276	0.79713	0.878	0.0	.	0.99989700	5.21	.	.	.	0.388781	0.996656271029341	0.66629	D	.	.	.	0.6922	0.92637	p.Met1775Lys	.	.	-12.423	0.8988125	.	0.92339	17695	D	.	BRCA1	.	D	0.734	.	.	D	.	0.943	A/A	principal2																																																																																																				
RET_Arg330Gln	-1.7958396916116608	0.11558602092288398	12.792825715139873	4.1342425315877565e-6	2025_01_Batch_13-14	0.9939309951224155	0.9707838684532181	0.9702720270096226	0.9826078401369326	0.9759573065456218	0.8106779897676171	0.9131511378755663	0.9477362189792289	0.8397761269106413	0.7493257015759742	0.9023044924450163	0.9419675031643922	0.9590041229944257	0.9111919835237869	0.862641504060798	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET	ENSG00000165731	8858	202957	CCSBVarC006881	ALE00006879	NC_000010.11:43106497:G:A	989G>A	Arg330Gln	CEGS2	CegsMutGDEh1026	D12	GDEhDisVCh_40066	F05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Arg330Gln	10	43106497	G	A	10											10-43106497-G-A	-	0.72592	0.997	330	.	0	.	10	43601945	A	6.196810e-07	.	10	3_Conflicting	NC_000010.11	1	Arg330Gln	.	25.8	.	0	.	D	0	5	5	.	.	.	.	.	0	0.82371	Select	0.5279	.	0.73231	.	.	T	D	63922	0.826949697597	0	0	.	.	.	0.23448	.	44862	0	.	0.26154	.	.	0.43230	0.976	.	42.0	0.819018	4.38	0.58	A	single nucleotide variant	NC_000010.11:g.43106497G>A	0	.	3	0.109657414	.	0	0.24423973	0	A	.	.	.	.	.	500	.	0	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	.	.	0.000000e+00	0	0.75656	P	0.26223	D	M	5.326549	1	G/G	84	0	.	1613734	Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia, type 2	.	0.81321	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106497	.	-	8.604000	.	0.69480	29592	0	1179844	.	germline	91026	Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.1985)| Gain of loop (P = 0.2045)| Loss of catalytic residue at R330 (P = 0.2566)| Loss of MoRF binding (P = 0.3113)	0.88590	GRCh38	862	criteria provided, conflicting classifications	c.989G>A	.	0.75341	1	.	.	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	.	.	B	0	0.000000e+00	NM_020975.6(RET):c.989G>A (p.Arg330Gln)	1	.	RET_HUMAN	.	58.0	0.535811506893486	.	T	0.27073	0.21209615	+	.	.	6.84263e-7	.	.	0	.	criteria_provided,_conflicting_classifications	0.99765	.	0	.	.	60004	p.Arg330Gln	0	0.77773	.	germline	.	43106497	G	Jun 22, 2023	.	G/G	.	.	1.0	N	10q11.21	23858	.	.	SCV001577045|SCV004817287|SCV005198055|SCV005849412	Conflicting_classifications_of_pathogenicity	.	.	Gln	Q	-	912	ENSP00000347942	ENST00000355710	.	0.241	.	.	0.672	G	.	4.587702	0.07765	D	T	-	5.732199	.	0.75354	628	.	.	0.64578	0	43106497	Y	10	0	.	0.000000e+00	P07949	.	0.474583	0.99913	G	.	0.775	D	.	0.1090586	.	0.56441	5979	0.330437	1	-0.99	.	8.475700e-07	0.17740	.	.	75040	.	6056	.	0.26374	10	RET	0.000000e+00	0	Arg	32060	.	10-43106497-G-A	Hirschsprung_disease,_susceptibility_to,_1|not_provided|Multiple_endocrine_neoplasia,_type_2	0	.	42921951	ClinGen:CA009415|OMIM:164761.0022|UniProtKB:P07949#VAR_006302	0.525698	0.69059	0	RCV000014951|RCV004696636|RCV001379274	D	0	.	c.989G>A	.	0	0	0.85088	G/G	rs80236571	43106497	.	G	.	P07949	.	0.47042	.	0.68239	10	.	.	0.000000e+00	2.585	0	1	264690	5.32	0.80450	108	D	T	.	.	0	24	.	.	.	388|653	13926	0.84893	0.67244	0.956602513790131	2314	.	0.71675	0.54678	.	.	1179844	4.133	.	N	.	.	3.7780044E-6	0	142623	0.57831	10	.	ENSG00000165731	0.000000e+00	4.191466174867969E-5	.	0	0.6768372825309222	2	0.63015	0.33096	.	1	.	0.000000e+00	0.557793047773544	YES	0.000000e+00	0.089999	28965	HGNC:9967	D	.	simple_aae	0.47	.	43106497	CGG	1.000000	.	-	0	0.84978	8.475700e-07	0	0	Conflicting classifications of pathogenicity	0.21738	.	0	0	ClinGen:CA009415,UniProtKB:P07949#VAR_006302,OMIM:164761.0022	R	.	0.965051945311	-	0.757	-	0.62248	.	4558	0.67462	0.388616234064	0.1014	0	0.99947467890025776	94	-	989G>A 	.	0	C3888239|C3661900|C4048306	.	.	.	.	NM_020975.6	-	.	.	1	0.47499	80236571	.	3.1191515907673116E-5	0.96435	0.71788	0.607	0.612	2230	0.99982280	5.32	.	.	.	0.236874	0.758352146287697	0.75368	T	84	.	.	-0.0406	0.82381	p.Arg330Gln	0	0	-3.803	0.85925674	0	0.69115	13926	T	.	RET	.	D	0.569	.	R330Q	T	0.82553	0.70176	G/G	principal4																																																																																																				
RET_Arg330Gln	-1.7958396916116608	0.11558602092288398	12.792825715139873	4.1342425315877565e-6	2025_01_Batch_13-14	0.9939309951224155	0.9707838684532181	0.9702720270096226	0.9826078401369326	0.9759573065456218	0.8106779897676171	0.9131511378755663	0.9477362189792289	0.8397761269106413	0.7493257015759742	0.9023044924450163	0.9419675031643922	0.9590041229944257	0.9111919835237869	0.862641504060798	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET		8858		CCSBVarC006881		NC_000010.11:43106497:G:A		Arg330Gln																												RET_Arg330Gln	10	43106497	G	A	10	allele	989G>A	C09	527_CAVA_Array_P05	E17	B13A7A8P2_R1	B14A7A8P2_R2				10-43106497-G-A	-	0.72592	0.997	330	.	0	.	10	43601945	A	6.196810e-07	.	10	3_Conflicting	NC_000010.11	1	Arg330Gln	.	25.8	.	0	.	D	0	5	5	.	.	.	.	.	0	0.82371	Select	0.5279	.	0.73231	.	.	T	D	63922	0.826949697597	0	0	.	.	.	0.23448	.	44862	0	.	0.26154	.	.	0.43230	0.976	.	42.0	0.819018	4.38	0.58	A	single nucleotide variant	NC_000010.11:g.43106497G>A	0	.	3	0.109657414	.	0	0.24423973	0	A	.	.	.	.	.	500	.	0	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MedGen:C3661900|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	.	.	0.000000e+00	0	0.75656	P	0.26223	D	M	5.326549	1	G/G	84	0	.	1613734	Hirschsprung disease, susceptibility to, 1|not provided|Multiple endocrine neoplasia, type 2	.	0.81321	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106497	.	-	8.604000	.	0.69480	29592	0	1179844	.	germline	91026	Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.1985)| Gain of loop (P = 0.2045)| Loss of catalytic residue at R330 (P = 0.2566)| Loss of MoRF binding (P = 0.3113)	0.88590	GRCh38	862	criteria provided, conflicting classifications	c.989G>A	.	0.75341	1	.	.	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	.	.	B	0	0.000000e+00	NM_020975.6(RET):c.989G>A (p.Arg330Gln)	1	.	RET_HUMAN	.	58.0	0.535811506893486	.	T	0.27073	0.21209615	+	.	.	6.84263e-7	.	.	0	.	criteria_provided,_conflicting_classifications	0.99765	.	0	.	.	60004	p.Arg330Gln	0	0.77773	.	germline	.	43106497	G	Jun 22, 2023	.	G/G	.	.	1.0	N	10q11.21	23858	.	.	SCV001577045|SCV004817287|SCV005198055|SCV005849412	Conflicting_classifications_of_pathogenicity	.	.	Gln	Q	-	912	ENSP00000347942	ENST00000355710	.	0.241	.	.	0.672	G	.	4.587702	0.07765	D	T	-	5.732199	.	0.75354	628	.	.	0.64578	0	43106497	Y	10	0	.	0.000000e+00	P07949	.	0.474583	0.99913	G	.	0.775	D	.	0.1090586	.	0.56441	5979	0.330437	1	-0.99	.	8.475700e-07	0.17740	.	.	75040	.	6056	.	0.26374	10	RET	0.000000e+00	0	Arg	32060	.	10-43106497-G-A	Hirschsprung_disease,_susceptibility_to,_1|not_provided|Multiple_endocrine_neoplasia,_type_2	0	.	42921951	ClinGen:CA009415|OMIM:164761.0022|UniProtKB:P07949#VAR_006302	0.525698	0.69059	0	RCV000014951|RCV004696636|RCV001379274	D	0	.	c.989G>A	.	0	0	0.85088	G/G	rs80236571	43106497	.	G	.	P07949	.	0.47042	.	0.68239	10	.	.	0.000000e+00	2.585	0	1	264690	5.32	0.80450	108	D	T	.	.	0	24	.	.	.	388|653	13926	0.84893	0.67244	0.956602513790131	2314	.	0.71675	0.54678	.	.	1179844	4.133	.	N	.	.	3.7780044E-6	0	142623	0.57831	10	.	ENSG00000165731	0.000000e+00	4.191466174867969E-5	.	0	0.6768372825309222	2	0.63015	0.33096	.	1	.	0.000000e+00	0.557793047773544	YES	0.000000e+00	0.089999	28965	HGNC:9967	D	.	simple_aae	0.47	.	43106497	CGG	1.000000	.	-	0	0.84978	8.475700e-07	0	0	Conflicting classifications of pathogenicity	0.21738	.	0	0	ClinGen:CA009415,UniProtKB:P07949#VAR_006302,OMIM:164761.0022	R	.	0.965051945311	-	0.757	-	0.62248	.	4558	0.67462	0.388616234064	0.1014	0	0.99947467890025776	94	-	989G>A 	.	0	C3888239|C3661900|C4048306	.	.	.	.	NM_020975.6	-	.	.	1	0.47499	80236571	.	3.1191515907673116E-5	0.96435	0.71788	0.607	0.612	2230	0.99982280	5.32	.	.	.	0.236874	0.758352146287697	0.75368	T	84	.	.	-0.0406	0.82381	p.Arg330Gln	0	0	-3.803	0.85925674	0	0.69115	13926	T	.	RET	.	D	0.569	.	R330Q	T	0.82553	0.70176	G/G	principal4																																																																																																				
RAD51D_Val56Gly	1.9985217593357885	0.08580618781279473	6.150467942611997	0.00046732469968957475	2025_01_Batch_13-14	0.6854161433565101	0.7903470561584305	0.8642881205783758	0.8287716597985677	0.6506081281818463	0.43725980088048955	0.6049024150896948	0.7474274935923941	0.6306652566123854	0.427543295429101	0.5613379721184999	0.6976247356240626	0.805857807085385	0.7297184582054765	0.5390757118054736	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024801		NC_000017.11:35118597:A:C		Val56Gly																												RAD51D_Val56Gly	17	35118597	A	C	17	allele	167T>G	F12	527_CAVA_Array_P04	L24	B13A7A8P1_R1	B14A7A8P1_R2				17-35118597-A-C	-	0.85944	0.722	56	2	.	0	17	33445616	C	.	0	17	3_Conflicting	NC_000017.11	.	Val56Gly	3	28.7	3	.	3.525890e-04	T	.	2	5	42660	3.485740e-04	.	30514	0.000000e+00	.	0.75010	.	0.1726	102102	0.42404	0	.	T	D	.	.	.	.	0.000000e+00	0	0	.	17078	.	.	2.247860e-04	0.62039	2	.	0.55690	0.989	.	.	0.559044	.	.	C	single nucleotide variant	NC_000017.11:g.35118597A>C	.	16510	2	0.3519664	108972	.	0.33676666	.		8	235244	0	0	1.700870e-04	.	4.688230e-05	.	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN221562	7	39	.	.	.	P	0.60545	P	L	4.538864	.	A/A	.	.	7146	.	Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer	16102	0.49699	.	.	-	35118597	3.333330e-04	-	11.047000	1	0.63571	.	.	.	3	germline	.	Loss of stability (P = 2e-04)| Gain of helix (P = 0.0425)| Loss of loop (P = 0.0804)| Gain of relative solvent accessibility (P = 0.1066)| Loss of MoRF binding (P = 0.1311)	0.74554	GRCh38	926	criteria provided, conflicting classifications	c.167T>G	3.277180e-05	0.60860	.	0	0	RAD51D, N-terminal domain	6.056940e-05	9000	P	.	.	NM_002878.4(RAD51D):c.167T>G (p.Val56Gly)	1	0	RA51D_HUMAN	0	.	0.430607372517603	0	T	0.68420	0.33676666	-	0.000000e+00	.		3	0.000000e+00	0	34214	criteria_provided,_conflicting_classifications	0.97206	6.423670e-05	.	7.588400e-05	0	.	p.Val56Gly	.	0.85271	.	germline	3		A	May 03, 2021	1	A/A	0	88982	1.0	N	17q12	.	.	6.210410e-05	SCV001623514|SCV002043212	Conflicting_classifications_of_pathogenicity	1	0	Gly	G	-	.	ENSP00000378090	ENST00000394589	17638	.	13346	0	0.756	A	0	5.133939	0.79703	D	D	-	4.855777	.	0.75174	.	0	.	0.09708	.	35118597	Y	10	.	102102	.	O75771	0	0.488934	0.82849		0	0.488	D	13346	0.3519664	9000	0.64309	5892	0.239419	.	.	.	.	0.31374	6.378360e-05	0	.	3.333330e-04	.	0	0.60544	17	RAD51D	.	.	Val	.	2.247650e-05	17-35118597-A-C	Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	.	36	30469729	.	0.946436	0.62920	.	RCV001779181|RCV001799083	T	.	0	c.167T>G	0	.	.	0.77440	A/A	rs745307359	35118597	14812	A	.	O75771	15678	0.55690	1.874280e-03	0.68239		0	0	.	1.795	.	.	.	4.79	0.81292	.	T	.	1	0.000000e+00	.	.	.	0	1	145	1098881	0.77147	.	0.0787749525895067	.	.	0.71675	0.95573	0.000000e+00	2.247860e-04	.	7.519	3.863690e-05	.	13178	0	.	.	614291	0.80763	17	6.751280e-05	ENSG00000185379	.	.	1	.	.	2	0.47286	0.17784	30596	.	3.525890e-04	.	0.465062733801357	.	.	0.089068	1087626	HGNC:9823	.	0	.	0.385	207056	35118597	GTG	1.000000	.	-	.	0.01460	.	.	.	Conflicting classifications of pathogenicity	0.61675	1	.	.	ClinGen:CA8499636	V	0	0.776739155903	-	0.613	-	0.72170	82	.	.	.	0.5902	.	0.99732360981923829	.	-	167T>G 	36	.	CN221562|C3280345	0	0	0	0	NM_002878.4	-	.	.	0	0.19237	745307359	2320	.	0.77291	0.65503	0.721	0.002	.	0.99278045	4.79	.	.	3.268400e-05	0.106132	0.0493707858960898	0.47093	T	.	6194	9556	-0.8783	0.51308	p.Val56Gly	.	.	-8.078	0.03294766	.	0.37072	1098881	D	30476	RAD51D	0.000000e+00	D	.	20808	V56G	.	.	0.943	A/A	principal1	962248	RAD51D_unpublished_var156495	Yes						overall function		Cell survival			V		167	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Val56Gly		true	c.167T>G						9823.0	35118597.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				Val56Gly						G	May 03, 2021					missense_variant		56.0	T			-0.0642389		Conflicting classifications of pathogenicity	35118597.0	missense_variant		0.451	functionally_normal				Cell viability			RAD51D_Val56Gly
RAD51D_Val56Gly	1.9985217593357885	0.08580618781279473	6.150467942611997	0.00046732469968957475	2025_01_Batch_13-14	0.6854161433565101	0.7903470561584305	0.8642881205783758	0.8287716597985677	0.6506081281818463	0.43725980088048955	0.6049024150896948	0.7474274935923941	0.6306652566123854	0.427543295429101	0.5613379721184999	0.6976247356240626	0.805857807085385	0.7297184582054765	0.5390757118054736	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024801	ALE00032628	NC_000017.11:35118597:A:C	167T>G	Val56Gly	CAVA																											RAD51D_Val56Gly	17	35118597	A	C	17								1	1	1	17-35118597-A-C	-	0.85944	0.722	56	2	.	0	17	33445616	C	.	0	17	3_Conflicting	NC_000017.11	.	Val56Gly	3	28.7	3	.	3.525890e-04	T	.	2	5	42660	3.485740e-04	.	30514	0.000000e+00	.	0.75010	.	0.1726	102102	0.42404	0	.	T	D	.	.	.	.	0.000000e+00	0	0	.	17078	.	.	2.247860e-04	0.62039	2	.	0.55690	0.989	.	.	0.559044	.	.	C	single nucleotide variant	NC_000017.11:g.35118597A>C	.	16510	2	0.3519664	108972	.	0.33676666	.		8	235244	0	0	1.700870e-04	.	4.688230e-05	.	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN221562	7	39	.	.	.	P	0.60545	P	L	4.538864	.	A/A	.	.	7146	.	Breast-ovarian cancer, familial, susceptibility to, 4|Breast and/or ovarian cancer	16102	0.49699	.	.	-	35118597	3.333330e-04	-	11.047000	1	0.63571	.	.	.	3	germline	.	Loss of stability (P = 2e-04)| Gain of helix (P = 0.0425)| Loss of loop (P = 0.0804)| Gain of relative solvent accessibility (P = 0.1066)| Loss of MoRF binding (P = 0.1311)	0.74554	GRCh38	926	criteria provided, conflicting classifications	c.167T>G	3.277180e-05	0.60860	.	0	0	RAD51D, N-terminal domain	6.056940e-05	9000	P	.	.	NM_002878.4(RAD51D):c.167T>G (p.Val56Gly)	1	0	RA51D_HUMAN	0	.	0.430607372517603	0	T	0.68420	0.33676666	-	0.000000e+00	.		3	0.000000e+00	0	34214	criteria_provided,_conflicting_classifications	0.97206	6.423670e-05	.	7.588400e-05	0	.	p.Val56Gly	.	0.85271	.	germline	3		A	May 03, 2021	1	A/A	0	88982	1.0	N	17q12	.	.	6.210410e-05	SCV001623514|SCV002043212	Conflicting_classifications_of_pathogenicity	1	0	Gly	G	-	.	ENSP00000378090	ENST00000394589	17638	.	13346	0	0.756	A	0	5.133939	0.79703	D	D	-	4.855777	.	0.75174	.	0	.	0.09708	.	35118597	Y	10	.	102102	.	O75771	0	0.488934	0.82849		0	0.488	D	13346	0.3519664	9000	0.64309	5892	0.239419	.	.	.	.	0.31374	6.378360e-05	0	.	3.333330e-04	.	0	0.60544	17	RAD51D	.	.	Val	.	2.247650e-05	17-35118597-A-C	Breast_and/or_ovarian_cancer|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	.	36	30469729	.	0.946436	0.62920	.	RCV001779181|RCV001799083	T	.	0	c.167T>G	0	.	.	0.77440	A/A	rs745307359	35118597	14812	A	.	O75771	15678	0.55690	1.874280e-03	0.68239		0	0	.	1.795	.	.	.	4.79	0.81292	.	T	.	1	0.000000e+00	.	.	.	0	1	145	1098881	0.77147	.	0.0787749525895067	.	.	0.71675	0.95573	0.000000e+00	2.247860e-04	.	7.519	3.863690e-05	.	13178	0	.	.	614291	0.80763	17	6.751280e-05	ENSG00000185379	.	.	1	.	.	2	0.47286	0.17784	30596	.	3.525890e-04	.	0.465062733801357	.	.	0.089068	1087626	HGNC:9823	.	0	.	0.385	207056	35118597	GTG	1.000000	.	-	.	0.01460	.	.	.	Conflicting classifications of pathogenicity	0.61675	1	.	.	ClinGen:CA8499636	V	0	0.776739155903	-	0.613	-	0.72170	82	.	.	.	0.5902	.	0.99732360981923829	.	-	167T>G 	36	.	CN221562|C3280345	0	0	0	0	NM_002878.4	-	.	.	0	0.19237	745307359	2320	.	0.77291	0.65503	0.721	0.002	.	0.99278045	4.79	.	.	3.268400e-05	0.106132	0.0493707858960898	0.47093	T	.	6194	9556	-0.8783	0.51308	p.Val56Gly	.	.	-8.078	0.03294766	.	0.37072	1098881	D	30476	RAD51D	0.000000e+00	D	.	20808	V56G	.	.	0.943	A/A	principal1	962248	RAD51D_unpublished_var156495	Yes						overall function		Cell survival			V		167	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Val56Gly		true	c.167T>G						9823.0	35118597.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				Val56Gly						G	May 03, 2021					missense_variant		56.0	T			-0.0642389		Conflicting classifications of pathogenicity	35118597.0	missense_variant		0.451	functionally_normal				Cell viability			RAD51D_Val56Gly
F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	0.7144251743292489	0.8819927674073826	0.9535374330992443	0.8604436111266539	0.7973320287624389	0.6825216822184693	0.8804889522580996	0.9748413272343945	0.891529193226357	0.8683469650847679	0.6984734282738592	0.8812408598327411	0.9641893801668194	0.8759864021765055	0.8328394969236035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A		Cys335Tyr																												F9_Cys335Tyr	23	139561689	G	A	X	allele	1004G>A	E03	527_CAVA_Array_P02	I06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561689-G-A	-	0.82746	1.0	335	.	.	.	X	138643848	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys335Tyr	.	27.9	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99346	Select	0.9328	.	0.90580	.	.	D	D	.	2.12843697498	.	.	.	.	.	0.70762	.	.	.	.	0.99269	.	.	0.99970	0.993	.	2.0	0.924008	4.99	0.98	A	single nucleotide variant	NC_000023.11:g.139561689G>A	.	.	2	0.9910561	.	.	0.9958085	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97016	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.98918	.	.	-	139561689	.	-	11.887000	.	0.99985	.	.	.	.	unknown	.	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.99597	GRCh38	924	criteria provided, single submitter	c.1004G>A	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	1	.	FA9_HUMAN	.	98.0	.	.	D	0.92459	0.9953884	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys335Tyr	.	0.98990	.	unknown	.		G	Feb 23, 2023	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV003841472	Likely_pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.989535	0.92967	.	D	-	.	.	0.99487	.	.	.	0.99958	.	139561689	Y	10	.	.	.	P00740	.	0.971543	0.87142		.	1.0	D	.	0.9928213	.	0.69292	2158	0.699893	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	.	Cys	.	.	X-139561689-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471514	.	.	.	.	RCV003152922	D	.	.	c.1004G>A	.	.	.	0.99928	G/G	.	139561689	.	G	.	P00740	.	0.99978	.	0.68239		.	.	.	3.995	.	.	.	5.66	0.99693	.	D	T	.	.	.	.	.	.	.	98879	2444124	0.99928	0.95120	0.999975562095642	.	.	0.71675	.	.	.	.	9.568	.	D	.	.	.	.	306900	0.97322	X	.	ENSG00000101981	.	.	.	.	0.9999824557020938	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.929597	2417857	HGNC:3551	D	.	simple_aae	1	.	139561689	TGC	1.000000	.	-	.	0.99955	.	.	.	Likely pathogenic	0.75565	.	.	.	ClinGen:CA414445316	C	.	0.997392873545	-	0.961	-	0.99419	.	.	0.99998	0.725244283676	0.986	.	0.99785198512514828	.	-	1004G>A 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.72162	-1	.	.	0.99732	.	0.878	0.0	.	0.99999330	5.66	.	.	.	0.767572	0.999974611784801	0.96666	D	.	.	.	1.0812	0.97780	p.Cys335Tyr	.	.	-10.266	0.9946557	.	0.99427	2444124	D	.	F9	.	D	0.959	.	C335Y	D	0.89858	0.76753	G/G	principal1	143361	F9_Popp_2025_carboxy_F9_specific_var227706	No											C		1004	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys335Tyr		true	c.1004G>A						3551.0	139561689.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Cys335Tyr						Y	Feb 23, 2023					missense_variant		335.0				0.002802343		Likely pathogenic	139561689.0	missense_variant		0.959					Reporter			F9_Cys335Tyr
F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	0.7144251743292489	0.8819927674073826	0.9535374330992443	0.8604436111266539	0.7973320287624389	0.6825216822184693	0.8804889522580996	0.9748413272343945	0.891529193226357	0.8683469650847679	0.6984734282738592	0.8812408598327411	0.9641893801668194	0.8759864021765055	0.8328394969236035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A		Cys335Tyr																												F9_Cys335Tyr	23	139561689	G	A	X	allele	1004G>A	E03	527_CAVA_Array_P02	I06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561689-G-A	-	0.82746	1.0	335	.	.	.	X	138643848	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys335Tyr	.	27.9	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99346	Select	0.9328	.	0.90580	.	.	D	D	.	2.12843697498	.	.	.	.	.	0.70762	.	.	.	.	0.99269	.	.	0.99970	0.993	.	2.0	0.924008	4.99	0.98	A	single nucleotide variant	NC_000023.11:g.139561689G>A	.	.	2	0.9910561	.	.	0.9958085	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97016	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.98918	.	.	-	139561689	.	-	11.887000	.	0.99985	.	.	.	.	unknown	.	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.99597	GRCh38	924	criteria provided, single submitter	c.1004G>A	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	1	.	FA9_HUMAN	.	98.0	.	.	D	0.92459	0.9953884	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys335Tyr	.	0.98990	.	unknown	.		G	Feb 23, 2023	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV003841472	Likely_pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.989535	0.92967	.	D	-	.	.	0.99487	.	.	.	0.99958	.	139561689	Y	10	.	.	.	P00740	.	0.971543	0.87142		.	1.0	D	.	0.9928213	.	0.69292	2158	0.699893	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	.	Cys	.	.	X-139561689-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471514	.	.	.	.	RCV003152922	D	.	.	c.1004G>A	.	.	.	0.99928	G/G	.	139561689	.	G	.	P00740	.	0.99978	.	0.68239		.	.	.	3.995	.	.	.	5.66	0.99693	.	D	T	.	.	.	.	.	.	.	98879	2444124	0.99928	0.95120	0.999975562095642	.	.	0.71675	.	.	.	.	9.568	.	D	.	.	.	.	306900	0.97322	X	.	ENSG00000101981	.	.	.	.	0.9999824557020938	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.929597	2417857	HGNC:3551	D	.	simple_aae	1	.	139561689	TGC	1.000000	.	-	.	0.99955	.	.	.	Likely pathogenic	0.75565	.	.	.	ClinGen:CA414445316	C	.	0.997392873545	-	0.961	-	0.99419	.	.	0.99998	0.725244283676	0.986	.	0.99785198512514828	.	-	1004G>A 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.72162	-1	.	.	0.99732	.	0.878	0.0	.	0.99999330	5.66	.	.	.	0.767572	0.999974611784801	0.96666	D	.	.	.	1.0812	0.97780	p.Cys335Tyr	.	.	-10.266	0.9946557	.	0.99427	2444124	D	.	F9	.	D	0.959	.	C335Y	D	0.89858	0.76753	G/G	principal1	198393	F9_Popp_2025_heavy_chain_var237387	No											C		1004	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys335Tyr		true	c.1004G>A						3551.0	139561689.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Cys335Tyr						Y	Feb 23, 2023					missense_variant		335.0				0.065910745		Likely pathogenic	139561689.0	missense_variant		0.959					Reporter			F9_Cys335Tyr
F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	0.7144251743292489	0.8819927674073826	0.9535374330992443	0.8604436111266539	0.7973320287624389	0.6825216822184693	0.8804889522580996	0.9748413272343945	0.891529193226357	0.8683469650847679	0.6984734282738592	0.8812408598327411	0.9641893801668194	0.8759864021765055	0.8328394969236035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A		Cys335Tyr																												F9_Cys335Tyr	23	139561689	G	A	X	allele	1004G>A	E03	527_CAVA_Array_P02	I06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561689-G-A	-	0.82746	1.0	335	.	.	.	X	138643848	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys335Tyr	.	27.9	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99346	Select	0.9328	.	0.90580	.	.	D	D	.	2.12843697498	.	.	.	.	.	0.70762	.	.	.	.	0.99269	.	.	0.99970	0.993	.	2.0	0.924008	4.99	0.98	A	single nucleotide variant	NC_000023.11:g.139561689G>A	.	.	2	0.9910561	.	.	0.9958085	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97016	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.98918	.	.	-	139561689	.	-	11.887000	.	0.99985	.	.	.	.	unknown	.	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.99597	GRCh38	924	criteria provided, single submitter	c.1004G>A	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	1	.	FA9_HUMAN	.	98.0	.	.	D	0.92459	0.9953884	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys335Tyr	.	0.98990	.	unknown	.		G	Feb 23, 2023	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV003841472	Likely_pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.989535	0.92967	.	D	-	.	.	0.99487	.	.	.	0.99958	.	139561689	Y	10	.	.	.	P00740	.	0.971543	0.87142		.	1.0	D	.	0.9928213	.	0.69292	2158	0.699893	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	.	Cys	.	.	X-139561689-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471514	.	.	.	.	RCV003152922	D	.	.	c.1004G>A	.	.	.	0.99928	G/G	.	139561689	.	G	.	P00740	.	0.99978	.	0.68239		.	.	.	3.995	.	.	.	5.66	0.99693	.	D	T	.	.	.	.	.	.	.	98879	2444124	0.99928	0.95120	0.999975562095642	.	.	0.71675	.	.	.	.	9.568	.	D	.	.	.	.	306900	0.97322	X	.	ENSG00000101981	.	.	.	.	0.9999824557020938	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.929597	2417857	HGNC:3551	D	.	simple_aae	1	.	139561689	TGC	1.000000	.	-	.	0.99955	.	.	.	Likely pathogenic	0.75565	.	.	.	ClinGen:CA414445316	C	.	0.997392873545	-	0.961	-	0.99419	.	.	0.99998	0.725244283676	0.986	.	0.99785198512514828	.	-	1004G>A 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.72162	-1	.	.	0.99732	.	0.878	0.0	.	0.99999330	5.66	.	.	.	0.767572	0.999974611784801	0.96666	D	.	.	.	1.0812	0.97780	p.Cys335Tyr	.	.	-10.266	0.9946557	.	0.99427	2444124	D	.	F9	.	D	0.959	.	C335Y	D	0.89858	0.76753	G/G	principal1	253425	F9_Popp_2025_strep_2_var266430	No											C		1004	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys335Tyr		true	c.1004G>A						3551.0	139561689.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Cys335Tyr						Y	Feb 23, 2023					missense_variant		335.0				0.048180928625395		Likely pathogenic	139561689.0	missense_variant		0.959					Reporter			F9_Cys335Tyr
F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	0.7144251743292489	0.8819927674073826	0.9535374330992443	0.8604436111266539	0.7973320287624389	0.6825216822184693	0.8804889522580996	0.9748413272343945	0.891529193226357	0.8683469650847679	0.6984734282738592	0.8812408598327411	0.9641893801668194	0.8759864021765055	0.8328394969236035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A		Cys335Tyr																												F9_Cys335Tyr	23	139561689	G	A	X	allele	1004G>A	E03	527_CAVA_Array_P02	I06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561689-G-A	-	0.82746	1.0	335	.	.	.	X	138643848	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys335Tyr	.	27.9	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99346	Select	0.9328	.	0.90580	.	.	D	D	.	2.12843697498	.	.	.	.	.	0.70762	.	.	.	.	0.99269	.	.	0.99970	0.993	.	2.0	0.924008	4.99	0.98	A	single nucleotide variant	NC_000023.11:g.139561689G>A	.	.	2	0.9910561	.	.	0.9958085	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97016	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.98918	.	.	-	139561689	.	-	11.887000	.	0.99985	.	.	.	.	unknown	.	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.99597	GRCh38	924	criteria provided, single submitter	c.1004G>A	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	1	.	FA9_HUMAN	.	98.0	.	.	D	0.92459	0.9953884	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys335Tyr	.	0.98990	.	unknown	.		G	Feb 23, 2023	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV003841472	Likely_pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.989535	0.92967	.	D	-	.	.	0.99487	.	.	.	0.99958	.	139561689	Y	10	.	.	.	P00740	.	0.971543	0.87142		.	1.0	D	.	0.9928213	.	0.69292	2158	0.699893	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	.	Cys	.	.	X-139561689-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471514	.	.	.	.	RCV003152922	D	.	.	c.1004G>A	.	.	.	0.99928	G/G	.	139561689	.	G	.	P00740	.	0.99978	.	0.68239		.	.	.	3.995	.	.	.	5.66	0.99693	.	D	T	.	.	.	.	.	.	.	98879	2444124	0.99928	0.95120	0.999975562095642	.	.	0.71675	.	.	.	.	9.568	.	D	.	.	.	.	306900	0.97322	X	.	ENSG00000101981	.	.	.	.	0.9999824557020938	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.929597	2417857	HGNC:3551	D	.	simple_aae	1	.	139561689	TGC	1.000000	.	-	.	0.99955	.	.	.	Likely pathogenic	0.75565	.	.	.	ClinGen:CA414445316	C	.	0.997392873545	-	0.961	-	0.99419	.	.	0.99998	0.725244283676	0.986	.	0.99785198512514828	.	-	1004G>A 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.72162	-1	.	.	0.99732	.	0.878	0.0	.	0.99999330	5.66	.	.	.	0.767572	0.999974611784801	0.96666	D	.	.	.	1.0812	0.97780	p.Cys335Tyr	.	.	-10.266	0.9946557	.	0.99427	2444124	D	.	F9	.	D	0.959	.	C335Y	D	0.89858	0.76753	G/G	principal1	225909	F9_Popp_2025_light_chain_var247068	No											C		1004	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys335Tyr		true	c.1004G>A						3551.0	139561689.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Cys335Tyr						Y	Feb 23, 2023					missense_variant		335.0				0.004308598		Likely pathogenic	139561689.0	missense_variant		0.959					Reporter			F9_Cys335Tyr
F9_Cys335Tyr	-4.914890869136402	0.001723632887315511	4.56786619174951	0.002580667543327912	2025_01_Batch_13-14	0.7144251743292489	0.8819927674073826	0.9535374330992443	0.8604436111266539	0.7973320287624389	0.6825216822184693	0.8804889522580996	0.9748413272343945	0.891529193226357	0.8683469650847679	0.6984734282738592	0.8812408598327411	0.9641893801668194	0.8759864021765055	0.8328394969236035	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030611		NC_000023.11:139561689:G:A		Cys335Tyr																												F9_Cys335Tyr	23	139561689	G	A	X	allele	1004G>A	E03	527_CAVA_Array_P02	I06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561689-G-A	-	0.82746	1.0	335	.	.	.	X	138643848	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys335Tyr	.	27.9	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99346	Select	0.9328	.	0.90580	.	.	D	D	.	2.12843697498	.	.	.	.	.	0.70762	.	.	.	.	0.99269	.	.	0.99970	0.993	.	2.0	0.924008	4.99	0.98	A	single nucleotide variant	NC_000023.11:g.139561689G>A	.	.	2	0.9910561	.	.	0.9958085	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97016	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.98918	.	.	-	139561689	.	-	11.887000	.	0.99985	.	.	.	.	unknown	.	Gain of catalytic residue at I334 (P = 0.0284)| Gain of methylation at K339 (P = 0.0534)| Gain of sheet (P = 0.0827)| Gain of ubiquitination at K339 (P = 0.1025)| Loss of loop (P = 0.2897)	0.99597	GRCh38	924	criteria provided, single submitter	c.1004G>A	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1004G>A (p.Cys335Tyr)	1	.	FA9_HUMAN	.	98.0	.	.	D	0.92459	0.9953884	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys335Tyr	.	0.98990	.	unknown	.		G	Feb 23, 2023	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV003841472	Likely_pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	4.989535	0.92967	.	D	-	.	.	0.99487	.	.	.	0.99958	.	139561689	Y	10	.	.	.	P00740	.	0.971543	0.87142		.	1.0	D	.	0.9928213	.	0.69292	2158	0.699893	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	.	Cys	.	.	X-139561689-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471514	.	.	.	.	RCV003152922	D	.	.	c.1004G>A	.	.	.	0.99928	G/G	.	139561689	.	G	.	P00740	.	0.99978	.	0.68239		.	.	.	3.995	.	.	.	5.66	0.99693	.	D	T	.	.	.	.	.	.	.	98879	2444124	0.99928	0.95120	0.999975562095642	.	.	0.71675	.	.	.	.	9.568	.	D	.	.	.	.	306900	0.97322	X	.	ENSG00000101981	.	.	.	.	0.9999824557020938	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.929597	2417857	HGNC:3551	D	.	simple_aae	1	.	139561689	TGC	1.000000	.	-	.	0.99955	.	.	.	Likely pathogenic	0.75565	.	.	.	ClinGen:CA414445316	C	.	0.997392873545	-	0.961	-	0.99419	.	.	0.99998	0.725244283676	0.986	.	0.99785198512514828	.	-	1004G>A 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.72162	-1	.	.	0.99732	.	0.878	0.0	.	0.99999330	5.66	.	.	.	0.767572	0.999974611784801	0.96666	D	.	.	.	1.0812	0.97780	p.Cys335Tyr	.	.	-10.266	0.9946557	.	0.99427	2444124	D	.	F9	.	D	0.959	.	C335Y	D	0.89858	0.76753	G/G	principal1	170877	F9_Popp_2025_carboxy_gla_motif_var256749	No											C		1004	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys335Tyr		true	c.1004G>A						3551.0	139561689.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Cys335Tyr						Y	Feb 23, 2023					missense_variant		335.0				0.003812298		Likely pathogenic	139561689.0	missense_variant		0.959					Reporter			F9_Cys335Tyr
FH_Arg233Leu	1.6531294030768622	0.14939045875507265	-2.3788375489716853	0.04896572564958671	2025_01_Batch_13-14	0.6513057530980928	0.623315681074625	0.7060392869124406	0.7205268032862571	0.5721998696228244	0.6740664054693245	0.6565749262015617	0.7368276161684507	0.69855261265139	0.6449922739380513	0.6626860792837086	0.6399453036380933	0.7214334515404457	0.7095397079688235	0.6085960717804378	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH	ENSG00000091483	3408	214595	CCSBVarC004050	ALE00004050	NC_000001.11:241508643:C:A	698G>T	Arg233Leu	CEGS2	CegsMutGDEh1040	H07	GDEhDisVCh_40065	E08	1	CegsMutGDDh1040	H07	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	1	0			0			0			FH_Arg233Leu	1	241508643	C	A	1											1-241508643-C-A	-	0.87283	1.0	233	0	0	0	1	241671943	A	3.098260e-06	0	1	1_Pathogenic	NC_000001.11	5	Arg233Leu	0	29.2	0	.	3.276330e-05	D	0	7	1	42766	4.224040e-06	.	30522	0.000000e+00	.	0.98886	Select	0.9945	30522	0.90580	0	.	D	D	64020	1.09694667183	.	0	0.000000e+00	0	0	0.86606	17102	44856	5	0.000000e+00	0.93080	0	.	0.99821	0.948	.	1.0	0.988918	6.32	0.99	A	single nucleotide variant	NC_000001.11:g.241508643C>A	0	16732	3	0.9549934	109390	.	0.99120563	.	A	1	236740	0	0	0.000000e+00	.	0.000000e+00	.	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	1	0	0.000000e+00	0	0.97926	D	0.98673	D	H	16.70746	5	C/C	.	.	7164	1613808	Hereditary leiomyomatosis and renal cell cancer|not provided|Hereditary cancer-predisposing syndrome	16216	0.96051	.	.	-	241508643	6.374300e-05	-	7.704000	0	0.99985	29598	.	91072	0	germline;unknown	91072	Loss of phosphorylation at T236 (P = 0.0525)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of methylation at K230 (P = 0.0761)| Loss of MoRF binding (P = 0.0923)| Loss of glycosylation at K230 (P = 0.1752)	0.97257	GRCh38	975	criteria provided, multiple submitters, no conflicts	c.698G>T	3.276330e-05	0.86862	.	0	0	Fumarate lyase, N-terminal	0.000000e+00	9044	P	.	0.000000e+00	NM_000143.4(FH):c.698G>T (p.Arg233Leu)	2	0	FUMH_HUMAN	0	99.0	1.08057729138192	0	D	0.95323	0.99120563	-	0.000000e+00	.	3.42101e-6	1	0.000000e+00	0	34228	criteria_provided,_multiple_submitters,_no_conflicts	0.92608	9.141600e-06	0	0.000000e+00	0	60012	p.Arg233Leu	0	0.66498	.	germline	1	241508643	C	Mar 04, 2025	1	C/C	0	89538	1.0	N	1q43	.	.	0.000000e+00	SCV000537240|SCV001430110|SCV002219616|SCV002665339|SCV004017822|SCV004025213	Pathogenic/Likely_pathogenic	0	0	Leu	L	-	912	ENSP00000355518	ENST00000366560	17690	0.0	13414	0	0.599	C	0	5.201626	0.92967	D	D	-	15.68653	.	0.97960	.	0	.	0.99730	.	241508643	Y	10	.	102598	0.000000e+00	P07954	0	0.995902	0.94461	C	0	1.0	D	30604	0.9549934	15688	0.49339	2271	0.51557	0	-6.84	.	5.490160e-05	0.91343	6.374300e-05	0	74994	0.000000e+00	6060	0	0.98673	1	FH	0.000000e+00	.	Arg	.	0.000000e+00	1-241508643-C-A	not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	0	0	239738566	ClinGen:CA257461|OMIM:136850.0008	0.927182	0.97745	0	RCV000017624|RCV001781272|RCV002362588	D	0	0	c.698G>T	0	0	0	0.94692	C/C	rs121913123	241508643	14900	C	.	P07954	15688	0.99821	0.000000e+00	0.68239	1	0	0	0.000000e+00	5.07	.	.	.	5.65	0.99993	.	D	D	0	0.000000e+00	.	.	.	0	0	523|140162	16237	0.96962	0.77481	0.999926209449768	.	.	0.71675	0.90912	0.000000e+00	3.267550e-05	1179792	7.503	4.805980e-06	D	13392	0	.	.	150800	0.80522	1	0.000000e+00	ENSG00000091483	0.000000e+00	.	1	.	0.9751746669812705	2	0.97365	0.05314	30604	.	0.000000e+00	0.000000e+00	0.942227821079248	YES	5.490160e-05	0.745296	31276	HGNC:3700	A	0	simple_aae	1	208074	241508643	CGT	1.000000	.	-	.	0.99460	0.000000e+00	.	0	Pathogenic/Likely pathogenic	0.97705	1	0	0	ClinGen:CA257461,OMIM:136850.0008	R	0	0.972808251769	-	0.889	-	0.97332	1	.	0.97494	0.830429792404	0.9946	0	0.99866098052584062	.	-	698G>T 	1	.	C3661900|C1708350|C0027672	0	0	0	0	NM_000143.4	-	.	.	1	0.96274	121913123	2320	.	0.97225	0.97147	0.963	0.0	.	0.93478185	5.65	.	.	3.267550e-05	0.599658	0.999900398311514	0.99905	D	.	6210	9566	0.9273	0.99874	p.Arg233Leu	.	0	-15.96	0.989849	0	0.98723	16237	D	30494	FH	0.000000e+00	D	0.945	21628	R233L	D	0.99010	0.40292	C/C	principal1																																																																																																				
FH_Arg233Leu	1.6531294030768622	0.14939045875507265	-2.3788375489716853	0.04896572564958671	2025_01_Batch_13-14	0.6513057530980928	0.623315681074625	0.7060392869124406	0.7205268032862571	0.5721998696228244	0.6740664054693245	0.6565749262015617	0.7368276161684507	0.69855261265139	0.6449922739380513	0.6626860792837086	0.6399453036380933	0.7214334515404457	0.7095397079688235	0.6085960717804378	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH		3408		CCSBVarC004050		NC_000001.11:241508643:C:A		Arg233Leu																												FH_Arg233Leu	1	241508643	C	A	1	allele	698G>T	E03	527_CAVA_Array_P03	J05	B13A7A8P1_R1	B14A7A8P1_R2				1-241508643-C-A	-	0.87283	1.0	233	0	0	0	1	241671943	A	3.098260e-06	0	1	1_Pathogenic	NC_000001.11	5	Arg233Leu	0	29.2	0	.	3.276330e-05	D	0	7	1	42766	4.224040e-06	.	30522	0.000000e+00	.	0.98886	Select	0.9945	30522	0.90580	0	.	D	D	64020	1.09694667183	.	0	0.000000e+00	0	0	0.86606	17102	44856	5	0.000000e+00	0.93080	0	.	0.99821	0.948	.	1.0	0.988918	6.32	0.99	A	single nucleotide variant	NC_000001.11:g.241508643C>A	0	16732	3	0.9549934	109390	.	0.99120563	.	A	1	236740	0	0	0.000000e+00	.	0.000000e+00	.	Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	1	0	0.000000e+00	0	0.97926	D	0.98673	D	H	16.70746	5	C/C	.	.	7164	1613808	Hereditary leiomyomatosis and renal cell cancer|not provided|Hereditary cancer-predisposing syndrome	16216	0.96051	.	.	-	241508643	6.374300e-05	-	7.704000	0	0.99985	29598	.	91072	0	germline;unknown	91072	Loss of phosphorylation at T236 (P = 0.0525)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of methylation at K230 (P = 0.0761)| Loss of MoRF binding (P = 0.0923)| Loss of glycosylation at K230 (P = 0.1752)	0.97257	GRCh38	975	criteria provided, multiple submitters, no conflicts	c.698G>T	3.276330e-05	0.86862	.	0	0	Fumarate lyase, N-terminal	0.000000e+00	9044	P	.	0.000000e+00	NM_000143.4(FH):c.698G>T (p.Arg233Leu)	2	0	FUMH_HUMAN	0	99.0	1.08057729138192	0	D	0.95323	0.99120563	-	0.000000e+00	.	3.42101e-6	1	0.000000e+00	0	34228	criteria_provided,_multiple_submitters,_no_conflicts	0.92608	9.141600e-06	0	0.000000e+00	0	60012	p.Arg233Leu	0	0.66498	.	germline	1	241508643	C	Mar 04, 2025	1	C/C	0	89538	1.0	N	1q43	.	.	0.000000e+00	SCV000537240|SCV001430110|SCV002219616|SCV002665339|SCV004017822|SCV004025213	Pathogenic/Likely_pathogenic	0	0	Leu	L	-	912	ENSP00000355518	ENST00000366560	17690	0.0	13414	0	0.599	C	0	5.201626	0.92967	D	D	-	15.68653	.	0.97960	.	0	.	0.99730	.	241508643	Y	10	.	102598	0.000000e+00	P07954	0	0.995902	0.94461	C	0	1.0	D	30604	0.9549934	15688	0.49339	2271	0.51557	0	-6.84	.	5.490160e-05	0.91343	6.374300e-05	0	74994	0.000000e+00	6060	0	0.98673	1	FH	0.000000e+00	.	Arg	.	0.000000e+00	1-241508643-C-A	not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	0	0	239738566	ClinGen:CA257461|OMIM:136850.0008	0.927182	0.97745	0	RCV000017624|RCV001781272|RCV002362588	D	0	0	c.698G>T	0	0	0	0.94692	C/C	rs121913123	241508643	14900	C	.	P07954	15688	0.99821	0.000000e+00	0.68239	1	0	0	0.000000e+00	5.07	.	.	.	5.65	0.99993	.	D	D	0	0.000000e+00	.	.	.	0	0	523|140162	16237	0.96962	0.77481	0.999926209449768	.	.	0.71675	0.90912	0.000000e+00	3.267550e-05	1179792	7.503	4.805980e-06	D	13392	0	.	.	150800	0.80522	1	0.000000e+00	ENSG00000091483	0.000000e+00	.	1	.	0.9751746669812705	2	0.97365	0.05314	30604	.	0.000000e+00	0.000000e+00	0.942227821079248	YES	5.490160e-05	0.745296	31276	HGNC:3700	A	0	simple_aae	1	208074	241508643	CGT	1.000000	.	-	.	0.99460	0.000000e+00	.	0	Pathogenic/Likely pathogenic	0.97705	1	0	0	ClinGen:CA257461,OMIM:136850.0008	R	0	0.972808251769	-	0.889	-	0.97332	1	.	0.97494	0.830429792404	0.9946	0	0.99866098052584062	.	-	698G>T 	1	.	C3661900|C1708350|C0027672	0	0	0	0	NM_000143.4	-	.	.	1	0.96274	121913123	2320	.	0.97225	0.97147	0.963	0.0	.	0.93478185	5.65	.	.	3.267550e-05	0.599658	0.999900398311514	0.99905	D	.	6210	9566	0.9273	0.99874	p.Arg233Leu	.	0	-15.96	0.989849	0	0.98723	16237	D	30494	FH	0.000000e+00	D	0.945	21628	R233L	D	0.99010	0.40292	C/C	principal1																																																																																																				
KRAS_Tyr71His	-4.892479479558333	0.001768232186353	6.312032320641843	0.0003995147857415345	2025_01_Batch_13-14	0.5929192664186796	0.8707022147652246	0.9420249261358699	0.8641048224066088	0.43523395060883235											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214490	CCSBVarC006099	ALE00006099	NC_000012.12:25227313:A:G	211T>C	Tyr71His	CEGS2	CegsMutGDEh1036	F03	GDEhDisVCh_40061	B09	1	CegsMutGDDh1036	F03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Tyr71His	12	25227313	A	G	12											12-25227313-A-G	-	0.83126	0.919	71	.	.	.	12	25380247	G	.	.	12	1_Pathogenic	NC_000012.12	.	Tyr71His	.	28.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97016	Plus_Clinical	0.7268	.	0.50939	.	.	D	D	.	3.04366087562	0	.	.	.	.	0.99483	.	.	.	.	0.77749	.	.	0.93859	0.998	.	2.0	0.884911	3.95	0.98	G	single nucleotide variant	NC_000012.12:g.25227313A>G	.	.	1	0.8970921	.	0	0.93090373	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	.	.	.	.	0.97016	D	0.95206	P	M	7.988538	.	A/A	0	0	.	.	Cardiofaciocutaneous syndrome 2	.	0.91886	.	.	-	25227313	.	-	11.259000	.	0.99559	.	0	.	.	germline	.	Gain of catalytic residue at T74 (P = 0.0026)| Gain of disorder (P = 0.029)| Loss of phosphorylation at Y71 (P = 0.0387)| Loss of stability (P = 0.1315)| Loss of helix (P = 0.1706)	0.82954	GRCh38	856	no assertion criteria provided	c.211T>C	.	0.91065	0	.	.	Small GTP-binding domain	.	.	P	0	.	NM_033360.4(KRAS):c.211T>C (p.Tyr71His)		.	RASK_HUMAN	.	98.0	0.756487767865435	.	D	0.98903	0.927135	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.98921	.	.	.	.	.	p.Tyr71His	.	0.91022	.	germline	.		A	Jan 15, 2013	.	A/A	.	.	1.0	N	12p12.1	0	.	.	SCV000050483	Pathogenic	.	.	His	H	-	.	ENSP00000256078	ENST00000256078	.	0.025	.	.	0.731	A	.	5.005977	0.45880	D	T	-	9.459321	.	0.76586	0	.	.	0.78358	0	25227313	Y	10	0	.	.	P01116	.	0.901474	0.93915		.	0.913	D	.	0.9041667	.	0.85369	3845	0.41344	.	-4.45	.	.	0.48345	.	.	.	.	.	.	0.94698	12	KRAS	.	0	Tyr	478	.	12-25227313-A-G	Cardiofaciocutaneous_syndrome_2	.	.	25271514	ClinGen:CA279983|OMIM:190070.0021|UniProtKB:P01116#VAR_069784	0.873516	0.83238	.	RCV000024617	D	.	.	c.211T>C	.	.	.	0.90604	A/A	rs387907205	25227313	.	A	.	P01116	.	0.94241	.	0.68239		.	.	.	2.48	0	0	.	5.77	0.98050	0	D	D	.	.	0	0	.	.	.	1340	31940	0.90487	0.99279	0.988144636154175	426	.	0.71675	0.79516	.	.	.	9.309	.	D	.	.	.	0	615278	0.95324	12	.	ENSG00000133703	.	0	.	0	0.9119234105740558	1	0.64880	0.34333	.	.	.	.	0.776357426611185	.	.	0.096778	40605	HGNC:6407	A	.	simple_aae	0.987	.	25227313	TAC	1.000000	.	-	0	0.87583	.	0	.	Pathogenic	0.85144	.	.	.	ClinGen:CA279983,UniProtKB:P01116#VAR_069784,OMIM:190070.0021	Y	.	0.967032760806	-	0.693	-	0.97870	.	52	0.91111	0.940733075142	0.9986	.	0.99860396733546142	0	-	211T>C 	.	0	C3809005	.	.	.	.	NM_033360.4	-	.	.	1	0.60851	387907205	.	0	0.96637	0.88040	0.968	0.061	426	0.99871314	5.77	.	.	.	0.356102	0.999975559545648	0.71880	D	0	.	.	0.6011	0.90619	p.Tyr71His	0	.	-12.052	0.88397557	.	0.99427	31940	D	.	KRAS	.	D	0.895	.	Y71H	D	0.75212	0.85655	A/A	alternative1																																																																																																				
KRAS_Tyr71His	-4.892479479558333	0.001768232186353	6.312032320641843	0.0003995147857415345	2025_01_Batch_13-14	0.5929192664186796	0.8707022147652246	0.9420249261358699	0.8641048224066088	0.43523395060883235											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006099		NC_000012.12:25227313:A:G		Tyr71His																												KRAS_Tyr71His	12	25227313	A	G	12	allele	211T>C	B08	527_CAVA_Array_P03	D15	B13A7A8P1_R1	B14A7A8P1_R2				12-25227313-A-G	-	0.83126	0.919	71	.	.	.	12	25380247	G	.	.	12	1_Pathogenic	NC_000012.12	.	Tyr71His	.	28.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97016	Plus_Clinical	0.7268	.	0.50939	.	.	D	D	.	3.04366087562	0	.	.	.	.	0.99483	.	.	.	.	0.77749	.	.	0.93859	0.998	.	2.0	0.884911	3.95	0.98	G	single nucleotide variant	NC_000012.12:g.25227313A>G	.	.	1	0.8970921	.	0	0.93090373	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	.	.	.	.	0.97016	D	0.95206	P	M	7.988538	.	A/A	0	0	.	.	Cardiofaciocutaneous syndrome 2	.	0.91886	.	.	-	25227313	.	-	11.259000	.	0.99559	.	0	.	.	germline	.	Gain of catalytic residue at T74 (P = 0.0026)| Gain of disorder (P = 0.029)| Loss of phosphorylation at Y71 (P = 0.0387)| Loss of stability (P = 0.1315)| Loss of helix (P = 0.1706)	0.82954	GRCh38	856	no assertion criteria provided	c.211T>C	.	0.91065	0	.	.	Small GTP-binding domain	.	.	P	0	.	NM_033360.4(KRAS):c.211T>C (p.Tyr71His)		.	RASK_HUMAN	.	98.0	0.756487767865435	.	D	0.98903	0.927135	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.98921	.	.	.	.	.	p.Tyr71His	.	0.91022	.	germline	.		A	Jan 15, 2013	.	A/A	.	.	1.0	N	12p12.1	0	.	.	SCV000050483	Pathogenic	.	.	His	H	-	.	ENSP00000256078	ENST00000256078	.	0.025	.	.	0.731	A	.	5.005977	0.45880	D	T	-	9.459321	.	0.76586	0	.	.	0.78358	0	25227313	Y	10	0	.	.	P01116	.	0.901474	0.93915		.	0.913	D	.	0.9041667	.	0.85369	3845	0.41344	.	-4.45	.	.	0.48345	.	.	.	.	.	.	0.94698	12	KRAS	.	0	Tyr	478	.	12-25227313-A-G	Cardiofaciocutaneous_syndrome_2	.	.	25271514	ClinGen:CA279983|OMIM:190070.0021|UniProtKB:P01116#VAR_069784	0.873516	0.83238	.	RCV000024617	D	.	.	c.211T>C	.	.	.	0.90604	A/A	rs387907205	25227313	.	A	.	P01116	.	0.94241	.	0.68239		.	.	.	2.48	0	0	.	5.77	0.98050	0	D	D	.	.	0	0	.	.	.	1340	31940	0.90487	0.99279	0.988144636154175	426	.	0.71675	0.79516	.	.	.	9.309	.	D	.	.	.	0	615278	0.95324	12	.	ENSG00000133703	.	0	.	0	0.9119234105740558	1	0.64880	0.34333	.	.	.	.	0.776357426611185	.	.	0.096778	40605	HGNC:6407	A	.	simple_aae	0.987	.	25227313	TAC	1.000000	.	-	0	0.87583	.	0	.	Pathogenic	0.85144	.	.	.	ClinGen:CA279983,UniProtKB:P01116#VAR_069784,OMIM:190070.0021	Y	.	0.967032760806	-	0.693	-	0.97870	.	52	0.91111	0.940733075142	0.9986	.	0.99860396733546142	0	-	211T>C 	.	0	C3809005	.	.	.	.	NM_033360.4	-	.	.	1	0.60851	387907205	.	0	0.96637	0.88040	0.968	0.061	426	0.99871314	5.77	.	.	.	0.356102	0.999975559545648	0.71880	D	0	.	.	0.6011	0.90619	p.Tyr71His	0	.	-12.052	0.88397557	.	0.99427	31940	D	.	KRAS	.	D	0.895	.	Y71H	D	0.75212	0.85655	A/A	alternative1																																																																																																				
RPS19_Arg62Trp	2.4791241841752996	0.042264292882514945	-2.5644722198235086	0.03730742779147683	2025_01_Batch_13-14	0.7290373796001558	0.5877760909668668	0.7600550019338441	0.5555206693929152	0.74341438863389											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RPS19	RPS19	ENSG00000105372	3441	6069	CCSBVarC000467	ALE00000467	NC_000019.10:41869042:C:T	184C>T	Arg62Trp	RC4	RC4_Mut_GDEh1010	F11	GDEhDisVCh_40042	C02	2	RC4_Mut_GDDh1010	F11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			RPS19_Arg62Trp	19	41869042	C	T	19											19-41869042-C-T	-	0.94003	0.987	62	.	.	.	19	42373112	T	.	.	19	1_Pathogenic	NC_000019.10	.	Arg62Trp	.	33.0	.	.	.	T	.	6	1	.	.	.	.	.	.	.	Select	0.4950	.	0.61929	.	.	D	D	.	1.09019113237	.	.	.	.	.	0.88322	.	.	.	.	.	.	.	0.94732	0.996	.	3.0	.	.	0.97	T	single nucleotide variant	NC_000019.10:g.41869042C>T	.	.	3	0.88595665	.	.	0.96338874	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|MedGen:C3661900|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124|	.	.	.	.	0.96253	P	0.93466	D	H	6.914856	.	./.	.	.	.	.	Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia|RPS19-related disorder	.	0.87220	.	.	-	41869042	.	-	2.200000	.	0.41634	.	.	.	.	germline	.	Gain of catalytic residue at A61 (P = 0.0262)| Loss of methylation at R67 (P = 0.0445)| Loss of disorder (P = 0.0768)| Loss of phosphorylation at T60 (P = 0.1237)| Loss of MoRF binding (P = 0.1355)	0.99827	GRCh38	748	criteria provided, multiple submitters, no conflicts	c.184C>T	.	0.50482	.	.	.	.	.	.	LP	.	.	NM_001022.4(RPS19):c.184C>T (p.Arg62Trp)	2	.	RS19_HUMAN	.	97.0	0.68503384224157	.	.	0.90441	0.93570024	+	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99939	.	.	.	.	.	p.Arg62Trp	.	0.31363	.	germline	.		C	Mar 09, 2023	.	./.	.	.	0.995	N	19q13.2	.	.	.	SCV000589354|SCV001230721|SCV002717112|SCV004047404|SCV004112877	Pathogenic	.	.	Trp	W	-	.	ENSP00000470972	ENST00000598742	.	.	.	.	0.596	C	.	5.900132	0.60067	D	D	-	6.180586	.	0.98386	.	.	.	0.91622	.	41869042	Y	9	.	.	.	P39019	.	0.99269	0.97802		.	0.679	D	.	0.87987745	.	0.76032	6223	0.423948	.	.	.	.	.	.	.	.	.	.	.	0.93899	19	RPS19	.	.	Arg	.	.	19-41869042-C-T	RPS19-related_disorder|Diamond-Blackfan_anemia|not_provided|Diamond-Blackfan_anemia_1	.	.	47064952	ClinGen:CA130763|OMIM:603474.0002|UniProtKB:P39019#VAR_006924	0.886495	0.78536	.	RCV000033183|RCV000497714|RCV001065746|RCV003415668	D	.	.	c.184C>T	.	.	.	0.91161	./.	rs104894711	41869042	.	C	.	P39019	.	0.97581	.	0.30138		.	.	.	3.89	.	.	.	4.3	0.99976	.	D	D	.	.	.	.	.	.	.	124|124	6314	0.91051	0.77275	0.997496426105499	.	.	0.38864	0.81725	.	.	.	3.204	.	.	.	.	.	.	PS105650|105650	0.5088	19	.	ENSG00000105372	.	.	.	.	0.9363405839023272	1	0.53438	0.52085	.	.	.	.	0.596564645006298	YES	.	0.794641	21353	HGNC:10402	A	.	simple_aae	0.169	.	41869042	CGG	0.976000	.	-	.	0.99322	.	.	.	Pathogenic	0.86392	.	.	.	ClinGen:CA130763,UniProtKB:P39019#VAR_006924,OMIM:603474.0002	R	.	0.969246388482	-	0.982	-	0.96999	.	.	0.93574	0.841621756554	0.9544	.	0.99907463222353998	.	-	184C>T 	.	.	C1260899|C3661900|C2676137	.	.	.	.	NM_001022.4	-	.	.	1	0.75590	104894711	.	.	0.96863	0.74551	0.96	0.019	.	0.99993860	4.3	.	.	.	0.371195	0.999645938344676	0.95985	D	.	.	.	0.2823	0.80784	p.Arg62Trp	.	.	-12.316	0.98888874	.	0.97310	6314	D	.	RPS19	.	D	.	.	R62W	.	.	0.33565	./.	principal1																																																																																																				
RPS19_Arg62Trp	2.4791241841752996	0.042264292882514945	-2.5644722198235086	0.03730742779147683	2025_01_Batch_13-14	0.7290373796001558	0.5877760909668668	0.7600550019338441	0.5555206693929152	0.74341438863389											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RPS19	RPS19		3441		CCSBVarC000467		NC_000019.10:41869042:C:T		Arg62Trp																												RPS19_Arg62Trp	19	41869042	C	T	19	allele	184C>T	F10	527_CAVA_Array_P05	K19	B13A7A8P2_R1	B14A7A8P2_R2				19-41869042-C-T	-	0.94003	0.987	62	.	.	.	19	42373112	T	.	.	19	1_Pathogenic	NC_000019.10	.	Arg62Trp	.	33.0	.	.	.	T	.	6	1	.	.	.	.	.	.	.	Select	0.4950	.	0.61929	.	.	D	D	.	1.09019113237	.	.	.	.	.	0.88322	.	.	.	.	.	.	.	0.94732	0.996	.	3.0	.	.	0.97	T	single nucleotide variant	NC_000019.10:g.41869042C>T	.	.	3	0.88595665	.	.	0.96338874	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|MedGen:C3661900|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124|	.	.	.	.	0.96253	P	0.93466	D	H	6.914856	.	./.	.	.	.	.	Diamond-Blackfan anemia 1|not provided|Diamond-Blackfan anemia|RPS19-related disorder	.	0.87220	.	.	-	41869042	.	-	2.200000	.	0.41634	.	.	.	.	germline	.	Gain of catalytic residue at A61 (P = 0.0262)| Loss of methylation at R67 (P = 0.0445)| Loss of disorder (P = 0.0768)| Loss of phosphorylation at T60 (P = 0.1237)| Loss of MoRF binding (P = 0.1355)	0.99827	GRCh38	748	criteria provided, multiple submitters, no conflicts	c.184C>T	.	0.50482	.	.	.	.	.	.	LP	.	.	NM_001022.4(RPS19):c.184C>T (p.Arg62Trp)	2	.	RS19_HUMAN	.	97.0	0.68503384224157	.	.	0.90441	0.93570024	+	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99939	.	.	.	.	.	p.Arg62Trp	.	0.31363	.	germline	.		C	Mar 09, 2023	.	./.	.	.	0.995	N	19q13.2	.	.	.	SCV000589354|SCV001230721|SCV002717112|SCV004047404|SCV004112877	Pathogenic	.	.	Trp	W	-	.	ENSP00000470972	ENST00000598742	.	.	.	.	0.596	C	.	5.900132	0.60067	D	D	-	6.180586	.	0.98386	.	.	.	0.91622	.	41869042	Y	9	.	.	.	P39019	.	0.99269	0.97802		.	0.679	D	.	0.87987745	.	0.76032	6223	0.423948	.	.	.	.	.	.	.	.	.	.	.	0.93899	19	RPS19	.	.	Arg	.	.	19-41869042-C-T	RPS19-related_disorder|Diamond-Blackfan_anemia|not_provided|Diamond-Blackfan_anemia_1	.	.	47064952	ClinGen:CA130763|OMIM:603474.0002|UniProtKB:P39019#VAR_006924	0.886495	0.78536	.	RCV000033183|RCV000497714|RCV001065746|RCV003415668	D	.	.	c.184C>T	.	.	.	0.91161	./.	rs104894711	41869042	.	C	.	P39019	.	0.97581	.	0.30138		.	.	.	3.89	.	.	.	4.3	0.99976	.	D	D	.	.	.	.	.	.	.	124|124	6314	0.91051	0.77275	0.997496426105499	.	.	0.38864	0.81725	.	.	.	3.204	.	.	.	.	.	.	PS105650|105650	0.5088	19	.	ENSG00000105372	.	.	.	.	0.9363405839023272	1	0.53438	0.52085	.	.	.	.	0.596564645006298	YES	.	0.794641	21353	HGNC:10402	A	.	simple_aae	0.169	.	41869042	CGG	0.976000	.	-	.	0.99322	.	.	.	Pathogenic	0.86392	.	.	.	ClinGen:CA130763,UniProtKB:P39019#VAR_006924,OMIM:603474.0002	R	.	0.969246388482	-	0.982	-	0.96999	.	.	0.93574	0.841621756554	0.9544	.	0.99907463222353998	.	-	184C>T 	.	.	C1260899|C3661900|C2676137	.	.	.	.	NM_001022.4	-	.	.	1	0.75590	104894711	.	.	0.96863	0.74551	0.96	0.019	.	0.99993860	4.3	.	.	.	0.371195	0.999645938344676	0.95985	D	.	.	.	0.2823	0.80784	p.Arg62Trp	.	.	-12.316	0.98888874	.	0.97310	6314	D	.	RPS19	.	D	.	.	R62W	.	.	0.33565	./.	principal1																																																																																																				
KRAS_Thr58Ile	-0.39527774123572407	0.7044069422700285	1.3907484853397487	0.20691013190075047	2025_01_Batch_13-14	0.7960650923919101	0.8465006346220918	0.6496548415989407	0.7589450425882613	0.6643028810530798	0.8874702078262242	0.8358419254696432	0.787848804329627	0.922114026728086	0.7446185007678706	0.8417676501090672	0.8411712800458675	0.7187518229642839	0.8405295346581736	0.7044606909104751	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214487	CCSBVarC006096	ALE00006096	NC_000012.12:25227351:G:A	173C>T	Thr58Ile	CEGS2	CegsMutGDEh1040	G09	GDEhDisVCh_40061	H09	1	CegsMutGDDh1040	G09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	2	0			0			0			KRAS_Thr58Ile	12	25227351	G	A	12											12-25227351-G-A	-	0.91162	1.0	58	.	0	.	12	25380285	A	6.195830e-07	.	12	1_Pathogenic	NC_000012.12	1	Thr58Ile	.	32.0	.	0	.	D	0	7	1	.	.	.	.	.	0	0.98001	Plus_Clinical	0.8519	.	0.90580	.	.	D	D	64002	2.79487049805	0	0	.	.	.	0.98917	.	44872	0	.	0.88318	.	.	0.99559	1.0	.	13.0	0.931307	3.17	0.87	A	single nucleotide variant	NC_000012.12:g.25227351G>A	0	.	3	0.97297084	.	0	0.98686	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	0.000000e+00	0	0.90832	D	0.99355	D	M	13.60356	1	./.	114	0	.	1613990	Noonan syndrome 3|not provided|Noonan syndrome|RASopathy	.	0.96522	.	.	-	25227351	.	-	9.977000	.	0.99892	29598	0	64002	.	germline	91080	Gain of catalytic residue at A59 (P = 0)| Loss of glycosylation at T58 (P = 0.0493)| Loss of disorder (P = 0.0697)| Loss of sheet (P = 0.1398)| Loss of phosphorylation at T58 (P = 0.1979)	0.93687	GRCh38	855	reviewed by expert panel	c.173C>T	.	0.62830	0	.	.	Small GTP-binding domain	.	.	P	0	0.000000e+00	NM_004985.5(KRAS):c.173C>T (p.Thr58Ile)	3	.	RASK_HUMAN	.	87.0	0.989759110368124	.	D	0.99054	0.98655695	-	.	.	6.8411e-7	.	.	0	.	reviewed_by_expert_panel	0.99231	.	0	.	.	60018	p.Thr58Ile	0	0.82927	.	germline	.	25227351	G	Apr 03, 2017	.	./.	.	.	1.0	N	12p12.1	9690	.	.	SCV000616369	Pathogenic	.	.	Ile	I	-	912	ENSP00000256078	ENST00000256078	.	0.0	.	.	0.654	G	.	5.459501	0.92967	D	D	-	13.95184	.	0.89556	610	.	.	0.91549	0	25227351	Y	9	0	.	0.000000e+00	P01116	.	0.892475	0.96438	G	.	1.0	D	.	0.96777624	.	0.97202	3845	0.461113	0	-5.82	.	1.562450e-05	0.91343	.	.	75010	.	6060	.	0.99581	12	KRAS	0.000000e+00	0	Thr	14528	.	12-25227351-G-A	Noonan_syndrome|RASopathy|Noonan_syndrome_3|not_provided	0	.	25271552	ClinGen:CA256480|OMIM:190070.0011|UniProtKB:P01116#VAR_026111	0.874898	0.95396	0	RCV000013419|RCV000157933|RCV000211785|RCV000704828	D	0	.	c.173C>T	.	0	1	0.92920	./.	rs104894364	25227351	.	G	.	P01116	.	0.99577	.	0.68239	12	.	.	0.000000e+00	2.76	0	0	.	4.87	0.97806	112	D	D	.	.	0	26	.	.	.	648|536391|648	12588	0.92832	0.98863	0.997460722923279	3324	.	0.71675	0.79727	.	.	1179936	9.985	.	D	.	.	.	0	PS163950|609942	0.99185	12	.	ENSG00000133703	1.562450e-05	0	.	0	0.9692766844020148	2	0.97365	0.34655	.	.	.	0.000000e+00	0.904634796992952	.	0.000000e+00	0.262968	27627	HGNC:6407	A	.	simple_aae	0.997	.	25227351	ACA	1.000000	.	-	0	0.94271	0.000000e+00	0	0	Pathogenic	0.90103	.	0	0	ClinGen:CA256480,UniProtKB:P01116#VAR_026111,OMIM:190070.0011	T	.	0.993069005404	-	0.826	-	0.99419	.	548	0.96898	0.928796410561	0.9994	0	0.99889978765528353	98	-	173C>T 	.	0	C0028326|C5555857|C1860991|C3661900	.	.	.	.	NM_004985.5	-	.	.	1	0.74400	104894364	.	0	0.99291	0.95748	0.985	0.0	3210	0.99922788	5.77	.	.	.	0.42458	0.999977356359875	0.80456	D	86	.	.	0.9591	0.95052	p.Thr58Ile	0	0	-12.877	0.95001256	0	0.99427	12588	D	.	KRAS	.	D	0.921	.	T58I	D	0.57548	0.53775	./.	alternative1																																																																																																				
KRAS_Thr58Ile	-0.39527774123572407	0.7044069422700285	1.3907484853397487	0.20691013190075047	2025_01_Batch_13-14	0.7960650923919101	0.8465006346220918	0.6496548415989407	0.7589450425882613	0.6643028810530798	0.8874702078262242	0.8358419254696432	0.787848804329627	0.922114026728086	0.7446185007678706	0.8417676501090672	0.8411712800458675	0.7187518229642839	0.8405295346581736	0.7044606909104751	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006096		NC_000012.12:25227351:G:A		Thr58Ile																												KRAS_Thr58Ile	12	25227351	G	A	12	allele	173C>T	G07	527_CAVA_Array_P03	N13	B13A7A8P1_R1	B14A7A8P1_R2				12-25227351-G-A	-	0.91162	1.0	58	.	0	.	12	25380285	A	6.195830e-07	.	12	1_Pathogenic	NC_000012.12	1	Thr58Ile	.	32.0	.	0	.	D	0	7	1	.	.	.	.	.	0	0.98001	Plus_Clinical	0.8519	.	0.90580	.	.	D	D	64002	2.79487049805	0	0	.	.	.	0.98917	.	44872	0	.	0.88318	.	.	0.99559	1.0	.	13.0	0.931307	3.17	0.87	A	single nucleotide variant	NC_000012.12:g.25227351G>A	0	.	3	0.97297084	.	0	0.98686	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	0.000000e+00	0	0.90832	D	0.99355	D	M	13.60356	1	./.	114	0	.	1613990	Noonan syndrome 3|not provided|Noonan syndrome|RASopathy	.	0.96522	.	.	-	25227351	.	-	9.977000	.	0.99892	29598	0	64002	.	germline	91080	Gain of catalytic residue at A59 (P = 0)| Loss of glycosylation at T58 (P = 0.0493)| Loss of disorder (P = 0.0697)| Loss of sheet (P = 0.1398)| Loss of phosphorylation at T58 (P = 0.1979)	0.93687	GRCh38	855	reviewed by expert panel	c.173C>T	.	0.62830	0	.	.	Small GTP-binding domain	.	.	P	0	0.000000e+00	NM_004985.5(KRAS):c.173C>T (p.Thr58Ile)	3	.	RASK_HUMAN	.	87.0	0.989759110368124	.	D	0.99054	0.98655695	-	.	.	6.8411e-7	.	.	0	.	reviewed_by_expert_panel	0.99231	.	0	.	.	60018	p.Thr58Ile	0	0.82927	.	germline	.	25227351	G	Apr 03, 2017	.	./.	.	.	1.0	N	12p12.1	9690	.	.	SCV000616369	Pathogenic	.	.	Ile	I	-	912	ENSP00000256078	ENST00000256078	.	0.0	.	.	0.654	G	.	5.459501	0.92967	D	D	-	13.95184	.	0.89556	610	.	.	0.91549	0	25227351	Y	9	0	.	0.000000e+00	P01116	.	0.892475	0.96438	G	.	1.0	D	.	0.96777624	.	0.97202	3845	0.461113	0	-5.82	.	1.562450e-05	0.91343	.	.	75010	.	6060	.	0.99581	12	KRAS	0.000000e+00	0	Thr	14528	.	12-25227351-G-A	Noonan_syndrome|RASopathy|Noonan_syndrome_3|not_provided	0	.	25271552	ClinGen:CA256480|OMIM:190070.0011|UniProtKB:P01116#VAR_026111	0.874898	0.95396	0	RCV000013419|RCV000157933|RCV000211785|RCV000704828	D	0	.	c.173C>T	.	0	1	0.92920	./.	rs104894364	25227351	.	G	.	P01116	.	0.99577	.	0.68239	12	.	.	0.000000e+00	2.76	0	0	.	4.87	0.97806	112	D	D	.	.	0	26	.	.	.	648|536391|648	12588	0.92832	0.98863	0.997460722923279	3324	.	0.71675	0.79727	.	.	1179936	9.985	.	D	.	.	.	0	PS163950|609942	0.99185	12	.	ENSG00000133703	1.562450e-05	0	.	0	0.9692766844020148	2	0.97365	0.34655	.	.	.	0.000000e+00	0.904634796992952	.	0.000000e+00	0.262968	27627	HGNC:6407	A	.	simple_aae	0.997	.	25227351	ACA	1.000000	.	-	0	0.94271	0.000000e+00	0	0	Pathogenic	0.90103	.	0	0	ClinGen:CA256480,UniProtKB:P01116#VAR_026111,OMIM:190070.0011	T	.	0.993069005404	-	0.826	-	0.99419	.	548	0.96898	0.928796410561	0.9994	0	0.99889978765528353	98	-	173C>T 	.	0	C0028326|C5555857|C1860991|C3661900	.	.	.	.	NM_004985.5	-	.	.	1	0.74400	104894364	.	0	0.99291	0.95748	0.985	0.0	3210	0.99922788	5.77	.	.	.	0.42458	0.999977356359875	0.80456	D	86	.	.	0.9591	0.95052	p.Thr58Ile	0	0	-12.877	0.95001256	0	0.99427	12588	D	.	KRAS	.	D	0.921	.	T58I	D	0.57548	0.53775	./.	alternative1																																																																																																				
CTCF_Arg567Trp	-2.2467893963047323	0.05947914658227662	4.260796641789189	0.0037429098147742346	2025_01_Batch_13-14	0.845062424909783	0.9353934882605206	0.9929235469435809	0.98291111648267	0.958814571357891	0.8577022478605603	0.925778215348259	0.9961799374689079	0.9836805419035566	0.9789552684935916	0.8513823363851716	0.9305858518043898	0.9945517422062444	0.9832958291931133	0.9688849199257413	0.0	0.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	CTCF	CTCF		6173		CCSBVarC010838		NC_000016.10:67628550:C:T		Arg567Trp																												CTCF_Arg567Trp	16	67628550	C	T	16	allele	1699C>T	C02	527_CAVA_Array_P02	E04	B13A7A8P1_R1	B14A7A8P1_R2				16-67628550-C-T	-	0.93734	1.0	567	.	.	.	16	67662453	T	.	.	16	1_Pathogenic	NC_000016.10	.	Arg567Trp	.	33.0	.	.	.	T	.	11	1	.	.	.	.	.	.	0.76095	Select	0.4630	.	0.90580	.	.	T	D	.	1.77042804158	.	.	.	.	.	0.99381	.	.	.	.	0.00067	.	.	0.43549	0.998	.	10.0	.	2.48	0.9	T	single nucleotide variant	NC_000016.10:g.67628550C>T	.	.	3	0.19353762	.	.	0.34531498	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MedGen:C3661900||MeSH:D030342,MedGen:C0950123|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756	.	.	.	.	0.92286	D	0.44068	D	L	3.452482	.	C/C	.	.	.	.	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|not provided|CTCF-related syndromic intellectual disability|Inborn genetic diseases|Intellectual disability	.	0.77803	.	.	-	67628550	.	-	3.253000	.	0.60781	.	.	.	.	de novo;germline;unknown	.	Loss of disorder (P = 0.0022)| Gain of catalytic residue at M570 (P = 0.0054)| Loss of ubiquitination at K562 (P = 0.0595)| Loss of glycosylation at T565 (P = 0.062)| Gain of MoRF binding (P = 0.0672)	0.59796	GRCh38	53	criteria provided, multiple submitters, no conflicts	c.1699C>T	.	0.89363	.	.	.	.	.	.	.	.	.	NM_006565.4(CTCF):c.1699C>T (p.Arg567Trp)	2	.	CTCF_HUMAN	.	90.0	0.233022080859582	.	.	0.88398	0.21461935	+	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.92403	.	.	.	.	.	p.Arg567Trp	.	0.37120	.	germline	.		C	Oct 04, 2024	.	C/C	.	.	0.997	N	16q22.1	.	.	.	SCV000491326|SCV001140119|SCV001763559|SCV002026307|SCV002540226|SCV002712444|SCV004012893|SCV005418082|SCV005420471	Pathogenic	.	.	Trp	W	-	.	ENSP00000264010	ENST00000264010	.	0.272	.	.	0.599	C	.	5.827689	0.53775	D	D	-	4.116707	.	0.89437	.	.	.	0.43448	.	67628550	Y	10	.	.	.	P49711	.	0.337032	0.98168		.	0.996	D	.	0.20212594	.	0.85369	10664	0.299086	.	3.81	.	.	0.16020	.	.	.	.	.	.	0.42778	16	CTCF	.	.	Arg	.	.	16-67628550-C-T	Inborn_genetic_diseases|CTCF-related_syndromic_intellectual_disability|not_provided|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome	.	.	66219954	ClinGen:CA10575614|OMIM:604167.0003|UniProtKB:P49711#VAR_070776	0.650883	0.52570	.	RCV000074335|RCV000413282|RCV002260512|RCV002399425|RCV004798770	D	.	.	c.1699C>T	.	.	.	0.82769	C/C	rs879255516	67628550	.	C	.	P49711	.	0.56370	.	0.35501		.	.	.	0.975	.	.	.	5.72	0.70472	.	D	D	.	.	.	.	.	.	.	363611	88638	0.82547	0.91237	0.758090436458588	.	.	0.40243	0.62348	.	.	.	3.487	.	N	.	.	.	.	615502	0.53079	16	.	ENSG00000102974	.	.	.	.	.	1	0.84488	0.97599	.	.	.	.	0.364610182935106	YES	.	0.259847	94227	HGNC:13723	A	.	simple_aae	0.348	.	67628550	CGG	0.999000	.	-	.	0.58637	.	.	.	Pathogenic/Likely pathogenic	0.81389	.	.	.	ClinGen:CA10575614,UniProtKB:P49711#VAR_070776,OMIM:604167.0003	R	.	0.924862249397	-	0.505	-	0.86807	.	.	0.85423	0.938079476357	.	.	0.99912878870036514	.	-	1699C>T 	.	.	C0950123|C3661900|C3809686	.	.	.	.	NM_006565.4	-	.	.	1	0.72299	879255516	.	.	0.92352	0.59176	0.871	0.032	.	0.93024755	5.72	.	.	.	0.19184	0.977421928894321	0.24371	T	.	.	.	-0.1910	0.79128	p.Arg567Trp	.	.	-8.437	0.45562387	.	0.84724	88638	D	.	CTCF	.	D	0.467	.	R567W	T	0.45773	0.40292	C/C	principal4																																																																																																				
F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	0.7827194086302407	0.7722172073904454	0.6948973070114324	0.7985744700478877	0.5683757034214649	0.5381132628825487	0.6420214737947247	0.6432236490031396	0.688543948505332	0.45417516709558364	0.6604163357563947	0.7071193405925851	0.669060478007286	0.7435592092766099	0.5112754352585243	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A		Ser220Thr																												F9_Ser220Thr	23	139551199	T	A	X	allele	658T>A	H08	527_CAVA_Array_P02	O16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551199-T-A	-	0.0104	0.0	220	0	0	0	X	138633358	A	6.118060e-05	22	X	2_Benign	NC_000023.11	71	Ser220Thr	0	0.044	0	0	2.061020e-03	D	1	4	1	30956	3.773120e-04	.	19007	0.000000e+00	1	0.33155	Select	0.6106	27171	0.02950	56	.	T	T	46522	0.600742330255	0	0	0.000000e+00	0	1	0.19008	13667	33747	0	0.000000e+00	0.13346	0	.	0.10077	0.021	.	98.0	0.538146	-4.88	0.02	A	single nucleotide variant	NC_000023.11:g.139551199T>A	0	12192	2	0.06703769	80344	0	0.066854715	0		57	172271	1	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	23	0	0.000000e+00	0	0.08015	B	0.11090	B	L	.	74	T/T	114	0	5702	1209534	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	13134	0.74375	.	.	-	139551199	1.609720e-03	-	-2.955000	0	0.47926	22028	0.001639344262295082	45655	0	germline;unknown	56756	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.25438	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.658T>A	0.000000e+00	0.01209	1	1	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2	0	FA9_HUMAN	1	2.0	.	48	T	0.05513	0.053613782	+	0.000000e+00	.		48	0.000000e+00	0	27171	criteria_provided,_multiple_submitters,_no_conflicts	0.99461	2.862690e-04	1	0.000000e+00	0	45655	p.Ser220Thr	0	0.03212	.	germline	22		T	Nov 26, 2024	0	T/T	2	64670	0.0	N	Xq27.1	9690	.	0.000000e+00	SCV000481884|SCV001002642|SCV002806336	Benign/Likely_benign	0	0	Thr	T	-	686	ENSP00000218099	ENST00000218099	13316	0.323	10125	2	0.665	T	0	-0.836136	0.09916	.	T	-	.	.	0.91165	610	1	.	0.02660	0	139551199	Y	10	0	73484	0.000000e+00	P00740	0	0.331657	0.04982		1	0.003	D	24393	0.059238464	13667	0.11764	2158	-0.470828	0	-0.33	.	1.555140e-03	0.13513	0.000000e+00	0	57031	0.000000e+00	4376	0	0.13813	X	F9	0.000000e+00	0	Ser	14050	0.000000e+00	X-139551199-T-A	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	0	0	138461024	ClinGen:CA10529817	.	.	0	RCV000279243|RCV000862176|RCV002502409|RCV003950311	T	0	0	c.658T>A	0	0	0	0.00791	T/T	rs777361659	139551199	12064	T	.	P00740	9951	0.14292	0.000000e+00	0.08389		0	0	0.000000e+00	1.1	0	0	264690	-7.5	0.69995	112	T	T	0	1.967780e-03	0	26	.	0	0	98879	368001	0.26695	0.54859	0.0342450906531738	2898	.	0.06393	.	2.061020e-03	1.967780e-03	895139	-0.667	3.753430e-04	N	9934	1	2.8335032E-4	0	301052|306900|300807	0.05383	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.8672301792330431	1	0.08696	0.18019	19072	75	0.000000e+00	1.555140e-03	.	YES	0.000000e+00	0.311014	352093	HGNC:3551	N	0	simple_aae	0.214	151861	139551199	TCA	0.000000	.	-	0	0.00246	0.000000e+00	0	0	Benign/Likely benign	0.18335	0	0	71	ClinGen:CA10529817	S	0	0.68087794957	-	0.293	-	0.14545	65	496	0.86606	0.357546925545	0.0749	1	0.53336181712178654	98	-	658T>A 	56	0	C5393318|C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.20839	777361659	1767	7.117437722419929E-5	0.67565	.	0.092	0.558	2784	0.99953437	5.31	.	.	0.000000e+00	-0.455873	0.483090820042852	0.27864	T	86	4649	7083	-0.3176	0.86163	p.Ser220Thr	0	0	-3.522	0.011437386	0	0.60269	368001	T	24393	F9	1.609720e-03	T	0.120	15997	S220T	T	0.04680	0.62996	T/T	principal1	191500	F9_Popp_2025_heavy_chain_var234975	No											S		658	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ser220Thr		true	c.658T>A						3551.0	139551199.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				Ser220Thr						T	Jan 27, 2024					missense_variant		220.0			0.0000611805869037	0.985123728674622		Benign/Likely benign	139551199.0	missense_variant		0.12					Reporter			F9_Ser220Thr
F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	0.7827194086302407	0.7722172073904454	0.6948973070114324	0.7985744700478877	0.5683757034214649	0.5381132628825487	0.6420214737947247	0.6432236490031396	0.688543948505332	0.45417516709558364	0.6604163357563947	0.7071193405925851	0.669060478007286	0.7435592092766099	0.5112754352585243	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A		Ser220Thr																												F9_Ser220Thr	23	139551199	T	A	X	allele	658T>A	H08	527_CAVA_Array_P02	O16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551199-T-A	-	0.0104	0.0	220	0	0	0	X	138633358	A	6.118060e-05	22	X	2_Benign	NC_000023.11	71	Ser220Thr	0	0.044	0	0	2.061020e-03	D	1	4	1	30956	3.773120e-04	.	19007	0.000000e+00	1	0.33155	Select	0.6106	27171	0.02950	56	.	T	T	46522	0.600742330255	0	0	0.000000e+00	0	1	0.19008	13667	33747	0	0.000000e+00	0.13346	0	.	0.10077	0.021	.	98.0	0.538146	-4.88	0.02	A	single nucleotide variant	NC_000023.11:g.139551199T>A	0	12192	2	0.06703769	80344	0	0.066854715	0		57	172271	1	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	23	0	0.000000e+00	0	0.08015	B	0.11090	B	L	.	74	T/T	114	0	5702	1209534	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	13134	0.74375	.	.	-	139551199	1.609720e-03	-	-2.955000	0	0.47926	22028	0.001639344262295082	45655	0	germline;unknown	56756	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.25438	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.658T>A	0.000000e+00	0.01209	1	1	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2	0	FA9_HUMAN	1	2.0	.	48	T	0.05513	0.053613782	+	0.000000e+00	.		48	0.000000e+00	0	27171	criteria_provided,_multiple_submitters,_no_conflicts	0.99461	2.862690e-04	1	0.000000e+00	0	45655	p.Ser220Thr	0	0.03212	.	germline	22		T	Nov 26, 2024	0	T/T	2	64670	0.0	N	Xq27.1	9690	.	0.000000e+00	SCV000481884|SCV001002642|SCV002806336	Benign/Likely_benign	0	0	Thr	T	-	686	ENSP00000218099	ENST00000218099	13316	0.323	10125	2	0.665	T	0	-0.836136	0.09916	.	T	-	.	.	0.91165	610	1	.	0.02660	0	139551199	Y	10	0	73484	0.000000e+00	P00740	0	0.331657	0.04982		1	0.003	D	24393	0.059238464	13667	0.11764	2158	-0.470828	0	-0.33	.	1.555140e-03	0.13513	0.000000e+00	0	57031	0.000000e+00	4376	0	0.13813	X	F9	0.000000e+00	0	Ser	14050	0.000000e+00	X-139551199-T-A	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	0	0	138461024	ClinGen:CA10529817	.	.	0	RCV000279243|RCV000862176|RCV002502409|RCV003950311	T	0	0	c.658T>A	0	0	0	0.00791	T/T	rs777361659	139551199	12064	T	.	P00740	9951	0.14292	0.000000e+00	0.08389		0	0	0.000000e+00	1.1	0	0	264690	-7.5	0.69995	112	T	T	0	1.967780e-03	0	26	.	0	0	98879	368001	0.26695	0.54859	0.0342450906531738	2898	.	0.06393	.	2.061020e-03	1.967780e-03	895139	-0.667	3.753430e-04	N	9934	1	2.8335032E-4	0	301052|306900|300807	0.05383	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.8672301792330431	1	0.08696	0.18019	19072	75	0.000000e+00	1.555140e-03	.	YES	0.000000e+00	0.311014	352093	HGNC:3551	N	0	simple_aae	0.214	151861	139551199	TCA	0.000000	.	-	0	0.00246	0.000000e+00	0	0	Benign/Likely benign	0.18335	0	0	71	ClinGen:CA10529817	S	0	0.68087794957	-	0.293	-	0.14545	65	496	0.86606	0.357546925545	0.0749	1	0.53336181712178654	98	-	658T>A 	56	0	C5393318|C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.20839	777361659	1767	7.117437722419929E-5	0.67565	.	0.092	0.558	2784	0.99953437	5.31	.	.	0.000000e+00	-0.455873	0.483090820042852	0.27864	T	86	4649	7083	-0.3176	0.86163	p.Ser220Thr	0	0	-3.522	0.011437386	0	0.60269	368001	T	24393	F9	1.609720e-03	T	0.120	15997	S220T	T	0.04680	0.62996	T/T	principal1	219016	F9_Popp_2025_light_chain_var244656	No											S		658	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ser220Thr		true	c.658T>A						3551.0	139551199.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				Ser220Thr						T	Jan 27, 2024					missense_variant		220.0			0.0000611805869037	0.9359157740770834		Benign/Likely benign	139551199.0	missense_variant		0.12					Reporter			F9_Ser220Thr
F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	0.7827194086302407	0.7722172073904454	0.6948973070114324	0.7985744700478877	0.5683757034214649	0.5381132628825487	0.6420214737947247	0.6432236490031396	0.688543948505332	0.45417516709558364	0.6604163357563947	0.7071193405925851	0.669060478007286	0.7435592092766099	0.5112754352585243	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A		Ser220Thr																												F9_Ser220Thr	23	139551199	T	A	X	allele	658T>A	H08	527_CAVA_Array_P02	O16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551199-T-A	-	0.0104	0.0	220	0	0	0	X	138633358	A	6.118060e-05	22	X	2_Benign	NC_000023.11	71	Ser220Thr	0	0.044	0	0	2.061020e-03	D	1	4	1	30956	3.773120e-04	.	19007	0.000000e+00	1	0.33155	Select	0.6106	27171	0.02950	56	.	T	T	46522	0.600742330255	0	0	0.000000e+00	0	1	0.19008	13667	33747	0	0.000000e+00	0.13346	0	.	0.10077	0.021	.	98.0	0.538146	-4.88	0.02	A	single nucleotide variant	NC_000023.11:g.139551199T>A	0	12192	2	0.06703769	80344	0	0.066854715	0		57	172271	1	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	23	0	0.000000e+00	0	0.08015	B	0.11090	B	L	.	74	T/T	114	0	5702	1209534	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	13134	0.74375	.	.	-	139551199	1.609720e-03	-	-2.955000	0	0.47926	22028	0.001639344262295082	45655	0	germline;unknown	56756	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.25438	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.658T>A	0.000000e+00	0.01209	1	1	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2	0	FA9_HUMAN	1	2.0	.	48	T	0.05513	0.053613782	+	0.000000e+00	.		48	0.000000e+00	0	27171	criteria_provided,_multiple_submitters,_no_conflicts	0.99461	2.862690e-04	1	0.000000e+00	0	45655	p.Ser220Thr	0	0.03212	.	germline	22		T	Nov 26, 2024	0	T/T	2	64670	0.0	N	Xq27.1	9690	.	0.000000e+00	SCV000481884|SCV001002642|SCV002806336	Benign/Likely_benign	0	0	Thr	T	-	686	ENSP00000218099	ENST00000218099	13316	0.323	10125	2	0.665	T	0	-0.836136	0.09916	.	T	-	.	.	0.91165	610	1	.	0.02660	0	139551199	Y	10	0	73484	0.000000e+00	P00740	0	0.331657	0.04982		1	0.003	D	24393	0.059238464	13667	0.11764	2158	-0.470828	0	-0.33	.	1.555140e-03	0.13513	0.000000e+00	0	57031	0.000000e+00	4376	0	0.13813	X	F9	0.000000e+00	0	Ser	14050	0.000000e+00	X-139551199-T-A	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	0	0	138461024	ClinGen:CA10529817	.	.	0	RCV000279243|RCV000862176|RCV002502409|RCV003950311	T	0	0	c.658T>A	0	0	0	0.00791	T/T	rs777361659	139551199	12064	T	.	P00740	9951	0.14292	0.000000e+00	0.08389		0	0	0.000000e+00	1.1	0	0	264690	-7.5	0.69995	112	T	T	0	1.967780e-03	0	26	.	0	0	98879	368001	0.26695	0.54859	0.0342450906531738	2898	.	0.06393	.	2.061020e-03	1.967780e-03	895139	-0.667	3.753430e-04	N	9934	1	2.8335032E-4	0	301052|306900|300807	0.05383	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.8672301792330431	1	0.08696	0.18019	19072	75	0.000000e+00	1.555140e-03	.	YES	0.000000e+00	0.311014	352093	HGNC:3551	N	0	simple_aae	0.214	151861	139551199	TCA	0.000000	.	-	0	0.00246	0.000000e+00	0	0	Benign/Likely benign	0.18335	0	0	71	ClinGen:CA10529817	S	0	0.68087794957	-	0.293	-	0.14545	65	496	0.86606	0.357546925545	0.0749	1	0.53336181712178654	98	-	658T>A 	56	0	C5393318|C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.20839	777361659	1767	7.117437722419929E-5	0.67565	.	0.092	0.558	2784	0.99953437	5.31	.	.	0.000000e+00	-0.455873	0.483090820042852	0.27864	T	86	4649	7083	-0.3176	0.86163	p.Ser220Thr	0	0	-3.522	0.011437386	0	0.60269	368001	T	24393	F9	1.609720e-03	T	0.120	15997	S220T	T	0.04680	0.62996	T/T	principal1	136468	F9_Popp_2025_carboxy_F9_specific_var225294	No											S		658	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ser220Thr		true	c.658T>A						3551.0	139551199.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				Ser220Thr						T	Jan 27, 2024					missense_variant		220.0			0.0000611805869037	0.9827713024496731		Benign/Likely benign	139551199.0	missense_variant		0.12					Reporter			F9_Ser220Thr
F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	0.7827194086302407	0.7722172073904454	0.6948973070114324	0.7985744700478877	0.5683757034214649	0.5381132628825487	0.6420214737947247	0.6432236490031396	0.688543948505332	0.45417516709558364	0.6604163357563947	0.7071193405925851	0.669060478007286	0.7435592092766099	0.5112754352585243	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A		Ser220Thr																												F9_Ser220Thr	23	139551199	T	A	X	allele	658T>A	H08	527_CAVA_Array_P02	O16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551199-T-A	-	0.0104	0.0	220	0	0	0	X	138633358	A	6.118060e-05	22	X	2_Benign	NC_000023.11	71	Ser220Thr	0	0.044	0	0	2.061020e-03	D	1	4	1	30956	3.773120e-04	.	19007	0.000000e+00	1	0.33155	Select	0.6106	27171	0.02950	56	.	T	T	46522	0.600742330255	0	0	0.000000e+00	0	1	0.19008	13667	33747	0	0.000000e+00	0.13346	0	.	0.10077	0.021	.	98.0	0.538146	-4.88	0.02	A	single nucleotide variant	NC_000023.11:g.139551199T>A	0	12192	2	0.06703769	80344	0	0.066854715	0		57	172271	1	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	23	0	0.000000e+00	0	0.08015	B	0.11090	B	L	.	74	T/T	114	0	5702	1209534	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	13134	0.74375	.	.	-	139551199	1.609720e-03	-	-2.955000	0	0.47926	22028	0.001639344262295082	45655	0	germline;unknown	56756	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.25438	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.658T>A	0.000000e+00	0.01209	1	1	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2	0	FA9_HUMAN	1	2.0	.	48	T	0.05513	0.053613782	+	0.000000e+00	.		48	0.000000e+00	0	27171	criteria_provided,_multiple_submitters,_no_conflicts	0.99461	2.862690e-04	1	0.000000e+00	0	45655	p.Ser220Thr	0	0.03212	.	germline	22		T	Nov 26, 2024	0	T/T	2	64670	0.0	N	Xq27.1	9690	.	0.000000e+00	SCV000481884|SCV001002642|SCV002806336	Benign/Likely_benign	0	0	Thr	T	-	686	ENSP00000218099	ENST00000218099	13316	0.323	10125	2	0.665	T	0	-0.836136	0.09916	.	T	-	.	.	0.91165	610	1	.	0.02660	0	139551199	Y	10	0	73484	0.000000e+00	P00740	0	0.331657	0.04982		1	0.003	D	24393	0.059238464	13667	0.11764	2158	-0.470828	0	-0.33	.	1.555140e-03	0.13513	0.000000e+00	0	57031	0.000000e+00	4376	0	0.13813	X	F9	0.000000e+00	0	Ser	14050	0.000000e+00	X-139551199-T-A	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	0	0	138461024	ClinGen:CA10529817	.	.	0	RCV000279243|RCV000862176|RCV002502409|RCV003950311	T	0	0	c.658T>A	0	0	0	0.00791	T/T	rs777361659	139551199	12064	T	.	P00740	9951	0.14292	0.000000e+00	0.08389		0	0	0.000000e+00	1.1	0	0	264690	-7.5	0.69995	112	T	T	0	1.967780e-03	0	26	.	0	0	98879	368001	0.26695	0.54859	0.0342450906531738	2898	.	0.06393	.	2.061020e-03	1.967780e-03	895139	-0.667	3.753430e-04	N	9934	1	2.8335032E-4	0	301052|306900|300807	0.05383	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.8672301792330431	1	0.08696	0.18019	19072	75	0.000000e+00	1.555140e-03	.	YES	0.000000e+00	0.311014	352093	HGNC:3551	N	0	simple_aae	0.214	151861	139551199	TCA	0.000000	.	-	0	0.00246	0.000000e+00	0	0	Benign/Likely benign	0.18335	0	0	71	ClinGen:CA10529817	S	0	0.68087794957	-	0.293	-	0.14545	65	496	0.86606	0.357546925545	0.0749	1	0.53336181712178654	98	-	658T>A 	56	0	C5393318|C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.20839	777361659	1767	7.117437722419929E-5	0.67565	.	0.092	0.558	2784	0.99953437	5.31	.	.	0.000000e+00	-0.455873	0.483090820042852	0.27864	T	86	4649	7083	-0.3176	0.86163	p.Ser220Thr	0	0	-3.522	0.011437386	0	0.60269	368001	T	24393	F9	1.609720e-03	T	0.120	15997	S220T	T	0.04680	0.62996	T/T	principal1	163984	F9_Popp_2025_carboxy_gla_motif_var254337	No											S		658	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ser220Thr		true	c.658T>A						3551.0	139551199.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				Ser220Thr						T	Jan 27, 2024					missense_variant		220.0			0.0000611805869037	0.9422268415037416		Benign/Likely benign	139551199.0	missense_variant		0.12					Reporter			F9_Ser220Thr
F9_Ser220Thr	-1.5813680655719948	0.1578072999155839	-0.4279713934093683	0.6815309193523282	2025_01_Batch_13-14	0.7827194086302407	0.7722172073904454	0.6948973070114324	0.7985744700478877	0.5683757034214649	0.5381132628825487	0.6420214737947247	0.6432236490031396	0.688543948505332	0.45417516709558364	0.6604163357563947	0.7071193405925851	0.669060478007286	0.7435592092766099	0.5112754352585243	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030564		NC_000023.11:139551199:T:A		Ser220Thr																												F9_Ser220Thr	23	139551199	T	A	X	allele	658T>A	H08	527_CAVA_Array_P02	O16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551199-T-A	-	0.0104	0.0	220	0	0	0	X	138633358	A	6.118060e-05	22	X	2_Benign	NC_000023.11	71	Ser220Thr	0	0.044	0	0	2.061020e-03	D	1	4	1	30956	3.773120e-04	.	19007	0.000000e+00	1	0.33155	Select	0.6106	27171	0.02950	56	.	T	T	46522	0.600742330255	0	0	0.000000e+00	0	1	0.19008	13667	33747	0	0.000000e+00	0.13346	0	.	0.10077	0.021	.	98.0	0.538146	-4.88	0.02	A	single nucleotide variant	NC_000023.11:g.139551199T>A	0	12192	2	0.06703769	80344	0	0.066854715	0		57	172271	1	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|	23	0	0.000000e+00	0	0.08015	B	0.11090	B	L	.	74	T/T	114	0	5702	1209534	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|F9-related disorder	13134	0.74375	.	.	-	139551199	1.609720e-03	-	-2.955000	0	0.47926	22028	0.001639344262295082	45655	0	germline;unknown	56756	Gain of phosphorylation at S220 (P = 0.0775)| Loss of disorder (P = 0.1117)| Loss of glycosylation at T218 (P = 0.241)| Loss of loop (P = 0.3664)| Gain of sheet (P = 0.4423)	0.25438	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.658T>A	0.000000e+00	0.01209	1	1	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.658T>A (p.Ser220Thr)	2	0	FA9_HUMAN	1	2.0	.	48	T	0.05513	0.053613782	+	0.000000e+00	.		48	0.000000e+00	0	27171	criteria_provided,_multiple_submitters,_no_conflicts	0.99461	2.862690e-04	1	0.000000e+00	0	45655	p.Ser220Thr	0	0.03212	.	germline	22		T	Nov 26, 2024	0	T/T	2	64670	0.0	N	Xq27.1	9690	.	0.000000e+00	SCV000481884|SCV001002642|SCV002806336	Benign/Likely_benign	0	0	Thr	T	-	686	ENSP00000218099	ENST00000218099	13316	0.323	10125	2	0.665	T	0	-0.836136	0.09916	.	T	-	.	.	0.91165	610	1	.	0.02660	0	139551199	Y	10	0	73484	0.000000e+00	P00740	0	0.331657	0.04982		1	0.003	D	24393	0.059238464	13667	0.11764	2158	-0.470828	0	-0.33	.	1.555140e-03	0.13513	0.000000e+00	0	57031	0.000000e+00	4376	0	0.13813	X	F9	0.000000e+00	0	Ser	14050	0.000000e+00	X-139551199-T-A	Warfarin_sensitivity,_X-linked|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder	0	0	138461024	ClinGen:CA10529817	.	.	0	RCV000279243|RCV000862176|RCV002502409|RCV003950311	T	0	0	c.658T>A	0	0	0	0.00791	T/T	rs777361659	139551199	12064	T	.	P00740	9951	0.14292	0.000000e+00	0.08389		0	0	0.000000e+00	1.1	0	0	264690	-7.5	0.69995	112	T	T	0	1.967780e-03	0	26	.	0	0	98879	368001	0.26695	0.54859	0.0342450906531738	2898	.	0.06393	.	2.061020e-03	1.967780e-03	895139	-0.667	3.753430e-04	N	9934	1	2.8335032E-4	0	301052|306900|300807	0.05383	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.8672301792330431	1	0.08696	0.18019	19072	75	0.000000e+00	1.555140e-03	.	YES	0.000000e+00	0.311014	352093	HGNC:3551	N	0	simple_aae	0.214	151861	139551199	TCA	0.000000	.	-	0	0.00246	0.000000e+00	0	0	Benign/Likely benign	0.18335	0	0	71	ClinGen:CA10529817	S	0	0.68087794957	-	0.293	-	0.14545	65	496	0.86606	0.357546925545	0.0749	1	0.53336181712178654	98	-	658T>A 	56	0	C5393318|C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.20839	777361659	1767	7.117437722419929E-5	0.67565	.	0.092	0.558	2784	0.99953437	5.31	.	.	0.000000e+00	-0.455873	0.483090820042852	0.27864	T	86	4649	7083	-0.3176	0.86163	p.Ser220Thr	0	0	-3.522	0.011437386	0	0.60269	368001	T	24393	F9	1.609720e-03	T	0.120	15997	S220T	T	0.04680	0.62996	T/T	principal1	246532	F9_Popp_2025_strep_2_var264018	No											S		658	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ser220Thr		true	c.658T>A						3551.0	139551199.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				Ser220Thr						T	Jan 27, 2024					missense_variant		220.0			0.0000611805869037	0.9920700972578148		Benign/Likely benign	139551199.0	missense_variant		0.12					Reporter			F9_Ser220Thr
F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ala397Pro	23	139561874	G	C	X											X-139561874-G-C	-	0.85159	1.0	397	.	.	.	X	138644033	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ala397Pro	.	28.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99740	Select	0.9557	.	0.90580	.	.	D	D	.	1.86989205249	.	.	.	.	.	0.66230	.	.	.	.	0.82092	.	.	0.99973	0.998	.	0.0	0.941906	.	1.0	C	single nucleotide variant	NC_000023.11:g.139561874G>C	.	.	1	0.9920948	.	.	0.9954094	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99756	.	.	-	139561874	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.99533	GRCh38	924	no assertion criteria provided	c.1189G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)		.	FA9_HUMAN	.	100.0	.	.	D	0.94596	0.9955629	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ala397Pro	.	0.99016	.	germline	.		G	May 01, 1998	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031639	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.096493	0.92967	.	D	-	.	.	0.99582	.	.	.	0.98376	.	139561874	Y	10	.	.	.	P00740	.	0.972943	0.89450		.	0.999	D	.	0.992814	.	0.85369	2158	0.702117	.	-4.97	.	.	0.91343	.	.	.	.	.	.	0.99990	X	F9	.	.	Ala	.	.	X-139561874-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471699	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	.	.	.	RCV000011407	D	.	.	c.1189G>C	.	.	.	0.99930	G/G	rs137852281	139561874	.	G	.	P00740	.	0.99970	.	0.68239		.	.	.	4.115	.	.	.	5.66	0.99717	.	D	T	.	.	.	.	.	.	.	98879	10662	0.99930	0.92474	0.999667882919312	.	.	0.71675	.	.	.	.	7.987	.	D	.	.	.	.	306900	0.87843	X	.	ENSG00000101981	.	.	.	.	0.9999893549903599	1	0.92348	0.18019	.	.	.	.	.	YES	.	0.941142	25701	HGNC:3551	A	.	simple_aae	1	.	139561874	GCT	1.000000	.	-	.	0.99843	.	.	.	Pathogenic	0.98777	.	.	.	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	A	.	0.999646589023	-	0.957	-	0.96202	.	.	0.99998	0.694044589996	0.9929	.	0.99810165860495959	.	-	1189G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.78261	137852281	.	.	0.99963	.	0.878	0.0	.	0.99999404	5.66	.	.	.	0.770766	0.999994138420688	0.97347	D	.	.	.	1.1025	0.98562	p.Ala397Pro	.	.	-16.845	0.99310195	.	0.99831	10662	D	.	F9	.	D	0.974	.	A397P	D	.	0.76753	G/G	principal1	147114	F9_Popp_2025_carboxy_F9_specific_var229016	No											A		1189	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ala397Pro		true	c.1189G>C						3551.0	139561874.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Ala397Pro						P	May 01, 1998					missense_variant		397.0				0.0066197		Pathogenic	139561874.0	missense_variant		0.974					Reporter			F9_Ala397Pro
F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ala397Pro	23	139561874	G	C	X											X-139561874-G-C	-	0.85159	1.0	397	.	.	.	X	138644033	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ala397Pro	.	28.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99740	Select	0.9557	.	0.90580	.	.	D	D	.	1.86989205249	.	.	.	.	.	0.66230	.	.	.	.	0.82092	.	.	0.99973	0.998	.	0.0	0.941906	.	1.0	C	single nucleotide variant	NC_000023.11:g.139561874G>C	.	.	1	0.9920948	.	.	0.9954094	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99756	.	.	-	139561874	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.99533	GRCh38	924	no assertion criteria provided	c.1189G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)		.	FA9_HUMAN	.	100.0	.	.	D	0.94596	0.9955629	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ala397Pro	.	0.99016	.	germline	.		G	May 01, 1998	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031639	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.096493	0.92967	.	D	-	.	.	0.99582	.	.	.	0.98376	.	139561874	Y	10	.	.	.	P00740	.	0.972943	0.89450		.	0.999	D	.	0.992814	.	0.85369	2158	0.702117	.	-4.97	.	.	0.91343	.	.	.	.	.	.	0.99990	X	F9	.	.	Ala	.	.	X-139561874-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471699	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	.	.	.	RCV000011407	D	.	.	c.1189G>C	.	.	.	0.99930	G/G	rs137852281	139561874	.	G	.	P00740	.	0.99970	.	0.68239		.	.	.	4.115	.	.	.	5.66	0.99717	.	D	T	.	.	.	.	.	.	.	98879	10662	0.99930	0.92474	0.999667882919312	.	.	0.71675	.	.	.	.	7.987	.	D	.	.	.	.	306900	0.87843	X	.	ENSG00000101981	.	.	.	.	0.9999893549903599	1	0.92348	0.18019	.	.	.	.	.	YES	.	0.941142	25701	HGNC:3551	A	.	simple_aae	1	.	139561874	GCT	1.000000	.	-	.	0.99843	.	.	.	Pathogenic	0.98777	.	.	.	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	A	.	0.999646589023	-	0.957	-	0.96202	.	.	0.99998	0.694044589996	0.9929	.	0.99810165860495959	.	-	1189G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.78261	137852281	.	.	0.99963	.	0.878	0.0	.	0.99999404	5.66	.	.	.	0.770766	0.999994138420688	0.97347	D	.	.	.	1.1025	0.98562	p.Ala397Pro	.	.	-16.845	0.99310195	.	0.99831	10662	D	.	F9	.	D	0.974	.	A397P	D	.	0.76753	G/G	principal1	229662	F9_Popp_2025_light_chain_var248378	No											A		1189	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ala397Pro		true	c.1189G>C						3551.0	139561874.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Ala397Pro						P	May 01, 1998					missense_variant		397.0				0.015139726		Pathogenic	139561874.0	missense_variant		0.974					Reporter			F9_Ala397Pro
F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ala397Pro	23	139561874	G	C	X											X-139561874-G-C	-	0.85159	1.0	397	.	.	.	X	138644033	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ala397Pro	.	28.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99740	Select	0.9557	.	0.90580	.	.	D	D	.	1.86989205249	.	.	.	.	.	0.66230	.	.	.	.	0.82092	.	.	0.99973	0.998	.	0.0	0.941906	.	1.0	C	single nucleotide variant	NC_000023.11:g.139561874G>C	.	.	1	0.9920948	.	.	0.9954094	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99756	.	.	-	139561874	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.99533	GRCh38	924	no assertion criteria provided	c.1189G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)		.	FA9_HUMAN	.	100.0	.	.	D	0.94596	0.9955629	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ala397Pro	.	0.99016	.	germline	.		G	May 01, 1998	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031639	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.096493	0.92967	.	D	-	.	.	0.99582	.	.	.	0.98376	.	139561874	Y	10	.	.	.	P00740	.	0.972943	0.89450		.	0.999	D	.	0.992814	.	0.85369	2158	0.702117	.	-4.97	.	.	0.91343	.	.	.	.	.	.	0.99990	X	F9	.	.	Ala	.	.	X-139561874-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471699	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	.	.	.	RCV000011407	D	.	.	c.1189G>C	.	.	.	0.99930	G/G	rs137852281	139561874	.	G	.	P00740	.	0.99970	.	0.68239		.	.	.	4.115	.	.	.	5.66	0.99717	.	D	T	.	.	.	.	.	.	.	98879	10662	0.99930	0.92474	0.999667882919312	.	.	0.71675	.	.	.	.	7.987	.	D	.	.	.	.	306900	0.87843	X	.	ENSG00000101981	.	.	.	.	0.9999893549903599	1	0.92348	0.18019	.	.	.	.	.	YES	.	0.941142	25701	HGNC:3551	A	.	simple_aae	1	.	139561874	GCT	1.000000	.	-	.	0.99843	.	.	.	Pathogenic	0.98777	.	.	.	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	A	.	0.999646589023	-	0.957	-	0.96202	.	.	0.99998	0.694044589996	0.9929	.	0.99810165860495959	.	-	1189G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.78261	137852281	.	.	0.99963	.	0.878	0.0	.	0.99999404	5.66	.	.	.	0.770766	0.999994138420688	0.97347	D	.	.	.	1.1025	0.98562	p.Ala397Pro	.	.	-16.845	0.99310195	.	0.99831	10662	D	.	F9	.	D	0.974	.	A397P	D	.	0.76753	G/G	principal1	257178	F9_Popp_2025_strep_2_var267740	No											A		1189	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ala397Pro		true	c.1189G>C						3551.0	139561874.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Ala397Pro						P	May 01, 1998					missense_variant		397.0				0.157050150415891		Pathogenic	139561874.0	missense_variant		0.974					Reporter			F9_Ala397Pro
F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ala397Pro	23	139561874	G	C	X											X-139561874-G-C	-	0.85159	1.0	397	.	.	.	X	138644033	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ala397Pro	.	28.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99740	Select	0.9557	.	0.90580	.	.	D	D	.	1.86989205249	.	.	.	.	.	0.66230	.	.	.	.	0.82092	.	.	0.99973	0.998	.	0.0	0.941906	.	1.0	C	single nucleotide variant	NC_000023.11:g.139561874G>C	.	.	1	0.9920948	.	.	0.9954094	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99756	.	.	-	139561874	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.99533	GRCh38	924	no assertion criteria provided	c.1189G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)		.	FA9_HUMAN	.	100.0	.	.	D	0.94596	0.9955629	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ala397Pro	.	0.99016	.	germline	.		G	May 01, 1998	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031639	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.096493	0.92967	.	D	-	.	.	0.99582	.	.	.	0.98376	.	139561874	Y	10	.	.	.	P00740	.	0.972943	0.89450		.	0.999	D	.	0.992814	.	0.85369	2158	0.702117	.	-4.97	.	.	0.91343	.	.	.	.	.	.	0.99990	X	F9	.	.	Ala	.	.	X-139561874-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471699	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	.	.	.	RCV000011407	D	.	.	c.1189G>C	.	.	.	0.99930	G/G	rs137852281	139561874	.	G	.	P00740	.	0.99970	.	0.68239		.	.	.	4.115	.	.	.	5.66	0.99717	.	D	T	.	.	.	.	.	.	.	98879	10662	0.99930	0.92474	0.999667882919312	.	.	0.71675	.	.	.	.	7.987	.	D	.	.	.	.	306900	0.87843	X	.	ENSG00000101981	.	.	.	.	0.9999893549903599	1	0.92348	0.18019	.	.	.	.	.	YES	.	0.941142	25701	HGNC:3551	A	.	simple_aae	1	.	139561874	GCT	1.000000	.	-	.	0.99843	.	.	.	Pathogenic	0.98777	.	.	.	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	A	.	0.999646589023	-	0.957	-	0.96202	.	.	0.99998	0.694044589996	0.9929	.	0.99810165860495959	.	-	1189G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.78261	137852281	.	.	0.99963	.	0.878	0.0	.	0.99999404	5.66	.	.	.	0.770766	0.999994138420688	0.97347	D	.	.	.	1.1025	0.98562	p.Ala397Pro	.	.	-16.845	0.99310195	.	0.99831	10662	D	.	F9	.	D	0.974	.	A397P	D	.	0.76753	G/G	principal1	202146	F9_Popp_2025_heavy_chain_var238697	No											A		1189	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ala397Pro		true	c.1189G>C						3551.0	139561874.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Ala397Pro						P	May 01, 1998					missense_variant		397.0				0.035248798		Pathogenic	139561874.0	missense_variant		0.974					Reporter			F9_Ala397Pro
F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	NC_000023.11:139561874:G:C	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Ala397Pro	23	139561874	G	C	X											X-139561874-G-C	-	0.85159	1.0	397	.	.	.	X	138644033	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ala397Pro	.	28.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99740	Select	0.9557	.	0.90580	.	.	D	D	.	1.86989205249	.	.	.	.	.	0.66230	.	.	.	.	0.82092	.	.	0.99973	0.998	.	0.0	0.941906	.	1.0	C	single nucleotide variant	NC_000023.11:g.139561874G>C	.	.	1	0.9920948	.	.	0.9954094	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99756	.	.	-	139561874	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.99533	GRCh38	924	no assertion criteria provided	c.1189G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)		.	FA9_HUMAN	.	100.0	.	.	D	0.94596	0.9955629	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ala397Pro	.	0.99016	.	germline	.		G	May 01, 1998	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031639	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.096493	0.92967	.	D	-	.	.	0.99582	.	.	.	0.98376	.	139561874	Y	10	.	.	.	P00740	.	0.972943	0.89450		.	0.999	D	.	0.992814	.	0.85369	2158	0.702117	.	-4.97	.	.	0.91343	.	.	.	.	.	.	0.99990	X	F9	.	.	Ala	.	.	X-139561874-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471699	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	.	.	.	RCV000011407	D	.	.	c.1189G>C	.	.	.	0.99930	G/G	rs137852281	139561874	.	G	.	P00740	.	0.99970	.	0.68239		.	.	.	4.115	.	.	.	5.66	0.99717	.	D	T	.	.	.	.	.	.	.	98879	10662	0.99930	0.92474	0.999667882919312	.	.	0.71675	.	.	.	.	7.987	.	D	.	.	.	.	306900	0.87843	X	.	ENSG00000101981	.	.	.	.	0.9999893549903599	1	0.92348	0.18019	.	.	.	.	.	YES	.	0.941142	25701	HGNC:3551	A	.	simple_aae	1	.	139561874	GCT	1.000000	.	-	.	0.99843	.	.	.	Pathogenic	0.98777	.	.	.	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	A	.	0.999646589023	-	0.957	-	0.96202	.	.	0.99998	0.694044589996	0.9929	.	0.99810165860495959	.	-	1189G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.78261	137852281	.	.	0.99963	.	0.878	0.0	.	0.99999404	5.66	.	.	.	0.770766	0.999994138420688	0.97347	D	.	.	.	1.1025	0.98562	p.Ala397Pro	.	.	-16.845	0.99310195	.	0.99831	10662	D	.	F9	.	D	0.974	.	A397P	D	.	0.76753	G/G	principal1	174630	F9_Popp_2025_carboxy_gla_motif_var258059	No											A		1189	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ala397Pro		true	c.1189G>C						3551.0	139561874.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Ala397Pro						P	May 01, 1998					missense_variant		397.0				0.0229803689198257		Pathogenic	139561874.0	missense_variant		0.974					Reporter			F9_Ala397Pro
F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004392		NC_000023.11:139561874:G:C		Ala397Pro																												F9_Ala397Pro	23	139561874	G	C	X	allele	1189G>C	H04	527_CAVA_Array_P02	O08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561874-G-C	-	0.85159	1.0	397	.	.	.	X	138644033	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ala397Pro	.	28.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99740	Select	0.9557	.	0.90580	.	.	D	D	.	1.86989205249	.	.	.	.	.	0.66230	.	.	.	.	0.82092	.	.	0.99973	0.998	.	0.0	0.941906	.	1.0	C	single nucleotide variant	NC_000023.11:g.139561874G>C	.	.	1	0.9920948	.	.	0.9954094	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99756	.	.	-	139561874	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.99533	GRCh38	924	no assertion criteria provided	c.1189G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)		.	FA9_HUMAN	.	100.0	.	.	D	0.94596	0.9955629	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ala397Pro	.	0.99016	.	germline	.		G	May 01, 1998	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031639	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.096493	0.92967	.	D	-	.	.	0.99582	.	.	.	0.98376	.	139561874	Y	10	.	.	.	P00740	.	0.972943	0.89450		.	0.999	D	.	0.992814	.	0.85369	2158	0.702117	.	-4.97	.	.	0.91343	.	.	.	.	.	.	0.99990	X	F9	.	.	Ala	.	.	X-139561874-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471699	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	.	.	.	RCV000011407	D	.	.	c.1189G>C	.	.	.	0.99930	G/G	rs137852281	139561874	.	G	.	P00740	.	0.99970	.	0.68239		.	.	.	4.115	.	.	.	5.66	0.99717	.	D	T	.	.	.	.	.	.	.	98879	10662	0.99930	0.92474	0.999667882919312	.	.	0.71675	.	.	.	.	7.987	.	D	.	.	.	.	306900	0.87843	X	.	ENSG00000101981	.	.	.	.	0.9999893549903599	1	0.92348	0.18019	.	.	.	.	.	YES	.	0.941142	25701	HGNC:3551	A	.	simple_aae	1	.	139561874	GCT	1.000000	.	-	.	0.99843	.	.	.	Pathogenic	0.98777	.	.	.	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	A	.	0.999646589023	-	0.957	-	0.96202	.	.	0.99998	0.694044589996	0.9929	.	0.99810165860495959	.	-	1189G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.78261	137852281	.	.	0.99963	.	0.878	0.0	.	0.99999404	5.66	.	.	.	0.770766	0.999994138420688	0.97347	D	.	.	.	1.1025	0.98562	p.Ala397Pro	.	.	-16.845	0.99310195	.	0.99831	10662	D	.	F9	.	D	0.974	.	A397P	D	.	0.76753	G/G	principal1	147114	F9_Popp_2025_carboxy_F9_specific_var229016	No											A		1189	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ala397Pro		true	c.1189G>C						3551.0	139561874.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Ala397Pro						P	May 01, 1998					missense_variant		397.0				0.0066197		Pathogenic	139561874.0	missense_variant		0.974					Reporter			F9_Ala397Pro
F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004392		NC_000023.11:139561874:G:C		Ala397Pro																												F9_Ala397Pro	23	139561874	G	C	X	allele	1189G>C	H04	527_CAVA_Array_P02	O08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561874-G-C	-	0.85159	1.0	397	.	.	.	X	138644033	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ala397Pro	.	28.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99740	Select	0.9557	.	0.90580	.	.	D	D	.	1.86989205249	.	.	.	.	.	0.66230	.	.	.	.	0.82092	.	.	0.99973	0.998	.	0.0	0.941906	.	1.0	C	single nucleotide variant	NC_000023.11:g.139561874G>C	.	.	1	0.9920948	.	.	0.9954094	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99756	.	.	-	139561874	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.99533	GRCh38	924	no assertion criteria provided	c.1189G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)		.	FA9_HUMAN	.	100.0	.	.	D	0.94596	0.9955629	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ala397Pro	.	0.99016	.	germline	.		G	May 01, 1998	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031639	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.096493	0.92967	.	D	-	.	.	0.99582	.	.	.	0.98376	.	139561874	Y	10	.	.	.	P00740	.	0.972943	0.89450		.	0.999	D	.	0.992814	.	0.85369	2158	0.702117	.	-4.97	.	.	0.91343	.	.	.	.	.	.	0.99990	X	F9	.	.	Ala	.	.	X-139561874-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471699	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	.	.	.	RCV000011407	D	.	.	c.1189G>C	.	.	.	0.99930	G/G	rs137852281	139561874	.	G	.	P00740	.	0.99970	.	0.68239		.	.	.	4.115	.	.	.	5.66	0.99717	.	D	T	.	.	.	.	.	.	.	98879	10662	0.99930	0.92474	0.999667882919312	.	.	0.71675	.	.	.	.	7.987	.	D	.	.	.	.	306900	0.87843	X	.	ENSG00000101981	.	.	.	.	0.9999893549903599	1	0.92348	0.18019	.	.	.	.	.	YES	.	0.941142	25701	HGNC:3551	A	.	simple_aae	1	.	139561874	GCT	1.000000	.	-	.	0.99843	.	.	.	Pathogenic	0.98777	.	.	.	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	A	.	0.999646589023	-	0.957	-	0.96202	.	.	0.99998	0.694044589996	0.9929	.	0.99810165860495959	.	-	1189G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.78261	137852281	.	.	0.99963	.	0.878	0.0	.	0.99999404	5.66	.	.	.	0.770766	0.999994138420688	0.97347	D	.	.	.	1.1025	0.98562	p.Ala397Pro	.	.	-16.845	0.99310195	.	0.99831	10662	D	.	F9	.	D	0.974	.	A397P	D	.	0.76753	G/G	principal1	229662	F9_Popp_2025_light_chain_var248378	No											A		1189	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ala397Pro		true	c.1189G>C						3551.0	139561874.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Ala397Pro						P	May 01, 1998					missense_variant		397.0				0.015139726		Pathogenic	139561874.0	missense_variant		0.974					Reporter			F9_Ala397Pro
F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004392		NC_000023.11:139561874:G:C		Ala397Pro																												F9_Ala397Pro	23	139561874	G	C	X	allele	1189G>C	H04	527_CAVA_Array_P02	O08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561874-G-C	-	0.85159	1.0	397	.	.	.	X	138644033	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ala397Pro	.	28.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99740	Select	0.9557	.	0.90580	.	.	D	D	.	1.86989205249	.	.	.	.	.	0.66230	.	.	.	.	0.82092	.	.	0.99973	0.998	.	0.0	0.941906	.	1.0	C	single nucleotide variant	NC_000023.11:g.139561874G>C	.	.	1	0.9920948	.	.	0.9954094	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99756	.	.	-	139561874	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.99533	GRCh38	924	no assertion criteria provided	c.1189G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)		.	FA9_HUMAN	.	100.0	.	.	D	0.94596	0.9955629	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ala397Pro	.	0.99016	.	germline	.		G	May 01, 1998	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031639	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.096493	0.92967	.	D	-	.	.	0.99582	.	.	.	0.98376	.	139561874	Y	10	.	.	.	P00740	.	0.972943	0.89450		.	0.999	D	.	0.992814	.	0.85369	2158	0.702117	.	-4.97	.	.	0.91343	.	.	.	.	.	.	0.99990	X	F9	.	.	Ala	.	.	X-139561874-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471699	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	.	.	.	RCV000011407	D	.	.	c.1189G>C	.	.	.	0.99930	G/G	rs137852281	139561874	.	G	.	P00740	.	0.99970	.	0.68239		.	.	.	4.115	.	.	.	5.66	0.99717	.	D	T	.	.	.	.	.	.	.	98879	10662	0.99930	0.92474	0.999667882919312	.	.	0.71675	.	.	.	.	7.987	.	D	.	.	.	.	306900	0.87843	X	.	ENSG00000101981	.	.	.	.	0.9999893549903599	1	0.92348	0.18019	.	.	.	.	.	YES	.	0.941142	25701	HGNC:3551	A	.	simple_aae	1	.	139561874	GCT	1.000000	.	-	.	0.99843	.	.	.	Pathogenic	0.98777	.	.	.	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	A	.	0.999646589023	-	0.957	-	0.96202	.	.	0.99998	0.694044589996	0.9929	.	0.99810165860495959	.	-	1189G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.78261	137852281	.	.	0.99963	.	0.878	0.0	.	0.99999404	5.66	.	.	.	0.770766	0.999994138420688	0.97347	D	.	.	.	1.1025	0.98562	p.Ala397Pro	.	.	-16.845	0.99310195	.	0.99831	10662	D	.	F9	.	D	0.974	.	A397P	D	.	0.76753	G/G	principal1	257178	F9_Popp_2025_strep_2_var267740	No											A		1189	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ala397Pro		true	c.1189G>C						3551.0	139561874.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Ala397Pro						P	May 01, 1998					missense_variant		397.0				0.157050150415891		Pathogenic	139561874.0	missense_variant		0.974					Reporter			F9_Ala397Pro
F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004392		NC_000023.11:139561874:G:C		Ala397Pro																												F9_Ala397Pro	23	139561874	G	C	X	allele	1189G>C	H04	527_CAVA_Array_P02	O08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561874-G-C	-	0.85159	1.0	397	.	.	.	X	138644033	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ala397Pro	.	28.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99740	Select	0.9557	.	0.90580	.	.	D	D	.	1.86989205249	.	.	.	.	.	0.66230	.	.	.	.	0.82092	.	.	0.99973	0.998	.	0.0	0.941906	.	1.0	C	single nucleotide variant	NC_000023.11:g.139561874G>C	.	.	1	0.9920948	.	.	0.9954094	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99756	.	.	-	139561874	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.99533	GRCh38	924	no assertion criteria provided	c.1189G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)		.	FA9_HUMAN	.	100.0	.	.	D	0.94596	0.9955629	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ala397Pro	.	0.99016	.	germline	.		G	May 01, 1998	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031639	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.096493	0.92967	.	D	-	.	.	0.99582	.	.	.	0.98376	.	139561874	Y	10	.	.	.	P00740	.	0.972943	0.89450		.	0.999	D	.	0.992814	.	0.85369	2158	0.702117	.	-4.97	.	.	0.91343	.	.	.	.	.	.	0.99990	X	F9	.	.	Ala	.	.	X-139561874-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471699	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	.	.	.	RCV000011407	D	.	.	c.1189G>C	.	.	.	0.99930	G/G	rs137852281	139561874	.	G	.	P00740	.	0.99970	.	0.68239		.	.	.	4.115	.	.	.	5.66	0.99717	.	D	T	.	.	.	.	.	.	.	98879	10662	0.99930	0.92474	0.999667882919312	.	.	0.71675	.	.	.	.	7.987	.	D	.	.	.	.	306900	0.87843	X	.	ENSG00000101981	.	.	.	.	0.9999893549903599	1	0.92348	0.18019	.	.	.	.	.	YES	.	0.941142	25701	HGNC:3551	A	.	simple_aae	1	.	139561874	GCT	1.000000	.	-	.	0.99843	.	.	.	Pathogenic	0.98777	.	.	.	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	A	.	0.999646589023	-	0.957	-	0.96202	.	.	0.99998	0.694044589996	0.9929	.	0.99810165860495959	.	-	1189G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.78261	137852281	.	.	0.99963	.	0.878	0.0	.	0.99999404	5.66	.	.	.	0.770766	0.999994138420688	0.97347	D	.	.	.	1.1025	0.98562	p.Ala397Pro	.	.	-16.845	0.99310195	.	0.99831	10662	D	.	F9	.	D	0.974	.	A397P	D	.	0.76753	G/G	principal1	202146	F9_Popp_2025_heavy_chain_var238697	No											A		1189	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ala397Pro		true	c.1189G>C						3551.0	139561874.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Ala397Pro						P	May 01, 1998					missense_variant		397.0				0.035248798		Pathogenic	139561874.0	missense_variant		0.974					Reporter			F9_Ala397Pro
F9_Ala397Pro	-2.551530951626418	0.038018558926100524	0.9692244259217453	0.36472147421309253	2025_01_Batch_13-14	0.5545451181694817	0.7444868444254592	0.8364464089596053	0.8371838794420442	0.5250681058540909	0.5231752874300287	0.8454753262793433	0.9380829325557527	0.8888778762014203	0.6901486534189172	0.5388602027997552	0.7949810853524013	0.887264670757679	0.8630308778217323	0.607608379636504	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004392		NC_000023.11:139561874:G:C		Ala397Pro																												F9_Ala397Pro	23	139561874	G	C	X	allele	1189G>C	H04	527_CAVA_Array_P02	O08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561874-G-C	-	0.85159	1.0	397	.	.	.	X	138644033	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ala397Pro	.	28.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99740	Select	0.9557	.	0.90580	.	.	D	D	.	1.86989205249	.	.	.	.	.	0.66230	.	.	.	.	0.82092	.	.	0.99973	0.998	.	0.0	0.941906	.	1.0	C	single nucleotide variant	NC_000023.11:g.139561874G>C	.	.	1	0.9920948	.	.	0.9954094	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99993	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99756	.	.	-	139561874	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.99533	GRCh38	924	no assertion criteria provided	c.1189G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)		.	FA9_HUMAN	.	100.0	.	.	D	0.94596	0.9955629	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Ala397Pro	.	0.99016	.	germline	.		G	May 01, 1998	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031639	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.096493	0.92967	.	D	-	.	.	0.99582	.	.	.	0.98376	.	139561874	Y	10	.	.	.	P00740	.	0.972943	0.89450		.	0.999	D	.	0.992814	.	0.85369	2158	0.702117	.	-4.97	.	.	0.91343	.	.	.	.	.	.	0.99990	X	F9	.	.	Ala	.	.	X-139561874-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471699	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	.	.	.	RCV000011407	D	.	.	c.1189G>C	.	.	.	0.99930	G/G	rs137852281	139561874	.	G	.	P00740	.	0.99970	.	0.68239		.	.	.	4.115	.	.	.	5.66	0.99717	.	D	T	.	.	.	.	.	.	.	98879	10662	0.99930	0.92474	0.999667882919312	.	.	0.71675	.	.	.	.	7.987	.	D	.	.	.	.	306900	0.87843	X	.	ENSG00000101981	.	.	.	.	0.9999893549903599	1	0.92348	0.18019	.	.	.	.	.	YES	.	0.941142	25701	HGNC:3551	A	.	simple_aae	1	.	139561874	GCT	1.000000	.	-	.	0.99843	.	.	.	Pathogenic	0.98777	.	.	.	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	A	.	0.999646589023	-	0.957	-	0.96202	.	.	0.99998	0.694044589996	0.9929	.	0.99810165860495959	.	-	1189G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.78261	137852281	.	.	0.99963	.	0.878	0.0	.	0.99999404	5.66	.	.	.	0.770766	0.999994138420688	0.97347	D	.	.	.	1.1025	0.98562	p.Ala397Pro	.	.	-16.845	0.99310195	.	0.99831	10662	D	.	F9	.	D	0.974	.	A397P	D	.	0.76753	G/G	principal1	174630	F9_Popp_2025_carboxy_gla_motif_var258059	No											A		1189	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ala397Pro		true	c.1189G>C						3551.0	139561874.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Ala397Pro						P	May 01, 1998					missense_variant		397.0				0.0229803689198257		Pathogenic	139561874.0	missense_variant		0.974					Reporter			F9_Ala397Pro
BRCA1_His299Tyr	-2.033763125966286	0.08145918034371533	6.185243760707367	0.00045170431666583454	2025_01_Batch_13-14	0.9752599466533104	0.9407185611386177	0.9348006054634483	0.9749079994982701	0.8284316359193244	0.9839165423156767	0.9528075263033645	0.9500261278288228	0.9865447508415817	0.9324547560605925	0.9795882444844936	0.9467630437209911	0.9424133666461356	0.9807263751699259	0.8804431959899585	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011806		NC_000017.11:43082557:G:A		His299Tyr																												BRCA1_His299Tyr	17	43082557	G	A	17	allele	895C>T	C08	527_CAVA_Array_P01	E15	B13A7A8P1_R1	B14A7A8P1_R2				17-43082557-G-A	-	0.44401	0.019	1402	0	1	0	17	41234574	A	2.788070e-05	0	17	2_Benign	NC_000017.11	41	His1402Tyr	0	21.9	0	0	.	T	0	15	1	42768	4.222690e-06	.	30526	0.000000e+00	0	0.70364	.	0.3229	.	0.18002	0	.	T	T	63994	.	0	0	0.000000e+00	0	.	0.28977	17112	44900	0	0.000000e+00	0.40464	0	.	0.03337	0.79	.	.	.	3.41	.	A	single nucleotide variant	NC_000017.11:g.43082557G>A	0	16728	2	0.04356669	109398	0	0.035931196	0		1	236816	0	0	0.000000e+00	500	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0700268,MedGen:CN377757|	1	0	0.000000e+00	0	0.21442	B	0.07661	B	N	1.052213	45	G/G	108	0	7164	1614020	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|BRCA1-related cancer predisposition|BRCA1-related disorder	16218	0.56959	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43082557	.	-	2.733000	0	0.48657	29606	0	1180040	0	germline;unknown	91084	Loss of catalytic residue at L1404 (P = 0.0693)| Loss of ubiquitination at K1406 (P = 0.071)| Gain of methylation at K1406 (P = 0.1374)| Loss of disorder (P = 0.146)| Loss of phosphorylation at T1399 (P = 0.2256)	0.07846	GRCh38	520	reviewed by expert panel	.	0.000000e+00	0.51962	1	0	0	.	0.000000e+00	9042	.	0	3.377690e-05	NM_007294.4(BRCA1):c.4204C>T (p.His1402Tyr)	3	0	BRCA1_HUMAN	0	.	-0.564913128253644	0	.	0.23217	0.032783277	-	0.000000e+00	.		.	0.000000e+00	0	34260	reviewed_by_expert_panel	0.94420	9.140930e-06	0	0.000000e+00	0	59998	.	0	0.34485	.	germline	.		C	Aug 10, 2015	0	G/G	0	89540	0.996	N	17q21.31	24490	.	0.000000e+00	SCV000244356	Benign	0	0	Tyr	Y	-	912	ENSP00000419103	ENST00000494123	17680	.	13404	0	-0.805	G	0	3.245445	0.37649	N	.	-	1.490904	.	0.72087	628	0	.	0.18287	0	43082557	Y	10	0	102644	0.000000e+00	P38398	0	0.086384	0.34893		.	0.023	D	.	0.049696308	.	0.37345	672	0.0446199	41	.	.	3.474460e-05	0.27673	0.000000e+00	0	74914	0.000000e+00	6084	0	0.05464	17	BRCA1	1.334860e-05	0	His	33208	0.000000e+00	17-43082557-G-A	Hereditary_cancer-predisposing_syndrome|BRCA1-related_disorder|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_specified	0	0	38488100	BRCA1-HCI:BRCA1_00085|ClinGen:CA002707	0.283041	0.19776	0	RCV000048486|RCV000083205|RCV000162983|RCV000254639|RCV001087632|RCV004803996|RCV004554674	.	0	0	c.4204C>T	0	0	0	0.57354	G/G	rs80357365	43082557	14902	G	.	E9PFC7	15690	0.04282	0.000000e+00	0.68239		0	0	0.000000e+00	-0.345	0	1	264690	4.38	0.37435	108	T	T	0	0.000000e+00	0	24	.	0	0	140162|145|145	55140	0.56807	0.12517	0.169085681438446	2836	.	0.3946	0.39425	0.000000e+00	.	1180040	1.739	4.805470e-06	.	13388	.	2.644603E-5	0	604370	0.37947	17	0.000000e+00	ENSG00000012048	0.000000e+00	4.083299305839118E-5	0	0	.	1	0.19965	0.74375	30608	7	0.000000e+00	0.000000e+00	-0.336469916680358	.	0.000000e+00	0.075011	69807	HGNC:1100	.	0	.	0.22	208096	43082557	CAT	1.000000	.	-	0	0.14597	3.474460e-05	0	0	Benign	0.39583	0	0	0	BRCA1-HCI:BRCA1_00085,ClinGen:CA002707	H	0	.	-	0.173	-	0.37578	1	4552	0.05014	0.428560256958	.	0	0.97578969279789363	94	-	4204C>T 	.	0	C0027672|C0677776|C3661900|C2676676|CN169374	0	0	0	0	NM_007294.4	-	.	.	0	0.31359	80357365	2320	3.0113225728740063E-5	0.55302	0.26612	.	.	2728	0.96681190	5.35	.	.	0.000000e+00	-0.173683	0.00428760772610033	0.03334	T	84	6210	9568	-0.7649	0.69047	p.His1402Tyr	0	0	-4.172	.	1	0.17785	55140	T	30524	BRCA1	0.000000e+00	T	.	21626	H1402Y	.	0.61757	0.03126	G/G	principal2																																																																																																				
F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406763	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696463	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro414Thr	23	139561925	C	A	X											X-139561925-C-A	-	0.67023	1.0	414	.	.	.	X	138644084	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro414Thr	.	25.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99990	Select	0.9807	.	0.90580	.	.	D	D	.	1.73687855107	0	.	.	.	.	0.51248	.	.	.	.	0.96333	.	.	0.99846	0.964	.	5.0	0.982202	4.11	0.95	A	single nucleotide variant	NC_000023.11:g.139561925C>A	.	.	1	0.9748375	.	0	0.987573	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99835	D	H	.	.	C/C	84	0	.	.	Hereditary factor IX deficiency disease	.	0.98204	.	.	-	139561925	.	-	4.925000	.	0.99985	.	0	.	.	germline	.	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.99784	GRCh38	924	no assertion criteria provided	c.1240C>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)		.	FA9_HUMAN	.	95.0	.	.	D	0.82559	0.9917446	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro414Thr	.	0.46154	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031598	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.599	C	.	4.356568	0.92967	.	D	-	.	.	0.99553	610	.	.	0.99358	0	139561925	Y	10	0	.	.	P00740	.	0.971606	0.83867		.	0.999	D	.	0.98076874	.	0.52647	2158	0.735212	.	-7.95	.	.	0.91343	.	.	.	.	.	.	0.99652	X	F9	.	0	Pro	11340	.	X-139561925-C-A	Hereditary_factor_IX_deficiency_disease	.	.	138471750	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	.	.	.	RCV000011366	D	.	.	c.1240C>A	.	.	.	0.99960	C/C	rs137852265	139561925	.	C	.	P00740	.	0.99622	.	0.68239		.	.	.	4.135	0	0	264690	5.66	0.99695	142	D	T	.	.	0	24	.	.	.	98879	10620	0.99960	0.90779	0.999857425689697	2728	.	0.71675	.	.	.	.	7.879	.	D	.	.	1.51120175E-5	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9997634824830927	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.93761	25659	HGNC:3551	A	.	simple_aae	1	.	139561925	CCC	1.000000	.	-	0	0.99972	.	0	.	Pathogenic	0.89696	.	.	.	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	P	.	0.999276639572	-	0.977	-	0.97441	.	574	0.99976	0.588735103607	0.8299	.	0.99745405639585871	100	-	1240C>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.94194	137852265	.	0	0.99925	.	0.904	0.0	2644	0.99999330	5.66	.	.	.	0.818304	0.999697756973981	0.97453	D	118	.	.	1.0542	0.99405	p.Pro414Thr	0	.	-13.076	0.995023	.	0.97521	10620	D	.	F9	.	D	0.993	.	P414T	D	0.78390	0.40292	C/C	principal1	203179	F9_Popp_2025_heavy_chain_var239049	No											P		1240	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Pro414Thr		true	c.1240C>A						3551.0	139561925.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Pro414Thr						T	Oct 09, 2017					missense_variant		414.0				0.9854773236553624		Pathogenic	139561925.0	missense_variant		0.993					Reporter			F9_Pro414Thr
F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406763	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696463	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro414Thr	23	139561925	C	A	X											X-139561925-C-A	-	0.67023	1.0	414	.	.	.	X	138644084	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro414Thr	.	25.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99990	Select	0.9807	.	0.90580	.	.	D	D	.	1.73687855107	0	.	.	.	.	0.51248	.	.	.	.	0.96333	.	.	0.99846	0.964	.	5.0	0.982202	4.11	0.95	A	single nucleotide variant	NC_000023.11:g.139561925C>A	.	.	1	0.9748375	.	0	0.987573	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99835	D	H	.	.	C/C	84	0	.	.	Hereditary factor IX deficiency disease	.	0.98204	.	.	-	139561925	.	-	4.925000	.	0.99985	.	0	.	.	germline	.	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.99784	GRCh38	924	no assertion criteria provided	c.1240C>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)		.	FA9_HUMAN	.	95.0	.	.	D	0.82559	0.9917446	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro414Thr	.	0.46154	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031598	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.599	C	.	4.356568	0.92967	.	D	-	.	.	0.99553	610	.	.	0.99358	0	139561925	Y	10	0	.	.	P00740	.	0.971606	0.83867		.	0.999	D	.	0.98076874	.	0.52647	2158	0.735212	.	-7.95	.	.	0.91343	.	.	.	.	.	.	0.99652	X	F9	.	0	Pro	11340	.	X-139561925-C-A	Hereditary_factor_IX_deficiency_disease	.	.	138471750	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	.	.	.	RCV000011366	D	.	.	c.1240C>A	.	.	.	0.99960	C/C	rs137852265	139561925	.	C	.	P00740	.	0.99622	.	0.68239		.	.	.	4.135	0	0	264690	5.66	0.99695	142	D	T	.	.	0	24	.	.	.	98879	10620	0.99960	0.90779	0.999857425689697	2728	.	0.71675	.	.	.	.	7.879	.	D	.	.	1.51120175E-5	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9997634824830927	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.93761	25659	HGNC:3551	A	.	simple_aae	1	.	139561925	CCC	1.000000	.	-	0	0.99972	.	0	.	Pathogenic	0.89696	.	.	.	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	P	.	0.999276639572	-	0.977	-	0.97441	.	574	0.99976	0.588735103607	0.8299	.	0.99745405639585871	100	-	1240C>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.94194	137852265	.	0	0.99925	.	0.904	0.0	2644	0.99999330	5.66	.	.	.	0.818304	0.999697756973981	0.97453	D	118	.	.	1.0542	0.99405	p.Pro414Thr	0	.	-13.076	0.995023	.	0.97521	10620	D	.	F9	.	D	0.993	.	P414T	D	0.78390	0.40292	C/C	principal1	258211	F9_Popp_2025_strep_2_var268092	No											P		1240	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Pro414Thr		true	c.1240C>A						3551.0	139561925.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Pro414Thr						T	Oct 09, 2017					missense_variant		414.0				1.2386178883226602		Pathogenic	139561925.0	missense_variant		0.993					Reporter			F9_Pro414Thr
F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406763	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696463	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro414Thr	23	139561925	C	A	X											X-139561925-C-A	-	0.67023	1.0	414	.	.	.	X	138644084	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro414Thr	.	25.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99990	Select	0.9807	.	0.90580	.	.	D	D	.	1.73687855107	0	.	.	.	.	0.51248	.	.	.	.	0.96333	.	.	0.99846	0.964	.	5.0	0.982202	4.11	0.95	A	single nucleotide variant	NC_000023.11:g.139561925C>A	.	.	1	0.9748375	.	0	0.987573	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99835	D	H	.	.	C/C	84	0	.	.	Hereditary factor IX deficiency disease	.	0.98204	.	.	-	139561925	.	-	4.925000	.	0.99985	.	0	.	.	germline	.	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.99784	GRCh38	924	no assertion criteria provided	c.1240C>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)		.	FA9_HUMAN	.	95.0	.	.	D	0.82559	0.9917446	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro414Thr	.	0.46154	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031598	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.599	C	.	4.356568	0.92967	.	D	-	.	.	0.99553	610	.	.	0.99358	0	139561925	Y	10	0	.	.	P00740	.	0.971606	0.83867		.	0.999	D	.	0.98076874	.	0.52647	2158	0.735212	.	-7.95	.	.	0.91343	.	.	.	.	.	.	0.99652	X	F9	.	0	Pro	11340	.	X-139561925-C-A	Hereditary_factor_IX_deficiency_disease	.	.	138471750	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	.	.	.	RCV000011366	D	.	.	c.1240C>A	.	.	.	0.99960	C/C	rs137852265	139561925	.	C	.	P00740	.	0.99622	.	0.68239		.	.	.	4.135	0	0	264690	5.66	0.99695	142	D	T	.	.	0	24	.	.	.	98879	10620	0.99960	0.90779	0.999857425689697	2728	.	0.71675	.	.	.	.	7.879	.	D	.	.	1.51120175E-5	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9997634824830927	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.93761	25659	HGNC:3551	A	.	simple_aae	1	.	139561925	CCC	1.000000	.	-	0	0.99972	.	0	.	Pathogenic	0.89696	.	.	.	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	P	.	0.999276639572	-	0.977	-	0.97441	.	574	0.99976	0.588735103607	0.8299	.	0.99745405639585871	100	-	1240C>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.94194	137852265	.	0	0.99925	.	0.904	0.0	2644	0.99999330	5.66	.	.	.	0.818304	0.999697756973981	0.97453	D	118	.	.	1.0542	0.99405	p.Pro414Thr	0	.	-13.076	0.995023	.	0.97521	10620	D	.	F9	.	D	0.993	.	P414T	D	0.78390	0.40292	C/C	principal1	148147	F9_Popp_2025_carboxy_F9_specific_var229368	No											P		1240	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Pro414Thr		true	c.1240C>A						3551.0	139561925.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Pro414Thr						T	Oct 09, 2017					missense_variant		414.0				1.0132851938930971		Pathogenic	139561925.0	missense_variant		0.993					Reporter			F9_Pro414Thr
F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406763	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696463	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro414Thr	23	139561925	C	A	X											X-139561925-C-A	-	0.67023	1.0	414	.	.	.	X	138644084	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro414Thr	.	25.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99990	Select	0.9807	.	0.90580	.	.	D	D	.	1.73687855107	0	.	.	.	.	0.51248	.	.	.	.	0.96333	.	.	0.99846	0.964	.	5.0	0.982202	4.11	0.95	A	single nucleotide variant	NC_000023.11:g.139561925C>A	.	.	1	0.9748375	.	0	0.987573	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99835	D	H	.	.	C/C	84	0	.	.	Hereditary factor IX deficiency disease	.	0.98204	.	.	-	139561925	.	-	4.925000	.	0.99985	.	0	.	.	germline	.	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.99784	GRCh38	924	no assertion criteria provided	c.1240C>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)		.	FA9_HUMAN	.	95.0	.	.	D	0.82559	0.9917446	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro414Thr	.	0.46154	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031598	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.599	C	.	4.356568	0.92967	.	D	-	.	.	0.99553	610	.	.	0.99358	0	139561925	Y	10	0	.	.	P00740	.	0.971606	0.83867		.	0.999	D	.	0.98076874	.	0.52647	2158	0.735212	.	-7.95	.	.	0.91343	.	.	.	.	.	.	0.99652	X	F9	.	0	Pro	11340	.	X-139561925-C-A	Hereditary_factor_IX_deficiency_disease	.	.	138471750	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	.	.	.	RCV000011366	D	.	.	c.1240C>A	.	.	.	0.99960	C/C	rs137852265	139561925	.	C	.	P00740	.	0.99622	.	0.68239		.	.	.	4.135	0	0	264690	5.66	0.99695	142	D	T	.	.	0	24	.	.	.	98879	10620	0.99960	0.90779	0.999857425689697	2728	.	0.71675	.	.	.	.	7.879	.	D	.	.	1.51120175E-5	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9997634824830927	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.93761	25659	HGNC:3551	A	.	simple_aae	1	.	139561925	CCC	1.000000	.	-	0	0.99972	.	0	.	Pathogenic	0.89696	.	.	.	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	P	.	0.999276639572	-	0.977	-	0.97441	.	574	0.99976	0.588735103607	0.8299	.	0.99745405639585871	100	-	1240C>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.94194	137852265	.	0	0.99925	.	0.904	0.0	2644	0.99999330	5.66	.	.	.	0.818304	0.999697756973981	0.97453	D	118	.	.	1.0542	0.99405	p.Pro414Thr	0	.	-13.076	0.995023	.	0.97521	10620	D	.	F9	.	D	0.993	.	P414T	D	0.78390	0.40292	C/C	principal1	230695	F9_Popp_2025_light_chain_var248730	No											P		1240	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Pro414Thr		true	c.1240C>A						3551.0	139561925.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Pro414Thr						T	Oct 09, 2017					missense_variant		414.0				0.980100509		Pathogenic	139561925.0	missense_variant		0.993					Reporter			F9_Pro414Thr
F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406763	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696463	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	NC_000023.11:139561925:C:A	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro414Thr	23	139561925	C	A	X											X-139561925-C-A	-	0.67023	1.0	414	.	.	.	X	138644084	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro414Thr	.	25.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99990	Select	0.9807	.	0.90580	.	.	D	D	.	1.73687855107	0	.	.	.	.	0.51248	.	.	.	.	0.96333	.	.	0.99846	0.964	.	5.0	0.982202	4.11	0.95	A	single nucleotide variant	NC_000023.11:g.139561925C>A	.	.	1	0.9748375	.	0	0.987573	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99835	D	H	.	.	C/C	84	0	.	.	Hereditary factor IX deficiency disease	.	0.98204	.	.	-	139561925	.	-	4.925000	.	0.99985	.	0	.	.	germline	.	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.99784	GRCh38	924	no assertion criteria provided	c.1240C>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)		.	FA9_HUMAN	.	95.0	.	.	D	0.82559	0.9917446	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro414Thr	.	0.46154	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031598	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.599	C	.	4.356568	0.92967	.	D	-	.	.	0.99553	610	.	.	0.99358	0	139561925	Y	10	0	.	.	P00740	.	0.971606	0.83867		.	0.999	D	.	0.98076874	.	0.52647	2158	0.735212	.	-7.95	.	.	0.91343	.	.	.	.	.	.	0.99652	X	F9	.	0	Pro	11340	.	X-139561925-C-A	Hereditary_factor_IX_deficiency_disease	.	.	138471750	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	.	.	.	RCV000011366	D	.	.	c.1240C>A	.	.	.	0.99960	C/C	rs137852265	139561925	.	C	.	P00740	.	0.99622	.	0.68239		.	.	.	4.135	0	0	264690	5.66	0.99695	142	D	T	.	.	0	24	.	.	.	98879	10620	0.99960	0.90779	0.999857425689697	2728	.	0.71675	.	.	.	.	7.879	.	D	.	.	1.51120175E-5	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9997634824830927	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.93761	25659	HGNC:3551	A	.	simple_aae	1	.	139561925	CCC	1.000000	.	-	0	0.99972	.	0	.	Pathogenic	0.89696	.	.	.	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	P	.	0.999276639572	-	0.977	-	0.97441	.	574	0.99976	0.588735103607	0.8299	.	0.99745405639585871	100	-	1240C>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.94194	137852265	.	0	0.99925	.	0.904	0.0	2644	0.99999330	5.66	.	.	.	0.818304	0.999697756973981	0.97453	D	118	.	.	1.0542	0.99405	p.Pro414Thr	0	.	-13.076	0.995023	.	0.97521	10620	D	.	F9	.	D	0.993	.	P414T	D	0.78390	0.40292	C/C	principal1	175663	F9_Popp_2025_carboxy_gla_motif_var258411	No											P		1240	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Pro414Thr		true	c.1240C>A						3551.0	139561925.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Pro414Thr						T	Oct 09, 2017					missense_variant		414.0				0.9262422536804956		Pathogenic	139561925.0	missense_variant		0.993					Reporter			F9_Pro414Thr
F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406763	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696463	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004396		NC_000023.11:139561925:C:A		Pro414Thr																												F9_Pro414Thr	23	139561925	C	A	X	allele	1240C>A	D05	527_CAVA_Array_P02	G10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561925-C-A	-	0.67023	1.0	414	.	.	.	X	138644084	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro414Thr	.	25.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99990	Select	0.9807	.	0.90580	.	.	D	D	.	1.73687855107	0	.	.	.	.	0.51248	.	.	.	.	0.96333	.	.	0.99846	0.964	.	5.0	0.982202	4.11	0.95	A	single nucleotide variant	NC_000023.11:g.139561925C>A	.	.	1	0.9748375	.	0	0.987573	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99835	D	H	.	.	C/C	84	0	.	.	Hereditary factor IX deficiency disease	.	0.98204	.	.	-	139561925	.	-	4.925000	.	0.99985	.	0	.	.	germline	.	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.99784	GRCh38	924	no assertion criteria provided	c.1240C>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)		.	FA9_HUMAN	.	95.0	.	.	D	0.82559	0.9917446	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro414Thr	.	0.46154	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031598	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.599	C	.	4.356568	0.92967	.	D	-	.	.	0.99553	610	.	.	0.99358	0	139561925	Y	10	0	.	.	P00740	.	0.971606	0.83867		.	0.999	D	.	0.98076874	.	0.52647	2158	0.735212	.	-7.95	.	.	0.91343	.	.	.	.	.	.	0.99652	X	F9	.	0	Pro	11340	.	X-139561925-C-A	Hereditary_factor_IX_deficiency_disease	.	.	138471750	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	.	.	.	RCV000011366	D	.	.	c.1240C>A	.	.	.	0.99960	C/C	rs137852265	139561925	.	C	.	P00740	.	0.99622	.	0.68239		.	.	.	4.135	0	0	264690	5.66	0.99695	142	D	T	.	.	0	24	.	.	.	98879	10620	0.99960	0.90779	0.999857425689697	2728	.	0.71675	.	.	.	.	7.879	.	D	.	.	1.51120175E-5	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9997634824830927	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.93761	25659	HGNC:3551	A	.	simple_aae	1	.	139561925	CCC	1.000000	.	-	0	0.99972	.	0	.	Pathogenic	0.89696	.	.	.	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	P	.	0.999276639572	-	0.977	-	0.97441	.	574	0.99976	0.588735103607	0.8299	.	0.99745405639585871	100	-	1240C>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.94194	137852265	.	0	0.99925	.	0.904	0.0	2644	0.99999330	5.66	.	.	.	0.818304	0.999697756973981	0.97453	D	118	.	.	1.0542	0.99405	p.Pro414Thr	0	.	-13.076	0.995023	.	0.97521	10620	D	.	F9	.	D	0.993	.	P414T	D	0.78390	0.40292	C/C	principal1	203179	F9_Popp_2025_heavy_chain_var239049	No											P		1240	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Pro414Thr		true	c.1240C>A						3551.0	139561925.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Pro414Thr						T	Oct 09, 2017					missense_variant		414.0				0.9854773236553624		Pathogenic	139561925.0	missense_variant		0.993					Reporter			F9_Pro414Thr
F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406763	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696463	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004396		NC_000023.11:139561925:C:A		Pro414Thr																												F9_Pro414Thr	23	139561925	C	A	X	allele	1240C>A	D05	527_CAVA_Array_P02	G10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561925-C-A	-	0.67023	1.0	414	.	.	.	X	138644084	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro414Thr	.	25.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99990	Select	0.9807	.	0.90580	.	.	D	D	.	1.73687855107	0	.	.	.	.	0.51248	.	.	.	.	0.96333	.	.	0.99846	0.964	.	5.0	0.982202	4.11	0.95	A	single nucleotide variant	NC_000023.11:g.139561925C>A	.	.	1	0.9748375	.	0	0.987573	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99835	D	H	.	.	C/C	84	0	.	.	Hereditary factor IX deficiency disease	.	0.98204	.	.	-	139561925	.	-	4.925000	.	0.99985	.	0	.	.	germline	.	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.99784	GRCh38	924	no assertion criteria provided	c.1240C>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)		.	FA9_HUMAN	.	95.0	.	.	D	0.82559	0.9917446	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro414Thr	.	0.46154	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031598	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.599	C	.	4.356568	0.92967	.	D	-	.	.	0.99553	610	.	.	0.99358	0	139561925	Y	10	0	.	.	P00740	.	0.971606	0.83867		.	0.999	D	.	0.98076874	.	0.52647	2158	0.735212	.	-7.95	.	.	0.91343	.	.	.	.	.	.	0.99652	X	F9	.	0	Pro	11340	.	X-139561925-C-A	Hereditary_factor_IX_deficiency_disease	.	.	138471750	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	.	.	.	RCV000011366	D	.	.	c.1240C>A	.	.	.	0.99960	C/C	rs137852265	139561925	.	C	.	P00740	.	0.99622	.	0.68239		.	.	.	4.135	0	0	264690	5.66	0.99695	142	D	T	.	.	0	24	.	.	.	98879	10620	0.99960	0.90779	0.999857425689697	2728	.	0.71675	.	.	.	.	7.879	.	D	.	.	1.51120175E-5	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9997634824830927	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.93761	25659	HGNC:3551	A	.	simple_aae	1	.	139561925	CCC	1.000000	.	-	0	0.99972	.	0	.	Pathogenic	0.89696	.	.	.	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	P	.	0.999276639572	-	0.977	-	0.97441	.	574	0.99976	0.588735103607	0.8299	.	0.99745405639585871	100	-	1240C>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.94194	137852265	.	0	0.99925	.	0.904	0.0	2644	0.99999330	5.66	.	.	.	0.818304	0.999697756973981	0.97453	D	118	.	.	1.0542	0.99405	p.Pro414Thr	0	.	-13.076	0.995023	.	0.97521	10620	D	.	F9	.	D	0.993	.	P414T	D	0.78390	0.40292	C/C	principal1	258211	F9_Popp_2025_strep_2_var268092	No											P		1240	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Pro414Thr		true	c.1240C>A						3551.0	139561925.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Pro414Thr						T	Oct 09, 2017					missense_variant		414.0				1.2386178883226602		Pathogenic	139561925.0	missense_variant		0.993					Reporter			F9_Pro414Thr
F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406763	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696463	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004396		NC_000023.11:139561925:C:A		Pro414Thr																												F9_Pro414Thr	23	139561925	C	A	X	allele	1240C>A	D05	527_CAVA_Array_P02	G10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561925-C-A	-	0.67023	1.0	414	.	.	.	X	138644084	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro414Thr	.	25.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99990	Select	0.9807	.	0.90580	.	.	D	D	.	1.73687855107	0	.	.	.	.	0.51248	.	.	.	.	0.96333	.	.	0.99846	0.964	.	5.0	0.982202	4.11	0.95	A	single nucleotide variant	NC_000023.11:g.139561925C>A	.	.	1	0.9748375	.	0	0.987573	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99835	D	H	.	.	C/C	84	0	.	.	Hereditary factor IX deficiency disease	.	0.98204	.	.	-	139561925	.	-	4.925000	.	0.99985	.	0	.	.	germline	.	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.99784	GRCh38	924	no assertion criteria provided	c.1240C>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)		.	FA9_HUMAN	.	95.0	.	.	D	0.82559	0.9917446	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro414Thr	.	0.46154	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031598	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.599	C	.	4.356568	0.92967	.	D	-	.	.	0.99553	610	.	.	0.99358	0	139561925	Y	10	0	.	.	P00740	.	0.971606	0.83867		.	0.999	D	.	0.98076874	.	0.52647	2158	0.735212	.	-7.95	.	.	0.91343	.	.	.	.	.	.	0.99652	X	F9	.	0	Pro	11340	.	X-139561925-C-A	Hereditary_factor_IX_deficiency_disease	.	.	138471750	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	.	.	.	RCV000011366	D	.	.	c.1240C>A	.	.	.	0.99960	C/C	rs137852265	139561925	.	C	.	P00740	.	0.99622	.	0.68239		.	.	.	4.135	0	0	264690	5.66	0.99695	142	D	T	.	.	0	24	.	.	.	98879	10620	0.99960	0.90779	0.999857425689697	2728	.	0.71675	.	.	.	.	7.879	.	D	.	.	1.51120175E-5	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9997634824830927	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.93761	25659	HGNC:3551	A	.	simple_aae	1	.	139561925	CCC	1.000000	.	-	0	0.99972	.	0	.	Pathogenic	0.89696	.	.	.	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	P	.	0.999276639572	-	0.977	-	0.97441	.	574	0.99976	0.588735103607	0.8299	.	0.99745405639585871	100	-	1240C>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.94194	137852265	.	0	0.99925	.	0.904	0.0	2644	0.99999330	5.66	.	.	.	0.818304	0.999697756973981	0.97453	D	118	.	.	1.0542	0.99405	p.Pro414Thr	0	.	-13.076	0.995023	.	0.97521	10620	D	.	F9	.	D	0.993	.	P414T	D	0.78390	0.40292	C/C	principal1	148147	F9_Popp_2025_carboxy_F9_specific_var229368	No											P		1240	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Pro414Thr		true	c.1240C>A						3551.0	139561925.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Pro414Thr						T	Oct 09, 2017					missense_variant		414.0				1.0132851938930971		Pathogenic	139561925.0	missense_variant		0.993					Reporter			F9_Pro414Thr
F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406763	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696463	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004396		NC_000023.11:139561925:C:A		Pro414Thr																												F9_Pro414Thr	23	139561925	C	A	X	allele	1240C>A	D05	527_CAVA_Array_P02	G10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561925-C-A	-	0.67023	1.0	414	.	.	.	X	138644084	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro414Thr	.	25.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99990	Select	0.9807	.	0.90580	.	.	D	D	.	1.73687855107	0	.	.	.	.	0.51248	.	.	.	.	0.96333	.	.	0.99846	0.964	.	5.0	0.982202	4.11	0.95	A	single nucleotide variant	NC_000023.11:g.139561925C>A	.	.	1	0.9748375	.	0	0.987573	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99835	D	H	.	.	C/C	84	0	.	.	Hereditary factor IX deficiency disease	.	0.98204	.	.	-	139561925	.	-	4.925000	.	0.99985	.	0	.	.	germline	.	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.99784	GRCh38	924	no assertion criteria provided	c.1240C>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)		.	FA9_HUMAN	.	95.0	.	.	D	0.82559	0.9917446	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro414Thr	.	0.46154	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031598	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.599	C	.	4.356568	0.92967	.	D	-	.	.	0.99553	610	.	.	0.99358	0	139561925	Y	10	0	.	.	P00740	.	0.971606	0.83867		.	0.999	D	.	0.98076874	.	0.52647	2158	0.735212	.	-7.95	.	.	0.91343	.	.	.	.	.	.	0.99652	X	F9	.	0	Pro	11340	.	X-139561925-C-A	Hereditary_factor_IX_deficiency_disease	.	.	138471750	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	.	.	.	RCV000011366	D	.	.	c.1240C>A	.	.	.	0.99960	C/C	rs137852265	139561925	.	C	.	P00740	.	0.99622	.	0.68239		.	.	.	4.135	0	0	264690	5.66	0.99695	142	D	T	.	.	0	24	.	.	.	98879	10620	0.99960	0.90779	0.999857425689697	2728	.	0.71675	.	.	.	.	7.879	.	D	.	.	1.51120175E-5	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9997634824830927	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.93761	25659	HGNC:3551	A	.	simple_aae	1	.	139561925	CCC	1.000000	.	-	0	0.99972	.	0	.	Pathogenic	0.89696	.	.	.	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	P	.	0.999276639572	-	0.977	-	0.97441	.	574	0.99976	0.588735103607	0.8299	.	0.99745405639585871	100	-	1240C>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.94194	137852265	.	0	0.99925	.	0.904	0.0	2644	0.99999330	5.66	.	.	.	0.818304	0.999697756973981	0.97453	D	118	.	.	1.0542	0.99405	p.Pro414Thr	0	.	-13.076	0.995023	.	0.97521	10620	D	.	F9	.	D	0.993	.	P414T	D	0.78390	0.40292	C/C	principal1	230695	F9_Popp_2025_light_chain_var248730	No											P		1240	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Pro414Thr		true	c.1240C>A						3551.0	139561925.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Pro414Thr						T	Oct 09, 2017					missense_variant		414.0				0.980100509		Pathogenic	139561925.0	missense_variant		0.993					Reporter			F9_Pro414Thr
F9_Pro414Thr	-1.1216143046907852	0.29902269163657036	3.086613266343835	0.017650700472202088	2025_01_Batch_13-14	0.7411643768406763	0.5713085317690365	0.5122464098145436	0.6850563500483203	0.6121885811580178	0.6182419183696463	0.5398481381545175	0.5425375344051167	0.5000063947567659	0.569220487089082	0.6797031476051613	0.555578334961777	0.5273919721098301	0.5925313724025432	0.59070453412355	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004396		NC_000023.11:139561925:C:A		Pro414Thr																												F9_Pro414Thr	23	139561925	C	A	X	allele	1240C>A	D05	527_CAVA_Array_P02	G10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561925-C-A	-	0.67023	1.0	414	.	.	.	X	138644084	A	.	.	X	1_Pathogenic	NC_000023.11	.	Pro414Thr	.	25.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99990	Select	0.9807	.	0.90580	.	.	D	D	.	1.73687855107	0	.	.	.	.	0.51248	.	.	.	.	0.96333	.	.	0.99846	0.964	.	5.0	0.982202	4.11	0.95	A	single nucleotide variant	NC_000023.11:g.139561925C>A	.	.	1	0.9748375	.	0	0.987573	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99835	D	H	.	.	C/C	84	0	.	.	Hereditary factor IX deficiency disease	.	0.98204	.	.	-	139561925	.	-	4.925000	.	0.99985	.	0	.	.	germline	.	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.99784	GRCh38	924	no assertion criteria provided	c.1240C>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)		.	FA9_HUMAN	.	95.0	.	.	D	0.82559	0.9917446	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro414Thr	.	0.46154	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031598	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.599	C	.	4.356568	0.92967	.	D	-	.	.	0.99553	610	.	.	0.99358	0	139561925	Y	10	0	.	.	P00740	.	0.971606	0.83867		.	0.999	D	.	0.98076874	.	0.52647	2158	0.735212	.	-7.95	.	.	0.91343	.	.	.	.	.	.	0.99652	X	F9	.	0	Pro	11340	.	X-139561925-C-A	Hereditary_factor_IX_deficiency_disease	.	.	138471750	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	.	.	.	RCV000011366	D	.	.	c.1240C>A	.	.	.	0.99960	C/C	rs137852265	139561925	.	C	.	P00740	.	0.99622	.	0.68239		.	.	.	4.135	0	0	264690	5.66	0.99695	142	D	T	.	.	0	24	.	.	.	98879	10620	0.99960	0.90779	0.999857425689697	2728	.	0.71675	.	.	.	.	7.879	.	D	.	.	1.51120175E-5	0	306900	0.8573	X	.	ENSG00000101981	.	0	.	0	0.9997634824830927	1	0.92348	0.18019	.	4	.	.	.	YES	.	0.93761	25659	HGNC:3551	A	.	simple_aae	1	.	139561925	CCC	1.000000	.	-	0	0.99972	.	0	.	Pathogenic	0.89696	.	.	.	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	P	.	0.999276639572	-	0.977	-	0.97441	.	574	0.99976	0.588735103607	0.8299	.	0.99745405639585871	100	-	1240C>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.94194	137852265	.	0	0.99925	.	0.904	0.0	2644	0.99999330	5.66	.	.	.	0.818304	0.999697756973981	0.97453	D	118	.	.	1.0542	0.99405	p.Pro414Thr	0	.	-13.076	0.995023	.	0.97521	10620	D	.	F9	.	D	0.993	.	P414T	D	0.78390	0.40292	C/C	principal1	175663	F9_Popp_2025_carboxy_gla_motif_var258411	No											P		1240	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Pro414Thr		true	c.1240C>A						3551.0	139561925.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Pro414Thr						T	Oct 09, 2017					missense_variant		414.0				0.9262422536804956		Pathogenic	139561925.0	missense_variant		0.993					Reporter			F9_Pro414Thr
FH_Asn340Lys	10.63377390618422	0.00004075682484155514	-10.83270980690384	0.0000125974853100848	2025_01_Batch_13-14	0.7936091313455258	0.9166164475515988	0.9732167620651213	0.9632640191032386	0.790202418655738											0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	FH	FH	ENSG00000091483	3408	214598	CCSBVarC004054	ALE00004054	NC_000001.11:241504130:A:T	1020T>A	Asn340Lys	CEGS2	CegsMutGDEh1041	D11	GDEhDisVCh_40065	A09	1	CegsMutGDDh1041	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	6	0			0			0			FH_Asn340Lys	1	241504130	A	T	1											1-241504130-A-T	-	0.47456	1.0	340	2	0	0	1	241667430	T	6.195240e-06	0	1	1_Pathogenic	NC_000001.11	10	Asn340Lys	0	22.4	0	0	1.949090e-05	D	0	11	1	42768	1.267010e-05	.	30524	0.000000e+00	0	0.96643	Select	0.9852	102612	0.90580	0	.	D	D	64034	1.05267121501	0	0	0.000000e+00	0	0	0.84898	17102	44888	0	0.000000e+00	0.89297	1	.	0.95788	0.994	.	0.0	0.989601	-0.0628	1.0	T	single nucleotide variant	NC_000001.11:g.241504130A>T	0	16734	2	0.9137381	109394	0	0.9459451	0	T	3	236778	0	0	0.000000e+00	146	2.338200e-05	0	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24||MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	1	0	0.000000e+00	0	0.99291	D	0.95897	D	H	6.222027	10	./.	122	1	7164	1614142	not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|FH-related disorder|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	16218	0.98713	.	.	-	241504130	2.338200e-05	-	-0.065000	0	0.99076	29608	0	1179978	0	germline;unknown	91078	Gain of MoRF binding (P = 0.0281)| Loss of stability (P = 0.0682)| Gain of ubiquitination at N340 (P = 0.0797)| Loss of catalytic residue at D341 (P = 0.1005)| Gain of loop (P = 0.1069)	0.93687	GRCh38	975	criteria provided, multiple submitters, no conflicts	c.1020T>A	0.000000e+00	0.38299	2	0	0	Fumarate lyase, N-terminal	0.000000e+00	9042	P	0	0.000000e+00	NM_000143.4(FH):c.1020T>A (p.Asn340Lys)	2	0	FUMH_HUMAN	0	100.0	0.628093012181	0	D	0.95051	0.9459451	-	0.000000e+00	.	6.84079e-6	2	0.000000e+00	2	34236	criteria_provided,_multiple_submitters,_no_conflicts	0.91492	9.141270e-06	0	0.000000e+00	0	60018	p.Asn340Lys	0	0.12424	.	germline	1	241504130	A	Jan 11, 2025	0	./.	0	89552	0.996	N	1q43	15752	.	0.000000e+00	SCV000109978|SCV000251426|SCV000275280|SCV000283659|SCV000537251|SCV004037791|SCV004117278|SCV004186922|SCV004197347|SCV004218857|SCV005642265	Pathogenic/Likely_pathogenic	0	0	Lys	K	-	910	ENSP00000355518	ENST00000366560	17688	0.001	13412	0	0.751	A	0	3.413967	0.83643	N	D	-	5.235775	.	0.99521	610	0	.	0.89586	0	241504130	Y	10	0	102612	0.000000e+00	P07954	0	0.976563	0.92321	A	0	1.0	D	89552	0.9137381	42768	0.71086	2271	0.195964	10	-5.97	.	8.474730e-06	0.78662	0.000000e+00	0	75056	0.000000e+00	6062	0	0.95898	1	FH	0.000000e+00	0	Asn	23038	2.233340e-05	1-241504130-A-T	FH-related_disorder|Fumarase_deficiency|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	0	2	239734053	ClinGen:CA285319	0.475086	0.74823	0	RCV000078140|RCV000220396|RCV000445596|RCV003460741|RCV004555535|RCV005007992	D	0	0	c.1020T>A	0	0	0	0.73318	./.	rs398123159	241504130	14902	A	.	P07954	15690	0.95788	0.000000e+00	0.19951	1	0	0	0.000000e+00	4.43	0	1	264690	3.43	0.99778	168	D	D	0	0.000000e+00	0	56	segdup	0	0	24|523|140162	92447	0.77230	0.76067	0.996594965457916	3492	.	0.3946	0.51740	0.000000e+00	2.233340e-05	1179978	0.55	1.441610e-05	D	13394	0	1.1334013E-5	0	606812|150800	0.23134	1	0.000000e+00	ENSG00000091483	0.000000e+00	6.348400203148806E-5	0	0	0.992874591347995	3	0.97365	0.05314	30606	3	1.949090e-05	0.000000e+00	0.508360094466945	YES	0.000000e+00	0.933702	98356	HGNC:3700	A	0	simple_aae	0.975	208100	241504130	AAT	0.009000	.	-	0	0.98388	8.474730e-06	0	0	Pathogenic/Likely pathogenic	0.79130	0	0	0	ClinGen:CA285319	N	0	0.976600358983	-	0.826	-	0.99974	3	2772	0.99282	0.819319963455	0.994	0	0.99842744111750026	98	-	1020T>A 	2	3.6075036075036075E-4	C0342770|C3661900|C1708350|C0027672	0	0	0	0	NM_000143.4	-	.	.	1	0.96580	398123159	2320	8.681309141418526E-5	0.97612	0.68379	0.997	0.001	3370	0.90775520	5.73	.	.	0.000000e+00	0.107358	0.99958943095219	0.98728	D	112	6210	9566	1.0745	0.99552	p.Asn340Lys	0	0	-10.892	0.98295367	0	0.97080	92447	D	30502	FH	0.000000e+00	D	0.885	21632	N340K	D	0.21136	0.87726	./.	principal1																																																																																																				
FH_Asn340Lys	10.63377390618422	0.00004075682484155514	-10.83270980690384	0.0000125974853100848	2025_01_Batch_13-14	0.7936091313455258	0.9166164475515988	0.9732167620651213	0.9632640191032386	0.790202418655738											0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	FH	FH		3408		CCSBVarC004054		NC_000001.11:241504130:A:T		Asn340Lys																												FH_Asn340Lys	1	241504130	A	T	1	allele	1020T>A	D02	527_CAVA_Array_P03	H03	B13A7A8P1_R1	B14A7A8P1_R2				1-241504130-A-T	-	0.47456	1.0	340	2	0	0	1	241667430	T	6.195240e-06	0	1	1_Pathogenic	NC_000001.11	10	Asn340Lys	0	22.4	0	0	1.949090e-05	D	0	11	1	42768	1.267010e-05	.	30524	0.000000e+00	0	0.96643	Select	0.9852	102612	0.90580	0	.	D	D	64034	1.05267121501	0	0	0.000000e+00	0	0	0.84898	17102	44888	0	0.000000e+00	0.89297	1	.	0.95788	0.994	.	0.0	0.989601	-0.0628	1.0	T	single nucleotide variant	NC_000001.11:g.241504130A>T	0	16734	2	0.9137381	109394	0	0.9459451	0	T	3	236778	0	0	0.000000e+00	146	2.338200e-05	0	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24||MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523	1	0	0.000000e+00	0	0.99291	D	0.95897	D	H	6.222027	10	./.	122	1	7164	1614142	not provided|Hereditary cancer-predisposing syndrome|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|FH-related disorder|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer	16218	0.98713	.	.	-	241504130	2.338200e-05	-	-0.065000	0	0.99076	29608	0	1179978	0	germline;unknown	91078	Gain of MoRF binding (P = 0.0281)| Loss of stability (P = 0.0682)| Gain of ubiquitination at N340 (P = 0.0797)| Loss of catalytic residue at D341 (P = 0.1005)| Gain of loop (P = 0.1069)	0.93687	GRCh38	975	criteria provided, multiple submitters, no conflicts	c.1020T>A	0.000000e+00	0.38299	2	0	0	Fumarate lyase, N-terminal	0.000000e+00	9042	P	0	0.000000e+00	NM_000143.4(FH):c.1020T>A (p.Asn340Lys)	2	0	FUMH_HUMAN	0	100.0	0.628093012181	0	D	0.95051	0.9459451	-	0.000000e+00	.	6.84079e-6	2	0.000000e+00	2	34236	criteria_provided,_multiple_submitters,_no_conflicts	0.91492	9.141270e-06	0	0.000000e+00	0	60018	p.Asn340Lys	0	0.12424	.	germline	1	241504130	A	Jan 11, 2025	0	./.	0	89552	0.996	N	1q43	15752	.	0.000000e+00	SCV000109978|SCV000251426|SCV000275280|SCV000283659|SCV000537251|SCV004037791|SCV004117278|SCV004186922|SCV004197347|SCV004218857|SCV005642265	Pathogenic/Likely_pathogenic	0	0	Lys	K	-	910	ENSP00000355518	ENST00000366560	17688	0.001	13412	0	0.751	A	0	3.413967	0.83643	N	D	-	5.235775	.	0.99521	610	0	.	0.89586	0	241504130	Y	10	0	102612	0.000000e+00	P07954	0	0.976563	0.92321	A	0	1.0	D	89552	0.9137381	42768	0.71086	2271	0.195964	10	-5.97	.	8.474730e-06	0.78662	0.000000e+00	0	75056	0.000000e+00	6062	0	0.95898	1	FH	0.000000e+00	0	Asn	23038	2.233340e-05	1-241504130-A-T	FH-related_disorder|Fumarase_deficiency|not_provided|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome	0	2	239734053	ClinGen:CA285319	0.475086	0.74823	0	RCV000078140|RCV000220396|RCV000445596|RCV003460741|RCV004555535|RCV005007992	D	0	0	c.1020T>A	0	0	0	0.73318	./.	rs398123159	241504130	14902	A	.	P07954	15690	0.95788	0.000000e+00	0.19951	1	0	0	0.000000e+00	4.43	0	1	264690	3.43	0.99778	168	D	D	0	0.000000e+00	0	56	segdup	0	0	24|523|140162	92447	0.77230	0.76067	0.996594965457916	3492	.	0.3946	0.51740	0.000000e+00	2.233340e-05	1179978	0.55	1.441610e-05	D	13394	0	1.1334013E-5	0	606812|150800	0.23134	1	0.000000e+00	ENSG00000091483	0.000000e+00	6.348400203148806E-5	0	0	0.992874591347995	3	0.97365	0.05314	30606	3	1.949090e-05	0.000000e+00	0.508360094466945	YES	0.000000e+00	0.933702	98356	HGNC:3700	A	0	simple_aae	0.975	208100	241504130	AAT	0.009000	.	-	0	0.98388	8.474730e-06	0	0	Pathogenic/Likely pathogenic	0.79130	0	0	0	ClinGen:CA285319	N	0	0.976600358983	-	0.826	-	0.99974	3	2772	0.99282	0.819319963455	0.994	0	0.99842744111750026	98	-	1020T>A 	2	3.6075036075036075E-4	C0342770|C3661900|C1708350|C0027672	0	0	0	0	NM_000143.4	-	.	.	1	0.96580	398123159	2320	8.681309141418526E-5	0.97612	0.68379	0.997	0.001	3370	0.90775520	5.73	.	.	0.000000e+00	0.107358	0.99958943095219	0.98728	D	112	6210	9566	1.0745	0.99552	p.Asn340Lys	0	0	-10.892	0.98295367	0	0.97080	92447	D	30502	FH	0.000000e+00	D	0.885	21632	N340K	D	0.21136	0.87726	./.	principal1																																																																																																				
SHOC2_Met173Val	-0.3926407601204963	0.7062668529828494	5.87423967430277	0.0006152936639761048	2025_01_Batch_13-14	0.9420425639126733	0.9443311232849014	0.8642483312693653	0.9191645209764896	0.8315313073499484	0.7559028152029459	0.842184246675346	0.734967436996238	0.7478020295372072	0.6343408282006262	0.8489726895578096	0.8932576849801237	0.7996078841328016	0.8334832752568484	0.7329360677752873	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2	SHOC2		11602		CCSBVarC028030		NC_000010.11:110964875:A:G		Met173Val																												SHOC2_Met173Val	10	110964875	A	G	10	allele	517A>G	E02	527_CAVA_Array_P06	I04	B13A7A8P2_R1	B14A7A8P2_R2				10-110964875-A-G	-	0.33237	0.001	173	.	.	.	10	112724633	G	.	.	10	3_Conflicting	NC_000010.11	.	Met173Val	.	19.26	.	.	.	T	.	7	1	.	.	.	.	.	.	0.73376	Select	0.0449	.	0.22981	.	.	T	T	.	0.514162079924	.	.	.	.	.	0.88676	.	.	.	.	0.01825	.	.	0.13484	0.997	.	83.0	.	.	0.17	G	single nucleotide variant	NC_000010.11:g.110964875A>G	.	.	2	0.11111266	.	.	0.08041208	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|	.	.	.	.	0.49097	B	0.26242	B	N	0.9166258	.	A/A	.	.	.	.	not provided|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome-like disorder with loose anagen hair|RASopathy|SHOC2-related disorder	.	0.04794	.	.	-	110964875	.	-	11.206000	.	0.52136	.	.	.	.	de novo;germline	.	Loss of catalytic residue at M173 (P = 0.0099)| Gain of sheet (P = 0.0827)| Loss of ubiquitination at K170 (P = 0.0863)| Gain of relative solvent accessibility (P = 0.09)| Loss of disorder (P = 0.0906)	0.30091	GRCh38	916	criteria provided, conflicting classifications	c.517A>G	.	0.38414	.	.	.	.	.	.	B	.	.	NM_007373.4(SHOC2):c.517A>G (p.Met173Val)	1	.	SHOC2_HUMAN	.	17.0	-0.639719032405484	.	.	0.59484	0.06424035	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.40214	.	.	.	.	.	p.Met173Val	.	0.89238	.	germline	.		A	Jun 12, 2024	.	A/A	.	.	1.0	N	10q25.2	.	.	.	SCV000491653|SCV001821436|SCV002073493|SCV002581433|SCV004267682|SCV005086295	Conflicting_classifications_of_pathogenicity	.	.	Val	V	-	.	ENSP00000358464	ENST00000369452	.	0.877	.	.	0.751	A	.	2.561362	0.05615	D	T	-	1.327136	.	0.77096	.	.	.	0.52197	.	110964875	Y	10	.	.	.	Q9UQ13	.	0.106314	0.01631		.	0.002	D	.	0.10913989	.	0.79771	8036	-0.000997988	.	0.96	.	.	0.02574	.	.	.	.	.	.	0.26739	10	SHOC2	.	.	Met	.	.	10-110964875-A-G	not_provided|SHOC2-related_disorder|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|Noonan_syndrome-like_disorder_with_loose_anagen_hair|RASopathy	.	.	112714623	ClinGen:CA16042684	0.893472	0.17541	.	RCV000413825|RCV002272224|RCV001584108|RCV003539878|RCV003922677	D	.	.	c.517A>G	.	.	.	0.51194	A/A	rs1057518206	110964875	.	A	.	Q9UQ13	.	0.18257	.	0.68239		.	.	.	-0.795	.	.	.	3.44	0.41460	.	D	D	.	.	.	.	.	.	.	2701|2701|536391	373090	0.50551	0.49084	0.874729037284851	.	.	0.71675	0.83085	.	.	.	9.325	.	N	.	.	.	.	607721|PS607721	0.96016	10	.	ENSG00000108061	.	.	.	.	0.6131685434429178	1	0.23834	0.20739	.	.	.	.	-0.425424558940744	YES	.	0.099806	359795	HGNC:15454	A	.	simple_aae	0.251	.	110964875	ATG	1.000000	.	-	.	0.44206	.	.	.	Conflicting classifications of pathogenicity	0.57998	.	.	.	ClinGen:CA16042684	M	.	0.660270521957	-	0.322	-	0.76196	.	.	0.61071	0.843939304352	0.2724	.	0.30135072733151308	.	-	517A>G 	.	.	C3661900|C4478716|C1843181|C5555857	.	.	.	.	NM_007373.4	-	.	.	1	0.77035	1057518206	.	.	0.65475	0.23937	0.72	0.71	.	0.00909550	5.79	.	.	.	-0.23921	0.973092210519985	0.01632	T	.	.	.	-1.0948	0.19131	p.Met173Val	.	.	-7.545	0.2705949	.	0.83842	373090	D	.	SHOC2	.	T	0.428	.	M173V	T	.	0.87726	A/A	principal1																																																																																																				
GSS_Arg125Cys	4.177442907234131	0.004150453370346064	-2.753965771031018	0.028341435060829808	2025_01_Batch_13-14	0.6020717464597054	0.6530716599756321	0.7632120678816032	0.7237004988017183	0.5664566229065157	0.539236634922278	0.6194553452155342	0.5489669160702033	0.649187245267796	0.49930948990852253	0.5706541906909917	0.6362635025955832	0.6560894919759033	0.6864438720347572	0.5328830564075191	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	GSS	GSS	ENSG00000100983	5132	215352	CCSBVarC006739	ALE00006737	NC_000020.11:34942606:G:A	373C>T	Arg125Cys	CEGS2	CegsMutGDEh1044	F03	GDEhDisVCh_40044	H01	2	CegsMutGDDh1044	F03	VUSN2Hmut_GDN2h_09	D05	VUSMutpDEST2_04	F12	VUSmut_GDEh09	D05	1	1	1	1	1	1	1	1	1	1	1	1	1	GSS_Arg125Cys	20	34942606	G	A	20											20-34942606-G-A	-	0.94738	1.0	125	0	0	0	20	33530409	A	4.151420e-05	0	20	1_Pathogenic	NC_000020.11	56	Arg125Cys	0	34.0	0	5	6.711410e-04	D	0	5	.	42768	5.487550e-05	.	30524	0.000000e+00	0	.	Select	0.9543	14900	0.90580	0	.	D	D	64012	.	6.351626016260162E-4	0	0.000000e+00	0	0	0.76178	17110	44882	2	0.000000e+00	.	0	.	0.97374	0.994	.	.	.	3.8	.	A	single nucleotide variant	NC_000020.11:g.34942606G>A	0	16724	3	0.837919	109394	0	0.96310127	0	A	13	236900	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0017909,MedGen:CN030166,Orphanet:32|MedGen:C3661900|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0009947,MedGen:C0398746,OMIM:266130,Orphanet:289846|Human Phenotype Ontology:HP:0003343,MONDO:MONDO:0009947,MedGen:C0398746,OMIM:266130,Orphanet:289846;MONDO:MONDO:0009284,MedGen:C1856399,OMIM:231900,Orphanet:289849,Orphanet:32	6	2	0.000000e+00	0	.	D	0.91438	D	H	17.45189	67	G/G	298	0	7162	1613906	Inherited glutathione synthetase deficiency|not provided|Glutathione synthetase deficiency with 5-oxoprolinuria|Glutathione synthetase deficiency with 5-oxoprolinuria;Glutathione synthetase deficiency without 5-oxoprolinuria	16216	0.99266	.	.	-	34942606	6.981290e-04	-	11.765000	10	0.93768	29600	0	74906	0	germline	91078	.	.	GRCh38	.	criteria provided, multiple submitters, no conflicts	c.373C>T	3.276110e-05	0.91065	7	0	0	.	1.195890e-04	9046	.	0	0.000000e+00	NM_000178.4(GSS):c.373C>T (p.Arg125Cys)	2	0	GSHB_HUMAN	0	.	1.09872351892217	0	.	0.85836	0.96134293	-	6.981290e-04	.	0.0000205224	10	0.000000e+00	0	34256	criteria_provided,_multiple_submitters,_no_conflicts	0.95785	5.484760e-05	0	0.000000e+00	0	59982	p.Arg125Cys	0	0.95724	.	germline	5	34942606	G	Feb 14, 2024	1	G/G	0	89554	1.0	N	20q11.22	30460	.	6.166750e-04	SCV002204728|SCV002819864|SCV004238234|SCV005661820	Pathogenic/Likely_pathogenic	0	0	Cys	C	-	910	ENSP00000498303	ENST00000651619	17692	.	13416	0	0.676	G	0	6.177047	.	D	.	-	20.69962	.	0.92624	610	0	.	0.78469	0	34942606	Y	9	0	102716	0.000000e+00	P48637	0	0.979491	0.99886	G	0	0.999	D	16216	0.8506926	7162	0.71086	2937	0.272164	4	.	.	7.476040e-04	.	6.373490e-05	0	74906	0.000000e+00	6084	5	0.90580	20	GSS	7.476040e-04	0	Arg	41930	0.000000e+00	20-34942606-G-A	Glutathione_synthetase_deficiency_with_5-oxoprolinuria|Inherited_glutathione_synthetase_deficiency|not_provided	0	0	32994070	ClinGen:CA119694|OMIM:601002.0005	0.948579	0.98099	0	RCV000009055|RCV003488332|RCV004566701|RCV005025041	.	0	0	c.373C>T	0	0	2	0.80492	G/G	rs28936396	34942606	14900	G	.	.	15690	0.97551	9.249840e-05	0.68239	20	0	0	0.000000e+00	3.785	0	2	264690	5.77	0.99825	146	D	T	10	0.000000e+00	0	26	.	0	2	289846|32	8529	0.96156	.	0.988271415233612	8170	.	0.71675	0.96020	0.000000e+00	6.166750e-04	1179972	9.908	6.246580e-05	.	13384	0	2.531263E-4	0	266130	0.98664	20	6.711410e-04	ENSG00000100983	3.124410e-05	6.565988181221274E-5	1	0	.	1	0.92348	.	30606	67	0.000000e+00	0.000000e+00	1.02848604687915	YES	2.195920e-05	0.366447	23568	HGNC:4624	.	0	.	0.884	208114	34942606	CGC	1.000000	.	-	6.119951040391676E-4	0.91808	3.389910e-06	5	0	Pathogenic/Likely pathogenic	0.87232	1	0	0	ClinGen:CA119694,OMIM:601002.0005	R	0	.	-	.	-	.	13	2294	0.93149	0.761953830719	.	0	0.99944690997760832	104	-	373C>T 	10	0	C0398746|CN030166|C3661900	0	0	0	0	NM_000178.4	-	.	.	1	0.92613	28936396	2320	1.669449081803005E-4	.	0.99100	.	.	7872	0.98256360	5.77	.	.	3.267330e-05	0.567727	0.998758874737846	0.95215	D	120	6212	9570	1.0907	0.98514	p.Arg125Cys	0	0	-12.5	.	56	0.94998	8529	D	30520	GSS	0.000000e+00	D	.	21622	.	.	0.70283	0.76753	G/G	principal1																																																																																																				
BRCA1_Asp67Tyr	2.5125896208651195	0.04024421782312692	-0.9756740391325569	0.3617299832806894	2025_01_Batch_13-14	0.9909520492431141	0.9587707827180625	0.975413541128114	0.9870750278331963	0.9642158549481505	0.9162230980428752	0.8907745672989336	0.9196469894768488	0.9442195653598557	0.7599903085066182	0.9535875736429946	0.924772675008498	0.9475302653024813	0.965647296596526	0.8621030817273844	1.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC013083		NC_000017.11:43106469:C:A		Asp67Tyr																												BRCA1_Asp67Tyr	17	43106469	C	A	17	allele	199G>T	B11	527_CAVA_Array_P01	C21	B13A7A8P1_R1	B14A7A8P1_R2				17-43106469-C-A	-	0.29216	0.868	67	12	0	0	17	41258486	A	8.266640e-05	1	17	2_Benign	NC_000017.11	126	Asp67Tyr	0	18.03	0	0	1.464700e-04	D	0	24	.	42690	7.206200e-05	0	30216	0.000000e+00	0	0.87125	.	0.6621	102410	0.47756	2	0.0	T	D	63924	.	0	0	0.000000e+00	0	0	0.29092	16978	44696	0	0.000000e+00	0.75325	7	.	0.58872	0.993	0.0	.	.	1.19	.	A	single nucleotide variant	NC_000017.11:g.43106469C>A	0	16710	2	0.13106883	109008	0	0.28895706	0		14	235908	0	0	0.000000e+00	790	1.639730e-04	0	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333	8	0	0.000000e+00	0	0.51279	B	0.25949	P	L	1.713454	132	C/C	352	0	7140	1596780	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|Malignant tumor of breast|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4	16118	0.80864	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106469	1.639730e-04	-	-0.025000	0	0.79945	29466	0	1165696	0	germline;not applicable;unknown	89912	.	.	GRCh38	459	reviewed by expert panel	.	0.000000e+00	0.08479	12	0	0	.	0.000000e+00	9042	.	0	0.000000e+00	NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr)	3	0	BRCA1_HUMAN	0	.	-0.260466381601807	2	.	0.56478	0.378384	-	0.000000e+00	0		12	0.000000e+00	0	34062	reviewed_by_expert_panel	0.98344	7.338910e-05	0	0.000000e+00	0	59860	.	0	0.12924	.	germline	7		C	Aug 10, 2015	0	C/C	0	89212	0.943	N	17q21.31	129722	.	0.000000e+00	SCV000244311	Benign	0	0	Tyr	Y	-	912	ENSP00000518978	ENST00000713676	17668	.	13394	0	0.531	C	0	2.280806	0.79703	N	.	-	1.574398	.	0.90256	946	0	9.940357852882703E-4	0.03564	0	43106469	Y	10	0	102410	0.000000e+00	P38398	0	0.14757	0.59339		0	0.24	D	89212	0.10798522	42690	0.69292	672	0.108459	126	.	0.0	1.080900e-04	0.72322	0.000000e+00	0	74666	0.000000e+00	5778	0	0.31396	17	BRCA1	1.339300e-05	0	Asp	151220	1.345110e-04	17-43106469-C-A	Malignant_tumor_of_breast|not_provided|not_specified|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	0	15	38512012	BRCA1-HCI:BRCA1_00052|ClinGen:CA001328|UniProtKB:P38398#VAR_070460	0.233566	0.30407	0	RCV000047675|RCV000083176|RCV000148404|RCV000162582|RCV000195312|RCV000589035|RCV001353503|RCV002490619	.	0	0	c.199G>T	0	0	0	0.64942	C/C	rs80357102	43106469	14808	C	1.9968051118210862E-4	.	15548	0.51563	0.000000e+00	0.08389		0	0	0.000000e+00	1.25	0	12	264690	-1.4	0.48293	3352	T	T	0	6.592390e-05	0	626	.	0	0	145|227535|145|1333|140162	54431	0.81457	0.11448	0.0394584648311138	8616	1	0.32853	0.35440	5.871650e-05	1.345110e-04	1165696	0.033	6.759890e-05	.	13390	0	3.7780046E-5	0	114480|617883|604370|614320	0.13684	17	0.000000e+00	ENSG00000012048	0.000000e+00	9.250551178674396E-5	0	0	.	1	0.38861	0.78836	30298	10	1.464700e-04	3.341130e-05	-0.295009425429782	.	0.000000e+00	0.282437	69098	HGNC:1100	.	0	.	0.64	207104	43106469	GAT	0.000000	0	-	0	0.34335	1.080900e-04	0	0	Benign	0.51688	0	0	2	BRCA1-HCI:BRCA1_00052,ClinGen:CA001328,UniProtKB:P38398#VAR_070460	D	0	.	-	.	-	0.67836	17	7514	0.43573	0.42940607667	.	0	0.99318147251181976	280	-	199G>T 	15	0	C0006142|C3661900|CN169374|CN221562|C0677776|C0346153|C4554406|C2676676|C3280442|C0027672	0	0	0	0	NM_007294.4	-	1	0.0	0	0.83345	80357102	2308	7.935458272715249E-5	0.86240	0.27944	.	.	8264	0.99734180	4.64	.	.	0.000000e+00	0.173063	0.956250935363193	0.31597	T	2726	6186	9548	-0.0620	0.88225	p.Asp67Tyr	0	0	-6.164	.	1	0.81217	54431	T	30338	BRCA1	5.889980e-05	D	.	21604	.	.	0.30954	0.24877	C/C	principal2																																																																																																				
BRCA1_Met548Ile	0.2873204807817469	0.7821863607221871	4.279146156570467	0.003659222814302877	2025_01_Batch_13-14	0.9785719900798429	0.9429073217627154	0.924181783445701	0.9557560006145543	0.8910223522970666	0.9890623605680183	0.9493701734682697	0.9512223971201553	0.9882025107135686	0.9632357125212221	0.9838171753239306	0.9461387476154925	0.9377020902829282	0.9719792556640614	0.9271290324091443	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	BRCA1	BRCA1		14613		CCSBVarC013069		NC_000017.11:43070958:C:T		Met548Ile																												BRCA1_Met548Ile	17	43070958	C	T	17	allele	1644G>A	G10	527_CAVA_Array_P01	M19	B13A7A8P1_R1	B14A7A8P1_R2				17-43070958-C-T	-	0.29778	0.0	1652	1317	679	0	17	41222975	T	1.462430e-02	64	17	2_Benign	NC_000017.11	3175	Met1652Ile	2	18.21	1	31	3.796760e-02	T	99	46	1	42768	1.813540e-02	0	30526	2.887930e-02	9	0.73230	.	0.1432	30526	0.28566	144	0.0	T	T	64006	.	0.0029300567107750472	0	2.351590e-02	12	37	0.19429	17110	44892	3269	1.490760e-04	0.38141	632	.	0.48390	0.99	0.0	.	.	3.78	.	T	single nucleotide variant	NC_000017.11:g.43070958C>T	99	16726	2	0.11591255	109398	0.02142857142857143	0.19599688	0		3761	236388	48	0	1.130450e-04	818	1.477740e-02	1	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	2157	1113	7.692310e-03	7	0.16373	B	0.32824	B	N	1.678113	23606	C/C	394	228	7164	1614160	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Familial cancer of breast|Malignant tumor of breast|BRCA1-related cancer predisposition	16216	0.51511	3	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43070958	3.989800e-02	-	2.710000	30	0.48172	29608	0.008754863813229572	64006	2	germline;not applicable;unknown	91088	.	.	GRCh38	544	reviewed by expert panel	.	3.796760e-02	0.42561	3525	0	157	BRCT domain|BRCT domain|BRCT domain	5.321060e-02	9046	.	0	2.293300e-02	NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile)	3	0	BRCA1_HUMAN	0	.	-0.274289964374125	114	.	0.64691	0.25679418	-	1.395870e-03	37		1163	2.528180e-02	0	34258	reviewed_by_expert_panel	0.93539	1.971700e-02	338	5.401170e-02	2	60024	.	3	0.34310	.	germline	626		C	Aug 10, 2015	1159	C/C	80	89130	1.0	N	17q21.31	204736	.	1.850020e-03	SCV000244374	Benign	723	225	Ile	I	-	910	ENSP00000419274	ENST00000470026	17692	.	13416	88	0.599	C	31	2.32095	0.36968	N	.	-	2.142461	.	.	1028	0	0.015904572564612324	0.00082	0	43070958	Y	10	0.009779951100244499	102208	2.358960e-02	P38398	25	0.099528	0.30766		20	0.004	.	30608	0.13775083	15690	0.65338	672	-0.195766	15052	.	0.03783231083844581	4.960470e-02	0.33898	3.989800e-02	3	75032	1.105460e-04	6062	10	0.27917	17	BRCA1	1.905850e-03	6	Met	242310	1.477620e-02	17-43070958-C-T	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Familial_cancer_of_breast|Malignant_tumor_of_breast	8	1517	38476501	BRCA1-HCI:BRCA1_00107|ClinGen:CA003103|UniProtKB:P38398#VAR_007795	0.454853	0.29865	119	RCV000034756|RCV000128916|RCV000048709|RCV000112434|RCV000120261|RCV000476093|RCV001270155|RCV004803120	.	0	37	c.4956G>A	37	5	3175	0.21097	C/C	rs1799967	43070958	14902	C	0.011182108626198083	.	15690	0.41094	5.147060e-02	0.68239		37	11	1.113780e-04	0.175	0.0025380710659898475	3242	264690	3.78	0.40156	6406	T	T	27	3.735010e-03	8	1850	.	0	890	145|140162|145|227535	41830	0.68398	0.10046	0.0072100418028408	10974	56	0.71675	0.50568	4.203400e-03	3.799660e-02	1180032	1.313	1.810870e-02	.	13386	37	0.008776304	0	604370|114480	0.33295	17	1.811840e-03	ENSG00000012048	4.960470e-02	0.015835026570803375	1163	0	.	3	0.29523	0.72706	30608	2323	1.484230e-02	4.514860e-03	-0.0674097859341404	.	3.588840e-02	.	50269	HGNC:1100	.	20	.	0.216	207690	43070958	ATG	1.000000	0	-	0.00291598323309641	0.00157	1.275560e-02	32	99	Benign	0.35788	626	143	271	BRCA1-HCI:BRCA1_00107,ClinGen:CA003103,UniProtKB:P38398#VAR_007795	M	0	.	-	.	-	0.33676	4287	18068	0.30010	0.360434174538	.	0	0.96644426836776054	280	-	4956G>A 	1159	0.012618994908124861	C3661900|C0677776|C0027672|CN169374|C2676676|C0346153|C0006142	1	0	67	0	NM_007294.4	-	16	0.004322766570605188	0	0.64025	1799967	2320	0.014547480500185712	.	0.36444	.	.	10580	0.95295440	4.82	.	.	3.799660e-02	-0.0261181	0.164986458329954	0.08964	T	4556	6210	9568	-0.8538	0.46308	p.Met1652Ile	0	0	-4.756	.	143	0.48018	41830	T	30522	BRCA1	3.740500e-03	D	.	21624	.	.	0.69545	0.40292	C/C	principal2																																																																																																				
LMNA_Arg349Leu	1.0956468444891008	0.3094917419063528	4.167510144450547	0.00420217915215487	2025_01_Batch_13-14	0.5475822828122247	0.8102874186572842	0.9257224225340441	0.773820649870661	0.6142904451750753	0.5851680566044616	0.7547977913410235	0.8856390686863543	0.8115870574462624	0.583577916705548	0.5663751697083431	0.7825426049991538	0.9056807456101992	0.7927038536584616	0.5989341809403117	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	LMNA	LMNA	ENSG00000160789	3903	201322	CCSBVarC003621	ALE00003621	NC_000001.11:156136010:G:T	1046G>T	Arg349Leu	CEGS2	CegsMutGDEh1042	E02	GDEhDisVCh_40057	B10	1	CegsMutGDDh1042	E02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			LMNA_Arg349Leu	1	156136010	G	T	1											1-156136010-G-T	-	0.89027	0.775	349	.	.	.	1	156105801	T	.	.	1	3_Conflicting	NC_000001.11	.	Arg349Leu	.	29.8	.	0	.	D	.	4	5	.	.	.	.	.	0	0.96123	.	0.8633	.	0.90580	.	.	D	D	.	.	0	.	.	.	.	0.84010	.	.	.	.	0.91889	.	.	0.76503	0.955	.	3.0	.	4.47	0.97	T	single nucleotide variant	NC_000001.11:g.156136010G>T	.	.	2	0.61561835	.	0	0.7229245	0		.	.	.	.	.	146	.	0	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736	.	.	.	.	0.97016	P	0.79322	P	H	11.04923	.	G/G	84	0	.	.	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype	.	0.96410	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156136010	.	-	11.671000	.	0.99334	.	0	.	.	germline	.	Loss of MoRF binding (P = 0.0632)| Loss of methylation at R349 (P = 0.2199)| Gain of stability (P = 0.2765)| Loss of catalytic residue at M345 (P = 0.6375)| Loss of solvent accessibility (P = 0.6392)	0.91975	GRCh38	460	criteria provided, conflicting classifications	c.1046G>T	.	0.61832	0	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	LP	0	.	NM_170707.4(LMNA):c.1046G>T (p.Arg349Leu)	1	.	LMNA_HUMAN	.	97.0	0.899982601079214	.	.	0.83342	0.6761609	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99978	.	.	.	.	.	p.Arg349Leu	.	0.94110	.	germline	.		G	Sep 27, 2024	.	G/G	.	.	1.0	N	1q22	6962	.	.	SCV001715571|SCV002262706|SCV004074698	Conflicting_classifications_of_pathogenicity	.	.	Leu	L	-	.	ENSP00000355292	ENST00000361308	.	0.001	.	.	0.676	G	.	5.301637	0.79703	D	D	-	11.169	.	0.98052	610	.	.	0.83317	0	156136010	Y	10	0	.	.	P02545	.	0.967344	0.92668		.	0.896	D	.	0.65043724	.	0.50625	4000	0.495723	.	-6.56	.	.	0.78662	.	.	.	.	.	.	0.77388	1	LMNA	.	0	Arg	10680	.	1-156136010-G-T	Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|not_provided	.	.	154372425	ClinGen:CA016488|UniProtKB:P02545#VAR_039776	0.974698	0.91714	.	RCV000057219|RCV001854172|RCV003343625	D	.	.	c.1046G>T	.	.	.	0.94117	G/G	rs58789393	156136010	.	G	.	P02545	.	0.79081	.	0.68239		.	.	.	3.8	0	0	.	4.83	0.99617	108	D	D	.	.	0	24	.	.	.	64746	66763	0.94039	0.96624	0.992853701114655	2294	.	0.71675	0.99573	.	.	.	10.003	.	D	.	.	.	0	.	0.9969	1	.	ENSG00000160789	.	0	.	0	.	2	0.86259	0.78769	.	.	.	.	0.832866080674497	.	.	0.755624	77660	HGNC:6636	D	.	simple_aae	0.981	.	156136010	CGG	1.000000	.	-	0	0.96764	.	0	.	Conflicting classifications of pathogenicity	0.71001	.	.	.	ClinGen:CA016488,UniProtKB:P02545#VAR_039776	R	.	0.966327329089	-	0.801	-	0.98762	.	466	0.98457	0.813560366631	0.9091	.	0.99846690473892685	94	-	1046G>T 	.	0	C0270914|CN230736|C3661900	.	.	.	.	NM_170707.4	-	.	.	1	0.96357	58789393	.	0	0.96566	0.91933	0.965	0.003	2210	0.99996722	5.74	.	.	.	0.474295	0.999839382529083	0.95330	D	84	.	.	0.9518	0.95442	p.Arg349Leu	0	.	-8.52	0.97176325	.	0.98239	66763	D	.	LMNA	.	D	0.871	.	R349L	D	0.83830	0.76753	G/G	principal1																																																																																																				
LMNA_Arg349Leu	1.0956468444891008	0.3094917419063528	4.167510144450547	0.00420217915215487	2025_01_Batch_13-14	0.5475822828122247	0.8102874186572842	0.9257224225340441	0.773820649870661	0.6142904451750753	0.5851680566044616	0.7547977913410235	0.8856390686863543	0.8115870574462624	0.583577916705548	0.5663751697083431	0.7825426049991538	0.9056807456101992	0.7927038536584616	0.5989341809403117	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	LMNA	LMNA		3903		CCSBVarC003621		NC_000001.11:156136010:G:T		Arg349Leu																												LMNA_Arg349Leu	1	156136010	G	T	1	allele	1046G>T	D12	527_CAVA_Array_P03	H23	B13A7A8P1_R1	B14A7A8P1_R2				1-156136010-G-T	-	0.89027	0.775	349	.	.	.	1	156105801	T	.	.	1	3_Conflicting	NC_000001.11	.	Arg349Leu	.	29.8	.	0	.	D	.	4	5	.	.	.	.	.	0	0.96123	.	0.8633	.	0.90580	.	.	D	D	.	.	0	.	.	.	.	0.84010	.	.	.	.	0.91889	.	.	0.76503	0.955	.	3.0	.	4.47	0.97	T	single nucleotide variant	NC_000001.11:g.156136010G>T	.	.	2	0.61561835	.	0	0.7229245	0		.	.	.	.	.	146	.	0	MedGen:C3661900|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:CN230736	.	.	.	.	0.97016	P	0.79322	P	H	11.04923	.	G/G	84	0	.	.	not provided|Charcot-Marie-Tooth disease type 2|Cardiovascular phenotype	.	0.96410	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156136010	.	-	11.671000	.	0.99334	.	0	.	.	germline	.	Loss of MoRF binding (P = 0.0632)| Loss of methylation at R349 (P = 0.2199)| Gain of stability (P = 0.2765)| Loss of catalytic residue at M345 (P = 0.6375)| Loss of solvent accessibility (P = 0.6392)	0.91975	GRCh38	460	criteria provided, conflicting classifications	c.1046G>T	.	0.61832	0	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	LP	0	.	NM_170707.4(LMNA):c.1046G>T (p.Arg349Leu)	1	.	LMNA_HUMAN	.	97.0	0.899982601079214	.	.	0.83342	0.6761609	+	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.99978	.	.	.	.	.	p.Arg349Leu	.	0.94110	.	germline	.		G	Sep 27, 2024	.	G/G	.	.	1.0	N	1q22	6962	.	.	SCV001715571|SCV002262706|SCV004074698	Conflicting_classifications_of_pathogenicity	.	.	Leu	L	-	.	ENSP00000355292	ENST00000361308	.	0.001	.	.	0.676	G	.	5.301637	0.79703	D	D	-	11.169	.	0.98052	610	.	.	0.83317	0	156136010	Y	10	0	.	.	P02545	.	0.967344	0.92668		.	0.896	D	.	0.65043724	.	0.50625	4000	0.495723	.	-6.56	.	.	0.78662	.	.	.	.	.	.	0.77388	1	LMNA	.	0	Arg	10680	.	1-156136010-G-T	Charcot-Marie-Tooth_disease_type_2|Cardiovascular_phenotype|not_provided	.	.	154372425	ClinGen:CA016488|UniProtKB:P02545#VAR_039776	0.974698	0.91714	.	RCV000057219|RCV001854172|RCV003343625	D	.	.	c.1046G>T	.	.	.	0.94117	G/G	rs58789393	156136010	.	G	.	P02545	.	0.79081	.	0.68239		.	.	.	3.8	0	0	.	4.83	0.99617	108	D	D	.	.	0	24	.	.	.	64746	66763	0.94039	0.96624	0.992853701114655	2294	.	0.71675	0.99573	.	.	.	10.003	.	D	.	.	.	0	.	0.9969	1	.	ENSG00000160789	.	0	.	0	.	2	0.86259	0.78769	.	.	.	.	0.832866080674497	.	.	0.755624	77660	HGNC:6636	D	.	simple_aae	0.981	.	156136010	CGG	1.000000	.	-	0	0.96764	.	0	.	Conflicting classifications of pathogenicity	0.71001	.	.	.	ClinGen:CA016488,UniProtKB:P02545#VAR_039776	R	.	0.966327329089	-	0.801	-	0.98762	.	466	0.98457	0.813560366631	0.9091	.	0.99846690473892685	94	-	1046G>T 	.	0	C0270914|CN230736|C3661900	.	.	.	.	NM_170707.4	-	.	.	1	0.96357	58789393	.	0	0.96566	0.91933	0.965	0.003	2210	0.99996722	5.74	.	.	.	0.474295	0.999839382529083	0.95330	D	84	.	.	0.9518	0.95442	p.Arg349Leu	0	.	-8.52	0.97176325	.	0.98239	66763	D	.	LMNA	.	D	0.871	.	R349L	D	0.83830	0.76753	G/G	principal1																																																																																																				
BRCA1_Arg71Lys	0.07187573777971566	0.9447113095236084	2.3731690749830956	0.049375562988145376	2025_01_Batch_13-14	0.933072995991214	0.9452772116535713	0.8545819894997295	0.9024167501696188	0.7431486177108632	0.9796857254805389	0.9318387526566191	0.937694960222789	0.9745554138250025	0.9081625358729246	0.9563793607358764	0.9385579821550951	0.8961384748612593	0.9384860819973107	0.8256555767918938	1.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003297		NC_000017.11:43106456:C:T		Arg71Lys																												BRCA1_Arg71Lys	17	43106456	C	T	17	allele	212G>A	H06	527_CAVA_Array_P01	O11	B13A7A8P1_R1	B14A7A8P1_R2				17-43106456-C-T	-	0.91245	0.9	71	.	.	.	17	41258473	T	.	.	17	1_Pathogenic	NC_000017.11	.	Arg71Lys	.	32.0	.	0	.	D	.	11	1	.	.	.	.	.	0	0.90816	.	0.8430	.	0.59057	.	.	T	D	.	.	0	.	.	.	.	0.54292	.	.	.	.	0.59576	.	.	0.81221	0.995	.	.	.	.	.	T	single nucleotide variant	NC_000017.11:g.43106456C>T	.	.	2	0.3838624	.	0	0.80958927	0	T	.	.	.	.	.	0	.	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333	.	.	.	.	0.99291	B	0.69118	P	M	5.814887	.	C/C	0	0	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4	.	0.94146	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106456	.	-	7.641000	.	0.95747	.	0	.	.	germline;not applicable;unknown	.	Gain of methylation at R71 (P = 0.0062)| Gain of relative solvent accessibility (P = 0.0522)| Gain of ubiquitination at R71 (P = 0.068)| Gain of disorder (P = 0.0771)| Gain of solvent accessibility (P = 0.1456)	0.86044	GRCh38	459	criteria provided, multiple submitters, no conflicts	c.212G>A	.	0.57348	0	.	.	.	.	.	LP	0	.	NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys)	2	.	BRCA1_HUMAN	.	.	0.589132871463434	.	.	0.80812	0.759881	-	.	.	0.0	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99371	.	.	.	.	.	p.Arg71Lys	.	0.63257	.	germline	.	43106456	C	Jul 30, 2024	.	C/C	.	.	1.0	N	17q21.31	0	.	.	SCV000325249|SCV001345474|SCV001583916|SCV002046151|SCV002600545|SCV002726126|SCV003809169|SCV005416672	Pathogenic	.	.	Lys	K	-	.	ENSP00000419103	ENST00000494123	.	0.0	.	.	0.531	C	.	5.467383	0.68204	D	D	-	5.856808	.	0.95351	0	.	.	0.65672	0	43106456	Y	9	0	.	.	P38398	.	0.29865	0.68305	C	.	0.275	D	.	0.4717919	.	0.73271	672	0.411382	.	-0.66	.	.	0.91343	.	.	.	.	.	.	0.63093	17	BRCA1	.	0	Arg	476	.	17-43106456-C-T	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38511999	ClinGen:CA001420|UniProtKB:P38398#VAR_020681	0.849361	0.72350	.	RCV000112023|RCV000503702|RCV001180531|RCV001384425|RCV004795985	D	.	.	c.212G>A	.	.	.	0.90492	C/C	rs80356913	43106456	.	C	.	E9PFC7	.	0.84328	.	0.68239	17	.	.	.	2.455	0	0	.	4.64	0.66937	0	D	T	.	.	0	0	.	.	.	145|140162|145	54471	0.90373	0.17790	0.960748553276062	424	.	0.71675	0.76532	.	.	.	4.108	.	N	.	.	.	0	604370	0.57643	17	.	ENSG00000012048	.	0	.	0	.	2	0.68273	0.78836	.	.	.	.	0.56907193894025	.	.	0.514985	69138	HGNC:1100	.	.	.	0.917	.	43106456	AGG	1.000000	.	-	0	0.81025	.	0	.	Pathogenic	0.67174	.	.	.	ClinGen:CA001420,UniProtKB:P38398#VAR_020681	R	.	0.968767862813	-	0.727	-	0.78462	.	52	0.47432	0.610298812389	0.7791	.	0.99505402231752338	0	-	212G>A 	.	0	C0677776|C0027672|C3661900|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.27626	80356913	.	0	0.96814	0.72585	.	0.016	424	0.99942493	4.64	.	.	.	0.353145	0.996372846491178	0.71058	D	0	.	.	0.7801	0.94745	p.Arg71Lys	0	.	-8.907	0.82008123	.	0.92086	54471	D	.	BRCA1	.	D	0.737	.	R71K	D	.	0.24877	C/C	principal2																																																																																																				
BRCA1_Gly666Val	0.8111849338867764	0.4439619283781052	3.5112350638164833	0.009843009152846182	2025_01_Batch_13-14	0.8413339729777471	0.905374571810571	0.8714205125345021	0.9150813611590665	0.6980768194668904	0.9221979106285213	0.8248239232178372	0.8489993684039382	0.9412095699512582	0.7681921894318554	0.8817659418031343	0.8650992475142041	0.8602099404692202	0.9281454655551623	0.7331345044493729	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011818		NC_000017.11:43051086:C:A		Gly666Val																												BRCA1_Gly666Val	17	43051086	C	A	17	allele	1997G>T	D08	527_CAVA_Array_P01	G15	B13A7A8P1_R1	B14A7A8P1_R2				17-43051086-C-A	-	0.44882	0.583	1770	.	0	.	17	41203103	A	1.239310e-06	.	17	1_Pathogenic	NC_000017.11	1	Gly1770Val	.	22.0	.	.	.	D	0	13	1	.	.	.	.	.	.	0.94788	.	0.7985	.	0.77914	.	.	T	D	63966	.	.	0	.	.	.	0.36760	.	44870	1	.	0.90790	.	.	0.71528	0.98	.	.	.	4.36	.	A	single nucleotide variant	NC_000017.11:g.43051086C>A	0	.	2	0.32384387	.	.	0.58132803	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	.	.	0.000000e+00	0	0.99291	B	0.47467	P	M	4.920639	2	C/C	.	.	.	1613796	Malignant tumor of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	.	0.92930	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43051086	.	-	4.864000	.	0.95687	29600	.	91068	.	germline;not applicable;unknown	91068	.	.	GRCh38	449	reviewed by expert panel	.	.	0.46976	.	.	.	.	.	.	.	.	0.000000e+00	NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val)	3	.	BRCA1_HUMAN	.	.	0.484917239323781	.	.	0.77473	0.58380777	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99752	.	0	.	.	59982	.	0	0.45576	.	germline	.		C	Jul 18, 2018	.	C/C	.	.	0.981	N	17q21.31	.	.	.	SCV001161716	Pathogenic	.	.	Val	V	-	912	ENSP00000419103	ENST00000494123	.	.	.	.	0.599	C	.	3.272588	0.83643	N	.	-	4.689884	.	0.98318	.	.	.	0.71446	.	43051086	Y	10	.	.	0.000000e+00	P38398	.	0.327304	0.83570		.	0.055	D	.	0.22660044	.	0.58201	672	0.420504	0	.	.	1.098080e-05	0.78662	.	.	74882	.	6056	.	0.58085	17	BRCA1	0.000000e+00	.	Gly	.	.	17-43051086-C-A	Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	0	.	38456629	ClinGen:CA10590929	0.471283	0.66032	0	RCV000502156|RCV000477771|RCV001023895|RCV001572739|RCV001865421	.	0	.	c.5309G>T	.	0	0	0.90984	C/C	rs863224765	43051086	.	C	.	.	.	0.71391	.	0.68239		.	.	0.000000e+00	2.215	.	.	.	4.09	0.69606	.	D	T	.	.	.	.	.	.	.	140162|145|145	417832	0.90872	0.40658	0.977009236812592	.	.	0.35482	0.51522	.	.	1179952	2.72	.	.	.	.	.	.	604370	0.47021	17	.	ENSG00000012048	0.000000e+00	.	.	.	.	2	0.73565	0.79449	.	.	.	0.000000e+00	0.444495820101055	.	1.098080e-05	0.786529	404710	HGNC:1100	.	.	.	0.916	.	43051086	GGG	1.000000	.	-	.	0.91415	0.000000e+00	.	0	Pathogenic	0.85385	.	0	0	ClinGen:CA10590929	G	.	.	-	.	-	0.94206	.	.	0.83211	0.485455960035	.	0	0.99741871120433134	.	-	5309G>T 	.	.	C0006142|C0027672|C0677776|C3661900|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.91429	863224765	.	.	0.93785	0.64170	.	.	.	0.99981505	5.06	.	.	.	0.366249	0.994521859597463	0.62356	D	.	.	.	0.6824	0.93160	p.Gly1770Val	.	0	-9.173	.	0	0.90703	417832	D	.	BRCA1	.	D	.	.	.	.	0.82260	0.40292	C/C	principal2	48348	BRCA1_Adamovich_2022_HDR_var5517	No	[-0.562,-0.233]					Homology Directed Repair		Fluorescence	Not specified		G		5309	BRCA1_Adamovich_2022_HDR		ENST00000357654.9		Abnormal					immortalized human cells					p.Gly1770Val		true	c.5309G>T				Functional		1100.0	43051086.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-0.282751458;-0.705049372;-0.792067657;-0.454328143			Gly1770Val		LOF		(-0.233, Inf)		V	Jul 18, 2018		(-Inf, -0.562)			missense_variant		1770.0			1.2393140149e-6	-0.5585491575	Normal	Pathogenic	43051086.0	missense_variant		0.835		Intermediate			Reporter			BRCA1_Gly1770Val
BRCA1_Gly666Val	0.8111849338867764	0.4439619283781052	3.5112350638164833	0.009843009152846182	2025_01_Batch_13-14	0.8413339729777471	0.905374571810571	0.8714205125345021	0.9150813611590665	0.6980768194668904	0.9221979106285213	0.8248239232178372	0.8489993684039382	0.9412095699512582	0.7681921894318554	0.8817659418031343	0.8650992475142041	0.8602099404692202	0.9281454655551623	0.7331345044493729	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011818		NC_000017.11:43051086:C:A		Gly666Val																												BRCA1_Gly666Val	17	43051086	C	A	17	allele	1997G>T	D08	527_CAVA_Array_P01	G15	B13A7A8P1_R1	B14A7A8P1_R2				17-43051086-C-A	-	0.44882	0.583	1770	.	0	.	17	41203103	A	1.239310e-06	.	17	1_Pathogenic	NC_000017.11	1	Gly1770Val	.	22.0	.	.	.	D	0	13	1	.	.	.	.	.	.	0.94788	.	0.7985	.	0.77914	.	.	T	D	63966	.	.	0	.	.	.	0.36760	.	44870	1	.	0.90790	.	.	0.71528	0.98	.	.	.	4.36	.	A	single nucleotide variant	NC_000017.11:g.43051086C>A	0	.	2	0.32384387	.	.	0.58132803	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	.	.	0.000000e+00	0	0.99291	B	0.47467	P	M	4.920639	2	C/C	.	.	.	1613796	Malignant tumor of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome	.	0.92930	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43051086	.	-	4.864000	.	0.95687	29600	.	91068	.	germline;not applicable;unknown	91068	.	.	GRCh38	449	reviewed by expert panel	.	.	0.46976	.	.	.	.	.	.	.	.	0.000000e+00	NM_007294.4(BRCA1):c.5309G>T (p.Gly1770Val)	3	.	BRCA1_HUMAN	.	.	0.484917239323781	.	.	0.77473	0.58380777	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99752	.	0	.	.	59982	.	0	0.45576	.	germline	.		C	Jul 18, 2018	.	C/C	.	.	0.981	N	17q21.31	.	.	.	SCV001161716	Pathogenic	.	.	Val	V	-	912	ENSP00000419103	ENST00000494123	.	.	.	.	0.599	C	.	3.272588	0.83643	N	.	-	4.689884	.	0.98318	.	.	.	0.71446	.	43051086	Y	10	.	.	0.000000e+00	P38398	.	0.327304	0.83570		.	0.055	D	.	0.22660044	.	0.58201	672	0.420504	0	.	.	1.098080e-05	0.78662	.	.	74882	.	6056	.	0.58085	17	BRCA1	0.000000e+00	.	Gly	.	.	17-43051086-C-A	Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	0	.	38456629	ClinGen:CA10590929	0.471283	0.66032	0	RCV000502156|RCV000477771|RCV001023895|RCV001572739|RCV001865421	.	0	.	c.5309G>T	.	0	0	0.90984	C/C	rs863224765	43051086	.	C	.	.	.	0.71391	.	0.68239		.	.	0.000000e+00	2.215	.	.	.	4.09	0.69606	.	D	T	.	.	.	.	.	.	.	140162|145|145	417832	0.90872	0.40658	0.977009236812592	.	.	0.35482	0.51522	.	.	1179952	2.72	.	.	.	.	.	.	604370	0.47021	17	.	ENSG00000012048	0.000000e+00	.	.	.	.	2	0.73565	0.79449	.	.	.	0.000000e+00	0.444495820101055	.	1.098080e-05	0.786529	404710	HGNC:1100	.	.	.	0.916	.	43051086	GGG	1.000000	.	-	.	0.91415	0.000000e+00	.	0	Pathogenic	0.85385	.	0	0	ClinGen:CA10590929	G	.	.	-	.	-	0.94206	.	.	0.83211	0.485455960035	.	0	0.99741871120433134	.	-	5309G>T 	.	.	C0006142|C0027672|C0677776|C3661900|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.91429	863224765	.	.	0.93785	0.64170	.	.	.	0.99981505	5.06	.	.	.	0.366249	0.994521859597463	0.62356	D	.	.	.	0.6824	0.93160	p.Gly1770Val	.	0	-9.173	.	0	0.90703	417832	D	.	BRCA1	.	D	.	.	.	.	0.82260	0.40292	C/C	principal2	40086	BRCA1_Adamovich_2022_Cisplatin_var6912	No	[-0.729,-0.503]					Cisplatin resistance		Drug Resistance	Not specified		G		5309	BRCA1_Adamovich_2022_Cisplatin		ENST00000357654.9		Abnormal					immortalized human cells					p.Gly1770Val		true	c.5309G>T				Functional		1100.0	43051086.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-1.290499945;-0.697451801;-0.828356624;-0.875998648			Gly1770Val		LOF		(-0.503, Inf)		V	Jul 18, 2018		(-Inf, -0.729)			missense_variant		1770.0			1.2393140149e-6	-0.9230767545	Normal	Pathogenic	43051086.0	missense_variant		0.835		Intermediate			Cell Viability			BRCA1_Gly1770Val
KRAS_Gly60Arg	-2.525125755633534	0.03951338958819366	5.200356910662419	0.0012525185362658572	2025_01_Batch_13-14	0.45365823166693264	0.7496155511033935	0.8984087278620452	0.7991193309355495	0.43289043005965117	0.6027650545330492	0.8009975828816134	0.908421779053682	0.8281012607821395	0.4509740186202568	0.5282116430999909	0.7753065669925034	0.9034152534578637	0.8136102958588445	0.441932224339954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214488	CCSBVarC006097	ALE00006097	NC_000012.12:25227346:C:G	178G>C	Gly60Arg	CEGS2	CegsMutGDEh1041	E01	GDEhDisVCh_40061	A10	1	CegsMutGDDh1041	E01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Gly60Arg	12	25227346	C	G	12											12-25227346-C-G	-	0.87425	1.0	60	.	.	.	12	25380280	G	.	.	12	1_Pathogenic	NC_000012.12	.	Gly60Arg	.	29.2	.	.	.	D	.	9	1	.	.	.	.	.	.	0.98634	Plus_Clinical	0.9502	.	0.90580	.	.	D	D	.	2.98422368777	.	.	.	.	.	0.99682	.	.	.	.	0.95831	.	.	0.99743	1.0	.	1.0	0.89791	3.95	0.99	G	single nucleotide variant	NC_000012.12:g.25227346C>G	.	.	3	0.9740602	.	.	0.9893387	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	.	.	.	.	0.97926	D	0.99902	D	H	20.65427	.	C/C	.	.	.	.	Cardiofaciocutaneous syndrome 2|RASopathy|Cardio-facio-cutaneous syndrome|not provided|Inborn genetic diseases|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 3	.	0.99174	.	.	-	25227346	.	-	7.701000	.	0.99985	.	.	.	.	germline;unknown	.	Gain of catalytic residue at L56 (P = 0.1064)| Gain of phosphorylation at T58 (P = 0.1068)| Loss of glycosylation at T58 (P = 0.123)| Gain of solvent accessibility (P = 0.1319)| Gain of loop (P = 0.2045)	0.92046	GRCh38	855	reviewed by expert panel	c.178G>C	.	0.91065	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_004985.5(KRAS):c.178G>C (p.Gly60Arg)	3	.	RASK_HUMAN	.	99.0	1.15990254133055	.	D	0.99795	0.98968154	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99211	.	.	.	.	.	p.Gly60Arg	.	0.66341	.	germline	.		C	Apr 03, 2017	.	C/C	.	.	1.0	N	12p12.1	.	.	.	SCV000616370	Pathogenic	.	.	Arg	R	-	.	ENSP00000256078	ENST00000256078	.	0.0	.	.	0.58	C	.	5.208984	0.92967	D	D	-	22.78603	.	0.94345	.	.	.	0.99730	.	25227346	Y	9	.	.	.	P01116	.	0.960754	0.99621		.	1.0	D	.	0.98382205	.	0.97202	3845	0.541091	.	-7.76	.	.	0.91343	.	.	.	.	.	.	0.99623	12	KRAS	.	.	Gly	.	.	12-25227346-C-G	Cardiofaciocutaneous_syndrome_2|Inborn_genetic_diseases|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_3|not_provided|RASopathy|Noonan_syndrome	.	.	25271547	ClinGen:CA273416|OMIM:190070.0009|UniProtKB:P01116#VAR_026112	0.908603	0.99090	.	RCV000013416|RCV000157935|RCV000521390|RCV000254661|RCV001267316|RCV000844635|RCV003313917	D	.	.	c.178G>C	.	.	.	0.95437	C/C	rs104894359	25227346	.	C	.	P01116	.	0.99724	.	0.68239		.	.	.	4.17	.	.	.	5.77	0.99490	.	D	D	.	.	.	.	.	.	.	1340|1340|648|536391|648	12586	0.95369	0.99182	0.999921560287476	.	.	0.71675	0.86363	.	.	.	7.892	.	D	.	.	.	.	615278|PS115150|609942|PS163950	0.85894	12	.	ENSG00000133703	.	.	.	.	0.9776364459571039	1	0.97365	0.34655	.	.	.	.	1.0558655561841	.	.	0.451783	27625	HGNC:6407	A	.	simple_aae	1	.	25227346	GGT	1.000000	.	-	.	0.95603	.	.	.	Pathogenic	0.88337	.	.	.	ClinGen:CA273416,UniProtKB:P01116#VAR_026112,OMIM:190070.0009	G	.	0.995530386705	-	0.802	-	0.96546	.	.	0.97742	0.947138845921	0.9998	.	0.99936203639780719	.	-	178G>C 	.	.	C3809005|C0950123|C1275081|C1860991|C3661900|C5555857|C0028326	.	.	.	.	NM_004985.5	-	.	.	1	0.64215	104894359	.	.	0.99541	0.99443	0.956	0.0	.	0.99919980	5.77	.	.	.	0.539464	0.999979503899075	0.97633	D	.	.	.	1.0884	0.98375	p.Gly60Arg	.	.	-12.016	0.96227115	.	0.99427	12586	D	.	KRAS	.	D	0.938	.	G60R	D	0.75212	0.29757	C/C	alternative1																																																																																																				
KRAS_Gly60Arg	-2.525125755633534	0.03951338958819366	5.200356910662419	0.0012525185362658572	2025_01_Batch_13-14	0.45365823166693264	0.7496155511033935	0.8984087278620452	0.7991193309355495	0.43289043005965117	0.6027650545330492	0.8009975828816134	0.908421779053682	0.8281012607821395	0.4509740186202568	0.5282116430999909	0.7753065669925034	0.9034152534578637	0.8136102958588445	0.441932224339954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006097		NC_000012.12:25227346:C:G		Gly60Arg																												KRAS_Gly60Arg	12	25227346	C	G	12	allele	178G>C	A08	527_CAVA_Array_P03	B15	B13A7A8P1_R1	B14A7A8P1_R2				12-25227346-C-G	-	0.87425	1.0	60	.	.	.	12	25380280	G	.	.	12	1_Pathogenic	NC_000012.12	.	Gly60Arg	.	29.2	.	.	.	D	.	9	1	.	.	.	.	.	.	0.98634	Plus_Clinical	0.9502	.	0.90580	.	.	D	D	.	2.98422368777	.	.	.	.	.	0.99682	.	.	.	.	0.95831	.	.	0.99743	1.0	.	1.0	0.89791	3.95	0.99	G	single nucleotide variant	NC_000012.12:g.25227346C>G	.	.	3	0.9740602	.	.	0.9893387	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648	.	.	.	.	0.97926	D	0.99902	D	H	20.65427	.	C/C	.	.	.	.	Cardiofaciocutaneous syndrome 2|RASopathy|Cardio-facio-cutaneous syndrome|not provided|Inborn genetic diseases|Cardio-facio-cutaneous syndrome;Noonan syndrome|Noonan syndrome 3	.	0.99174	.	.	-	25227346	.	-	7.701000	.	0.99985	.	.	.	.	germline;unknown	.	Gain of catalytic residue at L56 (P = 0.1064)| Gain of phosphorylation at T58 (P = 0.1068)| Loss of glycosylation at T58 (P = 0.123)| Gain of solvent accessibility (P = 0.1319)| Gain of loop (P = 0.2045)	0.92046	GRCh38	855	reviewed by expert panel	c.178G>C	.	0.91065	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_004985.5(KRAS):c.178G>C (p.Gly60Arg)	3	.	RASK_HUMAN	.	99.0	1.15990254133055	.	D	0.99795	0.98968154	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99211	.	.	.	.	.	p.Gly60Arg	.	0.66341	.	germline	.		C	Apr 03, 2017	.	C/C	.	.	1.0	N	12p12.1	.	.	.	SCV000616370	Pathogenic	.	.	Arg	R	-	.	ENSP00000256078	ENST00000256078	.	0.0	.	.	0.58	C	.	5.208984	0.92967	D	D	-	22.78603	.	0.94345	.	.	.	0.99730	.	25227346	Y	9	.	.	.	P01116	.	0.960754	0.99621		.	1.0	D	.	0.98382205	.	0.97202	3845	0.541091	.	-7.76	.	.	0.91343	.	.	.	.	.	.	0.99623	12	KRAS	.	.	Gly	.	.	12-25227346-C-G	Cardiofaciocutaneous_syndrome_2|Inborn_genetic_diseases|Cardio-facio-cutaneous_syndrome|Noonan_syndrome_3|not_provided|RASopathy|Noonan_syndrome	.	.	25271547	ClinGen:CA273416|OMIM:190070.0009|UniProtKB:P01116#VAR_026112	0.908603	0.99090	.	RCV000013416|RCV000157935|RCV000521390|RCV000254661|RCV001267316|RCV000844635|RCV003313917	D	.	.	c.178G>C	.	.	.	0.95437	C/C	rs104894359	25227346	.	C	.	P01116	.	0.99724	.	0.68239		.	.	.	4.17	.	.	.	5.77	0.99490	.	D	D	.	.	.	.	.	.	.	1340|1340|648|536391|648	12586	0.95369	0.99182	0.999921560287476	.	.	0.71675	0.86363	.	.	.	7.892	.	D	.	.	.	.	615278|PS115150|609942|PS163950	0.85894	12	.	ENSG00000133703	.	.	.	.	0.9776364459571039	1	0.97365	0.34655	.	.	.	.	1.0558655561841	.	.	0.451783	27625	HGNC:6407	A	.	simple_aae	1	.	25227346	GGT	1.000000	.	-	.	0.95603	.	.	.	Pathogenic	0.88337	.	.	.	ClinGen:CA273416,UniProtKB:P01116#VAR_026112,OMIM:190070.0009	G	.	0.995530386705	-	0.802	-	0.96546	.	.	0.97742	0.947138845921	0.9998	.	0.99936203639780719	.	-	178G>C 	.	.	C3809005|C0950123|C1275081|C1860991|C3661900|C5555857|C0028326	.	.	.	.	NM_004985.5	-	.	.	1	0.64215	104894359	.	.	0.99541	0.99443	0.956	0.0	.	0.99919980	5.77	.	.	.	0.539464	0.999979503899075	0.97633	D	.	.	.	1.0884	0.98375	p.Gly60Arg	.	.	-12.016	0.96227115	.	0.99427	12586	D	.	KRAS	.	D	0.938	.	G60R	D	0.75212	0.29757	C/C	alternative1																																																																																																				
FH_Arg233Cys	0.840040754452072	0.4330774414127768	-0.5768098835051846	0.5821337323712967	2025_01_Batch_13-14	0.5681956161990315	0.591142855004605	0.7443955154689178	0.7275652312524326	0.4790616233228787	0.5987548645396555	0.687703462456375	0.7959572347361038	0.7904062805896533	0.5762077703311804	0.5834752403693435	0.6394231587304899	0.7701763751025108	0.7589857559210429	0.5276346968270296	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH	ENSG00000091483	3408	214594	CCSBVarC004049	ALE00004049	NC_000001.11:241508644:G:A	697C>T	Arg233Cys	CEGS2	CegsMutGDEh1039	B12	GDEhDisVCh_40065	D08	1	CegsMutGDDh1039	B12	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_Arg233Cys	1	241508644	G	A	1											1-241508644-G-A	-	0.92846	1.0	233	.	1	.	1	241671944	A	3.718170e-06	.	1	1_Pathogenic	NC_000001.11	1	Arg233Cys	.	33.0	.	0	.	D	0	10	1	.	.	.	.	.	0	0.99024	Select	0.9945	.	0.90580	.	.	D	D	64016	1.15023203385	0	0	.	.	.	0.90864	.	44874	0	.	0.95967	.	.	0.98865	0.947	.	4.0	0.994141	5.55	0.96	A	single nucleotide variant	NC_000001.11:g.241508644G>A	0	.	2	0.9070807	.	0	0.97714406	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	.	.	0.000000e+00	0	0.95575	D	0.95418	D	H	19.44741	6	G/G	114	0	.	1613696	Hereditary cancer-predisposing syndrome|not provided|Fumarase deficiency	.	0.96051	.	.	-	241508644	.	-	8.562000	.	0.99985	29598	0	29598	.	germline;unknown	91076	Loss of catalytic residue at R233 (P = 0.0152)| Loss of phosphorylation at T236 (P = 0.0683)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of MoRF binding (P = 0.0767)| Loss of methylation at K230 (P = 0.1519)	0.97304	GRCh38	975	criteria provided, multiple submitters, no conflicts	c.697C>T	.	0.86862	0	.	.	Fumarate lyase, N-terminal	.	.	P	0	3.378610e-05	NM_000143.4(FH):c.697C>T (p.Arg233Cys)	2	.	FUMH_HUMAN	.	96.0	1.1397818748542	.	D	0.90045	0.97714406	-	.	.	3.42099e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.92451	.	0	.	.	59986	p.Arg233Cys	0	0.77604	.	germline	.	241508644	G	Dec 18, 2024	.	G/G	.	.	1.0	N	1q43	9690	.	.	SCV000184662|SCV000230852|SCV000251418|SCV000632484|SCV002535569|SCV002544394|SCV004197373|SCV005625599|SCV005727144	Pathogenic	.	.	Cys	C	-	912	ENSP00000355518	ENST00000366560	.	0.0	.	.	0.676	G	.	5.655055	0.92967	D	D	-	19.13286	.	0.97538	610	.	.	0.99958	0	241508644	Y	10	0	.	0.000000e+00	P07954	.	0.994652	0.99043	G	.	1.0	D	.	0.9070807	.	0.4917	2271	0.592007	3	-7.81	.	3.378610e-05	0.91343	.	.	74894	.	6080	.	0.95418	1	FH	1.335220e-05	0	Arg	14050	.	1-241508644-G-A	Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|not_provided	0	.	239738567	ClinGen:CA165194	0.944500	0.98799	0	RCV000129845|RCV000153237|RCV000549060	D	0	.	c.697C>T	.	0	0	0.97345	G/G	rs587781682	241508644	.	G	.	P07954	.	0.98865	.	0.68239	1	.	.	0.000000e+00	5.07	0	0	264690	5.65	0.99988	112	D	D	.	.	0	26	.	.	.	24|140162	141355	0.97303	0.79062	0.999971151351929	2898	.	0.71675	0.95149	.	.	1179784	9.516	.	D	.	.	1.8890023E-5	0	606812	0.97049	1	.	ENSG00000091483	0.000000e+00	0	.	0	0.9655328358886819	1	0.97365	0.05314	.	5	.	0.000000e+00	1.00471014856407	YES	0.000000e+00	0.699957	151069	HGNC:3700	A	.	simple_aae	1	.	241508644	CGT	1.000000	.	-	0	0.99374	2.542840e-06	0	0	Pathogenic	0.90777	.	0	0	ClinGen:CA165194	R	.	0.967472502496	-	0.89	-	0.97221	.	496	0.96521	0.858424127102	0.9741	0	0.99925707796903818	98	-	697C>T 	.	0	C0342770|C0027672|C3661900	.	.	.	.	NM_000143.4	-	.	.	1	0.98073	587781682	.	0	0.96682	0.98709	0.962	0.0	2784	0.93132580	5.65	.	.	.	0.612601	0.999896646635663	0.99905	D	86	.	.	0.9273	0.99874	p.Arg233Cys	0	0	-13.351	0.9892357	1	0.98645	141355	D	.	FH	.	D	0.949	.	R233C	D	0.94672	0.76753	G/G	principal1																																																																																																				
FH_Arg233Cys	0.840040754452072	0.4330774414127768	-0.5768098835051846	0.5821337323712967	2025_01_Batch_13-14	0.5681956161990315	0.591142855004605	0.7443955154689178	0.7275652312524326	0.4790616233228787	0.5987548645396555	0.687703462456375	0.7959572347361038	0.7904062805896533	0.5762077703311804	0.5834752403693435	0.6394231587304899	0.7701763751025108	0.7589857559210429	0.5276346968270296	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH		3408		CCSBVarC004049		NC_000001.11:241508644:G:A		Arg233Cys																												FH_Arg233Cys	1	241508644	G	A	1	allele	697C>T	D03	527_CAVA_Array_P03	H05	B13A7A8P1_R1	B14A7A8P1_R2				1-241508644-G-A	-	0.92846	1.0	233	.	1	.	1	241671944	A	3.718170e-06	.	1	1_Pathogenic	NC_000001.11	1	Arg233Cys	.	33.0	.	0	.	D	0	10	1	.	.	.	.	.	0	0.99024	Select	0.9945	.	0.90580	.	.	D	D	64016	1.15023203385	0	0	.	.	.	0.90864	.	44874	0	.	0.95967	.	.	0.98865	0.947	.	4.0	0.994141	5.55	0.96	A	single nucleotide variant	NC_000001.11:g.241508644G>A	0	.	2	0.9070807	.	0	0.97714406	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	.	.	0.000000e+00	0	0.95575	D	0.95418	D	H	19.44741	6	G/G	114	0	.	1613696	Hereditary cancer-predisposing syndrome|not provided|Fumarase deficiency	.	0.96051	.	.	-	241508644	.	-	8.562000	.	0.99985	29598	0	29598	.	germline;unknown	91076	Loss of catalytic residue at R233 (P = 0.0152)| Loss of phosphorylation at T236 (P = 0.0683)| Gain of ubiquitination at K230 (P = 0.0707)| Loss of MoRF binding (P = 0.0767)| Loss of methylation at K230 (P = 0.1519)	0.97304	GRCh38	975	criteria provided, multiple submitters, no conflicts	c.697C>T	.	0.86862	0	.	.	Fumarate lyase, N-terminal	.	.	P	0	3.378610e-05	NM_000143.4(FH):c.697C>T (p.Arg233Cys)	2	.	FUMH_HUMAN	.	96.0	1.1397818748542	.	D	0.90045	0.97714406	-	.	.	3.42099e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.92451	.	0	.	.	59986	p.Arg233Cys	0	0.77604	.	germline	.	241508644	G	Dec 18, 2024	.	G/G	.	.	1.0	N	1q43	9690	.	.	SCV000184662|SCV000230852|SCV000251418|SCV000632484|SCV002535569|SCV002544394|SCV004197373|SCV005625599|SCV005727144	Pathogenic	.	.	Cys	C	-	912	ENSP00000355518	ENST00000366560	.	0.0	.	.	0.676	G	.	5.655055	0.92967	D	D	-	19.13286	.	0.97538	610	.	.	0.99958	0	241508644	Y	10	0	.	0.000000e+00	P07954	.	0.994652	0.99043	G	.	1.0	D	.	0.9070807	.	0.4917	2271	0.592007	3	-7.81	.	3.378610e-05	0.91343	.	.	74894	.	6080	.	0.95418	1	FH	1.335220e-05	0	Arg	14050	.	1-241508644-G-A	Fumarase_deficiency|Hereditary_cancer-predisposing_syndrome|not_provided	0	.	239738567	ClinGen:CA165194	0.944500	0.98799	0	RCV000129845|RCV000153237|RCV000549060	D	0	.	c.697C>T	.	0	0	0.97345	G/G	rs587781682	241508644	.	G	.	P07954	.	0.98865	.	0.68239	1	.	.	0.000000e+00	5.07	0	0	264690	5.65	0.99988	112	D	D	.	.	0	26	.	.	.	24|140162	141355	0.97303	0.79062	0.999971151351929	2898	.	0.71675	0.95149	.	.	1179784	9.516	.	D	.	.	1.8890023E-5	0	606812	0.97049	1	.	ENSG00000091483	0.000000e+00	0	.	0	0.9655328358886819	1	0.97365	0.05314	.	5	.	0.000000e+00	1.00471014856407	YES	0.000000e+00	0.699957	151069	HGNC:3700	A	.	simple_aae	1	.	241508644	CGT	1.000000	.	-	0	0.99374	2.542840e-06	0	0	Pathogenic	0.90777	.	0	0	ClinGen:CA165194	R	.	0.967472502496	-	0.89	-	0.97221	.	496	0.96521	0.858424127102	0.9741	0	0.99925707796903818	98	-	697C>T 	.	0	C0342770|C0027672|C3661900	.	.	.	.	NM_000143.4	-	.	.	1	0.98073	587781682	.	0	0.96682	0.98709	0.962	0.0	2784	0.93132580	5.65	.	.	.	0.612601	0.999896646635663	0.99905	D	86	.	.	0.9273	0.99874	p.Arg233Cys	0	0	-13.351	0.9892357	1	0.98645	141355	D	.	FH	.	D	0.949	.	R233C	D	0.94672	0.76753	G/G	principal1																																																																																																				
F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	0.7023750789365777	0.775574737902366	0.7125669134133822	0.7182219560398473	0.6291410557136246	0.8540042561209782	0.8912212975616018	0.8250969338123266	0.8996715909237751	0.6167847669633241	0.7781896675287779	0.833398017731984	0.7688319236128545	0.8089467734818112	0.6229629113384743	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A		Ala233Thr																												F9_Ala233Thr	23	139551238	G	A	X	allele	697G>A	C09	527_CAVA_Array_P02	E18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551238-G-A	-	0.43284	0.835	233	.	.	.	X	138633397	A	.	.	X	1_Pathogenic	NC_000023.11	.	Ala233Thr	.	21.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.84159	Select	0.8126	.	0.46269	.	.	D	D	.	0.692767066121	0	.	.	.	.	0.25417	.	.	.	.	0.40077	.	.	0.58855	0.98	.	19.0	0.912709	3.93	0.81	A	single nucleotide variant	NC_000023.11:g.139551238G>A	.	.	1	0.36422572	.	0	0.42786407	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.89397	P	0.63514	P	L	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.87093	.	.	-	139551238	.	-	6.519000	.	0.88827	.	0	.	.	germline	.	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.94387	GRCh38	924	no assertion criteria provided	c.697G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.697G>A (p.Ala233Thr)		.	FA9_HUMAN	.	81.0	.	.	D	0.46513	0.37815922	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99978	.	.	.	.	.	p.Ala233Thr	.	0.55895	.	germline	.		G	Sep 01, 1989	.	G/G	.	.	0.906	N	Xq27.1	78	.	.	SCV000031579	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.009	.	.	0.676	G	.	3.182106	0.58950	.	D	-	.	.	0.95863	0	.	.	0.35695	0	139551238	Y	10	0	.	.	P00740	.	0.679272	0.96668		.	0.508	D	.	0.38942766	.	0.58201	2158	0.294947	.	-1.68	.	.	0.57638	.	.	.	.	.	.	0.61553	X	F9	.	0	Ala	660	.	X-139551238-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138461063	ClinGen:CA255365|OMIM:300746.0042	.	.	.	RCV000011347	D	.	.	c.697G>A	.	.	.	0.82433	G/G	rs387906478	139551238	.	G	.	P00740	.	0.62291	.	0.68239		.	.	.	1.585	0	0	.	5.31	0.90470	34	D	T	.	.	0	0	.	.	.	98879	10601	0.82207	0.60419	0.590011954307556	434	.	0.31665	.	.	.	.	2.501	.	N	.	.	.	0	306900	0.4515	X	.	ENSG00000101981	.	0	.	0	0.9744568104967672	1	0.47888	0.18019	.	.	.	.	.	YES	.	0.551716	25640	HGNC:3551	A	.	simple_aae	0.798	.	139551238	GCC	1.000000	.	-	0	0.73158	.	0	.	Pathogenic	0.59571	.	.	.	ClinGen:CA255365,OMIM:300746.0042	A	.	0.996876262872	-	0.837	-	0.25325	.	108	0.97421	0.402713298798	0.2233	.	0.99893111899062204	6	-	697G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.71602	387906478	.	0	0.99680	.	0.205	0.02	434	0.99996746	5.31	.	.	.	0.185895	0.990832113786758	0.39718	D	34	.	.	0.2747	0.93664	p.Ala233Thr	0	.	-7.14	0.7169125	.	0.88755	10601	T	.	F9	.	D	0.601	.	A233T	D	0.74723	0.76753	G/G	principal1	164785	F9_Popp_2025_carboxy_gla_motif_var254610	No											A		697	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ala233Thr		true	c.697G>A						3551.0	139551238.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Ala233Thr						T	Sep 01, 1989					missense_variant		233.0				0.9277382175294492		Pathogenic	139551238.0	missense_variant		0.601					Reporter			F9_Ala233Thr
F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	0.7023750789365777	0.775574737902366	0.7125669134133822	0.7182219560398473	0.6291410557136246	0.8540042561209782	0.8912212975616018	0.8250969338123266	0.8996715909237751	0.6167847669633241	0.7781896675287779	0.833398017731984	0.7688319236128545	0.8089467734818112	0.6229629113384743	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A		Ala233Thr																												F9_Ala233Thr	23	139551238	G	A	X	allele	697G>A	C09	527_CAVA_Array_P02	E18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551238-G-A	-	0.43284	0.835	233	.	.	.	X	138633397	A	.	.	X	1_Pathogenic	NC_000023.11	.	Ala233Thr	.	21.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.84159	Select	0.8126	.	0.46269	.	.	D	D	.	0.692767066121	0	.	.	.	.	0.25417	.	.	.	.	0.40077	.	.	0.58855	0.98	.	19.0	0.912709	3.93	0.81	A	single nucleotide variant	NC_000023.11:g.139551238G>A	.	.	1	0.36422572	.	0	0.42786407	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.89397	P	0.63514	P	L	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.87093	.	.	-	139551238	.	-	6.519000	.	0.88827	.	0	.	.	germline	.	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.94387	GRCh38	924	no assertion criteria provided	c.697G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.697G>A (p.Ala233Thr)		.	FA9_HUMAN	.	81.0	.	.	D	0.46513	0.37815922	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99978	.	.	.	.	.	p.Ala233Thr	.	0.55895	.	germline	.		G	Sep 01, 1989	.	G/G	.	.	0.906	N	Xq27.1	78	.	.	SCV000031579	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.009	.	.	0.676	G	.	3.182106	0.58950	.	D	-	.	.	0.95863	0	.	.	0.35695	0	139551238	Y	10	0	.	.	P00740	.	0.679272	0.96668		.	0.508	D	.	0.38942766	.	0.58201	2158	0.294947	.	-1.68	.	.	0.57638	.	.	.	.	.	.	0.61553	X	F9	.	0	Ala	660	.	X-139551238-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138461063	ClinGen:CA255365|OMIM:300746.0042	.	.	.	RCV000011347	D	.	.	c.697G>A	.	.	.	0.82433	G/G	rs387906478	139551238	.	G	.	P00740	.	0.62291	.	0.68239		.	.	.	1.585	0	0	.	5.31	0.90470	34	D	T	.	.	0	0	.	.	.	98879	10601	0.82207	0.60419	0.590011954307556	434	.	0.31665	.	.	.	.	2.501	.	N	.	.	.	0	306900	0.4515	X	.	ENSG00000101981	.	0	.	0	0.9744568104967672	1	0.47888	0.18019	.	.	.	.	.	YES	.	0.551716	25640	HGNC:3551	A	.	simple_aae	0.798	.	139551238	GCC	1.000000	.	-	0	0.73158	.	0	.	Pathogenic	0.59571	.	.	.	ClinGen:CA255365,OMIM:300746.0042	A	.	0.996876262872	-	0.837	-	0.25325	.	108	0.97421	0.402713298798	0.2233	.	0.99893111899062204	6	-	697G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.71602	387906478	.	0	0.99680	.	0.205	0.02	434	0.99996746	5.31	.	.	.	0.185895	0.990832113786758	0.39718	D	34	.	.	0.2747	0.93664	p.Ala233Thr	0	.	-7.14	0.7169125	.	0.88755	10601	T	.	F9	.	D	0.601	.	A233T	D	0.74723	0.76753	G/G	principal1	219817	F9_Popp_2025_light_chain_var244929	No											A		697	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ala233Thr		true	c.697G>A						3551.0	139551238.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Ala233Thr						T	Sep 01, 1989					missense_variant		233.0				0.927565455095564		Pathogenic	139551238.0	missense_variant		0.601					Reporter			F9_Ala233Thr
F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	0.7023750789365777	0.775574737902366	0.7125669134133822	0.7182219560398473	0.6291410557136246	0.8540042561209782	0.8912212975616018	0.8250969338123266	0.8996715909237751	0.6167847669633241	0.7781896675287779	0.833398017731984	0.7688319236128545	0.8089467734818112	0.6229629113384743	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A		Ala233Thr																												F9_Ala233Thr	23	139551238	G	A	X	allele	697G>A	C09	527_CAVA_Array_P02	E18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551238-G-A	-	0.43284	0.835	233	.	.	.	X	138633397	A	.	.	X	1_Pathogenic	NC_000023.11	.	Ala233Thr	.	21.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.84159	Select	0.8126	.	0.46269	.	.	D	D	.	0.692767066121	0	.	.	.	.	0.25417	.	.	.	.	0.40077	.	.	0.58855	0.98	.	19.0	0.912709	3.93	0.81	A	single nucleotide variant	NC_000023.11:g.139551238G>A	.	.	1	0.36422572	.	0	0.42786407	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.89397	P	0.63514	P	L	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.87093	.	.	-	139551238	.	-	6.519000	.	0.88827	.	0	.	.	germline	.	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.94387	GRCh38	924	no assertion criteria provided	c.697G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.697G>A (p.Ala233Thr)		.	FA9_HUMAN	.	81.0	.	.	D	0.46513	0.37815922	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99978	.	.	.	.	.	p.Ala233Thr	.	0.55895	.	germline	.		G	Sep 01, 1989	.	G/G	.	.	0.906	N	Xq27.1	78	.	.	SCV000031579	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.009	.	.	0.676	G	.	3.182106	0.58950	.	D	-	.	.	0.95863	0	.	.	0.35695	0	139551238	Y	10	0	.	.	P00740	.	0.679272	0.96668		.	0.508	D	.	0.38942766	.	0.58201	2158	0.294947	.	-1.68	.	.	0.57638	.	.	.	.	.	.	0.61553	X	F9	.	0	Ala	660	.	X-139551238-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138461063	ClinGen:CA255365|OMIM:300746.0042	.	.	.	RCV000011347	D	.	.	c.697G>A	.	.	.	0.82433	G/G	rs387906478	139551238	.	G	.	P00740	.	0.62291	.	0.68239		.	.	.	1.585	0	0	.	5.31	0.90470	34	D	T	.	.	0	0	.	.	.	98879	10601	0.82207	0.60419	0.590011954307556	434	.	0.31665	.	.	.	.	2.501	.	N	.	.	.	0	306900	0.4515	X	.	ENSG00000101981	.	0	.	0	0.9744568104967672	1	0.47888	0.18019	.	.	.	.	.	YES	.	0.551716	25640	HGNC:3551	A	.	simple_aae	0.798	.	139551238	GCC	1.000000	.	-	0	0.73158	.	0	.	Pathogenic	0.59571	.	.	.	ClinGen:CA255365,OMIM:300746.0042	A	.	0.996876262872	-	0.837	-	0.25325	.	108	0.97421	0.402713298798	0.2233	.	0.99893111899062204	6	-	697G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.71602	387906478	.	0	0.99680	.	0.205	0.02	434	0.99996746	5.31	.	.	.	0.185895	0.990832113786758	0.39718	D	34	.	.	0.2747	0.93664	p.Ala233Thr	0	.	-7.14	0.7169125	.	0.88755	10601	T	.	F9	.	D	0.601	.	A233T	D	0.74723	0.76753	G/G	principal1	137269	F9_Popp_2025_carboxy_F9_specific_var225567	No											A		697	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ala233Thr		true	c.697G>A						3551.0	139551238.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Ala233Thr						T	Sep 01, 1989					missense_variant		233.0				0.9147990800527244		Pathogenic	139551238.0	missense_variant		0.601					Reporter			F9_Ala233Thr
F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	0.7023750789365777	0.775574737902366	0.7125669134133822	0.7182219560398473	0.6291410557136246	0.8540042561209782	0.8912212975616018	0.8250969338123266	0.8996715909237751	0.6167847669633241	0.7781896675287779	0.833398017731984	0.7688319236128545	0.8089467734818112	0.6229629113384743	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A		Ala233Thr																												F9_Ala233Thr	23	139551238	G	A	X	allele	697G>A	C09	527_CAVA_Array_P02	E18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551238-G-A	-	0.43284	0.835	233	.	.	.	X	138633397	A	.	.	X	1_Pathogenic	NC_000023.11	.	Ala233Thr	.	21.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.84159	Select	0.8126	.	0.46269	.	.	D	D	.	0.692767066121	0	.	.	.	.	0.25417	.	.	.	.	0.40077	.	.	0.58855	0.98	.	19.0	0.912709	3.93	0.81	A	single nucleotide variant	NC_000023.11:g.139551238G>A	.	.	1	0.36422572	.	0	0.42786407	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.89397	P	0.63514	P	L	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.87093	.	.	-	139551238	.	-	6.519000	.	0.88827	.	0	.	.	germline	.	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.94387	GRCh38	924	no assertion criteria provided	c.697G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.697G>A (p.Ala233Thr)		.	FA9_HUMAN	.	81.0	.	.	D	0.46513	0.37815922	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99978	.	.	.	.	.	p.Ala233Thr	.	0.55895	.	germline	.		G	Sep 01, 1989	.	G/G	.	.	0.906	N	Xq27.1	78	.	.	SCV000031579	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.009	.	.	0.676	G	.	3.182106	0.58950	.	D	-	.	.	0.95863	0	.	.	0.35695	0	139551238	Y	10	0	.	.	P00740	.	0.679272	0.96668		.	0.508	D	.	0.38942766	.	0.58201	2158	0.294947	.	-1.68	.	.	0.57638	.	.	.	.	.	.	0.61553	X	F9	.	0	Ala	660	.	X-139551238-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138461063	ClinGen:CA255365|OMIM:300746.0042	.	.	.	RCV000011347	D	.	.	c.697G>A	.	.	.	0.82433	G/G	rs387906478	139551238	.	G	.	P00740	.	0.62291	.	0.68239		.	.	.	1.585	0	0	.	5.31	0.90470	34	D	T	.	.	0	0	.	.	.	98879	10601	0.82207	0.60419	0.590011954307556	434	.	0.31665	.	.	.	.	2.501	.	N	.	.	.	0	306900	0.4515	X	.	ENSG00000101981	.	0	.	0	0.9744568104967672	1	0.47888	0.18019	.	.	.	.	.	YES	.	0.551716	25640	HGNC:3551	A	.	simple_aae	0.798	.	139551238	GCC	1.000000	.	-	0	0.73158	.	0	.	Pathogenic	0.59571	.	.	.	ClinGen:CA255365,OMIM:300746.0042	A	.	0.996876262872	-	0.837	-	0.25325	.	108	0.97421	0.402713298798	0.2233	.	0.99893111899062204	6	-	697G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.71602	387906478	.	0	0.99680	.	0.205	0.02	434	0.99996746	5.31	.	.	.	0.185895	0.990832113786758	0.39718	D	34	.	.	0.2747	0.93664	p.Ala233Thr	0	.	-7.14	0.7169125	.	0.88755	10601	T	.	F9	.	D	0.601	.	A233T	D	0.74723	0.76753	G/G	principal1	192301	F9_Popp_2025_heavy_chain_var235248	No											A		697	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ala233Thr		true	c.697G>A						3551.0	139551238.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Ala233Thr						T	Sep 01, 1989					missense_variant		233.0				0.8971889490305673		Pathogenic	139551238.0	missense_variant		0.601					Reporter			F9_Ala233Thr
F9_Ala233Thr	-0.7705435338155132	0.46618328932048236	3.587645258672378	0.008885010186593878	2025_01_Batch_13-14	0.7023750789365777	0.775574737902366	0.7125669134133822	0.7182219560398473	0.6291410557136246	0.8540042561209782	0.8912212975616018	0.8250969338123266	0.8996715909237751	0.6167847669633241	0.7781896675287779	0.833398017731984	0.7688319236128545	0.8089467734818112	0.6229629113384743	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030569		NC_000023.11:139551238:G:A		Ala233Thr																												F9_Ala233Thr	23	139551238	G	A	X	allele	697G>A	C09	527_CAVA_Array_P02	E18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551238-G-A	-	0.43284	0.835	233	.	.	.	X	138633397	A	.	.	X	1_Pathogenic	NC_000023.11	.	Ala233Thr	.	21.7	.	0	.	D	.	1	1	.	.	.	.	.	0	0.84159	Select	0.8126	.	0.46269	.	.	D	D	.	0.692767066121	0	.	.	.	.	0.25417	.	.	.	.	0.40077	.	.	0.58855	0.98	.	19.0	0.912709	3.93	0.81	A	single nucleotide variant	NC_000023.11:g.139551238G>A	.	.	1	0.36422572	.	0	0.42786407	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.89397	P	0.63514	P	L	.	.	G/G	0	0	.	.	Hereditary factor IX deficiency disease	.	0.87093	.	.	-	139551238	.	-	6.519000	.	0.88827	.	0	.	.	germline	.	Gain of phosphorylation at A233 (P = 0.0964)| Loss of ubiquitination at K234 (P = 0.1055)| Gain of disorder (P = 0.1288)| Gain of methylation at K234 (P = 0.1325)| Loss of sheet (P = 0.1907)	0.94387	GRCh38	924	no assertion criteria provided	c.697G>A	.	0.75027	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.697G>A (p.Ala233Thr)		.	FA9_HUMAN	.	81.0	.	.	D	0.46513	0.37815922	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99978	.	.	.	.	.	p.Ala233Thr	.	0.55895	.	germline	.		G	Sep 01, 1989	.	G/G	.	.	0.906	N	Xq27.1	78	.	.	SCV000031579	Pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.009	.	.	0.676	G	.	3.182106	0.58950	.	D	-	.	.	0.95863	0	.	.	0.35695	0	139551238	Y	10	0	.	.	P00740	.	0.679272	0.96668		.	0.508	D	.	0.38942766	.	0.58201	2158	0.294947	.	-1.68	.	.	0.57638	.	.	.	.	.	.	0.61553	X	F9	.	0	Ala	660	.	X-139551238-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138461063	ClinGen:CA255365|OMIM:300746.0042	.	.	.	RCV000011347	D	.	.	c.697G>A	.	.	.	0.82433	G/G	rs387906478	139551238	.	G	.	P00740	.	0.62291	.	0.68239		.	.	.	1.585	0	0	.	5.31	0.90470	34	D	T	.	.	0	0	.	.	.	98879	10601	0.82207	0.60419	0.590011954307556	434	.	0.31665	.	.	.	.	2.501	.	N	.	.	.	0	306900	0.4515	X	.	ENSG00000101981	.	0	.	0	0.9744568104967672	1	0.47888	0.18019	.	.	.	.	.	YES	.	0.551716	25640	HGNC:3551	A	.	simple_aae	0.798	.	139551238	GCC	1.000000	.	-	0	0.73158	.	0	.	Pathogenic	0.59571	.	.	.	ClinGen:CA255365,OMIM:300746.0042	A	.	0.996876262872	-	0.837	-	0.25325	.	108	0.97421	0.402713298798	0.2233	.	0.99893111899062204	6	-	697G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.71602	387906478	.	0	0.99680	.	0.205	0.02	434	0.99996746	5.31	.	.	.	0.185895	0.990832113786758	0.39718	D	34	.	.	0.2747	0.93664	p.Ala233Thr	0	.	-7.14	0.7169125	.	0.88755	10601	T	.	F9	.	D	0.601	.	A233T	D	0.74723	0.76753	G/G	principal1	247333	F9_Popp_2025_strep_2_var264291	No											A		697	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ala233Thr		true	c.697G>A						3551.0	139551238.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Ala233Thr						T	Sep 01, 1989					missense_variant		233.0				0.9995956496751132		Pathogenic	139551238.0	missense_variant		0.601					Reporter			F9_Ala233Thr
BRCA1_Glu116Lys	-0.5233944689523996	0.6168548518585896	-8.233502008527779	0.00007581852114808089	2025_01_Batch_13-14	0.5045541015624009	0.8997581228520514	0.9684817915298322	0.9519226502253639	0.53067015370023	0.47863625149603095	0.8685349197079164	0.9460941132888923	0.8720732274871875	0.5636348664071934	0.4915951765292159	0.8841465212799839	0.9572879524093623	0.9119979388562758	0.5471525100537117	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218399	CCSBVarC003298	ALE00003298	NC_000017.11:43104217:C:T	346G>A	Glu116Lys	CEGS2	CegsMutGDEh1028	G06	GDEhDisVCh_40059	G09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Glu116Lys	17	43104217	C	T	17											17-43104217-C-T	-	0.56124	0.956	116	.	.	.	17	41256234	T	.	.	17	4_VUS	NC_000017.11	.	Glu116Lys	.	23.7	.	2	.	D	.	2	1	.	.	.	.	.	0	0.89052	Select	0.9333	.	0.54679	.	.	T	D	.	.	2.717391304347826E-4	.	.	.	.	0.32716	.	.	.	.	0.54726	.	.	0.51944	0.994	.	1.0	.	.	0.99	T	single nucleotide variant	NC_000017.11:g.43104217C>T	.	.	3	0.32331142	.	0	0.30580968	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	.	.	0.97926	B	0.56841	P	M	5.192408	.	./.	292	0	.	.	Familial cancer of breast|Hereditary cancer-predisposing syndrome	.	0.98399	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43104217	.	-	3.839000	.	0.36038	.	0	.	.	germline	.	.	.	GRCh38	462	criteria provided, single submitter	c.346G>A	.	0.75341	2	.	.	.	.	.	B	0	.	NM_007294.4(BRCA1):c.346G>A (p.Glu116Lys)	1	.	BRCA1_HUMAN	.	99.0	0.519732155081613	.	.	0.24020	0.29307255	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99185	.	.	.	.	.	p.Glu116Lys	.	0.40112	.	germline	.		C	Jan 25, 2022	.	./.	.	.	1.0	N	17q21.31	17708	.	.	SCV002612990	Uncertain_significance	.	.	Lys	K	-	.	ENSP00000350283	ENST00000357654	.	0.001	.	.	0.599	C	.	3.863469	0.61973	D	D	-	5.588604	.	0.97412	610	.	.	0.65652	0	43104217	Y	10	0	.	.	P38398	.	0.167623	0.98450		.	0.275	D	.	0.31052214	.	0.71086	672	0.458962	.	-0.56	.	.	0.78662	.	.	.	.	.	.	0.58036	17	BRCA1	.	0	Glu	28222	.	17-43104217-C-T	Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast	.	.	38509760	ClinGen:CA002236	0.588432	0.68091	.	RCV000577079|RCV002453364	D	.	.	c.346G>A	.	.	.	0.92824	./.	rs397509071	43104217	.	C	.	.	.	0.53088	.	0.68239		.	.	.	2.455	0	0	264690	5.32	0.51184	108	D	T	.	.	0	24	.	.	.	140162|227535	54893	0.92735	0.25914	0.960671126842499	7652	.	0.71675	0.58423	.	.	.	2.768	.	N	.	.	3.7780044E-6	0	114480	0.47428	17	.	ENSG00000012048	.	0	.	0	.	1	0.40079	0.78630	.	1	.	.	0.544271718873321	YES	.	0.687104	69560	HGNC:1100	D	.	simple_aae	0.137	.	43104217	GAA	1.000000	.	-	2.6136957658128593E-4	0.75596	.	2	.	Uncertain significance	0.26444	.	.	.	ClinGen:CA002236	E	.	0.936910906656	-	.	-	0.73073	.	1904	0.48618	0.455957233906	0.103	.	0.99917023792078985	94	-	346G>A 	.	0	C0027672|C0346153	.	.	.	.	NM_007294.4	-	.	.	0	0.90678	397509071	.	7.086669973779322E-5	0.93576	0.70840	0.665	0.015	7360	0.99916387	5.32	.	.	.	0.42149	0.315487270864402	0.71058	D	84	.	.	1.0626	0.97797	p.Glu116Lys	0	.	-4.132	0.75375986	.	0.54793	54893	T	.	BRCA1	.	D	0.698	.	.	D	.	0.40292	./.	principal2																																																																																																				
BRCA1_Glu116Lys	-0.5233944689523996	0.6168548518585896	-8.233502008527779	0.00007581852114808089	2025_01_Batch_13-14	0.5045541015624009	0.8997581228520514	0.9684817915298322	0.9519226502253639	0.53067015370023	0.47863625149603095	0.8685349197079164	0.9460941132888923	0.8720732274871875	0.5636348664071934	0.4915951765292159	0.8841465212799839	0.9572879524093623	0.9119979388562758	0.5471525100537117	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003298		NC_000017.11:43104217:C:T		Glu116Lys																												BRCA1_Glu116Lys	17	43104217	C	T	17	allele	346G>A	A07	527_CAVA_Array_P01	A13	B13A7A8P1_R1	B14A7A8P1_R2				17-43104217-C-T	-	0.56124	0.956	116	.	.	.	17	41256234	T	.	.	17	4_VUS	NC_000017.11	.	Glu116Lys	.	23.7	.	2	.	D	.	2	1	.	.	.	.	.	0	0.89052	Select	0.9333	.	0.54679	.	.	T	D	.	.	2.717391304347826E-4	.	.	.	.	0.32716	.	.	.	.	0.54726	.	.	0.51944	0.994	.	1.0	.	.	0.99	T	single nucleotide variant	NC_000017.11:g.43104217C>T	.	.	3	0.32331142	.	0	0.30580968	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	.	.	0.97926	B	0.56841	P	M	5.192408	.	./.	292	0	.	.	Familial cancer of breast|Hereditary cancer-predisposing syndrome	.	0.98399	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43104217	.	-	3.839000	.	0.36038	.	0	.	.	germline	.	.	.	GRCh38	462	criteria provided, single submitter	c.346G>A	.	0.75341	2	.	.	.	.	.	B	0	.	NM_007294.4(BRCA1):c.346G>A (p.Glu116Lys)	1	.	BRCA1_HUMAN	.	99.0	0.519732155081613	.	.	0.24020	0.29307255	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99185	.	.	.	.	.	p.Glu116Lys	.	0.40112	.	germline	.		C	Jan 25, 2022	.	./.	.	.	1.0	N	17q21.31	17708	.	.	SCV002612990	Uncertain_significance	.	.	Lys	K	-	.	ENSP00000350283	ENST00000357654	.	0.001	.	.	0.599	C	.	3.863469	0.61973	D	D	-	5.588604	.	0.97412	610	.	.	0.65652	0	43104217	Y	10	0	.	.	P38398	.	0.167623	0.98450		.	0.275	D	.	0.31052214	.	0.71086	672	0.458962	.	-0.56	.	.	0.78662	.	.	.	.	.	.	0.58036	17	BRCA1	.	0	Glu	28222	.	17-43104217-C-T	Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast	.	.	38509760	ClinGen:CA002236	0.588432	0.68091	.	RCV000577079|RCV002453364	D	.	.	c.346G>A	.	.	.	0.92824	./.	rs397509071	43104217	.	C	.	.	.	0.53088	.	0.68239		.	.	.	2.455	0	0	264690	5.32	0.51184	108	D	T	.	.	0	24	.	.	.	140162|227535	54893	0.92735	0.25914	0.960671126842499	7652	.	0.71675	0.58423	.	.	.	2.768	.	N	.	.	3.7780044E-6	0	114480	0.47428	17	.	ENSG00000012048	.	0	.	0	.	1	0.40079	0.78630	.	1	.	.	0.544271718873321	YES	.	0.687104	69560	HGNC:1100	D	.	simple_aae	0.137	.	43104217	GAA	1.000000	.	-	2.6136957658128593E-4	0.75596	.	2	.	Uncertain significance	0.26444	.	.	.	ClinGen:CA002236	E	.	0.936910906656	-	.	-	0.73073	.	1904	0.48618	0.455957233906	0.103	.	0.99917023792078985	94	-	346G>A 	.	0	C0027672|C0346153	.	.	.	.	NM_007294.4	-	.	.	0	0.90678	397509071	.	7.086669973779322E-5	0.93576	0.70840	0.665	0.015	7360	0.99916387	5.32	.	.	.	0.42149	0.315487270864402	0.71058	D	84	.	.	1.0626	0.97797	p.Glu116Lys	0	.	-4.132	0.75375986	.	0.54793	54893	T	.	BRCA1	.	D	0.698	.	.	D	.	0.40292	./.	principal2																																																																																																				
RPS19_Gly127Glu	-7.707857851852217	0.0001154978914415701	-7.085159878747123	0.00019620691459792407	2025_01_Batch_13-14	0.7881639125929129	0.8742458682336376	0.9556596922239629	0.9121475347492455	0.719791289438861	0.729857031752785	0.8404173017407848	0.9484581259208962	0.8938388316256192	0.7354839190609905	0.759010472172849	0.8573315849872112	0.9520589090724295	0.9029931831874323	0.7276376042499257	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RPS19	RPS19	ENSG00000105372	3441	6078	CCSBVarC000469	ALE00000469	NC_000019.10:41869722:G:A	380G>A	Gly127Glu	RC4	RC4_Mut_GDEh1010	H11	GDEhDisVCh_40042	E02	2	RC4_Mut_GDDh1010	H11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	1	0			0			0			RPS19_Gly127Glu	19	41869722	G	A	19											19-41869722-G-A	-	0.82873	0.988	127	.	.	.	19	42373792	A	.	.	19	1_Pathogenic	NC_000019.10	.	Gly127Glu	.	27.9	.	.	.	D	.	2	3	.	.	.	.	.	.	0.91208	.	0.5614	.	0.62341	.	.	D	D	.	.	.	.	.	.	.	0.77078	.	.	.	.	.	.	.	0.96820	1.0	.	1.0	0.847515	.	0.99	A	single nucleotide variant	NC_000019.10:g.41869722G>A	.	.	3	0.9024854	.	.	0.97176737	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124	.	.	.	.	0.97926	D	0.97258	D	M	11.89543	.	./.	.	.	.	.	Diamond-Blackfan anemia 1|Diamond-Blackfan anemia	.	0.86794	.	.	-	41869722	.	-	11.829000	.	0.82402	.	.	.	.	germline	.	Loss of MoRF binding (P = 0.0171)| Gain of relative solvent accessibility (P = 0.09)| Gain of solvent accessibility (P = 0.0971)| Gain of methylation at K122 (P = 0.1056)| Gain of sheet (P = 0.1451)	0.99843	GRCh38	747	criteria provided, single submitter	c.380G>A	.	0.72825	.	.	.	.	.	.	P	.	.	NM_001022.4(RPS19):c.380G>A (p.Gly127Glu)	1	.	RS19_HUMAN	.	99.0	0.931537152194926	.	T	0.97478	0.9559469	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99924	.	.	.	.	.	p.Gly127Glu	.	0.97469	.	germline	.		G	Jan 12, 2022	.	./.	.	.	1.0	N	19q13.2	.	.	.	SCV003443917	Likely_pathogenic	.	.	Glu	E	-	.	ENSP00000470004	ENST00000593863	.	.	.	.	0.676	G	.	4.995052	0.53076	D	D	-	12.711	.	0.93515	.	.	.	0.81780	.	41869722	Y	9	.	.	.	P39019	.	0.98826	0.89361		.	0.996	D	.	0.93296444	.	0.97202	6223	0.558625	.	.	.	.	.	.	.	.	.	.	.	0.95086	19	RPS19	.	.	Gly	.	.	19-41869722-G-A	Diamond-Blackfan_anemia|Diamond-Blackfan_anemia_1	.	.	47065632	ClinGen:CA130769|OMIM:603474.0008|UniProtKB:P39019#VAR_055444	0.952808	0.93180	.	RCV000033189|RCV002512845	D	.	.	c.380G>A	.	.	.	0.96031	./.	rs786200936	41869722	.	G	.	P39019	.	0.98397	.	0.68239		.	.	.	2.73	.	.	.	5.24	0.99938	.	D	T	.	.	.	.	.	.	.	124|124	6320	0.95968	0.96144	0.991606083214429	.	.	0.71675	0.96846	.	.	.	8.506	.	.	.	.	.	.	PS105650|105650	0.90371	19	.	ENSG00000105372	.	.	.	.	.	2	0.84488	0.52199	.	.	.	.	0.874714639492237	.	.	0.407513	21359	HGNC:10402	A	.	simple_aae	0.683	.	41869722	GGA	1.000000	.	-	.	0.98908	.	.	.	Likely pathogenic	0.91730	.	.	.	ClinGen:CA130769,UniProtKB:P39019#VAR_055444,OMIM:603474.0008	G	.	0.972294440432	-	0.984	-	0.99419	.	.	0.99657	0.76795142889	0.9981	.	0.99809882945303208	.	-	380G>A 	.	.	C1260899|C2676137	.	.	.	.	NM_001022.4	-	.	.	1	0.52781	786200936	.	.	0.97173	0.94342	0.985	0.034	.	0.99993120	5.24	.	.	.	0.56465	0.999816468006815	0.79671	D	.	.	.	0.2563	0.83981	p.Gly127Glu	.	.	-13.608	0.9862165	.	0.98120	6320	D	.	RPS19	.	D	.	.	G127E	.	.	0.76753	./.	principal1																																																																																																				
RPS19_Gly127Glu	-7.707857851852217	0.0001154978914415701	-7.085159878747123	0.00019620691459792407	2025_01_Batch_13-14	0.7881639125929129	0.8742458682336376	0.9556596922239629	0.9121475347492455	0.719791289438861	0.729857031752785	0.8404173017407848	0.9484581259208962	0.8938388316256192	0.7354839190609905	0.759010472172849	0.8573315849872112	0.9520589090724295	0.9029931831874323	0.7276376042499257	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RPS19	RPS19		3441		CCSBVarC000469		NC_000019.10:41869722:G:A		Gly127Glu																												RPS19_Gly127Glu	19	41869722	G	A	19	allele	380G>A	H10	527_CAVA_Array_P05	O19	B13A7A8P2_R1	B14A7A8P2_R2				19-41869722-G-A	-	0.82873	0.988	127	.	.	.	19	42373792	A	.	.	19	1_Pathogenic	NC_000019.10	.	Gly127Glu	.	27.9	.	.	.	D	.	2	3	.	.	.	.	.	.	0.91208	.	0.5614	.	0.62341	.	.	D	D	.	.	.	.	.	.	.	0.77078	.	.	.	.	.	.	.	0.96820	1.0	.	1.0	0.847515	.	0.99	A	single nucleotide variant	NC_000019.10:g.41869722G>A	.	.	3	0.9024854	.	.	0.97176737	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124|Human Phenotype Ontology:HP:0004810,Human Phenotype Ontology:HP:0005545,MONDO:MONDO:0015253,MeSH:D029503,MedGen:C1260899,OMIM:PS105650,Orphanet:124	.	.	.	.	0.97926	D	0.97258	D	M	11.89543	.	./.	.	.	.	.	Diamond-Blackfan anemia 1|Diamond-Blackfan anemia	.	0.86794	.	.	-	41869722	.	-	11.829000	.	0.82402	.	.	.	.	germline	.	Loss of MoRF binding (P = 0.0171)| Gain of relative solvent accessibility (P = 0.09)| Gain of solvent accessibility (P = 0.0971)| Gain of methylation at K122 (P = 0.1056)| Gain of sheet (P = 0.1451)	0.99843	GRCh38	747	criteria provided, single submitter	c.380G>A	.	0.72825	.	.	.	.	.	.	P	.	.	NM_001022.4(RPS19):c.380G>A (p.Gly127Glu)	1	.	RS19_HUMAN	.	99.0	0.931537152194926	.	T	0.97478	0.9559469	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99924	.	.	.	.	.	p.Gly127Glu	.	0.97469	.	germline	.		G	Jan 12, 2022	.	./.	.	.	1.0	N	19q13.2	.	.	.	SCV003443917	Likely_pathogenic	.	.	Glu	E	-	.	ENSP00000470004	ENST00000593863	.	.	.	.	0.676	G	.	4.995052	0.53076	D	D	-	12.711	.	0.93515	.	.	.	0.81780	.	41869722	Y	9	.	.	.	P39019	.	0.98826	0.89361		.	0.996	D	.	0.93296444	.	0.97202	6223	0.558625	.	.	.	.	.	.	.	.	.	.	.	0.95086	19	RPS19	.	.	Gly	.	.	19-41869722-G-A	Diamond-Blackfan_anemia|Diamond-Blackfan_anemia_1	.	.	47065632	ClinGen:CA130769|OMIM:603474.0008|UniProtKB:P39019#VAR_055444	0.952808	0.93180	.	RCV000033189|RCV002512845	D	.	.	c.380G>A	.	.	.	0.96031	./.	rs786200936	41869722	.	G	.	P39019	.	0.98397	.	0.68239		.	.	.	2.73	.	.	.	5.24	0.99938	.	D	T	.	.	.	.	.	.	.	124|124	6320	0.95968	0.96144	0.991606083214429	.	.	0.71675	0.96846	.	.	.	8.506	.	.	.	.	.	.	PS105650|105650	0.90371	19	.	ENSG00000105372	.	.	.	.	.	2	0.84488	0.52199	.	.	.	.	0.874714639492237	.	.	0.407513	21359	HGNC:10402	A	.	simple_aae	0.683	.	41869722	GGA	1.000000	.	-	.	0.98908	.	.	.	Likely pathogenic	0.91730	.	.	.	ClinGen:CA130769,UniProtKB:P39019#VAR_055444,OMIM:603474.0008	G	.	0.972294440432	-	0.984	-	0.99419	.	.	0.99657	0.76795142889	0.9981	.	0.99809882945303208	.	-	380G>A 	.	.	C1260899|C2676137	.	.	.	.	NM_001022.4	-	.	.	1	0.52781	786200936	.	.	0.97173	0.94342	0.985	0.034	.	0.99993120	5.24	.	.	.	0.56465	0.999816468006815	0.79671	D	.	.	.	0.2563	0.83981	p.Gly127Glu	.	.	-13.608	0.9862165	.	0.98120	6320	D	.	RPS19	.	D	.	.	G127E	.	.	0.76753	./.	principal1																																																																																																				
BRCA1_Glu143Lys	1.0715681647773336	0.3194625014850119	-1.3011218450965234	0.23440439309487024	2025_01_Batch_13-14	0.9480245505139957	0.8955713661160429	0.9507439270755751	0.936478711330349	0.8952628504353902	0.8999099591246774	0.8491444594512151	0.8788213977275371	0.9218913473514789	0.748151341601417	0.9239672548193365	0.872357912783629	0.914782662401556	0.929185029340914	0.8217070960184036	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC013134		NC_000017.11:43104136:C:T		Glu143Lys																												BRCA1_Glu143Lys	17	43104136	C	T	17	allele	427G>A	B12	527_CAVA_Array_P01	C23	B13A7A8P1_R1	B14A7A8P1_R2				17-43104136-C-T	-	0.30377	0.019	143	6	0	0	17	41256153	T	6.694640e-05	1	17	2_Benign	NC_000017.11	11	Glu143Lys	8	18.4	5	0	4.528990e-04	D	0	16	1	42726	8.034300e-05	.	30402	0.000000e+00	0	0.79415	.	0.8767	17664	0.68795	1	.	T	T	63846	.	0	0	0.000000e+00	0	0	0.12679	17062	44878	6	3.734130e-04	0.42578	2	.	0.03876	0.293	.	.	0.851115	2.24	.	T	single nucleotide variant	NC_000017.11:g.43104136C>T	0	16710	2	0.05370916	109208	0	0.03369628	0		16	236486	0	0	4.528990e-04	500	4.680990e-05	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|	11	1	0.000000e+00	0	0.49097	B	0.06945	B	L	1.457724	108	C/C	122	0	7152	1613230	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified|not provided|Breast and/or ovarian cancer|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|BRCA1-related disorder	16186	0.90534	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43104136	5.530970e-04	-	1.666000	0	0.02411	29600	0	44878	5	germline;unknown	90930	Gain of ubiquitination at E143 (P = 0.0025)| Gain of MoRF binding (P = 0.0124)| Gain of methylation at E143 (P = 0.1317)| Gain of relative solvent accessibility (P = 0.1684)| Loss of phosphorylation at S146 (P = 0.184)	0.27037	GRCh38	462	reviewed by expert panel	.	1.315700e-04	0.36615	3	0	0	.	0.000000e+00	9040	.	0	0.000000e+00	NM_007294.4(BRCA1):c.427G>A (p.Glu143Lys)	3	0	BRCA1_HUMAN	0	.	-0.366331149050496	1	D	0.13983	0.034599107	-	0.000000e+00	.		5	0.000000e+00	0	34186	reviewed_by_expert_panel	0.98220	1.007250e-04	0	0.000000e+00	0	59920	.	0	0.28012	.	germline	5		C	Aug 10, 2015	4	C/C	0	89418	0.861	N	17q21.31	32728	.	0.000000e+00	SCV000244359	Benign	0	0	Lys	K	-	912	ENSP00000478114	ENST00000618469	17664	.	13390	0	-0.187	C	0	2.363521	0.57928	N	.	-	1.478785	.	0.88953	628	0	.	0.04979	0	43104136	Y	10	0	102588	0.000000e+00	P38398	0	0.158884	0.52206		0	0.006	D	13390	0.04770675	9040	0.24381	672	0.019488	89	.	.	2.451090e-04	0.34767	1.919880e-04	0	74812	5.530970e-04	6080	0	0.09113	17	BRCA1	0.000000e+00	0	Glu	45080	6.710060e-05	17-43104136-C-T	Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided	0	5	38509679	BRCA1-HCI:BRCA1_00055|ClinGen:CA002745	0.188915	0.26398	0	RCV000031161|RCV000162967|RCV000588563|RCV000159939|RCV001719704|RCV001798032|RCV002250474|RCV002504841|RCV004758611	.	0	0	c.427G>A	0	11	0	0.54001	C/C	rs80356991	43104136	14870	C	.	E9PFC7	15626	0.03605	4.629630e-05	0.28384		0	0	2.451090e-04	1.5	0	3	264690	3.28	0.49950	202	T	T	0	3.282560e-05	0	56	.	0	0	227535|1333|145|145|140162	37580	0.78090	0.10163	0.0473425365312362	3946	.	0.30721	0.31406	2.925170e-05	3.734130e-04	1179784	1.938	7.702750e-05	.	13370	0	3.7780046E-5	0	114480|614320|604370|617883	0.39936	17	0.000000e+00	ENSG00000012048	0.000000e+00	9.166462967489611E-5	4	0	.	1	0.55829	0.78630	30484	10	4.873860e-05	1.668890e-05	-0.342651888589345	.	6.598480e-05	0.247707	46136	HGNC:1100	.	0	.	0.018	207718	43104136	GAA	0.920000	.	-	0	0.21644	7.543750e-05	0	0	Benign	0.42050	3	0	1	BRCA1-HCI:BRCA1_00055,ClinGen:CA002745	E	0	.	-	0.303	-	0.38091	19	6972	0.37990	0.315168946981	.	0	0.99087417036739323	104	-	427G>A 	8	0	C0346153|C3280442|C2676676|C4554406|CN221562|C0677776|CN169374|C0027672|C3661900	0	0	0	0	NM_007294.4	-	.	.	0	0.53361	80356991	2320	6.654835847382431E-5	0.86141	0.26417	.	.	3824	0.99696964	5.32	.	.	1.312160e-04	0.120218	0.681098547151026	0.37685	D	146	6212	9572	0.5017	0.95897	p.Glu143Lys	0	0	-4.389	.	0	0.66393	37580	T	30464	BRCA1	5.860980e-05	D	.	21600	E143K	.	0.42522	0.09644	C/C	principal2																																																																																																				
ABCD1_Arg518Trp	8.231574645280068	0.00007593249847055185	-2.9770111643332635	0.020601941044853928																											ABCD1	ABCD1		100008637		CCSBVarC007022		NC_000023.11:153740155:C:T		Arg518Trp																												ABCD1_Arg518Trp	23	153740155	C	T	X	allele	1552C>T	B01	527_CAVA_Array_P01	C01	B13A7A8P1_R1	B14A7A8P1_R2				X-153740155-C-T	-	0.72229	0.9	518	.	.	.	X	153005609	T	.	.	X	1_Pathogenic	NC_000023.11	.	Arg518Trp	.	25.8	.	0	.	D	.	9	1	.	.	.	.	.	0	0.95124	Select	0.9928	.	0.49610	.	.	D	D	.	1.28273602722	0	.	.	.	.	0.71594	.	.	.	.	0.94211	.	.	0.86989	0.929	.	7.0	0.976102	.	0.93	T	single nucleotide variant	NC_000023.11:g.153740155C>T	.	.	3	0.8724228	.	0	0.84760565	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MONDO:MONDO:0010248,MedGen:C1848097,OMIM:300106,Orphanet:93349|MedGen:C3661900	.	.	.	.	0.93829	P	0.92940	P	M	.	.	C/C	0	0	.	.	Adrenoleukodystrophy|X-linked spondyloepimetaphyseal dysplasia|not provided	.	0.97497	.	.	-	153740155	.	-	.	.	0.98629	.	0	.	.	germline;unknown	.	Gain of catalytic residue at L516 (P = 0.0119)| Gain of methylation at K513 (P = 0.0313)| Loss of MoRF binding (P = 0.1001)| Loss of ubiquitination at K513 (P = 0.1202)| Loss of disorder (P = 0.1253)	0.99690	GRCh38	56	criteria provided, multiple submitters, no conflicts	c.1552C>T	.	0.46510	0	.	.	ABC transporter-like, ATP-binding domain|ABC transporter-like, ATP-binding domain|AAA+ ATPase domain	.	.	P	0	.	NM_000033.4(ABCD1):c.1552C>T (p.Arg518Trp)	2	.	ABCD1_HUMAN	.	93.0	.	.	D	0.88858	0.84760565	+	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98981	.	.	.	.	.	p.Arg518Trp	.	.	.	germline	.		C	Oct 05, 2022	.	C/C	.	.	1.0	N	Xq28	0	.	.	SCV000109783|SCV000918373|SCV001249771|SCV001592684|SCV002045831|SCV003920874|SCV005418162	Pathogenic/Likely_pathogenic	.	.	Trp	W	-	.	ENSP00000218104	ENST00000218104	.	0.007	.	.	0.599	C	.	4.573317	0.92967	.	D	-	.	.	0.99641	0	.	.	0.72158	0	153740155	Y	9	0	.	.	P33897	.	0.990187	0.97802		.	0.635	D	.	0.8724228	.	0.46613	215	0.634204	.	-7.19	.	.	0.60085	.	.	.	.	.	.	0.92940	X	ABCD1	.	0	Arg	478	.	X-153740155-C-T	X-linked_spondyloepimetaphyseal_dysplasia|Adrenoleukodystrophy|not_provided	.	.	152658803	ClinGen:CA278115|OMIM:300371.0016|UniProtKB:P33897#VAR_000071	.	.	.	RCV000012059|RCV001358358|RCV000723537	D	.	.	c.1552C>T	.	.	.	0.99871	C/C	rs128624224	153740155	.	C	.	P33897	.	0.86987	.	0.68239		.	.	.	3.32	0	0	.	4.06	0.99956	0	D	T	.	.	0	0	.	.	.	93349|43	11307	0.99870	0.82497	0.978487551212311	426	.	0.71675	.	.	.	.	0.985	.	D	.	.	.	0	300106|300100	0.29273	X	.	ENSG00000101986	.	0	.	0	0.9495563564850404	1	0.51905	0.97530	.	.	.	.	.	YES	.	0.948221	26346	HGNC:61	A	.	simple_aae	0.966	.	153740155	CGG	1.000000	.	-	0	0.99953	.	0	.	Pathogenic/Likely pathogenic	0.96338	.	.	.	ClinGen:CA278115,UniProtKB:P33897#VAR_000071,OMIM:300371.0016	R	.	0.99953428563	-	0.968	-	0.91621	.	52	0.94907	0.730939924717	0.9663	.	0.99908012509830546	0	-	1552C>T 	.	0	C1848097|C0162309|C3661900	.	.	.	.	NM_000033.4	-	.	.	1	0.91686	128624224	.	0	0.99951	.	0.914	0.0	426	0.99881697	4.93	.	.	.	0.673213	0.999868428588881	0.90595	D	0	.	.	1.0183	0.99829	p.Arg518Trp	0	.	-15.212	0.9946109	.	0.98431	11307	D	.	ABCD1	.	D	0.844	.	R518W	D	.	0.40292	C/C	principal1																																																																																																				
BRCA1_Met1Thr	2.6505609192138624	0.03291488248938516	-5.415058354854697	0.000992346045870956	2025_01_Batch_13-14	0.9188140326650334	0.9527153734968281	0.9840460552581236	0.984750990435898	0.793637090171406	0.8536066331104628	0.8623721456022353	0.9654591126834374	0.9354789732760659	0.8121469904325598	0.8862103328877481	0.9075437595495317	0.9747525839707805	0.960114981855982	0.8028920403019829	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218377	CCSBVarC003294	ALE00003294	NC_000017.11:43124095:A:G	2T>C	Met1Thr	CEGS2	CegsMutGDEh1015	F12	GDEhDisVCh_40059	F04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Met1Thr	17	43124095	A	G	17											17-43124095-A-G	-	0.58947	0.967	1	.	.	.	17	41276112	G	.	.	17	1_Pathogenic	NC_000017.11	.	Met1Thr	.	24.0	.	.	.	D	.	6	1	.	.	.	.	.	.	0.89789	.	0.7036	.	0.56423	.	.	T	D	.	.	.	.	.	.	.	.	.	.	.	.	0.71435	.	.	0.95450	0.255	.	.	0.9	2.37	.	G	single nucleotide variant	NC_000017.11:g.43124095A>G	.	.	2	0.7257	.	.	0.9435044	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	.	.	.	.	0.99291	D	0.83181	D	.	4.098281	.	./.	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	.	0.90013	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43124095	.	-	11.022000	.	.	.	.	.	.	germline;not applicable;unknown	.	Loss of stability (P = 2e-04)| Gain of catalytic residue at M1 (P = 0.0208)| Gain of glycosylation at M1 (P = 0.121)| Gain of disorder (P = 0.1374)| Gain of helix (P = 0.2684)	0.99867	GRCh38	469	criteria provided, multiple submitters, no conflicts	c.2T>C	.	0.43219	.	.	.	.	.	.	.	.	.	NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	2	.	BRCA1_HUMAN	.	.	0.358832926107613	.	D	.	0.9426614	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99428	.	.	.	.	.	p.Met1?	.	0.84990	.	germline	.		A	May 05, 2024	.	./.	.	.	1.0	N	17q21.31	.	.	.	SCV000325520|SCV000785479|SCV001179120|SCV001587504	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	.	ENSP00000478114	ENST00000618469	.	.	.	.	0.634	A	.	3.997208	0.92967	N	.	-	3.783919	.	0.99662	.	.	.	0.82073	.	43124095	Y	9	.	.	.	P38398	.	0.298644	0.35682		.	0.916	D	.	0.71842754	.	0.23438	672	0.3844	.	.	.	.	0.91343	.	.	.	.	.	.	0.83606	17	BRCA1	.	.	Met	.	.	17-43124095-A-G	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38529638	ClinGen:CA001954	0.056815	0.58998	.	RCV000111545|RCV001017950|RCV001387017	D	.	.	c.2T>C	.	.	.	0.88912	./.	rs80357111	43124095	.	A	.	E9PFC7	.	0.95537	.	0.68239		.	.	.	.	.	.	.	3.83	0.66936	.	D	.	.	.	.	.	.	.	.	145|140162|145	54745	0.88772	.	0.991858303546906	.	.	0.71675	0.10376	.	.	.	4.168	.	.	.	.	.	.	604370	0.58094	17	.	ENSG00000012048	.	.	.	.	.	2	0.65195	0.78193	.	.	.	.	0.311400030491244	.	.	0.950787	69412	HGNC:1100	.	.	.	.	.	43124095	ATG	1.000000	.	-	.	0.98978	.	.	.	Pathogenic/Likely pathogenic	0.82067	.	.	.	ClinGen:CA001954	M	.	0.883389812914	-	0.987	-	0.96886	.	.	0.29790	.	.	.	0.97714747887968068	.	-	2T>C 	.	.	C0677776|C0027672|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.64967	80357111	.	.	0.88134	0.55978	.	.	.	0.99948680	3.83	.	.	.	0.314388	0.999999935724936	.	D	.	.	.	0.4652	0.89769	p.Met1?	.	.	-9.871	0.98665875	.	0.99831	54745	D	.	BRCA1	.	D	.	.	M1T	.	0.44186	0.51995	./.	principal2																																																																																																				
BRCA1_Met1Thr	2.6505609192138624	0.03291488248938516	-5.415058354854697	0.000992346045870956	2025_01_Batch_13-14	0.9188140326650334	0.9527153734968281	0.9840460552581236	0.984750990435898	0.793637090171406	0.8536066331104628	0.8623721456022353	0.9654591126834374	0.9354789732760659	0.8121469904325598	0.8862103328877481	0.9075437595495317	0.9747525839707805	0.960114981855982	0.8028920403019829	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003294		NC_000017.11:43124095:A:G		Met1Thr																												BRCA1_Met1Thr	17	43124095	A	G	17	allele	2T>C	D06	527_CAVA_Array_P01	G11	B13A7A8P1_R1	B14A7A8P1_R2				17-43124095-A-G	-	0.58947	0.967	1	.	.	.	17	41276112	G	.	.	17	1_Pathogenic	NC_000017.11	.	Met1Thr	.	24.0	.	.	.	D	.	6	1	.	.	.	.	.	.	0.89789	.	0.7036	.	0.56423	.	.	T	D	.	.	.	.	.	.	.	.	.	.	.	.	0.71435	.	.	0.95450	0.255	.	.	0.9	2.37	.	G	single nucleotide variant	NC_000017.11:g.43124095A>G	.	.	2	0.7257	.	.	0.9435044	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	.	.	.	.	0.99291	D	0.83181	D	.	4.098281	.	./.	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	.	0.90013	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43124095	.	-	11.022000	.	.	.	.	.	.	germline;not applicable;unknown	.	Loss of stability (P = 2e-04)| Gain of catalytic residue at M1 (P = 0.0208)| Gain of glycosylation at M1 (P = 0.121)| Gain of disorder (P = 0.1374)| Gain of helix (P = 0.2684)	0.99867	GRCh38	469	criteria provided, multiple submitters, no conflicts	c.2T>C	.	0.43219	.	.	.	.	.	.	.	.	.	NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	2	.	BRCA1_HUMAN	.	.	0.358832926107613	.	D	.	0.9426614	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99428	.	.	.	.	.	p.Met1?	.	0.84990	.	germline	.		A	May 05, 2024	.	./.	.	.	1.0	N	17q21.31	.	.	.	SCV000325520|SCV000785479|SCV001179120|SCV001587504	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	.	ENSP00000478114	ENST00000618469	.	.	.	.	0.634	A	.	3.997208	0.92967	N	.	-	3.783919	.	0.99662	.	.	.	0.82073	.	43124095	Y	9	.	.	.	P38398	.	0.298644	0.35682		.	0.916	D	.	0.71842754	.	0.23438	672	0.3844	.	.	.	.	0.91343	.	.	.	.	.	.	0.83606	17	BRCA1	.	.	Met	.	.	17-43124095-A-G	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38529638	ClinGen:CA001954	0.056815	0.58998	.	RCV000111545|RCV001017950|RCV001387017	D	.	.	c.2T>C	.	.	.	0.88912	./.	rs80357111	43124095	.	A	.	E9PFC7	.	0.95537	.	0.68239		.	.	.	.	.	.	.	3.83	0.66936	.	D	.	.	.	.	.	.	.	.	145|140162|145	54745	0.88772	.	0.991858303546906	.	.	0.71675	0.10376	.	.	.	4.168	.	.	.	.	.	.	604370	0.58094	17	.	ENSG00000012048	.	.	.	.	.	2	0.65195	0.78193	.	.	.	.	0.311400030491244	.	.	0.950787	69412	HGNC:1100	.	.	.	.	.	43124095	ATG	1.000000	.	-	.	0.98978	.	.	.	Pathogenic/Likely pathogenic	0.82067	.	.	.	ClinGen:CA001954	M	.	0.883389812914	-	0.987	-	0.96886	.	.	0.29790	.	.	.	0.97714747887968068	.	-	2T>C 	.	.	C0677776|C0027672|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.64967	80357111	.	.	0.88134	0.55978	.	.	.	0.99948680	3.83	.	.	.	0.314388	0.999999935724936	.	D	.	.	.	0.4652	0.89769	p.Met1?	.	.	-9.871	0.98665875	.	0.99831	54745	D	.	BRCA1	.	D	.	.	M1T	.	0.44186	0.51995	./.	principal2																																																																																																				
BRAF_Gln257Arg	-4.0967768173781565	0.004591621866850185	-0.4372464292354162	0.6751046251185971	2025_01_Batch_13-14	0.7356388350237879	0.7482928419550411	0.8074035000113406	0.7098961831331446	0.614278519703086	0.6803782168890007	0.7208613333729822	0.784087971461417	0.725016897765799	0.6871363480348	0.7080085259563943	0.7345770876640116	0.7957457357363789	0.7174565404494718	0.6507074338689429	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220590	CCSBVarC003156	ALE00003156	NC_000007.14:140801502:T:C	770A>G	Gln257Arg	CEGS2	CegsMutGDEh1027	G07	GDEhDisVCh_40058	D10	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	2	0		0			0			0			BRAF_Gln257Arg	7	140801502	T	C	7											7-140801502-T-C	-	0.82746	0.959	257	.	.	.	7	140501302	C	.	.	7	1_Pathogenic	NC_000007.14	.	Gln257Arg	.	27.9	.	0	.	D	.	33	.	.	.	.	.	.	0	0.94900	Select	0.8814	.	0.55150	.	.	D	D	.	.	0	.	.	.	.	0.93441	.	.	.	.	0.25939	.	.	0.85393	0.997	.	.	0.937906	.	.	C	single nucleotide variant	NC_000007.14:g.140801502T>C	.	.	3	0.65886503	.	0	0.8394073	0	C	.	.	.	.	.	0	.	0	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500;MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648;MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648||MedGen:CN230736|6 conditions	.	.	.	.	0.94956	P	0.79429	D	M	8.812097	.	./.	0	0	.	.	Cardiofaciocutaneous syndrome 1|RASopathy|not provided|Cardio-facio-cutaneous syndrome|LEOPARD syndrome 3;Noonan syndrome 7;Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|LEOPARD syndrome 3|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1|BRAF-related disorder|Cardiovascular phenotype|6 conditions	.	0.97459	.	.	-	140801502	.	-	7.808000	.	0.80291	.	0	.	.	de novo;germline;unknown	.	Gain of MoRF binding (P = 0.0136)| Loss of helix (P = 0.0376)| Loss of sheet (P = 0.0457)| Gain of loop (P = 0.0502)| Loss of ubiquitination at K253 (P = 0.0525)	0.98337	GRCh38	794	reviewed by expert panel	c.770A>G	.	0.78977	0	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	.	.	P	0	.	NM_004333.6(BRAF):c.770A>G (p.Gln257Arg)	3	.	BRAF_HUMAN	.	.	0.801626318931521	.	D	0.93940	0.8253214	-	.	.	6.84148e-7	.	.	0	.	reviewed_by_expert_panel	0.97698	.	.	.	.	.	p.Gln257Arg	.	0.69392	.	germline	.	140801502	T	Apr 03, 2017	.	./.	.	.	1.0	N	7q34	0	.	.	SCV000616360	Pathogenic	.	.	Arg	R	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.661	T	.	4.989844	0.24199	D	.	-	9.087886	.	0.88624	0	.	.	0.62335	0	140801502	Y	9	0	.	.	P15056	.	0.758931	0.91119	T	.	0.626	D	.	0.6523551	.	0.79771	673	0.497157	.	.	.	.	0.48802	.	.	.	.	.	.	0.79796	7	BRAF	.	0	Gln	478	.	7-140801502-T-C	Cardiofaciocutaneous_syndrome_1|Noonan_syndrome_7|LEOPARD_syndrome_3|Cardio-facio-cutaneous_syndrome|Lung_cancer|Colorectal_cancer|Melanoma,_cutaneous_malignant,_susceptibility_to,_1|Noonan_syndrome_1|Noonan_syndrome_and_Noonan-related_syndrome|Cardiovascular_phenotype|RASopathy|not_provided	.	.	140147771	ClinGen:CA222583|OMIM:164757.0013|UniProtKB:P15056#VAR_026114	0.858490	0.86133	.	RCV000015007|RCV000033289|RCV000080904|RCV000208766|RCV001027771|RCV001261967|RCV001329219|RCV001813208|RCV001813744|RCV004752707|RCV004018628|RCV003224098	D	.	.	c.770A>G	.	.	.	0.94149	./.	rs180177035	140801502	.	T	.	P15056	.	0.86387	.	0.68239	7	.	.	.	3.07	0	0	.	5.43	0.93394	0	D	D	.	.	0	0	.	.	.	1340|648|500|1340|618|648|98733|536391	13973	0.94072	0.81887	0.946888327598572	426	.	0.71675	0.77519	.	.	.	7.971	.	.	.	.	.	0	115150|613706|613707|PS115150|211980|114500|155600|163950	0.87647	7	.	ENSG00000157764	.	0	.	0	.	2	0.51596	0.45529	.	.	.	.	0.761899469924724	YES	.	0.23991	29012	HGNC:1097	.	.	.	0.646	.	140801502	CAG	1.000000	.	-	0	0.95685	.	0	.	Pathogenic	0.90620	.	.	.	ClinGen:CA222583,UniProtKB:P15056#VAR_026114,OMIM:164757.0013	Q	.	.	-	0.914	-	0.91737	.	52	0.99541	0.876263439655	0.9831	.	0.99828950546521744	0	-	770A>G 	.	0	CN029449|C3150970|C3150971|C1275081|C0242379|C0346629|C1835047|C4551602|C5681679|CN230736|C5555857|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.77715	180177035	.	0	0.99132	0.86971	.	.	426	0.99508744	5.43	.	.	.	0.476355	0.984355110891765	0.86962	D	0	.	.	1.0162	0.96054	p.Gln257Arg	0	.	-13.31	0.962993	.	0.86463	13973	D	.	BRAF	.	D	.	.	Q257R	.	.	0.55789	./.	principal4																																																																																																				
BRAF_Gln257Arg	-4.0967768173781565	0.004591621866850185	-0.4372464292354162	0.6751046251185971	2025_01_Batch_13-14	0.7356388350237879	0.7482928419550411	0.8074035000113406	0.7098961831331446	0.614278519703086	0.6803782168890007	0.7208613333729822	0.784087971461417	0.725016897765799	0.6871363480348	0.7080085259563943	0.7345770876640116	0.7957457357363789	0.7174565404494718	0.6507074338689429	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003156		NC_000007.14:140801502:T:C		Gln257Arg																												BRAF_Gln257Arg	7	140801502	T	C	7	allele	770A>G	G05	527_CAVA_Array_P01	M09	B13A7A8P1_R1	B14A7A8P1_R2				7-140801502-T-C	-	0.82746	0.959	257	.	.	.	7	140501302	C	.	.	7	1_Pathogenic	NC_000007.14	.	Gln257Arg	.	27.9	.	0	.	D	.	33	.	.	.	.	.	.	0	0.94900	Select	0.8814	.	0.55150	.	.	D	D	.	.	0	.	.	.	.	0.93441	.	.	.	.	0.25939	.	.	0.85393	0.997	.	.	0.937906	.	.	C	single nucleotide variant	NC_000007.14:g.140801502T>C	.	.	3	0.65886503	.	0	0.8394073	0	C	.	.	.	.	.	0	.	0	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500;MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648;MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0013380,MedGen:C3150971,OMIM:613707,Orphanet:500|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648||MedGen:CN230736|6 conditions	.	.	.	.	0.94956	P	0.79429	D	M	8.812097	.	./.	0	0	.	.	Cardiofaciocutaneous syndrome 1|RASopathy|not provided|Cardio-facio-cutaneous syndrome|LEOPARD syndrome 3;Noonan syndrome 7;Cardiofaciocutaneous syndrome 1|Noonan syndrome 7|LEOPARD syndrome 3|Noonan syndrome and Noonan-related syndrome|Noonan syndrome 1|BRAF-related disorder|Cardiovascular phenotype|6 conditions	.	0.97459	.	.	-	140801502	.	-	7.808000	.	0.80291	.	0	.	.	de novo;germline;unknown	.	Gain of MoRF binding (P = 0.0136)| Loss of helix (P = 0.0376)| Loss of sheet (P = 0.0457)| Gain of loop (P = 0.0502)| Loss of ubiquitination at K253 (P = 0.0525)	0.98337	GRCh38	794	reviewed by expert panel	c.770A>G	.	0.78977	0	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	.	.	P	0	.	NM_004333.6(BRAF):c.770A>G (p.Gln257Arg)	3	.	BRAF_HUMAN	.	.	0.801626318931521	.	D	0.93940	0.8253214	-	.	.	6.84148e-7	.	.	0	.	reviewed_by_expert_panel	0.97698	.	.	.	.	.	p.Gln257Arg	.	0.69392	.	germline	.	140801502	T	Apr 03, 2017	.	./.	.	.	1.0	N	7q34	0	.	.	SCV000616360	Pathogenic	.	.	Arg	R	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.661	T	.	4.989844	0.24199	D	.	-	9.087886	.	0.88624	0	.	.	0.62335	0	140801502	Y	9	0	.	.	P15056	.	0.758931	0.91119	T	.	0.626	D	.	0.6523551	.	0.79771	673	0.497157	.	.	.	.	0.48802	.	.	.	.	.	.	0.79796	7	BRAF	.	0	Gln	478	.	7-140801502-T-C	Cardiofaciocutaneous_syndrome_1|Noonan_syndrome_7|LEOPARD_syndrome_3|Cardio-facio-cutaneous_syndrome|Lung_cancer|Colorectal_cancer|Melanoma,_cutaneous_malignant,_susceptibility_to,_1|Noonan_syndrome_1|Noonan_syndrome_and_Noonan-related_syndrome|Cardiovascular_phenotype|RASopathy|not_provided	.	.	140147771	ClinGen:CA222583|OMIM:164757.0013|UniProtKB:P15056#VAR_026114	0.858490	0.86133	.	RCV000015007|RCV000033289|RCV000080904|RCV000208766|RCV001027771|RCV001261967|RCV001329219|RCV001813208|RCV001813744|RCV004752707|RCV004018628|RCV003224098	D	.	.	c.770A>G	.	.	.	0.94149	./.	rs180177035	140801502	.	T	.	P15056	.	0.86387	.	0.68239	7	.	.	.	3.07	0	0	.	5.43	0.93394	0	D	D	.	.	0	0	.	.	.	1340|648|500|1340|618|648|98733|536391	13973	0.94072	0.81887	0.946888327598572	426	.	0.71675	0.77519	.	.	.	7.971	.	.	.	.	.	0	115150|613706|613707|PS115150|211980|114500|155600|163950	0.87647	7	.	ENSG00000157764	.	0	.	0	.	2	0.51596	0.45529	.	.	.	.	0.761899469924724	YES	.	0.23991	29012	HGNC:1097	.	.	.	0.646	.	140801502	CAG	1.000000	.	-	0	0.95685	.	0	.	Pathogenic	0.90620	.	.	.	ClinGen:CA222583,UniProtKB:P15056#VAR_026114,OMIM:164757.0013	Q	.	.	-	0.914	-	0.91737	.	52	0.99541	0.876263439655	0.9831	.	0.99828950546521744	0	-	770A>G 	.	0	CN029449|C3150970|C3150971|C1275081|C0242379|C0346629|C1835047|C4551602|C5681679|CN230736|C5555857|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.77715	180177035	.	0	0.99132	0.86971	.	.	426	0.99508744	5.43	.	.	.	0.476355	0.984355110891765	0.86962	D	0	.	.	1.0162	0.96054	p.Gln257Arg	0	.	-13.31	0.962993	.	0.86463	13973	D	.	BRAF	.	D	.	.	Q257R	.	.	0.55789	./.	principal4																																																																																																				
FLCN_Arg239Cys	0.9174070101483766	0.38944335444511674	-15.695201041940072	1.0316623825275126e-6	2025_01_Batch_13-14	0.6408863296451378	0.8484363666697667	0.9442798550729118	0.9041886224631396	0.5304129016913728	0.6063071551797774	0.858095563825877	0.9457511173724349	0.8848038913580585	0.5856402538884513	0.6235967424124575	0.8532659652478218	0.9450154862226734	0.894496256910599	0.558026577789912	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FLCN	FLCN	ENSG00000154803	7588	13751	CCSBVarC001199	ALE00001199	NC_000017.11:17222565:G:A	715C>T	Arg239Cys	RC4	RC4_Mut_GDEh1002	H08	GDEhDisVCh_40008	C09	2	RC4_Mut_GDDh1002	H08	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FLCN_Arg239Cys	17	17222565	G	A	17											17-17222565-G-A	-	0.91433	1.0	239	44	1	0	17	17125879	A	4.379790e-04	1	17	3_Conflicting	NC_000017.11	660	Arg239Cys	0	32.0	0	0	5.061320e-04	D	0	15	1	42768	2.532330e-04	0	30526	0.000000e+00	0	0.97735	Select	0.8908	102740	0.90580	2	0.0	D	D	64044	1.37465409467	0	0	0.000000e+00	0	0	0.93578	17110	44880	10	0.000000e+00	0.90996	25	.	0.89604	0.875	0.0	.	0.963104	3.64	.	A	single nucleotide variant	NC_000017.11:g.17222565G>A	0	16732	2	0.6441645	109404	0	0.8436355	0	A	52	236936	0	0	0.000000e+00	524	5.845490e-04	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0800444,MedGen:C0346010,OMIM:PS135150,Orphanet:122|MedGen:C3661900|	29	0	0.000000e+00	0	0.71237	D	0.79478	D	M	9.584683	707	G/G	306	7	7164	1614232	Hereditary cancer-predisposing syndrome|not specified|Birt-Hogg-Dube syndrome|not provided|FLCN-related disorder	16216	0.96499	1	.	-	17222565	5.845490e-04	-	11.729000	2	0.95083	29602	0	1180052	0	germline;unknown	91086	.	.	GRCh38	794	criteria provided, conflicting classifications	c.715C>T	9.827690e-05	0.89013	41	0	0	Folliculin/SMCR8, longin domain|Folliculin/SMCR8, tripartite DENN domain	0.000000e+00	9046	P	0	3.378150e-05	NM_144997.7(FLCN):c.715C>T (p.Arg239Cys)	1	0	FLCN_HUMAN	0	.	0.838685424223754	1	D	0.95096	0.8809669	-	1.395870e-04	0	0.000457627	44	0.000000e+00	0	34254	criteria_provided,_conflicting_classifications	0.93842	2.650730e-04	1	0.000000e+00	0	60034	p.Arg239Cys	0	0.94967	.	germline	25	17222565	G	Mar 04, 2025	3	G/G	0	89476	1.0	N	17p11.2	50198	.	1.233350e-04	SCV000190215|SCV000213928|SCV000291452|SCV000298054|SCV000401012|SCV000616724|SCV001140313|SCV002009831|SCV002530153|SCV002551355|SCV002774598|SCV004142321|SCV005412678	Conflicting_classifications_of_pathogenicity	0	0	Cys	C	-	912	ENSP00000285071	ENST00000285071	17692	0.0	13414	0	0.676	G	0	5.485253	0.83643	D	D	-	9.865392	.	0.89792	668	0	0.0019880715705765406	0.28980	0	17222565	Y	10	0	102740	1.649620e-04	Q8NFG4	0	0.965284	0.99621	G	0	0.999	D	89476	0.653225	42768	0.41772	201163	0.232675	660	-5.68	0.0	5.592970e-04	0.91343	1.274700e-04	0	75048	0.000000e+00	6062	1	0.78972	17	FLCN	7.994880e-05	0	Arg	72234	4.917520e-04	17-17222565-G-A	Hereditary_cancer-predisposing_syndrome|Birt-Hogg-Dube_syndrome|not_specified|not_provided|FLCN-related_disorder	0	52	17066604	ClinGen:CA159776|UniProtKB:Q8NFG4#VAR_066026	0.883493	0.88390	0	RCV000163388|RCV000121104|RCV000148504|RCV000656850|RCV003945073	D	0	0	c.715C>T	0	1	1	0.76800	G/G	rs78683075	17222565	14902	G	5.990415335463259E-4	.	15690	0.86694	0.000000e+00	0.68239	17	0	0	2.228160e-05	2.82	0	34	264690	5.71	0.99578	194	T	D	2	3.276970e-05	0	62	.	0	0	140162|122	134427	0.93307	0.84558	0.409195610064091	9150	3	0.71675	0.81176	5.838730e-05	4.917520e-04	1180052	7.113	2.499620e-04	D	13392	0	2.3045827E-4	0	PS135150	0.76785	17	1.342100e-04	ENSG00000154803	1.561430e-05	6.773178214271485E-4	3	0	0.8131863604073064	1	0.92348	0.45529	30608	61	5.061320e-04	8.328610e-05	0.79110123621525	YES	1.097860e-04	0.269279	138166	HGNC:27310	.	0	.	0.906	208032	17222565	CGC	1.000000	0	-	0	0.80205	5.592970e-04	0	1	Conflicting classifications of pathogenicity	0.31080	2	1	5	ClinGen:CA159776,UniProtKB:Q8NFG4#VAR_066026	R	0	0.92713276706	-	.	-	0.99730	60	11386	0.81164	0.877251982689	0.9888	0	0.99936625225274212	114	-	715C>T 	52	6.147900930967855E-4	C0027672|C0346010|CN169374|C3661900	0	0	0	0	NM_144997.7	-	2	0.001440922190201729	0	0.86253	78683075	2320	5.675997452723095E-4	0.92582	0.89107	0.99	0.001	8844	0.95808370	5.71	.	.	9.801360e-05	0.441383	0.987758183785664	0.81940	D	132	6206	9572	0.9576	0.96369	p.Arg239Cys	0	0	-4.512	0.8112291	6	0.87550	134427	T	30516	FLCN	5.844540e-05	D	0.914	21630	.	D	0.66725	0.76753	G/G	principal1																																																																																																				
FLCN_Arg239Cys	0.9174070101483766	0.38944335444511674	-15.695201041940072	1.0316623825275126e-6	2025_01_Batch_13-14	0.6408863296451378	0.8484363666697667	0.9442798550729118	0.9041886224631396	0.5304129016913728	0.6063071551797774	0.858095563825877	0.9457511173724349	0.8848038913580585	0.5856402538884513	0.6235967424124575	0.8532659652478218	0.9450154862226734	0.894496256910599	0.558026577789912	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FLCN	FLCN		7588		CCSBVarC001199		NC_000017.11:17222565:G:A		Arg239Cys																												FLCN_Arg239Cys	17	17222565	G	A	17	allele	715C>T	C04	527_CAVA_Array_P03	F07	B13A7A8P1_R1	B14A7A8P1_R2				17-17222565-G-A	-	0.91433	1.0	239	44	1	0	17	17125879	A	4.379790e-04	1	17	3_Conflicting	NC_000017.11	660	Arg239Cys	0	32.0	0	0	5.061320e-04	D	0	15	1	42768	2.532330e-04	0	30526	0.000000e+00	0	0.97735	Select	0.8908	102740	0.90580	2	0.0	D	D	64044	1.37465409467	0	0	0.000000e+00	0	0	0.93578	17110	44880	10	0.000000e+00	0.90996	25	.	0.89604	0.875	0.0	.	0.963104	3.64	.	A	single nucleotide variant	NC_000017.11:g.17222565G>A	0	16732	2	0.6441645	109404	0	0.8436355	0	A	52	236936	0	0	0.000000e+00	524	5.845490e-04	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0800444,MedGen:C0346010,OMIM:PS135150,Orphanet:122|MedGen:C3661900|	29	0	0.000000e+00	0	0.71237	D	0.79478	D	M	9.584683	707	G/G	306	7	7164	1614232	Hereditary cancer-predisposing syndrome|not specified|Birt-Hogg-Dube syndrome|not provided|FLCN-related disorder	16216	0.96499	1	.	-	17222565	5.845490e-04	-	11.729000	2	0.95083	29602	0	1180052	0	germline;unknown	91086	.	.	GRCh38	794	criteria provided, conflicting classifications	c.715C>T	9.827690e-05	0.89013	41	0	0	Folliculin/SMCR8, longin domain|Folliculin/SMCR8, tripartite DENN domain	0.000000e+00	9046	P	0	3.378150e-05	NM_144997.7(FLCN):c.715C>T (p.Arg239Cys)	1	0	FLCN_HUMAN	0	.	0.838685424223754	1	D	0.95096	0.8809669	-	1.395870e-04	0	0.000457627	44	0.000000e+00	0	34254	criteria_provided,_conflicting_classifications	0.93842	2.650730e-04	1	0.000000e+00	0	60034	p.Arg239Cys	0	0.94967	.	germline	25	17222565	G	Mar 04, 2025	3	G/G	0	89476	1.0	N	17p11.2	50198	.	1.233350e-04	SCV000190215|SCV000213928|SCV000291452|SCV000298054|SCV000401012|SCV000616724|SCV001140313|SCV002009831|SCV002530153|SCV002551355|SCV002774598|SCV004142321|SCV005412678	Conflicting_classifications_of_pathogenicity	0	0	Cys	C	-	912	ENSP00000285071	ENST00000285071	17692	0.0	13414	0	0.676	G	0	5.485253	0.83643	D	D	-	9.865392	.	0.89792	668	0	0.0019880715705765406	0.28980	0	17222565	Y	10	0	102740	1.649620e-04	Q8NFG4	0	0.965284	0.99621	G	0	0.999	D	89476	0.653225	42768	0.41772	201163	0.232675	660	-5.68	0.0	5.592970e-04	0.91343	1.274700e-04	0	75048	0.000000e+00	6062	1	0.78972	17	FLCN	7.994880e-05	0	Arg	72234	4.917520e-04	17-17222565-G-A	Hereditary_cancer-predisposing_syndrome|Birt-Hogg-Dube_syndrome|not_specified|not_provided|FLCN-related_disorder	0	52	17066604	ClinGen:CA159776|UniProtKB:Q8NFG4#VAR_066026	0.883493	0.88390	0	RCV000163388|RCV000121104|RCV000148504|RCV000656850|RCV003945073	D	0	0	c.715C>T	0	1	1	0.76800	G/G	rs78683075	17222565	14902	G	5.990415335463259E-4	.	15690	0.86694	0.000000e+00	0.68239	17	0	0	2.228160e-05	2.82	0	34	264690	5.71	0.99578	194	T	D	2	3.276970e-05	0	62	.	0	0	140162|122	134427	0.93307	0.84558	0.409195610064091	9150	3	0.71675	0.81176	5.838730e-05	4.917520e-04	1180052	7.113	2.499620e-04	D	13392	0	2.3045827E-4	0	PS135150	0.76785	17	1.342100e-04	ENSG00000154803	1.561430e-05	6.773178214271485E-4	3	0	0.8131863604073064	1	0.92348	0.45529	30608	61	5.061320e-04	8.328610e-05	0.79110123621525	YES	1.097860e-04	0.269279	138166	HGNC:27310	.	0	.	0.906	208032	17222565	CGC	1.000000	0	-	0	0.80205	5.592970e-04	0	1	Conflicting classifications of pathogenicity	0.31080	2	1	5	ClinGen:CA159776,UniProtKB:Q8NFG4#VAR_066026	R	0	0.92713276706	-	.	-	0.99730	60	11386	0.81164	0.877251982689	0.9888	0	0.99936625225274212	114	-	715C>T 	52	6.147900930967855E-4	C0027672|C0346010|CN169374|C3661900	0	0	0	0	NM_144997.7	-	2	0.001440922190201729	0	0.86253	78683075	2320	5.675997452723095E-4	0.92582	0.89107	0.99	0.001	8844	0.95808370	5.71	.	.	9.801360e-05	0.441383	0.987758183785664	0.81940	D	132	6206	9572	0.9576	0.96369	p.Arg239Cys	0	0	-4.512	0.8112291	6	0.87550	134427	T	30516	FLCN	5.844540e-05	D	0.914	21630	.	D	0.66725	0.76753	G/G	principal1																																																																																																				
BRCA1_Cys39Arg	0.8472010433103342	0.4248979667525149	4.1294175576416	0.004407203445207837	2025_01_Batch_13-14	0.9113364851976637	0.9137217340058423	0.9073086621204074	0.9371120204690024	0.7799000081227152	0.9652418848774538	0.9170687102373754	0.9237966176939698	0.9615767892708877	0.9409877921854897	0.9382891850375588	0.9153952221216088	0.9155526399071886	0.9493444048699451	0.8604439001541024	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011862		NC_000017.11:43115745:A:G		Cys39Arg																												BRCA1_Cys39Arg	17	43115745	A	G	17	allele	115T>C	G09	527_CAVA_Array_P01	M17	B13A7A8P1_R1	B14A7A8P1_R2				17-43115745-A-G	-	0.81398	0.987	39	.	0	.	17	41267762	G	6.196820e-07	.	17	1_Pathogenic	NC_000017.11	1	Cys39Arg	.	27.5	.	0	.	D	0	18	.	.	.	.	.	.	0	0.98488	.	0.9931	.	0.90580	.	.	T	D	64014	.	0	0	.	.	.	0.77978	.	44862	0	.	0.99400	.	.	0.98709	0.998	.	.	.	3.64	.	G	single nucleotide variant	NC_000017.11:g.43115745A>G	0	.	2	0.93651694	.	0	0.98947704	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562	.	.	0.000000e+00	0	0.99291	P	0.97245	D	H	13.04323	1	A/A	84	0	.	1613730	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer	.	0.96410	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43115745	.	-	11.102000	.	0.99727	29584	0	1179810	.	germline;not applicable;unknown	91016	Gain of catalytic residue at C39 (P = 0.0465)| Gain of phosphorylation at T37 (P = 0.077)| Gain of helix (P = 0.132)| Gain of MoRF binding (P = 0.136)| Gain of glycosylation at T37 (P = 0.1377)	0.99957	GRCh38	464	reviewed by expert panel	.	.	0.96929	0	.	.	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	.	.	.	0	0.000000e+00	NM_007294.4(BRCA1):c.115T>C (p.Cys39Arg)	3	.	BRCA1_HUMAN	.	.	0.971278320987367	.	.	0.97565	0.97528833	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99752	.	0	.	.	59942	.	0	0.86162	.	germline	.		A	Aug 10, 2015	.	A/A	.	.	1.0	N	17q21.31	6962	.	.	SCV000244296	Pathogenic	.	.	Arg	R	-	910	ENSP00000518978	ENST00000713676	.	.	.	.	0.756	A	.	4.933548	0.92967	D	.	-	12.75438	.	0.99312	610	.	.	0.95303	0	43115745	Y	10	0	.	0.000000e+00	P38398	.	0.409909	0.80955		.	0.879	D	.	0.93276787	.	0.85369	672	0.564887	1	.	.	8.475940e-07	0.91343	.	.	75044	.	6060	.	0.97501	17	BRCA1	0.000000e+00	0	Cys	11158	.	17-43115745-A-G	Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	0	.	38521288	BRCA1-HCI:BRCA1_00113|ClinGen:CA000766	0.797421	0.94761	0	RCV000077483|RCV000496824|RCV000570028|RCV000985365|RCV001270963	.	0	.	c.115T>C	.	0	0	0.96297	A/A	rs80357164	43115745	.	A	.	E9PFC7	.	0.99732	.	0.68239		.	.	0.000000e+00	4.355	0	0	.	5.97	0.93004	108	D	T	.	.	0	24	.	.	.	145|145|140162	54152	0.96237	0.50598	0.998840510845184	2720	.	0.71675	0.72325	.	.	1179810	4.109	.	.	.	.	.	0	604370	0.57651	17	.	ENSG00000012048	0.000000e+00	0	.	0	.	1	0.92348	0.78507	.	.	.	0.000000e+00	0.87581144299615	.	0.000000e+00	0.908305	68819	HGNC:1100	.	.	.	0.992	.	43115745	TGT	1.000000	.	-	0	0.99503	8.475940e-07	0	0	Pathogenic	0.98539	.	0	0	BRCA1-HCI:BRCA1_00113,ClinGen:CA000766	C	.	.	-	0.996	-	0.97441	.	518	0.93989	0.773955702782	.	0	0.99705377574859155	94	-	115T>C 	.	0	C0677776|CN221562|C3661900|C2676676|C0027672	.	.	.	.	NM_007294.4	-	.	.	1	0.97903	80357164	.	0	0.99932	0.94398	.	.	2636	0.99980813	5.97	.	.	.	0.573645	0.999949474096148	0.98454	D	84	.	.	0.9518	0.99838	p.Cys39Arg	0	0	-13.367	.	0	0.99079	54152	D	.	BRCA1	.	D	.	.	C39R	.	0.66725	0.943	A/A	principal2																																																																																																				
BRCA1_Phe591Leu	1.6193629120142436	0.14940127798338723	2.277705449148239	0.056828180249927085	2025_01_Batch_13-14	0.937408693262149	0.9212174631292718	0.8452376868441218	0.8871382643932934	0.920129200991745	0.9166854857442854	0.8859929476156592	0.8991794953942224	0.9508716312140828	0.8529090893143416	0.9270470895032172	0.9036052053724655	0.8722085911191721	0.9190049478036881	0.8865191451530433	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218428	CCSBVarC003305	ALE00003305	NC_000017.11:43063941:A:T	1773T>A	Phe591Leu	CEGS2	CegsMutGDEh1019	H03	GDEhDisVCh_40059	F06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Phe591Leu	17	43063941	A	T	17											17-43063941-A-T	-	0.25095	0.237	1695	0	.	0	17	41215958	T	.	0	17	3_Conflicting	NC_000017.11	.	Phe1695Leu	0	16.62	0	.	9.743550e-06	D	.	4	1	42754	4.223790e-06	.	30518	0.000000e+00	.	0.77150	.	0.6291	102632	0.30812	0	.	T	D	.	.	.	.	0.000000e+00	0	0	0.58154	17104	.	.	0.000000e+00	0.42578	0	.	0.50311	0.996	.	.	.	1.84	.	T	single nucleotide variant	NC_000017.11:g.43063941A>T	.	16734	2	0.17792259	109358	.	0.2819536	.		0	236754	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	0	0	.	.	.	B	0.35630	B	N	1.522421	.	A/A	.	.	7154	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	16194	0.89578	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063941	.	-	2.150000	0	0.73422	.	.	.	0	germline;not applicable	.	.	.	GRCh38	549	criteria provided, conflicting classifications	.	0.000000e+00	0.59667	.	0	0	BRCT domain|BRCT domain|BRCT domain	0.000000e+00	9038	.	.	.	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	1	0	BRCA1_HUMAN	0	.	-0.338194724745546	0	.	0.80507	0.2757978	-	0.000000e+00	.		.	0.000000e+00	2	34246	criteria_provided,_conflicting_classifications	0.99153	0.000000e+00	.	0.000000e+00	0	.	.	.	0.30988	.	germline	.		A	Apr 26, 2023	0	A/A	0	89470	1.0	N	17q21.31	.	.	0.000000e+00	SCV000660974|SCV002187048	Conflicting_classifications_of_pathogenicity	0	0	Leu	L	-	.	ENSP00000419274	ENST00000470026	17682	.	13402	0	0.665	A	0	1.972208	0.09167	N	.	-	1.89438	.	0.98164	.	0	.	0.25715	.	43063941	Y	10	.	102632	.	P38398	0	0.133578	0.21471		.	0.107	D	.	0.15177552	.	0.76032	672	0.169896	.	.	.	.	0.25997	0.000000e+00	0	.	0.000000e+00	.	0	0.40291	17	BRCA1	.	.	Phe	.	0.000000e+00	17-43063941-A-T	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	1	38469484	ClinGen:CA003223	0.371736	0.27430	.	RCV000112493|RCV000562837|RCV001853018	.	.	0	c.5085T>A	0	.	.	0.70900	A/A	rs80357387	43063941	14886	A	.	.	15686	0.50902	0.000000e+00	0.68239		0	0	.	0.135	.	.	.	4.74	0.46135	.	T	T	0	0.000000e+00	.	.	.	0	0	145|140162|145	55389	0.70525	0.27990	0.324614346916885	.	.	0.71675	0.45580	0.000000e+00	.	.	1.51	0.000000e+00	.	13394	.	.	.	604370	0.35504	17	0.000000e+00	ENSG00000012048	.	.	0	.	.	3	0.31213	0.72286	30600	.	9.743550e-06	.	-0.156317829821601	.	.	0.768432	70056	HGNC:1100	.	0	.	0.531	207972	43063941	TTT	1.000000	.	-	.	0.54565	.	.	.	Conflicting classifications of pathogenicity	0.38578	0	.	.	ClinGen:CA003223	F	0	.	-	.	-	0.55139	1	.	0.46484	0.637575030327	.	.	0.91899320551777408	.	-	5085T>A 	1	.	C0677776|C0027672|C2676676	0	0	0	0	NM_007294.4	-	.	.	0	0.56037	80357387	2314	.	0.82922	0.32854	.	.	.	0.99911267	5.83	.	.	0.000000e+00	0.00626705	0.151693788840998	0.08601	D	.	6206	9556	0.4353	0.86934	p.Phe1695Leu	.	.	-3.59	.	.	0.47210	55389	T	30508	BRCA1	0.000000e+00	D	.	21628	.	.	0.37836	0.62996	A/A	principal2	37999	BRCA1_Adamovich_2022_Cisplatin_var6347	No	[-0.729,-0.503]		0.8055131489792701			Cisplatin resistance		Drug Resistance	Not specified		F	Likely Benign	5085	BRCA1_Adamovich_2022_Cisplatin		ENST00000357654.9		Abnormal					immortalized human cells					p.Phe1695Ile		true	c.5085T>A				Functional		1100.0	43063941.0	No		BRCA1				NM_007294.4		-1.0			aa				1.0330920372							criteria provided, conflicting classifications	-0.582208315;-0.028561318;-0.156309496;-0.267607508			Phe1695Ile		LOF		(-0.503, Inf)		I	Apr 26, 2023		(-Inf, -0.729)	0.1		missense_variant		1695.0				-0.25867165925	Normal	Conflicting classifications of pathogenicity	43063941.0	missense_variant				Intermediate	0.77971092599		Cell Viability		0.08214900502816846	BRCA1_Phe1695Ile
BRCA1_Phe591Leu	1.6193629120142436	0.14940127798338723	2.277705449148239	0.056828180249927085	2025_01_Batch_13-14	0.937408693262149	0.9212174631292718	0.8452376868441218	0.8871382643932934	0.920129200991745	0.9166854857442854	0.8859929476156592	0.8991794953942224	0.9508716312140828	0.8529090893143416	0.9270470895032172	0.9036052053724655	0.8722085911191721	0.9190049478036881	0.8865191451530433	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218428	CCSBVarC003305	ALE00003305	NC_000017.11:43063941:A:T	1773T>A	Phe591Leu	CEGS2	CegsMutGDEh1019	H03	GDEhDisVCh_40059	F06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Phe591Leu	17	43063941	A	T	17											17-43063941-A-T	-	0.25095	0.237	1695	0	.	0	17	41215958	T	.	0	17	3_Conflicting	NC_000017.11	.	Phe1695Leu	0	16.62	0	.	9.743550e-06	D	.	4	1	42754	4.223790e-06	.	30518	0.000000e+00	.	0.77150	.	0.6291	102632	0.30812	0	.	T	D	.	.	.	.	0.000000e+00	0	0	0.58154	17104	.	.	0.000000e+00	0.42578	0	.	0.50311	0.996	.	.	.	1.84	.	T	single nucleotide variant	NC_000017.11:g.43063941A>T	.	16734	2	0.17792259	109358	.	0.2819536	.		0	236754	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	0	0	.	.	.	B	0.35630	B	N	1.522421	.	A/A	.	.	7154	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	16194	0.89578	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063941	.	-	2.150000	0	0.73422	.	.	.	0	germline;not applicable	.	.	.	GRCh38	549	criteria provided, conflicting classifications	.	0.000000e+00	0.59667	.	0	0	BRCT domain|BRCT domain|BRCT domain	0.000000e+00	9038	.	.	.	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	1	0	BRCA1_HUMAN	0	.	-0.338194724745546	0	.	0.80507	0.2757978	-	0.000000e+00	.		.	0.000000e+00	2	34246	criteria_provided,_conflicting_classifications	0.99153	0.000000e+00	.	0.000000e+00	0	.	.	.	0.30988	.	germline	.		A	Apr 26, 2023	0	A/A	0	89470	1.0	N	17q21.31	.	.	0.000000e+00	SCV000660974|SCV002187048	Conflicting_classifications_of_pathogenicity	0	0	Leu	L	-	.	ENSP00000419274	ENST00000470026	17682	.	13402	0	0.665	A	0	1.972208	0.09167	N	.	-	1.89438	.	0.98164	.	0	.	0.25715	.	43063941	Y	10	.	102632	.	P38398	0	0.133578	0.21471		.	0.107	D	.	0.15177552	.	0.76032	672	0.169896	.	.	.	.	0.25997	0.000000e+00	0	.	0.000000e+00	.	0	0.40291	17	BRCA1	.	.	Phe	.	0.000000e+00	17-43063941-A-T	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	1	38469484	ClinGen:CA003223	0.371736	0.27430	.	RCV000112493|RCV000562837|RCV001853018	.	.	0	c.5085T>A	0	.	.	0.70900	A/A	rs80357387	43063941	14886	A	.	.	15686	0.50902	0.000000e+00	0.68239		0	0	.	0.135	.	.	.	4.74	0.46135	.	T	T	0	0.000000e+00	.	.	.	0	0	145|140162|145	55389	0.70525	0.27990	0.324614346916885	.	.	0.71675	0.45580	0.000000e+00	.	.	1.51	0.000000e+00	.	13394	.	.	.	604370	0.35504	17	0.000000e+00	ENSG00000012048	.	.	0	.	.	3	0.31213	0.72286	30600	.	9.743550e-06	.	-0.156317829821601	.	.	0.768432	70056	HGNC:1100	.	0	.	0.531	207972	43063941	TTT	1.000000	.	-	.	0.54565	.	.	.	Conflicting classifications of pathogenicity	0.38578	0	.	.	ClinGen:CA003223	F	0	.	-	.	-	0.55139	1	.	0.46484	0.637575030327	.	.	0.91899320551777408	.	-	5085T>A 	1	.	C0677776|C0027672|C2676676	0	0	0	0	NM_007294.4	-	.	.	0	0.56037	80357387	2314	.	0.82922	0.32854	.	.	.	0.99911267	5.83	.	.	0.000000e+00	0.00626705	0.151693788840998	0.08601	D	.	6206	9556	0.4353	0.86934	p.Phe1695Leu	.	.	-3.59	.	.	0.47210	55389	T	30508	BRCA1	0.000000e+00	D	.	21628	.	.	0.37836	0.62996	A/A	principal2	46030	BRCA1_Adamovich_2022_HDR_var4885	No	[-0.562,-0.233]		0.8055131489792701			Homology Directed Repair		Fluorescence	Not specified		F	Likely Benign	5085	BRCA1_Adamovich_2022_HDR		ENST00000357654.9		Abnormal					immortalized human cells					p.Phe1695Ile		true	c.5085T>A				Functional		1100.0	43063941.0	No		BRCA1				NM_007294.4		-1.0			aa				1.0330920372							criteria provided, conflicting classifications	-0.763772346;-0.689828835;-0.943148576;-0.70694949			Phe1695Ile		LOF		(-0.233, Inf)		I	Apr 26, 2023		(-Inf, -0.562)	0.1		missense_variant		1695.0				-0.77592481225	Normal	Conflicting classifications of pathogenicity	43063941.0	missense_variant				Intermediate	0.77971092599		Reporter		0.08214900502816846	BRCA1_Phe1695Ile
BRCA1_Phe591Leu	1.6193629120142436	0.14940127798338723	2.277705449148239	0.056828180249927085	2025_01_Batch_13-14	0.937408693262149	0.9212174631292718	0.8452376868441218	0.8871382643932934	0.920129200991745	0.9166854857442854	0.8859929476156592	0.8991794953942224	0.9508716312140828	0.8529090893143416	0.9270470895032172	0.9036052053724655	0.8722085911191721	0.9190049478036881	0.8865191451530433	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003305		NC_000017.11:43063941:A:T		Phe591Leu																												BRCA1_Phe591Leu	17	43063941	A	T	17	allele	1773T>A	E07	527_CAVA_Array_P01	I13	B13A7A8P1_R1	B14A7A8P1_R2				17-43063941-A-T	-	0.25095	0.237	1695	0	.	0	17	41215958	T	.	0	17	3_Conflicting	NC_000017.11	.	Phe1695Leu	0	16.62	0	.	9.743550e-06	D	.	4	1	42754	4.223790e-06	.	30518	0.000000e+00	.	0.77150	.	0.6291	102632	0.30812	0	.	T	D	.	.	.	.	0.000000e+00	0	0	0.58154	17104	.	.	0.000000e+00	0.42578	0	.	0.50311	0.996	.	.	.	1.84	.	T	single nucleotide variant	NC_000017.11:g.43063941A>T	.	16734	2	0.17792259	109358	.	0.2819536	.		0	236754	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	0	0	.	.	.	B	0.35630	B	N	1.522421	.	A/A	.	.	7154	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	16194	0.89578	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063941	.	-	2.150000	0	0.73422	.	.	.	0	germline;not applicable	.	.	.	GRCh38	549	criteria provided, conflicting classifications	.	0.000000e+00	0.59667	.	0	0	BRCT domain|BRCT domain|BRCT domain	0.000000e+00	9038	.	.	.	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	1	0	BRCA1_HUMAN	0	.	-0.338194724745546	0	.	0.80507	0.2757978	-	0.000000e+00	.		.	0.000000e+00	2	34246	criteria_provided,_conflicting_classifications	0.99153	0.000000e+00	.	0.000000e+00	0	.	.	.	0.30988	.	germline	.		A	Apr 26, 2023	0	A/A	0	89470	1.0	N	17q21.31	.	.	0.000000e+00	SCV000660974|SCV002187048	Conflicting_classifications_of_pathogenicity	0	0	Leu	L	-	.	ENSP00000419274	ENST00000470026	17682	.	13402	0	0.665	A	0	1.972208	0.09167	N	.	-	1.89438	.	0.98164	.	0	.	0.25715	.	43063941	Y	10	.	102632	.	P38398	0	0.133578	0.21471		.	0.107	D	.	0.15177552	.	0.76032	672	0.169896	.	.	.	.	0.25997	0.000000e+00	0	.	0.000000e+00	.	0	0.40291	17	BRCA1	.	.	Phe	.	0.000000e+00	17-43063941-A-T	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	1	38469484	ClinGen:CA003223	0.371736	0.27430	.	RCV000112493|RCV000562837|RCV001853018	.	.	0	c.5085T>A	0	.	.	0.70900	A/A	rs80357387	43063941	14886	A	.	.	15686	0.50902	0.000000e+00	0.68239		0	0	.	0.135	.	.	.	4.74	0.46135	.	T	T	0	0.000000e+00	.	.	.	0	0	145|140162|145	55389	0.70525	0.27990	0.324614346916885	.	.	0.71675	0.45580	0.000000e+00	.	.	1.51	0.000000e+00	.	13394	.	.	.	604370	0.35504	17	0.000000e+00	ENSG00000012048	.	.	0	.	.	3	0.31213	0.72286	30600	.	9.743550e-06	.	-0.156317829821601	.	.	0.768432	70056	HGNC:1100	.	0	.	0.531	207972	43063941	TTT	1.000000	.	-	.	0.54565	.	.	.	Conflicting classifications of pathogenicity	0.38578	0	.	.	ClinGen:CA003223	F	0	.	-	.	-	0.55139	1	.	0.46484	0.637575030327	.	.	0.91899320551777408	.	-	5085T>A 	1	.	C0677776|C0027672|C2676676	0	0	0	0	NM_007294.4	-	.	.	0	0.56037	80357387	2314	.	0.82922	0.32854	.	.	.	0.99911267	5.83	.	.	0.000000e+00	0.00626705	0.151693788840998	0.08601	D	.	6206	9556	0.4353	0.86934	p.Phe1695Leu	.	.	-3.59	.	.	0.47210	55389	T	30508	BRCA1	0.000000e+00	D	.	21628	.	.	0.37836	0.62996	A/A	principal2	37999	BRCA1_Adamovich_2022_Cisplatin_var6347	No	[-0.729,-0.503]		0.8055131489792701			Cisplatin resistance		Drug Resistance	Not specified		F	Likely Benign	5085	BRCA1_Adamovich_2022_Cisplatin		ENST00000357654.9		Abnormal					immortalized human cells					p.Phe1695Ile		true	c.5085T>A				Functional		1100.0	43063941.0	No		BRCA1				NM_007294.4		-1.0			aa				1.0330920372							criteria provided, conflicting classifications	-0.582208315;-0.028561318;-0.156309496;-0.267607508			Phe1695Ile		LOF		(-0.503, Inf)		I	Apr 26, 2023		(-Inf, -0.729)	0.1		missense_variant		1695.0				-0.25867165925	Normal	Conflicting classifications of pathogenicity	43063941.0	missense_variant				Intermediate	0.77971092599		Cell Viability		0.08214900502816846	BRCA1_Phe1695Ile
BRCA1_Phe591Leu	1.6193629120142436	0.14940127798338723	2.277705449148239	0.056828180249927085	2025_01_Batch_13-14	0.937408693262149	0.9212174631292718	0.8452376868441218	0.8871382643932934	0.920129200991745	0.9166854857442854	0.8859929476156592	0.8991794953942224	0.9508716312140828	0.8529090893143416	0.9270470895032172	0.9036052053724655	0.8722085911191721	0.9190049478036881	0.8865191451530433	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003305		NC_000017.11:43063941:A:T		Phe591Leu																												BRCA1_Phe591Leu	17	43063941	A	T	17	allele	1773T>A	E07	527_CAVA_Array_P01	I13	B13A7A8P1_R1	B14A7A8P1_R2				17-43063941-A-T	-	0.25095	0.237	1695	0	.	0	17	41215958	T	.	0	17	3_Conflicting	NC_000017.11	.	Phe1695Leu	0	16.62	0	.	9.743550e-06	D	.	4	1	42754	4.223790e-06	.	30518	0.000000e+00	.	0.77150	.	0.6291	102632	0.30812	0	.	T	D	.	.	.	.	0.000000e+00	0	0	0.58154	17104	.	.	0.000000e+00	0.42578	0	.	0.50311	0.996	.	.	.	1.84	.	T	single nucleotide variant	NC_000017.11:g.43063941A>T	.	16734	2	0.17792259	109358	.	0.2819536	.		0	236754	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	0	0	.	.	.	B	0.35630	B	N	1.522421	.	A/A	.	.	7154	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	16194	0.89578	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063941	.	-	2.150000	0	0.73422	.	.	.	0	germline;not applicable	.	.	.	GRCh38	549	criteria provided, conflicting classifications	.	0.000000e+00	0.59667	.	0	0	BRCT domain|BRCT domain|BRCT domain	0.000000e+00	9038	.	.	.	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	1	0	BRCA1_HUMAN	0	.	-0.338194724745546	0	.	0.80507	0.2757978	-	0.000000e+00	.		.	0.000000e+00	2	34246	criteria_provided,_conflicting_classifications	0.99153	0.000000e+00	.	0.000000e+00	0	.	.	.	0.30988	.	germline	.		A	Apr 26, 2023	0	A/A	0	89470	1.0	N	17q21.31	.	.	0.000000e+00	SCV000660974|SCV002187048	Conflicting_classifications_of_pathogenicity	0	0	Leu	L	-	.	ENSP00000419274	ENST00000470026	17682	.	13402	0	0.665	A	0	1.972208	0.09167	N	.	-	1.89438	.	0.98164	.	0	.	0.25715	.	43063941	Y	10	.	102632	.	P38398	0	0.133578	0.21471		.	0.107	D	.	0.15177552	.	0.76032	672	0.169896	.	.	.	.	0.25997	0.000000e+00	0	.	0.000000e+00	.	0	0.40291	17	BRCA1	.	.	Phe	.	0.000000e+00	17-43063941-A-T	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	1	38469484	ClinGen:CA003223	0.371736	0.27430	.	RCV000112493|RCV000562837|RCV001853018	.	.	0	c.5085T>A	0	.	.	0.70900	A/A	rs80357387	43063941	14886	A	.	.	15686	0.50902	0.000000e+00	0.68239		0	0	.	0.135	.	.	.	4.74	0.46135	.	T	T	0	0.000000e+00	.	.	.	0	0	145|140162|145	55389	0.70525	0.27990	0.324614346916885	.	.	0.71675	0.45580	0.000000e+00	.	.	1.51	0.000000e+00	.	13394	.	.	.	604370	0.35504	17	0.000000e+00	ENSG00000012048	.	.	0	.	.	3	0.31213	0.72286	30600	.	9.743550e-06	.	-0.156317829821601	.	.	0.768432	70056	HGNC:1100	.	0	.	0.531	207972	43063941	TTT	1.000000	.	-	.	0.54565	.	.	.	Conflicting classifications of pathogenicity	0.38578	0	.	.	ClinGen:CA003223	F	0	.	-	.	-	0.55139	1	.	0.46484	0.637575030327	.	.	0.91899320551777408	.	-	5085T>A 	1	.	C0677776|C0027672|C2676676	0	0	0	0	NM_007294.4	-	.	.	0	0.56037	80357387	2314	.	0.82922	0.32854	.	.	.	0.99911267	5.83	.	.	0.000000e+00	0.00626705	0.151693788840998	0.08601	D	.	6206	9556	0.4353	0.86934	p.Phe1695Leu	.	.	-3.59	.	.	0.47210	55389	T	30508	BRCA1	0.000000e+00	D	.	21628	.	.	0.37836	0.62996	A/A	principal2	46030	BRCA1_Adamovich_2022_HDR_var4885	No	[-0.562,-0.233]		0.8055131489792701			Homology Directed Repair		Fluorescence	Not specified		F	Likely Benign	5085	BRCA1_Adamovich_2022_HDR		ENST00000357654.9		Abnormal					immortalized human cells					p.Phe1695Ile		true	c.5085T>A				Functional		1100.0	43063941.0	No		BRCA1				NM_007294.4		-1.0			aa				1.0330920372							criteria provided, conflicting classifications	-0.763772346;-0.689828835;-0.943148576;-0.70694949			Phe1695Ile		LOF		(-0.233, Inf)		I	Apr 26, 2023		(-Inf, -0.562)	0.1		missense_variant		1695.0				-0.77592481225	Normal	Conflicting classifications of pathogenicity	43063941.0	missense_variant				Intermediate	0.77971092599		Reporter		0.08214900502816846	BRCA1_Phe1695Ile
KRAS_Gly12Asp	-1.282954401654033	0.24035037393394657	6.504027749209328	0.00033287040797068537	2025_01_Batch_13-14	0.7891330351514627	0.9019244309890346	0.857924198148612	0.8194808192304905	0.6907045859261781	0.9535033127374848	0.9281999305094811	0.9429165101818704	0.9554522581627367	0.8882067631690442	0.8713181739444738	0.9150621807492578	0.9004203541652411	0.8874665386966136	0.7894556745476111	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214484	CCSBVarC006090	ALE00006090	NC_000012.12:25245350:C:T	35G>A	Gly12Asp	CEGS2	CegsMutGDEh1034	G11	GDEhDisVCh_40061	F08	1	CegsMutGDDh1034	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Gly12Asp	12	25245350	C	T	12											12-25245350-C-T	-	0.81187	0.517	12	1	0	0	12	25398284	T	3.720370e-06	0	12	1_Pathogenic	NC_000012.12	5	Gly12Asp	0	27.5	0	0	9.831870e-06	D	0	24	1	42218	4.255460e-06	.	30152	0.000000e+00	0	0.96271	Plus_Clinical	0.5809	101710	0.37470	0	.	D	D	63988	2.25690945348	0	0	0.000000e+00	0	0	0.98932	17030	44868	0	0.000000e+00	0.90914	1	.	0.94746	1.0	.	0.0	0.331367	.	1.0	T	single nucleotide variant	NC_000012.12:g.25245350C>T	0	16720	3	0.9112568	108342	0	0.92127717	0	T	1	234992	0	0	0.000000e+00	436	2.368660e-05	0	MedGen:C3661900|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519|MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C4302356|MONDO:MONDO:0020783,MedGen:C4747394,OMIM:608354,Orphanet:137667,Orphanet:90307|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724||Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0006096,MedGen:C0349579;MONDO:MONDO:0006193,MedGen:C1516855|MedGen:CN230736|Human Phenotype Ontology:HP:0010816,MONDO:MONDO:0008093,MedGen:C0334082,OMIM:162900,Orphanet:79414|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|12 conditions|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396||Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	1	0	0.000000e+00	0	0.99291	B	0.96683	P	M	5.981318	6	./.	162	1	7046	1612744	not provided|Acute myeloid leukemia|Carcinoma of pancreas|Primary low grade serous adenocarcinoma of ovary|Capillary malformation-arteriovenous malformation 1|RASopathy|Cerebral arteriovenous malformation|Vascular Tumors Including Pyogenic Granuloma|Gastric cancer|Atypical endometrial hyperplasia;Endometrial hyperplasia without atypia|Cardiovascular phenotype|Epidermal nevus|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Non-small cell lung carcinoma|Ovarian neoplasm|12 conditions|Encephalocraniocutaneous lipomatosis|Congenital Pulmonary Airway Malformations|Neoplasm	16014	0.86969	.	.	-	25245350	2.368660e-05	-	7.698000	0	0.99826	29524	0	1179306	0	de novo;germline;somatic;unknown	90798	Gain of catalytic residue at G13 (P = 0.001)| Gain of ubiquitination at K16 (P = 0.1181)| Loss of methylation at K16 (P = 0.1388)| Gain of solvent accessibility (P = 0.2192)| Loss of sheet (P = 0.302)	0.89792	GRCh38	707	criteria provided, multiple submitters, no conflicts	c.35G>A	0.000000e+00	0.88004	1	0	0	Small GTP-binding domain	0.000000e+00	9026	P	0	0.000000e+00	NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	2	0	RASK_HUMAN	0	100.0	0.605638712679719	0	T	0.98378	0.9358444	-	0.000000e+00	.	2.73867e-6	1	0.000000e+00	0	34116	criteria_provided,_multiple_submitters,_no_conflicts	0.98508	9.230030e-06	0	0.000000e+00	0	59938	p.Gly12Asp	0	0.66189	.	germline/somatic	1	25245350	C	Oct 07, 2024	0	./.	0	88728	1.0	N	12p12.1	90742	.	0.000000e+00	SCV000329383|SCV000659085|SCV001736991|SCV002318898|SCV002525678|SCV002601600|SCV002821689|SCV004176950|SCV005023563|SCV005044128|SCV005414064|SCV005634967	Pathogenic/Likely_pathogenic	0	0	Asp	D	-	912	ENSP00000256078	ENST00000256078	17666	0.01	13384	0	0.58	C	0	4.925041	0.92967	D	D	-	7.073244	.	0.84329	928	0	.	0.67026	0	25245350	Y	10	0	101710	0.000000e+00	P01116	0	0.839213	0.86444	C	0	0.361	D	88728	0.924745	42218	0.97202	3845	0.397866	5	-5.37	.	4.239780e-06	0.56615	0.000000e+00	0	74904	0.000000e+00	6084	0	0.95720	12	KRAS	0.000000e+00	0	Gly	101828	1.127040e-05	12-25245350-C-T	Juvenile_myelomonocytic_leukemia|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Acute_myeloid_leukemia|Gastric_cancer|Congenital_Pulmonary_Airway_Malformations|not_provided|Carcinoma_of_pancreas|Cardiovascular_phenotype|Ovarian_neoplasm|RASopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|Non-small_cell_lung_carcinoma|Capillary_malformation-arteriovenous_malformation_1|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|Linear_nevus_sebaceous_syndrome|Vascular_Tumors_Including_Pyogenic_Granuloma|Atypical_endometrial_hyperplasia|Endometrial_hyperplasia_without_atypia|Cerebral_arteriovenous_malformation|Lung_carcinoma|Epidermal_nevus	0	1	25289551	ClinGen:CA122538|OMIM:190070.0005|OMIM:190070.0025|UniProtKB:P01116#VAR_016026	0.891815	0.73388	0	RCV000272938|RCV000433573|RCV000013411|RCV000856666|RCV001799604|RCV000548006|RCV000585796|RCV000662266|RCV002508117|RCV003327361|RCV004018620|RCV000022799|RCV000029214|RCV000029215|RCV000144969|RCV000144970|RCV000150896|RCV000150897|RCV005007840|RCV001839445|RCV004554600|RCV004668724	D	0	0	c.35G>A	0	0	0	0.89719	./.	rs121913529	25245350	14710	C	.	P01116	15506	0.93272	0.000000e+00	0.68239	12	0	0	0.000000e+00	2.685	0	0	.	5.68	0.96205	3304	D	D	0	0.000000e+00	0	624	.	0	0	86834|2396|100087|519|1333|217074|536391|137667|90307|268114|2612|46724|79414	12582	0.89591	0.96132	0.965350031852722	4106	.	0.71675	0.82751	0.000000e+00	1.127040e-05	1179306	7.892	4.844870e-06	D	13384	0	.	0	607785|613001|601626|613659|608354|614470|163200|108010|162900	0.85894	12	0.000000e+00	ENSG00000133703	0.000000e+00	0	0	0	0.9871709593781199	2	0.43233	0.56997	30232	.	9.831870e-06	0.000000e+00	0.66049645547495	.	0.000000e+00	0.164646	27621	HGNC:6407	A	0	simple_aae	0.995	206404	25245350	GGT	1.000000	.	SCV005094257	0	0.89008	4.239780e-06	0	0	Pathogenic/Likely pathogenic	0.96931	0	0	0	ClinGen:CA122538,UniProtKB:P01116#VAR_016026,OMIM:190070.0005,OMIM:190070.0025	G	0	0.957447700615	Mar 04, 2025	0.772	Oncogenic	0.91737	1	2036	0.98706	0.929049253464	0.9984	0	0.99776655469088438	276	criteria provided, single submitter	35G>A 	1	4.911591355599214E-4	C0349639|C0406612|C0009404|C0040136|C0023467|C0024623|C3661900|C0235974|CN230736|C0919267|C5555857|C4302356|C0007131|C4747394|C2674723|C3854181|C4552097|C0349579|C1516855|C0917804|C0684249|C0334082	0	0	0	0	NM_004985.5	-	.	.	1	0.19106	121913529	2232	9.820481596417489E-6	0.95662	0.79283	0.915	0.0	3944	0.99778840	5.68	.	.	0.000000e+00	0.33373	0.999983137957112	0.78379	D	2680	6112	9462	0.2670	0.84869	p.Gly12Asp	0	0	-14.566	0.897719	0	0.99579	12582	D	30376	KRAS	0.000000e+00	D	0.875	21592	G12D	D	.	0.29757	./.	alternative1																																																																																																				
KRAS_Gly12Asp	-1.282954401654033	0.24035037393394657	6.504027749209328	0.00033287040797068537	2025_01_Batch_13-14	0.7891330351514627	0.9019244309890346	0.857924198148612	0.8194808192304905	0.6907045859261781	0.9535033127374848	0.9281999305094811	0.9429165101818704	0.9554522581627367	0.8882067631690442	0.8713181739444738	0.9150621807492578	0.9004203541652411	0.8874665386966136	0.7894556745476111	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006090		NC_000012.12:25245350:C:T		Gly12Asp																												KRAS_Gly12Asp	12	25245350	C	T	12	allele	35G>A	D08	527_CAVA_Array_P03	H15	B13A7A8P1_R1	B14A7A8P1_R2				12-25245350-C-T	-	0.81187	0.517	12	1	0	0	12	25398284	T	3.720370e-06	0	12	1_Pathogenic	NC_000012.12	5	Gly12Asp	0	27.5	0	0	9.831870e-06	D	0	24	1	42218	4.255460e-06	.	30152	0.000000e+00	0	0.96271	Plus_Clinical	0.5809	101710	0.37470	0	.	D	D	63988	2.25690945348	0	0	0.000000e+00	0	0	0.98932	17030	44868	0	0.000000e+00	0.90914	1	.	0.94746	1.0	.	0.0	0.331367	.	1.0	T	single nucleotide variant	NC_000012.12:g.25245350C>T	0	16720	3	0.9112568	108342	0	0.92127717	0	T	1	234992	0	0	0.000000e+00	436	2.368660e-05	0	MedGen:C3661900|Human Phenotype Ontology:HP:0001914,Human Phenotype Ontology:HP:0004808,Human Phenotype Ontology:HP:0004843,Human Phenotype Ontology:HP:0005516,Human Phenotype Ontology:HP:0006724,Human Phenotype Ontology:HP:0006728,MONDO:MONDO:0018874,MeSH:D015470,MedGen:C0023467,OMIM:601626,Orphanet:519|MONDO:MONDO:0005192,MeSH:C562463,MedGen:C0235974,Orphanet:1333,Orphanet:217074|MedGen:C4302356|MONDO:MONDO:0020783,MedGen:C4747394,OMIM:608354,Orphanet:137667,Orphanet:90307|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0002408,MONDO:MONDO:0007154,MedGen:C0917804,OMIM:108010,Orphanet:46724||Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0006096,MedGen:C0349579;MONDO:MONDO:0006193,MedGen:C1516855|MedGen:CN230736|Human Phenotype Ontology:HP:0010816,MONDO:MONDO:0008093,MedGen:C0334082,OMIM:162900,Orphanet:79414|Human Phenotype Ontology:HP:0010815,MedGen:C3854181|Human Phenotype Ontology:HP:0010817,MONDO:MONDO:0008097,MedGen:C4552097,OMIM:163200,Orphanet:2612|Human Phenotype Ontology:HP:0012209,MONDO:MONDO:0011908,MedGen:C0349639,OMIM:607785,Orphanet:86834|MONDO:MONDO:0013767,MedGen:C2674723,OMIM:614470,Orphanet:268114|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|12 conditions|MONDO:MONDO:0013074,MedGen:C0406612,OMIM:613001,Orphanet:2396||Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	1	0	0.000000e+00	0	0.99291	B	0.96683	P	M	5.981318	6	./.	162	1	7046	1612744	not provided|Acute myeloid leukemia|Carcinoma of pancreas|Primary low grade serous adenocarcinoma of ovary|Capillary malformation-arteriovenous malformation 1|RASopathy|Cerebral arteriovenous malformation|Vascular Tumors Including Pyogenic Granuloma|Gastric cancer|Atypical endometrial hyperplasia;Endometrial hyperplasia without atypia|Cardiovascular phenotype|Epidermal nevus|Nevus sebaceous|Linear nevus sebaceous syndrome|Juvenile myelomonocytic leukemia|Autoimmune lymphoproliferative syndrome type 4|Non-small cell lung carcinoma|Ovarian neoplasm|12 conditions|Encephalocraniocutaneous lipomatosis|Congenital Pulmonary Airway Malformations|Neoplasm	16014	0.86969	.	.	-	25245350	2.368660e-05	-	7.698000	0	0.99826	29524	0	1179306	0	de novo;germline;somatic;unknown	90798	Gain of catalytic residue at G13 (P = 0.001)| Gain of ubiquitination at K16 (P = 0.1181)| Loss of methylation at K16 (P = 0.1388)| Gain of solvent accessibility (P = 0.2192)| Loss of sheet (P = 0.302)	0.89792	GRCh38	707	criteria provided, multiple submitters, no conflicts	c.35G>A	0.000000e+00	0.88004	1	0	0	Small GTP-binding domain	0.000000e+00	9026	P	0	0.000000e+00	NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	2	0	RASK_HUMAN	0	100.0	0.605638712679719	0	T	0.98378	0.9358444	-	0.000000e+00	.	2.73867e-6	1	0.000000e+00	0	34116	criteria_provided,_multiple_submitters,_no_conflicts	0.98508	9.230030e-06	0	0.000000e+00	0	59938	p.Gly12Asp	0	0.66189	.	germline/somatic	1	25245350	C	Oct 07, 2024	0	./.	0	88728	1.0	N	12p12.1	90742	.	0.000000e+00	SCV000329383|SCV000659085|SCV001736991|SCV002318898|SCV002525678|SCV002601600|SCV002821689|SCV004176950|SCV005023563|SCV005044128|SCV005414064|SCV005634967	Pathogenic/Likely_pathogenic	0	0	Asp	D	-	912	ENSP00000256078	ENST00000256078	17666	0.01	13384	0	0.58	C	0	4.925041	0.92967	D	D	-	7.073244	.	0.84329	928	0	.	0.67026	0	25245350	Y	10	0	101710	0.000000e+00	P01116	0	0.839213	0.86444	C	0	0.361	D	88728	0.924745	42218	0.97202	3845	0.397866	5	-5.37	.	4.239780e-06	0.56615	0.000000e+00	0	74904	0.000000e+00	6084	0	0.95720	12	KRAS	0.000000e+00	0	Gly	101828	1.127040e-05	12-25245350-C-T	Juvenile_myelomonocytic_leukemia|Encephalocraniocutaneous_lipomatosis|Neoplasm_of_the_large_intestine|Thyroid_tumor|Acute_myeloid_leukemia|Gastric_cancer|Congenital_Pulmonary_Airway_Malformations|not_provided|Carcinoma_of_pancreas|Cardiovascular_phenotype|Ovarian_neoplasm|RASopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|Non-small_cell_lung_carcinoma|Capillary_malformation-arteriovenous_malformation_1|Autoimmune_lymphoproliferative_syndrome_type_4|Nevus_sebaceous|Linear_nevus_sebaceous_syndrome|Vascular_Tumors_Including_Pyogenic_Granuloma|Atypical_endometrial_hyperplasia|Endometrial_hyperplasia_without_atypia|Cerebral_arteriovenous_malformation|Lung_carcinoma|Epidermal_nevus	0	1	25289551	ClinGen:CA122538|OMIM:190070.0005|OMIM:190070.0025|UniProtKB:P01116#VAR_016026	0.891815	0.73388	0	RCV000272938|RCV000433573|RCV000013411|RCV000856666|RCV001799604|RCV000548006|RCV000585796|RCV000662266|RCV002508117|RCV003327361|RCV004018620|RCV000022799|RCV000029214|RCV000029215|RCV000144969|RCV000144970|RCV000150896|RCV000150897|RCV005007840|RCV001839445|RCV004554600|RCV004668724	D	0	0	c.35G>A	0	0	0	0.89719	./.	rs121913529	25245350	14710	C	.	P01116	15506	0.93272	0.000000e+00	0.68239	12	0	0	0.000000e+00	2.685	0	0	.	5.68	0.96205	3304	D	D	0	0.000000e+00	0	624	.	0	0	86834|2396|100087|519|1333|217074|536391|137667|90307|268114|2612|46724|79414	12582	0.89591	0.96132	0.965350031852722	4106	.	0.71675	0.82751	0.000000e+00	1.127040e-05	1179306	7.892	4.844870e-06	D	13384	0	.	0	607785|613001|601626|613659|608354|614470|163200|108010|162900	0.85894	12	0.000000e+00	ENSG00000133703	0.000000e+00	0	0	0	0.9871709593781199	2	0.43233	0.56997	30232	.	9.831870e-06	0.000000e+00	0.66049645547495	.	0.000000e+00	0.164646	27621	HGNC:6407	A	0	simple_aae	0.995	206404	25245350	GGT	1.000000	.	SCV005094257	0	0.89008	4.239780e-06	0	0	Pathogenic/Likely pathogenic	0.96931	0	0	0	ClinGen:CA122538,UniProtKB:P01116#VAR_016026,OMIM:190070.0005,OMIM:190070.0025	G	0	0.957447700615	Mar 04, 2025	0.772	Oncogenic	0.91737	1	2036	0.98706	0.929049253464	0.9984	0	0.99776655469088438	276	criteria provided, single submitter	35G>A 	1	4.911591355599214E-4	C0349639|C0406612|C0009404|C0040136|C0023467|C0024623|C3661900|C0235974|CN230736|C0919267|C5555857|C4302356|C0007131|C4747394|C2674723|C3854181|C4552097|C0349579|C1516855|C0917804|C0684249|C0334082	0	0	0	0	NM_004985.5	-	.	.	1	0.19106	121913529	2232	9.820481596417489E-6	0.95662	0.79283	0.915	0.0	3944	0.99778840	5.68	.	.	0.000000e+00	0.33373	0.999983137957112	0.78379	D	2680	6112	9462	0.2670	0.84869	p.Gly12Asp	0	0	-14.566	0.897719	0	0.99579	12582	D	30376	KRAS	0.000000e+00	D	0.875	21592	G12D	D	.	0.29757	./.	alternative1																																																																																																				
KRAS_Lys5Asn	0.08584326223585399	0.9339947865923037	3.404403617783895	0.01137409970321642	2025_01_Batch_13-14	0.7643973846320817	0.8256332232634764	0.6737030480655471	0.7182558406829578	0.7185386418366262	0.9116284136781583	0.912010913750465	0.933254336216494	0.9285246539974151	0.6998069022683362	0.83801289915512	0.8688220685069707	0.8034786921410206	0.8233902473401864	0.7091727720524812	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214478	CCSBVarC006087	ALE00006087	NC_000012.12:25245370:T:A	15A>T	Lys5Asn	CEGS2	CegsMutGDEh1038	C11	GDEhDisVCh_40061	C09	1	CegsMutGDDh1038	C11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Lys5Asn	12	25245370	T	A	12											12-25245370-T-A	-	0.6352	1.0	5	.	.	.	12	25398304	A	.	.	12	1_Pathogenic	NC_000012.12	.	Lys5Asn	.	24.6	.	.	.	D	.	4	1	.	.	.	.	.	.	0.91975	Plus_Clinical	0.7261	.	0.90580	.	.	D	D	.	2.91440076523	.	.	.	.	.	0.96255	.	.	.	.	0.80714	.	.	0.97588	0.997	.	0.0	0.913609	2.79	1.0	A	single nucleotide variant	NC_000012.12:g.25245370T>A	.	.	3	0.8948088	.	.	0.95635056	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MeSH:D030342,MedGen:C0950123	.	.	.	.	0.99291	D	0.94198	D	M	6.077792	.	./.	.	.	.	.	not provided|Noonan syndrome|Cardiofaciocutaneous syndrome 2|Inborn genetic diseases	.	0.93439	.	.	-	25245370	.	-	1.824000	.	0.99826	.	.	.	.	germline	.	Gain of catalytic residue at E3 (P = 8e-04)| Loss of methylation at T5 (P = 0.0037)| Loss of ubiquitination at K5 (P = 0.021)| Gain of glycosylation at K2 (P = 0.1048)| Loss of disorder (P = 0.1189)	0.87676	GRCh38	707	reviewed by expert panel	c.15A>T	.	0.55376	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	3	.	RASK_HUMAN	.	100.0	0.614844979912789	.	D	0.96154	0.96346295	-	.	.		.	.	2	.	reviewed_by_expert_panel	0.98658	.	.	.	.	.	p.Lys5Asn	.	0.29148	.	germline	.		T	Apr 03, 2017	.	./.	.	.	1.0	N	12p12.1	.	.	.	SCV000616404	Pathogenic	.	.	Asn	N	-	.	ENSP00000256078	ENST00000256078	.	0.0	.	.	-0.137	T	.	4.203335	0.92967	N	D	-	5.797508	.	0.86630	.	.	.	0.93318	.	25245370	Y	9	.	.	.	P01116	.	0.815684	0.93824		.	0.992	D	.	0.89014167	.	0.79771	3845	0.180387	.	-3.84	.	.	0.91343	.	.	.	.	.	.	0.94534	12	KRAS	.	.	Lys	.	.	12-25245370-T-A	Cardiofaciocutaneous_syndrome_2|not_provided|Noonan_syndrome|Inborn_genetic_diseases	.	.	25289571	ClinGen:CA234191|OMIM:190070.0017|UniProtKB:P01116#VAR_064849	0.371023	0.73972	.	RCV000153427|RCV000520745|RCV000013425|RCV000623267	D	.	.	c.15A>T	.	.	.	0.71872	./.	rs104894361	25245370	.	T	.	P01116	.	0.96861	.	0.68239		.	.	.	2.925	.	.	.	4.55	0.95403	.	D	D	.	.	.	.	.	.	.	1340|648	12594	0.71506	0.99109	0.998155415058136	.	.	0.71675	0.45534	.	.	.	0.726	.	D	.	.	.	.	615278|PS163950	0.25745	12	.	ENSG00000133703	.	.	.	.	0.9939208319203104	3	0.80453	0.56997	.	.	.	.	0.563747131663172	.	.	0.199646	27633	HGNC:6407	A	.	simple_aae	0.995	.	25245370	AAA	1.000000	.	-	.	0.88765	.	.	.	Pathogenic	0.83720	.	.	.	ClinGen:CA234191,UniProtKB:P01116#VAR_064849,OMIM:190070.0017	K	.	0.988022322716	-	0.746	-	0.99419	.	.	0.99388	0.898385763168	0.992	.	0.99859761066323194	.	-	15A>T 	.	.	C3809005|C3661900|C0028326|C0950123	.	.	.	.	NM_033360.4	-	.	.	1	0.69172	104894361	.	.	0.98776	0.72208	0.972	0.0	.	0.99815910	5.68	.	.	.	0.0213364	0.999992346462973	0.84244	D	.	.	.	0.7231	0.90593	p.Lys5Asn	.	.	-11.193	0.89535224	.	0.99831	12594	D	.	KRAS	.	D	0.764	.	K5N	D	0.51050	0.12603	./.	alternative1																																																																																																				
KRAS_Lys5Asn	0.08584326223585399	0.9339947865923037	3.404403617783895	0.01137409970321642	2025_01_Batch_13-14	0.7643973846320817	0.8256332232634764	0.6737030480655471	0.7182558406829578	0.7185386418366262	0.9116284136781583	0.912010913750465	0.933254336216494	0.9285246539974151	0.6998069022683362	0.83801289915512	0.8688220685069707	0.8034786921410206	0.8233902473401864	0.7091727720524812	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006087		NC_000012.12:25245370:T:A		Lys5Asn																												KRAS_Lys5Asn	12	25245370	T	A	12	allele	15A>T	E07	527_CAVA_Array_P03	J13	B13A7A8P1_R1	B14A7A8P1_R2				12-25245370-T-A	-	0.6352	1.0	5	.	.	.	12	25398304	A	.	.	12	1_Pathogenic	NC_000012.12	.	Lys5Asn	.	24.6	.	.	.	D	.	4	1	.	.	.	.	.	.	0.91975	Plus_Clinical	0.7261	.	0.90580	.	.	D	D	.	2.91440076523	.	.	.	.	.	0.96255	.	.	.	.	0.80714	.	.	0.97588	0.997	.	0.0	0.913609	2.79	1.0	A	single nucleotide variant	NC_000012.12:g.25245370T>A	.	.	3	0.8948088	.	.	0.95635056	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340|MeSH:D030342,MedGen:C0950123	.	.	.	.	0.99291	D	0.94198	D	M	6.077792	.	./.	.	.	.	.	not provided|Noonan syndrome|Cardiofaciocutaneous syndrome 2|Inborn genetic diseases	.	0.93439	.	.	-	25245370	.	-	1.824000	.	0.99826	.	.	.	.	germline	.	Gain of catalytic residue at E3 (P = 8e-04)| Loss of methylation at T5 (P = 0.0037)| Loss of ubiquitination at K5 (P = 0.021)| Gain of glycosylation at K2 (P = 0.1048)| Loss of disorder (P = 0.1189)	0.87676	GRCh38	707	reviewed by expert panel	c.15A>T	.	0.55376	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_033360.4(KRAS):c.15A>T (p.Lys5Asn)	3	.	RASK_HUMAN	.	100.0	0.614844979912789	.	D	0.96154	0.96346295	-	.	.		.	.	2	.	reviewed_by_expert_panel	0.98658	.	.	.	.	.	p.Lys5Asn	.	0.29148	.	germline	.		T	Apr 03, 2017	.	./.	.	.	1.0	N	12p12.1	.	.	.	SCV000616404	Pathogenic	.	.	Asn	N	-	.	ENSP00000256078	ENST00000256078	.	0.0	.	.	-0.137	T	.	4.203335	0.92967	N	D	-	5.797508	.	0.86630	.	.	.	0.93318	.	25245370	Y	9	.	.	.	P01116	.	0.815684	0.93824		.	0.992	D	.	0.89014167	.	0.79771	3845	0.180387	.	-3.84	.	.	0.91343	.	.	.	.	.	.	0.94534	12	KRAS	.	.	Lys	.	.	12-25245370-T-A	Cardiofaciocutaneous_syndrome_2|not_provided|Noonan_syndrome|Inborn_genetic_diseases	.	.	25289571	ClinGen:CA234191|OMIM:190070.0017|UniProtKB:P01116#VAR_064849	0.371023	0.73972	.	RCV000153427|RCV000520745|RCV000013425|RCV000623267	D	.	.	c.15A>T	.	.	.	0.71872	./.	rs104894361	25245370	.	T	.	P01116	.	0.96861	.	0.68239		.	.	.	2.925	.	.	.	4.55	0.95403	.	D	D	.	.	.	.	.	.	.	1340|648	12594	0.71506	0.99109	0.998155415058136	.	.	0.71675	0.45534	.	.	.	0.726	.	D	.	.	.	.	615278|PS163950	0.25745	12	.	ENSG00000133703	.	.	.	.	0.9939208319203104	3	0.80453	0.56997	.	.	.	.	0.563747131663172	.	.	0.199646	27633	HGNC:6407	A	.	simple_aae	0.995	.	25245370	AAA	1.000000	.	-	.	0.88765	.	.	.	Pathogenic	0.83720	.	.	.	ClinGen:CA234191,UniProtKB:P01116#VAR_064849,OMIM:190070.0017	K	.	0.988022322716	-	0.746	-	0.99419	.	.	0.99388	0.898385763168	0.992	.	0.99859761066323194	.	-	15A>T 	.	.	C3809005|C3661900|C0028326|C0950123	.	.	.	.	NM_033360.4	-	.	.	1	0.69172	104894361	.	.	0.98776	0.72208	0.972	0.0	.	0.99815910	5.68	.	.	.	0.0213364	0.999992346462973	0.84244	D	.	.	.	0.7231	0.90593	p.Lys5Asn	.	.	-11.193	0.89535224	.	0.99831	12594	D	.	KRAS	.	D	0.764	.	K5N	D	0.51050	0.12603	./.	alternative1																																																																																																				
SHOC2_Gln269Arg	-1.8731767698109718	0.10319517574123058	4.883717454830403	0.001786015443663744	2025_01_Batch_13-14	0.6157670407013233	0.7034325372287237	0.6721865775921672	0.5990108450587132	0.5973191878592183	0.6764018619453296	0.5925631045270634	0.67241443224796	0.5574465641286752	0.6788020234629276	0.6460844513233264	0.6479978208778936	0.6723005049200637	0.5782287045936942	0.6380606056610729	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											
F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	0.6558178130219405	0.6025004035799757	0.5698035918988065	0.6591622700607214	0.5756913680537931	0.42893701875699064	0.5783218019352754	0.6299593146532336	0.6219176204810789	0.3981671099046378	0.5423774158894656	0.5904111027576255	0.59988145327602	0.6405399452709002	0.4869292389792154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A		Val227Ile																												F9_Val227Ile	23	139551220	G	A	X	allele	679G>A	B09	527_CAVA_Array_P02	C18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551220-G-A	-	0.02094	0.0	227	9	0	0	X	138633379	A	1.238270e-05	0	X	2_Benign	NC_000023.11	14	Val227Ile	0	0.194	0	0	1.633450e-04	T	0	1	1	30956	6.966500e-05	.	19009	0.000000e+00	0	0.57011	Select	0.2776	73464	0.02950	0	.	T	T	46797	0.556390487147	0	0	0.000000e+00	0	0	0.14662	13667	33840	0	0.000000e+00	0.02974	5	.	0.34352	0.969	.	95.0	0.725427	0.0673	0.05	A	single nucleotide variant	NC_000023.11:g.139551220G>A	0	12192	2	0.11417206	80344	0	0.15264371	0		9	172253	0	0	0.000000e+00	146	1.615200e-04	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	5	0	0.000000e+00	0	0.16373	B	0.27496	B	N	.	15	G/G	84	0	5702	1211372	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	13134	0.59247	.	.	-	139551220	1.615200e-04	-	-0.575000	0	0.48537	22042	0	895405	0	germline	56953	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.76495	GRCh38	924	criteria provided, single submitter	c.679G>A	0.000000e+00	0.16159	0	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.679G>A (p.Val227Ile)	1	0	FA9_HUMAN	0	5.0	.	0	T	0.07209	0.15264371	+	0.000000e+00	.		9	0.000000e+00	0	27171	criteria_provided,_single_submitter	0.99185	6.223240e-05	0	0.000000e+00	0	45983	p.Val227Ile	0	0.08443	.	germline	5		G	Nov 02, 2020	0	G/G	0	64659	0.012	N	Xq27.1	6962	.	0.000000e+00	SCV002408526	Benign	0	0	Ile	I	-	687	ENSP00000218099	ENST00000218099	13318	1.0	10127	0	0.676	G	0	-0.434396	0.01173	.	T	-	.	.	0.96713	610	0	.	0.00329	0	139551220	Y	10	0	73464	0.000000e+00	P00740	0	0.268576	0.01097		0	0.002	D	64659	0.11417206	30956	0.5403	2158	-0.334459	14	0.55	.	1.563540e-05	0.00968	0.000000e+00	0	57663	0.000000e+00	4355	0	0.27495	X	F9	0.000000e+00	0	Val	10680	1.391920e-04	X-139551220-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	12	138461045	.	.	.	0	RCV002127085	D	0	0	c.679G>A	0	0	0	0.05599	G/G	rs137852242	139551220	12064	G	.	P00740	9951	0.34352	0.000000e+00	0.08389		0	0	0.000000e+00	-0.745	0	0	264690	0.512	0.63869	108	T	T	0	0.000000e+00	0	24	.	0	0	98879	1596936	0.25179	0.52008	0.0151561946545469	2294	.	0.18747	.	0.000000e+00	1.391920e-04	895405	-0.416	5.926750e-05	N	9934	0	3.7780044E-6	0	306900|300807	0.07178	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9149323540622197	1	0.06938	0.18019	19074	1	1.633450e-04	0.000000e+00	.	YES	0.000000e+00	0.621022	1602531	HGNC:3551	N	0	simple_aae	0.219	151854	139551220	GTT	0.000000	.	-	0	0.54669	1.563540e-05	0	0	Benign	0.03887	0	0	0	ClinGen:CA10529819	V	0	0.643927873118	-	0.63	-	0.10159	12	466	0.91414	0.328283965588	0.0705	0	0.24669674744976147	94	-	679G>A 	12	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.40678	137852242	1767	0	0.63820	.	0.111	1.0	2210	0.99916210	5.31	.	.	0.000000e+00	-0.469894	0.115496154533624	0.01745	T	84	4649	7083	-0.7209	0.64798	p.Val227Ile	0	0	-1.977	0.39294234	0	0.44646	1596936	T	24393	F9	0.000000e+00	T	0.260	15997	V227I	T	0.22013	0.76753	G/G	principal1	191910	F9_Popp_2025_heavy_chain_var235115	No											V		679	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Val227Ile		true	c.679G>A						3551.0	139551220.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Val227Ile						I	Nov 02, 2020					missense_variant		227.0			0.0000123826537182	1.029189915641788		Benign	139551220.0	missense_variant		0.26					Reporter			F9_Val227Ile
F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	0.6558178130219405	0.6025004035799757	0.5698035918988065	0.6591622700607214	0.5756913680537931	0.42893701875699064	0.5783218019352754	0.6299593146532336	0.6219176204810789	0.3981671099046378	0.5423774158894656	0.5904111027576255	0.59988145327602	0.6405399452709002	0.4869292389792154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A		Val227Ile																												F9_Val227Ile	23	139551220	G	A	X	allele	679G>A	B09	527_CAVA_Array_P02	C18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551220-G-A	-	0.02094	0.0	227	9	0	0	X	138633379	A	1.238270e-05	0	X	2_Benign	NC_000023.11	14	Val227Ile	0	0.194	0	0	1.633450e-04	T	0	1	1	30956	6.966500e-05	.	19009	0.000000e+00	0	0.57011	Select	0.2776	73464	0.02950	0	.	T	T	46797	0.556390487147	0	0	0.000000e+00	0	0	0.14662	13667	33840	0	0.000000e+00	0.02974	5	.	0.34352	0.969	.	95.0	0.725427	0.0673	0.05	A	single nucleotide variant	NC_000023.11:g.139551220G>A	0	12192	2	0.11417206	80344	0	0.15264371	0		9	172253	0	0	0.000000e+00	146	1.615200e-04	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	5	0	0.000000e+00	0	0.16373	B	0.27496	B	N	.	15	G/G	84	0	5702	1211372	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	13134	0.59247	.	.	-	139551220	1.615200e-04	-	-0.575000	0	0.48537	22042	0	895405	0	germline	56953	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.76495	GRCh38	924	criteria provided, single submitter	c.679G>A	0.000000e+00	0.16159	0	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.679G>A (p.Val227Ile)	1	0	FA9_HUMAN	0	5.0	.	0	T	0.07209	0.15264371	+	0.000000e+00	.		9	0.000000e+00	0	27171	criteria_provided,_single_submitter	0.99185	6.223240e-05	0	0.000000e+00	0	45983	p.Val227Ile	0	0.08443	.	germline	5		G	Nov 02, 2020	0	G/G	0	64659	0.012	N	Xq27.1	6962	.	0.000000e+00	SCV002408526	Benign	0	0	Ile	I	-	687	ENSP00000218099	ENST00000218099	13318	1.0	10127	0	0.676	G	0	-0.434396	0.01173	.	T	-	.	.	0.96713	610	0	.	0.00329	0	139551220	Y	10	0	73464	0.000000e+00	P00740	0	0.268576	0.01097		0	0.002	D	64659	0.11417206	30956	0.5403	2158	-0.334459	14	0.55	.	1.563540e-05	0.00968	0.000000e+00	0	57663	0.000000e+00	4355	0	0.27495	X	F9	0.000000e+00	0	Val	10680	1.391920e-04	X-139551220-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	12	138461045	.	.	.	0	RCV002127085	D	0	0	c.679G>A	0	0	0	0.05599	G/G	rs137852242	139551220	12064	G	.	P00740	9951	0.34352	0.000000e+00	0.08389		0	0	0.000000e+00	-0.745	0	0	264690	0.512	0.63869	108	T	T	0	0.000000e+00	0	24	.	0	0	98879	1596936	0.25179	0.52008	0.0151561946545469	2294	.	0.18747	.	0.000000e+00	1.391920e-04	895405	-0.416	5.926750e-05	N	9934	0	3.7780044E-6	0	306900|300807	0.07178	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9149323540622197	1	0.06938	0.18019	19074	1	1.633450e-04	0.000000e+00	.	YES	0.000000e+00	0.621022	1602531	HGNC:3551	N	0	simple_aae	0.219	151854	139551220	GTT	0.000000	.	-	0	0.54669	1.563540e-05	0	0	Benign	0.03887	0	0	0	ClinGen:CA10529819	V	0	0.643927873118	-	0.63	-	0.10159	12	466	0.91414	0.328283965588	0.0705	0	0.24669674744976147	94	-	679G>A 	12	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.40678	137852242	1767	0	0.63820	.	0.111	1.0	2210	0.99916210	5.31	.	.	0.000000e+00	-0.469894	0.115496154533624	0.01745	T	84	4649	7083	-0.7209	0.64798	p.Val227Ile	0	0	-1.977	0.39294234	0	0.44646	1596936	T	24393	F9	0.000000e+00	T	0.260	15997	V227I	T	0.22013	0.76753	G/G	principal1	219426	F9_Popp_2025_light_chain_var244796	No											V		679	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Val227Ile		true	c.679G>A						3551.0	139551220.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Val227Ile						I	Nov 02, 2020					missense_variant		227.0			0.0000123826537182	1.037087801312708		Benign	139551220.0	missense_variant		0.26					Reporter			F9_Val227Ile
F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	0.6558178130219405	0.6025004035799757	0.5698035918988065	0.6591622700607214	0.5756913680537931	0.42893701875699064	0.5783218019352754	0.6299593146532336	0.6219176204810789	0.3981671099046378	0.5423774158894656	0.5904111027576255	0.59988145327602	0.6405399452709002	0.4869292389792154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A		Val227Ile																												F9_Val227Ile	23	139551220	G	A	X	allele	679G>A	B09	527_CAVA_Array_P02	C18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551220-G-A	-	0.02094	0.0	227	9	0	0	X	138633379	A	1.238270e-05	0	X	2_Benign	NC_000023.11	14	Val227Ile	0	0.194	0	0	1.633450e-04	T	0	1	1	30956	6.966500e-05	.	19009	0.000000e+00	0	0.57011	Select	0.2776	73464	0.02950	0	.	T	T	46797	0.556390487147	0	0	0.000000e+00	0	0	0.14662	13667	33840	0	0.000000e+00	0.02974	5	.	0.34352	0.969	.	95.0	0.725427	0.0673	0.05	A	single nucleotide variant	NC_000023.11:g.139551220G>A	0	12192	2	0.11417206	80344	0	0.15264371	0		9	172253	0	0	0.000000e+00	146	1.615200e-04	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	5	0	0.000000e+00	0	0.16373	B	0.27496	B	N	.	15	G/G	84	0	5702	1211372	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	13134	0.59247	.	.	-	139551220	1.615200e-04	-	-0.575000	0	0.48537	22042	0	895405	0	germline	56953	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.76495	GRCh38	924	criteria provided, single submitter	c.679G>A	0.000000e+00	0.16159	0	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.679G>A (p.Val227Ile)	1	0	FA9_HUMAN	0	5.0	.	0	T	0.07209	0.15264371	+	0.000000e+00	.		9	0.000000e+00	0	27171	criteria_provided,_single_submitter	0.99185	6.223240e-05	0	0.000000e+00	0	45983	p.Val227Ile	0	0.08443	.	germline	5		G	Nov 02, 2020	0	G/G	0	64659	0.012	N	Xq27.1	6962	.	0.000000e+00	SCV002408526	Benign	0	0	Ile	I	-	687	ENSP00000218099	ENST00000218099	13318	1.0	10127	0	0.676	G	0	-0.434396	0.01173	.	T	-	.	.	0.96713	610	0	.	0.00329	0	139551220	Y	10	0	73464	0.000000e+00	P00740	0	0.268576	0.01097		0	0.002	D	64659	0.11417206	30956	0.5403	2158	-0.334459	14	0.55	.	1.563540e-05	0.00968	0.000000e+00	0	57663	0.000000e+00	4355	0	0.27495	X	F9	0.000000e+00	0	Val	10680	1.391920e-04	X-139551220-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	12	138461045	.	.	.	0	RCV002127085	D	0	0	c.679G>A	0	0	0	0.05599	G/G	rs137852242	139551220	12064	G	.	P00740	9951	0.34352	0.000000e+00	0.08389		0	0	0.000000e+00	-0.745	0	0	264690	0.512	0.63869	108	T	T	0	0.000000e+00	0	24	.	0	0	98879	1596936	0.25179	0.52008	0.0151561946545469	2294	.	0.18747	.	0.000000e+00	1.391920e-04	895405	-0.416	5.926750e-05	N	9934	0	3.7780044E-6	0	306900|300807	0.07178	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9149323540622197	1	0.06938	0.18019	19074	1	1.633450e-04	0.000000e+00	.	YES	0.000000e+00	0.621022	1602531	HGNC:3551	N	0	simple_aae	0.219	151854	139551220	GTT	0.000000	.	-	0	0.54669	1.563540e-05	0	0	Benign	0.03887	0	0	0	ClinGen:CA10529819	V	0	0.643927873118	-	0.63	-	0.10159	12	466	0.91414	0.328283965588	0.0705	0	0.24669674744976147	94	-	679G>A 	12	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.40678	137852242	1767	0	0.63820	.	0.111	1.0	2210	0.99916210	5.31	.	.	0.000000e+00	-0.469894	0.115496154533624	0.01745	T	84	4649	7083	-0.7209	0.64798	p.Val227Ile	0	0	-1.977	0.39294234	0	0.44646	1596936	T	24393	F9	0.000000e+00	T	0.260	15997	V227I	T	0.22013	0.76753	G/G	principal1	246942	F9_Popp_2025_strep_2_var264158	No											V		679	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Val227Ile		true	c.679G>A						3551.0	139551220.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Val227Ile						I	Nov 02, 2020					missense_variant		227.0			0.0000123826537182	1.0140900236697072		Benign	139551220.0	missense_variant		0.26					Reporter			F9_Val227Ile
F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	0.6558178130219405	0.6025004035799757	0.5698035918988065	0.6591622700607214	0.5756913680537931	0.42893701875699064	0.5783218019352754	0.6299593146532336	0.6219176204810789	0.3981671099046378	0.5423774158894656	0.5904111027576255	0.59988145327602	0.6405399452709002	0.4869292389792154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A		Val227Ile																												F9_Val227Ile	23	139551220	G	A	X	allele	679G>A	B09	527_CAVA_Array_P02	C18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551220-G-A	-	0.02094	0.0	227	9	0	0	X	138633379	A	1.238270e-05	0	X	2_Benign	NC_000023.11	14	Val227Ile	0	0.194	0	0	1.633450e-04	T	0	1	1	30956	6.966500e-05	.	19009	0.000000e+00	0	0.57011	Select	0.2776	73464	0.02950	0	.	T	T	46797	0.556390487147	0	0	0.000000e+00	0	0	0.14662	13667	33840	0	0.000000e+00	0.02974	5	.	0.34352	0.969	.	95.0	0.725427	0.0673	0.05	A	single nucleotide variant	NC_000023.11:g.139551220G>A	0	12192	2	0.11417206	80344	0	0.15264371	0		9	172253	0	0	0.000000e+00	146	1.615200e-04	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	5	0	0.000000e+00	0	0.16373	B	0.27496	B	N	.	15	G/G	84	0	5702	1211372	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	13134	0.59247	.	.	-	139551220	1.615200e-04	-	-0.575000	0	0.48537	22042	0	895405	0	germline	56953	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.76495	GRCh38	924	criteria provided, single submitter	c.679G>A	0.000000e+00	0.16159	0	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.679G>A (p.Val227Ile)	1	0	FA9_HUMAN	0	5.0	.	0	T	0.07209	0.15264371	+	0.000000e+00	.		9	0.000000e+00	0	27171	criteria_provided,_single_submitter	0.99185	6.223240e-05	0	0.000000e+00	0	45983	p.Val227Ile	0	0.08443	.	germline	5		G	Nov 02, 2020	0	G/G	0	64659	0.012	N	Xq27.1	6962	.	0.000000e+00	SCV002408526	Benign	0	0	Ile	I	-	687	ENSP00000218099	ENST00000218099	13318	1.0	10127	0	0.676	G	0	-0.434396	0.01173	.	T	-	.	.	0.96713	610	0	.	0.00329	0	139551220	Y	10	0	73464	0.000000e+00	P00740	0	0.268576	0.01097		0	0.002	D	64659	0.11417206	30956	0.5403	2158	-0.334459	14	0.55	.	1.563540e-05	0.00968	0.000000e+00	0	57663	0.000000e+00	4355	0	0.27495	X	F9	0.000000e+00	0	Val	10680	1.391920e-04	X-139551220-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	12	138461045	.	.	.	0	RCV002127085	D	0	0	c.679G>A	0	0	0	0.05599	G/G	rs137852242	139551220	12064	G	.	P00740	9951	0.34352	0.000000e+00	0.08389		0	0	0.000000e+00	-0.745	0	0	264690	0.512	0.63869	108	T	T	0	0.000000e+00	0	24	.	0	0	98879	1596936	0.25179	0.52008	0.0151561946545469	2294	.	0.18747	.	0.000000e+00	1.391920e-04	895405	-0.416	5.926750e-05	N	9934	0	3.7780044E-6	0	306900|300807	0.07178	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9149323540622197	1	0.06938	0.18019	19074	1	1.633450e-04	0.000000e+00	.	YES	0.000000e+00	0.621022	1602531	HGNC:3551	N	0	simple_aae	0.219	151854	139551220	GTT	0.000000	.	-	0	0.54669	1.563540e-05	0	0	Benign	0.03887	0	0	0	ClinGen:CA10529819	V	0	0.643927873118	-	0.63	-	0.10159	12	466	0.91414	0.328283965588	0.0705	0	0.24669674744976147	94	-	679G>A 	12	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.40678	137852242	1767	0	0.63820	.	0.111	1.0	2210	0.99916210	5.31	.	.	0.000000e+00	-0.469894	0.115496154533624	0.01745	T	84	4649	7083	-0.7209	0.64798	p.Val227Ile	0	0	-1.977	0.39294234	0	0.44646	1596936	T	24393	F9	0.000000e+00	T	0.260	15997	V227I	T	0.22013	0.76753	G/G	principal1	136878	F9_Popp_2025_carboxy_F9_specific_var225434	No											V		679	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Val227Ile		true	c.679G>A						3551.0	139551220.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Val227Ile						I	Nov 02, 2020					missense_variant		227.0			0.0000123826537182	1.024657254936364		Benign	139551220.0	missense_variant		0.26					Reporter			F9_Val227Ile
F9_Val227Ile	-2.373689508444221	0.049337789284427086	2.6131162566212125	0.03475541658228683	2025_01_Batch_13-14	0.6558178130219405	0.6025004035799757	0.5698035918988065	0.6591622700607214	0.5756913680537931	0.42893701875699064	0.5783218019352754	0.6299593146532336	0.6219176204810789	0.3981671099046378	0.5423774158894656	0.5904111027576255	0.59988145327602	0.6405399452709002	0.4869292389792154	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030567		NC_000023.11:139551220:G:A		Val227Ile																												F9_Val227Ile	23	139551220	G	A	X	allele	679G>A	B09	527_CAVA_Array_P02	C18	B13A7A8P1_R1	B14A7A8P1_R2				X-139551220-G-A	-	0.02094	0.0	227	9	0	0	X	138633379	A	1.238270e-05	0	X	2_Benign	NC_000023.11	14	Val227Ile	0	0.194	0	0	1.633450e-04	T	0	1	1	30956	6.966500e-05	.	19009	0.000000e+00	0	0.57011	Select	0.2776	73464	0.02950	0	.	T	T	46797	0.556390487147	0	0	0.000000e+00	0	0	0.14662	13667	33840	0	0.000000e+00	0.02974	5	.	0.34352	0.969	.	95.0	0.725427	0.0673	0.05	A	single nucleotide variant	NC_000023.11:g.139551220G>A	0	12192	2	0.11417206	80344	0	0.15264371	0		9	172253	0	0	0.000000e+00	146	1.615200e-04	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	5	0	0.000000e+00	0	0.16373	B	0.27496	B	N	.	15	G/G	84	0	5702	1211372	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	13134	0.59247	.	.	-	139551220	1.615200e-04	-	-0.575000	0	0.48537	22042	0	895405	0	germline	56953	Loss of disorder (P = 0.1551)| Loss of sheet (P = 0.1907)| Loss of phosphorylation at T225 (P = 0.2186)| Gain of relative solvent accessibility (P = 0.2363)| Gain of catalytic residue at V228 (P = 0.2612)	0.76495	GRCh38	924	criteria provided, single submitter	c.679G>A	0.000000e+00	0.16159	0	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.679G>A (p.Val227Ile)	1	0	FA9_HUMAN	0	5.0	.	0	T	0.07209	0.15264371	+	0.000000e+00	.		9	0.000000e+00	0	27171	criteria_provided,_single_submitter	0.99185	6.223240e-05	0	0.000000e+00	0	45983	p.Val227Ile	0	0.08443	.	germline	5		G	Nov 02, 2020	0	G/G	0	64659	0.012	N	Xq27.1	6962	.	0.000000e+00	SCV002408526	Benign	0	0	Ile	I	-	687	ENSP00000218099	ENST00000218099	13318	1.0	10127	0	0.676	G	0	-0.434396	0.01173	.	T	-	.	.	0.96713	610	0	.	0.00329	0	139551220	Y	10	0	73464	0.000000e+00	P00740	0	0.268576	0.01097		0	0.002	D	64659	0.11417206	30956	0.5403	2158	-0.334459	14	0.55	.	1.563540e-05	0.00968	0.000000e+00	0	57663	0.000000e+00	4355	0	0.27495	X	F9	0.000000e+00	0	Val	10680	1.391920e-04	X-139551220-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	12	138461045	.	.	.	0	RCV002127085	D	0	0	c.679G>A	0	0	0	0.05599	G/G	rs137852242	139551220	12064	G	.	P00740	9951	0.34352	0.000000e+00	0.08389		0	0	0.000000e+00	-0.745	0	0	264690	0.512	0.63869	108	T	T	0	0.000000e+00	0	24	.	0	0	98879	1596936	0.25179	0.52008	0.0151561946545469	2294	.	0.18747	.	0.000000e+00	1.391920e-04	895405	-0.416	5.926750e-05	N	9934	0	3.7780044E-6	0	306900|300807	0.07178	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9149323540622197	1	0.06938	0.18019	19074	1	1.633450e-04	0.000000e+00	.	YES	0.000000e+00	0.621022	1602531	HGNC:3551	N	0	simple_aae	0.219	151854	139551220	GTT	0.000000	.	-	0	0.54669	1.563540e-05	0	0	Benign	0.03887	0	0	0	ClinGen:CA10529819	V	0	0.643927873118	-	0.63	-	0.10159	12	466	0.91414	0.328283965588	0.0705	0	0.24669674744976147	94	-	679G>A 	12	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.40678	137852242	1767	0	0.63820	.	0.111	1.0	2210	0.99916210	5.31	.	.	0.000000e+00	-0.469894	0.115496154533624	0.01745	T	84	4649	7083	-0.7209	0.64798	p.Val227Ile	0	0	-1.977	0.39294234	0	0.44646	1596936	T	24393	F9	0.000000e+00	T	0.260	15997	V227I	T	0.22013	0.76753	G/G	principal1	164394	F9_Popp_2025_carboxy_gla_motif_var254477	No											V		679	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Val227Ile		true	c.679G>A						3551.0	139551220.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Val227Ile						I	Nov 02, 2020					missense_variant		227.0			0.0000123826537182	1.0573560919262863		Benign	139551220.0	missense_variant		0.26					Reporter			F9_Val227Ile
FH_Ala308Thr	-0.7120971186723563	0.5031403010535435	-11.394484282268747	8.993403746646915e-6	2025_01_Batch_13-14	0.752578540982823	0.9337486622872755	0.9810411602833721	0.9518229092496397	0.7970626847446404	0.6025578030294673	0.9278030839343621	0.984147163271062	0.9551586938342534	0.6860769792243886	0.677568172006145	0.9307758731108188	0.982594161777217	0.9534908015419465	0.7415698319845145	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH		3408		CCSBVarC000454		NC_000001.11:241504228:C:T		Ala308Thr																												FH_Ala308Thr	1	241504228	C	T	1	allele	922G>A	E02	527_CAVA_Array_P03	J03	B13A7A8P1_R1	B14A7A8P1_R2				1-241504228-C-T	-	0.83151	0.996	308	.	.	.	1	241667528	T	.	.	1	1_Pathogenic	NC_000001.11	.	Ala308Thr	.	28.0	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98921	Select	0.9836	.	0.68795	.	.	D	D	.	0.952392643853	.	.	.	.	.	0.72926	.	.	.	.	0.69272	.	.	0.92766	1.0	.	5.0	0.979469	6.28	0.95	T	single nucleotide variant	NC_000001.11:g.241504228C>T	.	.	2	0.86255217	.	.	0.9160993	.		.	.	.	.	.	.	.	.	MedGen:C3661900	.	.	.	.	0.94956	D	0.92251	D	M	11.90403	.	./.	.	.	.	.	not provided	.	0.98315	.	.	-	241504228	.	-	7.627000	.	0.98523	.	.	.	.	germline	.	Gain of glycosylation at A308 (P = 0.0142)| Gain of phosphorylation at A308 (P = 0.0426)| Gain of ubiquitination at K311 (P = 0.1092)| Gain of methylation at K311 (P = 0.1332)| Gain of disorder (P = 0.3258)	0.78347	GRCh38	975	criteria provided, single submitter	c.922G>A	.	0.89714	.	.	.	Fumarate lyase, N-terminal	.	.	P	.	.	NM_000143.4(FH):c.922G>A (p.Ala308Thr)	1	.	FUMH_HUMAN	.	95.0	0.931844876423458	.	D	0.67484	0.9160993	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.93461	.	.	.	.	.	p.Ala308Thr	.	0.62620	.	germline	.		C	Sep 24, 2022	.	./.	.	.	1.0	N	1q43	.	.	.	SCV003523960	Pathogenic	.	.	Thr	T	-	.	ENSP00000355518	ENST00000366560	.	0.0	.	.	0.599	C	.	5.006822	0.83643	D	D	-	13.55806	.	0.98751	.	.	.	0.73841	.	241504228	Y	9	.	.	.	P07954	.	0.976808	0.99334		.	0.958	D	.	0.86255217	.	0.97202	2271	0.554402	.	-3.59	.	.	0.91343	.	.	.	.	.	.	0.92252	1	FH	.	.	Ala	.	.	1-241504228-C-T	not_provided	.	.	239734151	.	0.921872	0.93192	.	RCV001781102	D	.	.	c.922G>A	.	.	.	0.95837	./.	rs121913118	241504228	.	C	.	P07954	.	0.92765	.	0.68239		.	.	.	3.44	.	.	.	5.73	0.99782	.	D	T	.	.	.	.	.	.	.	.	1324397	0.95773	0.72524	0.981637419267628	.	.	0.71675	0.89561	.	.	.	5.666	.	D	.	.	.	.	.	0.67804	1	.	ENSG00000091483	.	.	.	.	0.9325441300373446	1	0.70027	0.05314	.	.	.	.	0.895432979793859	YES	.	0.83885	1314669	HGNC:3700	D	.	simple_aae	0.964	.	241504228	GCT	1.000000	.	-	.	0.93162	.	.	.	Pathogenic	0.85877	.	.	.	ClinGen:CA40327917	A	.	0.973295160969	-	0.647	-	0.93968	.	.	0.93191	0.740001261234	0.5677	.	0.99930399122775604	.	-	922G>A 	.	.	C3661900	.	.	.	.	NM_000143.4	-	.	.	1	0.92945	121913118	.	.	0.97274	0.95345	0.934	0.001	.	0.95155084	5.73	.	.	.	0.558584	0.993749286198762	0.92016	D	.	.	.	1.0591	0.99499	p.Ala308Thr	.	.	-12.206	0.9391092	.	0.90224	1324397	D	.	FH	.	D	0.946	.	A308T	D	0.98834	0.40292	./.	principal1																																																																																																				
SHOC2_Glu13Ala	-3.1184142906339396	0.01688113056320015	-0.28172720498089704	0.7862994852852396	2025_01_Batch_13-14	0.9758010558329374	0.9675799270557529	0.9190054001628293	0.966785908068938	0.8998938874806812	0.7147733879096405	0.6330256924172691	0.5847508451405554	0.5905716697947689	0.7257046416676216	0.845287221871289	0.800302809736511	0.7518781226516924	0.7786787889318535	0.8127992645741514	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											
LMNA_Arg41His	4.266345707886469	0.0037173824125443845	-7.249892521424595	0.00016994557101229237	2025_01_Batch_13-14	0.9685184608031403	0.9546879748106982	0.9518480534400747	0.9287920510754318	0.9546152002699522	0.9361856833297665	0.9459083085923632	0.965736028721621	0.9723880485089806	0.9082688556380418	0.9523520720664533	0.9502981417015307	0.9587920410808479	0.9505900497922062	0.931442027953997	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	LMNA	LMNA		3903		CCSBVarC021100		NC_000001.11:156115040:G:A		Arg41His																												LMNA_Arg41His	1	156115040	G	A	1	allele	122G>A	F09	527_CAVA_Array_P03	L17	B13A7A8P1_R1	B14A7A8P1_R2				1-156115040-G-A	-	0.93103	1.0	41	.	.	.	1	156084831	A	.	.	1	1_Pathogenic	NC_000001.11	.	Arg41His	.	33.0	.	.	.	D	.	2	.	.	.	.	.	.	.	0.98921	.	0.8998	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.86008	.	.	.	.	0.76931	.	.	0.77980	0.996	.	.	.	5.21	.	A	single nucleotide variant	NC_000001.11:g.156115040G>A	.	.	2	0.6304929	.	.	0.8277698	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MedGen:C3661900	.	.	.	.	0.99291	D	0.80513	D	H	11.59756	.	G/G	.	.	.	.	Charcot-Marie-Tooth disease type 2|not provided	.	0.97344	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156115040	.	-	11.667000	.	0.99628	.	.	.	.	germline	.	Loss of disorder (P = 0.0408)| Loss of MoRF binding (P = 0.0657)| Loss of stability (P = 0.0853)| Gain of catalytic residue at Y45 (P = 0.2364)| Gain of phosphorylation at Y45 (P = 0.3525)	0.94511	GRCh38	420	criteria provided, multiple submitters, no conflicts	.	.	0.60376	.	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	.	.	.	NM_170707.4(LMNA):c.122G>A (p.Arg41His)	2	.	LMNA_HUMAN	.	.	0.920677880494411	.	.	0.93873	0.7031715	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99953	.	.	.	.	.	.	.	0.94064	.	germline	.		G	Mar 14, 2023	.	G/G	.	.	1.0	N	1q22	.	.	.	SCV000548863|SCV001147454	Pathogenic	.	.	His	H	-	.	ENSP00000502256	ENST00000675939	.	.	.	.	0.59	G	.	5.697397	0.79703	D	.	-	11.77651	.	0.97514	.	.	.	0.95146	.	156115040	Y	10	.	.	.	P02545	.	0.981432	0.99734		.	0.997	D	.	0.67164475	.	0.76032	4000	0.543151	.	.	.	.	0.78662	.	.	.	.	.	.	0.78213	1	LMNA	.	.	Arg	.	.	1-156115040-G-A	Charcot-Marie-Tooth_disease_type_2|not_provided	.	.	154351455	ClinGen:CA16609885	0.969077	0.92694	.	RCV000457713|RCV000994129	.	.	.	c.122G>A	.	.	.	0.95472	G/G	rs1060502215	156115040	.	G	.	P02545	.	0.85561	.	0.68239		.	.	.	3.65	.	.	.	4.77	0.99855	.	D	D	.	.	.	.	.	.	.	64746	408994	0.95404	0.96618	0.998799562454224	.	.	0.71675	0.99147	.	.	.	9.725	.	.	.	.	.	.	.	0.9802	1	.	ENSG00000160789	.	.	.	.	.	2	0.86259	0.81453	.	.	.	.	0.8501245464411	.	.	0.697456	390827	HGNC:6636	.	.	.	0.989	.	156115040	CGC	1.000000	.	-	.	0.95527	.	.	.	Pathogenic	0.83363	.	.	.	ClinGen:CA16609885	R	.	.	-	0.839	-	0.94442	.	.	0.99019	0.826536655426	.	.	0.99939450855587175	.	-	122G>A 	.	.	C0270914|C3661900	.	.	.	.	NM_170707.4	-	.	.	1	0.60605	1060502215	.	.	0.98195	0.92984	.	.	.	0.99995460	4.77	.	.	.	0.542423	0.999670505958946	0.94095	D	.	.	.	1.0096	0.96669	p.Arg41His	.	.	-11.691	.	.	0.97434	408994	D	.	LMNA	.	D	.	.	R41H	.	0.92006	0.31918	G/G	principal1																																																																																																				
CTCF_Pro643Ser	-1.7124595339057247	0.13054179486316442	1.7682708607040438	0.1203399615971312	2025_01_Batch_13-14	0.5445619721105004	0.6598887700312495	0.600793935814599	0.6456517057217984	0.47991567103928157	0.6683800679644131	0.7041990439999969	0.5319774876104315	0.5987681854550634	0.6621843567519261	0.6064710200374568	0.6820439070156232	0.5663857117125153	0.6222099455884309	0.5710500138956038	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF		6173		CCSBVarC010816		NC_000016.10:67636779:C:T		Pro643Ser																												CTCF_Pro643Ser	16	67636779	C	T	16	allele	1927C>T	E02	527_CAVA_Array_P02	I04	B13A7A8P1_R1	B14A7A8P1_R2				16-67636779-C-T	-	0.76095	0.993	643	434	2	0	16	67670682	T	4.683900e-03	9	16	2_Benign	NC_000016.10	7107	Pro643Ser	0	26.4	0	11	4.503970e-03	T	20	12	.	42284	2.210420e-03	0	29276	0.000000e+00	2	0.47884	.	0.0334	101466	0.65587	21	0.0	T	T	63952	.	0.001166242578456319	0	0.000000e+00	2	2	0.53464	16122	44268	4	0.000000e+00	0.13539	205	.	0.11430	0.99	0.0	.	.	.	.	T	single nucleotide variant	NC_000016.10:g.67636779C>T	0	16706	2	0.12383783	106748	0	0.048771452	0		481	231178	2	0	0.000000e+00	796	4.848170e-03	0	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MeSH:D030342,MedGen:C0950123|	221	7	0.000000e+00	0	0.81345	D	0.30913	D	L	6.303452	7521	C/C	360	70	7038	1605712	not specified|not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|Inborn genetic diseases|CTCF-related disorder	15880	0.01844	1	.	-	67636779	4.848170e-03	-	7.668000	14	0.41634	29508	0.002066115702479339	1176036	0	germline;unknown	89172	.	.	GRCh38	50	criteria provided, multiple submitters, no conflicts	c.1927C>T	0.000000e+00	0.97795	1075	0	0	.	1.795760e-04	8772	.	0	6.777820e-05	NM_006565.4(CTCF):c.1927C>T (p.Pro643Ser)	2	0	CTCF_HUMAN	0	.	0.635361922304199	21	.	0.19907	0.057762917	+	5.683430e-04	0		434	0.000000e+00	0	32292	criteria_provided,_multiple_submitters,_no_conflicts	0.82312	2.070300e-03	22	0.000000e+00	0	58944	p.Pro643Ser	0	0.64675	.	germline	205		C	Nov 01, 2024	0	C/C	1	88384	1.0	N	16q22.1	194484	.	8.816120e-04	SCV000247133|SCV000511014|SCV000706245|SCV000847384|SCV001096543|SCV001140120|SCV001855650|SCV002497922|SCV005218571	Benign/Likely_benign	0	0	Ser	S	-	912	ENSP00000494538	ENST00000646076	17100	.	12828	2	0.599	C	0	4.725224	0.43323	D	.	-	7.695614	.	0.44775	968	0	0.0	0.02675	0	67636779	Y	10	0	101466	0.000000e+00	P49711	0	0.358122	0.97950		2	0.968	T	88384	0.12885952	42284	0.65338	10664	-0.428226	7107	.	0.0	6.043180e-03	0.36067	0.000000e+00	2	74680	0.000000e+00	6046	4	0.29781	16	CTCF	9.507230e-04	0	Pro	230128	4.910390e-03	16-67636779-C-T	not_specified|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder|not_provided|Inborn_genetic_diseases	0	457	66228183	ClinGen:CA207677	0.770006	0.75292	20	RCV000193895|RCV000427860|RCV000989613|RCV002314799|RCV004530110	T	0	0	c.1927C>T	0	0	26	0.01423	C/C	rs145727304	67636779	14564	C	1.9968051118210862E-4	.	15048	0.08473	3.241340e-04	0.68239		0	1	0.000000e+00	1.75	0	992	264690	6.03	0.72301	6394	T	T	11	7.342140e-04	0	1848	.	0	3	363611	210800	0.34534	0.88493	0.0343362705906861	9792	1	0.71675	0.70400	6.503160e-04	4.910390e-03	1176036	6.114	2.374610e-03	.	13394	1	0.0029468434	0	615502	0.71317	16	7.552870e-04	ENSG00000102974	4.065550e-04	0.005100676662347545	0	0	0.4567110836694177	1	0.71743	0.97656	29358	780	4.503970e-03	9.161240e-04	0.69695071304512	.	4.485710e-05	0.022134	208297	HGNC:13723	.	0	.	0.169	202560	67636779	CCA	1.000000	0	-	0.0011233660130718953	0.00193	6.043180e-03	11	0	Benign/Likely benign	0.42817	0	0	54	ClinGen:CA207677	P	0	.	-	.	-	0.50538	511	17414	0.45390	0.604438900948	.	0	0.99909288397707574	280	-	1927C>T 	457	0.004019754220741932	CN169374|C3809686|C3661900|C0950123	0	0	0	0	NM_006565.4	-	0	0.001440922190201729	0	0.58028	145727304	2306	0.004671313356045331	0.36087	0.82049	.	.	9432	0.51967055	6.03	.	.	0.000000e+00	-0.387077	0.950983739944161	0.45271	T	4546	6170	9506	-1.1289	0.14266	p.Pro643Ser	0	0	-5.595	0.008668512	71	0.80561	210800	T	28602	CTCF	5.582430e-04	T	.	21596	.	.	.	0.40292	C/C	principal4																																																																																																				
CTCF_Pro643Ser	-1.7124595339057247	0.13054179486316442	1.7682708607040438	0.1203399615971312	2025_01_Batch_13-14	0.5445619721105004	0.6598887700312495	0.600793935814599	0.6456517057217984	0.47991567103928157	0.6683800679644131	0.7041990439999969	0.5319774876104315	0.5987681854550634	0.6621843567519261	0.6064710200374568	0.6820439070156232	0.5663857117125153	0.6222099455884309	0.5710500138956038	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF				CCSBVarC010816	ALE00008908	NC_000016.10:67636779:C:T	1927C>T	Pro643Ser	CAVA																											CTCF_Pro643Ser	16	67636779	C	T	16								1	1	1	16-67636779-C-T	-	0.76095	0.993	643	434	2	0	16	67670682	T	4.683900e-03	9	16	2_Benign	NC_000016.10	7107	Pro643Ser	0	26.4	0	11	4.503970e-03	T	20	12	.	42284	2.210420e-03	0	29276	0.000000e+00	2	0.47884	.	0.0334	101466	0.65587	21	0.0	T	T	63952	.	0.001166242578456319	0	0.000000e+00	2	2	0.53464	16122	44268	4	0.000000e+00	0.13539	205	.	0.11430	0.99	0.0	.	.	.	.	T	single nucleotide variant	NC_000016.10:g.67636779C>T	0	16706	2	0.12383783	106748	0	0.048771452	0		481	231178	2	0	0.000000e+00	796	4.848170e-03	0	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611|MeSH:D030342,MedGen:C0950123|	221	7	0.000000e+00	0	0.81345	D	0.30913	D	L	6.303452	7521	C/C	360	70	7038	1605712	not specified|not provided|Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome|Inborn genetic diseases|CTCF-related disorder	15880	0.01844	1	.	-	67636779	4.848170e-03	-	7.668000	14	0.41634	29508	0.002066115702479339	1176036	0	germline;unknown	89172	.	.	GRCh38	50	criteria provided, multiple submitters, no conflicts	c.1927C>T	0.000000e+00	0.97795	1075	0	0	.	1.795760e-04	8772	.	0	6.777820e-05	NM_006565.4(CTCF):c.1927C>T (p.Pro643Ser)	2	0	CTCF_HUMAN	0	.	0.635361922304199	21	.	0.19907	0.057762917	+	5.683430e-04	0		434	0.000000e+00	0	32292	criteria_provided,_multiple_submitters,_no_conflicts	0.82312	2.070300e-03	22	0.000000e+00	0	58944	p.Pro643Ser	0	0.64675	.	germline	205		C	Nov 01, 2024	0	C/C	1	88384	1.0	N	16q22.1	194484	.	8.816120e-04	SCV000247133|SCV000511014|SCV000706245|SCV000847384|SCV001096543|SCV001140120|SCV001855650|SCV002497922|SCV005218571	Benign/Likely_benign	0	0	Ser	S	-	912	ENSP00000494538	ENST00000646076	17100	.	12828	2	0.599	C	0	4.725224	0.43323	D	.	-	7.695614	.	0.44775	968	0	0.0	0.02675	0	67636779	Y	10	0	101466	0.000000e+00	P49711	0	0.358122	0.97950		2	0.968	T	88384	0.12885952	42284	0.65338	10664	-0.428226	7107	.	0.0	6.043180e-03	0.36067	0.000000e+00	2	74680	0.000000e+00	6046	4	0.29781	16	CTCF	9.507230e-04	0	Pro	230128	4.910390e-03	16-67636779-C-T	not_specified|Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome|CTCF-related_disorder|not_provided|Inborn_genetic_diseases	0	457	66228183	ClinGen:CA207677	0.770006	0.75292	20	RCV000193895|RCV000427860|RCV000989613|RCV002314799|RCV004530110	T	0	0	c.1927C>T	0	0	26	0.01423	C/C	rs145727304	67636779	14564	C	1.9968051118210862E-4	.	15048	0.08473	3.241340e-04	0.68239		0	1	0.000000e+00	1.75	0	992	264690	6.03	0.72301	6394	T	T	11	7.342140e-04	0	1848	.	0	3	363611	210800	0.34534	0.88493	0.0343362705906861	9792	1	0.71675	0.70400	6.503160e-04	4.910390e-03	1176036	6.114	2.374610e-03	.	13394	1	0.0029468434	0	615502	0.71317	16	7.552870e-04	ENSG00000102974	4.065550e-04	0.005100676662347545	0	0	0.4567110836694177	1	0.71743	0.97656	29358	780	4.503970e-03	9.161240e-04	0.69695071304512	.	4.485710e-05	0.022134	208297	HGNC:13723	.	0	.	0.169	202560	67636779	CCA	1.000000	0	-	0.0011233660130718953	0.00193	6.043180e-03	11	0	Benign/Likely benign	0.42817	0	0	54	ClinGen:CA207677	P	0	.	-	.	-	0.50538	511	17414	0.45390	0.604438900948	.	0	0.99909288397707574	280	-	1927C>T 	457	0.004019754220741932	CN169374|C3809686|C3661900|C0950123	0	0	0	0	NM_006565.4	-	0	0.001440922190201729	0	0.58028	145727304	2306	0.004671313356045331	0.36087	0.82049	.	.	9432	0.51967055	6.03	.	.	0.000000e+00	-0.387077	0.950983739944161	0.45271	T	4546	6170	9506	-1.1289	0.14266	p.Pro643Ser	0	0	-5.595	0.008668512	71	0.80561	210800	T	28602	CTCF	5.582430e-04	T	.	21596	.	.	.	0.40292	C/C	principal4																																																																																																				
F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu79Asp	23	139537158	A	C	X											X-139537158-A-C	-	0.55032	0.994	79	.	.	.	X	138619317	C	.	.	X	1_Pathogenic	NC_000023.11	.	Glu79Asp	.	23.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97356	Select	0.9746	.	0.66535	.	.	D	D	.	0.409842432222	0	.	.	.	.	0.60380	.	.	.	.	0.53117	.	.	0.97710	0.986	.	15.0	0.824718	.	0.85	C	single nucleotide variant	NC_000023.11:g.139537158A>C	.	.	1	0.9036028	.	0	0.95628124	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.95767	D	H	.	.	A/A	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99298	.	.	-	139537158	.	-	7.954000	.	0.95445	.	0	.	.	germline	.	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.99639	GRCh38	924	no assertion criteria provided	c.237A>C	.	0.45905	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	0	.	NM_000133.4(F9):c.237A>C (p.Glu79Asp)		.	FA9_HUMAN	.	85.0	.	.	T	0.72962	0.96466774	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu79Asp	.	0.75935	.	germline	.		A	Sep 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	78	.	.	SCV000031551	Pathogenic	.	.	Asp	D	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	3.810108	0.66047	.	D	-	.	.	0.99393	0	.	.	0.86625	0	139537158	Y	9	0	.	.	P00740	.	0.969314	0.22783		.	0.962	D	.	0.9119187	.	0.61779	2158	0.676114	.	-2.37	.	.	0.91343	.	.	.	.	.	.	0.95166	X	F9	.	0	Glu	660	.	X-139537158-A-C	Hereditary_factor_IX_deficiency_disease	.	.	138446983	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	.	.	.	RCV000011320	D	.	.	c.237A>C	.	.	.	0.99906	A/A	rs137852229	139537158	.	A	.	P00740	.	0.96853	.	0.68239		.	.	.	3.63	0	0	.	4.02	0.99654	34	D	T	.	.	0	0	.	.	.	98879	10574	0.99905	0.41506	0.995045900344849	434	.	0.71675	.	.	.	.	1.126	.	N	.	.	.	0	306900	0.31059	X	.	ENSG00000101981	.	0	.	0	0.9717501412150729	3	0.70672	0.18019	.	.	.	.	.	YES	.	0.918148	25613	HGNC:3551	A	.	simple_aae	0.912	.	139537158	GAA	1.000000	.	-	0	0.99023	.	0	.	Pathogenic	0.61484	.	.	.	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	E	.	0.999777502907	-	0.964	-	0.85520	.	108	0.97149	0.653217494488	0.6918	.	0.92958632986930401	6	-	237A>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48513	137852229	.	0	0.99977	.	0.688	0.011	434	0.99999140	5.19	.	.	.	0.733415	0.99825584643864	0.93919	D	34	.	.	1.0915	0.99205	p.Glu79Asp	0	.	-8.05	0.9869484	.	0.94179	10574	D	.	F9	.	D	0.904	.	E79D	D	.	0.943	A/A	principal1	238164	F9_Popp_2025_strep_2_var261066	No											E		237	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Glu79Asp		true	c.237A>C						3551.0	139537158.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Glu79Asp						D	Sep 01, 1989					missense_variant		79.0				1.1083447740611316		Pathogenic	139537158.0	missense_variant		0.904					Reporter			F9_Glu79Asp
F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu79Asp	23	139537158	A	C	X											X-139537158-A-C	-	0.55032	0.994	79	.	.	.	X	138619317	C	.	.	X	1_Pathogenic	NC_000023.11	.	Glu79Asp	.	23.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97356	Select	0.9746	.	0.66535	.	.	D	D	.	0.409842432222	0	.	.	.	.	0.60380	.	.	.	.	0.53117	.	.	0.97710	0.986	.	15.0	0.824718	.	0.85	C	single nucleotide variant	NC_000023.11:g.139537158A>C	.	.	1	0.9036028	.	0	0.95628124	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.95767	D	H	.	.	A/A	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99298	.	.	-	139537158	.	-	7.954000	.	0.95445	.	0	.	.	germline	.	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.99639	GRCh38	924	no assertion criteria provided	c.237A>C	.	0.45905	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	0	.	NM_000133.4(F9):c.237A>C (p.Glu79Asp)		.	FA9_HUMAN	.	85.0	.	.	T	0.72962	0.96466774	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu79Asp	.	0.75935	.	germline	.		A	Sep 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	78	.	.	SCV000031551	Pathogenic	.	.	Asp	D	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	3.810108	0.66047	.	D	-	.	.	0.99393	0	.	.	0.86625	0	139537158	Y	9	0	.	.	P00740	.	0.969314	0.22783		.	0.962	D	.	0.9119187	.	0.61779	2158	0.676114	.	-2.37	.	.	0.91343	.	.	.	.	.	.	0.95166	X	F9	.	0	Glu	660	.	X-139537158-A-C	Hereditary_factor_IX_deficiency_disease	.	.	138446983	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	.	.	.	RCV000011320	D	.	.	c.237A>C	.	.	.	0.99906	A/A	rs137852229	139537158	.	A	.	P00740	.	0.96853	.	0.68239		.	.	.	3.63	0	0	.	4.02	0.99654	34	D	T	.	.	0	0	.	.	.	98879	10574	0.99905	0.41506	0.995045900344849	434	.	0.71675	.	.	.	.	1.126	.	N	.	.	.	0	306900	0.31059	X	.	ENSG00000101981	.	0	.	0	0.9717501412150729	3	0.70672	0.18019	.	.	.	.	.	YES	.	0.918148	25613	HGNC:3551	A	.	simple_aae	0.912	.	139537158	GAA	1.000000	.	-	0	0.99023	.	0	.	Pathogenic	0.61484	.	.	.	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	E	.	0.999777502907	-	0.964	-	0.85520	.	108	0.97149	0.653217494488	0.6918	.	0.92958632986930401	6	-	237A>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48513	137852229	.	0	0.99977	.	0.688	0.011	434	0.99999140	5.19	.	.	.	0.733415	0.99825584643864	0.93919	D	34	.	.	1.0915	0.99205	p.Glu79Asp	0	.	-8.05	0.9869484	.	0.94179	10574	D	.	F9	.	D	0.904	.	E79D	D	.	0.943	A/A	principal1	128100	F9_Popp_2025_carboxy_F9_specific_var222342	No											E		237	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Glu79Asp		true	c.237A>C						3551.0	139537158.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Glu79Asp						D	Sep 01, 1989					missense_variant		79.0				1.071385309115317		Pathogenic	139537158.0	missense_variant		0.904					Reporter			F9_Glu79Asp
F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu79Asp	23	139537158	A	C	X											X-139537158-A-C	-	0.55032	0.994	79	.	.	.	X	138619317	C	.	.	X	1_Pathogenic	NC_000023.11	.	Glu79Asp	.	23.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97356	Select	0.9746	.	0.66535	.	.	D	D	.	0.409842432222	0	.	.	.	.	0.60380	.	.	.	.	0.53117	.	.	0.97710	0.986	.	15.0	0.824718	.	0.85	C	single nucleotide variant	NC_000023.11:g.139537158A>C	.	.	1	0.9036028	.	0	0.95628124	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.95767	D	H	.	.	A/A	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99298	.	.	-	139537158	.	-	7.954000	.	0.95445	.	0	.	.	germline	.	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.99639	GRCh38	924	no assertion criteria provided	c.237A>C	.	0.45905	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	0	.	NM_000133.4(F9):c.237A>C (p.Glu79Asp)		.	FA9_HUMAN	.	85.0	.	.	T	0.72962	0.96466774	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu79Asp	.	0.75935	.	germline	.		A	Sep 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	78	.	.	SCV000031551	Pathogenic	.	.	Asp	D	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	3.810108	0.66047	.	D	-	.	.	0.99393	0	.	.	0.86625	0	139537158	Y	9	0	.	.	P00740	.	0.969314	0.22783		.	0.962	D	.	0.9119187	.	0.61779	2158	0.676114	.	-2.37	.	.	0.91343	.	.	.	.	.	.	0.95166	X	F9	.	0	Glu	660	.	X-139537158-A-C	Hereditary_factor_IX_deficiency_disease	.	.	138446983	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	.	.	.	RCV000011320	D	.	.	c.237A>C	.	.	.	0.99906	A/A	rs137852229	139537158	.	A	.	P00740	.	0.96853	.	0.68239		.	.	.	3.63	0	0	.	4.02	0.99654	34	D	T	.	.	0	0	.	.	.	98879	10574	0.99905	0.41506	0.995045900344849	434	.	0.71675	.	.	.	.	1.126	.	N	.	.	.	0	306900	0.31059	X	.	ENSG00000101981	.	0	.	0	0.9717501412150729	3	0.70672	0.18019	.	.	.	.	.	YES	.	0.918148	25613	HGNC:3551	A	.	simple_aae	0.912	.	139537158	GAA	1.000000	.	-	0	0.99023	.	0	.	Pathogenic	0.61484	.	.	.	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	E	.	0.999777502907	-	0.964	-	0.85520	.	108	0.97149	0.653217494488	0.6918	.	0.92958632986930401	6	-	237A>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48513	137852229	.	0	0.99977	.	0.688	0.011	434	0.99999140	5.19	.	.	.	0.733415	0.99825584643864	0.93919	D	34	.	.	1.0915	0.99205	p.Glu79Asp	0	.	-8.05	0.9869484	.	0.94179	10574	D	.	F9	.	D	0.904	.	E79D	D	.	0.943	A/A	principal1	183132	F9_Popp_2025_heavy_chain_var232023	No											E		237	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Glu79Asp		true	c.237A>C						3551.0	139537158.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Glu79Asp						D	Sep 01, 1989					missense_variant		79.0				1.1370137533445022		Pathogenic	139537158.0	missense_variant		0.904					Reporter			F9_Glu79Asp
F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu79Asp	23	139537158	A	C	X											X-139537158-A-C	-	0.55032	0.994	79	.	.	.	X	138619317	C	.	.	X	1_Pathogenic	NC_000023.11	.	Glu79Asp	.	23.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97356	Select	0.9746	.	0.66535	.	.	D	D	.	0.409842432222	0	.	.	.	.	0.60380	.	.	.	.	0.53117	.	.	0.97710	0.986	.	15.0	0.824718	.	0.85	C	single nucleotide variant	NC_000023.11:g.139537158A>C	.	.	1	0.9036028	.	0	0.95628124	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.95767	D	H	.	.	A/A	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99298	.	.	-	139537158	.	-	7.954000	.	0.95445	.	0	.	.	germline	.	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.99639	GRCh38	924	no assertion criteria provided	c.237A>C	.	0.45905	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	0	.	NM_000133.4(F9):c.237A>C (p.Glu79Asp)		.	FA9_HUMAN	.	85.0	.	.	T	0.72962	0.96466774	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu79Asp	.	0.75935	.	germline	.		A	Sep 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	78	.	.	SCV000031551	Pathogenic	.	.	Asp	D	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	3.810108	0.66047	.	D	-	.	.	0.99393	0	.	.	0.86625	0	139537158	Y	9	0	.	.	P00740	.	0.969314	0.22783		.	0.962	D	.	0.9119187	.	0.61779	2158	0.676114	.	-2.37	.	.	0.91343	.	.	.	.	.	.	0.95166	X	F9	.	0	Glu	660	.	X-139537158-A-C	Hereditary_factor_IX_deficiency_disease	.	.	138446983	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	.	.	.	RCV000011320	D	.	.	c.237A>C	.	.	.	0.99906	A/A	rs137852229	139537158	.	A	.	P00740	.	0.96853	.	0.68239		.	.	.	3.63	0	0	.	4.02	0.99654	34	D	T	.	.	0	0	.	.	.	98879	10574	0.99905	0.41506	0.995045900344849	434	.	0.71675	.	.	.	.	1.126	.	N	.	.	.	0	306900	0.31059	X	.	ENSG00000101981	.	0	.	0	0.9717501412150729	3	0.70672	0.18019	.	.	.	.	.	YES	.	0.918148	25613	HGNC:3551	A	.	simple_aae	0.912	.	139537158	GAA	1.000000	.	-	0	0.99023	.	0	.	Pathogenic	0.61484	.	.	.	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	E	.	0.999777502907	-	0.964	-	0.85520	.	108	0.97149	0.653217494488	0.6918	.	0.92958632986930401	6	-	237A>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48513	137852229	.	0	0.99977	.	0.688	0.011	434	0.99999140	5.19	.	.	.	0.733415	0.99825584643864	0.93919	D	34	.	.	1.0915	0.99205	p.Glu79Asp	0	.	-8.05	0.9869484	.	0.94179	10574	D	.	F9	.	D	0.904	.	E79D	D	.	0.943	A/A	principal1	210648	F9_Popp_2025_light_chain_var241704	No											E		237	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Glu79Asp		true	c.237A>C						3551.0	139537158.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Glu79Asp						D	Sep 01, 1989					missense_variant		79.0				1.1215083178570668		Pathogenic	139537158.0	missense_variant		0.904					Reporter			F9_Glu79Asp
F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	NC_000023.11:139537158:A:C	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Glu79Asp	23	139537158	A	C	X											X-139537158-A-C	-	0.55032	0.994	79	.	.	.	X	138619317	C	.	.	X	1_Pathogenic	NC_000023.11	.	Glu79Asp	.	23.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97356	Select	0.9746	.	0.66535	.	.	D	D	.	0.409842432222	0	.	.	.	.	0.60380	.	.	.	.	0.53117	.	.	0.97710	0.986	.	15.0	0.824718	.	0.85	C	single nucleotide variant	NC_000023.11:g.139537158A>C	.	.	1	0.9036028	.	0	0.95628124	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.95767	D	H	.	.	A/A	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99298	.	.	-	139537158	.	-	7.954000	.	0.95445	.	0	.	.	germline	.	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.99639	GRCh38	924	no assertion criteria provided	c.237A>C	.	0.45905	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	0	.	NM_000133.4(F9):c.237A>C (p.Glu79Asp)		.	FA9_HUMAN	.	85.0	.	.	T	0.72962	0.96466774	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu79Asp	.	0.75935	.	germline	.		A	Sep 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	78	.	.	SCV000031551	Pathogenic	.	.	Asp	D	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	3.810108	0.66047	.	D	-	.	.	0.99393	0	.	.	0.86625	0	139537158	Y	9	0	.	.	P00740	.	0.969314	0.22783		.	0.962	D	.	0.9119187	.	0.61779	2158	0.676114	.	-2.37	.	.	0.91343	.	.	.	.	.	.	0.95166	X	F9	.	0	Glu	660	.	X-139537158-A-C	Hereditary_factor_IX_deficiency_disease	.	.	138446983	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	.	.	.	RCV000011320	D	.	.	c.237A>C	.	.	.	0.99906	A/A	rs137852229	139537158	.	A	.	P00740	.	0.96853	.	0.68239		.	.	.	3.63	0	0	.	4.02	0.99654	34	D	T	.	.	0	0	.	.	.	98879	10574	0.99905	0.41506	0.995045900344849	434	.	0.71675	.	.	.	.	1.126	.	N	.	.	.	0	306900	0.31059	X	.	ENSG00000101981	.	0	.	0	0.9717501412150729	3	0.70672	0.18019	.	.	.	.	.	YES	.	0.918148	25613	HGNC:3551	A	.	simple_aae	0.912	.	139537158	GAA	1.000000	.	-	0	0.99023	.	0	.	Pathogenic	0.61484	.	.	.	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	E	.	0.999777502907	-	0.964	-	0.85520	.	108	0.97149	0.653217494488	0.6918	.	0.92958632986930401	6	-	237A>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48513	137852229	.	0	0.99977	.	0.688	0.011	434	0.99999140	5.19	.	.	.	0.733415	0.99825584643864	0.93919	D	34	.	.	1.0915	0.99205	p.Glu79Asp	0	.	-8.05	0.9869484	.	0.94179	10574	D	.	F9	.	D	0.904	.	E79D	D	.	0.943	A/A	principal1	155616	F9_Popp_2025_carboxy_gla_motif_var251385	No											E		237	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Glu79Asp		true	c.237A>C						3551.0	139537158.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Glu79Asp						D	Sep 01, 1989					missense_variant		79.0				1.2205893016605571		Pathogenic	139537158.0	missense_variant		0.904					Reporter			F9_Glu79Asp
F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004375		NC_000023.11:139537158:A:C		Glu79Asp																												F9_Glu79Asp	23	139537158	A	C	X	allele	237A>C	G06	527_CAVA_Array_P02	M12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537158-A-C	-	0.55032	0.994	79	.	.	.	X	138619317	C	.	.	X	1_Pathogenic	NC_000023.11	.	Glu79Asp	.	23.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97356	Select	0.9746	.	0.66535	.	.	D	D	.	0.409842432222	0	.	.	.	.	0.60380	.	.	.	.	0.53117	.	.	0.97710	0.986	.	15.0	0.824718	.	0.85	C	single nucleotide variant	NC_000023.11:g.139537158A>C	.	.	1	0.9036028	.	0	0.95628124	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.95767	D	H	.	.	A/A	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99298	.	.	-	139537158	.	-	7.954000	.	0.95445	.	0	.	.	germline	.	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.99639	GRCh38	924	no assertion criteria provided	c.237A>C	.	0.45905	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	0	.	NM_000133.4(F9):c.237A>C (p.Glu79Asp)		.	FA9_HUMAN	.	85.0	.	.	T	0.72962	0.96466774	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu79Asp	.	0.75935	.	germline	.		A	Sep 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	78	.	.	SCV000031551	Pathogenic	.	.	Asp	D	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	3.810108	0.66047	.	D	-	.	.	0.99393	0	.	.	0.86625	0	139537158	Y	9	0	.	.	P00740	.	0.969314	0.22783		.	0.962	D	.	0.9119187	.	0.61779	2158	0.676114	.	-2.37	.	.	0.91343	.	.	.	.	.	.	0.95166	X	F9	.	0	Glu	660	.	X-139537158-A-C	Hereditary_factor_IX_deficiency_disease	.	.	138446983	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	.	.	.	RCV000011320	D	.	.	c.237A>C	.	.	.	0.99906	A/A	rs137852229	139537158	.	A	.	P00740	.	0.96853	.	0.68239		.	.	.	3.63	0	0	.	4.02	0.99654	34	D	T	.	.	0	0	.	.	.	98879	10574	0.99905	0.41506	0.995045900344849	434	.	0.71675	.	.	.	.	1.126	.	N	.	.	.	0	306900	0.31059	X	.	ENSG00000101981	.	0	.	0	0.9717501412150729	3	0.70672	0.18019	.	.	.	.	.	YES	.	0.918148	25613	HGNC:3551	A	.	simple_aae	0.912	.	139537158	GAA	1.000000	.	-	0	0.99023	.	0	.	Pathogenic	0.61484	.	.	.	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	E	.	0.999777502907	-	0.964	-	0.85520	.	108	0.97149	0.653217494488	0.6918	.	0.92958632986930401	6	-	237A>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48513	137852229	.	0	0.99977	.	0.688	0.011	434	0.99999140	5.19	.	.	.	0.733415	0.99825584643864	0.93919	D	34	.	.	1.0915	0.99205	p.Glu79Asp	0	.	-8.05	0.9869484	.	0.94179	10574	D	.	F9	.	D	0.904	.	E79D	D	.	0.943	A/A	principal1	238164	F9_Popp_2025_strep_2_var261066	No											E		237	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Glu79Asp		true	c.237A>C						3551.0	139537158.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Glu79Asp						D	Sep 01, 1989					missense_variant		79.0				1.1083447740611316		Pathogenic	139537158.0	missense_variant		0.904					Reporter			F9_Glu79Asp
F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004375		NC_000023.11:139537158:A:C		Glu79Asp																												F9_Glu79Asp	23	139537158	A	C	X	allele	237A>C	G06	527_CAVA_Array_P02	M12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537158-A-C	-	0.55032	0.994	79	.	.	.	X	138619317	C	.	.	X	1_Pathogenic	NC_000023.11	.	Glu79Asp	.	23.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97356	Select	0.9746	.	0.66535	.	.	D	D	.	0.409842432222	0	.	.	.	.	0.60380	.	.	.	.	0.53117	.	.	0.97710	0.986	.	15.0	0.824718	.	0.85	C	single nucleotide variant	NC_000023.11:g.139537158A>C	.	.	1	0.9036028	.	0	0.95628124	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.95767	D	H	.	.	A/A	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99298	.	.	-	139537158	.	-	7.954000	.	0.95445	.	0	.	.	germline	.	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.99639	GRCh38	924	no assertion criteria provided	c.237A>C	.	0.45905	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	0	.	NM_000133.4(F9):c.237A>C (p.Glu79Asp)		.	FA9_HUMAN	.	85.0	.	.	T	0.72962	0.96466774	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu79Asp	.	0.75935	.	germline	.		A	Sep 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	78	.	.	SCV000031551	Pathogenic	.	.	Asp	D	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	3.810108	0.66047	.	D	-	.	.	0.99393	0	.	.	0.86625	0	139537158	Y	9	0	.	.	P00740	.	0.969314	0.22783		.	0.962	D	.	0.9119187	.	0.61779	2158	0.676114	.	-2.37	.	.	0.91343	.	.	.	.	.	.	0.95166	X	F9	.	0	Glu	660	.	X-139537158-A-C	Hereditary_factor_IX_deficiency_disease	.	.	138446983	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	.	.	.	RCV000011320	D	.	.	c.237A>C	.	.	.	0.99906	A/A	rs137852229	139537158	.	A	.	P00740	.	0.96853	.	0.68239		.	.	.	3.63	0	0	.	4.02	0.99654	34	D	T	.	.	0	0	.	.	.	98879	10574	0.99905	0.41506	0.995045900344849	434	.	0.71675	.	.	.	.	1.126	.	N	.	.	.	0	306900	0.31059	X	.	ENSG00000101981	.	0	.	0	0.9717501412150729	3	0.70672	0.18019	.	.	.	.	.	YES	.	0.918148	25613	HGNC:3551	A	.	simple_aae	0.912	.	139537158	GAA	1.000000	.	-	0	0.99023	.	0	.	Pathogenic	0.61484	.	.	.	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	E	.	0.999777502907	-	0.964	-	0.85520	.	108	0.97149	0.653217494488	0.6918	.	0.92958632986930401	6	-	237A>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48513	137852229	.	0	0.99977	.	0.688	0.011	434	0.99999140	5.19	.	.	.	0.733415	0.99825584643864	0.93919	D	34	.	.	1.0915	0.99205	p.Glu79Asp	0	.	-8.05	0.9869484	.	0.94179	10574	D	.	F9	.	D	0.904	.	E79D	D	.	0.943	A/A	principal1	128100	F9_Popp_2025_carboxy_F9_specific_var222342	No											E		237	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Glu79Asp		true	c.237A>C						3551.0	139537158.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Glu79Asp						D	Sep 01, 1989					missense_variant		79.0				1.071385309115317		Pathogenic	139537158.0	missense_variant		0.904					Reporter			F9_Glu79Asp
F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004375		NC_000023.11:139537158:A:C		Glu79Asp																												F9_Glu79Asp	23	139537158	A	C	X	allele	237A>C	G06	527_CAVA_Array_P02	M12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537158-A-C	-	0.55032	0.994	79	.	.	.	X	138619317	C	.	.	X	1_Pathogenic	NC_000023.11	.	Glu79Asp	.	23.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97356	Select	0.9746	.	0.66535	.	.	D	D	.	0.409842432222	0	.	.	.	.	0.60380	.	.	.	.	0.53117	.	.	0.97710	0.986	.	15.0	0.824718	.	0.85	C	single nucleotide variant	NC_000023.11:g.139537158A>C	.	.	1	0.9036028	.	0	0.95628124	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.95767	D	H	.	.	A/A	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99298	.	.	-	139537158	.	-	7.954000	.	0.95445	.	0	.	.	germline	.	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.99639	GRCh38	924	no assertion criteria provided	c.237A>C	.	0.45905	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	0	.	NM_000133.4(F9):c.237A>C (p.Glu79Asp)		.	FA9_HUMAN	.	85.0	.	.	T	0.72962	0.96466774	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu79Asp	.	0.75935	.	germline	.		A	Sep 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	78	.	.	SCV000031551	Pathogenic	.	.	Asp	D	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	3.810108	0.66047	.	D	-	.	.	0.99393	0	.	.	0.86625	0	139537158	Y	9	0	.	.	P00740	.	0.969314	0.22783		.	0.962	D	.	0.9119187	.	0.61779	2158	0.676114	.	-2.37	.	.	0.91343	.	.	.	.	.	.	0.95166	X	F9	.	0	Glu	660	.	X-139537158-A-C	Hereditary_factor_IX_deficiency_disease	.	.	138446983	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	.	.	.	RCV000011320	D	.	.	c.237A>C	.	.	.	0.99906	A/A	rs137852229	139537158	.	A	.	P00740	.	0.96853	.	0.68239		.	.	.	3.63	0	0	.	4.02	0.99654	34	D	T	.	.	0	0	.	.	.	98879	10574	0.99905	0.41506	0.995045900344849	434	.	0.71675	.	.	.	.	1.126	.	N	.	.	.	0	306900	0.31059	X	.	ENSG00000101981	.	0	.	0	0.9717501412150729	3	0.70672	0.18019	.	.	.	.	.	YES	.	0.918148	25613	HGNC:3551	A	.	simple_aae	0.912	.	139537158	GAA	1.000000	.	-	0	0.99023	.	0	.	Pathogenic	0.61484	.	.	.	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	E	.	0.999777502907	-	0.964	-	0.85520	.	108	0.97149	0.653217494488	0.6918	.	0.92958632986930401	6	-	237A>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48513	137852229	.	0	0.99977	.	0.688	0.011	434	0.99999140	5.19	.	.	.	0.733415	0.99825584643864	0.93919	D	34	.	.	1.0915	0.99205	p.Glu79Asp	0	.	-8.05	0.9869484	.	0.94179	10574	D	.	F9	.	D	0.904	.	E79D	D	.	0.943	A/A	principal1	183132	F9_Popp_2025_heavy_chain_var232023	No											E		237	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Glu79Asp		true	c.237A>C						3551.0	139537158.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Glu79Asp						D	Sep 01, 1989					missense_variant		79.0				1.1370137533445022		Pathogenic	139537158.0	missense_variant		0.904					Reporter			F9_Glu79Asp
F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004375		NC_000023.11:139537158:A:C		Glu79Asp																												F9_Glu79Asp	23	139537158	A	C	X	allele	237A>C	G06	527_CAVA_Array_P02	M12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537158-A-C	-	0.55032	0.994	79	.	.	.	X	138619317	C	.	.	X	1_Pathogenic	NC_000023.11	.	Glu79Asp	.	23.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97356	Select	0.9746	.	0.66535	.	.	D	D	.	0.409842432222	0	.	.	.	.	0.60380	.	.	.	.	0.53117	.	.	0.97710	0.986	.	15.0	0.824718	.	0.85	C	single nucleotide variant	NC_000023.11:g.139537158A>C	.	.	1	0.9036028	.	0	0.95628124	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.95767	D	H	.	.	A/A	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99298	.	.	-	139537158	.	-	7.954000	.	0.95445	.	0	.	.	germline	.	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.99639	GRCh38	924	no assertion criteria provided	c.237A>C	.	0.45905	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	0	.	NM_000133.4(F9):c.237A>C (p.Glu79Asp)		.	FA9_HUMAN	.	85.0	.	.	T	0.72962	0.96466774	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu79Asp	.	0.75935	.	germline	.		A	Sep 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	78	.	.	SCV000031551	Pathogenic	.	.	Asp	D	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	3.810108	0.66047	.	D	-	.	.	0.99393	0	.	.	0.86625	0	139537158	Y	9	0	.	.	P00740	.	0.969314	0.22783		.	0.962	D	.	0.9119187	.	0.61779	2158	0.676114	.	-2.37	.	.	0.91343	.	.	.	.	.	.	0.95166	X	F9	.	0	Glu	660	.	X-139537158-A-C	Hereditary_factor_IX_deficiency_disease	.	.	138446983	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	.	.	.	RCV000011320	D	.	.	c.237A>C	.	.	.	0.99906	A/A	rs137852229	139537158	.	A	.	P00740	.	0.96853	.	0.68239		.	.	.	3.63	0	0	.	4.02	0.99654	34	D	T	.	.	0	0	.	.	.	98879	10574	0.99905	0.41506	0.995045900344849	434	.	0.71675	.	.	.	.	1.126	.	N	.	.	.	0	306900	0.31059	X	.	ENSG00000101981	.	0	.	0	0.9717501412150729	3	0.70672	0.18019	.	.	.	.	.	YES	.	0.918148	25613	HGNC:3551	A	.	simple_aae	0.912	.	139537158	GAA	1.000000	.	-	0	0.99023	.	0	.	Pathogenic	0.61484	.	.	.	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	E	.	0.999777502907	-	0.964	-	0.85520	.	108	0.97149	0.653217494488	0.6918	.	0.92958632986930401	6	-	237A>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48513	137852229	.	0	0.99977	.	0.688	0.011	434	0.99999140	5.19	.	.	.	0.733415	0.99825584643864	0.93919	D	34	.	.	1.0915	0.99205	p.Glu79Asp	0	.	-8.05	0.9869484	.	0.94179	10574	D	.	F9	.	D	0.904	.	E79D	D	.	0.943	A/A	principal1	210648	F9_Popp_2025_light_chain_var241704	No											E		237	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Glu79Asp		true	c.237A>C						3551.0	139537158.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Glu79Asp						D	Sep 01, 1989					missense_variant		79.0				1.1215083178570668		Pathogenic	139537158.0	missense_variant		0.904					Reporter			F9_Glu79Asp
F9_Glu79Asp	-2.573421637299557	0.03682372229763606	0.22047699236965554	0.8317921252859086	2025_01_Batch_13-14	0.7668926021102467	0.624655314780562	0.5717637727016314	0.7401965367721299	0.6377602432753857	0.7350557791127735	0.6449935782296168	0.6132676902571083	0.6759135609235649	0.7409098527923751	0.7509741906115102	0.6348244465050894	0.5925157314793699	0.7080550488478474	0.6893350480338805	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004375		NC_000023.11:139537158:A:C		Glu79Asp																												F9_Glu79Asp	23	139537158	A	C	X	allele	237A>C	G06	527_CAVA_Array_P02	M12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537158-A-C	-	0.55032	0.994	79	.	.	.	X	138619317	C	.	.	X	1_Pathogenic	NC_000023.11	.	Glu79Asp	.	23.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97356	Select	0.9746	.	0.66535	.	.	D	D	.	0.409842432222	0	.	.	.	.	0.60380	.	.	.	.	0.53117	.	.	0.97710	0.986	.	15.0	0.824718	.	0.85	C	single nucleotide variant	NC_000023.11:g.139537158A>C	.	.	1	0.9036028	.	0	0.95628124	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.95767	D	H	.	.	A/A	0	0	.	.	Hereditary factor IX deficiency disease	.	0.99298	.	.	-	139537158	.	-	7.954000	.	0.95445	.	0	.	.	germline	.	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.99639	GRCh38	924	no assertion criteria provided	c.237A>C	.	0.45905	0	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	0	.	NM_000133.4(F9):c.237A>C (p.Glu79Asp)		.	FA9_HUMAN	.	85.0	.	.	T	0.72962	0.96466774	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Glu79Asp	.	0.75935	.	germline	.		A	Sep 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	78	.	.	SCV000031551	Pathogenic	.	.	Asp	D	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	3.810108	0.66047	.	D	-	.	.	0.99393	0	.	.	0.86625	0	139537158	Y	9	0	.	.	P00740	.	0.969314	0.22783		.	0.962	D	.	0.9119187	.	0.61779	2158	0.676114	.	-2.37	.	.	0.91343	.	.	.	.	.	.	0.95166	X	F9	.	0	Glu	660	.	X-139537158-A-C	Hereditary_factor_IX_deficiency_disease	.	.	138446983	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	.	.	.	RCV000011320	D	.	.	c.237A>C	.	.	.	0.99906	A/A	rs137852229	139537158	.	A	.	P00740	.	0.96853	.	0.68239		.	.	.	3.63	0	0	.	4.02	0.99654	34	D	T	.	.	0	0	.	.	.	98879	10574	0.99905	0.41506	0.995045900344849	434	.	0.71675	.	.	.	.	1.126	.	N	.	.	.	0	306900	0.31059	X	.	ENSG00000101981	.	0	.	0	0.9717501412150729	3	0.70672	0.18019	.	.	.	.	.	YES	.	0.918148	25613	HGNC:3551	A	.	simple_aae	0.912	.	139537158	GAA	1.000000	.	-	0	0.99023	.	0	.	Pathogenic	0.61484	.	.	.	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	E	.	0.999777502907	-	0.964	-	0.85520	.	108	0.97149	0.653217494488	0.6918	.	0.92958632986930401	6	-	237A>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48513	137852229	.	0	0.99977	.	0.688	0.011	434	0.99999140	5.19	.	.	.	0.733415	0.99825584643864	0.93919	D	34	.	.	1.0915	0.99205	p.Glu79Asp	0	.	-8.05	0.9869484	.	0.94179	10574	D	.	F9	.	D	0.904	.	E79D	D	.	0.943	A/A	principal1	155616	F9_Popp_2025_carboxy_gla_motif_var251385	No											E		237	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Glu79Asp		true	c.237A>C						3551.0	139537158.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Glu79Asp						D	Sep 01, 1989					missense_variant		79.0				1.2205893016605571		Pathogenic	139537158.0	missense_variant		0.904					Reporter			F9_Glu79Asp
F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	F9	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro333Leu	23	139561683	C	T	X											X-139561683-C-T	-	0.76387	1.0	333	.	.	.	X	138643842	T	.	.	X	1_Pathogenic	NC_000023.11	.	Pro333Leu	.	26.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97963	Select	0.9163	.	0.90580	.	.	D	D	.	1.66441580669	0	.	.	.	.	0.59115	.	.	.	.	0.98771	.	.	0.98935	0.989	.	25.0	0.950305	4.99	0.75	T	single nucleotide variant	NC_000023.11:g.139561683C>T	.	.	1	0.9592478	.	0	0.97182083	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.98516	D	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97454	.	.	-	139561683	.	-	7.707000	.	0.99661	.	0	.	.	germline	.	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.99725	GRCh38	924	no assertion criteria provided	c.998C>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.998C>T (p.Pro333Leu)		.	FA9_HUMAN	.	75.0	.	.	D	0.76851	0.9780011	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro333Leu	.	0.66650	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031583	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	-0.202	C	.	4.736439	0.83643	.	D	-	.	.	0.96267	0	.	.	0.95025	0	139561683	Y	10	0	.	.	P00740	.	0.94424	0.81581		.	1.0	D	.	0.9523348	.	0.64309	2158	0.648334	.	-9.94	.	.	0.78662	.	.	.	.	.	.	0.98914	X	F9	.	0	Pro	660	.	X-139561683-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471508	ClinGen:CA255375|OMIM:300746.0048	.	.	.	RCV000011351	D	.	.	c.998C>T	.	.	.	0.99884	C/C	rs137852252	139561683	.	C	.	P00740	.	0.98401	.	0.68239		.	.	.	2.73	0	0	.	4.8	0.99137	34	D	T	.	.	0	0	.	.	.	98879	10605	0.99883	0.89687	0.998754501342773	434	.	0.71675	.	.	.	.	7.542	.	D	.	.	.	0	306900	0.81082	X	.	ENSG00000101981	.	0	.	0	0.9992527010438141	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.583299	25644	HGNC:3551	A	.	simple_aae	0.99	.	139561683	CCT	1.000000	.	-	0	0.99736	.	0	.	Pathogenic	0.78441	.	.	.	ClinGen:CA255375,OMIM:300746.0048	P	.	0.995518902514	-	0.971	-	0.92671	.	108	0.99925	0.644322156906	0.6712	.	0.99714179622655752	6	-	998C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.80941	137852252	.	0	0.99540	.	0.859	0.001	434	0.99999225	5.66	.	.	.	0.69351	0.999792545073085	0.79671	D	34	.	.	1.0159	0.97222	p.Pro333Leu	0	.	-10.768	0.99203384	.	0.98009	10605	D	.	F9	.	D	0.920	.	P333L	D	0.89858	0.08747	C/C	principal1	198263	F9_Popp_2025_heavy_chain_var237342	No											P		998	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Pro333Leu		true	c.998C>T						3551.0	139561683.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Pro333Leu						L	Oct 09, 2017					missense_variant		333.0				0.016075737		Pathogenic	139561683.0	missense_variant		0.92					Reporter			F9_Pro333Leu
F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	F9	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro333Leu	23	139561683	C	T	X											X-139561683-C-T	-	0.76387	1.0	333	.	.	.	X	138643842	T	.	.	X	1_Pathogenic	NC_000023.11	.	Pro333Leu	.	26.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97963	Select	0.9163	.	0.90580	.	.	D	D	.	1.66441580669	0	.	.	.	.	0.59115	.	.	.	.	0.98771	.	.	0.98935	0.989	.	25.0	0.950305	4.99	0.75	T	single nucleotide variant	NC_000023.11:g.139561683C>T	.	.	1	0.9592478	.	0	0.97182083	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.98516	D	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97454	.	.	-	139561683	.	-	7.707000	.	0.99661	.	0	.	.	germline	.	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.99725	GRCh38	924	no assertion criteria provided	c.998C>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.998C>T (p.Pro333Leu)		.	FA9_HUMAN	.	75.0	.	.	D	0.76851	0.9780011	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro333Leu	.	0.66650	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031583	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	-0.202	C	.	4.736439	0.83643	.	D	-	.	.	0.96267	0	.	.	0.95025	0	139561683	Y	10	0	.	.	P00740	.	0.94424	0.81581		.	1.0	D	.	0.9523348	.	0.64309	2158	0.648334	.	-9.94	.	.	0.78662	.	.	.	.	.	.	0.98914	X	F9	.	0	Pro	660	.	X-139561683-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471508	ClinGen:CA255375|OMIM:300746.0048	.	.	.	RCV000011351	D	.	.	c.998C>T	.	.	.	0.99884	C/C	rs137852252	139561683	.	C	.	P00740	.	0.98401	.	0.68239		.	.	.	2.73	0	0	.	4.8	0.99137	34	D	T	.	.	0	0	.	.	.	98879	10605	0.99883	0.89687	0.998754501342773	434	.	0.71675	.	.	.	.	7.542	.	D	.	.	.	0	306900	0.81082	X	.	ENSG00000101981	.	0	.	0	0.9992527010438141	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.583299	25644	HGNC:3551	A	.	simple_aae	0.99	.	139561683	CCT	1.000000	.	-	0	0.99736	.	0	.	Pathogenic	0.78441	.	.	.	ClinGen:CA255375,OMIM:300746.0048	P	.	0.995518902514	-	0.971	-	0.92671	.	108	0.99925	0.644322156906	0.6712	.	0.99714179622655752	6	-	998C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.80941	137852252	.	0	0.99540	.	0.859	0.001	434	0.99999225	5.66	.	.	.	0.69351	0.999792545073085	0.79671	D	34	.	.	1.0159	0.97222	p.Pro333Leu	0	.	-10.768	0.99203384	.	0.98009	10605	D	.	F9	.	D	0.920	.	P333L	D	0.89858	0.08747	C/C	principal1	170747	F9_Popp_2025_carboxy_gla_motif_var256704	No											P		998	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Pro333Leu		true	c.998C>T						3551.0	139561683.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Pro333Leu						L	Oct 09, 2017					missense_variant		333.0				0.0144597012858405		Pathogenic	139561683.0	missense_variant		0.92					Reporter			F9_Pro333Leu
F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	F9	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro333Leu	23	139561683	C	T	X											X-139561683-C-T	-	0.76387	1.0	333	.	.	.	X	138643842	T	.	.	X	1_Pathogenic	NC_000023.11	.	Pro333Leu	.	26.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97963	Select	0.9163	.	0.90580	.	.	D	D	.	1.66441580669	0	.	.	.	.	0.59115	.	.	.	.	0.98771	.	.	0.98935	0.989	.	25.0	0.950305	4.99	0.75	T	single nucleotide variant	NC_000023.11:g.139561683C>T	.	.	1	0.9592478	.	0	0.97182083	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.98516	D	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97454	.	.	-	139561683	.	-	7.707000	.	0.99661	.	0	.	.	germline	.	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.99725	GRCh38	924	no assertion criteria provided	c.998C>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.998C>T (p.Pro333Leu)		.	FA9_HUMAN	.	75.0	.	.	D	0.76851	0.9780011	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro333Leu	.	0.66650	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031583	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	-0.202	C	.	4.736439	0.83643	.	D	-	.	.	0.96267	0	.	.	0.95025	0	139561683	Y	10	0	.	.	P00740	.	0.94424	0.81581		.	1.0	D	.	0.9523348	.	0.64309	2158	0.648334	.	-9.94	.	.	0.78662	.	.	.	.	.	.	0.98914	X	F9	.	0	Pro	660	.	X-139561683-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471508	ClinGen:CA255375|OMIM:300746.0048	.	.	.	RCV000011351	D	.	.	c.998C>T	.	.	.	0.99884	C/C	rs137852252	139561683	.	C	.	P00740	.	0.98401	.	0.68239		.	.	.	2.73	0	0	.	4.8	0.99137	34	D	T	.	.	0	0	.	.	.	98879	10605	0.99883	0.89687	0.998754501342773	434	.	0.71675	.	.	.	.	7.542	.	D	.	.	.	0	306900	0.81082	X	.	ENSG00000101981	.	0	.	0	0.9992527010438141	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.583299	25644	HGNC:3551	A	.	simple_aae	0.99	.	139561683	CCT	1.000000	.	-	0	0.99736	.	0	.	Pathogenic	0.78441	.	.	.	ClinGen:CA255375,OMIM:300746.0048	P	.	0.995518902514	-	0.971	-	0.92671	.	108	0.99925	0.644322156906	0.6712	.	0.99714179622655752	6	-	998C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.80941	137852252	.	0	0.99540	.	0.859	0.001	434	0.99999225	5.66	.	.	.	0.69351	0.999792545073085	0.79671	D	34	.	.	1.0159	0.97222	p.Pro333Leu	0	.	-10.768	0.99203384	.	0.98009	10605	D	.	F9	.	D	0.920	.	P333L	D	0.89858	0.08747	C/C	principal1	143231	F9_Popp_2025_carboxy_F9_specific_var227661	No											P		998	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Pro333Leu		true	c.998C>T						3551.0	139561683.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Pro333Leu						L	Oct 09, 2017					missense_variant		333.0				0.002747442		Pathogenic	139561683.0	missense_variant		0.92					Reporter			F9_Pro333Leu
F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	F9	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro333Leu	23	139561683	C	T	X											X-139561683-C-T	-	0.76387	1.0	333	.	.	.	X	138643842	T	.	.	X	1_Pathogenic	NC_000023.11	.	Pro333Leu	.	26.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97963	Select	0.9163	.	0.90580	.	.	D	D	.	1.66441580669	0	.	.	.	.	0.59115	.	.	.	.	0.98771	.	.	0.98935	0.989	.	25.0	0.950305	4.99	0.75	T	single nucleotide variant	NC_000023.11:g.139561683C>T	.	.	1	0.9592478	.	0	0.97182083	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.98516	D	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97454	.	.	-	139561683	.	-	7.707000	.	0.99661	.	0	.	.	germline	.	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.99725	GRCh38	924	no assertion criteria provided	c.998C>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.998C>T (p.Pro333Leu)		.	FA9_HUMAN	.	75.0	.	.	D	0.76851	0.9780011	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro333Leu	.	0.66650	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031583	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	-0.202	C	.	4.736439	0.83643	.	D	-	.	.	0.96267	0	.	.	0.95025	0	139561683	Y	10	0	.	.	P00740	.	0.94424	0.81581		.	1.0	D	.	0.9523348	.	0.64309	2158	0.648334	.	-9.94	.	.	0.78662	.	.	.	.	.	.	0.98914	X	F9	.	0	Pro	660	.	X-139561683-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471508	ClinGen:CA255375|OMIM:300746.0048	.	.	.	RCV000011351	D	.	.	c.998C>T	.	.	.	0.99884	C/C	rs137852252	139561683	.	C	.	P00740	.	0.98401	.	0.68239		.	.	.	2.73	0	0	.	4.8	0.99137	34	D	T	.	.	0	0	.	.	.	98879	10605	0.99883	0.89687	0.998754501342773	434	.	0.71675	.	.	.	.	7.542	.	D	.	.	.	0	306900	0.81082	X	.	ENSG00000101981	.	0	.	0	0.9992527010438141	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.583299	25644	HGNC:3551	A	.	simple_aae	0.99	.	139561683	CCT	1.000000	.	-	0	0.99736	.	0	.	Pathogenic	0.78441	.	.	.	ClinGen:CA255375,OMIM:300746.0048	P	.	0.995518902514	-	0.971	-	0.92671	.	108	0.99925	0.644322156906	0.6712	.	0.99714179622655752	6	-	998C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.80941	137852252	.	0	0.99540	.	0.859	0.001	434	0.99999225	5.66	.	.	.	0.69351	0.999792545073085	0.79671	D	34	.	.	1.0159	0.97222	p.Pro333Leu	0	.	-10.768	0.99203384	.	0.98009	10605	D	.	F9	.	D	0.920	.	P333L	D	0.89858	0.08747	C/C	principal1	225779	F9_Popp_2025_light_chain_var247023	No											P		998	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Pro333Leu		true	c.998C>T						3551.0	139561683.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Pro333Leu						L	Oct 09, 2017					missense_variant		333.0				0.009126677		Pathogenic	139561683.0	missense_variant		0.92					Reporter			F9_Pro333Leu
F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	F9	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	NC_000023.11:139561683:C:T	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Pro333Leu	23	139561683	C	T	X											X-139561683-C-T	-	0.76387	1.0	333	.	.	.	X	138643842	T	.	.	X	1_Pathogenic	NC_000023.11	.	Pro333Leu	.	26.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97963	Select	0.9163	.	0.90580	.	.	D	D	.	1.66441580669	0	.	.	.	.	0.59115	.	.	.	.	0.98771	.	.	0.98935	0.989	.	25.0	0.950305	4.99	0.75	T	single nucleotide variant	NC_000023.11:g.139561683C>T	.	.	1	0.9592478	.	0	0.97182083	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.98516	D	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97454	.	.	-	139561683	.	-	7.707000	.	0.99661	.	0	.	.	germline	.	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.99725	GRCh38	924	no assertion criteria provided	c.998C>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.998C>T (p.Pro333Leu)		.	FA9_HUMAN	.	75.0	.	.	D	0.76851	0.9780011	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro333Leu	.	0.66650	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031583	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	-0.202	C	.	4.736439	0.83643	.	D	-	.	.	0.96267	0	.	.	0.95025	0	139561683	Y	10	0	.	.	P00740	.	0.94424	0.81581		.	1.0	D	.	0.9523348	.	0.64309	2158	0.648334	.	-9.94	.	.	0.78662	.	.	.	.	.	.	0.98914	X	F9	.	0	Pro	660	.	X-139561683-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471508	ClinGen:CA255375|OMIM:300746.0048	.	.	.	RCV000011351	D	.	.	c.998C>T	.	.	.	0.99884	C/C	rs137852252	139561683	.	C	.	P00740	.	0.98401	.	0.68239		.	.	.	2.73	0	0	.	4.8	0.99137	34	D	T	.	.	0	0	.	.	.	98879	10605	0.99883	0.89687	0.998754501342773	434	.	0.71675	.	.	.	.	7.542	.	D	.	.	.	0	306900	0.81082	X	.	ENSG00000101981	.	0	.	0	0.9992527010438141	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.583299	25644	HGNC:3551	A	.	simple_aae	0.99	.	139561683	CCT	1.000000	.	-	0	0.99736	.	0	.	Pathogenic	0.78441	.	.	.	ClinGen:CA255375,OMIM:300746.0048	P	.	0.995518902514	-	0.971	-	0.92671	.	108	0.99925	0.644322156906	0.6712	.	0.99714179622655752	6	-	998C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.80941	137852252	.	0	0.99540	.	0.859	0.001	434	0.99999225	5.66	.	.	.	0.69351	0.999792545073085	0.79671	D	34	.	.	1.0159	0.97222	p.Pro333Leu	0	.	-10.768	0.99203384	.	0.98009	10605	D	.	F9	.	D	0.920	.	P333L	D	0.89858	0.08747	C/C	principal1	253295	F9_Popp_2025_strep_2_var266385	No											P		998	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Pro333Leu		true	c.998C>T						3551.0	139561683.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Pro333Leu						L	Oct 09, 2017					missense_variant		333.0				0.0257791412491283		Pathogenic	139561683.0	missense_variant		0.92					Reporter			F9_Pro333Leu
F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	F9	F9		52861		CCSBVarC004385		NC_000023.11:139561683:C:T		Pro333Leu																												F9_Pro333Leu	23	139561683	C	T	X	allele	998C>T	H10	527_CAVA_Array_P02	O20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561683-C-T	-	0.76387	1.0	333	.	.	.	X	138643842	T	.	.	X	1_Pathogenic	NC_000023.11	.	Pro333Leu	.	26.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97963	Select	0.9163	.	0.90580	.	.	D	D	.	1.66441580669	0	.	.	.	.	0.59115	.	.	.	.	0.98771	.	.	0.98935	0.989	.	25.0	0.950305	4.99	0.75	T	single nucleotide variant	NC_000023.11:g.139561683C>T	.	.	1	0.9592478	.	0	0.97182083	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.98516	D	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97454	.	.	-	139561683	.	-	7.707000	.	0.99661	.	0	.	.	germline	.	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.99725	GRCh38	924	no assertion criteria provided	c.998C>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.998C>T (p.Pro333Leu)		.	FA9_HUMAN	.	75.0	.	.	D	0.76851	0.9780011	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro333Leu	.	0.66650	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031583	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	-0.202	C	.	4.736439	0.83643	.	D	-	.	.	0.96267	0	.	.	0.95025	0	139561683	Y	10	0	.	.	P00740	.	0.94424	0.81581		.	1.0	D	.	0.9523348	.	0.64309	2158	0.648334	.	-9.94	.	.	0.78662	.	.	.	.	.	.	0.98914	X	F9	.	0	Pro	660	.	X-139561683-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471508	ClinGen:CA255375|OMIM:300746.0048	.	.	.	RCV000011351	D	.	.	c.998C>T	.	.	.	0.99884	C/C	rs137852252	139561683	.	C	.	P00740	.	0.98401	.	0.68239		.	.	.	2.73	0	0	.	4.8	0.99137	34	D	T	.	.	0	0	.	.	.	98879	10605	0.99883	0.89687	0.998754501342773	434	.	0.71675	.	.	.	.	7.542	.	D	.	.	.	0	306900	0.81082	X	.	ENSG00000101981	.	0	.	0	0.9992527010438141	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.583299	25644	HGNC:3551	A	.	simple_aae	0.99	.	139561683	CCT	1.000000	.	-	0	0.99736	.	0	.	Pathogenic	0.78441	.	.	.	ClinGen:CA255375,OMIM:300746.0048	P	.	0.995518902514	-	0.971	-	0.92671	.	108	0.99925	0.644322156906	0.6712	.	0.99714179622655752	6	-	998C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.80941	137852252	.	0	0.99540	.	0.859	0.001	434	0.99999225	5.66	.	.	.	0.69351	0.999792545073085	0.79671	D	34	.	.	1.0159	0.97222	p.Pro333Leu	0	.	-10.768	0.99203384	.	0.98009	10605	D	.	F9	.	D	0.920	.	P333L	D	0.89858	0.08747	C/C	principal1	198263	F9_Popp_2025_heavy_chain_var237342	No											P		998	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Pro333Leu		true	c.998C>T						3551.0	139561683.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Pro333Leu						L	Oct 09, 2017					missense_variant		333.0				0.016075737		Pathogenic	139561683.0	missense_variant		0.92					Reporter			F9_Pro333Leu
F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	F9	F9		52861		CCSBVarC004385		NC_000023.11:139561683:C:T		Pro333Leu																												F9_Pro333Leu	23	139561683	C	T	X	allele	998C>T	H10	527_CAVA_Array_P02	O20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561683-C-T	-	0.76387	1.0	333	.	.	.	X	138643842	T	.	.	X	1_Pathogenic	NC_000023.11	.	Pro333Leu	.	26.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97963	Select	0.9163	.	0.90580	.	.	D	D	.	1.66441580669	0	.	.	.	.	0.59115	.	.	.	.	0.98771	.	.	0.98935	0.989	.	25.0	0.950305	4.99	0.75	T	single nucleotide variant	NC_000023.11:g.139561683C>T	.	.	1	0.9592478	.	0	0.97182083	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.98516	D	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97454	.	.	-	139561683	.	-	7.707000	.	0.99661	.	0	.	.	germline	.	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.99725	GRCh38	924	no assertion criteria provided	c.998C>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.998C>T (p.Pro333Leu)		.	FA9_HUMAN	.	75.0	.	.	D	0.76851	0.9780011	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro333Leu	.	0.66650	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031583	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	-0.202	C	.	4.736439	0.83643	.	D	-	.	.	0.96267	0	.	.	0.95025	0	139561683	Y	10	0	.	.	P00740	.	0.94424	0.81581		.	1.0	D	.	0.9523348	.	0.64309	2158	0.648334	.	-9.94	.	.	0.78662	.	.	.	.	.	.	0.98914	X	F9	.	0	Pro	660	.	X-139561683-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471508	ClinGen:CA255375|OMIM:300746.0048	.	.	.	RCV000011351	D	.	.	c.998C>T	.	.	.	0.99884	C/C	rs137852252	139561683	.	C	.	P00740	.	0.98401	.	0.68239		.	.	.	2.73	0	0	.	4.8	0.99137	34	D	T	.	.	0	0	.	.	.	98879	10605	0.99883	0.89687	0.998754501342773	434	.	0.71675	.	.	.	.	7.542	.	D	.	.	.	0	306900	0.81082	X	.	ENSG00000101981	.	0	.	0	0.9992527010438141	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.583299	25644	HGNC:3551	A	.	simple_aae	0.99	.	139561683	CCT	1.000000	.	-	0	0.99736	.	0	.	Pathogenic	0.78441	.	.	.	ClinGen:CA255375,OMIM:300746.0048	P	.	0.995518902514	-	0.971	-	0.92671	.	108	0.99925	0.644322156906	0.6712	.	0.99714179622655752	6	-	998C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.80941	137852252	.	0	0.99540	.	0.859	0.001	434	0.99999225	5.66	.	.	.	0.69351	0.999792545073085	0.79671	D	34	.	.	1.0159	0.97222	p.Pro333Leu	0	.	-10.768	0.99203384	.	0.98009	10605	D	.	F9	.	D	0.920	.	P333L	D	0.89858	0.08747	C/C	principal1	170747	F9_Popp_2025_carboxy_gla_motif_var256704	No											P		998	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Pro333Leu		true	c.998C>T						3551.0	139561683.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Pro333Leu						L	Oct 09, 2017					missense_variant		333.0				0.0144597012858405		Pathogenic	139561683.0	missense_variant		0.92					Reporter			F9_Pro333Leu
F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	F9	F9		52861		CCSBVarC004385		NC_000023.11:139561683:C:T		Pro333Leu																												F9_Pro333Leu	23	139561683	C	T	X	allele	998C>T	H10	527_CAVA_Array_P02	O20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561683-C-T	-	0.76387	1.0	333	.	.	.	X	138643842	T	.	.	X	1_Pathogenic	NC_000023.11	.	Pro333Leu	.	26.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97963	Select	0.9163	.	0.90580	.	.	D	D	.	1.66441580669	0	.	.	.	.	0.59115	.	.	.	.	0.98771	.	.	0.98935	0.989	.	25.0	0.950305	4.99	0.75	T	single nucleotide variant	NC_000023.11:g.139561683C>T	.	.	1	0.9592478	.	0	0.97182083	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.98516	D	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97454	.	.	-	139561683	.	-	7.707000	.	0.99661	.	0	.	.	germline	.	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.99725	GRCh38	924	no assertion criteria provided	c.998C>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.998C>T (p.Pro333Leu)		.	FA9_HUMAN	.	75.0	.	.	D	0.76851	0.9780011	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro333Leu	.	0.66650	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031583	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	-0.202	C	.	4.736439	0.83643	.	D	-	.	.	0.96267	0	.	.	0.95025	0	139561683	Y	10	0	.	.	P00740	.	0.94424	0.81581		.	1.0	D	.	0.9523348	.	0.64309	2158	0.648334	.	-9.94	.	.	0.78662	.	.	.	.	.	.	0.98914	X	F9	.	0	Pro	660	.	X-139561683-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471508	ClinGen:CA255375|OMIM:300746.0048	.	.	.	RCV000011351	D	.	.	c.998C>T	.	.	.	0.99884	C/C	rs137852252	139561683	.	C	.	P00740	.	0.98401	.	0.68239		.	.	.	2.73	0	0	.	4.8	0.99137	34	D	T	.	.	0	0	.	.	.	98879	10605	0.99883	0.89687	0.998754501342773	434	.	0.71675	.	.	.	.	7.542	.	D	.	.	.	0	306900	0.81082	X	.	ENSG00000101981	.	0	.	0	0.9992527010438141	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.583299	25644	HGNC:3551	A	.	simple_aae	0.99	.	139561683	CCT	1.000000	.	-	0	0.99736	.	0	.	Pathogenic	0.78441	.	.	.	ClinGen:CA255375,OMIM:300746.0048	P	.	0.995518902514	-	0.971	-	0.92671	.	108	0.99925	0.644322156906	0.6712	.	0.99714179622655752	6	-	998C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.80941	137852252	.	0	0.99540	.	0.859	0.001	434	0.99999225	5.66	.	.	.	0.69351	0.999792545073085	0.79671	D	34	.	.	1.0159	0.97222	p.Pro333Leu	0	.	-10.768	0.99203384	.	0.98009	10605	D	.	F9	.	D	0.920	.	P333L	D	0.89858	0.08747	C/C	principal1	143231	F9_Popp_2025_carboxy_F9_specific_var227661	No											P		998	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Pro333Leu		true	c.998C>T						3551.0	139561683.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Pro333Leu						L	Oct 09, 2017					missense_variant		333.0				0.002747442		Pathogenic	139561683.0	missense_variant		0.92					Reporter			F9_Pro333Leu
F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	F9	F9		52861		CCSBVarC004385		NC_000023.11:139561683:C:T		Pro333Leu																												F9_Pro333Leu	23	139561683	C	T	X	allele	998C>T	H10	527_CAVA_Array_P02	O20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561683-C-T	-	0.76387	1.0	333	.	.	.	X	138643842	T	.	.	X	1_Pathogenic	NC_000023.11	.	Pro333Leu	.	26.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97963	Select	0.9163	.	0.90580	.	.	D	D	.	1.66441580669	0	.	.	.	.	0.59115	.	.	.	.	0.98771	.	.	0.98935	0.989	.	25.0	0.950305	4.99	0.75	T	single nucleotide variant	NC_000023.11:g.139561683C>T	.	.	1	0.9592478	.	0	0.97182083	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.98516	D	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97454	.	.	-	139561683	.	-	7.707000	.	0.99661	.	0	.	.	germline	.	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.99725	GRCh38	924	no assertion criteria provided	c.998C>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.998C>T (p.Pro333Leu)		.	FA9_HUMAN	.	75.0	.	.	D	0.76851	0.9780011	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro333Leu	.	0.66650	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031583	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	-0.202	C	.	4.736439	0.83643	.	D	-	.	.	0.96267	0	.	.	0.95025	0	139561683	Y	10	0	.	.	P00740	.	0.94424	0.81581		.	1.0	D	.	0.9523348	.	0.64309	2158	0.648334	.	-9.94	.	.	0.78662	.	.	.	.	.	.	0.98914	X	F9	.	0	Pro	660	.	X-139561683-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471508	ClinGen:CA255375|OMIM:300746.0048	.	.	.	RCV000011351	D	.	.	c.998C>T	.	.	.	0.99884	C/C	rs137852252	139561683	.	C	.	P00740	.	0.98401	.	0.68239		.	.	.	2.73	0	0	.	4.8	0.99137	34	D	T	.	.	0	0	.	.	.	98879	10605	0.99883	0.89687	0.998754501342773	434	.	0.71675	.	.	.	.	7.542	.	D	.	.	.	0	306900	0.81082	X	.	ENSG00000101981	.	0	.	0	0.9992527010438141	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.583299	25644	HGNC:3551	A	.	simple_aae	0.99	.	139561683	CCT	1.000000	.	-	0	0.99736	.	0	.	Pathogenic	0.78441	.	.	.	ClinGen:CA255375,OMIM:300746.0048	P	.	0.995518902514	-	0.971	-	0.92671	.	108	0.99925	0.644322156906	0.6712	.	0.99714179622655752	6	-	998C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.80941	137852252	.	0	0.99540	.	0.859	0.001	434	0.99999225	5.66	.	.	.	0.69351	0.999792545073085	0.79671	D	34	.	.	1.0159	0.97222	p.Pro333Leu	0	.	-10.768	0.99203384	.	0.98009	10605	D	.	F9	.	D	0.920	.	P333L	D	0.89858	0.08747	C/C	principal1	225779	F9_Popp_2025_light_chain_var247023	No											P		998	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Pro333Leu		true	c.998C>T						3551.0	139561683.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Pro333Leu						L	Oct 09, 2017					missense_variant		333.0				0.009126677		Pathogenic	139561683.0	missense_variant		0.92					Reporter			F9_Pro333Leu
F9_Pro333Leu	-4.0195915697666935	0.010124880784179249	3.78958013146929	0.006806627697826317	2025_01_Batch_13-14						0.8173212006324524	0.8876100772023314	0.9805115281620245	0.9315337174178693	0.8480305496058552						0.0			0.0		0.0	0.0		0.0	0.0	F9	F9		52861		CCSBVarC004385		NC_000023.11:139561683:C:T		Pro333Leu																												F9_Pro333Leu	23	139561683	C	T	X	allele	998C>T	H10	527_CAVA_Array_P02	O20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561683-C-T	-	0.76387	1.0	333	.	.	.	X	138643842	T	.	.	X	1_Pathogenic	NC_000023.11	.	Pro333Leu	.	26.5	.	0	.	D	.	1	1	.	.	.	.	.	0	0.97963	Select	0.9163	.	0.90580	.	.	D	D	.	1.66441580669	0	.	.	.	.	0.59115	.	.	.	.	0.98771	.	.	0.98935	0.989	.	25.0	0.950305	4.99	0.75	T	single nucleotide variant	NC_000023.11:g.139561683C>T	.	.	1	0.9592478	.	0	0.97182083	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.90832	D	0.98516	D	M	.	.	C/C	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97454	.	.	-	139561683	.	-	7.707000	.	0.99661	.	0	.	.	germline	.	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.99725	GRCh38	924	no assertion criteria provided	c.998C>T	.	0.61109	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.998C>T (p.Pro333Leu)		.	FA9_HUMAN	.	75.0	.	.	D	0.76851	0.9780011	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Pro333Leu	.	0.66650	.	germline	.		C	Oct 09, 2017	.	C/C	.	.	1.0	N	Xq27.1	78	.	.	SCV000031583	Pathogenic	.	.	Leu	L	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	-0.202	C	.	4.736439	0.83643	.	D	-	.	.	0.96267	0	.	.	0.95025	0	139561683	Y	10	0	.	.	P00740	.	0.94424	0.81581		.	1.0	D	.	0.9523348	.	0.64309	2158	0.648334	.	-9.94	.	.	0.78662	.	.	.	.	.	.	0.98914	X	F9	.	0	Pro	660	.	X-139561683-C-T	Hereditary_factor_IX_deficiency_disease	.	.	138471508	ClinGen:CA255375|OMIM:300746.0048	.	.	.	RCV000011351	D	.	.	c.998C>T	.	.	.	0.99884	C/C	rs137852252	139561683	.	C	.	P00740	.	0.98401	.	0.68239		.	.	.	2.73	0	0	.	4.8	0.99137	34	D	T	.	.	0	0	.	.	.	98879	10605	0.99883	0.89687	0.998754501342773	434	.	0.71675	.	.	.	.	7.542	.	D	.	.	.	0	306900	0.81082	X	.	ENSG00000101981	.	0	.	0	0.9992527010438141	2	0.97365	0.18019	.	.	.	.	.	YES	.	0.583299	25644	HGNC:3551	A	.	simple_aae	0.99	.	139561683	CCT	1.000000	.	-	0	0.99736	.	0	.	Pathogenic	0.78441	.	.	.	ClinGen:CA255375,OMIM:300746.0048	P	.	0.995518902514	-	0.971	-	0.92671	.	108	0.99925	0.644322156906	0.6712	.	0.99714179622655752	6	-	998C>T 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.80941	137852252	.	0	0.99540	.	0.859	0.001	434	0.99999225	5.66	.	.	.	0.69351	0.999792545073085	0.79671	D	34	.	.	1.0159	0.97222	p.Pro333Leu	0	.	-10.768	0.99203384	.	0.98009	10605	D	.	F9	.	D	0.920	.	P333L	D	0.89858	0.08747	C/C	principal1	253295	F9_Popp_2025_strep_2_var266385	No											P		998	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Pro333Leu		true	c.998C>T						3551.0	139561683.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Pro333Leu						L	Oct 09, 2017					missense_variant		333.0				0.0257791412491283		Pathogenic	139561683.0	missense_variant		0.92					Reporter			F9_Pro333Leu
BRCA1_Leu660Pro	0.7722291595565172	0.4652467741162628	-0.4813800816904408	0.6449300602568304	2025_01_Batch_13-14	0.6971719961665781	0.7869883368284541	0.8313592527357382	0.834891704386117	0.49776189252515146	0.5429659929631443	0.5390418791814273	0.5403372846854197	0.5283318857429251	0.49704311042399857	0.6200689945648612	0.6630151080049407	0.6858482687105789	0.6816117950645211	0.497402501474575	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218449	CCSBVarC003309	ALE00003309	NC_000017.11:43051104:A:G	1979T>C	Leu660Pro	CEGS2	CegsMutGDEh1027	B03	GDEhDisVCh_40059	B09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Leu660Pro	17	43051104	A	G	17											17-43051104-A-G	-	0.79856	0.999	1764	.	.	.	17	41203121	G	.	.	17	1_Pathogenic	NC_000017.11	.	Leu1764Pro	.	27.2	.	.	.	D	.	12	1	.	.	.	.	.	.	0.88008	.	0.7595	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.46456	.	.	.	.	0.80457	.	.	0.90488	0.96	.	.	0.89611	5.33	.	G	single nucleotide variant	NC_000017.11:g.43051104A>G	.	.	2	0.55023813	.	.	0.8910151	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	.	.	.	.	0.99291	D	0.77645	D	M	5.834971	.	A/A	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	.	0.92204	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43051104	.	-	11.097000	.	0.98304	.	.	.	.	germline;not applicable;unknown	.	.	.	GRCh38	449	reviewed by expert panel	.	.	0.67796	.	.	.	.	.	.	.	.	.	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	3	.	BRCA1_HUMAN	.	.	0.591172089691292	.	D	0.84401	0.89131314	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99835	.	.	.	.	.	.	.	0.86063	.	germline	.		A	Aug 10, 2015	.	A/A	.	.	1.0	N	17q21.31	.	.	.	SCV000244395	Pathogenic	.	.	Pro	P	-	.	ENSP00000478114	ENST00000618469	.	.	.	.	0.756	A	.	4.871541	0.79703	D	.	-	5.826055	.	0.98860	.	.	.	0.85335	.	43051104	Y	10	.	.	.	P38398	.	0.394982	0.97125		.	0.937	D	.	0.6202942	.	0.51684	672	0.436743	.	.	.	.	0.91343	.	.	.	.	.	.	0.73742	17	BRCA1	.	.	Leu	.	.	17-43051104-A-G	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38456647	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	0.796452	0.72477	.	RCV000112604|RCV000509995|RCV000588744|RCV001528204	.	.	.	c.5291T>C	.	.	.	0.91807	A/A	rs80357281	43051104	.	A	.	.	.	0.90460	.	0.68239		.	.	.	2.255	.	.	.	5.06	0.75228	.	D	T	.	.	.	.	.	.	.	145|140162|145	55510	0.91707	0.52805	0.994264304637909	.	.	0.71675	0.72256	.	.	.	5.026	.	.	.	.	.	.	604370	0.63961	17	.	ENSG00000012048	.	.	.	.	.	2	0.77493	0.79449	.	.	.	.	0.566318150584601	.	.	0.852334	70177	HGNC:1100	.	.	.	0.96	.	43051104	CTA	1.000000	.	-	.	0.90949	.	.	.	Pathogenic	0.82186	.	.	.	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	L	.	.	-	.	-	0.93732	.	.	0.82492	0.554721057415	.	.	0.99898762507631778	.	-	5291T>C 	.	.	C3661900|C0677776|C0027672|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.63951	80357281	.	.	0.98778	0.72388	.	.	.	0.99987125	5.06	.	.	.	0.389575	0.997750985165462	0.63995	D	.	.	.	0.6256	0.91786	p.Leu1764Pro	.	.	-11.462	.	.	0.93509	55510	D	.	BRCA1	.	D	.	.	.	.	0.93090	0.943	A/A	principal2	39822	BRCA1_Adamovich_2022_Cisplatin_var6840	No	[-0.729,-0.503]					Cisplatin resistance		Drug Resistance	Not specified		L		5291	BRCA1_Adamovich_2022_Cisplatin		ENST00000357654.9		Abnormal					immortalized human cells					p.Leu1764Pro		true	c.5291T>C				Functional		1100.0	43051104.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-0.923573456;-1.20864809;-1.418871427;-0.888281028			Leu1764Pro		LOF		(-0.503, Inf)		P	Aug 10, 2015		(-Inf, -0.729)			missense_variant		1764.0				-1.1098435	Normal	Pathogenic	43051104.0	missense_variant		0.676		Intermediate			Cell Viability			BRCA1_Leu1764Pro
BRCA1_Leu660Pro	0.7722291595565172	0.4652467741162628	-0.4813800816904408	0.6449300602568304	2025_01_Batch_13-14	0.6971719961665781	0.7869883368284541	0.8313592527357382	0.834891704386117	0.49776189252515146	0.5429659929631443	0.5390418791814273	0.5403372846854197	0.5283318857429251	0.49704311042399857	0.6200689945648612	0.6630151080049407	0.6858482687105789	0.6816117950645211	0.497402501474575	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218449	CCSBVarC003309	ALE00003309	NC_000017.11:43051104:A:G	1979T>C	Leu660Pro	CEGS2	CegsMutGDEh1027	B03	GDEhDisVCh_40059	B09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Leu660Pro	17	43051104	A	G	17											17-43051104-A-G	-	0.79856	0.999	1764	.	.	.	17	41203121	G	.	.	17	1_Pathogenic	NC_000017.11	.	Leu1764Pro	.	27.2	.	.	.	D	.	12	1	.	.	.	.	.	.	0.88008	.	0.7595	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.46456	.	.	.	.	0.80457	.	.	0.90488	0.96	.	.	0.89611	5.33	.	G	single nucleotide variant	NC_000017.11:g.43051104A>G	.	.	2	0.55023813	.	.	0.8910151	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	.	.	.	.	0.99291	D	0.77645	D	M	5.834971	.	A/A	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	.	0.92204	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43051104	.	-	11.097000	.	0.98304	.	.	.	.	germline;not applicable;unknown	.	.	.	GRCh38	449	reviewed by expert panel	.	.	0.67796	.	.	.	.	.	.	.	.	.	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	3	.	BRCA1_HUMAN	.	.	0.591172089691292	.	D	0.84401	0.89131314	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99835	.	.	.	.	.	.	.	0.86063	.	germline	.		A	Aug 10, 2015	.	A/A	.	.	1.0	N	17q21.31	.	.	.	SCV000244395	Pathogenic	.	.	Pro	P	-	.	ENSP00000478114	ENST00000618469	.	.	.	.	0.756	A	.	4.871541	0.79703	D	.	-	5.826055	.	0.98860	.	.	.	0.85335	.	43051104	Y	10	.	.	.	P38398	.	0.394982	0.97125		.	0.937	D	.	0.6202942	.	0.51684	672	0.436743	.	.	.	.	0.91343	.	.	.	.	.	.	0.73742	17	BRCA1	.	.	Leu	.	.	17-43051104-A-G	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38456647	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	0.796452	0.72477	.	RCV000112604|RCV000509995|RCV000588744|RCV001528204	.	.	.	c.5291T>C	.	.	.	0.91807	A/A	rs80357281	43051104	.	A	.	.	.	0.90460	.	0.68239		.	.	.	2.255	.	.	.	5.06	0.75228	.	D	T	.	.	.	.	.	.	.	145|140162|145	55510	0.91707	0.52805	0.994264304637909	.	.	0.71675	0.72256	.	.	.	5.026	.	.	.	.	.	.	604370	0.63961	17	.	ENSG00000012048	.	.	.	.	.	2	0.77493	0.79449	.	.	.	.	0.566318150584601	.	.	0.852334	70177	HGNC:1100	.	.	.	0.96	.	43051104	CTA	1.000000	.	-	.	0.90949	.	.	.	Pathogenic	0.82186	.	.	.	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	L	.	.	-	.	-	0.93732	.	.	0.82492	0.554721057415	.	.	0.99898762507631778	.	-	5291T>C 	.	.	C3661900|C0677776|C0027672|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.63951	80357281	.	.	0.98778	0.72388	.	.	.	0.99987125	5.06	.	.	.	0.389575	0.997750985165462	0.63995	D	.	.	.	0.6256	0.91786	p.Leu1764Pro	.	.	-11.462	.	.	0.93509	55510	D	.	BRCA1	.	D	.	.	.	.	0.93090	0.943	A/A	principal2	48095	BRCA1_Adamovich_2022_HDR_var5452	No	[-0.562,-0.233]					Homology Directed Repair		Fluorescence	Not specified		L		5291	BRCA1_Adamovich_2022_HDR		ENST00000357654.9		Abnormal					immortalized human cells					p.Leu1764Pro		true	c.5291T>C				Functional		1100.0	43051104.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-2.021654763;-1.722566836;-2.060424092;-2.276281712			Leu1764Pro		LOF		(-0.233, Inf)		P	Aug 10, 2015		(-Inf, -0.562)			missense_variant		1764.0				-2.02023185075	Normal	Pathogenic	43051104.0	missense_variant		0.676		Intermediate			Reporter			BRCA1_Leu1764Pro
BRCA1_Leu660Pro	0.7722291595565172	0.4652467741162628	-0.4813800816904408	0.6449300602568304	2025_01_Batch_13-14	0.6971719961665781	0.7869883368284541	0.8313592527357382	0.834891704386117	0.49776189252515146	0.5429659929631443	0.5390418791814273	0.5403372846854197	0.5283318857429251	0.49704311042399857	0.6200689945648612	0.6630151080049407	0.6858482687105789	0.6816117950645211	0.497402501474575	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003309		NC_000017.11:43051104:A:G		Leu660Pro																												BRCA1_Leu660Pro	17	43051104	A	G	17	allele	1979T>C	A08	527_CAVA_Array_P01	A15	B13A7A8P1_R1	B14A7A8P1_R2				17-43051104-A-G	-	0.79856	0.999	1764	.	.	.	17	41203121	G	.	.	17	1_Pathogenic	NC_000017.11	.	Leu1764Pro	.	27.2	.	.	.	D	.	12	1	.	.	.	.	.	.	0.88008	.	0.7595	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.46456	.	.	.	.	0.80457	.	.	0.90488	0.96	.	.	0.89611	5.33	.	G	single nucleotide variant	NC_000017.11:g.43051104A>G	.	.	2	0.55023813	.	.	0.8910151	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	.	.	.	.	0.99291	D	0.77645	D	M	5.834971	.	A/A	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	.	0.92204	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43051104	.	-	11.097000	.	0.98304	.	.	.	.	germline;not applicable;unknown	.	.	.	GRCh38	449	reviewed by expert panel	.	.	0.67796	.	.	.	.	.	.	.	.	.	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	3	.	BRCA1_HUMAN	.	.	0.591172089691292	.	D	0.84401	0.89131314	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99835	.	.	.	.	.	.	.	0.86063	.	germline	.		A	Aug 10, 2015	.	A/A	.	.	1.0	N	17q21.31	.	.	.	SCV000244395	Pathogenic	.	.	Pro	P	-	.	ENSP00000478114	ENST00000618469	.	.	.	.	0.756	A	.	4.871541	0.79703	D	.	-	5.826055	.	0.98860	.	.	.	0.85335	.	43051104	Y	10	.	.	.	P38398	.	0.394982	0.97125		.	0.937	D	.	0.6202942	.	0.51684	672	0.436743	.	.	.	.	0.91343	.	.	.	.	.	.	0.73742	17	BRCA1	.	.	Leu	.	.	17-43051104-A-G	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38456647	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	0.796452	0.72477	.	RCV000112604|RCV000509995|RCV000588744|RCV001528204	.	.	.	c.5291T>C	.	.	.	0.91807	A/A	rs80357281	43051104	.	A	.	.	.	0.90460	.	0.68239		.	.	.	2.255	.	.	.	5.06	0.75228	.	D	T	.	.	.	.	.	.	.	145|140162|145	55510	0.91707	0.52805	0.994264304637909	.	.	0.71675	0.72256	.	.	.	5.026	.	.	.	.	.	.	604370	0.63961	17	.	ENSG00000012048	.	.	.	.	.	2	0.77493	0.79449	.	.	.	.	0.566318150584601	.	.	0.852334	70177	HGNC:1100	.	.	.	0.96	.	43051104	CTA	1.000000	.	-	.	0.90949	.	.	.	Pathogenic	0.82186	.	.	.	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	L	.	.	-	.	-	0.93732	.	.	0.82492	0.554721057415	.	.	0.99898762507631778	.	-	5291T>C 	.	.	C3661900|C0677776|C0027672|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.63951	80357281	.	.	0.98778	0.72388	.	.	.	0.99987125	5.06	.	.	.	0.389575	0.997750985165462	0.63995	D	.	.	.	0.6256	0.91786	p.Leu1764Pro	.	.	-11.462	.	.	0.93509	55510	D	.	BRCA1	.	D	.	.	.	.	0.93090	0.943	A/A	principal2	39822	BRCA1_Adamovich_2022_Cisplatin_var6840	No	[-0.729,-0.503]					Cisplatin resistance		Drug Resistance	Not specified		L		5291	BRCA1_Adamovich_2022_Cisplatin		ENST00000357654.9		Abnormal					immortalized human cells					p.Leu1764Pro		true	c.5291T>C				Functional		1100.0	43051104.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-0.923573456;-1.20864809;-1.418871427;-0.888281028			Leu1764Pro		LOF		(-0.503, Inf)		P	Aug 10, 2015		(-Inf, -0.729)			missense_variant		1764.0				-1.1098435	Normal	Pathogenic	43051104.0	missense_variant		0.676		Intermediate			Cell Viability			BRCA1_Leu1764Pro
BRCA1_Leu660Pro	0.7722291595565172	0.4652467741162628	-0.4813800816904408	0.6449300602568304	2025_01_Batch_13-14	0.6971719961665781	0.7869883368284541	0.8313592527357382	0.834891704386117	0.49776189252515146	0.5429659929631443	0.5390418791814273	0.5403372846854197	0.5283318857429251	0.49704311042399857	0.6200689945648612	0.6630151080049407	0.6858482687105789	0.6816117950645211	0.497402501474575	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003309		NC_000017.11:43051104:A:G		Leu660Pro																												BRCA1_Leu660Pro	17	43051104	A	G	17	allele	1979T>C	A08	527_CAVA_Array_P01	A15	B13A7A8P1_R1	B14A7A8P1_R2				17-43051104-A-G	-	0.79856	0.999	1764	.	.	.	17	41203121	G	.	.	17	1_Pathogenic	NC_000017.11	.	Leu1764Pro	.	27.2	.	.	.	D	.	12	1	.	.	.	.	.	.	0.88008	.	0.7595	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.46456	.	.	.	.	0.80457	.	.	0.90488	0.96	.	.	0.89611	5.33	.	G	single nucleotide variant	NC_000017.11:g.43051104A>G	.	.	2	0.55023813	.	.	0.8910151	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	.	.	.	.	0.99291	D	0.77645	D	M	5.834971	.	A/A	.	.	.	.	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	.	0.92204	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43051104	.	-	11.097000	.	0.98304	.	.	.	.	germline;not applicable;unknown	.	.	.	GRCh38	449	reviewed by expert panel	.	.	0.67796	.	.	.	.	.	.	.	.	.	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	3	.	BRCA1_HUMAN	.	.	0.591172089691292	.	D	0.84401	0.89131314	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99835	.	.	.	.	.	.	.	0.86063	.	germline	.		A	Aug 10, 2015	.	A/A	.	.	1.0	N	17q21.31	.	.	.	SCV000244395	Pathogenic	.	.	Pro	P	-	.	ENSP00000478114	ENST00000618469	.	.	.	.	0.756	A	.	4.871541	0.79703	D	.	-	5.826055	.	0.98860	.	.	.	0.85335	.	43051104	Y	10	.	.	.	P38398	.	0.394982	0.97125		.	0.937	D	.	0.6202942	.	0.51684	672	0.436743	.	.	.	.	0.91343	.	.	.	.	.	.	0.73742	17	BRCA1	.	.	Leu	.	.	17-43051104-A-G	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38456647	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	0.796452	0.72477	.	RCV000112604|RCV000509995|RCV000588744|RCV001528204	.	.	.	c.5291T>C	.	.	.	0.91807	A/A	rs80357281	43051104	.	A	.	.	.	0.90460	.	0.68239		.	.	.	2.255	.	.	.	5.06	0.75228	.	D	T	.	.	.	.	.	.	.	145|140162|145	55510	0.91707	0.52805	0.994264304637909	.	.	0.71675	0.72256	.	.	.	5.026	.	.	.	.	.	.	604370	0.63961	17	.	ENSG00000012048	.	.	.	.	.	2	0.77493	0.79449	.	.	.	.	0.566318150584601	.	.	0.852334	70177	HGNC:1100	.	.	.	0.96	.	43051104	CTA	1.000000	.	-	.	0.90949	.	.	.	Pathogenic	0.82186	.	.	.	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	L	.	.	-	.	-	0.93732	.	.	0.82492	0.554721057415	.	.	0.99898762507631778	.	-	5291T>C 	.	.	C3661900|C0677776|C0027672|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.63951	80357281	.	.	0.98778	0.72388	.	.	.	0.99987125	5.06	.	.	.	0.389575	0.997750985165462	0.63995	D	.	.	.	0.6256	0.91786	p.Leu1764Pro	.	.	-11.462	.	.	0.93509	55510	D	.	BRCA1	.	D	.	.	.	.	0.93090	0.943	A/A	principal2	48095	BRCA1_Adamovich_2022_HDR_var5452	No	[-0.562,-0.233]					Homology Directed Repair		Fluorescence	Not specified		L		5291	BRCA1_Adamovich_2022_HDR		ENST00000357654.9		Abnormal					immortalized human cells					p.Leu1764Pro		true	c.5291T>C				Functional		1100.0	43051104.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-2.021654763;-1.722566836;-2.060424092;-2.276281712			Leu1764Pro		LOF		(-0.233, Inf)		P	Aug 10, 2015		(-Inf, -0.562)			missense_variant		1764.0				-2.02023185075	Normal	Pathogenic	43051104.0	missense_variant		0.676		Intermediate			Reporter			BRCA1_Leu1764Pro
F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	0.6190484411596221	0.6324728600124633	0.5614231522157421	0.5529304178271445	0.5644077790297184	0.5542314805939508	0.6656168471071865	0.5956852555852532	0.6424023932064375	0.47985358105168185	0.5866399608767865	0.6490448535598249	0.5785542039004976	0.5976664055167911	0.5221306800407002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A		Arg3His																												F9_Arg3His	23	139530772	G	A	X	allele	8G>A	D10	527_CAVA_Array_P02	G20	B13A7A8P1_R1	B14A7A8P1_R2				X-139530772-G-A	-	0.09195	0.001	3	7	0	0	X	138612931	A	1.531190e-04	0	X	2_Benign	NC_000023.11	78	Arg3His	5	5.951	3	10	1.823910e-03	T	0	7	1	30950	2.444130e-04	.	19003	0.000000e+00	0	0.80205	Select	0.3975	12062	0.07480	1	.	T	T	46663	0.0904167817641	0.0021231422505307855	0	0.000000e+00	0	0	0.00444	13657	33770	21	3.952570e-04	0.05100	5	.	0.08789	0.697	.	98.0	0.586841	0.286	0.02	A	single nucleotide variant	NC_000023.11:g.139530772G>A	0	12166	2	0.0453144	80300	0	0.04500583	0.0015748031496062992		40	171840	0	0	3.756290e-04	442	1.615510e-04	0	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	22	0	0.000000e+00	0	0.08015	B	0.04300	B	N	.	185	G/G	176	4	5701	1208214	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	13132	0.61281	.	.	-	139530772	1.929490e-03	-	0.503000	24	0.09634	22010	0	57381	4	germline;unknown	56779	.	.	GRCh38	937	reviewed by expert panel	c.8G>A	2.104930e-04	0.16423	29	0	0	.	0.000000e+00	6914	B	0.0011106175033318525	0.000000e+00	NM_000133.4(F9):c.8G>A (p.Arg3His)	3	0	FA9_HUMAN	0	2.0	.	1	T	0.23673	0.04972076	+	1.929490e-03	.		24	0.000000e+00	0	27124	reviewed_by_expert_panel	0.99739	2.739730e-04	2	0.000000e+00	0	45755	p.Arg3His	0	0.19087	.	germline	11		G	Feb 09, 2024	4	G/G	0	64659	0.081	N	Xq27.1	152892	.	1.827600e-03	SCV004363691	Benign	0	0	His	H	-	687	ENSP00000218099	ENST00000218099	13311	0.54	10120	0	0.674	G	0	0.548254	0.07487	.	T	-	.	.	0.68674	950	0	.	0.00022	10	139530772	Y	10	0	73164	2.300970e-04	P00740	0	0.285427	0.03427		0	0.001	D	13132	0.04018554	5701	0.34088	2158	-0.230633	49	0.19	.	1.359330e-03	0.06843	3.015080e-04	0	57381	4.339020e-04	4346	11	0.06085	X	F9	1.359330e-03	0	Arg	177512	1.082600e-04	X-139530772-G-A	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	0	10	138440597	.	.	.	1	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	T	0	0	c.8G>A	0	18	0	0.16278	G/G	rs148060786	139530772	12062	G	.	.	9950	0.07223	0.000000e+00	0.20072		0	0	5.330170e-04	0.205	0	5	264690	0.559	0.65629	6350	T	T	22	4.107110e-05	0	1848	.	0	0	98879	695909	0.62239	0.09995	0.00217856688188496	4886	.	0.22441	.	3.686770e-05	1.827600e-03	893284	0.553	2.635650e-04	N	9911	0	5.4403266E-4	5	306900|301052|300807	0.2318	X	1.823910e-03	ENSG00000101981	0.000000e+00	3.270282290767339E-5	4	0.0027056277056277055	0.607146497614182	2	0.04348	0.14592	19068	144	1.366790e-04	2.404110e-04	.	YES	3.698550e-04	0.062861	684952	HGNC:3551	N	0	simple_aae	0.04	151765	139530772	CGC	0.010000	.	-	0.002046663937781416	0.00265	5.485380e-05	10	1	Benign	0.29885	3	1	11	ClinGen:CA10529706	R	0	0.989276777832	-	.	-	0.23222	42	11712	0.60467	0.199505895376	0.0795	0	0.44299318418515177	280	-	8G>A 	22	3.4153005464480874E-4	C0008533|C5393318|C2749016|C3661900|CN169374	0	0	0	0	NM_000133.4	-	.	.	0	0.21248	148060786	1767	1.6336923700932895E-4	0.98903	.	0.091	0.623	4710	0.99980062	5.08	.	.	2.097760e-04	-0.111328	0.255918012225158	0.09279	T	4502	4649	7072	-0.6784	0.74876	p.Arg3His	5	0	-4.362	0.012512207	78	0.52475	695909	T	24348	F9	0.000000e+00	T	0.532	15968	.	T	0.23548	0.70877	G/G	principal1	151153	F9_Popp_2025_carboxy_gla_motif_var249787	No		7/11/24		2053df3d-ec43-4e86-9818-57fac97974cb							R		8	F9_Popp_2025_carboxy_gla_motif	695909.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA10529706	immortalized human cells		false			p.Arg3His		true	c.8G>A						3551.0	139530772.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa	BA1						PS4,PP3,BP4		The c.8G>A (p.Arg3His) variant is reported at an MAF of 0.001469 (28/19065 alleles) in the African/African American population in gnomAD v2.1.1 with 8 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. gnomAD v3.1.1 reports 13 hemizygotes. REVEL score does not meet thresholds for PP3 or BP4. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BA1	Arg3His	https://erepo.genome.network/evrepo/ui/classification/2053df3d-ec43-4e86-9818-57fac97974cb					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	3.0		hemophilia B	0.0001531185700546	0.8784470844182611		Benign	139530772.0	missense_variant		0.532					Reporter			F9_Arg3His
F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	0.6190484411596221	0.6324728600124633	0.5614231522157421	0.5529304178271445	0.5644077790297184	0.5542314805939508	0.6656168471071865	0.5956852555852532	0.6424023932064375	0.47985358105168185	0.5866399608767865	0.6490448535598249	0.5785542039004976	0.5976664055167911	0.5221306800407002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A		Arg3His																												F9_Arg3His	23	139530772	G	A	X	allele	8G>A	D10	527_CAVA_Array_P02	G20	B13A7A8P1_R1	B14A7A8P1_R2				X-139530772-G-A	-	0.09195	0.001	3	7	0	0	X	138612931	A	1.531190e-04	0	X	2_Benign	NC_000023.11	78	Arg3His	5	5.951	3	10	1.823910e-03	T	0	7	1	30950	2.444130e-04	.	19003	0.000000e+00	0	0.80205	Select	0.3975	12062	0.07480	1	.	T	T	46663	0.0904167817641	0.0021231422505307855	0	0.000000e+00	0	0	0.00444	13657	33770	21	3.952570e-04	0.05100	5	.	0.08789	0.697	.	98.0	0.586841	0.286	0.02	A	single nucleotide variant	NC_000023.11:g.139530772G>A	0	12166	2	0.0453144	80300	0	0.04500583	0.0015748031496062992		40	171840	0	0	3.756290e-04	442	1.615510e-04	0	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	22	0	0.000000e+00	0	0.08015	B	0.04300	B	N	.	185	G/G	176	4	5701	1208214	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	13132	0.61281	.	.	-	139530772	1.929490e-03	-	0.503000	24	0.09634	22010	0	57381	4	germline;unknown	56779	.	.	GRCh38	937	reviewed by expert panel	c.8G>A	2.104930e-04	0.16423	29	0	0	.	0.000000e+00	6914	B	0.0011106175033318525	0.000000e+00	NM_000133.4(F9):c.8G>A (p.Arg3His)	3	0	FA9_HUMAN	0	2.0	.	1	T	0.23673	0.04972076	+	1.929490e-03	.		24	0.000000e+00	0	27124	reviewed_by_expert_panel	0.99739	2.739730e-04	2	0.000000e+00	0	45755	p.Arg3His	0	0.19087	.	germline	11		G	Feb 09, 2024	4	G/G	0	64659	0.081	N	Xq27.1	152892	.	1.827600e-03	SCV004363691	Benign	0	0	His	H	-	687	ENSP00000218099	ENST00000218099	13311	0.54	10120	0	0.674	G	0	0.548254	0.07487	.	T	-	.	.	0.68674	950	0	.	0.00022	10	139530772	Y	10	0	73164	2.300970e-04	P00740	0	0.285427	0.03427		0	0.001	D	13132	0.04018554	5701	0.34088	2158	-0.230633	49	0.19	.	1.359330e-03	0.06843	3.015080e-04	0	57381	4.339020e-04	4346	11	0.06085	X	F9	1.359330e-03	0	Arg	177512	1.082600e-04	X-139530772-G-A	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	0	10	138440597	.	.	.	1	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	T	0	0	c.8G>A	0	18	0	0.16278	G/G	rs148060786	139530772	12062	G	.	.	9950	0.07223	0.000000e+00	0.20072		0	0	5.330170e-04	0.205	0	5	264690	0.559	0.65629	6350	T	T	22	4.107110e-05	0	1848	.	0	0	98879	695909	0.62239	0.09995	0.00217856688188496	4886	.	0.22441	.	3.686770e-05	1.827600e-03	893284	0.553	2.635650e-04	N	9911	0	5.4403266E-4	5	306900|301052|300807	0.2318	X	1.823910e-03	ENSG00000101981	0.000000e+00	3.270282290767339E-5	4	0.0027056277056277055	0.607146497614182	2	0.04348	0.14592	19068	144	1.366790e-04	2.404110e-04	.	YES	3.698550e-04	0.062861	684952	HGNC:3551	N	0	simple_aae	0.04	151765	139530772	CGC	0.010000	.	-	0.002046663937781416	0.00265	5.485380e-05	10	1	Benign	0.29885	3	1	11	ClinGen:CA10529706	R	0	0.989276777832	-	.	-	0.23222	42	11712	0.60467	0.199505895376	0.0795	0	0.44299318418515177	280	-	8G>A 	22	3.4153005464480874E-4	C0008533|C5393318|C2749016|C3661900|CN169374	0	0	0	0	NM_000133.4	-	.	.	0	0.21248	148060786	1767	1.6336923700932895E-4	0.98903	.	0.091	0.623	4710	0.99980062	5.08	.	.	2.097760e-04	-0.111328	0.255918012225158	0.09279	T	4502	4649	7072	-0.6784	0.74876	p.Arg3His	5	0	-4.362	0.012512207	78	0.52475	695909	T	24348	F9	0.000000e+00	T	0.532	15968	.	T	0.23548	0.70877	G/G	principal1	206185	F9_Popp_2025_light_chain_var240106	No		7/11/24		2053df3d-ec43-4e86-9818-57fac97974cb							R		8	F9_Popp_2025_light_chain	695909.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA10529706	immortalized human cells		false			p.Arg3His		true	c.8G>A						3551.0	139530772.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa	BA1						PS4,PP3,BP4		The c.8G>A (p.Arg3His) variant is reported at an MAF of 0.001469 (28/19065 alleles) in the African/African American population in gnomAD v2.1.1 with 8 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. gnomAD v3.1.1 reports 13 hemizygotes. REVEL score does not meet thresholds for PP3 or BP4. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BA1	Arg3His	https://erepo.genome.network/evrepo/ui/classification/2053df3d-ec43-4e86-9818-57fac97974cb					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	3.0		hemophilia B	0.0001531185700546	0.9370607228975518		Benign	139530772.0	missense_variant		0.532					Reporter			F9_Arg3His
F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	0.6190484411596221	0.6324728600124633	0.5614231522157421	0.5529304178271445	0.5644077790297184	0.5542314805939508	0.6656168471071865	0.5956852555852532	0.6424023932064375	0.47985358105168185	0.5866399608767865	0.6490448535598249	0.5785542039004976	0.5976664055167911	0.5221306800407002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A		Arg3His																												F9_Arg3His	23	139530772	G	A	X	allele	8G>A	D10	527_CAVA_Array_P02	G20	B13A7A8P1_R1	B14A7A8P1_R2				X-139530772-G-A	-	0.09195	0.001	3	7	0	0	X	138612931	A	1.531190e-04	0	X	2_Benign	NC_000023.11	78	Arg3His	5	5.951	3	10	1.823910e-03	T	0	7	1	30950	2.444130e-04	.	19003	0.000000e+00	0	0.80205	Select	0.3975	12062	0.07480	1	.	T	T	46663	0.0904167817641	0.0021231422505307855	0	0.000000e+00	0	0	0.00444	13657	33770	21	3.952570e-04	0.05100	5	.	0.08789	0.697	.	98.0	0.586841	0.286	0.02	A	single nucleotide variant	NC_000023.11:g.139530772G>A	0	12166	2	0.0453144	80300	0	0.04500583	0.0015748031496062992		40	171840	0	0	3.756290e-04	442	1.615510e-04	0	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	22	0	0.000000e+00	0	0.08015	B	0.04300	B	N	.	185	G/G	176	4	5701	1208214	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	13132	0.61281	.	.	-	139530772	1.929490e-03	-	0.503000	24	0.09634	22010	0	57381	4	germline;unknown	56779	.	.	GRCh38	937	reviewed by expert panel	c.8G>A	2.104930e-04	0.16423	29	0	0	.	0.000000e+00	6914	B	0.0011106175033318525	0.000000e+00	NM_000133.4(F9):c.8G>A (p.Arg3His)	3	0	FA9_HUMAN	0	2.0	.	1	T	0.23673	0.04972076	+	1.929490e-03	.		24	0.000000e+00	0	27124	reviewed_by_expert_panel	0.99739	2.739730e-04	2	0.000000e+00	0	45755	p.Arg3His	0	0.19087	.	germline	11		G	Feb 09, 2024	4	G/G	0	64659	0.081	N	Xq27.1	152892	.	1.827600e-03	SCV004363691	Benign	0	0	His	H	-	687	ENSP00000218099	ENST00000218099	13311	0.54	10120	0	0.674	G	0	0.548254	0.07487	.	T	-	.	.	0.68674	950	0	.	0.00022	10	139530772	Y	10	0	73164	2.300970e-04	P00740	0	0.285427	0.03427		0	0.001	D	13132	0.04018554	5701	0.34088	2158	-0.230633	49	0.19	.	1.359330e-03	0.06843	3.015080e-04	0	57381	4.339020e-04	4346	11	0.06085	X	F9	1.359330e-03	0	Arg	177512	1.082600e-04	X-139530772-G-A	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	0	10	138440597	.	.	.	1	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	T	0	0	c.8G>A	0	18	0	0.16278	G/G	rs148060786	139530772	12062	G	.	.	9950	0.07223	0.000000e+00	0.20072		0	0	5.330170e-04	0.205	0	5	264690	0.559	0.65629	6350	T	T	22	4.107110e-05	0	1848	.	0	0	98879	695909	0.62239	0.09995	0.00217856688188496	4886	.	0.22441	.	3.686770e-05	1.827600e-03	893284	0.553	2.635650e-04	N	9911	0	5.4403266E-4	5	306900|301052|300807	0.2318	X	1.823910e-03	ENSG00000101981	0.000000e+00	3.270282290767339E-5	4	0.0027056277056277055	0.607146497614182	2	0.04348	0.14592	19068	144	1.366790e-04	2.404110e-04	.	YES	3.698550e-04	0.062861	684952	HGNC:3551	N	0	simple_aae	0.04	151765	139530772	CGC	0.010000	.	-	0.002046663937781416	0.00265	5.485380e-05	10	1	Benign	0.29885	3	1	11	ClinGen:CA10529706	R	0	0.989276777832	-	.	-	0.23222	42	11712	0.60467	0.199505895376	0.0795	0	0.44299318418515177	280	-	8G>A 	22	3.4153005464480874E-4	C0008533|C5393318|C2749016|C3661900|CN169374	0	0	0	0	NM_000133.4	-	.	.	0	0.21248	148060786	1767	1.6336923700932895E-4	0.98903	.	0.091	0.623	4710	0.99980062	5.08	.	.	2.097760e-04	-0.111328	0.255918012225158	0.09279	T	4502	4649	7072	-0.6784	0.74876	p.Arg3His	5	0	-4.362	0.012512207	78	0.52475	695909	T	24348	F9	0.000000e+00	T	0.532	15968	.	T	0.23548	0.70877	G/G	principal1	233701	F9_Popp_2025_strep_2_var259468	No		7/11/24		2053df3d-ec43-4e86-9818-57fac97974cb							R		8	F9_Popp_2025_strep_2	695909.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA10529706	immortalized human cells		false			p.Arg3His		true	c.8G>A						3551.0	139530772.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa	BA1						PS4,PP3,BP4		The c.8G>A (p.Arg3His) variant is reported at an MAF of 0.001469 (28/19065 alleles) in the African/African American population in gnomAD v2.1.1 with 8 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. gnomAD v3.1.1 reports 13 hemizygotes. REVEL score does not meet thresholds for PP3 or BP4. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BA1	Arg3His	https://erepo.genome.network/evrepo/ui/classification/2053df3d-ec43-4e86-9818-57fac97974cb					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	3.0		hemophilia B	0.0001531185700546	0.8685173675071735		Benign	139530772.0	missense_variant		0.532					Reporter			F9_Arg3His
F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	0.6190484411596221	0.6324728600124633	0.5614231522157421	0.5529304178271445	0.5644077790297184	0.5542314805939508	0.6656168471071865	0.5956852555852532	0.6424023932064375	0.47985358105168185	0.5866399608767865	0.6490448535598249	0.5785542039004976	0.5976664055167911	0.5221306800407002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A		Arg3His																												F9_Arg3His	23	139530772	G	A	X	allele	8G>A	D10	527_CAVA_Array_P02	G20	B13A7A8P1_R1	B14A7A8P1_R2				X-139530772-G-A	-	0.09195	0.001	3	7	0	0	X	138612931	A	1.531190e-04	0	X	2_Benign	NC_000023.11	78	Arg3His	5	5.951	3	10	1.823910e-03	T	0	7	1	30950	2.444130e-04	.	19003	0.000000e+00	0	0.80205	Select	0.3975	12062	0.07480	1	.	T	T	46663	0.0904167817641	0.0021231422505307855	0	0.000000e+00	0	0	0.00444	13657	33770	21	3.952570e-04	0.05100	5	.	0.08789	0.697	.	98.0	0.586841	0.286	0.02	A	single nucleotide variant	NC_000023.11:g.139530772G>A	0	12166	2	0.0453144	80300	0	0.04500583	0.0015748031496062992		40	171840	0	0	3.756290e-04	442	1.615510e-04	0	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	22	0	0.000000e+00	0	0.08015	B	0.04300	B	N	.	185	G/G	176	4	5701	1208214	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	13132	0.61281	.	.	-	139530772	1.929490e-03	-	0.503000	24	0.09634	22010	0	57381	4	germline;unknown	56779	.	.	GRCh38	937	reviewed by expert panel	c.8G>A	2.104930e-04	0.16423	29	0	0	.	0.000000e+00	6914	B	0.0011106175033318525	0.000000e+00	NM_000133.4(F9):c.8G>A (p.Arg3His)	3	0	FA9_HUMAN	0	2.0	.	1	T	0.23673	0.04972076	+	1.929490e-03	.		24	0.000000e+00	0	27124	reviewed_by_expert_panel	0.99739	2.739730e-04	2	0.000000e+00	0	45755	p.Arg3His	0	0.19087	.	germline	11		G	Feb 09, 2024	4	G/G	0	64659	0.081	N	Xq27.1	152892	.	1.827600e-03	SCV004363691	Benign	0	0	His	H	-	687	ENSP00000218099	ENST00000218099	13311	0.54	10120	0	0.674	G	0	0.548254	0.07487	.	T	-	.	.	0.68674	950	0	.	0.00022	10	139530772	Y	10	0	73164	2.300970e-04	P00740	0	0.285427	0.03427		0	0.001	D	13132	0.04018554	5701	0.34088	2158	-0.230633	49	0.19	.	1.359330e-03	0.06843	3.015080e-04	0	57381	4.339020e-04	4346	11	0.06085	X	F9	1.359330e-03	0	Arg	177512	1.082600e-04	X-139530772-G-A	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	0	10	138440597	.	.	.	1	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	T	0	0	c.8G>A	0	18	0	0.16278	G/G	rs148060786	139530772	12062	G	.	.	9950	0.07223	0.000000e+00	0.20072		0	0	5.330170e-04	0.205	0	5	264690	0.559	0.65629	6350	T	T	22	4.107110e-05	0	1848	.	0	0	98879	695909	0.62239	0.09995	0.00217856688188496	4886	.	0.22441	.	3.686770e-05	1.827600e-03	893284	0.553	2.635650e-04	N	9911	0	5.4403266E-4	5	306900|301052|300807	0.2318	X	1.823910e-03	ENSG00000101981	0.000000e+00	3.270282290767339E-5	4	0.0027056277056277055	0.607146497614182	2	0.04348	0.14592	19068	144	1.366790e-04	2.404110e-04	.	YES	3.698550e-04	0.062861	684952	HGNC:3551	N	0	simple_aae	0.04	151765	139530772	CGC	0.010000	.	-	0.002046663937781416	0.00265	5.485380e-05	10	1	Benign	0.29885	3	1	11	ClinGen:CA10529706	R	0	0.989276777832	-	.	-	0.23222	42	11712	0.60467	0.199505895376	0.0795	0	0.44299318418515177	280	-	8G>A 	22	3.4153005464480874E-4	C0008533|C5393318|C2749016|C3661900|CN169374	0	0	0	0	NM_000133.4	-	.	.	0	0.21248	148060786	1767	1.6336923700932895E-4	0.98903	.	0.091	0.623	4710	0.99980062	5.08	.	.	2.097760e-04	-0.111328	0.255918012225158	0.09279	T	4502	4649	7072	-0.6784	0.74876	p.Arg3His	5	0	-4.362	0.012512207	78	0.52475	695909	T	24348	F9	0.000000e+00	T	0.532	15968	.	T	0.23548	0.70877	G/G	principal1	178669	F9_Popp_2025_heavy_chain_var230425	No		7/11/24		2053df3d-ec43-4e86-9818-57fac97974cb							R		8	F9_Popp_2025_heavy_chain	695909.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA10529706	immortalized human cells		false			p.Arg3His		true	c.8G>A						3551.0	139530772.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa	BA1						PS4,PP3,BP4		The c.8G>A (p.Arg3His) variant is reported at an MAF of 0.001469 (28/19065 alleles) in the African/African American population in gnomAD v2.1.1 with 8 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. gnomAD v3.1.1 reports 13 hemizygotes. REVEL score does not meet thresholds for PP3 or BP4. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BA1	Arg3His	https://erepo.genome.network/evrepo/ui/classification/2053df3d-ec43-4e86-9818-57fac97974cb					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	3.0		hemophilia B	0.0001531185700546	0.8552991604647007		Benign	139530772.0	missense_variant		0.532					Reporter			F9_Arg3His
F9_Arg3His	-0.6646270003672425	0.5275693100249713	0.8991095686215548	0.3984661560449298	2025_01_Batch_13-14	0.6190484411596221	0.6324728600124633	0.5614231522157421	0.5529304178271445	0.5644077790297184	0.5542314805939508	0.6656168471071865	0.5956852555852532	0.6424023932064375	0.47985358105168185	0.5866399608767865	0.6490448535598249	0.5785542039004976	0.5976664055167911	0.5221306800407002	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030452		NC_000023.11:139530772:G:A		Arg3His																												F9_Arg3His	23	139530772	G	A	X	allele	8G>A	D10	527_CAVA_Array_P02	G20	B13A7A8P1_R1	B14A7A8P1_R2				X-139530772-G-A	-	0.09195	0.001	3	7	0	0	X	138612931	A	1.531190e-04	0	X	2_Benign	NC_000023.11	78	Arg3His	5	5.951	3	10	1.823910e-03	T	0	7	1	30950	2.444130e-04	.	19003	0.000000e+00	0	0.80205	Select	0.3975	12062	0.07480	1	.	T	T	46663	0.0904167817641	0.0021231422505307855	0	0.000000e+00	0	0	0.00444	13657	33770	21	3.952570e-04	0.05100	5	.	0.08789	0.697	.	98.0	0.586841	0.286	0.02	A	single nucleotide variant	NC_000023.11:g.139530772G>A	0	12166	2	0.0453144	80300	0	0.04500583	0.0015748031496062992		40	171840	0	0	3.756290e-04	442	1.615510e-04	0	MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	22	0	0.000000e+00	0	0.08015	B	0.04300	B	N	.	185	G/G	176	4	5701	1208214	not provided|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|Hereditary factor IX deficiency disease|F9-related disorder	13132	0.61281	.	.	-	139530772	1.929490e-03	-	0.503000	24	0.09634	22010	0	57381	4	germline;unknown	56779	.	.	GRCh38	937	reviewed by expert panel	c.8G>A	2.104930e-04	0.16423	29	0	0	.	0.000000e+00	6914	B	0.0011106175033318525	0.000000e+00	NM_000133.4(F9):c.8G>A (p.Arg3His)	3	0	FA9_HUMAN	0	2.0	.	1	T	0.23673	0.04972076	+	1.929490e-03	.		24	0.000000e+00	0	27124	reviewed_by_expert_panel	0.99739	2.739730e-04	2	0.000000e+00	0	45755	p.Arg3His	0	0.19087	.	germline	11		G	Feb 09, 2024	4	G/G	0	64659	0.081	N	Xq27.1	152892	.	1.827600e-03	SCV004363691	Benign	0	0	His	H	-	687	ENSP00000218099	ENST00000218099	13311	0.54	10120	0	0.674	G	0	0.548254	0.07487	.	T	-	.	.	0.68674	950	0	.	0.00022	10	139530772	Y	10	0	73164	2.300970e-04	P00740	0	0.285427	0.03427		0	0.001	D	13132	0.04018554	5701	0.34088	2158	-0.230633	49	0.19	.	1.359330e-03	0.06843	3.015080e-04	0	57381	4.339020e-04	4346	11	0.06085	X	F9	1.359330e-03	0	Arg	177512	1.082600e-04	X-139530772-G-A	Hereditary_factor_IX_deficiency_disease|Warfarin_sensitivity,_X-linked|Thrombophilia,_X-linked,_due_to_factor_9_defect|F9-related_disorder|not_provided|not_specified	0	10	138440597	.	.	.	1	RCV000861920|RCV001081775|RCV002265904|RCV002478952|RCV001825712|RCV003965649	T	0	0	c.8G>A	0	18	0	0.16278	G/G	rs148060786	139530772	12062	G	.	.	9950	0.07223	0.000000e+00	0.20072		0	0	5.330170e-04	0.205	0	5	264690	0.559	0.65629	6350	T	T	22	4.107110e-05	0	1848	.	0	0	98879	695909	0.62239	0.09995	0.00217856688188496	4886	.	0.22441	.	3.686770e-05	1.827600e-03	893284	0.553	2.635650e-04	N	9911	0	5.4403266E-4	5	306900|301052|300807	0.2318	X	1.823910e-03	ENSG00000101981	0.000000e+00	3.270282290767339E-5	4	0.0027056277056277055	0.607146497614182	2	0.04348	0.14592	19068	144	1.366790e-04	2.404110e-04	.	YES	3.698550e-04	0.062861	684952	HGNC:3551	N	0	simple_aae	0.04	151765	139530772	CGC	0.010000	.	-	0.002046663937781416	0.00265	5.485380e-05	10	1	Benign	0.29885	3	1	11	ClinGen:CA10529706	R	0	0.989276777832	-	.	-	0.23222	42	11712	0.60467	0.199505895376	0.0795	0	0.44299318418515177	280	-	8G>A 	22	3.4153005464480874E-4	C0008533|C5393318|C2749016|C3661900|CN169374	0	0	0	0	NM_000133.4	-	.	.	0	0.21248	148060786	1767	1.6336923700932895E-4	0.98903	.	0.091	0.623	4710	0.99980062	5.08	.	.	2.097760e-04	-0.111328	0.255918012225158	0.09279	T	4502	4649	7072	-0.6784	0.74876	p.Arg3His	5	0	-4.362	0.012512207	78	0.52475	695909	T	24348	F9	0.000000e+00	T	0.532	15968	.	T	0.23548	0.70877	G/G	principal1	123637	F9_Popp_2025_carboxy_F9_specific_var220744	No		7/11/24		2053df3d-ec43-4e86-9818-57fac97974cb							R		8	F9_Popp_2025_carboxy_F9_specific	695909.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA10529706	immortalized human cells		false			p.Arg3His		true	c.8G>A						3551.0	139530772.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa	BA1						PS4,PP3,BP4		The c.8G>A (p.Arg3His) variant is reported at an MAF of 0.001469 (28/19065 alleles) in the African/African American population in gnomAD v2.1.1 with 8 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. gnomAD v3.1.1 reports 13 hemizygotes. REVEL score does not meet thresholds for PP3 or BP4. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BA1	Arg3His	https://erepo.genome.network/evrepo/ui/classification/2053df3d-ec43-4e86-9818-57fac97974cb					H	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	3.0		hemophilia B	0.0001531185700546	0.9984466091759258		Benign	139530772.0	missense_variant		0.532					Reporter			F9_Arg3His
BCL10_Leu8Leu	-1.5935383687852434	0.1862617008735539	1.7560029875605396	0.12251506527087934	2025_01_Batch_13-14	0.5357539018783427	0.6352976459867357	0.6633090920136241	0.6918685112520384	0.4938630142328672	0.8823529411764706	0.7592329523787694	0.7647016099856008	0.8212394456232323	0.579185520361991	0.7090534215274067	0.6972652991827526	0.7140053509996125	0.7565539784376354	0.5365242672974291	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BCL10	BCL10	ENSG00000142867	11832	20121	CCSBVarC001764	ALE00001764	NC_000001.11:85276329:G:C	24C>G	Leu8Leu	RC4	RC4_Mut_GDEh1005	A04	GDEhDisVCh_40010	E03	2	RC4_Mut_GDDh1005	A04	NULL	NULL	VUSMutpDEST2_09	G09	VUSmut_GDEh12	C07	1	1	1	1	0			1	1	1	1	1	1	BCL10_Leu8Leu	1	85276329	G	C	1											1-85276329-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						
BCL10_Leu8Leu	-1.5935383687852434	0.1862617008735539	1.7560029875605396	0.12251506527087934	2025_01_Batch_13-14	0.5357539018783427	0.6352976459867357	0.6633090920136241	0.6918685112520384	0.4938630142328672	0.8823529411764706	0.7592329523787694	0.7647016099856008	0.8212394456232323	0.579185520361991	0.7090534215274067	0.6972652991827526	0.7140053509996125	0.7565539784376354	0.5365242672974291	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BCL10	BCL10		11832		CCSBVarC001764		NC_000001.11:85276329:G:C		Leu8Leu																												BCL10_Leu8Leu	1	85276329	G	C	1	allele	24C>G	D03	527_CAVA_Array_P01	G05	B13A7A8P1_R1	B14A7A8P1_R2				1-85276329-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						
BCL10_Leu8Leu	-1.5935383687852434	0.1862617008735539	1.7560029875605396	0.12251506527087934	2025_01_Batch_13-14	0.5357539018783427	0.6352976459867357	0.6633090920136241	0.6918685112520384	0.4938630142328672	0.8823529411764706	0.7592329523787694	0.7647016099856008	0.8212394456232323	0.579185520361991	0.7090534215274067	0.6972652991827526	0.7140053509996125	0.7565539784376354	0.5365242672974291	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BCL10	BCL10				CCSBVarC001764	ALE00001764	NC_000001.11:85276329:G:C	24C>G	Leu8Leu	CAVA																											BCL10_Leu8Leu	1	85276329	G	C	1								1	1	1	1-85276329-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																						
CTCF_Arg283His	-2.8543577306982333	0.029015397120621497	7.650237629061512	0.00012112361894122482																											CTCF	CTCF		6173		CCSBVarC010089		NC_000016.10:67612017:G:A		Arg283His																												CTCF_Arg283His	16	67612017	G	A	16	allele	848G>A	H02	527_CAVA_Array_P02	O04	B13A7A8P1_R1	B14A7A8P1_R2				16-67612017-G-A	-	0.91538	1.0	283	.	0	.	16	67645920	A	6.195380e-07	.	16	1_Pathogenic	NC_000016.10	1	Arg283His	.	32.0	.	.	.	T	0	2	.	.	.	.	.	.	.	0.76627	.	0.1674	.	0.90580	.	.	D	D	64016	.	.	0	.	.	.	0.99055	.	44878	0	.	0.79176	.	.	0.71095	0.982	.	.	0.90471	4.73	.	A	single nucleotide variant	NC_000016.10:g.67612017G>A	0	.	2	0.5171902	.	.	0.6065627	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611	.	.	0.000000e+00	0	0.86984	D	0.70979	D	M	10.48455	1	G/G	.	.	.	1614106	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome	.	0.49824	.	.	-	67612017	.	-	11.852000	.	0.97139	29606	.	1179998	.	de novo	91084	Gain of ubiquitination at K286 (P = 0.0316)| Gain of catalytic residue at R283 (P = 0.0879)| Loss of helix (P = 0.1299)| Loss of phosphorylation at S287 (P = 0.1428)| Loss of MoRF binding (P = 0.1691)	0.51309	GRCh38	55	criteria provided, multiple submitters, no conflicts	c.848G>A	.	0.71100	.	.	.	Zinc finger C2H2-type|Zinc finger C2H2-type|Zinc finger C2H2-type|Zinc finger C2H2-type	.	.	P	.	0.000000e+00	NM_006565.4(CTCF):c.848G>A (p.Arg283His)	2	.	CTCF_HUMAN	.	.	0.877484641891404	.	D	0.98152	0.5759158	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.90157	.	0	.	.	60010	p.Arg283His	0	0.98109	.	germline	.		G	Dec 21, 2019	.	G/G	.	.	1.0	N	16q22.1	.	.	.	SCV000809090|SCV002026290	Likely_pathogenic	.	.	His	H	-	912	ENSP00000495348	ENST00000645699	.	.	.	.	0.676	G	.	5.495371	0.92967	D	.	-	12.06598	.	0.34485	.	.	.	0.82143	.	67612017	Y	10	.	.	0.000000e+00	P49711	.	0.828034	0.99901		.	0.995	T	.	0.50243187	.	0.59239	10664	0.123205	1	.	.	8.474590e-07	0.78662	.	.	75034	.	6062	.	0.71847	16	CTCF	0.000000e+00	.	Arg	.	.	16-67612017-G-A	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome	0	.	66203421	.	0.927010	0.90563	0	RCV000681644	D	0	.	c.848G>A	.	0	0	0.66453	G/G	rs1567609067	67612017	.	G	.	P49711	.	0.72760	.	0.68239		.	.	0.000000e+00	2.24	.	.	.	5.18	0.95832	.	D	D	.	.	.	.	.	.	.	363611	562205	0.66034	0.99706	0.991913670484721	.	.	0.71675	0.90866	.	.	1179998	10.003	.	.	.	.	.	.	615502	0.9969	16	.	ENSG00000102974	0.000000e+00	.	.	.	.	2	0.83178	0.97558	.	.	.	0.000000e+00	0.857972629028617	.	0.000000e+00	0.014554	553394	HGNC:13723	.	.	.	0.94	.	67612017	CGT	1.000000	.	-	.	0.70446	8.474590e-07	.	0	Likely pathogenic	0.93215	.	0	0	ClinGen:CA396309112	R	.	.	-	0.452	-	0.58756	.	.	0.91243	0.931223094463	0.9988	0	0.99945887693281887	.	-	848G>A 	.	.	C3809686	.	.	.	.	NM_006565.4	-	.	.	1	0.67082	1567609067	.	.	0.73499	0.93436	.	.	.	0.86772230	5.18	.	.	.	-0.0608014	0.988895031134616	0.63167	T	.	.	.	-0.8767	0.50470	p.Arg283His	.	0	-14.045	0.6709697	0	0.87966	562205	D	.	CTCF	.	T	.	.	R283H	.	0.87084	0.76753	G/G	principal4	963647	CTCF_unpublished_var157894	Yes						overall function		Cell survival			R		848	CTCF_unpublished		ENST00000264010.10							immortalized human cells					p.Arg283His		true	c.848G>A						13723.0	67612017.0	Yes		CTCF				NM_006565.4		1.0			nucleotide		A									criteria provided, multiple submitters, no conflicts				Arg283His						H	Dec 21, 2019					missense_variant		283.0	G		6.195379981240389e-7	-0.00907555		Likely pathogenic	67612017.0	missense_variant		0.475	functionally_normal				Cell viability			CTCF_Arg283His
F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	0.78191504566733	0.7122875845034075	0.8207417031739346	0.8195747191013218	0.6111011003177287	0.5172996797401919	0.8062380577818159	0.9299567912089567	0.8863257136043384	0.7062120218580621	0.649607362703761	0.7592628211426117	0.8753492471914457	0.8529502163528302	0.6586565610878954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A		Phe395Ile																												F9_Phe395Ile	23	139561868	T	A	X	allele	1183T>A	F04	527_CAVA_Array_P02	K08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561868-T-A	-	0.69364	1.0	395	.	.	.	X	138644027	A	.	.	X	1_Pathogenic	NC_000023.11	.	Phe395Ile	.	25.4	.	0	.	D	.	1	1	.	.	.	.	.	0	0.96866	Select	0.6139	.	0.90580	.	.	D	D	.	1.94421044628	0	.	.	.	.	0.65668	.	.	.	.	0.89297	.	.	0.99591	0.999	.	0.0	0.906209	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561868T>A	.	.	2	0.9672711	.	0	0.9748932	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.99291	D	0.99587	D	L	.	.	T/T	114	0	.	.	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	.	0.89027	.	.	-	139561868	.	-	7.926000	.	0.99826	.	0	.	.	germline	.	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.97889	GRCh38	924	criteria provided, single submitter	c.1183T>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	1	.	FA9_HUMAN	.	100.0	.	.	D	0.73049	0.9870631	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Phe395Ile	.	0.74810	.	germline	.		T	Apr 18, 2021	.	T/T	.	.	1.0	N	Xq27.1	9690	.	.	SCV002132959	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.455722	0.92967	.	D	-	.	.	0.99041	610	.	.	0.95561	0	139561868	Y	10	0	.	.	P00740	.	0.860248	0.55483		.	0.98	D	.	0.9731375	.	0.91597	2158	0.52535	.	-5.97	.	.	0.91343	.	.	.	.	.	.	0.99332	X	F9	.	0	Phe	14050	.	X-139561868-T-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138471693	.	.	.	.	RCV001905309	D	.	.	c.1183T>A	.	.	.	0.94991	T/T	rs1175050951	139561868	.	T	.	P00740	.	0.98675	.	0.68239		.	.	.	0.935	0	0	264690	5.66	0.96868	112	D	T	.	.	0	26	.	.	.	98879	1364269	0.94917	0.93244	0.99892920255661	2898	.	0.71675	.	.	.	.	7.991	.	D	.	.	1.51120175E-5	0	306900|300807	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9980519219227515	1	0.74847	0.18019	.	4	.	.	.	YES	.	0.874725	1386208	HGNC:3551	D	.	simple_aae	0.995	.	139561868	TTC	1.000000	.	-	0	0.98730	.	0	.	Pathogenic	0.63197	.	.	.	ClinGen:CA414446355	F	.	0.999082510293	-	0.903	-	0.95387	.	496	0.99804	0.69013696909	0.6552	.	0.99205605394600549	98	-	1183T>A 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.66886	1175050951	.	0	0.99905	.	0.694	0.0	2784	0.99998820	5.66	.	.	.	0.516853	0.999904283247364	0.23470	D	86	.	.	0.3983	0.86302	p.Phe395Ile	0	.	-7.756	0.98510087	.	0.98723	1364269	D	.	F9	.	D	0.891	.	F395I	D	.	0.62996	T/T	principal1	146958	F9_Popp_2025_carboxy_F9_specific_var228962	No											F		1183	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Phe395Ile		true	c.1183T>A						3551.0	139561868.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Phe395Ile						I	Apr 18, 2021					missense_variant		395.0				0.0292381837381701		Pathogenic	139561868.0	missense_variant		0.891					Reporter			F9_Phe395Ile
F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	0.78191504566733	0.7122875845034075	0.8207417031739346	0.8195747191013218	0.6111011003177287	0.5172996797401919	0.8062380577818159	0.9299567912089567	0.8863257136043384	0.7062120218580621	0.649607362703761	0.7592628211426117	0.8753492471914457	0.8529502163528302	0.6586565610878954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A		Phe395Ile																												F9_Phe395Ile	23	139561868	T	A	X	allele	1183T>A	F04	527_CAVA_Array_P02	K08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561868-T-A	-	0.69364	1.0	395	.	.	.	X	138644027	A	.	.	X	1_Pathogenic	NC_000023.11	.	Phe395Ile	.	25.4	.	0	.	D	.	1	1	.	.	.	.	.	0	0.96866	Select	0.6139	.	0.90580	.	.	D	D	.	1.94421044628	0	.	.	.	.	0.65668	.	.	.	.	0.89297	.	.	0.99591	0.999	.	0.0	0.906209	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561868T>A	.	.	2	0.9672711	.	0	0.9748932	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.99291	D	0.99587	D	L	.	.	T/T	114	0	.	.	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	.	0.89027	.	.	-	139561868	.	-	7.926000	.	0.99826	.	0	.	.	germline	.	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.97889	GRCh38	924	criteria provided, single submitter	c.1183T>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	1	.	FA9_HUMAN	.	100.0	.	.	D	0.73049	0.9870631	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Phe395Ile	.	0.74810	.	germline	.		T	Apr 18, 2021	.	T/T	.	.	1.0	N	Xq27.1	9690	.	.	SCV002132959	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.455722	0.92967	.	D	-	.	.	0.99041	610	.	.	0.95561	0	139561868	Y	10	0	.	.	P00740	.	0.860248	0.55483		.	0.98	D	.	0.9731375	.	0.91597	2158	0.52535	.	-5.97	.	.	0.91343	.	.	.	.	.	.	0.99332	X	F9	.	0	Phe	14050	.	X-139561868-T-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138471693	.	.	.	.	RCV001905309	D	.	.	c.1183T>A	.	.	.	0.94991	T/T	rs1175050951	139561868	.	T	.	P00740	.	0.98675	.	0.68239		.	.	.	0.935	0	0	264690	5.66	0.96868	112	D	T	.	.	0	26	.	.	.	98879	1364269	0.94917	0.93244	0.99892920255661	2898	.	0.71675	.	.	.	.	7.991	.	D	.	.	1.51120175E-5	0	306900|300807	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9980519219227515	1	0.74847	0.18019	.	4	.	.	.	YES	.	0.874725	1386208	HGNC:3551	D	.	simple_aae	0.995	.	139561868	TTC	1.000000	.	-	0	0.98730	.	0	.	Pathogenic	0.63197	.	.	.	ClinGen:CA414446355	F	.	0.999082510293	-	0.903	-	0.95387	.	496	0.99804	0.69013696909	0.6552	.	0.99205605394600549	98	-	1183T>A 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.66886	1175050951	.	0	0.99905	.	0.694	0.0	2784	0.99998820	5.66	.	.	.	0.516853	0.999904283247364	0.23470	D	86	.	.	0.3983	0.86302	p.Phe395Ile	0	.	-7.756	0.98510087	.	0.98723	1364269	D	.	F9	.	D	0.891	.	F395I	D	.	0.62996	T/T	principal1	257022	F9_Popp_2025_strep_2_var267686	No											F		1183	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Phe395Ile		true	c.1183T>A						3551.0	139561868.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Phe395Ile						I	Apr 18, 2021					missense_variant		395.0				0.2464381922978602		Pathogenic	139561868.0	missense_variant		0.891					Reporter			F9_Phe395Ile
F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	0.78191504566733	0.7122875845034075	0.8207417031739346	0.8195747191013218	0.6111011003177287	0.5172996797401919	0.8062380577818159	0.9299567912089567	0.8863257136043384	0.7062120218580621	0.649607362703761	0.7592628211426117	0.8753492471914457	0.8529502163528302	0.6586565610878954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A		Phe395Ile																												F9_Phe395Ile	23	139561868	T	A	X	allele	1183T>A	F04	527_CAVA_Array_P02	K08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561868-T-A	-	0.69364	1.0	395	.	.	.	X	138644027	A	.	.	X	1_Pathogenic	NC_000023.11	.	Phe395Ile	.	25.4	.	0	.	D	.	1	1	.	.	.	.	.	0	0.96866	Select	0.6139	.	0.90580	.	.	D	D	.	1.94421044628	0	.	.	.	.	0.65668	.	.	.	.	0.89297	.	.	0.99591	0.999	.	0.0	0.906209	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561868T>A	.	.	2	0.9672711	.	0	0.9748932	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.99291	D	0.99587	D	L	.	.	T/T	114	0	.	.	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	.	0.89027	.	.	-	139561868	.	-	7.926000	.	0.99826	.	0	.	.	germline	.	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.97889	GRCh38	924	criteria provided, single submitter	c.1183T>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	1	.	FA9_HUMAN	.	100.0	.	.	D	0.73049	0.9870631	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Phe395Ile	.	0.74810	.	germline	.		T	Apr 18, 2021	.	T/T	.	.	1.0	N	Xq27.1	9690	.	.	SCV002132959	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.455722	0.92967	.	D	-	.	.	0.99041	610	.	.	0.95561	0	139561868	Y	10	0	.	.	P00740	.	0.860248	0.55483		.	0.98	D	.	0.9731375	.	0.91597	2158	0.52535	.	-5.97	.	.	0.91343	.	.	.	.	.	.	0.99332	X	F9	.	0	Phe	14050	.	X-139561868-T-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138471693	.	.	.	.	RCV001905309	D	.	.	c.1183T>A	.	.	.	0.94991	T/T	rs1175050951	139561868	.	T	.	P00740	.	0.98675	.	0.68239		.	.	.	0.935	0	0	264690	5.66	0.96868	112	D	T	.	.	0	26	.	.	.	98879	1364269	0.94917	0.93244	0.99892920255661	2898	.	0.71675	.	.	.	.	7.991	.	D	.	.	1.51120175E-5	0	306900|300807	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9980519219227515	1	0.74847	0.18019	.	4	.	.	.	YES	.	0.874725	1386208	HGNC:3551	D	.	simple_aae	0.995	.	139561868	TTC	1.000000	.	-	0	0.98730	.	0	.	Pathogenic	0.63197	.	.	.	ClinGen:CA414446355	F	.	0.999082510293	-	0.903	-	0.95387	.	496	0.99804	0.69013696909	0.6552	.	0.99205605394600549	98	-	1183T>A 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.66886	1175050951	.	0	0.99905	.	0.694	0.0	2784	0.99998820	5.66	.	.	.	0.516853	0.999904283247364	0.23470	D	86	.	.	0.3983	0.86302	p.Phe395Ile	0	.	-7.756	0.98510087	.	0.98723	1364269	D	.	F9	.	D	0.891	.	F395I	D	.	0.62996	T/T	principal1	174474	F9_Popp_2025_carboxy_gla_motif_var258005	No											F		1183	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Phe395Ile		true	c.1183T>A						3551.0	139561868.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Phe395Ile						I	Apr 18, 2021					missense_variant		395.0				0.0142730601583807		Pathogenic	139561868.0	missense_variant		0.891					Reporter			F9_Phe395Ile
F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	0.78191504566733	0.7122875845034075	0.8207417031739346	0.8195747191013218	0.6111011003177287	0.5172996797401919	0.8062380577818159	0.9299567912089567	0.8863257136043384	0.7062120218580621	0.649607362703761	0.7592628211426117	0.8753492471914457	0.8529502163528302	0.6586565610878954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A		Phe395Ile																												F9_Phe395Ile	23	139561868	T	A	X	allele	1183T>A	F04	527_CAVA_Array_P02	K08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561868-T-A	-	0.69364	1.0	395	.	.	.	X	138644027	A	.	.	X	1_Pathogenic	NC_000023.11	.	Phe395Ile	.	25.4	.	0	.	D	.	1	1	.	.	.	.	.	0	0.96866	Select	0.6139	.	0.90580	.	.	D	D	.	1.94421044628	0	.	.	.	.	0.65668	.	.	.	.	0.89297	.	.	0.99591	0.999	.	0.0	0.906209	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561868T>A	.	.	2	0.9672711	.	0	0.9748932	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.99291	D	0.99587	D	L	.	.	T/T	114	0	.	.	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	.	0.89027	.	.	-	139561868	.	-	7.926000	.	0.99826	.	0	.	.	germline	.	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.97889	GRCh38	924	criteria provided, single submitter	c.1183T>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	1	.	FA9_HUMAN	.	100.0	.	.	D	0.73049	0.9870631	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Phe395Ile	.	0.74810	.	germline	.		T	Apr 18, 2021	.	T/T	.	.	1.0	N	Xq27.1	9690	.	.	SCV002132959	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.455722	0.92967	.	D	-	.	.	0.99041	610	.	.	0.95561	0	139561868	Y	10	0	.	.	P00740	.	0.860248	0.55483		.	0.98	D	.	0.9731375	.	0.91597	2158	0.52535	.	-5.97	.	.	0.91343	.	.	.	.	.	.	0.99332	X	F9	.	0	Phe	14050	.	X-139561868-T-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138471693	.	.	.	.	RCV001905309	D	.	.	c.1183T>A	.	.	.	0.94991	T/T	rs1175050951	139561868	.	T	.	P00740	.	0.98675	.	0.68239		.	.	.	0.935	0	0	264690	5.66	0.96868	112	D	T	.	.	0	26	.	.	.	98879	1364269	0.94917	0.93244	0.99892920255661	2898	.	0.71675	.	.	.	.	7.991	.	D	.	.	1.51120175E-5	0	306900|300807	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9980519219227515	1	0.74847	0.18019	.	4	.	.	.	YES	.	0.874725	1386208	HGNC:3551	D	.	simple_aae	0.995	.	139561868	TTC	1.000000	.	-	0	0.98730	.	0	.	Pathogenic	0.63197	.	.	.	ClinGen:CA414446355	F	.	0.999082510293	-	0.903	-	0.95387	.	496	0.99804	0.69013696909	0.6552	.	0.99205605394600549	98	-	1183T>A 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.66886	1175050951	.	0	0.99905	.	0.694	0.0	2784	0.99998820	5.66	.	.	.	0.516853	0.999904283247364	0.23470	D	86	.	.	0.3983	0.86302	p.Phe395Ile	0	.	-7.756	0.98510087	.	0.98723	1364269	D	.	F9	.	D	0.891	.	F395I	D	.	0.62996	T/T	principal1	229506	F9_Popp_2025_light_chain_var248324	No											F		1183	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Phe395Ile		true	c.1183T>A						3551.0	139561868.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Phe395Ile						I	Apr 18, 2021					missense_variant		395.0				0.0209959529538574		Pathogenic	139561868.0	missense_variant		0.891					Reporter			F9_Phe395Ile
F9_Phe395Ile	-2.751249441409619	0.028452659811841512	2.16877350476657	0.06673777803491078	2025_01_Batch_13-14	0.78191504566733	0.7122875845034075	0.8207417031739346	0.8195747191013218	0.6111011003177287	0.5172996797401919	0.8062380577818159	0.9299567912089567	0.8863257136043384	0.7062120218580621	0.649607362703761	0.7592628211426117	0.8753492471914457	0.8529502163528302	0.6586565610878954	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030626		NC_000023.11:139561868:T:A		Phe395Ile																												F9_Phe395Ile	23	139561868	T	A	X	allele	1183T>A	F04	527_CAVA_Array_P02	K08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561868-T-A	-	0.69364	1.0	395	.	.	.	X	138644027	A	.	.	X	1_Pathogenic	NC_000023.11	.	Phe395Ile	.	25.4	.	0	.	D	.	1	1	.	.	.	.	.	0	0.96866	Select	0.6139	.	0.90580	.	.	D	D	.	1.94421044628	0	.	.	.	.	0.65668	.	.	.	.	0.89297	.	.	0.99591	0.999	.	0.0	0.906209	.	1.0	A	single nucleotide variant	NC_000023.11:g.139561868T>A	.	.	2	0.9672711	.	0	0.9748932	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	.	.	.	.	0.99291	D	0.99587	D	L	.	.	T/T	114	0	.	.	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	.	0.89027	.	.	-	139561868	.	-	7.926000	.	0.99826	.	0	.	.	germline	.	Gain of sheet (P = 0.1945)| Loss of stability (P = 0.3601)| Loss of loop (P = 0.3664)| Gain of MoRF binding (P = 0.3861)| Loss of disorder (P = 0.4337)	0.97889	GRCh38	924	criteria provided, single submitter	c.1183T>A	.	0.87274	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1183T>A (p.Phe395Ile)	1	.	FA9_HUMAN	.	100.0	.	.	D	0.73049	0.9870631	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Phe395Ile	.	0.74810	.	germline	.		T	Apr 18, 2021	.	T/T	.	.	1.0	N	Xq27.1	9690	.	.	SCV002132959	Pathogenic	.	.	Ile	I	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.455722	0.92967	.	D	-	.	.	0.99041	610	.	.	0.95561	0	139561868	Y	10	0	.	.	P00740	.	0.860248	0.55483		.	0.98	D	.	0.9731375	.	0.91597	2158	0.52535	.	-5.97	.	.	0.91343	.	.	.	.	.	.	0.99332	X	F9	.	0	Phe	14050	.	X-139561868-T-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138471693	.	.	.	.	RCV001905309	D	.	.	c.1183T>A	.	.	.	0.94991	T/T	rs1175050951	139561868	.	T	.	P00740	.	0.98675	.	0.68239		.	.	.	0.935	0	0	264690	5.66	0.96868	112	D	T	.	.	0	26	.	.	.	98879	1364269	0.94917	0.93244	0.99892920255661	2898	.	0.71675	.	.	.	.	7.991	.	D	.	.	1.51120175E-5	0	306900|300807	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9980519219227515	1	0.74847	0.18019	.	4	.	.	.	YES	.	0.874725	1386208	HGNC:3551	D	.	simple_aae	0.995	.	139561868	TTC	1.000000	.	-	0	0.98730	.	0	.	Pathogenic	0.63197	.	.	.	ClinGen:CA414446355	F	.	0.999082510293	-	0.903	-	0.95387	.	496	0.99804	0.69013696909	0.6552	.	0.99205605394600549	98	-	1183T>A 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.66886	1175050951	.	0	0.99905	.	0.694	0.0	2784	0.99998820	5.66	.	.	.	0.516853	0.999904283247364	0.23470	D	86	.	.	0.3983	0.86302	p.Phe395Ile	0	.	-7.756	0.98510087	.	0.98723	1364269	D	.	F9	.	D	0.891	.	F395I	D	.	0.62996	T/T	principal1	201990	F9_Popp_2025_heavy_chain_var238643	No											F		1183	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Phe395Ile		true	c.1183T>A						3551.0	139561868.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Phe395Ile						I	Apr 18, 2021					missense_variant		395.0				0.054036665		Pathogenic	139561868.0	missense_variant		0.891					Reporter			F9_Phe395Ile
BRCA1_Leu460Pro	1.3818159885120436	0.20951653672145118	0.01042038511580422	0.9919766475766167	2025_01_Batch_13-14	0.9059796392194737	0.8746551314367813	0.8376263836210487	0.8649401026154384	0.8901004495246302	0.9777652492427892	0.9238268256954807	0.9508407908301749	0.975894109288426	0.8550806083866495	0.9418724442311315	0.899240978566131	0.8942335872256117	0.9204171059519322	0.8725905289556398	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC013122		NC_000017.11:43071223:A:G		Leu460Pro																												BRCA1_Leu460Pro	17	43071223	A	G	17	allele	1379T>C	H11	527_CAVA_Array_P01	O21	B13A7A8P1_R1	B14A7A8P1_R2				17-43071223-A-G	-	0.26159	0.828	1564	0	0	0	17	41223240	G	1.040780e-04	1	17	2_Benign	NC_000017.11	161	Leu1564Pro	0	17.0	0	18	2.361990e-03	D	1	19	1	42764	1.565940e-04	6	30526	0.000000e+00	0	0.81507	Select	0.6710	14818	0.46036	2	0.0	T	D	64030	.	0.0020380434782608695	1	0.000000e+00	0	0	0.26905	17110	44888	0	0.000000e+00	0.60859	0	.	0.21792	0.036	0.0045385779122541605	78.0	.	3.93	0.22	G	single nucleotide variant	NC_000017.11:g.43071223A>G	0	16732	2	0.106218696	109386	0	0.15756732	0		41	236280	0	0	0.000000e+00	796	0.000000e+00	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0700268,MedGen:CN377757|	12	0	0.000000e+00	0	0.57141	B	0.29781	P	L	1.401419	168	A/A	352	1	7162	1614174	Breast-ovarian cancer, familial, susceptibility to, 1|Breast neoplasm|not specified|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1|BRCA1-related cancer predisposition|BRCA1-related disorder	16132	0.78666	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43071223	1.535880e-03	-	1.823000	38	0.80578	29606	0	75050	0	germline;unknown	91088	.	.	GRCh38	543	reviewed by expert panel	c.4691T>C	0.000000e+00	0.41665	19	0	0	.	0.000000e+00	9034	B	0	0.000000e+00	NM_007294.4(BRCA1):c.4691T>C (p.Leu1564Pro)	3	0	BRCA1_HUMAN	0	22.0	-0.391511225925735	2	.	0.54067	0.0936192	-	1.535880e-03	0		38	0.000000e+00	0	34254	reviewed_by_expert_panel	0.99411	1.097030e-04	1	0.000000e+00	0	60026	p.Leu1564Pro	0	0.29140	.	germline	11		A	Aug 10, 2015	0	A/A	0	89154	0.825	N	17q21.31	173958	.	2.355570e-03	SCV000244368	Benign	0	0	Pro	P	-	912	ENSP00000350283	ENST00000357654	17680	0.167	13404	0	0.756	A	0	2.053966	0.38212	N	T	-	1.422447	.	0.91538	968	0	0.0	0.00535	0	43071223	Y	10	0	102206	0.000000e+00	P38398	0	0.151297	0.32337		0	0.221	D	16132	0.12383379	7162	0.13876	672	0.0819011	0	-1.07	0.0	2.145240e-03	0.45915	0.000000e+00	0	75050	0.000000e+00	6062	11	0.25497	17	BRCA1	2.145240e-03	0	Leu	201838	0.000000e+00	17-43071223-A-G	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|Breast_neoplasm|not_specified	0	0	38476766	BRCA1-HCI:BRCA1_00023|ClinGen:CA002980	0.297615	0.25494	0	RCV000112385|RCV000148377|RCV000120262|RCV000162687|RCV000587835|RCV001082228|RCV002483063|RCV004804006|RCV004758629	T	0	0	c.4691T>C	0	0	0	0.61994	A/A	rs56119278	43071223	14818	A	0.0011980830670926517	.	15690	0.35205	0.000000e+00	0.08389		0	0	0.000000e+00	1.935	0	0	264690	3.71	0.48845	3338	T	T	35	6.553080e-05	0	652	.	0	0	145|227535|145|1333|140162	55262	0.89807	0.15464	0.0181525713158331	9184	6	0.30151	0.40519	5.838730e-05	2.355570e-03	1180006	1.355	1.974780e-04	N	13392	0	6.9515285E-4	0	114480|617883|604370|614320	0.33777	17	2.361990e-03	ENSG00000012048	0.000000e+00	0	0	0	.	2	0.37838	0.72771	30608	184	0.000000e+00	3.331890e-05	-0.372425254023125	YES	0.000000e+00	0.323959	69929	HGNC:1100	N	0	simple_aae	0.651	207618	43071223	CTG	0.000000	0	-	0.00195993031358885	0.04012	0.000000e+00	18	0	Benign	0.21903	0	0	2	BRCA1-HCI:BRCA1_00023,ClinGen:CA002980	L	0	0.776336265085	-	.	-	0.60290	37	13314	0.35316	0.41346591711	0.1809	0	0.97050371191633666	280	-	4691T>C 	35	7.51089079164789E-5	C3661900|C0677776|C0346153|C4554406|C2676676|C3280442|C0027672|C1458155|CN169374	0	0	0	0	NM_007294.4	-	0	0.0	0	0.39375	56119278	2320	9.41349002665504E-5	0.77250	0.25504	0.501	0.241	8832	0.99947375	4.78	.	.	0.000000e+00	0.339011	0.77319198328768	0.51654	T	2686	6210	9562	-0.1563	0.88560	p.Leu1564Pro	0	0	-3.859	0.047209352	161	0.69688	55262	T	30520	BRCA1	5.844540e-05	D	0.554	21630	.	T	0.74723	0.943	A/A	principal2																																																																																																				
RAD51D_Asn138His	1.6166526065546751	0.14998682499991292	10.652301864900743	0.000014084472813108453	2025_01_Batch_13-14	0.7661350354466941	0.8948077182600973	0.9743968861454785	0.9276685729320928	0.7468842806042563	0.9312611228377887	0.9490494215219716	0.9775521749267864	0.9623249119764552	0.8647562969491779	0.8486980791422414	0.9219285698910344	0.9759745305361325	0.944996742454274	0.8058202887767171	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024825		NC_000017.11:35107056:T:G		Asn138His																												RAD51D_Asn138His	17	35107056	T	G	17	allele	412A>C	D01	527_CAVA_Array_P05	G01	B13A7A8P2_R1	B14A7A8P2_R2				17-35107056-T-G	-	0.64815	0.395	138	1	0	0	17	33434075	G	1.363100e-05	0	17	3_Conflicting	NC_000017.11	21	Asn138His	0	24.7	0	0	1.070750e-04	T	0	11	5	42768	4.642600e-05	.	30526	0.000000e+00	0	0.59659	.	0.3126	102732	0.34741	0	.	T	T	64026	.	0	0	0.000000e+00	0	0	.	17112	44872	0	0.000000e+00	0.48032	2	.	0.33722	0.885	.	94.0	0.843016	2.95	0.06	G	single nucleotide variant	NC_000017.11:g.35107056T>G	0	16734	2	0.17573822	109408	0	0.14909644	0		1	236936	0	0	0.000000e+00	500	4.676390e-05	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	2	0	0.000000e+00	0	0.18971	P	0.39925	B	M	3.585971	22	T/T	114	0	7164	1613968	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	16218	0.70838	.	.	-	35107056	4.676390e-05	-	6.109000	0	0.22306	29608	0	1180018	0	germline;unknown	91090	Gain of sheet (P = 0.1945)| Gain of disorder (P = 0.2095)| Loss of stability (P = 0.211)| Loss of helix (P = 0.2662)| Loss of solvent accessibility (P = 0.2953)	0.75933	GRCh38	921	criteria provided, conflicting classifications	c.412A>C	0.000000e+00	0.39345	1	0	0	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	0.000000e+00	9046	B	0	0.000000e+00	NM_002878.4(RAD51D):c.412A>C (p.Asn138His)	1	0	RA51D_HUMAN	0	6.0	0.261244387338902	0	T	0.36807	0.14909644	-	0.000000e+00	.		1	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.84616	1.828020e-05	0	0.000000e+00	0	59980	p.Asn138His	0	0.53713	.	germline	2		T	Mar 04, 2025	0	T/T	0	89554	1.0	N	17q12	32854	.	0.000000e+00	SCV000149723|SCV000674693|SCV000686451|SCV000771512|SCV000822178|SCV000889821|SCV001472084|SCV002563404|SCV002579319|SCV004026736|SCV004208088	Conflicting_classifications_of_pathogenicity	0	0	His	H	-	912	ENSP00000378090	ENST00000394589	17692	.	13416	0	0.609	T	0	4.260774	0.56982	D	T	-	3.276757	.	0.83550	628	0	.	0.33898	0	35107056	Y	10	0	102732	0.000000e+00	O75771	0	0.188245	0.04613		0	0.591	D	89554	0.17573822	42768	0.42478	5892	-0.0652968	21	.	.	1.779630e-05	0.28402	0.000000e+00	0	74892	0.000000e+00	6084	0	0.39925	17	RAD51D	0.000000e+00	0	Asn	42184	1.116640e-05	17-35107056-T-G	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	11	30458188	ClinGen:CA287974	0.615052	0.53967	0	RCV000572128|RCV003321505|RCV000649680|RCV000760062	D	0	0	c.412A>C	0	0	0	0.41729	T/T	rs141690729	35107056	14902	T	.	O75771	15690	0.33722	0.000000e+00	0.68239		0	0	0.000000e+00	2.35	0	1	264690	3.52	0.53985	112	D	.	0	0.000000e+00	0	26	.	0	0	140162|145	127888	0.60868	0.40252	0.542844533920288	2966	.	0.71675	0.60072	0.000000e+00	1.116640e-05	1180018	4.397	4.804640e-06	.	13394	0	1.1334013E-5	0	614291	0.59537	17	0.000000e+00	ENSG00000185379	0.000000e+00	3.0437694040299505E-5	0	0	.	1	0.50477	0.19236	30608	3	1.070750e-04	0.000000e+00	0.218849069588625	.	0.000000e+00	0.154917	133345	HGNC:9823	N	0	simple_aae	0.079	208132	35107056	AAT	1.000000	.	-	0	0.58437	1.779630e-05	0	0	Conflicting classifications of pathogenicity	0.53382	0	0	0	ClinGen:CA287974	N	0	0.920393908519	-	0.625	-	0.34427	11	5026	0.26696	.	0.1649	0	0.51412546772186041	98	-	412A>C 	11	0	C0027672|CN169374|C3661900|C3280345	0	0	0	0	NM_002878.4	-	.	.	0	0.51848	141690729	2320	2.370567039635881E-5	0.91898	0.50637	0.307	0.1	2852	0.62988700	4.65	.	.	0.000000e+00	-0.127971	0.00403443879358769	0.67323	T	86	6212	9572	-0.4330	0.68139	p.Asn138His	0	0	-6.785	0.45225775	0	0.17381	127888	T	30524	RAD51D	0.000000e+00	T	0.281	21632	N138H	.	0.53955	0.47831	T/T	principal1	961212	RAD51D_unpublished_var155459	Yes						overall function		Cell survival			N		412	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Asn138His		true	c.412A>C						9823.0	35107056.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		C									criteria provided, conflicting classifications				Asn138His						H	Feb 22, 2024					missense_variant		138.0	A		0.0000136310013581	0.00946169		Conflicting classifications of pathogenicity	35107056.0	missense_variant		0.281	functionally_normal				Cell viability			RAD51D_Asn138His
F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	0.780442232559193	0.6633273479065258	0.7173445559633124	0.7618889422663242	0.628972195681177	0.683562763759731	0.6451334380833607	0.6882141274969147	0.7736982035283106	0.636145661500763	0.732002498159462	0.6542303929949432	0.7027793417301136	0.7677935728973174	0.6325589285909701	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G		Thr194Ala																												F9_Thr194Ala	23	139551121	A	G	X	allele	580A>G	D08	527_CAVA_Array_P02	G16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551121-A-G	-	0.03219	0.0	194	19457	5254	71	X	138633280	G	2.680850e-01	1374	X	2_Benign	NC_000023.11	270320	Thr194Ala	34	0.533	16	1539	3.032770e-01	T	27999	10	1	30871	2.142910e-01	137	18996	2.345610e-01	395	0.56351	Select	0.0001	73329	0.02950	2740	0.0013089005235602095	T	T	46443	0.622737437607	0.13705583756345177	343	2.389490e-01	2037	2037	0.18363	13659	33762	10024	2.073870e-03	0.26798	9294	.	0.12229	0.058	0.1365902293120638	99.0	0.315368	2.13	0.01	G	single nucleotide variant	NC_000023.11:g.139551121A>G	1065	12177	3	0.08421645	80228	0.18108728943338437	0.058962863	0.0021620063418852694		32071	172056	1323	38	2.552740e-03	1072	3.010590e-01	34	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	16623	4254	2.676470e-01	182	0.30097	B	0.11917	B	L	.	324101	A/A	410	3661	5700	1208948	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	13131	0.13578	72	.	-	139551121	3.010590e-01	-	1.468000	1728	0.55474	22031	0.1253968253968254	894493	21	germline	56776	.	.	GRCh38	924	reviewed by expert panel	c.580A>G	1.751950e-01	0.20193	82603	66	1078	.	2.672250e-01	6917	B	0.0016096579476861167	2.384820e-01	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	3	0	FA9_HUMAN	137	1.0	.	2323	T	0.03453	0.060261868	+	1.350880e-01	115		19457	2.320280e-01	0	27155	reviewed_by_expert_panel	0.95383	2.071970e-01	31752	2.642080e-01	131	45709	p.Thr194Ala	111	0.26817	.	germline	9294		A	Feb 09, 2024	3328	A/A	2535	64547	0.0	N	Xq27.1	252184	.	1.315970e-01	SCV004363688	Benign	2622	1692	Ala	A	-	680	ENSP00000218099	ENST00000218099	13319	0.648	10126	2944	0.756	A	252	-0.17694	0.09544	.	T	-	.	.	.	3150	115	0.293733681462141	0.00020	15	139551121	Y	9	0.23507462686567165	73329	2.747350e-01	P00740	201	0.375	0.02657		869	0.003	.	64547	0.061581787	30871	0.15862	2158	-0.540244	270320	-0.92	0.16016713091922005	3.022050e-01	0.04909	1.786000e-01	869	57124	2.313140e-03	4346	770	0.19334	X	F9	1.290350e-01	946	Thr	296768	3.014390e-01	X-139551121-A-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	418	22239	138460946	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	.	.	27999	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	T	0	136	c.580A>G	135	56	12521	0.00324	A/A	rs6048	139551121	12061	A	0.1456953642384106	.	9944	0.11817	2.662910e-01	0.08389		352	1795	1.658670e-03	1.52	0.08292682926829269	75761	264690	1.21	0.73694	6938	T	T	1589	9.529870e-02	252	1968	.	83	3254	98879	10588	0.32443	0.56240	0.00193173800424148	11639	550	0.06393	.	1.009020e-01	3.014390e-01	894493	0.555	2.114300e-01	N	9924	1795	0.20742	8	306900|300807	0.23211	X	1.317470e-01	ENSG00000101981	2.695990e-01	0.3004195349427402	3334	0.003556910569105691	0.9285000041175393	1	0.08696	0.18019	19061	54902	3.032770e-01	1.170230e-01	.	YES	1.765530e-01	.	25627	HGNC:3551	P	80	simple_aae	0.285	151686	139551121	ACT	0.000000	1	-	0.13514906778932897	0.00105	3.022050e-01	1573	425	Benign	0.18612	1776	1194	5349	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	T	0	.	-	.	-	0.03607	36870	16561	0.92783	0.353132814169	0.0698	284	0.38829522857183274	5224	-	580A>G 	22239	0.22106153010083932	C0008533|C2749016|C3661900|CN169374|C3275410	82	0	414	38	NM_000133.4	-	225	0.13740458015267176	0	0.07400	6048	1765	0.27834200452879015	.	.	0.064	0.745	11229	0.97858846	4.94	.	.	1.749120e-01	-0.40498	0.167231588560137	0.38202	T	4970	4646	7081	-1.0530	0.00038	p.Thr194Ala	7	14	-3.651	0.0049726367	7371	0.48150	10588	T	24376	F9	1.005930e-01	T	0.255	15975	.	T	0.41176	0.943	A/A	principal1	190001	F9_Popp_2025_heavy_chain_var234420	No		7/11/24		3b7d37ef-41c7-478a-a6de-0913aa2c42d9							T		580	F9_Popp_2025_heavy_chain	10588.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA121125	immortalized human cells		false			p.Thr194Ala		true	c.580A>G						3551.0	139551121.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa	BP4,BA1								The c.580A>G (p.Thr194Ala) variant is reported at an MAF of 0.3026 (27985/92495 alleles) in the non-Finnish European population in gnomAD v2.1.1 with 2609 homozygotes and 10667 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. Note that gnomAD v3.1.1 reports a frequency of 0.3041 in the NFE population, with 1859 homozygotes and 4024 hemizygotes. This missense variant has a REVEL score of 0.255 (<0.3) and SpliceAI predicts no impact on splicing, with a score of 0.0, meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BP4. 	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BA1	Thr194Ala	https://erepo.genome.network/evrepo/ui/classification/3b7d37ef-41c7-478a-a6de-0913aa2c42d9					A	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	194.0		hemophilia B	0.2680851451013608	0.9966376032652992		Benign	139551121.0	missense_variant		0.255					Reporter			F9_Thr194Ala
F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	0.780442232559193	0.6633273479065258	0.7173445559633124	0.7618889422663242	0.628972195681177	0.683562763759731	0.6451334380833607	0.6882141274969147	0.7736982035283106	0.636145661500763	0.732002498159462	0.6542303929949432	0.7027793417301136	0.7677935728973174	0.6325589285909701	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G		Thr194Ala																												F9_Thr194Ala	23	139551121	A	G	X	allele	580A>G	D08	527_CAVA_Array_P02	G16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551121-A-G	-	0.03219	0.0	194	19457	5254	71	X	138633280	G	2.680850e-01	1374	X	2_Benign	NC_000023.11	270320	Thr194Ala	34	0.533	16	1539	3.032770e-01	T	27999	10	1	30871	2.142910e-01	137	18996	2.345610e-01	395	0.56351	Select	0.0001	73329	0.02950	2740	0.0013089005235602095	T	T	46443	0.622737437607	0.13705583756345177	343	2.389490e-01	2037	2037	0.18363	13659	33762	10024	2.073870e-03	0.26798	9294	.	0.12229	0.058	0.1365902293120638	99.0	0.315368	2.13	0.01	G	single nucleotide variant	NC_000023.11:g.139551121A>G	1065	12177	3	0.08421645	80228	0.18108728943338437	0.058962863	0.0021620063418852694		32071	172056	1323	38	2.552740e-03	1072	3.010590e-01	34	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	16623	4254	2.676470e-01	182	0.30097	B	0.11917	B	L	.	324101	A/A	410	3661	5700	1208948	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	13131	0.13578	72	.	-	139551121	3.010590e-01	-	1.468000	1728	0.55474	22031	0.1253968253968254	894493	21	germline	56776	.	.	GRCh38	924	reviewed by expert panel	c.580A>G	1.751950e-01	0.20193	82603	66	1078	.	2.672250e-01	6917	B	0.0016096579476861167	2.384820e-01	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	3	0	FA9_HUMAN	137	1.0	.	2323	T	0.03453	0.060261868	+	1.350880e-01	115		19457	2.320280e-01	0	27155	reviewed_by_expert_panel	0.95383	2.071970e-01	31752	2.642080e-01	131	45709	p.Thr194Ala	111	0.26817	.	germline	9294		A	Feb 09, 2024	3328	A/A	2535	64547	0.0	N	Xq27.1	252184	.	1.315970e-01	SCV004363688	Benign	2622	1692	Ala	A	-	680	ENSP00000218099	ENST00000218099	13319	0.648	10126	2944	0.756	A	252	-0.17694	0.09544	.	T	-	.	.	.	3150	115	0.293733681462141	0.00020	15	139551121	Y	9	0.23507462686567165	73329	2.747350e-01	P00740	201	0.375	0.02657		869	0.003	.	64547	0.061581787	30871	0.15862	2158	-0.540244	270320	-0.92	0.16016713091922005	3.022050e-01	0.04909	1.786000e-01	869	57124	2.313140e-03	4346	770	0.19334	X	F9	1.290350e-01	946	Thr	296768	3.014390e-01	X-139551121-A-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	418	22239	138460946	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	.	.	27999	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	T	0	136	c.580A>G	135	56	12521	0.00324	A/A	rs6048	139551121	12061	A	0.1456953642384106	.	9944	0.11817	2.662910e-01	0.08389		352	1795	1.658670e-03	1.52	0.08292682926829269	75761	264690	1.21	0.73694	6938	T	T	1589	9.529870e-02	252	1968	.	83	3254	98879	10588	0.32443	0.56240	0.00193173800424148	11639	550	0.06393	.	1.009020e-01	3.014390e-01	894493	0.555	2.114300e-01	N	9924	1795	0.20742	8	306900|300807	0.23211	X	1.317470e-01	ENSG00000101981	2.695990e-01	0.3004195349427402	3334	0.003556910569105691	0.9285000041175393	1	0.08696	0.18019	19061	54902	3.032770e-01	1.170230e-01	.	YES	1.765530e-01	.	25627	HGNC:3551	P	80	simple_aae	0.285	151686	139551121	ACT	0.000000	1	-	0.13514906778932897	0.00105	3.022050e-01	1573	425	Benign	0.18612	1776	1194	5349	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	T	0	.	-	.	-	0.03607	36870	16561	0.92783	0.353132814169	0.0698	284	0.38829522857183274	5224	-	580A>G 	22239	0.22106153010083932	C0008533|C2749016|C3661900|CN169374|C3275410	82	0	414	38	NM_000133.4	-	225	0.13740458015267176	0	0.07400	6048	1765	0.27834200452879015	.	.	0.064	0.745	11229	0.97858846	4.94	.	.	1.749120e-01	-0.40498	0.167231588560137	0.38202	T	4970	4646	7081	-1.0530	0.00038	p.Thr194Ala	7	14	-3.651	0.0049726367	7371	0.48150	10588	T	24376	F9	1.005930e-01	T	0.255	15975	.	T	0.41176	0.943	A/A	principal1	245033	F9_Popp_2025_strep_2_var263463	No		7/11/24		3b7d37ef-41c7-478a-a6de-0913aa2c42d9							T		580	F9_Popp_2025_strep_2	10588.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA121125	immortalized human cells		false			p.Thr194Ala		true	c.580A>G						3551.0	139551121.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa	BP4,BA1								The c.580A>G (p.Thr194Ala) variant is reported at an MAF of 0.3026 (27985/92495 alleles) in the non-Finnish European population in gnomAD v2.1.1 with 2609 homozygotes and 10667 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. Note that gnomAD v3.1.1 reports a frequency of 0.3041 in the NFE population, with 1859 homozygotes and 4024 hemizygotes. This missense variant has a REVEL score of 0.255 (<0.3) and SpliceAI predicts no impact on splicing, with a score of 0.0, meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BP4. 	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BA1	Thr194Ala	https://erepo.genome.network/evrepo/ui/classification/3b7d37ef-41c7-478a-a6de-0913aa2c42d9					A	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	194.0		hemophilia B	0.2680851451013608	0.904152746		Benign	139551121.0	missense_variant		0.255					Reporter			F9_Thr194Ala
F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	0.780442232559193	0.6633273479065258	0.7173445559633124	0.7618889422663242	0.628972195681177	0.683562763759731	0.6451334380833607	0.6882141274969147	0.7736982035283106	0.636145661500763	0.732002498159462	0.6542303929949432	0.7027793417301136	0.7677935728973174	0.6325589285909701	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G		Thr194Ala																												F9_Thr194Ala	23	139551121	A	G	X	allele	580A>G	D08	527_CAVA_Array_P02	G16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551121-A-G	-	0.03219	0.0	194	19457	5254	71	X	138633280	G	2.680850e-01	1374	X	2_Benign	NC_000023.11	270320	Thr194Ala	34	0.533	16	1539	3.032770e-01	T	27999	10	1	30871	2.142910e-01	137	18996	2.345610e-01	395	0.56351	Select	0.0001	73329	0.02950	2740	0.0013089005235602095	T	T	46443	0.622737437607	0.13705583756345177	343	2.389490e-01	2037	2037	0.18363	13659	33762	10024	2.073870e-03	0.26798	9294	.	0.12229	0.058	0.1365902293120638	99.0	0.315368	2.13	0.01	G	single nucleotide variant	NC_000023.11:g.139551121A>G	1065	12177	3	0.08421645	80228	0.18108728943338437	0.058962863	0.0021620063418852694		32071	172056	1323	38	2.552740e-03	1072	3.010590e-01	34	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	16623	4254	2.676470e-01	182	0.30097	B	0.11917	B	L	.	324101	A/A	410	3661	5700	1208948	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	13131	0.13578	72	.	-	139551121	3.010590e-01	-	1.468000	1728	0.55474	22031	0.1253968253968254	894493	21	germline	56776	.	.	GRCh38	924	reviewed by expert panel	c.580A>G	1.751950e-01	0.20193	82603	66	1078	.	2.672250e-01	6917	B	0.0016096579476861167	2.384820e-01	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	3	0	FA9_HUMAN	137	1.0	.	2323	T	0.03453	0.060261868	+	1.350880e-01	115		19457	2.320280e-01	0	27155	reviewed_by_expert_panel	0.95383	2.071970e-01	31752	2.642080e-01	131	45709	p.Thr194Ala	111	0.26817	.	germline	9294		A	Feb 09, 2024	3328	A/A	2535	64547	0.0	N	Xq27.1	252184	.	1.315970e-01	SCV004363688	Benign	2622	1692	Ala	A	-	680	ENSP00000218099	ENST00000218099	13319	0.648	10126	2944	0.756	A	252	-0.17694	0.09544	.	T	-	.	.	.	3150	115	0.293733681462141	0.00020	15	139551121	Y	9	0.23507462686567165	73329	2.747350e-01	P00740	201	0.375	0.02657		869	0.003	.	64547	0.061581787	30871	0.15862	2158	-0.540244	270320	-0.92	0.16016713091922005	3.022050e-01	0.04909	1.786000e-01	869	57124	2.313140e-03	4346	770	0.19334	X	F9	1.290350e-01	946	Thr	296768	3.014390e-01	X-139551121-A-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	418	22239	138460946	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	.	.	27999	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	T	0	136	c.580A>G	135	56	12521	0.00324	A/A	rs6048	139551121	12061	A	0.1456953642384106	.	9944	0.11817	2.662910e-01	0.08389		352	1795	1.658670e-03	1.52	0.08292682926829269	75761	264690	1.21	0.73694	6938	T	T	1589	9.529870e-02	252	1968	.	83	3254	98879	10588	0.32443	0.56240	0.00193173800424148	11639	550	0.06393	.	1.009020e-01	3.014390e-01	894493	0.555	2.114300e-01	N	9924	1795	0.20742	8	306900|300807	0.23211	X	1.317470e-01	ENSG00000101981	2.695990e-01	0.3004195349427402	3334	0.003556910569105691	0.9285000041175393	1	0.08696	0.18019	19061	54902	3.032770e-01	1.170230e-01	.	YES	1.765530e-01	.	25627	HGNC:3551	P	80	simple_aae	0.285	151686	139551121	ACT	0.000000	1	-	0.13514906778932897	0.00105	3.022050e-01	1573	425	Benign	0.18612	1776	1194	5349	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	T	0	.	-	.	-	0.03607	36870	16561	0.92783	0.353132814169	0.0698	284	0.38829522857183274	5224	-	580A>G 	22239	0.22106153010083932	C0008533|C2749016|C3661900|CN169374|C3275410	82	0	414	38	NM_000133.4	-	225	0.13740458015267176	0	0.07400	6048	1765	0.27834200452879015	.	.	0.064	0.745	11229	0.97858846	4.94	.	.	1.749120e-01	-0.40498	0.167231588560137	0.38202	T	4970	4646	7081	-1.0530	0.00038	p.Thr194Ala	7	14	-3.651	0.0049726367	7371	0.48150	10588	T	24376	F9	1.005930e-01	T	0.255	15975	.	T	0.41176	0.943	A/A	principal1	134969	F9_Popp_2025_carboxy_F9_specific_var224739	No		7/11/24		3b7d37ef-41c7-478a-a6de-0913aa2c42d9							T		580	F9_Popp_2025_carboxy_F9_specific	10588.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA121125	immortalized human cells		false			p.Thr194Ala		true	c.580A>G						3551.0	139551121.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa	BP4,BA1								The c.580A>G (p.Thr194Ala) variant is reported at an MAF of 0.3026 (27985/92495 alleles) in the non-Finnish European population in gnomAD v2.1.1 with 2609 homozygotes and 10667 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. Note that gnomAD v3.1.1 reports a frequency of 0.3041 in the NFE population, with 1859 homozygotes and 4024 hemizygotes. This missense variant has a REVEL score of 0.255 (<0.3) and SpliceAI predicts no impact on splicing, with a score of 0.0, meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BP4. 	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BA1	Thr194Ala	https://erepo.genome.network/evrepo/ui/classification/3b7d37ef-41c7-478a-a6de-0913aa2c42d9					A	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	194.0		hemophilia B	0.2680851451013608	1.0363504808988786		Benign	139551121.0	missense_variant		0.255					Reporter			F9_Thr194Ala
F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	0.780442232559193	0.6633273479065258	0.7173445559633124	0.7618889422663242	0.628972195681177	0.683562763759731	0.6451334380833607	0.6882141274969147	0.7736982035283106	0.636145661500763	0.732002498159462	0.6542303929949432	0.7027793417301136	0.7677935728973174	0.6325589285909701	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G		Thr194Ala																												F9_Thr194Ala	23	139551121	A	G	X	allele	580A>G	D08	527_CAVA_Array_P02	G16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551121-A-G	-	0.03219	0.0	194	19457	5254	71	X	138633280	G	2.680850e-01	1374	X	2_Benign	NC_000023.11	270320	Thr194Ala	34	0.533	16	1539	3.032770e-01	T	27999	10	1	30871	2.142910e-01	137	18996	2.345610e-01	395	0.56351	Select	0.0001	73329	0.02950	2740	0.0013089005235602095	T	T	46443	0.622737437607	0.13705583756345177	343	2.389490e-01	2037	2037	0.18363	13659	33762	10024	2.073870e-03	0.26798	9294	.	0.12229	0.058	0.1365902293120638	99.0	0.315368	2.13	0.01	G	single nucleotide variant	NC_000023.11:g.139551121A>G	1065	12177	3	0.08421645	80228	0.18108728943338437	0.058962863	0.0021620063418852694		32071	172056	1323	38	2.552740e-03	1072	3.010590e-01	34	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	16623	4254	2.676470e-01	182	0.30097	B	0.11917	B	L	.	324101	A/A	410	3661	5700	1208948	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	13131	0.13578	72	.	-	139551121	3.010590e-01	-	1.468000	1728	0.55474	22031	0.1253968253968254	894493	21	germline	56776	.	.	GRCh38	924	reviewed by expert panel	c.580A>G	1.751950e-01	0.20193	82603	66	1078	.	2.672250e-01	6917	B	0.0016096579476861167	2.384820e-01	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	3	0	FA9_HUMAN	137	1.0	.	2323	T	0.03453	0.060261868	+	1.350880e-01	115		19457	2.320280e-01	0	27155	reviewed_by_expert_panel	0.95383	2.071970e-01	31752	2.642080e-01	131	45709	p.Thr194Ala	111	0.26817	.	germline	9294		A	Feb 09, 2024	3328	A/A	2535	64547	0.0	N	Xq27.1	252184	.	1.315970e-01	SCV004363688	Benign	2622	1692	Ala	A	-	680	ENSP00000218099	ENST00000218099	13319	0.648	10126	2944	0.756	A	252	-0.17694	0.09544	.	T	-	.	.	.	3150	115	0.293733681462141	0.00020	15	139551121	Y	9	0.23507462686567165	73329	2.747350e-01	P00740	201	0.375	0.02657		869	0.003	.	64547	0.061581787	30871	0.15862	2158	-0.540244	270320	-0.92	0.16016713091922005	3.022050e-01	0.04909	1.786000e-01	869	57124	2.313140e-03	4346	770	0.19334	X	F9	1.290350e-01	946	Thr	296768	3.014390e-01	X-139551121-A-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	418	22239	138460946	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	.	.	27999	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	T	0	136	c.580A>G	135	56	12521	0.00324	A/A	rs6048	139551121	12061	A	0.1456953642384106	.	9944	0.11817	2.662910e-01	0.08389		352	1795	1.658670e-03	1.52	0.08292682926829269	75761	264690	1.21	0.73694	6938	T	T	1589	9.529870e-02	252	1968	.	83	3254	98879	10588	0.32443	0.56240	0.00193173800424148	11639	550	0.06393	.	1.009020e-01	3.014390e-01	894493	0.555	2.114300e-01	N	9924	1795	0.20742	8	306900|300807	0.23211	X	1.317470e-01	ENSG00000101981	2.695990e-01	0.3004195349427402	3334	0.003556910569105691	0.9285000041175393	1	0.08696	0.18019	19061	54902	3.032770e-01	1.170230e-01	.	YES	1.765530e-01	.	25627	HGNC:3551	P	80	simple_aae	0.285	151686	139551121	ACT	0.000000	1	-	0.13514906778932897	0.00105	3.022050e-01	1573	425	Benign	0.18612	1776	1194	5349	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	T	0	.	-	.	-	0.03607	36870	16561	0.92783	0.353132814169	0.0698	284	0.38829522857183274	5224	-	580A>G 	22239	0.22106153010083932	C0008533|C2749016|C3661900|CN169374|C3275410	82	0	414	38	NM_000133.4	-	225	0.13740458015267176	0	0.07400	6048	1765	0.27834200452879015	.	.	0.064	0.745	11229	0.97858846	4.94	.	.	1.749120e-01	-0.40498	0.167231588560137	0.38202	T	4970	4646	7081	-1.0530	0.00038	p.Thr194Ala	7	14	-3.651	0.0049726367	7371	0.48150	10588	T	24376	F9	1.005930e-01	T	0.255	15975	.	T	0.41176	0.943	A/A	principal1	162485	F9_Popp_2025_carboxy_gla_motif_var253782	No		7/11/24		3b7d37ef-41c7-478a-a6de-0913aa2c42d9							T		580	F9_Popp_2025_carboxy_gla_motif	10588.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA121125	immortalized human cells		false			p.Thr194Ala		true	c.580A>G						3551.0	139551121.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa	BP4,BA1								The c.580A>G (p.Thr194Ala) variant is reported at an MAF of 0.3026 (27985/92495 alleles) in the non-Finnish European population in gnomAD v2.1.1 with 2609 homozygotes and 10667 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. Note that gnomAD v3.1.1 reports a frequency of 0.3041 in the NFE population, with 1859 homozygotes and 4024 hemizygotes. This missense variant has a REVEL score of 0.255 (<0.3) and SpliceAI predicts no impact on splicing, with a score of 0.0, meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BP4. 	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BA1	Thr194Ala	https://erepo.genome.network/evrepo/ui/classification/3b7d37ef-41c7-478a-a6de-0913aa2c42d9					A	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	194.0		hemophilia B	0.2680851451013608	1.0287167291236163		Benign	139551121.0	missense_variant		0.255					Reporter			F9_Thr194Ala
F9_Thr194Ala	-4.730674388204422	0.003222282231961676	3.466849610648739	0.010450298192967698	2025_01_Batch_13-14	0.780442232559193	0.6633273479065258	0.7173445559633124	0.7618889422663242	0.628972195681177	0.683562763759731	0.6451334380833607	0.6882141274969147	0.7736982035283106	0.636145661500763	0.732002498159462	0.6542303929949432	0.7027793417301136	0.7677935728973174	0.6325589285909701	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030557		NC_000023.11:139551121:A:G		Thr194Ala																												F9_Thr194Ala	23	139551121	A	G	X	allele	580A>G	D08	527_CAVA_Array_P02	G16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551121-A-G	-	0.03219	0.0	194	19457	5254	71	X	138633280	G	2.680850e-01	1374	X	2_Benign	NC_000023.11	270320	Thr194Ala	34	0.533	16	1539	3.032770e-01	T	27999	10	1	30871	2.142910e-01	137	18996	2.345610e-01	395	0.56351	Select	0.0001	73329	0.02950	2740	0.0013089005235602095	T	T	46443	0.622737437607	0.13705583756345177	343	2.389490e-01	2037	2037	0.18363	13659	33762	10024	2.073870e-03	0.26798	9294	.	0.12229	0.058	0.1365902293120638	99.0	0.315368	2.13	0.01	G	single nucleotide variant	NC_000023.11:g.139551121A>G	1065	12177	3	0.08421645	80228	0.18108728943338437	0.058962863	0.0021620063418852694		32071	172056	1323	38	2.552740e-03	1072	3.010590e-01	34	MedGen:CN169374|MedGen:C3275410|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	16623	4254	2.676470e-01	182	0.30097	B	0.11917	B	L	.	324101	A/A	410	3661	5700	1208948	not specified|Deep venous thrombosis, protection against|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided|Hereditary factor IX deficiency disease	13131	0.13578	72	.	-	139551121	3.010590e-01	-	1.468000	1728	0.55474	22031	0.1253968253968254	894493	21	germline	56776	.	.	GRCh38	924	reviewed by expert panel	c.580A>G	1.751950e-01	0.20193	82603	66	1078	.	2.672250e-01	6917	B	0.0016096579476861167	2.384820e-01	NM_000133.4(F9):c.580A>G (p.Thr194Ala)	3	0	FA9_HUMAN	137	1.0	.	2323	T	0.03453	0.060261868	+	1.350880e-01	115		19457	2.320280e-01	0	27155	reviewed_by_expert_panel	0.95383	2.071970e-01	31752	2.642080e-01	131	45709	p.Thr194Ala	111	0.26817	.	germline	9294		A	Feb 09, 2024	3328	A/A	2535	64547	0.0	N	Xq27.1	252184	.	1.315970e-01	SCV004363688	Benign	2622	1692	Ala	A	-	680	ENSP00000218099	ENST00000218099	13319	0.648	10126	2944	0.756	A	252	-0.17694	0.09544	.	T	-	.	.	.	3150	115	0.293733681462141	0.00020	15	139551121	Y	9	0.23507462686567165	73329	2.747350e-01	P00740	201	0.375	0.02657		869	0.003	.	64547	0.061581787	30871	0.15862	2158	-0.540244	270320	-0.92	0.16016713091922005	3.022050e-01	0.04909	1.786000e-01	869	57124	2.313140e-03	4346	770	0.19334	X	F9	1.290350e-01	946	Thr	296768	3.014390e-01	X-139551121-A-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided|not_specified|Deep_venous_thrombosis,_protection_against	418	22239	138460946	ClinGen:CA121125|OMIM:300746.0028|UniProtKB:P00740#VAR_011773	.	.	27999	RCV000244191|RCV000011334|RCV001521358|RCV001701639|RCV001810847|RCV000396693	T	0	136	c.580A>G	135	56	12521	0.00324	A/A	rs6048	139551121	12061	A	0.1456953642384106	.	9944	0.11817	2.662910e-01	0.08389		352	1795	1.658670e-03	1.52	0.08292682926829269	75761	264690	1.21	0.73694	6938	T	T	1589	9.529870e-02	252	1968	.	83	3254	98879	10588	0.32443	0.56240	0.00193173800424148	11639	550	0.06393	.	1.009020e-01	3.014390e-01	894493	0.555	2.114300e-01	N	9924	1795	0.20742	8	306900|300807	0.23211	X	1.317470e-01	ENSG00000101981	2.695990e-01	0.3004195349427402	3334	0.003556910569105691	0.9285000041175393	1	0.08696	0.18019	19061	54902	3.032770e-01	1.170230e-01	.	YES	1.765530e-01	.	25627	HGNC:3551	P	80	simple_aae	0.285	151686	139551121	ACT	0.000000	1	-	0.13514906778932897	0.00105	3.022050e-01	1573	425	Benign	0.18612	1776	1194	5349	ClinGen:CA121125,UniProtKB:P00740#VAR_011773,OMIM:300746.0028	T	0	.	-	.	-	0.03607	36870	16561	0.92783	0.353132814169	0.0698	284	0.38829522857183274	5224	-	580A>G 	22239	0.22106153010083932	C0008533|C2749016|C3661900|CN169374|C3275410	82	0	414	38	NM_000133.4	-	225	0.13740458015267176	0	0.07400	6048	1765	0.27834200452879015	.	.	0.064	0.745	11229	0.97858846	4.94	.	.	1.749120e-01	-0.40498	0.167231588560137	0.38202	T	4970	4646	7081	-1.0530	0.00038	p.Thr194Ala	7	14	-3.651	0.0049726367	7371	0.48150	10588	T	24376	F9	1.005930e-01	T	0.255	15975	.	T	0.41176	0.943	A/A	principal1	217517	F9_Popp_2025_light_chain_var244101	No		7/11/24		3b7d37ef-41c7-478a-a6de-0913aa2c42d9							T		580	F9_Popp_2025_light_chain	10588.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA121125	immortalized human cells		false			p.Thr194Ala		true	c.580A>G						3551.0	139551121.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa	BP4,BA1								The c.580A>G (p.Thr194Ala) variant is reported at an MAF of 0.3026 (27985/92495 alleles) in the non-Finnish European population in gnomAD v2.1.1 with 2609 homozygotes and 10667 hemizygotes, meeting BA1 criteria of MAF > 0.0000556. Note that gnomAD v3.1.1 reports a frequency of 0.3041 in the NFE population, with 1859 homozygotes and 4024 hemizygotes. This missense variant has a REVEL score of 0.255 (<0.3) and SpliceAI predicts no impact on splicing, with a score of 0.0, meeting BP4 criteria. In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BP4. 	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BA1	Thr194Ala	https://erepo.genome.network/evrepo/ui/classification/3b7d37ef-41c7-478a-a6de-0913aa2c42d9					A	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	194.0		hemophilia B	0.2680851451013608	1.0709261690420655		Benign	139551121.0	missense_variant		0.255					Reporter			F9_Thr194Ala
RAD51D_Ala231Ser	0.24888080055203415	0.8105973795143	15.706224815942015	1.0267282885890921e-6	2025_01_Batch_13-14	0.6124205899357344	0.7948659978902257	0.9617142773847289	0.779002624690744	0.6826065995404491	0.8818606767782569	0.9009835130033984	0.9606344086250178	0.9370644171431224	0.8438134656424551	0.7471406333569957	0.8479247554468121	0.9611743430048734	0.8580335209169332	0.7632100325914521	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024850		NC_000017.11:35103301:C:A		Ala231Ser																												RAD51D_Ala231Ser	17	35103301	C	A	17	allele	691G>T	H01	527_CAVA_Array_P05	O01	B13A7A8P2_R1	B14A7A8P2_R2				17-35103301-C-A	-	0.50833	0.68	231	0	0	0	17	33430320	A	2.915820e-05	0	17	3_Conflicting	NC_000017.11	46	Ala231Ser	0	23.0	0	0	5.034230e-04	T	0	5	5	41826	6.453060e-05	.	29796	0.000000e+00	0	0.41623	.	0.2791	29796	0.53374	0	.	T	T	63892	.	0	0	0.000000e+00	0	0	.	16800	44848	46	0.000000e+00	0.43338	0	.	0.72007	0.998	.	82.0	0.864413	3.22	0.18	A	single nucleotide variant	NC_000017.11:g.35103301C>A	0	16488	2	0.42019272	106972	0	0.5926053	0		15	232448	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	8	0	0.000000e+00	0	0.50204	P	0.65736	P	L	4.263942	47	C/C	84	0	6872	1611894	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	15702	0.63221	.	.	-	35103301	5.242460e-04	-	2.653000	0	0.50061	29510	0	90536	0	germline;unknown	90536	Gain of phosphorylation at A231 (P = 0.0655)| Gain of disorder (P = 0.0844)| Gain of MoRF binding (P = 0.1284)| Loss of ubiquitination at K235 (P = 0.2243)| Loss of methylation at R232 (P = 0.3779)	0.78027	GRCh38	908	criteria provided, conflicting classifications	c.691G>T	5.034230e-04	0.64102	0	0	0	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	0.000000e+00	8846	B	0	0.000000e+00	NM_002878.4(RAD51D):c.691G>T (p.Ala231Ser)	1	0	RA51D_HUMAN	0	18.0	0.387026469158641	0	D	0.32008	0.5926053	-	0.000000e+00	.		15	0.000000e+00	0	33672	criteria_provided,_conflicting_classifications	0.92618	7.478590e-05	0	0.000000e+00	0	59658	p.Ala231Ser	0	0.33911	.	germline	8		C	Jan 14, 2025	15	C/C	0	87500	1.0	N	17q12	6962	.	0.000000e+00	SCV000663829|SCV000686480|SCV001545958|SCV001990804|SCV004208079	Conflicting_classifications_of_pathogenicity	0	0	Ser	S	-	912	ENSP00000378090	ENST00000394589	17458	.	13302	0	0.549	C	0	3.594988	0.35663	D	T	-	4.600281	.	0.69852	610	0	.	0.21078	0	35103301	Y	10	0	100948	0.000000e+00	O75771	0	0.169282	0.29313		0	0.562	D	29876	0.42019272	15260	0.85369	5892	-0.0747325	0	.	.	5.080850e-04	0.39016	5.242460e-04	0	74890	0.000000e+00	6052	0	0.65736	17	RAD51D	0.000000e+00	0	Ala	11158	0.000000e+00	17-35103301-C-A	Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	0	30454433	ClinGen:CA8499378	0.620192	0.60517	0	RCV000575670|RCV001351481|RCV001764647	D	0	0	c.691G>T	0	0	0	0.40218	C/C	rs772135704	35103301	14484	C	.	O75771	15260	0.72005	0.000000e+00	0.68239		0	0	0.000000e+00	1.42	0	0	264690	4.92	0.51414	108	T	.	0	0.000000e+00	0	24	.	0	0	140162|145	480531	0.69677	0.36618	0.217512117147641	2720	.	0.71675	0.60393	0.000000e+00	5.020750e-04	1179196	4.112	7.368330e-05	.	13256	0	3.7780044E-6	0	614291	0.57674	17	0.000000e+00	ENSG00000185379	0.000000e+00	0	15	0	.	1	0.49607	0.22602	29876	1	0.000000e+00	0.000000e+00	0.432911172391861	.	5.080850e-04	0.066725	478474	HGNC:9823	N	0	simple_aae	0.232	203574	35103301	GCC	1.000000	.	-	0	0.58389	0.000000e+00	0	0	Conflicting classifications of pathogenicity	0.62579	8	0	0	ClinGen:CA8499378	A	0	0.942670400808	-	0.644	-	0.39513	15	518	0.52746	.	0.116	0	0.96226307501413078	94	-	691G>T 	15	0	C0027672|C3661900|C3280345	0	0	0	0	NM_002878.4	-	.	.	0	0.57408	772135704	2230	0	0.94162	0.63430	0.222	0.148	2636	0.93499870	4.92	.	.	5.020750e-04	-0.00673246	0.000766225569270482	0.35528	T	84	6046	9430	-0.6345	0.64952	p.Ala231Ser	0	0	-7.695	0.45145473	0	0.08395	480531	D	29908	RAD51D	0.000000e+00	D	0.162	21108	A231S	.	0.58372	0.27038	C/C	principal1	960115	RAD51D_unpublished_var154362	Yes						overall function		Cell survival			A		691	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Ala231Ser		true	c.691G>T						9823.0	35103301.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		T									criteria provided, conflicting classifications				Ala231Ser						S	Mar 21, 2024					missense_variant		231.0	G		0.0000291582448969	0.0141602		Conflicting classifications of pathogenicity	35103301.0	missense_variant		0.162	functionally_normal				Cell viability			RAD51D_Ala231Ser
RAD51D_Ala231Ser	0.24888080055203415	0.8105973795143	15.706224815942015	1.0267282885890921e-6	2025_01_Batch_13-14	0.6124205899357344	0.7948659978902257	0.9617142773847289	0.779002624690744	0.6826065995404491	0.8818606767782569	0.9009835130033984	0.9606344086250178	0.9370644171431224	0.8438134656424551	0.7471406333569957	0.8479247554468121	0.9611743430048734	0.8580335209169332	0.7632100325914521	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024850	ALE00021967	NC_000017.11:35103301:C:A	691G>T	Ala231Ser	CAVA																											RAD51D_Ala231Ser	17	35103301	C	A	17								1	1	1	17-35103301-C-A	-	0.50833	0.68	231	0	0	0	17	33430320	A	2.915820e-05	0	17	3_Conflicting	NC_000017.11	46	Ala231Ser	0	23.0	0	0	5.034230e-04	T	0	5	5	41826	6.453060e-05	.	29796	0.000000e+00	0	0.41623	.	0.2791	29796	0.53374	0	.	T	T	63892	.	0	0	0.000000e+00	0	0	.	16800	44848	46	0.000000e+00	0.43338	0	.	0.72007	0.998	.	82.0	0.864413	3.22	0.18	A	single nucleotide variant	NC_000017.11:g.35103301C>A	0	16488	2	0.42019272	106972	0	0.5926053	0		15	232448	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	8	0	0.000000e+00	0	0.50204	P	0.65736	P	L	4.263942	47	C/C	84	0	6872	1611894	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	15702	0.63221	.	.	-	35103301	5.242460e-04	-	2.653000	0	0.50061	29510	0	90536	0	germline;unknown	90536	Gain of phosphorylation at A231 (P = 0.0655)| Gain of disorder (P = 0.0844)| Gain of MoRF binding (P = 0.1284)| Loss of ubiquitination at K235 (P = 0.2243)| Loss of methylation at R232 (P = 0.3779)	0.78027	GRCh38	908	criteria provided, conflicting classifications	c.691G>T	5.034230e-04	0.64102	0	0	0	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	0.000000e+00	8846	B	0	0.000000e+00	NM_002878.4(RAD51D):c.691G>T (p.Ala231Ser)	1	0	RA51D_HUMAN	0	18.0	0.387026469158641	0	D	0.32008	0.5926053	-	0.000000e+00	.		15	0.000000e+00	0	33672	criteria_provided,_conflicting_classifications	0.92618	7.478590e-05	0	0.000000e+00	0	59658	p.Ala231Ser	0	0.33911	.	germline	8		C	Jan 14, 2025	15	C/C	0	87500	1.0	N	17q12	6962	.	0.000000e+00	SCV000663829|SCV000686480|SCV001545958|SCV001990804|SCV004208079	Conflicting_classifications_of_pathogenicity	0	0	Ser	S	-	912	ENSP00000378090	ENST00000394589	17458	.	13302	0	0.549	C	0	3.594988	0.35663	D	T	-	4.600281	.	0.69852	610	0	.	0.21078	0	35103301	Y	10	0	100948	0.000000e+00	O75771	0	0.169282	0.29313		0	0.562	D	29876	0.42019272	15260	0.85369	5892	-0.0747325	0	.	.	5.080850e-04	0.39016	5.242460e-04	0	74890	0.000000e+00	6052	0	0.65736	17	RAD51D	0.000000e+00	0	Ala	11158	0.000000e+00	17-35103301-C-A	Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	0	30454433	ClinGen:CA8499378	0.620192	0.60517	0	RCV000575670|RCV001351481|RCV001764647	D	0	0	c.691G>T	0	0	0	0.40218	C/C	rs772135704	35103301	14484	C	.	O75771	15260	0.72005	0.000000e+00	0.68239		0	0	0.000000e+00	1.42	0	0	264690	4.92	0.51414	108	T	.	0	0.000000e+00	0	24	.	0	0	140162|145	480531	0.69677	0.36618	0.217512117147641	2720	.	0.71675	0.60393	0.000000e+00	5.020750e-04	1179196	4.112	7.368330e-05	.	13256	0	3.7780044E-6	0	614291	0.57674	17	0.000000e+00	ENSG00000185379	0.000000e+00	0	15	0	.	1	0.49607	0.22602	29876	1	0.000000e+00	0.000000e+00	0.432911172391861	.	5.080850e-04	0.066725	478474	HGNC:9823	N	0	simple_aae	0.232	203574	35103301	GCC	1.000000	.	-	0	0.58389	0.000000e+00	0	0	Conflicting classifications of pathogenicity	0.62579	8	0	0	ClinGen:CA8499378	A	0	0.942670400808	-	0.644	-	0.39513	15	518	0.52746	.	0.116	0	0.96226307501413078	94	-	691G>T 	15	0	C0027672|C3661900|C3280345	0	0	0	0	NM_002878.4	-	.	.	0	0.57408	772135704	2230	0	0.94162	0.63430	0.222	0.148	2636	0.93499870	4.92	.	.	5.020750e-04	-0.00673246	0.000766225569270482	0.35528	T	84	6046	9430	-0.6345	0.64952	p.Ala231Ser	0	0	-7.695	0.45145473	0	0.08395	480531	D	29908	RAD51D	0.000000e+00	D	0.162	21108	A231S	.	0.58372	0.27038	C/C	principal1	960115	RAD51D_unpublished_var154362	Yes						overall function		Cell survival			A		691	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Ala231Ser		true	c.691G>T						9823.0	35103301.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		T									criteria provided, conflicting classifications				Ala231Ser						S	Mar 21, 2024					missense_variant		231.0	G		0.0000291582448969	0.0141602		Conflicting classifications of pathogenicity	35103301.0	missense_variant		0.162	functionally_normal				Cell viability			RAD51D_Ala231Ser
FH_His318Tyr	3.1703971636548824	0.019309050557584827	-8.740897838119132	0.000051562458963120044	2025_01_Batch_13-14	0.7185095770613064	0.9010962748991456	0.9437543763498761	0.9152637329177788	0.8993966433284734	0.718969205371559	0.8743944008886777	0.9583120119302941	0.9231214824713794	0.9184497594941273	0.7187393912164326	0.8877453378939116	0.9510331941400851	0.9191926076945791	0.9089232014113003	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	FH	FH	ENSG00000091483	3408	214597	CCSBVarC004052	ALE00004052	NC_000001.11:241504198:G:A	952C>T	His318Tyr	CEGS2	CegsMutGDEh1041	E03	GDEhDisVCh_40065	G08	1	CegsMutGDDh1041	E03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_His318Tyr	1	241504198	G	A	1											1-241504198-G-A	-	0.79665	0.998	318	.	0	.	1	241667498	A	6.195100e-07	.	1	1_Pathogenic	NC_000001.11	1	His318Tyr	.	27.1	.	.	.	D	0	12	1	.	.	.	.	.	.	0.99874	Select	0.9896	.	0.73231	.	.	D	D	64038	1.04814267846	.	0	.	.	.	0.92578	.	44890	0	.	0.83652	.	.	0.96862	0.976	.	49.0	0.990021	6.28	0.51	A	single nucleotide variant	NC_000001.11:g.241504198G>A	0	.	2	0.92381674	.	.	0.95636344	.	A	.	.	.	.	.	.	.	.	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	0.000000e+00	0	0.71237	D	0.96618	D	H	15.67457	1	./.	.	.	.	1614178	not provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Hereditary cancer-predisposing syndrome	.	0.97307	.	.	-	241504198	.	-	9.909000	.	0.99892	29608	.	1180018	.	germline;unknown	91080	Gain of phosphorylation at H318 (P = 0.111)| Loss of catalytic residue at D319 (P = 0.1709)| Loss of disorder (P = 0.2552)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.5184)	0.87844	GRCh38	975	criteria provided, multiple submitters, no conflicts	c.952C>T	.	0.89714	.	.	.	Fumarate lyase, N-terminal	.	.	P	.	0.000000e+00	NM_000143.4(FH):c.952C>T (p.His318Tyr)	2	.	FUMH_HUMAN	.	51.0	1.05284626535223	.	D	0.80553	0.95636344	-	.	.	6.84061e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.94067	.	0	.	.	60020	p.His318Tyr	0	0.82440	.	germline	.	241504198	G	Mar 04, 2025	.	./.	.	.	1.0	N	1q43	.	.	.	SCV000109990|SCV000251474|SCV000537249|SCV000756697|SCV000893293|SCV002580555|SCV002688460|SCV004187986|SCV004197372|SCV005090906|SCV005394266|SCV005625606	Pathogenic/Likely_pathogenic	.	.	Tyr	Y	-	912	ENSP00000355518	ENST00000366560	.	0.0	.	.	0.676	G	.	4.864406	0.79703	D	D	-	18.50119	.	0.98295	.	.	.	0.94843	.	241504198	Y	10	.	.	0.000000e+00	P07954	.	0.96242	0.92321	G	.	0.967	D	.	0.92381674	.	0.56441	2271	0.580039	1	-5.19	.	8.474450e-07	0.91343	.	.	75048	.	6062	.	0.96619	1	FH	0.000000e+00	.	His	.	.	1-241504198-G-A	Hereditary_leiomyomatosis_and_renal_cell_cancer|Fumarase_deficiency|not_provided|Hereditary_cancer-predisposing_syndrome	0	.	239734121	ClinGen:CA285329	0.934609	0.97140	0	RCV000078152|RCV000445608|RCV000762893|RCV003460742|RCV002371923	D	0	.	c.952C>T	.	0	0	0.96967	./.	rs398123168	241504198	.	G	.	P07954	.	0.96862	.	0.68239	1	.	.	0.000000e+00	4.24	.	.	.	5.73	0.99523	.	D	D	.	.	.	.	.	.	.	523|24|140162	92458	0.96917	0.75889	0.998691618442535	.	.	0.71675	0.92797	.	.	1180018	9.346	.	D	.	.	.	.	150800|606812	0.96466	1	.	ENSG00000091483	0.000000e+00	.	.	.	0.9644412197578099	1	0.71532	0.05314	.	.	.	0.000000e+00	0.99436337600402	YES	0.000000e+00	0.783796	98367	HGNC:3700	A	.	simple_aae	0.997	.	241504198	CAT	1.000000	.	-	.	0.95861	8.474450e-07	.	0	Pathogenic/Likely pathogenic	0.82269	.	0	0	ClinGen:CA285329	H	.	0.970197299285	-	0.748	-	0.85095	.	.	0.96411	0.870154500008	0.8651	0	0.99843370951524324	.	-	952C>T 	.	.	C1708350|C0342770|C3661900|C0027672	.	.	.	.	NM_000143.4	-	.	.	1	0.96938	398123168	.	.	0.96959	0.98507	0.855	0.002	.	0.96164210	5.73	.	.	.	0.595409	0.999672043470544	0.97965	D	.	.	.	1.0075	0.99711	p.His318Tyr	.	0	-11.478	0.96449435	0	0.97434	92458	D	.	FH	.	D	0.981	.	H318Y	D	0.98834	0.76753	./.	principal1																																																																																																				
FH_His318Tyr	3.1703971636548824	0.019309050557584827	-8.740897838119132	0.000051562458963120044	2025_01_Batch_13-14	0.7185095770613064	0.9010962748991456	0.9437543763498761	0.9152637329177788	0.8993966433284734	0.718969205371559	0.8743944008886777	0.9583120119302941	0.9231214824713794	0.9184497594941273	0.7187393912164326	0.8877453378939116	0.9510331941400851	0.9191926076945791	0.9089232014113003	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	FH	FH		3408		CCSBVarC004052		NC_000001.11:241504198:G:A		His318Tyr																												FH_His318Tyr	1	241504198	G	A	1	allele	952C>T	G03	527_CAVA_Array_P03	N05	B13A7A8P1_R1	B14A7A8P1_R2				1-241504198-G-A	-	0.79665	0.998	318	.	0	.	1	241667498	A	6.195100e-07	.	1	1_Pathogenic	NC_000001.11	1	His318Tyr	.	27.1	.	.	.	D	0	12	1	.	.	.	.	.	.	0.99874	Select	0.9896	.	0.73231	.	.	D	D	64038	1.04814267846	.	0	.	.	.	0.92578	.	44890	0	.	0.83652	.	.	0.96862	0.976	.	49.0	0.990021	6.28	0.51	A	single nucleotide variant	NC_000001.11:g.241504198G>A	0	.	2	0.92381674	.	.	0.95636344	.	A	.	.	.	.	.	.	.	.	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24;Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	0.000000e+00	0	0.71237	D	0.96618	D	H	15.67457	1	./.	.	.	.	1614178	not provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency;Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Hereditary cancer-predisposing syndrome	.	0.97307	.	.	-	241504198	.	-	9.909000	.	0.99892	29608	.	1180018	.	germline;unknown	91080	Gain of phosphorylation at H318 (P = 0.111)| Loss of catalytic residue at D319 (P = 0.1709)| Loss of disorder (P = 0.2552)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.5184)	0.87844	GRCh38	975	criteria provided, multiple submitters, no conflicts	c.952C>T	.	0.89714	.	.	.	Fumarate lyase, N-terminal	.	.	P	.	0.000000e+00	NM_000143.4(FH):c.952C>T (p.His318Tyr)	2	.	FUMH_HUMAN	.	51.0	1.05284626535223	.	D	0.80553	0.95636344	-	.	.	6.84061e-7	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.94067	.	0	.	.	60020	p.His318Tyr	0	0.82440	.	germline	.	241504198	G	Mar 04, 2025	.	./.	.	.	1.0	N	1q43	.	.	.	SCV000109990|SCV000251474|SCV000537249|SCV000756697|SCV000893293|SCV002580555|SCV002688460|SCV004187986|SCV004197372|SCV005090906|SCV005394266|SCV005625606	Pathogenic/Likely_pathogenic	.	.	Tyr	Y	-	912	ENSP00000355518	ENST00000366560	.	0.0	.	.	0.676	G	.	4.864406	0.79703	D	D	-	18.50119	.	0.98295	.	.	.	0.94843	.	241504198	Y	10	.	.	0.000000e+00	P07954	.	0.96242	0.92321	G	.	0.967	D	.	0.92381674	.	0.56441	2271	0.580039	1	-5.19	.	8.474450e-07	0.91343	.	.	75048	.	6062	.	0.96619	1	FH	0.000000e+00	.	His	.	.	1-241504198-G-A	Hereditary_leiomyomatosis_and_renal_cell_cancer|Fumarase_deficiency|not_provided|Hereditary_cancer-predisposing_syndrome	0	.	239734121	ClinGen:CA285329	0.934609	0.97140	0	RCV000078152|RCV000445608|RCV000762893|RCV003460742|RCV002371923	D	0	.	c.952C>T	.	0	0	0.96967	./.	rs398123168	241504198	.	G	.	P07954	.	0.96862	.	0.68239	1	.	.	0.000000e+00	4.24	.	.	.	5.73	0.99523	.	D	D	.	.	.	.	.	.	.	523|24|140162	92458	0.96917	0.75889	0.998691618442535	.	.	0.71675	0.92797	.	.	1180018	9.346	.	D	.	.	.	.	150800|606812	0.96466	1	.	ENSG00000091483	0.000000e+00	.	.	.	0.9644412197578099	1	0.71532	0.05314	.	.	.	0.000000e+00	0.99436337600402	YES	0.000000e+00	0.783796	98367	HGNC:3700	A	.	simple_aae	0.997	.	241504198	CAT	1.000000	.	-	.	0.95861	8.474450e-07	.	0	Pathogenic/Likely pathogenic	0.82269	.	0	0	ClinGen:CA285329	H	.	0.970197299285	-	0.748	-	0.85095	.	.	0.96411	0.870154500008	0.8651	0	0.99843370951524324	.	-	952C>T 	.	.	C1708350|C0342770|C3661900|C0027672	.	.	.	.	NM_000143.4	-	.	.	1	0.96938	398123168	.	.	0.96959	0.98507	0.855	0.002	.	0.96164210	5.73	.	.	.	0.595409	0.999672043470544	0.97965	D	.	.	.	1.0075	0.99711	p.His318Tyr	.	0	-11.478	0.96449435	0	0.97434	92458	D	.	FH	.	D	0.981	.	H318Y	D	0.98834	0.76753	./.	principal1																																																																																																				
BRAF_Val487Gly	-6.116199946608242	0.00048331137760885195	3.8723574361118165	0.006113032285350252	2025_01_Batch_13-14	0.5407661447805905	0.6765742692118035	0.7522435543255914	0.6841347854488865	0.507385551881682	0.7776936183988862	0.7968696578257537	0.7144309182995557	0.7060995616659878	0.6554421850724196	0.6592298815897384	0.7367219635187786	0.7333372363125736	0.6951171735574371	0.5814138684770508	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220606	CCSBVarC003164	ALE00003164	NC_000007.14:140778048:A:C	1460T>G	Val487Gly	CEGS2	CegsMutGDEh1011	H06	GDEhDisVCh_40058	E03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Val487Gly	7	140778048	A	C	7											7-140778048-A-C	-	0.8881	0.478	487	.	.	.	7	140477848	C	.	.	7	1_Pathogenic	NC_000007.14	.	Val487Gly	.	29.7	.	.	.	T	.	5	.	.	.	.	.	.	.	0.96086	Select	0.1922	.	0.36724	.	.	D	D	.	.	.	.	.	.	.	0.86370	.	.	.	.	.	.	.	0.96056	0.997	.	.	0.946505	.	.	C	single nucleotide variant	NC_000007.14:g.140778048A>C	.	.	2	0.9274714	.	.	0.9640127	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.99291	B	0.97310	P	L	4.002832	.	./.	.	.	.	.	not provided|Cardio-facio-cutaneous syndrome|Inborn genetic diseases|RASopathy	.	0.51413	.	.	-	140778048	.	-	11.177000	.	0.99892	.	.	.	.	germline	.	Gain of disorder (P = 0.0281)| Loss of stability (P = 0.0406)| Gain of ubiquitination at K483 (P = 0.0985)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.2005)	0.93817	GRCh38	776	criteria provided, multiple submitters, no conflicts	c.1460T>G	.	0.65108	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1460T>G (p.Val487Gly)	2	.	BRAF_HUMAN	.	.	0.341902369550804	.	D	0.95874	0.948537	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.97559	.	.	.	.	.	p.Val487Gly	.	0.88188	.	germline	.		A	Jul 21, 2021	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000061585|SCV000740925|SCV000928070|SCV002008924|SCV002196994	Pathogenic/Likely_pathogenic	.	.	Gly	G	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.686	A	.	5.288129	.	D	.	-	4.624474	.	0.85076	.	.	.	0.91358	.	140778048	Y	10	.	.	.	P15056	.	0.848438	0.73662		.	0.148	D	.	0.93370944	.	0.79771	673	0.417248	.	.	.	.	.	.	.	.	.	.	.	0.96876	7	BRAF	.	.	Val	.	.	7-140778048-A-C	Cardio-facio-cutaneous_syndrome|not_provided|Inborn_genetic_diseases|RASopathy	.	.	140124317	ClinGen:CA280007	0.903643	0.58100	.	RCV000788814|RCV000037922|RCV000622585|RCV001852794	D	.	.	c.1460T>G	.	.	.	0.90811	./.	rs397516893	140778048	.	A	.	P15056	.	0.97644	.	0.68239		.	.	.	0.895	.	.	.	4.96	0.96500	.	D	D	.	.	.	.	.	.	.	1340|536391	44806	0.90697	0.93269	0.99738210439682	.	.	0.71675	0.85245	.	.	.	9.289	.	.	.	.	.	.	PS115150	0.95099	7	.	ENSG00000157764	.	.	.	.	.	2	0.34068	0.48248	.	.	.	.	0.436077121338009	YES	.	0.174902	53973	HGNC:1097	.	.	.	0.997	.	140778048	GTG	1.000000	.	-	.	0.93461	.	.	.	Pathogenic/Likely pathogenic	0.92975	.	.	.	ClinGen:CA280007	V	.	.	-	0.828	-	.	.	.	0.92090	0.828899681568	0.9903	.	0.99591389096133687	.	-	1460T>G 	.	.	C1275081|C3661900|C0950123|C5555857	.	.	.	.	NM_004333.6	-	.	.	1	0.79494	397516893	.	.	0.98130	0.63630	.	.	.	0.99449290	4.96	.	.	.	0.361572	0.999977702097208	0.22286	T	.	.	.	-0.8552	0.54309	p.Val487Gly	.	.	-13.971	0.9420905	.	0.99427	44806	D	.	BRAF	.	D	.	.	V487G	.	.	0.82694	./.	principal4																																																																																																				
BRAF_Val487Gly	-6.116199946608242	0.00048331137760885195	3.8723574361118165	0.006113032285350252	2025_01_Batch_13-14	0.5407661447805905	0.6765742692118035	0.7522435543255914	0.6841347854488865	0.507385551881682	0.7776936183988862	0.7968696578257537	0.7144309182995557	0.7060995616659878	0.6554421850724196	0.6592298815897384	0.7367219635187786	0.7333372363125736	0.6951171735574371	0.5814138684770508	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003164		NC_000007.14:140778048:A:C		Val487Gly																												BRAF_Val487Gly	7	140778048	A	C	7	allele	1460T>G	C04	527_CAVA_Array_P01	E07	B13A7A8P1_R1	B14A7A8P1_R2				7-140778048-A-C	-	0.8881	0.478	487	.	.	.	7	140477848	C	.	.	7	1_Pathogenic	NC_000007.14	.	Val487Gly	.	29.7	.	.	.	T	.	5	.	.	.	.	.	.	.	0.96086	Select	0.1922	.	0.36724	.	.	D	D	.	.	.	.	.	.	.	0.86370	.	.	.	.	.	.	.	0.96056	0.997	.	.	0.946505	.	.	C	single nucleotide variant	NC_000007.14:g.140778048A>C	.	.	2	0.9274714	.	.	0.9640127	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.99291	B	0.97310	P	L	4.002832	.	./.	.	.	.	.	not provided|Cardio-facio-cutaneous syndrome|Inborn genetic diseases|RASopathy	.	0.51413	.	.	-	140778048	.	-	11.177000	.	0.99892	.	.	.	.	germline	.	Gain of disorder (P = 0.0281)| Loss of stability (P = 0.0406)| Gain of ubiquitination at K483 (P = 0.0985)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.2005)	0.93817	GRCh38	776	criteria provided, multiple submitters, no conflicts	c.1460T>G	.	0.65108	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1460T>G (p.Val487Gly)	2	.	BRAF_HUMAN	.	.	0.341902369550804	.	D	0.95874	0.948537	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.97559	.	.	.	.	.	p.Val487Gly	.	0.88188	.	germline	.		A	Jul 21, 2021	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000061585|SCV000740925|SCV000928070|SCV002008924|SCV002196994	Pathogenic/Likely_pathogenic	.	.	Gly	G	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.686	A	.	5.288129	.	D	.	-	4.624474	.	0.85076	.	.	.	0.91358	.	140778048	Y	10	.	.	.	P15056	.	0.848438	0.73662		.	0.148	D	.	0.93370944	.	0.79771	673	0.417248	.	.	.	.	.	.	.	.	.	.	.	0.96876	7	BRAF	.	.	Val	.	.	7-140778048-A-C	Cardio-facio-cutaneous_syndrome|not_provided|Inborn_genetic_diseases|RASopathy	.	.	140124317	ClinGen:CA280007	0.903643	0.58100	.	RCV000788814|RCV000037922|RCV000622585|RCV001852794	D	.	.	c.1460T>G	.	.	.	0.90811	./.	rs397516893	140778048	.	A	.	P15056	.	0.97644	.	0.68239		.	.	.	0.895	.	.	.	4.96	0.96500	.	D	D	.	.	.	.	.	.	.	1340|536391	44806	0.90697	0.93269	0.99738210439682	.	.	0.71675	0.85245	.	.	.	9.289	.	.	.	.	.	.	PS115150	0.95099	7	.	ENSG00000157764	.	.	.	.	.	2	0.34068	0.48248	.	.	.	.	0.436077121338009	YES	.	0.174902	53973	HGNC:1097	.	.	.	0.997	.	140778048	GTG	1.000000	.	-	.	0.93461	.	.	.	Pathogenic/Likely pathogenic	0.92975	.	.	.	ClinGen:CA280007	V	.	.	-	0.828	-	.	.	.	0.92090	0.828899681568	0.9903	.	0.99591389096133687	.	-	1460T>G 	.	.	C1275081|C3661900|C0950123|C5555857	.	.	.	.	NM_004333.6	-	.	.	1	0.79494	397516893	.	.	0.98130	0.63630	.	.	.	0.99449290	4.96	.	.	.	0.361572	0.999977702097208	0.22286	T	.	.	.	-0.8552	0.54309	p.Val487Gly	.	.	-13.971	0.9420905	.	0.99427	44806	D	.	BRAF	.	D	.	.	V487G	.	.	0.82694	./.	principal4																																																																																																				
F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg294Gln	23	139561566	G	A	X											X-139561566-G-A	-	0.6885	0.992	294	.	0	.	X	138643725	A	1.656120e-06	.	X	1_Pathogenic	NC_000023.11	2	Arg294Gln	.	25.3	.	0	.	D	0	11	1	.	.	.	.	.	0	0.82769	Select	0.8304	.	0.64752	.	.	D	D	46785	1.76066134508	0	0	.	.	.	0.04971	.	33771	0	.	0.37362	.	.	0.86012	0.999	.	24.0	0.787321	4.79	0.76	A	single nucleotide variant	NC_000023.11:g.139561566G>A	0	.	3	0.74242586	.	0	0.8708545	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.86984	P	0.90092	D	L	.	2	G/G	114	0	.	1207641	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	.	0.87825	.	.	-	139561566	.	-	9.966000	.	0.82854	21907	0	892887	.	germline;unknown	56270	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.97715	GRCh38	924	reviewed by expert panel	c.881G>A	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	3	.	FA9_HUMAN	.	76.0	.	.	T	0.47870	0.8341477	+	.	.	1.82809e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	45799	p.Arg294Gln	0	0.82858	.	germline	.	139561566	G	Nov 01, 2024	.	G/G	.	.	0.068	N	Xq27.1	9768	.	.	SCV005437142	Pathogenic	.	.	Gln	Q	-	685	ENSP00000218099	ENST00000218099	.	0.08	.	.	0.618	G	.	4.434207	0.30054	.	T	-	.	.	0.89905	610	.	.	0.59548	0	139561566	Y	10	0	.	0.000000e+00	P00740	.	0.696638	0.99661	G	.	0.541	D	.	0.8305342	.	0.91597	2158	0.313999	2	-1.54	.	2.239930e-06	0.36067	.	.	57732	.	4338	.	0.84591	X	F9	0.000000e+00	0	Arg	14710	.	X-139561566-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	.	138471391	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	.	.	0	RCV000011348|RCV000814168|RCV000851909|RCV004724733	D	0	.	c.881G>A	.	0	0	0.83923	G/G	rs137852249	139561566	.	G	.	P00740	.	0.88776	.	0.68239	X	.	.	0.000000e+00	1.665	0	0	264690	5.42	0.91142	146	D	T	.	.	0	26	.	.	.	98879|98878	10602	0.83714	0.91089	0.932065665721893	3332	.	0.2209	.	.	.	892887	2.44	.	N	.	.	2.1912425E-4	0	306900|134500|306700|300807	0.44615	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9585912016915898	2	0.48867	0.18019	.	58	.	0.000000e+00	.	YES	0.000000e+00	0.272407	25641	HGNC:3551	A	.	simple_aae	0.691	.	139561566	CGA	1.000000	.	-	0	0.96923	2.239930e-06	0	0	Pathogenic	0.77265	.	0	0	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	R	.	0.992843060398	-	0.899	-	0.49268	.	604	0.95820	0.260667711496	0.1903	0	0.99937078441635274	104	-	881G>A 	.	0	C0008533|C0019069|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.42431	137852249	.	0	0.99267	.	0.334	0.177	3218	0.99998462	5.42	.	.	.	0.213262	0.988798436711402	0.42444	D	120	.	.	0.3200	0.94300	p.Arg294Gln	0	0	-10.286	0.97296536	0	0.87928	10602	D	.	F9	.	D	0.576	.	R294Q	T	0.87757	0.50684	G/G	principal1	195915	F9_Popp_2025_heavy_chain_var236531	No		11/1/24		317fdec6-df8d-4c37-90c0-0c5ae79cb5ad							R		881	F9_Popp_2025_heavy_chain	10602.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255368	immortalized human cells		false			p.Arg294Gln		true	c.881G>A						3551.0	139561566.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1						PP3,PM5		The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	Arg294Gln	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad					Q	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	294.0		hemophilia B	1.6561213141e-6	0.059427999		Pathogenic	139561566.0	missense_variant		0.576					Reporter			F9_Arg294Gln
F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg294Gln	23	139561566	G	A	X											X-139561566-G-A	-	0.6885	0.992	294	.	0	.	X	138643725	A	1.656120e-06	.	X	1_Pathogenic	NC_000023.11	2	Arg294Gln	.	25.3	.	0	.	D	0	11	1	.	.	.	.	.	0	0.82769	Select	0.8304	.	0.64752	.	.	D	D	46785	1.76066134508	0	0	.	.	.	0.04971	.	33771	0	.	0.37362	.	.	0.86012	0.999	.	24.0	0.787321	4.79	0.76	A	single nucleotide variant	NC_000023.11:g.139561566G>A	0	.	3	0.74242586	.	0	0.8708545	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.86984	P	0.90092	D	L	.	2	G/G	114	0	.	1207641	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	.	0.87825	.	.	-	139561566	.	-	9.966000	.	0.82854	21907	0	892887	.	germline;unknown	56270	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.97715	GRCh38	924	reviewed by expert panel	c.881G>A	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	3	.	FA9_HUMAN	.	76.0	.	.	T	0.47870	0.8341477	+	.	.	1.82809e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	45799	p.Arg294Gln	0	0.82858	.	germline	.	139561566	G	Nov 01, 2024	.	G/G	.	.	0.068	N	Xq27.1	9768	.	.	SCV005437142	Pathogenic	.	.	Gln	Q	-	685	ENSP00000218099	ENST00000218099	.	0.08	.	.	0.618	G	.	4.434207	0.30054	.	T	-	.	.	0.89905	610	.	.	0.59548	0	139561566	Y	10	0	.	0.000000e+00	P00740	.	0.696638	0.99661	G	.	0.541	D	.	0.8305342	.	0.91597	2158	0.313999	2	-1.54	.	2.239930e-06	0.36067	.	.	57732	.	4338	.	0.84591	X	F9	0.000000e+00	0	Arg	14710	.	X-139561566-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	.	138471391	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	.	.	0	RCV000011348|RCV000814168|RCV000851909|RCV004724733	D	0	.	c.881G>A	.	0	0	0.83923	G/G	rs137852249	139561566	.	G	.	P00740	.	0.88776	.	0.68239	X	.	.	0.000000e+00	1.665	0	0	264690	5.42	0.91142	146	D	T	.	.	0	26	.	.	.	98879|98878	10602	0.83714	0.91089	0.932065665721893	3332	.	0.2209	.	.	.	892887	2.44	.	N	.	.	2.1912425E-4	0	306900|134500|306700|300807	0.44615	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9585912016915898	2	0.48867	0.18019	.	58	.	0.000000e+00	.	YES	0.000000e+00	0.272407	25641	HGNC:3551	A	.	simple_aae	0.691	.	139561566	CGA	1.000000	.	-	0	0.96923	2.239930e-06	0	0	Pathogenic	0.77265	.	0	0	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	R	.	0.992843060398	-	0.899	-	0.49268	.	604	0.95820	0.260667711496	0.1903	0	0.99937078441635274	104	-	881G>A 	.	0	C0008533|C0019069|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.42431	137852249	.	0	0.99267	.	0.334	0.177	3218	0.99998462	5.42	.	.	.	0.213262	0.988798436711402	0.42444	D	120	.	.	0.3200	0.94300	p.Arg294Gln	0	0	-10.286	0.97296536	0	0.87928	10602	D	.	F9	.	D	0.576	.	R294Q	T	0.87757	0.50684	G/G	principal1	223431	F9_Popp_2025_light_chain_var246212	No		11/1/24		317fdec6-df8d-4c37-90c0-0c5ae79cb5ad							R		881	F9_Popp_2025_light_chain	10602.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255368	immortalized human cells		false			p.Arg294Gln		true	c.881G>A						3551.0	139561566.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1						PP3,PM5		The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	Arg294Gln	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad					Q	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	294.0		hemophilia B	1.6561213141e-6	0.094617019		Pathogenic	139561566.0	missense_variant		0.576					Reporter			F9_Arg294Gln
F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg294Gln	23	139561566	G	A	X											X-139561566-G-A	-	0.6885	0.992	294	.	0	.	X	138643725	A	1.656120e-06	.	X	1_Pathogenic	NC_000023.11	2	Arg294Gln	.	25.3	.	0	.	D	0	11	1	.	.	.	.	.	0	0.82769	Select	0.8304	.	0.64752	.	.	D	D	46785	1.76066134508	0	0	.	.	.	0.04971	.	33771	0	.	0.37362	.	.	0.86012	0.999	.	24.0	0.787321	4.79	0.76	A	single nucleotide variant	NC_000023.11:g.139561566G>A	0	.	3	0.74242586	.	0	0.8708545	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.86984	P	0.90092	D	L	.	2	G/G	114	0	.	1207641	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	.	0.87825	.	.	-	139561566	.	-	9.966000	.	0.82854	21907	0	892887	.	germline;unknown	56270	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.97715	GRCh38	924	reviewed by expert panel	c.881G>A	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	3	.	FA9_HUMAN	.	76.0	.	.	T	0.47870	0.8341477	+	.	.	1.82809e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	45799	p.Arg294Gln	0	0.82858	.	germline	.	139561566	G	Nov 01, 2024	.	G/G	.	.	0.068	N	Xq27.1	9768	.	.	SCV005437142	Pathogenic	.	.	Gln	Q	-	685	ENSP00000218099	ENST00000218099	.	0.08	.	.	0.618	G	.	4.434207	0.30054	.	T	-	.	.	0.89905	610	.	.	0.59548	0	139561566	Y	10	0	.	0.000000e+00	P00740	.	0.696638	0.99661	G	.	0.541	D	.	0.8305342	.	0.91597	2158	0.313999	2	-1.54	.	2.239930e-06	0.36067	.	.	57732	.	4338	.	0.84591	X	F9	0.000000e+00	0	Arg	14710	.	X-139561566-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	.	138471391	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	.	.	0	RCV000011348|RCV000814168|RCV000851909|RCV004724733	D	0	.	c.881G>A	.	0	0	0.83923	G/G	rs137852249	139561566	.	G	.	P00740	.	0.88776	.	0.68239	X	.	.	0.000000e+00	1.665	0	0	264690	5.42	0.91142	146	D	T	.	.	0	26	.	.	.	98879|98878	10602	0.83714	0.91089	0.932065665721893	3332	.	0.2209	.	.	.	892887	2.44	.	N	.	.	2.1912425E-4	0	306900|134500|306700|300807	0.44615	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9585912016915898	2	0.48867	0.18019	.	58	.	0.000000e+00	.	YES	0.000000e+00	0.272407	25641	HGNC:3551	A	.	simple_aae	0.691	.	139561566	CGA	1.000000	.	-	0	0.96923	2.239930e-06	0	0	Pathogenic	0.77265	.	0	0	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	R	.	0.992843060398	-	0.899	-	0.49268	.	604	0.95820	0.260667711496	0.1903	0	0.99937078441635274	104	-	881G>A 	.	0	C0008533|C0019069|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.42431	137852249	.	0	0.99267	.	0.334	0.177	3218	0.99998462	5.42	.	.	.	0.213262	0.988798436711402	0.42444	D	120	.	.	0.3200	0.94300	p.Arg294Gln	0	0	-10.286	0.97296536	0	0.87928	10602	D	.	F9	.	D	0.576	.	R294Q	T	0.87757	0.50684	G/G	principal1	140883	F9_Popp_2025_carboxy_F9_specific_var226850	No		11/1/24		317fdec6-df8d-4c37-90c0-0c5ae79cb5ad							R		881	F9_Popp_2025_carboxy_F9_specific	10602.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255368	immortalized human cells		false			p.Arg294Gln		true	c.881G>A						3551.0	139561566.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1						PP3,PM5		The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	Arg294Gln	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad					Q	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	294.0		hemophilia B	1.6561213141e-6	0.057010278		Pathogenic	139561566.0	missense_variant		0.576					Reporter			F9_Arg294Gln
F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg294Gln	23	139561566	G	A	X											X-139561566-G-A	-	0.6885	0.992	294	.	0	.	X	138643725	A	1.656120e-06	.	X	1_Pathogenic	NC_000023.11	2	Arg294Gln	.	25.3	.	0	.	D	0	11	1	.	.	.	.	.	0	0.82769	Select	0.8304	.	0.64752	.	.	D	D	46785	1.76066134508	0	0	.	.	.	0.04971	.	33771	0	.	0.37362	.	.	0.86012	0.999	.	24.0	0.787321	4.79	0.76	A	single nucleotide variant	NC_000023.11:g.139561566G>A	0	.	3	0.74242586	.	0	0.8708545	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.86984	P	0.90092	D	L	.	2	G/G	114	0	.	1207641	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	.	0.87825	.	.	-	139561566	.	-	9.966000	.	0.82854	21907	0	892887	.	germline;unknown	56270	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.97715	GRCh38	924	reviewed by expert panel	c.881G>A	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	3	.	FA9_HUMAN	.	76.0	.	.	T	0.47870	0.8341477	+	.	.	1.82809e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	45799	p.Arg294Gln	0	0.82858	.	germline	.	139561566	G	Nov 01, 2024	.	G/G	.	.	0.068	N	Xq27.1	9768	.	.	SCV005437142	Pathogenic	.	.	Gln	Q	-	685	ENSP00000218099	ENST00000218099	.	0.08	.	.	0.618	G	.	4.434207	0.30054	.	T	-	.	.	0.89905	610	.	.	0.59548	0	139561566	Y	10	0	.	0.000000e+00	P00740	.	0.696638	0.99661	G	.	0.541	D	.	0.8305342	.	0.91597	2158	0.313999	2	-1.54	.	2.239930e-06	0.36067	.	.	57732	.	4338	.	0.84591	X	F9	0.000000e+00	0	Arg	14710	.	X-139561566-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	.	138471391	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	.	.	0	RCV000011348|RCV000814168|RCV000851909|RCV004724733	D	0	.	c.881G>A	.	0	0	0.83923	G/G	rs137852249	139561566	.	G	.	P00740	.	0.88776	.	0.68239	X	.	.	0.000000e+00	1.665	0	0	264690	5.42	0.91142	146	D	T	.	.	0	26	.	.	.	98879|98878	10602	0.83714	0.91089	0.932065665721893	3332	.	0.2209	.	.	.	892887	2.44	.	N	.	.	2.1912425E-4	0	306900|134500|306700|300807	0.44615	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9585912016915898	2	0.48867	0.18019	.	58	.	0.000000e+00	.	YES	0.000000e+00	0.272407	25641	HGNC:3551	A	.	simple_aae	0.691	.	139561566	CGA	1.000000	.	-	0	0.96923	2.239930e-06	0	0	Pathogenic	0.77265	.	0	0	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	R	.	0.992843060398	-	0.899	-	0.49268	.	604	0.95820	0.260667711496	0.1903	0	0.99937078441635274	104	-	881G>A 	.	0	C0008533|C0019069|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.42431	137852249	.	0	0.99267	.	0.334	0.177	3218	0.99998462	5.42	.	.	.	0.213262	0.988798436711402	0.42444	D	120	.	.	0.3200	0.94300	p.Arg294Gln	0	0	-10.286	0.97296536	0	0.87928	10602	D	.	F9	.	D	0.576	.	R294Q	T	0.87757	0.50684	G/G	principal1	250947	F9_Popp_2025_strep_2_var265574	No		11/1/24		317fdec6-df8d-4c37-90c0-0c5ae79cb5ad							R		881	F9_Popp_2025_strep_2	10602.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255368	immortalized human cells		false			p.Arg294Gln		true	c.881G>A						3551.0	139561566.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1						PP3,PM5		The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	Arg294Gln	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad					Q	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	294.0		hemophilia B	1.6561213141e-6	0.1320033759338407		Pathogenic	139561566.0	missense_variant		0.576					Reporter			F9_Arg294Gln
F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	NC_000023.11:139561566:G:A	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg294Gln	23	139561566	G	A	X											X-139561566-G-A	-	0.6885	0.992	294	.	0	.	X	138643725	A	1.656120e-06	.	X	1_Pathogenic	NC_000023.11	2	Arg294Gln	.	25.3	.	0	.	D	0	11	1	.	.	.	.	.	0	0.82769	Select	0.8304	.	0.64752	.	.	D	D	46785	1.76066134508	0	0	.	.	.	0.04971	.	33771	0	.	0.37362	.	.	0.86012	0.999	.	24.0	0.787321	4.79	0.76	A	single nucleotide variant	NC_000023.11:g.139561566G>A	0	.	3	0.74242586	.	0	0.8708545	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.86984	P	0.90092	D	L	.	2	G/G	114	0	.	1207641	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	.	0.87825	.	.	-	139561566	.	-	9.966000	.	0.82854	21907	0	892887	.	germline;unknown	56270	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.97715	GRCh38	924	reviewed by expert panel	c.881G>A	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	3	.	FA9_HUMAN	.	76.0	.	.	T	0.47870	0.8341477	+	.	.	1.82809e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	45799	p.Arg294Gln	0	0.82858	.	germline	.	139561566	G	Nov 01, 2024	.	G/G	.	.	0.068	N	Xq27.1	9768	.	.	SCV005437142	Pathogenic	.	.	Gln	Q	-	685	ENSP00000218099	ENST00000218099	.	0.08	.	.	0.618	G	.	4.434207	0.30054	.	T	-	.	.	0.89905	610	.	.	0.59548	0	139561566	Y	10	0	.	0.000000e+00	P00740	.	0.696638	0.99661	G	.	0.541	D	.	0.8305342	.	0.91597	2158	0.313999	2	-1.54	.	2.239930e-06	0.36067	.	.	57732	.	4338	.	0.84591	X	F9	0.000000e+00	0	Arg	14710	.	X-139561566-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	.	138471391	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	.	.	0	RCV000011348|RCV000814168|RCV000851909|RCV004724733	D	0	.	c.881G>A	.	0	0	0.83923	G/G	rs137852249	139561566	.	G	.	P00740	.	0.88776	.	0.68239	X	.	.	0.000000e+00	1.665	0	0	264690	5.42	0.91142	146	D	T	.	.	0	26	.	.	.	98879|98878	10602	0.83714	0.91089	0.932065665721893	3332	.	0.2209	.	.	.	892887	2.44	.	N	.	.	2.1912425E-4	0	306900|134500|306700|300807	0.44615	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9585912016915898	2	0.48867	0.18019	.	58	.	0.000000e+00	.	YES	0.000000e+00	0.272407	25641	HGNC:3551	A	.	simple_aae	0.691	.	139561566	CGA	1.000000	.	-	0	0.96923	2.239930e-06	0	0	Pathogenic	0.77265	.	0	0	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	R	.	0.992843060398	-	0.899	-	0.49268	.	604	0.95820	0.260667711496	0.1903	0	0.99937078441635274	104	-	881G>A 	.	0	C0008533|C0019069|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.42431	137852249	.	0	0.99267	.	0.334	0.177	3218	0.99998462	5.42	.	.	.	0.213262	0.988798436711402	0.42444	D	120	.	.	0.3200	0.94300	p.Arg294Gln	0	0	-10.286	0.97296536	0	0.87928	10602	D	.	F9	.	D	0.576	.	R294Q	T	0.87757	0.50684	G/G	principal1	168399	F9_Popp_2025_carboxy_gla_motif_var255893	No		11/1/24		317fdec6-df8d-4c37-90c0-0c5ae79cb5ad							R		881	F9_Popp_2025_carboxy_gla_motif	10602.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255368	immortalized human cells		false			p.Arg294Gln		true	c.881G>A						3551.0	139561566.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1						PP3,PM5		The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	Arg294Gln	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad					Q	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	294.0		hemophilia B	1.6561213141e-6	0.067749693		Pathogenic	139561566.0	missense_variant		0.576					Reporter			F9_Arg294Gln
F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004382		NC_000023.11:139561566:G:A		Arg294Gln																												F9_Arg294Gln	23	139561566	G	A	X	allele	881G>A	B10	527_CAVA_Array_P02	C20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561566-G-A	-	0.6885	0.992	294	.	0	.	X	138643725	A	1.656120e-06	.	X	1_Pathogenic	NC_000023.11	2	Arg294Gln	.	25.3	.	0	.	D	0	11	1	.	.	.	.	.	0	0.82769	Select	0.8304	.	0.64752	.	.	D	D	46785	1.76066134508	0	0	.	.	.	0.04971	.	33771	0	.	0.37362	.	.	0.86012	0.999	.	24.0	0.787321	4.79	0.76	A	single nucleotide variant	NC_000023.11:g.139561566G>A	0	.	3	0.74242586	.	0	0.8708545	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.86984	P	0.90092	D	L	.	2	G/G	114	0	.	1207641	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	.	0.87825	.	.	-	139561566	.	-	9.966000	.	0.82854	21907	0	892887	.	germline;unknown	56270	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.97715	GRCh38	924	reviewed by expert panel	c.881G>A	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	3	.	FA9_HUMAN	.	76.0	.	.	T	0.47870	0.8341477	+	.	.	1.82809e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	45799	p.Arg294Gln	0	0.82858	.	germline	.	139561566	G	Nov 01, 2024	.	G/G	.	.	0.068	N	Xq27.1	9768	.	.	SCV005437142	Pathogenic	.	.	Gln	Q	-	685	ENSP00000218099	ENST00000218099	.	0.08	.	.	0.618	G	.	4.434207	0.30054	.	T	-	.	.	0.89905	610	.	.	0.59548	0	139561566	Y	10	0	.	0.000000e+00	P00740	.	0.696638	0.99661	G	.	0.541	D	.	0.8305342	.	0.91597	2158	0.313999	2	-1.54	.	2.239930e-06	0.36067	.	.	57732	.	4338	.	0.84591	X	F9	0.000000e+00	0	Arg	14710	.	X-139561566-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	.	138471391	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	.	.	0	RCV000011348|RCV000814168|RCV000851909|RCV004724733	D	0	.	c.881G>A	.	0	0	0.83923	G/G	rs137852249	139561566	.	G	.	P00740	.	0.88776	.	0.68239	X	.	.	0.000000e+00	1.665	0	0	264690	5.42	0.91142	146	D	T	.	.	0	26	.	.	.	98879|98878	10602	0.83714	0.91089	0.932065665721893	3332	.	0.2209	.	.	.	892887	2.44	.	N	.	.	2.1912425E-4	0	306900|134500|306700|300807	0.44615	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9585912016915898	2	0.48867	0.18019	.	58	.	0.000000e+00	.	YES	0.000000e+00	0.272407	25641	HGNC:3551	A	.	simple_aae	0.691	.	139561566	CGA	1.000000	.	-	0	0.96923	2.239930e-06	0	0	Pathogenic	0.77265	.	0	0	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	R	.	0.992843060398	-	0.899	-	0.49268	.	604	0.95820	0.260667711496	0.1903	0	0.99937078441635274	104	-	881G>A 	.	0	C0008533|C0019069|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.42431	137852249	.	0	0.99267	.	0.334	0.177	3218	0.99998462	5.42	.	.	.	0.213262	0.988798436711402	0.42444	D	120	.	.	0.3200	0.94300	p.Arg294Gln	0	0	-10.286	0.97296536	0	0.87928	10602	D	.	F9	.	D	0.576	.	R294Q	T	0.87757	0.50684	G/G	principal1	195915	F9_Popp_2025_heavy_chain_var236531	No		11/1/24		317fdec6-df8d-4c37-90c0-0c5ae79cb5ad							R		881	F9_Popp_2025_heavy_chain	10602.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255368	immortalized human cells		false			p.Arg294Gln		true	c.881G>A						3551.0	139561566.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1						PP3,PM5		The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	Arg294Gln	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad					Q	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	294.0		hemophilia B	1.6561213141e-6	0.059427999		Pathogenic	139561566.0	missense_variant		0.576					Reporter			F9_Arg294Gln
F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004382		NC_000023.11:139561566:G:A		Arg294Gln																												F9_Arg294Gln	23	139561566	G	A	X	allele	881G>A	B10	527_CAVA_Array_P02	C20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561566-G-A	-	0.6885	0.992	294	.	0	.	X	138643725	A	1.656120e-06	.	X	1_Pathogenic	NC_000023.11	2	Arg294Gln	.	25.3	.	0	.	D	0	11	1	.	.	.	.	.	0	0.82769	Select	0.8304	.	0.64752	.	.	D	D	46785	1.76066134508	0	0	.	.	.	0.04971	.	33771	0	.	0.37362	.	.	0.86012	0.999	.	24.0	0.787321	4.79	0.76	A	single nucleotide variant	NC_000023.11:g.139561566G>A	0	.	3	0.74242586	.	0	0.8708545	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.86984	P	0.90092	D	L	.	2	G/G	114	0	.	1207641	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	.	0.87825	.	.	-	139561566	.	-	9.966000	.	0.82854	21907	0	892887	.	germline;unknown	56270	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.97715	GRCh38	924	reviewed by expert panel	c.881G>A	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	3	.	FA9_HUMAN	.	76.0	.	.	T	0.47870	0.8341477	+	.	.	1.82809e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	45799	p.Arg294Gln	0	0.82858	.	germline	.	139561566	G	Nov 01, 2024	.	G/G	.	.	0.068	N	Xq27.1	9768	.	.	SCV005437142	Pathogenic	.	.	Gln	Q	-	685	ENSP00000218099	ENST00000218099	.	0.08	.	.	0.618	G	.	4.434207	0.30054	.	T	-	.	.	0.89905	610	.	.	0.59548	0	139561566	Y	10	0	.	0.000000e+00	P00740	.	0.696638	0.99661	G	.	0.541	D	.	0.8305342	.	0.91597	2158	0.313999	2	-1.54	.	2.239930e-06	0.36067	.	.	57732	.	4338	.	0.84591	X	F9	0.000000e+00	0	Arg	14710	.	X-139561566-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	.	138471391	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	.	.	0	RCV000011348|RCV000814168|RCV000851909|RCV004724733	D	0	.	c.881G>A	.	0	0	0.83923	G/G	rs137852249	139561566	.	G	.	P00740	.	0.88776	.	0.68239	X	.	.	0.000000e+00	1.665	0	0	264690	5.42	0.91142	146	D	T	.	.	0	26	.	.	.	98879|98878	10602	0.83714	0.91089	0.932065665721893	3332	.	0.2209	.	.	.	892887	2.44	.	N	.	.	2.1912425E-4	0	306900|134500|306700|300807	0.44615	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9585912016915898	2	0.48867	0.18019	.	58	.	0.000000e+00	.	YES	0.000000e+00	0.272407	25641	HGNC:3551	A	.	simple_aae	0.691	.	139561566	CGA	1.000000	.	-	0	0.96923	2.239930e-06	0	0	Pathogenic	0.77265	.	0	0	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	R	.	0.992843060398	-	0.899	-	0.49268	.	604	0.95820	0.260667711496	0.1903	0	0.99937078441635274	104	-	881G>A 	.	0	C0008533|C0019069|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.42431	137852249	.	0	0.99267	.	0.334	0.177	3218	0.99998462	5.42	.	.	.	0.213262	0.988798436711402	0.42444	D	120	.	.	0.3200	0.94300	p.Arg294Gln	0	0	-10.286	0.97296536	0	0.87928	10602	D	.	F9	.	D	0.576	.	R294Q	T	0.87757	0.50684	G/G	principal1	223431	F9_Popp_2025_light_chain_var246212	No		11/1/24		317fdec6-df8d-4c37-90c0-0c5ae79cb5ad							R		881	F9_Popp_2025_light_chain	10602.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255368	immortalized human cells		false			p.Arg294Gln		true	c.881G>A						3551.0	139561566.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1						PP3,PM5		The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	Arg294Gln	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad					Q	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	294.0		hemophilia B	1.6561213141e-6	0.094617019		Pathogenic	139561566.0	missense_variant		0.576					Reporter			F9_Arg294Gln
F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004382		NC_000023.11:139561566:G:A		Arg294Gln																												F9_Arg294Gln	23	139561566	G	A	X	allele	881G>A	B10	527_CAVA_Array_P02	C20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561566-G-A	-	0.6885	0.992	294	.	0	.	X	138643725	A	1.656120e-06	.	X	1_Pathogenic	NC_000023.11	2	Arg294Gln	.	25.3	.	0	.	D	0	11	1	.	.	.	.	.	0	0.82769	Select	0.8304	.	0.64752	.	.	D	D	46785	1.76066134508	0	0	.	.	.	0.04971	.	33771	0	.	0.37362	.	.	0.86012	0.999	.	24.0	0.787321	4.79	0.76	A	single nucleotide variant	NC_000023.11:g.139561566G>A	0	.	3	0.74242586	.	0	0.8708545	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.86984	P	0.90092	D	L	.	2	G/G	114	0	.	1207641	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	.	0.87825	.	.	-	139561566	.	-	9.966000	.	0.82854	21907	0	892887	.	germline;unknown	56270	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.97715	GRCh38	924	reviewed by expert panel	c.881G>A	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	3	.	FA9_HUMAN	.	76.0	.	.	T	0.47870	0.8341477	+	.	.	1.82809e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	45799	p.Arg294Gln	0	0.82858	.	germline	.	139561566	G	Nov 01, 2024	.	G/G	.	.	0.068	N	Xq27.1	9768	.	.	SCV005437142	Pathogenic	.	.	Gln	Q	-	685	ENSP00000218099	ENST00000218099	.	0.08	.	.	0.618	G	.	4.434207	0.30054	.	T	-	.	.	0.89905	610	.	.	0.59548	0	139561566	Y	10	0	.	0.000000e+00	P00740	.	0.696638	0.99661	G	.	0.541	D	.	0.8305342	.	0.91597	2158	0.313999	2	-1.54	.	2.239930e-06	0.36067	.	.	57732	.	4338	.	0.84591	X	F9	0.000000e+00	0	Arg	14710	.	X-139561566-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	.	138471391	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	.	.	0	RCV000011348|RCV000814168|RCV000851909|RCV004724733	D	0	.	c.881G>A	.	0	0	0.83923	G/G	rs137852249	139561566	.	G	.	P00740	.	0.88776	.	0.68239	X	.	.	0.000000e+00	1.665	0	0	264690	5.42	0.91142	146	D	T	.	.	0	26	.	.	.	98879|98878	10602	0.83714	0.91089	0.932065665721893	3332	.	0.2209	.	.	.	892887	2.44	.	N	.	.	2.1912425E-4	0	306900|134500|306700|300807	0.44615	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9585912016915898	2	0.48867	0.18019	.	58	.	0.000000e+00	.	YES	0.000000e+00	0.272407	25641	HGNC:3551	A	.	simple_aae	0.691	.	139561566	CGA	1.000000	.	-	0	0.96923	2.239930e-06	0	0	Pathogenic	0.77265	.	0	0	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	R	.	0.992843060398	-	0.899	-	0.49268	.	604	0.95820	0.260667711496	0.1903	0	0.99937078441635274	104	-	881G>A 	.	0	C0008533|C0019069|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.42431	137852249	.	0	0.99267	.	0.334	0.177	3218	0.99998462	5.42	.	.	.	0.213262	0.988798436711402	0.42444	D	120	.	.	0.3200	0.94300	p.Arg294Gln	0	0	-10.286	0.97296536	0	0.87928	10602	D	.	F9	.	D	0.576	.	R294Q	T	0.87757	0.50684	G/G	principal1	140883	F9_Popp_2025_carboxy_F9_specific_var226850	No		11/1/24		317fdec6-df8d-4c37-90c0-0c5ae79cb5ad							R		881	F9_Popp_2025_carboxy_F9_specific	10602.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255368	immortalized human cells		false			p.Arg294Gln		true	c.881G>A						3551.0	139561566.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1						PP3,PM5		The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	Arg294Gln	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad					Q	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	294.0		hemophilia B	1.6561213141e-6	0.057010278		Pathogenic	139561566.0	missense_variant		0.576					Reporter			F9_Arg294Gln
F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004382		NC_000023.11:139561566:G:A		Arg294Gln																												F9_Arg294Gln	23	139561566	G	A	X	allele	881G>A	B10	527_CAVA_Array_P02	C20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561566-G-A	-	0.6885	0.992	294	.	0	.	X	138643725	A	1.656120e-06	.	X	1_Pathogenic	NC_000023.11	2	Arg294Gln	.	25.3	.	0	.	D	0	11	1	.	.	.	.	.	0	0.82769	Select	0.8304	.	0.64752	.	.	D	D	46785	1.76066134508	0	0	.	.	.	0.04971	.	33771	0	.	0.37362	.	.	0.86012	0.999	.	24.0	0.787321	4.79	0.76	A	single nucleotide variant	NC_000023.11:g.139561566G>A	0	.	3	0.74242586	.	0	0.8708545	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.86984	P	0.90092	D	L	.	2	G/G	114	0	.	1207641	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	.	0.87825	.	.	-	139561566	.	-	9.966000	.	0.82854	21907	0	892887	.	germline;unknown	56270	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.97715	GRCh38	924	reviewed by expert panel	c.881G>A	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	3	.	FA9_HUMAN	.	76.0	.	.	T	0.47870	0.8341477	+	.	.	1.82809e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	45799	p.Arg294Gln	0	0.82858	.	germline	.	139561566	G	Nov 01, 2024	.	G/G	.	.	0.068	N	Xq27.1	9768	.	.	SCV005437142	Pathogenic	.	.	Gln	Q	-	685	ENSP00000218099	ENST00000218099	.	0.08	.	.	0.618	G	.	4.434207	0.30054	.	T	-	.	.	0.89905	610	.	.	0.59548	0	139561566	Y	10	0	.	0.000000e+00	P00740	.	0.696638	0.99661	G	.	0.541	D	.	0.8305342	.	0.91597	2158	0.313999	2	-1.54	.	2.239930e-06	0.36067	.	.	57732	.	4338	.	0.84591	X	F9	0.000000e+00	0	Arg	14710	.	X-139561566-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	.	138471391	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	.	.	0	RCV000011348|RCV000814168|RCV000851909|RCV004724733	D	0	.	c.881G>A	.	0	0	0.83923	G/G	rs137852249	139561566	.	G	.	P00740	.	0.88776	.	0.68239	X	.	.	0.000000e+00	1.665	0	0	264690	5.42	0.91142	146	D	T	.	.	0	26	.	.	.	98879|98878	10602	0.83714	0.91089	0.932065665721893	3332	.	0.2209	.	.	.	892887	2.44	.	N	.	.	2.1912425E-4	0	306900|134500|306700|300807	0.44615	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9585912016915898	2	0.48867	0.18019	.	58	.	0.000000e+00	.	YES	0.000000e+00	0.272407	25641	HGNC:3551	A	.	simple_aae	0.691	.	139561566	CGA	1.000000	.	-	0	0.96923	2.239930e-06	0	0	Pathogenic	0.77265	.	0	0	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	R	.	0.992843060398	-	0.899	-	0.49268	.	604	0.95820	0.260667711496	0.1903	0	0.99937078441635274	104	-	881G>A 	.	0	C0008533|C0019069|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.42431	137852249	.	0	0.99267	.	0.334	0.177	3218	0.99998462	5.42	.	.	.	0.213262	0.988798436711402	0.42444	D	120	.	.	0.3200	0.94300	p.Arg294Gln	0	0	-10.286	0.97296536	0	0.87928	10602	D	.	F9	.	D	0.576	.	R294Q	T	0.87757	0.50684	G/G	principal1	250947	F9_Popp_2025_strep_2_var265574	No		11/1/24		317fdec6-df8d-4c37-90c0-0c5ae79cb5ad							R		881	F9_Popp_2025_strep_2	10602.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255368	immortalized human cells		false			p.Arg294Gln		true	c.881G>A						3551.0	139561566.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1						PP3,PM5		The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	Arg294Gln	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad					Q	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	294.0		hemophilia B	1.6561213141e-6	0.1320033759338407		Pathogenic	139561566.0	missense_variant		0.576					Reporter			F9_Arg294Gln
F9_Arg294Gln	-3.301016310544247	0.016387103988651584	3.6977465243052414	0.007677762494573888	2025_01_Batch_13-14	0.7565656990470252	0.8617514493114371	0.962275331505049	0.9085594111787956	0.8213537820014284	0.694923602720794	0.8641169537147129	0.9672887435080819	0.869780174195553	0.7653805039488925	0.7257446508839096	0.862934201513075	0.9647820375065654	0.8891697926871742	0.7933671429751604	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004382		NC_000023.11:139561566:G:A		Arg294Gln																												F9_Arg294Gln	23	139561566	G	A	X	allele	881G>A	B10	527_CAVA_Array_P02	C20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561566-G-A	-	0.6885	0.992	294	.	0	.	X	138643725	A	1.656120e-06	.	X	1_Pathogenic	NC_000023.11	2	Arg294Gln	.	25.3	.	0	.	D	0	11	1	.	.	.	.	.	0	0.82769	Select	0.8304	.	0.64752	.	.	D	D	46785	1.76066134508	0	0	.	.	.	0.04971	.	33771	0	.	0.37362	.	.	0.86012	0.999	.	24.0	0.787321	4.79	0.76	A	single nucleotide variant	NC_000023.11:g.139561566G>A	0	.	3	0.74242586	.	0	0.8708545	0	A	.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	.	.	0.000000e+00	0	0.86984	P	0.90092	D	L	.	2	G/G	114	0	.	1207641	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	.	0.87825	.	.	-	139561566	.	-	9.966000	.	0.82854	21907	0	892887	.	germline;unknown	56270	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.97715	GRCh38	924	reviewed by expert panel	c.881G>A	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	0.000000e+00	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	3	.	FA9_HUMAN	.	76.0	.	.	T	0.47870	0.8341477	+	.	.	1.82809e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	.	0	.	.	45799	p.Arg294Gln	0	0.82858	.	germline	.	139561566	G	Nov 01, 2024	.	G/G	.	.	0.068	N	Xq27.1	9768	.	.	SCV005437142	Pathogenic	.	.	Gln	Q	-	685	ENSP00000218099	ENST00000218099	.	0.08	.	.	0.618	G	.	4.434207	0.30054	.	T	-	.	.	0.89905	610	.	.	0.59548	0	139561566	Y	10	0	.	0.000000e+00	P00740	.	0.696638	0.99661	G	.	0.541	D	.	0.8305342	.	0.91597	2158	0.313999	2	-1.54	.	2.239930e-06	0.36067	.	.	57732	.	4338	.	0.84591	X	F9	0.000000e+00	0	Arg	14710	.	X-139561566-G-A	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	.	138471391	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	.	.	0	RCV000011348|RCV000814168|RCV000851909|RCV004724733	D	0	.	c.881G>A	.	0	0	0.83923	G/G	rs137852249	139561566	.	G	.	P00740	.	0.88776	.	0.68239	X	.	.	0.000000e+00	1.665	0	0	264690	5.42	0.91142	146	D	T	.	.	0	26	.	.	.	98879|98878	10602	0.83714	0.91089	0.932065665721893	3332	.	0.2209	.	.	.	892887	2.44	.	N	.	.	2.1912425E-4	0	306900|134500|306700|300807	0.44615	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9585912016915898	2	0.48867	0.18019	.	58	.	0.000000e+00	.	YES	0.000000e+00	0.272407	25641	HGNC:3551	A	.	simple_aae	0.691	.	139561566	CGA	1.000000	.	-	0	0.96923	2.239930e-06	0	0	Pathogenic	0.77265	.	0	0	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	R	.	0.992843060398	-	0.899	-	0.49268	.	604	0.95820	0.260667711496	0.1903	0	0.99937078441635274	104	-	881G>A 	.	0	C0008533|C0019069|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.42431	137852249	.	0	0.99267	.	0.334	0.177	3218	0.99998462	5.42	.	.	.	0.213262	0.988798436711402	0.42444	D	120	.	.	0.3200	0.94300	p.Arg294Gln	0	0	-10.286	0.97296536	0	0.87928	10602	D	.	F9	.	D	0.576	.	R294Q	T	0.87757	0.50684	G/G	principal1	168399	F9_Popp_2025_carboxy_gla_motif_var255893	No		11/1/24		317fdec6-df8d-4c37-90c0-0c5ae79cb5ad							R		881	F9_Popp_2025_carboxy_gla_motif	10602.0	ENST00000218099.7	Likely Pathogenic				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255368	immortalized human cells		false			p.Arg294Gln		true	c.881G>A						3551.0	139561566.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1						PP3,PM5		The c.881G>A, p.Arg294Gln variant affects one of the functional domains (aa 227-459; Peptidase S1 domain) in the F9 protein meeting PM1. The variant is absent from male population databases (gnomAD v4.1) meeting PM2_Supporting. At least 30 patients with mild, moderate or severe hemophilia B have been reported in the literature reviewed meeting PS4_Very Strong and PP4_Moderate (PMID: 29296726, 15921378, 8091381).  In-vitro functional studies show that the variant causes ER retention of the F9 protein, leading to reduced antigen levels meeting PS3_Supporting. REVEL score for this variant does not fall within the thresholds for pathogenic or benign predictions, and no splicing impact is noted by SpliceAI. In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very Strong, PM1, PP4_Moderate, PS3_Supporting, PM2_Supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting,PS3_Supporting,PM1,PP1	Arg294Gln	https://erepo.genome.network/evrepo/ui/classification/317fdec6-df8d-4c37-90c0-0c5ae79cb5ad					Q	Nov 01, 2024				11/1/24	missense_variant	Coagulation Factor Deficiency VCEP	294.0		hemophilia B	1.6561213141e-6	0.067749693		Pathogenic	139561566.0	missense_variant		0.576					Reporter			F9_Arg294Gln
BRCA1_Thr581Ile	2.1265294642858166	0.07103329880869202	-0.158636793647094	0.8784347489809712	2025_01_Batch_13-14	0.9316618456321135	0.9092375600621425	0.93286056207861	0.9617341429430188	0.8089472055930808	0.9794941865604404	0.9271412523148135	0.9097639680467864	0.9723372998209778	0.9052711664396076	0.955578016096277	0.918189406188478	0.9213122650626981	0.9670357213819983	0.8571091860163442	1.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218422	CCSBVarC003303	ALE00003303	NC_000017.11:43067628:G:A	1742C>T	Thr581Ile	CEGS2	CegsMutGDEh1018	D09	GDEhDisVCh_40059	C06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Thr581Ile	17	43067628	G	A	17											17-43067628-G-A	-	0.62705	0.89	1685	.	0	.	17	41219645	A	1.860870e-06	.	17	1_Pathogenic	NC_000017.11	1	Thr1685Ile	.	24.5	.	.	.	D	0	9	1	.	.	.	.	.	.	0.96457	.	0.7898	.	0.90580	.	.	T	D	64008	.	.	0	.	.	.	0.74914	.	44884	0	.	0.82367	.	.	0.91869	0.976	.	.	0.958004	.	.	A	single nucleotide variant	NC_000017.11:g.43067628G>A	0	.	2	0.62467957	.	.	0.88979423	.	A	.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	.	.	0.000000e+00	0	0.99291	B	0.78957	P	M	9.04512	3	G/G	.	.	.	1612146	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	.	0.93898	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43067628	.	-	11.804000	.	0.99559	29592	.	44884	.	germline;not applicable;unknown	91058	.	.	GRCh38	545	reviewed by expert panel	.	.	0.72825	.	.	.	BRCT domain|BRCT domain|BRCT domain	.	.	.	.	0.000000e+00	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	3	.	BRCA1_HUMAN	.	.	0.813238141695724	.	D	0.91617	0.9066492	-	.	.	1.36983e-6	.	.	0	.	reviewed_by_expert_panel	0.99835	.	0	.	.	59984	.	0	0.96740	.	germline	.	43067628	G	Aug 10, 2015	.	G/G	.	.	1.0	N	17q21.31	.	.	.	SCV000244380	Pathogenic	.	.	Ile	I	-	912	ENSP00000478114	ENST00000618469	.	.	.	.	0.569	G	.	4.1672	0.92967	D	.	-	8.988454	.	0.97777	.	.	.	0.74950	.	43067628	Y	10	.	.	0.000000e+00	P38398	.	0.409904	0.97578	G	.	0.329	D	.	0.6439081	.	0.56441	672	0.438305	2	.	.	2.227970e-05	0.91343	.	.	74826	.	6078	.	0.77890	17	BRCA1	0.000000e+00	.	Thr	.	.	17-43067628-G-A	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	0	.	38473171	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	0.771366	0.86857	0	RCV000112476|RCV001853017|RCV002336188|RCV004998172	.	0	.	c.5054C>T	.	1	0	0.91883	G/G	rs80357043	43067628	.	G	.	.	.	0.90355	.	0.68239	17	.	.	2.227970e-05	3.31	.	.	.	5.24	0.82120	.	D	T	.	.	.	.	.	.	.	145|145|140162	55365	0.91782	0.19319	0.983474791049957	.	.	0.71675	0.70495	.	.	1178384	6.008	.	.	.	.	.	.	604370	0.70468	17	.	ENSG00000012048	0.000000e+00	.	.	.	.	2	0.92348	0.72635	.	.	.	0.000000e+00	0.757877512501455	.	0.000000e+00	0.72506	70032	HGNC:1100	.	.	.	0.987	.	43067628	ACT	1.000000	.	-	.	0.85827	1.697240e-06	.	0	Pathogenic	0.94802	.	0	0	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	T	.	.	-	.	-	0.95034	.	.	0.90972	0.753464519978	.	0	0.99904362282002479	.	-	5054C>T 	.	.	C0677776|C2676676|C0027672	.	.	.	.	NM_007294.4	-	.	.	1	0.85541	80357043	.	.	0.96144	0.86669	.	.	.	0.99987290	5.24	.	.	.	0.391819	0.991231594940223	0.90471	D	.	.	.	0.7600	0.92853	p.Thr1685Ile	.	0	-14.562	.	0	0.88934	55365	D	.	BRCA1	.	D	.	.	.	.	.	0.28905	G/G	principal2	45752	BRCA1_Adamovich_2022_HDR_var4810	No	[-0.562,-0.233]					Homology Directed Repair		Fluorescence	Not specified		T		5054	BRCA1_Adamovich_2022_HDR		ENST00000357654.9		Abnormal					immortalized human cells					p.Thr1685Ile		true	c.5054C>T				Functional		1100.0	43067628.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-1.749740061;-1.61491971;-1.600068476;-1.476186784			Thr1685Ile		LOF		(-0.233, Inf)		I	Aug 10, 2015		(-Inf, -0.562)			missense_variant		1685.0			1.8608736429e-6	-1.6102287575	Normal	Pathogenic	43067628.0	missense_variant		0.88		Intermediate			Reporter			BRCA1_Thr1685Ile
BRCA1_Thr581Ile	2.1265294642858166	0.07103329880869202	-0.158636793647094	0.8784347489809712	2025_01_Batch_13-14	0.9316618456321135	0.9092375600621425	0.93286056207861	0.9617341429430188	0.8089472055930808	0.9794941865604404	0.9271412523148135	0.9097639680467864	0.9723372998209778	0.9052711664396076	0.955578016096277	0.918189406188478	0.9213122650626981	0.9670357213819983	0.8571091860163442	1.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218422	CCSBVarC003303	ALE00003303	NC_000017.11:43067628:G:A	1742C>T	Thr581Ile	CEGS2	CegsMutGDEh1018	D09	GDEhDisVCh_40059	C06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Thr581Ile	17	43067628	G	A	17											17-43067628-G-A	-	0.62705	0.89	1685	.	0	.	17	41219645	A	1.860870e-06	.	17	1_Pathogenic	NC_000017.11	1	Thr1685Ile	.	24.5	.	.	.	D	0	9	1	.	.	.	.	.	.	0.96457	.	0.7898	.	0.90580	.	.	T	D	64008	.	.	0	.	.	.	0.74914	.	44884	0	.	0.82367	.	.	0.91869	0.976	.	.	0.958004	.	.	A	single nucleotide variant	NC_000017.11:g.43067628G>A	0	.	2	0.62467957	.	.	0.88979423	.	A	.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	.	.	0.000000e+00	0	0.99291	B	0.78957	P	M	9.04512	3	G/G	.	.	.	1612146	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	.	0.93898	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43067628	.	-	11.804000	.	0.99559	29592	.	44884	.	germline;not applicable;unknown	91058	.	.	GRCh38	545	reviewed by expert panel	.	.	0.72825	.	.	.	BRCT domain|BRCT domain|BRCT domain	.	.	.	.	0.000000e+00	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	3	.	BRCA1_HUMAN	.	.	0.813238141695724	.	D	0.91617	0.9066492	-	.	.	1.36983e-6	.	.	0	.	reviewed_by_expert_panel	0.99835	.	0	.	.	59984	.	0	0.96740	.	germline	.	43067628	G	Aug 10, 2015	.	G/G	.	.	1.0	N	17q21.31	.	.	.	SCV000244380	Pathogenic	.	.	Ile	I	-	912	ENSP00000478114	ENST00000618469	.	.	.	.	0.569	G	.	4.1672	0.92967	D	.	-	8.988454	.	0.97777	.	.	.	0.74950	.	43067628	Y	10	.	.	0.000000e+00	P38398	.	0.409904	0.97578	G	.	0.329	D	.	0.6439081	.	0.56441	672	0.438305	2	.	.	2.227970e-05	0.91343	.	.	74826	.	6078	.	0.77890	17	BRCA1	0.000000e+00	.	Thr	.	.	17-43067628-G-A	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	0	.	38473171	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	0.771366	0.86857	0	RCV000112476|RCV001853017|RCV002336188|RCV004998172	.	0	.	c.5054C>T	.	1	0	0.91883	G/G	rs80357043	43067628	.	G	.	.	.	0.90355	.	0.68239	17	.	.	2.227970e-05	3.31	.	.	.	5.24	0.82120	.	D	T	.	.	.	.	.	.	.	145|145|140162	55365	0.91782	0.19319	0.983474791049957	.	.	0.71675	0.70495	.	.	1178384	6.008	.	.	.	.	.	.	604370	0.70468	17	.	ENSG00000012048	0.000000e+00	.	.	.	.	2	0.92348	0.72635	.	.	.	0.000000e+00	0.757877512501455	.	0.000000e+00	0.72506	70032	HGNC:1100	.	.	.	0.987	.	43067628	ACT	1.000000	.	-	.	0.85827	1.697240e-06	.	0	Pathogenic	0.94802	.	0	0	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	T	.	.	-	.	-	0.95034	.	.	0.90972	0.753464519978	.	0	0.99904362282002479	.	-	5054C>T 	.	.	C0677776|C2676676|C0027672	.	.	.	.	NM_007294.4	-	.	.	1	0.85541	80357043	.	.	0.96144	0.86669	.	.	.	0.99987290	5.24	.	.	.	0.391819	0.991231594940223	0.90471	D	.	.	.	0.7600	0.92853	p.Thr1685Ile	.	0	-14.562	.	0	0.88934	55365	D	.	BRCA1	.	D	.	.	.	.	.	0.28905	G/G	principal2	37742	BRCA1_Adamovich_2022_Cisplatin_var6277	No	[-0.729,-0.503]					Cisplatin resistance		Drug Resistance	Not specified		T		5054	BRCA1_Adamovich_2022_Cisplatin		ENST00000357654.9		Abnormal					immortalized human cells					p.Thr1685Ile		true	c.5054C>T				Functional		1100.0	43067628.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-1.321210618;-1.433452633;-0.670731515;-0.708615272			Thr1685Ile		LOF		(-0.503, Inf)		I	Aug 10, 2015		(-Inf, -0.729)			missense_variant		1685.0			1.8608736429e-6	-1.03350250925	Normal	Pathogenic	43067628.0	missense_variant		0.88		Intermediate			Cell Viability			BRCA1_Thr1685Ile
BRCA1_Thr581Ile	2.1265294642858166	0.07103329880869202	-0.158636793647094	0.8784347489809712	2025_01_Batch_13-14	0.9316618456321135	0.9092375600621425	0.93286056207861	0.9617341429430188	0.8089472055930808	0.9794941865604404	0.9271412523148135	0.9097639680467864	0.9723372998209778	0.9052711664396076	0.955578016096277	0.918189406188478	0.9213122650626981	0.9670357213819983	0.8571091860163442	1.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003303		NC_000017.11:43067628:G:A		Thr581Ile																												BRCA1_Thr581Ile	17	43067628	G	A	17	allele	1742C>T	C07	527_CAVA_Array_P01	E13	B13A7A8P1_R1	B14A7A8P1_R2				17-43067628-G-A	-	0.62705	0.89	1685	.	0	.	17	41219645	A	1.860870e-06	.	17	1_Pathogenic	NC_000017.11	1	Thr1685Ile	.	24.5	.	.	.	D	0	9	1	.	.	.	.	.	.	0.96457	.	0.7898	.	0.90580	.	.	T	D	64008	.	.	0	.	.	.	0.74914	.	44884	0	.	0.82367	.	.	0.91869	0.976	.	.	0.958004	.	.	A	single nucleotide variant	NC_000017.11:g.43067628G>A	0	.	2	0.62467957	.	.	0.88979423	.	A	.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	.	.	0.000000e+00	0	0.99291	B	0.78957	P	M	9.04512	3	G/G	.	.	.	1612146	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	.	0.93898	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43067628	.	-	11.804000	.	0.99559	29592	.	44884	.	germline;not applicable;unknown	91058	.	.	GRCh38	545	reviewed by expert panel	.	.	0.72825	.	.	.	BRCT domain|BRCT domain|BRCT domain	.	.	.	.	0.000000e+00	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	3	.	BRCA1_HUMAN	.	.	0.813238141695724	.	D	0.91617	0.9066492	-	.	.	1.36983e-6	.	.	0	.	reviewed_by_expert_panel	0.99835	.	0	.	.	59984	.	0	0.96740	.	germline	.	43067628	G	Aug 10, 2015	.	G/G	.	.	1.0	N	17q21.31	.	.	.	SCV000244380	Pathogenic	.	.	Ile	I	-	912	ENSP00000478114	ENST00000618469	.	.	.	.	0.569	G	.	4.1672	0.92967	D	.	-	8.988454	.	0.97777	.	.	.	0.74950	.	43067628	Y	10	.	.	0.000000e+00	P38398	.	0.409904	0.97578	G	.	0.329	D	.	0.6439081	.	0.56441	672	0.438305	2	.	.	2.227970e-05	0.91343	.	.	74826	.	6078	.	0.77890	17	BRCA1	0.000000e+00	.	Thr	.	.	17-43067628-G-A	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	0	.	38473171	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	0.771366	0.86857	0	RCV000112476|RCV001853017|RCV002336188|RCV004998172	.	0	.	c.5054C>T	.	1	0	0.91883	G/G	rs80357043	43067628	.	G	.	.	.	0.90355	.	0.68239	17	.	.	2.227970e-05	3.31	.	.	.	5.24	0.82120	.	D	T	.	.	.	.	.	.	.	145|145|140162	55365	0.91782	0.19319	0.983474791049957	.	.	0.71675	0.70495	.	.	1178384	6.008	.	.	.	.	.	.	604370	0.70468	17	.	ENSG00000012048	0.000000e+00	.	.	.	.	2	0.92348	0.72635	.	.	.	0.000000e+00	0.757877512501455	.	0.000000e+00	0.72506	70032	HGNC:1100	.	.	.	0.987	.	43067628	ACT	1.000000	.	-	.	0.85827	1.697240e-06	.	0	Pathogenic	0.94802	.	0	0	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	T	.	.	-	.	-	0.95034	.	.	0.90972	0.753464519978	.	0	0.99904362282002479	.	-	5054C>T 	.	.	C0677776|C2676676|C0027672	.	.	.	.	NM_007294.4	-	.	.	1	0.85541	80357043	.	.	0.96144	0.86669	.	.	.	0.99987290	5.24	.	.	.	0.391819	0.991231594940223	0.90471	D	.	.	.	0.7600	0.92853	p.Thr1685Ile	.	0	-14.562	.	0	0.88934	55365	D	.	BRCA1	.	D	.	.	.	.	.	0.28905	G/G	principal2	45752	BRCA1_Adamovich_2022_HDR_var4810	No	[-0.562,-0.233]					Homology Directed Repair		Fluorescence	Not specified		T		5054	BRCA1_Adamovich_2022_HDR		ENST00000357654.9		Abnormal					immortalized human cells					p.Thr1685Ile		true	c.5054C>T				Functional		1100.0	43067628.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-1.749740061;-1.61491971;-1.600068476;-1.476186784			Thr1685Ile		LOF		(-0.233, Inf)		I	Aug 10, 2015		(-Inf, -0.562)			missense_variant		1685.0			1.8608736429e-6	-1.6102287575	Normal	Pathogenic	43067628.0	missense_variant		0.88		Intermediate			Reporter			BRCA1_Thr1685Ile
BRCA1_Thr581Ile	2.1265294642858166	0.07103329880869202	-0.158636793647094	0.8784347489809712	2025_01_Batch_13-14	0.9316618456321135	0.9092375600621425	0.93286056207861	0.9617341429430188	0.8089472055930808	0.9794941865604404	0.9271412523148135	0.9097639680467864	0.9723372998209778	0.9052711664396076	0.955578016096277	0.918189406188478	0.9213122650626981	0.9670357213819983	0.8571091860163442	1.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003303		NC_000017.11:43067628:G:A		Thr581Ile																												BRCA1_Thr581Ile	17	43067628	G	A	17	allele	1742C>T	C07	527_CAVA_Array_P01	E13	B13A7A8P1_R1	B14A7A8P1_R2				17-43067628-G-A	-	0.62705	0.89	1685	.	0	.	17	41219645	A	1.860870e-06	.	17	1_Pathogenic	NC_000017.11	1	Thr1685Ile	.	24.5	.	.	.	D	0	9	1	.	.	.	.	.	.	0.96457	.	0.7898	.	0.90580	.	.	T	D	64008	.	.	0	.	.	.	0.74914	.	44884	0	.	0.82367	.	.	0.91869	0.976	.	.	0.958004	.	.	A	single nucleotide variant	NC_000017.11:g.43067628G>A	0	.	2	0.62467957	.	.	0.88979423	.	A	.	.	.	.	.	.	.	.	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	.	.	0.000000e+00	0	0.99291	B	0.78957	P	M	9.04512	3	G/G	.	.	.	1612146	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	.	0.93898	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43067628	.	-	11.804000	.	0.99559	29592	.	44884	.	germline;not applicable;unknown	91058	.	.	GRCh38	545	reviewed by expert panel	.	.	0.72825	.	.	.	BRCT domain|BRCT domain|BRCT domain	.	.	.	.	0.000000e+00	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	3	.	BRCA1_HUMAN	.	.	0.813238141695724	.	D	0.91617	0.9066492	-	.	.	1.36983e-6	.	.	0	.	reviewed_by_expert_panel	0.99835	.	0	.	.	59984	.	0	0.96740	.	germline	.	43067628	G	Aug 10, 2015	.	G/G	.	.	1.0	N	17q21.31	.	.	.	SCV000244380	Pathogenic	.	.	Ile	I	-	912	ENSP00000478114	ENST00000618469	.	.	.	.	0.569	G	.	4.1672	0.92967	D	.	-	8.988454	.	0.97777	.	.	.	0.74950	.	43067628	Y	10	.	.	0.000000e+00	P38398	.	0.409904	0.97578	G	.	0.329	D	.	0.6439081	.	0.56441	672	0.438305	2	.	.	2.227970e-05	0.91343	.	.	74826	.	6078	.	0.77890	17	BRCA1	0.000000e+00	.	Thr	.	.	17-43067628-G-A	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	0	.	38473171	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	0.771366	0.86857	0	RCV000112476|RCV001853017|RCV002336188|RCV004998172	.	0	.	c.5054C>T	.	1	0	0.91883	G/G	rs80357043	43067628	.	G	.	.	.	0.90355	.	0.68239	17	.	.	2.227970e-05	3.31	.	.	.	5.24	0.82120	.	D	T	.	.	.	.	.	.	.	145|145|140162	55365	0.91782	0.19319	0.983474791049957	.	.	0.71675	0.70495	.	.	1178384	6.008	.	.	.	.	.	.	604370	0.70468	17	.	ENSG00000012048	0.000000e+00	.	.	.	.	2	0.92348	0.72635	.	.	.	0.000000e+00	0.757877512501455	.	0.000000e+00	0.72506	70032	HGNC:1100	.	.	.	0.987	.	43067628	ACT	1.000000	.	-	.	0.85827	1.697240e-06	.	0	Pathogenic	0.94802	.	0	0	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	T	.	.	-	.	-	0.95034	.	.	0.90972	0.753464519978	.	0	0.99904362282002479	.	-	5054C>T 	.	.	C0677776|C2676676|C0027672	.	.	.	.	NM_007294.4	-	.	.	1	0.85541	80357043	.	.	0.96144	0.86669	.	.	.	0.99987290	5.24	.	.	.	0.391819	0.991231594940223	0.90471	D	.	.	.	0.7600	0.92853	p.Thr1685Ile	.	0	-14.562	.	0	0.88934	55365	D	.	BRCA1	.	D	.	.	.	.	.	0.28905	G/G	principal2	37742	BRCA1_Adamovich_2022_Cisplatin_var6277	No	[-0.729,-0.503]					Cisplatin resistance		Drug Resistance	Not specified		T		5054	BRCA1_Adamovich_2022_Cisplatin		ENST00000357654.9		Abnormal					immortalized human cells					p.Thr1685Ile		true	c.5054C>T				Functional		1100.0	43067628.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-1.321210618;-1.433452633;-0.670731515;-0.708615272			Thr1685Ile		LOF		(-0.503, Inf)		I	Aug 10, 2015		(-Inf, -0.729)			missense_variant		1685.0			1.8608736429e-6	-1.03350250925	Normal	Pathogenic	43067628.0	missense_variant		0.88		Intermediate			Cell Viability			BRCA1_Thr1685Ile
ZC4H2_Arg211Trp	-11.187153169578217	0.00001016631686776567	7.731852774534217	0.00011324258461463719	2025_01_Batch_13-14	0.7362756564933739	0.8753523082842992	0.9440339686968097	0.9020731924419153	0.7336457636726176	0.8338733312953966	0.9208244182493037	0.9747809732699688	0.9508706383015921	0.8333377750320684	0.7850744938943852	0.8980883632668015	0.9594074709833893	0.9264719153717538	0.783491769352343	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC009207		NC_000023.11:64917827:G:A		Arg211Trp																												ZC4H2_Arg211Trp	23	64917827	G	A	X	allele	631C>T	F05	527_CAVA_Array_P06	K10	B13A7A8P2_R1	B14A7A8P2_R2				X-64917827-G-A	-	0.86543	0.999	211	.	.	.	X	64137707	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg211Trp	.	28.9	.	.	.	T	.	5	1	.	.	.	.	.	.	0.87175	Select	0.4448	.	0.77914	.	.	D	D	.	3.13339230401	.	.	.	.	.	0.97112	.	.	.	.	0.93964	.	.	0.93238	0.997	.	14.0	0.950905	3.42	0.86	A	single nucleotide variant	NC_000023.11:g.64917827G>A	.	.	2	0.9177878	.	.	0.9233236	.		.	.	.	.	.	.	.	.	MedGen:C3661900||Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	.	.	.	.	0.90832	D	0.96584	D	.	.	.	G/G	.	.	.	.	not provided|ZC4H2-related disorder|Wieacker-Wolff syndrome	.	0.80920	.	.	-	64917827	.	-	6.482000	.	0.99892	.	.	.	.	germline;maternal	.	Gain of glycosylation at K207 (P = 0.1309)| Gain of methylation at K209 (P = 0.1951)| Loss of MoRF binding (P = 0.2024)| Loss of helix (P = 0.2662)| Loss of solvent accessibility (P = 0.2668)	0.65470	GRCh38	40	criteria provided, multiple submitters, no conflicts	c.631C>T	.	0.78637	.	.	.	Zinc finger C4H2-type	.	.	P	.	.	NM_018684.4(ZC4H2):c.631C>T (p.Arg211Trp)	2	.	ZC4H2_HUMAN	.	86.0	.	.	D	0.99217	0.92091435	-	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98937	.	.	.	.	.	p.Arg211Trp	.	0.55808	.	germline	.		G	Feb 27, 2024	.	G/G	.	.	1.0	N	Xq11.2	.	.	.	SCV000619821|SCV001572998|SCV002581693|SCV005880170	Likely_pathogenic	.	.	Trp	W	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.676	G	.	5.163537	0.92967	.	D	-	.	.	0.99664	.	.	.	0.98285	.	64917827	Y	8	.	.	.	Q9NQZ6	.	0.864508	0.98722		.	0.993	D	.	0.92333007	.	0.79771	55906	0.550822	.	-7.09	.	.	0.91343	.	.	.	.	.	.	0.96190	X	ZC4H2	.	.	Arg	.	.	X-64917827-G-A	not_provided|Wieacker-Wolff_syndrome	.	.	64054432	ClinGen:CA413411099	.	.	.	RCV000521213|RCV004758699|RCV001375995	D	.	.	c.631C>T	.	.	.	0.95775	G/G	rs1555933616	64917827	.	G	.	Q9NQZ6	.	0.93476	.	0.68239		.	.	.	.	.	.	.	5.42	0.96996	.	D	D	.	.	.	.	.	.	.	3454|85283	451159	0.95711	0.99404	0.99964702129364	.	.	0.71675	.	.	.	.	7.402	.	D	.	.	.	.	314580	0.79258	X	.	ENSG00000126970	.	.	.	.	0.7471255375488876	1	0.81117	0.97963	.	.	.	.	.	YES	.	0.951091	446729	HGNC:24931	A	.	simple_aae	0.997	.	64917827	CGG	1.000000	.	-	.	0.89353	.	.	.	Likely pathogenic	0.95317	.	.	.	ClinGen:CA413411099	R	.	0.962268395915	-	0.543	-	0.76009	.	.	0.74521	0.906362950802	0.9995	.	0.99920383742745356	.	-	631C>T 	.	.	C3661900|C0796200	.	.	.	.	NM_018684.4	-	.	.	1	0.82300	1555933616	.	.	0.96153	.	0.739	0.0	.	0.99873880	5.42	.	.	.	0.553441	0.998500480413866	.	T	.	.	.	-0.0594	0.78059	p.Arg211Trp	.	.	-14.699	0.9010761	.	0.94564	451159	D	.	ZC4H2	.	D	0.659	.	R211W	D	0.61925	0.76753	G/G	principal1																																																																																																				
RHO_Pro267Thr	-6.437157064447852	0.0003545519851312502	-11.95420622579369	6.523550915399581e-6	2025_01_Batch_13-14	0.8513456128397525	0.9025171263040506	0.994589753999556	0.9802752080130739	0.9175107261259643	0.9556344726701156	0.9715736384186505	0.998483276351947	0.9941971552212685	0.9456879602265387	0.903490042754934	0.9370453823613505	0.9965365151757515	0.9872361816171712	0.9315993431762515	0.0	0.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	RHO	RHO		40080645		CCSBVarC013575		NC_000003.12:129532635:C:A		Pro267Thr																												RHO_Pro267Thr	3	129532635	C	A	3	allele	799C>A	A10	527_CAVA_Array_P05	A19	B13A7A8P2_R1	B14A7A8P2_R2				3-129532635-C-A	-	0.78897	1.0	267	.	.	.	3	129251478	A	.	.	3	1_Pathogenic	NC_000003.12	.	Pro267Thr	.	27.0	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98921	Select	0.8404	.	0.90580	.	.	D	D	.	0.915089302012	0	.	.	.	.	0.67140	.	.	.	.	0.94038	.	.	0.97253	0.798	.	.	0.989501	.	.	A	single nucleotide variant	NC_000003.12:g.129532635C>A	.	.	2	0.9319166	.	0	0.9601639	0		.	.	.	.	.	146	.	0	MedGen:C3661900	.	.	.	.	.	D	0.97186	D	H	17.37958	.	C/C	84	0	.	.	not provided	.	0.97178	.	.	-	129532635	.	-	7.708000	.	0.99826	.	0	.	.	germline	.	Loss of glycosylation at S270 (P = 0.1504)| Gain of helix (P = 0.1736)| Gain of catalytic residue at P267 (P = 0.1854)| Loss of loop (P = 0.2897)| Loss of sheet (P = 0.302)	0.98766	GRCh38	511	criteria provided, single submitter	c.799C>A	.	0.81744	0	.	.	GPCR, rhodopsin-like, 7TM	.	.	P	0	.	NM_000539.3(RHO):c.799C>A (p.Pro267Thr)	1	.	OPSD_HUMAN	.	.	1.09702721159454	.	D	0.88720	0.9601639	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99909	.	.	.	.	.	p.Pro267Thr	.	0.66701	.	germline	.		C	Nov 18, 2024	.	C/C	.	.	1.0	N	3q22.1	6962	.	.	SCV001222770	Pathogenic	.	.	Thr	T	-	.	ENSP00000296271	ENST00000296271	.	0.0	.	.	0.599	C	.	4.83405	0.92967	D	D	-	17.41673	.	0.94193	610	.	.	0.99193	0	129532635	Y	10	0	.	.	P08100	.	0.905498	0.88826		.	0.999	D	.	0.9319166	.	0.37682	6010	0.464614	.	-7.12	.	.	0.91343	.	.	.	.	.	.	0.97186	3	RHO	.	0	Pro	10680	.	3-129532635-C-A	not_provided	.	.	130734168	.	0.897847	0.98067	.	RCV001058214	D	.	.	c.799C>A	.	.	.	0.93069	C/C	rs2084789550	129532635	.	C	.	P08100	.	0.97253	.	0.68239		.	.	.	4.65	0	0	264690	5.51	0.98159	108	D	T	.	.	0	24	.	.	.	.	853413	0.92983	0.71030	0.999821364879608	2294	.	0.71675	0.83988	.	.	.	7.9	.	D	.	.	3.7780044E-6	0	.	0.86061	3	.	ENSG00000163914	.	0	.	0	0.9222913745428601	1	0.92348	0.75154	.	1	.	.	0.975528194122127	YES	.	0.443179	827539	HGNC:10012	.	.	.	0.995	.	129532635	CCC	1.000000	.	-	0	0.99666	.	0	.	Pathogenic	0.90947	.	.	.	ClinGen:CA354470391	P	.	0.990985566321	-	0.926	-	0.97550	.	466	0.92157	0.700365960598	0.9653	.	0.99803833658587948	94	-	799C>A 	.	0	C3661900	.	.	.	.	NM_000539.3	-	.	.	1	0.96561	2084789550	.	0	0.99077	0.98084	0.965	0.0	2210	0.99991560	5.51	.	.	.	0.429609	0.999611079235613	0.99359	D	84	.	.	0.9999	0.94654	p.Pro267Thr	0	.	-13.396	0.99142945	.	0.97193	853413	D	.	RHO	.	D	0.946	.	P267T	D	.	0.40292	C/C	principal1																																																																																																				
BRCA1_Cys64Ser	-0.5198160846601582	0.619220375890755	-3.278051964362376	0.013523323462305666	2025_01_Batch_13-14	0.509193303597748	0.665192591066776	0.7746920340779846	0.7189477005715086	0.4156154156519475	0.7305620324311284	0.5904017028232041	0.7157838760695898	0.7219623155263104	0.700675173216614	0.6198776680144382	0.6277971469449901	0.7452379550737872	0.7204550080489095	0.5581452944342807	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011841		NC_000017.11:43106477:C:G		Cys64Ser																												BRCA1_Cys64Ser	17	43106477	C	G	17	allele	191G>C	A09	527_CAVA_Array_P01	A17	B13A7A8P1_R1	B14A7A8P1_R2				17-43106477-C-G	-	0.85032	0.99	64	.	.	.	17	41258494	G	.	.	17	1_Pathogenic	NC_000017.11	.	Cys64Ser	.	28.5	.	.	.	D	.	2	1	.	.	.	.	.	.	0.98039	Select	0.9931	.	0.68795	.	.	T	D	.	.	.	.	.	.	.	0.69562	.	.	.	.	0.98450	.	.	0.98806	0.997	.	0.0	.	.	1.0	G	single nucleotide variant	NC_000017.11:g.43106477C>G	.	.	2	0.88973695	.	.	0.9870781	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	.	.	.	.	0.99291	P	0.94188	D	H	11.39386	.	C/C	.	.	.	.	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1	.	0.96208	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106477	.	-	7.641000	.	0.98523	.	.	.	.	germline;not applicable	.	Gain of disorder (P = 0.0079)| Loss of stability (P = 0.0171)| Gain of phosphorylation at C64 (P = 0.0837)| Gain of glycosylation at P62 (P = 0.1363)| Loss of methylation at K65 (P = 0.1443)	0.99690	GRCh38	459	criteria provided, single submitter	c.191G>C	.	0.57348	.	.	.	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	.	.	P	.	.	NM_007294.4(BRCA1):c.191G>C (p.Cys64Ser)	1	.	BRCA1_HUMAN	.	100.0	0.91310061370465	.	.	0.97310	0.97642994	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99701	.	.	.	.	.	p.Cys64Ser	.	0.63257	.	germline	.		C	Nov 09, 2022	.	C/C	.	.	1.0	N	17q21.31	.	.	.	SCV000635819	Pathogenic	.	.	Ser	S	-	.	ENSP00000350283	ENST00000357654	.	0.0	.	.	0.531	C	.	5.090651	0.92967	D	D	-	9.654935	.	0.99729	.	.	.	0.91262	.	43106477	Y	10	.	.	.	P38398	.	0.46945	0.52805		.	0.903	D	.	0.88999635	.	0.79771	672	0.553376	.	-1.45	.	.	0.91343	.	.	.	.	.	.	0.94170	17	BRCA1	.	.	Cys	.	.	17-43106477-C-G	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	.	.	38512020	ClinGen:CA10601786	0.851286	0.92344	.	RCV000559047|RCV001076723	D	.	.	c.191G>C	.	.	.	0.95819	C/C	rs55851803	43106477	.	C	.	E9PFC7	.	0.99591	.	0.68239		.	.	.	3.99	.	.	.	4.64	0.92995	.	D	T	.	.	.	.	.	.	.	145|145	462571	0.95755	0.40765	0.997346639633179	.	.	0.71675	0.76729	.	.	.	4.108	.	N	.	.	.	.	604370	0.57643	17	.	ENSG00000012048	.	.	.	.	.	2	0.78943	0.78836	.	.	.	.	0.783598264701654	YES	.	0.959083	468251	HGNC:1100	A	.	simple_aae	0.964	.	43106477	TGT	1.000000	.	-	.	0.99322	.	.	.	Pathogenic	0.92342	.	.	.	ClinGen:CA10601786	C	.	0.999450167335	-	0.968	-	0.99346	.	.	0.86148	0.717033147812	0.9961	.	0.99110843159672235	.	-	191G>C 	.	.	C2676676|C0677776	.	.	.	.	NM_007294.4	-	.	.	1	0.80441	55851803	.	.	0.99943	0.88566	0.982	0.0	.	0.99976617	4.64	.	.	.	0.55711	0.999399190328388	0.96635	D	.	.	.	0.9381	0.99838	p.Cys64Ser	.	.	-12.832	0.9888865	.	0.96461	462571	D	.	BRCA1	.	D	0.922	.	C64S	D	.	0.24877	C/C	principal2																																																																																																				
F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	0.6658774891976692	0.6045212236661197	0.6804156175327694	0.7516638087602934	0.47011848476019796	0.5481832914031204	0.5815975833010563	0.6261145076922536	0.6709982643362411	0.4544356929945508	0.6070303903003949	0.593059403483588	0.6532650626125115	0.7113310365482672	0.4622770888773744	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T		Ile7Phe																												F9_Ile7Phe	23	139530783	A	T	X	allele	19A>T	B06	527_CAVA_Array_P02	C12	B13A7A8P1_R1	B14A7A8P1_R2				X-139530783-A-T	-	0.25303	0.003	7	109	0	0	X	138612942	T	1.271300e-03	9	X	2_Benign	NC_000023.11	1437	Ile7Phe	0	16.7	0	0	1.707860e-03	D	2	10	1	30953	8.958850e-04	0	19003	0.000000e+00	2	0.83109	Select	0.5839	73191	0.11208	17	0.0	T	T	46726	0.154389061079	0	0	0.000000e+00	0	0	0.31890	13660	33784	0	0.000000e+00	0.13539	46	.	0.27032	0.903	0.0	86.0	0.762524	2.76	0.14	T	single nucleotide variant	NC_000023.11:g.139530783A>T	0	12179	3	0.089293085	80318	0	0.09779945	0		134	171897	0	0	0.000000e+00	436	1.486120e-03	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	62	8	0.000000e+00	0	0.35500	B	0.23494	B	M	.	1538	A/A	174	4	5701	1209789	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	13132	0.75458	0	.	-	139530783	1.486120e-03	-	6.602000	1	0.50624	22018	0.0021551724137931034	894566	0	germline;unknown	56833	.	.	GRCh38	937	reviewed by expert panel	c.19A>T	0.000000e+00	0.25790	148	0	0	.	4.926510e-04	6915	B	0	0.000000e+00	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	3	0	FA9_HUMAN	0	14.0	.	14	T	0.14905	0.115587294	+	0.000000e+00	0		109	0.000000e+00	0	27135	reviewed_by_expert_panel	0.99909	7.719320e-04	2	4.031450e-04	0	45789	p.Ile7Phe	0	0.56127	.	germline	46		A	Feb 09, 2024	0	A/A	0	64670	0.994	N	Xq27.1	79906	.	7.614990e-05	SCV004363695	Benign	4	0	Phe	F	-	685	ENSP00000218099	ENST00000218099	13314	0.006	10123	0	0.754	A	0	1.98797	0.49207	.	T	-	.	.	0.77263	928	0	0.0039164490861618795	0.01881	0	139530783	Y	10	0	73191	9.191180e-04	P00740	0	0.32948	0.21554		0	0.002	D	64670	0.098687075	30953	0.43926	2158	-0.0400873	1437	-0.35	0.0	1.606370e-03	0.61594	0.000000e+00	0	57439	0.000000e+00	4352	0	0.20840	X	F9	1.740980e-04	0	Ile	92926	1.685480e-03	X-139530783-A-T	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	0	125	138440608	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	.	.	2	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	T	0	0	c.19A>T	0	0	21	0.45599	A/A	rs150190385	139530783	12062	A	7.947019867549669E-4	.	9950	0.22850	5.005320e-04	0.68239		0	0	0.000000e+00	2.08	0	142	264690	2.05	0.69801	3328	T	T	1	5.747360e-04	0	656	.	0	6	98879	367997	0.80917	0.17172	0.0293591555932887	4292	3	0.38383	.	6.264970e-04	1.685480e-03	894566	3.489	8.827350e-04	N	9922	0	9.029431E-4	0	306900|300807|301052	0.53093	X	8.290500e-05	ENSG00000101981	4.494290e-04	0.0017770880784922284	0	0	0.7807951246571943	1	0.06938	0.14592	19068	239	1.707860e-03	4.367860e-04	.	YES	0.000000e+00	0.100824	348532	HGNC:3551	P	0	simple_aae	0.237	151801	139530783	ATC	1.000000	0	-	0	0.00744	1.606370e-03	0	0	Benign	0.33321	0	4	20	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	I	0	0.997412915613	-	.	-	0.79233	154	3764	0.77906	0.449907898903	0.0753	0	0.9197213938187907	272	-	19A>T 	125	0.0010626992561105207	C0008533|C2749016|C5393318|C3661900	0	0	0	0	NM_000133.4	-	3	0.0	0	0.38598	150190385	1767	0.0015926651313948733	0.99734	.	0.495	0.056	4118	0.99992085	4.55	.	.	0.000000e+00	0.164093	0.920702462215045	0.57221	T	2672	4647	7073	-0.2790	0.85002	p.Ile7Phe	0	0	-4.69	0.025558144	10	0.77602	367997	T	24359	F9	6.588580e-04	D	0.582	15983	.	D	0.50502	0.88385	A/A	principal1	123848	F9_Popp_2025_carboxy_F9_specific_var220817	No		7/11/24		b888a6e8-55cd-449a-a9d9-bc586edb7b6c							I		19	F9_Popp_2025_carboxy_F9_specific	367997.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA10529708	immortalized human cells		false			p.Ile7Phe		true	c.19A>T						3551.0	139530783.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa	BS2,BA1						PS4,BP4		NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BS2,BA1	Ile7Phe	https://erepo.genome.network/evrepo/ui/classification/b888a6e8-55cd-449a-a9d9-bc586edb7b6c					F	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	7.0		hemophilia B	0.0012712960689839	0.93154916889732		Benign	139530783.0	missense_variant		0.582					Reporter			F9_Ile7Phe
F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	0.6658774891976692	0.6045212236661197	0.6804156175327694	0.7516638087602934	0.47011848476019796	0.5481832914031204	0.5815975833010563	0.6261145076922536	0.6709982643362411	0.4544356929945508	0.6070303903003949	0.593059403483588	0.6532650626125115	0.7113310365482672	0.4622770888773744	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T		Ile7Phe																												F9_Ile7Phe	23	139530783	A	T	X	allele	19A>T	B06	527_CAVA_Array_P02	C12	B13A7A8P1_R1	B14A7A8P1_R2				X-139530783-A-T	-	0.25303	0.003	7	109	0	0	X	138612942	T	1.271300e-03	9	X	2_Benign	NC_000023.11	1437	Ile7Phe	0	16.7	0	0	1.707860e-03	D	2	10	1	30953	8.958850e-04	0	19003	0.000000e+00	2	0.83109	Select	0.5839	73191	0.11208	17	0.0	T	T	46726	0.154389061079	0	0	0.000000e+00	0	0	0.31890	13660	33784	0	0.000000e+00	0.13539	46	.	0.27032	0.903	0.0	86.0	0.762524	2.76	0.14	T	single nucleotide variant	NC_000023.11:g.139530783A>T	0	12179	3	0.089293085	80318	0	0.09779945	0		134	171897	0	0	0.000000e+00	436	1.486120e-03	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	62	8	0.000000e+00	0	0.35500	B	0.23494	B	M	.	1538	A/A	174	4	5701	1209789	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	13132	0.75458	0	.	-	139530783	1.486120e-03	-	6.602000	1	0.50624	22018	0.0021551724137931034	894566	0	germline;unknown	56833	.	.	GRCh38	937	reviewed by expert panel	c.19A>T	0.000000e+00	0.25790	148	0	0	.	4.926510e-04	6915	B	0	0.000000e+00	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	3	0	FA9_HUMAN	0	14.0	.	14	T	0.14905	0.115587294	+	0.000000e+00	0		109	0.000000e+00	0	27135	reviewed_by_expert_panel	0.99909	7.719320e-04	2	4.031450e-04	0	45789	p.Ile7Phe	0	0.56127	.	germline	46		A	Feb 09, 2024	0	A/A	0	64670	0.994	N	Xq27.1	79906	.	7.614990e-05	SCV004363695	Benign	4	0	Phe	F	-	685	ENSP00000218099	ENST00000218099	13314	0.006	10123	0	0.754	A	0	1.98797	0.49207	.	T	-	.	.	0.77263	928	0	0.0039164490861618795	0.01881	0	139530783	Y	10	0	73191	9.191180e-04	P00740	0	0.32948	0.21554		0	0.002	D	64670	0.098687075	30953	0.43926	2158	-0.0400873	1437	-0.35	0.0	1.606370e-03	0.61594	0.000000e+00	0	57439	0.000000e+00	4352	0	0.20840	X	F9	1.740980e-04	0	Ile	92926	1.685480e-03	X-139530783-A-T	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	0	125	138440608	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	.	.	2	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	T	0	0	c.19A>T	0	0	21	0.45599	A/A	rs150190385	139530783	12062	A	7.947019867549669E-4	.	9950	0.22850	5.005320e-04	0.68239		0	0	0.000000e+00	2.08	0	142	264690	2.05	0.69801	3328	T	T	1	5.747360e-04	0	656	.	0	6	98879	367997	0.80917	0.17172	0.0293591555932887	4292	3	0.38383	.	6.264970e-04	1.685480e-03	894566	3.489	8.827350e-04	N	9922	0	9.029431E-4	0	306900|300807|301052	0.53093	X	8.290500e-05	ENSG00000101981	4.494290e-04	0.0017770880784922284	0	0	0.7807951246571943	1	0.06938	0.14592	19068	239	1.707860e-03	4.367860e-04	.	YES	0.000000e+00	0.100824	348532	HGNC:3551	P	0	simple_aae	0.237	151801	139530783	ATC	1.000000	0	-	0	0.00744	1.606370e-03	0	0	Benign	0.33321	0	4	20	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	I	0	0.997412915613	-	.	-	0.79233	154	3764	0.77906	0.449907898903	0.0753	0	0.9197213938187907	272	-	19A>T 	125	0.0010626992561105207	C0008533|C2749016|C5393318|C3661900	0	0	0	0	NM_000133.4	-	3	0.0	0	0.38598	150190385	1767	0.0015926651313948733	0.99734	.	0.495	0.056	4118	0.99992085	4.55	.	.	0.000000e+00	0.164093	0.920702462215045	0.57221	T	2672	4647	7073	-0.2790	0.85002	p.Ile7Phe	0	0	-4.69	0.025558144	10	0.77602	367997	T	24359	F9	6.588580e-04	D	0.582	15983	.	D	0.50502	0.88385	A/A	principal1	151364	F9_Popp_2025_carboxy_gla_motif_var249860	No		7/11/24		b888a6e8-55cd-449a-a9d9-bc586edb7b6c							I		19	F9_Popp_2025_carboxy_gla_motif	367997.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA10529708	immortalized human cells		false			p.Ile7Phe		true	c.19A>T						3551.0	139530783.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa	BS2,BA1						PS4,BP4		NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BS2,BA1	Ile7Phe	https://erepo.genome.network/evrepo/ui/classification/b888a6e8-55cd-449a-a9d9-bc586edb7b6c					F	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	7.0		hemophilia B	0.0012712960689839	0.9056385132737776		Benign	139530783.0	missense_variant		0.582					Reporter			F9_Ile7Phe
F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	0.6658774891976692	0.6045212236661197	0.6804156175327694	0.7516638087602934	0.47011848476019796	0.5481832914031204	0.5815975833010563	0.6261145076922536	0.6709982643362411	0.4544356929945508	0.6070303903003949	0.593059403483588	0.6532650626125115	0.7113310365482672	0.4622770888773744	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T		Ile7Phe																												F9_Ile7Phe	23	139530783	A	T	X	allele	19A>T	B06	527_CAVA_Array_P02	C12	B13A7A8P1_R1	B14A7A8P1_R2				X-139530783-A-T	-	0.25303	0.003	7	109	0	0	X	138612942	T	1.271300e-03	9	X	2_Benign	NC_000023.11	1437	Ile7Phe	0	16.7	0	0	1.707860e-03	D	2	10	1	30953	8.958850e-04	0	19003	0.000000e+00	2	0.83109	Select	0.5839	73191	0.11208	17	0.0	T	T	46726	0.154389061079	0	0	0.000000e+00	0	0	0.31890	13660	33784	0	0.000000e+00	0.13539	46	.	0.27032	0.903	0.0	86.0	0.762524	2.76	0.14	T	single nucleotide variant	NC_000023.11:g.139530783A>T	0	12179	3	0.089293085	80318	0	0.09779945	0		134	171897	0	0	0.000000e+00	436	1.486120e-03	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	62	8	0.000000e+00	0	0.35500	B	0.23494	B	M	.	1538	A/A	174	4	5701	1209789	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	13132	0.75458	0	.	-	139530783	1.486120e-03	-	6.602000	1	0.50624	22018	0.0021551724137931034	894566	0	germline;unknown	56833	.	.	GRCh38	937	reviewed by expert panel	c.19A>T	0.000000e+00	0.25790	148	0	0	.	4.926510e-04	6915	B	0	0.000000e+00	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	3	0	FA9_HUMAN	0	14.0	.	14	T	0.14905	0.115587294	+	0.000000e+00	0		109	0.000000e+00	0	27135	reviewed_by_expert_panel	0.99909	7.719320e-04	2	4.031450e-04	0	45789	p.Ile7Phe	0	0.56127	.	germline	46		A	Feb 09, 2024	0	A/A	0	64670	0.994	N	Xq27.1	79906	.	7.614990e-05	SCV004363695	Benign	4	0	Phe	F	-	685	ENSP00000218099	ENST00000218099	13314	0.006	10123	0	0.754	A	0	1.98797	0.49207	.	T	-	.	.	0.77263	928	0	0.0039164490861618795	0.01881	0	139530783	Y	10	0	73191	9.191180e-04	P00740	0	0.32948	0.21554		0	0.002	D	64670	0.098687075	30953	0.43926	2158	-0.0400873	1437	-0.35	0.0	1.606370e-03	0.61594	0.000000e+00	0	57439	0.000000e+00	4352	0	0.20840	X	F9	1.740980e-04	0	Ile	92926	1.685480e-03	X-139530783-A-T	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	0	125	138440608	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	.	.	2	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	T	0	0	c.19A>T	0	0	21	0.45599	A/A	rs150190385	139530783	12062	A	7.947019867549669E-4	.	9950	0.22850	5.005320e-04	0.68239		0	0	0.000000e+00	2.08	0	142	264690	2.05	0.69801	3328	T	T	1	5.747360e-04	0	656	.	0	6	98879	367997	0.80917	0.17172	0.0293591555932887	4292	3	0.38383	.	6.264970e-04	1.685480e-03	894566	3.489	8.827350e-04	N	9922	0	9.029431E-4	0	306900|300807|301052	0.53093	X	8.290500e-05	ENSG00000101981	4.494290e-04	0.0017770880784922284	0	0	0.7807951246571943	1	0.06938	0.14592	19068	239	1.707860e-03	4.367860e-04	.	YES	0.000000e+00	0.100824	348532	HGNC:3551	P	0	simple_aae	0.237	151801	139530783	ATC	1.000000	0	-	0	0.00744	1.606370e-03	0	0	Benign	0.33321	0	4	20	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	I	0	0.997412915613	-	.	-	0.79233	154	3764	0.77906	0.449907898903	0.0753	0	0.9197213938187907	272	-	19A>T 	125	0.0010626992561105207	C0008533|C2749016|C5393318|C3661900	0	0	0	0	NM_000133.4	-	3	0.0	0	0.38598	150190385	1767	0.0015926651313948733	0.99734	.	0.495	0.056	4118	0.99992085	4.55	.	.	0.000000e+00	0.164093	0.920702462215045	0.57221	T	2672	4647	7073	-0.2790	0.85002	p.Ile7Phe	0	0	-4.69	0.025558144	10	0.77602	367997	T	24359	F9	6.588580e-04	D	0.582	15983	.	D	0.50502	0.88385	A/A	principal1	233912	F9_Popp_2025_strep_2_var259541	No		7/11/24		b888a6e8-55cd-449a-a9d9-bc586edb7b6c							I		19	F9_Popp_2025_strep_2	367997.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA10529708	immortalized human cells		false			p.Ile7Phe		true	c.19A>T						3551.0	139530783.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa	BS2,BA1						PS4,BP4		NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BS2,BA1	Ile7Phe	https://erepo.genome.network/evrepo/ui/classification/b888a6e8-55cd-449a-a9d9-bc586edb7b6c					F	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	7.0		hemophilia B	0.0012712960689839	1.0643644677340538		Benign	139530783.0	missense_variant		0.582					Reporter			F9_Ile7Phe
F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	0.6658774891976692	0.6045212236661197	0.6804156175327694	0.7516638087602934	0.47011848476019796	0.5481832914031204	0.5815975833010563	0.6261145076922536	0.6709982643362411	0.4544356929945508	0.6070303903003949	0.593059403483588	0.6532650626125115	0.7113310365482672	0.4622770888773744	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T		Ile7Phe																												F9_Ile7Phe	23	139530783	A	T	X	allele	19A>T	B06	527_CAVA_Array_P02	C12	B13A7A8P1_R1	B14A7A8P1_R2				X-139530783-A-T	-	0.25303	0.003	7	109	0	0	X	138612942	T	1.271300e-03	9	X	2_Benign	NC_000023.11	1437	Ile7Phe	0	16.7	0	0	1.707860e-03	D	2	10	1	30953	8.958850e-04	0	19003	0.000000e+00	2	0.83109	Select	0.5839	73191	0.11208	17	0.0	T	T	46726	0.154389061079	0	0	0.000000e+00	0	0	0.31890	13660	33784	0	0.000000e+00	0.13539	46	.	0.27032	0.903	0.0	86.0	0.762524	2.76	0.14	T	single nucleotide variant	NC_000023.11:g.139530783A>T	0	12179	3	0.089293085	80318	0	0.09779945	0		134	171897	0	0	0.000000e+00	436	1.486120e-03	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	62	8	0.000000e+00	0	0.35500	B	0.23494	B	M	.	1538	A/A	174	4	5701	1209789	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	13132	0.75458	0	.	-	139530783	1.486120e-03	-	6.602000	1	0.50624	22018	0.0021551724137931034	894566	0	germline;unknown	56833	.	.	GRCh38	937	reviewed by expert panel	c.19A>T	0.000000e+00	0.25790	148	0	0	.	4.926510e-04	6915	B	0	0.000000e+00	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	3	0	FA9_HUMAN	0	14.0	.	14	T	0.14905	0.115587294	+	0.000000e+00	0		109	0.000000e+00	0	27135	reviewed_by_expert_panel	0.99909	7.719320e-04	2	4.031450e-04	0	45789	p.Ile7Phe	0	0.56127	.	germline	46		A	Feb 09, 2024	0	A/A	0	64670	0.994	N	Xq27.1	79906	.	7.614990e-05	SCV004363695	Benign	4	0	Phe	F	-	685	ENSP00000218099	ENST00000218099	13314	0.006	10123	0	0.754	A	0	1.98797	0.49207	.	T	-	.	.	0.77263	928	0	0.0039164490861618795	0.01881	0	139530783	Y	10	0	73191	9.191180e-04	P00740	0	0.32948	0.21554		0	0.002	D	64670	0.098687075	30953	0.43926	2158	-0.0400873	1437	-0.35	0.0	1.606370e-03	0.61594	0.000000e+00	0	57439	0.000000e+00	4352	0	0.20840	X	F9	1.740980e-04	0	Ile	92926	1.685480e-03	X-139530783-A-T	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	0	125	138440608	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	.	.	2	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	T	0	0	c.19A>T	0	0	21	0.45599	A/A	rs150190385	139530783	12062	A	7.947019867549669E-4	.	9950	0.22850	5.005320e-04	0.68239		0	0	0.000000e+00	2.08	0	142	264690	2.05	0.69801	3328	T	T	1	5.747360e-04	0	656	.	0	6	98879	367997	0.80917	0.17172	0.0293591555932887	4292	3	0.38383	.	6.264970e-04	1.685480e-03	894566	3.489	8.827350e-04	N	9922	0	9.029431E-4	0	306900|300807|301052	0.53093	X	8.290500e-05	ENSG00000101981	4.494290e-04	0.0017770880784922284	0	0	0.7807951246571943	1	0.06938	0.14592	19068	239	1.707860e-03	4.367860e-04	.	YES	0.000000e+00	0.100824	348532	HGNC:3551	P	0	simple_aae	0.237	151801	139530783	ATC	1.000000	0	-	0	0.00744	1.606370e-03	0	0	Benign	0.33321	0	4	20	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	I	0	0.997412915613	-	.	-	0.79233	154	3764	0.77906	0.449907898903	0.0753	0	0.9197213938187907	272	-	19A>T 	125	0.0010626992561105207	C0008533|C2749016|C5393318|C3661900	0	0	0	0	NM_000133.4	-	3	0.0	0	0.38598	150190385	1767	0.0015926651313948733	0.99734	.	0.495	0.056	4118	0.99992085	4.55	.	.	0.000000e+00	0.164093	0.920702462215045	0.57221	T	2672	4647	7073	-0.2790	0.85002	p.Ile7Phe	0	0	-4.69	0.025558144	10	0.77602	367997	T	24359	F9	6.588580e-04	D	0.582	15983	.	D	0.50502	0.88385	A/A	principal1	178880	F9_Popp_2025_heavy_chain_var230498	No		7/11/24		b888a6e8-55cd-449a-a9d9-bc586edb7b6c							I		19	F9_Popp_2025_heavy_chain	367997.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA10529708	immortalized human cells		false			p.Ile7Phe		true	c.19A>T						3551.0	139530783.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa	BS2,BA1						PS4,BP4		NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BS2,BA1	Ile7Phe	https://erepo.genome.network/evrepo/ui/classification/b888a6e8-55cd-449a-a9d9-bc586edb7b6c					F	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	7.0		hemophilia B	0.0012712960689839	1.0011792876785426		Benign	139530783.0	missense_variant		0.582					Reporter			F9_Ile7Phe
F9_Ile7Phe	-1.8798922387074215	0.10218205798682319	2.0281260799966656	0.08213958470108292	2025_01_Batch_13-14	0.6658774891976692	0.6045212236661197	0.6804156175327694	0.7516638087602934	0.47011848476019796	0.5481832914031204	0.5815975833010563	0.6261145076922536	0.6709982643362411	0.4544356929945508	0.6070303903003949	0.593059403483588	0.6532650626125115	0.7113310365482672	0.4622770888773744	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030454		NC_000023.11:139530783:A:T		Ile7Phe																												F9_Ile7Phe	23	139530783	A	T	X	allele	19A>T	B06	527_CAVA_Array_P02	C12	B13A7A8P1_R1	B14A7A8P1_R2				X-139530783-A-T	-	0.25303	0.003	7	109	0	0	X	138612942	T	1.271300e-03	9	X	2_Benign	NC_000023.11	1437	Ile7Phe	0	16.7	0	0	1.707860e-03	D	2	10	1	30953	8.958850e-04	0	19003	0.000000e+00	2	0.83109	Select	0.5839	73191	0.11208	17	0.0	T	T	46726	0.154389061079	0	0	0.000000e+00	0	0	0.31890	13660	33784	0	0.000000e+00	0.13539	46	.	0.27032	0.903	0.0	86.0	0.762524	2.76	0.14	T	single nucleotide variant	NC_000023.11:g.139530783A>T	0	12179	3	0.089293085	80318	0	0.09779945	0		134	171897	0	0	0.000000e+00	436	1.486120e-03	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052|MedGen:C3661900||	62	8	0.000000e+00	0	0.35500	B	0.23494	B	M	.	1538	A/A	174	4	5701	1209789	Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked|not provided|F9 POLYMORPHISM|F9-related disorder	13132	0.75458	0	.	-	139530783	1.486120e-03	-	6.602000	1	0.50624	22018	0.0021551724137931034	894566	0	germline;unknown	56833	.	.	GRCh38	937	reviewed by expert panel	c.19A>T	0.000000e+00	0.25790	148	0	0	.	4.926510e-04	6915	B	0	0.000000e+00	NM_000133.4(F9):c.19A>T (p.Ile7Phe)	3	0	FA9_HUMAN	0	14.0	.	14	T	0.14905	0.115587294	+	0.000000e+00	0		109	0.000000e+00	0	27135	reviewed_by_expert_panel	0.99909	7.719320e-04	2	4.031450e-04	0	45789	p.Ile7Phe	0	0.56127	.	germline	46		A	Feb 09, 2024	0	A/A	0	64670	0.994	N	Xq27.1	79906	.	7.614990e-05	SCV004363695	Benign	4	0	Phe	F	-	685	ENSP00000218099	ENST00000218099	13314	0.006	10123	0	0.754	A	0	1.98797	0.49207	.	T	-	.	.	0.77263	928	0	0.0039164490861618795	0.01881	0	139530783	Y	10	0	73191	9.191180e-04	P00740	0	0.32948	0.21554		0	0.002	D	64670	0.098687075	30953	0.43926	2158	-0.0400873	1437	-0.35	0.0	1.606370e-03	0.61594	0.000000e+00	0	57439	0.000000e+00	4352	0	0.20840	X	F9	1.740980e-04	0	Ile	92926	1.685480e-03	X-139530783-A-T	F9-related_disorder|FACTOR_IX_POLYMORPHISM|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Warfarin_sensitivity,_X-linked|not_provided	0	125	138440608	ClinGen:CA10529708|OMIM:300746.0005|UniProtKB:P00740#VAR_006520	.	.	2	RCV000291239|RCV001080823|RCV002488831|RCV003389717|RCV004992192|RCV003970084	T	0	0	c.19A>T	0	0	21	0.45599	A/A	rs150190385	139530783	12062	A	7.947019867549669E-4	.	9950	0.22850	5.005320e-04	0.68239		0	0	0.000000e+00	2.08	0	142	264690	2.05	0.69801	3328	T	T	1	5.747360e-04	0	656	.	0	6	98879	367997	0.80917	0.17172	0.0293591555932887	4292	3	0.38383	.	6.264970e-04	1.685480e-03	894566	3.489	8.827350e-04	N	9922	0	9.029431E-4	0	306900|300807|301052	0.53093	X	8.290500e-05	ENSG00000101981	4.494290e-04	0.0017770880784922284	0	0	0.7807951246571943	1	0.06938	0.14592	19068	239	1.707860e-03	4.367860e-04	.	YES	0.000000e+00	0.100824	348532	HGNC:3551	P	0	simple_aae	0.237	151801	139530783	ATC	1.000000	0	-	0	0.00744	1.606370e-03	0	0	Benign	0.33321	0	4	20	ClinGen:CA10529708,UniProtKB:P00740#VAR_006520,OMIM:300746.0005	I	0	0.997412915613	-	.	-	0.79233	154	3764	0.77906	0.449907898903	0.0753	0	0.9197213938187907	272	-	19A>T 	125	0.0010626992561105207	C0008533|C2749016|C5393318|C3661900	0	0	0	0	NM_000133.4	-	3	0.0	0	0.38598	150190385	1767	0.0015926651313948733	0.99734	.	0.495	0.056	4118	0.99992085	4.55	.	.	0.000000e+00	0.164093	0.920702462215045	0.57221	T	2672	4647	7073	-0.2790	0.85002	p.Ile7Phe	0	0	-4.69	0.025558144	10	0.77602	367997	T	24359	F9	6.588580e-04	D	0.582	15983	.	D	0.50502	0.88385	A/A	principal1	206396	F9_Popp_2025_light_chain_var240179	No		7/11/24		b888a6e8-55cd-449a-a9d9-bc586edb7b6c							I		19	F9_Popp_2025_light_chain	367997.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA10529708	immortalized human cells		false			p.Ile7Phe		true	c.19A>T						3551.0	139530783.0	No	Benign	F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa	BS2,BA1						PS4,BP4		NM_000133.3:c.19A>T variant results in a missense change in the signal peptide. This variant is reported at a frequency of 0.001643 (152/92537 alleles with 57 hemizygotes) in the non-Finnish European population in gnomAD v2.1.1, meeting the BA1 cut-off of >= 0.0000556. At least 2 individuals with the variant and normal FIX levels from the literature and internal laboratory data are reported (PMID: 29296726) meeting the BS2 criterion. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: BA1, BS2.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	BS2,BA1	Ile7Phe	https://erepo.genome.network/evrepo/ui/classification/b888a6e8-55cd-449a-a9d9-bc586edb7b6c					F	Feb 09, 2024				2/9/24	missense_variant	Coagulation Factor Deficiency VCEP	7.0		hemophilia B	0.0012712960689839	0.9413312528693004		Benign	139530783.0	missense_variant		0.582					Reporter			F9_Ile7Phe
RAD51D_Thr328Ile	0.5151692477436156	0.6222994408448728	18.307890143801554	3.592313339156725e-7	2025_01_Batch_13-14	0.7437025918455917	0.9031293954033862	0.9760822387039301	0.8935058931837492	0.7639484780788016	0.929689903410934	0.9488310980965327	0.9693401858737757	0.9579251898475452	0.9120513828608797	0.8366962476282629	0.9259802467499594	0.9727112122888528	0.9257155415156472	0.8379999304698407	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024896		NC_000017.11:35100957:G:A		Thr328Ile																												RAD51D_Thr328Ile	17	35100957	G	A	17	allele	983C>T	H02	527_CAVA_Array_P05	O03	B13A7A8P2_R1	B14A7A8P2_R2				17-35100957-G-A	-	0.14598	0.0	328	0	0	0	17	33427976	A	5.957830e-05	0	17	3_Conflicting	NC_000017.11	80	Thr328Ile	0	11.14	0	9	9.394710e-04	T	1	11	1	42768	7.174510e-05	4	30526	0.000000e+00	0	0.05575	Select	0.0417	14902	0.02950	2	0.0	T	T	64034	.	9.613330484939116E-4	1	0.000000e+00	0	0	.	17112	44862	2	0.000000e+00	0.32965	0	.	0.18434	0.07	0.0030257186081694403	100.0	.	-1.09	0.0	A	single nucleotide variant	NC_000017.11:g.35100957G>A	0	16734	2	0.09681502	109408	0	0.08105616	0		19	236950	0	0	0.000000e+00	442	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|	6	0	0.000000e+00	0	0.01751	B	0.22979	B	N	0.2282938	96	G/G	360	0	7164	1611324	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|RAD51D-related disorder	16218	0.16258	0	.	-	35100957	8.375210e-04	-	-0.087000	17	0.06833	29586	0	74978	0	germline;unknown	91016	.	.	GRCh38	914	criteria provided, conflicting classifications	c.983C>T	3.275900e-05	0.07582	10	0	0	.	0.000000e+00	9046	LB	0	0.000000e+00	NM_002878.4(RAD51D):c.983C>T (p.Thr328Ile)	1	0	RA51D_HUMAN	0	0.0	-1.19812197881439	1	.	0.28639	0.08105616	-	8.375210e-04	0		17	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.76376	5.484060e-05	1	0.000000e+00	0	60018	p.Thr328Ile	0	0.12155	.	germline	6		G	Feb 03, 2025	1	G/G	0	89558	0.0	N	17q12	163022	.	1.048220e-03	SCV000184643|SCV000211662|SCV000488575|SCV000551327|SCV000902869|SCV001134809|SCV001140402|SCV001363868|SCV002527059|SCV004017733	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	912	ENSP00000338790	ENST00000345365	17692	0.0	13416	0	-0.119	G	0	1.075211	0.92967	N	D	-	0.2610204	.	0.17625	950	0	0.0	0.09265	0	35100957	Y	10	0	102746	3.315650e-04	O75771	0	0.115639	0.06433		0	0.001	T	16218	0.09681502	7164	0.16685	5892	-0.601611	0	-1.32	0.0	1.066980e-03	0.91343	0.000000e+00	0	74978	0.000000e+00	6032	6	0.22979	17	RAD51D	1.066980e-03	0	Thr	189130	0.000000e+00	17-35100957-G-A	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|RAD51D-related_disorder|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	0	0	30452089	ClinGen:CA294126	0.051862	0.04971	0	RCV000129828|RCV000254688|RCV000411668|RCV000859034|RCV003935215	T	0	0	c.983C>T	0	0	0	0.00139	G/G	rs138969595	35100957	14902	G	7.987220447284345E-4	.	15690	0.18434	0.000000e+00	0.08389		0	0	0.000000e+00	0.145	0	1	264690	-1.75	0.43135	3394	T	.	14	3.276110e-05	0	682	.	0	0	145|140162	141343	0.06933	0.45724	0.075320455379959	9722	4	0.06393	0.09058	5.837710e-05	1.048220e-03	1177472	-0.5	9.128650e-05	N	13394	0	2.8712835E-4	0	614291	0.065	17	9.394710e-04	ENSG00000185379	0.000000e+00	6.13414140422765E-6	1	0	.	2	0.04348	0.21043	30608	76	0.000000e+00	6.664670e-05	-1.22724989160509	YES	2.197420e-05	0.006771	151057	HGNC:9823	N	0	simple_aae	0.032	208136	35100957	ACA	0.000000	0	-	9.257354453816088E-4	0.00221	0.000000e+00	9	0	Conflicting classifications of pathogenicity	0.29411	0	2	4	ClinGen:CA294126	T	0	0.207176502487	-	.	-	0.21823	17	11320	0.26638	.	0.1002	0	0.59940449977036514	280	-	983C>T 	14	0	C3280345|C0027672|CN169374|C3661900	0	0	0	0	NM_002878.4	-	0	0.0	0	0.22097	138969595	2320	5.287368476709142E-5	0.19935	0.05389	0.053	0.0	9362	0.28552076	5.12	.	.	3.267120e-05	-0.677482	4.77421596645541e-05	0.08752	T	2712	6212	9572	-1.0435	0.17815	p.Thr328Ile	0	0	-4.387	0.009995133	80	0.01873	141343	T	30524	RAD51D	0.000000e+00	T	0.026	21632	.	D	0.15326	0.14328	G/G	principal1	958901	RAD51D_unpublished_var153148	Yes						overall function		Cell survival			T		983	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Thr328Ile		true	c.983C>T						9823.0	35100957.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		T									criteria provided, conflicting classifications				Thr328Ile						I	Feb 01, 2024					missense_variant		328.0	C		0.0000595783343387	-0.0127746		Conflicting classifications of pathogenicity	35100957.0	missense_variant		0.026	functionally_normal				Cell viability			RAD51D_Thr328Ile
RAD51D_Thr328Ile	0.5151692477436156	0.6222994408448728	18.307890143801554	3.592313339156725e-7	2025_01_Batch_13-14	0.7437025918455917	0.9031293954033862	0.9760822387039301	0.8935058931837492	0.7639484780788016	0.929689903410934	0.9488310980965327	0.9693401858737757	0.9579251898475452	0.9120513828608797	0.8366962476282629	0.9259802467499594	0.9727112122888528	0.9257155415156472	0.8379999304698407	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024896	ALE00029788	NC_000017.11:35100957:G:A	983C>T	Thr328Ile	CAVA																											RAD51D_Thr328Ile	17	35100957	G	A	17								1	1	1	17-35100957-G-A	-	0.14598	0.0	328	0	0	0	17	33427976	A	5.957830e-05	0	17	3_Conflicting	NC_000017.11	80	Thr328Ile	0	11.14	0	9	9.394710e-04	T	1	11	1	42768	7.174510e-05	4	30526	0.000000e+00	0	0.05575	Select	0.0417	14902	0.02950	2	0.0	T	T	64034	.	9.613330484939116E-4	1	0.000000e+00	0	0	.	17112	44862	2	0.000000e+00	0.32965	0	.	0.18434	0.07	0.0030257186081694403	100.0	.	-1.09	0.0	A	single nucleotide variant	NC_000017.11:g.35100957G>A	0	16734	2	0.09681502	109408	0	0.08105616	0		19	236950	0	0	0.000000e+00	442	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|	6	0	0.000000e+00	0	0.01751	B	0.22979	B	N	0.2282938	96	G/G	360	0	7164	1611324	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|RAD51D-related disorder	16218	0.16258	0	.	-	35100957	8.375210e-04	-	-0.087000	17	0.06833	29586	0	74978	0	germline;unknown	91016	.	.	GRCh38	914	criteria provided, conflicting classifications	c.983C>T	3.275900e-05	0.07582	10	0	0	.	0.000000e+00	9046	LB	0	0.000000e+00	NM_002878.4(RAD51D):c.983C>T (p.Thr328Ile)	1	0	RA51D_HUMAN	0	0.0	-1.19812197881439	1	.	0.28639	0.08105616	-	8.375210e-04	0		17	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.76376	5.484060e-05	1	0.000000e+00	0	60018	p.Thr328Ile	0	0.12155	.	germline	6		G	Feb 03, 2025	1	G/G	0	89558	0.0	N	17q12	163022	.	1.048220e-03	SCV000184643|SCV000211662|SCV000488575|SCV000551327|SCV000902869|SCV001134809|SCV001140402|SCV001363868|SCV002527059|SCV004017733	Conflicting_classifications_of_pathogenicity	0	0	Ile	I	-	912	ENSP00000338790	ENST00000345365	17692	0.0	13416	0	-0.119	G	0	1.075211	0.92967	N	D	-	0.2610204	.	0.17625	950	0	0.0	0.09265	0	35100957	Y	10	0	102746	3.315650e-04	O75771	0	0.115639	0.06433		0	0.001	T	16218	0.09681502	7164	0.16685	5892	-0.601611	0	-1.32	0.0	1.066980e-03	0.91343	0.000000e+00	0	74978	0.000000e+00	6032	6	0.22979	17	RAD51D	1.066980e-03	0	Thr	189130	0.000000e+00	17-35100957-G-A	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|RAD51D-related_disorder|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	0	0	30452089	ClinGen:CA294126	0.051862	0.04971	0	RCV000129828|RCV000254688|RCV000411668|RCV000859034|RCV003935215	T	0	0	c.983C>T	0	0	0	0.00139	G/G	rs138969595	35100957	14902	G	7.987220447284345E-4	.	15690	0.18434	0.000000e+00	0.08389		0	0	0.000000e+00	0.145	0	1	264690	-1.75	0.43135	3394	T	.	14	3.276110e-05	0	682	.	0	0	145|140162	141343	0.06933	0.45724	0.075320455379959	9722	4	0.06393	0.09058	5.837710e-05	1.048220e-03	1177472	-0.5	9.128650e-05	N	13394	0	2.8712835E-4	0	614291	0.065	17	9.394710e-04	ENSG00000185379	0.000000e+00	6.13414140422765E-6	1	0	.	2	0.04348	0.21043	30608	76	0.000000e+00	6.664670e-05	-1.22724989160509	YES	2.197420e-05	0.006771	151057	HGNC:9823	N	0	simple_aae	0.032	208136	35100957	ACA	0.000000	0	-	9.257354453816088E-4	0.00221	0.000000e+00	9	0	Conflicting classifications of pathogenicity	0.29411	0	2	4	ClinGen:CA294126	T	0	0.207176502487	-	.	-	0.21823	17	11320	0.26638	.	0.1002	0	0.59940449977036514	280	-	983C>T 	14	0	C3280345|C0027672|CN169374|C3661900	0	0	0	0	NM_002878.4	-	0	0.0	0	0.22097	138969595	2320	5.287368476709142E-5	0.19935	0.05389	0.053	0.0	9362	0.28552076	5.12	.	.	3.267120e-05	-0.677482	4.77421596645541e-05	0.08752	T	2712	6212	9572	-1.0435	0.17815	p.Thr328Ile	0	0	-4.387	0.009995133	80	0.01873	141343	T	30524	RAD51D	0.000000e+00	T	0.026	21632	.	D	0.15326	0.14328	G/G	principal1	958901	RAD51D_unpublished_var153148	Yes						overall function		Cell survival			T		983	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Thr328Ile		true	c.983C>T						9823.0	35100957.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		T									criteria provided, conflicting classifications				Thr328Ile						I	Feb 01, 2024					missense_variant		328.0	C		0.0000595783343387	-0.0127746		Conflicting classifications of pathogenicity	35100957.0	missense_variant		0.026	functionally_normal				Cell viability			RAD51D_Thr328Ile
SOS2_Pro1318Ser	1.0493118206423042	0.328906085228044	9.648726316236788	0.000027068206037967004	2025_01_Batch_13-14	0.554340213938575	0.6887243058977645	0.870454493436902	0.745988592406421	0.5811270840807448	0.6722103852923177	0.8100490546522804	0.9536180356480155	0.910307686853788	0.6730856149034364	0.6132752996154464	0.7493866802750224	0.9120362645424587	0.8281481396301045	0.6271063494920905	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SOS2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											
BRCA1_Val632Ala	2.1490587662768768	0.06870905490576534	3.81823247434967	0.006557305473716378	2025_01_Batch_13-14	0.8813107186301908	0.8772968783547237	0.8683821066344395	0.905743118181431	0.7797971771542498	0.9800312051341327	0.9247600758234454	0.9297751709075213	0.9743619796830157	0.9522056147366262	0.9306709618821618	0.9010284770890846	0.8990786387709804	0.9400525489322233	0.866001395945438	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011853		NC_000017.11:43057122:A:G		Val632Ala																												BRCA1_Val632Ala	17	43057122	A	G	17	allele	1895T>C	E09	527_CAVA_Array_P01	I17	B13A7A8P1_R1	B14A7A8P1_R2				17-43057122-A-G	-	0.74972	0.802	1736	.	0	.	17	41209139	G	8.054600e-06	.	17	1_Pathogenic	NC_000017.11	12	Val1736Ala	.	26.2	.	0	.	D	0	24	.	.	.	.	.	.	0	0.94487	.	0.8418	.	0.90580	.	.	T	D	64010	.	0	0	.	.	.	0.50045	.	44870	0	.	0.66695	.	.	0.70704	1.0	.	.	.	.	.	G	single nucleotide variant	NC_000017.11:g.43057122A>G	0	.	3	0.19759434	.	0	0.64500636	0		.	.	.	.	.	500	.	0	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883	.	.	0.000000e+00	0	0.99291	B	0.40826	P	M	7.641852	13	A/A	84	0	.	1613984	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group S	.	0.95041	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43057122	.	-	10.840000	.	0.89500	29600	0	1179920	.	germline;not applicable;unknown	91084	.	.	GRCh38	518	reviewed by expert panel	.	.	0.68064	1	.	.	BRCT domain	.	.	.	0	0.000000e+00	NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala)	3	.	BRCA1_HUMAN	.	.	0.735250864207851	.	.	0.87654	0.56882757	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99714	.	0	.	.	59990	.	0	0.83929	.	germline	.		A	Jun 25, 2019	.	A/A	.	.	1.0	N	17q21.31	24506	.	.	SCV001161713	Pathogenic	.	.	Ala	A	-	912	ENSP00000518978	ENST00000713676	.	.	.	.	0.748	A	.	4.681403	0.92967	D	.	-	7.543151	.	0.98037	628	.	.	0.74278	0	43057122	Y	10	0	.	0.000000e+00	P38398	.	0.137814	0.95656		.	0.38	D	.	0.18117532	.	0.97202	672	0.456703	12	.	.	1.017020e-05	0.91343	.	.	75034	.	6056	.	0.43395	17	BRCA1	0.000000e+00	0	Val	33208	.	17-43057122-A-G	not_provided|Fanconi_anemia,_complementation_group_S|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	0	.	38462665	ClinGen:CA003357|OMIM:113705.0038|UniProtKB:P38398#VAR_070506	0.684452	0.81845	0	RCV000195366|RCV000031229|RCV000048857|RCV000131291|RCV000585878	.	0	.	c.5207T>C	.	0	0	0.92720	A/A	rs45553935	43057122	.	A	.	.	.	0.74826	.	0.68239		.	.	0.000000e+00	3.265	0	1	.	5.07	0.46804	108	D	T	.	.	0	24	.	.	.	140162|145|145	37648	0.92630	0.13518	0.982382714748383	2740	.	0.71675	0.64551	.	.	1179920	5.554	.	.	.	.	.	0	617883|604370	0.67074	17	.	ENSG00000012048	0.000000e+00	4.080633314290378E-5	.	0	.	2	0.92348	0.74567	.	.	.	0.000000e+00	0.688539164513861	.	0.000000e+00	0.753957	46204	HGNC:1100	.	.	.	0.81	.	43057122	GTC	1.000000	.	-	0	0.91075	1.017020e-05	0	0	Pathogenic	0.64259	.	0	0	ClinGen:CA003357,UniProtKB:P38398#VAR_070506,OMIM:113705.0038	V	.	.	-	.	-	0.89680	.	4632	0.79043	0.580183625221	.	0	0.99880114867489878	94	-	5207T>C 	.	0	C3661900|C4554406|C0027672|C2676676|C0677776	.	.	.	.	NM_007294.4	-	.	.	1	0.83839	45553935	.	3.0113225728740063E-5	0.89179	0.81406	.	.	2656	0.99978083	5.07	.	.	.	0.418246	0.989452318288449	0.89891	D	84	.	.	0.8523	0.94704	p.Val1736Ala	0	0	-8.463	.	0	0.88181	37648	D	.	BRCA1	.	D	.	.	.	.	.	0.86774	A/A	principal2	47114	BRCA1_Adamovich_2022_HDR_var5176	No	[-0.562,-0.233]					Homology Directed Repair		Fluorescence	Not specified		V		5207	BRCA1_Adamovich_2022_HDR		ENST00000357654.9		Abnormal					immortalized human cells					p.Val1736Ala		true	c.5207T>C				Functional		1100.0	43057122.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-0.931080134;0.251635;-0.708107784;-0.152076352			Val1736Ala		LOF		(-0.233, Inf)		A	Jun 25, 2019		(-Inf, -0.562)			missense_variant		1736.0			8.0546027717e-6	-0.3849073175	Normal	Pathogenic	43057122.0	missense_variant		0.827		Intermediate			Reporter			BRCA1_Val1736Ala
BRCA1_Val632Ala	2.1490587662768768	0.06870905490576534	3.81823247434967	0.006557305473716378	2025_01_Batch_13-14	0.8813107186301908	0.8772968783547237	0.8683821066344395	0.905743118181431	0.7797971771542498	0.9800312051341327	0.9247600758234454	0.9297751709075213	0.9743619796830157	0.9522056147366262	0.9306709618821618	0.9010284770890846	0.8990786387709804	0.9400525489322233	0.866001395945438	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011853		NC_000017.11:43057122:A:G		Val632Ala																												BRCA1_Val632Ala	17	43057122	A	G	17	allele	1895T>C	E09	527_CAVA_Array_P01	I17	B13A7A8P1_R1	B14A7A8P1_R2				17-43057122-A-G	-	0.74972	0.802	1736	.	0	.	17	41209139	G	8.054600e-06	.	17	1_Pathogenic	NC_000017.11	12	Val1736Ala	.	26.2	.	0	.	D	0	24	.	.	.	.	.	.	0	0.94487	.	0.8418	.	0.90580	.	.	T	D	64010	.	0	0	.	.	.	0.50045	.	44870	0	.	0.66695	.	.	0.70704	1.0	.	.	.	.	.	G	single nucleotide variant	NC_000017.11:g.43057122A>G	0	.	3	0.19759434	.	0	0.64500636	0		.	.	.	.	.	500	.	0	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883	.	.	0.000000e+00	0	0.99291	B	0.40826	P	M	7.641852	13	A/A	84	0	.	1613984	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group S	.	0.95041	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43057122	.	-	10.840000	.	0.89500	29600	0	1179920	.	germline;not applicable;unknown	91084	.	.	GRCh38	518	reviewed by expert panel	.	.	0.68064	1	.	.	BRCT domain	.	.	.	0	0.000000e+00	NM_007294.4(BRCA1):c.5207T>C (p.Val1736Ala)	3	.	BRCA1_HUMAN	.	.	0.735250864207851	.	.	0.87654	0.56882757	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99714	.	0	.	.	59990	.	0	0.83929	.	germline	.		A	Jun 25, 2019	.	A/A	.	.	1.0	N	17q21.31	24506	.	.	SCV001161713	Pathogenic	.	.	Ala	A	-	912	ENSP00000518978	ENST00000713676	.	.	.	.	0.748	A	.	4.681403	0.92967	D	.	-	7.543151	.	0.98037	628	.	.	0.74278	0	43057122	Y	10	0	.	0.000000e+00	P38398	.	0.137814	0.95656		.	0.38	D	.	0.18117532	.	0.97202	672	0.456703	12	.	.	1.017020e-05	0.91343	.	.	75034	.	6056	.	0.43395	17	BRCA1	0.000000e+00	0	Val	33208	.	17-43057122-A-G	not_provided|Fanconi_anemia,_complementation_group_S|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	0	.	38462665	ClinGen:CA003357|OMIM:113705.0038|UniProtKB:P38398#VAR_070506	0.684452	0.81845	0	RCV000195366|RCV000031229|RCV000048857|RCV000131291|RCV000585878	.	0	.	c.5207T>C	.	0	0	0.92720	A/A	rs45553935	43057122	.	A	.	.	.	0.74826	.	0.68239		.	.	0.000000e+00	3.265	0	1	.	5.07	0.46804	108	D	T	.	.	0	24	.	.	.	140162|145|145	37648	0.92630	0.13518	0.982382714748383	2740	.	0.71675	0.64551	.	.	1179920	5.554	.	.	.	.	.	0	617883|604370	0.67074	17	.	ENSG00000012048	0.000000e+00	4.080633314290378E-5	.	0	.	2	0.92348	0.74567	.	.	.	0.000000e+00	0.688539164513861	.	0.000000e+00	0.753957	46204	HGNC:1100	.	.	.	0.81	.	43057122	GTC	1.000000	.	-	0	0.91075	1.017020e-05	0	0	Pathogenic	0.64259	.	0	0	ClinGen:CA003357,UniProtKB:P38398#VAR_070506,OMIM:113705.0038	V	.	.	-	.	-	0.89680	.	4632	0.79043	0.580183625221	.	0	0.99880114867489878	94	-	5207T>C 	.	0	C3661900|C4554406|C0027672|C2676676|C0677776	.	.	.	.	NM_007294.4	-	.	.	1	0.83839	45553935	.	3.0113225728740063E-5	0.89179	0.81406	.	.	2656	0.99978083	5.07	.	.	.	0.418246	0.989452318288449	0.89891	D	84	.	.	0.8523	0.94704	p.Val1736Ala	0	0	-8.463	.	0	0.88181	37648	D	.	BRCA1	.	D	.	.	.	.	.	0.86774	A/A	principal2	38923	BRCA1_Adamovich_2022_Cisplatin_var6590	No	[-0.729,-0.503]					Cisplatin resistance		Drug Resistance	Not specified		V		5207	BRCA1_Adamovich_2022_Cisplatin		ENST00000357654.9		Abnormal					immortalized human cells					p.Val1736Ala		true	c.5207T>C				Functional		1100.0	43057122.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-0.503452878;-0.197632461;-0.259319621;-1.249912663			Val1736Ala		LOF		(-0.503, Inf)		A	Jun 25, 2019		(-Inf, -0.729)			missense_variant		1736.0			8.0546027717e-6	-0.55257940575	Normal	Pathogenic	43057122.0	missense_variant		0.827		Intermediate			Cell Viability			BRCA1_Val1736Ala
BRCA1_Thr616Ala	-6.233928517816243	0.0004308100442908221	-7.543974029456267	0.00013232858766953467																											BRCA1	BRCA1		14613		CCSBVarC013127		NC_000017.11:43063368:T:C		Thr616Ala																												BRCA1_Thr616Ala	17	43063368	T	C	17	allele	1846A>G	A12	527_CAVA_Array_P01	A23	B13A7A8P1_R1	B14A7A8P1_R2				17-43063368-T-C	-	0.39651	0.021	1720	7	0	0	17	41215385	C	1.259500e-04	17	17	2_Benign	NC_000017.11	51	Thr1720Ala	0	21.0	0	0	9.053210e-04	D	0	22	1	42744	1.818240e-04	0	30514	0.000000e+00	0	0.74592	Select	0.5083	34242	0.53291	31	0.0	T	T	63804	.	0	0	0.000000e+00	0	0	0.26642	17104	44876	0	0.000000e+00	0.52959	2	.	0.65926	0.998	0.0	77.0	.	5.1	0.23	C	single nucleotide variant	NC_000017.11:g.43063368T>C	0	16516	2	0.13745041	109126	0	0.2736807	0		39	236492	0	0	0.000000e+00	796	4.679020e-05	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|	20	0	0.000000e+00	0	0.50204	B	0.29029	B	M	2.092868	203	T/T	350	1	7160	1611752	Breast-ovarian cancer, familial, susceptibility to, 1|not specified|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|not provided|Malignant tumor of breast|BRCA1-related disorder	16208	0.68463	1	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063368	9.939200e-04	-	2.751000	1	0.66488	29600	0	60008	0	germline;not applicable;unknown	91026	.	.	GRCh38	549	reviewed by expert panel	c.5158A>G	0.000000e+00	0.35328	13	0	0	BRCT domain|BRCT domain|BRCT domain	0.000000e+00	9032	B	0	0.000000e+00	NM_007294.4(BRCA1):c.5158A>G (p.Thr1720Ala)	3	0	BRCA1_HUMAN	0	23.0	-0.126275122101043	28	.	0.49112	0.48555672	-	1.396650e-04	0		28	0.000000e+00	0	34242	reviewed_by_expert_panel	0.99003	1.832740e-04	0	0.000000e+00	0	60008	p.Thr1720Ala	0	0.34617	.	germline	17		T	Aug 10, 2015	0	T/T	0	89490	0.102	N	17q21.31	165778	.	6.169790e-05	SCV000244390	Benign	0	0	Ala	A	-	912	ENSP00000350283	ENST00000357654	17668	0.01	13392	0	0.609	T	0	2.969506	0.43880	N	T	-	2.161836	.	0.91275	968	0	0.0	0.02162	0	43063368	Y	10	0	102598	0.000000e+00	P38398	0	0.14986	0.31711		0	0.066	D	30508	0.12058569	17104	0.85369	672	-0.108625	143	-0.84	0.0	8.498870e-04	0.56615	0.000000e+00	0	74974	0.000000e+00	6056	1	0.32761	17	BRCA1	1.333800e-05	0	Thr	192996	7.822100e-05	17-43063368-T-C	not_provided|not_specified|Malignant_tumor_of_breast|BRCA1-related_disorder|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	0	8	38468911	BRCA1-HCI:BRCA1_00093|ClinGen:CA003312|UniProtKB:P38398#VAR_070504	0.110795	0.35976	0	RCV000077605|RCV000175327|RCV000162823|RCV000203648|RCV003149710|RCV003736568|RCV001353742|RCV004554687	T	0	0	c.5158A>G	0	0	0	0.34639	T/T	rs56195342	43063368	14894	T	1.9968051118210862E-4	.	15684	0.50103	0.000000e+00	0.68239		0	0	0.000000e+00	2.125	0	12	264690	3.16	0.48633	3338	T	T	1	9.177920e-04	0	652	.	0	0	145|140162|145	55438	0.70099	0.22090	0.0311792727904229	9122	1	0.22913	0.21747	9.053210e-04	9.177920e-04	1178052	0.492	1.877080e-04	N	13176	0	1.6245419E-4	0	604370	0.22223	17	6.714110e-05	ENSG00000012048	0.000000e+00	7.238596194911267E-5	0	0	.	1	0.48451	0.72286	30596	43	7.797420e-05	8.498870e-04	-0.0610072656409511	YES	0.000000e+00	0.314787	70105	HGNC:1100	N	0	simple_aae	0.426	207770	43063368	ACC	1.000000	0	-	0	0.08686	1.213870e-04	0	0	Benign	0.73014	0	0	51	BRCA1-HCI:BRCA1_00093,ClinGen:CA003312,UniProtKB:P38398#VAR_070504	T	0	0.789056459329	-	.	-	0.60461	43	12714	0.26244	0.411568820477	0.1171	0	0.96895934447641918	280	-	5158A>G 	31	7.865345288658172E-5	C3661900|CN169374|C0006142|C0677776|CN221562|C0027672|C2676676	0	0	0	0	NM_007294.4	-	0	0.001440922190201729	0	0.71327	56195342	2320	6.73589089929325E-5	0.78542	0.36715	0.567	0.095	8772	0.99886380	5.46	.	.	0.000000e+00	-0.000295152	0.698941713513221	0.58867	T	2686	6210	9568	-0.5013	0.81431	p.Thr1720Ala	0	0	-9.542	0.065047204	1	0.66991	55438	D	30508	BRCA1	9.939200e-04	D	0.445	21410	.	D	0.90952	0.47831	T/T	principal2																																																																																																				
F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	0.7809611787373809	0.650771112292108	0.6642850168139603	0.7778573689367987	0.7013014941919294	0.7672337164122793	0.7551715266446457	0.7114424851077479	0.8145010085051057	0.6403010837499816	0.7740974475748301	0.7029713194683769	0.6878637509608541	0.7961791887209522	0.6708012889709556	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T		His282Tyr																												F9_His282Tyr	23	139561529	C	T	X	allele	844C>T	H09	527_CAVA_Array_P02	O18	B13A7A8P1_R1	B14A7A8P1_R2				X-139561529-C-T	-	0.0912	0.015	282	0	0	0	X	138643688	T	1.082490e-05	0	X	2_Benign	NC_000023.11	11	His282Tyr	0	5.876	0	0	1.783060e-04	D	0	1	1	30415	2.414740e-05	.	16825	0.000000e+00	0	0.70688	Select	0.5140	16825	0.17100	0	.	D	T	46466	0.807526858809	0	0	0.000000e+00	0	0	0.22139	13111	33709	11	0.000000e+00	0.55206	0	.	0.64101	0.615	.	97.0	0.768423	1.6	0.03	T	single nucleotide variant	NC_000023.11:g.139561529C>T	0	12043	2	0.36480957	77986	0	0.4559485	0		4	165649	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	2	0	0.000000e+00	0	0.10877	B	0.61600	B	N	.	13	C/C	84	0	5683	1200931	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	13056	0.64851	.	.	-	139561529	1.116690e-04	-	0.134000	0	0.81949	21785	0	55470	0	germline	55470	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.90415	GRCh38	924	criteria provided, single submitter	c.844C>T	1.783060e-04	0.24773	0	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	0.000000e+00	6903	B	0	0.000000e+00	NM_000133.4(F9):c.844C>T (p.His282Tyr)	1	0	FA9_HUMAN	0	3.0	.	0	T	0.06927	0.4559485	+	0.000000e+00	.		3	0.000000e+00	0	26076	criteria_provided,_single_submitter	0.99778	2.564560e-05	0	0.000000e+00	0	45208	p.His282Tyr	0	0.15149	.	germline	1		C	Feb 14, 2024	3	C/C	0	62696	0.051	N	Xq27.1	6962	.	0.000000e+00	SCV001684474	Likely_benign	0	0	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13127	0.68	10097	0	0.549	C	0	0.540746	0.16506	.	T	-	.	.	0.65667	610	0	.	0.14014	0	139561529	Y	10	0	71276	0.000000e+00	P00740	0	0.829846	0.04879		0	0.058	D	16890	0.36480957	8955	0.31811	2158	-0.23264	0	-2.55	.	1.983050e-04	0.06480	1.116690e-04	0	56966	0.000000e+00	4344	0	0.61600	X	F9	0.000000e+00	0	His	10680	0.000000e+00	X-139561529-C-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	0	0	138471354	.	.	.	0	RCV001480159	T	0	0	c.844C>T	0	0	0	0.16016	C/C	rs763399530	139561529	11986	C	.	P00740	8955	0.64101	0.000000e+00	0.24915		0	0	0.000000e+00	0.8	0	0	.	1.91	0.95894	108	T	T	0	0.000000e+00	0	24	.	0	0	98879	1142361	0.44102	0.66347	0.117615622490317	2294	.	0.21521	.	0.000000e+00	1.776200e-04	889011	0.11	2.740330e-05	D	9844	0	.	0	300807|306900	0.1532	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	3	0	0.9940287968305028	1	0.26454	0.18019	16890	.	0.000000e+00	0.000000e+00	.	YES	1.983050e-04	0.054279	1150446	HGNC:3551	N	0	simple_aae	0.675	145968	139561529	CAT	0.427000	.	-	0	0.34189	0.000000e+00	0	0	Likely benign	0.15190	1	0	0	ClinGen:CA10529850	H	0	0.96162791622	-	0.78	-	0.14965	4	466	0.99398	0.379336297512	0.0731	0	0.52811199848246315	94	-	844C>T 	3	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	.	.	0	0.39558	763399530	1665	0	0.96087	.	0.148	0.512	2210	0.99983406	5.42	.	.	1.776200e-04	-0.302648	0.48480680668397	0.19557	T	84	4328	6612	-0.5954	0.81707	p.His282Tyr	0	0	-3.409	0.18958774	0	0.60322	1142361	T	23376	F9	0.000000e+00	T	0.393	15766	H282Y	T	0.35226	0.27038	C/C	principal1	167769	F9_Popp_2025_carboxy_gla_motif_var255636	No											H		844	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.His282Tyr		true	c.844C>T						3551.0	139561529.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				His282Tyr						Y	Jan 11, 2024					missense_variant		282.0			0.0000108249349879	1.070452298486182		Likely benign	139561529.0	missense_variant		0.393					Reporter			F9_His282Tyr
F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	0.7809611787373809	0.650771112292108	0.6642850168139603	0.7778573689367987	0.7013014941919294	0.7672337164122793	0.7551715266446457	0.7114424851077479	0.8145010085051057	0.6403010837499816	0.7740974475748301	0.7029713194683769	0.6878637509608541	0.7961791887209522	0.6708012889709556	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T		His282Tyr																												F9_His282Tyr	23	139561529	C	T	X	allele	844C>T	H09	527_CAVA_Array_P02	O18	B13A7A8P1_R1	B14A7A8P1_R2				X-139561529-C-T	-	0.0912	0.015	282	0	0	0	X	138643688	T	1.082490e-05	0	X	2_Benign	NC_000023.11	11	His282Tyr	0	5.876	0	0	1.783060e-04	D	0	1	1	30415	2.414740e-05	.	16825	0.000000e+00	0	0.70688	Select	0.5140	16825	0.17100	0	.	D	T	46466	0.807526858809	0	0	0.000000e+00	0	0	0.22139	13111	33709	11	0.000000e+00	0.55206	0	.	0.64101	0.615	.	97.0	0.768423	1.6	0.03	T	single nucleotide variant	NC_000023.11:g.139561529C>T	0	12043	2	0.36480957	77986	0	0.4559485	0		4	165649	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	2	0	0.000000e+00	0	0.10877	B	0.61600	B	N	.	13	C/C	84	0	5683	1200931	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	13056	0.64851	.	.	-	139561529	1.116690e-04	-	0.134000	0	0.81949	21785	0	55470	0	germline	55470	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.90415	GRCh38	924	criteria provided, single submitter	c.844C>T	1.783060e-04	0.24773	0	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	0.000000e+00	6903	B	0	0.000000e+00	NM_000133.4(F9):c.844C>T (p.His282Tyr)	1	0	FA9_HUMAN	0	3.0	.	0	T	0.06927	0.4559485	+	0.000000e+00	.		3	0.000000e+00	0	26076	criteria_provided,_single_submitter	0.99778	2.564560e-05	0	0.000000e+00	0	45208	p.His282Tyr	0	0.15149	.	germline	1		C	Feb 14, 2024	3	C/C	0	62696	0.051	N	Xq27.1	6962	.	0.000000e+00	SCV001684474	Likely_benign	0	0	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13127	0.68	10097	0	0.549	C	0	0.540746	0.16506	.	T	-	.	.	0.65667	610	0	.	0.14014	0	139561529	Y	10	0	71276	0.000000e+00	P00740	0	0.829846	0.04879		0	0.058	D	16890	0.36480957	8955	0.31811	2158	-0.23264	0	-2.55	.	1.983050e-04	0.06480	1.116690e-04	0	56966	0.000000e+00	4344	0	0.61600	X	F9	0.000000e+00	0	His	10680	0.000000e+00	X-139561529-C-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	0	0	138471354	.	.	.	0	RCV001480159	T	0	0	c.844C>T	0	0	0	0.16016	C/C	rs763399530	139561529	11986	C	.	P00740	8955	0.64101	0.000000e+00	0.24915		0	0	0.000000e+00	0.8	0	0	.	1.91	0.95894	108	T	T	0	0.000000e+00	0	24	.	0	0	98879	1142361	0.44102	0.66347	0.117615622490317	2294	.	0.21521	.	0.000000e+00	1.776200e-04	889011	0.11	2.740330e-05	D	9844	0	.	0	300807|306900	0.1532	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	3	0	0.9940287968305028	1	0.26454	0.18019	16890	.	0.000000e+00	0.000000e+00	.	YES	1.983050e-04	0.054279	1150446	HGNC:3551	N	0	simple_aae	0.675	145968	139561529	CAT	0.427000	.	-	0	0.34189	0.000000e+00	0	0	Likely benign	0.15190	1	0	0	ClinGen:CA10529850	H	0	0.96162791622	-	0.78	-	0.14965	4	466	0.99398	0.379336297512	0.0731	0	0.52811199848246315	94	-	844C>T 	3	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	.	.	0	0.39558	763399530	1665	0	0.96087	.	0.148	0.512	2210	0.99983406	5.42	.	.	1.776200e-04	-0.302648	0.48480680668397	0.19557	T	84	4328	6612	-0.5954	0.81707	p.His282Tyr	0	0	-3.409	0.18958774	0	0.60322	1142361	T	23376	F9	0.000000e+00	T	0.393	15766	H282Y	T	0.35226	0.27038	C/C	principal1	195285	F9_Popp_2025_heavy_chain_var236274	No											H		844	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.His282Tyr		true	c.844C>T						3551.0	139561529.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				His282Tyr						Y	Jan 11, 2024					missense_variant		282.0			0.0000108249349879	1.0267283664931162		Likely benign	139561529.0	missense_variant		0.393					Reporter			F9_His282Tyr
F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	0.7809611787373809	0.650771112292108	0.6642850168139603	0.7778573689367987	0.7013014941919294	0.7672337164122793	0.7551715266446457	0.7114424851077479	0.8145010085051057	0.6403010837499816	0.7740974475748301	0.7029713194683769	0.6878637509608541	0.7961791887209522	0.6708012889709556	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T		His282Tyr																												F9_His282Tyr	23	139561529	C	T	X	allele	844C>T	H09	527_CAVA_Array_P02	O18	B13A7A8P1_R1	B14A7A8P1_R2				X-139561529-C-T	-	0.0912	0.015	282	0	0	0	X	138643688	T	1.082490e-05	0	X	2_Benign	NC_000023.11	11	His282Tyr	0	5.876	0	0	1.783060e-04	D	0	1	1	30415	2.414740e-05	.	16825	0.000000e+00	0	0.70688	Select	0.5140	16825	0.17100	0	.	D	T	46466	0.807526858809	0	0	0.000000e+00	0	0	0.22139	13111	33709	11	0.000000e+00	0.55206	0	.	0.64101	0.615	.	97.0	0.768423	1.6	0.03	T	single nucleotide variant	NC_000023.11:g.139561529C>T	0	12043	2	0.36480957	77986	0	0.4559485	0		4	165649	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	2	0	0.000000e+00	0	0.10877	B	0.61600	B	N	.	13	C/C	84	0	5683	1200931	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	13056	0.64851	.	.	-	139561529	1.116690e-04	-	0.134000	0	0.81949	21785	0	55470	0	germline	55470	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.90415	GRCh38	924	criteria provided, single submitter	c.844C>T	1.783060e-04	0.24773	0	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	0.000000e+00	6903	B	0	0.000000e+00	NM_000133.4(F9):c.844C>T (p.His282Tyr)	1	0	FA9_HUMAN	0	3.0	.	0	T	0.06927	0.4559485	+	0.000000e+00	.		3	0.000000e+00	0	26076	criteria_provided,_single_submitter	0.99778	2.564560e-05	0	0.000000e+00	0	45208	p.His282Tyr	0	0.15149	.	germline	1		C	Feb 14, 2024	3	C/C	0	62696	0.051	N	Xq27.1	6962	.	0.000000e+00	SCV001684474	Likely_benign	0	0	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13127	0.68	10097	0	0.549	C	0	0.540746	0.16506	.	T	-	.	.	0.65667	610	0	.	0.14014	0	139561529	Y	10	0	71276	0.000000e+00	P00740	0	0.829846	0.04879		0	0.058	D	16890	0.36480957	8955	0.31811	2158	-0.23264	0	-2.55	.	1.983050e-04	0.06480	1.116690e-04	0	56966	0.000000e+00	4344	0	0.61600	X	F9	0.000000e+00	0	His	10680	0.000000e+00	X-139561529-C-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	0	0	138471354	.	.	.	0	RCV001480159	T	0	0	c.844C>T	0	0	0	0.16016	C/C	rs763399530	139561529	11986	C	.	P00740	8955	0.64101	0.000000e+00	0.24915		0	0	0.000000e+00	0.8	0	0	.	1.91	0.95894	108	T	T	0	0.000000e+00	0	24	.	0	0	98879	1142361	0.44102	0.66347	0.117615622490317	2294	.	0.21521	.	0.000000e+00	1.776200e-04	889011	0.11	2.740330e-05	D	9844	0	.	0	300807|306900	0.1532	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	3	0	0.9940287968305028	1	0.26454	0.18019	16890	.	0.000000e+00	0.000000e+00	.	YES	1.983050e-04	0.054279	1150446	HGNC:3551	N	0	simple_aae	0.675	145968	139561529	CAT	0.427000	.	-	0	0.34189	0.000000e+00	0	0	Likely benign	0.15190	1	0	0	ClinGen:CA10529850	H	0	0.96162791622	-	0.78	-	0.14965	4	466	0.99398	0.379336297512	0.0731	0	0.52811199848246315	94	-	844C>T 	3	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	.	.	0	0.39558	763399530	1665	0	0.96087	.	0.148	0.512	2210	0.99983406	5.42	.	.	1.776200e-04	-0.302648	0.48480680668397	0.19557	T	84	4328	6612	-0.5954	0.81707	p.His282Tyr	0	0	-3.409	0.18958774	0	0.60322	1142361	T	23376	F9	0.000000e+00	T	0.393	15766	H282Y	T	0.35226	0.27038	C/C	principal1	222801	F9_Popp_2025_light_chain_var245955	No											H		844	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.His282Tyr		true	c.844C>T						3551.0	139561529.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				His282Tyr						Y	Jan 11, 2024					missense_variant		282.0			0.0000108249349879	1.0602912554291422		Likely benign	139561529.0	missense_variant		0.393					Reporter			F9_His282Tyr
F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	0.7809611787373809	0.650771112292108	0.6642850168139603	0.7778573689367987	0.7013014941919294	0.7672337164122793	0.7551715266446457	0.7114424851077479	0.8145010085051057	0.6403010837499816	0.7740974475748301	0.7029713194683769	0.6878637509608541	0.7961791887209522	0.6708012889709556	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T		His282Tyr																												F9_His282Tyr	23	139561529	C	T	X	allele	844C>T	H09	527_CAVA_Array_P02	O18	B13A7A8P1_R1	B14A7A8P1_R2				X-139561529-C-T	-	0.0912	0.015	282	0	0	0	X	138643688	T	1.082490e-05	0	X	2_Benign	NC_000023.11	11	His282Tyr	0	5.876	0	0	1.783060e-04	D	0	1	1	30415	2.414740e-05	.	16825	0.000000e+00	0	0.70688	Select	0.5140	16825	0.17100	0	.	D	T	46466	0.807526858809	0	0	0.000000e+00	0	0	0.22139	13111	33709	11	0.000000e+00	0.55206	0	.	0.64101	0.615	.	97.0	0.768423	1.6	0.03	T	single nucleotide variant	NC_000023.11:g.139561529C>T	0	12043	2	0.36480957	77986	0	0.4559485	0		4	165649	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	2	0	0.000000e+00	0	0.10877	B	0.61600	B	N	.	13	C/C	84	0	5683	1200931	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	13056	0.64851	.	.	-	139561529	1.116690e-04	-	0.134000	0	0.81949	21785	0	55470	0	germline	55470	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.90415	GRCh38	924	criteria provided, single submitter	c.844C>T	1.783060e-04	0.24773	0	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	0.000000e+00	6903	B	0	0.000000e+00	NM_000133.4(F9):c.844C>T (p.His282Tyr)	1	0	FA9_HUMAN	0	3.0	.	0	T	0.06927	0.4559485	+	0.000000e+00	.		3	0.000000e+00	0	26076	criteria_provided,_single_submitter	0.99778	2.564560e-05	0	0.000000e+00	0	45208	p.His282Tyr	0	0.15149	.	germline	1		C	Feb 14, 2024	3	C/C	0	62696	0.051	N	Xq27.1	6962	.	0.000000e+00	SCV001684474	Likely_benign	0	0	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13127	0.68	10097	0	0.549	C	0	0.540746	0.16506	.	T	-	.	.	0.65667	610	0	.	0.14014	0	139561529	Y	10	0	71276	0.000000e+00	P00740	0	0.829846	0.04879		0	0.058	D	16890	0.36480957	8955	0.31811	2158	-0.23264	0	-2.55	.	1.983050e-04	0.06480	1.116690e-04	0	56966	0.000000e+00	4344	0	0.61600	X	F9	0.000000e+00	0	His	10680	0.000000e+00	X-139561529-C-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	0	0	138471354	.	.	.	0	RCV001480159	T	0	0	c.844C>T	0	0	0	0.16016	C/C	rs763399530	139561529	11986	C	.	P00740	8955	0.64101	0.000000e+00	0.24915		0	0	0.000000e+00	0.8	0	0	.	1.91	0.95894	108	T	T	0	0.000000e+00	0	24	.	0	0	98879	1142361	0.44102	0.66347	0.117615622490317	2294	.	0.21521	.	0.000000e+00	1.776200e-04	889011	0.11	2.740330e-05	D	9844	0	.	0	300807|306900	0.1532	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	3	0	0.9940287968305028	1	0.26454	0.18019	16890	.	0.000000e+00	0.000000e+00	.	YES	1.983050e-04	0.054279	1150446	HGNC:3551	N	0	simple_aae	0.675	145968	139561529	CAT	0.427000	.	-	0	0.34189	0.000000e+00	0	0	Likely benign	0.15190	1	0	0	ClinGen:CA10529850	H	0	0.96162791622	-	0.78	-	0.14965	4	466	0.99398	0.379336297512	0.0731	0	0.52811199848246315	94	-	844C>T 	3	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	.	.	0	0.39558	763399530	1665	0	0.96087	.	0.148	0.512	2210	0.99983406	5.42	.	.	1.776200e-04	-0.302648	0.48480680668397	0.19557	T	84	4328	6612	-0.5954	0.81707	p.His282Tyr	0	0	-3.409	0.18958774	0	0.60322	1142361	T	23376	F9	0.000000e+00	T	0.393	15766	H282Y	T	0.35226	0.27038	C/C	principal1	250317	F9_Popp_2025_strep_2_var265317	No											H		844	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.His282Tyr		true	c.844C>T						3551.0	139561529.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				His282Tyr						Y	Jan 11, 2024					missense_variant		282.0			0.0000108249349879	0.9838825621857352		Likely benign	139561529.0	missense_variant		0.393					Reporter			F9_His282Tyr
F9_His282Tyr	-1.3745699158063474	0.21165219075946431	-0.0665369108871065	0.9488108779187232	2025_01_Batch_13-14	0.7809611787373809	0.650771112292108	0.6642850168139603	0.7778573689367987	0.7013014941919294	0.7672337164122793	0.7551715266446457	0.7114424851077479	0.8145010085051057	0.6403010837499816	0.7740974475748301	0.7029713194683769	0.6878637509608541	0.7961791887209522	0.6708012889709556	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030577		NC_000023.11:139561529:C:T		His282Tyr																												F9_His282Tyr	23	139561529	C	T	X	allele	844C>T	H09	527_CAVA_Array_P02	O18	B13A7A8P1_R1	B14A7A8P1_R2				X-139561529-C-T	-	0.0912	0.015	282	0	0	0	X	138643688	T	1.082490e-05	0	X	2_Benign	NC_000023.11	11	His282Tyr	0	5.876	0	0	1.783060e-04	D	0	1	1	30415	2.414740e-05	.	16825	0.000000e+00	0	0.70688	Select	0.5140	16825	0.17100	0	.	D	T	46466	0.807526858809	0	0	0.000000e+00	0	0	0.22139	13111	33709	11	0.000000e+00	0.55206	0	.	0.64101	0.615	.	97.0	0.768423	1.6	0.03	T	single nucleotide variant	NC_000023.11:g.139561529C>T	0	12043	2	0.36480957	77986	0	0.4559485	0		4	165649	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	2	0	0.000000e+00	0	0.10877	B	0.61600	B	N	.	13	C/C	84	0	5683	1200931	Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect	13056	0.64851	.	.	-	139561529	1.116690e-04	-	0.134000	0	0.81949	21785	0	55470	0	germline	55470	Loss of disorder (P = 0.0439)| Gain of phosphorylation at H282 (P = 0.0704)| Loss of catalytic residue at N283 (P = 0.111)| Gain of sheet (P = 0.1208)| Gain of loop (P = 0.2045)	0.90415	GRCh38	924	criteria provided, single submitter	c.844C>T	1.783060e-04	0.24773	0	0	0	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	0.000000e+00	6903	B	0	0.000000e+00	NM_000133.4(F9):c.844C>T (p.His282Tyr)	1	0	FA9_HUMAN	0	3.0	.	0	T	0.06927	0.4559485	+	0.000000e+00	.		3	0.000000e+00	0	26076	criteria_provided,_single_submitter	0.99778	2.564560e-05	0	0.000000e+00	0	45208	p.His282Tyr	0	0.15149	.	germline	1		C	Feb 14, 2024	3	C/C	0	62696	0.051	N	Xq27.1	6962	.	0.000000e+00	SCV001684474	Likely_benign	0	0	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13127	0.68	10097	0	0.549	C	0	0.540746	0.16506	.	T	-	.	.	0.65667	610	0	.	0.14014	0	139561529	Y	10	0	71276	0.000000e+00	P00740	0	0.829846	0.04879		0	0.058	D	16890	0.36480957	8955	0.31811	2158	-0.23264	0	-2.55	.	1.983050e-04	0.06480	1.116690e-04	0	56966	0.000000e+00	4344	0	0.61600	X	F9	0.000000e+00	0	His	10680	0.000000e+00	X-139561529-C-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	0	0	138471354	.	.	.	0	RCV001480159	T	0	0	c.844C>T	0	0	0	0.16016	C/C	rs763399530	139561529	11986	C	.	P00740	8955	0.64101	0.000000e+00	0.24915		0	0	0.000000e+00	0.8	0	0	.	1.91	0.95894	108	T	T	0	0.000000e+00	0	24	.	0	0	98879	1142361	0.44102	0.66347	0.117615622490317	2294	.	0.21521	.	0.000000e+00	1.776200e-04	889011	0.11	2.740330e-05	D	9844	0	.	0	300807|306900	0.1532	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	3	0	0.9940287968305028	1	0.26454	0.18019	16890	.	0.000000e+00	0.000000e+00	.	YES	1.983050e-04	0.054279	1150446	HGNC:3551	N	0	simple_aae	0.675	145968	139561529	CAT	0.427000	.	-	0	0.34189	0.000000e+00	0	0	Likely benign	0.15190	1	0	0	ClinGen:CA10529850	H	0	0.96162791622	-	0.78	-	0.14965	4	466	0.99398	0.379336297512	0.0731	0	0.52811199848246315	94	-	844C>T 	3	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	.	.	0	0.39558	763399530	1665	0	0.96087	.	0.148	0.512	2210	0.99983406	5.42	.	.	1.776200e-04	-0.302648	0.48480680668397	0.19557	T	84	4328	6612	-0.5954	0.81707	p.His282Tyr	0	0	-3.409	0.18958774	0	0.60322	1142361	T	23376	F9	0.000000e+00	T	0.393	15766	H282Y	T	0.35226	0.27038	C/C	principal1	140253	F9_Popp_2025_carboxy_F9_specific_var226593	No											H		844	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.His282Tyr		true	c.844C>T						3551.0	139561529.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				His282Tyr						Y	Jan 11, 2024					missense_variant		282.0			0.0000108249349879	1.0374047023638455		Likely benign	139561529.0	missense_variant		0.393					Reporter			F9_His282Tyr
BRCA1_Phe558Ser	1.6111167737238428	0.15118946477997378	4.615270970171342	0.0024397297238219016	2025_01_Batch_13-14	0.9498482441279533	0.9308024365566823	0.9137788511755762	0.9572502165200717	0.8165718573701302	0.9856023871263442	0.9300413434020081	0.9248850903557055	0.9816134932174742	0.9586068154103601	0.9677253156271488	0.9304218899793452	0.9193319707656409	0.9694318548687729	0.8875893363902452	1.0	0.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC013021		NC_000017.11:43070929:A:G		Phe558Ser																												BRCA1_Phe558Ser	17	43070929	A	G	17	allele	1673T>C	E10	527_CAVA_Array_P01	I19	B13A7A8P1_R1	B14A7A8P1_R2				17-43070929-A-G	-	0.20196	0.327	1662	0	0	0	17	41222946	G	1.301100e-05	0	17	2_Benign	NC_000017.11	17	Phe1662Ser	2	14.62	1	0	1.130580e-04	T	0	10	1	42768	1.274000e-05	.	30526	0.000000e+00	0	0.79537	Select	0.2316	17690	0.33186	1	.	T	T	63964	.	0	0	0.000000e+00	0	0	0.14450	17112	44902	0	1.490980e-04	0.54888	0	.	0.35072	0.808	.	74.0	.	-3.96	0.26	G	single nucleotide variant	NC_000017.11:g.43070929A>G	0	16690	2	0.06600715	109362	0	0.15882574	0		2	235478	0	0	1.130580e-04	648	0.000000e+00	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	1	0	0.000000e+00	0	0.51279	B	0.09445	B	N	0.2298717	21	A/A	238	0	7164	1614022	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	16214	0.54115	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43070929	1.105710e-04	-	1.542000	0	0.31465	29608	0	44902	2	germline;not applicable;unknown	91090	.	.	GRCh38	544	reviewed by expert panel	c.4985T>C	0.000000e+00	0.07934	0	0	0	BRCT domain|BRCT domain|BRCT domain	0.000000e+00	9044	B	0	0.000000e+00	NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser)	3	0	BRCA1_HUMAN	0	26.0	-1.19592149865023	0	.	0.48135	0.15678944	-	0.000000e+00	.		2	0.000000e+00	0	34258	reviewed_by_expert_panel	0.97952	9.143940e-06	0	0.000000e+00	0	60004	p.Phe1662Ser	0	0.27319	.	germline	1		A	Aug 10, 2015	0	A/A	0	88440	0.006	N	17q21.31	85192	.	0.000000e+00	SCV000244375	Benign	0	0	Ser	S	-	912	ENSP00000350283	ENST00000357654	17690	0.324	13414	0	-0.681	A	0	1.575156	0.15624	N	T	-	0.2786036	.	0.76440	2154	0	.	0.00137	0	43070929	Y	10	0	101348	0.000000e+00	P38398	0	0.127873	0.07307		0	0.072	D	13414	0.05462813	9044	0.38116	672	-0.0538666	2	-0.41	.	3.786020e-04	0.13470	0.000000e+00	0	74928	1.105710e-04	6084	0	0.13457	17	BRCA1	1.334610e-05	0	Phe	97594	0.000000e+00	17-43070929-A-G	Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	0	0	38476472	BRCA1-HCI:BRCA1_00091|ClinGen:CA003117	0.176669	0.05004	0	RCV000112441|RCV000130003|RCV000443012|RCV001421999|RCV001703954	T	0	0	c.4985T>C	0	17	0	0.43515	A/A	rs28897695	43070929	14902	A	.	.	15690	0.35418	0.000000e+00	0.08389		0	0	3.786020e-04	0	0	0	264690	-1.61	0.45213	594	T	T	0	0.000000e+00	0	126	.	0	0	140162|145|145	55339	0.63948	0.17918	0.0101923026540198	6234	.	0.17427	0.30175	2.919030e-05	1.490980e-04	1180042	0.047	9.663980e-06	N	13350	0	1.51120175E-5	0	604370	0.13983	17	0.000000e+00	ENSG00000012048	0.000000e+00	0	0	0	.	2	0.28044	0.72706	30608	4	0.000000e+00	1.666560e-05	-1.20530321707257	YES	0.000000e+00	0.095936	70006	HGNC:1100	N	0	simple_aae	0.115	206954	43070929	TTT	0.000000	.	-	0	0.15320	1.694850e-06	0	0	Benign	0.15503	0	0	1	BRCA1-HCI:BRCA1_00091,ClinGen:CA003117	F	0	0.346544149963	-	.	-	0.20657	3	2604	0.38144	0.32687741518	0.1159	0	0.63349936367485471	168	-	4985T>C 	2	0	C0027672|CN169374|C0677776|C3661900|C2676676	0	0	0	0	NM_007294.4	-	.	.	0	0.29269	28897695	2320	0	0.33848	0.05732	0.17	0.483	5996	0.99607220	4.82	.	.	0.000000e+00	-0.0894503	0.242492734673284	0.06502	T	468	6208	9566	-0.8141	0.59602	p.Phe1662Ser	0	0	-2.062	0.08930129	1	0.51903	55339	T	30522	BRCA1	0.000000e+00	T	0.521	21588	.	T	0.06349	0.0423	A/A	principal2	45062	BRCA1_Adamovich_2022_HDR_var4616	No	[-0.562,-0.233]					Homology Directed Repair		Fluorescence	Not specified		F		4985	BRCA1_Adamovich_2022_HDR		ENST00000357654.9		Abnormal					immortalized human cells					p.Phe1662Ser		true	c.4985T>C				Functional		1100.0	43070929.0	No		BRCA1				NM_007294.4		-1.0			aa											reviewed by expert panel	-0.267857585;-0.25651947;-0.250480607;-0.456838457			Phe1662Ser		LOF		(-0.233, Inf)		S	Aug 10, 2015		(-Inf, -0.562)			missense_variant		1662.0			0.0000130109750672	-0.3079240295	Normal	Benign	43070929.0	missense_variant,splice_region_variant		0.521		Intermediate			Reporter			BRCA1_Phe1662Ser
BAP1_Arg718Gln	-0.9458164145836372	0.37573764594446835	-3.420989205735933	0.01112045469917	2025_01_Batch_13-14	0.6172341215461941	0.6324678911973177	0.6666082700400914	0.5700899595063859	0.5552474311534583	0.5676986968568678	0.5770429480093268	0.6575517587246613	0.6233743242745674	0.5716707982217748	0.5924664092015309	0.6047554196033222	0.6620800143823764	0.5967321418904766	0.5634591146876166	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009488		NC_000003.12:52402325:C:T		Arg718Gln																												BAP1_Arg718Gln	3	52402325	C	T	3	allele	2153G>A	C02	527_CAVA_Array_P01	E03	B13A7A8P1_R1	B14A7A8P1_R2				3-52402325-C-T	-	0.80464	0.105	718	0	0	0	3	52436341	T	1.881250e-06	1	3	4_VUS	NC_000003.12	1	Arg718Gln	0	27.3	0	.	3.345150e-05	T	0	4	1	35934	4.897880e-06	.	26736	0.000000e+00	.	0.22039	Select	0.0947	29894	0.26009	1	.	T	T	61120	1.18041734594	.	0	0.000000e+00	0	0	0.94942	14932	44170	0	0.000000e+00	0.33774	0	.	0.45888	0.99	.	55.0	0.89941	2.61	0.45	T	single nucleotide variant	NC_000003.12:g.52402325C>T	0	13878	2	0.15140484	91766	.	0.23402792	.		1	204170	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013692,MedGen:C3280492,OMIM:614327,Orphanet:289539	1	0	0.000000e+00	0	0.67594	B	0.35558	B	N	2.750997	3	C/C	.	.	5246	1594688	Neurodevelopmental disorder|Hereditary cancer-predisposing syndrome|BAP1-related tumor predisposition syndrome	13106	0.18929	.	.	-	52402325	6.697030e-05	-	5.982000	0	0.72347	29090	.	56488	0	de novo;germline;unknown	87956	Gain of glycosylation at S721 (P = 0.0061)| Gain of relative solvent accessibility (P = 0.0999)| Loss of stability (P = 0.1254)| Gain of helix (P = 0.132)| Loss of ubiquitination at K714 (P = 0.1982)	0.24003	GRCh38	68	criteria provided, multiple submitters, no conflicts	c.2153G>A	0.000000e+00	0.57348	.	0	0	.	0.000000e+00	7348	P	.	0.000000e+00	NM_004656.4(BAP1):c.2153G>A (p.Arg718Gln)	2	0	BAP1_HUMAN	0	45.0	0.0651513950594368	1	D	0.95515	0.23402792	-	0.000000e+00	.		1	0.000000e+00	0	29894	criteria_provided,_multiple_submitters,_no_conflicts	0.98401	1.089730e-05	0	0.000000e+00	0	56488	p.Arg718Gln	0	0.52258	.	germline	1		C	Jul 16, 2024	0	C/C	0	75596	1.0	N	3p21.1	.	.	0.000000e+00	SCV003284341|SCV004053060|SCV004213163	Uncertain_significance	0	0	Gln	Q	-	912	ENSP00000417132	ENST00000460680	15560	0.029	12242	0	0.599	C	0	4.896201	0.63436	D	T	-	3.327653	.	0.39328	.	0	.	0.40057	.	52402325	Y	10	.	88666	0.000000e+00	Q92560	0	0.031629	0.92495		0	0.013	T	26036	0.15140484	14932	0.65338	8314	-0.0791375	2	-1.06	.	1.770290e-05	0.47069	0.000000e+00	0	74946	0.000000e+00	6016	0	0.35557	3	BAP1	0.000000e+00	.	Arg	.	0.000000e+00	3-52402325-C-T	Hereditary_cancer-predisposing_syndrome|Neurodevelopmental_disorder|BAP1-related_tumor_predisposition_syndrome	0	0	52411381	.	0.924435	0.44583	0	RCV001797190|RCV003365424|RCV002568140	D	0	0	c.2153G>A	0	0	0	0.39503	C/C	rs1440748203	52402325	12254	C	.	Q92560	13430	0.45888	0.000000e+00	0.68239		0	0	0.000000e+00	0.695	.	.	.	4.64	0.21892	.	D	D	0	3.840840e-05	.	.	.	0	0	140162|289539	1173084	0.38683	0.79892	0.692419946193695	.	.	0.71675	0.90210	3.345150e-05	3.840840e-05	1172136	7.848	5.642510e-06	N	11372	0	.	.	614327	0.85237	3	0.000000e+00	ENSG00000163930	0.000000e+00	.	0	.	0.9176963108472813	2	0.16457	0.97129	26784	.	0.000000e+00	1.770290e-05	0.22881620568532	YES	0.000000e+00	0.017745	1162261	HGNC:950	N	0	simple_aae	0.514	177226	52402325	CGG	1.000000	.	-	.	0.45144	1.706290e-06	.	0	Uncertain significance	0.24154	0	0	1	ClinGen:CA353094106	R	0	0.666395784662	-	0.284	-	0.51792	1	.	0.91693	0.887522280216	0.9167	0	0.99844496711451181	.	-	2153G>A 	1	.	C0027672|C1535926|C3280492	0	0	0	0	NM_004656.4	-	.	.	1	0.65736	1440748203	1838	.	0.66096	0.51201	0.486	0.067	.	0.99749726	5.52	.	.	0.000000e+00	-0.351452	0.894653573905079	0.17891	T	.	5376	8858	-1.0347	0.35615	p.Arg718Gln	.	0	-4.022	0.27956486	0	0.75692	1173084	T	26036	BAP1	6.697030e-05	T	0.076	17108	R718Q	D	0.47779	0.40292	C/C	principal1																																																																																																				
KRAS_Met72Leu	-2.4492678134739627	0.04415464746417742	4.235830569813894	0.0038601676600614906	2025_01_Batch_13-14	0.4657425354048401	0.6313495228635834	0.7353367754214719	0.5598039567361075	0.4527555289657161	0.9548916440252072	0.8679559118427225	0.8655475433667056	0.9265372687972608	0.8558404984612935	0.7103170897150237	0.7496527173531529	0.8004421593940887	0.7431706127666842	0.6542980137135048	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214491	CCSBVarC006100	ALE00006100	NC_000012.12:25227310:T:G	214A>C	Met72Leu	CEGS2	CegsMutGDEh1041	F08	GDEhDisVCh_40061	B10	1	CegsMutGDDh1041	F08	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			KRAS_Met72Leu	12	25227310	T	G	12											12-25227310-T-G	-	0.75207	0.236	72	.	.	.	12	25380244	G	.	.	12	1_Pathogenic	NC_000012.12	.	Met72Leu	.	26.3	.	.	.	T	.	1	1	.	.	.	.	.	.	0.87125	Plus_Clinical	0.3464	.	0.30787	.	.	D	D	.	1.59547003884	.	.	.	.	.	0.95540	.	.	.	.	0.55206	.	.	0.96601	0.999	.	3.0	0.939506	3.95	0.97	G	single nucleotide variant	NC_000012.12:g.25227310T>G	.	.	2	0.89415234	.	.	0.9555017	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.96253	B	0.93122	B	L	3.579291	.	T/T	.	.	.	.	RASopathy	.	0.71845	.	.	-	25227310	.	-	7.919000	.	0.99524	.	.	.	.	germline	.	Gain of catalytic residue at T74 (P = 0.0197)| Loss of phosphorylation at Y71 (P = 0.0909)| Loss of disorder (P = 0.0926)| Loss of helix (P = 0.2271)| Loss of sheet (P = 0.302)	0.80215	GRCh38	856	criteria provided, single submitter	c.214A>C	.	0.91065	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_004985.5(KRAS):c.214A>C (p.Met72Leu)	1	.	RASK_HUMAN	.	97.0	0.259874108519936	.	D	0.80172	0.9538084	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.97604	.	.	.	.	.	p.Met72Leu	.	0.74463	.	germline	.		T	Jun 19, 2022	.	T/T	.	.	1.0	N	12p12.1	.	.	.	SCV001505744	Likely_pathogenic	.	.	Leu	L	-	.	ENSP00000256078	ENST00000256078	.	0.029	.	.	0.644	T	.	4.690966	0.41751	D	T	-	4.543828	.	0.62008	.	.	.	0.42477	.	25227310	Y	10	.	.	.	P01116	.	0.810422	0.34888		.	0.256	D	.	0.87500864	.	0.91597	3845	0.353299	.	-2.55	.	.	0.46288	.	.	.	.	.	.	0.94486	12	KRAS	.	.	Met	.	.	12-25227310-T-G	RASopathy	.	.	25271511	.	0.885317	0.53898	.	RCV001315183	D	.	.	c.214A>C	.	.	.	0.86638	T/T	rs727504662	25227310	.	T	.	P01116	.	0.96774	.	0.68239		.	.	.	0.855	.	.	.	5.77	0.95217	.	D	D	.	.	.	.	.	.	.	536391	1016209	0.86464	0.88549	0.740672528743744	.	.	0.71675	0.81506	.	.	.	8.004	.	D	.	.	.	.	.	0.88091	12	.	ENSG00000133703	.	.	.	.	0.8560956093177353	1	0.39260	0.34333	.	.	.	.	0.425460968171894	.	.	0.0458	1010371	HGNC:6407	D	.	simple_aae	0.986	.	25227310	ATG	1.000000	.	-	.	0.67986	.	.	.	Likely pathogenic	0.66608	.	.	.	ClinGen:CA384151976	M	.	0.869051532231	-	0.665	-	0.75268	.	.	0.85484	0.892316937447	0.8556	.	0.97578417483957014	.	-	214A>C 	.	.	C5555857	.	.	.	.	NM_004985.5	-	.	.	1	0.77609	727504662	.	.	0.86675	0.62956	0.755	0.083	.	0.99469410	5.77	.	.	.	0.269713	0.999925671145259	0.21196	T	.	.	.	-0.4018	0.71002	p.Met72Leu	.	.	-8.664	0.6263549	.	0.98892	1016209	D	.	KRAS	.	D	0.658	.	M72L	D	0.75212	0.52462	T/T	alternative1																																																																																																				
KRAS_Met72Leu	-2.4492678134739627	0.04415464746417742	4.235830569813894	0.0038601676600614906	2025_01_Batch_13-14	0.4657425354048401	0.6313495228635834	0.7353367754214719	0.5598039567361075	0.4527555289657161	0.9548916440252072	0.8679559118427225	0.8655475433667056	0.9265372687972608	0.8558404984612935	0.7103170897150237	0.7496527173531529	0.8004421593940887	0.7431706127666842	0.6542980137135048	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006100		NC_000012.12:25227310:T:G		Met72Leu																												KRAS_Met72Leu	12	25227310	T	G	12	allele	214A>C	C08	527_CAVA_Array_P03	F15	B13A7A8P1_R1	B14A7A8P1_R2				12-25227310-T-G	-	0.75207	0.236	72	.	.	.	12	25380244	G	.	.	12	1_Pathogenic	NC_000012.12	.	Met72Leu	.	26.3	.	.	.	T	.	1	1	.	.	.	.	.	.	0.87125	Plus_Clinical	0.3464	.	0.30787	.	.	D	D	.	1.59547003884	.	.	.	.	.	0.95540	.	.	.	.	0.55206	.	.	0.96601	0.999	.	3.0	0.939506	3.95	0.97	G	single nucleotide variant	NC_000012.12:g.25227310T>G	.	.	2	0.89415234	.	.	0.9555017	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.96253	B	0.93122	B	L	3.579291	.	T/T	.	.	.	.	RASopathy	.	0.71845	.	.	-	25227310	.	-	7.919000	.	0.99524	.	.	.	.	germline	.	Gain of catalytic residue at T74 (P = 0.0197)| Loss of phosphorylation at Y71 (P = 0.0909)| Loss of disorder (P = 0.0926)| Loss of helix (P = 0.2271)| Loss of sheet (P = 0.302)	0.80215	GRCh38	856	criteria provided, single submitter	c.214A>C	.	0.91065	.	.	.	Small GTP-binding domain	.	.	P	.	.	NM_004985.5(KRAS):c.214A>C (p.Met72Leu)	1	.	RASK_HUMAN	.	97.0	0.259874108519936	.	D	0.80172	0.9538084	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.97604	.	.	.	.	.	p.Met72Leu	.	0.74463	.	germline	.		T	Jun 19, 2022	.	T/T	.	.	1.0	N	12p12.1	.	.	.	SCV001505744	Likely_pathogenic	.	.	Leu	L	-	.	ENSP00000256078	ENST00000256078	.	0.029	.	.	0.644	T	.	4.690966	0.41751	D	T	-	4.543828	.	0.62008	.	.	.	0.42477	.	25227310	Y	10	.	.	.	P01116	.	0.810422	0.34888		.	0.256	D	.	0.87500864	.	0.91597	3845	0.353299	.	-2.55	.	.	0.46288	.	.	.	.	.	.	0.94486	12	KRAS	.	.	Met	.	.	12-25227310-T-G	RASopathy	.	.	25271511	.	0.885317	0.53898	.	RCV001315183	D	.	.	c.214A>C	.	.	.	0.86638	T/T	rs727504662	25227310	.	T	.	P01116	.	0.96774	.	0.68239		.	.	.	0.855	.	.	.	5.77	0.95217	.	D	D	.	.	.	.	.	.	.	536391	1016209	0.86464	0.88549	0.740672528743744	.	.	0.71675	0.81506	.	.	.	8.004	.	D	.	.	.	.	.	0.88091	12	.	ENSG00000133703	.	.	.	.	0.8560956093177353	1	0.39260	0.34333	.	.	.	.	0.425460968171894	.	.	0.0458	1010371	HGNC:6407	D	.	simple_aae	0.986	.	25227310	ATG	1.000000	.	-	.	0.67986	.	.	.	Likely pathogenic	0.66608	.	.	.	ClinGen:CA384151976	M	.	0.869051532231	-	0.665	-	0.75268	.	.	0.85484	0.892316937447	0.8556	.	0.97578417483957014	.	-	214A>C 	.	.	C5555857	.	.	.	.	NM_004985.5	-	.	.	1	0.77609	727504662	.	.	0.86675	0.62956	0.755	0.083	.	0.99469410	5.77	.	.	.	0.269713	0.999925671145259	0.21196	T	.	.	.	-0.4018	0.71002	p.Met72Leu	.	.	-8.664	0.6263549	.	0.98892	1016209	D	.	KRAS	.	D	0.658	.	M72L	D	0.75212	0.52462	T/T	alternative1																																																																																																				
CTCF_Ala697Thr	-1.1232772209850925	0.298362229751802	1.4887201352067425	0.18016786356357115	2025_01_Batch_13-14	0.427811937381813	0.5241640544122318	0.5867910532063902	0.5020659078393217	0.45735774894400333	0.5498372877198431	0.6931457300702335	0.5644693377632063	0.6763488058324778	0.4648068175958196	0.48882461255082804	0.6086548922412327	0.5756301954847982	0.5892073568358998	0.46108228326991146	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF		6173		CCSBVarC010818		NC_000016.10:67637777:G:A		Ala697Thr																												CTCF_Ala697Thr	16	67637777	G	A	16	allele	2089G>A	F02	527_CAVA_Array_P02	K04	B13A7A8P1_R1	B14A7A8P1_R2				16-67637777-G-A	-	0.19306	0.0	697	1	0	0	16	67671680	A	2.231440e-05	1	16	3_Conflicting	NC_000016.10	3	Ala697Thr	1	14.18	0	0	5.652910e-05	T	0	3	1	42764	1.267200e-05	.	30522	0.000000e+00	1	0.24571	Select	0.0130	17690	0.02950	1	.	T	T	64024	0.580823813372	0	0	0.000000e+00	0	0	0.07880	17112	44888	1	7.453790e-05	0.23318	0	.	0.01251	0.323	.	94.0	.	1.78	0.06	A	single nucleotide variant	NC_000016.10:g.67637777G>A	0	16732	2	0.0497265	109398	0	0.019917462	0		3	236742	0	0	5.652910e-05	796	0.000000e+00	0	MeSH:D030342,MedGen:C0950123||MedGen:CN169374	1	0	0.000000e+00	0	0.40172	B	0.07099	B	N	1.066043	36	G/G	176	1	7162	1613310	Inborn genetic diseases|CTCF-related disorder|not specified	16214	0.40759	.	.	-	67637777	5.843850e-05	-	1.282000	0	0.04491	29602	0.0010330578512396695	44888	1	germline	91036	Gain of phosphorylation at A697 (P = 0.0106)| Gain of glycosylation at A697 (P = 0.0115)| Gain of loop (P = 0.0502)| Gain of solvent accessibility (P = 0.2291)| Gain of helix (P = 0.2684)	0.00976	GRCh38	50	criteria provided, conflicting classifications	c.2089G>A	0.000000e+00	0.32820	11	0	0	.	0.000000e+00	9046	.	0	0.000000e+00	NM_006565.4(CTCF):c.2089G>A (p.Ala697Thr)	1	0	CTCF_HUMAN	0	6.0	-0.557516232399653	1	.	0.04616	0.02436098	+	0.000000e+00	.		1	0.000000e+00	0	34256	criteria_provided,_conflicting_classifications	0.72542	9.140930e-06	0	0.000000e+00	0	59996	p.Ala697Thr	0	0.25443	.	germline	1		G	Aug 22, 2023	0	G/G	0	89478	0.923	N	16q22.1	163634	.	0.000000e+00	SCV000849791|SCV004029010|SCV004113932	Conflicting_classifications_of_pathogenicity	0	0	Thr	T	-	912	ENSP00000264010	ENST00000264010	17690	0.222	13416	0	-0.108	G	0	1.499315	0.23039	N	T	-	1.340807	.	0.08537	968	0	.	0.08383	0	67637777	Y	10	0	102564	0.000000e+00	P49711	0	0.353355	0.20385		0	0.0	T	13416	0.048129845	17112	0.25089	10664	-0.426293	28	-0.8	.	6.683300e-05	0.23840	0.000000e+00	0	74890	0.000000e+00	5544	0	0.07671	16	CTCF	0.000000e+00	0	Ala	187690	1.117590e-05	16-67637777-G-A	not_specified|CTCF-related_disorder|Inborn_genetic_diseases	0	1	66229181	.	0.269145	0.20004	0	RCV002318105|RCV004535791|RCV003323701	T	0	0	c.2089G>A	0	3	0	0.01463	G/G	rs201916739	67637777	14898	G	.	P49711	15686	0.00532	0.000000e+00	0.17376		0	0	6.683300e-05	0.345	0	9	264690	2.91	0.71894	3392	T	T	0	3.276330e-05	0	682	.	0	0	.	589165	0.06720	0.53620	0.068806566298008	4920	.	0.3214	0.38347	2.919200e-05	7.453790e-05	1180018	3.992	1.442040e-05	N	13394	0	5.289206E-5	0	.	0.56781	16	0.000000e+00	ENSG00000102974	0.000000e+00	5.5000794455919916E-5	0	0	.	1	0.01384	0.97656	30604	14	9.750010e-06	1.666780e-05	-0.41758376025414	YES	1.098470e-05	0.003775	580362	HGNC:13723	N	0	simple_aae	0.025	208038	67637777	GCA	0.001000	.	-	0	0.11429	2.372850e-05	0	0	Conflicting classifications of pathogenicity	0.28985	0	0	1	ClinGen:CA8112854	A	0	0.352914559346	-	0.089	-	0.10018	3	13700	0.11959	0.28278157115	.	0	0.90883258671168698	280	-	2089G>A 	1	7.299270072992701E-5	CN169374|C0950123	0	0	0	0	NM_006565.4	-	.	.	0	0.24416	201916739	2320	5.860727795833555E-5	0.34492	0.24164	0.113	0.358	4744	0.18858771	5.92	.	.	0.000000e+00	-0.680989	0.0183708095774007	0.11102	T	2710	6210	9566	-0.9502	0.05035	p.Ala697Thr	0	0	-4.231	0.074863106	0	0.28756	589165	T	30522	CTCF	5.843850e-05	T	0.085	21628	A697T	T	0.37175	0.15302	G/G	principal4																																																																																																				
F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	0.8696055339288283	0.8054023729403156	0.9015045582024344	0.8784566601927848	0.8156113504953498	0.7554776103131811	0.8884079349073506	0.9512757742969193	0.9071344848689584	0.8792616597666947	0.8125415721210048	0.846905153923833	0.9263901662496768	0.8927955725308716	0.8474365051310222	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G		Tyr161Cys																												F9_Tyr161Cys	23	139548453	A	G	X	allele	482A>G	D07	527_CAVA_Array_P02	G14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548453-A-G	-	0.63338	1.0	161	.	.	.	X	138630612	G	.	.	X	1_Pathogenic	NC_000023.11	.	Tyr161Cys	.	24.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99622	Select	0.9698	.	0.90580	.	.	D	D	.	3.35052041495	0	.	.	.	.	0.45607	.	.	.	.	0.95177	.	.	0.99107	0.954	.	4.0	0.907809	4.69	0.96	G	single nucleotide variant	NC_000023.11:g.139548453A>G	.	.	2	0.95718026	.	0	0.98005635	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99354	D	H	.	.	A/A	84	0	.	.	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.98968	.	.	-	139548453	.	-	9.248000	.	0.99628	.	0	.	.	germline	.	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.99364	GRCh38	924	criteria provided, single submitter	c.482A>G	.	0.64600	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	1	.	FA9_HUMAN	.	96.0	.	.	D	0.87118	0.9801722	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Tyr161Cys	.	0.79501	.	germline	.		A	Sep 09, 2019	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV001410919	Likely_pathogenic	.	.	Cys	C	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.691	A	.	4.195203	0.83643	.	D	-	.	.	0.97795	610	.	.	0.97053	0	139548453	Y	9	0	.	.	P00740	.	0.947563	0.87318		.	1.0	D	.	0.9677569	.	0.50428	2158	0.709682	.	-7.54	.	.	0.78662	.	.	.	.	.	.	0.98799	X	F9	.	0	Tyr	10680	.	X-139548453-A-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138458278	.	.	.	.	RCV001238122	D	.	.	c.482A>G	.	.	.	0.99937	A/A	rs1927768329	139548453	.	A	.	P00740	.	0.99098	.	0.68239		.	.	.	4.505	0	0	264690	4.94	0.99211	108	D	T	.	.	0	24	.	.	.	98879	963994	0.99937	0.99644	0.999352633953094	2294	.	0.71675	.	.	.	.	6.975	.	D	.	.	7.5560088E-6	0	306900|300807	0.7597	X	.	ENSG00000101981	.	0	.	0	0.9993750153719172	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.727081	951629	HGNC:3551	A	.	simple_aae	0.989	.	139548453	TAT	1.000000	.	-	0	0.99791	.	0	.	Likely pathogenic	0.91210	.	.	.	ClinGen:CA414439233	Y	.	0.999628882684	-	0.948	-	0.94798	.	466	0.99937	0.548684835434	0.817	.	0.99787297672792052	94	-	482A>G 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.67286	1927768329	.	0	0.99961	.	0.86	0.002	2210	0.99999213	4.94	.	.	.	0.781633	0.999984402408099	0.98972	D	84	.	.	1.0827	0.99044	p.Tyr161Cys	0	.	-13.466	0.9925639	.	0.99579	963994	D	.	F9	.	D	0.969	.	Y161C	D	0.86632	0.84104	A/A	principal1	188010	F9_Popp_2025_heavy_chain_var233739	No											Y		482	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Tyr161Cys		true	c.482A>G						3551.0	139548453.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Tyr161Cys						C	Sep 09, 2019					missense_variant		161.0				-0.005053132		Likely pathogenic	139548453.0	missense_variant		0.969					Reporter			F9_Tyr161Cys
F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	0.8696055339288283	0.8054023729403156	0.9015045582024344	0.8784566601927848	0.8156113504953498	0.7554776103131811	0.8884079349073506	0.9512757742969193	0.9071344848689584	0.8792616597666947	0.8125415721210048	0.846905153923833	0.9263901662496768	0.8927955725308716	0.8474365051310222	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G		Tyr161Cys																												F9_Tyr161Cys	23	139548453	A	G	X	allele	482A>G	D07	527_CAVA_Array_P02	G14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548453-A-G	-	0.63338	1.0	161	.	.	.	X	138630612	G	.	.	X	1_Pathogenic	NC_000023.11	.	Tyr161Cys	.	24.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99622	Select	0.9698	.	0.90580	.	.	D	D	.	3.35052041495	0	.	.	.	.	0.45607	.	.	.	.	0.95177	.	.	0.99107	0.954	.	4.0	0.907809	4.69	0.96	G	single nucleotide variant	NC_000023.11:g.139548453A>G	.	.	2	0.95718026	.	0	0.98005635	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99354	D	H	.	.	A/A	84	0	.	.	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.98968	.	.	-	139548453	.	-	9.248000	.	0.99628	.	0	.	.	germline	.	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.99364	GRCh38	924	criteria provided, single submitter	c.482A>G	.	0.64600	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	1	.	FA9_HUMAN	.	96.0	.	.	D	0.87118	0.9801722	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Tyr161Cys	.	0.79501	.	germline	.		A	Sep 09, 2019	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV001410919	Likely_pathogenic	.	.	Cys	C	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.691	A	.	4.195203	0.83643	.	D	-	.	.	0.97795	610	.	.	0.97053	0	139548453	Y	9	0	.	.	P00740	.	0.947563	0.87318		.	1.0	D	.	0.9677569	.	0.50428	2158	0.709682	.	-7.54	.	.	0.78662	.	.	.	.	.	.	0.98799	X	F9	.	0	Tyr	10680	.	X-139548453-A-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138458278	.	.	.	.	RCV001238122	D	.	.	c.482A>G	.	.	.	0.99937	A/A	rs1927768329	139548453	.	A	.	P00740	.	0.99098	.	0.68239		.	.	.	4.505	0	0	264690	4.94	0.99211	108	D	T	.	.	0	24	.	.	.	98879	963994	0.99937	0.99644	0.999352633953094	2294	.	0.71675	.	.	.	.	6.975	.	D	.	.	7.5560088E-6	0	306900|300807	0.7597	X	.	ENSG00000101981	.	0	.	0	0.9993750153719172	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.727081	951629	HGNC:3551	A	.	simple_aae	0.989	.	139548453	TAT	1.000000	.	-	0	0.99791	.	0	.	Likely pathogenic	0.91210	.	.	.	ClinGen:CA414439233	Y	.	0.999628882684	-	0.948	-	0.94798	.	466	0.99937	0.548684835434	0.817	.	0.99787297672792052	94	-	482A>G 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.67286	1927768329	.	0	0.99961	.	0.86	0.002	2210	0.99999213	4.94	.	.	.	0.781633	0.999984402408099	0.98972	D	84	.	.	1.0827	0.99044	p.Tyr161Cys	0	.	-13.466	0.9925639	.	0.99579	963994	D	.	F9	.	D	0.969	.	Y161C	D	0.86632	0.84104	A/A	principal1	215526	F9_Popp_2025_light_chain_var243420	No											Y		482	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Tyr161Cys		true	c.482A>G						3551.0	139548453.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Tyr161Cys						C	Sep 09, 2019					missense_variant		161.0				0.0167764641005361		Likely pathogenic	139548453.0	missense_variant		0.969					Reporter			F9_Tyr161Cys
F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	0.8696055339288283	0.8054023729403156	0.9015045582024344	0.8784566601927848	0.8156113504953498	0.7554776103131811	0.8884079349073506	0.9512757742969193	0.9071344848689584	0.8792616597666947	0.8125415721210048	0.846905153923833	0.9263901662496768	0.8927955725308716	0.8474365051310222	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G		Tyr161Cys																												F9_Tyr161Cys	23	139548453	A	G	X	allele	482A>G	D07	527_CAVA_Array_P02	G14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548453-A-G	-	0.63338	1.0	161	.	.	.	X	138630612	G	.	.	X	1_Pathogenic	NC_000023.11	.	Tyr161Cys	.	24.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99622	Select	0.9698	.	0.90580	.	.	D	D	.	3.35052041495	0	.	.	.	.	0.45607	.	.	.	.	0.95177	.	.	0.99107	0.954	.	4.0	0.907809	4.69	0.96	G	single nucleotide variant	NC_000023.11:g.139548453A>G	.	.	2	0.95718026	.	0	0.98005635	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99354	D	H	.	.	A/A	84	0	.	.	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.98968	.	.	-	139548453	.	-	9.248000	.	0.99628	.	0	.	.	germline	.	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.99364	GRCh38	924	criteria provided, single submitter	c.482A>G	.	0.64600	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	1	.	FA9_HUMAN	.	96.0	.	.	D	0.87118	0.9801722	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Tyr161Cys	.	0.79501	.	germline	.		A	Sep 09, 2019	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV001410919	Likely_pathogenic	.	.	Cys	C	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.691	A	.	4.195203	0.83643	.	D	-	.	.	0.97795	610	.	.	0.97053	0	139548453	Y	9	0	.	.	P00740	.	0.947563	0.87318		.	1.0	D	.	0.9677569	.	0.50428	2158	0.709682	.	-7.54	.	.	0.78662	.	.	.	.	.	.	0.98799	X	F9	.	0	Tyr	10680	.	X-139548453-A-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138458278	.	.	.	.	RCV001238122	D	.	.	c.482A>G	.	.	.	0.99937	A/A	rs1927768329	139548453	.	A	.	P00740	.	0.99098	.	0.68239		.	.	.	4.505	0	0	264690	4.94	0.99211	108	D	T	.	.	0	24	.	.	.	98879	963994	0.99937	0.99644	0.999352633953094	2294	.	0.71675	.	.	.	.	6.975	.	D	.	.	7.5560088E-6	0	306900|300807	0.7597	X	.	ENSG00000101981	.	0	.	0	0.9993750153719172	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.727081	951629	HGNC:3551	A	.	simple_aae	0.989	.	139548453	TAT	1.000000	.	-	0	0.99791	.	0	.	Likely pathogenic	0.91210	.	.	.	ClinGen:CA414439233	Y	.	0.999628882684	-	0.948	-	0.94798	.	466	0.99937	0.548684835434	0.817	.	0.99787297672792052	94	-	482A>G 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.67286	1927768329	.	0	0.99961	.	0.86	0.002	2210	0.99999213	4.94	.	.	.	0.781633	0.999984402408099	0.98972	D	84	.	.	1.0827	0.99044	p.Tyr161Cys	0	.	-13.466	0.9925639	.	0.99579	963994	D	.	F9	.	D	0.969	.	Y161C	D	0.86632	0.84104	A/A	principal1	243042	F9_Popp_2025_strep_2_var262782	No											Y		482	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Tyr161Cys		true	c.482A>G						3551.0	139548453.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Tyr161Cys						C	Sep 09, 2019					missense_variant		161.0				0.0249196274567227		Likely pathogenic	139548453.0	missense_variant		0.969					Reporter			F9_Tyr161Cys
F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	0.8696055339288283	0.8054023729403156	0.9015045582024344	0.8784566601927848	0.8156113504953498	0.7554776103131811	0.8884079349073506	0.9512757742969193	0.9071344848689584	0.8792616597666947	0.8125415721210048	0.846905153923833	0.9263901662496768	0.8927955725308716	0.8474365051310222	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G		Tyr161Cys																												F9_Tyr161Cys	23	139548453	A	G	X	allele	482A>G	D07	527_CAVA_Array_P02	G14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548453-A-G	-	0.63338	1.0	161	.	.	.	X	138630612	G	.	.	X	1_Pathogenic	NC_000023.11	.	Tyr161Cys	.	24.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99622	Select	0.9698	.	0.90580	.	.	D	D	.	3.35052041495	0	.	.	.	.	0.45607	.	.	.	.	0.95177	.	.	0.99107	0.954	.	4.0	0.907809	4.69	0.96	G	single nucleotide variant	NC_000023.11:g.139548453A>G	.	.	2	0.95718026	.	0	0.98005635	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99354	D	H	.	.	A/A	84	0	.	.	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.98968	.	.	-	139548453	.	-	9.248000	.	0.99628	.	0	.	.	germline	.	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.99364	GRCh38	924	criteria provided, single submitter	c.482A>G	.	0.64600	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	1	.	FA9_HUMAN	.	96.0	.	.	D	0.87118	0.9801722	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Tyr161Cys	.	0.79501	.	germline	.		A	Sep 09, 2019	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV001410919	Likely_pathogenic	.	.	Cys	C	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.691	A	.	4.195203	0.83643	.	D	-	.	.	0.97795	610	.	.	0.97053	0	139548453	Y	9	0	.	.	P00740	.	0.947563	0.87318		.	1.0	D	.	0.9677569	.	0.50428	2158	0.709682	.	-7.54	.	.	0.78662	.	.	.	.	.	.	0.98799	X	F9	.	0	Tyr	10680	.	X-139548453-A-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138458278	.	.	.	.	RCV001238122	D	.	.	c.482A>G	.	.	.	0.99937	A/A	rs1927768329	139548453	.	A	.	P00740	.	0.99098	.	0.68239		.	.	.	4.505	0	0	264690	4.94	0.99211	108	D	T	.	.	0	24	.	.	.	98879	963994	0.99937	0.99644	0.999352633953094	2294	.	0.71675	.	.	.	.	6.975	.	D	.	.	7.5560088E-6	0	306900|300807	0.7597	X	.	ENSG00000101981	.	0	.	0	0.9993750153719172	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.727081	951629	HGNC:3551	A	.	simple_aae	0.989	.	139548453	TAT	1.000000	.	-	0	0.99791	.	0	.	Likely pathogenic	0.91210	.	.	.	ClinGen:CA414439233	Y	.	0.999628882684	-	0.948	-	0.94798	.	466	0.99937	0.548684835434	0.817	.	0.99787297672792052	94	-	482A>G 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.67286	1927768329	.	0	0.99961	.	0.86	0.002	2210	0.99999213	4.94	.	.	.	0.781633	0.999984402408099	0.98972	D	84	.	.	1.0827	0.99044	p.Tyr161Cys	0	.	-13.466	0.9925639	.	0.99579	963994	D	.	F9	.	D	0.969	.	Y161C	D	0.86632	0.84104	A/A	principal1	160494	F9_Popp_2025_carboxy_gla_motif_var253101	No											Y		482	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Tyr161Cys		true	c.482A>G						3551.0	139548453.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Tyr161Cys						C	Sep 09, 2019					missense_variant		161.0				0.0005122839584507		Likely pathogenic	139548453.0	missense_variant		0.969					Reporter			F9_Tyr161Cys
F9_Tyr161Cys	-4.181331575015963	0.004130393319615212	5.876260287856266	0.0006140365131649915	2025_01_Batch_13-14	0.8696055339288283	0.8054023729403156	0.9015045582024344	0.8784566601927848	0.8156113504953498	0.7554776103131811	0.8884079349073506	0.9512757742969193	0.9071344848689584	0.8792616597666947	0.8125415721210048	0.846905153923833	0.9263901662496768	0.8927955725308716	0.8474365051310222	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030535		NC_000023.11:139548453:A:G		Tyr161Cys																												F9_Tyr161Cys	23	139548453	A	G	X	allele	482A>G	D07	527_CAVA_Array_P02	G14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548453-A-G	-	0.63338	1.0	161	.	.	.	X	138630612	G	.	.	X	1_Pathogenic	NC_000023.11	.	Tyr161Cys	.	24.6	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99622	Select	0.9698	.	0.90580	.	.	D	D	.	3.35052041495	0	.	.	.	.	0.45607	.	.	.	.	0.95177	.	.	0.99107	0.954	.	4.0	0.907809	4.69	0.96	G	single nucleotide variant	NC_000023.11:g.139548453A>G	.	.	2	0.95718026	.	0	0.98005635	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.95575	D	0.99354	D	H	.	.	A/A	84	0	.	.	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.98968	.	.	-	139548453	.	-	9.248000	.	0.99628	.	0	.	.	germline	.	Gain of disorder (P = 0.0139)| Gain of sheet (P = 0.1945)| Loss of catalytic residue at Y161 (P = 0.2002)| Loss of phosphorylation at Y161 (P = 0.2026)| Loss of loop (P = 0.3664)	0.99364	GRCh38	924	criteria provided, single submitter	c.482A>G	.	0.64600	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.482A>G (p.Tyr161Cys)	1	.	FA9_HUMAN	.	96.0	.	.	D	0.87118	0.9801722	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Tyr161Cys	.	0.79501	.	germline	.		A	Sep 09, 2019	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV001410919	Likely_pathogenic	.	.	Cys	C	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.691	A	.	4.195203	0.83643	.	D	-	.	.	0.97795	610	.	.	0.97053	0	139548453	Y	9	0	.	.	P00740	.	0.947563	0.87318		.	1.0	D	.	0.9677569	.	0.50428	2158	0.709682	.	-7.54	.	.	0.78662	.	.	.	.	.	.	0.98799	X	F9	.	0	Tyr	10680	.	X-139548453-A-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138458278	.	.	.	.	RCV001238122	D	.	.	c.482A>G	.	.	.	0.99937	A/A	rs1927768329	139548453	.	A	.	P00740	.	0.99098	.	0.68239		.	.	.	4.505	0	0	264690	4.94	0.99211	108	D	T	.	.	0	24	.	.	.	98879	963994	0.99937	0.99644	0.999352633953094	2294	.	0.71675	.	.	.	.	6.975	.	D	.	.	7.5560088E-6	0	306900|300807	0.7597	X	.	ENSG00000101981	.	0	.	0	0.9993750153719172	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.727081	951629	HGNC:3551	A	.	simple_aae	0.989	.	139548453	TAT	1.000000	.	-	0	0.99791	.	0	.	Likely pathogenic	0.91210	.	.	.	ClinGen:CA414439233	Y	.	0.999628882684	-	0.948	-	0.94798	.	466	0.99937	0.548684835434	0.817	.	0.99787297672792052	94	-	482A>G 	.	0	C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.67286	1927768329	.	0	0.99961	.	0.86	0.002	2210	0.99999213	4.94	.	.	.	0.781633	0.999984402408099	0.98972	D	84	.	.	1.0827	0.99044	p.Tyr161Cys	0	.	-13.466	0.9925639	.	0.99579	963994	D	.	F9	.	D	0.969	.	Y161C	D	0.86632	0.84104	A/A	principal1	132978	F9_Popp_2025_carboxy_F9_specific_var224058	No											Y		482	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Tyr161Cys		true	c.482A>G						3551.0	139548453.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Tyr161Cys						C	Sep 09, 2019					missense_variant		161.0				0.009457715		Likely pathogenic	139548453.0	missense_variant		0.969					Reporter			F9_Tyr161Cys
RAD51D_Ser46Cys	0.7829957094149949	0.4592952894564183	2.61629208398007	0.03459523845265817	2025_01_Batch_13-14	0.49040677581802167	0.646948468082983	0.6251686851710547	0.5838162373290128	0.4417403194913215	0.5648243070034517	0.6555887017994018	0.704324560526074	0.6506322595267637	0.5392594278649514	0.5276155414107366	0.6512685849411923	0.6647466228485643	0.6172242484278883	0.4904998736781364	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024795		NC_000017.11:35119118:G:C		Ser46Cys																												RAD51D_Ser46Cys	17	35119118	G	C	17	allele	137C>G	D12	527_CAVA_Array_P04	H24	B13A7A8P1_R1	B14A7A8P1_R2				17-35119118-G-C	-	0.89758	1.0	46	12	0	0	17	33446137	C	1.047490e-04	1	17	3_Conflicting	NC_000017.11	9	Ser46Cys	0	31.0	0	0	1.265630e-04	T	0	18	5	42754	7.600770e-05	.	30526	0.000000e+00	0	0.75352	.	0.3321	102716	0.90580	4	.	D	T	64038	.	0	0	0.000000e+00	0	0	.	17104	44884	0	0.000000e+00	0.72035	7	.	0.71975	0.96	.	.	0.883212	.	.	C	single nucleotide variant	NC_000017.11:g.35119118G>C	0	16734	2	0.31285465	109378	0	0.53418267	0		16	236818	0	0	0.000000e+00	500	1.637270e-04	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:C1333600|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN221562	8	0	0.000000e+00	0	0.68318	D	0.54022	D	M	8.828211	169	G/G	122	0	7160	1613388	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|Hereditary cancer|Malignant tumor of breast|Breast and/or ovarian cancer	16198	0.73009	.	.	-	35119118	1.637270e-04	-	11.447000	0	0.74295	29604	0	59998	0	germline;unknown	91082	.	.	GRCh38	926	criteria provided, conflicting classifications	c.137C>G	0.000000e+00	0.66699	14	0	0	RAD51D, N-terminal domain	0.000000e+00	9042	B	0	0.000000e+00	NM_002878.4(RAD51D):c.137C>G (p.Ser46Cys)	1	0	RA51D_HUMAN	0	.	0.802452879217227	3	D	0.50240	0.5920361	-	0.000000e+00	.		12	0.000000e+00	0	34250	criteria_provided,_conflicting_classifications	0.94298	7.314090e-05	0	0.000000e+00	0	59998	p.Ser46Cys	0	0.92795	.	germline	7		G	Mar 04, 2025	0	G/G	0	89498	1.0	N	17q12	32650	.	0.000000e+00	SCV000149717|SCV000185614|SCV000287698|SCV000604997|SCV000686419|SCV000784997|SCV000839197|SCV002043210|SCV002534771|SCV002760915|SCV002819352|SCV004017757|SCV004208087|SCV004220162|SCV005641839	Conflicting_classifications_of_pathogenicity	0	0	Cys	C	-	912	ENSP00000378090	ENST00000394589	17688	0.007	13412	0	0.676	G	0	5.349603	0.79703	D	D	-	9.284908	.	0.63381	628	0	.	0.47789	0	35119118	Y	10	0.002	102716	0.000000e+00	O75771	0	0.683251	0.53541		0	0.956	D	89498	0.28243348	42754	0.51684	5892	-0.0213529	155	-3.45	.	1.500050e-04	0.63383	0.000000e+00	0	74900	0.000000e+00	6084	0	0.57062	17	RAD51D	0.000000e+00	0	Ser	44420	1.340810e-04	17-35119118-G-C	Malignant_tumor_of_breast|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer|not_specified|not_provided	0	13	30470250	ClinGen:CA287956	0.928860	0.86184	0	RCV000115808|RCV000212953|RCV000228533|RCV000656964|RCV003492493|RCV001354278|RCV001798341	D	0	0	c.137C>G	0	0	0	0.48331	G/G	rs587780102	35119118	14886	G	.	.	15690	0.68768	0.000000e+00	0.68239		0	0	0.000000e+00	2.72	0	13	264690	5.02	0.90627	168	D	.	0	9.831550e-05	1	56	.	0	0	140162|145	127882	0.69239	0.43501	0.823957562446594	3512	.	0.71675	0.91342	1.167880e-04	1.340810e-04	1179426	5.745	7.690900e-05	D	13394	0	1.17118136E-4	0	614291	0.68382	17	0.000000e+00	ENSG00000185379	0.000000e+00	3.9816232771822357E-4	0	0	.	2	0.86259	0.17784	30608	31	1.265630e-04	1.500050e-04	0.769679193341177	.	0.000000e+00	0.048765	133339	HGNC:9823	.	0	.	0.545	208038	35119118	TCT	1.000000	.	-	0	0.77446	1.314200e-04	0	0	Conflicting classifications of pathogenicity	0.78452	0	0	9	ClinGen:CA287956	S	0	0.947946397878	-	.	-	0.70828	18	6864	0.54121	.	0.2118	0	0.99138447258004703	98	-	137C>G 	13	0	C0006142|CN221562|C0027672|C3280345|C1333600|CN169374|C3661900	0	0	0	0	NM_002878.4	-	.	.	0	0.68570	587780102	2320	3.1517334533993696E-4	0.94697	0.87549	0.683	0.023	3390	0.96507460	5.02	.	.	0.000000e+00	-0.0134026	0.0651732501033949	0.79369	T	112	6212	9572	-0.3645	0.69833	p.Ser46Cys	0	0	-10.77	0.7786217	0	0.39495	127882	D	30514	RAD51D	5.846590e-05	D	0.456	21562	.	D	.	0.76753	G/G	principal1	962534	RAD51D_unpublished_var156781	Yes						overall function		Cell survival			S		137	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Ser46Cys		true	c.137C>G						9823.0	35119118.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				Ser46Cys						C	Mar 19, 2024					missense_variant		46.0	C		0.0001047485167857	-0.0108749		Conflicting classifications of pathogenicity	35119118.0	missense_variant		0.456	functionally_normal				Cell viability			RAD51D_Ser46Cys
ZC4H2_Cys192Tyr	-5.160461914766019	0.03556021322527632																													ZC4H2	ZC4H2		4320		CCSBVarC009185		NC_000023.11:64917883:C:T		Cys192Tyr																												ZC4H2_Cys192Tyr	23	64917883	C	T	X	allele	575G>A	H04	527_CAVA_Array_P06	O08	B13A7A8P2_R1	B14A7A8P2_R2				X-64917883-C-T	-	0.88668	0.997	192	.	.	.	X	64137763	T	.	.	X	1_Pathogenic	NC_000023.11	.	Cys192Tyr	.	29.7	.	.	.	T	.	1	1	.	.	.	.	.	.	0.97887	Select	0.1258	.	0.70687	.	.	D	D	.	3.87732945386	.	.	.	.	.	0.99313	.	.	.	.	0.98608	.	.	0.97018	0.999	.	17.0	0.954504	.	0.83	T	single nucleotide variant	NC_000023.11:g.64917883C>T	.	.	2	0.96367556	.	.	0.9578642	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0026762,MedGen:C5393303,OMIM:301041	.	.	.	.	0.88920	D	0.99152	D	.	.	.	C/C	.	.	.	.	Wieacker-Wolff syndrome, female-restricted	.	0.31030	.	.	-	64917883	.	-	7.539000	.	0.99956	.	.	.	.	de novo	.	Gain of phosphorylation at C192 (P = 0.0524)| Gain of helix (P = 0.0854)| Gain of MoRF binding (P = 0.0968)| Gain of methylation at K187 (P = 0.1201)| Loss of ubiquitination at K187 (P = 0.1223)	0.79395	GRCh38	40	no assertion criteria provided	c.575G>A	.	0.73761	.	.	.	Zinc finger C4H2-type	.	.	P	.	.	NM_018684.4(ZC4H2):c.575G>A (p.Cys192Tyr)		.	ZC4H2_HUMAN	.	83.0	.	.	D	0.99952	0.9578642	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.98515	.	.	.	.	.	p.Cys192Tyr	.	0.60115	.	germline	.		C	May 13, 2021	.	C/C	.	.	1.0	N	Xq11.2	.	.	.	SCV001712255	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.599	C	.	5.279833	0.83643	.	D	-	.	.	0.96878	.	.	.	0.98098	.	64917883	Y	8	.	.	.	Q9NQZ6	.	0.84433	0.81861		.	0.995	D	.	0.96367556	.	0.91597	55906	0.544047	.	-9.7	.	.	0.91343	.	.	.	.	.	.	0.99152	X	ZC4H2	.	.	Cys	.	.	X-64917883-C-T	Wieacker-Wolff_syndrome,_female-restricted	.	.	64054488	.	.	.	.	RCV001788550	D	.	.	c.575G>A	.	.	.	0.95487	C/C	rs2147345743	64917883	.	C	.	Q9NQZ6	.	0.97018	.	0.68239		.	.	.	.	.	.	.	5.27	0.96370	.	D	D	.	.	.	.	.	.	.	.	1164068	0.95419	0.99863	0.999605476856232	.	.	0.71675	.	.	.	.	7.301	.	D	.	.	.	.	301041	0.78228	X	.	ENSG00000126970	.	.	.	.	0.9787259826617718	2	0.83178	0.97963	.	.	.	.	.	YES	.	0.635824	1153067	HGNC:24931	D	.	simple_aae	0.999	.	64917883	TGT	1.000000	.	-	.	0.92768	.	.	.	Pathogenic	0.98612	.	.	.	ClinGen:CA413411258	C	.	0.935945739039	-	0.657	-	0.91045	.	.	0.97853	0.936483502388	1.0	.	0.99718193828610802	.	-	575G>A 	.	.	C5393303	.	.	.	.	NM_018684.4	-	.	.	1	0.82661	2147345743	.	.	0.93478	.	0.899	0.001	.	0.99780840	5.27	.	.	.	0.54371	0.999120994212341	.	T	.	.	.	-0.9956	0.42921	p.Cys192Tyr	.	.	-16.676	0.93517613	.	0.95759	1164068	D	.	ZC4H2	.	D	0.918	.	C192Y	D	.	0.40292	C/C	principal1																																																																																																				
F9_Ile210Thr	-3.317402673587866	0.01281062663396674	9.025273762716747	0.0000418858688751677	2025_01_Batch_13-14	0.8642193932432928	0.7772071254523895	0.8242607574809934	0.8106279239489359	0.8591761497090777	0.8545018665708942	0.7969390629561975	0.9046824198973468	0.8457988611924971	0.7333836392544959	0.8593606299070935	0.7870730942042935	0.8644715886891701	0.8282133925707165	0.7962798944817868	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Ile210Thr																												F9_Ile210Thr						allele	767T>C	D11	527_CAVA_Array_P02	G22	B13A7A8P1_R1	B14A7A8P1_R2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
F9_Ile210Thr	-3.317402673587866	0.01281062663396674	9.025273762716747	0.0000418858688751677	2025_01_Batch_13-14	0.8642193932432928	0.7772071254523895	0.8242607574809934	0.8106279239489359	0.8591761497090777	0.8545018665708942	0.7969390629561975	0.9046824198973468	0.8457988611924971	0.7333836392544959	0.8593606299070935	0.7870730942042935	0.8644715886891701	0.8282133925707165	0.7962798944817868	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Ile210Thr																												F9_Ile210Thr						allele	767T>C	D11	527_CAVA_Array_P02	G22	B13A7A8P1_R1	B14A7A8P1_R2																																																																																																																																																																																																																																																																																																																																																																																																																																																							135853	F9_Popp_2025_carboxy_F9_specific_var225084	No											I		629	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ile210Thr		true	c.629T>C						3551.0	139551170.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa															Ile210Thr						T						missense_variant		210.0				1.0631676621712276			139551170.0	missense_variant		0.113					Reporter			
F9_Ile210Thr	-3.317402673587866	0.01281062663396674	9.025273762716747	0.0000418858688751677	2025_01_Batch_13-14	0.8642193932432928	0.7772071254523895	0.8242607574809934	0.8106279239489359	0.8591761497090777	0.8545018665708942	0.7969390629561975	0.9046824198973468	0.8457988611924971	0.7333836392544959	0.8593606299070935	0.7870730942042935	0.8644715886891701	0.8282133925707165	0.7962798944817868	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Ile210Thr																												F9_Ile210Thr						allele	767T>C	D11	527_CAVA_Array_P02	G22	B13A7A8P1_R1	B14A7A8P1_R2																																																																																																																																																																																																																																																																																																																																																																																																																																																							245917	F9_Popp_2025_strep_2_var263808	No											I		629	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ile210Thr		true	c.629T>C						3551.0	139551170.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa															Ile210Thr						T						missense_variant		210.0				1.059311766566273			139551170.0	missense_variant		0.113					Reporter			
F9_Ile210Thr	-3.317402673587866	0.01281062663396674	9.025273762716747	0.0000418858688751677	2025_01_Batch_13-14	0.8642193932432928	0.7772071254523895	0.8242607574809934	0.8106279239489359	0.8591761497090777	0.8545018665708942	0.7969390629561975	0.9046824198973468	0.8457988611924971	0.7333836392544959	0.8593606299070935	0.7870730942042935	0.8644715886891701	0.8282133925707165	0.7962798944817868	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Ile210Thr																												F9_Ile210Thr						allele	767T>C	D11	527_CAVA_Array_P02	G22	B13A7A8P1_R1	B14A7A8P1_R2																																																																																																																																																																																																																																																																																																																																																																																																																																																							190885	F9_Popp_2025_heavy_chain_var234765	No											I		629	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ile210Thr		true	c.629T>C						3551.0	139551170.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa															Ile210Thr						T						missense_variant		210.0				1.0343435677748638			139551170.0	missense_variant		0.113					Reporter			
F9_Ile210Thr	-3.317402673587866	0.01281062663396674	9.025273762716747	0.0000418858688751677	2025_01_Batch_13-14	0.8642193932432928	0.7772071254523895	0.8242607574809934	0.8106279239489359	0.8591761497090777	0.8545018665708942	0.7969390629561975	0.9046824198973468	0.8457988611924971	0.7333836392544959	0.8593606299070935	0.7870730942042935	0.8644715886891701	0.8282133925707165	0.7962798944817868	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Ile210Thr																												F9_Ile210Thr						allele	767T>C	D11	527_CAVA_Array_P02	G22	B13A7A8P1_R1	B14A7A8P1_R2																																																																																																																																																																																																																																																																																																																																																																																																																																																							218401	F9_Popp_2025_light_chain_var244446	No											I		629	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ile210Thr		true	c.629T>C						3551.0	139551170.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa															Ile210Thr						T						missense_variant		210.0				1.056701022316394			139551170.0	missense_variant		0.113					Reporter			
F9_Ile210Thr	-3.317402673587866	0.01281062663396674	9.025273762716747	0.0000418858688751677	2025_01_Batch_13-14	0.8642193932432928	0.7772071254523895	0.8242607574809934	0.8106279239489359	0.8591761497090777	0.8545018665708942	0.7969390629561975	0.9046824198973468	0.8457988611924971	0.7333836392544959	0.8593606299070935	0.7870730942042935	0.8644715886891701	0.8282133925707165	0.7962798944817868	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861						Ile210Thr																												F9_Ile210Thr						allele	767T>C	D11	527_CAVA_Array_P02	G22	B13A7A8P1_R1	B14A7A8P1_R2																																																																																																																																																																																																																																																																																																																																																																																																																																																							163369	F9_Popp_2025_carboxy_gla_motif_var254127	No											I		629	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ile210Thr		true	c.629T>C						3551.0	139551170.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa															Ile210Thr						T						missense_variant		210.0				1.0681693761322255			139551170.0	missense_variant		0.113					Reporter			
SHOC2_Ser2Gly	-3.1962184734631762	0.015145173112769224	10.615593920721482	0.000014410874200003568	2025_01_Batch_13-14	0.8812307260582743	0.9445404273697964	0.9778620886638342	0.9103892689734077	0.777721700702442														0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2	SHOC2	ENSG00000108061	11602	203498	CCSBVarC003572	ALE00003572	NC_000010.11:110964362:A:G	4A>G	Ser2Gly	CEGS2	CegsMutGDEh1003	E02	GDEhDisVCh_40089	E02	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			SHOC2_Ser2Gly	10	110964362	A	G	10											10-110964362-A-G	-	0.66885	0.924	2	.	1	.	10	112724120	G	3.719770e-06	.	10	1_Pathogenic	NC_000010.11	1	Ser2Gly	.	25.0	.	0	.	T	0	45	.	.	.	.	.	.	0	0.70445	.	0.1062	.	0.54410	.	.	T	D	63960	.	0	0	.	.	.	0.68519	.	44884	0	.	0.18812	.	.	0.60151	1.0	.	.	0.756024	.	.	G	single nucleotide variant	NC_000010.11:g.110964362A>G	0	.	3	0.3356854	.	0	0.43829516	0	G	.	.	.	.	.	0	.	0	MedGen:C3661900|MeSH:D030342,MedGen:C0950123|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0033004,MedGen:C4540575,OMIM:263200||MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701;Human Phenotype Ontology:HP:0000767,Human Phenotype Ontology:HP:0006613,Human Phenotype Ontology:HP:0006617,MONDO:MONDO:0008213,MedGen:C2051831,OMIM:169300|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0011899,MedGen:C1843181,OMIM:PS607721,Orphanet:2701	.	.	0.000000e+00	0	0.90832	P	0.59430	P	M	5.084776	6	A/A	0	0	.	1613004	not provided|Inborn genetic diseases|Noonan syndrome-like disorder with loose anagen hair 1|Noonan syndrome|Polycystic kidney disease 4|SHOC2-related disorder|Noonan syndrome and Noonan-related syndrome|Noonan syndrome-like disorder with loose anagen hair 1;Pectus excavatum|RASopathy|Noonan syndrome-like disorder with loose anagen hair	.	0.50259	.	.	-	110964362	.	-	10.555000	.	0.54055	29596	0	29596	.	de novo;germline;unknown	90972	Loss of phosphorylation at S2 (P = 0.0013)| Gain of sheet (P = 0.0028)| Loss of loop (P = 0.0112)| Gain of ubiquitination at K7 (P = 0.0913)| Loss of methylation at K7 (P = 0.0917)	0.86913	GRCh38	914	reviewed by expert panel	.	.	0.72246	0	.	.	.	.	.	.	0	3.378830e-05	NM_007373.4(SHOC2):c.4A>G (p.Ser2Gly)	3	.	SHOC2_HUMAN	.	.	0.506295370116211	.	T	0.20926	0.3963055	+	.	.	3.42269e-6	.	.	0	.	reviewed_by_expert_panel	0.55985	.	0	.	.	59750	.	0	0.83455	.	germline	.	110964362	A	Apr 03, 2017	.	A/A	.	.	1.0	N	10q25.2	78	.	.	SCV000616382	Pathogenic	.	.	Gly	G	-	912	ENSP00000510554	ENST00000689118	.	.	.	.	0.751	A	.	4.350761	0.08048	D	.	-	5.944563	.	0.45962	0	.	.	0.63597	0	110964362	Y	10	0	.	0.000000e+00	Q9UQ13	.	0.168512	0.80133	A	.	0.827	T	.	0.3389099	.	0.97202	8036	0.158547	5	.	.	3.378830e-05	0.91343	.	.	74876	.	6084	.	0.59147	10	SHOC2	0.000000e+00	0	Ser	660	.	10-110964362-A-G	Noonan_syndrome_and_Noonan-related_syndrome|Noonan_syndrome|Noonan_syndrome-like_disorder_with_loose_anagen_hair|RASopathy|Polycystic_kidney_disease_4|Inborn_genetic_diseases|not_provided|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|Pectus_excavatum	0	.	112714110	ClinGen:CA118524|OMIM:602775.0001|UniProtKB:Q9UQ13#VAR_060199	0.926990	0.67289	0	RCV000213000|RCV000624656|RCV000007223|RCV000208379|RCV002221469|RCV004752691|RCV001813181|RCV003330311|RCV000149834|RCV000853278	.	0	.	c.4A>G	.	0	0	0.69846	A/A	rs267607048	110964362	.	A	.	Q9UQ13	.	0.62973	.	0.68239	10	.	.	0.000000e+00	1.95	0	0	.	5.22	0.51307	34	D	T	.	.	0	0	.	.	.	98733|648|2701|536391|2701	6821	0.69461	0.81400	0.952564656734467	434	.	0.71675	0.90862	.	.	1179528	8.492	.	.	.	.	.	0	PS163950|PS607721|263200|607721|169300	0.90332	10	.	ENSG00000108061	0.000000e+00	0	.	0	.	1	0.65195	0.21043	.	.	.	0.000000e+00	0.576779642148786	.	0.000000e+00	0.02323	21860	HGNC:15454	.	.	.	0.27	.	110964362	AGT	1.000000	.	-	0	0.84179	4.238980e-06	0	0	Pathogenic	0.17366	.	0	0	ClinGen:CA118524,UniProtKB:Q9UQ13#VAR_060199,OMIM:602775.0001	S	.	.	-	0.737	-	0.79136	.	108	0.01588	0.709850311279	.	0	0.99693813541009024	6	-	4A>G 	.	0	C5681679|C0028326|C1843181|C5555857|C4540575|C0950123|C3661900|C4478716|C2051831	.	.	.	.	NM_007373.4	-	.	.	1	0.37697	267607048	.	0	0.50012	0.73134	.	.	434	0.03609608	5.22	.	.	.	-0.0100348	0.949115075084258	0.52299	T	34	.	.	-0.8710	0.38523	p.Ser2Gly	0	0	-3.508	.	0	0.80343	6821	T	.	SHOC2	.	D	.	.	S2G	.	.	0.87726	A/A	principal1																																																																																																				
FANCC_Asp195Val	1.2566203609821562	0.24919974099408038	-11.629347596522699	7.846369178135278e-6	2025_01_Batch_13-14	0.6351832855990385	0.8836968194865118	0.92331818841267	0.8959693048993332	0.8450017977379654	0.48485712487139987	0.8679383114423312	0.940108021231868	0.8875135436883358	0.7647837148139124	0.5600202052352192	0.8758175654644216	0.931713104822269	0.8917414242938345	0.8048927562759389	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FANCC	FANCC	ENSG00000158169	7699	13987	CCSBVarC001229	ALE00001229	NC_000009.12:95150025:T:A	584A>T	Asp195Val	RC4	RC4_Mut_GDEh1009	B09	GDEhDisVCh_40044	E07	2	RC4_Mut_GDDh1009	B09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FANCC_Asp195Val	9	95150025	T	A	9											9-95150025-T-A	-	0.55272	0.992	195	434	94	0	9	97912307	A	3.944760e-03	47	9	3_Conflicting	NC_000009.12	31	Asp195Val	0	23.6	0	6	4.539520e-03	T	0	27	1	42762	3.048960e-03	1	30510	2.155170e-03	2	0.72559	.	0.2312	102654	0.64752	89	0.0	D	T	64010	.	0.001433349259436216	0	3.867870e-03	3	3	0.22378	17110	44868	308	0.000000e+00	0.86481	204	.	0.62503	0.174	7.564296520423601E-4	96.0	0.893711	.	0.04	A	single nucleotide variant	NC_000009.12:g.95150025T>A	0	16734	2	0.41695112	109386	0.0036496350364963502	0.4535079	0	A	661	236802	2	0	0.000000e+00	790	4.770590e-03	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0007254,MedGen:C0006142	319	7	0.000000e+00	0	0.13669	D	0.61960	D	M	4.969212	6367	T/T	174	41	7162	1614040	Hereditary cancer-predisposing syndrome|not specified|not provided|Fanconi anemia|Fanconi anemia complementation group C|Fanconi anemia complementation group A|Malignant tumor of breast	16212	0.67564	0	.	-	95150025	4.770590e-03	-	5.887000	6	0.71835	29606	0.0021141649048625794	6060	0	germline;unknown	91058	.	.	GRCh38	167	criteria provided, conflicting classifications	c.584A>T	3.343170e-03	0.60376	500	0	18	.	2.987930e-04	9044	B	0	3.175030e-03	NM_000136.3(FANCC):c.584A>T (p.Asp195Val)	1	0	FANCC_HUMAN	1	4.0	0.491382671950936	82	D	0.50323	0.43107343	-	5.585030e-04	0	0.00405785	434	2.898550e-03	0	34242	criteria_provided,_conflicting_classifications	0.81662	2.916280e-03	26	2.239810e-04	0	60004	p.Asp195Val	0	0.50787	.	germline	204	95150025	T	Jan 29, 2025	102	T/T	4	89528	0.999	N	9q22.32	92472	.	3.700960e-04	SCV000168402|SCV000232007|SCV000261219|SCV000267037|SCV000281279|SCV000302521|SCV000539136|SCV000594678|SCV000673285|SCV000791802|SCV000892896|SCV001137852|SCV001329919|SCV001522905|SCV001653385|SCV002010154|SCV002047091|SCV002535110|SCV005875402	Conflicting_classifications_of_pathogenicity	3	37	Val	V	-	912	ENSP00000364454	ENST00000375305	17690	0.004	13414	4	0.665	T	0	3.822049	0.79703	N	D	-	4.395473	.	.	946	1	0.011928429423459244	0.01743	0	95150025	Y	10	0.010126582278481013	102654	5.115510e-03	Q00597	0	0.508738	0.59720	T	2	0.971	.	89528	0.3693059	42762	0.21152	2176	-0.186631	5355	-5.58	0.0	5.115510e-03	0.65576	3.124200e-03	2	75002	0.000000e+00	6060	4	0.65510	9	FANCC	6.933150e-04	1	Asp	110208	4.847650e-03	9-95150025-T-A	Fanconi_anemia_complementation_group_A|Fanconi_anemia|Malignant_tumor_of_breast|Fanconi_anemia_complementation_group_C|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome	0	466	96952128	ClinGen:CA247025|UniProtKB:Q00597#VAR_005228	0.471210	0.66409	18	RCV000124962|RCV000120978|RCV000179716|RCV001083500|RCV000667368|RCV000988215|RCV001356570	T	0	0	c.584A>T	0	1	37	0.22426	T/T	rs1800365	95150025	14900	T	0.002595846645367412	.	15684	0.63947	3.235950e-04	0.68239	9	0	3	2.228760e-05	2.395	0	442	264690	4.77	0.82439	3330	T	T	5	2.687820e-03	8	656	.	0	5	84|84|84|140162	134305	0.67662	0.40953	0.028442771770713	4360	13	0.42732	0.51517	2.599150e-03	4.847650e-03	1180010	4.533	3.177030e-03	D	13394	3	0.0031735238	0	227650|PS227650|227645	0.60413	9	3.355700e-04	ENSG00000158169	5.780350e-04	0.004779825244398304	102	0	.	2	0.72446	0.93511	30592	840	4.539520e-03	2.899810e-03	0.405209269013319	.	3.382460e-03	.	138044	HGNC:3584	N	0	simple_aae	0.506	208056	95150025	GAT	1.000000	0	-	0.0013761467889908258	0.00870	4.538100e-03	6	4	Conflicting classifications of pathogenicity	0.29534	49	31	174	UniProtKB:Q00597#VAR_005228,ClinGen:CA247025	D	0	0.869862672899	-	.	-	0.82505	722	8036	0.49056	0.38103300333	0.2603	1	0.99328517196819688	274	-	584A>T 	466	0.00510204081632653	C3469521|C0015625|C0006142|C3468041|C3661900|CN169374|C0027672	0	0	5	0	NM_000136.3	-	12	0.0	0	0.71646	1800365	2320	0.004536875725900116	0.86759	0.61683	0.83	0.002	4186	0.48957047	4.77	.	.	3.334210e-03	-0.0371334	0.427087705106892	0.69015	T	2674	6210	9566	-0.5256	0.59552	p.Asp195Val	0	0	-4.396	0.027212769	52	0.58537	134305	T	30508	FANCC	2.746930e-03	D	0.417	21632	.	D	.	0.62996	T/T	principal1																																																																																																				
FANCC_Asp195Val	1.2566203609821562	0.24919974099408038	-11.629347596522699	7.846369178135278e-6	2025_01_Batch_13-14	0.6351832855990385	0.8836968194865118	0.92331818841267	0.8959693048993332	0.8450017977379654	0.48485712487139987	0.8679383114423312	0.940108021231868	0.8875135436883358	0.7647837148139124	0.5600202052352192	0.8758175654644216	0.931713104822269	0.8917414242938345	0.8048927562759389	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FANCC	FANCC		7699		CCSBVarC001229		NC_000009.12:95150025:T:A		Asp195Val																												FANCC_Asp195Val	9	95150025	T	A	9	allele	584A>T	G11	527_CAVA_Array_P02	M22	B13A7A8P1_R1	B14A7A8P1_R2				9-95150025-T-A	-	0.55272	0.992	195	434	94	0	9	97912307	A	3.944760e-03	47	9	3_Conflicting	NC_000009.12	31	Asp195Val	0	23.6	0	6	4.539520e-03	T	0	27	1	42762	3.048960e-03	1	30510	2.155170e-03	2	0.72559	.	0.2312	102654	0.64752	89	0.0	D	T	64010	.	0.001433349259436216	0	3.867870e-03	3	3	0.22378	17110	44868	308	0.000000e+00	0.86481	204	.	0.62503	0.174	7.564296520423601E-4	96.0	0.893711	.	0.04	A	single nucleotide variant	NC_000009.12:g.95150025T>A	0	16734	2	0.41695112	109386	0.0036496350364963502	0.4535079	0	A	661	236802	2	0	0.000000e+00	790	4.770590e-03	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0009215,MedGen:C3469521,OMIM:227650,Orphanet:84|MONDO:MONDO:0007254,MedGen:C0006142	319	7	0.000000e+00	0	0.13669	D	0.61960	D	M	4.969212	6367	T/T	174	41	7162	1614040	Hereditary cancer-predisposing syndrome|not specified|not provided|Fanconi anemia|Fanconi anemia complementation group C|Fanconi anemia complementation group A|Malignant tumor of breast	16212	0.67564	0	.	-	95150025	4.770590e-03	-	5.887000	6	0.71835	29606	0.0021141649048625794	6060	0	germline;unknown	91058	.	.	GRCh38	167	criteria provided, conflicting classifications	c.584A>T	3.343170e-03	0.60376	500	0	18	.	2.987930e-04	9044	B	0	3.175030e-03	NM_000136.3(FANCC):c.584A>T (p.Asp195Val)	1	0	FANCC_HUMAN	1	4.0	0.491382671950936	82	D	0.50323	0.43107343	-	5.585030e-04	0	0.00405785	434	2.898550e-03	0	34242	criteria_provided,_conflicting_classifications	0.81662	2.916280e-03	26	2.239810e-04	0	60004	p.Asp195Val	0	0.50787	.	germline	204	95150025	T	Jan 29, 2025	102	T/T	4	89528	0.999	N	9q22.32	92472	.	3.700960e-04	SCV000168402|SCV000232007|SCV000261219|SCV000267037|SCV000281279|SCV000302521|SCV000539136|SCV000594678|SCV000673285|SCV000791802|SCV000892896|SCV001137852|SCV001329919|SCV001522905|SCV001653385|SCV002010154|SCV002047091|SCV002535110|SCV005875402	Conflicting_classifications_of_pathogenicity	3	37	Val	V	-	912	ENSP00000364454	ENST00000375305	17690	0.004	13414	4	0.665	T	0	3.822049	0.79703	N	D	-	4.395473	.	.	946	1	0.011928429423459244	0.01743	0	95150025	Y	10	0.010126582278481013	102654	5.115510e-03	Q00597	0	0.508738	0.59720	T	2	0.971	.	89528	0.3693059	42762	0.21152	2176	-0.186631	5355	-5.58	0.0	5.115510e-03	0.65576	3.124200e-03	2	75002	0.000000e+00	6060	4	0.65510	9	FANCC	6.933150e-04	1	Asp	110208	4.847650e-03	9-95150025-T-A	Fanconi_anemia_complementation_group_A|Fanconi_anemia|Malignant_tumor_of_breast|Fanconi_anemia_complementation_group_C|not_provided|not_specified|Hereditary_cancer-predisposing_syndrome	0	466	96952128	ClinGen:CA247025|UniProtKB:Q00597#VAR_005228	0.471210	0.66409	18	RCV000124962|RCV000120978|RCV000179716|RCV001083500|RCV000667368|RCV000988215|RCV001356570	T	0	0	c.584A>T	0	1	37	0.22426	T/T	rs1800365	95150025	14900	T	0.002595846645367412	.	15684	0.63947	3.235950e-04	0.68239	9	0	3	2.228760e-05	2.395	0	442	264690	4.77	0.82439	3330	T	T	5	2.687820e-03	8	656	.	0	5	84|84|84|140162	134305	0.67662	0.40953	0.028442771770713	4360	13	0.42732	0.51517	2.599150e-03	4.847650e-03	1180010	4.533	3.177030e-03	D	13394	3	0.0031735238	0	227650|PS227650|227645	0.60413	9	3.355700e-04	ENSG00000158169	5.780350e-04	0.004779825244398304	102	0	.	2	0.72446	0.93511	30592	840	4.539520e-03	2.899810e-03	0.405209269013319	.	3.382460e-03	.	138044	HGNC:3584	N	0	simple_aae	0.506	208056	95150025	GAT	1.000000	0	-	0.0013761467889908258	0.00870	4.538100e-03	6	4	Conflicting classifications of pathogenicity	0.29534	49	31	174	UniProtKB:Q00597#VAR_005228,ClinGen:CA247025	D	0	0.869862672899	-	.	-	0.82505	722	8036	0.49056	0.38103300333	0.2603	1	0.99328517196819688	274	-	584A>T 	466	0.00510204081632653	C3469521|C0015625|C0006142|C3468041|C3661900|CN169374|C0027672	0	0	5	0	NM_000136.3	-	12	0.0	0	0.71646	1800365	2320	0.004536875725900116	0.86759	0.61683	0.83	0.002	4186	0.48957047	4.77	.	.	3.334210e-03	-0.0371334	0.427087705106892	0.69015	T	2674	6210	9566	-0.5256	0.59552	p.Asp195Val	0	0	-4.396	0.027212769	52	0.58537	134305	T	30508	FANCC	2.746930e-03	D	0.417	21632	.	D	.	0.62996	T/T	principal1																																																																																																				
RET_Gly321Arg	1.6968224836440589	0.13354425044658957	6.221935624960898	0.00043585464276858364	2025_01_Batch_13-14	0.977325363031224	0.9133247694306528	0.8509189221520284	0.9512187140707647	0.8969964654655831	0.6741510909770319	0.7575514441441777	0.7529307083998097	0.7488623181549918	0.6210943775883868	0.8257382270041279	0.8354381067874153	0.8019248152759191	0.8500405161128783	0.759045421526985	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET	ENSG00000165731	8858	202955	CCSBVarC006879	ALE00006877	NC_000010.11:43106469:G:A	961G>A	Gly321Arg	CEGS2	CegsMutGDEh1026	B06	GDEhDisVCh_40066	D05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Gly321Arg	10	43106469	G	A	10											10-43106469-G-A	-	0.1371	0.007	321	11	0	0	10	43601917	A	5.331180e-05	1	10	3_Conflicting	NC_000010.11	8	Gly321Arg	2	10.23	2	2	1.475770e-04	T	0	12	5	42326	7.681080e-05	.	30312	0.000000e+00	0	0.73376	Select	0.1969	101642	0.16277	1	.	T	T	63818	0.238921890069	2.3691068467187872E-4	0	0.000000e+00	0	0	0.17459	17008	44842	1	7.527850e-05	0.39308	6	.	0.17355	0.251	.	96.0	0.673133	-4.57	0.04	A	single nucleotide variant	NC_000010.11:g.43106469G>A	0	16620	2	0.065889634	108388	0	0.1105618	0	A	14	234342	0	0	1.137140e-04	146	1.417570e-04	0	Human Phenotype Ontology:HP:0002865,MONDO:MONDO:0015277,MeSH:C536914,MedGen:C0238462,Orphanet:1332|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|	9	0	0.000000e+00	0	0.13669	B	0.12879	B	L	0.3294123	86	G/G	306	0	7006	1613150	Medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Hirschsprung disease, susceptibility to, 1|RET-related disorder	15894	0.35787	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106469	2.229650e-04	-	0.913000	1	0.50061	29578	0	44842	1	germline;unknown	90932	Gain of solvent accessibility (P = 0.019)| Gain of sheet (P = 0.0477)| Gain of MoRF binding (P = 0.0483)| Gain of phosphorylation at T323 (P = 0.1426)| Loss of catalytic residue at W324 (P = 0.1943)	0.82670	GRCh38	862	criteria provided, conflicting classifications	c.961G>A	0.000000e+00	0.08700	7	0	0	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	0.000000e+00	8970	B	0	0.000000e+00	NM_020975.6(RET):c.961G>A (p.Gly321Arg)	1	0	RET_HUMAN	0	4.0	-1.07470700909571	1	T	0.13936	0.07723053	+	0.000000e+00	.	0.0000499656	11	0.000000e+00	0	34086	criteria_provided,_conflicting_classifications	0.99055	8.303500e-05	0	0.000000e+00	0	59956	p.Gly321Arg	0	0.22725	.	germline	2	43106469	G	Mar 04, 2025	0	G/G	0	88210	0.0	N	10q11.21	31942	.	6.291680e-05	SCV000190513|SCV000290569|SCV000674744|SCV000807066|SCV000838373|SCV002011439|SCV002069391|SCV002527937|SCV004208632|SCV004243365|SCV004699800|SCV005623126	Conflicting_classifications_of_pathogenicity	0	0	Arg	R	-	912	ENSP00000347942	ENST00000355710	17588	0.231	13284	0	-0.752	G	0	0.991371	0.09199	N	T	-	0.4273997	.	0.53831	610	0	.	0.00371	0	43106469	Y	10	0	101642	0.000000e+00	P07949	0	0.435003	0.20078	G	0	0.003	D	88210	0.06433436	8970	0.23335	5979	-0.129129	61	-1.64	.	1.784040e-04	0.18346	0.000000e+00	0	74884	2.229650e-04	6078	0	0.13420	10	RET	9.347790e-05	0	Gly	46214	1.247020e-04	10-43106469-G-A	RET-related_disorder|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|not_specified|not_provided|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Medullary_thyroid_carcinoma	0	15	42921923	ClinGen:CA009403	0.047661	0.07027	0	RCV000148776|RCV000679758|RCV000709104|RCV000567555|RCV000231209|RCV001818171|RCV003460487|RCV004528128	T	0	0	c.961G>A	0	8	0	0.31279	G/G	rs377767388	43106469	14646	G	.	P07949	15586	0.25900	0.000000e+00	0.23666	10	0	0	1.784040e-04	1.1	0	5	264690	-1.32	0.78028	168	T	T	0	3.297070e-05	0	56	.	0	0	247698|653|388|653|140162|1332	24881	0.55604	0.26162	0.0158652041221491	8748	.	0.06393	0.07918	2.933760e-05	1.247020e-04	1179700	0.268	6.806950e-05	N	13298	0	1.17118136E-4	0	171400|142623	0.18399	10	0.000000e+00	ENSG00000165731	0.000000e+00	1.5653371736271994E-4	0	0	0.6768714346963912	1	0.12129	0.33096	30384	31	1.475770e-04	1.000730e-04	-1.05180989670877	YES	1.099720e-05	0.032094	36222	HGNC:9967	N	0	simple_aae	0.232	205672	43106469	GGG	0.204000	.	-	2.2862368541380886E-4	0.18741	5.170810e-05	2	0	Conflicting classifications of pathogenicity	0.42597	0	0	6	ClinGen:CA009403	G	0	0.940005915424	-	0.69	-	0.27952	18	4502	0.67466	0.346982002258	0.0874	0	0.90570527367935905	98	-	961G>A 	15	0	C0025268|C3888239|CN169374|C3661900|C4048306|C0027672|C0238462	0	0	0	0	NM_020975.6	-	.	.	0	0.27914	377767388	2296	1.514692517418964E-4	0.93891	0.08525	0.222	0.565	8442	0.99895360	5.32	.	.	0.000000e+00	-0.186593	0.0249176742024401	0.27864	T	112	6148	9534	-0.9759	0.54992	p.Gly321Arg	0	0	-5.573	0.103147626	7	0.31262	24881	T	30330	RET	5.879590e-05	T	0.428	20960	G321R	T	0.05201	0.03581	G/G	principal4																																																																																																				
RET_Gly321Arg	1.6968224836440589	0.13354425044658957	6.221935624960898	0.00043585464276858364	2025_01_Batch_13-14	0.977325363031224	0.9133247694306528	0.8509189221520284	0.9512187140707647	0.8969964654655831	0.6741510909770319	0.7575514441441777	0.7529307083998097	0.7488623181549918	0.6210943775883868	0.8257382270041279	0.8354381067874153	0.8019248152759191	0.8500405161128783	0.759045421526985	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET		8858		CCSBVarC006879		NC_000010.11:43106469:G:A		Gly321Arg																												RET_Gly321Arg	10	43106469	G	A	10	allele	961G>A	B09	527_CAVA_Array_P05	C17	B13A7A8P2_R1	B14A7A8P2_R2				10-43106469-G-A	-	0.1371	0.007	321	11	0	0	10	43601917	A	5.331180e-05	1	10	3_Conflicting	NC_000010.11	8	Gly321Arg	2	10.23	2	2	1.475770e-04	T	0	12	5	42326	7.681080e-05	.	30312	0.000000e+00	0	0.73376	Select	0.1969	101642	0.16277	1	.	T	T	63818	0.238921890069	2.3691068467187872E-4	0	0.000000e+00	0	0	0.17459	17008	44842	1	7.527850e-05	0.39308	6	.	0.17355	0.251	.	96.0	0.673133	-4.57	0.04	A	single nucleotide variant	NC_000010.11:g.43106469G>A	0	16620	2	0.065889634	108388	0	0.1105618	0	A	14	234342	0	0	1.137140e-04	146	1.417570e-04	0	Human Phenotype Ontology:HP:0002865,MONDO:MONDO:0015277,MeSH:C536914,MedGen:C0238462,Orphanet:1332|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MedGen:CN169374|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|	9	0	0.000000e+00	0	0.13669	B	0.12879	B	L	0.3294123	86	G/G	306	0	7006	1613150	Medullary thyroid carcinoma|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|not specified|Hirschsprung disease, susceptibility to, 1|RET-related disorder	15894	0.35787	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106469	2.229650e-04	-	0.913000	1	0.50061	29578	0	44842	1	germline;unknown	90932	Gain of solvent accessibility (P = 0.019)| Gain of sheet (P = 0.0477)| Gain of MoRF binding (P = 0.0483)| Gain of phosphorylation at T323 (P = 0.1426)| Loss of catalytic residue at W324 (P = 0.1943)	0.82670	GRCh38	862	criteria provided, conflicting classifications	c.961G>A	0.000000e+00	0.08700	7	0	0	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	0.000000e+00	8970	B	0	0.000000e+00	NM_020975.6(RET):c.961G>A (p.Gly321Arg)	1	0	RET_HUMAN	0	4.0	-1.07470700909571	1	T	0.13936	0.07723053	+	0.000000e+00	.	0.0000499656	11	0.000000e+00	0	34086	criteria_provided,_conflicting_classifications	0.99055	8.303500e-05	0	0.000000e+00	0	59956	p.Gly321Arg	0	0.22725	.	germline	2	43106469	G	Mar 04, 2025	0	G/G	0	88210	0.0	N	10q11.21	31942	.	6.291680e-05	SCV000190513|SCV000290569|SCV000674744|SCV000807066|SCV000838373|SCV002011439|SCV002069391|SCV002527937|SCV004208632|SCV004243365|SCV004699800|SCV005623126	Conflicting_classifications_of_pathogenicity	0	0	Arg	R	-	912	ENSP00000347942	ENST00000355710	17588	0.231	13284	0	-0.752	G	0	0.991371	0.09199	N	T	-	0.4273997	.	0.53831	610	0	.	0.00371	0	43106469	Y	10	0	101642	0.000000e+00	P07949	0	0.435003	0.20078	G	0	0.003	D	88210	0.06433436	8970	0.23335	5979	-0.129129	61	-1.64	.	1.784040e-04	0.18346	0.000000e+00	0	74884	2.229650e-04	6078	0	0.13420	10	RET	9.347790e-05	0	Gly	46214	1.247020e-04	10-43106469-G-A	RET-related_disorder|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|not_specified|not_provided|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Medullary_thyroid_carcinoma	0	15	42921923	ClinGen:CA009403	0.047661	0.07027	0	RCV000148776|RCV000679758|RCV000709104|RCV000567555|RCV000231209|RCV001818171|RCV003460487|RCV004528128	T	0	0	c.961G>A	0	8	0	0.31279	G/G	rs377767388	43106469	14646	G	.	P07949	15586	0.25900	0.000000e+00	0.23666	10	0	0	1.784040e-04	1.1	0	5	264690	-1.32	0.78028	168	T	T	0	3.297070e-05	0	56	.	0	0	247698|653|388|653|140162|1332	24881	0.55604	0.26162	0.0158652041221491	8748	.	0.06393	0.07918	2.933760e-05	1.247020e-04	1179700	0.268	6.806950e-05	N	13298	0	1.17118136E-4	0	171400|142623	0.18399	10	0.000000e+00	ENSG00000165731	0.000000e+00	1.5653371736271994E-4	0	0	0.6768714346963912	1	0.12129	0.33096	30384	31	1.475770e-04	1.000730e-04	-1.05180989670877	YES	1.099720e-05	0.032094	36222	HGNC:9967	N	0	simple_aae	0.232	205672	43106469	GGG	0.204000	.	-	2.2862368541380886E-4	0.18741	5.170810e-05	2	0	Conflicting classifications of pathogenicity	0.42597	0	0	6	ClinGen:CA009403	G	0	0.940005915424	-	0.69	-	0.27952	18	4502	0.67466	0.346982002258	0.0874	0	0.90570527367935905	98	-	961G>A 	15	0	C0025268|C3888239|CN169374|C3661900|C4048306|C0027672|C0238462	0	0	0	0	NM_020975.6	-	.	.	0	0.27914	377767388	2296	1.514692517418964E-4	0.93891	0.08525	0.222	0.565	8442	0.99895360	5.32	.	.	0.000000e+00	-0.186593	0.0249176742024401	0.27864	T	112	6148	9534	-0.9759	0.54992	p.Gly321Arg	0	0	-5.573	0.103147626	7	0.31262	24881	T	30330	RET	5.879590e-05	T	0.428	20960	G321R	T	0.05201	0.03581	G/G	principal4																																																																																																				
F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Glu73Lys	23	139537138	G	A	X											X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																			237850	F9_Popp_2025_strep_2_var260939	No											E		217	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Glu73Lys		true	c.217G>A						3551.0	139537138.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa															Glu73Lys						K						missense_variant		73.0				0.8272562915068931			139537138.0	missense_variant		0.966					Reporter			F9_Glu73Lys
F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Glu73Lys	23	139537138	G	A	X											X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																			127786	F9_Popp_2025_carboxy_F9_specific_var222215	No											E		217	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Glu73Lys		true	c.217G>A						3551.0	139537138.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa															Glu73Lys						K						missense_variant		73.0				-0.018606189			139537138.0	missense_variant		0.966					Reporter			F9_Glu73Lys
F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Glu73Lys	23	139537138	G	A	X											X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																			210334	F9_Popp_2025_light_chain_var241577	No											E		217	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Glu73Lys		true	c.217G>A						3551.0	139537138.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa															Glu73Lys						K						missense_variant		73.0				0.8803589625521939			139537138.0	missense_variant		0.966					Reporter			F9_Glu73Lys
F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Glu73Lys	23	139537138	G	A	X											X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																			155302	F9_Popp_2025_carboxy_gla_motif_var251258	No											E		217	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Glu73Lys		true	c.217G>A						3551.0	139537138.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa															Glu73Lys						K						missense_variant		73.0				0.8322240601368638			139537138.0	missense_variant		0.966					Reporter			F9_Glu73Lys
F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	NC_000023.11:139537138:G:A	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Glu73Lys	23	139537138	G	A	X											X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																			182818	F9_Popp_2025_heavy_chain_var231896	No											E		217	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Glu73Lys		true	c.217G>A						3551.0	139537138.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa															Glu73Lys						K						missense_variant		73.0				0.8068546545593508			139537138.0	missense_variant		0.966					Reporter			F9_Glu73Lys
F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002180		NC_000023.11:139537138:G:A		Glu73Lys																												F9_Glu73Lys	23	139537138	G	A	X	allele	217G>A	C06	527_CAVA_Array_P02	E12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																			237850	F9_Popp_2025_strep_2_var260939	No											E		217	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Glu73Lys		true	c.217G>A						3551.0	139537138.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa															Glu73Lys						K						missense_variant		73.0				0.8272562915068931			139537138.0	missense_variant		0.966					Reporter			F9_Glu73Lys
F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002180		NC_000023.11:139537138:G:A		Glu73Lys																												F9_Glu73Lys	23	139537138	G	A	X	allele	217G>A	C06	527_CAVA_Array_P02	E12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																			127786	F9_Popp_2025_carboxy_F9_specific_var222215	No											E		217	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Glu73Lys		true	c.217G>A						3551.0	139537138.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa															Glu73Lys						K						missense_variant		73.0				-0.018606189			139537138.0	missense_variant		0.966					Reporter			F9_Glu73Lys
F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002180		NC_000023.11:139537138:G:A		Glu73Lys																												F9_Glu73Lys	23	139537138	G	A	X	allele	217G>A	C06	527_CAVA_Array_P02	E12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																			210334	F9_Popp_2025_light_chain_var241577	No											E		217	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Glu73Lys		true	c.217G>A						3551.0	139537138.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa															Glu73Lys						K						missense_variant		73.0				0.8803589625521939			139537138.0	missense_variant		0.966					Reporter			F9_Glu73Lys
F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002180		NC_000023.11:139537138:G:A		Glu73Lys																												F9_Glu73Lys	23	139537138	G	A	X	allele	217G>A	C06	527_CAVA_Array_P02	E12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																			155302	F9_Popp_2025_carboxy_gla_motif_var251258	No											E		217	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Glu73Lys		true	c.217G>A						3551.0	139537138.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa															Glu73Lys						K						missense_variant		73.0				0.8322240601368638			139537138.0	missense_variant		0.966					Reporter			F9_Glu73Lys
F9_Glu73Lys	-4.161802409004811	0.0042322222478180975	4.733840396936638	0.0021230372127589514	2025_01_Batch_13-14	0.7973980911773066	0.728972055903696	0.6417363100862536	0.6126236306187102	0.7479509351289371	0.6327735864448181	0.7098352375489585	0.68747028425481	0.6407482624631967	0.6071118246219231	0.7150858388110624	0.7194036467263272	0.6646032971705318	0.6266859465409534	0.6775313798754301	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002180		NC_000023.11:139537138:G:A		Glu73Lys																												F9_Glu73Lys	23	139537138	G	A	X	allele	217G>A	C06	527_CAVA_Array_P02	E12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																																			182818	F9_Popp_2025_heavy_chain_var231896	No											E		217	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Glu73Lys		true	c.217G>A						3551.0	139537138.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa															Glu73Lys						K						missense_variant		73.0				0.8068546545593508			139537138.0	missense_variant		0.966					Reporter			F9_Glu73Lys
BRAF_Glu501Lys	0.6633972900818994	0.528310912774345	-0.6694140404872534	0.5246885914445109	2025_01_Batch_13-14	0.5795877855320548	0.7519196371322805	0.7961102983764758	0.7376978443703014	0.4759953809032452	0.5613240661661344	0.8224787036917817	0.8169991370326886	0.7926714600855322	0.5109504785266199	0.5704559258490947	0.7871991704120311	0.8065547177045822	0.7651846522279169	0.49347292971493256	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003167		NC_000007.14:140778007:C:T		Glu501Lys																												BRAF_Glu501Lys	7	140778007	C	T	7	allele	1501G>A	F04	527_CAVA_Array_P01	K07	B13A7A8P1_R1	B14A7A8P1_R2				7-140778007-C-T	-	0.92725	1.0	501	.	.	.	7	140477807	T	.	.	7	1_Pathogenic	NC_000007.14	.	Glu501Lys	.	32.0	.	0	.	D	.	7	.	.	.	.	.	.	0	0.99740	Select	0.6189	.	0.90580	.	.	D	D	.	.	0	.	.	.	.	0.99402	.	.	.	.	.	.	.	0.97269	0.999	.	.	0.959604	6.58	.	T	single nucleotide variant	NC_000007.14:g.140778007C>T	.	.	3	0.83118904	.	0	0.9500797	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MedGen:CN230736	.	.	.	.	0.96253	D	0.92749	D	M	6.346777	.	C/C	0	0	.	.	Cardiofaciocutaneous syndrome 1|not provided|RASopathy|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiovascular phenotype	.	0.90891	.	.	-	140778007	.	-	7.641000	.	0.99826	.	0	.	.	germline;unknown	.	Gain of MoRF binding (P = 0.0045)| Gain of methylation at E501 (P = 0.0827)| Loss of ubiquitination at K499 (P = 0.1356)| Loss of stability (P = 0.2896)| Gain of catalytic residue at K499 (P = 0.3037)	0.99843	GRCh38	776	criteria provided, multiple submitters, no conflicts	c.1501G>A	.	0.65108	0	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	0	.	NM_004333.6(BRAF):c.1501G>A (p.Glu501Lys)	2	.	BRAF_HUMAN	.	.	0.639137191857678	.	D	0.99795	0.96031433	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99238	.	.	.	.	.	p.Glu501Lys	.	0.63257	.	germline	.		C	Jan 29, 2025	.	C/C	.	.	1.0	N	7q34	0	.	.	SCV000263065|SCV000338452|SCV000948576|SCV002767018|SCV003610904	Pathogenic/Likely_pathogenic	.	.	Lys	K	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.545	C	.	5.637157	.	D	.	-	6.628201	.	0.93618	0	.	.	0.97327	0	140778007	Y	9	0	.	.	P15056	.	0.958012	0.97428		.	1.0	D	.	0.8697107	.	0.91597	673	0.554969	.	.	.	.	.	.	.	.	.	.	.	0.90135	7	BRAF	.	0	Glu	478	.	7-140778007-C-T	Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Cardiovascular_phenotype|not_provided|Cardiofaciocutaneous_syndrome_1|RASopathy	.	.	140124276	ClinGen:CA273130|OMIM:164757.0017|UniProtKB:P15056#VAR_026118	0.904129	0.75537	.	RCV000015011|RCV000207513|RCV000033315|RCV000844616|RCV004018630	D	.	.	c.1501G>A	.	.	.	0.95963	C/C	rs180177038	140778007	.	C	.	P15056	.	0.96215	.	0.68239		.	.	.	2.92	0	0	.	4.96	0.99434	0	D	D	.	.	0	0	.	.	.	648|1340|1340|536391	13977	0.95900	0.95797	0.99942809343338	426	.	0.71675	0.85351	.	.	.	7.869	.	.	.	.	.	0	PS163950|PS115150|115150	0.85551	7	.	ENSG00000157764	.	0	.	0	.	1	0.97365	0.48248	.	.	.	.	0.630565185681596	YES	.	0.412682	29016	HGNC:1097	.	.	.	0.995	.	140778007	GAA	1.000000	.	-	0	0.99108	.	0	.	Pathogenic/Likely pathogenic	0.88701	.	.	.	ClinGen:CA273130,UniProtKB:P15056#VAR_026118,OMIM:164757.0017	E	.	.	-	0.984	-	.	.	52	0.99420	0.938608407974	0.9999	.	0.99903041562417938	0	-	1501G>A 	.	0	C0028326|C1275081|CN230736|C3661900|CN029449|C5555857	.	.	.	.	NM_004333.6	-	.	.	1	0.84795	180177038	.	0	0.99090	0.77043	.	.	426	0.99923956	4.96	.	.	.	0.559398	0.999976740337915	0.84163	D	0	.	.	0.5272	0.86511	p.Glu501Lys	0	.	-12.836	0.98748183	.	0.99427	13977	D	.	BRAF	.	D	.	.	E501K	.	0.99812	0.25635	C/C	principal4																																																																																																				
F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp410His	23	139561913	G	C	X											X-139561913-G-C	-	0.85675	1.0	410	.	.	.	X	138644072	C	.	.	X	1_Pathogenic	NC_000023.11	.	Asp410His	.	28.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99189	Select	0.9623	.	0.90580	.	.	D	D	.	1.79064612635	.	.	.	.	.	0.71981	.	.	.	.	0.93527	.	.	0.99910	0.997	.	4.0	0.968703	.	0.96	C	single nucleotide variant	NC_000023.11:g.139561913G>C	.	.	1	0.9909176	.	.	0.99075	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99983	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561913	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.99997	GRCh38	924	no assertion criteria provided	c.1228G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1228G>C (p.Asp410His)		.	FA9_HUMAN	.	96.0	.	.	D	0.95768	0.99331653	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp410His	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031629	Pathogenic	.	.	His	H	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.120913	0.92967	.	D	-	.	.	0.99258	.	.	.	0.98975	.	139561913	Y	10	.	.	.	P00740	.	0.959989	0.63599		.	0.99	D	.	0.9907161	.	0.79771	2158	0.708444	.	-6.96	.	.	0.91343	.	.	.	.	.	.	0.99984	X	F9	.	.	Asp	.	.	X-139561913-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471738	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	.	.	.	RCV000011397	D	.	.	c.1228G>C	.	.	.	0.99934	G/G	rs137852278	139561913	.	G	.	P00740	.	0.99798	.	0.68239		.	.	.	4.53	.	.	.	5.66	0.99474	.	D	T	.	.	.	.	.	.	.	98879	10651	0.99934	0.91462	0.999785840511322	.	.	0.71675	.	.	.	.	9.968	.	D	.	.	.	.	306900	0.99105	X	.	ENSG00000101981	.	.	.	.	0.9997216736224621	1	0.78943	0.18019	.	.	.	.	.	YES	.	0.901637	25690	HGNC:3551	A	.	simple_aae	1	.	139561913	GAT	1.000000	.	-	.	0.99952	.	.	.	Pathogenic	0.94345	.	.	.	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	D	.	0.999097391152	-	1	-	0.99866	.	.	0.99972	0.733585119247	0.9895	.	0.99416941699044747	.	-	1228G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.88661	137852278	.	.	0.99907	.	0.934	0.0	.	0.99999249	5.66	.	.	.	0.779854	0.999898921842201	0.99048	D	.	.	.	1.0945	0.98787	p.Asp410His	.	.	-13.989	0.9945991	.	0.98645	10651	D	.	F9	.	D	0.954	.	D410H	D	.	0.76753	G/G	principal1	257987	F9_Popp_2025_strep_2_var268015	No											D		1228	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Asp410His		true	c.1228G>C						3551.0	139561913.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Asp410His						H	Mar 01, 1992					missense_variant		410.0				1.2630256435449565		Pathogenic	139561913.0	missense_variant		0.954					Reporter			F9_Asp410His
F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp410His	23	139561913	G	C	X											X-139561913-G-C	-	0.85675	1.0	410	.	.	.	X	138644072	C	.	.	X	1_Pathogenic	NC_000023.11	.	Asp410His	.	28.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99189	Select	0.9623	.	0.90580	.	.	D	D	.	1.79064612635	.	.	.	.	.	0.71981	.	.	.	.	0.93527	.	.	0.99910	0.997	.	4.0	0.968703	.	0.96	C	single nucleotide variant	NC_000023.11:g.139561913G>C	.	.	1	0.9909176	.	.	0.99075	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99983	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561913	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.99997	GRCh38	924	no assertion criteria provided	c.1228G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1228G>C (p.Asp410His)		.	FA9_HUMAN	.	96.0	.	.	D	0.95768	0.99331653	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp410His	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031629	Pathogenic	.	.	His	H	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.120913	0.92967	.	D	-	.	.	0.99258	.	.	.	0.98975	.	139561913	Y	10	.	.	.	P00740	.	0.959989	0.63599		.	0.99	D	.	0.9907161	.	0.79771	2158	0.708444	.	-6.96	.	.	0.91343	.	.	.	.	.	.	0.99984	X	F9	.	.	Asp	.	.	X-139561913-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471738	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	.	.	.	RCV000011397	D	.	.	c.1228G>C	.	.	.	0.99934	G/G	rs137852278	139561913	.	G	.	P00740	.	0.99798	.	0.68239		.	.	.	4.53	.	.	.	5.66	0.99474	.	D	T	.	.	.	.	.	.	.	98879	10651	0.99934	0.91462	0.999785840511322	.	.	0.71675	.	.	.	.	9.968	.	D	.	.	.	.	306900	0.99105	X	.	ENSG00000101981	.	.	.	.	0.9997216736224621	1	0.78943	0.18019	.	.	.	.	.	YES	.	0.901637	25690	HGNC:3551	A	.	simple_aae	1	.	139561913	GAT	1.000000	.	-	.	0.99952	.	.	.	Pathogenic	0.94345	.	.	.	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	D	.	0.999097391152	-	1	-	0.99866	.	.	0.99972	0.733585119247	0.9895	.	0.99416941699044747	.	-	1228G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.88661	137852278	.	.	0.99907	.	0.934	0.0	.	0.99999249	5.66	.	.	.	0.779854	0.999898921842201	0.99048	D	.	.	.	1.0945	0.98787	p.Asp410His	.	.	-13.989	0.9945991	.	0.98645	10651	D	.	F9	.	D	0.954	.	D410H	D	.	0.76753	G/G	principal1	175439	F9_Popp_2025_carboxy_gla_motif_var258334	No											D		1228	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Asp410His		true	c.1228G>C						3551.0	139561913.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Asp410His						H	Mar 01, 1992					missense_variant		410.0				1.1058332950544445		Pathogenic	139561913.0	missense_variant		0.954					Reporter			F9_Asp410His
F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp410His	23	139561913	G	C	X											X-139561913-G-C	-	0.85675	1.0	410	.	.	.	X	138644072	C	.	.	X	1_Pathogenic	NC_000023.11	.	Asp410His	.	28.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99189	Select	0.9623	.	0.90580	.	.	D	D	.	1.79064612635	.	.	.	.	.	0.71981	.	.	.	.	0.93527	.	.	0.99910	0.997	.	4.0	0.968703	.	0.96	C	single nucleotide variant	NC_000023.11:g.139561913G>C	.	.	1	0.9909176	.	.	0.99075	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99983	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561913	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.99997	GRCh38	924	no assertion criteria provided	c.1228G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1228G>C (p.Asp410His)		.	FA9_HUMAN	.	96.0	.	.	D	0.95768	0.99331653	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp410His	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031629	Pathogenic	.	.	His	H	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.120913	0.92967	.	D	-	.	.	0.99258	.	.	.	0.98975	.	139561913	Y	10	.	.	.	P00740	.	0.959989	0.63599		.	0.99	D	.	0.9907161	.	0.79771	2158	0.708444	.	-6.96	.	.	0.91343	.	.	.	.	.	.	0.99984	X	F9	.	.	Asp	.	.	X-139561913-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471738	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	.	.	.	RCV000011397	D	.	.	c.1228G>C	.	.	.	0.99934	G/G	rs137852278	139561913	.	G	.	P00740	.	0.99798	.	0.68239		.	.	.	4.53	.	.	.	5.66	0.99474	.	D	T	.	.	.	.	.	.	.	98879	10651	0.99934	0.91462	0.999785840511322	.	.	0.71675	.	.	.	.	9.968	.	D	.	.	.	.	306900	0.99105	X	.	ENSG00000101981	.	.	.	.	0.9997216736224621	1	0.78943	0.18019	.	.	.	.	.	YES	.	0.901637	25690	HGNC:3551	A	.	simple_aae	1	.	139561913	GAT	1.000000	.	-	.	0.99952	.	.	.	Pathogenic	0.94345	.	.	.	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	D	.	0.999097391152	-	1	-	0.99866	.	.	0.99972	0.733585119247	0.9895	.	0.99416941699044747	.	-	1228G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.88661	137852278	.	.	0.99907	.	0.934	0.0	.	0.99999249	5.66	.	.	.	0.779854	0.999898921842201	0.99048	D	.	.	.	1.0945	0.98787	p.Asp410His	.	.	-13.989	0.9945991	.	0.98645	10651	D	.	F9	.	D	0.954	.	D410H	D	.	0.76753	G/G	principal1	147923	F9_Popp_2025_carboxy_F9_specific_var229291	No											D		1228	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Asp410His		true	c.1228G>C						3551.0	139561913.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Asp410His						H	Mar 01, 1992					missense_variant		410.0				1.0852044630902586		Pathogenic	139561913.0	missense_variant		0.954					Reporter			F9_Asp410His
F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp410His	23	139561913	G	C	X											X-139561913-G-C	-	0.85675	1.0	410	.	.	.	X	138644072	C	.	.	X	1_Pathogenic	NC_000023.11	.	Asp410His	.	28.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99189	Select	0.9623	.	0.90580	.	.	D	D	.	1.79064612635	.	.	.	.	.	0.71981	.	.	.	.	0.93527	.	.	0.99910	0.997	.	4.0	0.968703	.	0.96	C	single nucleotide variant	NC_000023.11:g.139561913G>C	.	.	1	0.9909176	.	.	0.99075	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99983	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561913	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.99997	GRCh38	924	no assertion criteria provided	c.1228G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1228G>C (p.Asp410His)		.	FA9_HUMAN	.	96.0	.	.	D	0.95768	0.99331653	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp410His	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031629	Pathogenic	.	.	His	H	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.120913	0.92967	.	D	-	.	.	0.99258	.	.	.	0.98975	.	139561913	Y	10	.	.	.	P00740	.	0.959989	0.63599		.	0.99	D	.	0.9907161	.	0.79771	2158	0.708444	.	-6.96	.	.	0.91343	.	.	.	.	.	.	0.99984	X	F9	.	.	Asp	.	.	X-139561913-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471738	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	.	.	.	RCV000011397	D	.	.	c.1228G>C	.	.	.	0.99934	G/G	rs137852278	139561913	.	G	.	P00740	.	0.99798	.	0.68239		.	.	.	4.53	.	.	.	5.66	0.99474	.	D	T	.	.	.	.	.	.	.	98879	10651	0.99934	0.91462	0.999785840511322	.	.	0.71675	.	.	.	.	9.968	.	D	.	.	.	.	306900	0.99105	X	.	ENSG00000101981	.	.	.	.	0.9997216736224621	1	0.78943	0.18019	.	.	.	.	.	YES	.	0.901637	25690	HGNC:3551	A	.	simple_aae	1	.	139561913	GAT	1.000000	.	-	.	0.99952	.	.	.	Pathogenic	0.94345	.	.	.	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	D	.	0.999097391152	-	1	-	0.99866	.	.	0.99972	0.733585119247	0.9895	.	0.99416941699044747	.	-	1228G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.88661	137852278	.	.	0.99907	.	0.934	0.0	.	0.99999249	5.66	.	.	.	0.779854	0.999898921842201	0.99048	D	.	.	.	1.0945	0.98787	p.Asp410His	.	.	-13.989	0.9945991	.	0.98645	10651	D	.	F9	.	D	0.954	.	D410H	D	.	0.76753	G/G	principal1	230471	F9_Popp_2025_light_chain_var248653	No											D		1228	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Asp410His		true	c.1228G>C						3551.0	139561913.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Asp410His						H	Mar 01, 1992					missense_variant		410.0				1.103006949273624		Pathogenic	139561913.0	missense_variant		0.954					Reporter			F9_Asp410His
F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	NC_000023.11:139561913:G:C	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asp410His	23	139561913	G	C	X											X-139561913-G-C	-	0.85675	1.0	410	.	.	.	X	138644072	C	.	.	X	1_Pathogenic	NC_000023.11	.	Asp410His	.	28.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99189	Select	0.9623	.	0.90580	.	.	D	D	.	1.79064612635	.	.	.	.	.	0.71981	.	.	.	.	0.93527	.	.	0.99910	0.997	.	4.0	0.968703	.	0.96	C	single nucleotide variant	NC_000023.11:g.139561913G>C	.	.	1	0.9909176	.	.	0.99075	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99983	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561913	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.99997	GRCh38	924	no assertion criteria provided	c.1228G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1228G>C (p.Asp410His)		.	FA9_HUMAN	.	96.0	.	.	D	0.95768	0.99331653	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp410His	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031629	Pathogenic	.	.	His	H	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.120913	0.92967	.	D	-	.	.	0.99258	.	.	.	0.98975	.	139561913	Y	10	.	.	.	P00740	.	0.959989	0.63599		.	0.99	D	.	0.9907161	.	0.79771	2158	0.708444	.	-6.96	.	.	0.91343	.	.	.	.	.	.	0.99984	X	F9	.	.	Asp	.	.	X-139561913-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471738	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	.	.	.	RCV000011397	D	.	.	c.1228G>C	.	.	.	0.99934	G/G	rs137852278	139561913	.	G	.	P00740	.	0.99798	.	0.68239		.	.	.	4.53	.	.	.	5.66	0.99474	.	D	T	.	.	.	.	.	.	.	98879	10651	0.99934	0.91462	0.999785840511322	.	.	0.71675	.	.	.	.	9.968	.	D	.	.	.	.	306900	0.99105	X	.	ENSG00000101981	.	.	.	.	0.9997216736224621	1	0.78943	0.18019	.	.	.	.	.	YES	.	0.901637	25690	HGNC:3551	A	.	simple_aae	1	.	139561913	GAT	1.000000	.	-	.	0.99952	.	.	.	Pathogenic	0.94345	.	.	.	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	D	.	0.999097391152	-	1	-	0.99866	.	.	0.99972	0.733585119247	0.9895	.	0.99416941699044747	.	-	1228G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.88661	137852278	.	.	0.99907	.	0.934	0.0	.	0.99999249	5.66	.	.	.	0.779854	0.999898921842201	0.99048	D	.	.	.	1.0945	0.98787	p.Asp410His	.	.	-13.989	0.9945991	.	0.98645	10651	D	.	F9	.	D	0.954	.	D410H	D	.	0.76753	G/G	principal1	202955	F9_Popp_2025_heavy_chain_var238972	No											D		1228	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Asp410His		true	c.1228G>C						3551.0	139561913.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Asp410His						H	Mar 01, 1992					missense_variant		410.0				1.0976181926572208		Pathogenic	139561913.0	missense_variant		0.954					Reporter			F9_Asp410His
F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004394		NC_000023.11:139561913:G:C		Asp410His																												F9_Asp410His	23	139561913	G	C	X	allele	1228G>C	B05	527_CAVA_Array_P02	C10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561913-G-C	-	0.85675	1.0	410	.	.	.	X	138644072	C	.	.	X	1_Pathogenic	NC_000023.11	.	Asp410His	.	28.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99189	Select	0.9623	.	0.90580	.	.	D	D	.	1.79064612635	.	.	.	.	.	0.71981	.	.	.	.	0.93527	.	.	0.99910	0.997	.	4.0	0.968703	.	0.96	C	single nucleotide variant	NC_000023.11:g.139561913G>C	.	.	1	0.9909176	.	.	0.99075	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99983	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561913	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.99997	GRCh38	924	no assertion criteria provided	c.1228G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1228G>C (p.Asp410His)		.	FA9_HUMAN	.	96.0	.	.	D	0.95768	0.99331653	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp410His	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031629	Pathogenic	.	.	His	H	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.120913	0.92967	.	D	-	.	.	0.99258	.	.	.	0.98975	.	139561913	Y	10	.	.	.	P00740	.	0.959989	0.63599		.	0.99	D	.	0.9907161	.	0.79771	2158	0.708444	.	-6.96	.	.	0.91343	.	.	.	.	.	.	0.99984	X	F9	.	.	Asp	.	.	X-139561913-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471738	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	.	.	.	RCV000011397	D	.	.	c.1228G>C	.	.	.	0.99934	G/G	rs137852278	139561913	.	G	.	P00740	.	0.99798	.	0.68239		.	.	.	4.53	.	.	.	5.66	0.99474	.	D	T	.	.	.	.	.	.	.	98879	10651	0.99934	0.91462	0.999785840511322	.	.	0.71675	.	.	.	.	9.968	.	D	.	.	.	.	306900	0.99105	X	.	ENSG00000101981	.	.	.	.	0.9997216736224621	1	0.78943	0.18019	.	.	.	.	.	YES	.	0.901637	25690	HGNC:3551	A	.	simple_aae	1	.	139561913	GAT	1.000000	.	-	.	0.99952	.	.	.	Pathogenic	0.94345	.	.	.	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	D	.	0.999097391152	-	1	-	0.99866	.	.	0.99972	0.733585119247	0.9895	.	0.99416941699044747	.	-	1228G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.88661	137852278	.	.	0.99907	.	0.934	0.0	.	0.99999249	5.66	.	.	.	0.779854	0.999898921842201	0.99048	D	.	.	.	1.0945	0.98787	p.Asp410His	.	.	-13.989	0.9945991	.	0.98645	10651	D	.	F9	.	D	0.954	.	D410H	D	.	0.76753	G/G	principal1	257987	F9_Popp_2025_strep_2_var268015	No											D		1228	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Asp410His		true	c.1228G>C						3551.0	139561913.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Asp410His						H	Mar 01, 1992					missense_variant		410.0				1.2630256435449565		Pathogenic	139561913.0	missense_variant		0.954					Reporter			F9_Asp410His
F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004394		NC_000023.11:139561913:G:C		Asp410His																												F9_Asp410His	23	139561913	G	C	X	allele	1228G>C	B05	527_CAVA_Array_P02	C10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561913-G-C	-	0.85675	1.0	410	.	.	.	X	138644072	C	.	.	X	1_Pathogenic	NC_000023.11	.	Asp410His	.	28.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99189	Select	0.9623	.	0.90580	.	.	D	D	.	1.79064612635	.	.	.	.	.	0.71981	.	.	.	.	0.93527	.	.	0.99910	0.997	.	4.0	0.968703	.	0.96	C	single nucleotide variant	NC_000023.11:g.139561913G>C	.	.	1	0.9909176	.	.	0.99075	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99983	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561913	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.99997	GRCh38	924	no assertion criteria provided	c.1228G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1228G>C (p.Asp410His)		.	FA9_HUMAN	.	96.0	.	.	D	0.95768	0.99331653	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp410His	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031629	Pathogenic	.	.	His	H	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.120913	0.92967	.	D	-	.	.	0.99258	.	.	.	0.98975	.	139561913	Y	10	.	.	.	P00740	.	0.959989	0.63599		.	0.99	D	.	0.9907161	.	0.79771	2158	0.708444	.	-6.96	.	.	0.91343	.	.	.	.	.	.	0.99984	X	F9	.	.	Asp	.	.	X-139561913-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471738	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	.	.	.	RCV000011397	D	.	.	c.1228G>C	.	.	.	0.99934	G/G	rs137852278	139561913	.	G	.	P00740	.	0.99798	.	0.68239		.	.	.	4.53	.	.	.	5.66	0.99474	.	D	T	.	.	.	.	.	.	.	98879	10651	0.99934	0.91462	0.999785840511322	.	.	0.71675	.	.	.	.	9.968	.	D	.	.	.	.	306900	0.99105	X	.	ENSG00000101981	.	.	.	.	0.9997216736224621	1	0.78943	0.18019	.	.	.	.	.	YES	.	0.901637	25690	HGNC:3551	A	.	simple_aae	1	.	139561913	GAT	1.000000	.	-	.	0.99952	.	.	.	Pathogenic	0.94345	.	.	.	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	D	.	0.999097391152	-	1	-	0.99866	.	.	0.99972	0.733585119247	0.9895	.	0.99416941699044747	.	-	1228G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.88661	137852278	.	.	0.99907	.	0.934	0.0	.	0.99999249	5.66	.	.	.	0.779854	0.999898921842201	0.99048	D	.	.	.	1.0945	0.98787	p.Asp410His	.	.	-13.989	0.9945991	.	0.98645	10651	D	.	F9	.	D	0.954	.	D410H	D	.	0.76753	G/G	principal1	175439	F9_Popp_2025_carboxy_gla_motif_var258334	No											D		1228	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Asp410His		true	c.1228G>C						3551.0	139561913.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Asp410His						H	Mar 01, 1992					missense_variant		410.0				1.1058332950544445		Pathogenic	139561913.0	missense_variant		0.954					Reporter			F9_Asp410His
F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004394		NC_000023.11:139561913:G:C		Asp410His																												F9_Asp410His	23	139561913	G	C	X	allele	1228G>C	B05	527_CAVA_Array_P02	C10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561913-G-C	-	0.85675	1.0	410	.	.	.	X	138644072	C	.	.	X	1_Pathogenic	NC_000023.11	.	Asp410His	.	28.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99189	Select	0.9623	.	0.90580	.	.	D	D	.	1.79064612635	.	.	.	.	.	0.71981	.	.	.	.	0.93527	.	.	0.99910	0.997	.	4.0	0.968703	.	0.96	C	single nucleotide variant	NC_000023.11:g.139561913G>C	.	.	1	0.9909176	.	.	0.99075	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99983	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561913	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.99997	GRCh38	924	no assertion criteria provided	c.1228G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1228G>C (p.Asp410His)		.	FA9_HUMAN	.	96.0	.	.	D	0.95768	0.99331653	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp410His	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031629	Pathogenic	.	.	His	H	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.120913	0.92967	.	D	-	.	.	0.99258	.	.	.	0.98975	.	139561913	Y	10	.	.	.	P00740	.	0.959989	0.63599		.	0.99	D	.	0.9907161	.	0.79771	2158	0.708444	.	-6.96	.	.	0.91343	.	.	.	.	.	.	0.99984	X	F9	.	.	Asp	.	.	X-139561913-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471738	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	.	.	.	RCV000011397	D	.	.	c.1228G>C	.	.	.	0.99934	G/G	rs137852278	139561913	.	G	.	P00740	.	0.99798	.	0.68239		.	.	.	4.53	.	.	.	5.66	0.99474	.	D	T	.	.	.	.	.	.	.	98879	10651	0.99934	0.91462	0.999785840511322	.	.	0.71675	.	.	.	.	9.968	.	D	.	.	.	.	306900	0.99105	X	.	ENSG00000101981	.	.	.	.	0.9997216736224621	1	0.78943	0.18019	.	.	.	.	.	YES	.	0.901637	25690	HGNC:3551	A	.	simple_aae	1	.	139561913	GAT	1.000000	.	-	.	0.99952	.	.	.	Pathogenic	0.94345	.	.	.	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	D	.	0.999097391152	-	1	-	0.99866	.	.	0.99972	0.733585119247	0.9895	.	0.99416941699044747	.	-	1228G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.88661	137852278	.	.	0.99907	.	0.934	0.0	.	0.99999249	5.66	.	.	.	0.779854	0.999898921842201	0.99048	D	.	.	.	1.0945	0.98787	p.Asp410His	.	.	-13.989	0.9945991	.	0.98645	10651	D	.	F9	.	D	0.954	.	D410H	D	.	0.76753	G/G	principal1	147923	F9_Popp_2025_carboxy_F9_specific_var229291	No											D		1228	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Asp410His		true	c.1228G>C						3551.0	139561913.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Asp410His						H	Mar 01, 1992					missense_variant		410.0				1.0852044630902586		Pathogenic	139561913.0	missense_variant		0.954					Reporter			F9_Asp410His
F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004394		NC_000023.11:139561913:G:C		Asp410His																												F9_Asp410His	23	139561913	G	C	X	allele	1228G>C	B05	527_CAVA_Array_P02	C10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561913-G-C	-	0.85675	1.0	410	.	.	.	X	138644072	C	.	.	X	1_Pathogenic	NC_000023.11	.	Asp410His	.	28.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99189	Select	0.9623	.	0.90580	.	.	D	D	.	1.79064612635	.	.	.	.	.	0.71981	.	.	.	.	0.93527	.	.	0.99910	0.997	.	4.0	0.968703	.	0.96	C	single nucleotide variant	NC_000023.11:g.139561913G>C	.	.	1	0.9909176	.	.	0.99075	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99983	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561913	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.99997	GRCh38	924	no assertion criteria provided	c.1228G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1228G>C (p.Asp410His)		.	FA9_HUMAN	.	96.0	.	.	D	0.95768	0.99331653	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp410His	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031629	Pathogenic	.	.	His	H	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.120913	0.92967	.	D	-	.	.	0.99258	.	.	.	0.98975	.	139561913	Y	10	.	.	.	P00740	.	0.959989	0.63599		.	0.99	D	.	0.9907161	.	0.79771	2158	0.708444	.	-6.96	.	.	0.91343	.	.	.	.	.	.	0.99984	X	F9	.	.	Asp	.	.	X-139561913-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471738	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	.	.	.	RCV000011397	D	.	.	c.1228G>C	.	.	.	0.99934	G/G	rs137852278	139561913	.	G	.	P00740	.	0.99798	.	0.68239		.	.	.	4.53	.	.	.	5.66	0.99474	.	D	T	.	.	.	.	.	.	.	98879	10651	0.99934	0.91462	0.999785840511322	.	.	0.71675	.	.	.	.	9.968	.	D	.	.	.	.	306900	0.99105	X	.	ENSG00000101981	.	.	.	.	0.9997216736224621	1	0.78943	0.18019	.	.	.	.	.	YES	.	0.901637	25690	HGNC:3551	A	.	simple_aae	1	.	139561913	GAT	1.000000	.	-	.	0.99952	.	.	.	Pathogenic	0.94345	.	.	.	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	D	.	0.999097391152	-	1	-	0.99866	.	.	0.99972	0.733585119247	0.9895	.	0.99416941699044747	.	-	1228G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.88661	137852278	.	.	0.99907	.	0.934	0.0	.	0.99999249	5.66	.	.	.	0.779854	0.999898921842201	0.99048	D	.	.	.	1.0945	0.98787	p.Asp410His	.	.	-13.989	0.9945991	.	0.98645	10651	D	.	F9	.	D	0.954	.	D410H	D	.	0.76753	G/G	principal1	230471	F9_Popp_2025_light_chain_var248653	No											D		1228	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Asp410His		true	c.1228G>C						3551.0	139561913.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Asp410His						H	Mar 01, 1992					missense_variant		410.0				1.103006949273624		Pathogenic	139561913.0	missense_variant		0.954					Reporter			F9_Asp410His
F9_Asp410His	-0.30216283032682023	0.7713082509933437	3.93429836591186	0.005644463979138862	2025_01_Batch_13-14	0.6303119289172239	0.6151733421401693	0.6960345407864246	0.6830241641625603	0.6333698623598298	0.6582861406899879	0.7327200045453127	0.6886061592626981	0.7745370214892127	0.5272039373620467	0.644299034803606	0.673946673342741	0.6923203500245614	0.7287805928258865	0.5802868998609383	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004394		NC_000023.11:139561913:G:C		Asp410His																												F9_Asp410His	23	139561913	G	C	X	allele	1228G>C	B05	527_CAVA_Array_P02	C10	B13A7A8P1_R1	B14A7A8P1_R2				X-139561913-G-C	-	0.85675	1.0	410	.	.	.	X	138644072	C	.	.	X	1_Pathogenic	NC_000023.11	.	Asp410His	.	28.7	.	.	.	D	.	1	1	.	.	.	.	.	.	0.99189	Select	0.9623	.	0.90580	.	.	D	D	.	1.79064612635	.	.	.	.	.	0.71981	.	.	.	.	0.93527	.	.	0.99910	0.997	.	4.0	0.968703	.	0.96	C	single nucleotide variant	NC_000023.11:g.139561913G>C	.	.	1	0.9909176	.	.	0.99075	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99983	D	H	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.99425	.	.	-	139561913	.	-	11.888000	.	0.99985	.	.	.	.	germline	.	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.99997	GRCh38	924	no assertion criteria provided	c.1228G>C	.	0.87274	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1228G>C (p.Asp410His)		.	FA9_HUMAN	.	96.0	.	.	D	0.95768	0.99331653	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Asp410His	.	0.99016	.	germline	.		G	Mar 01, 1992	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV000031629	Pathogenic	.	.	His	H	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.120913	0.92967	.	D	-	.	.	0.99258	.	.	.	0.98975	.	139561913	Y	10	.	.	.	P00740	.	0.959989	0.63599		.	0.99	D	.	0.9907161	.	0.79771	2158	0.708444	.	-6.96	.	.	0.91343	.	.	.	.	.	.	0.99984	X	F9	.	.	Asp	.	.	X-139561913-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471738	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	.	.	.	RCV000011397	D	.	.	c.1228G>C	.	.	.	0.99934	G/G	rs137852278	139561913	.	G	.	P00740	.	0.99798	.	0.68239		.	.	.	4.53	.	.	.	5.66	0.99474	.	D	T	.	.	.	.	.	.	.	98879	10651	0.99934	0.91462	0.999785840511322	.	.	0.71675	.	.	.	.	9.968	.	D	.	.	.	.	306900	0.99105	X	.	ENSG00000101981	.	.	.	.	0.9997216736224621	1	0.78943	0.18019	.	.	.	.	.	YES	.	0.901637	25690	HGNC:3551	A	.	simple_aae	1	.	139561913	GAT	1.000000	.	-	.	0.99952	.	.	.	Pathogenic	0.94345	.	.	.	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	D	.	0.999097391152	-	1	-	0.99866	.	.	0.99972	0.733585119247	0.9895	.	0.99416941699044747	.	-	1228G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.88661	137852278	.	.	0.99907	.	0.934	0.0	.	0.99999249	5.66	.	.	.	0.779854	0.999898921842201	0.99048	D	.	.	.	1.0945	0.98787	p.Asp410His	.	.	-13.989	0.9945991	.	0.98645	10651	D	.	F9	.	D	0.954	.	D410H	D	.	0.76753	G/G	principal1	202955	F9_Popp_2025_heavy_chain_var238972	No											D		1228	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Asp410His		true	c.1228G>C						3551.0	139561913.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Asp410His						H	Mar 01, 1992					missense_variant		410.0				1.0976181926572208		Pathogenic	139561913.0	missense_variant		0.954					Reporter			F9_Asp410His
RAD51D_Val66Met	-0.545546479468292	0.6023201818835449	9.486270453812262	0.000030256308289431174	2025_01_Batch_13-14	0.7562182404004095	0.8179277119701884	0.8685760632494186	0.8268199895224255	0.6855978670709192	0.5251440850520803	0.7154595109435239	0.8414875127860665	0.7385265014914997	0.5175576559932441	0.640681162726245	0.7666936114568561	0.8550317880177425	0.7826732455069626	0.6015777615320816	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024804		NC_000017.11:35118568:C:T		Val66Met																												RAD51D_Val66Met	17	35118568	C	T	17	allele	196G>A	G12	527_CAVA_Array_P04	N24	B13A7A8P1_R1	B14A7A8P1_R2				17-35118568-C-T	-	0.19181	0.476	66	4	1	0	17	33445587	T	2.601940e-04	1	17	3_Conflicting	NC_000017.11	374	Val66Met	65	14.12	24	0	3.674390e-03	T	1	16	1	42766	3.208320e-04	1	30526	0.000000e+00	0	0.25383	Select	0.1126	17690	0.36683	4	0.001984126984126984	T	T	64024	.	0	0	0.000000e+00	0	0	.	17112	44872	17	3.578350e-03	0.16529	2	.	0.19787	0.443	7.564296520423601E-4	95.0	.	-5.85	0.05	T	single nucleotide variant	NC_000017.11:g.35118568C>T	0	16706	2	0.05022742	109376	0	0.085984245	0.003781909864481563		60	236884	0	0	3.674390e-03	442	4.676610e-05	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562|	30	0	0.000000e+00	0	0.16373	B	0.07854	P	L	0.5605822	420	C/C	176	9	7164	1614178	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer|RAD51D-related disorder	16218	0.31561	0	.	-	35118568	2.653690e-03	-	0.681000	1	0.07875	29608	0	44872	48	germline;unknown	91078	Loss of catalytic residue at V66 (P = 0.1757)| Gain of disorder (P = 0.2016)| Gain of relative solvent accessibility (P = 0.2816)| Loss of glycosylation at S62 (P = 0.3483)| Gain of loop (P = 0.3485)	0.63879	GRCh38	926	criteria provided, conflicting classifications	c.196G>A	3.275900e-05	0.12675	34	0	0	.	0.000000e+00	9044	LB	0.004001778568252557	3.377470e-05	NM_002878.4(RAD51D):c.196G>A (p.Val66Met)	1	0	RA51D_HUMAN	0	5.0	-0.868469024722056	2	.	0.24734	0.085984245	-	1.395870e-04	0		48	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.90830	2.742830e-04	1	0.000000e+00	0	60016	p.Val66Met	0	0.20762	.	germline	24		C	Mar 04, 2025	1	C/C	0	89522	0.001	N	17q12	153016	.	6.165990e-05	SCV000184996|SCV000287700|SCV000297127|SCV000489108|SCV000515953|SCV000686426|SCV000920125|SCV001193731|SCV001470086|SCV002043215|SCV002534780|SCV004017746|SCV004024299	Conflicting_classifications_of_pathogenicity	0	0	Met	M	-	912	ENSP00000338790	ENST00000345365	17690	0.095	13414	0	-1.926	C	0	1.488353	0.44850	N	T	-	0.6448988	.	0.47635	950	0	0.0	0.02783	24	35118568	Y	10	0	102710	1.649620e-04	O75771	0	0.159822	0.16045		0	0.365	T	13414	0.05022742	9044	0.27788	5892	-0.540521	9	-0.54	0.0	8.334820e-03	0.34240	6.373490e-05	0	75058	2.653690e-03	6062	1	0.07854	17	RAD51D	1.332300e-05	0	Val	177652	4.468180e-05	17-35118568-C-T	Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|RAD51D-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	2	30469700	ClinGen:CA165840	0.093680	0.11459	0	RCV000130161|RCV000238834|RCV000225779|RCV001030594|RCV001284344|RCV001798441|RCV003952682	T	1	0	c.196G>A	0	374	0	0.00322	C/C	rs56026142	35118568	14902	C	5.990415335463259E-4	O75771	15690	0.19788	0.000000e+00	0.24998		0	0	8.334820e-03	1.2	0	1	264690	-0.163	0.50082	6346	T	.	1	6.552220e-05	0	1848	.	0	0	140162|145|145	141578	0.17258	.	0.0349691153311283	4900	3	0.13799	0.18747	1.167540e-04	3.578350e-03	1180038	0.004	2.883700e-04	N	13366	0	2.0023424E-4	18	614291	0.13047	17	6.710510e-05	ENSG00000185379	0.000000e+00	6.535264286087729E-6	1	0.003246753246753247	.	1	0.43339	0.17784	30608	53	1.947230e-05	8.331110e-05	-0.881724750457004	YES	1.866530e-04	0.024861	151292	HGNC:9823	N	0	simple_aae	0.035	208066	35118568	GTG	0.444000	2	-	0	0.00228	7.626870e-06	0	0	Conflicting classifications of pathogenicity	0.28513	1	1	5	ClinGen:CA165840	V	0	0.485420873983	-	0.532	-	0.39815	76	11718	.	.	0.1196	0	0.85296696707845254	280	-	196G>A 	65	7.680491551459293E-4	C0027672|CN221562|C3661900|C0677776|CN169374|C3280345	0	0	0	0	NM_002878.4	-	0	0.0	0	0.67135	56026142	2320	1.9138540517416071E-4	0.47807	0.12311	0.358	0.066	4724	0.88900130	4.79	.	.	3.267120e-05	-0.547555	0.000394112558413836	0.30152	T	4498	6212	9572	-0.9936	0.40048	p.Val66Met	6	0	-4.122	0.010412663	1	0.06034	141578	T	30524	RAD51D	5.843850e-05	T	0.088	21604	V66M	T	0.03264	0.00504	C/C	principal1	962165	RAD51D_unpublished_var156412	Yes						overall function		Cell survival			V		196	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Val66Met		true	c.196G>A						9823.0	35118568.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		A									criteria provided, conflicting classifications				Val66Met						M	Jan 28, 2024					missense_variant		66.0	G		0.0002601943527913	0.00606963		Conflicting classifications of pathogenicity	35118568.0	missense_variant		0.088	functionally_normal				Cell viability			RAD51D_Val66Met
RAD51D_Val66Met	-0.545546479468292	0.6023201818835449	9.486270453812262	0.000030256308289431174	2025_01_Batch_13-14	0.7562182404004095	0.8179277119701884	0.8685760632494186	0.8268199895224255	0.6855978670709192	0.5251440850520803	0.7154595109435239	0.8414875127860665	0.7385265014914997	0.5175576559932441	0.640681162726245	0.7666936114568561	0.8550317880177425	0.7826732455069626	0.6015777615320816	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024804	ALE00029792	NC_000017.11:35118568:C:T	196G>A	Val66Met	CAVA																											RAD51D_Val66Met	17	35118568	C	T	17								1	1	1	17-35118568-C-T	-	0.19181	0.476	66	4	1	0	17	33445587	T	2.601940e-04	1	17	3_Conflicting	NC_000017.11	374	Val66Met	65	14.12	24	0	3.674390e-03	T	1	16	1	42766	3.208320e-04	1	30526	0.000000e+00	0	0.25383	Select	0.1126	17690	0.36683	4	0.001984126984126984	T	T	64024	.	0	0	0.000000e+00	0	0	.	17112	44872	17	3.578350e-03	0.16529	2	.	0.19787	0.443	7.564296520423601E-4	95.0	.	-5.85	0.05	T	single nucleotide variant	NC_000017.11:g.35118568C>T	0	16706	2	0.05022742	109376	0	0.085984245	0.003781909864481563		60	236884	0	0	3.674390e-03	442	4.676610e-05	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN221562|	30	0	0.000000e+00	0	0.16373	B	0.07854	P	L	0.5605822	420	C/C	176	9	7164	1614178	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|not provided|Breast and/or ovarian cancer|RAD51D-related disorder	16218	0.31561	0	.	-	35118568	2.653690e-03	-	0.681000	1	0.07875	29608	0	44872	48	germline;unknown	91078	Loss of catalytic residue at V66 (P = 0.1757)| Gain of disorder (P = 0.2016)| Gain of relative solvent accessibility (P = 0.2816)| Loss of glycosylation at S62 (P = 0.3483)| Gain of loop (P = 0.3485)	0.63879	GRCh38	926	criteria provided, conflicting classifications	c.196G>A	3.275900e-05	0.12675	34	0	0	.	0.000000e+00	9044	LB	0.004001778568252557	3.377470e-05	NM_002878.4(RAD51D):c.196G>A (p.Val66Met)	1	0	RA51D_HUMAN	0	5.0	-0.868469024722056	2	.	0.24734	0.085984245	-	1.395870e-04	0		48	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.90830	2.742830e-04	1	0.000000e+00	0	60016	p.Val66Met	0	0.20762	.	germline	24		C	Mar 04, 2025	1	C/C	0	89522	0.001	N	17q12	153016	.	6.165990e-05	SCV000184996|SCV000287700|SCV000297127|SCV000489108|SCV000515953|SCV000686426|SCV000920125|SCV001193731|SCV001470086|SCV002043215|SCV002534780|SCV004017746|SCV004024299	Conflicting_classifications_of_pathogenicity	0	0	Met	M	-	912	ENSP00000338790	ENST00000345365	17690	0.095	13414	0	-1.926	C	0	1.488353	0.44850	N	T	-	0.6448988	.	0.47635	950	0	0.0	0.02783	24	35118568	Y	10	0	102710	1.649620e-04	O75771	0	0.159822	0.16045		0	0.365	T	13414	0.05022742	9044	0.27788	5892	-0.540521	9	-0.54	0.0	8.334820e-03	0.34240	6.373490e-05	0	75058	2.653690e-03	6062	1	0.07854	17	RAD51D	1.332300e-05	0	Val	177652	4.468180e-05	17-35118568-C-T	Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|RAD51D-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	2	30469700	ClinGen:CA165840	0.093680	0.11459	0	RCV000130161|RCV000238834|RCV000225779|RCV001030594|RCV001284344|RCV001798441|RCV003952682	T	1	0	c.196G>A	0	374	0	0.00322	C/C	rs56026142	35118568	14902	C	5.990415335463259E-4	O75771	15690	0.19788	0.000000e+00	0.24998		0	0	8.334820e-03	1.2	0	1	264690	-0.163	0.50082	6346	T	.	1	6.552220e-05	0	1848	.	0	0	140162|145|145	141578	0.17258	.	0.0349691153311283	4900	3	0.13799	0.18747	1.167540e-04	3.578350e-03	1180038	0.004	2.883700e-04	N	13366	0	2.0023424E-4	18	614291	0.13047	17	6.710510e-05	ENSG00000185379	0.000000e+00	6.535264286087729E-6	1	0.003246753246753247	.	1	0.43339	0.17784	30608	53	1.947230e-05	8.331110e-05	-0.881724750457004	YES	1.866530e-04	0.024861	151292	HGNC:9823	N	0	simple_aae	0.035	208066	35118568	GTG	0.444000	2	-	0	0.00228	7.626870e-06	0	0	Conflicting classifications of pathogenicity	0.28513	1	1	5	ClinGen:CA165840	V	0	0.485420873983	-	0.532	-	0.39815	76	11718	.	.	0.1196	0	0.85296696707845254	280	-	196G>A 	65	7.680491551459293E-4	C0027672|CN221562|C3661900|C0677776|CN169374|C3280345	0	0	0	0	NM_002878.4	-	0	0.0	0	0.67135	56026142	2320	1.9138540517416071E-4	0.47807	0.12311	0.358	0.066	4724	0.88900130	4.79	.	.	3.267120e-05	-0.547555	0.000394112558413836	0.30152	T	4498	6212	9572	-0.9936	0.40048	p.Val66Met	6	0	-4.122	0.010412663	1	0.06034	141578	T	30524	RAD51D	5.843850e-05	T	0.088	21604	V66M	T	0.03264	0.00504	C/C	principal1	962165	RAD51D_unpublished_var156412	Yes						overall function		Cell survival			V		196	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Val66Met		true	c.196G>A						9823.0	35118568.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		A									criteria provided, conflicting classifications				Val66Met						M	Jan 28, 2024					missense_variant		66.0	G		0.0002601943527913	0.00606963		Conflicting classifications of pathogenicity	35118568.0	missense_variant		0.088	functionally_normal				Cell viability			RAD51D_Val66Met
BAP1_Cys91Gly	1.5164097053786887	0.17319848524644227	-4.617978065799683	0.0024319418319997716	2025_01_Batch_13-14	0.5863642072617119	0.7187541665516547	0.8351907724968624	0.795822950306513	0.6109290087208261	0.8059496747384488	0.8150315617787417	0.7801839214064152	0.8950993774317042	0.5548470031652829	0.6961569410000803	0.7668928641651982	0.8076873469516388	0.8454611638691085	0.5828880059430546	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009482		NC_000003.12:52408062:A:C		Cys91Gly																												BAP1_Cys91Gly	3	52408062	A	C	3	allele	271T>G	A02	527_CAVA_Array_P01	A03	B13A7A8P1_R1	B14A7A8P1_R2				3-52408062-A-C	-	0.88304	1.0	91	.	.	.	3	52442078	C	.	.	3	4_VUS	NC_000003.12	.	Cys91Gly	.	29.5	.	.	.	D	.	2	1	.	.	.	.	.	.	0.99840	Select	0.9443	.	0.90580	.	.	D	D	.	2.76950302636	.	.	.	.	.	0.89059	.	.	.	.	0.99595	.	.	0.98337	0.999	.	.	0.998744	3.34	.	C	single nucleotide variant	NC_000003.12:g.52408062A>C	.	.	2	0.9594046	.	.	0.97112095	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	.	.	.	D	0.98923	D	H	14.15777	.	A/A	.	.	.	.	Neurodevelopmental disorder|Hereditary cancer-predisposing syndrome	.	0.99732	.	.	-	52408062	.	-	11.129000	.	0.97790	.	.	.	.	de novo;germline	.	Loss of stability (P = 0.0176)| Gain of disorder (P = 0.0416)| Gain of sheet (P = 0.1208)| Loss of helix (P = 0.1299)| Gain of loop (P = 0.2045)	0.98665	GRCh38	68	criteria provided, single submitter	c.271T>G	.	0.80997	.	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	.	.	P	.	.	NM_004656.4(BAP1):c.271T>G (p.Cys91Gly)	1	.	BAP1_HUMAN	.	.	1.0074398562281	.	D	0.98152	0.97112095	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99864	.	.	.	.	.	p.Cys91Gly	.	0.86768	.	germline	.		A	Sep 14, 2021	.	A/A	.	.	1.0	N	3p21.1	.	.	.	SCV002743592	Uncertain_significance	.	.	Gly	G	-	.	ENSP00000417132	ENST00000460680	.	0.001	.	.	0.756	A	.	5.258269	0.92967	D	D	-	14.54242	.	0.97092	.	.	.	0.99678	.	52408062	Y	10	.	.	.	Q92560	.	0.614019	0.36682		.	1.0	D	.	0.9594046	.	0.91597	8314	0.551935	.	-11.35	.	.	0.78662	.	.	.	.	.	.	0.98923	3	BAP1	.	.	Cys	.	.	3-52408062-A-C	Hereditary_cancer-predisposing_syndrome|Neurodevelopmental_disorder	.	.	52417118	.	0.954137	0.95947	.	RCV001797188|RCV002424967	D	.	.	c.271T>G	.	.	.	0.95794	A/A	rs1705222655	52408062	.	A	.	Q92560	.	0.98337	.	0.68239		.	.	.	4.145	.	.	.	5.49	0.87693	.	D	D	.	.	.	.	.	.	.	140162	1173082	0.95730	0.98787	0.999918460845947	.	.	0.71675	0.97089	.	.	.	9.031	.	D	.	.	.	.	.	0.93237	3	.	ENSG00000163930	.	.	.	.	0.9635444637645938	1	0.97365	0.97129	.	.	.	.	0.917979903155774	YES	.	0.655758	1162264	HGNC:950	.	.	.	0.951	.	52408062	TGT	1.000000	.	-	.	0.99640	.	.	.	Uncertain significance	0.90565	.	.	.	ClinGen:CA353112613	C	.	0.981038681151	-	0.923	-	0.98575	.	.	0.96320	0.846445500851	0.9988	.	0.97870451339973896	.	-	271T>G 	.	.	C0027672|C1535926	.	.	.	.	NM_004656.4	-	.	.	1	0.99359	1705222655	.	.	0.98064	0.96288	0.974	0.0	.	0.99989021	5.49	.	.	.	0.55504	0.999985923692613	0.97505	D	.	.	.	1.1018	0.98173	p.Cys91Gly	.	.	-13.296	0.99121475	.	0.99579	1173082	D	.	BAP1	.	D	0.979	.	C91G	D	0.60572	0.943	A/A	principal1																																																																																																				
F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368682	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586484	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_His303Tyr	23	139561592	C	T	X											X-139561592-C-T	-	0.19488	0.0	303	65	5	0	X	138643751	T	7.593360e-04	0	X	2_Benign	NC_000023.11	856	His303Tyr	0	14.27	0	1	9.248780e-04	D	1	5	1	30478	4.726260e-04	.	17864	0.000000e+00	0	0.81214	Select	0.5304	72442	0.02950	2	.	D	T	46566	0.738624950036	2.1240441801189465E-4	0	1.464340e-04	0	0	0.30325	13550	33722	2	0.000000e+00	0.48032	26	.	0.54850	0.866	.	97.0	0.640436	0.182	0.03	T	single nucleotide variant	NC_000023.11:g.139561592C>T	0	12089	3	0.2341255	79075	0	0.22414766	0	T	77	169267	0	0	0.000000e+00	442	8.530740e-04	0	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	30	3	0.000000e+00	0	0.13669	B	0.40065	B	N	.	916	C/C	176	8	5695	1206317	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13110	0.67220	.	.	-	139561592	8.530740e-04	-	-0.323000	2	0.52448	21910	0	892587	0	germline;unknown	56193	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.907C>T	0.000000e+00	0.23158	124	0	2	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.271980e-05	6914	B	0	2.282060e-04	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2	0	FA9_HUMAN	0	3.0	.	2	T	0.19100	0.32649112	+	1.755930e-04	.	0.000794178	65	4.473270e-04	0	26917	criteria_provided,_multiple_submitters,_no_conflicts	0.99864	3.793870e-04	2	1.015740e-04	0	45609	p.His303Tyr	0	0.09991	.	germline	26	139561592	C	Jan 19, 2025	0	C/C	0	63767	0.989	N	Xq27.1	152922	.	1.525550e-04	SCV001001225|SCV001330208|SCV002804939	Benign/Likely_benign	1	1	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13305	1.0	10122	0	-0.916	C	0	1.514762	0.40770	.	T	-	.	.	0.72008	950	0	.	0.00239	0	139561592	Y	10	0	72442	0.000000e+00	P00740	0	0.723082	0.01925	C	0	0.002	D	63767	0.17656629	30478	0.41182	2158	-0.0624261	856	-2.11	.	9.590100e-04	0.00968	0.000000e+00	0	57230	0.000000e+00	4367	1	0.48437	X	F9	1.572600e-04	0	His	172758	1.019340e-03	X-139561592-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	0	67	138471417	ClinGen:CA121135|OMIM:300746.0085	.	.	1	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	T	0	0	c.907C>T	0	0	18	0.42182	C/C	rs1801202	139561592	12041	C	.	.	9460	0.44724	1.900060e-04	0.08389	X	0	0	0.000000e+00	0.65	0	115	264690	1.68	0.92116	3394	T	T	2	8.267200e-05	0	682	.	0	1	98879	10641	0.75097	0.62872	0.0133548470984691	4884	.	0.36837	.	7.430250e-05	1.019340e-03	892587	2.06	5.159300e-04	N	9845	0	3.5891042E-4	0	306900|300807|301052	0.41124	X	1.660990e-04	ENSG00000101981	3.865480e-04	7.520173683315677E-4	0	0	0.9381481836570156	1	0.06938	0.18019	17929	95	9.248780e-04	8.770200e-05	.	YES	3.559160e-05	0.074688	25680	HGNC:3551	N	0	simple_aae	0.254	149245	139561592	CAC	0.000000	.	-	2.0475020475020476E-4	0.06886	9.590100e-04	1	1	Benign/Likely benign	0.19630	0	0	4	ClinGen:CA121135,OMIM:300746.0085	H	0	0.999367092589	-	.	-	0.12993	80	9886	0.93756	0.438427627087	0.0722	0	0.32830897832429229	280	-	907C>T 	67	8.092251669026907E-4	C0008533|C2749016|C5393318	0	0	0	0	NM_000133.4	-	.	.	0	0.25033	1801202	1702	7.177670498616562E-4	0.99934	.	0.134	0.089	4708	0.99989235	5.42	.	.	0.000000e+00	0.075559	0.69627509395232	0.16042	T	2712	4471	6829	-0.5347	0.82502	p.His303Tyr	0	0	-3.72	0.058540702	9	0.66900	10641	T	24192	F9	0.000000e+00	D	0.549	15789	.	T	0.22814	0.02232	C/C	principal1	223948	F9_Popp_2025_light_chain_var246396	No											H		907	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.His303Tyr		true	c.907C>T						3551.0	139561592.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				His303Tyr						Y	Jan 29, 2024					missense_variant		303.0			0.0007593360617482	1.0817989057893431		Benign/Likely benign	139561592.0	missense_variant		0.549					Reporter			F9_His303Tyr
F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368682	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586484	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_His303Tyr	23	139561592	C	T	X											X-139561592-C-T	-	0.19488	0.0	303	65	5	0	X	138643751	T	7.593360e-04	0	X	2_Benign	NC_000023.11	856	His303Tyr	0	14.27	0	1	9.248780e-04	D	1	5	1	30478	4.726260e-04	.	17864	0.000000e+00	0	0.81214	Select	0.5304	72442	0.02950	2	.	D	T	46566	0.738624950036	2.1240441801189465E-4	0	1.464340e-04	0	0	0.30325	13550	33722	2	0.000000e+00	0.48032	26	.	0.54850	0.866	.	97.0	0.640436	0.182	0.03	T	single nucleotide variant	NC_000023.11:g.139561592C>T	0	12089	3	0.2341255	79075	0	0.22414766	0	T	77	169267	0	0	0.000000e+00	442	8.530740e-04	0	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	30	3	0.000000e+00	0	0.13669	B	0.40065	B	N	.	916	C/C	176	8	5695	1206317	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13110	0.67220	.	.	-	139561592	8.530740e-04	-	-0.323000	2	0.52448	21910	0	892587	0	germline;unknown	56193	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.907C>T	0.000000e+00	0.23158	124	0	2	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.271980e-05	6914	B	0	2.282060e-04	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2	0	FA9_HUMAN	0	3.0	.	2	T	0.19100	0.32649112	+	1.755930e-04	.	0.000794178	65	4.473270e-04	0	26917	criteria_provided,_multiple_submitters,_no_conflicts	0.99864	3.793870e-04	2	1.015740e-04	0	45609	p.His303Tyr	0	0.09991	.	germline	26	139561592	C	Jan 19, 2025	0	C/C	0	63767	0.989	N	Xq27.1	152922	.	1.525550e-04	SCV001001225|SCV001330208|SCV002804939	Benign/Likely_benign	1	1	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13305	1.0	10122	0	-0.916	C	0	1.514762	0.40770	.	T	-	.	.	0.72008	950	0	.	0.00239	0	139561592	Y	10	0	72442	0.000000e+00	P00740	0	0.723082	0.01925	C	0	0.002	D	63767	0.17656629	30478	0.41182	2158	-0.0624261	856	-2.11	.	9.590100e-04	0.00968	0.000000e+00	0	57230	0.000000e+00	4367	1	0.48437	X	F9	1.572600e-04	0	His	172758	1.019340e-03	X-139561592-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	0	67	138471417	ClinGen:CA121135|OMIM:300746.0085	.	.	1	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	T	0	0	c.907C>T	0	0	18	0.42182	C/C	rs1801202	139561592	12041	C	.	.	9460	0.44724	1.900060e-04	0.08389	X	0	0	0.000000e+00	0.65	0	115	264690	1.68	0.92116	3394	T	T	2	8.267200e-05	0	682	.	0	1	98879	10641	0.75097	0.62872	0.0133548470984691	4884	.	0.36837	.	7.430250e-05	1.019340e-03	892587	2.06	5.159300e-04	N	9845	0	3.5891042E-4	0	306900|300807|301052	0.41124	X	1.660990e-04	ENSG00000101981	3.865480e-04	7.520173683315677E-4	0	0	0.9381481836570156	1	0.06938	0.18019	17929	95	9.248780e-04	8.770200e-05	.	YES	3.559160e-05	0.074688	25680	HGNC:3551	N	0	simple_aae	0.254	149245	139561592	CAC	0.000000	.	-	2.0475020475020476E-4	0.06886	9.590100e-04	1	1	Benign/Likely benign	0.19630	0	0	4	ClinGen:CA121135,OMIM:300746.0085	H	0	0.999367092589	-	.	-	0.12993	80	9886	0.93756	0.438427627087	0.0722	0	0.32830897832429229	280	-	907C>T 	67	8.092251669026907E-4	C0008533|C2749016|C5393318	0	0	0	0	NM_000133.4	-	.	.	0	0.25033	1801202	1702	7.177670498616562E-4	0.99934	.	0.134	0.089	4708	0.99989235	5.42	.	.	0.000000e+00	0.075559	0.69627509395232	0.16042	T	2712	4471	6829	-0.5347	0.82502	p.His303Tyr	0	0	-3.72	0.058540702	9	0.66900	10641	T	24192	F9	0.000000e+00	D	0.549	15789	.	T	0.22814	0.02232	C/C	principal1	251464	F9_Popp_2025_strep_2_var265758	No											H		907	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.His303Tyr		true	c.907C>T						3551.0	139561592.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				His303Tyr						Y	Jan 29, 2024					missense_variant		303.0			0.0007593360617482	1.128190842767414		Benign/Likely benign	139561592.0	missense_variant		0.549					Reporter			F9_His303Tyr
F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368682	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586484	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_His303Tyr	23	139561592	C	T	X											X-139561592-C-T	-	0.19488	0.0	303	65	5	0	X	138643751	T	7.593360e-04	0	X	2_Benign	NC_000023.11	856	His303Tyr	0	14.27	0	1	9.248780e-04	D	1	5	1	30478	4.726260e-04	.	17864	0.000000e+00	0	0.81214	Select	0.5304	72442	0.02950	2	.	D	T	46566	0.738624950036	2.1240441801189465E-4	0	1.464340e-04	0	0	0.30325	13550	33722	2	0.000000e+00	0.48032	26	.	0.54850	0.866	.	97.0	0.640436	0.182	0.03	T	single nucleotide variant	NC_000023.11:g.139561592C>T	0	12089	3	0.2341255	79075	0	0.22414766	0	T	77	169267	0	0	0.000000e+00	442	8.530740e-04	0	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	30	3	0.000000e+00	0	0.13669	B	0.40065	B	N	.	916	C/C	176	8	5695	1206317	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13110	0.67220	.	.	-	139561592	8.530740e-04	-	-0.323000	2	0.52448	21910	0	892587	0	germline;unknown	56193	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.907C>T	0.000000e+00	0.23158	124	0	2	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.271980e-05	6914	B	0	2.282060e-04	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2	0	FA9_HUMAN	0	3.0	.	2	T	0.19100	0.32649112	+	1.755930e-04	.	0.000794178	65	4.473270e-04	0	26917	criteria_provided,_multiple_submitters,_no_conflicts	0.99864	3.793870e-04	2	1.015740e-04	0	45609	p.His303Tyr	0	0.09991	.	germline	26	139561592	C	Jan 19, 2025	0	C/C	0	63767	0.989	N	Xq27.1	152922	.	1.525550e-04	SCV001001225|SCV001330208|SCV002804939	Benign/Likely_benign	1	1	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13305	1.0	10122	0	-0.916	C	0	1.514762	0.40770	.	T	-	.	.	0.72008	950	0	.	0.00239	0	139561592	Y	10	0	72442	0.000000e+00	P00740	0	0.723082	0.01925	C	0	0.002	D	63767	0.17656629	30478	0.41182	2158	-0.0624261	856	-2.11	.	9.590100e-04	0.00968	0.000000e+00	0	57230	0.000000e+00	4367	1	0.48437	X	F9	1.572600e-04	0	His	172758	1.019340e-03	X-139561592-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	0	67	138471417	ClinGen:CA121135|OMIM:300746.0085	.	.	1	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	T	0	0	c.907C>T	0	0	18	0.42182	C/C	rs1801202	139561592	12041	C	.	.	9460	0.44724	1.900060e-04	0.08389	X	0	0	0.000000e+00	0.65	0	115	264690	1.68	0.92116	3394	T	T	2	8.267200e-05	0	682	.	0	1	98879	10641	0.75097	0.62872	0.0133548470984691	4884	.	0.36837	.	7.430250e-05	1.019340e-03	892587	2.06	5.159300e-04	N	9845	0	3.5891042E-4	0	306900|300807|301052	0.41124	X	1.660990e-04	ENSG00000101981	3.865480e-04	7.520173683315677E-4	0	0	0.9381481836570156	1	0.06938	0.18019	17929	95	9.248780e-04	8.770200e-05	.	YES	3.559160e-05	0.074688	25680	HGNC:3551	N	0	simple_aae	0.254	149245	139561592	CAC	0.000000	.	-	2.0475020475020476E-4	0.06886	9.590100e-04	1	1	Benign/Likely benign	0.19630	0	0	4	ClinGen:CA121135,OMIM:300746.0085	H	0	0.999367092589	-	.	-	0.12993	80	9886	0.93756	0.438427627087	0.0722	0	0.32830897832429229	280	-	907C>T 	67	8.092251669026907E-4	C0008533|C2749016|C5393318	0	0	0	0	NM_000133.4	-	.	.	0	0.25033	1801202	1702	7.177670498616562E-4	0.99934	.	0.134	0.089	4708	0.99989235	5.42	.	.	0.000000e+00	0.075559	0.69627509395232	0.16042	T	2712	4471	6829	-0.5347	0.82502	p.His303Tyr	0	0	-3.72	0.058540702	9	0.66900	10641	T	24192	F9	0.000000e+00	D	0.549	15789	.	T	0.22814	0.02232	C/C	principal1	196432	F9_Popp_2025_heavy_chain_var236715	No											H		907	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.His303Tyr		true	c.907C>T						3551.0	139561592.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				His303Tyr						Y	Jan 29, 2024					missense_variant		303.0			0.0007593360617482	1.06892381		Benign/Likely benign	139561592.0	missense_variant		0.549					Reporter			F9_His303Tyr
F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368682	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586484	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_His303Tyr	23	139561592	C	T	X											X-139561592-C-T	-	0.19488	0.0	303	65	5	0	X	138643751	T	7.593360e-04	0	X	2_Benign	NC_000023.11	856	His303Tyr	0	14.27	0	1	9.248780e-04	D	1	5	1	30478	4.726260e-04	.	17864	0.000000e+00	0	0.81214	Select	0.5304	72442	0.02950	2	.	D	T	46566	0.738624950036	2.1240441801189465E-4	0	1.464340e-04	0	0	0.30325	13550	33722	2	0.000000e+00	0.48032	26	.	0.54850	0.866	.	97.0	0.640436	0.182	0.03	T	single nucleotide variant	NC_000023.11:g.139561592C>T	0	12089	3	0.2341255	79075	0	0.22414766	0	T	77	169267	0	0	0.000000e+00	442	8.530740e-04	0	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	30	3	0.000000e+00	0	0.13669	B	0.40065	B	N	.	916	C/C	176	8	5695	1206317	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13110	0.67220	.	.	-	139561592	8.530740e-04	-	-0.323000	2	0.52448	21910	0	892587	0	germline;unknown	56193	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.907C>T	0.000000e+00	0.23158	124	0	2	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.271980e-05	6914	B	0	2.282060e-04	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2	0	FA9_HUMAN	0	3.0	.	2	T	0.19100	0.32649112	+	1.755930e-04	.	0.000794178	65	4.473270e-04	0	26917	criteria_provided,_multiple_submitters,_no_conflicts	0.99864	3.793870e-04	2	1.015740e-04	0	45609	p.His303Tyr	0	0.09991	.	germline	26	139561592	C	Jan 19, 2025	0	C/C	0	63767	0.989	N	Xq27.1	152922	.	1.525550e-04	SCV001001225|SCV001330208|SCV002804939	Benign/Likely_benign	1	1	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13305	1.0	10122	0	-0.916	C	0	1.514762	0.40770	.	T	-	.	.	0.72008	950	0	.	0.00239	0	139561592	Y	10	0	72442	0.000000e+00	P00740	0	0.723082	0.01925	C	0	0.002	D	63767	0.17656629	30478	0.41182	2158	-0.0624261	856	-2.11	.	9.590100e-04	0.00968	0.000000e+00	0	57230	0.000000e+00	4367	1	0.48437	X	F9	1.572600e-04	0	His	172758	1.019340e-03	X-139561592-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	0	67	138471417	ClinGen:CA121135|OMIM:300746.0085	.	.	1	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	T	0	0	c.907C>T	0	0	18	0.42182	C/C	rs1801202	139561592	12041	C	.	.	9460	0.44724	1.900060e-04	0.08389	X	0	0	0.000000e+00	0.65	0	115	264690	1.68	0.92116	3394	T	T	2	8.267200e-05	0	682	.	0	1	98879	10641	0.75097	0.62872	0.0133548470984691	4884	.	0.36837	.	7.430250e-05	1.019340e-03	892587	2.06	5.159300e-04	N	9845	0	3.5891042E-4	0	306900|300807|301052	0.41124	X	1.660990e-04	ENSG00000101981	3.865480e-04	7.520173683315677E-4	0	0	0.9381481836570156	1	0.06938	0.18019	17929	95	9.248780e-04	8.770200e-05	.	YES	3.559160e-05	0.074688	25680	HGNC:3551	N	0	simple_aae	0.254	149245	139561592	CAC	0.000000	.	-	2.0475020475020476E-4	0.06886	9.590100e-04	1	1	Benign/Likely benign	0.19630	0	0	4	ClinGen:CA121135,OMIM:300746.0085	H	0	0.999367092589	-	.	-	0.12993	80	9886	0.93756	0.438427627087	0.0722	0	0.32830897832429229	280	-	907C>T 	67	8.092251669026907E-4	C0008533|C2749016|C5393318	0	0	0	0	NM_000133.4	-	.	.	0	0.25033	1801202	1702	7.177670498616562E-4	0.99934	.	0.134	0.089	4708	0.99989235	5.42	.	.	0.000000e+00	0.075559	0.69627509395232	0.16042	T	2712	4471	6829	-0.5347	0.82502	p.His303Tyr	0	0	-3.72	0.058540702	9	0.66900	10641	T	24192	F9	0.000000e+00	D	0.549	15789	.	T	0.22814	0.02232	C/C	principal1	168916	F9_Popp_2025_carboxy_gla_motif_var256077	No											H		907	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.His303Tyr		true	c.907C>T						3551.0	139561592.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				His303Tyr						Y	Jan 29, 2024					missense_variant		303.0			0.0007593360617482	1.0448265944586022		Benign/Likely benign	139561592.0	missense_variant		0.549					Reporter			F9_His303Tyr
F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368682	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586484	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	NC_000023.11:139561592:C:T	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_His303Tyr	23	139561592	C	T	X											X-139561592-C-T	-	0.19488	0.0	303	65	5	0	X	138643751	T	7.593360e-04	0	X	2_Benign	NC_000023.11	856	His303Tyr	0	14.27	0	1	9.248780e-04	D	1	5	1	30478	4.726260e-04	.	17864	0.000000e+00	0	0.81214	Select	0.5304	72442	0.02950	2	.	D	T	46566	0.738624950036	2.1240441801189465E-4	0	1.464340e-04	0	0	0.30325	13550	33722	2	0.000000e+00	0.48032	26	.	0.54850	0.866	.	97.0	0.640436	0.182	0.03	T	single nucleotide variant	NC_000023.11:g.139561592C>T	0	12089	3	0.2341255	79075	0	0.22414766	0	T	77	169267	0	0	0.000000e+00	442	8.530740e-04	0	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	30	3	0.000000e+00	0	0.13669	B	0.40065	B	N	.	916	C/C	176	8	5695	1206317	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13110	0.67220	.	.	-	139561592	8.530740e-04	-	-0.323000	2	0.52448	21910	0	892587	0	germline;unknown	56193	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.907C>T	0.000000e+00	0.23158	124	0	2	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.271980e-05	6914	B	0	2.282060e-04	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2	0	FA9_HUMAN	0	3.0	.	2	T	0.19100	0.32649112	+	1.755930e-04	.	0.000794178	65	4.473270e-04	0	26917	criteria_provided,_multiple_submitters,_no_conflicts	0.99864	3.793870e-04	2	1.015740e-04	0	45609	p.His303Tyr	0	0.09991	.	germline	26	139561592	C	Jan 19, 2025	0	C/C	0	63767	0.989	N	Xq27.1	152922	.	1.525550e-04	SCV001001225|SCV001330208|SCV002804939	Benign/Likely_benign	1	1	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13305	1.0	10122	0	-0.916	C	0	1.514762	0.40770	.	T	-	.	.	0.72008	950	0	.	0.00239	0	139561592	Y	10	0	72442	0.000000e+00	P00740	0	0.723082	0.01925	C	0	0.002	D	63767	0.17656629	30478	0.41182	2158	-0.0624261	856	-2.11	.	9.590100e-04	0.00968	0.000000e+00	0	57230	0.000000e+00	4367	1	0.48437	X	F9	1.572600e-04	0	His	172758	1.019340e-03	X-139561592-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	0	67	138471417	ClinGen:CA121135|OMIM:300746.0085	.	.	1	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	T	0	0	c.907C>T	0	0	18	0.42182	C/C	rs1801202	139561592	12041	C	.	.	9460	0.44724	1.900060e-04	0.08389	X	0	0	0.000000e+00	0.65	0	115	264690	1.68	0.92116	3394	T	T	2	8.267200e-05	0	682	.	0	1	98879	10641	0.75097	0.62872	0.0133548470984691	4884	.	0.36837	.	7.430250e-05	1.019340e-03	892587	2.06	5.159300e-04	N	9845	0	3.5891042E-4	0	306900|300807|301052	0.41124	X	1.660990e-04	ENSG00000101981	3.865480e-04	7.520173683315677E-4	0	0	0.9381481836570156	1	0.06938	0.18019	17929	95	9.248780e-04	8.770200e-05	.	YES	3.559160e-05	0.074688	25680	HGNC:3551	N	0	simple_aae	0.254	149245	139561592	CAC	0.000000	.	-	2.0475020475020476E-4	0.06886	9.590100e-04	1	1	Benign/Likely benign	0.19630	0	0	4	ClinGen:CA121135,OMIM:300746.0085	H	0	0.999367092589	-	.	-	0.12993	80	9886	0.93756	0.438427627087	0.0722	0	0.32830897832429229	280	-	907C>T 	67	8.092251669026907E-4	C0008533|C2749016|C5393318	0	0	0	0	NM_000133.4	-	.	.	0	0.25033	1801202	1702	7.177670498616562E-4	0.99934	.	0.134	0.089	4708	0.99989235	5.42	.	.	0.000000e+00	0.075559	0.69627509395232	0.16042	T	2712	4471	6829	-0.5347	0.82502	p.His303Tyr	0	0	-3.72	0.058540702	9	0.66900	10641	T	24192	F9	0.000000e+00	D	0.549	15789	.	T	0.22814	0.02232	C/C	principal1	141400	F9_Popp_2025_carboxy_F9_specific_var227034	No											H		907	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.His303Tyr		true	c.907C>T						3551.0	139561592.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				His303Tyr						Y	Jan 29, 2024					missense_variant		303.0			0.0007593360617482	1.0177519699244646		Benign/Likely benign	139561592.0	missense_variant		0.549					Reporter			F9_His303Tyr
F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368682	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586484	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004383		NC_000023.11:139561592:C:T		His303Tyr																												F9_His303Tyr	23	139561592	C	T	X	allele	907C>T	E10	527_CAVA_Array_P02	I20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561592-C-T	-	0.19488	0.0	303	65	5	0	X	138643751	T	7.593360e-04	0	X	2_Benign	NC_000023.11	856	His303Tyr	0	14.27	0	1	9.248780e-04	D	1	5	1	30478	4.726260e-04	.	17864	0.000000e+00	0	0.81214	Select	0.5304	72442	0.02950	2	.	D	T	46566	0.738624950036	2.1240441801189465E-4	0	1.464340e-04	0	0	0.30325	13550	33722	2	0.000000e+00	0.48032	26	.	0.54850	0.866	.	97.0	0.640436	0.182	0.03	T	single nucleotide variant	NC_000023.11:g.139561592C>T	0	12089	3	0.2341255	79075	0	0.22414766	0	T	77	169267	0	0	0.000000e+00	442	8.530740e-04	0	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	30	3	0.000000e+00	0	0.13669	B	0.40065	B	N	.	916	C/C	176	8	5695	1206317	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13110	0.67220	.	.	-	139561592	8.530740e-04	-	-0.323000	2	0.52448	21910	0	892587	0	germline;unknown	56193	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.907C>T	0.000000e+00	0.23158	124	0	2	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.271980e-05	6914	B	0	2.282060e-04	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2	0	FA9_HUMAN	0	3.0	.	2	T	0.19100	0.32649112	+	1.755930e-04	.	0.000794178	65	4.473270e-04	0	26917	criteria_provided,_multiple_submitters,_no_conflicts	0.99864	3.793870e-04	2	1.015740e-04	0	45609	p.His303Tyr	0	0.09991	.	germline	26	139561592	C	Jan 19, 2025	0	C/C	0	63767	0.989	N	Xq27.1	152922	.	1.525550e-04	SCV001001225|SCV001330208|SCV002804939	Benign/Likely_benign	1	1	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13305	1.0	10122	0	-0.916	C	0	1.514762	0.40770	.	T	-	.	.	0.72008	950	0	.	0.00239	0	139561592	Y	10	0	72442	0.000000e+00	P00740	0	0.723082	0.01925	C	0	0.002	D	63767	0.17656629	30478	0.41182	2158	-0.0624261	856	-2.11	.	9.590100e-04	0.00968	0.000000e+00	0	57230	0.000000e+00	4367	1	0.48437	X	F9	1.572600e-04	0	His	172758	1.019340e-03	X-139561592-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	0	67	138471417	ClinGen:CA121135|OMIM:300746.0085	.	.	1	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	T	0	0	c.907C>T	0	0	18	0.42182	C/C	rs1801202	139561592	12041	C	.	.	9460	0.44724	1.900060e-04	0.08389	X	0	0	0.000000e+00	0.65	0	115	264690	1.68	0.92116	3394	T	T	2	8.267200e-05	0	682	.	0	1	98879	10641	0.75097	0.62872	0.0133548470984691	4884	.	0.36837	.	7.430250e-05	1.019340e-03	892587	2.06	5.159300e-04	N	9845	0	3.5891042E-4	0	306900|300807|301052	0.41124	X	1.660990e-04	ENSG00000101981	3.865480e-04	7.520173683315677E-4	0	0	0.9381481836570156	1	0.06938	0.18019	17929	95	9.248780e-04	8.770200e-05	.	YES	3.559160e-05	0.074688	25680	HGNC:3551	N	0	simple_aae	0.254	149245	139561592	CAC	0.000000	.	-	2.0475020475020476E-4	0.06886	9.590100e-04	1	1	Benign/Likely benign	0.19630	0	0	4	ClinGen:CA121135,OMIM:300746.0085	H	0	0.999367092589	-	.	-	0.12993	80	9886	0.93756	0.438427627087	0.0722	0	0.32830897832429229	280	-	907C>T 	67	8.092251669026907E-4	C0008533|C2749016|C5393318	0	0	0	0	NM_000133.4	-	.	.	0	0.25033	1801202	1702	7.177670498616562E-4	0.99934	.	0.134	0.089	4708	0.99989235	5.42	.	.	0.000000e+00	0.075559	0.69627509395232	0.16042	T	2712	4471	6829	-0.5347	0.82502	p.His303Tyr	0	0	-3.72	0.058540702	9	0.66900	10641	T	24192	F9	0.000000e+00	D	0.549	15789	.	T	0.22814	0.02232	C/C	principal1	223948	F9_Popp_2025_light_chain_var246396	No											H		907	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.His303Tyr		true	c.907C>T						3551.0	139561592.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				His303Tyr						Y	Jan 29, 2024					missense_variant		303.0			0.0007593360617482	1.0817989057893431		Benign/Likely benign	139561592.0	missense_variant		0.549					Reporter			F9_His303Tyr
F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368682	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586484	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004383		NC_000023.11:139561592:C:T		His303Tyr																												F9_His303Tyr	23	139561592	C	T	X	allele	907C>T	E10	527_CAVA_Array_P02	I20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561592-C-T	-	0.19488	0.0	303	65	5	0	X	138643751	T	7.593360e-04	0	X	2_Benign	NC_000023.11	856	His303Tyr	0	14.27	0	1	9.248780e-04	D	1	5	1	30478	4.726260e-04	.	17864	0.000000e+00	0	0.81214	Select	0.5304	72442	0.02950	2	.	D	T	46566	0.738624950036	2.1240441801189465E-4	0	1.464340e-04	0	0	0.30325	13550	33722	2	0.000000e+00	0.48032	26	.	0.54850	0.866	.	97.0	0.640436	0.182	0.03	T	single nucleotide variant	NC_000023.11:g.139561592C>T	0	12089	3	0.2341255	79075	0	0.22414766	0	T	77	169267	0	0	0.000000e+00	442	8.530740e-04	0	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	30	3	0.000000e+00	0	0.13669	B	0.40065	B	N	.	916	C/C	176	8	5695	1206317	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13110	0.67220	.	.	-	139561592	8.530740e-04	-	-0.323000	2	0.52448	21910	0	892587	0	germline;unknown	56193	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.907C>T	0.000000e+00	0.23158	124	0	2	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.271980e-05	6914	B	0	2.282060e-04	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2	0	FA9_HUMAN	0	3.0	.	2	T	0.19100	0.32649112	+	1.755930e-04	.	0.000794178	65	4.473270e-04	0	26917	criteria_provided,_multiple_submitters,_no_conflicts	0.99864	3.793870e-04	2	1.015740e-04	0	45609	p.His303Tyr	0	0.09991	.	germline	26	139561592	C	Jan 19, 2025	0	C/C	0	63767	0.989	N	Xq27.1	152922	.	1.525550e-04	SCV001001225|SCV001330208|SCV002804939	Benign/Likely_benign	1	1	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13305	1.0	10122	0	-0.916	C	0	1.514762	0.40770	.	T	-	.	.	0.72008	950	0	.	0.00239	0	139561592	Y	10	0	72442	0.000000e+00	P00740	0	0.723082	0.01925	C	0	0.002	D	63767	0.17656629	30478	0.41182	2158	-0.0624261	856	-2.11	.	9.590100e-04	0.00968	0.000000e+00	0	57230	0.000000e+00	4367	1	0.48437	X	F9	1.572600e-04	0	His	172758	1.019340e-03	X-139561592-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	0	67	138471417	ClinGen:CA121135|OMIM:300746.0085	.	.	1	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	T	0	0	c.907C>T	0	0	18	0.42182	C/C	rs1801202	139561592	12041	C	.	.	9460	0.44724	1.900060e-04	0.08389	X	0	0	0.000000e+00	0.65	0	115	264690	1.68	0.92116	3394	T	T	2	8.267200e-05	0	682	.	0	1	98879	10641	0.75097	0.62872	0.0133548470984691	4884	.	0.36837	.	7.430250e-05	1.019340e-03	892587	2.06	5.159300e-04	N	9845	0	3.5891042E-4	0	306900|300807|301052	0.41124	X	1.660990e-04	ENSG00000101981	3.865480e-04	7.520173683315677E-4	0	0	0.9381481836570156	1	0.06938	0.18019	17929	95	9.248780e-04	8.770200e-05	.	YES	3.559160e-05	0.074688	25680	HGNC:3551	N	0	simple_aae	0.254	149245	139561592	CAC	0.000000	.	-	2.0475020475020476E-4	0.06886	9.590100e-04	1	1	Benign/Likely benign	0.19630	0	0	4	ClinGen:CA121135,OMIM:300746.0085	H	0	0.999367092589	-	.	-	0.12993	80	9886	0.93756	0.438427627087	0.0722	0	0.32830897832429229	280	-	907C>T 	67	8.092251669026907E-4	C0008533|C2749016|C5393318	0	0	0	0	NM_000133.4	-	.	.	0	0.25033	1801202	1702	7.177670498616562E-4	0.99934	.	0.134	0.089	4708	0.99989235	5.42	.	.	0.000000e+00	0.075559	0.69627509395232	0.16042	T	2712	4471	6829	-0.5347	0.82502	p.His303Tyr	0	0	-3.72	0.058540702	9	0.66900	10641	T	24192	F9	0.000000e+00	D	0.549	15789	.	T	0.22814	0.02232	C/C	principal1	251464	F9_Popp_2025_strep_2_var265758	No											H		907	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.His303Tyr		true	c.907C>T						3551.0	139561592.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				His303Tyr						Y	Jan 29, 2024					missense_variant		303.0			0.0007593360617482	1.128190842767414		Benign/Likely benign	139561592.0	missense_variant		0.549					Reporter			F9_His303Tyr
F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368682	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586484	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004383		NC_000023.11:139561592:C:T		His303Tyr																												F9_His303Tyr	23	139561592	C	T	X	allele	907C>T	E10	527_CAVA_Array_P02	I20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561592-C-T	-	0.19488	0.0	303	65	5	0	X	138643751	T	7.593360e-04	0	X	2_Benign	NC_000023.11	856	His303Tyr	0	14.27	0	1	9.248780e-04	D	1	5	1	30478	4.726260e-04	.	17864	0.000000e+00	0	0.81214	Select	0.5304	72442	0.02950	2	.	D	T	46566	0.738624950036	2.1240441801189465E-4	0	1.464340e-04	0	0	0.30325	13550	33722	2	0.000000e+00	0.48032	26	.	0.54850	0.866	.	97.0	0.640436	0.182	0.03	T	single nucleotide variant	NC_000023.11:g.139561592C>T	0	12089	3	0.2341255	79075	0	0.22414766	0	T	77	169267	0	0	0.000000e+00	442	8.530740e-04	0	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	30	3	0.000000e+00	0	0.13669	B	0.40065	B	N	.	916	C/C	176	8	5695	1206317	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13110	0.67220	.	.	-	139561592	8.530740e-04	-	-0.323000	2	0.52448	21910	0	892587	0	germline;unknown	56193	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.907C>T	0.000000e+00	0.23158	124	0	2	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.271980e-05	6914	B	0	2.282060e-04	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2	0	FA9_HUMAN	0	3.0	.	2	T	0.19100	0.32649112	+	1.755930e-04	.	0.000794178	65	4.473270e-04	0	26917	criteria_provided,_multiple_submitters,_no_conflicts	0.99864	3.793870e-04	2	1.015740e-04	0	45609	p.His303Tyr	0	0.09991	.	germline	26	139561592	C	Jan 19, 2025	0	C/C	0	63767	0.989	N	Xq27.1	152922	.	1.525550e-04	SCV001001225|SCV001330208|SCV002804939	Benign/Likely_benign	1	1	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13305	1.0	10122	0	-0.916	C	0	1.514762	0.40770	.	T	-	.	.	0.72008	950	0	.	0.00239	0	139561592	Y	10	0	72442	0.000000e+00	P00740	0	0.723082	0.01925	C	0	0.002	D	63767	0.17656629	30478	0.41182	2158	-0.0624261	856	-2.11	.	9.590100e-04	0.00968	0.000000e+00	0	57230	0.000000e+00	4367	1	0.48437	X	F9	1.572600e-04	0	His	172758	1.019340e-03	X-139561592-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	0	67	138471417	ClinGen:CA121135|OMIM:300746.0085	.	.	1	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	T	0	0	c.907C>T	0	0	18	0.42182	C/C	rs1801202	139561592	12041	C	.	.	9460	0.44724	1.900060e-04	0.08389	X	0	0	0.000000e+00	0.65	0	115	264690	1.68	0.92116	3394	T	T	2	8.267200e-05	0	682	.	0	1	98879	10641	0.75097	0.62872	0.0133548470984691	4884	.	0.36837	.	7.430250e-05	1.019340e-03	892587	2.06	5.159300e-04	N	9845	0	3.5891042E-4	0	306900|300807|301052	0.41124	X	1.660990e-04	ENSG00000101981	3.865480e-04	7.520173683315677E-4	0	0	0.9381481836570156	1	0.06938	0.18019	17929	95	9.248780e-04	8.770200e-05	.	YES	3.559160e-05	0.074688	25680	HGNC:3551	N	0	simple_aae	0.254	149245	139561592	CAC	0.000000	.	-	2.0475020475020476E-4	0.06886	9.590100e-04	1	1	Benign/Likely benign	0.19630	0	0	4	ClinGen:CA121135,OMIM:300746.0085	H	0	0.999367092589	-	.	-	0.12993	80	9886	0.93756	0.438427627087	0.0722	0	0.32830897832429229	280	-	907C>T 	67	8.092251669026907E-4	C0008533|C2749016|C5393318	0	0	0	0	NM_000133.4	-	.	.	0	0.25033	1801202	1702	7.177670498616562E-4	0.99934	.	0.134	0.089	4708	0.99989235	5.42	.	.	0.000000e+00	0.075559	0.69627509395232	0.16042	T	2712	4471	6829	-0.5347	0.82502	p.His303Tyr	0	0	-3.72	0.058540702	9	0.66900	10641	T	24192	F9	0.000000e+00	D	0.549	15789	.	T	0.22814	0.02232	C/C	principal1	196432	F9_Popp_2025_heavy_chain_var236715	No											H		907	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.His303Tyr		true	c.907C>T						3551.0	139561592.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				His303Tyr						Y	Jan 29, 2024					missense_variant		303.0			0.0007593360617482	1.06892381		Benign/Likely benign	139561592.0	missense_variant		0.549					Reporter			F9_His303Tyr
F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368682	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586484	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004383		NC_000023.11:139561592:C:T		His303Tyr																												F9_His303Tyr	23	139561592	C	T	X	allele	907C>T	E10	527_CAVA_Array_P02	I20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561592-C-T	-	0.19488	0.0	303	65	5	0	X	138643751	T	7.593360e-04	0	X	2_Benign	NC_000023.11	856	His303Tyr	0	14.27	0	1	9.248780e-04	D	1	5	1	30478	4.726260e-04	.	17864	0.000000e+00	0	0.81214	Select	0.5304	72442	0.02950	2	.	D	T	46566	0.738624950036	2.1240441801189465E-4	0	1.464340e-04	0	0	0.30325	13550	33722	2	0.000000e+00	0.48032	26	.	0.54850	0.866	.	97.0	0.640436	0.182	0.03	T	single nucleotide variant	NC_000023.11:g.139561592C>T	0	12089	3	0.2341255	79075	0	0.22414766	0	T	77	169267	0	0	0.000000e+00	442	8.530740e-04	0	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	30	3	0.000000e+00	0	0.13669	B	0.40065	B	N	.	916	C/C	176	8	5695	1206317	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13110	0.67220	.	.	-	139561592	8.530740e-04	-	-0.323000	2	0.52448	21910	0	892587	0	germline;unknown	56193	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.907C>T	0.000000e+00	0.23158	124	0	2	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.271980e-05	6914	B	0	2.282060e-04	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2	0	FA9_HUMAN	0	3.0	.	2	T	0.19100	0.32649112	+	1.755930e-04	.	0.000794178	65	4.473270e-04	0	26917	criteria_provided,_multiple_submitters,_no_conflicts	0.99864	3.793870e-04	2	1.015740e-04	0	45609	p.His303Tyr	0	0.09991	.	germline	26	139561592	C	Jan 19, 2025	0	C/C	0	63767	0.989	N	Xq27.1	152922	.	1.525550e-04	SCV001001225|SCV001330208|SCV002804939	Benign/Likely_benign	1	1	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13305	1.0	10122	0	-0.916	C	0	1.514762	0.40770	.	T	-	.	.	0.72008	950	0	.	0.00239	0	139561592	Y	10	0	72442	0.000000e+00	P00740	0	0.723082	0.01925	C	0	0.002	D	63767	0.17656629	30478	0.41182	2158	-0.0624261	856	-2.11	.	9.590100e-04	0.00968	0.000000e+00	0	57230	0.000000e+00	4367	1	0.48437	X	F9	1.572600e-04	0	His	172758	1.019340e-03	X-139561592-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	0	67	138471417	ClinGen:CA121135|OMIM:300746.0085	.	.	1	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	T	0	0	c.907C>T	0	0	18	0.42182	C/C	rs1801202	139561592	12041	C	.	.	9460	0.44724	1.900060e-04	0.08389	X	0	0	0.000000e+00	0.65	0	115	264690	1.68	0.92116	3394	T	T	2	8.267200e-05	0	682	.	0	1	98879	10641	0.75097	0.62872	0.0133548470984691	4884	.	0.36837	.	7.430250e-05	1.019340e-03	892587	2.06	5.159300e-04	N	9845	0	3.5891042E-4	0	306900|300807|301052	0.41124	X	1.660990e-04	ENSG00000101981	3.865480e-04	7.520173683315677E-4	0	0	0.9381481836570156	1	0.06938	0.18019	17929	95	9.248780e-04	8.770200e-05	.	YES	3.559160e-05	0.074688	25680	HGNC:3551	N	0	simple_aae	0.254	149245	139561592	CAC	0.000000	.	-	2.0475020475020476E-4	0.06886	9.590100e-04	1	1	Benign/Likely benign	0.19630	0	0	4	ClinGen:CA121135,OMIM:300746.0085	H	0	0.999367092589	-	.	-	0.12993	80	9886	0.93756	0.438427627087	0.0722	0	0.32830897832429229	280	-	907C>T 	67	8.092251669026907E-4	C0008533|C2749016|C5393318	0	0	0	0	NM_000133.4	-	.	.	0	0.25033	1801202	1702	7.177670498616562E-4	0.99934	.	0.134	0.089	4708	0.99989235	5.42	.	.	0.000000e+00	0.075559	0.69627509395232	0.16042	T	2712	4471	6829	-0.5347	0.82502	p.His303Tyr	0	0	-3.72	0.058540702	9	0.66900	10641	T	24192	F9	0.000000e+00	D	0.549	15789	.	T	0.22814	0.02232	C/C	principal1	168916	F9_Popp_2025_carboxy_gla_motif_var256077	No											H		907	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.His303Tyr		true	c.907C>T						3551.0	139561592.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				His303Tyr						Y	Jan 29, 2024					missense_variant		303.0			0.0007593360617482	1.0448265944586022		Benign/Likely benign	139561592.0	missense_variant		0.549					Reporter			F9_His303Tyr
F9_His303Tyr	-1.5857317182942252	0.15682003259997593	1.0751387058760036	0.31796787724790854	2025_01_Batch_13-14	0.6756812609368682	0.586632030944468	0.510599459620558	0.6037616745328747	0.5965526914812336	0.7437183219804285	0.7151662846419982	0.7051624352438142	0.7985734242410008	0.6669666875581233	0.7096997914586484	0.650899157793233	0.607880947432186	0.7011675493869377	0.6317596895196784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004383		NC_000023.11:139561592:C:T		His303Tyr																												F9_His303Tyr	23	139561592	C	T	X	allele	907C>T	E10	527_CAVA_Array_P02	I20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561592-C-T	-	0.19488	0.0	303	65	5	0	X	138643751	T	7.593360e-04	0	X	2_Benign	NC_000023.11	856	His303Tyr	0	14.27	0	1	9.248780e-04	D	1	5	1	30478	4.726260e-04	.	17864	0.000000e+00	0	0.81214	Select	0.5304	72442	0.02950	2	.	D	T	46566	0.738624950036	2.1240441801189465E-4	0	1.464340e-04	0	0	0.30325	13550	33722	2	0.000000e+00	0.48032	26	.	0.54850	0.866	.	97.0	0.640436	0.182	0.03	T	single nucleotide variant	NC_000023.11:g.139561592C>T	0	12089	3	0.2341255	79075	0	0.22414766	0	T	77	169267	0	0	0.000000e+00	442	8.530740e-04	0	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	30	3	0.000000e+00	0	0.13669	B	0.40065	B	N	.	916	C/C	176	8	5695	1206317	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	13110	0.67220	.	.	-	139561592	8.530740e-04	-	-0.323000	2	0.52448	21910	0	892587	0	germline;unknown	56193	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.907C>T	0.000000e+00	0.23158	124	0	2	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	8.271980e-05	6914	B	0	2.282060e-04	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2	0	FA9_HUMAN	0	3.0	.	2	T	0.19100	0.32649112	+	1.755930e-04	.	0.000794178	65	4.473270e-04	0	26917	criteria_provided,_multiple_submitters,_no_conflicts	0.99864	3.793870e-04	2	1.015740e-04	0	45609	p.His303Tyr	0	0.09991	.	germline	26	139561592	C	Jan 19, 2025	0	C/C	0	63767	0.989	N	Xq27.1	152922	.	1.525550e-04	SCV001001225|SCV001330208|SCV002804939	Benign/Likely_benign	1	1	Tyr	Y	-	687	ENSP00000218099	ENST00000218099	13305	1.0	10122	0	-0.916	C	0	1.514762	0.40770	.	T	-	.	.	0.72008	950	0	.	0.00239	0	139561592	Y	10	0	72442	0.000000e+00	P00740	0	0.723082	0.01925	C	0	0.002	D	63767	0.17656629	30478	0.41182	2158	-0.0624261	856	-2.11	.	9.590100e-04	0.00968	0.000000e+00	0	57230	0.000000e+00	4367	1	0.48437	X	F9	1.572600e-04	0	His	172758	1.019340e-03	X-139561592-C-T	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	0	67	138471417	ClinGen:CA121135|OMIM:300746.0085	.	.	1	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	T	0	0	c.907C>T	0	0	18	0.42182	C/C	rs1801202	139561592	12041	C	.	.	9460	0.44724	1.900060e-04	0.08389	X	0	0	0.000000e+00	0.65	0	115	264690	1.68	0.92116	3394	T	T	2	8.267200e-05	0	682	.	0	1	98879	10641	0.75097	0.62872	0.0133548470984691	4884	.	0.36837	.	7.430250e-05	1.019340e-03	892587	2.06	5.159300e-04	N	9845	0	3.5891042E-4	0	306900|300807|301052	0.41124	X	1.660990e-04	ENSG00000101981	3.865480e-04	7.520173683315677E-4	0	0	0.9381481836570156	1	0.06938	0.18019	17929	95	9.248780e-04	8.770200e-05	.	YES	3.559160e-05	0.074688	25680	HGNC:3551	N	0	simple_aae	0.254	149245	139561592	CAC	0.000000	.	-	2.0475020475020476E-4	0.06886	9.590100e-04	1	1	Benign/Likely benign	0.19630	0	0	4	ClinGen:CA121135,OMIM:300746.0085	H	0	0.999367092589	-	.	-	0.12993	80	9886	0.93756	0.438427627087	0.0722	0	0.32830897832429229	280	-	907C>T 	67	8.092251669026907E-4	C0008533|C2749016|C5393318	0	0	0	0	NM_000133.4	-	.	.	0	0.25033	1801202	1702	7.177670498616562E-4	0.99934	.	0.134	0.089	4708	0.99989235	5.42	.	.	0.000000e+00	0.075559	0.69627509395232	0.16042	T	2712	4471	6829	-0.5347	0.82502	p.His303Tyr	0	0	-3.72	0.058540702	9	0.66900	10641	T	24192	F9	0.000000e+00	D	0.549	15789	.	T	0.22814	0.02232	C/C	principal1	141400	F9_Popp_2025_carboxy_F9_specific_var227034	No											H		907	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.His303Tyr		true	c.907C>T						3551.0	139561592.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				His303Tyr						Y	Jan 29, 2024					missense_variant		303.0			0.0007593360617482	1.0177519699244646		Benign/Likely benign	139561592.0	missense_variant		0.549					Reporter			F9_His303Tyr
BRCA1_Ser408Ile	0.010557865224829883	0.9918707968983869	7.590508759060606	0.00012728381971504132	2025_01_Batch_13-14	0.9181762445456895	0.9086261201690247	0.9073856712001231	0.9506161820158945	0.7015349709065566	0.7476501008970957	0.7291219676646428	0.8250321224071917	0.8637183099221826	0.6720566719455782	0.8329131727213925	0.8188740439168337	0.8662088968036574	0.9071672459690385	0.6867958214260674	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011797		NC_000017.11:43074471:C:A		Ser408Ile																												BRCA1_Ser408Ile	17	43074471	C	A	17	allele	1223G>T	B08	527_CAVA_Array_P01	C15	B13A7A8P1_R1	B14A7A8P1_R2				17-43074471-C-A	-	0.30125	0.337	1512	348	164	0	17	41226488	A	3.078440e-03	37	17	2_Benign	NC_000017.11	164	Ser1512Ile	0	18.32	0	12	3.770170e-03	D	2	40	1	42766	2.339230e-03	1	30526	6.034480e-03	3	0.79231	.	0.6215	102648	0.48353	59	0.0	T	T	64022	.	0.001272264631043257	1	4.389630e-03	1	1	0.09368	17112	44892	61	0.000000e+00	0.69035	154	.	0.29740	0.122	7.564296520423601E-4	.	0.844516	2.01	.	A	single nucleotide variant	NC_000017.11:g.43074471C>A	1	16730	2	0.1181652	109396	0.0035714285714285713	0.08077421	0		497	236830	0	0	0.000000e+00	796	3.600990e-03	0	MedGen:C3661900|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0700268,MedGen:CN377757|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	244	31	0.000000e+00	0	0.30097	B	0.24785	B	L	1.548759	4969	C/C	360	57	7164	1614128	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|not specified|Hereditary cancer-predisposing syndrome|BRCA1-related cancer predisposition|Familial cancer of breast;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1	16218	0.79542	1	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43074471	3.600990e-03	-	1.912000	12	0.50624	29606	0.0030991735537190084	29606	0	germline;unknown	91076	.	.	GRCh38	534	reviewed by expert panel	.	4.913840e-04	0.45320	907	0	29	.	1.613870e-03	9040	.	0	5.539420e-03	NM_007294.4(BRCA1):c.4535G>T (p.Ser1512Ile)	3	0	BRCA1_HUMAN	0	.	-0.32701834229789	58	T	0.43431	0.12831177	-	5.583470e-04	0		348	4.669890e-03	0	34260	reviewed_by_expert_panel	0.99395	2.230430e-03	17	1.717700e-03	0	60012	.	0	0.29737	.	germline	154		c	Aug 10, 2015	15	C/C	1	89544	0.012	N	17q21.31	200638	.	7.399190e-04	SCV000244362	Benign	23	42	Ile	I	-	912	ENSP00000478114	ENST00000618469	17686	.	13410	1	0.591	C	0	2.346036	0.83643	N	.	-	1.347945	.	0.97361	968	0	9.940357852882703E-4	0.02419	0	43074471	Y	10	0.001256281407035176	102648	1.980200e-03	P38398	0	0.248577	0.58603		0	0.133	D	89544	0.10349156	42766	0.19292	672	-0.0795722	4340	.	0.0	5.539420e-03	0.78662	7.010830e-04	0	75028	0.000000e+00	6060	4	0.28456	17	BRCA1	6.530900e-04	1	Ser	231748	3.886360e-03	17-43074471-C-A	Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|not_specified|not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome	2	387	38480014	BRCA1-HCI:BRCA1_00016|ClinGen:CA002898|UniProtKB:P38398#VAR_007788	0.255502	0.27846	10	RCV000034752|RCV000112356|RCV000048591|RCV000120258|RCV000162492|RCV004803118|RCV002490467	.	0	0	c.4535G>T	0	0	86	0.39433	C/C	rs1800744	43074471	14902	C	5.990415335463259E-4	.	15690	0.18357	1.433330e-03	0.19288		0	1	0.000000e+00	1.895	0	833	264690	3.98	0.61629	3438	T	T	12	1.900140e-03	1	682	.	0	27	227535|1333|145|140162|145	41826	0.77610	0.11066	0.0327816211501777	9792	3	0.18747	0.37258	1.722120e-03	3.886360e-03	1180008	3.214	2.388180e-03	.	13390	1	0.0024065888	0	114480|614320|604370|617883	0.50958	17	8.052610e-04	ENSG00000012048	1.343290e-03	0.004151755898683201	15	0	.	2	0.44046	0.73376	30608	637	3.770170e-03	1.449710e-03	-0.413545015947272	.	6.697700e-04	0.681988	50265	HGNC:1100	.	0	.	0.237	208108	43074471	AGT	0.005000	0	-	0.0012254901960784314	0.01326	3.677940e-03	12	2	Benign	0.39100	11	12	87	BRCA1-HCI:BRCA1_00016,ClinGen:CA002898,UniProtKB:P38398#VAR_007788	S	0	.	-	.	-	0.51076	554	15836	0.41210	0.293080568314	.	0	0.99298489580117766	280	-	4535G>T 	387	0.0035993937863096743	C0346153|C3280442|C2676676|C4554406|CN169374|C3661900|C0027672|C0677776	0	0	14	0	NM_007294.4	-	1	0.001440922190201729	0	0.52040	1800744	2320	0.003913733883356059	0.85105	0.24281	.	.	9432	0.99944790	4.95	.	.	4.900680e-04	0.113053	0.215013996355067	0.50187	T	2756	6210	9568	-0.1200	0.86620	p.Ser1512Ile	0	0	-5.059	.	49	0.50654	41826	T	30524	BRCA1	2.162230e-03	D	.	21628	.	.	0.39759	0.32125	C/C	principal2																																																																																																				
F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly442Arg	23	139562009	G	A	X											X-139562009-G-A	-	0.86372	1.0	442	.	.	.	X	138644168	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly442Arg	.	28.9	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98451	Select	0.8991	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.79185	.	.	.	.	0.95858	.	.	0.99977	0.999	.	1.0	0.965103	.	0.99	A	single nucleotide variant	NC_000023.11:g.139562009G>A	.	.	1	0.99248934	.	0	0.99552697	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99998	D	H	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97918	.	.	-	139562009	.	-	11.850000	.	0.99985	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.99735	GRCh38	924	no assertion criteria provided	c.1324G>A	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)		.	FA9_HUMAN	.	99.0	.	.	D	0.90335	0.9957567	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Gly442Arg	.	0.98052	.	germline	.		G	Sep 11, 2013	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031602	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.154634	0.92967	.	D	-	.	.	0.99356	610	.	.	0.98769	0	139562009	Y	10	0	.	.	P00740	.	0.940243	0.99164		.	1.0	D	.	0.9947084	.	0.91597	2158	0.629632	.	-7.77	.	.	0.91343	.	.	.	.	.	.	0.99992	X	F9	.	0	Gly	11340	.	X-139562009-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471834	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	.	.	.	RCV000011370	D	.	.	c.1324G>A	.	.	.	0.99865	G/G	rs137852267	139562009	.	G	.	P00740	.	0.99973	.	0.68239		.	.	.	3.73	0	0	264690	5.59	0.99046	142	D	T	.	.	0	24	.	.	.	98879	10624	0.99864	0.91559	0.999747335910797	2728	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.999816845241638	1	0.97365	0.18019	.	2	.	.	.	YES	.	0.913615	25663	HGNC:3551	A	.	simple_aae	1	.	139562009	GGA	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.91198	.	.	.	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	G	.	0.998199755148	-	0.972	-	0.99617	.	574	0.99981	0.781957983971	0.9389	.	0.99927308363601752	100	-	1324G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.90715	137852267	.	0	0.99815	.	0.927	0.0	2644	0.99999270	5.59	.	.	.	0.666647	0.999681950866998	0.94777	D	118	.	.	1.0406	0.96646	p.Gly442Arg	0	.	-13.463	0.9946803	.	0.97477	10624	D	.	F9	.	D	0.933	.	G442R	D	.	0.76753	G/G	principal1	204898	F9_Popp_2025_heavy_chain_var239643	No											G		1324	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Gly442Arg		true	c.1324G>A						3551.0	139562009.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Gly442Arg						R	Sep 11, 2013					missense_variant		442.0				0.9530577974528428		Pathogenic	139562009.0	missense_variant		0.933					Reporter			F9_Gly442Arg
F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly442Arg	23	139562009	G	A	X											X-139562009-G-A	-	0.86372	1.0	442	.	.	.	X	138644168	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly442Arg	.	28.9	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98451	Select	0.8991	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.79185	.	.	.	.	0.95858	.	.	0.99977	0.999	.	1.0	0.965103	.	0.99	A	single nucleotide variant	NC_000023.11:g.139562009G>A	.	.	1	0.99248934	.	0	0.99552697	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99998	D	H	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97918	.	.	-	139562009	.	-	11.850000	.	0.99985	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.99735	GRCh38	924	no assertion criteria provided	c.1324G>A	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)		.	FA9_HUMAN	.	99.0	.	.	D	0.90335	0.9957567	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Gly442Arg	.	0.98052	.	germline	.		G	Sep 11, 2013	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031602	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.154634	0.92967	.	D	-	.	.	0.99356	610	.	.	0.98769	0	139562009	Y	10	0	.	.	P00740	.	0.940243	0.99164		.	1.0	D	.	0.9947084	.	0.91597	2158	0.629632	.	-7.77	.	.	0.91343	.	.	.	.	.	.	0.99992	X	F9	.	0	Gly	11340	.	X-139562009-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471834	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	.	.	.	RCV000011370	D	.	.	c.1324G>A	.	.	.	0.99865	G/G	rs137852267	139562009	.	G	.	P00740	.	0.99973	.	0.68239		.	.	.	3.73	0	0	264690	5.59	0.99046	142	D	T	.	.	0	24	.	.	.	98879	10624	0.99864	0.91559	0.999747335910797	2728	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.999816845241638	1	0.97365	0.18019	.	2	.	.	.	YES	.	0.913615	25663	HGNC:3551	A	.	simple_aae	1	.	139562009	GGA	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.91198	.	.	.	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	G	.	0.998199755148	-	0.972	-	0.99617	.	574	0.99981	0.781957983971	0.9389	.	0.99927308363601752	100	-	1324G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.90715	137852267	.	0	0.99815	.	0.927	0.0	2644	0.99999270	5.59	.	.	.	0.666647	0.999681950866998	0.94777	D	118	.	.	1.0406	0.96646	p.Gly442Arg	0	.	-13.463	0.9946803	.	0.97477	10624	D	.	F9	.	D	0.933	.	G442R	D	.	0.76753	G/G	principal1	259930	F9_Popp_2025_strep_2_var268686	No											G		1324	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Gly442Arg		true	c.1324G>A						3551.0	139562009.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Gly442Arg						R	Sep 11, 2013					missense_variant		442.0				1.2791282997000697		Pathogenic	139562009.0	missense_variant		0.933					Reporter			F9_Gly442Arg
F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly442Arg	23	139562009	G	A	X											X-139562009-G-A	-	0.86372	1.0	442	.	.	.	X	138644168	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly442Arg	.	28.9	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98451	Select	0.8991	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.79185	.	.	.	.	0.95858	.	.	0.99977	0.999	.	1.0	0.965103	.	0.99	A	single nucleotide variant	NC_000023.11:g.139562009G>A	.	.	1	0.99248934	.	0	0.99552697	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99998	D	H	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97918	.	.	-	139562009	.	-	11.850000	.	0.99985	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.99735	GRCh38	924	no assertion criteria provided	c.1324G>A	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)		.	FA9_HUMAN	.	99.0	.	.	D	0.90335	0.9957567	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Gly442Arg	.	0.98052	.	germline	.		G	Sep 11, 2013	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031602	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.154634	0.92967	.	D	-	.	.	0.99356	610	.	.	0.98769	0	139562009	Y	10	0	.	.	P00740	.	0.940243	0.99164		.	1.0	D	.	0.9947084	.	0.91597	2158	0.629632	.	-7.77	.	.	0.91343	.	.	.	.	.	.	0.99992	X	F9	.	0	Gly	11340	.	X-139562009-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471834	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	.	.	.	RCV000011370	D	.	.	c.1324G>A	.	.	.	0.99865	G/G	rs137852267	139562009	.	G	.	P00740	.	0.99973	.	0.68239		.	.	.	3.73	0	0	264690	5.59	0.99046	142	D	T	.	.	0	24	.	.	.	98879	10624	0.99864	0.91559	0.999747335910797	2728	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.999816845241638	1	0.97365	0.18019	.	2	.	.	.	YES	.	0.913615	25663	HGNC:3551	A	.	simple_aae	1	.	139562009	GGA	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.91198	.	.	.	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	G	.	0.998199755148	-	0.972	-	0.99617	.	574	0.99981	0.781957983971	0.9389	.	0.99927308363601752	100	-	1324G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.90715	137852267	.	0	0.99815	.	0.927	0.0	2644	0.99999270	5.59	.	.	.	0.666647	0.999681950866998	0.94777	D	118	.	.	1.0406	0.96646	p.Gly442Arg	0	.	-13.463	0.9946803	.	0.97477	10624	D	.	F9	.	D	0.933	.	G442R	D	.	0.76753	G/G	principal1	149866	F9_Popp_2025_carboxy_F9_specific_var229962	No											G		1324	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Gly442Arg		true	c.1324G>A						3551.0	139562009.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Gly442Arg						R	Sep 11, 2013					missense_variant		442.0				0.9488668190430832		Pathogenic	139562009.0	missense_variant		0.933					Reporter			F9_Gly442Arg
F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly442Arg	23	139562009	G	A	X											X-139562009-G-A	-	0.86372	1.0	442	.	.	.	X	138644168	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly442Arg	.	28.9	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98451	Select	0.8991	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.79185	.	.	.	.	0.95858	.	.	0.99977	0.999	.	1.0	0.965103	.	0.99	A	single nucleotide variant	NC_000023.11:g.139562009G>A	.	.	1	0.99248934	.	0	0.99552697	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99998	D	H	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97918	.	.	-	139562009	.	-	11.850000	.	0.99985	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.99735	GRCh38	924	no assertion criteria provided	c.1324G>A	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)		.	FA9_HUMAN	.	99.0	.	.	D	0.90335	0.9957567	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Gly442Arg	.	0.98052	.	germline	.		G	Sep 11, 2013	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031602	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.154634	0.92967	.	D	-	.	.	0.99356	610	.	.	0.98769	0	139562009	Y	10	0	.	.	P00740	.	0.940243	0.99164		.	1.0	D	.	0.9947084	.	0.91597	2158	0.629632	.	-7.77	.	.	0.91343	.	.	.	.	.	.	0.99992	X	F9	.	0	Gly	11340	.	X-139562009-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471834	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	.	.	.	RCV000011370	D	.	.	c.1324G>A	.	.	.	0.99865	G/G	rs137852267	139562009	.	G	.	P00740	.	0.99973	.	0.68239		.	.	.	3.73	0	0	264690	5.59	0.99046	142	D	T	.	.	0	24	.	.	.	98879	10624	0.99864	0.91559	0.999747335910797	2728	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.999816845241638	1	0.97365	0.18019	.	2	.	.	.	YES	.	0.913615	25663	HGNC:3551	A	.	simple_aae	1	.	139562009	GGA	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.91198	.	.	.	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	G	.	0.998199755148	-	0.972	-	0.99617	.	574	0.99981	0.781957983971	0.9389	.	0.99927308363601752	100	-	1324G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.90715	137852267	.	0	0.99815	.	0.927	0.0	2644	0.99999270	5.59	.	.	.	0.666647	0.999681950866998	0.94777	D	118	.	.	1.0406	0.96646	p.Gly442Arg	0	.	-13.463	0.9946803	.	0.97477	10624	D	.	F9	.	D	0.933	.	G442R	D	.	0.76753	G/G	principal1	232414	F9_Popp_2025_light_chain_var249324	No											G		1324	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Gly442Arg		true	c.1324G>A						3551.0	139562009.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Gly442Arg						R	Sep 11, 2013					missense_variant		442.0				0.9706696689975236		Pathogenic	139562009.0	missense_variant		0.933					Reporter			F9_Gly442Arg
F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	NC_000023.11:139562009:G:A	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Gly442Arg	23	139562009	G	A	X											X-139562009-G-A	-	0.86372	1.0	442	.	.	.	X	138644168	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly442Arg	.	28.9	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98451	Select	0.8991	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.79185	.	.	.	.	0.95858	.	.	0.99977	0.999	.	1.0	0.965103	.	0.99	A	single nucleotide variant	NC_000023.11:g.139562009G>A	.	.	1	0.99248934	.	0	0.99552697	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99998	D	H	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97918	.	.	-	139562009	.	-	11.850000	.	0.99985	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.99735	GRCh38	924	no assertion criteria provided	c.1324G>A	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)		.	FA9_HUMAN	.	99.0	.	.	D	0.90335	0.9957567	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Gly442Arg	.	0.98052	.	germline	.		G	Sep 11, 2013	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031602	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.154634	0.92967	.	D	-	.	.	0.99356	610	.	.	0.98769	0	139562009	Y	10	0	.	.	P00740	.	0.940243	0.99164		.	1.0	D	.	0.9947084	.	0.91597	2158	0.629632	.	-7.77	.	.	0.91343	.	.	.	.	.	.	0.99992	X	F9	.	0	Gly	11340	.	X-139562009-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471834	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	.	.	.	RCV000011370	D	.	.	c.1324G>A	.	.	.	0.99865	G/G	rs137852267	139562009	.	G	.	P00740	.	0.99973	.	0.68239		.	.	.	3.73	0	0	264690	5.59	0.99046	142	D	T	.	.	0	24	.	.	.	98879	10624	0.99864	0.91559	0.999747335910797	2728	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.999816845241638	1	0.97365	0.18019	.	2	.	.	.	YES	.	0.913615	25663	HGNC:3551	A	.	simple_aae	1	.	139562009	GGA	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.91198	.	.	.	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	G	.	0.998199755148	-	0.972	-	0.99617	.	574	0.99981	0.781957983971	0.9389	.	0.99927308363601752	100	-	1324G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.90715	137852267	.	0	0.99815	.	0.927	0.0	2644	0.99999270	5.59	.	.	.	0.666647	0.999681950866998	0.94777	D	118	.	.	1.0406	0.96646	p.Gly442Arg	0	.	-13.463	0.9946803	.	0.97477	10624	D	.	F9	.	D	0.933	.	G442R	D	.	0.76753	G/G	principal1	177382	F9_Popp_2025_carboxy_gla_motif_var259005	No											G		1324	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Gly442Arg		true	c.1324G>A						3551.0	139562009.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Gly442Arg						R	Sep 11, 2013					missense_variant		442.0				0.9605804541680274		Pathogenic	139562009.0	missense_variant		0.933					Reporter			F9_Gly442Arg
F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004397		NC_000023.11:139562009:G:A		Gly442Arg																												F9_Gly442Arg	23	139562009	G	A	X	allele	1324G>A	F05	527_CAVA_Array_P02	K10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562009-G-A	-	0.86372	1.0	442	.	.	.	X	138644168	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly442Arg	.	28.9	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98451	Select	0.8991	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.79185	.	.	.	.	0.95858	.	.	0.99977	0.999	.	1.0	0.965103	.	0.99	A	single nucleotide variant	NC_000023.11:g.139562009G>A	.	.	1	0.99248934	.	0	0.99552697	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99998	D	H	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97918	.	.	-	139562009	.	-	11.850000	.	0.99985	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.99735	GRCh38	924	no assertion criteria provided	c.1324G>A	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)		.	FA9_HUMAN	.	99.0	.	.	D	0.90335	0.9957567	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Gly442Arg	.	0.98052	.	germline	.		G	Sep 11, 2013	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031602	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.154634	0.92967	.	D	-	.	.	0.99356	610	.	.	0.98769	0	139562009	Y	10	0	.	.	P00740	.	0.940243	0.99164		.	1.0	D	.	0.9947084	.	0.91597	2158	0.629632	.	-7.77	.	.	0.91343	.	.	.	.	.	.	0.99992	X	F9	.	0	Gly	11340	.	X-139562009-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471834	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	.	.	.	RCV000011370	D	.	.	c.1324G>A	.	.	.	0.99865	G/G	rs137852267	139562009	.	G	.	P00740	.	0.99973	.	0.68239		.	.	.	3.73	0	0	264690	5.59	0.99046	142	D	T	.	.	0	24	.	.	.	98879	10624	0.99864	0.91559	0.999747335910797	2728	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.999816845241638	1	0.97365	0.18019	.	2	.	.	.	YES	.	0.913615	25663	HGNC:3551	A	.	simple_aae	1	.	139562009	GGA	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.91198	.	.	.	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	G	.	0.998199755148	-	0.972	-	0.99617	.	574	0.99981	0.781957983971	0.9389	.	0.99927308363601752	100	-	1324G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.90715	137852267	.	0	0.99815	.	0.927	0.0	2644	0.99999270	5.59	.	.	.	0.666647	0.999681950866998	0.94777	D	118	.	.	1.0406	0.96646	p.Gly442Arg	0	.	-13.463	0.9946803	.	0.97477	10624	D	.	F9	.	D	0.933	.	G442R	D	.	0.76753	G/G	principal1	204898	F9_Popp_2025_heavy_chain_var239643	No											G		1324	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Gly442Arg		true	c.1324G>A						3551.0	139562009.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Gly442Arg						R	Sep 11, 2013					missense_variant		442.0				0.9530577974528428		Pathogenic	139562009.0	missense_variant		0.933					Reporter			F9_Gly442Arg
F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004397		NC_000023.11:139562009:G:A		Gly442Arg																												F9_Gly442Arg	23	139562009	G	A	X	allele	1324G>A	F05	527_CAVA_Array_P02	K10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562009-G-A	-	0.86372	1.0	442	.	.	.	X	138644168	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly442Arg	.	28.9	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98451	Select	0.8991	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.79185	.	.	.	.	0.95858	.	.	0.99977	0.999	.	1.0	0.965103	.	0.99	A	single nucleotide variant	NC_000023.11:g.139562009G>A	.	.	1	0.99248934	.	0	0.99552697	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99998	D	H	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97918	.	.	-	139562009	.	-	11.850000	.	0.99985	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.99735	GRCh38	924	no assertion criteria provided	c.1324G>A	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)		.	FA9_HUMAN	.	99.0	.	.	D	0.90335	0.9957567	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Gly442Arg	.	0.98052	.	germline	.		G	Sep 11, 2013	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031602	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.154634	0.92967	.	D	-	.	.	0.99356	610	.	.	0.98769	0	139562009	Y	10	0	.	.	P00740	.	0.940243	0.99164		.	1.0	D	.	0.9947084	.	0.91597	2158	0.629632	.	-7.77	.	.	0.91343	.	.	.	.	.	.	0.99992	X	F9	.	0	Gly	11340	.	X-139562009-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471834	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	.	.	.	RCV000011370	D	.	.	c.1324G>A	.	.	.	0.99865	G/G	rs137852267	139562009	.	G	.	P00740	.	0.99973	.	0.68239		.	.	.	3.73	0	0	264690	5.59	0.99046	142	D	T	.	.	0	24	.	.	.	98879	10624	0.99864	0.91559	0.999747335910797	2728	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.999816845241638	1	0.97365	0.18019	.	2	.	.	.	YES	.	0.913615	25663	HGNC:3551	A	.	simple_aae	1	.	139562009	GGA	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.91198	.	.	.	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	G	.	0.998199755148	-	0.972	-	0.99617	.	574	0.99981	0.781957983971	0.9389	.	0.99927308363601752	100	-	1324G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.90715	137852267	.	0	0.99815	.	0.927	0.0	2644	0.99999270	5.59	.	.	.	0.666647	0.999681950866998	0.94777	D	118	.	.	1.0406	0.96646	p.Gly442Arg	0	.	-13.463	0.9946803	.	0.97477	10624	D	.	F9	.	D	0.933	.	G442R	D	.	0.76753	G/G	principal1	259930	F9_Popp_2025_strep_2_var268686	No											G		1324	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Gly442Arg		true	c.1324G>A						3551.0	139562009.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Gly442Arg						R	Sep 11, 2013					missense_variant		442.0				1.2791282997000697		Pathogenic	139562009.0	missense_variant		0.933					Reporter			F9_Gly442Arg
F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004397		NC_000023.11:139562009:G:A		Gly442Arg																												F9_Gly442Arg	23	139562009	G	A	X	allele	1324G>A	F05	527_CAVA_Array_P02	K10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562009-G-A	-	0.86372	1.0	442	.	.	.	X	138644168	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly442Arg	.	28.9	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98451	Select	0.8991	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.79185	.	.	.	.	0.95858	.	.	0.99977	0.999	.	1.0	0.965103	.	0.99	A	single nucleotide variant	NC_000023.11:g.139562009G>A	.	.	1	0.99248934	.	0	0.99552697	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99998	D	H	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97918	.	.	-	139562009	.	-	11.850000	.	0.99985	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.99735	GRCh38	924	no assertion criteria provided	c.1324G>A	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)		.	FA9_HUMAN	.	99.0	.	.	D	0.90335	0.9957567	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Gly442Arg	.	0.98052	.	germline	.		G	Sep 11, 2013	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031602	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.154634	0.92967	.	D	-	.	.	0.99356	610	.	.	0.98769	0	139562009	Y	10	0	.	.	P00740	.	0.940243	0.99164		.	1.0	D	.	0.9947084	.	0.91597	2158	0.629632	.	-7.77	.	.	0.91343	.	.	.	.	.	.	0.99992	X	F9	.	0	Gly	11340	.	X-139562009-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471834	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	.	.	.	RCV000011370	D	.	.	c.1324G>A	.	.	.	0.99865	G/G	rs137852267	139562009	.	G	.	P00740	.	0.99973	.	0.68239		.	.	.	3.73	0	0	264690	5.59	0.99046	142	D	T	.	.	0	24	.	.	.	98879	10624	0.99864	0.91559	0.999747335910797	2728	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.999816845241638	1	0.97365	0.18019	.	2	.	.	.	YES	.	0.913615	25663	HGNC:3551	A	.	simple_aae	1	.	139562009	GGA	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.91198	.	.	.	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	G	.	0.998199755148	-	0.972	-	0.99617	.	574	0.99981	0.781957983971	0.9389	.	0.99927308363601752	100	-	1324G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.90715	137852267	.	0	0.99815	.	0.927	0.0	2644	0.99999270	5.59	.	.	.	0.666647	0.999681950866998	0.94777	D	118	.	.	1.0406	0.96646	p.Gly442Arg	0	.	-13.463	0.9946803	.	0.97477	10624	D	.	F9	.	D	0.933	.	G442R	D	.	0.76753	G/G	principal1	149866	F9_Popp_2025_carboxy_F9_specific_var229962	No											G		1324	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Gly442Arg		true	c.1324G>A						3551.0	139562009.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Gly442Arg						R	Sep 11, 2013					missense_variant		442.0				0.9488668190430832		Pathogenic	139562009.0	missense_variant		0.933					Reporter			F9_Gly442Arg
F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004397		NC_000023.11:139562009:G:A		Gly442Arg																												F9_Gly442Arg	23	139562009	G	A	X	allele	1324G>A	F05	527_CAVA_Array_P02	K10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562009-G-A	-	0.86372	1.0	442	.	.	.	X	138644168	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly442Arg	.	28.9	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98451	Select	0.8991	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.79185	.	.	.	.	0.95858	.	.	0.99977	0.999	.	1.0	0.965103	.	0.99	A	single nucleotide variant	NC_000023.11:g.139562009G>A	.	.	1	0.99248934	.	0	0.99552697	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99998	D	H	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97918	.	.	-	139562009	.	-	11.850000	.	0.99985	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.99735	GRCh38	924	no assertion criteria provided	c.1324G>A	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)		.	FA9_HUMAN	.	99.0	.	.	D	0.90335	0.9957567	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Gly442Arg	.	0.98052	.	germline	.		G	Sep 11, 2013	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031602	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.154634	0.92967	.	D	-	.	.	0.99356	610	.	.	0.98769	0	139562009	Y	10	0	.	.	P00740	.	0.940243	0.99164		.	1.0	D	.	0.9947084	.	0.91597	2158	0.629632	.	-7.77	.	.	0.91343	.	.	.	.	.	.	0.99992	X	F9	.	0	Gly	11340	.	X-139562009-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471834	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	.	.	.	RCV000011370	D	.	.	c.1324G>A	.	.	.	0.99865	G/G	rs137852267	139562009	.	G	.	P00740	.	0.99973	.	0.68239		.	.	.	3.73	0	0	264690	5.59	0.99046	142	D	T	.	.	0	24	.	.	.	98879	10624	0.99864	0.91559	0.999747335910797	2728	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.999816845241638	1	0.97365	0.18019	.	2	.	.	.	YES	.	0.913615	25663	HGNC:3551	A	.	simple_aae	1	.	139562009	GGA	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.91198	.	.	.	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	G	.	0.998199755148	-	0.972	-	0.99617	.	574	0.99981	0.781957983971	0.9389	.	0.99927308363601752	100	-	1324G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.90715	137852267	.	0	0.99815	.	0.927	0.0	2644	0.99999270	5.59	.	.	.	0.666647	0.999681950866998	0.94777	D	118	.	.	1.0406	0.96646	p.Gly442Arg	0	.	-13.463	0.9946803	.	0.97477	10624	D	.	F9	.	D	0.933	.	G442R	D	.	0.76753	G/G	principal1	232414	F9_Popp_2025_light_chain_var249324	No											G		1324	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Gly442Arg		true	c.1324G>A						3551.0	139562009.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Gly442Arg						R	Sep 11, 2013					missense_variant		442.0				0.9706696689975236		Pathogenic	139562009.0	missense_variant		0.933					Reporter			F9_Gly442Arg
F9_Gly442Arg	1.7405705383053478	0.1253045662462782	-0.32204583824703	0.756822233337272	2025_01_Batch_13-14	0.7460344492262554	0.7492680935785165	0.6368043165107827	0.7642515512449607	0.6574226292404438	0.5702105708587752	0.47854928950637193	0.5181615715023183	0.49661279308477535	0.5825358385411202	0.6581225100425153	0.6139086915424442	0.5774829440065505	0.630432172164868	0.619979233890782	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004397		NC_000023.11:139562009:G:A		Gly442Arg																												F9_Gly442Arg	23	139562009	G	A	X	allele	1324G>A	F05	527_CAVA_Array_P02	K10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562009-G-A	-	0.86372	1.0	442	.	.	.	X	138644168	A	.	.	X	1_Pathogenic	NC_000023.11	.	Gly442Arg	.	28.9	.	0	.	D	.	1	1	.	.	.	.	.	0	0.98451	Select	0.8991	.	0.90580	.	.	D	D	.	1.79749068387	0	.	.	.	.	0.79185	.	.	.	.	0.95858	.	.	0.99977	0.999	.	1.0	0.965103	.	0.99	A	single nucleotide variant	NC_000023.11:g.139562009G>A	.	.	1	0.99248934	.	0	0.99552697	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.97926	D	0.99998	D	H	.	.	G/G	84	0	.	.	Hereditary factor IX deficiency disease	.	0.97918	.	.	-	139562009	.	-	11.850000	.	0.99985	.	0	.	.	germline	.	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.99735	GRCh38	924	no assertion criteria provided	c.1324G>A	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)		.	FA9_HUMAN	.	99.0	.	.	D	0.90335	0.9957567	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Gly442Arg	.	0.98052	.	germline	.		G	Sep 11, 2013	.	G/G	.	.	1.0	N	Xq27.1	7040	.	.	SCV000031602	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.676	G	.	5.154634	0.92967	.	D	-	.	.	0.99356	610	.	.	0.98769	0	139562009	Y	10	0	.	.	P00740	.	0.940243	0.99164		.	1.0	D	.	0.9947084	.	0.91597	2158	0.629632	.	-7.77	.	.	0.91343	.	.	.	.	.	.	0.99992	X	F9	.	0	Gly	11340	.	X-139562009-G-A	Hereditary_factor_IX_deficiency_disease	.	.	138471834	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	.	.	.	RCV000011370	D	.	.	c.1324G>A	.	.	.	0.99865	G/G	rs137852267	139562009	.	G	.	P00740	.	0.99973	.	0.68239		.	.	.	3.73	0	0	264690	5.59	0.99046	142	D	T	.	.	0	24	.	.	.	98879	10624	0.99864	0.91559	0.999747335910797	2728	.	0.71675	.	.	.	.	9.968	.	D	.	.	7.5560088E-6	0	306900	0.99105	X	.	ENSG00000101981	.	0	.	0	0.999816845241638	1	0.97365	0.18019	.	2	.	.	.	YES	.	0.913615	25663	HGNC:3551	A	.	simple_aae	1	.	139562009	GGA	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.91198	.	.	.	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	G	.	0.998199755148	-	0.972	-	0.99617	.	574	0.99981	0.781957983971	0.9389	.	0.99927308363601752	100	-	1324G>A 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.90715	137852267	.	0	0.99815	.	0.927	0.0	2644	0.99999270	5.59	.	.	.	0.666647	0.999681950866998	0.94777	D	118	.	.	1.0406	0.96646	p.Gly442Arg	0	.	-13.463	0.9946803	.	0.97477	10624	D	.	F9	.	D	0.933	.	G442R	D	.	0.76753	G/G	principal1	177382	F9_Popp_2025_carboxy_gla_motif_var259005	No											G		1324	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Gly442Arg		true	c.1324G>A						3551.0	139562009.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Gly442Arg						R	Sep 11, 2013					missense_variant		442.0				0.9605804541680274		Pathogenic	139562009.0	missense_variant		0.933					Reporter			F9_Gly442Arg
RHO_Cys110Tyr	-5.373754793745742	0.001037313511567956	-13.627094674258373	2.697354088123665e-6	2025_01_Batch_13-14	0.8727911260092511	0.9709315205985769	0.9993528754968187	0.9960781336949563	0.9790524850900243	0.8790816179354186	0.9874507908671495	0.9997490029378209	0.9972559771541037	0.985504947476264	0.8759363719723349	0.9791911557328632	0.9995509392173199	0.99666705542453	0.9822787162831441	0.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	RHO	RHO		40080645		CCSBVarC013625		NC_000003.12:129529062:G:A		Cys110Tyr																												RHO_Cys110Tyr	3	129529062	G	A	3	allele	329G>A	B10	527_CAVA_Array_P05	C19	B13A7A8P2_R1	B14A7A8P2_R2				3-129529062-G-A	-	0.83352	1.0	110	.	.	.	3	129247905	A	.	.	3	1_Pathogenic	NC_000003.12	.	Cys110Tyr	.	28.0	.	0	.	D	.	4	1	.	.	.	.	.	0	0.93044	Select	0.6727	.	0.90580	.	.	D	D	.	1.14035379566	0	.	.	.	.	0.57451	.	.	.	.	0.98944	.	.	0.99822	0.566	.	1.0	0.989657	4.99	0.99	A	single nucleotide variant	NC_000003.12:g.129529062G>A	.	.	3	0.9922701	.	0	0.9926738	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	.	.	.	.	0.97926	D	0.99929	D	H	20.11403	.	G/G	0	0	.	.	Retinitis pigmentosa 4|not provided|Retinal dystrophy	.	0.93623	.	.	-	129529062	.	-	11.806000	.	0.99892	.	0	.	.	germline	.	Loss of glycosylation at T108 (P = 0.1174)| Loss of catalytic residue at C110 (P = 0.1303)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.437)| Loss of stability (P = 0.5943)	0.99070	GRCh38	511	criteria provided, multiple submitters, no conflicts	c.329G>A	.	0.75027	0	.	.	GPCR, rhodopsin-like, 7TM	.	.	P	0	.	NM_000539.3(RHO):c.329G>A (p.Cys110Tyr)	2	.	OPSD_HUMAN	.	99.0	1.15131989520089	.	D	0.97230	0.99123245	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99879	.	.	.	.	.	p.Cys110Tyr	.	0.96796	.	germline	.		G	Dec 19, 2020	.	G/G	.	.	1.0	N	3q22.1	78	.	.	SCV001239186|SCV001407585|SCV001779172	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000296271	ENST00000296271	.	0.0	.	.	0.676	G	.	5.01551	0.92967	D	D	-	20.03965	.	0.92389	0	.	.	0.99981	0	129529062	Y	9	0	.	.	P08100	.	0.872212	0.86015		.	1.0	D	.	0.9854278	.	0.306	6010	0.401147	.	-10.25	.	.	0.91343	.	.	.	.	.	.	0.99991	3	RHO	.	0	Cys	660	.	3-129529062-G-A	not_provided|Retinitis_pigmentosa_4|Retinal_dystrophy	.	.	130730595	ClinGen:CA256681|OMIM:180380.0035|UniProtKB:P08100#VAR_004790	0.938668	0.98970	.	RCV000013910|RCV001234924|RCV001073635	D	.	.	c.329G>A	.	.	.	0.89909	G/G	rs104893787	129529062	.	G	.	P08100	.	0.99885	.	0.68239		.	.	.	4.65	0	0	.	5.31	0.97226	34	D	T	.	.	0	0	.	.	.	791|71862	13035	0.89782	0.78786	0.999984264373779	434	.	0.71675	0.93795	.	.	.	9.996	.	D	.	.	.	0	613731	0.99292	3	.	ENSG00000163914	.	0	.	0	0.9872522222524879	2	0.97365	0.75154	.	.	.	.	1.01875670206705	YES	.	0.356575	28074	HGNC:10012	A	.	simple_aae	0.997	.	129529062	TGC	1.000000	.	-	0	0.99956	.	0	.	Pathogenic	0.72523	.	.	.	ClinGen:CA256681,UniProtKB:P08100#VAR_004790,OMIM:180380.0035	C	.	0.98071754066	-	0.936	-	0.98381	.	108	0.98714	0.632616996765	0.9978	.	0.9977197502818197	6	-	329G>A 	.	0	C3661900|C3151001|C0854723	.	.	.	.	NM_000539.3	-	.	.	1	0.96643	104893787	.	0	0.98031	0.98952	0.973	0.0	434	0.99990320	5.31	.	.	.	0.338444	0.999956226333039	0.99359	D	34	.	.	0.7379	0.88624	p.Cys110Tyr	0	.	-9.757	0.99468315	.	0.99183	13035	D	.	RHO	.	D	0.790	.	C110Y	D	0.89858	0.76753	G/G	principal1	999325	RHO_Wan_2019_var220532	No						cell surface expression		Fluorescence			C		329	RHO_Wan_2019		ENST00000296271.4							immortalized human cells					p.Cys110Tyr		true	c.329G>A						10012.0	129529062.0	No		RHO				NM_000539.3		1.0	urn:mavedb:00000099-a-1		nucleotide		A									criteria provided, multiple submitters, no conflicts				Cys110Tyr						Y	Dec 19, 2020					missense_variant		110.0	G			0.1827611768972291		Pathogenic	129529062.0	missense_variant		0.79					Reporter			RHO_Cys110Tyr
F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039862	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545489	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Cys170Tyr	23	139548480	G	A	X											X-139548480-G-A	-	0.78068	1.0	170	.	.	.	X	138630639	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys170Tyr	.	26.8	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9985	.	0.90580	.	.	D	D	.	2.12843697498	0	.	.	.	.	0.47599	.	.	.	.	0.98352	.	.	0.99988	0.965	.	1.0	0.919108	4.69	0.99	A	single nucleotide variant	NC_000023.11:g.139548480G>A	.	.	2	0.99270505	.	0	0.9961493	0		.	.	.	.	.	146	.	0	MedGen:CN169374	.	.	.	.	0.97926	D	0.99990	D	H	.	.	G/G	84	0	.	.	not specified	.	0.95765	.	.	-	139548480	.	-	11.769000	.	0.99826	.	0	.	.	germline	.	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.99885	GRCh38	924	criteria provided, single submitter	c.509G>A	.	0.68332	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	1	.	FA9_HUMAN	.	99.0	.	.	D	0.94596	0.9964981	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys170Tyr	.	0.95819	.	germline	.		G	Jun 28, 2019	.	G/G	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158668	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.618	G	.	4.801854	0.83643	.	D	-	.	.	0.98706	610	.	.	0.99730	0	139548480	Y	9	0	.	.	P00740	.	0.964843	0.64033		.	1.0	D	.	0.9921017	.	0.52907	2158	0.720938	.	-9.32	.	.	0.78662	.	.	.	.	.	.	0.99993	X	F9	.	0	Cys	10680	.	X-139548480-G-A	not_specified	.	.	138458305	.	.	.	.	RCV001001432	D	.	.	c.509G>A	.	.	.	0.99946	G/G	rs1603265500	139548480	.	G	.	P00740	.	0.99983	.	0.68239		.	.	.	4.73	0	0	264690	5.08	0.99570	108	D	T	.	.	0	24	.	.	.	.	811517	0.99946	0.95120	0.99992847442627	2294	.	0.71675	.	.	.	.	7.385	.	D	.	.	7.5560088E-6	0	.	0.7908	X	.	ENSG00000101981	.	0	.	0	0.9999921642813904	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.833338	800231	HGNC:3551	A	.	simple_aae	0.995	.	139548480	TGT	1.000000	.	-	0	0.99929	.	0	.	Pathogenic	0.95493	.	.	.	ClinGen:CA414439424	C	.	0.998542052572	-	0.989	-	0.95970	.	466	0.99999	0.562821447849	0.9818	.	0.99425548895376659	94	-	509G>A 	.	0	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.70775	1603265500	.	0	0.99850	.	0.88	0.001	2210	0.99999344	5.08	.	.	.	0.797801	0.999918678679179	0.99523	D	84	.	.	0.9074	0.99959	p.Cys170Tyr	0	.	-14.847	0.9941932	.	0.98806	811517	D	.	F9	.	D	0.971	.	C170Y	D	0.86632	0.50684	G/G	principal1	133516	F9_Popp_2025_carboxy_F9_specific_var224241	No											C		509	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys170Tyr		true	c.509G>A						3551.0	139548480.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Cys170Tyr						Y	Jun 28, 2019					missense_variant		170.0				0.019039701		Pathogenic	139548480.0	missense_variant		0.971					Reporter			F9_Cys170Tyr
F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039862	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545489	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Cys170Tyr	23	139548480	G	A	X											X-139548480-G-A	-	0.78068	1.0	170	.	.	.	X	138630639	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys170Tyr	.	26.8	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9985	.	0.90580	.	.	D	D	.	2.12843697498	0	.	.	.	.	0.47599	.	.	.	.	0.98352	.	.	0.99988	0.965	.	1.0	0.919108	4.69	0.99	A	single nucleotide variant	NC_000023.11:g.139548480G>A	.	.	2	0.99270505	.	0	0.9961493	0		.	.	.	.	.	146	.	0	MedGen:CN169374	.	.	.	.	0.97926	D	0.99990	D	H	.	.	G/G	84	0	.	.	not specified	.	0.95765	.	.	-	139548480	.	-	11.769000	.	0.99826	.	0	.	.	germline	.	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.99885	GRCh38	924	criteria provided, single submitter	c.509G>A	.	0.68332	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	1	.	FA9_HUMAN	.	99.0	.	.	D	0.94596	0.9964981	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys170Tyr	.	0.95819	.	germline	.		G	Jun 28, 2019	.	G/G	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158668	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.618	G	.	4.801854	0.83643	.	D	-	.	.	0.98706	610	.	.	0.99730	0	139548480	Y	9	0	.	.	P00740	.	0.964843	0.64033		.	1.0	D	.	0.9921017	.	0.52907	2158	0.720938	.	-9.32	.	.	0.78662	.	.	.	.	.	.	0.99993	X	F9	.	0	Cys	10680	.	X-139548480-G-A	not_specified	.	.	138458305	.	.	.	.	RCV001001432	D	.	.	c.509G>A	.	.	.	0.99946	G/G	rs1603265500	139548480	.	G	.	P00740	.	0.99983	.	0.68239		.	.	.	4.73	0	0	264690	5.08	0.99570	108	D	T	.	.	0	24	.	.	.	.	811517	0.99946	0.95120	0.99992847442627	2294	.	0.71675	.	.	.	.	7.385	.	D	.	.	7.5560088E-6	0	.	0.7908	X	.	ENSG00000101981	.	0	.	0	0.9999921642813904	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.833338	800231	HGNC:3551	A	.	simple_aae	0.995	.	139548480	TGT	1.000000	.	-	0	0.99929	.	0	.	Pathogenic	0.95493	.	.	.	ClinGen:CA414439424	C	.	0.998542052572	-	0.989	-	0.95970	.	466	0.99999	0.562821447849	0.9818	.	0.99425548895376659	94	-	509G>A 	.	0	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.70775	1603265500	.	0	0.99850	.	0.88	0.001	2210	0.99999344	5.08	.	.	.	0.797801	0.999918678679179	0.99523	D	84	.	.	0.9074	0.99959	p.Cys170Tyr	0	.	-14.847	0.9941932	.	0.98806	811517	D	.	F9	.	D	0.971	.	C170Y	D	0.86632	0.50684	G/G	principal1	216064	F9_Popp_2025_light_chain_var243603	No											C		509	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys170Tyr		true	c.509G>A						3551.0	139548480.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Cys170Tyr						Y	Jun 28, 2019					missense_variant		170.0				0.004052954		Pathogenic	139548480.0	missense_variant		0.971					Reporter			F9_Cys170Tyr
F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039862	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545489	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Cys170Tyr	23	139548480	G	A	X											X-139548480-G-A	-	0.78068	1.0	170	.	.	.	X	138630639	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys170Tyr	.	26.8	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9985	.	0.90580	.	.	D	D	.	2.12843697498	0	.	.	.	.	0.47599	.	.	.	.	0.98352	.	.	0.99988	0.965	.	1.0	0.919108	4.69	0.99	A	single nucleotide variant	NC_000023.11:g.139548480G>A	.	.	2	0.99270505	.	0	0.9961493	0		.	.	.	.	.	146	.	0	MedGen:CN169374	.	.	.	.	0.97926	D	0.99990	D	H	.	.	G/G	84	0	.	.	not specified	.	0.95765	.	.	-	139548480	.	-	11.769000	.	0.99826	.	0	.	.	germline	.	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.99885	GRCh38	924	criteria provided, single submitter	c.509G>A	.	0.68332	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	1	.	FA9_HUMAN	.	99.0	.	.	D	0.94596	0.9964981	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys170Tyr	.	0.95819	.	germline	.		G	Jun 28, 2019	.	G/G	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158668	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.618	G	.	4.801854	0.83643	.	D	-	.	.	0.98706	610	.	.	0.99730	0	139548480	Y	9	0	.	.	P00740	.	0.964843	0.64033		.	1.0	D	.	0.9921017	.	0.52907	2158	0.720938	.	-9.32	.	.	0.78662	.	.	.	.	.	.	0.99993	X	F9	.	0	Cys	10680	.	X-139548480-G-A	not_specified	.	.	138458305	.	.	.	.	RCV001001432	D	.	.	c.509G>A	.	.	.	0.99946	G/G	rs1603265500	139548480	.	G	.	P00740	.	0.99983	.	0.68239		.	.	.	4.73	0	0	264690	5.08	0.99570	108	D	T	.	.	0	24	.	.	.	.	811517	0.99946	0.95120	0.99992847442627	2294	.	0.71675	.	.	.	.	7.385	.	D	.	.	7.5560088E-6	0	.	0.7908	X	.	ENSG00000101981	.	0	.	0	0.9999921642813904	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.833338	800231	HGNC:3551	A	.	simple_aae	0.995	.	139548480	TGT	1.000000	.	-	0	0.99929	.	0	.	Pathogenic	0.95493	.	.	.	ClinGen:CA414439424	C	.	0.998542052572	-	0.989	-	0.95970	.	466	0.99999	0.562821447849	0.9818	.	0.99425548895376659	94	-	509G>A 	.	0	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.70775	1603265500	.	0	0.99850	.	0.88	0.001	2210	0.99999344	5.08	.	.	.	0.797801	0.999918678679179	0.99523	D	84	.	.	0.9074	0.99959	p.Cys170Tyr	0	.	-14.847	0.9941932	.	0.98806	811517	D	.	F9	.	D	0.971	.	C170Y	D	0.86632	0.50684	G/G	principal1	243580	F9_Popp_2025_strep_2_var262965	No											C		509	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys170Tyr		true	c.509G>A						3551.0	139548480.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Cys170Tyr						Y	Jun 28, 2019					missense_variant		170.0				0.0135093224369561		Pathogenic	139548480.0	missense_variant		0.971					Reporter			F9_Cys170Tyr
F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039862	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545489	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Cys170Tyr	23	139548480	G	A	X											X-139548480-G-A	-	0.78068	1.0	170	.	.	.	X	138630639	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys170Tyr	.	26.8	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9985	.	0.90580	.	.	D	D	.	2.12843697498	0	.	.	.	.	0.47599	.	.	.	.	0.98352	.	.	0.99988	0.965	.	1.0	0.919108	4.69	0.99	A	single nucleotide variant	NC_000023.11:g.139548480G>A	.	.	2	0.99270505	.	0	0.9961493	0		.	.	.	.	.	146	.	0	MedGen:CN169374	.	.	.	.	0.97926	D	0.99990	D	H	.	.	G/G	84	0	.	.	not specified	.	0.95765	.	.	-	139548480	.	-	11.769000	.	0.99826	.	0	.	.	germline	.	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.99885	GRCh38	924	criteria provided, single submitter	c.509G>A	.	0.68332	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	1	.	FA9_HUMAN	.	99.0	.	.	D	0.94596	0.9964981	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys170Tyr	.	0.95819	.	germline	.		G	Jun 28, 2019	.	G/G	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158668	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.618	G	.	4.801854	0.83643	.	D	-	.	.	0.98706	610	.	.	0.99730	0	139548480	Y	9	0	.	.	P00740	.	0.964843	0.64033		.	1.0	D	.	0.9921017	.	0.52907	2158	0.720938	.	-9.32	.	.	0.78662	.	.	.	.	.	.	0.99993	X	F9	.	0	Cys	10680	.	X-139548480-G-A	not_specified	.	.	138458305	.	.	.	.	RCV001001432	D	.	.	c.509G>A	.	.	.	0.99946	G/G	rs1603265500	139548480	.	G	.	P00740	.	0.99983	.	0.68239		.	.	.	4.73	0	0	264690	5.08	0.99570	108	D	T	.	.	0	24	.	.	.	.	811517	0.99946	0.95120	0.99992847442627	2294	.	0.71675	.	.	.	.	7.385	.	D	.	.	7.5560088E-6	0	.	0.7908	X	.	ENSG00000101981	.	0	.	0	0.9999921642813904	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.833338	800231	HGNC:3551	A	.	simple_aae	0.995	.	139548480	TGT	1.000000	.	-	0	0.99929	.	0	.	Pathogenic	0.95493	.	.	.	ClinGen:CA414439424	C	.	0.998542052572	-	0.989	-	0.95970	.	466	0.99999	0.562821447849	0.9818	.	0.99425548895376659	94	-	509G>A 	.	0	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.70775	1603265500	.	0	0.99850	.	0.88	0.001	2210	0.99999344	5.08	.	.	.	0.797801	0.999918678679179	0.99523	D	84	.	.	0.9074	0.99959	p.Cys170Tyr	0	.	-14.847	0.9941932	.	0.98806	811517	D	.	F9	.	D	0.971	.	C170Y	D	0.86632	0.50684	G/G	principal1	188548	F9_Popp_2025_heavy_chain_var233922	No											C		509	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys170Tyr		true	c.509G>A						3551.0	139548480.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Cys170Tyr						Y	Jun 28, 2019					missense_variant		170.0				-0.002632687		Pathogenic	139548480.0	missense_variant		0.971					Reporter			F9_Cys170Tyr
F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039862	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545489	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	NC_000023.11:139548480:G:A	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			F9_Cys170Tyr	23	139548480	G	A	X											X-139548480-G-A	-	0.78068	1.0	170	.	.	.	X	138630639	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys170Tyr	.	26.8	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9985	.	0.90580	.	.	D	D	.	2.12843697498	0	.	.	.	.	0.47599	.	.	.	.	0.98352	.	.	0.99988	0.965	.	1.0	0.919108	4.69	0.99	A	single nucleotide variant	NC_000023.11:g.139548480G>A	.	.	2	0.99270505	.	0	0.9961493	0		.	.	.	.	.	146	.	0	MedGen:CN169374	.	.	.	.	0.97926	D	0.99990	D	H	.	.	G/G	84	0	.	.	not specified	.	0.95765	.	.	-	139548480	.	-	11.769000	.	0.99826	.	0	.	.	germline	.	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.99885	GRCh38	924	criteria provided, single submitter	c.509G>A	.	0.68332	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	1	.	FA9_HUMAN	.	99.0	.	.	D	0.94596	0.9964981	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys170Tyr	.	0.95819	.	germline	.		G	Jun 28, 2019	.	G/G	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158668	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.618	G	.	4.801854	0.83643	.	D	-	.	.	0.98706	610	.	.	0.99730	0	139548480	Y	9	0	.	.	P00740	.	0.964843	0.64033		.	1.0	D	.	0.9921017	.	0.52907	2158	0.720938	.	-9.32	.	.	0.78662	.	.	.	.	.	.	0.99993	X	F9	.	0	Cys	10680	.	X-139548480-G-A	not_specified	.	.	138458305	.	.	.	.	RCV001001432	D	.	.	c.509G>A	.	.	.	0.99946	G/G	rs1603265500	139548480	.	G	.	P00740	.	0.99983	.	0.68239		.	.	.	4.73	0	0	264690	5.08	0.99570	108	D	T	.	.	0	24	.	.	.	.	811517	0.99946	0.95120	0.99992847442627	2294	.	0.71675	.	.	.	.	7.385	.	D	.	.	7.5560088E-6	0	.	0.7908	X	.	ENSG00000101981	.	0	.	0	0.9999921642813904	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.833338	800231	HGNC:3551	A	.	simple_aae	0.995	.	139548480	TGT	1.000000	.	-	0	0.99929	.	0	.	Pathogenic	0.95493	.	.	.	ClinGen:CA414439424	C	.	0.998542052572	-	0.989	-	0.95970	.	466	0.99999	0.562821447849	0.9818	.	0.99425548895376659	94	-	509G>A 	.	0	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.70775	1603265500	.	0	0.99850	.	0.88	0.001	2210	0.99999344	5.08	.	.	.	0.797801	0.999918678679179	0.99523	D	84	.	.	0.9074	0.99959	p.Cys170Tyr	0	.	-14.847	0.9941932	.	0.98806	811517	D	.	F9	.	D	0.971	.	C170Y	D	0.86632	0.50684	G/G	principal1	161032	F9_Popp_2025_carboxy_gla_motif_var253284	No											C		509	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys170Tyr		true	c.509G>A						3551.0	139548480.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Cys170Tyr						Y	Jun 28, 2019					missense_variant		170.0				-0.001641377		Pathogenic	139548480.0	missense_variant		0.971					Reporter			F9_Cys170Tyr
F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039862	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545489	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002181		NC_000023.11:139548480:G:A		Cys170Tyr																												F9_Cys170Tyr	23	139548480	G	A	X	allele	509G>A	G07	527_CAVA_Array_P02	M14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548480-G-A	-	0.78068	1.0	170	.	.	.	X	138630639	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys170Tyr	.	26.8	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9985	.	0.90580	.	.	D	D	.	2.12843697498	0	.	.	.	.	0.47599	.	.	.	.	0.98352	.	.	0.99988	0.965	.	1.0	0.919108	4.69	0.99	A	single nucleotide variant	NC_000023.11:g.139548480G>A	.	.	2	0.99270505	.	0	0.9961493	0		.	.	.	.	.	146	.	0	MedGen:CN169374	.	.	.	.	0.97926	D	0.99990	D	H	.	.	G/G	84	0	.	.	not specified	.	0.95765	.	.	-	139548480	.	-	11.769000	.	0.99826	.	0	.	.	germline	.	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.99885	GRCh38	924	criteria provided, single submitter	c.509G>A	.	0.68332	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	1	.	FA9_HUMAN	.	99.0	.	.	D	0.94596	0.9964981	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys170Tyr	.	0.95819	.	germline	.		G	Jun 28, 2019	.	G/G	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158668	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.618	G	.	4.801854	0.83643	.	D	-	.	.	0.98706	610	.	.	0.99730	0	139548480	Y	9	0	.	.	P00740	.	0.964843	0.64033		.	1.0	D	.	0.9921017	.	0.52907	2158	0.720938	.	-9.32	.	.	0.78662	.	.	.	.	.	.	0.99993	X	F9	.	0	Cys	10680	.	X-139548480-G-A	not_specified	.	.	138458305	.	.	.	.	RCV001001432	D	.	.	c.509G>A	.	.	.	0.99946	G/G	rs1603265500	139548480	.	G	.	P00740	.	0.99983	.	0.68239		.	.	.	4.73	0	0	264690	5.08	0.99570	108	D	T	.	.	0	24	.	.	.	.	811517	0.99946	0.95120	0.99992847442627	2294	.	0.71675	.	.	.	.	7.385	.	D	.	.	7.5560088E-6	0	.	0.7908	X	.	ENSG00000101981	.	0	.	0	0.9999921642813904	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.833338	800231	HGNC:3551	A	.	simple_aae	0.995	.	139548480	TGT	1.000000	.	-	0	0.99929	.	0	.	Pathogenic	0.95493	.	.	.	ClinGen:CA414439424	C	.	0.998542052572	-	0.989	-	0.95970	.	466	0.99999	0.562821447849	0.9818	.	0.99425548895376659	94	-	509G>A 	.	0	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.70775	1603265500	.	0	0.99850	.	0.88	0.001	2210	0.99999344	5.08	.	.	.	0.797801	0.999918678679179	0.99523	D	84	.	.	0.9074	0.99959	p.Cys170Tyr	0	.	-14.847	0.9941932	.	0.98806	811517	D	.	F9	.	D	0.971	.	C170Y	D	0.86632	0.50684	G/G	principal1	133516	F9_Popp_2025_carboxy_F9_specific_var224241	No											C		509	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys170Tyr		true	c.509G>A						3551.0	139548480.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Cys170Tyr						Y	Jun 28, 2019					missense_variant		170.0				0.019039701		Pathogenic	139548480.0	missense_variant		0.971					Reporter			F9_Cys170Tyr
F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039862	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545489	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002181		NC_000023.11:139548480:G:A		Cys170Tyr																												F9_Cys170Tyr	23	139548480	G	A	X	allele	509G>A	G07	527_CAVA_Array_P02	M14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548480-G-A	-	0.78068	1.0	170	.	.	.	X	138630639	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys170Tyr	.	26.8	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9985	.	0.90580	.	.	D	D	.	2.12843697498	0	.	.	.	.	0.47599	.	.	.	.	0.98352	.	.	0.99988	0.965	.	1.0	0.919108	4.69	0.99	A	single nucleotide variant	NC_000023.11:g.139548480G>A	.	.	2	0.99270505	.	0	0.9961493	0		.	.	.	.	.	146	.	0	MedGen:CN169374	.	.	.	.	0.97926	D	0.99990	D	H	.	.	G/G	84	0	.	.	not specified	.	0.95765	.	.	-	139548480	.	-	11.769000	.	0.99826	.	0	.	.	germline	.	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.99885	GRCh38	924	criteria provided, single submitter	c.509G>A	.	0.68332	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	1	.	FA9_HUMAN	.	99.0	.	.	D	0.94596	0.9964981	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys170Tyr	.	0.95819	.	germline	.		G	Jun 28, 2019	.	G/G	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158668	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.618	G	.	4.801854	0.83643	.	D	-	.	.	0.98706	610	.	.	0.99730	0	139548480	Y	9	0	.	.	P00740	.	0.964843	0.64033		.	1.0	D	.	0.9921017	.	0.52907	2158	0.720938	.	-9.32	.	.	0.78662	.	.	.	.	.	.	0.99993	X	F9	.	0	Cys	10680	.	X-139548480-G-A	not_specified	.	.	138458305	.	.	.	.	RCV001001432	D	.	.	c.509G>A	.	.	.	0.99946	G/G	rs1603265500	139548480	.	G	.	P00740	.	0.99983	.	0.68239		.	.	.	4.73	0	0	264690	5.08	0.99570	108	D	T	.	.	0	24	.	.	.	.	811517	0.99946	0.95120	0.99992847442627	2294	.	0.71675	.	.	.	.	7.385	.	D	.	.	7.5560088E-6	0	.	0.7908	X	.	ENSG00000101981	.	0	.	0	0.9999921642813904	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.833338	800231	HGNC:3551	A	.	simple_aae	0.995	.	139548480	TGT	1.000000	.	-	0	0.99929	.	0	.	Pathogenic	0.95493	.	.	.	ClinGen:CA414439424	C	.	0.998542052572	-	0.989	-	0.95970	.	466	0.99999	0.562821447849	0.9818	.	0.99425548895376659	94	-	509G>A 	.	0	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.70775	1603265500	.	0	0.99850	.	0.88	0.001	2210	0.99999344	5.08	.	.	.	0.797801	0.999918678679179	0.99523	D	84	.	.	0.9074	0.99959	p.Cys170Tyr	0	.	-14.847	0.9941932	.	0.98806	811517	D	.	F9	.	D	0.971	.	C170Y	D	0.86632	0.50684	G/G	principal1	216064	F9_Popp_2025_light_chain_var243603	No											C		509	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys170Tyr		true	c.509G>A						3551.0	139548480.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Cys170Tyr						Y	Jun 28, 2019					missense_variant		170.0				0.004052954		Pathogenic	139548480.0	missense_variant		0.971					Reporter			F9_Cys170Tyr
F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039862	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545489	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002181		NC_000023.11:139548480:G:A		Cys170Tyr																												F9_Cys170Tyr	23	139548480	G	A	X	allele	509G>A	G07	527_CAVA_Array_P02	M14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548480-G-A	-	0.78068	1.0	170	.	.	.	X	138630639	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys170Tyr	.	26.8	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9985	.	0.90580	.	.	D	D	.	2.12843697498	0	.	.	.	.	0.47599	.	.	.	.	0.98352	.	.	0.99988	0.965	.	1.0	0.919108	4.69	0.99	A	single nucleotide variant	NC_000023.11:g.139548480G>A	.	.	2	0.99270505	.	0	0.9961493	0		.	.	.	.	.	146	.	0	MedGen:CN169374	.	.	.	.	0.97926	D	0.99990	D	H	.	.	G/G	84	0	.	.	not specified	.	0.95765	.	.	-	139548480	.	-	11.769000	.	0.99826	.	0	.	.	germline	.	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.99885	GRCh38	924	criteria provided, single submitter	c.509G>A	.	0.68332	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	1	.	FA9_HUMAN	.	99.0	.	.	D	0.94596	0.9964981	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys170Tyr	.	0.95819	.	germline	.		G	Jun 28, 2019	.	G/G	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158668	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.618	G	.	4.801854	0.83643	.	D	-	.	.	0.98706	610	.	.	0.99730	0	139548480	Y	9	0	.	.	P00740	.	0.964843	0.64033		.	1.0	D	.	0.9921017	.	0.52907	2158	0.720938	.	-9.32	.	.	0.78662	.	.	.	.	.	.	0.99993	X	F9	.	0	Cys	10680	.	X-139548480-G-A	not_specified	.	.	138458305	.	.	.	.	RCV001001432	D	.	.	c.509G>A	.	.	.	0.99946	G/G	rs1603265500	139548480	.	G	.	P00740	.	0.99983	.	0.68239		.	.	.	4.73	0	0	264690	5.08	0.99570	108	D	T	.	.	0	24	.	.	.	.	811517	0.99946	0.95120	0.99992847442627	2294	.	0.71675	.	.	.	.	7.385	.	D	.	.	7.5560088E-6	0	.	0.7908	X	.	ENSG00000101981	.	0	.	0	0.9999921642813904	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.833338	800231	HGNC:3551	A	.	simple_aae	0.995	.	139548480	TGT	1.000000	.	-	0	0.99929	.	0	.	Pathogenic	0.95493	.	.	.	ClinGen:CA414439424	C	.	0.998542052572	-	0.989	-	0.95970	.	466	0.99999	0.562821447849	0.9818	.	0.99425548895376659	94	-	509G>A 	.	0	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.70775	1603265500	.	0	0.99850	.	0.88	0.001	2210	0.99999344	5.08	.	.	.	0.797801	0.999918678679179	0.99523	D	84	.	.	0.9074	0.99959	p.Cys170Tyr	0	.	-14.847	0.9941932	.	0.98806	811517	D	.	F9	.	D	0.971	.	C170Y	D	0.86632	0.50684	G/G	principal1	243580	F9_Popp_2025_strep_2_var262965	No											C		509	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys170Tyr		true	c.509G>A						3551.0	139548480.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Cys170Tyr						Y	Jun 28, 2019					missense_variant		170.0				0.0135093224369561		Pathogenic	139548480.0	missense_variant		0.971					Reporter			F9_Cys170Tyr
F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039862	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545489	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002181		NC_000023.11:139548480:G:A		Cys170Tyr																												F9_Cys170Tyr	23	139548480	G	A	X	allele	509G>A	G07	527_CAVA_Array_P02	M14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548480-G-A	-	0.78068	1.0	170	.	.	.	X	138630639	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys170Tyr	.	26.8	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9985	.	0.90580	.	.	D	D	.	2.12843697498	0	.	.	.	.	0.47599	.	.	.	.	0.98352	.	.	0.99988	0.965	.	1.0	0.919108	4.69	0.99	A	single nucleotide variant	NC_000023.11:g.139548480G>A	.	.	2	0.99270505	.	0	0.9961493	0		.	.	.	.	.	146	.	0	MedGen:CN169374	.	.	.	.	0.97926	D	0.99990	D	H	.	.	G/G	84	0	.	.	not specified	.	0.95765	.	.	-	139548480	.	-	11.769000	.	0.99826	.	0	.	.	germline	.	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.99885	GRCh38	924	criteria provided, single submitter	c.509G>A	.	0.68332	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	1	.	FA9_HUMAN	.	99.0	.	.	D	0.94596	0.9964981	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys170Tyr	.	0.95819	.	germline	.		G	Jun 28, 2019	.	G/G	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158668	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.618	G	.	4.801854	0.83643	.	D	-	.	.	0.98706	610	.	.	0.99730	0	139548480	Y	9	0	.	.	P00740	.	0.964843	0.64033		.	1.0	D	.	0.9921017	.	0.52907	2158	0.720938	.	-9.32	.	.	0.78662	.	.	.	.	.	.	0.99993	X	F9	.	0	Cys	10680	.	X-139548480-G-A	not_specified	.	.	138458305	.	.	.	.	RCV001001432	D	.	.	c.509G>A	.	.	.	0.99946	G/G	rs1603265500	139548480	.	G	.	P00740	.	0.99983	.	0.68239		.	.	.	4.73	0	0	264690	5.08	0.99570	108	D	T	.	.	0	24	.	.	.	.	811517	0.99946	0.95120	0.99992847442627	2294	.	0.71675	.	.	.	.	7.385	.	D	.	.	7.5560088E-6	0	.	0.7908	X	.	ENSG00000101981	.	0	.	0	0.9999921642813904	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.833338	800231	HGNC:3551	A	.	simple_aae	0.995	.	139548480	TGT	1.000000	.	-	0	0.99929	.	0	.	Pathogenic	0.95493	.	.	.	ClinGen:CA414439424	C	.	0.998542052572	-	0.989	-	0.95970	.	466	0.99999	0.562821447849	0.9818	.	0.99425548895376659	94	-	509G>A 	.	0	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.70775	1603265500	.	0	0.99850	.	0.88	0.001	2210	0.99999344	5.08	.	.	.	0.797801	0.999918678679179	0.99523	D	84	.	.	0.9074	0.99959	p.Cys170Tyr	0	.	-14.847	0.9941932	.	0.98806	811517	D	.	F9	.	D	0.971	.	C170Y	D	0.86632	0.50684	G/G	principal1	188548	F9_Popp_2025_heavy_chain_var233922	No											C		509	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys170Tyr		true	c.509G>A						3551.0	139548480.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Cys170Tyr						Y	Jun 28, 2019					missense_variant		170.0				-0.002632687		Pathogenic	139548480.0	missense_variant		0.971					Reporter			F9_Cys170Tyr
F9_Cys170Tyr	-5.196104915678863	0.0012583859585505689	2.607836994019341	0.03502339256961306	2025_01_Batch_13-14	0.8892735093039862	0.7561848273421976	0.9070192044711107	0.8641364563942026	0.8233886404938451	0.6928223052051115	0.8865534239551376	0.9766545361665918	0.9180511387246488	0.8601555021733753	0.7910479072545489	0.8213691256486676	0.9418368703188513	0.8910937975594257	0.8417720713336102	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002181		NC_000023.11:139548480:G:A		Cys170Tyr																												F9_Cys170Tyr	23	139548480	G	A	X	allele	509G>A	G07	527_CAVA_Array_P02	M14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548480-G-A	-	0.78068	1.0	170	.	.	.	X	138630639	A	.	.	X	1_Pathogenic	NC_000023.11	.	Cys170Tyr	.	26.8	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99671	Select	0.9985	.	0.90580	.	.	D	D	.	2.12843697498	0	.	.	.	.	0.47599	.	.	.	.	0.98352	.	.	0.99988	0.965	.	1.0	0.919108	4.69	0.99	A	single nucleotide variant	NC_000023.11:g.139548480G>A	.	.	2	0.99270505	.	0	0.9961493	0		.	.	.	.	.	146	.	0	MedGen:CN169374	.	.	.	.	0.97926	D	0.99990	D	H	.	.	G/G	84	0	.	.	not specified	.	0.95765	.	.	-	139548480	.	-	11.769000	.	0.99826	.	0	.	.	germline	.	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.99885	GRCh38	924	criteria provided, single submitter	c.509G>A	.	0.68332	0	.	.	.	.	.	P	0	.	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	1	.	FA9_HUMAN	.	99.0	.	.	D	0.94596	0.9964981	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys170Tyr	.	0.95819	.	germline	.		G	Jun 28, 2019	.	G/G	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158668	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.618	G	.	4.801854	0.83643	.	D	-	.	.	0.98706	610	.	.	0.99730	0	139548480	Y	9	0	.	.	P00740	.	0.964843	0.64033		.	1.0	D	.	0.9921017	.	0.52907	2158	0.720938	.	-9.32	.	.	0.78662	.	.	.	.	.	.	0.99993	X	F9	.	0	Cys	10680	.	X-139548480-G-A	not_specified	.	.	138458305	.	.	.	.	RCV001001432	D	.	.	c.509G>A	.	.	.	0.99946	G/G	rs1603265500	139548480	.	G	.	P00740	.	0.99983	.	0.68239		.	.	.	4.73	0	0	264690	5.08	0.99570	108	D	T	.	.	0	24	.	.	.	.	811517	0.99946	0.95120	0.99992847442627	2294	.	0.71675	.	.	.	.	7.385	.	D	.	.	7.5560088E-6	0	.	0.7908	X	.	ENSG00000101981	.	0	.	0	0.9999921642813904	2	0.97365	0.18019	.	2	.	.	.	YES	.	0.833338	800231	HGNC:3551	A	.	simple_aae	0.995	.	139548480	TGT	1.000000	.	-	0	0.99929	.	0	.	Pathogenic	0.95493	.	.	.	ClinGen:CA414439424	C	.	0.998542052572	-	0.989	-	0.95970	.	466	0.99999	0.562821447849	0.9818	.	0.99425548895376659	94	-	509G>A 	.	0	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.70775	1603265500	.	0	0.99850	.	0.88	0.001	2210	0.99999344	5.08	.	.	.	0.797801	0.999918678679179	0.99523	D	84	.	.	0.9074	0.99959	p.Cys170Tyr	0	.	-14.847	0.9941932	.	0.98806	811517	D	.	F9	.	D	0.971	.	C170Y	D	0.86632	0.50684	G/G	principal1	161032	F9_Popp_2025_carboxy_gla_motif_var253284	No											C		509	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys170Tyr		true	c.509G>A						3551.0	139548480.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Cys170Tyr						Y	Jun 28, 2019					missense_variant		170.0				-0.001641377		Pathogenic	139548480.0	missense_variant		0.971					Reporter			F9_Cys170Tyr
RAD51D_Phe305Leu	0.583403789039403	0.6005843938160091	3.733061609886038	0.033504115466645654	2025_01_Batch_13-14						0.899373938602152	0.9326561923583545	0.9572311202580884	0.9425515409215897	0.7934838271957201										0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024886		NC_000017.11:35101025:G:C		Phe305Leu																												RAD51D_Phe305Leu	17	35101025	G	C	17	allele	915C>G	E02	527_CAVA_Array_P05	I03	B13A7A8P2_R1	B14A7A8P2_R2				17-35101025-G-C	-	0.15999	0.0	305	.	0	.	17	33428044	C	1.239310e-06	.	17	3_Conflicting	NC_000017.11	2	Phe305Leu	.	12.23	.	0	.	T	0	4	1	.	.	.	.	.	0	0.04912	Select	0.1042	.	0.02950	.	.	T	T	64040	.	0	0	.	.	.	.	.	44886	0	.	0.05476	.	.	0.07282	0.621	.	.	.	1.17	.	C	single nucleotide variant	NC_000017.11:g.35101025G>C	0	.	2	0.032197934	.	0	0.045180835	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	.	.	0.000000e+00	0	.	B	0.01928	B	L	0.357995	2	G/G	108	0	.	1613800	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	.	0.23176	.	.	-	35101025	.	-	1.312000	.	0.00124	29606	0	1179680	.	germline	91072	Gain of disorder (P = 0.0917)| Gain of MoRF binding (P = 0.1056)| Loss of phosphorylation at T303 (P = 0.1899)| Gain of relative solvent accessibility (P = 0.2629)| Loss of sheet (P = 0.302)	0.26717	GRCh38	913	criteria provided, conflicting classifications	c.915C>G	.	0.22627	0	.	.	.	.	.	A	0	0.000000e+00	NM_002878.4(RAD51D):c.915C>G (p.Phe305Leu)	1	.	RA51D_HUMAN	.	.	-1.04489556684859	.	.	0.57023	0.045180835	-	.	.		.	.	2	.	criteria_provided,_conflicting_classifications	0.75297	.	0	.	.	60016	p.Phe305Leu	0	0.25630	.	germline	.		G	Apr 20, 2024	.	G/G	.	.	0.788	N	17q12	7618	.	.	SCV000664927|SCV000911553|SCV001204278|SCV005369137	Conflicting_classifications_of_pathogenicity	.	.	Leu	L	-	912	ENSP00000338790	ENST00000345365	.	1.0	.	.	-0.105	G	.	1.205182	0.05249	N	T	-	0.543092	.	0.25673	610	.	.	0.03670	0	35101025	Y	10	0	.	0.000000e+00	O75771	.	0.051884	0.15012		.	0.0	T	.	0.032197934	.	0.31965	5892	-0.259589	2	0.13	.	1.695380e-06	0.00968	.	.	75040	.	6062	.	0.01928	17	RAD51D	0.000000e+00	0	Phe	11862	.	17-35101025-G-C	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	.	30452157	ClinGen:CA399086171	0.108385	0.07596	0	RCV001040689|RCV000568982|RCV004760603	T	0	.	c.915C>G	.	0	0	0.12690	G/G	rs1316114457	35101025	.	G	.	O75771	.	0.07283	.	0.68239		.	.	0.000000e+00	0.83	0	0	264690	1.6	0.28757	108	T	.	.	.	0	24	.	.	.	140162|145	480950	0.11674	0.10592	0.0400510121688084	2816	.	0.29661	0.21352	.	.	1179680	-0.02	.	N	.	.	3.7780044E-6	0	614291	0.12505	17	.	ENSG00000185379	0.000000e+00	0	.	0	.	3	0.01384	0.21155	.	1	.	0.000000e+00	-0.957731270841975	YES	0.000000e+00	0.009973	478443	HGNC:9823	.	.	.	0.005	.	35101025	TTC	1.000000	.	-	0	0.02691	1.695380e-06	0	0	Conflicting classifications of pathogenicity	0.08768	.	0	0	ClinGen:CA399086171	F	.	0.444807159249	-	0.301	-	0.11150	.	470	0.23376	.	0.3499	0	0.83537688913623076	94	-	915C>G 	.	0	C0027672|C3280345	.	.	.	.	NM_002878.4	-	.	.	0	0.18007	1316114457	.	0	0.43722	0.10562	0.053	1.0	2708	0.25410953	5.16	.	.	.	-0.610658	4.50213563311964e-06	0.20850	T	84	.	.	-1.0215	0.38033	p.Phe305Leu	0	0	-2.604	0.040840566	0	0.00398	480950	T	.	RAD51D	.	T	0.024	.	F305L	T	0.30762	0.15707	G/G	principal1	959097	RAD51D_unpublished_var153344	Yes						overall function		Cell survival			F		915	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Phe305Leu		true	c.915C>G						9823.0	35101025.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				Phe305Leu						L	Apr 01, 2024					missense_variant		305.0	C		1.2393109431e-6	0.00648996		Conflicting classifications of pathogenicity	35101025.0	missense_variant		0.024	functionally_normal				Cell viability			RAD51D_Phe305Leu
RAD51D_Phe305Leu	0.583403789039403	0.6005843938160091	3.733061609886038	0.033504115466645654	2025_01_Batch_13-14						0.899373938602152	0.9326561923583545	0.9572311202580884	0.9425515409215897	0.7934838271957201										0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024886	ALE00031726	NC_000017.11:35101025:G:C	915C>G	Phe305Leu	CAVA																											RAD51D_Phe305Leu	17	35101025	G	C	17								1	1	1	17-35101025-G-C	-	0.15999	0.0	305	.	0	.	17	33428044	C	1.239310e-06	.	17	3_Conflicting	NC_000017.11	2	Phe305Leu	.	12.23	.	0	.	T	0	4	1	.	.	.	.	.	0	0.04912	Select	0.1042	.	0.02950	.	.	T	T	64040	.	0	0	.	.	.	.	.	44886	0	.	0.05476	.	.	0.07282	0.621	.	.	.	1.17	.	C	single nucleotide variant	NC_000017.11:g.35101025G>C	0	.	2	0.032197934	.	0	0.045180835	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	.	.	0.000000e+00	0	.	B	0.01928	B	L	0.357995	2	G/G	108	0	.	1613800	Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not provided	.	0.23176	.	.	-	35101025	.	-	1.312000	.	0.00124	29606	0	1179680	.	germline	91072	Gain of disorder (P = 0.0917)| Gain of MoRF binding (P = 0.1056)| Loss of phosphorylation at T303 (P = 0.1899)| Gain of relative solvent accessibility (P = 0.2629)| Loss of sheet (P = 0.302)	0.26717	GRCh38	913	criteria provided, conflicting classifications	c.915C>G	.	0.22627	0	.	.	.	.	.	A	0	0.000000e+00	NM_002878.4(RAD51D):c.915C>G (p.Phe305Leu)	1	.	RA51D_HUMAN	.	.	-1.04489556684859	.	.	0.57023	0.045180835	-	.	.		.	.	2	.	criteria_provided,_conflicting_classifications	0.75297	.	0	.	.	60016	p.Phe305Leu	0	0.25630	.	germline	.		G	Apr 20, 2024	.	G/G	.	.	0.788	N	17q12	7618	.	.	SCV000664927|SCV000911553|SCV001204278|SCV005369137	Conflicting_classifications_of_pathogenicity	.	.	Leu	L	-	912	ENSP00000338790	ENST00000345365	.	1.0	.	.	-0.105	G	.	1.205182	0.05249	N	T	-	0.543092	.	0.25673	610	.	.	0.03670	0	35101025	Y	10	0	.	0.000000e+00	O75771	.	0.051884	0.15012		.	0.0	T	.	0.032197934	.	0.31965	5892	-0.259589	2	0.13	.	1.695380e-06	0.00968	.	.	75040	.	6062	.	0.01928	17	RAD51D	0.000000e+00	0	Phe	11862	.	17-35101025-G-C	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	.	30452157	ClinGen:CA399086171	0.108385	0.07596	0	RCV001040689|RCV000568982|RCV004760603	T	0	.	c.915C>G	.	0	0	0.12690	G/G	rs1316114457	35101025	.	G	.	O75771	.	0.07283	.	0.68239		.	.	0.000000e+00	0.83	0	0	264690	1.6	0.28757	108	T	.	.	.	0	24	.	.	.	140162|145	480950	0.11674	0.10592	0.0400510121688084	2816	.	0.29661	0.21352	.	.	1179680	-0.02	.	N	.	.	3.7780044E-6	0	614291	0.12505	17	.	ENSG00000185379	0.000000e+00	0	.	0	.	3	0.01384	0.21155	.	1	.	0.000000e+00	-0.957731270841975	YES	0.000000e+00	0.009973	478443	HGNC:9823	.	.	.	0.005	.	35101025	TTC	1.000000	.	-	0	0.02691	1.695380e-06	0	0	Conflicting classifications of pathogenicity	0.08768	.	0	0	ClinGen:CA399086171	F	.	0.444807159249	-	0.301	-	0.11150	.	470	0.23376	.	0.3499	0	0.83537688913623076	94	-	915C>G 	.	0	C0027672|C3280345	.	.	.	.	NM_002878.4	-	.	.	0	0.18007	1316114457	.	0	0.43722	0.10562	0.053	1.0	2708	0.25410953	5.16	.	.	.	-0.610658	4.50213563311964e-06	0.20850	T	84	.	.	-1.0215	0.38033	p.Phe305Leu	0	0	-2.604	0.040840566	0	0.00398	480950	T	.	RAD51D	.	T	0.024	.	F305L	T	0.30762	0.15707	G/G	principal1	959097	RAD51D_unpublished_var153344	Yes						overall function		Cell survival			F		915	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Phe305Leu		true	c.915C>G						9823.0	35101025.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				Phe305Leu						L	Apr 01, 2024					missense_variant		305.0	C		1.2393109431e-6	0.00648996		Conflicting classifications of pathogenicity	35101025.0	missense_variant		0.024	functionally_normal				Cell viability			RAD51D_Phe305Leu
BRCA1_His41Arg	-0.7905479031010616	0.45515193572773704	2.625988804254552	0.03411090005792832	2025_01_Batch_13-14	0.7635952103109365	0.9180190411090324	0.6955686537564537	0.6385853229034477	0.5758214868863146	0.9836352860827905	0.9407984783796364	0.9415830691802393	0.9804317122724854	0.9444769747268804	0.8736152481968635	0.9294087597443343	0.8185758614683465	0.8095085175879666	0.7601492308065976	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011865		NC_000017.11:43115738:T:C		His41Arg																												BRCA1_His41Arg	17	43115738	T	C	17	allele	122A>G	H09	527_CAVA_Array_P01	O17	B13A7A8P1_R1	B14A7A8P1_R2				17-43115738-T-C	-	0.70206	0.959	41	.	.	.	17	41267755	C	.	.	17	1_Pathogenic	NC_000017.11	.	His41Arg	.	25.5	.	.	.	D	.	11	1	.	.	.	.	.	.	0.99491	.	0.9917	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.66732	.	.	.	.	0.95148	.	.	0.91402	0.999	.	.	0.955504	.	.	C	single nucleotide variant	NC_000017.11:g.43115738T>C	.	.	2	0.6761325	.	.	0.9505324	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	.	.	0.99291	P	0.78232	D	H	12.13134	.	T/T	.	.	.	.	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome	.	0.96663	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43115738	.	-	7.815000	.	0.98523	.	.	.	.	germline;not applicable;unknown	.	Gain of MoRF binding (P = 0.0172)| Loss of catalytic residue at D40 (P = 0.0761)| Gain of disorder (P = 0.0885)| Gain of helix (P = 0.132)| Gain of phosphorylation at T37 (P = 0.2265)	0.99665	GRCh38	464	reviewed by expert panel	.	.	0.96929	.	.	.	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	.	.	.	.	.	NM_007294.4(BRCA1):c.122A>G (p.His41Arg)	3	.	BRCA1_HUMAN	.	.	0.939969350591933	.	D	0.95417	0.9015565	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99505	.	.	.	.	.	.	.	0.69605	.	germline	.		T	Aug 10, 2015	.	T/T	.	.	1.0	N	17q21.31	.	.	.	SCV000244297	Pathogenic	.	.	Arg	R	-	.	ENSP00000478114	ENST00000618469	.	.	.	.	0.665	T	.	4.490848	0.92967	D	.	-	11.79838	.	0.99127	.	.	.	0.93292	.	43115738	Y	10	.	.	.	P38398	.	0.460215	0.77280		.	0.542	D	.	0.6308536	.	0.91597	672	0.562828	.	.	.	.	0.91343	.	.	.	.	.	.	0.80766	17	BRCA1	.	.	His	.	.	17-43115738-T-C	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38521281	BRCA1-HCI:BRCA1_00130|ClinGen:CA000805	0.750685	0.93540	.	RCV000047383|RCV000111820|RCV000484980|RCV000569789	.	.	.	c.122A>G	.	.	.	0.96258	T/T	rs80357276	43115738	.	T	.	E9PFC7	.	0.96261	.	0.68239		.	.	.	3.995	.	.	.	5.97	0.93020	.	D	T	.	.	.	.	.	.	.	145|140162|145	54166	0.96198	0.46401	0.998141407966614	.	.	0.71675	0.69060	.	.	.	3.518	.	.	.	.	.	.	604370	0.533	17	.	ENSG00000012048	.	.	.	.	.	2	0.92348	0.78507	.	.	.	.	0.850731219321243	.	.	0.885446	68833	HGNC:1100	.	.	.	0.964	.	43115738	CAC	1.000000	.	-	.	0.99449	.	.	.	Pathogenic	0.93979	.	.	.	BRCA1-HCI:BRCA1_00130,ClinGen:CA000805	H	.	.	-	0.966	-	0.88119	.	.	0.94303	0.697537183762	.	.	0.99650553719529922	.	-	122A>G 	.	.	C0677776|C0027672|C3661900|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.83052	80357276	.	.	0.99628	0.93019	.	.	.	0.99957854	5.97	.	.	.	0.570687	0.999422575166627	0.96666	D	.	.	.	0.9682	0.99792	p.His41Arg	.	.	-13.38	.	.	0.96550	54166	D	.	BRCA1	.	D	.	.	H41R	.	.	0.62996	T/T	principal2																																																																																																				
F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											F9	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	NC_000023.11:139561602:A:G	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn306Ser	23	139561602	A	G	X											X-139561602-A-G	-	0.4701	0.25	306	.	.	.	X	138643761	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asn306Ser	.	22.4	.	0	.	D	.	2	1	.	.	.	.	.	0	0.82883	Select	0.7974	.	0.31206	.	.	D	T	.	1.46342036736	0	.	.	.	.	0.33292	.	.	.	.	0.54569	.	.	0.70926	0.992	.	28.0	0.945705	3.79	0.72	G	single nucleotide variant	NC_000023.11:g.139561602A>G	.	.	3	0.7595891	.	0	0.68832976	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.86560	B	N	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.92292	.	.	-	139561602	.	-	11.260000	.	0.84761	.	0	.	.	germline;unknown	.	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.94817	GRCh38	924	criteria provided, single submitter	c.917A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	1	.	FA9_HUMAN	.	72.0	.	.	D	0.19222	0.57284623	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Asn306Ser	.	0.91057	.	germline	.		A	Jul 22, 2024	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV005627711	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.128	.	.	0.691	A	.	3.389643	0.28160	.	T	-	.	.	0.98816	610	.	.	0.58161	0	139561602	Y	10	0	.	.	P00740	.	0.7397	0.94097		.	0.039	D	.	0.7750274	.	0.67791	2158	0.0619128	.	-2.34	.	.	0.33072	.	.	.	.	.	.	0.85621	X	F9	.	0	Asn	11158	.	X-139561602-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138471427	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	.	.	.	RCV000011350	D	.	.	c.917A>G	.	.	.	0.59570	A/A	rs137852251	139561602	.	A	.	P00740	.	0.77164	.	0.68239		.	.	.	0.51	0	0	.	5.42	0.92714	108	D	T	.	.	0	24	.	.	.	98879	10604	0.59060	0.86334	0.923391759395599	2720	.	0.71675	.	.	.	.	7.108	.	N	.	.	.	0	306900	0.76751	X	.	ENSG00000101981	.	0	.	0	0.9591642282066425	2	0.23609	0.18019	.	.	.	.	.	YES	.	0.846921	25643	HGNC:3551	A	.	simple_aae	0.725	.	139561602	AAT	1.000000	.	-	0	0.90484	.	0	.	Likely pathogenic	0.48981	.	.	.	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	N	.	0.970814190553	-	0.844	-	0.81098	.	518	0.95878	0.460176557302	0.0936	.	0.99862385950794386	94	-	917A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79299	137852251	.	0	0.97022	.	0.417	0.333	2636	0.99995030	5.42	.	.	.	-0.148843	0.983465118204216	0.13403	D	84	.	.	0.6325	0.93121	p.Asn306Ser	0	.	-6.325	0.91224134	.	0.86210	10604	T	.	F9	.	T	0.578	.	N306S	T	0.69847	0.84104	A/A	principal1	169108	F9_Popp_2025_carboxy_gla_motif_var256142	No											N		917	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Asn306Ser		true	c.917A>G						3551.0	139561602.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Asn306Ser						S	Sep 01, 1989					missense_variant		306.0				0.4440151418526494		Pathogenic	139561602.0	missense_variant		0.578					Reporter			F9_Asn306Ser
F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											F9	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	NC_000023.11:139561602:A:G	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn306Ser	23	139561602	A	G	X											X-139561602-A-G	-	0.4701	0.25	306	.	.	.	X	138643761	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asn306Ser	.	22.4	.	0	.	D	.	2	1	.	.	.	.	.	0	0.82883	Select	0.7974	.	0.31206	.	.	D	T	.	1.46342036736	0	.	.	.	.	0.33292	.	.	.	.	0.54569	.	.	0.70926	0.992	.	28.0	0.945705	3.79	0.72	G	single nucleotide variant	NC_000023.11:g.139561602A>G	.	.	3	0.7595891	.	0	0.68832976	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.86560	B	N	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.92292	.	.	-	139561602	.	-	11.260000	.	0.84761	.	0	.	.	germline;unknown	.	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.94817	GRCh38	924	criteria provided, single submitter	c.917A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	1	.	FA9_HUMAN	.	72.0	.	.	D	0.19222	0.57284623	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Asn306Ser	.	0.91057	.	germline	.		A	Jul 22, 2024	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV005627711	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.128	.	.	0.691	A	.	3.389643	0.28160	.	T	-	.	.	0.98816	610	.	.	0.58161	0	139561602	Y	10	0	.	.	P00740	.	0.7397	0.94097		.	0.039	D	.	0.7750274	.	0.67791	2158	0.0619128	.	-2.34	.	.	0.33072	.	.	.	.	.	.	0.85621	X	F9	.	0	Asn	11158	.	X-139561602-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138471427	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	.	.	.	RCV000011350	D	.	.	c.917A>G	.	.	.	0.59570	A/A	rs137852251	139561602	.	A	.	P00740	.	0.77164	.	0.68239		.	.	.	0.51	0	0	.	5.42	0.92714	108	D	T	.	.	0	24	.	.	.	98879	10604	0.59060	0.86334	0.923391759395599	2720	.	0.71675	.	.	.	.	7.108	.	N	.	.	.	0	306900	0.76751	X	.	ENSG00000101981	.	0	.	0	0.9591642282066425	2	0.23609	0.18019	.	.	.	.	.	YES	.	0.846921	25643	HGNC:3551	A	.	simple_aae	0.725	.	139561602	AAT	1.000000	.	-	0	0.90484	.	0	.	Likely pathogenic	0.48981	.	.	.	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	N	.	0.970814190553	-	0.844	-	0.81098	.	518	0.95878	0.460176557302	0.0936	.	0.99862385950794386	94	-	917A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79299	137852251	.	0	0.97022	.	0.417	0.333	2636	0.99995030	5.42	.	.	.	-0.148843	0.983465118204216	0.13403	D	84	.	.	0.6325	0.93121	p.Asn306Ser	0	.	-6.325	0.91224134	.	0.86210	10604	T	.	F9	.	T	0.578	.	N306S	T	0.69847	0.84104	A/A	principal1	141592	F9_Popp_2025_carboxy_F9_specific_var227099	No											N		917	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Asn306Ser		true	c.917A>G						3551.0	139561602.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Asn306Ser						S	Sep 01, 1989					missense_variant		306.0				0.5514024847166168		Pathogenic	139561602.0	missense_variant		0.578					Reporter			F9_Asn306Ser
F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											F9	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	NC_000023.11:139561602:A:G	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn306Ser	23	139561602	A	G	X											X-139561602-A-G	-	0.4701	0.25	306	.	.	.	X	138643761	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asn306Ser	.	22.4	.	0	.	D	.	2	1	.	.	.	.	.	0	0.82883	Select	0.7974	.	0.31206	.	.	D	T	.	1.46342036736	0	.	.	.	.	0.33292	.	.	.	.	0.54569	.	.	0.70926	0.992	.	28.0	0.945705	3.79	0.72	G	single nucleotide variant	NC_000023.11:g.139561602A>G	.	.	3	0.7595891	.	0	0.68832976	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.86560	B	N	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.92292	.	.	-	139561602	.	-	11.260000	.	0.84761	.	0	.	.	germline;unknown	.	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.94817	GRCh38	924	criteria provided, single submitter	c.917A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	1	.	FA9_HUMAN	.	72.0	.	.	D	0.19222	0.57284623	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Asn306Ser	.	0.91057	.	germline	.		A	Jul 22, 2024	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV005627711	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.128	.	.	0.691	A	.	3.389643	0.28160	.	T	-	.	.	0.98816	610	.	.	0.58161	0	139561602	Y	10	0	.	.	P00740	.	0.7397	0.94097		.	0.039	D	.	0.7750274	.	0.67791	2158	0.0619128	.	-2.34	.	.	0.33072	.	.	.	.	.	.	0.85621	X	F9	.	0	Asn	11158	.	X-139561602-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138471427	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	.	.	.	RCV000011350	D	.	.	c.917A>G	.	.	.	0.59570	A/A	rs137852251	139561602	.	A	.	P00740	.	0.77164	.	0.68239		.	.	.	0.51	0	0	.	5.42	0.92714	108	D	T	.	.	0	24	.	.	.	98879	10604	0.59060	0.86334	0.923391759395599	2720	.	0.71675	.	.	.	.	7.108	.	N	.	.	.	0	306900	0.76751	X	.	ENSG00000101981	.	0	.	0	0.9591642282066425	2	0.23609	0.18019	.	.	.	.	.	YES	.	0.846921	25643	HGNC:3551	A	.	simple_aae	0.725	.	139561602	AAT	1.000000	.	-	0	0.90484	.	0	.	Likely pathogenic	0.48981	.	.	.	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	N	.	0.970814190553	-	0.844	-	0.81098	.	518	0.95878	0.460176557302	0.0936	.	0.99862385950794386	94	-	917A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79299	137852251	.	0	0.97022	.	0.417	0.333	2636	0.99995030	5.42	.	.	.	-0.148843	0.983465118204216	0.13403	D	84	.	.	0.6325	0.93121	p.Asn306Ser	0	.	-6.325	0.91224134	.	0.86210	10604	T	.	F9	.	T	0.578	.	N306S	T	0.69847	0.84104	A/A	principal1	224140	F9_Popp_2025_light_chain_var246461	No											N		917	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Asn306Ser		true	c.917A>G						3551.0	139561602.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Asn306Ser						S	Sep 01, 1989					missense_variant		306.0				0.5262446676818676		Pathogenic	139561602.0	missense_variant		0.578					Reporter			F9_Asn306Ser
F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											F9	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	NC_000023.11:139561602:A:G	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn306Ser	23	139561602	A	G	X											X-139561602-A-G	-	0.4701	0.25	306	.	.	.	X	138643761	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asn306Ser	.	22.4	.	0	.	D	.	2	1	.	.	.	.	.	0	0.82883	Select	0.7974	.	0.31206	.	.	D	T	.	1.46342036736	0	.	.	.	.	0.33292	.	.	.	.	0.54569	.	.	0.70926	0.992	.	28.0	0.945705	3.79	0.72	G	single nucleotide variant	NC_000023.11:g.139561602A>G	.	.	3	0.7595891	.	0	0.68832976	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.86560	B	N	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.92292	.	.	-	139561602	.	-	11.260000	.	0.84761	.	0	.	.	germline;unknown	.	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.94817	GRCh38	924	criteria provided, single submitter	c.917A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	1	.	FA9_HUMAN	.	72.0	.	.	D	0.19222	0.57284623	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Asn306Ser	.	0.91057	.	germline	.		A	Jul 22, 2024	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV005627711	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.128	.	.	0.691	A	.	3.389643	0.28160	.	T	-	.	.	0.98816	610	.	.	0.58161	0	139561602	Y	10	0	.	.	P00740	.	0.7397	0.94097		.	0.039	D	.	0.7750274	.	0.67791	2158	0.0619128	.	-2.34	.	.	0.33072	.	.	.	.	.	.	0.85621	X	F9	.	0	Asn	11158	.	X-139561602-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138471427	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	.	.	.	RCV000011350	D	.	.	c.917A>G	.	.	.	0.59570	A/A	rs137852251	139561602	.	A	.	P00740	.	0.77164	.	0.68239		.	.	.	0.51	0	0	.	5.42	0.92714	108	D	T	.	.	0	24	.	.	.	98879	10604	0.59060	0.86334	0.923391759395599	2720	.	0.71675	.	.	.	.	7.108	.	N	.	.	.	0	306900	0.76751	X	.	ENSG00000101981	.	0	.	0	0.9591642282066425	2	0.23609	0.18019	.	.	.	.	.	YES	.	0.846921	25643	HGNC:3551	A	.	simple_aae	0.725	.	139561602	AAT	1.000000	.	-	0	0.90484	.	0	.	Likely pathogenic	0.48981	.	.	.	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	N	.	0.970814190553	-	0.844	-	0.81098	.	518	0.95878	0.460176557302	0.0936	.	0.99862385950794386	94	-	917A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79299	137852251	.	0	0.97022	.	0.417	0.333	2636	0.99995030	5.42	.	.	.	-0.148843	0.983465118204216	0.13403	D	84	.	.	0.6325	0.93121	p.Asn306Ser	0	.	-6.325	0.91224134	.	0.86210	10604	T	.	F9	.	T	0.578	.	N306S	T	0.69847	0.84104	A/A	principal1	196624	F9_Popp_2025_heavy_chain_var236780	No											N		917	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Asn306Ser		true	c.917A>G						3551.0	139561602.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Asn306Ser						S	Sep 01, 1989					missense_variant		306.0				0.6069392182469997		Pathogenic	139561602.0	missense_variant		0.578					Reporter			F9_Asn306Ser
F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											F9	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	NC_000023.11:139561602:A:G	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn306Ser	23	139561602	A	G	X											X-139561602-A-G	-	0.4701	0.25	306	.	.	.	X	138643761	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asn306Ser	.	22.4	.	0	.	D	.	2	1	.	.	.	.	.	0	0.82883	Select	0.7974	.	0.31206	.	.	D	T	.	1.46342036736	0	.	.	.	.	0.33292	.	.	.	.	0.54569	.	.	0.70926	0.992	.	28.0	0.945705	3.79	0.72	G	single nucleotide variant	NC_000023.11:g.139561602A>G	.	.	3	0.7595891	.	0	0.68832976	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.86560	B	N	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.92292	.	.	-	139561602	.	-	11.260000	.	0.84761	.	0	.	.	germline;unknown	.	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.94817	GRCh38	924	criteria provided, single submitter	c.917A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	1	.	FA9_HUMAN	.	72.0	.	.	D	0.19222	0.57284623	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Asn306Ser	.	0.91057	.	germline	.		A	Jul 22, 2024	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV005627711	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.128	.	.	0.691	A	.	3.389643	0.28160	.	T	-	.	.	0.98816	610	.	.	0.58161	0	139561602	Y	10	0	.	.	P00740	.	0.7397	0.94097		.	0.039	D	.	0.7750274	.	0.67791	2158	0.0619128	.	-2.34	.	.	0.33072	.	.	.	.	.	.	0.85621	X	F9	.	0	Asn	11158	.	X-139561602-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138471427	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	.	.	.	RCV000011350	D	.	.	c.917A>G	.	.	.	0.59570	A/A	rs137852251	139561602	.	A	.	P00740	.	0.77164	.	0.68239		.	.	.	0.51	0	0	.	5.42	0.92714	108	D	T	.	.	0	24	.	.	.	98879	10604	0.59060	0.86334	0.923391759395599	2720	.	0.71675	.	.	.	.	7.108	.	N	.	.	.	0	306900	0.76751	X	.	ENSG00000101981	.	0	.	0	0.9591642282066425	2	0.23609	0.18019	.	.	.	.	.	YES	.	0.846921	25643	HGNC:3551	A	.	simple_aae	0.725	.	139561602	AAT	1.000000	.	-	0	0.90484	.	0	.	Likely pathogenic	0.48981	.	.	.	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	N	.	0.970814190553	-	0.844	-	0.81098	.	518	0.95878	0.460176557302	0.0936	.	0.99862385950794386	94	-	917A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79299	137852251	.	0	0.97022	.	0.417	0.333	2636	0.99995030	5.42	.	.	.	-0.148843	0.983465118204216	0.13403	D	84	.	.	0.6325	0.93121	p.Asn306Ser	0	.	-6.325	0.91224134	.	0.86210	10604	T	.	F9	.	T	0.578	.	N306S	T	0.69847	0.84104	A/A	principal1	251656	F9_Popp_2025_strep_2_var265823	No											N		917	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Asn306Ser		true	c.917A>G						3551.0	139561602.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Asn306Ser						S	Sep 01, 1989					missense_variant		306.0				0.9838242373602404		Pathogenic	139561602.0	missense_variant		0.578					Reporter			F9_Asn306Ser
F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											F9	F9		52861		CCSBVarC004384		NC_000023.11:139561602:A:G		Asn306Ser																												F9_Asn306Ser	23	139561602	A	G	X	allele	917A>G	F10	527_CAVA_Array_P02	K20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561602-A-G	-	0.4701	0.25	306	.	.	.	X	138643761	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asn306Ser	.	22.4	.	0	.	D	.	2	1	.	.	.	.	.	0	0.82883	Select	0.7974	.	0.31206	.	.	D	T	.	1.46342036736	0	.	.	.	.	0.33292	.	.	.	.	0.54569	.	.	0.70926	0.992	.	28.0	0.945705	3.79	0.72	G	single nucleotide variant	NC_000023.11:g.139561602A>G	.	.	3	0.7595891	.	0	0.68832976	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.86560	B	N	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.92292	.	.	-	139561602	.	-	11.260000	.	0.84761	.	0	.	.	germline;unknown	.	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.94817	GRCh38	924	criteria provided, single submitter	c.917A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	1	.	FA9_HUMAN	.	72.0	.	.	D	0.19222	0.57284623	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Asn306Ser	.	0.91057	.	germline	.		A	Jul 22, 2024	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV005627711	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.128	.	.	0.691	A	.	3.389643	0.28160	.	T	-	.	.	0.98816	610	.	.	0.58161	0	139561602	Y	10	0	.	.	P00740	.	0.7397	0.94097		.	0.039	D	.	0.7750274	.	0.67791	2158	0.0619128	.	-2.34	.	.	0.33072	.	.	.	.	.	.	0.85621	X	F9	.	0	Asn	11158	.	X-139561602-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138471427	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	.	.	.	RCV000011350	D	.	.	c.917A>G	.	.	.	0.59570	A/A	rs137852251	139561602	.	A	.	P00740	.	0.77164	.	0.68239		.	.	.	0.51	0	0	.	5.42	0.92714	108	D	T	.	.	0	24	.	.	.	98879	10604	0.59060	0.86334	0.923391759395599	2720	.	0.71675	.	.	.	.	7.108	.	N	.	.	.	0	306900	0.76751	X	.	ENSG00000101981	.	0	.	0	0.9591642282066425	2	0.23609	0.18019	.	.	.	.	.	YES	.	0.846921	25643	HGNC:3551	A	.	simple_aae	0.725	.	139561602	AAT	1.000000	.	-	0	0.90484	.	0	.	Likely pathogenic	0.48981	.	.	.	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	N	.	0.970814190553	-	0.844	-	0.81098	.	518	0.95878	0.460176557302	0.0936	.	0.99862385950794386	94	-	917A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79299	137852251	.	0	0.97022	.	0.417	0.333	2636	0.99995030	5.42	.	.	.	-0.148843	0.983465118204216	0.13403	D	84	.	.	0.6325	0.93121	p.Asn306Ser	0	.	-6.325	0.91224134	.	0.86210	10604	T	.	F9	.	T	0.578	.	N306S	T	0.69847	0.84104	A/A	principal1	169108	F9_Popp_2025_carboxy_gla_motif_var256142	No											N		917	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Asn306Ser		true	c.917A>G						3551.0	139561602.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Asn306Ser						S	Sep 01, 1989					missense_variant		306.0				0.4440151418526494		Pathogenic	139561602.0	missense_variant		0.578					Reporter			F9_Asn306Ser
F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											F9	F9		52861		CCSBVarC004384		NC_000023.11:139561602:A:G		Asn306Ser																												F9_Asn306Ser	23	139561602	A	G	X	allele	917A>G	F10	527_CAVA_Array_P02	K20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561602-A-G	-	0.4701	0.25	306	.	.	.	X	138643761	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asn306Ser	.	22.4	.	0	.	D	.	2	1	.	.	.	.	.	0	0.82883	Select	0.7974	.	0.31206	.	.	D	T	.	1.46342036736	0	.	.	.	.	0.33292	.	.	.	.	0.54569	.	.	0.70926	0.992	.	28.0	0.945705	3.79	0.72	G	single nucleotide variant	NC_000023.11:g.139561602A>G	.	.	3	0.7595891	.	0	0.68832976	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.86560	B	N	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.92292	.	.	-	139561602	.	-	11.260000	.	0.84761	.	0	.	.	germline;unknown	.	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.94817	GRCh38	924	criteria provided, single submitter	c.917A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	1	.	FA9_HUMAN	.	72.0	.	.	D	0.19222	0.57284623	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Asn306Ser	.	0.91057	.	germline	.		A	Jul 22, 2024	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV005627711	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.128	.	.	0.691	A	.	3.389643	0.28160	.	T	-	.	.	0.98816	610	.	.	0.58161	0	139561602	Y	10	0	.	.	P00740	.	0.7397	0.94097		.	0.039	D	.	0.7750274	.	0.67791	2158	0.0619128	.	-2.34	.	.	0.33072	.	.	.	.	.	.	0.85621	X	F9	.	0	Asn	11158	.	X-139561602-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138471427	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	.	.	.	RCV000011350	D	.	.	c.917A>G	.	.	.	0.59570	A/A	rs137852251	139561602	.	A	.	P00740	.	0.77164	.	0.68239		.	.	.	0.51	0	0	.	5.42	0.92714	108	D	T	.	.	0	24	.	.	.	98879	10604	0.59060	0.86334	0.923391759395599	2720	.	0.71675	.	.	.	.	7.108	.	N	.	.	.	0	306900	0.76751	X	.	ENSG00000101981	.	0	.	0	0.9591642282066425	2	0.23609	0.18019	.	.	.	.	.	YES	.	0.846921	25643	HGNC:3551	A	.	simple_aae	0.725	.	139561602	AAT	1.000000	.	-	0	0.90484	.	0	.	Likely pathogenic	0.48981	.	.	.	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	N	.	0.970814190553	-	0.844	-	0.81098	.	518	0.95878	0.460176557302	0.0936	.	0.99862385950794386	94	-	917A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79299	137852251	.	0	0.97022	.	0.417	0.333	2636	0.99995030	5.42	.	.	.	-0.148843	0.983465118204216	0.13403	D	84	.	.	0.6325	0.93121	p.Asn306Ser	0	.	-6.325	0.91224134	.	0.86210	10604	T	.	F9	.	T	0.578	.	N306S	T	0.69847	0.84104	A/A	principal1	141592	F9_Popp_2025_carboxy_F9_specific_var227099	No											N		917	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Asn306Ser		true	c.917A>G						3551.0	139561602.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Asn306Ser						S	Sep 01, 1989					missense_variant		306.0				0.5514024847166168		Pathogenic	139561602.0	missense_variant		0.578					Reporter			F9_Asn306Ser
F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											F9	F9		52861		CCSBVarC004384		NC_000023.11:139561602:A:G		Asn306Ser																												F9_Asn306Ser	23	139561602	A	G	X	allele	917A>G	F10	527_CAVA_Array_P02	K20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561602-A-G	-	0.4701	0.25	306	.	.	.	X	138643761	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asn306Ser	.	22.4	.	0	.	D	.	2	1	.	.	.	.	.	0	0.82883	Select	0.7974	.	0.31206	.	.	D	T	.	1.46342036736	0	.	.	.	.	0.33292	.	.	.	.	0.54569	.	.	0.70926	0.992	.	28.0	0.945705	3.79	0.72	G	single nucleotide variant	NC_000023.11:g.139561602A>G	.	.	3	0.7595891	.	0	0.68832976	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.86560	B	N	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.92292	.	.	-	139561602	.	-	11.260000	.	0.84761	.	0	.	.	germline;unknown	.	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.94817	GRCh38	924	criteria provided, single submitter	c.917A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	1	.	FA9_HUMAN	.	72.0	.	.	D	0.19222	0.57284623	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Asn306Ser	.	0.91057	.	germline	.		A	Jul 22, 2024	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV005627711	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.128	.	.	0.691	A	.	3.389643	0.28160	.	T	-	.	.	0.98816	610	.	.	0.58161	0	139561602	Y	10	0	.	.	P00740	.	0.7397	0.94097		.	0.039	D	.	0.7750274	.	0.67791	2158	0.0619128	.	-2.34	.	.	0.33072	.	.	.	.	.	.	0.85621	X	F9	.	0	Asn	11158	.	X-139561602-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138471427	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	.	.	.	RCV000011350	D	.	.	c.917A>G	.	.	.	0.59570	A/A	rs137852251	139561602	.	A	.	P00740	.	0.77164	.	0.68239		.	.	.	0.51	0	0	.	5.42	0.92714	108	D	T	.	.	0	24	.	.	.	98879	10604	0.59060	0.86334	0.923391759395599	2720	.	0.71675	.	.	.	.	7.108	.	N	.	.	.	0	306900	0.76751	X	.	ENSG00000101981	.	0	.	0	0.9591642282066425	2	0.23609	0.18019	.	.	.	.	.	YES	.	0.846921	25643	HGNC:3551	A	.	simple_aae	0.725	.	139561602	AAT	1.000000	.	-	0	0.90484	.	0	.	Likely pathogenic	0.48981	.	.	.	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	N	.	0.970814190553	-	0.844	-	0.81098	.	518	0.95878	0.460176557302	0.0936	.	0.99862385950794386	94	-	917A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79299	137852251	.	0	0.97022	.	0.417	0.333	2636	0.99995030	5.42	.	.	.	-0.148843	0.983465118204216	0.13403	D	84	.	.	0.6325	0.93121	p.Asn306Ser	0	.	-6.325	0.91224134	.	0.86210	10604	T	.	F9	.	T	0.578	.	N306S	T	0.69847	0.84104	A/A	principal1	224140	F9_Popp_2025_light_chain_var246461	No											N		917	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Asn306Ser		true	c.917A>G						3551.0	139561602.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Asn306Ser						S	Sep 01, 1989					missense_variant		306.0				0.5262446676818676		Pathogenic	139561602.0	missense_variant		0.578					Reporter			F9_Asn306Ser
F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											F9	F9		52861		CCSBVarC004384		NC_000023.11:139561602:A:G		Asn306Ser																												F9_Asn306Ser	23	139561602	A	G	X	allele	917A>G	F10	527_CAVA_Array_P02	K20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561602-A-G	-	0.4701	0.25	306	.	.	.	X	138643761	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asn306Ser	.	22.4	.	0	.	D	.	2	1	.	.	.	.	.	0	0.82883	Select	0.7974	.	0.31206	.	.	D	T	.	1.46342036736	0	.	.	.	.	0.33292	.	.	.	.	0.54569	.	.	0.70926	0.992	.	28.0	0.945705	3.79	0.72	G	single nucleotide variant	NC_000023.11:g.139561602A>G	.	.	3	0.7595891	.	0	0.68832976	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.86560	B	N	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.92292	.	.	-	139561602	.	-	11.260000	.	0.84761	.	0	.	.	germline;unknown	.	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.94817	GRCh38	924	criteria provided, single submitter	c.917A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	1	.	FA9_HUMAN	.	72.0	.	.	D	0.19222	0.57284623	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Asn306Ser	.	0.91057	.	germline	.		A	Jul 22, 2024	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV005627711	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.128	.	.	0.691	A	.	3.389643	0.28160	.	T	-	.	.	0.98816	610	.	.	0.58161	0	139561602	Y	10	0	.	.	P00740	.	0.7397	0.94097		.	0.039	D	.	0.7750274	.	0.67791	2158	0.0619128	.	-2.34	.	.	0.33072	.	.	.	.	.	.	0.85621	X	F9	.	0	Asn	11158	.	X-139561602-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138471427	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	.	.	.	RCV000011350	D	.	.	c.917A>G	.	.	.	0.59570	A/A	rs137852251	139561602	.	A	.	P00740	.	0.77164	.	0.68239		.	.	.	0.51	0	0	.	5.42	0.92714	108	D	T	.	.	0	24	.	.	.	98879	10604	0.59060	0.86334	0.923391759395599	2720	.	0.71675	.	.	.	.	7.108	.	N	.	.	.	0	306900	0.76751	X	.	ENSG00000101981	.	0	.	0	0.9591642282066425	2	0.23609	0.18019	.	.	.	.	.	YES	.	0.846921	25643	HGNC:3551	A	.	simple_aae	0.725	.	139561602	AAT	1.000000	.	-	0	0.90484	.	0	.	Likely pathogenic	0.48981	.	.	.	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	N	.	0.970814190553	-	0.844	-	0.81098	.	518	0.95878	0.460176557302	0.0936	.	0.99862385950794386	94	-	917A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79299	137852251	.	0	0.97022	.	0.417	0.333	2636	0.99995030	5.42	.	.	.	-0.148843	0.983465118204216	0.13403	D	84	.	.	0.6325	0.93121	p.Asn306Ser	0	.	-6.325	0.91224134	.	0.86210	10604	T	.	F9	.	T	0.578	.	N306S	T	0.69847	0.84104	A/A	principal1	196624	F9_Popp_2025_heavy_chain_var236780	No											N		917	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Asn306Ser		true	c.917A>G						3551.0	139561602.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Asn306Ser						S	Sep 01, 1989					missense_variant		306.0				0.6069392182469997		Pathogenic	139561602.0	missense_variant		0.578					Reporter			F9_Asn306Ser
F9_Asn306Ser	-2.991649545755544	0.09592530850505995	5.129812155289865	0.0013539320413639188																											F9	F9		52861		CCSBVarC004384		NC_000023.11:139561602:A:G		Asn306Ser																												F9_Asn306Ser	23	139561602	A	G	X	allele	917A>G	F10	527_CAVA_Array_P02	K20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561602-A-G	-	0.4701	0.25	306	.	.	.	X	138643761	G	.	.	X	1_Pathogenic	NC_000023.11	.	Asn306Ser	.	22.4	.	0	.	D	.	2	1	.	.	.	.	.	0	0.82883	Select	0.7974	.	0.31206	.	.	D	T	.	1.46342036736	0	.	.	.	.	0.33292	.	.	.	.	0.54569	.	.	0.70926	0.992	.	28.0	0.945705	3.79	0.72	G	single nucleotide variant	NC_000023.11:g.139561602A>G	.	.	3	0.7595891	.	0	0.68832976	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.88440	B	0.86560	B	N	.	.	A/A	84	0	.	.	Hereditary factor IX deficiency disease	.	0.92292	.	.	-	139561602	.	-	11.260000	.	0.84761	.	0	.	.	germline;unknown	.	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.94817	GRCh38	924	criteria provided, single submitter	c.917A>G	.	0.78637	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	B	0	.	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	1	.	FA9_HUMAN	.	72.0	.	.	D	0.19222	0.57284623	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99953	.	.	.	.	.	p.Asn306Ser	.	0.91057	.	germline	.		A	Jul 22, 2024	.	A/A	.	.	1.0	N	Xq27.1	6962	.	.	SCV005627711	Pathogenic	.	.	Ser	S	-	.	ENSP00000218099	ENST00000218099	.	0.128	.	.	0.691	A	.	3.389643	0.28160	.	T	-	.	.	0.98816	610	.	.	0.58161	0	139561602	Y	10	0	.	.	P00740	.	0.7397	0.94097		.	0.039	D	.	0.7750274	.	0.67791	2158	0.0619128	.	-2.34	.	.	0.33072	.	.	.	.	.	.	0.85621	X	F9	.	0	Asn	11158	.	X-139561602-A-G	Hereditary_factor_IX_deficiency_disease	.	.	138471427	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	.	.	.	RCV000011350	D	.	.	c.917A>G	.	.	.	0.59570	A/A	rs137852251	139561602	.	A	.	P00740	.	0.77164	.	0.68239		.	.	.	0.51	0	0	.	5.42	0.92714	108	D	T	.	.	0	24	.	.	.	98879	10604	0.59060	0.86334	0.923391759395599	2720	.	0.71675	.	.	.	.	7.108	.	N	.	.	.	0	306900	0.76751	X	.	ENSG00000101981	.	0	.	0	0.9591642282066425	2	0.23609	0.18019	.	.	.	.	.	YES	.	0.846921	25643	HGNC:3551	A	.	simple_aae	0.725	.	139561602	AAT	1.000000	.	-	0	0.90484	.	0	.	Likely pathogenic	0.48981	.	.	.	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	N	.	0.970814190553	-	0.844	-	0.81098	.	518	0.95878	0.460176557302	0.0936	.	0.99862385950794386	94	-	917A>G 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.79299	137852251	.	0	0.97022	.	0.417	0.333	2636	0.99995030	5.42	.	.	.	-0.148843	0.983465118204216	0.13403	D	84	.	.	0.6325	0.93121	p.Asn306Ser	0	.	-6.325	0.91224134	.	0.86210	10604	T	.	F9	.	T	0.578	.	N306S	T	0.69847	0.84104	A/A	principal1	251656	F9_Popp_2025_strep_2_var265823	No											N		917	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Asn306Ser		true	c.917A>G						3551.0	139561602.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Asn306Ser						S	Sep 01, 1989					missense_variant		306.0				0.9838242373602404		Pathogenic	139561602.0	missense_variant		0.578					Reporter			F9_Asn306Ser
BRAF_Leu485Phe	-3.8216848768826113	0.006527941362460827	3.8578981633103693	0.006228415739546075	2025_01_Batch_13-14	0.5105169863396426	0.5661450889840837	0.6849601012265331	0.6268169169653752	0.5124263589993301	0.598299584251907	0.5775729635304778	0.6184960341014689	0.6586304615480807	0.5200454290084522	0.5544082852957748	0.5718590262572807	0.6517280676640009	0.642723689256728	0.5162358940038911	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220605	CCSBVarC003163	ALE00003163	NC_000007.14:140778053:C:G	1455G>C	Leu485Phe	CEGS2	CegsMutGDEh1018	H07	GDEhDisVCh_40058	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Leu485Phe	7	140778053	C	G	7											7-140778053-C-G	-	0.6203	0.264	485	.	.	.	7	140477853	G	.	.	7	1_Pathogenic	NC_000007.14	.	Leu485Phe	.	24.4	.	.	.	T	.	13	.	.	.	.	.	.	.	0.91679	Select	0.1770	.	0.31620	.	.	D	D	.	.	.	.	.	.	.	0.96345	.	.	.	.	0.43153	.	.	0.95501	0.999	.	.	0.993067	4.1	.	G	single nucleotide variant	NC_000007.14:g.140778053C>G	.	.	3	0.88148624	.	.	0.9472474	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||MedGen:CN230736|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	.	.	.	.	0.97926	B	0.92780	B	L	3.302872	.	./.	.	.	.	.	Cardio-facio-cutaneous syndrome|RASopathy|BRAF-related disorder|Cardiovascular phenotype|not provided|Cardiofaciocutaneous syndrome 1|Ataxia-telangiectasia syndrome|Noonan syndrome;Cardio-facio-cutaneous syndrome	.	0.60048	.	.	-	140778053	.	-	4.860000	.	0.97907	.	.	.	.	germline	.	Gain of catalytic residue at L485 (P = 0.046)| Loss of ubiquitination at K483 (P = 0.1322)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.1405)| Loss of glycosylation at P490 (P = 0.2882)	0.95694	GRCh38	776	reviewed by expert panel	c.1455G>C	.	0.47761	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1455G>C (p.Leu485Phe)	3	.	BRAF_HUMAN	.	.	0.19994089429288	.	D	0.97942	0.94315636	-	.	.		.	.	2	.	reviewed_by_expert_panel	0.97927	.	.	.	.	.	p.Leu485Phe	.	0.45538	.	germline	.		C	Feb 28, 2020	.	./.	.	.	1.0	N	7q34	.	.	.	SCV001335323	Pathogenic	.	.	Phe	F	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.545	C	.	4.137508	.	D	.	-	3.495244	.	0.74669	.	.	.	0.83810	.	140778053	Y	9	.	.	.	P15056	.	0.854571	0.96668		.	0.309	D	.	0.87014675	.	0.91597	673	0.40148	.	.	.	.	0.20412	.	.	.	.	.	.	0.93580	7	BRAF	.	.	Leu	.	.	7-140778053-C-G	BRAF-related_disorder|Ataxia-telangiectasia_syndrome|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Cardiofaciocutaneous_syndrome_1|Cardiovascular_phenotype|not_provided|RASopathy	.	.	140124322	ClinGen:CA273414|OMIM:164757.0015|UniProtKB:P15056#VAR_026115	0.649139	0.50957	.	RCV000208764|RCV001172276|RCV003415705|RCV004018629|RCV000680805|RCV000015009|RCV001849264|RCV000211749	D	.	.	c.1455G>C	.	.	.	0.89929	./.	rs180177036	140778053	.	C	.	P15056	.	0.95923	.	0.68239		.	.	.	1.13	.	.	.	4.14	0.96693	.	D	D	.	.	.	.	.	.	.	100|648|1340|1340|536391	13975	0.89804	0.95017	0.993222117424011	.	.	0.71675	0.62235	.	.	.	5.0	.	.	.	.	.	.	208900|PS163950|PS115150|115150	0.63767	7	.	ENSG00000157764	.	.	.	.	.	3	0.41361	0.48248	.	.	.	.	0.260588829807926	YES	.	0.08652	29014	HGNC:1097	.	.	.	0.953	.	140778053	TTG	1.000000	.	-	.	0.93527	.	.	.	Pathogenic	0.74092	.	.	.	ClinGen:CA273414,UniProtKB:P15056#VAR_026115,OMIM:164757.0015	L	.	.	-	0.859	-	.	.	.	0.81127	0.899181604385	0.9978	.	0.99892768971460666	.	-	1455G>C 	.	.	C0004135|C0028326|C1275081|CN029449|CN230736|C3661900|C5555857	.	.	.	.	NM_004333.6	-	.	.	1	0.97789	180177036	.	.	0.99026	0.53010	.	.	.	0.99597543	5.03	.	.	.	0.338922	0.999864334331402	0.28751	T	.	.	.	-0.7046	0.52004	p.Leu485Phe	.	.	-10.017	0.94275165	.	0.98431	13975	D	.	BRAF	.	D	.	.	L485F	.	0.78208	0.25635	./.	principal4																																																																																																				
BRAF_Leu485Phe	-3.8216848768826113	0.006527941362460827	3.8578981633103693	0.006228415739546075	2025_01_Batch_13-14	0.5105169863396426	0.5661450889840837	0.6849601012265331	0.6268169169653752	0.5124263589993301	0.598299584251907	0.5775729635304778	0.6184960341014689	0.6586304615480807	0.5200454290084522	0.5544082852957748	0.5718590262572807	0.6517280676640009	0.642723689256728	0.5162358940038911	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003163		NC_000007.14:140778053:C:G		Leu485Phe																												BRAF_Leu485Phe	7	140778053	C	G	7	allele	1455G>C	B04	527_CAVA_Array_P01	C07	B13A7A8P1_R1	B14A7A8P1_R2				7-140778053-C-G	-	0.6203	0.264	485	.	.	.	7	140477853	G	.	.	7	1_Pathogenic	NC_000007.14	.	Leu485Phe	.	24.4	.	.	.	T	.	13	.	.	.	.	.	.	.	0.91679	Select	0.1770	.	0.31620	.	.	D	D	.	.	.	.	.	.	.	0.96345	.	.	.	.	0.43153	.	.	0.95501	0.999	.	.	0.993067	4.1	.	G	single nucleotide variant	NC_000007.14:g.140778053C>G	.	.	3	0.88148624	.	.	0.9472474	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391||MedGen:CN230736|MedGen:C3661900|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648;MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340	.	.	.	.	0.97926	B	0.92780	B	L	3.302872	.	./.	.	.	.	.	Cardio-facio-cutaneous syndrome|RASopathy|BRAF-related disorder|Cardiovascular phenotype|not provided|Cardiofaciocutaneous syndrome 1|Ataxia-telangiectasia syndrome|Noonan syndrome;Cardio-facio-cutaneous syndrome	.	0.60048	.	.	-	140778053	.	-	4.860000	.	0.97907	.	.	.	.	germline	.	Gain of catalytic residue at L485 (P = 0.046)| Loss of ubiquitination at K483 (P = 0.1322)| Loss of sheet (P = 0.1398)| Loss of MoRF binding (P = 0.1405)| Loss of glycosylation at P490 (P = 0.2882)	0.95694	GRCh38	776	reviewed by expert panel	c.1455G>C	.	0.47761	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1455G>C (p.Leu485Phe)	3	.	BRAF_HUMAN	.	.	0.19994089429288	.	D	0.97942	0.94315636	-	.	.		.	.	2	.	reviewed_by_expert_panel	0.97927	.	.	.	.	.	p.Leu485Phe	.	0.45538	.	germline	.		C	Feb 28, 2020	.	./.	.	.	1.0	N	7q34	.	.	.	SCV001335323	Pathogenic	.	.	Phe	F	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.545	C	.	4.137508	.	D	.	-	3.495244	.	0.74669	.	.	.	0.83810	.	140778053	Y	9	.	.	.	P15056	.	0.854571	0.96668		.	0.309	D	.	0.87014675	.	0.91597	673	0.40148	.	.	.	.	0.20412	.	.	.	.	.	.	0.93580	7	BRAF	.	.	Leu	.	.	7-140778053-C-G	BRAF-related_disorder|Ataxia-telangiectasia_syndrome|Noonan_syndrome|Cardio-facio-cutaneous_syndrome|Cardiofaciocutaneous_syndrome_1|Cardiovascular_phenotype|not_provided|RASopathy	.	.	140124322	ClinGen:CA273414|OMIM:164757.0015|UniProtKB:P15056#VAR_026115	0.649139	0.50957	.	RCV000208764|RCV001172276|RCV003415705|RCV004018629|RCV000680805|RCV000015009|RCV001849264|RCV000211749	D	.	.	c.1455G>C	.	.	.	0.89929	./.	rs180177036	140778053	.	C	.	P15056	.	0.95923	.	0.68239		.	.	.	1.13	.	.	.	4.14	0.96693	.	D	D	.	.	.	.	.	.	.	100|648|1340|1340|536391	13975	0.89804	0.95017	0.993222117424011	.	.	0.71675	0.62235	.	.	.	5.0	.	.	.	.	.	.	208900|PS163950|PS115150|115150	0.63767	7	.	ENSG00000157764	.	.	.	.	.	3	0.41361	0.48248	.	.	.	.	0.260588829807926	YES	.	0.08652	29014	HGNC:1097	.	.	.	0.953	.	140778053	TTG	1.000000	.	-	.	0.93527	.	.	.	Pathogenic	0.74092	.	.	.	ClinGen:CA273414,UniProtKB:P15056#VAR_026115,OMIM:164757.0015	L	.	.	-	0.859	-	.	.	.	0.81127	0.899181604385	0.9978	.	0.99892768971460666	.	-	1455G>C 	.	.	C0004135|C0028326|C1275081|CN029449|CN230736|C3661900|C5555857	.	.	.	.	NM_004333.6	-	.	.	1	0.97789	180177036	.	.	0.99026	0.53010	.	.	.	0.99597543	5.03	.	.	.	0.338922	0.999864334331402	0.28751	T	.	.	.	-0.7046	0.52004	p.Leu485Phe	.	.	-10.017	0.94275165	.	0.98431	13975	D	.	BRAF	.	D	.	.	L485F	.	0.78208	0.25635	./.	principal4																																																																																																				
F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	0.7806735852079177	0.5729967658920669	0.5805918120440388	0.6641688898577275	0.6567913956539897	0.6061063760837944	0.464970228843791	0.5472480972054419	0.5119616355787338	0.6155139690296906	0.6933899806458561	0.518983497367929	0.5639199546247403	0.5880652627182306	0.6361526823418402	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A		Arg75Gln																												F9_Arg75Gln	23	139537145	G	A	X	allele	224G>A	E06	527_CAVA_Array_P02	I12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537145-G-A	-	0.67086	1.0	75	0	0	0	X	138619304	A	3.302770e-06	1	X	1_Pathogenic	NC_000023.11	1	Arg75Gln	0	25.0	0	0	3.684730e-05	D	0	9	1	30951	5.821090e-06	.	18982	0.000000e+00	0	0.97356	Select	0.9754	27139	0.90580	1	.	D	D	46861	0.164289705123	0	0	0.000000e+00	0	0	0.38922	13652	33765	0	0.000000e+00	0.64159	0	.	0.81330	0.997	.	13.0	0.667233	4.22	0.87	A	single nucleotide variant	NC_000023.11:g.139537145G>A	0	12188	3	0.6656928	80303	0	0.83249354	0		1	171789	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	0.000000e+00	0	0.91311	D	0.76837	D	M	.	4	G/G	84	0	5701	1211104	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13067	0.99385	.	.	-	139537145	7.324930e-05	-	9.750000	0	0.97199	22029	0	45990	0	germline;unknown	56959	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.98631	GRCh38	924	reviewed by expert panel	c.224G>A	0.000000e+00	0.51026	0	0	0	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	0.000000e+00	6911	B	0	0.000000e+00	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	3	0	FA9_HUMAN	0	87.0	.	1	T	0.32639	0.7617112	+	0.000000e+00	.		1	0.000000e+00	0	27139	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	1.245280e-05	0	0.000000e+00	0	45990	p.Arg75Gln	0	0.81498	.	germline	1		G	Oct 11, 2024	0	G/G	0	64582	1.0	N	Xq27.1	7040	.	0.000000e+00	SCV005437139	Pathogenic/Likely_pathogenic	0	0	Gln	Q	-	689	ENSP00000218099	ENST00000218099	13313	0.003	10118	0	-0.113	G	0	4.359394	0.74454	.	D	-	.	.	0.94319	610	0	.	0.57309	0	139537145	Y	10	0	73179	0.000000e+00	P00740	0	0.964669	0.99957		0	0.997	D	24361	0.6057016	13652	0.79771	2158	0.400284	3	-3.08	.	2.174390e-05	0.68399	0.000000e+00	0	57788	0.000000e+00	4343	0	0.80179	X	F9	0.000000e+00	0	Arg	11340	0.000000e+00	X-139537145-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	0	0	138446970	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	.	.	0	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	D	0	0	c.224G>A	0	0	0	0.89858	G/G	rs137852228	139537145	11996	G	.	P00740	9939	0.85893	0.000000e+00	0.68239		0	0	0.000000e+00	2.865	0	0	.	4.33	0.99567	142	D	T	0	4.104920e-05	0	24	.	0	0	98879|98878	10573	0.93519	0.18266	0.917611181735992	2728	.	0.71675	.	3.684730e-05	4.104920e-05	895062	7.322	6.595870e-06	D	9932	0	.	0	306900|300807|134500|306700|301052	0.78419	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9873855396371272	2	0.86259	0.18019	19047	.	0.000000e+00	2.174390e-05	.	YES	0.000000e+00	0.450308	25612	HGNC:3551	A	0	simple_aae	0.941	151610	139537145	CGA	1.000000	.	-	0	0.95480	3.351720e-06	0	0	Pathogenic	0.66059	0	0	1	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	R	0	0.998839519055	-	0.922	-	0.83632	1	574	0.98728	0.501060843468	0.1299	0	0.99953252965582506	100	-	224G>A 	1	0	C0008533|C2749016|C0019069|C5393318|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.27380	137852228	1767	0	0.99881	.	0.619	0.004	2644	0.99998808	5.19	.	.	0.000000e+00	0.449695	0.994754450870779	0.82980	D	118	4642	7069	1.0936	0.99231	p.Arg75Gln	0	0	-8.736	0.9611795	0	0.90854	10573	D	24361	F9	7.324930e-05	D	0.904	15991	R75Q	D	0.80172	0.14846	G/G	principal1	210375	F9_Popp_2025_light_chain_var241613	No		1/7/25		178efdc9-7922-4e7d-8479-352a42eedd02							R		224	F9_Popp_2025_light_chain	10573.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255318	immortalized human cells		false			p.Arg75Gln		true	c.224G>A						3551.0	139537145.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PP3						PM1		NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting	Arg75Gln	https://erepo.genome.network/evrepo/ui/classification/178efdc9-7922-4e7d-8479-352a42eedd02					Q	Oct 11, 2024				10/11/24	missense_variant	Coagulation Factor Deficiency VCEP	75.0		hemophilia B	3.3027716859e-6	0.7745385738532904		Pathogenic	139537145.0	missense_variant		0.904					Reporter			F9_Arg75Gln
F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	0.7806735852079177	0.5729967658920669	0.5805918120440388	0.6641688898577275	0.6567913956539897	0.6061063760837944	0.464970228843791	0.5472480972054419	0.5119616355787338	0.6155139690296906	0.6933899806458561	0.518983497367929	0.5639199546247403	0.5880652627182306	0.6361526823418402	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A		Arg75Gln																												F9_Arg75Gln	23	139537145	G	A	X	allele	224G>A	E06	527_CAVA_Array_P02	I12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537145-G-A	-	0.67086	1.0	75	0	0	0	X	138619304	A	3.302770e-06	1	X	1_Pathogenic	NC_000023.11	1	Arg75Gln	0	25.0	0	0	3.684730e-05	D	0	9	1	30951	5.821090e-06	.	18982	0.000000e+00	0	0.97356	Select	0.9754	27139	0.90580	1	.	D	D	46861	0.164289705123	0	0	0.000000e+00	0	0	0.38922	13652	33765	0	0.000000e+00	0.64159	0	.	0.81330	0.997	.	13.0	0.667233	4.22	0.87	A	single nucleotide variant	NC_000023.11:g.139537145G>A	0	12188	3	0.6656928	80303	0	0.83249354	0		1	171789	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	0.000000e+00	0	0.91311	D	0.76837	D	M	.	4	G/G	84	0	5701	1211104	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13067	0.99385	.	.	-	139537145	7.324930e-05	-	9.750000	0	0.97199	22029	0	45990	0	germline;unknown	56959	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.98631	GRCh38	924	reviewed by expert panel	c.224G>A	0.000000e+00	0.51026	0	0	0	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	0.000000e+00	6911	B	0	0.000000e+00	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	3	0	FA9_HUMAN	0	87.0	.	1	T	0.32639	0.7617112	+	0.000000e+00	.		1	0.000000e+00	0	27139	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	1.245280e-05	0	0.000000e+00	0	45990	p.Arg75Gln	0	0.81498	.	germline	1		G	Oct 11, 2024	0	G/G	0	64582	1.0	N	Xq27.1	7040	.	0.000000e+00	SCV005437139	Pathogenic/Likely_pathogenic	0	0	Gln	Q	-	689	ENSP00000218099	ENST00000218099	13313	0.003	10118	0	-0.113	G	0	4.359394	0.74454	.	D	-	.	.	0.94319	610	0	.	0.57309	0	139537145	Y	10	0	73179	0.000000e+00	P00740	0	0.964669	0.99957		0	0.997	D	24361	0.6057016	13652	0.79771	2158	0.400284	3	-3.08	.	2.174390e-05	0.68399	0.000000e+00	0	57788	0.000000e+00	4343	0	0.80179	X	F9	0.000000e+00	0	Arg	11340	0.000000e+00	X-139537145-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	0	0	138446970	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	.	.	0	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	D	0	0	c.224G>A	0	0	0	0.89858	G/G	rs137852228	139537145	11996	G	.	P00740	9939	0.85893	0.000000e+00	0.68239		0	0	0.000000e+00	2.865	0	0	.	4.33	0.99567	142	D	T	0	4.104920e-05	0	24	.	0	0	98879|98878	10573	0.93519	0.18266	0.917611181735992	2728	.	0.71675	.	3.684730e-05	4.104920e-05	895062	7.322	6.595870e-06	D	9932	0	.	0	306900|300807|134500|306700|301052	0.78419	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9873855396371272	2	0.86259	0.18019	19047	.	0.000000e+00	2.174390e-05	.	YES	0.000000e+00	0.450308	25612	HGNC:3551	A	0	simple_aae	0.941	151610	139537145	CGA	1.000000	.	-	0	0.95480	3.351720e-06	0	0	Pathogenic	0.66059	0	0	1	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	R	0	0.998839519055	-	0.922	-	0.83632	1	574	0.98728	0.501060843468	0.1299	0	0.99953252965582506	100	-	224G>A 	1	0	C0008533|C2749016|C0019069|C5393318|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.27380	137852228	1767	0	0.99881	.	0.619	0.004	2644	0.99998808	5.19	.	.	0.000000e+00	0.449695	0.994754450870779	0.82980	D	118	4642	7069	1.0936	0.99231	p.Arg75Gln	0	0	-8.736	0.9611795	0	0.90854	10573	D	24361	F9	7.324930e-05	D	0.904	15991	R75Q	D	0.80172	0.14846	G/G	principal1	155343	F9_Popp_2025_carboxy_gla_motif_var251294	No		1/7/25		178efdc9-7922-4e7d-8479-352a42eedd02							R		224	F9_Popp_2025_carboxy_gla_motif	10573.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255318	immortalized human cells		false			p.Arg75Gln		true	c.224G>A						3551.0	139537145.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PP3						PM1		NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting	Arg75Gln	https://erepo.genome.network/evrepo/ui/classification/178efdc9-7922-4e7d-8479-352a42eedd02					Q	Oct 11, 2024				10/11/24	missense_variant	Coagulation Factor Deficiency VCEP	75.0		hemophilia B	3.3027716859e-6	0.9527583231469484		Pathogenic	139537145.0	missense_variant		0.904					Reporter			F9_Arg75Gln
F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	0.7806735852079177	0.5729967658920669	0.5805918120440388	0.6641688898577275	0.6567913956539897	0.6061063760837944	0.464970228843791	0.5472480972054419	0.5119616355787338	0.6155139690296906	0.6933899806458561	0.518983497367929	0.5639199546247403	0.5880652627182306	0.6361526823418402	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A		Arg75Gln																												F9_Arg75Gln	23	139537145	G	A	X	allele	224G>A	E06	527_CAVA_Array_P02	I12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537145-G-A	-	0.67086	1.0	75	0	0	0	X	138619304	A	3.302770e-06	1	X	1_Pathogenic	NC_000023.11	1	Arg75Gln	0	25.0	0	0	3.684730e-05	D	0	9	1	30951	5.821090e-06	.	18982	0.000000e+00	0	0.97356	Select	0.9754	27139	0.90580	1	.	D	D	46861	0.164289705123	0	0	0.000000e+00	0	0	0.38922	13652	33765	0	0.000000e+00	0.64159	0	.	0.81330	0.997	.	13.0	0.667233	4.22	0.87	A	single nucleotide variant	NC_000023.11:g.139537145G>A	0	12188	3	0.6656928	80303	0	0.83249354	0		1	171789	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	0.000000e+00	0	0.91311	D	0.76837	D	M	.	4	G/G	84	0	5701	1211104	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13067	0.99385	.	.	-	139537145	7.324930e-05	-	9.750000	0	0.97199	22029	0	45990	0	germline;unknown	56959	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.98631	GRCh38	924	reviewed by expert panel	c.224G>A	0.000000e+00	0.51026	0	0	0	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	0.000000e+00	6911	B	0	0.000000e+00	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	3	0	FA9_HUMAN	0	87.0	.	1	T	0.32639	0.7617112	+	0.000000e+00	.		1	0.000000e+00	0	27139	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	1.245280e-05	0	0.000000e+00	0	45990	p.Arg75Gln	0	0.81498	.	germline	1		G	Oct 11, 2024	0	G/G	0	64582	1.0	N	Xq27.1	7040	.	0.000000e+00	SCV005437139	Pathogenic/Likely_pathogenic	0	0	Gln	Q	-	689	ENSP00000218099	ENST00000218099	13313	0.003	10118	0	-0.113	G	0	4.359394	0.74454	.	D	-	.	.	0.94319	610	0	.	0.57309	0	139537145	Y	10	0	73179	0.000000e+00	P00740	0	0.964669	0.99957		0	0.997	D	24361	0.6057016	13652	0.79771	2158	0.400284	3	-3.08	.	2.174390e-05	0.68399	0.000000e+00	0	57788	0.000000e+00	4343	0	0.80179	X	F9	0.000000e+00	0	Arg	11340	0.000000e+00	X-139537145-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	0	0	138446970	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	.	.	0	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	D	0	0	c.224G>A	0	0	0	0.89858	G/G	rs137852228	139537145	11996	G	.	P00740	9939	0.85893	0.000000e+00	0.68239		0	0	0.000000e+00	2.865	0	0	.	4.33	0.99567	142	D	T	0	4.104920e-05	0	24	.	0	0	98879|98878	10573	0.93519	0.18266	0.917611181735992	2728	.	0.71675	.	3.684730e-05	4.104920e-05	895062	7.322	6.595870e-06	D	9932	0	.	0	306900|300807|134500|306700|301052	0.78419	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9873855396371272	2	0.86259	0.18019	19047	.	0.000000e+00	2.174390e-05	.	YES	0.000000e+00	0.450308	25612	HGNC:3551	A	0	simple_aae	0.941	151610	139537145	CGA	1.000000	.	-	0	0.95480	3.351720e-06	0	0	Pathogenic	0.66059	0	0	1	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	R	0	0.998839519055	-	0.922	-	0.83632	1	574	0.98728	0.501060843468	0.1299	0	0.99953252965582506	100	-	224G>A 	1	0	C0008533|C2749016|C0019069|C5393318|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.27380	137852228	1767	0	0.99881	.	0.619	0.004	2644	0.99998808	5.19	.	.	0.000000e+00	0.449695	0.994754450870779	0.82980	D	118	4642	7069	1.0936	0.99231	p.Arg75Gln	0	0	-8.736	0.9611795	0	0.90854	10573	D	24361	F9	7.324930e-05	D	0.904	15991	R75Q	D	0.80172	0.14846	G/G	principal1	182859	F9_Popp_2025_heavy_chain_var231932	No		1/7/25		178efdc9-7922-4e7d-8479-352a42eedd02							R		224	F9_Popp_2025_heavy_chain	10573.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255318	immortalized human cells		false			p.Arg75Gln		true	c.224G>A						3551.0	139537145.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PP3						PM1		NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting	Arg75Gln	https://erepo.genome.network/evrepo/ui/classification/178efdc9-7922-4e7d-8479-352a42eedd02					Q	Oct 11, 2024				10/11/24	missense_variant	Coagulation Factor Deficiency VCEP	75.0		hemophilia B	3.3027716859e-6	0.8204446127049808		Pathogenic	139537145.0	missense_variant		0.904					Reporter			F9_Arg75Gln
F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	0.7806735852079177	0.5729967658920669	0.5805918120440388	0.6641688898577275	0.6567913956539897	0.6061063760837944	0.464970228843791	0.5472480972054419	0.5119616355787338	0.6155139690296906	0.6933899806458561	0.518983497367929	0.5639199546247403	0.5880652627182306	0.6361526823418402	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A		Arg75Gln																												F9_Arg75Gln	23	139537145	G	A	X	allele	224G>A	E06	527_CAVA_Array_P02	I12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537145-G-A	-	0.67086	1.0	75	0	0	0	X	138619304	A	3.302770e-06	1	X	1_Pathogenic	NC_000023.11	1	Arg75Gln	0	25.0	0	0	3.684730e-05	D	0	9	1	30951	5.821090e-06	.	18982	0.000000e+00	0	0.97356	Select	0.9754	27139	0.90580	1	.	D	D	46861	0.164289705123	0	0	0.000000e+00	0	0	0.38922	13652	33765	0	0.000000e+00	0.64159	0	.	0.81330	0.997	.	13.0	0.667233	4.22	0.87	A	single nucleotide variant	NC_000023.11:g.139537145G>A	0	12188	3	0.6656928	80303	0	0.83249354	0		1	171789	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	0.000000e+00	0	0.91311	D	0.76837	D	M	.	4	G/G	84	0	5701	1211104	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13067	0.99385	.	.	-	139537145	7.324930e-05	-	9.750000	0	0.97199	22029	0	45990	0	germline;unknown	56959	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.98631	GRCh38	924	reviewed by expert panel	c.224G>A	0.000000e+00	0.51026	0	0	0	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	0.000000e+00	6911	B	0	0.000000e+00	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	3	0	FA9_HUMAN	0	87.0	.	1	T	0.32639	0.7617112	+	0.000000e+00	.		1	0.000000e+00	0	27139	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	1.245280e-05	0	0.000000e+00	0	45990	p.Arg75Gln	0	0.81498	.	germline	1		G	Oct 11, 2024	0	G/G	0	64582	1.0	N	Xq27.1	7040	.	0.000000e+00	SCV005437139	Pathogenic/Likely_pathogenic	0	0	Gln	Q	-	689	ENSP00000218099	ENST00000218099	13313	0.003	10118	0	-0.113	G	0	4.359394	0.74454	.	D	-	.	.	0.94319	610	0	.	0.57309	0	139537145	Y	10	0	73179	0.000000e+00	P00740	0	0.964669	0.99957		0	0.997	D	24361	0.6057016	13652	0.79771	2158	0.400284	3	-3.08	.	2.174390e-05	0.68399	0.000000e+00	0	57788	0.000000e+00	4343	0	0.80179	X	F9	0.000000e+00	0	Arg	11340	0.000000e+00	X-139537145-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	0	0	138446970	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	.	.	0	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	D	0	0	c.224G>A	0	0	0	0.89858	G/G	rs137852228	139537145	11996	G	.	P00740	9939	0.85893	0.000000e+00	0.68239		0	0	0.000000e+00	2.865	0	0	.	4.33	0.99567	142	D	T	0	4.104920e-05	0	24	.	0	0	98879|98878	10573	0.93519	0.18266	0.917611181735992	2728	.	0.71675	.	3.684730e-05	4.104920e-05	895062	7.322	6.595870e-06	D	9932	0	.	0	306900|300807|134500|306700|301052	0.78419	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9873855396371272	2	0.86259	0.18019	19047	.	0.000000e+00	2.174390e-05	.	YES	0.000000e+00	0.450308	25612	HGNC:3551	A	0	simple_aae	0.941	151610	139537145	CGA	1.000000	.	-	0	0.95480	3.351720e-06	0	0	Pathogenic	0.66059	0	0	1	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	R	0	0.998839519055	-	0.922	-	0.83632	1	574	0.98728	0.501060843468	0.1299	0	0.99953252965582506	100	-	224G>A 	1	0	C0008533|C2749016|C0019069|C5393318|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.27380	137852228	1767	0	0.99881	.	0.619	0.004	2644	0.99998808	5.19	.	.	0.000000e+00	0.449695	0.994754450870779	0.82980	D	118	4642	7069	1.0936	0.99231	p.Arg75Gln	0	0	-8.736	0.9611795	0	0.90854	10573	D	24361	F9	7.324930e-05	D	0.904	15991	R75Q	D	0.80172	0.14846	G/G	principal1	127827	F9_Popp_2025_carboxy_F9_specific_var222251	No		1/7/25		178efdc9-7922-4e7d-8479-352a42eedd02							R		224	F9_Popp_2025_carboxy_F9_specific	10573.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255318	immortalized human cells		false			p.Arg75Gln		true	c.224G>A						3551.0	139537145.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PP3						PM1		NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting	Arg75Gln	https://erepo.genome.network/evrepo/ui/classification/178efdc9-7922-4e7d-8479-352a42eedd02					Q	Oct 11, 2024				10/11/24	missense_variant	Coagulation Factor Deficiency VCEP	75.0		hemophilia B	3.3027716859e-6	0.8265238286063324		Pathogenic	139537145.0	missense_variant		0.904					Reporter			F9_Arg75Gln
F9_Arg75Gln	-0.6220852274614853	0.5535999388326938	2.1795977289238957	0.0656797080553944	2025_01_Batch_13-14	0.7806735852079177	0.5729967658920669	0.5805918120440388	0.6641688898577275	0.6567913956539897	0.6061063760837944	0.464970228843791	0.5472480972054419	0.5119616355787338	0.6155139690296906	0.6933899806458561	0.518983497367929	0.5639199546247403	0.5880652627182306	0.6361526823418402	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030501		NC_000023.11:139537145:G:A		Arg75Gln																												F9_Arg75Gln	23	139537145	G	A	X	allele	224G>A	E06	527_CAVA_Array_P02	I12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537145-G-A	-	0.67086	1.0	75	0	0	0	X	138619304	A	3.302770e-06	1	X	1_Pathogenic	NC_000023.11	1	Arg75Gln	0	25.0	0	0	3.684730e-05	D	0	9	1	30951	5.821090e-06	.	18982	0.000000e+00	0	0.97356	Select	0.9754	27139	0.90580	1	.	D	D	46861	0.164289705123	0	0	0.000000e+00	0	0	0.38922	13652	33765	0	0.000000e+00	0.64159	0	.	0.81330	0.997	.	13.0	0.667233	4.22	0.87	A	single nucleotide variant	NC_000023.11:g.139537145G>A	0	12188	3	0.6656928	80303	0	0.83249354	0		1	171789	0	0	0.000000e+00	146	0.000000e+00	0	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	0.000000e+00	0	0.91311	D	0.76837	D	M	.	4	G/G	84	0	5701	1211104	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13067	0.99385	.	.	-	139537145	7.324930e-05	-	9.750000	0	0.97199	22029	0	45990	0	germline;unknown	56959	Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)| Gain of relative solvent accessibility (P = 0.2629)| Gain of catalytic residue at R75 (P = 0.319)| Loss of phosphorylation at S70 (P = 0.3465)	0.98631	GRCh38	924	reviewed by expert panel	c.224G>A	0.000000e+00	0.51026	0	0	0	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	0.000000e+00	6911	B	0	0.000000e+00	NM_000133.4(F9):c.224G>A (p.Arg75Gln)	3	0	FA9_HUMAN	0	87.0	.	1	T	0.32639	0.7617112	+	0.000000e+00	.		1	0.000000e+00	0	27139	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	1.245280e-05	0	0.000000e+00	0	45990	p.Arg75Gln	0	0.81498	.	germline	1		G	Oct 11, 2024	0	G/G	0	64582	1.0	N	Xq27.1	7040	.	0.000000e+00	SCV005437139	Pathogenic/Likely_pathogenic	0	0	Gln	Q	-	689	ENSP00000218099	ENST00000218099	13313	0.003	10118	0	-0.113	G	0	4.359394	0.74454	.	D	-	.	.	0.94319	610	0	.	0.57309	0	139537145	Y	10	0	73179	0.000000e+00	P00740	0	0.964669	0.99957		0	0.997	D	24361	0.6057016	13652	0.79771	2158	0.400284	3	-3.08	.	2.174390e-05	0.68399	0.000000e+00	0	57788	0.000000e+00	4343	0	0.80179	X	F9	0.000000e+00	0	Arg	11340	0.000000e+00	X-139537145-G-A	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_VIII_deficiency_disease|Warfarin_sensitivity,_X-linked|not_provided	0	0	138446970	ClinGen:CA255318|OMIM:300746.0016|UniProtKB:P00740#VAR_017308	.	.	0	RCV000757260|RCV002490353|RCV000852079|RCV000011319|RCV001851790	D	0	0	c.224G>A	0	0	0	0.89858	G/G	rs137852228	139537145	11996	G	.	P00740	9939	0.85893	0.000000e+00	0.68239		0	0	0.000000e+00	2.865	0	0	.	4.33	0.99567	142	D	T	0	4.104920e-05	0	24	.	0	0	98879|98878	10573	0.93519	0.18266	0.917611181735992	2728	.	0.71675	.	3.684730e-05	4.104920e-05	895062	7.322	6.595870e-06	D	9932	0	.	0	306900|300807|134500|306700|301052	0.78419	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9873855396371272	2	0.86259	0.18019	19047	.	0.000000e+00	2.174390e-05	.	YES	0.000000e+00	0.450308	25612	HGNC:3551	A	0	simple_aae	0.941	151610	139537145	CGA	1.000000	.	-	0	0.95480	3.351720e-06	0	0	Pathogenic	0.66059	0	0	1	ClinGen:CA255318,UniProtKB:P00740#VAR_017308,OMIM:300746.0016	R	0	0.998839519055	-	0.922	-	0.83632	1	574	0.98728	0.501060843468	0.1299	0	0.99953252965582506	100	-	224G>A 	1	0	C0008533|C2749016|C0019069|C5393318|C3661900	0	0	0	0	NM_000133.4	-	.	.	1	0.27380	137852228	1767	0	0.99881	.	0.619	0.004	2644	0.99998808	5.19	.	.	0.000000e+00	0.449695	0.994754450870779	0.82980	D	118	4642	7069	1.0936	0.99231	p.Arg75Gln	0	0	-8.736	0.9611795	0	0.90854	10573	D	24361	F9	7.324930e-05	D	0.904	15991	R75Q	D	0.80172	0.14846	G/G	principal1	237891	F9_Popp_2025_strep_2_var260975	No		1/7/25		178efdc9-7922-4e7d-8479-352a42eedd02							R		224	F9_Popp_2025_strep_2	10573.0	ENST00000218099.7	VUS				https://cspec.clinicalgenome.org/cspec/ui/svi/affiliation/50041	CA255318	immortalized human cells		false			p.Arg75Gln		true	c.224G>A						3551.0	139537145.0	No	Pathogenic	F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa	PP4_Moderate,PS4_Very,PM2_Supporting,PP3						PM1		NM_000133.4(F9):c.224G>A (p.Arg75Gln) missense variant has a REVEL score of 0.904, which meets criteria for PP3. This variant is absent from males in population databases (gnomAD v2.1.1/gnomAD v3). Approximately 24 patients are reported in the literature with mild hemophilia B and this variant, meeting F9 phenotype criteria for PS4_Very strong (PMID: 31064749, PMID: 2066105, PMID: 8314564, PMID: 29296726, PMID: 27213901, PMID: 2773937). In summary, this variant meets criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Coagulation Factor Deficiency Variant Curation Expert Panel for F9: PS4_Very strong, PP4_Moderate, PP3, PM2_supporting.	MONDO:0010604	reviewed by expert panel		X-linked inheritance	PS4_Very,PM2_Supporting	Arg75Gln	https://erepo.genome.network/evrepo/ui/classification/178efdc9-7922-4e7d-8479-352a42eedd02					Q	Oct 11, 2024				10/11/24	missense_variant	Coagulation Factor Deficiency VCEP	75.0		hemophilia B	3.3027716859e-6	0.6763994715577879		Pathogenic	139537145.0	missense_variant		0.904					Reporter			F9_Arg75Gln
RAD51D_Arg55Trp	1.021432754244928	0.341046466783239	-0.6516104897040346	0.5354521334844584	2025_01_Batch_13-14	0.5773047600598085	0.7310209948174875	0.731383595365466	0.6615307574655238	0.566970418461294	0.5398752335334412	0.7123554891322557	0.7037045509736447	0.6637786417422724	0.5275149052822954	0.5585899967966248	0.7216882419748716	0.7175440731695554	0.6626546996038981	0.5472426618717947	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024799		NC_000017.11:35118601:G:A		Arg55Trp																												RAD51D_Arg55Trp	17	35118601	G	A	17	allele	163C>T	E12	527_CAVA_Array_P04	J24	B13A7A8P1_R1	B14A7A8P1_R2				17-35118601-G-A	-	0.89281	0.997	55	0	0	0	17	33445620	A	2.230390e-05	0	17	3_Conflicting	NC_000017.11	31	Arg55Trp	0	29.9	0	0	3.275900e-05	T	0	9	1	42764	8.447660e-06	.	30526	4.310340e-04	0	0.69109	Select	0.2724	30526	0.70687	0	.	D	T	64002	.	0	0	1.045370e-04	0	0	.	17108	44900	1	0.000000e+00	0.83383	0	.	0.65280	0.993	.	37.0	.	1.94	0.63	A	single nucleotide variant	NC_000017.11:g.35118601G>A	0	16684	2	0.46390733	109344	0	0.47494522	0		2	236752	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	1	0	0.000000e+00	0	0.78586	D	0.68623	D	M	4.441516	36	G/G	298	0	7164	1614066	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	16164	0.67624	.	.	-	35118601	.	-	3.143000	0	0.77554	29608	0	6084	0	germline;unknown	91096	Gain of catalytic residue at L53 (P = 0.0031)| Gain of helix (P = 0.005)| Loss of loop (P = 0.0153)| Loss of MoRF binding (P = 0.0884)| Loss of solvent accessibility (P = 0.1202)	0.72759	GRCh38	926	criteria provided, conflicting classifications	c.163C>T	3.275900e-05	0.19474	1	0	1	RAD51D, N-terminal domain	0.000000e+00	9040	A	0	0.000000e+00	NM_002878.4(RAD51D):c.163C>T (p.Arg55Trp)	1	0	RA51D_HUMAN	0	63.0	0.415643171291693	0	.	0.65611	0.47494522	-	0.000000e+00	.		1	1.611340e-04	2	34256	criteria_provided,_conflicting_classifications	0.97637	9.145450e-06	0	0.000000e+00	0	60004	p.Arg55Trp	0	0.36573	.	germline	.		G	Jan 26, 2025	1	G/G	0	89422	1.0	N	17q12	19700	.	0.000000e+00	SCV000274193|SCV000651718|SCV000912002|SCV001766967|SCV002511654|SCV003926632|SCV004033554|SCV004208078|SCV004236536	Conflicting_classifications_of_pathogenicity	0	1	Trp	W	-	912	ENSP00000338790	ENST00000345365	17686	0.003	13410	0	0.676	G	0	5.317904	0.83643	D	D	-	3.859249	.	0.78916	610	0	.	0.62559	0	35118601	Y	10	0	102668	5.095330e-03	O75771	0	0.547731	0.96206		.	0.915	D	30608	0.46390733	.	0.69292	5892	0.0541436	0	-5.15	.	5.095330e-03	0.68399	0.000000e+00	0	74938	0.000000e+00	6084	0	0.68623	17	RAD51D	0.000000e+00	0	Arg	30328	0.000000e+00	17-35118601-G-A	not_specified|not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	0	30469733	ClinGen:CA8499638	0.817233	0.62085	0	RCV000222465|RCV000555250|RCV001547298|RCV002229933	D	0	0	c.163C>T	0	0	0	0.58585	G/G	rs775268017	35118601	14848	G	.	O75771	15690	0.65280	0.000000e+00	0.68239		0	0	0.000000e+00	2.6	0	1	264690	1.09	0.84489	112	D	.	0	0.000000e+00	0	26	.	0	0	140162|145	230594	0.65870	.	0.94793289899826	7734	.	0.71675	0.73781	0.000000e+00	3.267120e-05	1180034	3.953	9.621120e-06	D	13344	0	1.8890023E-5	0	614291	0.56497	17	0.000000e+00	ENSG00000185379	0.000000e+00	5.076142131979695E-5	1	0	.	1	0.65085	0.17784	30608	5	0.000000e+00	3.333110e-05	0.323933020451451	YES	1.097740e-05	0.111863	235907	HGNC:9823	D	0	simple_aae	0.599	207876	35118601	CGG	1.000000	.	-	0	0.79845	0.000000e+00	0	0	Conflicting classifications of pathogenicity	0.69817	0	31	2	ClinGen:CA8499638	R	0	0.873687315659	-	0.598	-	0.81999	2	1928	.	.	0.4599	0	0.99887546840030128	98	-	163C>T 	1	0	CN169374|C3661900|C0027672|C3280345	0	0	1	0	NM_002878.4	-	.	.	0	0.72299	775268017	2320	3.297283038776049E-5	0.87147	0.56721	0.825	0.001	7436	0.99482584	4.79	.	.	3.267120e-05	-0.0631489	0.00577304038068542	0.75898	T	86	6206	9566	-0.5240	0.64261	p.Arg55Trp	0	0	-9.321	0.8072227	0	0.19858	230594	D	30520	RAD51D	0.000000e+00	T	0.374	21582	R55W	D	0.38959	0.76753	G/G	principal1	962260	RAD51D_unpublished_var156507	Yes						overall function		Cell survival			R		163	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Arg55Trp		true	c.163C>T						9823.0	35118601.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		T									criteria provided, conflicting classifications				Arg55Trp						W	Jan 18, 2024					missense_variant		55.0	C		0.0000223039206575	0.0105931		Conflicting classifications of pathogenicity	35118601.0	missense_variant		0.374	functionally_normal				Cell viability			RAD51D_Arg55Trp
LMNA_Arg335Trp	4.583862108039076	0.0025321301333144763	-0.9255931267106533	0.385456246323218	2025_01_Batch_13-14	0.711489638930998	0.8279131353541587	0.768175515004324	0.6641384677519655	0.6181679353333233	0.5907092384194192	0.6694165414177452	0.7801505531661583	0.7028534388956819	0.5982227051075442	0.6510994386752087	0.748664838385952	0.7741630340852412	0.6834959533238236	0.6081953202204338	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	LMNA	LMNA	ENSG00000160789	3903	201328	CCSBVarC003620	ALE00003620	NC_000001.11:156135967:C:T	1003C>T	Arg335Trp	CEGS2	CegsMutGDEh1047	B06	GDEhDisVCh_40057	G10	1	CegsMutGDDh1047	B06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			LMNA_Arg335Trp	1	156135967	C	T	1											1-156135967-C-T	-	0.90388	1.0	335	.	0	.	1	156105758	T	6.196090e-07	.	1	1_Pathogenic	NC_000001.11	1	Arg335Trp	.	31.0	.	0	.	D	0	18	1	.	.	.	.	.	0	0.94182	Select	0.8766	.	0.90580	.	.	D	D	63884	2.09983672442	0	0	.	.	.	0.74014	.	44890	0	.	0.93600	.	.	0.85040	0.992	.	2.0	0.962604	.	0.98	T	single nucleotide variant	NC_000001.11:g.156135967C>T	0	.	3	0.8051204	.	0	0.8800445	0		.	.	.	.	.	500	.	0	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900|MONDO:MONDO:0012417,MedGen:C1857829,OMIM:610140,Orphanet:168796|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247|MONDO:MONDO:0016333,MedGen:C0340427,OMIM:PS115200,Orphanet:217607|MONDO:MONDO:0021106,MedGen:C5392094,Orphanet:98301;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0007269,MedGen:C1449563,OMIM:115200,Orphanet:300751|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|11 conditions||MedGen:CN230736|Human Phenotype Ontology:HP:0030682,MONDO:MONDO:0018901,MedGen:C1960469,OMIM:PS604169,Orphanet:54260	.	.	0.000000e+00	0	0.99291	D	0.88487	D	H	9.3793	1	C/C	114	1	.	1613920	Primary dilated cardiomyopathy|not provided|Heart-hand syndrome, Slovenian type|Charcot-Marie-Tooth disease type 2|Arrhythmogenic right ventricular cardiomyopathy|Primary familial dilated cardiomyopathy|Laminopathy;Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Cardiomyopathy|11 conditions|LMNA-related disorder|Cardiovascular phenotype|Left ventricular noncompaction	.	0.96209	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156135967	.	-	4.774000	.	0.87822	29604	0	1180030	.	germline;unknown	91088	Loss of solvent accessibility (P = 0.1077)| Gain of MoRF binding (P = 0.1637)| Loss of relative solvent accessibility (P = 0.3219)| Loss of methylation at R331 (P = 0.4354)| Loss of glycosylation at S334 (P = 0.5435)	0.71518	GRCh38	460	criteria provided, multiple submitters, no conflicts	c.1003C>T	.	0.94257	2	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	P	0	0.000000e+00	NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	2	.	LMNA_HUMAN	.	98.0	0.829224154962615	.	D	0.68353	0.8201633	+	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	60016	p.Arg335Trp	0	0.44870	.	germline	.		C	Sep 12, 2024	.	C/C	.	.	1.0	N	1q22	26588	.	.	SCV000052800|SCV000064996|SCV000234691|SCV000611277|SCV000657788|SCV000736761|SCV000927154|SCV000987545|SCV000995090|SCV001366997|SCV001715569|SCV003838810|SCV004112973|SCV004240883|SCV005196726|SCV005427697	Pathogenic/Likely_pathogenic	.	.	Trp	W	-	912	ENSP00000357283	ENST00000368300	.	0.001	.	.	0.599	C	.	5.395437	0.92967	D	D	-	9.496604	.	0.98568	628	.	.	0.91475	0	156135967	Y	10	0	.	0.000000e+00	P02545	.	0.978141	0.98853		.	0.964	D	.	0.80577844	.	0.67791	4000	0.458005	1	-6.78	.	8.474360e-07	0.91343	.	.	74930	.	6082	.	0.88446	1	LMNA	0.000000e+00	0	Arg	35432	.	1-156135967-C-T	LMNA-related_disorder|Cardiovascular_phenotype|Left_ventricular_noncompaction|Cardiomyopathy|Primary_familial_dilated_cardiomyopathy|not_provided|Arrhythmogenic_right_ventricular_cardiomyopathy|Charcot-Marie-Tooth_disease_type_2B1|Emery-Dreifuss_muscular_dystrophy_2,_autosomal_dominant|Mandibuloacral_dysplasia_with_type_A_lipodystrophy|Dilated_cardiomyopathy-hypergonadotropic_hypogonadism_syndrome|Dilated_cardiomyopathy_1A|Heart-hand_syndrome,_Slovenian_type|Hutchinson-Gilford_syndrome|Emery-Dreifuss_muscular_dystrophy_3,_autosomal_recessive|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Familial_partial_lipodystrophy,_Dunnigan_type|Restrictive_dermopathy_2|Primary_dilated_cardiomyopathy|Laminopathy|Charcot-Marie-Tooth_disease_type_2	0	.	154372382	ClinGen:CA016426|OMIM:150330.0058	0.948098	0.87830	0	RCV000030145|RCV000182368|RCV000721960|RCV000546102|RCV000852407|RCV003492303|RCV000844672|RCV001196390|RCV003149579|RCV002477025|RCV004532421|RCV000620788|RCV000845456	D	0	.	c.1003C>T	.	0	0	0.92783	C/C	rs386134243	156135967	.	C	.	P02545	.	0.89526	.	0.68239		.	.	0.000000e+00	3.775	0	1	.	5.87	0.99804	112	D	T	.	.	0	26	.	.	.	54260|167848|217607|247|98856|261|264|2457|90153|2229|300751|168796|740|261|98855|157973|2348|217604|98301|64746	36473	0.92694	0.94792	0.997435510158539	2918	.	0.71675	0.95922	.	.	1180030	2.013	.	D	.	.	.	0	PS604169|PS115200|605588|181350|248370|212112|115200|610140|176670|616516|613205|151660|619793	0.40665	1	.	ENSG00000160789	0.000000e+00	3.761095230931247E-5	.	0	0.9541123517558469	1	0.76461	0.78769	.	.	.	0.000000e+00	0.777752911999856	YES	0.000000e+00	0.816539	45135	HGNC:6636	A	.	simple_aae	0.78	.	156135967	CGG	1.000000	.	-	0	0.91967	8.474360e-07	0	0	Pathogenic/Likely pathogenic	0.89664	.	0	0	ClinGen:CA016426,OMIM:150330.0058	R	.	0.964334009803	-	0.588	-	0.97765	.	4588	0.95368	0.747377514839	0.5886	0	0.99922039172766042	98	-	1003C>T 	.	2.1795989537925023E-4	CN230736|C1960469|C0878544|C0340427|C3661900|C0349788|C1854154|C0410190|C5399785|C0796031|C1449563|C1857829|C0033300|C2750035|C2750785|C1720860|C5676942|C0007193|C5392094|C0270914	.	.	.	.	NM_170707.4	-	.	.	1	0.86719	386134243	.	5.644615037254459E-5	0.96363	0.88143	0.96	0.003	2804	0.99997473	5.87	.	.	.	0.420116	0.99922285455029	0.95135	D	86	.	.	0.9382	0.95894	p.Arg335Trp	0	0	-12.785	0.9271074	0	0.96001	36473	D	.	LMNA	.	D	0.819	.	R335W	D	.	0.40292	C/C	principal1																																																																																																				
LMNA_Arg335Trp	4.583862108039076	0.0025321301333144763	-0.9255931267106533	0.385456246323218	2025_01_Batch_13-14	0.711489638930998	0.8279131353541587	0.768175515004324	0.6641384677519655	0.6181679353333233	0.5907092384194192	0.6694165414177452	0.7801505531661583	0.7028534388956819	0.5982227051075442	0.6510994386752087	0.748664838385952	0.7741630340852412	0.6834959533238236	0.6081953202204338	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	LMNA	LMNA		3903		CCSBVarC003620		NC_000001.11:156135967:C:T		Arg335Trp																												LMNA_Arg335Trp	1	156135967	C	T	1	allele	1003C>T	H12	527_CAVA_Array_P03	P23	B13A7A8P1_R1	B14A7A8P1_R2				1-156135967-C-T	-	0.90388	1.0	335	.	0	.	1	156105758	T	6.196090e-07	.	1	1_Pathogenic	NC_000001.11	1	Arg335Trp	.	31.0	.	0	.	D	0	18	1	.	.	.	.	.	0	0.94182	Select	0.8766	.	0.90580	.	.	D	D	63884	2.09983672442	0	0	.	.	.	0.74014	.	44890	0	.	0.93600	.	.	0.85040	0.992	.	2.0	0.962604	.	0.98	T	single nucleotide variant	NC_000001.11:g.156135967C>T	0	.	3	0.8051204	.	0	0.8800445	0		.	.	.	.	.	500	.	0	EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MedGen:C3661900|MONDO:MONDO:0012417,MedGen:C1857829,OMIM:610140,Orphanet:168796|MONDO:MONDO:0018993,MedGen:C0270914,Orphanet:64746|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247|MONDO:MONDO:0016333,MedGen:C0340427,OMIM:PS115200,Orphanet:217607|MONDO:MONDO:0021106,MedGen:C5392094,Orphanet:98301;EFO:EFO_0000407,Human Phenotype Ontology:HP:0001644,Human Phenotype Ontology:HP:0001725,Human Phenotype Ontology:HP:0005159,Human Phenotype Ontology:HP:0200130,MONDO:MONDO:0005021,MeSH:D002311,MedGen:C0007193,Orphanet:217604|MONDO:MONDO:0007269,MedGen:C1449563,OMIM:115200,Orphanet:300751|Human Phenotype Ontology:HP:0001638,MONDO:MONDO:0004994,MedGen:C0878544,Orphanet:167848|11 conditions||MedGen:CN230736|Human Phenotype Ontology:HP:0030682,MONDO:MONDO:0018901,MedGen:C1960469,OMIM:PS604169,Orphanet:54260	.	.	0.000000e+00	0	0.99291	D	0.88487	D	H	9.3793	1	C/C	114	1	.	1613920	Primary dilated cardiomyopathy|not provided|Heart-hand syndrome, Slovenian type|Charcot-Marie-Tooth disease type 2|Arrhythmogenic right ventricular cardiomyopathy|Primary familial dilated cardiomyopathy|Laminopathy;Primary dilated cardiomyopathy|Dilated cardiomyopathy 1A|Cardiomyopathy|11 conditions|LMNA-related disorder|Cardiovascular phenotype|Left ventricular noncompaction	.	0.96209	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156135967	.	-	4.774000	.	0.87822	29604	0	1180030	.	germline;unknown	91088	Loss of solvent accessibility (P = 0.1077)| Gain of MoRF binding (P = 0.1637)| Loss of relative solvent accessibility (P = 0.3219)| Loss of methylation at R331 (P = 0.4354)| Loss of glycosylation at S334 (P = 0.5435)	0.71518	GRCh38	460	criteria provided, multiple submitters, no conflicts	c.1003C>T	.	0.94257	2	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	P	0	0.000000e+00	NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp)	2	.	LMNA_HUMAN	.	98.0	0.829224154962615	.	D	0.68353	0.8201633	+	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99978	.	0	.	.	60016	p.Arg335Trp	0	0.44870	.	germline	.		C	Sep 12, 2024	.	C/C	.	.	1.0	N	1q22	26588	.	.	SCV000052800|SCV000064996|SCV000234691|SCV000611277|SCV000657788|SCV000736761|SCV000927154|SCV000987545|SCV000995090|SCV001366997|SCV001715569|SCV003838810|SCV004112973|SCV004240883|SCV005196726|SCV005427697	Pathogenic/Likely_pathogenic	.	.	Trp	W	-	912	ENSP00000357283	ENST00000368300	.	0.001	.	.	0.599	C	.	5.395437	0.92967	D	D	-	9.496604	.	0.98568	628	.	.	0.91475	0	156135967	Y	10	0	.	0.000000e+00	P02545	.	0.978141	0.98853		.	0.964	D	.	0.80577844	.	0.67791	4000	0.458005	1	-6.78	.	8.474360e-07	0.91343	.	.	74930	.	6082	.	0.88446	1	LMNA	0.000000e+00	0	Arg	35432	.	1-156135967-C-T	LMNA-related_disorder|Cardiovascular_phenotype|Left_ventricular_noncompaction|Cardiomyopathy|Primary_familial_dilated_cardiomyopathy|not_provided|Arrhythmogenic_right_ventricular_cardiomyopathy|Charcot-Marie-Tooth_disease_type_2B1|Emery-Dreifuss_muscular_dystrophy_2,_autosomal_dominant|Mandibuloacral_dysplasia_with_type_A_lipodystrophy|Dilated_cardiomyopathy-hypergonadotropic_hypogonadism_syndrome|Dilated_cardiomyopathy_1A|Heart-hand_syndrome,_Slovenian_type|Hutchinson-Gilford_syndrome|Emery-Dreifuss_muscular_dystrophy_3,_autosomal_recessive|Congenital_muscular_dystrophy_due_to_LMNA_mutation|Familial_partial_lipodystrophy,_Dunnigan_type|Restrictive_dermopathy_2|Primary_dilated_cardiomyopathy|Laminopathy|Charcot-Marie-Tooth_disease_type_2	0	.	154372382	ClinGen:CA016426|OMIM:150330.0058	0.948098	0.87830	0	RCV000030145|RCV000182368|RCV000721960|RCV000546102|RCV000852407|RCV003492303|RCV000844672|RCV001196390|RCV003149579|RCV002477025|RCV004532421|RCV000620788|RCV000845456	D	0	.	c.1003C>T	.	0	0	0.92783	C/C	rs386134243	156135967	.	C	.	P02545	.	0.89526	.	0.68239		.	.	0.000000e+00	3.775	0	1	.	5.87	0.99804	112	D	T	.	.	0	26	.	.	.	54260|167848|217607|247|98856|261|264|2457|90153|2229|300751|168796|740|261|98855|157973|2348|217604|98301|64746	36473	0.92694	0.94792	0.997435510158539	2918	.	0.71675	0.95922	.	.	1180030	2.013	.	D	.	.	.	0	PS604169|PS115200|605588|181350|248370|212112|115200|610140|176670|616516|613205|151660|619793	0.40665	1	.	ENSG00000160789	0.000000e+00	3.761095230931247E-5	.	0	0.9541123517558469	1	0.76461	0.78769	.	.	.	0.000000e+00	0.777752911999856	YES	0.000000e+00	0.816539	45135	HGNC:6636	A	.	simple_aae	0.78	.	156135967	CGG	1.000000	.	-	0	0.91967	8.474360e-07	0	0	Pathogenic/Likely pathogenic	0.89664	.	0	0	ClinGen:CA016426,OMIM:150330.0058	R	.	0.964334009803	-	0.588	-	0.97765	.	4588	0.95368	0.747377514839	0.5886	0	0.99922039172766042	98	-	1003C>T 	.	2.1795989537925023E-4	CN230736|C1960469|C0878544|C0340427|C3661900|C0349788|C1854154|C0410190|C5399785|C0796031|C1449563|C1857829|C0033300|C2750035|C2750785|C1720860|C5676942|C0007193|C5392094|C0270914	.	.	.	.	NM_170707.4	-	.	.	1	0.86719	386134243	.	5.644615037254459E-5	0.96363	0.88143	0.96	0.003	2804	0.99997473	5.87	.	.	.	0.420116	0.99922285455029	0.95135	D	86	.	.	0.9382	0.95894	p.Arg335Trp	0	0	-12.785	0.9271074	0	0.96001	36473	D	.	LMNA	.	D	0.819	.	R335W	D	.	0.40292	C/C	principal1																																																																																																				
F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	0.7029388431329561	0.6639941960024667	0.6414383780251568	0.7148120661176882	0.44746059654442905	0.6593769088586301	0.622762978974506	0.6561878803626179	0.6615128318072457	0.6772224047801471	0.681157875995793	0.6433785874884863	0.6488131291938873	0.6881624489624669	0.562341500662288	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G		Val195Gly																												F9_Val195Gly	23	139551125	T	G	X	allele	584T>G	F08	527_CAVA_Array_P02	K16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551125-T-G	-	0.12793	0.0	195	0	0	0	X	138633284	G	3.306860e-06	1	X	2_Benign	NC_000023.11	3	Val195Gly	0	9.29	0	0	3.680940e-05	D	0	1	1	30956	5.804770e-06	.	19006	0.000000e+00	0	0.61985	Select	0.6775	27167	0.02950	1	.	T	T	46636	0.852731849783	0	0	0.000000e+00	0	0	0.11558	13666	33786	0	0.000000e+00	0.38726	0	.	0.46144	0.062	.	85.0	0.483452	3.33	0.15	G	single nucleotide variant	NC_000023.11:g.139551125T>G	0	12189	2	0.14323859	80340	0	0.23625271	0		1	172272	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	0.000000e+00	0	0.45549	B	0.33951	B	N	.	4	T/T	114	0	5701	1209607	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13132	0.77642	.	.	-	139551125	7.317430e-05	-	2.316000	0	0.59271	22036	0	57267	0	germline	56793	.	.	GRCh38	924	criteria provided, single submitter	c.584T>G	0.000000e+00	0.64600	0	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.584T>G (p.Val195Gly)	1	0	FA9_HUMAN	0	15.0	.	1	T	0.21572	0.23625271	+	0.000000e+00	.		1	0.000000e+00	0	27167	criteria_provided,_single_submitter	0.99765	1.244710e-05	0	0.000000e+00	0	45773	p.Val195Gly	0	0.32189	.	germline	1		T	Aug 23, 2023	0	T/T	0	64675	0.186	N	Xq27.1	9690	.	0.000000e+00	SCV003501528	Likely_benign	0	0	Gly	G	-	685	ENSP00000218099	ENST00000218099	13319	0.349	10128	0	0.665	T	0	0.903261	0.16408	.	T	-	.	.	0.68789	610	0	.	0.02159	0	139551125	Y	10	0	73497	0.000000e+00	P00740	0	0.471326	0.03062		0	0.002	D	24389	0.14323859	13666	0.16152	2158	-0.0125828	0	-1.61	.	5.238620e-05	0.12418	0.000000e+00	0	57267	0.000000e+00	4374	0	0.33950	X	F9	5.238620e-05	0	Val	14050	0.000000e+00	X-139551125-T-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138460950	.	.	.	0	RCV002632292	T	0	0	c.584T>G	0	0	0	0.49576	T/T	rs374674030	139551125	12062	T	.	.	9951	0.46144	0.000000e+00	0.24039		0	0	0.000000e+00	0	0	0	264690	4.94	0.80258	112	T	T	0	4.100210e-05	0	26	.	0	0	98879	2184672	0.59542	0.68423	0.0311624814342412	2898	.	0.24222	.	3.680940e-05	4.100210e-05	894681	1.842	6.585100e-06	N	9932	0	1.8890023E-5	0	306900|300807	0.38995	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9536002345262253	2	0.06938	0.18019	19071	5	0.000000e+00	2.184690e-05	.	YES	0.000000e+00	0.063227	1921180	HGNC:3551	N	0	simple_aae	0.329	151858	139551125	GTT	0.258000	.	-	0	0.26271	0.000000e+00	0	0	Likely benign	0.26473	0	0	1	ClinGen:CA336137420	V	0	0.941715556567	-	.	-	0.17857	1	496	0.95316	0.307745546103	0.0972	0	0.41800775336298984	98	-	584T>G 	1	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.15897	-1	1767	0	0.94064	.	0.132	0.376	2784	0.99982518	4.94	.	.	0.000000e+00	-0.14336	0.962737860313214	0.06502	T	86	4649	7083	-0.1972	0.88803	p.Val195Gly	0	0	-4.071	0.1398688	3	0.82113	2184672	T	24389	F9	7.317430e-05	T	0.301	15994	.	T	0.60393	0.62996	T/T	principal1	162585	F9_Popp_2025_carboxy_gla_motif_var253816	No											V		584	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Val195Gly		true	c.584T>G						3551.0	139551125.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Val195Gly						G	Aug 23, 2023					missense_variant		195.0			3.3068591699e-6	1.072928962725921		Likely benign	139551125.0	missense_variant		0.301					Reporter			F9_Val195Gly
F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	0.7029388431329561	0.6639941960024667	0.6414383780251568	0.7148120661176882	0.44746059654442905	0.6593769088586301	0.622762978974506	0.6561878803626179	0.6615128318072457	0.6772224047801471	0.681157875995793	0.6433785874884863	0.6488131291938873	0.6881624489624669	0.562341500662288	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G		Val195Gly																												F9_Val195Gly	23	139551125	T	G	X	allele	584T>G	F08	527_CAVA_Array_P02	K16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551125-T-G	-	0.12793	0.0	195	0	0	0	X	138633284	G	3.306860e-06	1	X	2_Benign	NC_000023.11	3	Val195Gly	0	9.29	0	0	3.680940e-05	D	0	1	1	30956	5.804770e-06	.	19006	0.000000e+00	0	0.61985	Select	0.6775	27167	0.02950	1	.	T	T	46636	0.852731849783	0	0	0.000000e+00	0	0	0.11558	13666	33786	0	0.000000e+00	0.38726	0	.	0.46144	0.062	.	85.0	0.483452	3.33	0.15	G	single nucleotide variant	NC_000023.11:g.139551125T>G	0	12189	2	0.14323859	80340	0	0.23625271	0		1	172272	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	0.000000e+00	0	0.45549	B	0.33951	B	N	.	4	T/T	114	0	5701	1209607	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13132	0.77642	.	.	-	139551125	7.317430e-05	-	2.316000	0	0.59271	22036	0	57267	0	germline	56793	.	.	GRCh38	924	criteria provided, single submitter	c.584T>G	0.000000e+00	0.64600	0	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.584T>G (p.Val195Gly)	1	0	FA9_HUMAN	0	15.0	.	1	T	0.21572	0.23625271	+	0.000000e+00	.		1	0.000000e+00	0	27167	criteria_provided,_single_submitter	0.99765	1.244710e-05	0	0.000000e+00	0	45773	p.Val195Gly	0	0.32189	.	germline	1		T	Aug 23, 2023	0	T/T	0	64675	0.186	N	Xq27.1	9690	.	0.000000e+00	SCV003501528	Likely_benign	0	0	Gly	G	-	685	ENSP00000218099	ENST00000218099	13319	0.349	10128	0	0.665	T	0	0.903261	0.16408	.	T	-	.	.	0.68789	610	0	.	0.02159	0	139551125	Y	10	0	73497	0.000000e+00	P00740	0	0.471326	0.03062		0	0.002	D	24389	0.14323859	13666	0.16152	2158	-0.0125828	0	-1.61	.	5.238620e-05	0.12418	0.000000e+00	0	57267	0.000000e+00	4374	0	0.33950	X	F9	5.238620e-05	0	Val	14050	0.000000e+00	X-139551125-T-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138460950	.	.	.	0	RCV002632292	T	0	0	c.584T>G	0	0	0	0.49576	T/T	rs374674030	139551125	12062	T	.	.	9951	0.46144	0.000000e+00	0.24039		0	0	0.000000e+00	0	0	0	264690	4.94	0.80258	112	T	T	0	4.100210e-05	0	26	.	0	0	98879	2184672	0.59542	0.68423	0.0311624814342412	2898	.	0.24222	.	3.680940e-05	4.100210e-05	894681	1.842	6.585100e-06	N	9932	0	1.8890023E-5	0	306900|300807	0.38995	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9536002345262253	2	0.06938	0.18019	19071	5	0.000000e+00	2.184690e-05	.	YES	0.000000e+00	0.063227	1921180	HGNC:3551	N	0	simple_aae	0.329	151858	139551125	GTT	0.258000	.	-	0	0.26271	0.000000e+00	0	0	Likely benign	0.26473	0	0	1	ClinGen:CA336137420	V	0	0.941715556567	-	.	-	0.17857	1	496	0.95316	0.307745546103	0.0972	0	0.41800775336298984	98	-	584T>G 	1	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.15897	-1	1767	0	0.94064	.	0.132	0.376	2784	0.99982518	4.94	.	.	0.000000e+00	-0.14336	0.962737860313214	0.06502	T	86	4649	7083	-0.1972	0.88803	p.Val195Gly	0	0	-4.071	0.1398688	3	0.82113	2184672	T	24389	F9	7.317430e-05	T	0.301	15994	.	T	0.60393	0.62996	T/T	principal1	217617	F9_Popp_2025_light_chain_var244135	No											V		584	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Val195Gly		true	c.584T>G						3551.0	139551125.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Val195Gly						G	Aug 23, 2023					missense_variant		195.0			3.3068591699e-6	1.090559473007268		Likely benign	139551125.0	missense_variant		0.301					Reporter			F9_Val195Gly
F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	0.7029388431329561	0.6639941960024667	0.6414383780251568	0.7148120661176882	0.44746059654442905	0.6593769088586301	0.622762978974506	0.6561878803626179	0.6615128318072457	0.6772224047801471	0.681157875995793	0.6433785874884863	0.6488131291938873	0.6881624489624669	0.562341500662288	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G		Val195Gly																												F9_Val195Gly	23	139551125	T	G	X	allele	584T>G	F08	527_CAVA_Array_P02	K16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551125-T-G	-	0.12793	0.0	195	0	0	0	X	138633284	G	3.306860e-06	1	X	2_Benign	NC_000023.11	3	Val195Gly	0	9.29	0	0	3.680940e-05	D	0	1	1	30956	5.804770e-06	.	19006	0.000000e+00	0	0.61985	Select	0.6775	27167	0.02950	1	.	T	T	46636	0.852731849783	0	0	0.000000e+00	0	0	0.11558	13666	33786	0	0.000000e+00	0.38726	0	.	0.46144	0.062	.	85.0	0.483452	3.33	0.15	G	single nucleotide variant	NC_000023.11:g.139551125T>G	0	12189	2	0.14323859	80340	0	0.23625271	0		1	172272	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	0.000000e+00	0	0.45549	B	0.33951	B	N	.	4	T/T	114	0	5701	1209607	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13132	0.77642	.	.	-	139551125	7.317430e-05	-	2.316000	0	0.59271	22036	0	57267	0	germline	56793	.	.	GRCh38	924	criteria provided, single submitter	c.584T>G	0.000000e+00	0.64600	0	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.584T>G (p.Val195Gly)	1	0	FA9_HUMAN	0	15.0	.	1	T	0.21572	0.23625271	+	0.000000e+00	.		1	0.000000e+00	0	27167	criteria_provided,_single_submitter	0.99765	1.244710e-05	0	0.000000e+00	0	45773	p.Val195Gly	0	0.32189	.	germline	1		T	Aug 23, 2023	0	T/T	0	64675	0.186	N	Xq27.1	9690	.	0.000000e+00	SCV003501528	Likely_benign	0	0	Gly	G	-	685	ENSP00000218099	ENST00000218099	13319	0.349	10128	0	0.665	T	0	0.903261	0.16408	.	T	-	.	.	0.68789	610	0	.	0.02159	0	139551125	Y	10	0	73497	0.000000e+00	P00740	0	0.471326	0.03062		0	0.002	D	24389	0.14323859	13666	0.16152	2158	-0.0125828	0	-1.61	.	5.238620e-05	0.12418	0.000000e+00	0	57267	0.000000e+00	4374	0	0.33950	X	F9	5.238620e-05	0	Val	14050	0.000000e+00	X-139551125-T-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138460950	.	.	.	0	RCV002632292	T	0	0	c.584T>G	0	0	0	0.49576	T/T	rs374674030	139551125	12062	T	.	.	9951	0.46144	0.000000e+00	0.24039		0	0	0.000000e+00	0	0	0	264690	4.94	0.80258	112	T	T	0	4.100210e-05	0	26	.	0	0	98879	2184672	0.59542	0.68423	0.0311624814342412	2898	.	0.24222	.	3.680940e-05	4.100210e-05	894681	1.842	6.585100e-06	N	9932	0	1.8890023E-5	0	306900|300807	0.38995	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9536002345262253	2	0.06938	0.18019	19071	5	0.000000e+00	2.184690e-05	.	YES	0.000000e+00	0.063227	1921180	HGNC:3551	N	0	simple_aae	0.329	151858	139551125	GTT	0.258000	.	-	0	0.26271	0.000000e+00	0	0	Likely benign	0.26473	0	0	1	ClinGen:CA336137420	V	0	0.941715556567	-	.	-	0.17857	1	496	0.95316	0.307745546103	0.0972	0	0.41800775336298984	98	-	584T>G 	1	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.15897	-1	1767	0	0.94064	.	0.132	0.376	2784	0.99982518	4.94	.	.	0.000000e+00	-0.14336	0.962737860313214	0.06502	T	86	4649	7083	-0.1972	0.88803	p.Val195Gly	0	0	-4.071	0.1398688	3	0.82113	2184672	T	24389	F9	7.317430e-05	T	0.301	15994	.	T	0.60393	0.62996	T/T	principal1	135069	F9_Popp_2025_carboxy_F9_specific_var224773	No											V		584	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Val195Gly		true	c.584T>G						3551.0	139551125.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Val195Gly						G	Aug 23, 2023					missense_variant		195.0			3.3068591699e-6	1.0683572142925006		Likely benign	139551125.0	missense_variant		0.301					Reporter			F9_Val195Gly
F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	0.7029388431329561	0.6639941960024667	0.6414383780251568	0.7148120661176882	0.44746059654442905	0.6593769088586301	0.622762978974506	0.6561878803626179	0.6615128318072457	0.6772224047801471	0.681157875995793	0.6433785874884863	0.6488131291938873	0.6881624489624669	0.562341500662288	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G		Val195Gly																												F9_Val195Gly	23	139551125	T	G	X	allele	584T>G	F08	527_CAVA_Array_P02	K16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551125-T-G	-	0.12793	0.0	195	0	0	0	X	138633284	G	3.306860e-06	1	X	2_Benign	NC_000023.11	3	Val195Gly	0	9.29	0	0	3.680940e-05	D	0	1	1	30956	5.804770e-06	.	19006	0.000000e+00	0	0.61985	Select	0.6775	27167	0.02950	1	.	T	T	46636	0.852731849783	0	0	0.000000e+00	0	0	0.11558	13666	33786	0	0.000000e+00	0.38726	0	.	0.46144	0.062	.	85.0	0.483452	3.33	0.15	G	single nucleotide variant	NC_000023.11:g.139551125T>G	0	12189	2	0.14323859	80340	0	0.23625271	0		1	172272	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	0.000000e+00	0	0.45549	B	0.33951	B	N	.	4	T/T	114	0	5701	1209607	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13132	0.77642	.	.	-	139551125	7.317430e-05	-	2.316000	0	0.59271	22036	0	57267	0	germline	56793	.	.	GRCh38	924	criteria provided, single submitter	c.584T>G	0.000000e+00	0.64600	0	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.584T>G (p.Val195Gly)	1	0	FA9_HUMAN	0	15.0	.	1	T	0.21572	0.23625271	+	0.000000e+00	.		1	0.000000e+00	0	27167	criteria_provided,_single_submitter	0.99765	1.244710e-05	0	0.000000e+00	0	45773	p.Val195Gly	0	0.32189	.	germline	1		T	Aug 23, 2023	0	T/T	0	64675	0.186	N	Xq27.1	9690	.	0.000000e+00	SCV003501528	Likely_benign	0	0	Gly	G	-	685	ENSP00000218099	ENST00000218099	13319	0.349	10128	0	0.665	T	0	0.903261	0.16408	.	T	-	.	.	0.68789	610	0	.	0.02159	0	139551125	Y	10	0	73497	0.000000e+00	P00740	0	0.471326	0.03062		0	0.002	D	24389	0.14323859	13666	0.16152	2158	-0.0125828	0	-1.61	.	5.238620e-05	0.12418	0.000000e+00	0	57267	0.000000e+00	4374	0	0.33950	X	F9	5.238620e-05	0	Val	14050	0.000000e+00	X-139551125-T-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138460950	.	.	.	0	RCV002632292	T	0	0	c.584T>G	0	0	0	0.49576	T/T	rs374674030	139551125	12062	T	.	.	9951	0.46144	0.000000e+00	0.24039		0	0	0.000000e+00	0	0	0	264690	4.94	0.80258	112	T	T	0	4.100210e-05	0	26	.	0	0	98879	2184672	0.59542	0.68423	0.0311624814342412	2898	.	0.24222	.	3.680940e-05	4.100210e-05	894681	1.842	6.585100e-06	N	9932	0	1.8890023E-5	0	306900|300807	0.38995	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9536002345262253	2	0.06938	0.18019	19071	5	0.000000e+00	2.184690e-05	.	YES	0.000000e+00	0.063227	1921180	HGNC:3551	N	0	simple_aae	0.329	151858	139551125	GTT	0.258000	.	-	0	0.26271	0.000000e+00	0	0	Likely benign	0.26473	0	0	1	ClinGen:CA336137420	V	0	0.941715556567	-	.	-	0.17857	1	496	0.95316	0.307745546103	0.0972	0	0.41800775336298984	98	-	584T>G 	1	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.15897	-1	1767	0	0.94064	.	0.132	0.376	2784	0.99982518	4.94	.	.	0.000000e+00	-0.14336	0.962737860313214	0.06502	T	86	4649	7083	-0.1972	0.88803	p.Val195Gly	0	0	-4.071	0.1398688	3	0.82113	2184672	T	24389	F9	7.317430e-05	T	0.301	15994	.	T	0.60393	0.62996	T/T	principal1	190101	F9_Popp_2025_heavy_chain_var234454	No											V		584	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Val195Gly		true	c.584T>G						3551.0	139551125.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Val195Gly						G	Aug 23, 2023					missense_variant		195.0			3.3068591699e-6	1.045738961249948		Likely benign	139551125.0	missense_variant		0.301					Reporter			F9_Val195Gly
F9_Val195Gly	1.4590067567152354	0.18792919742567601	0.5614375506637511	0.5920110805676679	2025_01_Batch_13-14	0.7029388431329561	0.6639941960024667	0.6414383780251568	0.7148120661176882	0.44746059654442905	0.6593769088586301	0.622762978974506	0.6561878803626179	0.6615128318072457	0.6772224047801471	0.681157875995793	0.6433785874884863	0.6488131291938873	0.6881624489624669	0.562341500662288	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030560		NC_000023.11:139551125:T:G		Val195Gly																												F9_Val195Gly	23	139551125	T	G	X	allele	584T>G	F08	527_CAVA_Array_P02	K16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551125-T-G	-	0.12793	0.0	195	0	0	0	X	138633284	G	3.306860e-06	1	X	2_Benign	NC_000023.11	3	Val195Gly	0	9.29	0	0	3.680940e-05	D	0	1	1	30956	5.804770e-06	.	19006	0.000000e+00	0	0.61985	Select	0.6775	27167	0.02950	1	.	T	T	46636	0.852731849783	0	0	0.000000e+00	0	0	0.11558	13666	33786	0	0.000000e+00	0.38726	0	.	0.46144	0.062	.	85.0	0.483452	3.33	0.15	G	single nucleotide variant	NC_000023.11:g.139551125T>G	0	12189	2	0.14323859	80340	0	0.23625271	0		1	172272	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	0.000000e+00	0	0.45549	B	0.33951	B	N	.	4	T/T	114	0	5701	1209607	Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13132	0.77642	.	.	-	139551125	7.317430e-05	-	2.316000	0	0.59271	22036	0	57267	0	germline	56793	.	.	GRCh38	924	criteria provided, single submitter	c.584T>G	0.000000e+00	0.64600	0	0	0	.	0.000000e+00	6917	B	0	0.000000e+00	NM_000133.4(F9):c.584T>G (p.Val195Gly)	1	0	FA9_HUMAN	0	15.0	.	1	T	0.21572	0.23625271	+	0.000000e+00	.		1	0.000000e+00	0	27167	criteria_provided,_single_submitter	0.99765	1.244710e-05	0	0.000000e+00	0	45773	p.Val195Gly	0	0.32189	.	germline	1		T	Aug 23, 2023	0	T/T	0	64675	0.186	N	Xq27.1	9690	.	0.000000e+00	SCV003501528	Likely_benign	0	0	Gly	G	-	685	ENSP00000218099	ENST00000218099	13319	0.349	10128	0	0.665	T	0	0.903261	0.16408	.	T	-	.	.	0.68789	610	0	.	0.02159	0	139551125	Y	10	0	73497	0.000000e+00	P00740	0	0.471326	0.03062		0	0.002	D	24389	0.14323859	13666	0.16152	2158	-0.0125828	0	-1.61	.	5.238620e-05	0.12418	0.000000e+00	0	57267	0.000000e+00	4374	0	0.33950	X	F9	5.238620e-05	0	Val	14050	0.000000e+00	X-139551125-T-G	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	0	0	138460950	.	.	.	0	RCV002632292	T	0	0	c.584T>G	0	0	0	0.49576	T/T	rs374674030	139551125	12062	T	.	.	9951	0.46144	0.000000e+00	0.24039		0	0	0.000000e+00	0	0	0	264690	4.94	0.80258	112	T	T	0	4.100210e-05	0	26	.	0	0	98879	2184672	0.59542	0.68423	0.0311624814342412	2898	.	0.24222	.	3.680940e-05	4.100210e-05	894681	1.842	6.585100e-06	N	9932	0	1.8890023E-5	0	306900|300807	0.38995	X	0.000000e+00	ENSG00000101981	0.000000e+00	0	0	0	0.9536002345262253	2	0.06938	0.18019	19071	5	0.000000e+00	2.184690e-05	.	YES	0.000000e+00	0.063227	1921180	HGNC:3551	N	0	simple_aae	0.329	151858	139551125	GTT	0.258000	.	-	0	0.26271	0.000000e+00	0	0	Likely benign	0.26473	0	0	1	ClinGen:CA336137420	V	0	0.941715556567	-	.	-	0.17857	1	496	0.95316	0.307745546103	0.0972	0	0.41800775336298984	98	-	584T>G 	1	0	C0008533|C2749016	0	0	0	0	NM_000133.4	-	.	.	0	0.15897	-1	1767	0	0.94064	.	0.132	0.376	2784	0.99982518	4.94	.	.	0.000000e+00	-0.14336	0.962737860313214	0.06502	T	86	4649	7083	-0.1972	0.88803	p.Val195Gly	0	0	-4.071	0.1398688	3	0.82113	2184672	T	24389	F9	7.317430e-05	T	0.301	15994	.	T	0.60393	0.62996	T/T	principal1	245133	F9_Popp_2025_strep_2_var263497	No											V		584	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Val195Gly		true	c.584T>G						3551.0	139551125.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Val195Gly						G	Aug 23, 2023					missense_variant		195.0			3.3068591699e-6	1.095708345689263		Likely benign	139551125.0	missense_variant		0.301					Reporter			F9_Val195Gly
F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Pro	23	139561836	G	C	X											X-139561836-G-C	-	0.53962	0.811	384	.	.	.	X	138643995	C	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Pro	.	23.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.84859	Select	0.6380	.	0.45417	.	.	D	D	.	1.87772444659	.	.	.	.	.	0.17476	.	.	.	.	0.61611	.	.	0.98574	0.988	.	9.0	0.864914	3.27	0.91	C	single nucleotide variant	NC_000023.11:g.139561836G>C	.	.	1	0.86487466	.	.	0.9766411	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.92786	P	0.96996	P	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.77327	.	.	-	139561836	.	-	4.414000	.	0.87600	.	.	.	.	germline	.	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.96136	GRCh38	924	no assertion criteria provided	c.1151G>C	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)		.	FA9_HUMAN	.	91.0	.	.	D	0.83164	0.97375035	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Arg384Pro	.	0.43370	.	germline	.		G	Aug 04, 2016	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031645	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.113	.	.	0.676	G	.	3.756788	0.35539	.	T	-	.	.	0.97099	.	.	.	0.64392	.	139561836	Y	10	.	.	.	P00740	.	0.844472	0.64520		.	0.626	D	.	0.92917997	.	0.63383	2158	0.41848	.	-2.95	.	.	0.30937	.	.	.	.	.	.	0.92413	X	F9	.	.	Arg	.	.	X-139561836-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA255463|OMIM:300746.0111	.	.	.	RCV000011413	D	.	.	c.1151G>C	.	.	.	0.90875	G/G	rs137852283	139561836	.	G	.	P00740	.	0.98823	.	0.68239		.	.	.	1.8	.	.	.	2.91	0.96374	.	D	T	.	.	.	.	.	.	.	98879	10660	0.90761	0.92541	0.955869972705841	.	.	0.20792	.	.	.	.	1.5	.	D	.	.	.	.	306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.9930344317450107	2	0.51596	0.18019	.	.	.	.	.	YES	.	0.656409	25699	HGNC:3551	A	.	simple_aae	0.776	.	139561836	CGA	1.000000	.	-	.	0.94661	.	.	.	Pathogenic	0.67458	.	.	.	ClinGen:CA255463,OMIM:300746.0111	R	.	0.999870480019	-	0.867	-	0.88450	.	.	0.99298	0.347094744444	0.7086	.	0.99434905878668101	.	-	1151G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.58713	137852283	.	.	0.99986	.	0.576	0.126	.	0.99998236	5.66	.	.	.	0.363341	0.999433055132211	0.47294	T	.	.	.	-0.2094	0.87292	p.Arg384Pro	.	.	-8.889	0.953725	.	0.96580	10660	D	.	F9	.	D	0.614	.	R384P	T	0.59264	0.76753	G/G	principal1	201414	F9_Popp_2025_heavy_chain_var238424	No											R		1151	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Arg384Pro		true	c.1151G>C						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Arg384Pro						P	Aug 04, 2016					missense_variant		384.0				0.9618802619983524		Pathogenic	139561836.0	missense_variant		0.614					Reporter			F9_Arg384Pro
F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Pro	23	139561836	G	C	X											X-139561836-G-C	-	0.53962	0.811	384	.	.	.	X	138643995	C	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Pro	.	23.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.84859	Select	0.6380	.	0.45417	.	.	D	D	.	1.87772444659	.	.	.	.	.	0.17476	.	.	.	.	0.61611	.	.	0.98574	0.988	.	9.0	0.864914	3.27	0.91	C	single nucleotide variant	NC_000023.11:g.139561836G>C	.	.	1	0.86487466	.	.	0.9766411	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.92786	P	0.96996	P	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.77327	.	.	-	139561836	.	-	4.414000	.	0.87600	.	.	.	.	germline	.	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.96136	GRCh38	924	no assertion criteria provided	c.1151G>C	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)		.	FA9_HUMAN	.	91.0	.	.	D	0.83164	0.97375035	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Arg384Pro	.	0.43370	.	germline	.		G	Aug 04, 2016	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031645	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.113	.	.	0.676	G	.	3.756788	0.35539	.	T	-	.	.	0.97099	.	.	.	0.64392	.	139561836	Y	10	.	.	.	P00740	.	0.844472	0.64520		.	0.626	D	.	0.92917997	.	0.63383	2158	0.41848	.	-2.95	.	.	0.30937	.	.	.	.	.	.	0.92413	X	F9	.	.	Arg	.	.	X-139561836-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA255463|OMIM:300746.0111	.	.	.	RCV000011413	D	.	.	c.1151G>C	.	.	.	0.90875	G/G	rs137852283	139561836	.	G	.	P00740	.	0.98823	.	0.68239		.	.	.	1.8	.	.	.	2.91	0.96374	.	D	T	.	.	.	.	.	.	.	98879	10660	0.90761	0.92541	0.955869972705841	.	.	0.20792	.	.	.	.	1.5	.	D	.	.	.	.	306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.9930344317450107	2	0.51596	0.18019	.	.	.	.	.	YES	.	0.656409	25699	HGNC:3551	A	.	simple_aae	0.776	.	139561836	CGA	1.000000	.	-	.	0.94661	.	.	.	Pathogenic	0.67458	.	.	.	ClinGen:CA255463,OMIM:300746.0111	R	.	0.999870480019	-	0.867	-	0.88450	.	.	0.99298	0.347094744444	0.7086	.	0.99434905878668101	.	-	1151G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.58713	137852283	.	.	0.99986	.	0.576	0.126	.	0.99998236	5.66	.	.	.	0.363341	0.999433055132211	0.47294	T	.	.	.	-0.2094	0.87292	p.Arg384Pro	.	.	-8.889	0.953725	.	0.96580	10660	D	.	F9	.	D	0.614	.	R384P	T	0.59264	0.76753	G/G	principal1	228930	F9_Popp_2025_light_chain_var248105	No											R		1151	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Arg384Pro		true	c.1151G>C						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Arg384Pro						P	Aug 04, 2016					missense_variant		384.0				0.8699484344005443		Pathogenic	139561836.0	missense_variant		0.614					Reporter			F9_Arg384Pro
F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Pro	23	139561836	G	C	X											X-139561836-G-C	-	0.53962	0.811	384	.	.	.	X	138643995	C	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Pro	.	23.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.84859	Select	0.6380	.	0.45417	.	.	D	D	.	1.87772444659	.	.	.	.	.	0.17476	.	.	.	.	0.61611	.	.	0.98574	0.988	.	9.0	0.864914	3.27	0.91	C	single nucleotide variant	NC_000023.11:g.139561836G>C	.	.	1	0.86487466	.	.	0.9766411	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.92786	P	0.96996	P	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.77327	.	.	-	139561836	.	-	4.414000	.	0.87600	.	.	.	.	germline	.	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.96136	GRCh38	924	no assertion criteria provided	c.1151G>C	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)		.	FA9_HUMAN	.	91.0	.	.	D	0.83164	0.97375035	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Arg384Pro	.	0.43370	.	germline	.		G	Aug 04, 2016	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031645	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.113	.	.	0.676	G	.	3.756788	0.35539	.	T	-	.	.	0.97099	.	.	.	0.64392	.	139561836	Y	10	.	.	.	P00740	.	0.844472	0.64520		.	0.626	D	.	0.92917997	.	0.63383	2158	0.41848	.	-2.95	.	.	0.30937	.	.	.	.	.	.	0.92413	X	F9	.	.	Arg	.	.	X-139561836-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA255463|OMIM:300746.0111	.	.	.	RCV000011413	D	.	.	c.1151G>C	.	.	.	0.90875	G/G	rs137852283	139561836	.	G	.	P00740	.	0.98823	.	0.68239		.	.	.	1.8	.	.	.	2.91	0.96374	.	D	T	.	.	.	.	.	.	.	98879	10660	0.90761	0.92541	0.955869972705841	.	.	0.20792	.	.	.	.	1.5	.	D	.	.	.	.	306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.9930344317450107	2	0.51596	0.18019	.	.	.	.	.	YES	.	0.656409	25699	HGNC:3551	A	.	simple_aae	0.776	.	139561836	CGA	1.000000	.	-	.	0.94661	.	.	.	Pathogenic	0.67458	.	.	.	ClinGen:CA255463,OMIM:300746.0111	R	.	0.999870480019	-	0.867	-	0.88450	.	.	0.99298	0.347094744444	0.7086	.	0.99434905878668101	.	-	1151G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.58713	137852283	.	.	0.99986	.	0.576	0.126	.	0.99998236	5.66	.	.	.	0.363341	0.999433055132211	0.47294	T	.	.	.	-0.2094	0.87292	p.Arg384Pro	.	.	-8.889	0.953725	.	0.96580	10660	D	.	F9	.	D	0.614	.	R384P	T	0.59264	0.76753	G/G	principal1	173898	F9_Popp_2025_carboxy_gla_motif_var257786	No											R		1151	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Arg384Pro		true	c.1151G>C						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Arg384Pro						P	Aug 04, 2016					missense_variant		384.0				0.8635991262506653		Pathogenic	139561836.0	missense_variant		0.614					Reporter			F9_Arg384Pro
F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Pro	23	139561836	G	C	X											X-139561836-G-C	-	0.53962	0.811	384	.	.	.	X	138643995	C	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Pro	.	23.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.84859	Select	0.6380	.	0.45417	.	.	D	D	.	1.87772444659	.	.	.	.	.	0.17476	.	.	.	.	0.61611	.	.	0.98574	0.988	.	9.0	0.864914	3.27	0.91	C	single nucleotide variant	NC_000023.11:g.139561836G>C	.	.	1	0.86487466	.	.	0.9766411	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.92786	P	0.96996	P	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.77327	.	.	-	139561836	.	-	4.414000	.	0.87600	.	.	.	.	germline	.	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.96136	GRCh38	924	no assertion criteria provided	c.1151G>C	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)		.	FA9_HUMAN	.	91.0	.	.	D	0.83164	0.97375035	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Arg384Pro	.	0.43370	.	germline	.		G	Aug 04, 2016	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031645	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.113	.	.	0.676	G	.	3.756788	0.35539	.	T	-	.	.	0.97099	.	.	.	0.64392	.	139561836	Y	10	.	.	.	P00740	.	0.844472	0.64520		.	0.626	D	.	0.92917997	.	0.63383	2158	0.41848	.	-2.95	.	.	0.30937	.	.	.	.	.	.	0.92413	X	F9	.	.	Arg	.	.	X-139561836-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA255463|OMIM:300746.0111	.	.	.	RCV000011413	D	.	.	c.1151G>C	.	.	.	0.90875	G/G	rs137852283	139561836	.	G	.	P00740	.	0.98823	.	0.68239		.	.	.	1.8	.	.	.	2.91	0.96374	.	D	T	.	.	.	.	.	.	.	98879	10660	0.90761	0.92541	0.955869972705841	.	.	0.20792	.	.	.	.	1.5	.	D	.	.	.	.	306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.9930344317450107	2	0.51596	0.18019	.	.	.	.	.	YES	.	0.656409	25699	HGNC:3551	A	.	simple_aae	0.776	.	139561836	CGA	1.000000	.	-	.	0.94661	.	.	.	Pathogenic	0.67458	.	.	.	ClinGen:CA255463,OMIM:300746.0111	R	.	0.999870480019	-	0.867	-	0.88450	.	.	0.99298	0.347094744444	0.7086	.	0.99434905878668101	.	-	1151G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.58713	137852283	.	.	0.99986	.	0.576	0.126	.	0.99998236	5.66	.	.	.	0.363341	0.999433055132211	0.47294	T	.	.	.	-0.2094	0.87292	p.Arg384Pro	.	.	-8.889	0.953725	.	0.96580	10660	D	.	F9	.	D	0.614	.	R384P	T	0.59264	0.76753	G/G	principal1	256446	F9_Popp_2025_strep_2_var267467	No											R		1151	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Arg384Pro		true	c.1151G>C						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Arg384Pro						P	Aug 04, 2016					missense_variant		384.0				1.144264790037835		Pathogenic	139561836.0	missense_variant		0.614					Reporter			F9_Arg384Pro
F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	NC_000023.11:139561836:G:C	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Arg384Pro	23	139561836	G	C	X											X-139561836-G-C	-	0.53962	0.811	384	.	.	.	X	138643995	C	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Pro	.	23.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.84859	Select	0.6380	.	0.45417	.	.	D	D	.	1.87772444659	.	.	.	.	.	0.17476	.	.	.	.	0.61611	.	.	0.98574	0.988	.	9.0	0.864914	3.27	0.91	C	single nucleotide variant	NC_000023.11:g.139561836G>C	.	.	1	0.86487466	.	.	0.9766411	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.92786	P	0.96996	P	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.77327	.	.	-	139561836	.	-	4.414000	.	0.87600	.	.	.	.	germline	.	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.96136	GRCh38	924	no assertion criteria provided	c.1151G>C	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)		.	FA9_HUMAN	.	91.0	.	.	D	0.83164	0.97375035	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Arg384Pro	.	0.43370	.	germline	.		G	Aug 04, 2016	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031645	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.113	.	.	0.676	G	.	3.756788	0.35539	.	T	-	.	.	0.97099	.	.	.	0.64392	.	139561836	Y	10	.	.	.	P00740	.	0.844472	0.64520		.	0.626	D	.	0.92917997	.	0.63383	2158	0.41848	.	-2.95	.	.	0.30937	.	.	.	.	.	.	0.92413	X	F9	.	.	Arg	.	.	X-139561836-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA255463|OMIM:300746.0111	.	.	.	RCV000011413	D	.	.	c.1151G>C	.	.	.	0.90875	G/G	rs137852283	139561836	.	G	.	P00740	.	0.98823	.	0.68239		.	.	.	1.8	.	.	.	2.91	0.96374	.	D	T	.	.	.	.	.	.	.	98879	10660	0.90761	0.92541	0.955869972705841	.	.	0.20792	.	.	.	.	1.5	.	D	.	.	.	.	306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.9930344317450107	2	0.51596	0.18019	.	.	.	.	.	YES	.	0.656409	25699	HGNC:3551	A	.	simple_aae	0.776	.	139561836	CGA	1.000000	.	-	.	0.94661	.	.	.	Pathogenic	0.67458	.	.	.	ClinGen:CA255463,OMIM:300746.0111	R	.	0.999870480019	-	0.867	-	0.88450	.	.	0.99298	0.347094744444	0.7086	.	0.99434905878668101	.	-	1151G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.58713	137852283	.	.	0.99986	.	0.576	0.126	.	0.99998236	5.66	.	.	.	0.363341	0.999433055132211	0.47294	T	.	.	.	-0.2094	0.87292	p.Arg384Pro	.	.	-8.889	0.953725	.	0.96580	10660	D	.	F9	.	D	0.614	.	R384P	T	0.59264	0.76753	G/G	principal1	146382	F9_Popp_2025_carboxy_F9_specific_var228743	No											R		1151	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Arg384Pro		true	c.1151G>C						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Arg384Pro						P	Aug 04, 2016					missense_variant		384.0				0.852812671		Pathogenic	139561836.0	missense_variant		0.614					Reporter			F9_Arg384Pro
F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004389		NC_000023.11:139561836:G:C		Arg384Pro																												F9_Arg384Pro	23	139561836	G	C	X	allele	1151G>C	B04	527_CAVA_Array_P02	C08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-C	-	0.53962	0.811	384	.	.	.	X	138643995	C	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Pro	.	23.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.84859	Select	0.6380	.	0.45417	.	.	D	D	.	1.87772444659	.	.	.	.	.	0.17476	.	.	.	.	0.61611	.	.	0.98574	0.988	.	9.0	0.864914	3.27	0.91	C	single nucleotide variant	NC_000023.11:g.139561836G>C	.	.	1	0.86487466	.	.	0.9766411	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.92786	P	0.96996	P	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.77327	.	.	-	139561836	.	-	4.414000	.	0.87600	.	.	.	.	germline	.	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.96136	GRCh38	924	no assertion criteria provided	c.1151G>C	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)		.	FA9_HUMAN	.	91.0	.	.	D	0.83164	0.97375035	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Arg384Pro	.	0.43370	.	germline	.		G	Aug 04, 2016	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031645	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.113	.	.	0.676	G	.	3.756788	0.35539	.	T	-	.	.	0.97099	.	.	.	0.64392	.	139561836	Y	10	.	.	.	P00740	.	0.844472	0.64520		.	0.626	D	.	0.92917997	.	0.63383	2158	0.41848	.	-2.95	.	.	0.30937	.	.	.	.	.	.	0.92413	X	F9	.	.	Arg	.	.	X-139561836-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA255463|OMIM:300746.0111	.	.	.	RCV000011413	D	.	.	c.1151G>C	.	.	.	0.90875	G/G	rs137852283	139561836	.	G	.	P00740	.	0.98823	.	0.68239		.	.	.	1.8	.	.	.	2.91	0.96374	.	D	T	.	.	.	.	.	.	.	98879	10660	0.90761	0.92541	0.955869972705841	.	.	0.20792	.	.	.	.	1.5	.	D	.	.	.	.	306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.9930344317450107	2	0.51596	0.18019	.	.	.	.	.	YES	.	0.656409	25699	HGNC:3551	A	.	simple_aae	0.776	.	139561836	CGA	1.000000	.	-	.	0.94661	.	.	.	Pathogenic	0.67458	.	.	.	ClinGen:CA255463,OMIM:300746.0111	R	.	0.999870480019	-	0.867	-	0.88450	.	.	0.99298	0.347094744444	0.7086	.	0.99434905878668101	.	-	1151G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.58713	137852283	.	.	0.99986	.	0.576	0.126	.	0.99998236	5.66	.	.	.	0.363341	0.999433055132211	0.47294	T	.	.	.	-0.2094	0.87292	p.Arg384Pro	.	.	-8.889	0.953725	.	0.96580	10660	D	.	F9	.	D	0.614	.	R384P	T	0.59264	0.76753	G/G	principal1	201414	F9_Popp_2025_heavy_chain_var238424	No											R		1151	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Arg384Pro		true	c.1151G>C						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Arg384Pro						P	Aug 04, 2016					missense_variant		384.0				0.9618802619983524		Pathogenic	139561836.0	missense_variant		0.614					Reporter			F9_Arg384Pro
F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004389		NC_000023.11:139561836:G:C		Arg384Pro																												F9_Arg384Pro	23	139561836	G	C	X	allele	1151G>C	B04	527_CAVA_Array_P02	C08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-C	-	0.53962	0.811	384	.	.	.	X	138643995	C	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Pro	.	23.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.84859	Select	0.6380	.	0.45417	.	.	D	D	.	1.87772444659	.	.	.	.	.	0.17476	.	.	.	.	0.61611	.	.	0.98574	0.988	.	9.0	0.864914	3.27	0.91	C	single nucleotide variant	NC_000023.11:g.139561836G>C	.	.	1	0.86487466	.	.	0.9766411	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.92786	P	0.96996	P	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.77327	.	.	-	139561836	.	-	4.414000	.	0.87600	.	.	.	.	germline	.	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.96136	GRCh38	924	no assertion criteria provided	c.1151G>C	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)		.	FA9_HUMAN	.	91.0	.	.	D	0.83164	0.97375035	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Arg384Pro	.	0.43370	.	germline	.		G	Aug 04, 2016	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031645	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.113	.	.	0.676	G	.	3.756788	0.35539	.	T	-	.	.	0.97099	.	.	.	0.64392	.	139561836	Y	10	.	.	.	P00740	.	0.844472	0.64520		.	0.626	D	.	0.92917997	.	0.63383	2158	0.41848	.	-2.95	.	.	0.30937	.	.	.	.	.	.	0.92413	X	F9	.	.	Arg	.	.	X-139561836-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA255463|OMIM:300746.0111	.	.	.	RCV000011413	D	.	.	c.1151G>C	.	.	.	0.90875	G/G	rs137852283	139561836	.	G	.	P00740	.	0.98823	.	0.68239		.	.	.	1.8	.	.	.	2.91	0.96374	.	D	T	.	.	.	.	.	.	.	98879	10660	0.90761	0.92541	0.955869972705841	.	.	0.20792	.	.	.	.	1.5	.	D	.	.	.	.	306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.9930344317450107	2	0.51596	0.18019	.	.	.	.	.	YES	.	0.656409	25699	HGNC:3551	A	.	simple_aae	0.776	.	139561836	CGA	1.000000	.	-	.	0.94661	.	.	.	Pathogenic	0.67458	.	.	.	ClinGen:CA255463,OMIM:300746.0111	R	.	0.999870480019	-	0.867	-	0.88450	.	.	0.99298	0.347094744444	0.7086	.	0.99434905878668101	.	-	1151G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.58713	137852283	.	.	0.99986	.	0.576	0.126	.	0.99998236	5.66	.	.	.	0.363341	0.999433055132211	0.47294	T	.	.	.	-0.2094	0.87292	p.Arg384Pro	.	.	-8.889	0.953725	.	0.96580	10660	D	.	F9	.	D	0.614	.	R384P	T	0.59264	0.76753	G/G	principal1	228930	F9_Popp_2025_light_chain_var248105	No											R		1151	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Arg384Pro		true	c.1151G>C						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Arg384Pro						P	Aug 04, 2016					missense_variant		384.0				0.8699484344005443		Pathogenic	139561836.0	missense_variant		0.614					Reporter			F9_Arg384Pro
F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004389		NC_000023.11:139561836:G:C		Arg384Pro																												F9_Arg384Pro	23	139561836	G	C	X	allele	1151G>C	B04	527_CAVA_Array_P02	C08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-C	-	0.53962	0.811	384	.	.	.	X	138643995	C	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Pro	.	23.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.84859	Select	0.6380	.	0.45417	.	.	D	D	.	1.87772444659	.	.	.	.	.	0.17476	.	.	.	.	0.61611	.	.	0.98574	0.988	.	9.0	0.864914	3.27	0.91	C	single nucleotide variant	NC_000023.11:g.139561836G>C	.	.	1	0.86487466	.	.	0.9766411	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.92786	P	0.96996	P	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.77327	.	.	-	139561836	.	-	4.414000	.	0.87600	.	.	.	.	germline	.	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.96136	GRCh38	924	no assertion criteria provided	c.1151G>C	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)		.	FA9_HUMAN	.	91.0	.	.	D	0.83164	0.97375035	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Arg384Pro	.	0.43370	.	germline	.		G	Aug 04, 2016	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031645	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.113	.	.	0.676	G	.	3.756788	0.35539	.	T	-	.	.	0.97099	.	.	.	0.64392	.	139561836	Y	10	.	.	.	P00740	.	0.844472	0.64520		.	0.626	D	.	0.92917997	.	0.63383	2158	0.41848	.	-2.95	.	.	0.30937	.	.	.	.	.	.	0.92413	X	F9	.	.	Arg	.	.	X-139561836-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA255463|OMIM:300746.0111	.	.	.	RCV000011413	D	.	.	c.1151G>C	.	.	.	0.90875	G/G	rs137852283	139561836	.	G	.	P00740	.	0.98823	.	0.68239		.	.	.	1.8	.	.	.	2.91	0.96374	.	D	T	.	.	.	.	.	.	.	98879	10660	0.90761	0.92541	0.955869972705841	.	.	0.20792	.	.	.	.	1.5	.	D	.	.	.	.	306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.9930344317450107	2	0.51596	0.18019	.	.	.	.	.	YES	.	0.656409	25699	HGNC:3551	A	.	simple_aae	0.776	.	139561836	CGA	1.000000	.	-	.	0.94661	.	.	.	Pathogenic	0.67458	.	.	.	ClinGen:CA255463,OMIM:300746.0111	R	.	0.999870480019	-	0.867	-	0.88450	.	.	0.99298	0.347094744444	0.7086	.	0.99434905878668101	.	-	1151G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.58713	137852283	.	.	0.99986	.	0.576	0.126	.	0.99998236	5.66	.	.	.	0.363341	0.999433055132211	0.47294	T	.	.	.	-0.2094	0.87292	p.Arg384Pro	.	.	-8.889	0.953725	.	0.96580	10660	D	.	F9	.	D	0.614	.	R384P	T	0.59264	0.76753	G/G	principal1	173898	F9_Popp_2025_carboxy_gla_motif_var257786	No											R		1151	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Arg384Pro		true	c.1151G>C						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Arg384Pro						P	Aug 04, 2016					missense_variant		384.0				0.8635991262506653		Pathogenic	139561836.0	missense_variant		0.614					Reporter			F9_Arg384Pro
F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004389		NC_000023.11:139561836:G:C		Arg384Pro																												F9_Arg384Pro	23	139561836	G	C	X	allele	1151G>C	B04	527_CAVA_Array_P02	C08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-C	-	0.53962	0.811	384	.	.	.	X	138643995	C	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Pro	.	23.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.84859	Select	0.6380	.	0.45417	.	.	D	D	.	1.87772444659	.	.	.	.	.	0.17476	.	.	.	.	0.61611	.	.	0.98574	0.988	.	9.0	0.864914	3.27	0.91	C	single nucleotide variant	NC_000023.11:g.139561836G>C	.	.	1	0.86487466	.	.	0.9766411	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.92786	P	0.96996	P	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.77327	.	.	-	139561836	.	-	4.414000	.	0.87600	.	.	.	.	germline	.	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.96136	GRCh38	924	no assertion criteria provided	c.1151G>C	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)		.	FA9_HUMAN	.	91.0	.	.	D	0.83164	0.97375035	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Arg384Pro	.	0.43370	.	germline	.		G	Aug 04, 2016	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031645	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.113	.	.	0.676	G	.	3.756788	0.35539	.	T	-	.	.	0.97099	.	.	.	0.64392	.	139561836	Y	10	.	.	.	P00740	.	0.844472	0.64520		.	0.626	D	.	0.92917997	.	0.63383	2158	0.41848	.	-2.95	.	.	0.30937	.	.	.	.	.	.	0.92413	X	F9	.	.	Arg	.	.	X-139561836-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA255463|OMIM:300746.0111	.	.	.	RCV000011413	D	.	.	c.1151G>C	.	.	.	0.90875	G/G	rs137852283	139561836	.	G	.	P00740	.	0.98823	.	0.68239		.	.	.	1.8	.	.	.	2.91	0.96374	.	D	T	.	.	.	.	.	.	.	98879	10660	0.90761	0.92541	0.955869972705841	.	.	0.20792	.	.	.	.	1.5	.	D	.	.	.	.	306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.9930344317450107	2	0.51596	0.18019	.	.	.	.	.	YES	.	0.656409	25699	HGNC:3551	A	.	simple_aae	0.776	.	139561836	CGA	1.000000	.	-	.	0.94661	.	.	.	Pathogenic	0.67458	.	.	.	ClinGen:CA255463,OMIM:300746.0111	R	.	0.999870480019	-	0.867	-	0.88450	.	.	0.99298	0.347094744444	0.7086	.	0.99434905878668101	.	-	1151G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.58713	137852283	.	.	0.99986	.	0.576	0.126	.	0.99998236	5.66	.	.	.	0.363341	0.999433055132211	0.47294	T	.	.	.	-0.2094	0.87292	p.Arg384Pro	.	.	-8.889	0.953725	.	0.96580	10660	D	.	F9	.	D	0.614	.	R384P	T	0.59264	0.76753	G/G	principal1	256446	F9_Popp_2025_strep_2_var267467	No											R		1151	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Arg384Pro		true	c.1151G>C						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Arg384Pro						P	Aug 04, 2016					missense_variant		384.0				1.144264790037835		Pathogenic	139561836.0	missense_variant		0.614					Reporter			F9_Arg384Pro
F9_Arg384Pro	-3.6845709938138382	0.007812380013432871	3.0708156160011555	0.018046802699958293	2025_01_Batch_13-14	0.5373757644945938	0.5822627811327424	0.6515171411520758	0.6578265106439414	0.4497192100803939	0.46120986089648197	0.5154848989713752	0.6385454776595112	0.6399176903188355	0.45680744584274763	0.4992928126955379	0.5488738400520587	0.6450313094057936	0.6488721004813884	0.45326332796157076	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004389		NC_000023.11:139561836:G:C		Arg384Pro																												F9_Arg384Pro	23	139561836	G	C	X	allele	1151G>C	B04	527_CAVA_Array_P02	C08	B13A7A8P1_R1	B14A7A8P1_R2				X-139561836-G-C	-	0.53962	0.811	384	.	.	.	X	138643995	C	.	.	X	1_Pathogenic	NC_000023.11	.	Arg384Pro	.	23.4	.	.	.	D	.	1	1	.	.	.	.	.	.	0.84859	Select	0.6380	.	0.45417	.	.	D	D	.	1.87772444659	.	.	.	.	.	0.17476	.	.	.	.	0.61611	.	.	0.98574	0.988	.	9.0	0.864914	3.27	0.91	C	single nucleotide variant	NC_000023.11:g.139561836G>C	.	.	1	0.86487466	.	.	0.9766411	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.92786	P	0.96996	P	L	.	.	G/G	.	.	.	.	Hereditary factor IX deficiency disease	.	0.77327	.	.	-	139561836	.	-	4.414000	.	0.87600	.	.	.	.	germline	.	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.96136	GRCh38	924	no assertion criteria provided	c.1151G>C	.	0.32820	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)		.	FA9_HUMAN	.	91.0	.	.	D	0.83164	0.97375035	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99989	.	.	.	.	.	p.Arg384Pro	.	0.43370	.	germline	.		G	Aug 04, 2016	.	G/G	.	.	0.035	N	Xq27.1	.	.	.	SCV000031645	Pathogenic	.	.	Pro	P	-	.	ENSP00000218099	ENST00000218099	.	0.113	.	.	0.676	G	.	3.756788	0.35539	.	T	-	.	.	0.97099	.	.	.	0.64392	.	139561836	Y	10	.	.	.	P00740	.	0.844472	0.64520		.	0.626	D	.	0.92917997	.	0.63383	2158	0.41848	.	-2.95	.	.	0.30937	.	.	.	.	.	.	0.92413	X	F9	.	.	Arg	.	.	X-139561836-G-C	Hereditary_factor_IX_deficiency_disease	.	.	138471661	ClinGen:CA255463|OMIM:300746.0111	.	.	.	RCV000011413	D	.	.	c.1151G>C	.	.	.	0.90875	G/G	rs137852283	139561836	.	G	.	P00740	.	0.98823	.	0.68239		.	.	.	1.8	.	.	.	2.91	0.96374	.	D	T	.	.	.	.	.	.	.	98879	10660	0.90761	0.92541	0.955869972705841	.	.	0.20792	.	.	.	.	1.5	.	D	.	.	.	.	306900	0.35396	X	.	ENSG00000101981	.	.	.	.	0.9930344317450107	2	0.51596	0.18019	.	.	.	.	.	YES	.	0.656409	25699	HGNC:3551	A	.	simple_aae	0.776	.	139561836	CGA	1.000000	.	-	.	0.94661	.	.	.	Pathogenic	0.67458	.	.	.	ClinGen:CA255463,OMIM:300746.0111	R	.	0.999870480019	-	0.867	-	0.88450	.	.	0.99298	0.347094744444	0.7086	.	0.99434905878668101	.	-	1151G>C 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.58713	137852283	.	.	0.99986	.	0.576	0.126	.	0.99998236	5.66	.	.	.	0.363341	0.999433055132211	0.47294	T	.	.	.	-0.2094	0.87292	p.Arg384Pro	.	.	-8.889	0.953725	.	0.96580	10660	D	.	F9	.	D	0.614	.	R384P	T	0.59264	0.76753	G/G	principal1	146382	F9_Popp_2025_carboxy_F9_specific_var228743	No											R		1151	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Arg384Pro		true	c.1151G>C						3551.0	139561836.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Arg384Pro						P	Aug 04, 2016					missense_variant		384.0				0.852812671		Pathogenic	139561836.0	missense_variant		0.614					Reporter			F9_Arg384Pro
BRCA1_Cys61Gly	0.9686368160707995	0.36499496144588084	4.370983692104869	0.003270140985358988	2025_01_Batch_13-14	0.9816626134163466	0.9382680897369753	0.9381794369642189	0.9675114203479335	0.8882441185541432	0.94979174340731	0.83386982555295	0.8932073113961976	0.9429165361361207	0.9062998562885225	0.9657271784118283	0.8860689576449626	0.9156933741802082	0.955213978242027	0.8972719874213329	1.0	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	1.0	BRCA1	BRCA1		14613		CCSBVarC011874		NC_000017.11:43106487:A:C		Cys61Gly																												BRCA1_Cys61Gly	17	43106487	A	C	17	allele	181T>G	D10	527_CAVA_Array_P01	G19	B13A7A8P1_R1	B14A7A8P1_R2				17-43106487-A-C	-	0.62863	0.116	61	6	0	0	17	41258504	C	1.869370e-05	0	17	1_Pathogenic	NC_000017.11	28	Cys61Gly	0	24.5	0	0	4.877570e-05	D	0	59	1	42724	2.539400e-05	.	30366	0.000000e+00	0	0.98989	.	0.9929	102510	0.77914	0	.	T	D	63978	.	0	0	0.000000e+00	0	0	0.59765	17022	44766	0	0.000000e+00	0.99397	3	.	0.99313	0.995	.	.	.	5.61	.	C	single nucleotide variant	NC_000017.11:g.43106487A>C	0	16718	3	0.9264142	109170	0	0.9937476	0		7	236276	0	0	0.000000e+00	154	7.021810e-05	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|Human Phenotype Ontology:HP:0003002,MONDO:MONDO:0004989,MedGen:C0678222|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757	4	1	0.000000e+00	0	0.99291	B	0.98025	B	H	9.572342	30	A/A	144	0	7152	1604818	Breast-ovarian cancer, familial, susceptibility to, 1|Breast carcinoma|not provided|Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm|Breast and/or ovarian cancer|Ovarian neoplasm|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition	16132	0.96392	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106487	7.021810e-05	-	11.169000	0	0.99450	29524	0	1172588	0	germline;not applicable;somatic;unknown	90418	Gain of disorder (P = 0.0488)| Loss of stability (P = 0.105)| Gain of phosphorylation at S59 (P = 0.1362)| Loss of methylation at K56 (P = 0.1519)| Gain of glycosylation at P62 (P = 0.1609)	0.99946	GRCh38	459	reviewed by expert panel	c.181T>G	0.000000e+00	0.70808	0	0	0	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	5.981580e-05	9042	LP	0	0.000000e+00	NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)	3	0	BRCA1_HUMAN	0	.	0.838128507262834	0	.	0.94756	0.98292416	-	0.000000e+00	.		6	0.000000e+00	0	34140	reviewed_by_expert_panel	0.99726	3.664010e-05	0	7.468260e-05	0	59940	p.Cys61Gly	0	0.87924	.	germline/somatic	3		A	Aug 10, 2015	0	A/A	0	89312	1.0	N	17q21.31	10344	.	0.000000e+00	SCV000244308	Pathogenic	1	0	Gly	G	-	912	ENSP00000419103	ENST00000494123	17674	0.0	13404	0	0.667	A	0	4.174515	0.92967	D	D	-	8.62807	.	0.99761	616	0	.	0.75212	0	43106487	Y	10	0	102510	0.000000e+00	P38398	0	0.479885	0.42557		0	0.026	D	89312	0.9444327	42724	0.73271	672	0.433365	28	-2.81	.	2.387880e-05	0.91343	0.000000e+00	0	74730	0.000000e+00	5856	0	0.96801	17	BRCA1	0.000000e+00	0	Cys	16646	6.718020e-05	17-43106487-A-C	Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided|Pancreatic_cancer,_susceptibility_to,_4|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_carcinoma|Breast_neoplasm|Ovarian_neoplasm	0	5	38512030	BRCA1-HCI:BRCA1_00099|ClinGen:CA001182|OMIM:113705.0002|UniProtKB:P38398#VAR_007757	0.869181	0.88357	0	RCV000019229|RCV000415051|RCV000159935|RCV000239114|RCV000047597|RCV000131902|RCV000412714|RCV001270967|RCV000785199|RCV005003390|RCV004802937	D	0	0	c.181T>G	0	0	1	0.91638	A/A	rs28897672	43106487	14822	A	.	E9PFC7	15618	0.99925	4.626630e-05	0.68239		0	0	0.000000e+00	4.355	0	0	264690	5.17	0.92979	116	D	T	0	0.000000e+00	0	28	.	0	1	145|227535|140162|1333|145	17661	0.95972	0.44456	0.983885645866394	4458	.	0.71675	0.78883	0.000000e+00	6.718020e-05	1172588	5.098	3.373980e-05	D	13390	0	1.51120175E-5	0	604370|114480|614320|617883	0.64462	17	0.000000e+00	ENSG00000012048	1.563040e-05	0	0	0	.	1	0.82066	0.78836	30448	4	4.877570e-05	0.000000e+00	0.742507123425794	.	0.000000e+00	0.963103	32700	HGNC:1100	.	0	.	0.984	207470	43106487	TGT	1.000000	.	-	0	0.99706	2.387880e-05	0	0	Pathogenic	0.98194	0	0	0	OMIM:113705.0002,BRCA1-HCI:BRCA1_00099,ClinGen:CA001182,UniProtKB:P38398#VAR_007757	C	0	0.998499671764	-	0.995	-	0.99781	6	860	0.90513	0.648884236813	0.9865	0	0.98518170788822967	98	-	181T>G 	5	0	C2676676|C0346153|C0027672|CN221562|C3661900|C3280442|C4554406|C0677776|C0678222|C1458155|C0919267	0	0	0	0	NM_007294.4	-	.	.	1	0.85963	28897672	2310	0	0.99845	0.85517	.	0.0	4314	0.99978560	5.17	.	.	0.000000e+00	0.565018	0.998778029465221	0.98454	D	88	6194	9556	0.9506	0.99832	p.Cys61Gly	0	0	-14.65	0.99176705	0	0.95035	17661	D	30412	BRCA1	0.000000e+00	D	0.948	21614	C61G	D	0.95042	0.69024	A/A	principal2																																																																																																				
RET_Arg313Gln	-2.285823693071175	0.05615212771343529	5.8231339538018	0.0006480669481361119	2025_01_Batch_13-14	0.9161398862175612	0.8072101041676472	0.7295364397706064	0.7379005221049658	0.9027683134943302	0.7932106296157397	0.8362920594514416	0.8350719839598196	0.8951382626290518	0.6446830720386535	0.8546752579166504	0.8217510818095444	0.782304211865213	0.8165193923670089	0.7737256927664918	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET	ENSG00000165731	8858	202958	CCSBVarC006882	ALE00006880	NC_000010.11:43106446:G:A	938G>A	Arg313Gln	CEGS2	CegsMutGDEh1024	A02	GDEhDisVCh_40066	A05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Arg313Gln	10	43106446	G	A	10											10-43106446-G-A	-	0.49142	0.943	313	1	1	0	10	43601894	A	2.789270e-05	13	10	4_VUS	NC_000010.11	30	Arg313Gln	0	22.7	0	1	7.625980e-04	T	0	8	5	42460	1.276820e-04	.	30362	0.000000e+00	0	0.81390	Select	0.3274	34094	0.56216	26	.	T	T	63780	0.306023030952	2.628811777076761E-4	0	1.047120e-04	0	0	0.25557	17006	44874	2	0.000000e+00	0.18812	0	.	0.39154	0.71	.	36.0	0.875612	2.0	0.64	A	single nucleotide variant	NC_000010.11:g.43106446G>A	0	16628	3	0.08550162	108632	0	0.2721727	0	A	26	234958	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653;MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361|MedGen:C3661900	13	0	0.000000e+00	0	0.79151	B	0.32442	P	M	2.784067	45	G/G	122	0	7066	1613324	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Multiple endocrine neoplasia type 2B;Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Familial medullary thyroid carcinoma|not provided	15982	0.64360	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106446	7.644360e-04	-	6.435000	0	0.67864	29586	0	59952	0	germline;unknown	90976	Gain of sheet (P = 0.0049)| Gain of loop (P = 0.0312)| Loss of stability (P = 0.1084)| Loss of phosphorylation at T315 (P = 0.1211)| Gain of glycosylation at S316 (P = 0.2382)	0.85693	GRCh38	862	criteria provided, multiple submitters, no conflicts	c.938G>A	0.000000e+00	0.26894	1	0	1	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	0.000000e+00	8992	B	0	3.379980e-05	NM_020975.6(RET):c.938G>A (p.Arg313Gln)	2	0	RET_HUMAN	0	64.0	0.0737859261210792	24	D	0.33018	0.18244144	+	0.000000e+00	.	0.0000287445	24	1.622850e-04	0	34094	criteria_provided,_multiple_submitters,_no_conflicts	0.99505	1.196700e-04	0	0.000000e+00	0	59952	p.Arg313Gln	0	0.55709	.	germline	13	43106446	G	Jan 24, 2025	0	G/G	0	88370	0.959	N	10q11.21	15826	.	0.000000e+00	SCV000674841|SCV000776486|SCV000785424|SCV000896054|SCV003798648|SCV004018491|SCV005623124	Uncertain_significance	0	1	Gln	Q	-	912	ENSP00000347942	ENST00000355710	17626	0.017	13304	0	0.672	G	0	3.504925	0.36834	N	T	-	2.600265	.	0.81879	610	0	.	0.17507	0	43106446	Y	10	0	101936	0.000000e+00	P07949	0	0.452479	0.96668	G	0	0.173	D	30344	0.13592933	17006	0.34491	5979	-0.102543	9	-0.65	.	5.004000e-04	0.51407	0.000000e+00	0	74906	0.000000e+00	6052	0	0.19721	10	RET	1.335010e-05	0	Arg	23690	1.131610e-05	10-43106446-G-A	Multiple_endocrine_neoplasia,_type_2|not_provided|Pheochromocytoma|Hirschsprung_disease,_susceptibility_to,_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hereditary_cancer-predisposing_syndrome	0	2	42921900	ClinGen:CA009384|OMIM:164761.0028|UniProtKB:P07949#VAR_009465	0.080145	0.44985	0	RCV000014957|RCV000662693|RCV000654592|RCV000566081|RCV002476968|RCV003114192	T	0	0	c.938G>A	0	0	0	0.35646	G/G	rs77702891	43106446	14734	G	.	P07949	15588	0.49956	0.000000e+00	0.68239	10	0	0	0.000000e+00	2.44	0	0	264690	2.2	0.79124	202	T	T	0	7.909310e-04	0	56	.	0	0	653|29072|388|653|99361|247698|653|247709|653|140162	13932	0.69996	0.32606	0.158066955150649	3926	.	0.33632	0.16005	7.625980e-04	7.909310e-04	1179830	2.392	1.261810e-04	N	13308	0	6.044807E-5	0	171300|142623|155240|171400|162300	0.44189	10	0.000000e+00	ENSG00000165731	0.000000e+00	0	0	0	0.8295473270931635	2	0.45142	0.33096	30438	16	1.962020e-05	5.004000e-04	0.0662528309478524	YES	2.198380e-05	0.13682	28971	HGNC:9967	D	0	simple_aae	0.446	206054	43106446	CGG	1.000000	.	-	2.5471217524197657E-4	0.39382	7.628220e-06	1	0	Uncertain significance	0.26502	0	0	30	ClinGen:CA009384,UniProtKB:P07949#VAR_009465,OMIM:164761.0028	R	0	0.928844329528	-	0.723	-	0.48537	30	2876	0.82810	0.403721630573	0.1404	0	0.9989321191735554	104	-	938G>A 	26	0	C4048306|C3661900|C0031511|C3888239|C1833921|C0025268|C0025269|C0027672	0	0	0	0	NM_020975.6	-	.	.	0	0.58615	77702891	2304	4.2211903756859436E-5	0.92757	0.42582	0.45	0.116	3804	0.99958426	5.32	.	.	0.000000e+00	-0.0018559	0.547894901457323	0.70564	T	146	6162	9550	-0.6073	0.69436	p.Arg313Gln	0	0	-4.117	0.22862077	1	0.62233	13932	T	30344	RET	7.644360e-04	D	0.552	21064	R313Q	D	0.39643	0.70176	G/G	principal4																																																																																																				
RET_Arg313Gln	-2.285823693071175	0.05615212771343529	5.8231339538018	0.0006480669481361119	2025_01_Batch_13-14	0.9161398862175612	0.8072101041676472	0.7295364397706064	0.7379005221049658	0.9027683134943302	0.7932106296157397	0.8362920594514416	0.8350719839598196	0.8951382626290518	0.6446830720386535	0.8546752579166504	0.8217510818095444	0.782304211865213	0.8165193923670089	0.7737256927664918	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET		8858		CCSBVarC006882		NC_000010.11:43106446:G:A		Arg313Gln																												RET_Arg313Gln	10	43106446	G	A	10	allele	938G>A	A09	527_CAVA_Array_P05	A17	B13A7A8P2_R1	B14A7A8P2_R2				10-43106446-G-A	-	0.49142	0.943	313	1	1	0	10	43601894	A	2.789270e-05	13	10	4_VUS	NC_000010.11	30	Arg313Gln	0	22.7	0	1	7.625980e-04	T	0	8	5	42460	1.276820e-04	.	30362	0.000000e+00	0	0.81390	Select	0.3274	34094	0.56216	26	.	T	T	63780	0.306023030952	2.628811777076761E-4	0	1.047120e-04	0	0	0.25557	17006	44874	2	0.000000e+00	0.18812	0	.	0.39154	0.71	.	36.0	0.875612	2.0	0.64	A	single nucleotide variant	NC_000010.11:g.43106446G>A	0	16628	3	0.08550162	108632	0	0.2721727	0	A	26	234958	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072;MONDO:MONDO:0008082,MeSH:D018814,MedGen:C0025269,OMIM:162300,Orphanet:247709,Orphanet:653;MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388;MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653;MONDO:MONDO:0007958,MedGen:C1833921,OMIM:155240,Orphanet:653,Orphanet:99361|MedGen:C3661900	13	0	0.000000e+00	0	0.79151	B	0.32442	P	M	2.784067	45	G/G	122	0	7066	1613324	Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Pheochromocytoma;Multiple endocrine neoplasia type 2B;Hirschsprung disease, susceptibility to, 1;Multiple endocrine neoplasia type 2A;Familial medullary thyroid carcinoma|not provided	15982	0.64360	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106446	7.644360e-04	-	6.435000	0	0.67864	29586	0	59952	0	germline;unknown	90976	Gain of sheet (P = 0.0049)| Gain of loop (P = 0.0312)| Loss of stability (P = 0.1084)| Loss of phosphorylation at T315 (P = 0.1211)| Gain of glycosylation at S316 (P = 0.2382)	0.85693	GRCh38	862	criteria provided, multiple submitters, no conflicts	c.938G>A	0.000000e+00	0.26894	1	0	1	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	0.000000e+00	8992	B	0	3.379980e-05	NM_020975.6(RET):c.938G>A (p.Arg313Gln)	2	0	RET_HUMAN	0	64.0	0.0737859261210792	24	D	0.33018	0.18244144	+	0.000000e+00	.	0.0000287445	24	1.622850e-04	0	34094	criteria_provided,_multiple_submitters,_no_conflicts	0.99505	1.196700e-04	0	0.000000e+00	0	59952	p.Arg313Gln	0	0.55709	.	germline	13	43106446	G	Jan 24, 2025	0	G/G	0	88370	0.959	N	10q11.21	15826	.	0.000000e+00	SCV000674841|SCV000776486|SCV000785424|SCV000896054|SCV003798648|SCV004018491|SCV005623124	Uncertain_significance	0	1	Gln	Q	-	912	ENSP00000347942	ENST00000355710	17626	0.017	13304	0	0.672	G	0	3.504925	0.36834	N	T	-	2.600265	.	0.81879	610	0	.	0.17507	0	43106446	Y	10	0	101936	0.000000e+00	P07949	0	0.452479	0.96668	G	0	0.173	D	30344	0.13592933	17006	0.34491	5979	-0.102543	9	-0.65	.	5.004000e-04	0.51407	0.000000e+00	0	74906	0.000000e+00	6052	0	0.19721	10	RET	1.335010e-05	0	Arg	23690	1.131610e-05	10-43106446-G-A	Multiple_endocrine_neoplasia,_type_2|not_provided|Pheochromocytoma|Hirschsprung_disease,_susceptibility_to,_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia_type_2A|Multiple_endocrine_neoplasia_type_2B|Hereditary_cancer-predisposing_syndrome	0	2	42921900	ClinGen:CA009384|OMIM:164761.0028|UniProtKB:P07949#VAR_009465	0.080145	0.44985	0	RCV000014957|RCV000662693|RCV000654592|RCV000566081|RCV002476968|RCV003114192	T	0	0	c.938G>A	0	0	0	0.35646	G/G	rs77702891	43106446	14734	G	.	P07949	15588	0.49956	0.000000e+00	0.68239	10	0	0	0.000000e+00	2.44	0	0	264690	2.2	0.79124	202	T	T	0	7.909310e-04	0	56	.	0	0	653|29072|388|653|99361|247698|653|247709|653|140162	13932	0.69996	0.32606	0.158066955150649	3926	.	0.33632	0.16005	7.625980e-04	7.909310e-04	1179830	2.392	1.261810e-04	N	13308	0	6.044807E-5	0	171300|142623|155240|171400|162300	0.44189	10	0.000000e+00	ENSG00000165731	0.000000e+00	0	0	0	0.8295473270931635	2	0.45142	0.33096	30438	16	1.962020e-05	5.004000e-04	0.0662528309478524	YES	2.198380e-05	0.13682	28971	HGNC:9967	D	0	simple_aae	0.446	206054	43106446	CGG	1.000000	.	-	2.5471217524197657E-4	0.39382	7.628220e-06	1	0	Uncertain significance	0.26502	0	0	30	ClinGen:CA009384,UniProtKB:P07949#VAR_009465,OMIM:164761.0028	R	0	0.928844329528	-	0.723	-	0.48537	30	2876	0.82810	0.403721630573	0.1404	0	0.9989321191735554	104	-	938G>A 	26	0	C4048306|C3661900|C0031511|C3888239|C1833921|C0025268|C0025269|C0027672	0	0	0	0	NM_020975.6	-	.	.	0	0.58615	77702891	2304	4.2211903756859436E-5	0.92757	0.42582	0.45	0.116	3804	0.99958426	5.32	.	.	0.000000e+00	-0.0018559	0.547894901457323	0.70564	T	146	6162	9550	-0.6073	0.69436	p.Arg313Gln	0	0	-4.117	0.22862077	1	0.62233	13932	T	30344	RET	7.644360e-04	D	0.552	21064	R313Q	D	0.39643	0.70176	G/G	principal4																																																																																																				
BRCA1_Met1Ile	6.765004300970164	0.0002614050448425321	-8.007642466557492	0.0000905951237529456	2025_01_Batch_13-14	0.965432133065669	0.9708351231137582	0.9923100505613676	0.9890790736252655	0.9369278802773922	0.942537676845391	0.9128446786942379	0.9834795160559991	0.9841944238913661	0.876088559150052	0.95398490495553	0.941839900903998	0.9878947833086833	0.9866367487583159	0.9065082197137221	1.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	BRCA1	BRCA1		14613		CCSBVarC003295		NC_000017.11:43124094:C:A		Met1Ile																												BRCA1_Met1Ile	17	43124094	C	A	17	allele	3G>T	E06	527_CAVA_Array_P01	I11	B13A7A8P1_R1	B14A7A8P1_R2				17-43124094-C-A	-	0.62186	0.924	1	.	0	.	17	41276111	A	6.202850e-07	.	17	1_Pathogenic	NC_000017.11	1	Met1Ile	.	24.4	.	.	.	D	0	10	1	.	.	.	.	.	.	0.88959	.	0.7099	.	0.51298	.	.	T	D	64006	.	.	0	.	.	.	.	.	44826	0	.	0.54406	.	.	0.91737	0.255	.	.	.	.	.	A	single nucleotide variant	NC_000017.11:g.43124094C>A	0	.	2	0.64797	.	.	0.90739095	.	A	.	.	.	.	.	.	.	.	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MedGen:C3661900	.	.	0.000000e+00	0	0.99291	P	0.82542	P	.	4.029269	1	C/C	.	.	.	1612162	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|not provided	.	0.90822	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43124094	.	-	3.191000	.	.	29594	.	1178330	.	germline;not applicable;unknown	91032	Gain of catalytic residue at M1 (P = 0.0314)| Loss of disorder (P = 0.1193)| Loss of loop (P = 0.1242)| Gain of helix (P = 0.2684)| Loss of phosphorylation at S4 (P = 0.3332)	0.99957	GRCh38	469	reviewed by expert panel	c.3G>T	.	0.43219	.	.	.	.	.	.	.	.	0.000000e+00	NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	3	.	BRCA1_HUMAN	.	.	0.34664899273018	.	.	.	0.9052275	-	.	.	6.84988e-7	.	.	0	.	reviewed_by_expert_panel	0.99470	.	0	.	.	60018	p.Met1?	0	0.36784	.	germline	.	43124094	C	Jun 18, 2019	.	C/C	.	.	1.0	N	17q21.31	.	.	.	SCV001161632	Pathogenic	.	.	Ile	I	-	912	ENSP00000419274	ENST00000470026	.	0.0	.	.	-0.284	C	.	4.144486	0.92967	N	D	-	3.791295	.	0.99511	.	.	.	0.89105	.	43124094	Y	9	.	.	0.000000e+00	P38398	.	0.280176	0.76291	C	.	0.878	D	.	0.707353	.	0.23438	672	0.398321	1	-0.56	.	8.486590e-07	0.91343	.	.	74994	.	6024	.	0.79185	17	BRCA1	0.000000e+00	.	Met	.	.	17-43124094-C-A	Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_breast_ovarian_cancer_syndrome	0	.	38529637	ClinGen:CA002562	0.062568	0.58348	0	RCV000048405|RCV000111552|RCV000131890|RCV000763402|RCV001357041	D	0	.	c.3G>T	.	0	0	0.89744	C/C	rs80357475	43124094	.	C	.	E9PFC7	.	0.91937	.	0.68239	17	.	.	0.000000e+00	.	.	.	.	3.83	0.65093	.	D	.	.	.	.	.	.	.	.	140162|227535|145|1333|145	55072	0.89616	.	0.996361911296844	.	.	0.71675	0.11864	.	.	1178330	3.426	.	N	.	.	.	.	114480|617883|604370|614320	0.52638	17	.	ENSG00000012048	0.000000e+00	.	.	.	.	3	0.62305	0.78193	.	.	.	0.000000e+00	0.312639291828477	.	0.000000e+00	0.932498	69739	HGNC:1100	.	.	.	.	.	43124094	ATG	1.000000	.	-	.	0.99089	8.486590e-07	.	0	Pathogenic	0.90483	.	0	0	ClinGen:CA002562	M	.	0.887736870969	-	0.996	-	0.93850	.	.	0.24402	.	.	0	0.99635003892177543	.	-	3G>T 	.	.	C0027672|C3661900|C0346153|C4554406|C2676676|C3280442|C0677776	.	.	.	.	NM_007294.4	-	.	.	1	0.64967	80357475	.	.	0.88576	0.56049	.	0.009	.	0.99954283	3.83	.	.	.	0.334384	0.999999926062728	.	D	.	.	.	0.5223	0.90000	p.Met1?	.	0	-12.231	0.9873682	0	0.99831	55072	D	.	BRCA1	.	D	0.696	.	M1I	D	.	0.0639	C/C	principal2																																																																																																				
BRAF_Phe595Leu	-9.759425206849947	0.010336581546443782																													BRAF	BRAF	ENSG00000157764	71969	36663	CCSBVarC002859	ALE00002859	NC_000007.14:140753350:A:C	1785T>G	Phe595Leu	RC4	RC4_Mut_GDEh1030	D02	GDEhDisVCh_40058	F12	2	RC4_Mut_GDDh1030	D02	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			BRAF_Phe595Leu	7	140753350	A	C	7											7-140753350-A-C	-	0.73039	0.999	595	.	.	.	7	140453150	C	.	.	7	1_Pathogenic	NC_000007.14	.	Phe595Leu	.	25.9	.	.	.	T	.	7	.	.	.	.	.	.	.	0.97508	Select	0.3667	.	0.77914	.	.	D	D	.	.	.	.	.	.	.	0.98015	.	.	.	.	0.83515	.	.	0.97861	1.0	.	.	0.987801	4.29	.	C	single nucleotide variant	NC_000007.14:g.140753350A>C	.	.	2	0.88114095	.	.	0.9619178	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.91795	D	0.95192	D	L	4.092809	.	./.	.	.	.	.	not provided|Cardio-facio-cutaneous syndrome|RASopathy	.	0.74628	.	.	-	140753350	.	-	6.153000	.	0.99727	.	.	.	.	de novo;germline;unknown	.	Loss of methylation at K591 (P = 0.1346)| Gain of ubiquitination at K591 (P = 0.1989)| Gain of MoRF binding (P = 0.2559)| Gain of helix (P = 0.2684)| Loss of catalytic residue at G596 (P = 0.2908)	0.99765	GRCh38	789	reviewed by expert panel	c.1785T>G	.	0.54535	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1785T>G (p.Phe595Leu)	3	.	BRAF_HUMAN	.	.	0.357877466552978	.	D	0.99952	0.9661887	-	.	.		.	.	2	.	reviewed_by_expert_panel	0.99288	.	.	.	.	.	p.Phe595Leu	.	0.54294	.	germline	.		A	Apr 03, 2017	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000616396	Pathogenic	.	.	Leu	L	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.75	A	.	4.605393	.	N	.	-	4.310766	.	0.87129	.	.	.	0.86818	.	140753350	Y	10	.	.	.	P15056	.	0.894269	0.96206		.	0.995	D	.	0.903972	.	0.97202	673	0.503087	.	.	.	.	0.72322	.	.	.	.	.	.	0.93556	7	BRAF	.	.	Phe	.	.	7-140753350-A-C	Neoplasm|Cardio-facio-cutaneous_syndrome|not_provided|RASopathy|Melanoma	.	.	140099619	ClinGen:CA280058|UniProtKB:P15056#VAR_018625	0.498533	0.58945	.	RCV000157825|RCV000154266|RCV000522002	D	.	.	c.1785T>G	.	.	.	0.94327	./.	rs121913341	140753350	.	A	.	P15056	.	0.97432	.	0.68239		.	.	.	1.925	.	.	.	4.51	0.97856	.	D	D	.	.	.	.	.	.	.	1340|536391	177672	0.94247	0.91769	0.995151042938232	.	.	0.71675	0.53096	.	.	.	2.3	.	.	.	.	.	.	PS115150	0.43383	7	.	ENSG00000157764	.	.	.	.	.	3	0.83178	0.46282	.	.	.	.	0.393216519788526	YES	.	0.208711	174042	HGNC:1097	.	.	.	0.992	.	140753350	TTT	1.000000	.	-	.	0.98334	.	.	.	Pathogenic	0.77402	.	.	.	ClinGen:CA280058,UniProtKB:P15056#VAR_018625	F	.	.	-	0.975	-	.	.	.	0.96605	0.916151702404	1.0	.	0.99886805542060975	.	-	1785T>G 	.	.	C0027651|C1275081|C3661900|C5555857|C0025202	.	.	.	.	NM_004333.6	-	.	.	1	0.95872	121913341	.	.	0.99741	0.60939	.	.	.	0.99931383	5.65	.	.	.	0.484873	0.999967702599346	0.51193	T	.	.	.	-0.3087	0.72582	p.Phe595Leu	.	.	-10.584	0.98261863	.	0.99297	177672	D	.	BRAF	.	D	.	.	F595L	.	0.81260	0.87077	./.	principal4																																																																																																				
BRAF_Phe595Leu	-9.759425206849947	0.010336581546443782																													BRAF	BRAF		71969		CCSBVarC002859		NC_000007.14:140753350:A:C		Phe595Leu																												BRAF_Phe595Leu	7	140753350	A	C	7	allele	1785T>G	A05	527_CAVA_Array_P01	A09	B13A7A8P1_R1	B14A7A8P1_R2				7-140753350-A-C	-	0.73039	0.999	595	.	.	.	7	140453150	C	.	.	7	1_Pathogenic	NC_000007.14	.	Phe595Leu	.	25.9	.	.	.	T	.	7	.	.	.	.	.	.	.	0.97508	Select	0.3667	.	0.77914	.	.	D	D	.	.	.	.	.	.	.	0.98015	.	.	.	.	0.83515	.	.	0.97861	1.0	.	.	0.987801	4.29	.	C	single nucleotide variant	NC_000007.14:g.140753350A>C	.	.	2	0.88114095	.	.	0.9619178	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.91795	D	0.95192	D	L	4.092809	.	./.	.	.	.	.	not provided|Cardio-facio-cutaneous syndrome|RASopathy	.	0.74628	.	.	-	140753350	.	-	6.153000	.	0.99727	.	.	.	.	de novo;germline;unknown	.	Loss of methylation at K591 (P = 0.1346)| Gain of ubiquitination at K591 (P = 0.1989)| Gain of MoRF binding (P = 0.2559)| Gain of helix (P = 0.2684)| Loss of catalytic residue at G596 (P = 0.2908)	0.99765	GRCh38	789	reviewed by expert panel	c.1785T>G	.	0.54535	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1785T>G (p.Phe595Leu)	3	.	BRAF_HUMAN	.	.	0.357877466552978	.	D	0.99952	0.9661887	-	.	.		.	.	2	.	reviewed_by_expert_panel	0.99288	.	.	.	.	.	p.Phe595Leu	.	0.54294	.	germline	.		A	Apr 03, 2017	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000616396	Pathogenic	.	.	Leu	L	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.75	A	.	4.605393	.	N	.	-	4.310766	.	0.87129	.	.	.	0.86818	.	140753350	Y	10	.	.	.	P15056	.	0.894269	0.96206		.	0.995	D	.	0.903972	.	0.97202	673	0.503087	.	.	.	.	0.72322	.	.	.	.	.	.	0.93556	7	BRAF	.	.	Phe	.	.	7-140753350-A-C	Neoplasm|Cardio-facio-cutaneous_syndrome|not_provided|RASopathy|Melanoma	.	.	140099619	ClinGen:CA280058|UniProtKB:P15056#VAR_018625	0.498533	0.58945	.	RCV000157825|RCV000154266|RCV000522002	D	.	.	c.1785T>G	.	.	.	0.94327	./.	rs121913341	140753350	.	A	.	P15056	.	0.97432	.	0.68239		.	.	.	1.925	.	.	.	4.51	0.97856	.	D	D	.	.	.	.	.	.	.	1340|536391	177672	0.94247	0.91769	0.995151042938232	.	.	0.71675	0.53096	.	.	.	2.3	.	.	.	.	.	.	PS115150	0.43383	7	.	ENSG00000157764	.	.	.	.	.	3	0.83178	0.46282	.	.	.	.	0.393216519788526	YES	.	0.208711	174042	HGNC:1097	.	.	.	0.992	.	140753350	TTT	1.000000	.	-	.	0.98334	.	.	.	Pathogenic	0.77402	.	.	.	ClinGen:CA280058,UniProtKB:P15056#VAR_018625	F	.	.	-	0.975	-	.	.	.	0.96605	0.916151702404	1.0	.	0.99886805542060975	.	-	1785T>G 	.	.	C0027651|C1275081|C3661900|C5555857|C0025202	.	.	.	.	NM_004333.6	-	.	.	1	0.95872	121913341	.	.	0.99741	0.60939	.	.	.	0.99931383	5.65	.	.	.	0.484873	0.999967702599346	0.51193	T	.	.	.	-0.3087	0.72582	p.Phe595Leu	.	.	-10.584	0.98261863	.	0.99297	177672	D	.	BRAF	.	D	.	.	F595L	.	0.81260	0.87077	./.	principal4																																																																																																				
LMNA_Arg386Thr	1.4645911073941391	0.18644784142247456	-8.018250483099878	0.00008983232334729825	2025_01_Batch_13-14	0.7326336048613691	0.9260771229356421	0.9588176831317521	0.8918935283204882	0.7592879376153259	0.8178282772037097	0.895717817000669	0.9703621554708268	0.9530241965268922	0.8607817846899265	0.7752309410325393	0.9108974699681556	0.9645899193012895	0.9224588624236902	0.8100348611526262	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	LMNA	LMNA		3903		CCSBVarC021208		NC_000001.11:156136121:G:C		Arg386Thr																												LMNA_Arg386Thr	1	156136121	G	C	1	allele	1157G>C	E09	527_CAVA_Array_P03	J17	B13A7A8P1_R1	B14A7A8P1_R2				1-156136121-G-C	-	0.95128	1.0	386	.	.	.	1	156105912	C	.	.	1	1_Pathogenic	NC_000001.11	.	Arg386Thr	.	34.0	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98562	Select	0.9609	.	0.90580	.	.	D	D	.	2.52078213034	.	.	.	.	.	0.74556	.	.	.	.	0.89056	.	.	0.93811	0.991	.	0.0	0.986101	5.54	1.0	C	single nucleotide variant	NC_000001.11:g.156136121G>C	.	.	2	0.8441071	.	.	0.91762745	.		.	.	.	.	.	.	.	.	MedGen:CN230736	.	.	.	.	0.99291	D	0.90525	D	H	14.80981	.	G/G	.	.	.	.	Cardiovascular phenotype	.	0.99677	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	156136121	.	-	11.529000	.	0.99334	.	.	.	.	germline	.	Gain of helix (P = 0.0034)| Loss of loop (P = 0.0073)| Gain of phosphorylation at R386 (P = 0.033)| Loss of MoRF binding (P = 0.0798)| Loss of glycosylation at P391 (P = 0.2507)	0.79808	GRCh38	460	criteria provided, single submitter	c.1157G>C	.	0.74708	.	.	.	Intermediate filament, rod domain|Intermediate filament, rod domain|Intermediate filament, rod domain	.	.	P	.	.	NM_170707.4(LMNA):c.1157G>C (p.Arg386Thr)	1	.	LMNA_HUMAN	.	100.0	1.02757772399496	.	D	0.98500	0.9266469	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99989	.	.	.	.	.	p.Arg386Thr	.	0.93089	.	germline	.		G	Feb 16, 2016	.	G/G	.	.	1.0	N	1q22	.	.	.	SCV000320081	Pathogenic	.	.	Thr	T	-	.	ENSP00000357283	ENST00000368300	.	0.001	.	.	0.676	G	.	6.38395	0.83643	D	D	-	16.2953	.	0.99400	.	.	.	0.97697	.	156136121	Y	10	.	.	.	P02545	.	0.984156	0.42829		.	1.0	D	.	0.8370971	.	0.66489	4000	0.577996	.	-5.93	.	.	0.78662	.	.	.	.	.	.	0.90994	1	LMNA	.	.	Arg	.	.	1-156136121-G-C	Cardiovascular_phenotype	.	.	154372536	ClinGen:CA10587419	0.944311	0.96510	.	RCV000248263	D	.	.	c.1157G>C	.	.	.	0.96936	G/G	rs267607545	156136121	.	G	.	P02545	.	0.92915	.	0.68239		.	.	.	4.635	.	.	.	5.3	0.99893	.	D	T	.	.	.	.	.	.	.	.	264271	0.96885	0.97725	0.999515652656555	.	.	0.71675	0.95106	.	.	.	9.957	.	D	.	.	.	.	.	0.99008	1	.	ENSG00000160789	.	.	.	.	0.9678116666716702	2	0.97365	0.78769	.	.	.	.	0.954406358037594	YES	.	0.91892	257932	HGNC:6636	A	.	simple_aae	0.981	.	156136121	AGG	1.000000	.	-	.	0.89777	.	.	.	Pathogenic	0.93500	.	.	.	ClinGen:CA10587419	R	.	0.980401155553	-	0.661	-	0.87350	.	.	0.96751	0.751040816307	0.9991	.	0.98540116954095625	.	-	1157G>C 	.	.	CN230736	.	.	.	.	NM_170707.4	-	.	.	1	0.95472	267607545	.	.	0.97999	0.97520	0.857	0.002	.	0.99997771	5.3	.	.	.	0.592475	0.99996834705116	0.99325	D	.	.	.	1.1004	0.98739	p.Arg386Thr	.	.	-14.125	0.90525204	.	0.99297	264271	D	.	LMNA	.	D	0.936	.	R386T	D	0.94607	0.76753	G/G	principal1																																																																																																				
RET_Leu56Met	2.070499399299519	0.07715984473902697	4.176807048731463	0.004153743658106803	2025_01_Batch_13-14	0.9547018505169517	0.8922386929915563	0.8183809072225747	0.9252820879349938	0.8460785661873986	0.6442601120187283	0.7139921804489365	0.7069766295923227	0.7212286329031747	0.6685173300236056	0.7994809812678401	0.8031154367202464	0.7626787684074487	0.8232553604190842	0.7572979481055021	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET	ENSG00000165731	8858	202944	CCSBVarC006872	ALE00006870	NC_000010.11:43100551:C:A	166C>A	Leu56Met	CEGS2	CegsMutGDEh1027	G04	GDEhDisVCh_40066	G05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Leu56Met	10	43100551	C	A	10											10-43100551-C-A	-	0.13688	0.558	56	454	1	0	10	43595999	A	4.809970e-03	27	10	3_Conflicting	NC_000010.11	7135	Leu56Met	1	10.21	0	5	4.861380e-03	T	24	26	5	42756	2.641680e-03	1	30524	0.000000e+00	0	0.78612	Select	0.2838	102440	0.44790	53	0.0	T	T	63782	0.936903531846	5.301102629346904E-4	0	0.000000e+00	1	1	0.30008	17110	44880	2	7.457120e-05	0.20082	217	.	0.34482	0.004	7.564296520423601E-4	92.0	0.677732	1.56	0.08	A	single nucleotide variant	NC_000010.11:g.43100551C>A	1	16724	2	0.070077136	109366	0	0.13296163	0	A	564	236592	1	0	5.652270e-05	796	5.075310e-03	1	MedGen:CN169374|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388	289	49	0.000000e+00	0	0.23785	B	0.10627	P	L	1.605345	7763	C/C	360	54	7148	1613938	not specified|Multiple endocrine neoplasia|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Aganglionic megacolon|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1	16174	0.71275	1	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43100551	5.075310e-03	-	0.096000	11	0.31465	29608	0	1180022	1	germline;unknown	91090	.	.	GRCh38	862	criteria provided, conflicting classifications	c.166C>A	0.000000e+00	0.38072	1046	0	0	Ret, cadherin like domain 1	2.630950e-03	9046	B	0	3.377470e-05	NM_020975.6(RET):c.166C>A (p.Leu56Met)	1	0	RET_HUMAN	0	8.0	-0.303488539195444	40	T	0.51413	0.15338261	+	5.595970e-04	0	0.00499724	454	0.000000e+00	2	34256	criteria_provided,_conflicting_classifications	0.99252	2.642500e-03	25	2.615060e-03	0	60026	p.Leu56Met	0	0.14644	.	germline	217	43100551	C	Mar 04, 2025	0	C/C	1	89240	0.307	N	10q11.21	198634	.	6.801040e-04	SCV000113984|SCV000213794|SCV000258169|SCV000261742|SCV000514406|SCV000711342|SCV000807009|SCV001138019|SCV001147859|SCV001158030|SCV001266132|SCV001266133|SCV001266134|SCV001266135|SCV002011461|SCV002067079|SCV002529940|SCV002550377|SCV002774043|SCV004357214|SCV004838625	Conflicting_classifications_of_pathogenicity	35	0	Met	M	-	912	ENSP00000347942	ENST00000355710	17692	0.393	13410	1	0.599	C	0	0.98931	0.92967	N	T	-	1.44365	.	0.58137	966	0	0.003976143141153081	0.00074	0	43100551	Y	10	0.00628140703517588	102440	0.000000e+00	P07949	0	0.443185	0.36268	C	1	0.207	D	89240	0.057930265	42756	0.06081	5979	-0.161264	7135	-0.71	0.0	6.046500e-03	0.11116	0.000000e+00	1	75056	0.000000e+00	6060	4	0.14837	10	RET	7.194630e-04	0	Leu	234342	5.087400e-03	10-43100551-C-A	not_specified|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon	0	498	42916005	ClinGen:CA007702	0.071078	0.28736	24	RCV000121985|RCV000202649|RCV000034766|RCV000030402|RCV000163266|RCV001108850|RCV000148768|RCV001082759|RCV001108849|RCV001108851	T	0	0	c.166C>A	0	1	194	0.26220	C/C	rs145633958	43100551	14876	C	0.0011980830670926517	.	15688	0.30675	2.266420e-03	0.18726	10	0	1	2.228160e-05	1.74	0.002777777777777778	981	264690	3.41	0.78547	6374	T	T	9	1.310790e-03	5	1842	.	0	44	411709|276161|29072|140162|653|247698|653|388|388	36723	0.69900	0.71884	0.00669683503352234	9792	6	0.25474	0.13951	1.547170e-03	5.087400e-03	1180022	0.376	2.714980e-03	N	13384	1	0.0029430655	0	191830|PS131100|171300|171400|142623|PS142623	0.2034	10	6.050010e-04	ENSG00000165731	3.041610e-03	0.0049387315363935685	0	0	0.5310686656002561	1	0.43709	0.33096	30606	779	4.861380e-03	1.815880e-03	-0.361080103655587	YES	2.195630e-05	0.038562	45384	HGNC:9967	N	0	simple_aae	0.115	207736	43100551	CTG	0.003000	0	-	6.127450980392157E-4	0.00287	6.046500e-03	6	0	Conflicting classifications of pathogenicity	0.38089	0	0	109	ClinGen:CA007702	L	0	0.965681725857	-	.	-	0.27835	625	17500	0.52839	0.436104416847	0.2222	0	0.97808508319477172	280	-	166C>A 	498	0.003085714285714286	CN169374|C1619700|C0027662|C3661900|C0031511|C0027672|C4048306|C0025268|C3888239|C0019569	0	0	0	0	NM_020975.6	-	4	0.001440922190201729	0	0.28414	145633958	2320	0.004463561802835173	0.96499	0.25850	0.234	0.37	9432	0.99925655	5.51	.	.	0.000000e+00	-0.00332951	0.420929723777606	0.44959	T	4532	6206	9564	-0.4197	0.65421	p.Leu56Met	0	0	-5.112	0.01373741	54	0.58343	36723	T	30516	RET	1.578020e-03	D	0.506	21620	.	T	0.34791	0.40292	C/C	principal4																																																																																																				
RET_Leu56Met	2.070499399299519	0.07715984473902697	4.176807048731463	0.004153743658106803	2025_01_Batch_13-14	0.9547018505169517	0.8922386929915563	0.8183809072225747	0.9252820879349938	0.8460785661873986	0.6442601120187283	0.7139921804489365	0.7069766295923227	0.7212286329031747	0.6685173300236056	0.7994809812678401	0.8031154367202464	0.7626787684074487	0.8232553604190842	0.7572979481055021	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET		8858		CCSBVarC006872		NC_000010.11:43100551:C:A		Leu56Met																												RET_Leu56Met	10	43100551	C	A	10	allele	166C>A	B08	527_CAVA_Array_P05	C15	B13A7A8P2_R1	B14A7A8P2_R2				10-43100551-C-A	-	0.13688	0.558	56	454	1	0	10	43595999	A	4.809970e-03	27	10	3_Conflicting	NC_000010.11	7135	Leu56Met	1	10.21	0	5	4.861380e-03	T	24	26	5	42756	2.641680e-03	1	30524	0.000000e+00	0	0.78612	Select	0.2838	102440	0.44790	53	0.0	T	T	63782	0.936903531846	5.301102629346904E-4	0	0.000000e+00	1	1	0.30008	17110	44880	2	7.457120e-05	0.20082	217	.	0.34482	0.004	7.564296520423601E-4	92.0	0.677732	1.56	0.08	A	single nucleotide variant	NC_000010.11:g.43100551C>A	1	16724	2	0.070077136	109366	0	0.13296163	0	A	564	236592	1	0	5.652270e-05	796	5.075310e-03	1	MedGen:CN169374|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MedGen:C3661900|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|Human Phenotype Ontology:HP:0002029,Human Phenotype Ontology:HP:0002030,Human Phenotype Ontology:HP:0002251,Human Phenotype Ontology:HP:0002606,Human Phenotype Ontology:HP:0004391,MONDO:MONDO:0018309,MeSH:D006627,MedGen:C0019569,OMIM:PS142623,Orphanet:388|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388	289	49	0.000000e+00	0	0.23785	B	0.10627	P	L	1.605345	7763	C/C	360	54	7148	1613938	not specified|Multiple endocrine neoplasia|not provided|Multiple endocrine neoplasia type 2A|Hereditary cancer-predisposing syndrome|Pheochromocytoma|Aganglionic megacolon|Multiple endocrine neoplasia, type 2|Renal hypodysplasia/aplasia 1|Hirschsprung disease, susceptibility to, 1	16174	0.71275	1	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43100551	5.075310e-03	-	0.096000	11	0.31465	29608	0	1180022	1	germline;unknown	91090	.	.	GRCh38	862	criteria provided, conflicting classifications	c.166C>A	0.000000e+00	0.38072	1046	0	0	Ret, cadherin like domain 1	2.630950e-03	9046	B	0	3.377470e-05	NM_020975.6(RET):c.166C>A (p.Leu56Met)	1	0	RET_HUMAN	0	8.0	-0.303488539195444	40	T	0.51413	0.15338261	+	5.595970e-04	0	0.00499724	454	0.000000e+00	2	34256	criteria_provided,_conflicting_classifications	0.99252	2.642500e-03	25	2.615060e-03	0	60026	p.Leu56Met	0	0.14644	.	germline	217	43100551	C	Mar 04, 2025	0	C/C	1	89240	0.307	N	10q11.21	198634	.	6.801040e-04	SCV000113984|SCV000213794|SCV000258169|SCV000261742|SCV000514406|SCV000711342|SCV000807009|SCV001138019|SCV001147859|SCV001158030|SCV001266132|SCV001266133|SCV001266134|SCV001266135|SCV002011461|SCV002067079|SCV002529940|SCV002550377|SCV002774043|SCV004357214|SCV004838625	Conflicting_classifications_of_pathogenicity	35	0	Met	M	-	912	ENSP00000347942	ENST00000355710	17692	0.393	13410	1	0.599	C	0	0.98931	0.92967	N	T	-	1.44365	.	0.58137	966	0	0.003976143141153081	0.00074	0	43100551	Y	10	0.00628140703517588	102440	0.000000e+00	P07949	0	0.443185	0.36268	C	1	0.207	D	89240	0.057930265	42756	0.06081	5979	-0.161264	7135	-0.71	0.0	6.046500e-03	0.11116	0.000000e+00	1	75056	0.000000e+00	6060	4	0.14837	10	RET	7.194630e-04	0	Leu	234342	5.087400e-03	10-43100551-C-A	not_specified|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Hereditary_cancer-predisposing_syndrome|Multiple_endocrine_neoplasia,_type_2|Multiple_endocrine_neoplasia_type_2A|Hirschsprung_disease,_susceptibility_to,_1|Aganglionic_megacolon	0	498	42916005	ClinGen:CA007702	0.071078	0.28736	24	RCV000121985|RCV000202649|RCV000034766|RCV000030402|RCV000163266|RCV001108850|RCV000148768|RCV001082759|RCV001108849|RCV001108851	T	0	0	c.166C>A	0	1	194	0.26220	C/C	rs145633958	43100551	14876	C	0.0011980830670926517	.	15688	0.30675	2.266420e-03	0.18726	10	0	1	2.228160e-05	1.74	0.002777777777777778	981	264690	3.41	0.78547	6374	T	T	9	1.310790e-03	5	1842	.	0	44	411709|276161|29072|140162|653|247698|653|388|388	36723	0.69900	0.71884	0.00669683503352234	9792	6	0.25474	0.13951	1.547170e-03	5.087400e-03	1180022	0.376	2.714980e-03	N	13384	1	0.0029430655	0	191830|PS131100|171300|171400|142623|PS142623	0.2034	10	6.050010e-04	ENSG00000165731	3.041610e-03	0.0049387315363935685	0	0	0.5310686656002561	1	0.43709	0.33096	30606	779	4.861380e-03	1.815880e-03	-0.361080103655587	YES	2.195630e-05	0.038562	45384	HGNC:9967	N	0	simple_aae	0.115	207736	43100551	CTG	0.003000	0	-	6.127450980392157E-4	0.00287	6.046500e-03	6	0	Conflicting classifications of pathogenicity	0.38089	0	0	109	ClinGen:CA007702	L	0	0.965681725857	-	.	-	0.27835	625	17500	0.52839	0.436104416847	0.2222	0	0.97808508319477172	280	-	166C>A 	498	0.003085714285714286	CN169374|C1619700|C0027662|C3661900|C0031511|C0027672|C4048306|C0025268|C3888239|C0019569	0	0	0	0	NM_020975.6	-	4	0.001440922190201729	0	0.28414	145633958	2320	0.004463561802835173	0.96499	0.25850	0.234	0.37	9432	0.99925655	5.51	.	.	0.000000e+00	-0.00332951	0.420929723777606	0.44959	T	4532	6206	9564	-0.4197	0.65421	p.Leu56Met	0	0	-5.112	0.01373741	54	0.58343	36723	T	30516	RET	1.578020e-03	D	0.506	21620	.	T	0.34791	0.40292	C/C	principal4																																																																																																				
F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	0.8238798819066758	0.8054950025083605	0.801351506763675	0.7994653617496963	0.7906061765477359	0.593532433474832	0.7819791443911247	0.8733941452783907	0.7981677228468611	0.5171235394497027	0.7087061576907538	0.7937370734497426	0.8373728260210328	0.7988165422982787	0.6538648579987193	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002183		NC_000023.11:139561904:T:C		Cys407Arg																												F9_Cys407Arg	23	139561904	T	C	X	allele	1219T>C	B11	527_CAVA_Array_P02	C22	B13A7A8P1_R1	B14A7A8P1_R2				X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			175250	F9_Popp_2025_carboxy_gla_motif_var258270	No											C		1219	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys407Arg		true	c.1219T>C						3551.0	139561904.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa															Cys407Arg						R						missense_variant		407.0				0.6380485317766402			139561904.0	missense_variant		0.969					Reporter			F9_Cys407Arg
F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	0.8238798819066758	0.8054950025083605	0.801351506763675	0.7994653617496963	0.7906061765477359	0.593532433474832	0.7819791443911247	0.8733941452783907	0.7981677228468611	0.5171235394497027	0.7087061576907538	0.7937370734497426	0.8373728260210328	0.7988165422982787	0.6538648579987193	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002183		NC_000023.11:139561904:T:C		Cys407Arg																												F9_Cys407Arg	23	139561904	T	C	X	allele	1219T>C	B11	527_CAVA_Array_P02	C22	B13A7A8P1_R1	B14A7A8P1_R2				X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			230282	F9_Popp_2025_light_chain_var248589	No											C		1219	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys407Arg		true	c.1219T>C						3551.0	139561904.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa															Cys407Arg						R						missense_variant		407.0				0.65979911			139561904.0	missense_variant		0.969					Reporter			F9_Cys407Arg
F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	0.8238798819066758	0.8054950025083605	0.801351506763675	0.7994653617496963	0.7906061765477359	0.593532433474832	0.7819791443911247	0.8733941452783907	0.7981677228468611	0.5171235394497027	0.7087061576907538	0.7937370734497426	0.8373728260210328	0.7988165422982787	0.6538648579987193	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002183		NC_000023.11:139561904:T:C		Cys407Arg																												F9_Cys407Arg	23	139561904	T	C	X	allele	1219T>C	B11	527_CAVA_Array_P02	C22	B13A7A8P1_R1	B14A7A8P1_R2				X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			147734	F9_Popp_2025_carboxy_F9_specific_var229227	No											C		1219	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys407Arg		true	c.1219T>C						3551.0	139561904.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa															Cys407Arg						R						missense_variant		407.0				0.5418123518159481			139561904.0	missense_variant		0.969					Reporter			F9_Cys407Arg
F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	0.8238798819066758	0.8054950025083605	0.801351506763675	0.7994653617496963	0.7906061765477359	0.593532433474832	0.7819791443911247	0.8733941452783907	0.7981677228468611	0.5171235394497027	0.7087061576907538	0.7937370734497426	0.8373728260210328	0.7988165422982787	0.6538648579987193	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002183		NC_000023.11:139561904:T:C		Cys407Arg																												F9_Cys407Arg	23	139561904	T	C	X	allele	1219T>C	B11	527_CAVA_Array_P02	C22	B13A7A8P1_R1	B14A7A8P1_R2				X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			202766	F9_Popp_2025_heavy_chain_var238908	No											C		1219	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys407Arg		true	c.1219T>C						3551.0	139561904.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa															Cys407Arg						R						missense_variant		407.0				0.7058586342175659			139561904.0	missense_variant		0.969					Reporter			F9_Cys407Arg
F9_Cys407Arg	-3.15553232850932	0.016027863050384276	6.600675766224722	0.00030411560492763206	2025_01_Batch_13-14	0.8238798819066758	0.8054950025083605	0.801351506763675	0.7994653617496963	0.7906061765477359	0.593532433474832	0.7819791443911247	0.8733941452783907	0.7981677228468611	0.5171235394497027	0.7087061576907538	0.7937370734497426	0.8373728260210328	0.7988165422982787	0.6538648579987193	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC002183		NC_000023.11:139561904:T:C		Cys407Arg																												F9_Cys407Arg	23	139561904	T	C	X	allele	1219T>C	B11	527_CAVA_Array_P02	C22	B13A7A8P1_R1	B14A7A8P1_R2				X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			257798	F9_Popp_2025_strep_2_var267951	No											C		1219	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys407Arg		true	c.1219T>C						3551.0	139561904.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa															Cys407Arg						R						missense_variant		407.0				0.8486724561616644			139561904.0	missense_variant		0.969					Reporter			F9_Cys407Arg
RET_Thr278Asn	-0.6907675516055969	0.5119595315860082	6.503086124471587	0.00033316518625512326	2025_01_Batch_13-14	0.8320212540974146	0.8256731724420541	0.8831043347292347	0.8885259291901384	0.7689220201987548	0.5357371563328672	0.6689644492275445	0.8046262801654496	0.701802033042142	0.5392557432710541	0.6838792052151409	0.7473188108347992	0.8438653074473421	0.7951639811161402	0.6540888817349044	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET	ENSG00000165731	8858	202952	CCSBVarC006877	ALE00006875	NC_000010.11:43105159:C:A	833C>A	Thr278Asn	CEGS2	CegsMutGDEh1029	D06	GDEhDisVCh_40066	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			RET_Thr278Asn	10	43105159	C	A	10											10-43105159-C-A	-	0.43694	0.001	278	7	0	0	10	43600607	A	6.937920e-04	0	10	2_Benign	NC_000010.11	938	Thr278Asn	509	21.8	255	0	2.889090e-02	T	13	16	5	42634	2.321010e-03	0	30494	0.000000e+00	0	0.44851	Select	0.2726	17618	0.12194	2	0.018849206349206348	T	T	62980	0.869349038865	0	0	0.000000e+00	0	7	0.31525	17050	44842	75	2.661340e-02	0.27215	2	.	0.65819	0.997	0.0	95.0	0.865113	1.81	0.05	A	single nucleotide variant	NC_000010.11:g.43105159C>A	0	16456	2	0.30986196	108738	0	0.48162338	0.021725136787898294	A	382	233088	5	0	2.889090e-02	794	4.691090e-05	0	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	268	0	0.000000e+00	0	0.16373	B	0.56338	B	M	1.991452	1119	C/C	176	48	7086	1612876	not provided|not specified|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	15770	0.65873	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43105159	2.842180e-02	-	3.421000	0	0.75276	29582	0	44842	353	germline;unknown	91072	.	.	GRCh38	862	criteria provided, multiple submitters, no conflicts	c.833C>A	5.902800e-04	0.43085	190	0	0	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	0.000000e+00	8972	B	0.02349751468594668	0.000000e+00	NM_020975.6(RET):c.833C>A (p.Thr278Asn)	2	5	RET_HUMAN	0	5.0	-0.160029608786539	1	D	0.44951	0.48379323	+	0.000000e+00	1	0.000677802	353	0.000000e+00	0	34182	criteria_provided,_conflicting_classifications	0.98500	2.464640e-03	14	0.000000e+00	0	60014	p.Thr278Asn	0	0.38332	.	germline	255	43105159	C	Mar 04, 2025	18	C/C	6	85866	0.996	N	10q11.21	170470	.	0.000000e+00	SCV000213991|SCV000261217|SCV000267474|SCV000362270|SCV000540167|SCV000729739|SCV000807061|SCV001138021|SCV001261021|SCV001261022|SCV001261023|SCV002527928|SCV004127589|SCV004220048|SCV004243364|SCV004357223|SCV004564906	Conflicting_classifications_of_pathogenicity	0	0	Asn	N	-	912	ENSP00000347942	ENST00000355710	17618	0.035	13264	7	0.597	C	0	3.2057	0.28427	N	T	-	2.316717	.	.	968	0	0.0	0.06132	135	43105159	Y	10	0	99950	1.654530e-04	P07949	0	0.476434	0.32564	C	5	0.004	.	13264	0.3053008	8972	0.79771	5979	-0.352383	35	-1.04	0.0010224948875255625	2.091790e-02	0.43867	6.384070e-04	0	75052	2.842180e-02	6044	0	0.56777	10	RET	0.000000e+00	0	Thr	199350	8.152240e-05	10-43105159-C-A	Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia_type_2A|not_specified	0	10	42920613	ClinGen:CA009353|UniProtKB:P07949#VAR_041763	0.489384	0.34534	0	RCV000034778|RCV000121990|RCV000163444|RCV000490442|RCV000988341|RCV001104178|RCV001104180|RCV001104179|RCV001083124	T	13	0	c.833C>A	0	938	0	0.04410	C/C	rs35118262	43105159	14546	C	0.003993610223642172	.	15664	0.65687	0.000000e+00	0.34068	10	0	0	2.091790e-02	2.595	0	7	264690	3.82	0.80560	6214	T	T	0	3.287530e-05	0	1788	.	0	0	276161|29072|411709|653|140162|388|247698|653	41846	0.48694	0.69149	0.0540457288643749	4964	20	0.3946	0.52567	5.851030e-05	2.661340e-02	1179890	3.421	1.879290e-03	N	13120	6	0.0012391855	104	PS131100|171300|191830|142623|171400	0.52594	10	0.000000e+00	ENSG00000165731	0.000000e+00	4.1062943626444535E-5	18	0.017337807606263984	0.8788456336718098	2	0.16860	0.33096	30570	328	1.000500e-04	6.665110e-05	-0.0125543226448844	YES	8.235240e-04	.	50285	HGNC:9967	N	0	simple_aae	0.561	203268	43105159	ACC	0.998000	19	-	0	0.00127	2.966380e-05	0	1	Benign/Likely benign	0.07193	10	1	4	ClinGen:CA009353,UniProtKB:P07949#VAR_041763	T	6	0.764498015703	-	.	-	0.79815	541	15660	0.87776	0.447220146656	0.1721	0	0.97103921571150231	280	-	833C>A 	509	0.0030651340996168583	C0027662|C3661900|C0031511|C1619700|C4048306|C0027672|C3888239|C0025268|CN169374	0	7	0	0	NM_020975.6	-	0	0.0	0	0.56224	35118262	2308	9.530975670930524E-4	0.76048	0.38851	0.317	0.194	4788	0.99777067	4.73	.	.	5.888130e-04	-0.258001	0.723577208028241	0.75684	T	4426	6120	9522	-0.5698	0.64282	p.Thr278Asn	31	0	-2.309	0.0058131814	0	0.67844	41846	T	30418	RET	0.000000e+00	T	0.180	21196	.	D	0.37505	0.3436	C/C	principal4																																																																																																				
RET_Thr278Asn	-0.6907675516055969	0.5119595315860082	6.503086124471587	0.00033316518625512326	2025_01_Batch_13-14	0.8320212540974146	0.8256731724420541	0.8831043347292347	0.8885259291901384	0.7689220201987548	0.5357371563328672	0.6689644492275445	0.8046262801654496	0.701802033042142	0.5392557432710541	0.6838792052151409	0.7473188108347992	0.8438653074473421	0.7951639811161402	0.6540888817349044	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RET	RET		8858		CCSBVarC006877		NC_000010.11:43105159:C:A		Thr278Asn																												RET_Thr278Asn	10	43105159	C	A	10	allele	833C>A	G08	527_CAVA_Array_P05	M15	B13A7A8P2_R1	B14A7A8P2_R2				10-43105159-C-A	-	0.43694	0.001	278	7	0	0	10	43600607	A	6.937920e-04	0	10	2_Benign	NC_000010.11	938	Thr278Asn	509	21.8	255	0	2.889090e-02	T	13	16	5	42634	2.321010e-03	0	30494	0.000000e+00	0	0.44851	Select	0.2726	17618	0.12194	2	0.018849206349206348	T	T	62980	0.869349038865	0	0	0.000000e+00	0	7	0.31525	17050	44842	75	2.661340e-02	0.27215	2	.	0.65819	0.997	0.0	95.0	0.865113	1.81	0.05	A	single nucleotide variant	NC_000010.11:g.43105159C>A	0	16456	2	0.30986196	108738	0	0.48162338	0.021725136787898294	A	382	233088	5	0	2.889090e-02	794	4.691090e-05	0	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007723,MedGen:C3888239,OMIM:142623,Orphanet:388|MONDO:MONDO:0008234,MeSH:D018813,MedGen:C0025268,OMIM:171400,Orphanet:247698,Orphanet:653|Human Phenotype Ontology:HP:0002666,MONDO:MONDO:0008233,MedGen:C0031511,OMIM:171300,Orphanet:29072|MONDO:MONDO:0017169,MedGen:C0027662,OMIM:PS131100,Orphanet:276161|MONDO:MONDO:0024519,MedGen:C1619700,OMIM:191830,Orphanet:411709|MONDO:MONDO:0019003,MedGen:C4048306,Orphanet:653	268	0	0.000000e+00	0	0.16373	B	0.56338	B	M	1.991452	1119	C/C	176	48	7086	1612876	not provided|not specified|Hereditary cancer-predisposing syndrome|Hirschsprung disease, susceptibility to, 1|Multiple endocrine neoplasia type 2A|Pheochromocytoma|Multiple endocrine neoplasia|Renal hypodysplasia/aplasia 1|Multiple endocrine neoplasia, type 2	15770	0.65873	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43105159	2.842180e-02	-	3.421000	0	0.75276	29582	0	44842	353	germline;unknown	91072	.	.	GRCh38	862	criteria provided, multiple submitters, no conflicts	c.833C>A	5.902800e-04	0.43085	190	0	0	Tyrosine-protein kinase receptor Ret, cadherin like domain 3	0.000000e+00	8972	B	0.02349751468594668	0.000000e+00	NM_020975.6(RET):c.833C>A (p.Thr278Asn)	2	5	RET_HUMAN	0	5.0	-0.160029608786539	1	D	0.44951	0.48379323	+	0.000000e+00	1	0.000677802	353	0.000000e+00	0	34182	criteria_provided,_conflicting_classifications	0.98500	2.464640e-03	14	0.000000e+00	0	60014	p.Thr278Asn	0	0.38332	.	germline	255	43105159	C	Mar 04, 2025	18	C/C	6	85866	0.996	N	10q11.21	170470	.	0.000000e+00	SCV000213991|SCV000261217|SCV000267474|SCV000362270|SCV000540167|SCV000729739|SCV000807061|SCV001138021|SCV001261021|SCV001261022|SCV001261023|SCV002527928|SCV004127589|SCV004220048|SCV004243364|SCV004357223|SCV004564906	Conflicting_classifications_of_pathogenicity	0	0	Asn	N	-	912	ENSP00000347942	ENST00000355710	17618	0.035	13264	7	0.597	C	0	3.2057	0.28427	N	T	-	2.316717	.	.	968	0	0.0	0.06132	135	43105159	Y	10	0	99950	1.654530e-04	P07949	0	0.476434	0.32564	C	5	0.004	.	13264	0.3053008	8972	0.79771	5979	-0.352383	35	-1.04	0.0010224948875255625	2.091790e-02	0.43867	6.384070e-04	0	75052	2.842180e-02	6044	0	0.56777	10	RET	0.000000e+00	0	Thr	199350	8.152240e-05	10-43105159-C-A	Multiple_endocrine_neoplasia|not_provided|Pheochromocytoma|Renal_hypodysplasia/aplasia_1|Multiple_endocrine_neoplasia,_type_2|Hereditary_cancer-predisposing_syndrome|Hirschsprung_disease,_susceptibility_to,_1|Multiple_endocrine_neoplasia_type_2A|not_specified	0	10	42920613	ClinGen:CA009353|UniProtKB:P07949#VAR_041763	0.489384	0.34534	0	RCV000034778|RCV000121990|RCV000163444|RCV000490442|RCV000988341|RCV001104178|RCV001104180|RCV001104179|RCV001083124	T	13	0	c.833C>A	0	938	0	0.04410	C/C	rs35118262	43105159	14546	C	0.003993610223642172	.	15664	0.65687	0.000000e+00	0.34068	10	0	0	2.091790e-02	2.595	0	7	264690	3.82	0.80560	6214	T	T	0	3.287530e-05	0	1788	.	0	0	276161|29072|411709|653|140162|388|247698|653	41846	0.48694	0.69149	0.0540457288643749	4964	20	0.3946	0.52567	5.851030e-05	2.661340e-02	1179890	3.421	1.879290e-03	N	13120	6	0.0012391855	104	PS131100|171300|191830|142623|171400	0.52594	10	0.000000e+00	ENSG00000165731	0.000000e+00	4.1062943626444535E-5	18	0.017337807606263984	0.8788456336718098	2	0.16860	0.33096	30570	328	1.000500e-04	6.665110e-05	-0.0125543226448844	YES	8.235240e-04	.	50285	HGNC:9967	N	0	simple_aae	0.561	203268	43105159	ACC	0.998000	19	-	0	0.00127	2.966380e-05	0	1	Benign/Likely benign	0.07193	10	1	4	ClinGen:CA009353,UniProtKB:P07949#VAR_041763	T	6	0.764498015703	-	.	-	0.79815	541	15660	0.87776	0.447220146656	0.1721	0	0.97103921571150231	280	-	833C>A 	509	0.0030651340996168583	C0027662|C3661900|C0031511|C1619700|C4048306|C0027672|C3888239|C0025268|CN169374	0	7	0	0	NM_020975.6	-	0	0.0	0	0.56224	35118262	2308	9.530975670930524E-4	0.76048	0.38851	0.317	0.194	4788	0.99777067	4.73	.	.	5.888130e-04	-0.258001	0.723577208028241	0.75684	T	4426	6120	9522	-0.5698	0.64282	p.Thr278Asn	31	0	-2.309	0.0058131814	0	0.67844	41846	T	30418	RET	0.000000e+00	T	0.180	21196	.	D	0.37505	0.3436	C/C	principal4																																																																																																				
BRAF_Thr241Arg	-8.877044476380464	0.0000466454663945854	6.127715259649578	0.000477871903155989	2025_01_Batch_13-14	0.8299258911292273	0.7721124795906301	0.8035507867832169	0.7584846614033833	0.7485082955646319											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220596	CCSBVarC003154	ALE00003154	NC_000007.14:140801550:G:C	722C>G	Thr241Arg	CEGS2	CegsMutGDEh1016	G06	GDEhDisVCh_40058	D05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Thr241Arg	7	140801550	G	C	7											7-140801550-G-C	-	0.90554	1.0	241	.	.	.	7	140501350	C	.	.	7	1_Pathogenic	NC_000007.14	.	Thr241Arg	.	31.0	.	.	.	D	.	5	.	.	.	.	.	.	.	0.99124	Select	0.8732	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.98061	.	.	.	.	0.77586	.	.	0.93899	0.94	.	.	0.983902	.	.	C	single nucleotide variant	NC_000007.14:g.140801550G>C	.	.	3	0.90271693	.	.	0.94158983	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	.	.	.	.	0.86984	D	0.94691	D	M	10.64868	.	./.	.	.	.	.	Noonan syndrome 7|Noonan syndrome 1|RASopathy|Inborn genetic diseases|not provided	.	0.96274	.	.	-	140801550	.	-	11.755000	.	0.98982	.	.	.	.	germline	.	Gain of solvent accessibility (P = 0.008)| Gain of relative solvent accessibility (P = 0.0289)| Gain of MoRF binding (P = 0.033)| Gain of methylation at T241 (P = 0.0391)| Loss of ubiquitination at K240 (P = 0.0594)	0.98894	GRCh38	794	criteria provided, multiple submitters, no conflicts	c.722C>G	.	0.70808	.	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	.	.	P	.	.	NM_004333.6(BRAF):c.722C>G (p.Thr241Arg)	2	.	BRAF_HUMAN	.	.	0.884148484170867	.	D	0.98500	0.92752135	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.97933	.	.	.	.	.	p.Thr241Arg	.	0.95501	.	germline	.		G	Feb 01, 2023	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000057185|SCV000743069|SCV003440618	Pathogenic	.	.	Arg	R	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.672	G	.	5.408322	0.53421	D	.	-	11.61548	.	0.94148	.	.	.	0.93238	.	140801550	Y	10	.	.	.	P15056	.	0.89813	0.77405		.	0.998	D	.	0.8970028	.	0.48078	673	0.503099	.	.	.	.	0.91343	.	.	.	.	.	.	0.95103	7	BRAF	.	.	Thr	.	.	7-140801550-G-C	Inborn_genetic_diseases|RASopathy|not_provided|Noonan_syndrome_7|Noonan_syndrome_1	.	.	140147819	ClinGen:CA259663|OMIM:164757.0023|UniProtKB:P15056#VAR_058622	0.880398	0.90911	.	RCV000022679|RCV000208548|RCV002513171|RCV000624512|RCV001703420	D	.	.	c.722C>G	.	.	.	0.94327	./.	rs387906660	140801550	.	G	.	P15056	.	0.95338	.	0.68239		.	.	.	3.175	.	.	.	5.17	0.97961	.	D	D	.	.	.	.	.	.	.	536391|648|648	29806	0.94248	0.95664	0.998121440410614	.	.	0.71675	0.80631	.	.	.	9.943	.	.	.	.	.	.	613706|163950	0.9894	7	.	ENSG00000157764	.	.	.	.	.	2	0.88579	0.45529	.	.	.	.	0.845660358607975	YES	.	0.440713	38761	HGNC:1097	.	.	.	0.973	.	140801550	ACG	1.000000	.	-	.	0.97976	.	.	.	Pathogenic	0.94604	.	.	.	UniProtKB:P15056#VAR_058622,OMIM:164757.0023,ClinGen:CA259663	T	.	.	-	0.93	-	0.96886	.	.	0.97131	0.916709661484	0.9977	.	0.99652661569364764	.	-	722C>G 	.	.	C0950123|C5555857|C3661900|C3150970|C4551602	.	.	.	.	NM_004333.6	-	.	.	1	0.95725	387906660	.	.	0.98932	0.92720	.	.	.	0.99600226	5.17	.	.	.	0.484891	0.999963000543786	0.88626	D	.	.	.	0.9426	0.95778	p.Thr241Arg	.	.	-14.509	0.9803134	.	0.99297	29806	D	.	BRAF	.	D	.	.	T241R	.	.	0.70176	./.	principal4																																																																																																				
BRAF_Thr241Arg	-8.877044476380464	0.0000466454663945854	6.127715259649578	0.000477871903155989	2025_01_Batch_13-14	0.8299258911292273	0.7721124795906301	0.8035507867832169	0.7584846614033833	0.7485082955646319											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003154		NC_000007.14:140801550:G:C		Thr241Arg																												BRAF_Thr241Arg	7	140801550	G	C	7	allele	722C>G	D05	527_CAVA_Array_P01	G09	B13A7A8P1_R1	B14A7A8P1_R2				7-140801550-G-C	-	0.90554	1.0	241	.	.	.	7	140501350	C	.	.	7	1_Pathogenic	NC_000007.14	.	Thr241Arg	.	31.0	.	.	.	D	.	5	.	.	.	.	.	.	.	0.99124	Select	0.8732	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.98061	.	.	.	.	0.77586	.	.	0.93899	0.94	.	.	0.983902	.	.	C	single nucleotide variant	NC_000007.14:g.140801550G>C	.	.	3	0.90271693	.	.	0.94158983	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0013379,MedGen:C3150970,OMIM:613706,Orphanet:648|MONDO:MONDO:0008104,MedGen:C4551602,OMIM:163950,Orphanet:648|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	.	.	.	.	0.86984	D	0.94691	D	M	10.64868	.	./.	.	.	.	.	Noonan syndrome 7|Noonan syndrome 1|RASopathy|Inborn genetic diseases|not provided	.	0.96274	.	.	-	140801550	.	-	11.755000	.	0.98982	.	.	.	.	germline	.	Gain of solvent accessibility (P = 0.008)| Gain of relative solvent accessibility (P = 0.0289)| Gain of MoRF binding (P = 0.033)| Gain of methylation at T241 (P = 0.0391)| Loss of ubiquitination at K240 (P = 0.0594)	0.98894	GRCh38	794	criteria provided, multiple submitters, no conflicts	c.722C>G	.	0.70808	.	.	.	Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Diacylglycerol/phorbol-ester binding|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain|Protein kinase C-like, phorbol ester/diacylglycerol-binding domain	.	.	P	.	.	NM_004333.6(BRAF):c.722C>G (p.Thr241Arg)	2	.	BRAF_HUMAN	.	.	0.884148484170867	.	D	0.98500	0.92752135	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.97933	.	.	.	.	.	p.Thr241Arg	.	0.95501	.	germline	.		G	Feb 01, 2023	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000057185|SCV000743069|SCV003440618	Pathogenic	.	.	Arg	R	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.672	G	.	5.408322	0.53421	D	.	-	11.61548	.	0.94148	.	.	.	0.93238	.	140801550	Y	10	.	.	.	P15056	.	0.89813	0.77405		.	0.998	D	.	0.8970028	.	0.48078	673	0.503099	.	.	.	.	0.91343	.	.	.	.	.	.	0.95103	7	BRAF	.	.	Thr	.	.	7-140801550-G-C	Inborn_genetic_diseases|RASopathy|not_provided|Noonan_syndrome_7|Noonan_syndrome_1	.	.	140147819	ClinGen:CA259663|OMIM:164757.0023|UniProtKB:P15056#VAR_058622	0.880398	0.90911	.	RCV000022679|RCV000208548|RCV002513171|RCV000624512|RCV001703420	D	.	.	c.722C>G	.	.	.	0.94327	./.	rs387906660	140801550	.	G	.	P15056	.	0.95338	.	0.68239		.	.	.	3.175	.	.	.	5.17	0.97961	.	D	D	.	.	.	.	.	.	.	536391|648|648	29806	0.94248	0.95664	0.998121440410614	.	.	0.71675	0.80631	.	.	.	9.943	.	.	.	.	.	.	613706|163950	0.9894	7	.	ENSG00000157764	.	.	.	.	.	2	0.88579	0.45529	.	.	.	.	0.845660358607975	YES	.	0.440713	38761	HGNC:1097	.	.	.	0.973	.	140801550	ACG	1.000000	.	-	.	0.97976	.	.	.	Pathogenic	0.94604	.	.	.	UniProtKB:P15056#VAR_058622,OMIM:164757.0023,ClinGen:CA259663	T	.	.	-	0.93	-	0.96886	.	.	0.97131	0.916709661484	0.9977	.	0.99652661569364764	.	-	722C>G 	.	.	C0950123|C5555857|C3661900|C3150970|C4551602	.	.	.	.	NM_004333.6	-	.	.	1	0.95725	387906660	.	.	0.98932	0.92720	.	.	.	0.99600226	5.17	.	.	.	0.484891	0.999963000543786	0.88626	D	.	.	.	0.9426	0.95778	p.Thr241Arg	.	.	-14.509	0.9803134	.	0.99297	29806	D	.	BRAF	.	D	.	.	T241R	.	.	0.70176	./.	principal4																																																																																																				
BRAF_Val600Gly	3.466058469875043	0.010461482848769289	-2.3131620225658573	0.05393497039622505	2025_01_Batch_13-14	0.7373529082522765	0.8261058599222147	0.7598807105682761	0.742019466013257	0.6857756328655163	0.8034884350566569	0.9460347609785704	0.9197325531156546	0.9277834274342123	0.7887870651356114	0.7704206716544667	0.8860703104503926	0.8398066318419654	0.8349014467237346	0.7372813490005639	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220618	CCSBVarC003172	ALE00003172	NC_000007.14:140753336:A:C	1799T>G	Val600Gly	CEGS2	CegsMutGDEh1021	A01	GDEhDisVCh_40058	A09	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Val600Gly	7	140753336	A	C	7											7-140753336-A-C	-	0.90129	0.822	600	.	.	.	7	140453136	C	.	.	7	1_Pathogenic	NC_000007.14	.	Val600Gly	.	31.0	.	.	.	T	.	4	.	.	.	.	.	.	.	0.98152	Select	0.3689	.	0.45782	.	.	D	D	.	.	.	.	.	.	.	0.87585	.	.	.	.	.	.	.	0.98880	0.999	.	.	0.874613	.	.	C	single nucleotide variant	NC_000007.14:g.140753336A>C	.	.	3	0.9476951	.	.	0.9755868	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.99291	D	0.98836	P	L	5.322119	.	./.	.	.	.	.	Cardio-facio-cutaneous syndrome|not provided|RASopathy	.	0.72748	.	.	-	140753336	.	-	11.216000	.	0.99985	.	.	.	.	germline;unknown	.	Loss of stability (P = 0.0081)| Gain of disorder (P = 0.0094)| Gain of ubiquitination at K601 (P = 0.0582)| Gain of phosphorylation at S605 (P = 0.152)| Loss of sheet (P = 0.1907)	0.87927	GRCh38	789	reviewed by expert panel	c.1799T>G	.	0.86862	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1799T>G (p.Val600Gly)	3	.	BRAF_HUMAN	.	.	0.535279311356242	.	D	0.94797	0.9773177	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99303	.	.	.	.	.	p.Val600Gly	.	0.89597	.	germline	.		A	Jun 25, 2020	.	./.	.	.	1.0	Y	7q34	.	.	.	SCV001424737	Pathogenic	.	.	Gly	G	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.75	A	.	5.376319	.	D	.	-	6.300693	.	0.85412	.	.	.	0.87816	.	140753336	Y	10	.	.	.	P15056	.	0.854038	0.76475		.	0.963	D	.	0.95782745	.	0.91597	673	0.414274	.	.	.	.	.	.	.	.	.	.	.	0.98232	7	BRAF	.	.	Val	.	.	7-140753336-A-C	Cardio-facio-cutaneous_syndrome|RASopathy|Melanoma|not_provided	.	.	140099605	ClinGen:CA281998|Genetic_Testing_Registry_(GTR):GTR000522729|Genetic_Testing_Registry_(GTR):GTR000569880	0.917884	0.69026	.	RCV000208774|RCV001354831|RCV000798913	D	.	.	c.1799T>G	.	.	.	0.90651	./.	rs113488022	140753336	.	A	.	P15056	.	0.98734	.	0.68239		.	.	.	1.53	.	.	.	5.65	0.96676	.	D	D	.	.	.	.	.	.	.	1340|536391	40389	0.90535	0.91438	0.995703637599945	.	.	0.71675	0.88572	.	.	.	9.236	.	.	.	.	.	.	PS115150	0.94487	7	.	ENSG00000157764	.	.	.	.	.	2	0.70837	0.46282	.	.	.	.	0.606101544715016	YES	.	0.179839	48859	HGNC:1097	.	.	.	1	.	140753336	GTG	1.000000	.	-	.	0.90136	.	.	.	Pathogenic	0.96920	.	.	.	ClinGen:CA281998	V	.	.	-	0.749	-	.	.	.	0.95955	0.836802065372	0.9773	.	0.99637999643544239	.	-	1799T>G 	.	.	C1275081|C5555857|C0025202|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.58418	113488022	.	.	0.98536	0.75248	.	.	.	0.99933314	5.65	.	.	.	0.357299	0.999897984516839	0.38641	T	.	.	.	-0.3730	0.72751	p.Val600Gly	.	.	-15.5	0.9087879	.	0.98645	40389	D	.	BRAF	.	D	.	.	V600G	.	.	0.87077	./.	principal4																																																																																																				
BRAF_Val600Gly	3.466058469875043	0.010461482848769289	-2.3131620225658573	0.05393497039622505	2025_01_Batch_13-14	0.7373529082522765	0.8261058599222147	0.7598807105682761	0.742019466013257	0.6857756328655163	0.8034884350566569	0.9460347609785704	0.9197325531156546	0.9277834274342123	0.7887870651356114	0.7704206716544667	0.8860703104503926	0.8398066318419654	0.8349014467237346	0.7372813490005639	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003172		NC_000007.14:140753336:A:C		Val600Gly																												BRAF_Val600Gly	7	140753336	A	C	7	allele	1799T>G	C05	527_CAVA_Array_P01	E09	B13A7A8P1_R1	B14A7A8P1_R2				7-140753336-A-C	-	0.90129	0.822	600	.	.	.	7	140453136	C	.	.	7	1_Pathogenic	NC_000007.14	.	Val600Gly	.	31.0	.	.	.	T	.	4	.	.	.	.	.	.	.	0.98152	Select	0.3689	.	0.45782	.	.	D	D	.	.	.	.	.	.	.	0.87585	.	.	.	.	.	.	.	0.98880	0.999	.	.	0.874613	.	.	C	single nucleotide variant	NC_000007.14:g.140753336A>C	.	.	3	0.9476951	.	.	0.9755868	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.99291	D	0.98836	P	L	5.322119	.	./.	.	.	.	.	Cardio-facio-cutaneous syndrome|not provided|RASopathy	.	0.72748	.	.	-	140753336	.	-	11.216000	.	0.99985	.	.	.	.	germline;unknown	.	Loss of stability (P = 0.0081)| Gain of disorder (P = 0.0094)| Gain of ubiquitination at K601 (P = 0.0582)| Gain of phosphorylation at S605 (P = 0.152)| Loss of sheet (P = 0.1907)	0.87927	GRCh38	789	reviewed by expert panel	c.1799T>G	.	0.86862	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1799T>G (p.Val600Gly)	3	.	BRAF_HUMAN	.	.	0.535279311356242	.	D	0.94797	0.9773177	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99303	.	.	.	.	.	p.Val600Gly	.	0.89597	.	germline	.		A	Jun 25, 2020	.	./.	.	.	1.0	Y	7q34	.	.	.	SCV001424737	Pathogenic	.	.	Gly	G	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.75	A	.	5.376319	.	D	.	-	6.300693	.	0.85412	.	.	.	0.87816	.	140753336	Y	10	.	.	.	P15056	.	0.854038	0.76475		.	0.963	D	.	0.95782745	.	0.91597	673	0.414274	.	.	.	.	.	.	.	.	.	.	.	0.98232	7	BRAF	.	.	Val	.	.	7-140753336-A-C	Cardio-facio-cutaneous_syndrome|RASopathy|Melanoma|not_provided	.	.	140099605	ClinGen:CA281998|Genetic_Testing_Registry_(GTR):GTR000522729|Genetic_Testing_Registry_(GTR):GTR000569880	0.917884	0.69026	.	RCV000208774|RCV001354831|RCV000798913	D	.	.	c.1799T>G	.	.	.	0.90651	./.	rs113488022	140753336	.	A	.	P15056	.	0.98734	.	0.68239		.	.	.	1.53	.	.	.	5.65	0.96676	.	D	D	.	.	.	.	.	.	.	1340|536391	40389	0.90535	0.91438	0.995703637599945	.	.	0.71675	0.88572	.	.	.	9.236	.	.	.	.	.	.	PS115150	0.94487	7	.	ENSG00000157764	.	.	.	.	.	2	0.70837	0.46282	.	.	.	.	0.606101544715016	YES	.	0.179839	48859	HGNC:1097	.	.	.	1	.	140753336	GTG	1.000000	.	-	.	0.90136	.	.	.	Pathogenic	0.96920	.	.	.	ClinGen:CA281998	V	.	.	-	0.749	-	.	.	.	0.95955	0.836802065372	0.9773	.	0.99637999643544239	.	-	1799T>G 	.	.	C1275081|C5555857|C0025202|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.58418	113488022	.	.	0.98536	0.75248	.	.	.	0.99933314	5.65	.	.	.	0.357299	0.999897984516839	0.38641	T	.	.	.	-0.3730	0.72751	p.Val600Gly	.	.	-15.5	0.9087879	.	0.98645	40389	D	.	BRAF	.	D	.	.	V600G	.	.	0.87077	./.	principal4																																																																																																				
BRAF_Gly596Val	2.2257131093137597	0.06135777408658752	-3.8089973889178856	0.006636562833595199	2025_01_Batch_13-14	0.9381108039505246	0.9650002822404748	0.9443067789577735	0.9621695175747484	0.8710569467787093	0.968324621416676	0.9827263301360674	0.984221210961115	0.9883622952676646	0.8773427495051593	0.9532177126836003	0.9738633061882711	0.9642639949594443	0.9752659064212066	0.8741998481419343	1.0	1.0	0.0	1.0	1.0	1.0	1.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220614	CCSBVarC003171	ALE00003171	NC_000007.14:140753348:C:A	1787G>T	Gly596Val	CEGS2	CegsMutGDEh1020	G07	GDEhDisVCh_40058	F08	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Gly596Val	7	140753348	C	A	7											7-140753348-C-A	-	0.92161	1.0	596	.	.	.	7	140453148	A	.	.	7	1_Pathogenic	NC_000007.14	.	Gly596Val	.	32.0	.	.	.	D	.	12	.	.	.	.	.	.	.	0.99969	Select	0.6951	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.98320	.	.	.	.	.	.	.	0.99934	0.999	.	.	0.99514	.	.	A	single nucleotide variant	NC_000007.14:g.140753348C>A	.	.	3	0.98400426	.	.	0.99520737	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	.	.	.	.	0.97926	D	0.99912	D	M	7.749107	.	./.	.	.	.	.	RASopathy|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiofaciocutaneous syndrome 1|not provided|Inborn genetic diseases	.	0.92395	.	.	-	140753348	.	-	7.673000	.	0.99985	.	.	.	.	germline;unknown	.	Loss of sheet (P = 0.0817)| Loss of ubiquitination at K601 (P = 0.0992)| Loss of disorder (P = 0.1248)| Gain of methylation at K591 (P = 0.1331)| Loss of catalytic residue at G596 (P = 0.1549)	0.99859	GRCh38	789	reviewed by expert panel	c.1787G>T	.	0.86862	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1787G>T (p.Gly596Val)	3	.	BRAF_HUMAN	.	.	0.742007177940642	.	D	0.99584	0.9940386	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99632	.	.	.	.	.	p.Gly596Val	.	0.64945	.	germline	.		C	Apr 03, 2017	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000616388	Pathogenic	.	.	Val	V	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.595	C	.	5.562398	.	D	.	-	8.732487	.	0.93272	.	.	.	0.96398	.	140753348	Y	10	.	.	.	P15056	.	0.963797	0.88381		.	1.0	D	.	0.98436314	.	0.91597	673	0.575047	.	.	.	.	.	.	.	.	.	.	.	0.99906	7	BRAF	.	.	Gly	.	.	7-140753348-C-A	Transitional_cell_carcinoma_of_the_bladder|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|Inborn_genetic_diseases|Glioblastoma|not_provided|RASopathy|Multiple_myeloma|Lung_adenocarcinoma|Cardiofaciocutaneous_syndrome_1	.	.	140099617	ClinGen:CA220161|UniProtKB:P15056#VAR_035098	0.917943	0.82286	.	RCV000033332|RCV000208758|RCV000844615|RCV000856749|RCV000077865|RCV001265809	D	.	.	c.1787G>T	.	.	.	0.96883	./.	rs397507483	140753348	.	C	.	P15056	.	0.99966	.	0.68239		.	.	.	3.295	.	.	.	5.65	0.99550	.	D	D	.	.	.	.	.	.	.	1340|648|360|536391|29073|85443|1340	40387	0.96832	0.96552	0.999177873134613	.	.	0.71675	0.88587	.	.	.	7.831	.	.	.	.	.	.	PS115150|PS163950|254500|115150	0.84961	7	.	ENSG00000157764	.	.	.	.	.	2	0.97365	0.46282	.	.	.	.	0.747081129508623	YES	.	0.395627	48857	HGNC:1097	.	.	.	1	.	140753348	GGT	1.000000	.	-	.	0.99538	.	.	.	Pathogenic	0.88207	.	.	.	ClinGen:CA220161,UniProtKB:P15056#VAR_035098	G	.	.	-	0.986	-	.	.	.	0.98578	0.919968366623	0.9996	.	0.99798908246520857	.	-	1787G>T 	.	.	C0279680|C1275081|C0028326|C0950123|C0017636|C3661900|C5555857|C0026764|C0152013|CN029449	.	.	.	.	NM_004333.6	-	.	.	1	0.98365	397507483	.	.	0.98509	0.85861	.	.	.	0.99971479	5.65	.	.	.	0.588239	0.999992243767439	0.90281	D	.	.	.	0.6405	0.89454	p.Gly596Val	.	.	-12.721	0.99041414	.	0.99831	40387	D	.	BRAF	.	D	.	.	G596V	.	.	0.32887	./.	principal4																																																																																																				
BRAF_Gly596Val	2.2257131093137597	0.06135777408658752	-3.8089973889178856	0.006636562833595199	2025_01_Batch_13-14	0.9381108039505246	0.9650002822404748	0.9443067789577735	0.9621695175747484	0.8710569467787093	0.968324621416676	0.9827263301360674	0.984221210961115	0.9883622952676646	0.8773427495051593	0.9532177126836003	0.9738633061882711	0.9642639949594443	0.9752659064212066	0.8741998481419343	1.0	1.0	0.0	1.0	1.0	1.0	1.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003171		NC_000007.14:140753348:C:A		Gly596Val																												BRAF_Gly596Val	7	140753348	C	A	7	allele	1787G>T	B05	527_CAVA_Array_P01	C09	B13A7A8P1_R1	B14A7A8P1_R2				7-140753348-C-A	-	0.92161	1.0	596	.	.	.	7	140453148	A	.	.	7	1_Pathogenic	NC_000007.14	.	Gly596Val	.	32.0	.	.	.	D	.	12	.	.	.	.	.	.	.	0.99969	Select	0.6951	.	0.90580	.	.	D	D	.	.	.	.	.	.	.	0.98320	.	.	.	.	.	.	.	0.99934	0.999	.	.	0.99514	.	.	A	single nucleotide variant	NC_000007.14:g.140753348C>A	.	.	3	0.98400426	.	.	0.99520737	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340|MONDO:MONDO:0015280,MedGen:C1275081,OMIM:PS115150,Orphanet:1340;MONDO:MONDO:0018997,MeSH:D009634,MedGen:C0028326,OMIM:PS163950,Orphanet:648|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	.	.	.	.	0.97926	D	0.99912	D	M	7.749107	.	./.	.	.	.	.	RASopathy|Cardio-facio-cutaneous syndrome|Cardio-facio-cutaneous syndrome;Noonan syndrome|Cardiofaciocutaneous syndrome 1|not provided|Inborn genetic diseases	.	0.92395	.	.	-	140753348	.	-	7.673000	.	0.99985	.	.	.	.	germline;unknown	.	Loss of sheet (P = 0.0817)| Loss of ubiquitination at K601 (P = 0.0992)| Loss of disorder (P = 0.1248)| Gain of methylation at K591 (P = 0.1331)| Loss of catalytic residue at G596 (P = 0.1549)	0.99859	GRCh38	789	reviewed by expert panel	c.1787G>T	.	0.86862	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1787G>T (p.Gly596Val)	3	.	BRAF_HUMAN	.	.	0.742007177940642	.	D	0.99584	0.9940386	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99632	.	.	.	.	.	p.Gly596Val	.	0.64945	.	germline	.		C	Apr 03, 2017	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000616388	Pathogenic	.	.	Val	V	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.595	C	.	5.562398	.	D	.	-	8.732487	.	0.93272	.	.	.	0.96398	.	140753348	Y	10	.	.	.	P15056	.	0.963797	0.88381		.	1.0	D	.	0.98436314	.	0.91597	673	0.575047	.	.	.	.	.	.	.	.	.	.	.	0.99906	7	BRAF	.	.	Gly	.	.	7-140753348-C-A	Transitional_cell_carcinoma_of_the_bladder|Cardio-facio-cutaneous_syndrome|Noonan_syndrome|Inborn_genetic_diseases|Glioblastoma|not_provided|RASopathy|Multiple_myeloma|Lung_adenocarcinoma|Cardiofaciocutaneous_syndrome_1	.	.	140099617	ClinGen:CA220161|UniProtKB:P15056#VAR_035098	0.917943	0.82286	.	RCV000033332|RCV000208758|RCV000844615|RCV000856749|RCV000077865|RCV001265809	D	.	.	c.1787G>T	.	.	.	0.96883	./.	rs397507483	140753348	.	C	.	P15056	.	0.99966	.	0.68239		.	.	.	3.295	.	.	.	5.65	0.99550	.	D	D	.	.	.	.	.	.	.	1340|648|360|536391|29073|85443|1340	40387	0.96832	0.96552	0.999177873134613	.	.	0.71675	0.88587	.	.	.	7.831	.	.	.	.	.	.	PS115150|PS163950|254500|115150	0.84961	7	.	ENSG00000157764	.	.	.	.	.	2	0.97365	0.46282	.	.	.	.	0.747081129508623	YES	.	0.395627	48857	HGNC:1097	.	.	.	1	.	140753348	GGT	1.000000	.	-	.	0.99538	.	.	.	Pathogenic	0.88207	.	.	.	ClinGen:CA220161,UniProtKB:P15056#VAR_035098	G	.	.	-	0.986	-	.	.	.	0.98578	0.919968366623	0.9996	.	0.99798908246520857	.	-	1787G>T 	.	.	C0279680|C1275081|C0028326|C0950123|C0017636|C3661900|C5555857|C0026764|C0152013|CN029449	.	.	.	.	NM_004333.6	-	.	.	1	0.98365	397507483	.	.	0.98509	0.85861	.	.	.	0.99971479	5.65	.	.	.	0.588239	0.999992243767439	0.90281	D	.	.	.	0.6405	0.89454	p.Gly596Val	.	.	-12.721	0.99041414	.	0.99831	40387	D	.	BRAF	.	D	.	.	G596V	.	.	0.32887	./.	principal4																																																																																																				
CTCF_His455Gln	3.8257806455949326	0.006493290691325369	-3.9544631677107454	0.00550049482130096	2025_01_Batch_13-14	0.9144240132292991	0.9697413493209072	0.8484144726341254	0.8540200173951931	0.8175221726722572	0.8970715001416795	0.8606907982883133	0.7778673713016637	0.8237783231600767	0.8122234796292092	0.9057477566854892	0.9152160738046102	0.8131409219678946	0.8388991702776349	0.8148728261507332	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF		6173		CCSBVarC010858		NC_000016.10:67626562:C:G		His455Gln																												CTCF_His455Gln	16	67626562	C	G	16	allele	1365C>G	A02	527_CAVA_Array_P02	A04	B13A7A8P1_R1	B14A7A8P1_R2				16-67626562-C-G	-	0.56146	0.997	455	.	.	.	16	67660465	G	.	.	16	1_Pathogenic	NC_000016.10	.	His455Gln	.	23.7	.	.	.	T	.	1	1	.	.	.	.	.	.	0.82939	Select	0.3925	.	0.70687	.	.	D	D	.	3.03790854674	.	.	.	.	.	0.95192	.	.	.	.	0.95091	.	.	0.98182	0.99	.	18.0	.	2.62	0.82	G	single nucleotide variant	NC_000016.10:g.67626562C>G	.	.	2	0.83204865	.	.	0.969477	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611	.	.	.	.	0.88440	D	0.90192	D	H	4.666273	.	C/C	.	.	.	.	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome	.	0.75966	.	.	-	67626562	.	-	0.800000	.	0.92591	.	.	.	.	germline	.	Gain of MoRF binding (P = 0.0878)| Loss of helix (P = 0.1706)| Gain of disorder (P = 0.19)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2629)	0.87844	GRCh38	53	criteria provided, single submitter	c.1365C>G	.	0.25354	.	.	.	.	.	.	.	.	.	NM_006565.4(CTCF):c.1365C>G (p.His455Gln)	1	.	CTCF_HUMAN	.	82.0	0.449511622968474	.	.	0.99795	0.969477	+	.	.		.	.	2	.	criteria_provided,_single_submitter	0.96704	.	.	.	.	.	p.His455Gln	.	0.21732	.	germline	.		C	Jun 10, 2019	.	C/C	.	.	1.0	N	16q22.1	.	.	.	SCV001160523	Likely_pathogenic	.	.	Gln	Q	-	.	ENSP00000264010	ENST00000264010	.	0.0	.	.	-0.182	C	.	3.86468	0.92967	D	D	-	3.898847	.	0.83093	.	.	.	0.80030	.	67626562	Y	10	.	.	.	P49711	.	0.917886	0.53677		.	0.992	D	.	0.83204865	.	0.65338	10664	0.309664	.	-7.51	.	.	0.91343	.	.	.	.	.	.	0.90192	16	CTCF	.	.	His	.	.	16-67626562-C-G	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome	.	.	66217966	.	0.530946	0.63986	.	RCV001002552	D	.	.	c.1365C>G	.	.	.	0.83603	C/C	rs1597725291	67626562	.	C	.	P49711	.	0.98182	.	0.35501		.	.	.	4.485	.	.	.	1.99	0.98488	.	D	D	.	.	.	.	.	.	.	363611	812003	0.83391	0.99266	0.989961684048839	.	.	0.71675	0.54986	.	.	.	2.183	.	D	.	.	.	.	615502	0.42298	16	.	ENSG00000102974	.	.	.	.	.	3	0.80453	0.97599	.	.	.	.	0.33042528030055	YES	.	0.149609	799962	HGNC:13723	A	.	simple_aae	0.864	.	67626562	CAC	0.999000	.	-	.	0.88083	.	.	.	Likely pathogenic	0.89952	.	.	.	ClinGen:CA396317165	H	.	0.949006423897	-	0.748	-	0.92320	.	.	0.97634	0.889497578144	.	.	0.99143631297156454	.	-	1365C>G 	.	.	C3809686	.	.	.	.	NM_006565.4	-	.	.	1	0.80399	1597725291	.	.	0.94804	0.57107	0.92	0.0	.	0.98982334	5.48	.	.	.	0.207035	0.99981684735099	0.98910	T	.	.	.	-0.2605	0.74513	p.His455Gln	.	.	-13.14	0.8887602	.	0.98120	812003	D	.	CTCF	.	D	0.579	.	H455Q	D	0.47948	0.10118	C/C	principal4	966000	CTCF_unpublished_var160247	Yes						overall function		Cell survival			H		1365	CTCF_unpublished		ENST00000264010.10							immortalized human cells					p.His455Gln		true	c.1365C>G						13723.0	67626562.0	Yes		CTCF				NM_006565.4		1.0			nucleotide		G									criteria provided, single submitter				His455Gln						Q	Jun 10, 2019					missense_variant		455.0	C			-0.295056		Likely pathogenic	67626562.0	missense_variant		0.579	functionally_abnormal				Cell viability			CTCF_His455Gln
CTCF_His455Gln	3.8257806455949326	0.006493290691325369	-3.9544631677107454	0.00550049482130096	2025_01_Batch_13-14	0.9144240132292991	0.9697413493209072	0.8484144726341254	0.8540200173951931	0.8175221726722572	0.8970715001416795	0.8606907982883133	0.7778673713016637	0.8237783231600767	0.8122234796292092	0.9057477566854892	0.9152160738046102	0.8131409219678946	0.8388991702776349	0.8148728261507332	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	CTCF	CTCF				CCSBVarC010858	ALE00014571	NC_000016.10:67626562:C:G	1365C>G	His455Gln	CAVA																											CTCF_His455Gln	16	67626562	C	G	16								1	1	1	16-67626562-C-G	-	0.56146	0.997	455	.	.	.	16	67660465	G	.	.	16	1_Pathogenic	NC_000016.10	.	His455Gln	.	23.7	.	.	.	T	.	1	1	.	.	.	.	.	.	0.82939	Select	0.3925	.	0.70687	.	.	D	D	.	3.03790854674	.	.	.	.	.	0.95192	.	.	.	.	0.95091	.	.	0.98182	0.99	.	18.0	.	2.62	0.82	G	single nucleotide variant	NC_000016.10:g.67626562C>G	.	.	2	0.83204865	.	.	0.969477	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0014213,MedGen:C3809686,OMIM:615502,Orphanet:363611	.	.	.	.	0.88440	D	0.90192	D	H	4.666273	.	C/C	.	.	.	.	Intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome	.	0.75966	.	.	-	67626562	.	-	0.800000	.	0.92591	.	.	.	.	germline	.	Gain of MoRF binding (P = 0.0878)| Loss of helix (P = 0.1706)| Gain of disorder (P = 0.19)| Gain of loop (P = 0.2045)| Gain of relative solvent accessibility (P = 0.2629)	0.87844	GRCh38	53	criteria provided, single submitter	c.1365C>G	.	0.25354	.	.	.	.	.	.	.	.	.	NM_006565.4(CTCF):c.1365C>G (p.His455Gln)	1	.	CTCF_HUMAN	.	82.0	0.449511622968474	.	.	0.99795	0.969477	+	.	.		.	.	2	.	criteria_provided,_single_submitter	0.96704	.	.	.	.	.	p.His455Gln	.	0.21732	.	germline	.		C	Jun 10, 2019	.	C/C	.	.	1.0	N	16q22.1	.	.	.	SCV001160523	Likely_pathogenic	.	.	Gln	Q	-	.	ENSP00000264010	ENST00000264010	.	0.0	.	.	-0.182	C	.	3.86468	0.92967	D	D	-	3.898847	.	0.83093	.	.	.	0.80030	.	67626562	Y	10	.	.	.	P49711	.	0.917886	0.53677		.	0.992	D	.	0.83204865	.	0.65338	10664	0.309664	.	-7.51	.	.	0.91343	.	.	.	.	.	.	0.90192	16	CTCF	.	.	His	.	.	16-67626562-C-G	Intellectual_disability-feeding_difficulties-developmental_delay-microcephaly_syndrome	.	.	66217966	.	0.530946	0.63986	.	RCV001002552	D	.	.	c.1365C>G	.	.	.	0.83603	C/C	rs1597725291	67626562	.	C	.	P49711	.	0.98182	.	0.35501		.	.	.	4.485	.	.	.	1.99	0.98488	.	D	D	.	.	.	.	.	.	.	363611	812003	0.83391	0.99266	0.989961684048839	.	.	0.71675	0.54986	.	.	.	2.183	.	D	.	.	.	.	615502	0.42298	16	.	ENSG00000102974	.	.	.	.	.	3	0.80453	0.97599	.	.	.	.	0.33042528030055	YES	.	0.149609	799962	HGNC:13723	A	.	simple_aae	0.864	.	67626562	CAC	0.999000	.	-	.	0.88083	.	.	.	Likely pathogenic	0.89952	.	.	.	ClinGen:CA396317165	H	.	0.949006423897	-	0.748	-	0.92320	.	.	0.97634	0.889497578144	.	.	0.99143631297156454	.	-	1365C>G 	.	.	C3809686	.	.	.	.	NM_006565.4	-	.	.	1	0.80399	1597725291	.	.	0.94804	0.57107	0.92	0.0	.	0.98982334	5.48	.	.	.	0.207035	0.99981684735099	0.98910	T	.	.	.	-0.2605	0.74513	p.His455Gln	.	.	-13.14	0.8887602	.	0.98120	812003	D	.	CTCF	.	D	0.579	.	H455Q	D	0.47948	0.10118	C/C	principal4	966000	CTCF_unpublished_var160247	Yes						overall function		Cell survival			H		1365	CTCF_unpublished		ENST00000264010.10							immortalized human cells					p.His455Gln		true	c.1365C>G						13723.0	67626562.0	Yes		CTCF				NM_006565.4		1.0			nucleotide		G									criteria provided, single submitter				His455Gln						Q	Jun 10, 2019					missense_variant		455.0	C			-0.295056		Likely pathogenic	67626562.0	missense_variant		0.579	functionally_abnormal				Cell viability			CTCF_His455Gln
RAD51D_Ile17Val	0.8297191536322671	0.4340774464288859	15.438748804892429	1.1544372823221078e-6	2025_01_Batch_13-14	0.8462395722954138	0.9107998287096768	0.9677655186059482	0.9061313570579054	0.8558146293961573	0.8723700191028847	0.896111988582963	0.9544031038289187	0.9328278757579709	0.7865085636764857	0.8593047956991493	0.9034559086463199	0.9610843112174334	0.9194796164079382	0.8211615965363215	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024709		NC_000017.11:35119565:T:C		Ile17Val																												RAD51D_Ile17Val	17	35119565	T	C	17	allele	49A>G	F01	527_CAVA_Array_P05	K01	B13A7A8P2_R1	B14A7A8P2_R2				17-35119565-T-C	-	0.19582	0.0	17	.	0	.	17	33446584	C	8.061170e-06	.	17	3_Conflicting	NC_000017.11	1	Ile17Val	.	14.32	.	0	.	T	0	7	5	.	.	.	.	.	0	0.06252	.	0.0324	.	0.02950	.	.	T	T	62816	.	0	0	.	.	.	.	.	44872	0	.	0.07402	.	.	0.02476	0.792	.	83.0	0.689731	1.23	0.17	C	single nucleotide variant	NC_000017.11:g.35119565T>C	0	.	2	0.046668846	.	0	0.029664483	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	0.000000e+00	0	0.40172	B	0.06571	B	N	0.4445345	13	T/T	84	0	.	1612670	Breast-ovarian cancer, familial, susceptibility to, 4|not specified|not provided|Hereditary cancer-predisposing syndrome	.	0.31138	.	.	-	35119565	.	-	1.583000	.	0.02411	29600	0	60000	.	germline;unknown	91086	Gain of helix (P = 0.0854)| Gain of MoRF binding (P = 0.2615)| Loss of loop (P = 0.3664)| Loss of catalytic residue at L19 (P = 0.4141)| Gain of disorder (P = 0.4367)	0.37869	GRCh38	926	criteria provided, conflicting classifications	c.49A>G	.	0.28182	0	.	.	RAD51D, N-terminal domain	.	.	B	0	0.000000e+00	NM_002878.4(RAD51D):c.49A>G (p.Ile17Val)	1	.	RA51D_HUMAN	.	17.0	-0.963300152951958	.	T	0.22858	0.029664483	-	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.75187	.	0	.	.	60000	p.Ile17Val	0	0.27571	.	germline	.		T	Oct 09, 2024	.	T/T	.	.	0.997	N	17q12	6962	.	.	SCV000957288|SCV001134803|SCV001348793|SCV002066151|SCV002642374|SCV005054047|SCV005202652	Conflicting_classifications_of_pathogenicity	.	.	Val	V	-	912	ENSP00000378090	ENST00000394589	.	1.0	.	.	-0.201	T	.	1.523251	0.01173	N	T	-	0.8120932	.	0.47336	610	.	.	0.06971	0	35119565	Y	10	0	.	0.000000e+00	O75771	.	0.075739	0.08798		.	0.001	T	.	0.046668846	.	0.37428	5892	-0.308413	11	-0.03	.	1.666670e-05	0.00968	.	.	74904	.	6084	.	0.06570	17	RAD51D	0.000000e+00	0	Ile	10680	.	17-35119565-T-C	Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	0	.	30470697	.	0.077523	0.09283	0	RCV000816764|RCV001816897|RCV000986016|RCV001183136	T	0	.	c.49A>G	.	0	0	0.07683	T/T	rs1002032036	35119565	.	T	.	O75771	.	0.02476	.	0.28131		.	.	0.000000e+00	-0.695	0	0	.	2.36	0.34990	108	T	.	.	.	0	24	.	.	.	145|140162	659719	0.06732	0.07621	0.0592468314962335	2294	.	0.40243	0.15429	.	.	1179940	0.452	.	N	.	.	.	0	614291	0.21585	17	.	ENSG00000185379	0.000000e+00	0	.	0	.	1	0.04348	0.17784	.	.	.	1.666670e-05	-0.761465596440251	.	0.000000e+00	0.024558	645822	HGNC:9823	N	.	simple_aae	0.018	.	35119565	ATC	0.906000	.	-	0	0.04229	9.322510e-06	0	0	Conflicting classifications of pathogenicity	0.17524	.	0	1	ClinGen:CA290007271	I	.	0.429666569261	-	0.37	-	0.02082	.	466	0.13960	.	0.0821	0	0.6845253055721503	94	-	49A>G 	.	0	C3280345|C0027672|CN169374|C3661900	.	.	.	.	NM_002878.4	-	.	.	0	0.29652	1002032036	.	0	0.42198	0.15180	0.046	1.0	2210	0.25106364	4.37	.	.	.	-0.680791	8.01046792450614e-05	0.01869	T	84	.	.	-0.9952	0.13833	p.Ile17Val	0	0	-2.791	0.04814577	0	0.02668	659719	T	.	RAD51D	.	T	0.028	.	I17V	T	0.31344	0.08901	T/T	principal1	963058	RAD51D_unpublished_var157305	Yes						overall function		Cell survival			I		49	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Ile17Val		true	c.49A>G						9823.0	35119565.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		G									criteria provided, conflicting classifications				Ile17Val						V	Jul 11, 2024					missense_variant		17.0	A		8.0611656445e-6	-0.0206904		Conflicting classifications of pathogenicity	35119565.0	missense_variant		0.028	functionally_normal				Cell viability			RAD51D_Ile17Val
BRCA1_Thr587Arg	-0.4548873787721197	0.6629621326061451	7.926953340626399	0.00009664275201696506	2025_01_Batch_13-14	0.9122962314024993	0.914388731015901	0.8807865638647172	0.9193700972050594	0.8179770783922686	0.9243496868775378	0.8900549220076304	0.9045064548376147	0.9357637402398886	0.8313383016906821	0.9183229591400186	0.9022218265117656	0.892646509351166	0.927566918722474	0.8246576900414754	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218425	CCSBVarC003304	ALE00003304	NC_000017.11:43067610:G:C	1760C>G	Thr587Arg	CEGS2	CegsMutGDEh1003	H05	GDEhDisVCh_40059	C01	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Thr587Arg	17	43067610	G	C	17											17-43067610-G-C	-	0.64569	0.585	1691	.	.	.	17	41219627	C	.	.	17	1_Pathogenic	NC_000017.11	.	Thr1691Arg	.	24.7	.	.	.	D	.	4	1	.	.	.	.	.	.	0.94900	.	0.6944	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.76658	.	.	.	.	0.81626	.	.	0.96231	0.985	.	.	0.952305	.	.	C	single nucleotide variant	NC_000017.11:g.43067610G>C	.	.	3	0.7571084	.	.	0.955418	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	.	.	.	B	0.90111	P	M	8.314456	.	G/G	.	.	.	.	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	.	0.90791	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43067610	.	-	11.808000	.	0.99793	.	.	.	.	germline;not applicable	.	.	.	GRCh38	545	criteria provided, multiple submitters, no conflicts	.	.	0.72825	.	.	.	BRCT domain|BRCT domain|BRCT domain	.	.	.	.	.	NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg)	2	.	BRCA1_HUMAN	.	.	0.775208299271413	.	D	0.88256	0.950228	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99835	.	.	.	.	.	.	.	0.96854	.	germline	.		G	Oct 04, 2021	.	G/G	.	.	1.0	N	17q21.31	.	.	.	SCV002537807|SCV002644099	Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000478114	ENST00000618469	.	.	.	.	0.569	G	.	4.249871	0.92967	D	.	-	8.492664	.	0.98314	.	.	.	0.74950	.	43067610	Y	10	.	.	.	P38398	.	0.292953	0.68015		.	0.218	D	.	0.8308187	.	0.61072	672	0.409641	.	.	.	.	0.91343	.	.	.	.	.	.	0.85471	17	BRCA1	.	.	Thr	.	.	17-43067610-G-C	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38473153	ClinGen:CA003189	0.838290	0.84447	.	RCV000577017|RCV001077998|RCV002257395	.	.	.	c.5072C>G	.	.	.	0.90394	G/G	rs80357034	43067610	.	G	.	.	.	0.96765	.	0.68239		.	.	.	3.175	.	.	.	5.24	0.76109	.	D	T	.	.	.	.	.	.	.	227535|140162|145	55373	0.90276	0.15475	0.983474791049957	.	.	0.71675	0.75493	.	.	.	6.008	.	.	.	.	.	.	114480|604370	0.70468	17	.	ENSG00000012048	.	.	.	.	.	2	0.92348	0.72635	.	.	.	.	0.736429675756228	.	.	0.786117	70040	HGNC:1100	.	.	.	0.994	.	43067610	ACA	1.000000	.	-	.	0.86953	.	.	.	Likely pathogenic	0.63425	.	.	.	ClinGen:CA003189	T	.	.	-	.	-	0.90585	.	.	0.79901	0.765162229538	.	.	0.99500239805060597	.	-	5072C>G 	.	.	C0346153|C0027672|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.85727	80357034	.	.	0.94962	0.85057	.	.	.	0.99986839	5.24	.	.	.	0.350645	0.991494696303718	0.88626	D	.	.	.	0.5201	0.89429	p.Thr1691Arg	.	.	-6.573	.	.	0.89054	55373	T	.	BRCA1	.	D	.	.	.	.	.	0.28905	G/G	principal2																																																																																																				
BRCA1_Thr587Arg	-0.4548873787721197	0.6629621326061451	7.926953340626399	0.00009664275201696506	2025_01_Batch_13-14	0.9122962314024993	0.914388731015901	0.8807865638647172	0.9193700972050594	0.8179770783922686	0.9243496868775378	0.8900549220076304	0.9045064548376147	0.9357637402398886	0.8313383016906821	0.9183229591400186	0.9022218265117656	0.892646509351166	0.927566918722474	0.8246576900414754	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003304		NC_000017.11:43067610:G:C		Thr587Arg																												BRCA1_Thr587Arg	17	43067610	G	C	17	allele	1760C>G	D07	527_CAVA_Array_P01	G13	B13A7A8P1_R1	B14A7A8P1_R2				17-43067610-G-C	-	0.64569	0.585	1691	.	.	.	17	41219627	C	.	.	17	1_Pathogenic	NC_000017.11	.	Thr1691Arg	.	24.7	.	.	.	D	.	4	1	.	.	.	.	.	.	0.94900	.	0.6944	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	0.76658	.	.	.	.	0.81626	.	.	0.96231	0.985	.	.	0.952305	.	.	C	single nucleotide variant	NC_000017.11:g.43067610G>C	.	.	3	0.7571084	.	.	0.955418	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	.	.	.	B	0.90111	P	M	8.314456	.	G/G	.	.	.	.	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	.	0.90791	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43067610	.	-	11.808000	.	0.99793	.	.	.	.	germline;not applicable	.	.	.	GRCh38	545	criteria provided, multiple submitters, no conflicts	.	.	0.72825	.	.	.	BRCT domain|BRCT domain|BRCT domain	.	.	.	.	.	NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg)	2	.	BRCA1_HUMAN	.	.	0.775208299271413	.	D	0.88256	0.950228	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99835	.	.	.	.	.	.	.	0.96854	.	germline	.		G	Oct 04, 2021	.	G/G	.	.	1.0	N	17q21.31	.	.	.	SCV002537807|SCV002644099	Likely_pathogenic	.	.	Arg	R	-	.	ENSP00000478114	ENST00000618469	.	.	.	.	0.569	G	.	4.249871	0.92967	D	.	-	8.492664	.	0.98314	.	.	.	0.74950	.	43067610	Y	10	.	.	.	P38398	.	0.292953	0.68015		.	0.218	D	.	0.8308187	.	0.61072	672	0.409641	.	.	.	.	0.91343	.	.	.	.	.	.	0.85471	17	BRCA1	.	.	Thr	.	.	17-43067610-G-C	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	.	.	38473153	ClinGen:CA003189	0.838290	0.84447	.	RCV000577017|RCV001077998|RCV002257395	.	.	.	c.5072C>G	.	.	.	0.90394	G/G	rs80357034	43067610	.	G	.	.	.	0.96765	.	0.68239		.	.	.	3.175	.	.	.	5.24	0.76109	.	D	T	.	.	.	.	.	.	.	227535|140162|145	55373	0.90276	0.15475	0.983474791049957	.	.	0.71675	0.75493	.	.	.	6.008	.	.	.	.	.	.	114480|604370	0.70468	17	.	ENSG00000012048	.	.	.	.	.	2	0.92348	0.72635	.	.	.	.	0.736429675756228	.	.	0.786117	70040	HGNC:1100	.	.	.	0.994	.	43067610	ACA	1.000000	.	-	.	0.86953	.	.	.	Likely pathogenic	0.63425	.	.	.	ClinGen:CA003189	T	.	.	-	.	-	0.90585	.	.	0.79901	0.765162229538	.	.	0.99500239805060597	.	-	5072C>G 	.	.	C0346153|C0027672|C2676676	.	.	.	.	NM_007294.4	-	.	.	1	0.85727	80357034	.	.	0.94962	0.85057	.	.	.	0.99986839	5.24	.	.	.	0.350645	0.991494696303718	0.88626	D	.	.	.	0.5201	0.89429	p.Thr1691Arg	.	.	-6.573	.	.	0.89054	55373	T	.	BRCA1	.	D	.	.	.	.	.	0.28905	G/G	principal2																																																																																																				
BRCA1_Pro533Leu	-0.7528200911783965	0.47610774311243165	5.735636261825845	0.0007088088193576657	2025_01_Batch_13-14	0.8966973181666507	0.9046777827911453	0.8366561191366582	0.8836138891142781	0.846603016213943	0.9912462879532155	0.9120658558726263	0.9363661078945147	0.9848881106736286	0.8643488539991834	0.9439718030599331	0.9083718193318858	0.8865111135155864	0.9342509998939533	0.8554759351065632	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC013043		NC_000017.11:43071004:G:A		Pro533Leu																												BRCA1_Pro533Leu	17	43071004	G	A	17	allele	1598C>T	F10	527_CAVA_Array_P01	K19	B13A7A8P1_R1	B14A7A8P1_R2				17-43071004-G-A	-	0.27171	0.364	1637	7	0	0	17	41223021	A	3.717320e-05	0	17	2_Benign	NC_000017.11	57	Pro1637Leu	0	17.35	0	0	4.871960e-05	D	0	15	.	42768	2.111330e-05	.	30526	0.000000e+00	0	0.82485	.	0.7232	102628	0.66535	0	.	T	D	64024	.	0	0	0.000000e+00	0	0	0.09880	17110	44898	0	0.000000e+00	0.81462	1	.	0.07827	0.031	.	.	.	2.66	.	A	single nucleotide variant	NC_000017.11:g.43071004G>A	0	16730	2	0.055308446	109402	0	0.038577784	0		7	236818	0	0	0.000000e+00	146	2.338200e-05	0	MedGen:CN169374|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0007254,MedGen:C0006142|	1	0	0.000000e+00	0	0.53339	B	0.07993	B	L	2.761733	60	G/G	298	0	7164	1614068	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Hereditary breast ovarian cancer syndrome|Malignant tumor of breast|BRCA1-related disorder	16218	0.90403	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43071004	2.338200e-05	-	6.732000	0	0.66835	29608	0	1180046	0	germline;not applicable;unknown	91086	.	.	GRCh38	543	reviewed by expert panel	.	0.000000e+00	0.61594	1	0	0	.	0.000000e+00	9046	.	0	0.000000e+00	NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu)	3	0	BRCA1_HUMAN	0	.	0.0679651651785688	0	.	0.23603	0.046824034	-	0.000000e+00	.		7	0.000000e+00	0	34258	reviewed_by_expert_panel	0.99403	9.140600e-06	0	0.000000e+00	0	60004	.	0	0.56527	.	germline	1		G	Aug 10, 2015	0	G/G	0	89482	0.75	N	17q21.31	19780	.	0.000000e+00	SCV000244372	Benign	0	0	Leu	L	-	912	ENSP00000518978	ENST00000713676	17692	.	13416	0	-0.105	G	0	2.130503	0.79703	N	.	-	2.130881	.	0.94460	610	0	.	0.21745	0	43071004	Y	10	0	102628	0.000000e+00	P38398	0	0.271505	0.41758		0	0.057	D	89482	0.050610814	42768	0.13278	672	0.206619	57	.	.	4.830320e-05	0.58783	0.000000e+00	0	74916	0.000000e+00	6084	0	0.09687	17	BRCA1	0.000000e+00	0	Pro	30890	7.822800e-05	17-43071004-G-A	Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|BRCA1-related_disorder|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_specified	0	5	38476547	BRCA1-HCI:BRCA1_00090|ClinGen:CA003076|UniProtKB:P38398#VAR_007794	0.144722	0.44715	0	RCV000048691|RCV000077589|RCV000162989|RCV000586145|RCV001084321|RCV001358461|RCV004554683	.	0	0	c.4910C>T	0	0	0	0.74322	G/G	rs80357048	43071004	14902	G	.	.	15690	0.05118	0.000000e+00	0.68239		0	0	0.000000e+00	1.935	0	1	264690	4.82	0.64184	112	T	T	0	0.000000e+00	0	26	.	0	0	140162|145|145	55314	0.82413	0.09620	0.231254577636719	8162	.	0.29224	0.26561	0.000000e+00	7.822800e-05	1180046	0.768	3.364540e-05	.	13390	0	1.51120175E-5	0	604370	0.26344	17	0.000000e+00	ENSG00000012048	0.000000e+00	5.0556117290192114E-5	0	0	.	2	0.65195	0.72771	30608	4	4.871960e-05	0.000000e+00	-0.0712680779194096	.	0.000000e+00	0.458461	69981	HGNC:1100	.	0	.	0.431	208052	43071004	CCA	1.000000	.	-	0	0.62760	4.830320e-05	0	0	Benign	0.18016	0	0	0	BRCA1-HCI:BRCA1_00090,ClinGen:CA003076,UniProtKB:P38398#VAR_007794	P	0	.	-	.	-	0.43554	5	1982	0.27141	0.296533286572	.	0	0.98451927561516039	98	-	4910C>T 	5	0	C0027672|C0006142|C3661900|C0677776|C2676676|CN169374	0	0	0	0	NM_007294.4	-	.	.	0	0.48325	80357048	2320	3.237293622531564E-5	0.90380	0.36281	.	.	7864	0.99945563	4.82	.	.	0.000000e+00	0.189468	0.544346036701319	0.51654	D	86	6212	9572	0.4923	0.90488	p.Pro1637Leu	0	0	-3.524	.	0	0.62126	55314	T	30522	BRCA1	0.000000e+00	D	.	21626	.	.	0.48641	0.15707	G/G	principal2																																																																																																				
SHOC2_Leu174Phe	1.1759562196714102	0.2780523239715201	-1.9936040449264232	0.08643071743388651	2025_01_Batch_13-14	0.9295363964837904	0.9520932679612392	0.8115757110971933	0.9278015806273477	0.8310827847603361	0.9381013085387566	0.8911017667912078	0.8714141234060793	0.8963413969822411	0.9398888078018313	0.9338188525112735	0.9215975173762234	0.8414949172516363	0.9120714888047945	0.8854857962810837	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	SHOC2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																											
KRAS_Gly60Ser	-0.09720436679761342	0.9252887309563864	1.0463836155630004	0.3301649148324332	2025_01_Batch_13-14	0.922883940850429	0.9301994656009873	0.8885677701163717	0.9536311326762618	0.8033730258089217	0.4571340525190196	0.4377233061169961	0.5734952407648954	0.5612314373421075	0.4678445095810778	0.6900089966847243	0.6839613858589917	0.7310315054406336	0.7574312850091847	0.6356087676949997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS	ENSG00000133703	3084	214489	CCSBVarC006098	ALE00006098	NC_000012.12:25227346:C:T	178G>A	Gly60Ser	CEGS2	CegsMutGDEh1036	F02	GDEhDisVCh_40061	A09	1	CegsMutGDDh1036	F02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	3	0			0			0			KRAS_Gly60Ser	12	25227346	C	T	12											12-25227346-C-T	-	0.88766	1.0	60	.	.	.	12	25380280	T	.	.	12	1_Pathogenic	NC_000012.12	.	Gly60Ser	.	29.7	.	0	.	D	.	6	1	.	.	.	.	.	0	0.98815	Plus_Clinical	0.9342	.	0.90580	.	.	D	D	.	2.69341285729	0	.	.	.	.	0.98783	.	.	.	.	0.88318	.	.	0.98214	1.0	.	5.0	0.966103	3.95	0.95	T	single nucleotide variant	NC_000012.12:g.25227346C>T	.	.	3	0.94146484	.	0	0.98016226	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	.	.	.	.	0.94956	D	0.99077	D	M	16.26098	.	C/C	0	0	.	.	Noonan syndrome 3|not provided|RASopathy|Cardiofaciocutaneous syndrome 2	.	0.98496	.	.	-	25227346	.	-	7.701000	.	0.99892	.	0	.	.	de novo;germline	.	Gain of catalytic residue at L56 (P = 0.0034)| Gain of disorder (P = 0.0769)| Gain of phosphorylation at G60 (P = 0.0926)| Loss of sheet (P = 0.1398)| Loss of helix (P = 0.2022)	0.90105	GRCh38	855	criteria provided, multiple submitters, no conflicts	c.178G>A	.	0.91065	0	.	.	Small GTP-binding domain	.	.	P	0	.	NM_033360.4(KRAS):c.178G>A (p.Gly60Ser)	2	.	RASK_HUMAN	.	95.0	1.06893418515311	.	D	0.98500	0.9698139	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99274	.	.	.	.	.	p.Gly60Ser	.	0.66341	.	germline	.		C	Mar 29, 2024	.	C/C	.	.	1.0	N	12p12.1	0	.	.	SCV000207869|SCV000816735|SCV002318974|SCV002768383	Pathogenic	.	.	Ser	S	-	.	ENSP00000256078	ENST00000256078	.	0.001	.	.	0.58	C	.	5.28558	0.92967	D	D	-	18.70474	.	0.93510	0	.	.	0.96329	0	25227346	Y	10	0	.	.	P01116	.	0.929646	0.96438		.	1.0	D	.	0.96225566	.	0.97202	3845	0.524795	.	-5.82	.	.	0.78662	.	.	.	.	.	.	0.97832	12	KRAS	.	0	Gly	478	.	12-25227346-C-T	not_provided|RASopathy|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2	.	.	25271547	ClinGen:CA256484|OMIM:190070.0020|UniProtKB:P01116#VAR_065146	0.908603	0.97500	.	RCV000013428|RCV000157934|RCV000689097|RCV002470709	D	.	.	c.178G>A	.	.	.	0.94982	C/C	rs104894359	25227346	.	C	.	P01116	.	0.99107	.	0.68239		.	.	.	3.195	0	0	.	5.77	0.98786	0	D	D	.	.	0	0	.	.	.	536391|648|1340	12597	0.94909	0.98552	0.999157786369324	426	.	0.71675	0.86363	.	.	.	7.892	.	D	.	.	.	0	609942|615278	0.85894	12	.	ENSG00000133703	.	0	.	0	0.9459025843081321	1	0.97365	0.34655	.	.	.	.	0.997770489382923	.	.	0.407238	27636	HGNC:6407	A	.	simple_aae	0.997	.	25227346	GGT	1.000000	.	-	0	0.94136	.	0	.	Pathogenic	0.87851	.	.	.	OMIM:190070.0020,ClinGen:CA256484,UniProtKB:P01116#VAR_065146	G	.	0.996255802933	-	0.776	-	0.96773	.	52	0.94539	0.926605463028	0.9985	.	0.9989031345780135	0	-	178G>A 	.	0	C3661900|C5555857|C1860991|C3809005	.	.	.	.	NM_033360.4	-	.	.	1	0.87543	104894359	.	0	0.99616	0.98575	0.958	0.001	426	0.99929273	5.77	.	.	.	0.516055	0.999680939266056	0.88911	D	0	.	.	1.0665	0.97828	p.Gly60Ser	0	.	-12.139	0.9487096	.	0.97477	12597	D	.	KRAS	.	D	0.943	.	G60S	D	0.75212	0.29757	C/C	alternative1																																																																																																				
KRAS_Gly60Ser	-0.09720436679761342	0.9252887309563864	1.0463836155630004	0.3301649148324332	2025_01_Batch_13-14	0.922883940850429	0.9301994656009873	0.8885677701163717	0.9536311326762618	0.8033730258089217	0.4571340525190196	0.4377233061169961	0.5734952407648954	0.5612314373421075	0.4678445095810778	0.6900089966847243	0.6839613858589917	0.7310315054406336	0.7574312850091847	0.6356087676949997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	KRAS	KRAS		3084		CCSBVarC006098		NC_000012.12:25227346:C:T		Gly60Ser																												KRAS_Gly60Ser	12	25227346	C	T	12	allele	178G>A	H07	527_CAVA_Array_P03	P13	B13A7A8P1_R1	B14A7A8P1_R2				12-25227346-C-T	-	0.88766	1.0	60	.	.	.	12	25380280	T	.	.	12	1_Pathogenic	NC_000012.12	.	Gly60Ser	.	29.7	.	0	.	D	.	6	1	.	.	.	.	.	0	0.98815	Plus_Clinical	0.9342	.	0.90580	.	.	D	D	.	2.69341285729	0	.	.	.	.	0.98783	.	.	.	.	0.88318	.	.	0.98214	1.0	.	5.0	0.966103	3.95	0.95	T	single nucleotide variant	NC_000012.12:g.25227346C>T	.	.	3	0.94146484	.	0	0.98016226	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0012371,MedGen:C1860991,OMIM:609942,Orphanet:648|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0014112,MedGen:C3809005,OMIM:615278,Orphanet:1340	.	.	.	.	0.94956	D	0.99077	D	M	16.26098	.	C/C	0	0	.	.	Noonan syndrome 3|not provided|RASopathy|Cardiofaciocutaneous syndrome 2	.	0.98496	.	.	-	25227346	.	-	7.701000	.	0.99892	.	0	.	.	de novo;germline	.	Gain of catalytic residue at L56 (P = 0.0034)| Gain of disorder (P = 0.0769)| Gain of phosphorylation at G60 (P = 0.0926)| Loss of sheet (P = 0.1398)| Loss of helix (P = 0.2022)	0.90105	GRCh38	855	criteria provided, multiple submitters, no conflicts	c.178G>A	.	0.91065	0	.	.	Small GTP-binding domain	.	.	P	0	.	NM_033360.4(KRAS):c.178G>A (p.Gly60Ser)	2	.	RASK_HUMAN	.	95.0	1.06893418515311	.	D	0.98500	0.9698139	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99274	.	.	.	.	.	p.Gly60Ser	.	0.66341	.	germline	.		C	Mar 29, 2024	.	C/C	.	.	1.0	N	12p12.1	0	.	.	SCV000207869|SCV000816735|SCV002318974|SCV002768383	Pathogenic	.	.	Ser	S	-	.	ENSP00000256078	ENST00000256078	.	0.001	.	.	0.58	C	.	5.28558	0.92967	D	D	-	18.70474	.	0.93510	0	.	.	0.96329	0	25227346	Y	10	0	.	.	P01116	.	0.929646	0.96438		.	1.0	D	.	0.96225566	.	0.97202	3845	0.524795	.	-5.82	.	.	0.78662	.	.	.	.	.	.	0.97832	12	KRAS	.	0	Gly	478	.	12-25227346-C-T	not_provided|RASopathy|Noonan_syndrome_3|Cardiofaciocutaneous_syndrome_2	.	.	25271547	ClinGen:CA256484|OMIM:190070.0020|UniProtKB:P01116#VAR_065146	0.908603	0.97500	.	RCV000013428|RCV000157934|RCV000689097|RCV002470709	D	.	.	c.178G>A	.	.	.	0.94982	C/C	rs104894359	25227346	.	C	.	P01116	.	0.99107	.	0.68239		.	.	.	3.195	0	0	.	5.77	0.98786	0	D	D	.	.	0	0	.	.	.	536391|648|1340	12597	0.94909	0.98552	0.999157786369324	426	.	0.71675	0.86363	.	.	.	7.892	.	D	.	.	.	0	609942|615278	0.85894	12	.	ENSG00000133703	.	0	.	0	0.9459025843081321	1	0.97365	0.34655	.	.	.	.	0.997770489382923	.	.	0.407238	27636	HGNC:6407	A	.	simple_aae	0.997	.	25227346	GGT	1.000000	.	-	0	0.94136	.	0	.	Pathogenic	0.87851	.	.	.	OMIM:190070.0020,ClinGen:CA256484,UniProtKB:P01116#VAR_065146	G	.	0.996255802933	-	0.776	-	0.96773	.	52	0.94539	0.926605463028	0.9985	.	0.9989031345780135	0	-	178G>A 	.	0	C3661900|C5555857|C1860991|C3809005	.	.	.	.	NM_033360.4	-	.	.	1	0.87543	104894359	.	0	0.99616	0.98575	0.958	0.001	426	0.99929273	5.77	.	.	.	0.516055	0.999680939266056	0.88911	D	0	.	.	1.0665	0.97828	p.Gly60Ser	0	.	-12.139	0.9487096	.	0.97477	12597	D	.	KRAS	.	D	0.943	.	G60S	D	0.75212	0.29757	C/C	alternative1																																																																																																				
RAD51D_Gly289Ser	7.092665294834583	0.00019491549970907673	4.4242509106705175	0.0030654811896686784	2025_01_Batch_13-14	0.9505417159707916	0.8848897946836229	0.8829042769396422	0.8825882918074114	0.9324648798930826	0.9297212965001249	0.9409617617917445	0.9349827186011955	0.9512940765792127	0.8214073716130127	0.9401315062354583	0.9129257782376837	0.9089434977704189	0.916941184193312	0.8769361257530477	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024877		NC_000017.11:35101239:C:T		Gly289Ser																												RAD51D_Gly289Ser	17	35101239	C	T	17	allele	865G>A	D02	527_CAVA_Array_P05	G03	B13A7A8P2_R1	B14A7A8P2_R2				17-35101239-C-T	-	0.0421	0.008	289	1	0	0	17	33428258	T	6.814510e-06	0	17	3_Conflicting	NC_000017.11	1	Gly289Ser	0	1.022	0	.	3.275900e-05	T	0	5	5	42768	1.266260e-05	.	30526	0.000000e+00	.	0.06938	.	0.1048	30526	0.20016	1	.	T	T	64048	.	.	0	0.000000e+00	0	0	.	17112	44874	1	0.000000e+00	0.02351	1	.	0.00366	0.001	.	94.0	0.675032	-1.35	0.06	T	single nucleotide variant	NC_000017.11:g.35101239C>T	0	16730	2	0.023860626	109404	.	0.018450681	.		2	236918	0	0	0.000000e+00	.	2.338200e-05	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	2	0	0.000000e+00	0	0.18971	B	0.00404	B	N	0.1469401	11	C/C	.	.	7164	1614202	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	16214	0.25206	.	.	-	35101239	6.373490e-05	-	-0.662000	0	0.00393	29604	.	91088	0	germline	91088	Gain of phosphorylation at G289 (P = 0.0191)| Gain of glycosylation at G289 (P = 0.0564)| Loss of methylation at R290 (P = 0.0588)| Gain of disorder (P = 0.0724)| Gain of MoRF binding (P = 0.1175)	0.41625	GRCh38	912	criteria provided, conflicting classifications	c.865G>A	3.275900e-05	0.15050	.	0	0	DNA repair protein RAD51 homolog 4, C-terminal	0.000000e+00	9046	B	.	0.000000e+00	NM_002878.4(RAD51D):c.865G>A (p.Gly289Ser)	1	0	RA51D_HUMAN	0	6.0	-1.33388171991115	0	T	0.06786	0.018450681	-	0.000000e+00	.		1	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.70195	1.828090e-05	0	0.000000e+00	0	60024	p.Gly289Ser	0	0.08011	.	germline	1		C	Nov 29, 2024	1	C/C	0	89538	0.037	N	17q12	.	.	0.000000e+00	SCV000185558|SCV000551343|SCV000569950|SCV000908946|SCV001363870	Conflicting_classifications_of_pathogenicity	0	0	Ser	S	-	912	ENSP00000378090	ENST00000394589	17692	.	13416	0	-0.181	C	0	-0.012147	0.10481	N	T	-	0.2024671	.	0.36140	.	0	.	0.02239	.	35101239	Y	10	.	102720	0.000000e+00	O75771	0	0.105892	0.10886		0	0.008	T	30608	0.023860626	15690	0.02614	5892	-0.28641	9	.	.	1.097840e-05	0.00968	6.373490e-05	0	75044	0.000000e+00	6062	0	0.00404	17	RAD51D	0.000000e+00	.	Gly	.	1.116840e-05	17-35101239-C-T	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_specified	0	1	30452371	ClinGen:CA166871	0.042395	0.03260	0	RCV000130672|RCV000462688|RCV000480701|RCV001194378	T	0	0	c.865G>A	0	0	0	0.09770	C/C	rs587782129	35101239	14902	C	.	O75771	15690	0.00366	0.000000e+00	0.08389		0	0	0.000000e+00	-0.395	.	.	.	0.314	0.41382	.	T	.	0	0.000000e+00	.	.	.	0	0	140162|145	141945	0.16804	0.36811	0.0316729542490267	.	.	0.20898	0.06461	2.918860e-05	3.267120e-05	1180036	0.155	9.610490e-06	.	13390	0	.	.	614291	0.16235	17	0.000000e+00	ENSG00000185379	0.000000e+00	.	1	.	.	1	0.16009	0.21478	30608	.	9.735200e-06	0.000000e+00	-1.31009436204477	.	1.097840e-05	0.015582	151659	HGNC:9823	N	0	simple_aae	0.008	208106	35101239	GGC	0.000000	.	-	.	0.04072	7.626890e-06	.	0	Conflicting classifications of pathogenicity	0.11831	1	0	0	ClinGen:CA166871	G	0	0.0762999501168	-	0.393	-	0.25080	3	.	0.22253	.	0.0718	0	0.74482722392783784	.	-	865G>A 	1	.	C3661900|C0027672|C3280345|CN169374	0	0	0	0	NM_002878.4	-	.	.	0	0.28091	587782129	2320	.	0.06748	0.04234	0.225	1.0	.	0.14648667	4.86	.	.	3.267120e-05	-0.55233	2.70558370001736e-05	0.03015	T	.	6212	9572	-1.0152	0.38180	p.Gly289Ser	.	0	-2.752	0.047472775	0	0.01340	141945	T	30522	RAD51D	0.000000e+00	T	0.030	21628	G289S	.	0.14151	0.10317	C/C	principal1	959383	RAD51D_unpublished_var153630	Yes						overall function		Cell survival			G		865	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Gly289Ser		true	c.865G>A						9823.0	35101239.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		A									criteria provided, conflicting classifications				Gly289Ser						S	May 29, 2024					missense_variant		289.0	G		6.8145126818e-6	-0.00125449		Conflicting classifications of pathogenicity	35101239.0	missense_variant		0.03	functionally_normal				Cell viability			RAD51D_Gly289Ser
RAD51D_Gly289Ser	7.092665294834583	0.00019491549970907673	4.4242509106705175	0.0030654811896686784	2025_01_Batch_13-14	0.9505417159707916	0.8848897946836229	0.8829042769396422	0.8825882918074114	0.9324648798930826	0.9297212965001249	0.9409617617917445	0.9349827186011955	0.9512940765792127	0.8214073716130127	0.9401315062354583	0.9129257782376837	0.9089434977704189	0.916941184193312	0.8769361257530477	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024877	ALE00029794	NC_000017.11:35101239:C:T	865G>A	Gly289Ser	CAVA																											RAD51D_Gly289Ser	17	35101239	C	T	17								1	1	1	17-35101239-C-T	-	0.0421	0.008	289	1	0	0	17	33428258	T	6.814510e-06	0	17	3_Conflicting	NC_000017.11	1	Gly289Ser	0	1.022	0	.	3.275900e-05	T	0	5	5	42768	1.266260e-05	.	30526	0.000000e+00	.	0.06938	.	0.1048	30526	0.20016	1	.	T	T	64048	.	.	0	0.000000e+00	0	0	.	17112	44874	1	0.000000e+00	0.02351	1	.	0.00366	0.001	.	94.0	0.675032	-1.35	0.06	T	single nucleotide variant	NC_000017.11:g.35101239C>T	0	16730	2	0.023860626	109404	.	0.018450681	.		2	236918	0	0	0.000000e+00	.	2.338200e-05	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900|MedGen:CN169374	2	0	0.000000e+00	0	0.18971	B	0.00404	B	N	0.1469401	11	C/C	.	.	7164	1614202	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not provided|not specified	16214	0.25206	.	.	-	35101239	6.373490e-05	-	-0.662000	0	0.00393	29604	.	91088	0	germline	91088	Gain of phosphorylation at G289 (P = 0.0191)| Gain of glycosylation at G289 (P = 0.0564)| Loss of methylation at R290 (P = 0.0588)| Gain of disorder (P = 0.0724)| Gain of MoRF binding (P = 0.1175)	0.41625	GRCh38	912	criteria provided, conflicting classifications	c.865G>A	3.275900e-05	0.15050	.	0	0	DNA repair protein RAD51 homolog 4, C-terminal	0.000000e+00	9046	B	.	0.000000e+00	NM_002878.4(RAD51D):c.865G>A (p.Gly289Ser)	1	0	RA51D_HUMAN	0	6.0	-1.33388171991115	0	T	0.06786	0.018450681	-	0.000000e+00	.		1	0.000000e+00	0	34260	criteria_provided,_conflicting_classifications	0.70195	1.828090e-05	0	0.000000e+00	0	60024	p.Gly289Ser	0	0.08011	.	germline	1		C	Nov 29, 2024	1	C/C	0	89538	0.037	N	17q12	.	.	0.000000e+00	SCV000185558|SCV000551343|SCV000569950|SCV000908946|SCV001363870	Conflicting_classifications_of_pathogenicity	0	0	Ser	S	-	912	ENSP00000378090	ENST00000394589	17692	.	13416	0	-0.181	C	0	-0.012147	0.10481	N	T	-	0.2024671	.	0.36140	.	0	.	0.02239	.	35101239	Y	10	.	102720	0.000000e+00	O75771	0	0.105892	0.10886		0	0.008	T	30608	0.023860626	15690	0.02614	5892	-0.28641	9	.	.	1.097840e-05	0.00968	6.373490e-05	0	75044	0.000000e+00	6062	0	0.00404	17	RAD51D	0.000000e+00	.	Gly	.	1.116840e-05	17-35101239-C-T	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|not_specified	0	1	30452371	ClinGen:CA166871	0.042395	0.03260	0	RCV000130672|RCV000462688|RCV000480701|RCV001194378	T	0	0	c.865G>A	0	0	0	0.09770	C/C	rs587782129	35101239	14902	C	.	O75771	15690	0.00366	0.000000e+00	0.08389		0	0	0.000000e+00	-0.395	.	.	.	0.314	0.41382	.	T	.	0	0.000000e+00	.	.	.	0	0	140162|145	141945	0.16804	0.36811	0.0316729542490267	.	.	0.20898	0.06461	2.918860e-05	3.267120e-05	1180036	0.155	9.610490e-06	.	13390	0	.	.	614291	0.16235	17	0.000000e+00	ENSG00000185379	0.000000e+00	.	1	.	.	1	0.16009	0.21478	30608	.	9.735200e-06	0.000000e+00	-1.31009436204477	.	1.097840e-05	0.015582	151659	HGNC:9823	N	0	simple_aae	0.008	208106	35101239	GGC	0.000000	.	-	.	0.04072	7.626890e-06	.	0	Conflicting classifications of pathogenicity	0.11831	1	0	0	ClinGen:CA166871	G	0	0.0762999501168	-	0.393	-	0.25080	3	.	0.22253	.	0.0718	0	0.74482722392783784	.	-	865G>A 	1	.	C3661900|C0027672|C3280345|CN169374	0	0	0	0	NM_002878.4	-	.	.	0	0.28091	587782129	2320	.	0.06748	0.04234	0.225	1.0	.	0.14648667	4.86	.	.	3.267120e-05	-0.55233	2.70558370001736e-05	0.03015	T	.	6212	9572	-1.0152	0.38180	p.Gly289Ser	.	0	-2.752	0.047472775	0	0.01340	141945	T	30522	RAD51D	0.000000e+00	T	0.030	21628	G289S	.	0.14151	0.10317	C/C	principal1	959383	RAD51D_unpublished_var153630	Yes						overall function		Cell survival			G		865	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Gly289Ser		true	c.865G>A						9823.0	35101239.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		A									criteria provided, conflicting classifications				Gly289Ser						S	May 29, 2024					missense_variant		289.0	G		6.8145126818e-6	-0.00125449		Conflicting classifications of pathogenicity	35101239.0	missense_variant		0.03	functionally_normal				Cell viability			RAD51D_Gly289Ser
ABCD1_Arg518Gln	6.2907017796871	0.00040780087036125073	0.28092595257451625	0.7868893052001034	2025_01_Batch_13-14	0.7135505295908988	0.7087000096964757	0.7749904408990131	0.739258531964679	0.6905931159218803	0.7870494806388876	0.7733477088703725	0.8030117544768121	0.8436387413301347	0.6804770706761727	0.7503000051148931	0.7410238592834242	0.7890010976879126	0.791448636647407	0.6855350932990265	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ABCD1	ABCD1	ENSG00000101986	100008637	209132	CCSBVarC007021	ALE00007019	NC_000023.11:153740156:G:A	1553G>A	Arg518Gln	CEGS2	CegsMutGDEh1023	H06	GDEhDisVCh_40030	H07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			ABCD1_Arg518Gln	23	153740156	G	A	X											X-153740156-G-A	-	0.89461	0.999	518	1	0	0	X	153005610	A	8.258550e-07	0	X	1_Pathogenic	NC_000023.11	1	Arg518Gln	0	30.0	0	0	1.370010e-05	D	0	13	1	30802	5.838900e-06	.	18836	0.000000e+00	0	0.98779	Select	0.9934	72992	0.77914	0	.	D	D	46886	1.62602313597	0	0	0.000000e+00	0	0	0.52286	13607	33820	0	0.000000e+00	0.69394	1	.	0.91065	0.904	.	20.0	0.994593	.	0.8	A	single nucleotide variant	NC_000023.11:g.153740156G>A	0	12095	2	0.8459693	79946	0	0.8978354	0	A	1	171265	0	0	0.000000e+00	0	3.246540e-05	0	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900|	1	0	0.000000e+00	0	0.87470	D	0.91118	D	M	.	1	G/G	0	0	5702	1210866	Adrenoleukodystrophy|not provided|ABCD1-related disorder	13127	0.96101	.	.	-	153740156	3.246540e-05	-	.	0	0.99166	22002	0	894577	0	germline;unknown	56926	Gain of methylation at K513 (P = 0.0396)| Loss of MoRF binding (P = 0.0759)| Gain of ubiquitination at K513 (P = 0.1295)| Loss of catalytic residue at R518 (P = 0.1494)| Loss of loop (P = 0.2237)	0.99725	GRCh38	56	criteria provided, multiple submitters, no conflicts	c.1553G>A	0.000000e+00	0.64349	0	0	0	ABC transporter-like, ATP-binding domain|ABC transporter-like, ATP-binding domain|AAA+ ATPase domain	0.000000e+00	6916	P	0	0.000000e+00	NM_000033.4(ABCD1):c.1553G>A (p.Arg518Gln)	2	0	ABCD1_HUMAN	0	80.0	.	0	D	0.85514	0.8978354	+	0.000000e+00	.	9.11811e-7	1	0.000000e+00	0	27059	criteria_provided,_multiple_submitters,_no_conflicts	0.99115	1.250840e-05	0	0.000000e+00	0	46080	p.Arg518Gln	0	.	.	germline	1	153740156	G	Sep 23, 2024	0	G/G	0	64282	1.0	N	Xq28	0	.	0.000000e+00	SCV000109784|SCV000840437|SCV001207477|SCV001338473|SCV001447138|SCV001812929|SCV002022800|SCV002045832|SCV002822049|SCV004206299|SCV004231793|SCV005418721	Pathogenic	0	0	Gln	Q	-	687	ENSP00000218104	ENST00000218104	13307	0.001	10125	0	0.676	G	0	5.329675	0.92967	.	D	-	.	.	0.99039	0	0	.	0.63942	0	153740156	Y	10	0	72992	0.000000e+00	P33897	0	0.956453	0.99945	G	0	0.984	D	64282	0.8459693	30802	0.44015	215	0.679029	1	-3.6	.	1.117850e-06	0.78662	0.000000e+00	0	57962	0.000000e+00	4348	0	0.91119	X	ABCD1	0.000000e+00	0	Arg	476	1.555650e-05	X-153740156-G-A	Adrenoleukodystrophy|not_provided	0	1	152658804	ClinGen:CA278403|UniProtKB:P33897#VAR_000070	.	.	0	RCV000077955|RCV000723540|RCV004752737	D	0	0	c.1553G>A	0	0	0	0.99908	G/G	rs398123102	153740156	12059	G	.	P33897	9880	0.91064	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.185	0	0	.	4.93	0.99402	0	D	T	0	0.000000e+00	0	0	.	0	0	43	92317	0.99907	0.89103	0.954029619693756	424	.	0.71675	.	0.000000e+00	1.555650e-05	894577	9.996	6.620370e-06	D	9842	0	.	0	300100	0.99292	X	0.000000e+00	ENSG00000101986	0.000000e+00	0	0	0	0.9166754227494129	2	0.76117	0.97530	18901	.	1.370010e-05	0.000000e+00	.	YES	0.000000e+00	0.874464	98228	HGNC:61	A	0	simple_aae	0.977	151049	153740156	CGG	1.000000	.	-	0	0.99935	1.117850e-06	0	0	Pathogenic	0.89579	0	0	0	ClinGen:CA278403,UniProtKB:P33897#VAR_000070	R	0	0.999847574799	-	0.971	-	0.80898	1	52	0.91590	0.596089541912	0.9361	0	0.99951095395162337	0	-	1553G>A 	1	0	C0162309|C3661900	0	0	0	0	NM_000033.4	-	.	.	1	0.98244	398123102	1752	0	0.99984	.	0.814	0.0	424	0.99904543	4.93	.	.	0.000000e+00	0.737601	0.999942948768151	0.61163	D	0	4606	6992	0.9308	0.99846	p.Arg518Gln	0	0	-13.047	0.9942995	0	0.99079	92317	D	24304	ABCD1	0.000000e+00	D	0.942	15893	R518Q	D	.	0.76753	G/G	principal1																																																																																																				
ABCD1_Arg518Gln	6.2907017796871	0.00040780087036125073	0.28092595257451625	0.7868893052001034	2025_01_Batch_13-14	0.7135505295908988	0.7087000096964757	0.7749904408990131	0.739258531964679	0.6905931159218803	0.7870494806388876	0.7733477088703725	0.8030117544768121	0.8436387413301347	0.6804770706761727	0.7503000051148931	0.7410238592834242	0.7890010976879126	0.791448636647407	0.6855350932990265	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ABCD1	ABCD1		100008637		CCSBVarC007021		NC_000023.11:153740156:G:A		Arg518Gln																												ABCD1_Arg518Gln	23	153740156	G	A	X	allele	1553G>A	D01	527_CAVA_Array_P01	G01	B13A7A8P1_R1	B14A7A8P1_R2				X-153740156-G-A	-	0.89461	0.999	518	1	0	0	X	153005610	A	8.258550e-07	0	X	1_Pathogenic	NC_000023.11	1	Arg518Gln	0	30.0	0	0	1.370010e-05	D	0	13	1	30802	5.838900e-06	.	18836	0.000000e+00	0	0.98779	Select	0.9934	72992	0.77914	0	.	D	D	46886	1.62602313597	0	0	0.000000e+00	0	0	0.52286	13607	33820	0	0.000000e+00	0.69394	1	.	0.91065	0.904	.	20.0	0.994593	.	0.8	A	single nucleotide variant	NC_000023.11:g.153740156G>A	0	12095	2	0.8459693	79946	0	0.8978354	0	A	1	171265	0	0	0.000000e+00	0	3.246540e-05	0	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900|	1	0	0.000000e+00	0	0.87470	D	0.91118	D	M	.	1	G/G	0	0	5702	1210866	Adrenoleukodystrophy|not provided|ABCD1-related disorder	13127	0.96101	.	.	-	153740156	3.246540e-05	-	.	0	0.99166	22002	0	894577	0	germline;unknown	56926	Gain of methylation at K513 (P = 0.0396)| Loss of MoRF binding (P = 0.0759)| Gain of ubiquitination at K513 (P = 0.1295)| Loss of catalytic residue at R518 (P = 0.1494)| Loss of loop (P = 0.2237)	0.99725	GRCh38	56	criteria provided, multiple submitters, no conflicts	c.1553G>A	0.000000e+00	0.64349	0	0	0	ABC transporter-like, ATP-binding domain|ABC transporter-like, ATP-binding domain|AAA+ ATPase domain	0.000000e+00	6916	P	0	0.000000e+00	NM_000033.4(ABCD1):c.1553G>A (p.Arg518Gln)	2	0	ABCD1_HUMAN	0	80.0	.	0	D	0.85514	0.8978354	+	0.000000e+00	.	9.11811e-7	1	0.000000e+00	0	27059	criteria_provided,_multiple_submitters,_no_conflicts	0.99115	1.250840e-05	0	0.000000e+00	0	46080	p.Arg518Gln	0	.	.	germline	1	153740156	G	Sep 23, 2024	0	G/G	0	64282	1.0	N	Xq28	0	.	0.000000e+00	SCV000109784|SCV000840437|SCV001207477|SCV001338473|SCV001447138|SCV001812929|SCV002022800|SCV002045832|SCV002822049|SCV004206299|SCV004231793|SCV005418721	Pathogenic	0	0	Gln	Q	-	687	ENSP00000218104	ENST00000218104	13307	0.001	10125	0	0.676	G	0	5.329675	0.92967	.	D	-	.	.	0.99039	0	0	.	0.63942	0	153740156	Y	10	0	72992	0.000000e+00	P33897	0	0.956453	0.99945	G	0	0.984	D	64282	0.8459693	30802	0.44015	215	0.679029	1	-3.6	.	1.117850e-06	0.78662	0.000000e+00	0	57962	0.000000e+00	4348	0	0.91119	X	ABCD1	0.000000e+00	0	Arg	476	1.555650e-05	X-153740156-G-A	Adrenoleukodystrophy|not_provided	0	1	152658804	ClinGen:CA278403|UniProtKB:P33897#VAR_000070	.	.	0	RCV000077955|RCV000723540|RCV004752737	D	0	0	c.1553G>A	0	0	0	0.99908	G/G	rs398123102	153740156	12059	G	.	P33897	9880	0.91064	0.000000e+00	0.68239	X	0	0	0.000000e+00	2.185	0	0	.	4.93	0.99402	0	D	T	0	0.000000e+00	0	0	.	0	0	43	92317	0.99907	0.89103	0.954029619693756	424	.	0.71675	.	0.000000e+00	1.555650e-05	894577	9.996	6.620370e-06	D	9842	0	.	0	300100	0.99292	X	0.000000e+00	ENSG00000101986	0.000000e+00	0	0	0	0.9166754227494129	2	0.76117	0.97530	18901	.	1.370010e-05	0.000000e+00	.	YES	0.000000e+00	0.874464	98228	HGNC:61	A	0	simple_aae	0.977	151049	153740156	CGG	1.000000	.	-	0	0.99935	1.117850e-06	0	0	Pathogenic	0.89579	0	0	0	ClinGen:CA278403,UniProtKB:P33897#VAR_000070	R	0	0.999847574799	-	0.971	-	0.80898	1	52	0.91590	0.596089541912	0.9361	0	0.99951095395162337	0	-	1553G>A 	1	0	C0162309|C3661900	0	0	0	0	NM_000033.4	-	.	.	1	0.98244	398123102	1752	0	0.99984	.	0.814	0.0	424	0.99904543	4.93	.	.	0.000000e+00	0.737601	0.999942948768151	0.61163	D	0	4606	6992	0.9308	0.99846	p.Arg518Gln	0	0	-13.047	0.9942995	0	0.99079	92317	D	24304	ABCD1	0.000000e+00	D	0.942	15893	R518Q	D	.	0.76753	G/G	principal1																																																																																																				
ABCD1_Arg389Gly	7.214936905963234	0.00017516911910830517	1.732320833545961	0.1268204557777738	2025_01_Batch_13-14	0.557767958912841	0.6887665001171852	0.727044639701077	0.6603323432592614	0.543234493297224	0.8741370157660132	0.7529031388632945	0.7293784355538133	0.8889883508748937	0.7400267442465908	0.7159524873394272	0.7208348194902399	0.7282115376274452	0.7746603470670775	0.6416306187719074	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ABCD1	ABCD1		100008637		CCSBVarC007023		NC_000023.11:153736195:C:G		Arg389Gly																												ABCD1_Arg389Gly	23	153736195	C	G	X	allele	1165C>G	C01	527_CAVA_Array_P01	E01	B13A7A8P1_R1	B14A7A8P1_R2				X-153736195-C-G	-	0.62608	0.999	389	.	.	.	X	153001649	G	.	.	X	1_Pathogenic	NC_000023.11	.	Arg389Gly	.	24.5	.	.	.	D	.	3	1	.	.	.	.	.	.	0.96308	Select	0.8189	.	0.77914	.	.	D	D	.	1.06563260916	.	.	.	.	.	0.65032	.	.	.	.	0.88932	.	.	0.79257	0.99	.	3.0	0.963104	.	0.97	G	single nucleotide variant	NC_000023.11:g.153736195C>G	.	.	3	0.6468293	.	.	0.7260219	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0018544,MedGen:C0162309,OMIM:300100,Orphanet:43|MedGen:C3661900	.	.	.	.	0.96253	D	0.79120	D	M	.	.	C/C	.	.	.	.	Adrenoleukodystrophy|not provided	.	0.93647	.	.	-	153736195	.	-	.	.	0.96292	.	.	.	.	germline	.	Loss of helix (P = 3e-04)| Gain of loop (P = 0.002)| Gain of sheet (P = 0.0036)| Loss of MoRF binding (P = 0.0526)| Loss of stability (P = 0.0594)	0.95057	GRCh38	56	criteria provided, multiple submitters, no conflicts	c.1165C>G	.	0.62327	.	.	.	.	.	.	P	.	.	NM_000033.4(ABCD1):c.1165C>G (p.Arg389Gly)	2	.	ABCD1_HUMAN	.	97.0	.	.	D	0.79060	0.7260219	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99678	.	.	.	.	.	p.Arg389Gly	.	.	.	germline	.		C	May 29, 2023	.	C/C	.	.	1.0	N	Xq28	.	.	.	SCV000932772|SCV004238662	Pathogenic	.	.	Gly	G	-	.	ENSP00000218104	ENST00000218104	.	0.001	.	.	0.599	C	.	4.162932	0.83643	.	D	-	.	.	0.92514	.	.	.	0.85058	.	153736195	Y	9	.	.	.	P33897	.	0.896327	0.84091		.	0.975	D	.	0.6468293	.	0.65338	215	0.570331	.	-5.91	.	.	0.78662	.	.	.	.	.	.	0.79121	X	ABCD1	.	.	Arg	.	.	X-153736195-C-G	not_provided|Adrenoleukodystrophy	.	.	152654843	ClinGen:CA278102|OMIM:300371.0005|UniProtKB:P33897#VAR_000062	.	.	.	RCV000012048|RCV003488335	D	.	.	c.1165C>G	.	.	.	0.96581	C/C	rs128624215	153736195	.	C	.	P33897	.	0.79256	.	0.68239		.	.	.	2.46	.	.	.	4.85	0.97912	.	D	T	.	.	.	.	.	.	.	43	11296	0.96524	0.76482	0.994085788726807	.	.	0.71675	.	.	.	.	2.238	.	D	.	.	.	.	300100	0.42822	X	.	ENSG00000101986	.	.	.	.	0.9960308022787095	1	0.73364	0.97530	.	.	.	.	.	YES	.	0.361811	26335	HGNC:61	A	.	simple_aae	0.926	.	153736195	CGC	1.000000	.	-	.	0.97172	.	.	.	Pathogenic	0.66907	.	.	.	ClinGen:CA278102,UniProtKB:P33897#VAR_000062,OMIM:300371.0005	R	.	0.999475327291	-	0.848	-	0.84989	.	.	0.99601	0.685714960098	0.8374	.	0.99748446393215284	.	-	1165C>G 	.	.	C3661900|C0162309	.	.	.	.	NM_000033.4	-	.	.	1	0.86253	128624215	.	.	0.99945	.	0.854	0.001	.	0.99975282	4.85	.	.	.	0.581464	0.999806454133949	0.71273	D	.	.	.	0.7399	0.93891	p.Arg389Gly	.	.	-8.866	0.97479206	.	0.98063	11296	D	.	ABCD1	.	D	0.876	.	R389G	D	.	0.40292	C/C	principal1																																																																																																				
F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	0.8294935729820571	0.8216646242841691	0.9049360006536924	0.9071619363443628	0.7980510018430784	0.5868911879567651	0.7554353355654199	0.8788361751032804	0.8262022757621769	0.6573453711983824	0.708192380469411	0.7885499799247945	0.8918860878784864	0.8666821060532699	0.7276981865207304	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T		Arg191Cys																												F9_Arg191Cys	23	139551112	C	T	X	allele	571C>T	B08	527_CAVA_Array_P02	C16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551112-C-T	-	0.46322	1.0	191	1	.	0	X	138633271	T	.	0	X	1_Pathogenic	NC_000023.11	.	Arg191Cys	0	22.3	0	0	1.361100e-05	D	.	9	1	30954	5.805680e-06	.	19004	0.000000e+00	0	0.93758	Select	0.8689	73470	0.90580	0	.	D	D	.	1.92440498635	0	.	0.000000e+00	0	0	0.34817	13667	.	.	0.000000e+00	0.68090	1	.	0.64653	0.058	.	22.0	0.90041	.	0.78	T	single nucleotide variant	NC_000023.11:g.139551112C>T	.	12192	3	0.22915632	80341	0	0.42700288	0		1	172245	0	0	0.000000e+00	436	3.230600e-05	0	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	.	.	0.90354	P	0.49838	D	M	.	.	C/C	168	0	5701	.	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13133	0.94814	.	.	-	139551112	3.230600e-05	-	4.855000	0	0.87767	.	0	.	0	germline;maternal	.	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.571C>T	0.000000e+00	0.46200	0	0	0	.	0.000000e+00	6917	A	0	.	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2	0	FA9_HUMAN	0	78.0	.	0	D	0.67153	0.4647663	+	0.000000e+00	.		1	0.000000e+00	0	27168	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	1.244690e-05	.	0.000000e+00	0	.	p.Arg191Cys	.	0.45490	.	germline	1		C	Mar 11, 2024	0	C/C	0	64659	0.996	N	Xq27.1	92836	.	0.000000e+00	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	Pathogenic/Likely_pathogenic	0	0	Cys	C	-	.	ENSP00000218099	ENST00000218099	13319	0.007	10128	0	0.599	C	0	3.352229	0.67073	.	D	-	.	.	0.93868	928	0	.	0.50373	0	139551112	Y	10	0	73470	.	P00740	0	0.800814	0.91634		0	0.889	D	64659	0.24540712	30954	0.15862	2158	0.535847	.	-3.45	.	.	0.60085	0.000000e+00	0	.	0.000000e+00	.	0	0.47799	X	F9	.	0	Arg	103560	1.546580e-05	X-139551112-C-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	1	138460937	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	.	.	.	RCV004700216|RCV005042030|RCV000011330|RCV001390295	D	.	0	c.571C>T	0	.	.	0.95281	C/C	rs137852237	139551112	12063	C	.	.	9951	0.62235	0.000000e+00	0.68239		0	0	.	2.175	0	0	264690	4.04	0.94875	3308	D	T	0	0.000000e+00	0	626	.	0	0	98879	10584	0.95211	0.92993	0.855446166052384	3762	.	0.3946	.	0.000000e+00	1.546580e-05	.	2.17	6.585750e-06	D	9934	0	5.289206E-5	0	300807|306900	0.42174	X	0.000000e+00	ENSG00000101981	.	0	0	0	0.9946210614807007	1	0.63094	0.18019	19069	14	1.361100e-05	.	.	YES	.	0.425573	25623	HGNC:3551	A	0	simple_aae	0.779	151843	139551112	CGT	1.000000	.	-	0	0.90865	.	0	.	Pathogenic/Likely pathogenic	0.59626	0	.	.	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	R	0	0.999785564942	-	.	-	0.78558	1	2010	0.99458	0.471319615841	0.46	.	0.99835540160048397	280	-	571C>T 	1	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	.	.	1	0.67589	137852237	1767	0	0.99978	.	0.607	0.012	3594	0.99998224	4.94	.	.	0.000000e+00	0.53193	0.999002392944659	0.60790	D	2682	4647	7083	0.8340	0.95632	p.Arg191Cys	0	.	-7.779	0.9160565	.	0.95492	10584	D	24390	F9	0.000000e+00	D	0.808	15993	.	D	.	0.40292	C/C	principal1	189855	F9_Popp_2025_heavy_chain_var234369	No											R		571	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Arg191Cys		true	c.571C>T						3551.0	139551112.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				Arg191Cys						C	Feb 23, 2024					missense_variant		191.0				0.7279694452442058		Pathogenic/Likely pathogenic	139551112.0	missense_variant		0.808					Reporter			F9_Arg191Cys
F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	0.8294935729820571	0.8216646242841691	0.9049360006536924	0.9071619363443628	0.7980510018430784	0.5868911879567651	0.7554353355654199	0.8788361751032804	0.8262022757621769	0.6573453711983824	0.708192380469411	0.7885499799247945	0.8918860878784864	0.8666821060532699	0.7276981865207304	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T		Arg191Cys																												F9_Arg191Cys	23	139551112	C	T	X	allele	571C>T	B08	527_CAVA_Array_P02	C16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551112-C-T	-	0.46322	1.0	191	1	.	0	X	138633271	T	.	0	X	1_Pathogenic	NC_000023.11	.	Arg191Cys	0	22.3	0	0	1.361100e-05	D	.	9	1	30954	5.805680e-06	.	19004	0.000000e+00	0	0.93758	Select	0.8689	73470	0.90580	0	.	D	D	.	1.92440498635	0	.	0.000000e+00	0	0	0.34817	13667	.	.	0.000000e+00	0.68090	1	.	0.64653	0.058	.	22.0	0.90041	.	0.78	T	single nucleotide variant	NC_000023.11:g.139551112C>T	.	12192	3	0.22915632	80341	0	0.42700288	0		1	172245	0	0	0.000000e+00	436	3.230600e-05	0	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	.	.	0.90354	P	0.49838	D	M	.	.	C/C	168	0	5701	.	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13133	0.94814	.	.	-	139551112	3.230600e-05	-	4.855000	0	0.87767	.	0	.	0	germline;maternal	.	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.571C>T	0.000000e+00	0.46200	0	0	0	.	0.000000e+00	6917	A	0	.	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2	0	FA9_HUMAN	0	78.0	.	0	D	0.67153	0.4647663	+	0.000000e+00	.		1	0.000000e+00	0	27168	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	1.244690e-05	.	0.000000e+00	0	.	p.Arg191Cys	.	0.45490	.	germline	1		C	Mar 11, 2024	0	C/C	0	64659	0.996	N	Xq27.1	92836	.	0.000000e+00	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	Pathogenic/Likely_pathogenic	0	0	Cys	C	-	.	ENSP00000218099	ENST00000218099	13319	0.007	10128	0	0.599	C	0	3.352229	0.67073	.	D	-	.	.	0.93868	928	0	.	0.50373	0	139551112	Y	10	0	73470	.	P00740	0	0.800814	0.91634		0	0.889	D	64659	0.24540712	30954	0.15862	2158	0.535847	.	-3.45	.	.	0.60085	0.000000e+00	0	.	0.000000e+00	.	0	0.47799	X	F9	.	0	Arg	103560	1.546580e-05	X-139551112-C-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	1	138460937	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	.	.	.	RCV004700216|RCV005042030|RCV000011330|RCV001390295	D	.	0	c.571C>T	0	.	.	0.95281	C/C	rs137852237	139551112	12063	C	.	.	9951	0.62235	0.000000e+00	0.68239		0	0	.	2.175	0	0	264690	4.04	0.94875	3308	D	T	0	0.000000e+00	0	626	.	0	0	98879	10584	0.95211	0.92993	0.855446166052384	3762	.	0.3946	.	0.000000e+00	1.546580e-05	.	2.17	6.585750e-06	D	9934	0	5.289206E-5	0	300807|306900	0.42174	X	0.000000e+00	ENSG00000101981	.	0	0	0	0.9946210614807007	1	0.63094	0.18019	19069	14	1.361100e-05	.	.	YES	.	0.425573	25623	HGNC:3551	A	0	simple_aae	0.779	151843	139551112	CGT	1.000000	.	-	0	0.90865	.	0	.	Pathogenic/Likely pathogenic	0.59626	0	.	.	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	R	0	0.999785564942	-	.	-	0.78558	1	2010	0.99458	0.471319615841	0.46	.	0.99835540160048397	280	-	571C>T 	1	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	.	.	1	0.67589	137852237	1767	0	0.99978	.	0.607	0.012	3594	0.99998224	4.94	.	.	0.000000e+00	0.53193	0.999002392944659	0.60790	D	2682	4647	7083	0.8340	0.95632	p.Arg191Cys	0	.	-7.779	0.9160565	.	0.95492	10584	D	24390	F9	0.000000e+00	D	0.808	15993	.	D	.	0.40292	C/C	principal1	134823	F9_Popp_2025_carboxy_F9_specific_var224688	No											R		571	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Arg191Cys		true	c.571C>T						3551.0	139551112.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				Arg191Cys						C	Feb 23, 2024					missense_variant		191.0				0.707286787		Pathogenic/Likely pathogenic	139551112.0	missense_variant		0.808					Reporter			F9_Arg191Cys
F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	0.8294935729820571	0.8216646242841691	0.9049360006536924	0.9071619363443628	0.7980510018430784	0.5868911879567651	0.7554353355654199	0.8788361751032804	0.8262022757621769	0.6573453711983824	0.708192380469411	0.7885499799247945	0.8918860878784864	0.8666821060532699	0.7276981865207304	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T		Arg191Cys																												F9_Arg191Cys	23	139551112	C	T	X	allele	571C>T	B08	527_CAVA_Array_P02	C16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551112-C-T	-	0.46322	1.0	191	1	.	0	X	138633271	T	.	0	X	1_Pathogenic	NC_000023.11	.	Arg191Cys	0	22.3	0	0	1.361100e-05	D	.	9	1	30954	5.805680e-06	.	19004	0.000000e+00	0	0.93758	Select	0.8689	73470	0.90580	0	.	D	D	.	1.92440498635	0	.	0.000000e+00	0	0	0.34817	13667	.	.	0.000000e+00	0.68090	1	.	0.64653	0.058	.	22.0	0.90041	.	0.78	T	single nucleotide variant	NC_000023.11:g.139551112C>T	.	12192	3	0.22915632	80341	0	0.42700288	0		1	172245	0	0	0.000000e+00	436	3.230600e-05	0	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	.	.	0.90354	P	0.49838	D	M	.	.	C/C	168	0	5701	.	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13133	0.94814	.	.	-	139551112	3.230600e-05	-	4.855000	0	0.87767	.	0	.	0	germline;maternal	.	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.571C>T	0.000000e+00	0.46200	0	0	0	.	0.000000e+00	6917	A	0	.	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2	0	FA9_HUMAN	0	78.0	.	0	D	0.67153	0.4647663	+	0.000000e+00	.		1	0.000000e+00	0	27168	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	1.244690e-05	.	0.000000e+00	0	.	p.Arg191Cys	.	0.45490	.	germline	1		C	Mar 11, 2024	0	C/C	0	64659	0.996	N	Xq27.1	92836	.	0.000000e+00	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	Pathogenic/Likely_pathogenic	0	0	Cys	C	-	.	ENSP00000218099	ENST00000218099	13319	0.007	10128	0	0.599	C	0	3.352229	0.67073	.	D	-	.	.	0.93868	928	0	.	0.50373	0	139551112	Y	10	0	73470	.	P00740	0	0.800814	0.91634		0	0.889	D	64659	0.24540712	30954	0.15862	2158	0.535847	.	-3.45	.	.	0.60085	0.000000e+00	0	.	0.000000e+00	.	0	0.47799	X	F9	.	0	Arg	103560	1.546580e-05	X-139551112-C-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	1	138460937	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	.	.	.	RCV004700216|RCV005042030|RCV000011330|RCV001390295	D	.	0	c.571C>T	0	.	.	0.95281	C/C	rs137852237	139551112	12063	C	.	.	9951	0.62235	0.000000e+00	0.68239		0	0	.	2.175	0	0	264690	4.04	0.94875	3308	D	T	0	0.000000e+00	0	626	.	0	0	98879	10584	0.95211	0.92993	0.855446166052384	3762	.	0.3946	.	0.000000e+00	1.546580e-05	.	2.17	6.585750e-06	D	9934	0	5.289206E-5	0	300807|306900	0.42174	X	0.000000e+00	ENSG00000101981	.	0	0	0	0.9946210614807007	1	0.63094	0.18019	19069	14	1.361100e-05	.	.	YES	.	0.425573	25623	HGNC:3551	A	0	simple_aae	0.779	151843	139551112	CGT	1.000000	.	-	0	0.90865	.	0	.	Pathogenic/Likely pathogenic	0.59626	0	.	.	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	R	0	0.999785564942	-	.	-	0.78558	1	2010	0.99458	0.471319615841	0.46	.	0.99835540160048397	280	-	571C>T 	1	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	.	.	1	0.67589	137852237	1767	0	0.99978	.	0.607	0.012	3594	0.99998224	4.94	.	.	0.000000e+00	0.53193	0.999002392944659	0.60790	D	2682	4647	7083	0.8340	0.95632	p.Arg191Cys	0	.	-7.779	0.9160565	.	0.95492	10584	D	24390	F9	0.000000e+00	D	0.808	15993	.	D	.	0.40292	C/C	principal1	162339	F9_Popp_2025_carboxy_gla_motif_var253731	No											R		571	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Arg191Cys		true	c.571C>T						3551.0	139551112.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				Arg191Cys						C	Feb 23, 2024					missense_variant		191.0				0.6328657420181729		Pathogenic/Likely pathogenic	139551112.0	missense_variant		0.808					Reporter			F9_Arg191Cys
F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	0.8294935729820571	0.8216646242841691	0.9049360006536924	0.9071619363443628	0.7980510018430784	0.5868911879567651	0.7554353355654199	0.8788361751032804	0.8262022757621769	0.6573453711983824	0.708192380469411	0.7885499799247945	0.8918860878784864	0.8666821060532699	0.7276981865207304	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T		Arg191Cys																												F9_Arg191Cys	23	139551112	C	T	X	allele	571C>T	B08	527_CAVA_Array_P02	C16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551112-C-T	-	0.46322	1.0	191	1	.	0	X	138633271	T	.	0	X	1_Pathogenic	NC_000023.11	.	Arg191Cys	0	22.3	0	0	1.361100e-05	D	.	9	1	30954	5.805680e-06	.	19004	0.000000e+00	0	0.93758	Select	0.8689	73470	0.90580	0	.	D	D	.	1.92440498635	0	.	0.000000e+00	0	0	0.34817	13667	.	.	0.000000e+00	0.68090	1	.	0.64653	0.058	.	22.0	0.90041	.	0.78	T	single nucleotide variant	NC_000023.11:g.139551112C>T	.	12192	3	0.22915632	80341	0	0.42700288	0		1	172245	0	0	0.000000e+00	436	3.230600e-05	0	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	.	.	0.90354	P	0.49838	D	M	.	.	C/C	168	0	5701	.	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13133	0.94814	.	.	-	139551112	3.230600e-05	-	4.855000	0	0.87767	.	0	.	0	germline;maternal	.	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.571C>T	0.000000e+00	0.46200	0	0	0	.	0.000000e+00	6917	A	0	.	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2	0	FA9_HUMAN	0	78.0	.	0	D	0.67153	0.4647663	+	0.000000e+00	.		1	0.000000e+00	0	27168	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	1.244690e-05	.	0.000000e+00	0	.	p.Arg191Cys	.	0.45490	.	germline	1		C	Mar 11, 2024	0	C/C	0	64659	0.996	N	Xq27.1	92836	.	0.000000e+00	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	Pathogenic/Likely_pathogenic	0	0	Cys	C	-	.	ENSP00000218099	ENST00000218099	13319	0.007	10128	0	0.599	C	0	3.352229	0.67073	.	D	-	.	.	0.93868	928	0	.	0.50373	0	139551112	Y	10	0	73470	.	P00740	0	0.800814	0.91634		0	0.889	D	64659	0.24540712	30954	0.15862	2158	0.535847	.	-3.45	.	.	0.60085	0.000000e+00	0	.	0.000000e+00	.	0	0.47799	X	F9	.	0	Arg	103560	1.546580e-05	X-139551112-C-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	1	138460937	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	.	.	.	RCV004700216|RCV005042030|RCV000011330|RCV001390295	D	.	0	c.571C>T	0	.	.	0.95281	C/C	rs137852237	139551112	12063	C	.	.	9951	0.62235	0.000000e+00	0.68239		0	0	.	2.175	0	0	264690	4.04	0.94875	3308	D	T	0	0.000000e+00	0	626	.	0	0	98879	10584	0.95211	0.92993	0.855446166052384	3762	.	0.3946	.	0.000000e+00	1.546580e-05	.	2.17	6.585750e-06	D	9934	0	5.289206E-5	0	300807|306900	0.42174	X	0.000000e+00	ENSG00000101981	.	0	0	0	0.9946210614807007	1	0.63094	0.18019	19069	14	1.361100e-05	.	.	YES	.	0.425573	25623	HGNC:3551	A	0	simple_aae	0.779	151843	139551112	CGT	1.000000	.	-	0	0.90865	.	0	.	Pathogenic/Likely pathogenic	0.59626	0	.	.	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	R	0	0.999785564942	-	.	-	0.78558	1	2010	0.99458	0.471319615841	0.46	.	0.99835540160048397	280	-	571C>T 	1	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	.	.	1	0.67589	137852237	1767	0	0.99978	.	0.607	0.012	3594	0.99998224	4.94	.	.	0.000000e+00	0.53193	0.999002392944659	0.60790	D	2682	4647	7083	0.8340	0.95632	p.Arg191Cys	0	.	-7.779	0.9160565	.	0.95492	10584	D	24390	F9	0.000000e+00	D	0.808	15993	.	D	.	0.40292	C/C	principal1	244887	F9_Popp_2025_strep_2_var263412	No											R		571	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Arg191Cys		true	c.571C>T						3551.0	139551112.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				Arg191Cys						C	Feb 23, 2024					missense_variant		191.0				1.1185310922702083		Pathogenic/Likely pathogenic	139551112.0	missense_variant		0.808					Reporter			F9_Arg191Cys
F9_Arg191Cys	-3.11408960814349	0.020740463895787046	4.191694298278343	0.004077453669868551	2025_01_Batch_13-14	0.8294935729820571	0.8216646242841691	0.9049360006536924	0.9071619363443628	0.7980510018430784	0.5868911879567651	0.7554353355654199	0.8788361751032804	0.8262022757621769	0.6573453711983824	0.708192380469411	0.7885499799247945	0.8918860878784864	0.8666821060532699	0.7276981865207304	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030555		NC_000023.11:139551112:C:T		Arg191Cys																												F9_Arg191Cys	23	139551112	C	T	X	allele	571C>T	B08	527_CAVA_Array_P02	C16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551112-C-T	-	0.46322	1.0	191	1	.	0	X	138633271	T	.	0	X	1_Pathogenic	NC_000023.11	.	Arg191Cys	0	22.3	0	0	1.361100e-05	D	.	9	1	30954	5.805680e-06	.	19004	0.000000e+00	0	0.93758	Select	0.8689	73470	0.90580	0	.	D	D	.	1.92440498635	0	.	0.000000e+00	0	0	0.34817	13667	.	.	0.000000e+00	0.68090	1	.	0.64653	0.058	.	22.0	0.90041	.	0.78	T	single nucleotide variant	NC_000023.11:g.139551112C>T	.	12192	3	0.22915632	80341	0	0.42700288	0		1	172245	0	0	0.000000e+00	436	3.230600e-05	0	MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	1	0	.	.	0.90354	P	0.49838	D	M	.	.	C/C	168	0	5701	.	not provided|Thrombophilia, X-linked, due to factor 9 defect;Warfarin sensitivity, X-linked;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	13133	0.94814	.	.	-	139551112	3.230600e-05	-	4.855000	0	0.87767	.	0	.	0	germline;maternal	.	.	.	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.571C>T	0.000000e+00	0.46200	0	0	0	.	0.000000e+00	6917	A	0	.	NM_000133.4(F9):c.571C>T (p.Arg191Cys)	2	0	FA9_HUMAN	0	78.0	.	0	D	0.67153	0.4647663	+	0.000000e+00	.		1	0.000000e+00	0	27168	criteria_provided,_multiple_submitters,_no_conflicts	0.99989	1.244690e-05	.	0.000000e+00	0	.	p.Arg191Cys	.	0.45490	.	germline	1		C	Mar 11, 2024	0	C/C	0	64659	0.996	N	Xq27.1	92836	.	0.000000e+00	SCV001591978|SCV002556203|SCV002556900|SCV005201733|SCV005413444|SCV005682976	Pathogenic/Likely_pathogenic	0	0	Cys	C	-	.	ENSP00000218099	ENST00000218099	13319	0.007	10128	0	0.599	C	0	3.352229	0.67073	.	D	-	.	.	0.93868	928	0	.	0.50373	0	139551112	Y	10	0	73470	.	P00740	0	0.800814	0.91634		0	0.889	D	64659	0.24540712	30954	0.15862	2158	0.535847	.	-3.45	.	.	0.60085	0.000000e+00	0	.	0.000000e+00	.	0	0.47799	X	F9	.	0	Arg	103560	1.546580e-05	X-139551112-C-T	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	.	1	138460937	ClinGen:CA255340|OMIM:300746.0026|UniProtKB:P00740#VAR_006569	.	.	.	RCV004700216|RCV005042030|RCV000011330|RCV001390295	D	.	0	c.571C>T	0	.	.	0.95281	C/C	rs137852237	139551112	12063	C	.	.	9951	0.62235	0.000000e+00	0.68239		0	0	.	2.175	0	0	264690	4.04	0.94875	3308	D	T	0	0.000000e+00	0	626	.	0	0	98879	10584	0.95211	0.92993	0.855446166052384	3762	.	0.3946	.	0.000000e+00	1.546580e-05	.	2.17	6.585750e-06	D	9934	0	5.289206E-5	0	300807|306900	0.42174	X	0.000000e+00	ENSG00000101981	.	0	0	0	0.9946210614807007	1	0.63094	0.18019	19069	14	1.361100e-05	.	.	YES	.	0.425573	25623	HGNC:3551	A	0	simple_aae	0.779	151843	139551112	CGT	1.000000	.	-	0	0.90865	.	0	.	Pathogenic/Likely pathogenic	0.59626	0	.	.	ClinGen:CA255340,UniProtKB:P00740#VAR_006569,OMIM:300746.0026	R	0	0.999785564942	-	.	-	0.78558	1	2010	0.99458	0.471319615841	0.46	.	0.99835540160048397	280	-	571C>T 	1	0	C2749016|C0008533	0	0	0	0	NM_000133.4	-	.	.	1	0.67589	137852237	1767	0	0.99978	.	0.607	0.012	3594	0.99998224	4.94	.	.	0.000000e+00	0.53193	0.999002392944659	0.60790	D	2682	4647	7083	0.8340	0.95632	p.Arg191Cys	0	.	-7.779	0.9160565	.	0.95492	10584	D	24390	F9	0.000000e+00	D	0.808	15993	.	D	.	0.40292	C/C	principal1	217371	F9_Popp_2025_light_chain_var244050	No											R		571	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Arg191Cys		true	c.571C>T						3551.0	139551112.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				Arg191Cys						C	Feb 23, 2024					missense_variant		191.0				0.7229880596910316		Pathogenic/Likely pathogenic	139551112.0	missense_variant		0.808					Reporter			F9_Arg191Cys
RPS19_Arg101His	-2.407724429948076	0.04693058430635163	-2.3751250467398184	0.049233749168006886	2025_01_Batch_13-14	0.6359937086482906	0.7028646139639885	0.8764398964711966	0.6890256185775911	0.6304028995520288	0.5129238414684217	0.6200651778597204	0.8503985006356812	0.6485003411903558	0.5832903672878459	0.5744587750583562	0.6614648959118544	0.863419198553439	0.6687629798839735	0.6068466334199374	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RPS19	RPS19	ENSG00000105372	3441	6074	CCSBVarC000468	ALE00000468	NC_000019.10:41869160:G:A	302G>A	Arg101His	RC4	RC4_Mut_GDEh1010	G11	GDEhDisVCh_40042	D02	2	RC4_Mut_GDDh1010	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			RPS19_Arg101His	19	41869160	G	A	19											19-41869160-G-A	-	0.78331	0.576	101	.	.	.	19	42373230	A	.	.	19	1_Pathogenic	NC_000019.10	.	Arg101His	.	26.9	.	.	.	T	.	2	3	.	.	.	.	.	.	0.78612	.	0.1836	.	0.38738	.	.	D	D	.	.	.	.	.	.	.	0.55873	.	.	.	.	.	.	.	0.72387	0.789	.	2.0	0.919808	.	0.98	A	single nucleotide variant	NC_000019.10:g.41869160G>A	.	.	2	0.4817109	.	.	0.7501296	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124	.	.	.	.	0.97016	B	0.73150	P	M	3.169182	.	./.	.	.	.	.	not provided|Diamond-Blackfan anemia 1	.	0.62566	.	.	-	41869160	.	-	9.866000	.	0.74727	.	.	.	.	germline	.	Loss of stability (P = 0.0435)| Loss of MoRF binding (P = 0.0519)| Loss of phosphorylation at S98 (P = 0.0846)| Loss of disorder (P = 0.1018)| Loss of methylation at K97 (P = 0.1559)	0.99276	GRCh38	748	criteria provided, multiple submitters, no conflicts	c.302G>A	.	0.50482	.	.	.	Small ribosomal subunit protein eS19, conserved site	.	.	P	.	.	NM_001022.4(RPS19):c.302G>A (p.Arg101His)	2	.	RS19_HUMAN	.	98.0	0.169104588964979	.	D	0.85818	0.59962654	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99739	.	.	.	.	.	p.Arg101His	.	0.82120	.	germline	.		G	Sep 20, 2024	.	./.	.	.	1.0	N	19q13.2	.	.	.	SCV002065830|SCV005087142	Pathogenic/Likely_pathogenic	.	.	His	H	-	.	ENSP00000470004	ENST00000593863	.	.	.	.	0.658	G	.	4.811919	0.50294	D	D	-	3.108112	.	0.88316	.	.	.	0.69870	.	41869160	Y	9	.	.	.	P39019	.	0.973089	0.85596		.	0.098	D	.	0.5398206	.	0.37304	6223	0.540061	.	.	.	.	.	.	.	.	.	.	.	0.69730	19	RPS19	.	.	Arg	.	.	19-41869160-G-A	not_provided|Diamond-Blackfan_anemia_1	.	.	47065070	.	0.938159	0.49474	.	RCV001818012|RCV004594595	D	.	.	c.302G>A	.	.	.	0.95419	./.	rs2123284131	41869160	.	G	.	P39019	.	0.80644	.	0.68239		.	.	.	2.455	.	.	.	4.3	0.99719	.	D	T	.	.	.	.	.	.	.	124	1338641	0.95351	0.79939	0.973375916481018	.	.	0.71675	0.93672	.	.	.	6.962	.	.	.	.	.	.	105650	0.75901	19	.	ENSG00000105372	.	.	.	.	.	2	0.30481	0.52085	.	.	.	.	0.184437639525419	.	.	0.232972	1329648	HGNC:10402	D	.	simple_aae	0.552	.	41869160	CGC	1.000000	.	-	.	0.97692	.	.	.	Pathogenic/Likely pathogenic	0.89171	.	.	.	ClinGen:CA406030502	R	.	0.990308341565	-	0.944	-	0.84569	.	.	0.88980	0.621480226517	0.9394	.	0.99767382566551488	.	-	302G>A 	.	.	C3661900|C2676137	.	.	.	.	NM_001022.4	-	.	.	1	0.70916	2123284131	.	.	0.99009	0.48733	0.85	0.043	.	0.99979788	4.3	.	.	.	0.537984	0.998556217770197	0.71058	T	.	.	.	-0.6497	0.53023	p.Arg101His	.	.	-12.948	0.9784213	.	0.94646	1338641	D	.	RPS19	.	D	.	.	R101H	.	.	0.54518	./.	principal1																																																																																																				
RPS19_Arg101His	-2.407724429948076	0.04693058430635163	-2.3751250467398184	0.049233749168006886	2025_01_Batch_13-14	0.6359937086482906	0.7028646139639885	0.8764398964711966	0.6890256185775911	0.6304028995520288	0.5129238414684217	0.6200651778597204	0.8503985006356812	0.6485003411903558	0.5832903672878459	0.5744587750583562	0.6614648959118544	0.863419198553439	0.6687629798839735	0.6068466334199374	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RPS19	RPS19		3441		CCSBVarC000468		NC_000019.10:41869160:G:A		Arg101His																												RPS19_Arg101His	19	41869160	G	A	19	allele	302G>A	G10	527_CAVA_Array_P05	M19	B13A7A8P2_R1	B14A7A8P2_R2				19-41869160-G-A	-	0.78331	0.576	101	.	.	.	19	42373230	A	.	.	19	1_Pathogenic	NC_000019.10	.	Arg101His	.	26.9	.	.	.	T	.	2	3	.	.	.	.	.	.	0.78612	.	0.1836	.	0.38738	.	.	D	D	.	.	.	.	.	.	.	0.55873	.	.	.	.	.	.	.	0.72387	0.789	.	2.0	0.919808	.	0.98	A	single nucleotide variant	NC_000019.10:g.41869160G>A	.	.	2	0.4817109	.	.	0.7501296	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0007110,MedGen:C2676137,OMIM:105650,Orphanet:124	.	.	.	.	0.97016	B	0.73150	P	M	3.169182	.	./.	.	.	.	.	not provided|Diamond-Blackfan anemia 1	.	0.62566	.	.	-	41869160	.	-	9.866000	.	0.74727	.	.	.	.	germline	.	Loss of stability (P = 0.0435)| Loss of MoRF binding (P = 0.0519)| Loss of phosphorylation at S98 (P = 0.0846)| Loss of disorder (P = 0.1018)| Loss of methylation at K97 (P = 0.1559)	0.99276	GRCh38	748	criteria provided, multiple submitters, no conflicts	c.302G>A	.	0.50482	.	.	.	Small ribosomal subunit protein eS19, conserved site	.	.	P	.	.	NM_001022.4(RPS19):c.302G>A (p.Arg101His)	2	.	RS19_HUMAN	.	98.0	0.169104588964979	.	D	0.85818	0.59962654	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99739	.	.	.	.	.	p.Arg101His	.	0.82120	.	germline	.		G	Sep 20, 2024	.	./.	.	.	1.0	N	19q13.2	.	.	.	SCV002065830|SCV005087142	Pathogenic/Likely_pathogenic	.	.	His	H	-	.	ENSP00000470004	ENST00000593863	.	.	.	.	0.658	G	.	4.811919	0.50294	D	D	-	3.108112	.	0.88316	.	.	.	0.69870	.	41869160	Y	9	.	.	.	P39019	.	0.973089	0.85596		.	0.098	D	.	0.5398206	.	0.37304	6223	0.540061	.	.	.	.	.	.	.	.	.	.	.	0.69730	19	RPS19	.	.	Arg	.	.	19-41869160-G-A	not_provided|Diamond-Blackfan_anemia_1	.	.	47065070	.	0.938159	0.49474	.	RCV001818012|RCV004594595	D	.	.	c.302G>A	.	.	.	0.95419	./.	rs2123284131	41869160	.	G	.	P39019	.	0.80644	.	0.68239		.	.	.	2.455	.	.	.	4.3	0.99719	.	D	T	.	.	.	.	.	.	.	124	1338641	0.95351	0.79939	0.973375916481018	.	.	0.71675	0.93672	.	.	.	6.962	.	.	.	.	.	.	105650	0.75901	19	.	ENSG00000105372	.	.	.	.	.	2	0.30481	0.52085	.	.	.	.	0.184437639525419	.	.	0.232972	1329648	HGNC:10402	D	.	simple_aae	0.552	.	41869160	CGC	1.000000	.	-	.	0.97692	.	.	.	Pathogenic/Likely pathogenic	0.89171	.	.	.	ClinGen:CA406030502	R	.	0.990308341565	-	0.944	-	0.84569	.	.	0.88980	0.621480226517	0.9394	.	0.99767382566551488	.	-	302G>A 	.	.	C3661900|C2676137	.	.	.	.	NM_001022.4	-	.	.	1	0.70916	2123284131	.	.	0.99009	0.48733	0.85	0.043	.	0.99979788	4.3	.	.	.	0.537984	0.998556217770197	0.71058	T	.	.	.	-0.6497	0.53023	p.Arg101His	.	.	-12.948	0.9784213	.	0.94646	1338641	D	.	RPS19	.	D	.	.	R101H	.	.	0.54518	./.	principal1																																																																																																				
ZC4H2_Ala200Thr	-5.682062973976312	0.0007491281331314925	7.059848916684998	0.00020063357271856742	2025_01_Batch_13-14	0.69241397251165	0.8069410503271048	0.8641759199854547	0.8467151459798945	0.6814470523169307	0.7872116008291188	0.9338751932930486	0.9752223718690706	0.9513696573133672	0.7794601415888701	0.7398127866703844	0.8704081218100768	0.9196991459272627	0.8990424016466309	0.7304535969529005	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC009163		NC_000023.11:64917860:C:T		Ala200Thr																												ZC4H2_Ala200Thr	23	64917860	C	T	X	allele	598G>A	F04	527_CAVA_Array_P06	K08	B13A7A8P2_R1	B14A7A8P2_R2				X-64917860-C-T	-	0.83539	0.997	200	.	.	.	X	64137740	T	.	.	X	1_Pathogenic	NC_000023.11	.	Ala200Thr	.	28.1	.	.	.	T	.	1	1	.	.	.	.	.	.	0.77793	Select	0.1833	.	0.70687	.	.	D	D	.	3.0674637903	.	.	.	.	.	0.87150	.	.	.	.	0.68446	.	.	0.90873	0.997	.	3.0	0.958704	.	0.97	T	single nucleotide variant	NC_000023.11:g.64917860C>T	.	.	2	0.8811168	.	.	0.8956946	.		.	.	.	.	.	.	.	.	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	.	.	.	.	0.96253	D	0.93554	D	.	.	.	C/C	.	.	.	.	Wieacker-Wolff syndrome	.	0.48170	.	.	-	64917860	.	-	7.539000	.	0.99892	.	.	.	.	unknown	.	Gain of phosphorylation at A200 (P = 0.0325)| Loss of MoRF binding (P = 0.1211)| Loss of helix (P = 0.1299)| Loss of catalytic residue at A200 (P = 0.3072)| Loss of stability (P = 0.3362)	0.65184	GRCh38	40	criteria provided, single submitter	c.598G>A	.	0.78637	.	.	.	Zinc finger C4H2-type	.	.	P	.	.	NM_018684.4(ZC4H2):c.598G>A (p.Ala200Thr)	1	.	ZC4H2_HUMAN	.	97.0	.	.	D	0.99584	0.8956946	-	.	.		.	.	0	.	criteria_provided,_single_submitter	0.98026	.	.	.	.	.	p.Ala200Thr	.	0.60115	.	unknown	.		C	Mar 23, 2020	.	C/C	.	.	1.0	N	Xq11.2	.	.	.	SCV001367652	Pathogenic	.	.	Thr	T	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.599	C	.	5.023812	0.92967	.	D	-	.	.	0.96983	.	.	.	0.90886	.	64917860	Y	8	.	.	.	Q9NQZ6	.	0.861348	0.99824		.	0.994	D	.	0.8811168	.	0.79771	55906	0.478681	.	-3.52	.	.	0.91343	.	.	.	.	.	.	0.93554	X	ZC4H2	.	.	Ala	.	.	X-64917860-C-T	Wieacker-Wolff_syndrome	.	.	64054465	.	.	.	.	RCV001197017	D	.	.	c.598G>A	.	.	.	0.93601	C/C	rs1929006117	64917860	.	C	.	Q9NQZ6	.	0.90872	.	0.68239		.	.	.	.	.	.	.	5.42	0.96901	.	D	D	.	.	.	.	.	.	.	3454|85283	930963	0.93521	0.99314	0.997183978557587	.	.	0.71675	.	.	.	.	7.301	.	D	.	.	.	.	314580	0.78228	X	.	ENSG00000126970	.	.	.	.	0.8527665168203684	1	0.82066	0.97963	.	.	.	.	.	YES	.	0.645518	920050	HGNC:24931	A	.	simple_aae	0.997	.	64917860	GCA	1.000000	.	-	.	0.89172	.	.	.	Pathogenic	0.81389	.	.	.	ClinGen:CA413411194	A	.	0.883420790715	-	0.541	-	0.87678	.	.	0.85148	0.833977639675	0.9998	.	0.9994258080004339	.	-	598G>A 	.	.	C0796200	.	.	.	.	NM_018684.4	-	.	.	1	0.85578	1929006117	.	.	0.88137	.	0.866	0.0	.	0.99633140	5.42	.	.	.	0.449816	0.992700566218043	.	T	.	.	.	-0.8962	0.52977	p.Ala200Thr	.	.	-11.278	0.8993199	.	0.89650	930963	D	.	ZC4H2	.	D	0.493	.	A200T	D	.	0.40292	C/C	principal1																																																																																																				
F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn166Tyr	23	139548467	A	T	X											X-139548467-A-T	-	0.37541	0.895	166	.	.	.	X	138630626	T	.	.	X	1_Pathogenic	NC_000023.11	.	Asn166Tyr	.	20.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.81565	Select	0.8513	.	0.49259	.	.	D	D	.	1.40884785401	.	.	.	.	.	0.11640	.	.	.	.	0.73413	.	.	0.85263	0.959	.	19.0	0.882612	-2.27	0.81	T	single nucleotide variant	NC_000023.11:g.139548467A>T	.	.	1	0.63639706	.	.	0.8240546	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.87956	P	0.77910	P	M	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.91577	.	.	-	139548467	.	-	3.148000	.	0.97437	.	.	.	.	germline	.	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.96965	GRCh38	924	no assertion criteria provided	c.496A>T	.	0.25572	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)		.	FA9_HUMAN	.	81.0	.	.	D	0.59540	0.8234179	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Asn166Tyr	.	0.36593	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031559	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.003	.	.	-0.122	A	.	2.840319	0.79703	.	D	-	.	.	0.95325	.	.	.	0.75128	.	139548467	Y	9	.	.	.	P00740	.	0.959002	0.52061		.	0.615	D	.	0.6250371	.	0.5146	2158	0.133446	.	-3.77	.	.	0.68399	.	.	.	.	.	.	0.78539	X	F9	.	.	Asn	.	.	X-139548467-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138458292	ClinGen:CA255337|OMIM:300746.0025	.	.	.	RCV000011328	D	.	.	c.496A>T	.	.	.	0.67463	A/A	rs137852236	139548467	.	A	.	P00740	.	0.85305	.	0.68239		.	.	.	3.02	.	.	.	2.02	0.99454	.	D	T	.	.	.	.	.	.	.	98879	10582	0.67052	0.85328	0.983754932880402	.	.	0.71675	.	.	.	.	1.74	.	D	.	.	.	.	306900	0.37957	X	.	ENSG00000101981	.	.	.	.	0.9832254753781753	1	0.51228	0.18019	.	.	.	.	.	YES	.	0.513166	25621	HGNC:3551	A	.	simple_aae	0.945	.	139548467	AAC	1.000000	.	-	.	0.93464	.	.	.	Pathogenic	0.80089	.	.	.	ClinGen:CA255337,OMIM:300746.0025	N	.	0.970123982418	-	0.883	-	0.71543	.	.	0.98307	0.308290779591	0.1682	.	0.9908196188715952	.	-	496A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60210	137852236	.	.	0.96952	.	0.275	0.002	.	0.99996221	4.94	.	.	.	-0.0460908	0.99871094433747	0.86089	D	.	.	.	0.5779	0.95032	p.Asn166Tyr	.	.	-11.067	0.94212544	.	0.94924	10582	D	.	F9	.	D	0.555	.	N166Y	D	0.10681	0.13835	A/A	principal1	215818	F9_Popp_2025_light_chain_var243519	No											N		496	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Asn166Tyr		true	c.496A>T						3551.0	139548467.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Asn166Tyr						Y	Apr 01, 1989					missense_variant		166.0				0.115812176805143		Pathogenic	139548467.0	missense_variant		0.555					Reporter			F9_Asn166Tyr
F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn166Tyr	23	139548467	A	T	X											X-139548467-A-T	-	0.37541	0.895	166	.	.	.	X	138630626	T	.	.	X	1_Pathogenic	NC_000023.11	.	Asn166Tyr	.	20.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.81565	Select	0.8513	.	0.49259	.	.	D	D	.	1.40884785401	.	.	.	.	.	0.11640	.	.	.	.	0.73413	.	.	0.85263	0.959	.	19.0	0.882612	-2.27	0.81	T	single nucleotide variant	NC_000023.11:g.139548467A>T	.	.	1	0.63639706	.	.	0.8240546	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.87956	P	0.77910	P	M	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.91577	.	.	-	139548467	.	-	3.148000	.	0.97437	.	.	.	.	germline	.	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.96965	GRCh38	924	no assertion criteria provided	c.496A>T	.	0.25572	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)		.	FA9_HUMAN	.	81.0	.	.	D	0.59540	0.8234179	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Asn166Tyr	.	0.36593	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031559	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.003	.	.	-0.122	A	.	2.840319	0.79703	.	D	-	.	.	0.95325	.	.	.	0.75128	.	139548467	Y	9	.	.	.	P00740	.	0.959002	0.52061		.	0.615	D	.	0.6250371	.	0.5146	2158	0.133446	.	-3.77	.	.	0.68399	.	.	.	.	.	.	0.78539	X	F9	.	.	Asn	.	.	X-139548467-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138458292	ClinGen:CA255337|OMIM:300746.0025	.	.	.	RCV000011328	D	.	.	c.496A>T	.	.	.	0.67463	A/A	rs137852236	139548467	.	A	.	P00740	.	0.85305	.	0.68239		.	.	.	3.02	.	.	.	2.02	0.99454	.	D	T	.	.	.	.	.	.	.	98879	10582	0.67052	0.85328	0.983754932880402	.	.	0.71675	.	.	.	.	1.74	.	D	.	.	.	.	306900	0.37957	X	.	ENSG00000101981	.	.	.	.	0.9832254753781753	1	0.51228	0.18019	.	.	.	.	.	YES	.	0.513166	25621	HGNC:3551	A	.	simple_aae	0.945	.	139548467	AAC	1.000000	.	-	.	0.93464	.	.	.	Pathogenic	0.80089	.	.	.	ClinGen:CA255337,OMIM:300746.0025	N	.	0.970123982418	-	0.883	-	0.71543	.	.	0.98307	0.308290779591	0.1682	.	0.9908196188715952	.	-	496A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60210	137852236	.	.	0.96952	.	0.275	0.002	.	0.99996221	4.94	.	.	.	-0.0460908	0.99871094433747	0.86089	D	.	.	.	0.5779	0.95032	p.Asn166Tyr	.	.	-11.067	0.94212544	.	0.94924	10582	D	.	F9	.	D	0.555	.	N166Y	D	0.10681	0.13835	A/A	principal1	160786	F9_Popp_2025_carboxy_gla_motif_var253200	No											N		496	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Asn166Tyr		true	c.496A>T						3551.0	139548467.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Asn166Tyr						Y	Apr 01, 1989					missense_variant		166.0				0.06646977		Pathogenic	139548467.0	missense_variant		0.555					Reporter			F9_Asn166Tyr
F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn166Tyr	23	139548467	A	T	X											X-139548467-A-T	-	0.37541	0.895	166	.	.	.	X	138630626	T	.	.	X	1_Pathogenic	NC_000023.11	.	Asn166Tyr	.	20.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.81565	Select	0.8513	.	0.49259	.	.	D	D	.	1.40884785401	.	.	.	.	.	0.11640	.	.	.	.	0.73413	.	.	0.85263	0.959	.	19.0	0.882612	-2.27	0.81	T	single nucleotide variant	NC_000023.11:g.139548467A>T	.	.	1	0.63639706	.	.	0.8240546	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.87956	P	0.77910	P	M	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.91577	.	.	-	139548467	.	-	3.148000	.	0.97437	.	.	.	.	germline	.	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.96965	GRCh38	924	no assertion criteria provided	c.496A>T	.	0.25572	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)		.	FA9_HUMAN	.	81.0	.	.	D	0.59540	0.8234179	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Asn166Tyr	.	0.36593	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031559	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.003	.	.	-0.122	A	.	2.840319	0.79703	.	D	-	.	.	0.95325	.	.	.	0.75128	.	139548467	Y	9	.	.	.	P00740	.	0.959002	0.52061		.	0.615	D	.	0.6250371	.	0.5146	2158	0.133446	.	-3.77	.	.	0.68399	.	.	.	.	.	.	0.78539	X	F9	.	.	Asn	.	.	X-139548467-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138458292	ClinGen:CA255337|OMIM:300746.0025	.	.	.	RCV000011328	D	.	.	c.496A>T	.	.	.	0.67463	A/A	rs137852236	139548467	.	A	.	P00740	.	0.85305	.	0.68239		.	.	.	3.02	.	.	.	2.02	0.99454	.	D	T	.	.	.	.	.	.	.	98879	10582	0.67052	0.85328	0.983754932880402	.	.	0.71675	.	.	.	.	1.74	.	D	.	.	.	.	306900	0.37957	X	.	ENSG00000101981	.	.	.	.	0.9832254753781753	1	0.51228	0.18019	.	.	.	.	.	YES	.	0.513166	25621	HGNC:3551	A	.	simple_aae	0.945	.	139548467	AAC	1.000000	.	-	.	0.93464	.	.	.	Pathogenic	0.80089	.	.	.	ClinGen:CA255337,OMIM:300746.0025	N	.	0.970123982418	-	0.883	-	0.71543	.	.	0.98307	0.308290779591	0.1682	.	0.9908196188715952	.	-	496A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60210	137852236	.	.	0.96952	.	0.275	0.002	.	0.99996221	4.94	.	.	.	-0.0460908	0.99871094433747	0.86089	D	.	.	.	0.5779	0.95032	p.Asn166Tyr	.	.	-11.067	0.94212544	.	0.94924	10582	D	.	F9	.	D	0.555	.	N166Y	D	0.10681	0.13835	A/A	principal1	243334	F9_Popp_2025_strep_2_var262881	No											N		496	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Asn166Tyr		true	c.496A>T						3551.0	139548467.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Asn166Tyr						Y	Apr 01, 1989					missense_variant		166.0				0.3803852404443763		Pathogenic	139548467.0	missense_variant		0.555					Reporter			F9_Asn166Tyr
F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn166Tyr	23	139548467	A	T	X											X-139548467-A-T	-	0.37541	0.895	166	.	.	.	X	138630626	T	.	.	X	1_Pathogenic	NC_000023.11	.	Asn166Tyr	.	20.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.81565	Select	0.8513	.	0.49259	.	.	D	D	.	1.40884785401	.	.	.	.	.	0.11640	.	.	.	.	0.73413	.	.	0.85263	0.959	.	19.0	0.882612	-2.27	0.81	T	single nucleotide variant	NC_000023.11:g.139548467A>T	.	.	1	0.63639706	.	.	0.8240546	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.87956	P	0.77910	P	M	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.91577	.	.	-	139548467	.	-	3.148000	.	0.97437	.	.	.	.	germline	.	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.96965	GRCh38	924	no assertion criteria provided	c.496A>T	.	0.25572	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)		.	FA9_HUMAN	.	81.0	.	.	D	0.59540	0.8234179	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Asn166Tyr	.	0.36593	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031559	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.003	.	.	-0.122	A	.	2.840319	0.79703	.	D	-	.	.	0.95325	.	.	.	0.75128	.	139548467	Y	9	.	.	.	P00740	.	0.959002	0.52061		.	0.615	D	.	0.6250371	.	0.5146	2158	0.133446	.	-3.77	.	.	0.68399	.	.	.	.	.	.	0.78539	X	F9	.	.	Asn	.	.	X-139548467-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138458292	ClinGen:CA255337|OMIM:300746.0025	.	.	.	RCV000011328	D	.	.	c.496A>T	.	.	.	0.67463	A/A	rs137852236	139548467	.	A	.	P00740	.	0.85305	.	0.68239		.	.	.	3.02	.	.	.	2.02	0.99454	.	D	T	.	.	.	.	.	.	.	98879	10582	0.67052	0.85328	0.983754932880402	.	.	0.71675	.	.	.	.	1.74	.	D	.	.	.	.	306900	0.37957	X	.	ENSG00000101981	.	.	.	.	0.9832254753781753	1	0.51228	0.18019	.	.	.	.	.	YES	.	0.513166	25621	HGNC:3551	A	.	simple_aae	0.945	.	139548467	AAC	1.000000	.	-	.	0.93464	.	.	.	Pathogenic	0.80089	.	.	.	ClinGen:CA255337,OMIM:300746.0025	N	.	0.970123982418	-	0.883	-	0.71543	.	.	0.98307	0.308290779591	0.1682	.	0.9908196188715952	.	-	496A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60210	137852236	.	.	0.96952	.	0.275	0.002	.	0.99996221	4.94	.	.	.	-0.0460908	0.99871094433747	0.86089	D	.	.	.	0.5779	0.95032	p.Asn166Tyr	.	.	-11.067	0.94212544	.	0.94924	10582	D	.	F9	.	D	0.555	.	N166Y	D	0.10681	0.13835	A/A	principal1	133270	F9_Popp_2025_carboxy_F9_specific_var224157	No											N		496	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Asn166Tyr		true	c.496A>T						3551.0	139548467.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Asn166Tyr						Y	Apr 01, 1989					missense_variant		166.0				0.1024631778626351		Pathogenic	139548467.0	missense_variant		0.555					Reporter			F9_Asn166Tyr
F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	NC_000023.11:139548467:A:T	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Asn166Tyr	23	139548467	A	T	X											X-139548467-A-T	-	0.37541	0.895	166	.	.	.	X	138630626	T	.	.	X	1_Pathogenic	NC_000023.11	.	Asn166Tyr	.	20.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.81565	Select	0.8513	.	0.49259	.	.	D	D	.	1.40884785401	.	.	.	.	.	0.11640	.	.	.	.	0.73413	.	.	0.85263	0.959	.	19.0	0.882612	-2.27	0.81	T	single nucleotide variant	NC_000023.11:g.139548467A>T	.	.	1	0.63639706	.	.	0.8240546	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.87956	P	0.77910	P	M	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.91577	.	.	-	139548467	.	-	3.148000	.	0.97437	.	.	.	.	germline	.	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.96965	GRCh38	924	no assertion criteria provided	c.496A>T	.	0.25572	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)		.	FA9_HUMAN	.	81.0	.	.	D	0.59540	0.8234179	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Asn166Tyr	.	0.36593	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031559	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.003	.	.	-0.122	A	.	2.840319	0.79703	.	D	-	.	.	0.95325	.	.	.	0.75128	.	139548467	Y	9	.	.	.	P00740	.	0.959002	0.52061		.	0.615	D	.	0.6250371	.	0.5146	2158	0.133446	.	-3.77	.	.	0.68399	.	.	.	.	.	.	0.78539	X	F9	.	.	Asn	.	.	X-139548467-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138458292	ClinGen:CA255337|OMIM:300746.0025	.	.	.	RCV000011328	D	.	.	c.496A>T	.	.	.	0.67463	A/A	rs137852236	139548467	.	A	.	P00740	.	0.85305	.	0.68239		.	.	.	3.02	.	.	.	2.02	0.99454	.	D	T	.	.	.	.	.	.	.	98879	10582	0.67052	0.85328	0.983754932880402	.	.	0.71675	.	.	.	.	1.74	.	D	.	.	.	.	306900	0.37957	X	.	ENSG00000101981	.	.	.	.	0.9832254753781753	1	0.51228	0.18019	.	.	.	.	.	YES	.	0.513166	25621	HGNC:3551	A	.	simple_aae	0.945	.	139548467	AAC	1.000000	.	-	.	0.93464	.	.	.	Pathogenic	0.80089	.	.	.	ClinGen:CA255337,OMIM:300746.0025	N	.	0.970123982418	-	0.883	-	0.71543	.	.	0.98307	0.308290779591	0.1682	.	0.9908196188715952	.	-	496A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60210	137852236	.	.	0.96952	.	0.275	0.002	.	0.99996221	4.94	.	.	.	-0.0460908	0.99871094433747	0.86089	D	.	.	.	0.5779	0.95032	p.Asn166Tyr	.	.	-11.067	0.94212544	.	0.94924	10582	D	.	F9	.	D	0.555	.	N166Y	D	0.10681	0.13835	A/A	principal1	188302	F9_Popp_2025_heavy_chain_var233838	No											N		496	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Asn166Tyr		true	c.496A>T						3551.0	139548467.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Asn166Tyr						Y	Apr 01, 1989					missense_variant		166.0				0.1070931765453395		Pathogenic	139548467.0	missense_variant		0.555					Reporter			F9_Asn166Tyr
F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004378		NC_000023.11:139548467:A:T		Asn166Tyr																												F9_Asn166Tyr	23	139548467	A	T	X	allele	496A>T	E07	527_CAVA_Array_P02	I14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548467-A-T	-	0.37541	0.895	166	.	.	.	X	138630626	T	.	.	X	1_Pathogenic	NC_000023.11	.	Asn166Tyr	.	20.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.81565	Select	0.8513	.	0.49259	.	.	D	D	.	1.40884785401	.	.	.	.	.	0.11640	.	.	.	.	0.73413	.	.	0.85263	0.959	.	19.0	0.882612	-2.27	0.81	T	single nucleotide variant	NC_000023.11:g.139548467A>T	.	.	1	0.63639706	.	.	0.8240546	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.87956	P	0.77910	P	M	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.91577	.	.	-	139548467	.	-	3.148000	.	0.97437	.	.	.	.	germline	.	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.96965	GRCh38	924	no assertion criteria provided	c.496A>T	.	0.25572	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)		.	FA9_HUMAN	.	81.0	.	.	D	0.59540	0.8234179	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Asn166Tyr	.	0.36593	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031559	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.003	.	.	-0.122	A	.	2.840319	0.79703	.	D	-	.	.	0.95325	.	.	.	0.75128	.	139548467	Y	9	.	.	.	P00740	.	0.959002	0.52061		.	0.615	D	.	0.6250371	.	0.5146	2158	0.133446	.	-3.77	.	.	0.68399	.	.	.	.	.	.	0.78539	X	F9	.	.	Asn	.	.	X-139548467-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138458292	ClinGen:CA255337|OMIM:300746.0025	.	.	.	RCV000011328	D	.	.	c.496A>T	.	.	.	0.67463	A/A	rs137852236	139548467	.	A	.	P00740	.	0.85305	.	0.68239		.	.	.	3.02	.	.	.	2.02	0.99454	.	D	T	.	.	.	.	.	.	.	98879	10582	0.67052	0.85328	0.983754932880402	.	.	0.71675	.	.	.	.	1.74	.	D	.	.	.	.	306900	0.37957	X	.	ENSG00000101981	.	.	.	.	0.9832254753781753	1	0.51228	0.18019	.	.	.	.	.	YES	.	0.513166	25621	HGNC:3551	A	.	simple_aae	0.945	.	139548467	AAC	1.000000	.	-	.	0.93464	.	.	.	Pathogenic	0.80089	.	.	.	ClinGen:CA255337,OMIM:300746.0025	N	.	0.970123982418	-	0.883	-	0.71543	.	.	0.98307	0.308290779591	0.1682	.	0.9908196188715952	.	-	496A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60210	137852236	.	.	0.96952	.	0.275	0.002	.	0.99996221	4.94	.	.	.	-0.0460908	0.99871094433747	0.86089	D	.	.	.	0.5779	0.95032	p.Asn166Tyr	.	.	-11.067	0.94212544	.	0.94924	10582	D	.	F9	.	D	0.555	.	N166Y	D	0.10681	0.13835	A/A	principal1	215818	F9_Popp_2025_light_chain_var243519	No											N		496	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Asn166Tyr		true	c.496A>T						3551.0	139548467.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Asn166Tyr						Y	Apr 01, 1989					missense_variant		166.0				0.115812176805143		Pathogenic	139548467.0	missense_variant		0.555					Reporter			F9_Asn166Tyr
F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004378		NC_000023.11:139548467:A:T		Asn166Tyr																												F9_Asn166Tyr	23	139548467	A	T	X	allele	496A>T	E07	527_CAVA_Array_P02	I14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548467-A-T	-	0.37541	0.895	166	.	.	.	X	138630626	T	.	.	X	1_Pathogenic	NC_000023.11	.	Asn166Tyr	.	20.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.81565	Select	0.8513	.	0.49259	.	.	D	D	.	1.40884785401	.	.	.	.	.	0.11640	.	.	.	.	0.73413	.	.	0.85263	0.959	.	19.0	0.882612	-2.27	0.81	T	single nucleotide variant	NC_000023.11:g.139548467A>T	.	.	1	0.63639706	.	.	0.8240546	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.87956	P	0.77910	P	M	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.91577	.	.	-	139548467	.	-	3.148000	.	0.97437	.	.	.	.	germline	.	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.96965	GRCh38	924	no assertion criteria provided	c.496A>T	.	0.25572	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)		.	FA9_HUMAN	.	81.0	.	.	D	0.59540	0.8234179	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Asn166Tyr	.	0.36593	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031559	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.003	.	.	-0.122	A	.	2.840319	0.79703	.	D	-	.	.	0.95325	.	.	.	0.75128	.	139548467	Y	9	.	.	.	P00740	.	0.959002	0.52061		.	0.615	D	.	0.6250371	.	0.5146	2158	0.133446	.	-3.77	.	.	0.68399	.	.	.	.	.	.	0.78539	X	F9	.	.	Asn	.	.	X-139548467-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138458292	ClinGen:CA255337|OMIM:300746.0025	.	.	.	RCV000011328	D	.	.	c.496A>T	.	.	.	0.67463	A/A	rs137852236	139548467	.	A	.	P00740	.	0.85305	.	0.68239		.	.	.	3.02	.	.	.	2.02	0.99454	.	D	T	.	.	.	.	.	.	.	98879	10582	0.67052	0.85328	0.983754932880402	.	.	0.71675	.	.	.	.	1.74	.	D	.	.	.	.	306900	0.37957	X	.	ENSG00000101981	.	.	.	.	0.9832254753781753	1	0.51228	0.18019	.	.	.	.	.	YES	.	0.513166	25621	HGNC:3551	A	.	simple_aae	0.945	.	139548467	AAC	1.000000	.	-	.	0.93464	.	.	.	Pathogenic	0.80089	.	.	.	ClinGen:CA255337,OMIM:300746.0025	N	.	0.970123982418	-	0.883	-	0.71543	.	.	0.98307	0.308290779591	0.1682	.	0.9908196188715952	.	-	496A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60210	137852236	.	.	0.96952	.	0.275	0.002	.	0.99996221	4.94	.	.	.	-0.0460908	0.99871094433747	0.86089	D	.	.	.	0.5779	0.95032	p.Asn166Tyr	.	.	-11.067	0.94212544	.	0.94924	10582	D	.	F9	.	D	0.555	.	N166Y	D	0.10681	0.13835	A/A	principal1	160786	F9_Popp_2025_carboxy_gla_motif_var253200	No											N		496	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Asn166Tyr		true	c.496A>T						3551.0	139548467.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Asn166Tyr						Y	Apr 01, 1989					missense_variant		166.0				0.06646977		Pathogenic	139548467.0	missense_variant		0.555					Reporter			F9_Asn166Tyr
F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004378		NC_000023.11:139548467:A:T		Asn166Tyr																												F9_Asn166Tyr	23	139548467	A	T	X	allele	496A>T	E07	527_CAVA_Array_P02	I14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548467-A-T	-	0.37541	0.895	166	.	.	.	X	138630626	T	.	.	X	1_Pathogenic	NC_000023.11	.	Asn166Tyr	.	20.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.81565	Select	0.8513	.	0.49259	.	.	D	D	.	1.40884785401	.	.	.	.	.	0.11640	.	.	.	.	0.73413	.	.	0.85263	0.959	.	19.0	0.882612	-2.27	0.81	T	single nucleotide variant	NC_000023.11:g.139548467A>T	.	.	1	0.63639706	.	.	0.8240546	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.87956	P	0.77910	P	M	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.91577	.	.	-	139548467	.	-	3.148000	.	0.97437	.	.	.	.	germline	.	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.96965	GRCh38	924	no assertion criteria provided	c.496A>T	.	0.25572	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)		.	FA9_HUMAN	.	81.0	.	.	D	0.59540	0.8234179	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Asn166Tyr	.	0.36593	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031559	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.003	.	.	-0.122	A	.	2.840319	0.79703	.	D	-	.	.	0.95325	.	.	.	0.75128	.	139548467	Y	9	.	.	.	P00740	.	0.959002	0.52061		.	0.615	D	.	0.6250371	.	0.5146	2158	0.133446	.	-3.77	.	.	0.68399	.	.	.	.	.	.	0.78539	X	F9	.	.	Asn	.	.	X-139548467-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138458292	ClinGen:CA255337|OMIM:300746.0025	.	.	.	RCV000011328	D	.	.	c.496A>T	.	.	.	0.67463	A/A	rs137852236	139548467	.	A	.	P00740	.	0.85305	.	0.68239		.	.	.	3.02	.	.	.	2.02	0.99454	.	D	T	.	.	.	.	.	.	.	98879	10582	0.67052	0.85328	0.983754932880402	.	.	0.71675	.	.	.	.	1.74	.	D	.	.	.	.	306900	0.37957	X	.	ENSG00000101981	.	.	.	.	0.9832254753781753	1	0.51228	0.18019	.	.	.	.	.	YES	.	0.513166	25621	HGNC:3551	A	.	simple_aae	0.945	.	139548467	AAC	1.000000	.	-	.	0.93464	.	.	.	Pathogenic	0.80089	.	.	.	ClinGen:CA255337,OMIM:300746.0025	N	.	0.970123982418	-	0.883	-	0.71543	.	.	0.98307	0.308290779591	0.1682	.	0.9908196188715952	.	-	496A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60210	137852236	.	.	0.96952	.	0.275	0.002	.	0.99996221	4.94	.	.	.	-0.0460908	0.99871094433747	0.86089	D	.	.	.	0.5779	0.95032	p.Asn166Tyr	.	.	-11.067	0.94212544	.	0.94924	10582	D	.	F9	.	D	0.555	.	N166Y	D	0.10681	0.13835	A/A	principal1	243334	F9_Popp_2025_strep_2_var262881	No											N		496	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Asn166Tyr		true	c.496A>T						3551.0	139548467.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Asn166Tyr						Y	Apr 01, 1989					missense_variant		166.0				0.3803852404443763		Pathogenic	139548467.0	missense_variant		0.555					Reporter			F9_Asn166Tyr
F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004378		NC_000023.11:139548467:A:T		Asn166Tyr																												F9_Asn166Tyr	23	139548467	A	T	X	allele	496A>T	E07	527_CAVA_Array_P02	I14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548467-A-T	-	0.37541	0.895	166	.	.	.	X	138630626	T	.	.	X	1_Pathogenic	NC_000023.11	.	Asn166Tyr	.	20.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.81565	Select	0.8513	.	0.49259	.	.	D	D	.	1.40884785401	.	.	.	.	.	0.11640	.	.	.	.	0.73413	.	.	0.85263	0.959	.	19.0	0.882612	-2.27	0.81	T	single nucleotide variant	NC_000023.11:g.139548467A>T	.	.	1	0.63639706	.	.	0.8240546	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.87956	P	0.77910	P	M	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.91577	.	.	-	139548467	.	-	3.148000	.	0.97437	.	.	.	.	germline	.	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.96965	GRCh38	924	no assertion criteria provided	c.496A>T	.	0.25572	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)		.	FA9_HUMAN	.	81.0	.	.	D	0.59540	0.8234179	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Asn166Tyr	.	0.36593	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031559	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.003	.	.	-0.122	A	.	2.840319	0.79703	.	D	-	.	.	0.95325	.	.	.	0.75128	.	139548467	Y	9	.	.	.	P00740	.	0.959002	0.52061		.	0.615	D	.	0.6250371	.	0.5146	2158	0.133446	.	-3.77	.	.	0.68399	.	.	.	.	.	.	0.78539	X	F9	.	.	Asn	.	.	X-139548467-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138458292	ClinGen:CA255337|OMIM:300746.0025	.	.	.	RCV000011328	D	.	.	c.496A>T	.	.	.	0.67463	A/A	rs137852236	139548467	.	A	.	P00740	.	0.85305	.	0.68239		.	.	.	3.02	.	.	.	2.02	0.99454	.	D	T	.	.	.	.	.	.	.	98879	10582	0.67052	0.85328	0.983754932880402	.	.	0.71675	.	.	.	.	1.74	.	D	.	.	.	.	306900	0.37957	X	.	ENSG00000101981	.	.	.	.	0.9832254753781753	1	0.51228	0.18019	.	.	.	.	.	YES	.	0.513166	25621	HGNC:3551	A	.	simple_aae	0.945	.	139548467	AAC	1.000000	.	-	.	0.93464	.	.	.	Pathogenic	0.80089	.	.	.	ClinGen:CA255337,OMIM:300746.0025	N	.	0.970123982418	-	0.883	-	0.71543	.	.	0.98307	0.308290779591	0.1682	.	0.9908196188715952	.	-	496A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60210	137852236	.	.	0.96952	.	0.275	0.002	.	0.99996221	4.94	.	.	.	-0.0460908	0.99871094433747	0.86089	D	.	.	.	0.5779	0.95032	p.Asn166Tyr	.	.	-11.067	0.94212544	.	0.94924	10582	D	.	F9	.	D	0.555	.	N166Y	D	0.10681	0.13835	A/A	principal1	133270	F9_Popp_2025_carboxy_F9_specific_var224157	No											N		496	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Asn166Tyr		true	c.496A>T						3551.0	139548467.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Asn166Tyr						Y	Apr 01, 1989					missense_variant		166.0				0.1024631778626351		Pathogenic	139548467.0	missense_variant		0.555					Reporter			F9_Asn166Tyr
F9_Asn166Tyr	-2.143030102118312	0.06932343798974207	4.074624066623891	0.004721591716704368	2025_01_Batch_13-14	0.8558893364869741	0.7972960987930156	0.9246924919224093	0.85055398051898	0.7640671439537013	0.49681884586859676	0.8692814635057032	0.9631194127877329	0.885324051839863	0.7564733274500351	0.6763540911777854	0.8332887811493594	0.9439059523550711	0.8679390161794215	0.7602702357018682	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004378		NC_000023.11:139548467:A:T		Asn166Tyr																												F9_Asn166Tyr	23	139548467	A	T	X	allele	496A>T	E07	527_CAVA_Array_P02	I14	B13A7A8P1_R1	B14A7A8P1_R2				X-139548467-A-T	-	0.37541	0.895	166	.	.	.	X	138630626	T	.	.	X	1_Pathogenic	NC_000023.11	.	Asn166Tyr	.	20.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.81565	Select	0.8513	.	0.49259	.	.	D	D	.	1.40884785401	.	.	.	.	.	0.11640	.	.	.	.	0.73413	.	.	0.85263	0.959	.	19.0	0.882612	-2.27	0.81	T	single nucleotide variant	NC_000023.11:g.139548467A>T	.	.	1	0.63639706	.	.	0.8240546	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.87956	P	0.77910	P	M	.	.	A/A	.	.	.	.	Hereditary factor IX deficiency disease	.	0.91577	.	.	-	139548467	.	-	3.148000	.	0.97437	.	.	.	.	germline	.	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.96965	GRCh38	924	no assertion criteria provided	c.496A>T	.	0.25572	.	.	.	.	.	.	B	.	.	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)		.	FA9_HUMAN	.	81.0	.	.	D	0.59540	0.8234179	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99965	.	.	.	.	.	p.Asn166Tyr	.	0.36593	.	germline	.		A	Apr 01, 1989	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000031559	Pathogenic	.	.	Tyr	Y	-	.	ENSP00000218099	ENST00000218099	.	0.003	.	.	-0.122	A	.	2.840319	0.79703	.	D	-	.	.	0.95325	.	.	.	0.75128	.	139548467	Y	9	.	.	.	P00740	.	0.959002	0.52061		.	0.615	D	.	0.6250371	.	0.5146	2158	0.133446	.	-3.77	.	.	0.68399	.	.	.	.	.	.	0.78539	X	F9	.	.	Asn	.	.	X-139548467-A-T	Hereditary_factor_IX_deficiency_disease	.	.	138458292	ClinGen:CA255337|OMIM:300746.0025	.	.	.	RCV000011328	D	.	.	c.496A>T	.	.	.	0.67463	A/A	rs137852236	139548467	.	A	.	P00740	.	0.85305	.	0.68239		.	.	.	3.02	.	.	.	2.02	0.99454	.	D	T	.	.	.	.	.	.	.	98879	10582	0.67052	0.85328	0.983754932880402	.	.	0.71675	.	.	.	.	1.74	.	D	.	.	.	.	306900	0.37957	X	.	ENSG00000101981	.	.	.	.	0.9832254753781753	1	0.51228	0.18019	.	.	.	.	.	YES	.	0.513166	25621	HGNC:3551	A	.	simple_aae	0.945	.	139548467	AAC	1.000000	.	-	.	0.93464	.	.	.	Pathogenic	0.80089	.	.	.	ClinGen:CA255337,OMIM:300746.0025	N	.	0.970123982418	-	0.883	-	0.71543	.	.	0.98307	0.308290779591	0.1682	.	0.9908196188715952	.	-	496A>T 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.60210	137852236	.	.	0.96952	.	0.275	0.002	.	0.99996221	4.94	.	.	.	-0.0460908	0.99871094433747	0.86089	D	.	.	.	0.5779	0.95032	p.Asn166Tyr	.	.	-11.067	0.94212544	.	0.94924	10582	D	.	F9	.	D	0.555	.	N166Y	D	0.10681	0.13835	A/A	principal1	188302	F9_Popp_2025_heavy_chain_var233838	No											N		496	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Asn166Tyr		true	c.496A>T						3551.0	139548467.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Asn166Tyr						Y	Apr 01, 1989					missense_variant		166.0				0.1070931765453395		Pathogenic	139548467.0	missense_variant		0.555					Reporter			F9_Asn166Tyr
SHOC2_Thr205Ala	-0.7932454090740622	0.45367827402196725	2.8298723604947678	0.025410841904029143	2025_01_Batch_13-14	0.8085083031253772	0.8430397534984986	0.6808613914511137	0.7631580315275811	0.7875180084414044	0.6792168005819562	0.7906335064419769	0.7265913877311805	0.7882655763071058	0.582966710619111	0.7438625518536668	0.8168366299702378	0.7037263895911471	0.7757118039173434	0.6852423595302577	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2	SHOC2		11602		CCSBVarC028039		NC_000010.11:110964971:A:G		Thr205Ala																												SHOC2_Thr205Ala	10	110964971	A	G	10	allele	613A>G	F02	527_CAVA_Array_P06	K04	B13A7A8P2_R1	B14A7A8P2_R2				10-110964971-A-G	-	0.48451	0.485	205	1	0	0	10	112724729	G	1.921060e-05	0	10	2_Benign	NC_000010.11	30	Thr205Ala	0	22.6	0	.	3.932110e-04	T	0	2	.	42756	5.500550e-05	.	30518	0.000000e+00	.	0.57011	.	0.1724	30518	0.57842	0	.	T	T	63774	.	.	0	0.000000e+00	0	0	0.80559	17086	44880	30	0.000000e+00	0.43722	0	.	0.41895	1.0	.	.	.	.	.	G	single nucleotide variant	NC_000010.11:g.110964971A>G	0	16512	2	0.23230855	109120	.	0.22402976	.		13	236340	0	0	0.000000e+00	.	0.000000e+00	.	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MedGen:CN230736	6	0	0.000000e+00	0	0.60618	B	0.50279	P	M	5.666972	31	A/A	.	.	7158	1613690	RASopathy|Cardiovascular phenotype	16178	0.45454	.	.	-	110964971	3.825070e-04	-	11.226000	0	0.74849	29602	.	91078	0	germline	91078	Loss of methylation at K209 (P = 0.1135)| Gain of MoRF binding (P = 0.1344)| Loss of disorder (P = 0.1735)| Gain of helix (P = 0.1736)| Gain of ubiquitination at K209 (P = 0.2261)	0.25438	GRCh38	916	reviewed by expert panel	.	3.932110e-04	0.87274	.	0	0	.	0.000000e+00	9036	.	.	0.000000e+00	NM_007373.4(SHOC2):c.613A>G (p.Thr205Ala)	3	0	SHOC2_HUMAN	0	.	0.573813009677373	0	.	0.31635	0.20188108	+	0.000000e+00	.		12	0.000000e+00	0	34190	reviewed_by_expert_panel	0.50361	5.498530e-05	0	0.000000e+00	0	59980	.	0	0.89948	.	germline	6		A	Apr 18, 2017	12	A/A	0	89492	1.0	N	10q25.2	.	.	0.000000e+00	SCV000616496	Likely_benign	0	0	Ala	A	-	912	ENSP00000509686	ENST00000691441	17678	.	13402	0	0.751	A	0	3.467778	0.39834	D	.	-	6.666899	.	0.38486	.	0	.	0.22980	.	110964971	Y	10	.	102560	0.000000e+00	Q9UQ13	0	0.271683	0.81861		0	0.23	T	30600	0.24907	15686	0.97202	8036	-0.154376	1	.	.	3.293880e-04	0.34240	3.825070e-04	0	75032	0.000000e+00	6062	0	0.48205	10	SHOC2	0.000000e+00	.	Thr	.	1.117420e-05	10-110964971-A-G	RASopathy	0	1	112714719	ClinGen:CA5689601	0.899008	0.71391	0	RCV000521093|RCV004984937	.	0	0	c.613A>G	0	0	0	0.27280	A/A	rs768411950	110964971	14862	A	.	Q9UQ13	15686	0.44711	0.000000e+00	0.68239		0	0	0.000000e+00	2.615	.	.	.	5.66	0.64203	.	T	T	0	0.000000e+00	.	.	.	0	0	536391	448933	0.60050	0.84207	0.258627751812722	.	.	0.71675	0.84235	0.000000e+00	3.921570e-04	1179874	9.325	6.259450e-05	.	13172	0	.	.	.	0.96016	10	0.000000e+00	ENSG00000108061	0.000000e+00	.	12	.	.	1	0.72002	0.20739	30600	.	9.750390e-06	0.000000e+00	0.63331388771494	.	3.293880e-04	0.017149	442530	HGNC:15454	.	0	.	0.554	207686	110964971	ACT	1.000000	.	-	.	0.48935	8.475480e-07	.	0	Likely benign	0.42680	6	0	0	ClinGen:CA5689601	T	0	.	-	0.293	-	0.71096	13	.	0.63105	0.790986120701	.	0	0.99717881961411736	.	-	613A>G 	12	.	C5555857	0	0	0	0	NM_007373.4	-	.	.	0	0.68925	768411950	2320	.	0.40260	0.77249	.	.	.	0.02179968	5.66	.	.	3.921570e-04	-0.137561	0.875279691495204	0.76302	T	.	6206	9564	-0.9193	0.51276	p.Thr205Ala	.	0	-5.149	.	0	0.74491	448933	T	30454	SHOC2	0.000000e+00	T	.	21384	T205A	.	.	0.87726	A/A	principal1																																																																																																				
SHOC2_Ser57Phe	-1.2094902213471577	0.26573292360703604	3.471311167785418	0.010387464454151103	2025_01_Batch_13-14	0.529813433537089	0.6792801073072422	0.6143298928196269	0.5861049791074834	0.49563981606248964	0.9046983987114122	0.8257663079559578	0.7470538531880919	0.9234824052972537	0.6777269059748217	0.7172559161242507	0.7525232076316	0.6806918730038594	0.7547936922023686	0.5866833610186557	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	SHOC2	SHOC2		11602		CCSBVarC028011		NC_000010.11:110964528:C:T		Ser57Phe																												SHOC2_Ser57Phe	10	110964528	C	T	10	allele	170C>T	C02	527_CAVA_Array_P06	E04	B13A7A8P2_R1	B14A7A8P2_R2				10-110964528-C-T	-	0.55624	0.214	57	14	0	0	10	112724286	T	5.390230e-05	2	10	3_Conflicting	NC_000010.11	1	Ser57Phe	0	23.6	0	0	1.470010e-04	D	0	7	.	42762	9.743120e-05	0	30508	0.000000e+00	0	0.73303	.	0.7029	102040	0.33016	5	0.0	T	T	64008	.	0	0	0.000000e+00	0	0	0.59645	17094	44872	6	0.000000e+00	0.42386	4	.	0.47101	0.993	0.0	.	.	3.68	.	T	single nucleotide variant	NC_000010.11:g.110964528C>T	0	16728	2	0.22556585	109336	0	0.24477392	0		21	236064	0	0	0.000000e+00	500	9.354100e-05	0	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|MONDO:MONDO:0054637,MedGen:C4478716,OMIM:607721,Orphanet:2701|MedGen:CN230736	7	0	0.000000e+00	0	0.63842	B	0.47330	B	L	3.590762	87	C/C	306	1	7148	1614030	not specified|not provided|RASopathy|Noonan syndrome-like disorder with loose anagen hair 1|Cardiovascular phenotype	16156	0.87999	0	.	-	110964528	1.170000e-04	-	7.666000	0	0.61325	29606	0	6062	0	germline	91084	Loss of phosphorylation at S57 (P = 0.0075)| Loss of relative solvent accessibility (P = 0.0676)| Loss of loop (P = 0.0804)| Gain of helix (P = 0.0854)| Gain of methylation at K55 (P = 0.0918)	0.10912	GRCh38	915	criteria provided, conflicting classifications	.	9.833490e-05	0.97294	5	0	0	.	0.000000e+00	9036	.	0	0.000000e+00	NM_007373.4(SHOC2):c.170C>T (p.Ser57Phe)	1	0	SHOC2_HUMAN	0	.	0.262239601804826	4	.	0.31154	0.24477392	+	0.000000e+00	1		14	0.000000e+00	0	34202	criteria_provided,_conflicting_classifications	0.46015	6.402280e-05	1	0.000000e+00	0	59982	.	0	0.64570	.	germline	2		C	Nov 25, 2024	3	C/C	0	89460	1.0	N	10q25.2	42688	.	0.000000e+00	SCV000206277|SCV000547943|SCV000576695|SCV002048966|SCV002712264|SCV003933893|SCV004127491	Conflicting_classifications_of_pathogenicity	0	0	Phe	F	-	912	ENSP00000509273	ENST00000688928	17678	.	13392	0	0.596	C	0	3.839	0.59495	D	.	-	4.67194	.	0.63705	628	0	0.0	0.13402	0	110964528	Y	10	0	102040	1.649620e-04	Q9UQ13	0	0.393088	0.73250		0	0.191	D	89460	0.22556585	17094	0.69292	8036	-0.0567598	67	.	0.0010224948875255625	1.649620e-04	0.48802	6.380810e-05	0	75008	0.000000e+00	6062	0	0.47329	10	SHOC2	0.000000e+00	0	Ser	60696	1.564950e-04	10-110964528-C-T	Cardiovascular_phenotype|not_provided|RASopathy|Noonan_syndrome-like_disorder_with_loose_anagen_hair_1|not_specified	0	15	112714276	ClinGen:CA185080	0.764929	0.54016	1	RCV000156558|RCV000680347|RCV000471315|RCV001803094|RCV002399558	.	0	0	c.170C>T	0	0	0	0.43068	C/C	rs536611911	110964528	14884	C	1.9968051118210862E-4	Q9UQ13	15672	0.47101	0.000000e+00	0.68239		0	0	0.000000e+00	1.7	0	4	264690	5.99	0.75087	168	T	T	0	1.312770e-04	0	56	.	0	0	536391|2701	179760	0.65789	0.58683	0.111457248625392	8326	1	0.71675	0.70048	1.461900e-04	1.564950e-04	1179988	6.109	1.010310e-04	.	13392	0	3.7780046E-5	0	607721	0.71273	10	0.000000e+00	ENSG00000108061	0.000000e+00	9.37031484257871E-5	3	0	.	2	0.42849	0.20912	30590	10	1.470010e-04	1.500450e-04	0.442202180045834	.	6.587330e-05	0.049509	174882	HGNC:15454	.	0	.	0.355	207858	110964528	TCC	1.000000	0	-	0	0.24349	5.678020e-05	0	0	Conflicting classifications of pathogenicity	0.53367	1	1	9	ClinGen:CA185080	S	0	.	-	0.197	-	0.41012	23	8288	0.11358	0.648043274879	.	0	0.99584984580791636	98	-	170C>T 	15	1.2065637065637066E-4	CN230736|C3661900|C5555857|C4478716|CN169374	0	0	0	0	NM_007373.4	-	0	0.0	0	0.73431	536611911	2320	8.237775141689732E-5	0.33999	0.64024	.	.	8020	0.01493649	5.99	.	.	9.807130e-05	-0.0642621	0.980925639856185	0.43657	D	112	6204	9540	0.3313	0.89743	p.Ser57Phe	0	0	-6.9	.	0	0.85540	179760	T	30470	SHOC2	1.170000e-04	T	.	21616	S57F	.	0.67565	0.33565	C/C	principal1																																																																																																				
ZC4H2_Arg213Trp	-6.429607337566906	0.00035709788012483603	5.315249216584618	0.001104943707691982	2025_01_Batch_13-14	0.7307104948785454	0.734236566256333	0.7917511009968734	0.725454189582057	0.6164665656785188	0.7638881292976838	0.8631221770602862	0.9279671988362974	0.8745117495247433	0.7049967142868286	0.7472993120881146	0.7986793716583096	0.8598591499165854	0.7999829695534002	0.6607316399826737	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	ZC4H2	ZC4H2		4320		CCSBVarC009197		NC_000023.11:64917821:G:A		Arg213Trp																												ZC4H2_Arg213Trp	23	64917821	G	A	X	allele	637C>T	D05	527_CAVA_Array_P06	G10	B13A7A8P2_R1	B14A7A8P2_R2				X-64917821-G-A	-	0.71085	0.999	213	.	.	.	X	64137701	A	.	.	X	1_Pathogenic	NC_000023.11	.	Arg213Trp	.	25.6	.	.	.	T	.	4	1	.	.	.	.	.	.	0.69109	Select	0.4185	.	0.77914	.	.	D	D	.	3.13339230401	.	.	.	.	.	0.95671	.	.	.	.	0.92962	.	.	0.90028	1.0	.	8.0	0.984002	2.53	0.92	A	single nucleotide variant	NC_000023.11:g.64917821G>A	.	.	3	0.83650655	.	.	0.8943117	.		.	.	.	.	.	.	.	.	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283|MeSH:D030342,MedGen:C0950123|MedGen:C3661900	.	.	.	.	0.93300	D	0.87905	D	.	.	.	G/G	.	.	.	.	Wieacker-Wolff syndrome|Inborn genetic diseases|not provided	.	0.77155	.	.	-	64917821	.	-	4.548000	.	0.98982	.	.	.	.	germline	.	Loss of solvent accessibility (P = 0.0036)| Loss of methylation at K209 (P = 0.0666)| Loss of relative solvent accessibility (P = 0.0676)| Gain of glycosylation at S210 (P = 0.1548)| Loss of helix (P = 0.2662)	0.58232	GRCh38	40	criteria provided, multiple submitters, no conflicts	c.637C>T	.	0.40064	.	.	.	Zinc finger C4H2-type	.	.	P	.	.	NM_018684.4(ZC4H2):c.637C>T (p.Arg213Trp)	2	.	ZC4H2_HUMAN	.	92.0	.	.	D	0.99217	0.8859753	-	.	.		.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.98720	.	.	.	.	.	p.Arg213Trp	.	0.43870	.	germline	.		G	Feb 14, 2022	.	G/G	.	.	1.0	N	Xq11.2	.	.	.	SCV001583928|SCV002074112|SCV002655406	Pathogenic	.	.	Trp	W	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.676	G	.	4.527004	0.83643	.	D	-	.	.	0.99137	.	.	.	0.93893	.	64917821	Y	8	.	.	.	Q9NQZ6	.	0.814106	0.98380		.	0.993	D	.	0.79658544	.	0.97202	55906	0.49627	.	-6.81	.	.	0.91343	.	.	.	.	.	.	0.90487	X	ZC4H2	.	.	Arg	.	.	X-64917821-G-A	Wieacker-Wolff_syndrome|not_provided|Inborn_genetic_diseases	.	.	64054426	ClinGen:CA10575581|OMIM:300897.0004|UniProtKB:Q9NQZ6#VAR_069624	.	.	.	RCV000043679|RCV002354226|RCV001384432	D	.	.	c.637C>T	.	.	.	0.94129	G/G	rs879255236	64917821	.	G	.	Q9NQZ6	.	0.90750	.	0.68239		.	.	.	.	.	.	.	3.58	0.95348	.	D	D	.	.	.	.	.	.	.	3454|85283	50983	0.94052	0.99404	0.998362839221954	.	.	0.71675	.	.	.	.	3.404	.	D	.	.	.	.	314580	0.52465	X	.	ENSG00000126970	.	.	.	.	0.7886100765468459	1	0.81117	0.97963	.	.	.	.	.	YES	.	0.886685	65654	HGNC:24931	A	.	simple_aae	0.973	.	64917821	CGG	1.000000	.	-	.	0.82873	.	.	.	Pathogenic	0.87537	.	.	.	ClinGen:CA10575581,UniProtKB:Q9NQZ6#VAR_069624,OMIM:300897.0004	R	.	0.964658073467	-	0.495	-	0.64382	.	.	0.78692	0.893401861191	0.9996	.	0.99915480374987564	.	-	637C>T 	.	.	C0796200|C3661900|C0950123	.	.	.	.	NM_018684.4	-	.	.	1	0.95472	879255236	.	.	0.96396	.	0.63	0.001	.	0.99830365	5.42	.	.	.	0.475081	0.999161681495248	.	T	.	.	.	-0.2160	0.76351	p.Arg213Trp	.	.	-12.468	0.838971	.	0.95853	50983	D	.	ZC4H2	.	D	0.374	.	R213W	D	0.46530	0.76753	G/G	principal1																																																																																																				
F9_Cys178Phe	-11.216381779192723	0.001519226590029085	2.967597014339918	0.020878782165472228																											F9	F9		52861		CCSBVarC030553		NC_000023.11:139551074:G:T		Cys178Phe																												F9_Cys178Phe	23	139551074	G	T	X	allele	533G>T	A08	527_CAVA_Array_P02	A16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551074-G-T	-	0.82349	1.0	178	.	.	.	X	138633233	T	.	.	X	1_Pathogenic	NC_000023.11	.	Cys178Phe	.	27.8	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98488	Select	0.9025	.	0.90580	.	.	D	D	.	2.03962625952	.	.	.	.	.	0.37228	.	.	.	.	0.97951	.	.	0.98276	0.998	.	3.0	0.89971	4.7	0.97	T	single nucleotide variant	NC_000023.11:g.139551074G>T	.	.	2	0.9649957	.	.	0.9723726	.		.	.	.	.	.	.	.	.	MedGen:CN169374	.	.	.	.	0.96253	D	0.99311	D	M	.	.	G/G	.	.	.	.	not specified	.	0.97673	.	.	-	139551074	.	-	11.785000	.	0.98885	.	.	.	.	germline	.	Loss of catalytic residue at P177 (P = 0.0084)| Loss of disorder (P = 0.1069)| Gain of phosphorylation at S182 (P = 0.1778)| Gain of MoRF binding (P = 0.2922)| Loss of sheet (P = 0.437)	0.99581	GRCh38	924	criteria provided, single submitter	c.533G>T	.	0.69688	.	.	.	.	.	.	P	.	.	NM_000133.4(F9):c.533G>T (p.Cys178Phe)	1	.	FA9_HUMAN	.	97.0	.	.	D	0.86554	0.97047687	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys178Phe	.	0.96219	.	germline	.		G	May 26, 2019	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV001158669	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.97306	0.83643	.	D	-	.	.	0.93590	.	.	.	0.65474	.	139551074	Y	10	.	.	.	P00740	.	0.902337	0.49751		.	0.999	D	.	0.9668715	.	0.85369	2158	0.596124	.	-8.86	.	.	0.72322	.	.	.	.	.	.	0.99219	X	F9	.	.	Cys	.	.	X-139551074-G-T	not_specified	.	.	138460899	.	.	.	.	RCV001001433	D	.	.	c.533G>T	.	.	.	0.97612	G/G	rs1603265779	139551074	.	G	.	P00740	.	0.98452	.	0.68239		.	.	.	2.175	.	.	.	5.13	0.98074	.	D	T	.	.	.	.	.	.	.	.	811518	0.97575	0.94194	0.960028551474682	.	.	0.71675	.	.	.	.	5.955	.	D	.	.	.	.	.	0.70098	X	.	ENSG00000101981	.	.	.	.	0.9987586514114085	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.411263	800233	HGNC:3551	A	.	simple_aae	0.971	.	139551074	TGT	1.000000	.	-	.	0.99362	.	.	.	Pathogenic	0.96719	.	.	.	ClinGen:CA414440306	C	.	0.998265984387	-	0.96	-	0.87788	.	.	0.99874	0.488848567009	0.9469	.	0.98977113623540003	.	-	533G>T 	.	.	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.64775	1603265779	.	.	0.99822	.	0.831	0.001	.	0.99999130	5.13	.	.	.	0.618514	0.999894557545851	0.60790	D	.	.	.	1.0280	0.96759	p.Cys178Phe	.	.	-15.016	0.98915994	.	0.98645	811518	D	.	F9	.	D	0.934	.	C178F	D	0.86749	0.76753	G/G	principal1	134008	F9_Popp_2025_carboxy_F9_specific_var224408	No											C		533	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys178Phe		true	c.533G>T						3551.0	139551074.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Cys178Phe						F	May 26, 2019					missense_variant		178.0				0.027478519932592		Pathogenic	139551074.0	missense_variant		0.934					Reporter			F9_Cys178Phe
F9_Cys178Phe	-11.216381779192723	0.001519226590029085	2.967597014339918	0.020878782165472228																											F9	F9		52861		CCSBVarC030553		NC_000023.11:139551074:G:T		Cys178Phe																												F9_Cys178Phe	23	139551074	G	T	X	allele	533G>T	A08	527_CAVA_Array_P02	A16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551074-G-T	-	0.82349	1.0	178	.	.	.	X	138633233	T	.	.	X	1_Pathogenic	NC_000023.11	.	Cys178Phe	.	27.8	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98488	Select	0.9025	.	0.90580	.	.	D	D	.	2.03962625952	.	.	.	.	.	0.37228	.	.	.	.	0.97951	.	.	0.98276	0.998	.	3.0	0.89971	4.7	0.97	T	single nucleotide variant	NC_000023.11:g.139551074G>T	.	.	2	0.9649957	.	.	0.9723726	.		.	.	.	.	.	.	.	.	MedGen:CN169374	.	.	.	.	0.96253	D	0.99311	D	M	.	.	G/G	.	.	.	.	not specified	.	0.97673	.	.	-	139551074	.	-	11.785000	.	0.98885	.	.	.	.	germline	.	Loss of catalytic residue at P177 (P = 0.0084)| Loss of disorder (P = 0.1069)| Gain of phosphorylation at S182 (P = 0.1778)| Gain of MoRF binding (P = 0.2922)| Loss of sheet (P = 0.437)	0.99581	GRCh38	924	criteria provided, single submitter	c.533G>T	.	0.69688	.	.	.	.	.	.	P	.	.	NM_000133.4(F9):c.533G>T (p.Cys178Phe)	1	.	FA9_HUMAN	.	97.0	.	.	D	0.86554	0.97047687	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys178Phe	.	0.96219	.	germline	.		G	May 26, 2019	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV001158669	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.97306	0.83643	.	D	-	.	.	0.93590	.	.	.	0.65474	.	139551074	Y	10	.	.	.	P00740	.	0.902337	0.49751		.	0.999	D	.	0.9668715	.	0.85369	2158	0.596124	.	-8.86	.	.	0.72322	.	.	.	.	.	.	0.99219	X	F9	.	.	Cys	.	.	X-139551074-G-T	not_specified	.	.	138460899	.	.	.	.	RCV001001433	D	.	.	c.533G>T	.	.	.	0.97612	G/G	rs1603265779	139551074	.	G	.	P00740	.	0.98452	.	0.68239		.	.	.	2.175	.	.	.	5.13	0.98074	.	D	T	.	.	.	.	.	.	.	.	811518	0.97575	0.94194	0.960028551474682	.	.	0.71675	.	.	.	.	5.955	.	D	.	.	.	.	.	0.70098	X	.	ENSG00000101981	.	.	.	.	0.9987586514114085	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.411263	800233	HGNC:3551	A	.	simple_aae	0.971	.	139551074	TGT	1.000000	.	-	.	0.99362	.	.	.	Pathogenic	0.96719	.	.	.	ClinGen:CA414440306	C	.	0.998265984387	-	0.96	-	0.87788	.	.	0.99874	0.488848567009	0.9469	.	0.98977113623540003	.	-	533G>T 	.	.	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.64775	1603265779	.	.	0.99822	.	0.831	0.001	.	0.99999130	5.13	.	.	.	0.618514	0.999894557545851	0.60790	D	.	.	.	1.0280	0.96759	p.Cys178Phe	.	.	-15.016	0.98915994	.	0.98645	811518	D	.	F9	.	D	0.934	.	C178F	D	0.86749	0.76753	G/G	principal1	189040	F9_Popp_2025_heavy_chain_var234089	No											C		533	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys178Phe		true	c.533G>T						3551.0	139551074.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Cys178Phe						F	May 26, 2019					missense_variant		178.0				0.0137137661184121		Pathogenic	139551074.0	missense_variant		0.934					Reporter			F9_Cys178Phe
F9_Cys178Phe	-11.216381779192723	0.001519226590029085	2.967597014339918	0.020878782165472228																											F9	F9		52861		CCSBVarC030553		NC_000023.11:139551074:G:T		Cys178Phe																												F9_Cys178Phe	23	139551074	G	T	X	allele	533G>T	A08	527_CAVA_Array_P02	A16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551074-G-T	-	0.82349	1.0	178	.	.	.	X	138633233	T	.	.	X	1_Pathogenic	NC_000023.11	.	Cys178Phe	.	27.8	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98488	Select	0.9025	.	0.90580	.	.	D	D	.	2.03962625952	.	.	.	.	.	0.37228	.	.	.	.	0.97951	.	.	0.98276	0.998	.	3.0	0.89971	4.7	0.97	T	single nucleotide variant	NC_000023.11:g.139551074G>T	.	.	2	0.9649957	.	.	0.9723726	.		.	.	.	.	.	.	.	.	MedGen:CN169374	.	.	.	.	0.96253	D	0.99311	D	M	.	.	G/G	.	.	.	.	not specified	.	0.97673	.	.	-	139551074	.	-	11.785000	.	0.98885	.	.	.	.	germline	.	Loss of catalytic residue at P177 (P = 0.0084)| Loss of disorder (P = 0.1069)| Gain of phosphorylation at S182 (P = 0.1778)| Gain of MoRF binding (P = 0.2922)| Loss of sheet (P = 0.437)	0.99581	GRCh38	924	criteria provided, single submitter	c.533G>T	.	0.69688	.	.	.	.	.	.	P	.	.	NM_000133.4(F9):c.533G>T (p.Cys178Phe)	1	.	FA9_HUMAN	.	97.0	.	.	D	0.86554	0.97047687	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys178Phe	.	0.96219	.	germline	.		G	May 26, 2019	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV001158669	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.97306	0.83643	.	D	-	.	.	0.93590	.	.	.	0.65474	.	139551074	Y	10	.	.	.	P00740	.	0.902337	0.49751		.	0.999	D	.	0.9668715	.	0.85369	2158	0.596124	.	-8.86	.	.	0.72322	.	.	.	.	.	.	0.99219	X	F9	.	.	Cys	.	.	X-139551074-G-T	not_specified	.	.	138460899	.	.	.	.	RCV001001433	D	.	.	c.533G>T	.	.	.	0.97612	G/G	rs1603265779	139551074	.	G	.	P00740	.	0.98452	.	0.68239		.	.	.	2.175	.	.	.	5.13	0.98074	.	D	T	.	.	.	.	.	.	.	.	811518	0.97575	0.94194	0.960028551474682	.	.	0.71675	.	.	.	.	5.955	.	D	.	.	.	.	.	0.70098	X	.	ENSG00000101981	.	.	.	.	0.9987586514114085	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.411263	800233	HGNC:3551	A	.	simple_aae	0.971	.	139551074	TGT	1.000000	.	-	.	0.99362	.	.	.	Pathogenic	0.96719	.	.	.	ClinGen:CA414440306	C	.	0.998265984387	-	0.96	-	0.87788	.	.	0.99874	0.488848567009	0.9469	.	0.98977113623540003	.	-	533G>T 	.	.	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.64775	1603265779	.	.	0.99822	.	0.831	0.001	.	0.99999130	5.13	.	.	.	0.618514	0.999894557545851	0.60790	D	.	.	.	1.0280	0.96759	p.Cys178Phe	.	.	-15.016	0.98915994	.	0.98645	811518	D	.	F9	.	D	0.934	.	C178F	D	0.86749	0.76753	G/G	principal1	161524	F9_Popp_2025_carboxy_gla_motif_var253451	No											C		533	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys178Phe		true	c.533G>T						3551.0	139551074.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Cys178Phe						F	May 26, 2019					missense_variant		178.0				0.0129147483513136		Pathogenic	139551074.0	missense_variant		0.934					Reporter			F9_Cys178Phe
F9_Cys178Phe	-11.216381779192723	0.001519226590029085	2.967597014339918	0.020878782165472228																											F9	F9		52861		CCSBVarC030553		NC_000023.11:139551074:G:T		Cys178Phe																												F9_Cys178Phe	23	139551074	G	T	X	allele	533G>T	A08	527_CAVA_Array_P02	A16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551074-G-T	-	0.82349	1.0	178	.	.	.	X	138633233	T	.	.	X	1_Pathogenic	NC_000023.11	.	Cys178Phe	.	27.8	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98488	Select	0.9025	.	0.90580	.	.	D	D	.	2.03962625952	.	.	.	.	.	0.37228	.	.	.	.	0.97951	.	.	0.98276	0.998	.	3.0	0.89971	4.7	0.97	T	single nucleotide variant	NC_000023.11:g.139551074G>T	.	.	2	0.9649957	.	.	0.9723726	.		.	.	.	.	.	.	.	.	MedGen:CN169374	.	.	.	.	0.96253	D	0.99311	D	M	.	.	G/G	.	.	.	.	not specified	.	0.97673	.	.	-	139551074	.	-	11.785000	.	0.98885	.	.	.	.	germline	.	Loss of catalytic residue at P177 (P = 0.0084)| Loss of disorder (P = 0.1069)| Gain of phosphorylation at S182 (P = 0.1778)| Gain of MoRF binding (P = 0.2922)| Loss of sheet (P = 0.437)	0.99581	GRCh38	924	criteria provided, single submitter	c.533G>T	.	0.69688	.	.	.	.	.	.	P	.	.	NM_000133.4(F9):c.533G>T (p.Cys178Phe)	1	.	FA9_HUMAN	.	97.0	.	.	D	0.86554	0.97047687	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys178Phe	.	0.96219	.	germline	.		G	May 26, 2019	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV001158669	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.97306	0.83643	.	D	-	.	.	0.93590	.	.	.	0.65474	.	139551074	Y	10	.	.	.	P00740	.	0.902337	0.49751		.	0.999	D	.	0.9668715	.	0.85369	2158	0.596124	.	-8.86	.	.	0.72322	.	.	.	.	.	.	0.99219	X	F9	.	.	Cys	.	.	X-139551074-G-T	not_specified	.	.	138460899	.	.	.	.	RCV001001433	D	.	.	c.533G>T	.	.	.	0.97612	G/G	rs1603265779	139551074	.	G	.	P00740	.	0.98452	.	0.68239		.	.	.	2.175	.	.	.	5.13	0.98074	.	D	T	.	.	.	.	.	.	.	.	811518	0.97575	0.94194	0.960028551474682	.	.	0.71675	.	.	.	.	5.955	.	D	.	.	.	.	.	0.70098	X	.	ENSG00000101981	.	.	.	.	0.9987586514114085	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.411263	800233	HGNC:3551	A	.	simple_aae	0.971	.	139551074	TGT	1.000000	.	-	.	0.99362	.	.	.	Pathogenic	0.96719	.	.	.	ClinGen:CA414440306	C	.	0.998265984387	-	0.96	-	0.87788	.	.	0.99874	0.488848567009	0.9469	.	0.98977113623540003	.	-	533G>T 	.	.	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.64775	1603265779	.	.	0.99822	.	0.831	0.001	.	0.99999130	5.13	.	.	.	0.618514	0.999894557545851	0.60790	D	.	.	.	1.0280	0.96759	p.Cys178Phe	.	.	-15.016	0.98915994	.	0.98645	811518	D	.	F9	.	D	0.934	.	C178F	D	0.86749	0.76753	G/G	principal1	244072	F9_Popp_2025_strep_2_var263132	No											C		533	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys178Phe		true	c.533G>T						3551.0	139551074.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Cys178Phe						F	May 26, 2019					missense_variant		178.0				0.030263747		Pathogenic	139551074.0	missense_variant		0.934					Reporter			F9_Cys178Phe
F9_Cys178Phe	-11.216381779192723	0.001519226590029085	2.967597014339918	0.020878782165472228																											F9	F9		52861		CCSBVarC030553		NC_000023.11:139551074:G:T		Cys178Phe																												F9_Cys178Phe	23	139551074	G	T	X	allele	533G>T	A08	527_CAVA_Array_P02	A16	B13A7A8P1_R1	B14A7A8P1_R2				X-139551074-G-T	-	0.82349	1.0	178	.	.	.	X	138633233	T	.	.	X	1_Pathogenic	NC_000023.11	.	Cys178Phe	.	27.8	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98488	Select	0.9025	.	0.90580	.	.	D	D	.	2.03962625952	.	.	.	.	.	0.37228	.	.	.	.	0.97951	.	.	0.98276	0.998	.	3.0	0.89971	4.7	0.97	T	single nucleotide variant	NC_000023.11:g.139551074G>T	.	.	2	0.9649957	.	.	0.9723726	.		.	.	.	.	.	.	.	.	MedGen:CN169374	.	.	.	.	0.96253	D	0.99311	D	M	.	.	G/G	.	.	.	.	not specified	.	0.97673	.	.	-	139551074	.	-	11.785000	.	0.98885	.	.	.	.	germline	.	Loss of catalytic residue at P177 (P = 0.0084)| Loss of disorder (P = 0.1069)| Gain of phosphorylation at S182 (P = 0.1778)| Gain of MoRF binding (P = 0.2922)| Loss of sheet (P = 0.437)	0.99581	GRCh38	924	criteria provided, single submitter	c.533G>T	.	0.69688	.	.	.	.	.	.	P	.	.	NM_000133.4(F9):c.533G>T (p.Cys178Phe)	1	.	FA9_HUMAN	.	97.0	.	.	D	0.86554	0.97047687	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Cys178Phe	.	0.96219	.	germline	.		G	May 26, 2019	.	G/G	.	.	1.0	N	Xq27.1	.	.	.	SCV001158669	Pathogenic	.	.	Phe	F	-	.	ENSP00000218099	ENST00000218099	.	0.002	.	.	0.676	G	.	4.97306	0.83643	.	D	-	.	.	0.93590	.	.	.	0.65474	.	139551074	Y	10	.	.	.	P00740	.	0.902337	0.49751		.	0.999	D	.	0.9668715	.	0.85369	2158	0.596124	.	-8.86	.	.	0.72322	.	.	.	.	.	.	0.99219	X	F9	.	.	Cys	.	.	X-139551074-G-T	not_specified	.	.	138460899	.	.	.	.	RCV001001433	D	.	.	c.533G>T	.	.	.	0.97612	G/G	rs1603265779	139551074	.	G	.	P00740	.	0.98452	.	0.68239		.	.	.	2.175	.	.	.	5.13	0.98074	.	D	T	.	.	.	.	.	.	.	.	811518	0.97575	0.94194	0.960028551474682	.	.	0.71675	.	.	.	.	5.955	.	D	.	.	.	.	.	0.70098	X	.	ENSG00000101981	.	.	.	.	0.9987586514114085	2	0.92348	0.18019	.	.	.	.	.	YES	.	0.411263	800233	HGNC:3551	A	.	simple_aae	0.971	.	139551074	TGT	1.000000	.	-	.	0.99362	.	.	.	Pathogenic	0.96719	.	.	.	ClinGen:CA414440306	C	.	0.998265984387	-	0.96	-	0.87788	.	.	0.99874	0.488848567009	0.9469	.	0.98977113623540003	.	-	533G>T 	.	.	CN169374	.	.	.	.	NM_000133.4	-	.	.	1	0.64775	1603265779	.	.	0.99822	.	0.831	0.001	.	0.99999130	5.13	.	.	.	0.618514	0.999894557545851	0.60790	D	.	.	.	1.0280	0.96759	p.Cys178Phe	.	.	-15.016	0.98915994	.	0.98645	811518	D	.	F9	.	D	0.934	.	C178F	D	0.86749	0.76753	G/G	principal1	216556	F9_Popp_2025_light_chain_var243770	No											C		533	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys178Phe		true	c.533G>T						3551.0	139551074.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Cys178Phe						F	May 26, 2019					missense_variant		178.0				0.013786189047073		Pathogenic	139551074.0	missense_variant		0.934					Reporter			F9_Cys178Phe
BRAF_Gly464Val	-4.383115862384623	0.003222238147491784	2.1555502654060805	0.06805360380374736	2025_01_Batch_13-14	0.748407048873009	0.8220743875740791	0.8607412739439905	0.8736790115577736	0.6191896953787797	0.7144551952637169	0.819553662058156	0.8129907446191675	0.7329588157391633	0.6091677969392397	0.7314311220683629	0.8208140248161175	0.836866009281579	0.8033189136484684	0.6141787461590097	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220600	CCSBVarC003158	ALE00003158	NC_000007.14:140781617:C:A	1391G>T	Gly464Val	CEGS2	CegsMutGDEh1009	F10	GDEhDisVCh_40058	G01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Gly464Val	7	140781617	C	A	7											7-140781617-C-A	-	0.91993	0.999	464	.	.	.	7	140481417	A	.	.	7	1_Pathogenic	NC_000007.14	.	Gly464Val	.	32.0	.	0	.	D	.	7	.	.	.	.	.	.	0	0.98743	Select	0.9095	.	0.77914	.	.	D	D	.	.	0	.	.	.	.	0.91208	.	.	.	.	.	.	.	0.99669	0.998	.	.	0.835416	.	.	A	single nucleotide variant	NC_000007.14:g.140781617C>A	.	.	2	0.97783434	.	0	0.99103737	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	.	.	.	.	0.99291	D	0.99787	D	M	15.69308	.	./.	84	0	.	.	RASopathy|Non-small cell lung carcinoma|not provided|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1	.	0.98290	.	.	-	140781617	.	-	7.656000	.	0.99985	.	0	.	.	germline;somatic;unknown	.	Loss of disorder (P = 0.0738)| Gain of MoRF binding (P = 0.081)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S465 (P = 0.1405)| Loss of loop (P = 0.2237)	0.99867	GRCh38	809	criteria provided, multiple submitters, no conflicts	c.1391G>T	.	0.85695	0	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	.	.	P	0	.	NM_004333.6(BRAF):c.1391G>T (p.Gly464Val)	2	.	BRAF_HUMAN	.	.	1.05336862643538	.	T	0.99795	0.98836577	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99245	.	.	.	.	.	p.Gly464Val	.	0.64019	.	germline/somatic	.		C	Jul 16, 2023	.	./.	.	.	1.0	N	7q34	6962	.	.	SCV000061576|SCV000288405|SCV001471782|SCV002060473|SCV002521451|SCV005086395	Pathogenic/Likely_pathogenic	.	.	Val	V	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.549	C	.	5.543189	.	D	.	-	16.98583	.	0.95644	610	.	.	0.92787	0	140781617	Y	10	0	.	.	P15056	.	0.964298	0.91377		.	0.989	D	.	0.9789484	.	0.85369	673	0.488804	.	.	.	.	.	.	.	.	.	.	.	0.99754	7	BRAF	.	0	Gly	10680	.	7-140781617-C-A	RASopathy|Neoplasm|Noonan_syndrome_and_Noonan-related_syndrome|not_provided|Non-small_cell_lung_carcinoma|Breast_neoplasm|Cardiofaciocutaneous_syndrome_1	.	.	140127886	ClinGen:CA135076|UniProtKB:P15056#VAR_018616	0.896613	0.97152	.	RCV000033302|RCV000037914|RCV001811232|RCV001813221|RCV002250499	D	.	.	c.1391G>T	.	.	.	0.93915	./.	rs121913348	140781617	.	C	.	P15056	.	0.99812	.	0.68239		.	.	.	3.33	0	0	.	5.62	0.99559	108	D	D	.	.	0	24	.	.	.	536391|98733|1340	40364	0.93838	0.96493	0.997959613800049	2294	.	0.71675	0.83728	.	.	.	7.886	.	.	.	.	.	0	115150	0.85829	7	.	ENSG00000157764	.	0	.	0	.	2	0.78402	0.42973	.	.	.	.	0.967625534540837	YES	.	0.535553	48834	HGNC:1097	.	.	.	1	.	140781617	GGA	1.000000	.	-	0	0.99584	.	0	.	Pathogenic/Likely pathogenic	0.98310	.	.	.	ClinGen:CA135076,UniProtKB:P15056#VAR_018616	G	.	.	-	0.987	-	.	.	466	0.87595	0.860752463341	0.9999	.	0.99831981023057448	94	-	1391G>T 	.	0	C5555857|C0027651|C5681679|C3661900|C0007131|C1458155|CN029449	.	.	.	.	NM_004333.6	-	.	.	1	0.50397	121913348	.	0	0.98525	0.97885	.	.	2210	0.99925166	5.62	.	.	.	0.464356	0.999967477835789	0.90723	D	84	.	.	1.0580	0.96994	p.Gly464Val	0	.	-16.405	0.9907639	.	0.99297	40364	D	.	BRAF	.	D	.	.	G464V	.	.	0.27038	./.	principal4																																																																																																				
BRAF_Gly464Val	-4.383115862384623	0.003222238147491784	2.1555502654060805	0.06805360380374736	2025_01_Batch_13-14	0.748407048873009	0.8220743875740791	0.8607412739439905	0.8736790115577736	0.6191896953787797	0.7144551952637169	0.819553662058156	0.8129907446191675	0.7329588157391633	0.6091677969392397	0.7314311220683629	0.8208140248161175	0.836866009281579	0.8033189136484684	0.6141787461590097	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003158		NC_000007.14:140781617:C:A		Gly464Val																												BRAF_Gly464Val	7	140781617	C	A	7	allele	1391G>T	F03	527_CAVA_Array_P01	K05	B13A7A8P1_R1	B14A7A8P1_R2				7-140781617-C-A	-	0.91993	0.999	464	.	.	.	7	140481417	A	.	.	7	1_Pathogenic	NC_000007.14	.	Gly464Val	.	32.0	.	0	.	D	.	7	.	.	.	.	.	.	0	0.98743	Select	0.9095	.	0.77914	.	.	D	D	.	.	0	.	.	.	.	0.91208	.	.	.	.	.	.	.	0.99669	0.998	.	.	0.835416	.	.	A	single nucleotide variant	NC_000007.14:g.140781617C>A	.	.	2	0.97783434	.	0	0.99103737	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391|Human Phenotype Ontology:HP:0030358,MONDO:MONDO:0005233,MeSH:D002289,MedGen:C0007131|MedGen:C3661900|MONDO:MONDO:0020297,MedGen:C5681679,Orphanet:98733|MONDO:MONDO:0007265,MedGen:CN029449,OMIM:115150,Orphanet:1340	.	.	.	.	0.99291	D	0.99787	D	M	15.69308	.	./.	84	0	.	.	RASopathy|Non-small cell lung carcinoma|not provided|Noonan syndrome and Noonan-related syndrome|Cardiofaciocutaneous syndrome 1	.	0.98290	.	.	-	140781617	.	-	7.656000	.	0.99985	.	0	.	.	germline;somatic;unknown	.	Loss of disorder (P = 0.0738)| Gain of MoRF binding (P = 0.081)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S465 (P = 0.1405)| Loss of loop (P = 0.2237)	0.99867	GRCh38	809	criteria provided, multiple submitters, no conflicts	c.1391G>T	.	0.85695	0	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	.	.	P	0	.	NM_004333.6(BRAF):c.1391G>T (p.Gly464Val)	2	.	BRAF_HUMAN	.	.	1.05336862643538	.	T	0.99795	0.98836577	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99245	.	.	.	.	.	p.Gly464Val	.	0.64019	.	germline/somatic	.		C	Jul 16, 2023	.	./.	.	.	1.0	N	7q34	6962	.	.	SCV000061576|SCV000288405|SCV001471782|SCV002060473|SCV002521451|SCV005086395	Pathogenic/Likely_pathogenic	.	.	Val	V	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.549	C	.	5.543189	.	D	.	-	16.98583	.	0.95644	610	.	.	0.92787	0	140781617	Y	10	0	.	.	P15056	.	0.964298	0.91377		.	0.989	D	.	0.9789484	.	0.85369	673	0.488804	.	.	.	.	.	.	.	.	.	.	.	0.99754	7	BRAF	.	0	Gly	10680	.	7-140781617-C-A	RASopathy|Neoplasm|Noonan_syndrome_and_Noonan-related_syndrome|not_provided|Non-small_cell_lung_carcinoma|Breast_neoplasm|Cardiofaciocutaneous_syndrome_1	.	.	140127886	ClinGen:CA135076|UniProtKB:P15056#VAR_018616	0.896613	0.97152	.	RCV000033302|RCV000037914|RCV001811232|RCV001813221|RCV002250499	D	.	.	c.1391G>T	.	.	.	0.93915	./.	rs121913348	140781617	.	C	.	P15056	.	0.99812	.	0.68239		.	.	.	3.33	0	0	.	5.62	0.99559	108	D	D	.	.	0	24	.	.	.	536391|98733|1340	40364	0.93838	0.96493	0.997959613800049	2294	.	0.71675	0.83728	.	.	.	7.886	.	.	.	.	.	0	115150	0.85829	7	.	ENSG00000157764	.	0	.	0	.	2	0.78402	0.42973	.	.	.	.	0.967625534540837	YES	.	0.535553	48834	HGNC:1097	.	.	.	1	.	140781617	GGA	1.000000	.	-	0	0.99584	.	0	.	Pathogenic/Likely pathogenic	0.98310	.	.	.	ClinGen:CA135076,UniProtKB:P15056#VAR_018616	G	.	.	-	0.987	-	.	.	466	0.87595	0.860752463341	0.9999	.	0.99831981023057448	94	-	1391G>T 	.	0	C5555857|C0027651|C5681679|C3661900|C0007131|C1458155|CN029449	.	.	.	.	NM_004333.6	-	.	.	1	0.50397	121913348	.	0	0.98525	0.97885	.	.	2210	0.99925166	5.62	.	.	.	0.464356	0.999967477835789	0.90723	D	84	.	.	1.0580	0.96994	p.Gly464Val	0	.	-16.405	0.9907639	.	0.99297	40364	D	.	BRAF	.	D	.	.	G464V	.	.	0.27038	./.	principal4																																																																																																				
F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	0.5508116033443167	0.7741940432245226	0.9402112969107692	0.792682624193488	0.59657621055612	0.5034025204811217	0.8728177194328309	0.979047524752261	0.8675707348899288	0.6438643479818795	0.5271070619127192	0.8235058813286767	0.9596294108315151	0.8301266795417084	0.6202202792689997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G		Cys335Trp																												F9_Cys335Trp	23	139561690	C	G	X	allele	1005C>G	F03	527_CAVA_Array_P02	K06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561690-C-G	-	0.47852	1.0	335	.	.	.	X	138643849	G	.	.	X	1_Pathogenic	NC_000023.11	.	Cys335Trp	.	22.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.96234	Select	0.9301	.	0.90580	.	.	D	D	.	1.9161241583	.	.	.	.	.	0.65925	.	.	.	.	0.99269	.	.	0.99876	0.992	.	7.0	0.90321	1.11	0.93	G	single nucleotide variant	NC_000023.11:g.139561690C>G	.	.	2	0.9700131	.	.	0.99243474	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.93829	D	0.99457	D	H	.	.	C/C	.	.	.	.	Hereditary factor IX deficiency disease	.	0.95810	.	.	-	139561690	.	-	-0.017000	.	0.99209	.	.	.	.	germline	.	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.98799	GRCh38	924	no assertion criteria provided	c.1005C>G	.	0.24633	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)		.	FA9_HUMAN	.	93.0	.	.	D	0.93397	0.99243474	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys335Trp	.	0.13030	.	germline	.		C	Jun 01, 2019	.	C/C	.	.	0.857	N	Xq27.1	.	.	.	SCV001424890	Likely_pathogenic	.	.	Trp	W	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	-0.202	C	.	3.435492	0.92967	.	D	-	.	.	0.98309	.	.	.	0.99626	.	139561690	Y	10	.	.	.	P00740	.	0.970652	0.61211		.	1.0	D	.	0.9700131	.	0.67791	2158	0.619316	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.99457	X	F9	.	.	Cys	.	.	X-139561690-C-G	Hereditary_factor_IX_deficiency_disease	.	.	138471515	.	.	.	.	RCV001265097	D	.	.	c.1005C>G	.	.	.	0.98093	C/C	rs1928110579	139561690	.	C	.	P00740	.	0.99876	.	0.17376		.	.	.	4.345	.	.	.	1.89	0.99678	.	D	T	.	.	.	.	.	.	.	98879	973811	0.98062	0.92915	0.99990177154541	.	.	0.30652	.	.	.	.	1.625	.	D	.	.	.	.	306900	0.36745	X	.	ENSG00000101981	.	.	.	.	0.9999734769876236	3	0.97365	0.18019	.	.	.	.	.	YES	.	0.785421	962089	HGNC:3551	A	.	simple_aae	0.978	.	139561690	TGC	0.001000	.	-	.	0.99668	.	.	.	Likely pathogenic	0.90095	.	.	.	ClinGen:CA414445330	C	.	0.998771782893	-	0.927	-	0.94798	.	.	0.99997	0.691920042038	0.9894	.	0.99364900823550439	.	-	1005C>G 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.66020	1928110579	.	.	0.99874	.	0.867	0.0	.	0.99999310	5.66	.	.	.	0.651828	0.999969305192545	0.98414	D	.	.	.	0.9106	0.97688	p.Cys335Trp	.	.	-13.176	0.99144864	.	0.99297	973811	D	.	F9	.	D	0.874	.	C335W	D	0.30197	0.08747	C/C	principal1	170878	F9_Popp_2025_carboxy_gla_motif_var256750	No											C		1005	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Cys335Trp		true	c.1005C>G						3551.0	139561690.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Cys335Trp						W	Jun 01, 2019					missense_variant		335.0				-0.002064131		Likely pathogenic	139561690.0	missense_variant		0.874					Reporter			F9_Cys335Trp
F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	0.5508116033443167	0.7741940432245226	0.9402112969107692	0.792682624193488	0.59657621055612	0.5034025204811217	0.8728177194328309	0.979047524752261	0.8675707348899288	0.6438643479818795	0.5271070619127192	0.8235058813286767	0.9596294108315151	0.8301266795417084	0.6202202792689997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G		Cys335Trp																												F9_Cys335Trp	23	139561690	C	G	X	allele	1005C>G	F03	527_CAVA_Array_P02	K06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561690-C-G	-	0.47852	1.0	335	.	.	.	X	138643849	G	.	.	X	1_Pathogenic	NC_000023.11	.	Cys335Trp	.	22.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.96234	Select	0.9301	.	0.90580	.	.	D	D	.	1.9161241583	.	.	.	.	.	0.65925	.	.	.	.	0.99269	.	.	0.99876	0.992	.	7.0	0.90321	1.11	0.93	G	single nucleotide variant	NC_000023.11:g.139561690C>G	.	.	2	0.9700131	.	.	0.99243474	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.93829	D	0.99457	D	H	.	.	C/C	.	.	.	.	Hereditary factor IX deficiency disease	.	0.95810	.	.	-	139561690	.	-	-0.017000	.	0.99209	.	.	.	.	germline	.	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.98799	GRCh38	924	no assertion criteria provided	c.1005C>G	.	0.24633	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)		.	FA9_HUMAN	.	93.0	.	.	D	0.93397	0.99243474	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys335Trp	.	0.13030	.	germline	.		C	Jun 01, 2019	.	C/C	.	.	0.857	N	Xq27.1	.	.	.	SCV001424890	Likely_pathogenic	.	.	Trp	W	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	-0.202	C	.	3.435492	0.92967	.	D	-	.	.	0.98309	.	.	.	0.99626	.	139561690	Y	10	.	.	.	P00740	.	0.970652	0.61211		.	1.0	D	.	0.9700131	.	0.67791	2158	0.619316	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.99457	X	F9	.	.	Cys	.	.	X-139561690-C-G	Hereditary_factor_IX_deficiency_disease	.	.	138471515	.	.	.	.	RCV001265097	D	.	.	c.1005C>G	.	.	.	0.98093	C/C	rs1928110579	139561690	.	C	.	P00740	.	0.99876	.	0.17376		.	.	.	4.345	.	.	.	1.89	0.99678	.	D	T	.	.	.	.	.	.	.	98879	973811	0.98062	0.92915	0.99990177154541	.	.	0.30652	.	.	.	.	1.625	.	D	.	.	.	.	306900	0.36745	X	.	ENSG00000101981	.	.	.	.	0.9999734769876236	3	0.97365	0.18019	.	.	.	.	.	YES	.	0.785421	962089	HGNC:3551	A	.	simple_aae	0.978	.	139561690	TGC	0.001000	.	-	.	0.99668	.	.	.	Likely pathogenic	0.90095	.	.	.	ClinGen:CA414445330	C	.	0.998771782893	-	0.927	-	0.94798	.	.	0.99997	0.691920042038	0.9894	.	0.99364900823550439	.	-	1005C>G 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.66020	1928110579	.	.	0.99874	.	0.867	0.0	.	0.99999310	5.66	.	.	.	0.651828	0.999969305192545	0.98414	D	.	.	.	0.9106	0.97688	p.Cys335Trp	.	.	-13.176	0.99144864	.	0.99297	973811	D	.	F9	.	D	0.874	.	C335W	D	0.30197	0.08747	C/C	principal1	225910	F9_Popp_2025_light_chain_var247069	No											C		1005	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Cys335Trp		true	c.1005C>G						3551.0	139561690.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Cys335Trp						W	Jun 01, 2019					missense_variant		335.0				-0.001194971		Likely pathogenic	139561690.0	missense_variant		0.874					Reporter			F9_Cys335Trp
F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	0.5508116033443167	0.7741940432245226	0.9402112969107692	0.792682624193488	0.59657621055612	0.5034025204811217	0.8728177194328309	0.979047524752261	0.8675707348899288	0.6438643479818795	0.5271070619127192	0.8235058813286767	0.9596294108315151	0.8301266795417084	0.6202202792689997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G		Cys335Trp																												F9_Cys335Trp	23	139561690	C	G	X	allele	1005C>G	F03	527_CAVA_Array_P02	K06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561690-C-G	-	0.47852	1.0	335	.	.	.	X	138643849	G	.	.	X	1_Pathogenic	NC_000023.11	.	Cys335Trp	.	22.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.96234	Select	0.9301	.	0.90580	.	.	D	D	.	1.9161241583	.	.	.	.	.	0.65925	.	.	.	.	0.99269	.	.	0.99876	0.992	.	7.0	0.90321	1.11	0.93	G	single nucleotide variant	NC_000023.11:g.139561690C>G	.	.	2	0.9700131	.	.	0.99243474	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.93829	D	0.99457	D	H	.	.	C/C	.	.	.	.	Hereditary factor IX deficiency disease	.	0.95810	.	.	-	139561690	.	-	-0.017000	.	0.99209	.	.	.	.	germline	.	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.98799	GRCh38	924	no assertion criteria provided	c.1005C>G	.	0.24633	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)		.	FA9_HUMAN	.	93.0	.	.	D	0.93397	0.99243474	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys335Trp	.	0.13030	.	germline	.		C	Jun 01, 2019	.	C/C	.	.	0.857	N	Xq27.1	.	.	.	SCV001424890	Likely_pathogenic	.	.	Trp	W	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	-0.202	C	.	3.435492	0.92967	.	D	-	.	.	0.98309	.	.	.	0.99626	.	139561690	Y	10	.	.	.	P00740	.	0.970652	0.61211		.	1.0	D	.	0.9700131	.	0.67791	2158	0.619316	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.99457	X	F9	.	.	Cys	.	.	X-139561690-C-G	Hereditary_factor_IX_deficiency_disease	.	.	138471515	.	.	.	.	RCV001265097	D	.	.	c.1005C>G	.	.	.	0.98093	C/C	rs1928110579	139561690	.	C	.	P00740	.	0.99876	.	0.17376		.	.	.	4.345	.	.	.	1.89	0.99678	.	D	T	.	.	.	.	.	.	.	98879	973811	0.98062	0.92915	0.99990177154541	.	.	0.30652	.	.	.	.	1.625	.	D	.	.	.	.	306900	0.36745	X	.	ENSG00000101981	.	.	.	.	0.9999734769876236	3	0.97365	0.18019	.	.	.	.	.	YES	.	0.785421	962089	HGNC:3551	A	.	simple_aae	0.978	.	139561690	TGC	0.001000	.	-	.	0.99668	.	.	.	Likely pathogenic	0.90095	.	.	.	ClinGen:CA414445330	C	.	0.998771782893	-	0.927	-	0.94798	.	.	0.99997	0.691920042038	0.9894	.	0.99364900823550439	.	-	1005C>G 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.66020	1928110579	.	.	0.99874	.	0.867	0.0	.	0.99999310	5.66	.	.	.	0.651828	0.999969305192545	0.98414	D	.	.	.	0.9106	0.97688	p.Cys335Trp	.	.	-13.176	0.99144864	.	0.99297	973811	D	.	F9	.	D	0.874	.	C335W	D	0.30197	0.08747	C/C	principal1	198394	F9_Popp_2025_heavy_chain_var237388	No											C		1005	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Cys335Trp		true	c.1005C>G						3551.0	139561690.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Cys335Trp						W	Jun 01, 2019					missense_variant		335.0				0.016996726		Likely pathogenic	139561690.0	missense_variant		0.874					Reporter			F9_Cys335Trp
F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	0.5508116033443167	0.7741940432245226	0.9402112969107692	0.792682624193488	0.59657621055612	0.5034025204811217	0.8728177194328309	0.979047524752261	0.8675707348899288	0.6438643479818795	0.5271070619127192	0.8235058813286767	0.9596294108315151	0.8301266795417084	0.6202202792689997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G		Cys335Trp																												F9_Cys335Trp	23	139561690	C	G	X	allele	1005C>G	F03	527_CAVA_Array_P02	K06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561690-C-G	-	0.47852	1.0	335	.	.	.	X	138643849	G	.	.	X	1_Pathogenic	NC_000023.11	.	Cys335Trp	.	22.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.96234	Select	0.9301	.	0.90580	.	.	D	D	.	1.9161241583	.	.	.	.	.	0.65925	.	.	.	.	0.99269	.	.	0.99876	0.992	.	7.0	0.90321	1.11	0.93	G	single nucleotide variant	NC_000023.11:g.139561690C>G	.	.	2	0.9700131	.	.	0.99243474	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.93829	D	0.99457	D	H	.	.	C/C	.	.	.	.	Hereditary factor IX deficiency disease	.	0.95810	.	.	-	139561690	.	-	-0.017000	.	0.99209	.	.	.	.	germline	.	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.98799	GRCh38	924	no assertion criteria provided	c.1005C>G	.	0.24633	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)		.	FA9_HUMAN	.	93.0	.	.	D	0.93397	0.99243474	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys335Trp	.	0.13030	.	germline	.		C	Jun 01, 2019	.	C/C	.	.	0.857	N	Xq27.1	.	.	.	SCV001424890	Likely_pathogenic	.	.	Trp	W	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	-0.202	C	.	3.435492	0.92967	.	D	-	.	.	0.98309	.	.	.	0.99626	.	139561690	Y	10	.	.	.	P00740	.	0.970652	0.61211		.	1.0	D	.	0.9700131	.	0.67791	2158	0.619316	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.99457	X	F9	.	.	Cys	.	.	X-139561690-C-G	Hereditary_factor_IX_deficiency_disease	.	.	138471515	.	.	.	.	RCV001265097	D	.	.	c.1005C>G	.	.	.	0.98093	C/C	rs1928110579	139561690	.	C	.	P00740	.	0.99876	.	0.17376		.	.	.	4.345	.	.	.	1.89	0.99678	.	D	T	.	.	.	.	.	.	.	98879	973811	0.98062	0.92915	0.99990177154541	.	.	0.30652	.	.	.	.	1.625	.	D	.	.	.	.	306900	0.36745	X	.	ENSG00000101981	.	.	.	.	0.9999734769876236	3	0.97365	0.18019	.	.	.	.	.	YES	.	0.785421	962089	HGNC:3551	A	.	simple_aae	0.978	.	139561690	TGC	0.001000	.	-	.	0.99668	.	.	.	Likely pathogenic	0.90095	.	.	.	ClinGen:CA414445330	C	.	0.998771782893	-	0.927	-	0.94798	.	.	0.99997	0.691920042038	0.9894	.	0.99364900823550439	.	-	1005C>G 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.66020	1928110579	.	.	0.99874	.	0.867	0.0	.	0.99999310	5.66	.	.	.	0.651828	0.999969305192545	0.98414	D	.	.	.	0.9106	0.97688	p.Cys335Trp	.	.	-13.176	0.99144864	.	0.99297	973811	D	.	F9	.	D	0.874	.	C335W	D	0.30197	0.08747	C/C	principal1	253426	F9_Popp_2025_strep_2_var266431	No											C		1005	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Cys335Trp		true	c.1005C>G						3551.0	139561690.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Cys335Trp						W	Jun 01, 2019					missense_variant		335.0				0.0161410384652565		Likely pathogenic	139561690.0	missense_variant		0.874					Reporter			F9_Cys335Trp
F9_Cys335Trp	3.001490748607782	0.019900120042260484	1.5161983938537984	0.17325072705321565	2025_01_Batch_13-14	0.5508116033443167	0.7741940432245226	0.9402112969107692	0.792682624193488	0.59657621055612	0.5034025204811217	0.8728177194328309	0.979047524752261	0.8675707348899288	0.6438643479818795	0.5271070619127192	0.8235058813286767	0.9596294108315151	0.8301266795417084	0.6202202792689997	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030614		NC_000023.11:139561690:C:G		Cys335Trp																												F9_Cys335Trp	23	139561690	C	G	X	allele	1005C>G	F03	527_CAVA_Array_P02	K06	B13A7A8P1_R1	B14A7A8P1_R2				X-139561690-C-G	-	0.47852	1.0	335	.	.	.	X	138643849	G	.	.	X	1_Pathogenic	NC_000023.11	.	Cys335Trp	.	22.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.96234	Select	0.9301	.	0.90580	.	.	D	D	.	1.9161241583	.	.	.	.	.	0.65925	.	.	.	.	0.99269	.	.	0.99876	0.992	.	7.0	0.90321	1.11	0.93	G	single nucleotide variant	NC_000023.11:g.139561690C>G	.	.	2	0.9700131	.	.	0.99243474	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.93829	D	0.99457	D	H	.	.	C/C	.	.	.	.	Hereditary factor IX deficiency disease	.	0.95810	.	.	-	139561690	.	-	-0.017000	.	0.99209	.	.	.	.	germline	.	Gain of ubiquitination at K339 (P = 0.1025)| Gain of methylation at K339 (P = 0.1345)| Loss of stability (P = 0.2204)| Loss of sheet (P = 0.302)| Gain of catalytic residue at E340 (P = 0.3723)	0.98799	GRCh38	924	no assertion criteria provided	c.1005C>G	.	0.24633	.	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	.	.	NM_000133.4(F9):c.1005C>G (p.Cys335Trp)		.	FA9_HUMAN	.	93.0	.	.	D	0.93397	0.99243474	+	.	.		.	.	2	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Cys335Trp	.	0.13030	.	germline	.		C	Jun 01, 2019	.	C/C	.	.	0.857	N	Xq27.1	.	.	.	SCV001424890	Likely_pathogenic	.	.	Trp	W	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	-0.202	C	.	3.435492	0.92967	.	D	-	.	.	0.98309	.	.	.	0.99626	.	139561690	Y	10	.	.	.	P00740	.	0.970652	0.61211		.	1.0	D	.	0.9700131	.	0.67791	2158	0.619316	.	-10.94	.	.	0.91343	.	.	.	.	.	.	0.99457	X	F9	.	.	Cys	.	.	X-139561690-C-G	Hereditary_factor_IX_deficiency_disease	.	.	138471515	.	.	.	.	RCV001265097	D	.	.	c.1005C>G	.	.	.	0.98093	C/C	rs1928110579	139561690	.	C	.	P00740	.	0.99876	.	0.17376		.	.	.	4.345	.	.	.	1.89	0.99678	.	D	T	.	.	.	.	.	.	.	98879	973811	0.98062	0.92915	0.99990177154541	.	.	0.30652	.	.	.	.	1.625	.	D	.	.	.	.	306900	0.36745	X	.	ENSG00000101981	.	.	.	.	0.9999734769876236	3	0.97365	0.18019	.	.	.	.	.	YES	.	0.785421	962089	HGNC:3551	A	.	simple_aae	0.978	.	139561690	TGC	0.001000	.	-	.	0.99668	.	.	.	Likely pathogenic	0.90095	.	.	.	ClinGen:CA414445330	C	.	0.998771782893	-	0.927	-	0.94798	.	.	0.99997	0.691920042038	0.9894	.	0.99364900823550439	.	-	1005C>G 	.	.	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.66020	1928110579	.	.	0.99874	.	0.867	0.0	.	0.99999310	5.66	.	.	.	0.651828	0.999969305192545	0.98414	D	.	.	.	0.9106	0.97688	p.Cys335Trp	.	.	-13.176	0.99144864	.	0.99297	973811	D	.	F9	.	D	0.874	.	C335W	D	0.30197	0.08747	C/C	principal1	143362	F9_Popp_2025_carboxy_F9_specific_var227707	No											C		1005	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Cys335Trp		true	c.1005C>G						3551.0	139561690.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Cys335Trp						W	Jun 01, 2019					missense_variant		335.0				0.005012777		Likely pathogenic	139561690.0	missense_variant		0.874					Reporter			F9_Cys335Trp
FH_Arg160Gly	7.053545849662073	0.00040631942806925705	-6.7751149070571115	0.0002590061663729525	2025_01_Batch_13-14	0.9376294565533879	0.9837924347182717	0.9975807407127623	0.9927809552237875	0.993994406740671																					FH	FH		3408		CCSBVarC000453		NC_000001.11:241512044:T:C		Arg160Gly																												FH_Arg160Gly	1	241512044	T	C	1	allele	478A>G	A04	527_CAVA_Array_P03	B07	B13A7A8P1_R1	B14A7A8P1_R2				1-241512044-T-C	-	0.74516	0.998	160	.	0	.	1	241675344	C	6.195800e-07	.	1	1_Pathogenic	NC_000001.11	1	Arg160Gly	.	26.2	.	.	.	D	0	2	1	.	.	.	.	.	.	0.97963	Select	0.9928	.	0.73231	.	.	D	D	64008	1.07981011161	.	0	.	.	.	0.77643	.	44868	0	.	0.92238	.	.	0.98723	0.996	.	29.0	0.991801	4.75	0.71	C	single nucleotide variant	NC_000001.11:g.241512044T>C	0	.	2	0.9348335	.	.	0.975441	.	C	.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	0.000000e+00	0	0.82936	D	0.97387	D	H	8.140567	1	T/T	.	.	.	1613996	not provided|Hereditary cancer-predisposing syndrome	.	0.96857	.	.	-	241512044	.	-	3.698000	.	0.99121	29596	.	1179892	.	germline	91078	Loss of catalytic residue at R160 (P = 0.0886)| Gain of loop (P = 0.1069)| Loss of stability (P = 0.1215)| Gain of disorder (P = 0.1881)| Loss of helix (P = 0.2022)	0.92818	GRCh38	968	criteria provided, multiple submitters, no conflicts	c.478A>G	.	0.47135	.	.	.	Fumarate lyase, N-terminal	.	.	P	.	0.000000e+00	NM_000143.4(FH):c.478A>G (p.Arg160Gly)	2	.	FUMH_HUMAN	.	71.0	0.765365713599	.	D	0.91531	0.975441	-	.	.	6.84158e-7	.	.	2	.	criteria_provided,_multiple_submitters,_no_conflicts	0.92401	.	0	.	.	60028	p.Arg160Gly	0	0.39597	.	germline	.	241512044	T	Nov 16, 2023	.	T/T	.	.	1.0	N	1q43	.	.	.	SCV000283673|SCV001184862	Pathogenic	.	.	Gly	G	-	912	ENSP00000355518	ENST00000366560	.	0.001	.	.	0.665	T	.	4.663639	0.92967	D	D	-	6.42976	.	0.98852	.	.	.	0.94994	.	241512044	Y	10	.	.	0.000000e+00	P07954	.	0.98538	0.93107	T	.	0.975	D	.	0.9348335	.	0.76032	2271	0.550818	1	-6.64	.	8.475350e-07	0.78662	.	.	75054	.	6060	.	0.97387	1	FH	0.000000e+00	.	Arg	.	.	1-241512044-T-C	Hereditary_cancer-predisposing_syndrome|not_provided	0	.	239741967	ClinGen:CA10581784	0.644088	0.83814	0	RCV001782719|RCV001023046	D	0	.	c.478A>G	.	0	0	0.95775	T/T	rs878853694	241512044	.	T	.	P07954	.	0.98723	.	0.68239	1	.	.	0.000000e+00	4.81	.	.	.	4.1	0.99908	.	D	T	.	.	.	.	.	.	.	140162	237116	0.95711	0.76970	0.998749494552612	.	.	0.71675	0.61910	.	.	1179892	2.846	.	D	.	.	.	.	.	0.4806	1	.	ENSG00000091483	0.000000e+00	.	.	.	0.9654764021894513	1	0.73364	0.07020	.	.	.	0.000000e+00	0.616020889310283	YES	0.000000e+00	0.851385	238260	HGNC:3700	A	.	simple_aae	0.976	.	241512044	AGA	1.000000	.	-	.	0.97811	8.475350e-07	.	0	Pathogenic	0.92144	.	0	0	ClinGen:CA10581784	R	.	0.979233309591	-	0.813	-	0.95034	.	.	0.96515	0.771721363068	0.982	0	0.99852011306919974	.	-	478A>G 	.	.	C0027672|C3661900	.	.	.	.	NM_000143.4	-	.	.	1	0.97448	878853694	.	.	0.97880	0.75972	0.943	0.0	.	0.93021200	5.24	.	.	.	0.553435	0.999915695951876	0.99656	D	.	.	.	0.9804	0.99829	p.Arg160Gly	.	0	-13.725	0.9792192	0	0.98806	237116	D	.	FH	.	D	0.920	.	R160G	D	0.87304	0.62996	T/T	principal1																																																																																																				
BRCA1_Arg595Gln	-1.2480440075438437	0.25214139106590744	6.6623375981816295	0.00028723146358685287	2025_01_Batch_13-14	0.8646854932415327	0.9159245401802051	0.8449567484206457	0.8902121761198842	0.7604411608793911	0.9617129546881413	0.9017882958614198	0.8774439183540166	0.9559417941341498	0.9042748552747004	0.913199223964837	0.9088564180208125	0.8612003333873312	0.9230769851270171	0.8323580080770457	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218429	CCSBVarC003306	ALE00003306	NC_000017.11:43063930:C:T	1784G>A	Arg595Gln	CEGS2	CegsMutGDEh1012	D06	GDEhDisVCh_40059	B04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Arg595Gln	17	43063930	C	T	17											17-43063930-C-T	-	0.87233	0.995	1699	4	0	0	17	41215947	T	1.858950e-05	0	17	1_Pathogenic	NC_000017.11	3	Arg1699Gln	0	29.2	0	0	5.845560e-05	D	0	49	1	42748	2.534060e-05	.	30516	0.000000e+00	0	0.92843	.	0.8732	102642	0.90580	0	.	T	D	64006	.	0	0	0.000000e+00	0	0	0.61621	17106	44856	1	0.000000e+00	0.63232	2	.	0.98160	0.998	.	.	.	.	.	T	single nucleotide variant	NC_000017.11:g.43063930C>T	0	16734	3	0.77520096	109352	0	0.96523166	0	T	4	236774	0	0	0.000000e+00	498	4.678580e-05	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0700268,MedGen:CN377757|	2	0	0.000000e+00	0	0.97926	P	0.87946	D	M	10.32869	30	C/C	364	0	7152	1613816	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Ovarian neoplasm|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|Gastric cancer|BRCA1-related cancer predisposition|BRCA1-related disorder	16198	0.96178	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063930	4.678580e-05	-	7.634000	0	0.94843	29598	0	44856	0	germline;maternal;unknown	91080	.	.	GRCh38	549	reviewed by expert panel	.	0.000000e+00	0.93049	0	0	0	BRCT domain|BRCT domain|BRCT domain	0.000000e+00	9042	.	0	0.000000e+00	NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	3	0	BRCA1_HUMAN	0	.	0.871042515796463	0	.	0.82063	0.9692461	-	0.000000e+00	.	0.0000191545	4	0.000000e+00	0	34248	reviewed_by_expert_panel	0.99879	1.828960e-05	0	0.000000e+00	0	59980	.	0	0.62929	.	germline	2	43063930	C	May 10, 2017	0	C/C	0	89478	1.0	N	17q21.31	49660	.	0.000000e+00	SCV001156534	Pathogenic	0	0	Gln	Q	-	912	ENSP00000419274	ENST00000470026	17686	.	13408	0	0.53	C	0	5.19884	0.92967	D	.	-	11.14783	.	0.97975	802	0	.	0.63113	0	43063930	Y	10	0	102642	0.000000e+00	P38398	0	0.392783	0.99986	C	0	0.454	D	89478	0.7972393	42748	0.85369	672	0.34877	25	.	.	6.688070e-05	0.91343	0.000000e+00	0	74854	0.000000e+00	6084	0	0.86571	17	BRCA1	0.000000e+00	0	Arg	63838	4.470370e-05	17-43063930-C-T	BRCA1-related_disorder|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Ovarian_neoplasm|Gastric_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	0	6	38469473	ClinGen:CA003235|OMIM:113705.0037|UniProtKB:P38398#VAR_070501	0.805899	0.90217	0	RCV000031217|RCV000048790|RCV000131564|RCV000195350|RCV000735446|RCV000785422|RCV002250479|RCV002496477|RCV003162265|RCV004802991|RCV004554634	.	0	0	c.5096G>A	0	3	0	0.86324	C/C	rs41293459	43063930	14886	C	.	.	15686	0.97765	0.000000e+00	0.68239	17	0	0	6.688070e-05	3.23	0	0	264690	5.83	0.80349	460	D	T	0	0.000000e+00	0	62	.	0	0	227535|1333|145|145|140162	37636	0.92678	0.39535	0.950455367565155	9852	.	0.71675	0.72937	0.000000e+00	4.470370e-05	1179960	4.855	1.923130e-05	.	13394	0	2.2668026E-5	0	114480|614320|604370|617883|613659	0.62708	17	0.000000e+00	ENSG00000012048	0.000000e+00	0	0	0	.	2	0.97365	0.72286	30598	6	5.845560e-05	0.000000e+00	0.832238134394619	.	1.097940e-05	0.74691	46192	HGNC:1100	.	0	.	0.902	207994	43063930	CGG	1.000000	.	-	0	0.83114	2.118720e-05	0	0	Pathogenic	0.81678	0	0	0	ClinGen:CA003235,UniProtKB:P38398#VAR_070501,OMIM:113705.0037	R	0	.	-	.	-	0.96659	6	2420	0.87449	0.661911010742	.	0	0.99957871779371688	146	-	5096G>A 	6	0	C0346153|C3280442|C2676676|C4554406|C0677776|CN221562|C0919267|C0024623|C0027672|C3661900	0	0	0	0	NM_007294.4	-	.	.	1	0.97283	41293459	2310	0	0.96647	0.91891	.	.	9488	0.99990070	5.83	.	.	0.000000e+00	0.419574	0.987067707466189	0.89408	D	398	6206	9556	0.9361	0.95778	p.Arg1699Gln	0	0	-11.318	.	0	0.87311	37636	D	30512	BRCA1	0.000000e+00	D	.	21630	.	.	.	0.24764	C/C	principal2																																																																																																				
BRCA1_Arg595Gln	-1.2480440075438437	0.25214139106590744	6.6623375981816295	0.00028723146358685287	2025_01_Batch_13-14	0.8646854932415327	0.9159245401802051	0.8449567484206457	0.8902121761198842	0.7604411608793911	0.9617129546881413	0.9017882958614198	0.8774439183540166	0.9559417941341498	0.9042748552747004	0.913199223964837	0.9088564180208125	0.8612003333873312	0.9230769851270171	0.8323580080770457	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003306		NC_000017.11:43063930:C:T		Arg595Gln																												BRCA1_Arg595Gln	17	43063930	C	T	17	allele	1784G>A	G07	527_CAVA_Array_P01	M13	B13A7A8P1_R1	B14A7A8P1_R2				17-43063930-C-T	-	0.87233	0.995	1699	4	0	0	17	41215947	T	1.858950e-05	0	17	1_Pathogenic	NC_000017.11	3	Arg1699Gln	0	29.2	0	0	5.845560e-05	D	0	49	1	42748	2.534060e-05	.	30516	0.000000e+00	0	0.92843	.	0.8732	102642	0.90580	0	.	T	D	64006	.	0	0	0.000000e+00	0	0	0.61621	17106	44856	1	0.000000e+00	0.63232	2	.	0.98160	0.998	.	.	.	.	.	T	single nucleotide variant	NC_000017.11:g.43063930C>T	0	16734	3	0.77520096	109352	0	0.96523166	0	T	4	236774	0	0	0.000000e+00	498	4.678580e-05	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0700268,MedGen:CN377757|	2	0	0.000000e+00	0	0.97926	P	0.87946	D	M	10.32869	30	C/C	364	0	7152	1613816	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Ovarian neoplasm|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|Gastric cancer|BRCA1-related cancer predisposition|BRCA1-related disorder	16198	0.96178	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43063930	4.678580e-05	-	7.634000	0	0.94843	29598	0	44856	0	germline;maternal;unknown	91080	.	.	GRCh38	549	reviewed by expert panel	.	0.000000e+00	0.93049	0	0	0	BRCT domain|BRCT domain|BRCT domain	0.000000e+00	9042	.	0	0.000000e+00	NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	3	0	BRCA1_HUMAN	0	.	0.871042515796463	0	.	0.82063	0.9692461	-	0.000000e+00	.	0.0000191545	4	0.000000e+00	0	34248	reviewed_by_expert_panel	0.99879	1.828960e-05	0	0.000000e+00	0	59980	.	0	0.62929	.	germline	2	43063930	C	May 10, 2017	0	C/C	0	89478	1.0	N	17q21.31	49660	.	0.000000e+00	SCV001156534	Pathogenic	0	0	Gln	Q	-	912	ENSP00000419274	ENST00000470026	17686	.	13408	0	0.53	C	0	5.19884	0.92967	D	.	-	11.14783	.	0.97975	802	0	.	0.63113	0	43063930	Y	10	0	102642	0.000000e+00	P38398	0	0.392783	0.99986	C	0	0.454	D	89478	0.7972393	42748	0.85369	672	0.34877	25	.	.	6.688070e-05	0.91343	0.000000e+00	0	74854	0.000000e+00	6084	0	0.86571	17	BRCA1	0.000000e+00	0	Arg	63838	4.470370e-05	17-43063930-C-T	BRCA1-related_disorder|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Ovarian_neoplasm|Gastric_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	0	6	38469473	ClinGen:CA003235|OMIM:113705.0037|UniProtKB:P38398#VAR_070501	0.805899	0.90217	0	RCV000031217|RCV000048790|RCV000131564|RCV000195350|RCV000735446|RCV000785422|RCV002250479|RCV002496477|RCV003162265|RCV004802991|RCV004554634	.	0	0	c.5096G>A	0	3	0	0.86324	C/C	rs41293459	43063930	14886	C	.	.	15686	0.97765	0.000000e+00	0.68239	17	0	0	6.688070e-05	3.23	0	0	264690	5.83	0.80349	460	D	T	0	0.000000e+00	0	62	.	0	0	227535|1333|145|145|140162	37636	0.92678	0.39535	0.950455367565155	9852	.	0.71675	0.72937	0.000000e+00	4.470370e-05	1179960	4.855	1.923130e-05	.	13394	0	2.2668026E-5	0	114480|614320|604370|617883|613659	0.62708	17	0.000000e+00	ENSG00000012048	0.000000e+00	0	0	0	.	2	0.97365	0.72286	30598	6	5.845560e-05	0.000000e+00	0.832238134394619	.	1.097940e-05	0.74691	46192	HGNC:1100	.	0	.	0.902	207994	43063930	CGG	1.000000	.	-	0	0.83114	2.118720e-05	0	0	Pathogenic	0.81678	0	0	0	ClinGen:CA003235,UniProtKB:P38398#VAR_070501,OMIM:113705.0037	R	0	.	-	.	-	0.96659	6	2420	0.87449	0.661911010742	.	0	0.99957871779371688	146	-	5096G>A 	6	0	C0346153|C3280442|C2676676|C4554406|C0677776|CN221562|C0919267|C0024623|C0027672|C3661900	0	0	0	0	NM_007294.4	-	.	.	1	0.97283	41293459	2310	0	0.96647	0.91891	.	.	9488	0.99990070	5.83	.	.	0.000000e+00	0.419574	0.987067707466189	0.89408	D	398	6206	9556	0.9361	0.95778	p.Arg1699Gln	0	0	-11.318	.	0	0.87311	37636	D	30512	BRCA1	0.000000e+00	D	.	21630	.	.	.	0.24764	C/C	principal2																																																																																																				
BRAF_Val471Phe	2.3797904528016036	0.04889717181123469	-3.0812311870095046	0.01778459894246216	2025_01_Batch_13-14	0.9613681814926571	0.9661325211342289	0.8996643083809368	0.9590310998708382	0.8605722800791198	0.9842419434621872	0.9649148712016956	0.9721444810468575	0.985021780066256	0.9367247114276722	0.9728050624774222	0.9655236961679623	0.9359043947138972	0.9720264399685471	0.898648495753396	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	BRAF	BRAF	ENSG00000157764	71969	220601	CCSBVarC003161	ALE00003161	NC_000007.14:140781597:C:A	1411G>T	Val471Phe	CEGS2	CegsMutGDEh1018	F01	GDEhDisVCh_40058	C06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRAF_Val471Phe	7	140781597	C	A	7											7-140781597-C-A	-	0.9052	0.999	471	.	.	.	7	140481397	A	.	.	7	1_Pathogenic	NC_000007.14	.	Val471Phe	.	31.0	.	.	.	D	.	3	.	.	.	.	.	.	.	0.99762	Select	0.9940	.	0.77914	.	.	D	D	.	.	.	.	.	.	.	0.93326	.	.	.	.	0.75724	.	.	0.99197	0.994	.	.	0.994967	.	.	A	single nucleotide variant	NC_000007.14:g.140781597C>A	.	.	2	0.94787174	.	.	0.97874874	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.93300	D	0.98289	D	M	15.51097	.	./.	.	.	.	.	not provided|Ataxia-telangiectasia syndrome|RASopathy	.	0.96308	.	.	-	140781597	.	-	7.654000	.	0.99892	.	.	.	.	germline	.	Loss of MoRF binding (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of methylation at K473 (P = 0.132)| Gain of ubiquitination at K473 (P = 0.2122)| Gain of phosphorylation at T470 (P = 0.2345)	0.98831	GRCh38	809	criteria provided, multiple submitters, no conflicts	c.1411G>T	.	0.85695	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1411G>T (p.Val471Phe)	2	.	BRAF_HUMAN	.	.	1.04820146480743	.	D	0.99217	0.98134124	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99218	.	.	.	.	.	p.Val471Phe	.	0.63915	.	germline	.		C	May 17, 2024	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000057213|SCV000776865|SCV002318959	Pathogenic/Likely_pathogenic	.	.	Phe	F	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.549	C	.	5.405591	.	D	.	-	16.74944	.	0.98235	.	.	.	0.91167	.	140781597	Y	10	.	.	.	P15056	.	0.969342	0.81301		.	0.978	D	.	0.9485988	.	0.71086	673	0.565576	.	.	.	.	0.78662	.	.	.	.	.	.	0.98244	7	BRAF	.	.	Val	.	.	7-140781597-C-A	RASopathy|Ataxia-telangiectasia_syndrome|Melanoma|not_provided	.	.	140127866	ClinGen:CA281968	0.888659	0.97030	.	RCV000033308|RCV002051798|RCV000654957	D	.	.	c.1411G>T	.	.	.	0.96310	./.	rs121913376	140781597	.	C	.	P15056	.	0.98996	.	0.68239		.	.	.	3.085	.	.	.	5.62	0.99654	.	D	D	.	.	.	.	.	.	.	536391|100	40367	0.96250	0.94779	0.997305870056152	.	.	0.71675	0.82134	.	.	.	7.886	.	.	.	.	.	.	208900	0.85829	7	.	ENSG00000157764	.	.	.	.	.	1	0.74106	0.42973	.	.	.	.	0.96315625170976	YES	.	0.776752	48837	HGNC:1097	.	.	.	0.997	.	140781597	GTC	1.000000	.	-	.	0.99425	.	.	.	Pathogenic/Likely pathogenic	0.97989	.	.	.	ClinGen:CA281968	V	.	.	-	0.928	-	.	.	.	0.97785	0.875435829163	0.9991	.	0.99709975588964905	.	-	1411G>T 	.	.	C5555857|C0004135|C0025202|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.98313	121913376	.	.	0.99319	0.97767	.	.	.	0.99920601	5.62	.	.	.	0.574634	0.999981316373626	0.87210	D	.	.	.	0.9449	0.99862	p.Val471Phe	.	.	-16.156	0.98959863	.	0.99579	40367	D	.	BRAF	.	D	.	.	V471F	.	.	0.27038	./.	principal4																																																																																																				
BRAF_Val471Phe	2.3797904528016036	0.04889717181123469	-3.0812311870095046	0.01778459894246216	2025_01_Batch_13-14	0.9613681814926571	0.9661325211342289	0.8996643083809368	0.9590310998708382	0.8605722800791198	0.9842419434621872	0.9649148712016956	0.9721444810468575	0.985021780066256	0.9367247114276722	0.9728050624774222	0.9655236961679623	0.9359043947138972	0.9720264399685471	0.898648495753396	1.0	1.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	BRAF	BRAF		71969		CCSBVarC003161		NC_000007.14:140781597:C:A		Val471Phe																												BRAF_Val471Phe	7	140781597	C	A	7	allele	1411G>T	A04	527_CAVA_Array_P01	A07	B13A7A8P1_R1	B14A7A8P1_R2				7-140781597-C-A	-	0.9052	0.999	471	.	.	.	7	140481397	A	.	.	7	1_Pathogenic	NC_000007.14	.	Val471Phe	.	31.0	.	.	.	D	.	3	.	.	.	.	.	.	.	0.99762	Select	0.9940	.	0.77914	.	.	D	D	.	.	.	.	.	.	.	0.93326	.	.	.	.	0.75724	.	.	0.99197	0.994	.	.	0.994967	.	.	A	single nucleotide variant	NC_000007.14:g.140781597C>A	.	.	2	0.94787174	.	.	0.97874874	.		.	.	.	.	.	.	.	.	MedGen:C3661900|MONDO:MONDO:0008840,MedGen:C0004135,OMIM:208900,Orphanet:100|MONDO:MONDO:0021060,MedGen:C5555857,Orphanet:536391	.	.	.	.	0.93300	D	0.98289	D	M	15.51097	.	./.	.	.	.	.	not provided|Ataxia-telangiectasia syndrome|RASopathy	.	0.96308	.	.	-	140781597	.	-	7.654000	.	0.99892	.	.	.	.	germline	.	Loss of MoRF binding (P = 0.0797)| Gain of sheet (P = 0.0827)| Loss of methylation at K473 (P = 0.132)| Gain of ubiquitination at K473 (P = 0.2122)| Gain of phosphorylation at T470 (P = 0.2345)	0.98831	GRCh38	809	criteria provided, multiple submitters, no conflicts	c.1411G>T	.	0.85695	.	.	.	Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase, ATP binding site|Protein kinase domain|Protein kinase domain	.	.	P	.	.	NM_004333.6(BRAF):c.1411G>T (p.Val471Phe)	2	.	BRAF_HUMAN	.	.	1.04820146480743	.	D	0.99217	0.98134124	-	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99218	.	.	.	.	.	p.Val471Phe	.	0.63915	.	germline	.		C	May 17, 2024	.	./.	.	.	1.0	N	7q34	.	.	.	SCV000057213|SCV000776865|SCV002318959	Pathogenic/Likely_pathogenic	.	.	Phe	F	-	.	ENSP00000493543	ENST00000646891	.	.	.	.	0.549	C	.	5.405591	.	D	.	-	16.74944	.	0.98235	.	.	.	0.91167	.	140781597	Y	10	.	.	.	P15056	.	0.969342	0.81301		.	0.978	D	.	0.9485988	.	0.71086	673	0.565576	.	.	.	.	0.78662	.	.	.	.	.	.	0.98244	7	BRAF	.	.	Val	.	.	7-140781597-C-A	RASopathy|Ataxia-telangiectasia_syndrome|Melanoma|not_provided	.	.	140127866	ClinGen:CA281968	0.888659	0.97030	.	RCV000033308|RCV002051798|RCV000654957	D	.	.	c.1411G>T	.	.	.	0.96310	./.	rs121913376	140781597	.	C	.	P15056	.	0.98996	.	0.68239		.	.	.	3.085	.	.	.	5.62	0.99654	.	D	D	.	.	.	.	.	.	.	536391|100	40367	0.96250	0.94779	0.997305870056152	.	.	0.71675	0.82134	.	.	.	7.886	.	.	.	.	.	.	208900	0.85829	7	.	ENSG00000157764	.	.	.	.	.	1	0.74106	0.42973	.	.	.	.	0.96315625170976	YES	.	0.776752	48837	HGNC:1097	.	.	.	0.997	.	140781597	GTC	1.000000	.	-	.	0.99425	.	.	.	Pathogenic/Likely pathogenic	0.97989	.	.	.	ClinGen:CA281968	V	.	.	-	0.928	-	.	.	.	0.97785	0.875435829163	0.9991	.	0.99709975588964905	.	-	1411G>T 	.	.	C5555857|C0004135|C0025202|C3661900	.	.	.	.	NM_004333.6	-	.	.	1	0.98313	121913376	.	.	0.99319	0.97767	.	.	.	0.99920601	5.62	.	.	.	0.574634	0.999981316373626	0.87210	D	.	.	.	0.9449	0.99862	p.Val471Phe	.	.	-16.156	0.98959863	.	0.99579	40367	D	.	BRAF	.	D	.	.	V471F	.	.	0.27038	./.	principal4																																																																																																				
FANCC_Leu554Pro	-0.3335628604146983	0.7484786135159357	-4.383117084986827	0.0032222333592398064	2025_01_Batch_13-14	0.6828875378307329	0.9185174287367518	0.9441415721015707	0.9271406611938001	0.8591763545189698	0.9600094866432588	0.956978245322388	0.9678296569608629	0.977639538560533	0.9544129144970065	0.8214485122369959	0.9377478370295699	0.9559856145312168	0.9523900998771666	0.9067946345079881	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	FANCC	FANCC	ENSG00000158169	7699	13991	CCSBVarC001231	ALE00001231	NC_000009.12:95101723:A:G	1661T>C	Leu554Pro	RC4	RC4_Mut_GDEh1009	D09	GDEhDisVCh_40044	G07	2	RC4_Mut_GDDh1009	D09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FANCC_Leu554Pro	9	95101723	A	G	9											9-95101723-A-G	-	0.62948	1.0	554	2	0	0	9	97864005	G	1.487070e-05	0	9	1_Pathogenic	NC_000009.12	24	Leu554Pro	0	24.5	0	0	2.922500e-05	T	0	15	1	42740	1.267110e-05	.	30514	0.000000e+00	0	0.85019	Select	0.3880	102652	0.90580	0	.	T	D	63982	0.413463600646	0	0	0.000000e+00	0	0	0.51437	17096	44874	0	0.000000e+00	0.72390	2	.	0.88866	0.016	.	70.0	.	.	0.3	G	single nucleotide variant	NC_000009.12:g.95101723A>G	0	16720	3	0.8482753	109336	0	0.90733176	0	G	2	236760	0	0	0.000000e+00	436	4.679460e-05	0	MedGen:C3661900|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|	2	0	0.000000e+00	0	0.55288	D	0.92876	D	M	4.605117	24	A/A	168	0	7156	1613908	not provided|Fanconi anemia complementation group C|Hereditary cancer-predisposing syndrome|Fanconi anemia|FANCC-related disorder	16190	0.81584	.	.	-	95101723	4.679460e-05	-	10.861000	0	0.85095	29608	0	1180000	0	germline;unknown	91068	.	.	GRCh38	167	criteria provided, multiple submitters, no conflicts	c.1661T>C	0.000000e+00	0.60139	4	0	0	.	0.000000e+00	9046	LP	0	0.000000e+00	NM_000136.3(FANCC):c.1661T>C (p.Leu554Pro)	2	0	FANCC_HUMAN	0	30.0	0.440542923641051	0	.	0.72637	0.87194806	-	0.000000e+00	.	0.000014366	2	0.000000e+00	0	34228	criteria_provided,_multiple_submitters,_no_conflicts	0.93787	1.829220e-05	0	0.000000e+00	0	60006	p.Leu554Pro	0	0.84000	.	germline	2	95101723	A	Nov 18, 2024	0	A/A	0	89440	0.99	N	9q22.32	92818	.	0.000000e+00	SCV000512973|SCV001163619|SCV001363461|SCV001393476|SCV002022325|SCV002707544|SCV002776573|SCV004108354|SCV005625570	Pathogenic/Likely_pathogenic	0	0	Pro	P	-	912	ENSP00000289081	ENST00000289081	17692	0.0	13412	0	0.756	A	0	4.178114	0.92967	D	D	-	3.906634	.	0.66224	928	0	.	0.62897	0	95101723	Y	9	0	102652	0.000000e+00	Q00597	0	0.473774	0.92063	A	0	0.999	D	89440	0.87151235	42740	0.10745	2176	0.271784	24	-3.85	.	2.033900e-05	0.91343	0.000000e+00	0	74904	0.000000e+00	6074	0	0.91276	9	FANCC	0.000000e+00	0	Leu	104018	2.236140e-05	9-95101723-A-G	Fanconi_anemia_complementation_group_C|not_provided|Hereditary_cancer-predisposing_syndrome|Fanconi_anemia|FANCC-related_disorder	0	3	96903826	ClinGen:CA284829|Genetic_Testing_Registry_(GTR):GTR000603994|OMIM:613899.0001|UniProtKB:Q00597#VAR_005233	0.586505	0.63480	0	RCV000058925|RCV000012823|RCV002399319|RCV001221431|RCV003421917	D	0	0	c.1661T>C	0	0	0	0.80457	A/A	rs104886458	95101723	14880	A	.	.	15684	0.91931	0.000000e+00	0.68239	9	0	0	0.000000e+00	2.215	0	4	264690	4.76	0.80403	3306	D	T	0	0.000000e+00	0	626	.	0	0	84|140162|84	12043	0.83872	0.41766	0.949487268924713	4188	.	0.37076	0.58304	0.000000e+00	2.236140e-05	1180000	4.529	9.619450e-06	D	13380	0	1.8890023E-5	0	227645|PS227650	0.60386	9	0.000000e+00	ENSG00000158169	0.000000e+00	4.3095089314572604E-5	0	0	0.8253407305087601	2	0.92348	0.93511	30596	5	2.922500e-05	0.000000e+00	0.331677567903355	YES	0.000000e+00	0.055743	27082	HGNC:3584	A	0	simple_aae	0.731	207912	95101723	CTG	1.000000	.	-	0	0.93958	2.033900e-05	0	0	Pathogenic/Likely pathogenic	0.59149	0	0	0	ClinGen:CA284829,UniProtKB:Q00597#VAR_005233,OMIM:613899.0001	L	0	0.900282806353	-	.	-	0.89567	3	2062	0.82387	0.590069651604	0.6917	0	0.99839825199499255	280	-	1661T>C 	3	0	C3468041|C3661900|C0027672|C0015625	0	0	0	0	NM_000136.3	-	.	.	1	0.12239	104886458	2320	3.845488280874464E-5	0.89853	0.57182	0.896	0.0	4020	0.95718740	4.76	.	.	0.000000e+00	0.216268	0.921516655278869	0.62356	T	2680	6200	9568	-0.0283	0.74183	p.Leu554Pro	0	0	-7.71	0.9469856	0	0.77669	12043	D	30492	FANCC	0.000000e+00	D	0.617	21610	.	D	.	0.943	A/A	principal1																																																																																																				
FANCC_Leu554Pro	-0.3335628604146983	0.7484786135159357	-4.383117084986827	0.0032222333592398064	2025_01_Batch_13-14	0.6828875378307329	0.9185174287367518	0.9441415721015707	0.9271406611938001	0.8591763545189698	0.9600094866432588	0.956978245322388	0.9678296569608629	0.977639538560533	0.9544129144970065	0.8214485122369959	0.9377478370295699	0.9559856145312168	0.9523900998771666	0.9067946345079881	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	FANCC	FANCC		7699		CCSBVarC001231		NC_000009.12:95101723:A:G		Leu554Pro																												FANCC_Leu554Pro	9	95101723	A	G	9	allele	1661T>C	A12	527_CAVA_Array_P02	A24	B13A7A8P1_R1	B14A7A8P1_R2				9-95101723-A-G	-	0.62948	1.0	554	2	0	0	9	97864005	G	1.487070e-05	0	9	1_Pathogenic	NC_000009.12	24	Leu554Pro	0	24.5	0	0	2.922500e-05	T	0	15	1	42740	1.267110e-05	.	30514	0.000000e+00	0	0.85019	Select	0.3880	102652	0.90580	0	.	T	D	63982	0.413463600646	0	0	0.000000e+00	0	0	0.51437	17096	44874	0	0.000000e+00	0.72390	2	.	0.88866	0.016	.	70.0	.	.	0.3	G	single nucleotide variant	NC_000009.12:g.95101723A>G	0	16720	3	0.8482753	109336	0	0.90733176	0	G	2	236760	0	0	0.000000e+00	436	4.679460e-05	0	MedGen:C3661900|MONDO:MONDO:0009213,MedGen:C3468041,OMIM:227645,Orphanet:84|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0019391,MeSH:D005199,MedGen:C0015625,OMIM:PS227650,Orphanet:84|	2	0	0.000000e+00	0	0.55288	D	0.92876	D	M	4.605117	24	A/A	168	0	7156	1613908	not provided|Fanconi anemia complementation group C|Hereditary cancer-predisposing syndrome|Fanconi anemia|FANCC-related disorder	16190	0.81584	.	.	-	95101723	4.679460e-05	-	10.861000	0	0.85095	29608	0	1180000	0	germline;unknown	91068	.	.	GRCh38	167	criteria provided, multiple submitters, no conflicts	c.1661T>C	0.000000e+00	0.60139	4	0	0	.	0.000000e+00	9046	LP	0	0.000000e+00	NM_000136.3(FANCC):c.1661T>C (p.Leu554Pro)	2	0	FANCC_HUMAN	0	30.0	0.440542923641051	0	.	0.72637	0.87194806	-	0.000000e+00	.	0.000014366	2	0.000000e+00	0	34228	criteria_provided,_multiple_submitters,_no_conflicts	0.93787	1.829220e-05	0	0.000000e+00	0	60006	p.Leu554Pro	0	0.84000	.	germline	2	95101723	A	Nov 18, 2024	0	A/A	0	89440	0.99	N	9q22.32	92818	.	0.000000e+00	SCV000512973|SCV001163619|SCV001363461|SCV001393476|SCV002022325|SCV002707544|SCV002776573|SCV004108354|SCV005625570	Pathogenic/Likely_pathogenic	0	0	Pro	P	-	912	ENSP00000289081	ENST00000289081	17692	0.0	13412	0	0.756	A	0	4.178114	0.92967	D	D	-	3.906634	.	0.66224	928	0	.	0.62897	0	95101723	Y	9	0	102652	0.000000e+00	Q00597	0	0.473774	0.92063	A	0	0.999	D	89440	0.87151235	42740	0.10745	2176	0.271784	24	-3.85	.	2.033900e-05	0.91343	0.000000e+00	0	74904	0.000000e+00	6074	0	0.91276	9	FANCC	0.000000e+00	0	Leu	104018	2.236140e-05	9-95101723-A-G	Fanconi_anemia_complementation_group_C|not_provided|Hereditary_cancer-predisposing_syndrome|Fanconi_anemia|FANCC-related_disorder	0	3	96903826	ClinGen:CA284829|Genetic_Testing_Registry_(GTR):GTR000603994|OMIM:613899.0001|UniProtKB:Q00597#VAR_005233	0.586505	0.63480	0	RCV000058925|RCV000012823|RCV002399319|RCV001221431|RCV003421917	D	0	0	c.1661T>C	0	0	0	0.80457	A/A	rs104886458	95101723	14880	A	.	.	15684	0.91931	0.000000e+00	0.68239	9	0	0	0.000000e+00	2.215	0	4	264690	4.76	0.80403	3306	D	T	0	0.000000e+00	0	626	.	0	0	84|140162|84	12043	0.83872	0.41766	0.949487268924713	4188	.	0.37076	0.58304	0.000000e+00	2.236140e-05	1180000	4.529	9.619450e-06	D	13380	0	1.8890023E-5	0	227645|PS227650	0.60386	9	0.000000e+00	ENSG00000158169	0.000000e+00	4.3095089314572604E-5	0	0	0.8253407305087601	2	0.92348	0.93511	30596	5	2.922500e-05	0.000000e+00	0.331677567903355	YES	0.000000e+00	0.055743	27082	HGNC:3584	A	0	simple_aae	0.731	207912	95101723	CTG	1.000000	.	-	0	0.93958	2.033900e-05	0	0	Pathogenic/Likely pathogenic	0.59149	0	0	0	ClinGen:CA284829,UniProtKB:Q00597#VAR_005233,OMIM:613899.0001	L	0	0.900282806353	-	.	-	0.89567	3	2062	0.82387	0.590069651604	0.6917	0	0.99839825199499255	280	-	1661T>C 	3	0	C3468041|C3661900|C0027672|C0015625	0	0	0	0	NM_000136.3	-	.	.	1	0.12239	104886458	2320	3.845488280874464E-5	0.89853	0.57182	0.896	0.0	4020	0.95718740	4.76	.	.	0.000000e+00	0.216268	0.921516655278869	0.62356	T	2680	6200	9568	-0.0283	0.74183	p.Leu554Pro	0	0	-7.71	0.9469856	0	0.77669	12043	D	30492	FANCC	0.000000e+00	D	0.617	21610	.	D	.	0.943	A/A	principal1																																																																																																				
BRCA1_Ser186Tyr	1.7603534804730556	0.12173945667616726	-2.5675246326680874	0.03714171283359237	2025_01_Batch_13-14	0.9895433550447515	0.9737788841307277	0.9879681792570353	0.9891091271413341	0.9755578642730985	0.9891402010878071	0.9621113636599743	0.9776515180547332	0.9867512743655017	0.9603178873145011	0.9893417780662793	0.9679451238953509	0.9828098486558843	0.9879302007534179	0.9679378757937998	1.0	1.0	1.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	BRCA1	BRCA1		14613		CCSBVarC013090		NC_000017.11:43097280:G:T		Ser186Tyr																												BRCA1_Ser186Tyr	17	43097280	G	T	17	allele	557C>A	C11	527_CAVA_Array_P01	E21	B13A7A8P1_R1	B14A7A8P1_R2				17-43097280-G-T	-	0.84844	1.0	186	4	0	3	17	41249297	T	4.896240e-04	8	17	2_Benign	NC_000017.11	685	Ser186Tyr	0	28.4	0	82	9.558430e-03	D	5	35	1	42756	6.760640e-04	15	30504	0.000000e+00	0	0.92474	.	0.9635	14856	0.90580	10	0.0	T	T	64006	.	0.009729473184622686	5	0.000000e+00	0	3	0.39453	17072	44832	1	0.000000e+00	0.76284	1	.	0.66423	0.998	0.0113464447806354	.	0.962504	5.79	.	T	single nucleotide variant	NC_000017.11:g.43097280G>T	0	16734	2	0.5691173	109338	0	0.47664887	0		172	236664	3	3	0.000000e+00	804	2.338850e-05	0	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MedGen:CN221562|MONDO:MONDO:0007254,MedGen:C0006142	81	0	0.000000e+00	0	0.23785	D	0.70615	D	M	7.17216	790	./.	352	8	7158	1613484	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|not provided|Familial cancer of breast|Breast and/or ovarian cancer|Malignant tumor of breast	16170	0.95704	0	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43097280	9.918970e-03	-	11.485000	153	0.49947	29596	0	75010	0	germline;unknown	90940	.	.	GRCh38	473	reviewed by expert panel	.	0.000000e+00	0.65108	103	0	0	.	0.000000e+00	9044	.	0	0.000000e+00	NM_007294.4(BRCA1):c.557C>A (p.Ser186Tyr)	3	0	BRCA1_HUMAN	0	.	0.703775773492025	11	D	0.70541	0.4938498	-	9.918970e-03	0		153	0.000000e+00	0	34210	reviewed_by_expert_panel	0.99364	7.408220e-04	5	0.000000e+00	0	60008	.	0	0.92915	.	germline	71		G	Aug 10, 2015	0	./.	3	89398	1.0	N	17q21.31	173906	.	9.461970e-03	SCV000244407	Benign	0	0	Tyr	Y	-	912	ENSP00000478114	ENST00000618469	17688	.	13412	3	0.676	G	0	5.082168	0.92967	D	.	-	7.229281	.	.	974	0	0.0	0.02552	0	43097280	Y	10	0.0024875621890547263	102608	4.950500e-04	P38398	0	0.222563	0.64033		3	0.956	.	16170	0.49632788	7158	0.85369	672	0.0490491	12	.	0.0	9.132120e-03	0.91343	0.000000e+00	0	75010	0.000000e+00	6060	71	0.74804	17	BRCA1	9.132120e-03	0	Ser	201516	4.474370e-05	17-43097280-G-T	Malignant_tumor_of_breast|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_and/or_ovarian_cancer|not_specified|not_provided	0	4	38502823	BRCA1-HCI:BRCA1_00057|ClinGen:CA003732|UniProtKB:P38398#VAR_070467	0.805499	0.79770	0	RCV000049057|RCV000077630|RCV000162532|RCV000120269|RCV000224107|RCV000470710|RCV001170826|RCV001353515	.	0	0	c.557C>A	0	0	0	0.57930	./.	rs55688530	43097280	14856	G	0.0029952076677316293	.	15680	0.65384	0.000000e+00	0.68239		0	0	0.000000e+00	2.535	0	11	264690	4.96	0.58431	3308	T	T	142	3.609160e-04	2	654	.	3	0	145|140162|227535|145	55635	0.88335	0.47613	0.0335924297408818	8780	15	0.71675	0.72908	2.923120e-04	9.461970e-03	1179650	4.066	8.275840e-04	.	13394	3	0.0030979638	0	114480|604370	0.57326	17	9.558430e-03	ENSG00000012048	0.000000e+00	6.325256172875002E-5	0	0	.	2	0.80453	0.77929	30586	820	3.898330e-05	7.332360e-04	0.670198265778078	.	1.099630e-05	.	70302	HGNC:1100	.	0	.	0.231	207834	43097280	TCT	1.000000	0	-	0.009339407744874715	0.00228	1.017250e-05	82	0	Benign	0.52305	0	3	44	BRCA1-HCI:BRCA1_00057,ClinGen:CA003732,UniProtKB:P38398#VAR_070467	S	0	.	-	.	-	0.68711	160	13470	0.57312	0.504873514175	.	0	0.99425264648970257	274	-	557C>A 	142	5.939123979213066E-4	C0006142|C0677776|C0027672|C0346153|C2676676|CN221562|CN169374|C3661900	0	0	0	0	NM_007294.4	-	0	0.0	0	0.88031	55688530	2320	5.111256674407988E-4	0.96689	0.80013	.	.	8428	0.99941337	4.96	.	.	0.000000e+00	0.304786	0.995660278977707	0.73728	D	2654	6208	9568	0.9031	0.98828	p.Ser186Tyr	0	0	-6.751	.	685	0.91503	55635	T	30478	BRCA1	4.686040e-04	D	.	21630	.	.	0.96129	0.76753	./.	principal2																																																																																																				
F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											F9	F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	NC_000023.11:139560784:T:C	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			F9_Ile256Thr	23	139560784	T	C	X											X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			248741	F9_Popp_2025_strep_2_var264774	No											I		767	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ile256Thr		true	c.767T>C						3551.0	139560784.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa															Ile256Thr						T						missense_variant		256.0				0.2648858589123566			139560784.0	missense_variant		0.905					Reporter			F9_Ile256Thr
F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											F9	F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	NC_000023.11:139560784:T:C	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			F9_Ile256Thr	23	139560784	T	C	X											X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			138677	F9_Popp_2025_carboxy_F9_specific_var226050	No											I		767	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ile256Thr		true	c.767T>C						3551.0	139560784.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa															Ile256Thr						T						missense_variant		256.0				0.0367885946044001			139560784.0	missense_variant		0.905					Reporter			F9_Ile256Thr
F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											F9	F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	NC_000023.11:139560784:T:C	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			F9_Ile256Thr	23	139560784	T	C	X											X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			221225	F9_Popp_2025_light_chain_var245412	No											I		767	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ile256Thr		true	c.767T>C						3551.0	139560784.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa															Ile256Thr						T						missense_variant		256.0				0.038018179			139560784.0	missense_variant		0.905					Reporter			F9_Ile256Thr
F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											F9	F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	NC_000023.11:139560784:T:C	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			F9_Ile256Thr	23	139560784	T	C	X											X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			193709	F9_Popp_2025_heavy_chain_var235731	No											I		767	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ile256Thr		true	c.767T>C						3551.0	139560784.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa															Ile256Thr						T						missense_variant		256.0				0.091556578			139560784.0	missense_variant		0.905					Reporter			F9_Ile256Thr
F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											F9	F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	NC_000023.11:139560784:T:C	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0			0			0			F9_Ile256Thr	23	139560784	T	C	X											X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			166193	F9_Popp_2025_carboxy_gla_motif_var255093	No											I		767	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ile256Thr		true	c.767T>C						3551.0	139560784.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa															Ile256Thr						T						missense_variant		256.0				0.0164006844039541			139560784.0	missense_variant		0.905					Reporter			F9_Ile256Thr
F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											F9	F9		52861		CCSBVarC002182		NC_000023.11:139560784:T:C		Ile256Thr																												F9_Ile256Thr	23	139560784	T	C	X	allele	767T>C	A11	527_CAVA_Array_P02	A22	B13A7A8P1_R1	B14A7A8P1_R2				X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			248741	F9_Popp_2025_strep_2_var264774	No											I		767	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ile256Thr		true	c.767T>C						3551.0	139560784.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa															Ile256Thr						T						missense_variant		256.0				0.2648858589123566			139560784.0	missense_variant		0.905					Reporter			F9_Ile256Thr
F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											F9	F9		52861		CCSBVarC002182		NC_000023.11:139560784:T:C		Ile256Thr																												F9_Ile256Thr	23	139560784	T	C	X	allele	767T>C	A11	527_CAVA_Array_P02	A22	B13A7A8P1_R1	B14A7A8P1_R2				X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			138677	F9_Popp_2025_carboxy_F9_specific_var226050	No											I		767	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ile256Thr		true	c.767T>C						3551.0	139560784.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa															Ile256Thr						T						missense_variant		256.0				0.0367885946044001			139560784.0	missense_variant		0.905					Reporter			F9_Ile256Thr
F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											F9	F9		52861		CCSBVarC002182		NC_000023.11:139560784:T:C		Ile256Thr																												F9_Ile256Thr	23	139560784	T	C	X	allele	767T>C	A11	527_CAVA_Array_P02	A22	B13A7A8P1_R1	B14A7A8P1_R2				X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			221225	F9_Popp_2025_light_chain_var245412	No											I		767	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ile256Thr		true	c.767T>C						3551.0	139560784.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa															Ile256Thr						T						missense_variant		256.0				0.038018179			139560784.0	missense_variant		0.905					Reporter			F9_Ile256Thr
F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											F9	F9		52861		CCSBVarC002182		NC_000023.11:139560784:T:C		Ile256Thr																												F9_Ile256Thr	23	139560784	T	C	X	allele	767T>C	A11	527_CAVA_Array_P02	A22	B13A7A8P1_R1	B14A7A8P1_R2				X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			193709	F9_Popp_2025_heavy_chain_var235731	No											I		767	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ile256Thr		true	c.767T>C						3551.0	139560784.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa															Ile256Thr						T						missense_variant		256.0				0.091556578			139560784.0	missense_variant		0.905					Reporter			F9_Ile256Thr
F9_Ile256Thr	-4.433878016604986	0.004404706723192756	2.379972424129913	0.048884091588368726																											F9	F9		52861		CCSBVarC002182		NC_000023.11:139560784:T:C		Ile256Thr																												F9_Ile256Thr	23	139560784	T	C	X	allele	767T>C	A11	527_CAVA_Array_P02	A22	B13A7A8P1_R1	B14A7A8P1_R2				X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																																			166193	F9_Popp_2025_carboxy_gla_motif_var255093	No											I		767	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ile256Thr		true	c.767T>C						3551.0	139560784.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa															Ile256Thr						T						missense_variant		256.0				0.0164006844039541			139560784.0	missense_variant		0.905					Reporter			F9_Ile256Thr
F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Trp453Arg	23	139562042	T	C	X											X-139562042-T-C	-	0.80235	1.0	453	.	.	.	X	138644201	C	.	.	X	1_Pathogenic	NC_000023.11	.	Trp453Arg	.	27.3	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99918	Select	0.9857	.	0.90580	.	.	D	D	.	2.17286694384	0	.	.	.	.	0.80818	.	.	.	.	0.99834	.	.	0.99940	0.994	.	2.0	0.827517	.	0.98	C	single nucleotide variant	NC_000023.11:g.139562042T>C	.	.	1	0.99098927	.	0	0.9940456	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99989	D	H	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97321	.	.	-	139562042	.	-	7.901000	.	0.99985	.	0	.	.	germline	.	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.99835	GRCh38	924	no assertion criteria provided	c.1357T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)		.	FA9_HUMAN	.	98.0	.	.	T	0.94923	0.994228	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Trp453Arg	.	0.73593	.	germline	.		T	Sep 01, 1989	.	./.	.	.	1.0	N	Xq27.1	0	.	.	SCV000031604	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.886611	0.92967	.	D	-	.	.	0.99948	0	.	.	0.99780	0	139562042	Y	10	0	.	.	P00740	.	0.971015	0.74962		.	1.0	D	.	0.9917848	.	0.71086	2158	0.73814	.	-12.84	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	0	Trp	478	.	X-139562042-T-C	Hereditary_factor_IX_deficiency_disease	.	.	138471867	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	.	.	.	RCV000011372	D	.	.	c.1357T>C	.	.	.	0.99967	./.	rs137852269	139562042	.	T	.	P00740	.	0.99934	.	0.68239		.	.	.	4.5	0	0	.	5.59	0.99684	0	D	T	.	.	0	0	.	.	.	98879	10628	0.99967	0.95501	0.999932289123535	426	.	0.71675	.	.	.	.	7.991	.	D	.	.	.	0	306900	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9998368683257477	1	0.97365	0.18019	.	.	.	.	.	YES	.	0.987685	25667	HGNC:3551	A	.	simple_aae	1	.	139562042	TGG	1.000000	.	-	0	0.99934	.	0	.	Pathogenic	0.98135	.	.	.	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	W	.	0.999744162249	-	0.983	-	0.98940	.	52	0.99983	0.792695641518	0.9806	.	0.99613210292578003	0	-	1357T>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48982	137852269	.	0	0.99974	.	0.926	0.0	426	0.99999380	5.59	.	.	.	0.82251	0.999834134473653	0.98957	D	0	.	.	1.0083	0.99569	p.Trp453Arg	0	.	-16.213	0.99427634	.	0.98239	10628	D	.	F9	.	D	0.984	.	W453R	D	.	0.62996	./.	principal1	178054	F9_Popp_2025_carboxy_gla_motif_var259236	No											W		1357	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Trp453Arg		true	c.1357T>C						3551.0	139562042.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Trp453Arg						R	Sep 01, 1989					missense_variant		453.0				0.005097503		Pathogenic	139562042.0	missense_variant		0.984					Reporter			F9_Trp453Arg
F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Trp453Arg	23	139562042	T	C	X											X-139562042-T-C	-	0.80235	1.0	453	.	.	.	X	138644201	C	.	.	X	1_Pathogenic	NC_000023.11	.	Trp453Arg	.	27.3	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99918	Select	0.9857	.	0.90580	.	.	D	D	.	2.17286694384	0	.	.	.	.	0.80818	.	.	.	.	0.99834	.	.	0.99940	0.994	.	2.0	0.827517	.	0.98	C	single nucleotide variant	NC_000023.11:g.139562042T>C	.	.	1	0.99098927	.	0	0.9940456	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99989	D	H	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97321	.	.	-	139562042	.	-	7.901000	.	0.99985	.	0	.	.	germline	.	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.99835	GRCh38	924	no assertion criteria provided	c.1357T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)		.	FA9_HUMAN	.	98.0	.	.	T	0.94923	0.994228	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Trp453Arg	.	0.73593	.	germline	.		T	Sep 01, 1989	.	./.	.	.	1.0	N	Xq27.1	0	.	.	SCV000031604	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.886611	0.92967	.	D	-	.	.	0.99948	0	.	.	0.99780	0	139562042	Y	10	0	.	.	P00740	.	0.971015	0.74962		.	1.0	D	.	0.9917848	.	0.71086	2158	0.73814	.	-12.84	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	0	Trp	478	.	X-139562042-T-C	Hereditary_factor_IX_deficiency_disease	.	.	138471867	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	.	.	.	RCV000011372	D	.	.	c.1357T>C	.	.	.	0.99967	./.	rs137852269	139562042	.	T	.	P00740	.	0.99934	.	0.68239		.	.	.	4.5	0	0	.	5.59	0.99684	0	D	T	.	.	0	0	.	.	.	98879	10628	0.99967	0.95501	0.999932289123535	426	.	0.71675	.	.	.	.	7.991	.	D	.	.	.	0	306900	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9998368683257477	1	0.97365	0.18019	.	.	.	.	.	YES	.	0.987685	25667	HGNC:3551	A	.	simple_aae	1	.	139562042	TGG	1.000000	.	-	0	0.99934	.	0	.	Pathogenic	0.98135	.	.	.	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	W	.	0.999744162249	-	0.983	-	0.98940	.	52	0.99983	0.792695641518	0.9806	.	0.99613210292578003	0	-	1357T>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48982	137852269	.	0	0.99974	.	0.926	0.0	426	0.99999380	5.59	.	.	.	0.82251	0.999834134473653	0.98957	D	0	.	.	1.0083	0.99569	p.Trp453Arg	0	.	-16.213	0.99427634	.	0.98239	10628	D	.	F9	.	D	0.984	.	W453R	D	.	0.62996	./.	principal1	150538	F9_Popp_2025_carboxy_F9_specific_var230193	No											W		1357	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Trp453Arg		true	c.1357T>C						3551.0	139562042.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Trp453Arg						R	Sep 01, 1989					missense_variant		453.0				0.010689583		Pathogenic	139562042.0	missense_variant		0.984					Reporter			F9_Trp453Arg
F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Trp453Arg	23	139562042	T	C	X											X-139562042-T-C	-	0.80235	1.0	453	.	.	.	X	138644201	C	.	.	X	1_Pathogenic	NC_000023.11	.	Trp453Arg	.	27.3	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99918	Select	0.9857	.	0.90580	.	.	D	D	.	2.17286694384	0	.	.	.	.	0.80818	.	.	.	.	0.99834	.	.	0.99940	0.994	.	2.0	0.827517	.	0.98	C	single nucleotide variant	NC_000023.11:g.139562042T>C	.	.	1	0.99098927	.	0	0.9940456	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99989	D	H	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97321	.	.	-	139562042	.	-	7.901000	.	0.99985	.	0	.	.	germline	.	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.99835	GRCh38	924	no assertion criteria provided	c.1357T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)		.	FA9_HUMAN	.	98.0	.	.	T	0.94923	0.994228	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Trp453Arg	.	0.73593	.	germline	.		T	Sep 01, 1989	.	./.	.	.	1.0	N	Xq27.1	0	.	.	SCV000031604	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.886611	0.92967	.	D	-	.	.	0.99948	0	.	.	0.99780	0	139562042	Y	10	0	.	.	P00740	.	0.971015	0.74962		.	1.0	D	.	0.9917848	.	0.71086	2158	0.73814	.	-12.84	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	0	Trp	478	.	X-139562042-T-C	Hereditary_factor_IX_deficiency_disease	.	.	138471867	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	.	.	.	RCV000011372	D	.	.	c.1357T>C	.	.	.	0.99967	./.	rs137852269	139562042	.	T	.	P00740	.	0.99934	.	0.68239		.	.	.	4.5	0	0	.	5.59	0.99684	0	D	T	.	.	0	0	.	.	.	98879	10628	0.99967	0.95501	0.999932289123535	426	.	0.71675	.	.	.	.	7.991	.	D	.	.	.	0	306900	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9998368683257477	1	0.97365	0.18019	.	.	.	.	.	YES	.	0.987685	25667	HGNC:3551	A	.	simple_aae	1	.	139562042	TGG	1.000000	.	-	0	0.99934	.	0	.	Pathogenic	0.98135	.	.	.	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	W	.	0.999744162249	-	0.983	-	0.98940	.	52	0.99983	0.792695641518	0.9806	.	0.99613210292578003	0	-	1357T>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48982	137852269	.	0	0.99974	.	0.926	0.0	426	0.99999380	5.59	.	.	.	0.82251	0.999834134473653	0.98957	D	0	.	.	1.0083	0.99569	p.Trp453Arg	0	.	-16.213	0.99427634	.	0.98239	10628	D	.	F9	.	D	0.984	.	W453R	D	.	0.62996	./.	principal1	260602	F9_Popp_2025_strep_2_var268917	No											W		1357	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Trp453Arg		true	c.1357T>C						3551.0	139562042.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Trp453Arg						R	Sep 01, 1989					missense_variant		453.0				0.005218656		Pathogenic	139562042.0	missense_variant		0.984					Reporter			F9_Trp453Arg
F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Trp453Arg	23	139562042	T	C	X											X-139562042-T-C	-	0.80235	1.0	453	.	.	.	X	138644201	C	.	.	X	1_Pathogenic	NC_000023.11	.	Trp453Arg	.	27.3	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99918	Select	0.9857	.	0.90580	.	.	D	D	.	2.17286694384	0	.	.	.	.	0.80818	.	.	.	.	0.99834	.	.	0.99940	0.994	.	2.0	0.827517	.	0.98	C	single nucleotide variant	NC_000023.11:g.139562042T>C	.	.	1	0.99098927	.	0	0.9940456	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99989	D	H	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97321	.	.	-	139562042	.	-	7.901000	.	0.99985	.	0	.	.	germline	.	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.99835	GRCh38	924	no assertion criteria provided	c.1357T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)		.	FA9_HUMAN	.	98.0	.	.	T	0.94923	0.994228	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Trp453Arg	.	0.73593	.	germline	.		T	Sep 01, 1989	.	./.	.	.	1.0	N	Xq27.1	0	.	.	SCV000031604	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.886611	0.92967	.	D	-	.	.	0.99948	0	.	.	0.99780	0	139562042	Y	10	0	.	.	P00740	.	0.971015	0.74962		.	1.0	D	.	0.9917848	.	0.71086	2158	0.73814	.	-12.84	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	0	Trp	478	.	X-139562042-T-C	Hereditary_factor_IX_deficiency_disease	.	.	138471867	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	.	.	.	RCV000011372	D	.	.	c.1357T>C	.	.	.	0.99967	./.	rs137852269	139562042	.	T	.	P00740	.	0.99934	.	0.68239		.	.	.	4.5	0	0	.	5.59	0.99684	0	D	T	.	.	0	0	.	.	.	98879	10628	0.99967	0.95501	0.999932289123535	426	.	0.71675	.	.	.	.	7.991	.	D	.	.	.	0	306900	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9998368683257477	1	0.97365	0.18019	.	.	.	.	.	YES	.	0.987685	25667	HGNC:3551	A	.	simple_aae	1	.	139562042	TGG	1.000000	.	-	0	0.99934	.	0	.	Pathogenic	0.98135	.	.	.	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	W	.	0.999744162249	-	0.983	-	0.98940	.	52	0.99983	0.792695641518	0.9806	.	0.99613210292578003	0	-	1357T>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48982	137852269	.	0	0.99974	.	0.926	0.0	426	0.99999380	5.59	.	.	.	0.82251	0.999834134473653	0.98957	D	0	.	.	1.0083	0.99569	p.Trp453Arg	0	.	-16.213	0.99427634	.	0.98239	10628	D	.	F9	.	D	0.984	.	W453R	D	.	0.62996	./.	principal1	233086	F9_Popp_2025_light_chain_var249555	No											W		1357	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Trp453Arg		true	c.1357T>C						3551.0	139562042.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Trp453Arg						R	Sep 01, 1989					missense_variant		453.0				0.005952112		Pathogenic	139562042.0	missense_variant		0.984					Reporter			F9_Trp453Arg
F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	NC_000023.11:139562042:T:C	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			F9_Trp453Arg	23	139562042	T	C	X											X-139562042-T-C	-	0.80235	1.0	453	.	.	.	X	138644201	C	.	.	X	1_Pathogenic	NC_000023.11	.	Trp453Arg	.	27.3	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99918	Select	0.9857	.	0.90580	.	.	D	D	.	2.17286694384	0	.	.	.	.	0.80818	.	.	.	.	0.99834	.	.	0.99940	0.994	.	2.0	0.827517	.	0.98	C	single nucleotide variant	NC_000023.11:g.139562042T>C	.	.	1	0.99098927	.	0	0.9940456	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99989	D	H	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97321	.	.	-	139562042	.	-	7.901000	.	0.99985	.	0	.	.	germline	.	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.99835	GRCh38	924	no assertion criteria provided	c.1357T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)		.	FA9_HUMAN	.	98.0	.	.	T	0.94923	0.994228	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Trp453Arg	.	0.73593	.	germline	.		T	Sep 01, 1989	.	./.	.	.	1.0	N	Xq27.1	0	.	.	SCV000031604	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.886611	0.92967	.	D	-	.	.	0.99948	0	.	.	0.99780	0	139562042	Y	10	0	.	.	P00740	.	0.971015	0.74962		.	1.0	D	.	0.9917848	.	0.71086	2158	0.73814	.	-12.84	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	0	Trp	478	.	X-139562042-T-C	Hereditary_factor_IX_deficiency_disease	.	.	138471867	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	.	.	.	RCV000011372	D	.	.	c.1357T>C	.	.	.	0.99967	./.	rs137852269	139562042	.	T	.	P00740	.	0.99934	.	0.68239		.	.	.	4.5	0	0	.	5.59	0.99684	0	D	T	.	.	0	0	.	.	.	98879	10628	0.99967	0.95501	0.999932289123535	426	.	0.71675	.	.	.	.	7.991	.	D	.	.	.	0	306900	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9998368683257477	1	0.97365	0.18019	.	.	.	.	.	YES	.	0.987685	25667	HGNC:3551	A	.	simple_aae	1	.	139562042	TGG	1.000000	.	-	0	0.99934	.	0	.	Pathogenic	0.98135	.	.	.	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	W	.	0.999744162249	-	0.983	-	0.98940	.	52	0.99983	0.792695641518	0.9806	.	0.99613210292578003	0	-	1357T>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48982	137852269	.	0	0.99974	.	0.926	0.0	426	0.99999380	5.59	.	.	.	0.82251	0.999834134473653	0.98957	D	0	.	.	1.0083	0.99569	p.Trp453Arg	0	.	-16.213	0.99427634	.	0.98239	10628	D	.	F9	.	D	0.984	.	W453R	D	.	0.62996	./.	principal1	205570	F9_Popp_2025_heavy_chain_var239874	No											W		1357	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Trp453Arg		true	c.1357T>C						3551.0	139562042.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Trp453Arg						R	Sep 01, 1989					missense_variant		453.0				0.043974252		Pathogenic	139562042.0	missense_variant		0.984					Reporter			F9_Trp453Arg
F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004398		NC_000023.11:139562042:T:C		Trp453Arg																												F9_Trp453Arg	23	139562042	T	C	X	allele	1357T>C	H05	527_CAVA_Array_P02	O10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562042-T-C	-	0.80235	1.0	453	.	.	.	X	138644201	C	.	.	X	1_Pathogenic	NC_000023.11	.	Trp453Arg	.	27.3	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99918	Select	0.9857	.	0.90580	.	.	D	D	.	2.17286694384	0	.	.	.	.	0.80818	.	.	.	.	0.99834	.	.	0.99940	0.994	.	2.0	0.827517	.	0.98	C	single nucleotide variant	NC_000023.11:g.139562042T>C	.	.	1	0.99098927	.	0	0.9940456	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99989	D	H	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97321	.	.	-	139562042	.	-	7.901000	.	0.99985	.	0	.	.	germline	.	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.99835	GRCh38	924	no assertion criteria provided	c.1357T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)		.	FA9_HUMAN	.	98.0	.	.	T	0.94923	0.994228	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Trp453Arg	.	0.73593	.	germline	.		T	Sep 01, 1989	.	./.	.	.	1.0	N	Xq27.1	0	.	.	SCV000031604	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.886611	0.92967	.	D	-	.	.	0.99948	0	.	.	0.99780	0	139562042	Y	10	0	.	.	P00740	.	0.971015	0.74962		.	1.0	D	.	0.9917848	.	0.71086	2158	0.73814	.	-12.84	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	0	Trp	478	.	X-139562042-T-C	Hereditary_factor_IX_deficiency_disease	.	.	138471867	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	.	.	.	RCV000011372	D	.	.	c.1357T>C	.	.	.	0.99967	./.	rs137852269	139562042	.	T	.	P00740	.	0.99934	.	0.68239		.	.	.	4.5	0	0	.	5.59	0.99684	0	D	T	.	.	0	0	.	.	.	98879	10628	0.99967	0.95501	0.999932289123535	426	.	0.71675	.	.	.	.	7.991	.	D	.	.	.	0	306900	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9998368683257477	1	0.97365	0.18019	.	.	.	.	.	YES	.	0.987685	25667	HGNC:3551	A	.	simple_aae	1	.	139562042	TGG	1.000000	.	-	0	0.99934	.	0	.	Pathogenic	0.98135	.	.	.	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	W	.	0.999744162249	-	0.983	-	0.98940	.	52	0.99983	0.792695641518	0.9806	.	0.99613210292578003	0	-	1357T>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48982	137852269	.	0	0.99974	.	0.926	0.0	426	0.99999380	5.59	.	.	.	0.82251	0.999834134473653	0.98957	D	0	.	.	1.0083	0.99569	p.Trp453Arg	0	.	-16.213	0.99427634	.	0.98239	10628	D	.	F9	.	D	0.984	.	W453R	D	.	0.62996	./.	principal1	178054	F9_Popp_2025_carboxy_gla_motif_var259236	No											W		1357	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Trp453Arg		true	c.1357T>C						3551.0	139562042.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											no assertion criteria provided				Trp453Arg						R	Sep 01, 1989					missense_variant		453.0				0.005097503		Pathogenic	139562042.0	missense_variant		0.984					Reporter			F9_Trp453Arg
F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004398		NC_000023.11:139562042:T:C		Trp453Arg																												F9_Trp453Arg	23	139562042	T	C	X	allele	1357T>C	H05	527_CAVA_Array_P02	O10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562042-T-C	-	0.80235	1.0	453	.	.	.	X	138644201	C	.	.	X	1_Pathogenic	NC_000023.11	.	Trp453Arg	.	27.3	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99918	Select	0.9857	.	0.90580	.	.	D	D	.	2.17286694384	0	.	.	.	.	0.80818	.	.	.	.	0.99834	.	.	0.99940	0.994	.	2.0	0.827517	.	0.98	C	single nucleotide variant	NC_000023.11:g.139562042T>C	.	.	1	0.99098927	.	0	0.9940456	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99989	D	H	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97321	.	.	-	139562042	.	-	7.901000	.	0.99985	.	0	.	.	germline	.	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.99835	GRCh38	924	no assertion criteria provided	c.1357T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)		.	FA9_HUMAN	.	98.0	.	.	T	0.94923	0.994228	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Trp453Arg	.	0.73593	.	germline	.		T	Sep 01, 1989	.	./.	.	.	1.0	N	Xq27.1	0	.	.	SCV000031604	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.886611	0.92967	.	D	-	.	.	0.99948	0	.	.	0.99780	0	139562042	Y	10	0	.	.	P00740	.	0.971015	0.74962		.	1.0	D	.	0.9917848	.	0.71086	2158	0.73814	.	-12.84	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	0	Trp	478	.	X-139562042-T-C	Hereditary_factor_IX_deficiency_disease	.	.	138471867	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	.	.	.	RCV000011372	D	.	.	c.1357T>C	.	.	.	0.99967	./.	rs137852269	139562042	.	T	.	P00740	.	0.99934	.	0.68239		.	.	.	4.5	0	0	.	5.59	0.99684	0	D	T	.	.	0	0	.	.	.	98879	10628	0.99967	0.95501	0.999932289123535	426	.	0.71675	.	.	.	.	7.991	.	D	.	.	.	0	306900	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9998368683257477	1	0.97365	0.18019	.	.	.	.	.	YES	.	0.987685	25667	HGNC:3551	A	.	simple_aae	1	.	139562042	TGG	1.000000	.	-	0	0.99934	.	0	.	Pathogenic	0.98135	.	.	.	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	W	.	0.999744162249	-	0.983	-	0.98940	.	52	0.99983	0.792695641518	0.9806	.	0.99613210292578003	0	-	1357T>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48982	137852269	.	0	0.99974	.	0.926	0.0	426	0.99999380	5.59	.	.	.	0.82251	0.999834134473653	0.98957	D	0	.	.	1.0083	0.99569	p.Trp453Arg	0	.	-16.213	0.99427634	.	0.98239	10628	D	.	F9	.	D	0.984	.	W453R	D	.	0.62996	./.	principal1	150538	F9_Popp_2025_carboxy_F9_specific_var230193	No											W		1357	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Trp453Arg		true	c.1357T>C						3551.0	139562042.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											no assertion criteria provided				Trp453Arg						R	Sep 01, 1989					missense_variant		453.0				0.010689583		Pathogenic	139562042.0	missense_variant		0.984					Reporter			F9_Trp453Arg
F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004398		NC_000023.11:139562042:T:C		Trp453Arg																												F9_Trp453Arg	23	139562042	T	C	X	allele	1357T>C	H05	527_CAVA_Array_P02	O10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562042-T-C	-	0.80235	1.0	453	.	.	.	X	138644201	C	.	.	X	1_Pathogenic	NC_000023.11	.	Trp453Arg	.	27.3	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99918	Select	0.9857	.	0.90580	.	.	D	D	.	2.17286694384	0	.	.	.	.	0.80818	.	.	.	.	0.99834	.	.	0.99940	0.994	.	2.0	0.827517	.	0.98	C	single nucleotide variant	NC_000023.11:g.139562042T>C	.	.	1	0.99098927	.	0	0.9940456	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99989	D	H	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97321	.	.	-	139562042	.	-	7.901000	.	0.99985	.	0	.	.	germline	.	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.99835	GRCh38	924	no assertion criteria provided	c.1357T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)		.	FA9_HUMAN	.	98.0	.	.	T	0.94923	0.994228	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Trp453Arg	.	0.73593	.	germline	.		T	Sep 01, 1989	.	./.	.	.	1.0	N	Xq27.1	0	.	.	SCV000031604	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.886611	0.92967	.	D	-	.	.	0.99948	0	.	.	0.99780	0	139562042	Y	10	0	.	.	P00740	.	0.971015	0.74962		.	1.0	D	.	0.9917848	.	0.71086	2158	0.73814	.	-12.84	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	0	Trp	478	.	X-139562042-T-C	Hereditary_factor_IX_deficiency_disease	.	.	138471867	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	.	.	.	RCV000011372	D	.	.	c.1357T>C	.	.	.	0.99967	./.	rs137852269	139562042	.	T	.	P00740	.	0.99934	.	0.68239		.	.	.	4.5	0	0	.	5.59	0.99684	0	D	T	.	.	0	0	.	.	.	98879	10628	0.99967	0.95501	0.999932289123535	426	.	0.71675	.	.	.	.	7.991	.	D	.	.	.	0	306900	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9998368683257477	1	0.97365	0.18019	.	.	.	.	.	YES	.	0.987685	25667	HGNC:3551	A	.	simple_aae	1	.	139562042	TGG	1.000000	.	-	0	0.99934	.	0	.	Pathogenic	0.98135	.	.	.	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	W	.	0.999744162249	-	0.983	-	0.98940	.	52	0.99983	0.792695641518	0.9806	.	0.99613210292578003	0	-	1357T>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48982	137852269	.	0	0.99974	.	0.926	0.0	426	0.99999380	5.59	.	.	.	0.82251	0.999834134473653	0.98957	D	0	.	.	1.0083	0.99569	p.Trp453Arg	0	.	-16.213	0.99427634	.	0.98239	10628	D	.	F9	.	D	0.984	.	W453R	D	.	0.62996	./.	principal1	260602	F9_Popp_2025_strep_2_var268917	No											W		1357	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Trp453Arg		true	c.1357T>C						3551.0	139562042.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											no assertion criteria provided				Trp453Arg						R	Sep 01, 1989					missense_variant		453.0				0.005218656		Pathogenic	139562042.0	missense_variant		0.984					Reporter			F9_Trp453Arg
F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004398		NC_000023.11:139562042:T:C		Trp453Arg																												F9_Trp453Arg	23	139562042	T	C	X	allele	1357T>C	H05	527_CAVA_Array_P02	O10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562042-T-C	-	0.80235	1.0	453	.	.	.	X	138644201	C	.	.	X	1_Pathogenic	NC_000023.11	.	Trp453Arg	.	27.3	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99918	Select	0.9857	.	0.90580	.	.	D	D	.	2.17286694384	0	.	.	.	.	0.80818	.	.	.	.	0.99834	.	.	0.99940	0.994	.	2.0	0.827517	.	0.98	C	single nucleotide variant	NC_000023.11:g.139562042T>C	.	.	1	0.99098927	.	0	0.9940456	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99989	D	H	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97321	.	.	-	139562042	.	-	7.901000	.	0.99985	.	0	.	.	germline	.	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.99835	GRCh38	924	no assertion criteria provided	c.1357T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)		.	FA9_HUMAN	.	98.0	.	.	T	0.94923	0.994228	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Trp453Arg	.	0.73593	.	germline	.		T	Sep 01, 1989	.	./.	.	.	1.0	N	Xq27.1	0	.	.	SCV000031604	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.886611	0.92967	.	D	-	.	.	0.99948	0	.	.	0.99780	0	139562042	Y	10	0	.	.	P00740	.	0.971015	0.74962		.	1.0	D	.	0.9917848	.	0.71086	2158	0.73814	.	-12.84	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	0	Trp	478	.	X-139562042-T-C	Hereditary_factor_IX_deficiency_disease	.	.	138471867	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	.	.	.	RCV000011372	D	.	.	c.1357T>C	.	.	.	0.99967	./.	rs137852269	139562042	.	T	.	P00740	.	0.99934	.	0.68239		.	.	.	4.5	0	0	.	5.59	0.99684	0	D	T	.	.	0	0	.	.	.	98879	10628	0.99967	0.95501	0.999932289123535	426	.	0.71675	.	.	.	.	7.991	.	D	.	.	.	0	306900	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9998368683257477	1	0.97365	0.18019	.	.	.	.	.	YES	.	0.987685	25667	HGNC:3551	A	.	simple_aae	1	.	139562042	TGG	1.000000	.	-	0	0.99934	.	0	.	Pathogenic	0.98135	.	.	.	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	W	.	0.999744162249	-	0.983	-	0.98940	.	52	0.99983	0.792695641518	0.9806	.	0.99613210292578003	0	-	1357T>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48982	137852269	.	0	0.99974	.	0.926	0.0	426	0.99999380	5.59	.	.	.	0.82251	0.999834134473653	0.98957	D	0	.	.	1.0083	0.99569	p.Trp453Arg	0	.	-16.213	0.99427634	.	0.98239	10628	D	.	F9	.	D	0.984	.	W453R	D	.	0.62996	./.	principal1	233086	F9_Popp_2025_light_chain_var249555	No											W		1357	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Trp453Arg		true	c.1357T>C						3551.0	139562042.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											no assertion criteria provided				Trp453Arg						R	Sep 01, 1989					missense_variant		453.0				0.005952112		Pathogenic	139562042.0	missense_variant		0.984					Reporter			F9_Trp453Arg
F9_Trp453Arg	-4.222977072156634	0.0055429861400118005	3.948697672762188	0.00554124463815655	2025_01_Batch_13-14	0.6795327325368467	0.7698384278762065	0.945990142142907	0.8354864060599599	0.7273285479599236	0.6864270152505447	0.9403539146154916	0.977922920031806	0.9169112565921076	0.8659477124183007	0.6829798738936956	0.855096171245849	0.9619565310873566	0.8761988313260338	0.7966381301891121	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC004398		NC_000023.11:139562042:T:C		Trp453Arg																												F9_Trp453Arg	23	139562042	T	C	X	allele	1357T>C	H05	527_CAVA_Array_P02	O10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562042-T-C	-	0.80235	1.0	453	.	.	.	X	138644201	C	.	.	X	1_Pathogenic	NC_000023.11	.	Trp453Arg	.	27.3	.	0	.	D	.	1	1	.	.	.	.	.	0	0.99918	Select	0.9857	.	0.90580	.	.	D	D	.	2.17286694384	0	.	.	.	.	0.80818	.	.	.	.	0.99834	.	.	0.99940	0.994	.	2.0	0.827517	.	0.98	C	single nucleotide variant	NC_000023.11:g.139562042T>C	.	.	1	0.99098927	.	0	0.9940456	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	.	.	0.99291	D	0.99989	D	H	.	.	./.	0	0	.	.	Hereditary factor IX deficiency disease	.	0.97321	.	.	-	139562042	.	-	7.901000	.	0.99985	.	0	.	.	germline	.	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.99835	GRCh38	924	no assertion criteria provided	c.1357T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)		.	FA9_HUMAN	.	98.0	.	.	T	0.94923	0.994228	+	.	.		.	.	0	.	no_assertion_criteria_provided	0.99996	.	.	.	.	.	p.Trp453Arg	.	0.73593	.	germline	.		T	Sep 01, 1989	.	./.	.	.	1.0	N	Xq27.1	0	.	.	SCV000031604	Pathogenic	.	.	Arg	R	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.665	T	.	4.886611	0.92967	.	D	-	.	.	0.99948	0	.	.	0.99780	0	139562042	Y	10	0	.	.	P00740	.	0.971015	0.74962		.	1.0	D	.	0.9917848	.	0.71086	2158	0.73814	.	-12.84	.	.	0.91343	.	.	.	.	.	.	0.99985	X	F9	.	0	Trp	478	.	X-139562042-T-C	Hereditary_factor_IX_deficiency_disease	.	.	138471867	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	.	.	.	RCV000011372	D	.	.	c.1357T>C	.	.	.	0.99967	./.	rs137852269	139562042	.	T	.	P00740	.	0.99934	.	0.68239		.	.	.	4.5	0	0	.	5.59	0.99684	0	D	T	.	.	0	0	.	.	.	98879	10628	0.99967	0.95501	0.999932289123535	426	.	0.71675	.	.	.	.	7.991	.	D	.	.	.	0	306900	0.87929	X	.	ENSG00000101981	.	0	.	0	0.9998368683257477	1	0.97365	0.18019	.	.	.	.	.	YES	.	0.987685	25667	HGNC:3551	A	.	simple_aae	1	.	139562042	TGG	1.000000	.	-	0	0.99934	.	0	.	Pathogenic	0.98135	.	.	.	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	W	.	0.999744162249	-	0.983	-	0.98940	.	52	0.99983	0.792695641518	0.9806	.	0.99613210292578003	0	-	1357T>C 	.	0	C0008533	.	.	.	.	NM_000133.4	-	.	.	1	0.48982	137852269	.	0	0.99974	.	0.926	0.0	426	0.99999380	5.59	.	.	.	0.82251	0.999834134473653	0.98957	D	0	.	.	1.0083	0.99569	p.Trp453Arg	0	.	-16.213	0.99427634	.	0.98239	10628	D	.	F9	.	D	0.984	.	W453R	D	.	0.62996	./.	principal1	205570	F9_Popp_2025_heavy_chain_var239874	No											W		1357	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Trp453Arg		true	c.1357T>C						3551.0	139562042.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											no assertion criteria provided				Trp453Arg						R	Sep 01, 1989					missense_variant		453.0				0.043974252		Pathogenic	139562042.0	missense_variant		0.984					Reporter			F9_Trp453Arg
F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14						0.8380546549952954	0.9175078848884123	0.9750516487562308	0.9037037095107087	0.8754010822333609						0.0			0.0		0.0	0.0	0.0	0.0		F9	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C		Ile316Thr																												F9_Ile316Thr	23	139561632	T	C	X	allele	947T>C	G10	527_CAVA_Array_P02	M20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561632-T-C	-	0.71151	1.0	316	.	.	.	X	138643791	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ile316Thr	.	25.6	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99783	Select	0.9553	.	0.90580	.	.	D	D	.	1.84500378867	0	.	.	.	.	0.49171	.	.	.	.	0.80975	.	.	0.99336	0.989	.	10.0	0.935206	4.99	0.9	C	single nucleotide variant	NC_000023.11:g.139561632T>C	.	.	2	0.9520444	.	0	0.9802627	0		.	.	.	.	.	146	.	0	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	.	.	.	.	0.92786	D	0.99308	D	H	.	.	T/T	84	0	.	.	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	.	0.99323	.	.	-	139561632	.	-	7.922000	.	0.99334	.	0	.	.	germline	.	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.99639	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.947T>C	.	0.83999	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2	.	FA9_HUMAN	.	90.0	.	.	D	0.75544	0.98325217	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Ile316Thr	.	0.74613	.	germline	.		T	Nov 13, 2023	.	T/T	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158649|SCV004571525|SCV005413449	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.609	T	.	4.529531	0.83643	.	D	-	.	.	0.99811	610	.	.	0.95690	0	139561632	Y	10	0	.	.	P00740	.	0.972778	0.93824		.	0.998	D	.	0.9668009	.	0.64309	2158	0.694692	.	-4.77	.	.	0.78662	.	.	.	.	.	.	0.98499	X	F9	.	0	Ile	10680	.	X-139561632-T-C	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138471457	.	.	.	.	RCV001001414|RCV003769385|RCV004792605	D	.	.	c.947T>C	.	.	.	0.99926	T/T	rs1603267344	139561632	.	T	.	P00740	.	0.99114	.	0.68239		.	.	.	3.94	0	0	264690	5.57	0.99714	108	D	T	.	.	0	24	.	.	.	98879	811502	0.99925	0.92182	0.998964428901672	2294	.	0.71675	.	.	.	.	7.647	.	D	.	.	7.5560088E-6	0	306900|300807	0.82668	X	.	ENSG00000101981	.	0	.	0	0.9996498989908393	2	0.88579	0.18019	.	2	.	.	.	YES	.	0.969256	800240	HGNC:3551	A	.	simple_aae	0.981	.	139561632	ATT	1.000000	.	-	0	0.99921	.	0	.	Pathogenic/Likely pathogenic	0.85599	.	.	.	ClinGen:CA414444900	I	.	0.999203327797	-	0.964	-	0.98575	.	466	0.99964	0.573964655399	0.5673	.	0.99859680176771604	94	-	947T>C 	.	0	CN169374|C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.78054	1603267344	.	0	0.99918	.	0.884	0.001	2210	0.99999190	5.57	.	.	.	0.7601	0.999656738398078	0.96320	D	84	.	.	1.0921	0.98549	p.Ile316Thr	0	.	-12.147	0.99409103	.	0.97351	811502	D	.	F9	.	D	0.976	.	I316T	D	0.89858	0.47831	T/T	principal1	197239	F9_Popp_2025_heavy_chain_var236991	No											I		947	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ile316Thr		true	c.947T>C						3551.0	139561632.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				Ile316Thr						T	Nov 13, 2023					missense_variant		316.0				0.049148476		Pathogenic/Likely pathogenic	139561632.0	missense_variant		0.976					Reporter			F9_Ile316Thr
F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14						0.8380546549952954	0.9175078848884123	0.9750516487562308	0.9037037095107087	0.8754010822333609						0.0			0.0		0.0	0.0	0.0	0.0		F9	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C		Ile316Thr																												F9_Ile316Thr	23	139561632	T	C	X	allele	947T>C	G10	527_CAVA_Array_P02	M20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561632-T-C	-	0.71151	1.0	316	.	.	.	X	138643791	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ile316Thr	.	25.6	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99783	Select	0.9553	.	0.90580	.	.	D	D	.	1.84500378867	0	.	.	.	.	0.49171	.	.	.	.	0.80975	.	.	0.99336	0.989	.	10.0	0.935206	4.99	0.9	C	single nucleotide variant	NC_000023.11:g.139561632T>C	.	.	2	0.9520444	.	0	0.9802627	0		.	.	.	.	.	146	.	0	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	.	.	.	.	0.92786	D	0.99308	D	H	.	.	T/T	84	0	.	.	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	.	0.99323	.	.	-	139561632	.	-	7.922000	.	0.99334	.	0	.	.	germline	.	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.99639	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.947T>C	.	0.83999	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2	.	FA9_HUMAN	.	90.0	.	.	D	0.75544	0.98325217	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Ile316Thr	.	0.74613	.	germline	.		T	Nov 13, 2023	.	T/T	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158649|SCV004571525|SCV005413449	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.609	T	.	4.529531	0.83643	.	D	-	.	.	0.99811	610	.	.	0.95690	0	139561632	Y	10	0	.	.	P00740	.	0.972778	0.93824		.	0.998	D	.	0.9668009	.	0.64309	2158	0.694692	.	-4.77	.	.	0.78662	.	.	.	.	.	.	0.98499	X	F9	.	0	Ile	10680	.	X-139561632-T-C	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138471457	.	.	.	.	RCV001001414|RCV003769385|RCV004792605	D	.	.	c.947T>C	.	.	.	0.99926	T/T	rs1603267344	139561632	.	T	.	P00740	.	0.99114	.	0.68239		.	.	.	3.94	0	0	264690	5.57	0.99714	108	D	T	.	.	0	24	.	.	.	98879	811502	0.99925	0.92182	0.998964428901672	2294	.	0.71675	.	.	.	.	7.647	.	D	.	.	7.5560088E-6	0	306900|300807	0.82668	X	.	ENSG00000101981	.	0	.	0	0.9996498989908393	2	0.88579	0.18019	.	2	.	.	.	YES	.	0.969256	800240	HGNC:3551	A	.	simple_aae	0.981	.	139561632	ATT	1.000000	.	-	0	0.99921	.	0	.	Pathogenic/Likely pathogenic	0.85599	.	.	.	ClinGen:CA414444900	I	.	0.999203327797	-	0.964	-	0.98575	.	466	0.99964	0.573964655399	0.5673	.	0.99859680176771604	94	-	947T>C 	.	0	CN169374|C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.78054	1603267344	.	0	0.99918	.	0.884	0.001	2210	0.99999190	5.57	.	.	.	0.7601	0.999656738398078	0.96320	D	84	.	.	1.0921	0.98549	p.Ile316Thr	0	.	-12.147	0.99409103	.	0.97351	811502	D	.	F9	.	D	0.976	.	I316T	D	0.89858	0.47831	T/T	principal1	224755	F9_Popp_2025_light_chain_var246672	No											I		947	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ile316Thr		true	c.947T>C						3551.0	139561632.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				Ile316Thr						T	Nov 13, 2023					missense_variant		316.0				0.006403476		Pathogenic/Likely pathogenic	139561632.0	missense_variant		0.976					Reporter			F9_Ile316Thr
F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14						0.8380546549952954	0.9175078848884123	0.9750516487562308	0.9037037095107087	0.8754010822333609						0.0			0.0		0.0	0.0	0.0	0.0		F9	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C		Ile316Thr																												F9_Ile316Thr	23	139561632	T	C	X	allele	947T>C	G10	527_CAVA_Array_P02	M20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561632-T-C	-	0.71151	1.0	316	.	.	.	X	138643791	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ile316Thr	.	25.6	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99783	Select	0.9553	.	0.90580	.	.	D	D	.	1.84500378867	0	.	.	.	.	0.49171	.	.	.	.	0.80975	.	.	0.99336	0.989	.	10.0	0.935206	4.99	0.9	C	single nucleotide variant	NC_000023.11:g.139561632T>C	.	.	2	0.9520444	.	0	0.9802627	0		.	.	.	.	.	146	.	0	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	.	.	.	.	0.92786	D	0.99308	D	H	.	.	T/T	84	0	.	.	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	.	0.99323	.	.	-	139561632	.	-	7.922000	.	0.99334	.	0	.	.	germline	.	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.99639	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.947T>C	.	0.83999	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2	.	FA9_HUMAN	.	90.0	.	.	D	0.75544	0.98325217	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Ile316Thr	.	0.74613	.	germline	.		T	Nov 13, 2023	.	T/T	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158649|SCV004571525|SCV005413449	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.609	T	.	4.529531	0.83643	.	D	-	.	.	0.99811	610	.	.	0.95690	0	139561632	Y	10	0	.	.	P00740	.	0.972778	0.93824		.	0.998	D	.	0.9668009	.	0.64309	2158	0.694692	.	-4.77	.	.	0.78662	.	.	.	.	.	.	0.98499	X	F9	.	0	Ile	10680	.	X-139561632-T-C	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138471457	.	.	.	.	RCV001001414|RCV003769385|RCV004792605	D	.	.	c.947T>C	.	.	.	0.99926	T/T	rs1603267344	139561632	.	T	.	P00740	.	0.99114	.	0.68239		.	.	.	3.94	0	0	264690	5.57	0.99714	108	D	T	.	.	0	24	.	.	.	98879	811502	0.99925	0.92182	0.998964428901672	2294	.	0.71675	.	.	.	.	7.647	.	D	.	.	7.5560088E-6	0	306900|300807	0.82668	X	.	ENSG00000101981	.	0	.	0	0.9996498989908393	2	0.88579	0.18019	.	2	.	.	.	YES	.	0.969256	800240	HGNC:3551	A	.	simple_aae	0.981	.	139561632	ATT	1.000000	.	-	0	0.99921	.	0	.	Pathogenic/Likely pathogenic	0.85599	.	.	.	ClinGen:CA414444900	I	.	0.999203327797	-	0.964	-	0.98575	.	466	0.99964	0.573964655399	0.5673	.	0.99859680176771604	94	-	947T>C 	.	0	CN169374|C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.78054	1603267344	.	0	0.99918	.	0.884	0.001	2210	0.99999190	5.57	.	.	.	0.7601	0.999656738398078	0.96320	D	84	.	.	1.0921	0.98549	p.Ile316Thr	0	.	-12.147	0.99409103	.	0.97351	811502	D	.	F9	.	D	0.976	.	I316T	D	0.89858	0.47831	T/T	principal1	142207	F9_Popp_2025_carboxy_F9_specific_var227310	No											I		947	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ile316Thr		true	c.947T>C						3551.0	139561632.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				Ile316Thr						T	Nov 13, 2023					missense_variant		316.0				0.008825945		Pathogenic/Likely pathogenic	139561632.0	missense_variant		0.976					Reporter			F9_Ile316Thr
F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14						0.8380546549952954	0.9175078848884123	0.9750516487562308	0.9037037095107087	0.8754010822333609						0.0			0.0		0.0	0.0	0.0	0.0		F9	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C		Ile316Thr																												F9_Ile316Thr	23	139561632	T	C	X	allele	947T>C	G10	527_CAVA_Array_P02	M20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561632-T-C	-	0.71151	1.0	316	.	.	.	X	138643791	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ile316Thr	.	25.6	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99783	Select	0.9553	.	0.90580	.	.	D	D	.	1.84500378867	0	.	.	.	.	0.49171	.	.	.	.	0.80975	.	.	0.99336	0.989	.	10.0	0.935206	4.99	0.9	C	single nucleotide variant	NC_000023.11:g.139561632T>C	.	.	2	0.9520444	.	0	0.9802627	0		.	.	.	.	.	146	.	0	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	.	.	.	.	0.92786	D	0.99308	D	H	.	.	T/T	84	0	.	.	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	.	0.99323	.	.	-	139561632	.	-	7.922000	.	0.99334	.	0	.	.	germline	.	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.99639	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.947T>C	.	0.83999	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2	.	FA9_HUMAN	.	90.0	.	.	D	0.75544	0.98325217	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Ile316Thr	.	0.74613	.	germline	.		T	Nov 13, 2023	.	T/T	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158649|SCV004571525|SCV005413449	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.609	T	.	4.529531	0.83643	.	D	-	.	.	0.99811	610	.	.	0.95690	0	139561632	Y	10	0	.	.	P00740	.	0.972778	0.93824		.	0.998	D	.	0.9668009	.	0.64309	2158	0.694692	.	-4.77	.	.	0.78662	.	.	.	.	.	.	0.98499	X	F9	.	0	Ile	10680	.	X-139561632-T-C	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138471457	.	.	.	.	RCV001001414|RCV003769385|RCV004792605	D	.	.	c.947T>C	.	.	.	0.99926	T/T	rs1603267344	139561632	.	T	.	P00740	.	0.99114	.	0.68239		.	.	.	3.94	0	0	264690	5.57	0.99714	108	D	T	.	.	0	24	.	.	.	98879	811502	0.99925	0.92182	0.998964428901672	2294	.	0.71675	.	.	.	.	7.647	.	D	.	.	7.5560088E-6	0	306900|300807	0.82668	X	.	ENSG00000101981	.	0	.	0	0.9996498989908393	2	0.88579	0.18019	.	2	.	.	.	YES	.	0.969256	800240	HGNC:3551	A	.	simple_aae	0.981	.	139561632	ATT	1.000000	.	-	0	0.99921	.	0	.	Pathogenic/Likely pathogenic	0.85599	.	.	.	ClinGen:CA414444900	I	.	0.999203327797	-	0.964	-	0.98575	.	466	0.99964	0.573964655399	0.5673	.	0.99859680176771604	94	-	947T>C 	.	0	CN169374|C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.78054	1603267344	.	0	0.99918	.	0.884	0.001	2210	0.99999190	5.57	.	.	.	0.7601	0.999656738398078	0.96320	D	84	.	.	1.0921	0.98549	p.Ile316Thr	0	.	-12.147	0.99409103	.	0.97351	811502	D	.	F9	.	D	0.976	.	I316T	D	0.89858	0.47831	T/T	principal1	252271	F9_Popp_2025_strep_2_var266034	No											I		947	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ile316Thr		true	c.947T>C						3551.0	139561632.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				Ile316Thr						T	Nov 13, 2023					missense_variant		316.0				0.037217651		Pathogenic/Likely pathogenic	139561632.0	missense_variant		0.976					Reporter			F9_Ile316Thr
F9_Ile316Thr	-4.807759772349099	0.002977039338873639	5.600629239460329	0.0008154137445087137	2025_01_Batch_13-14						0.8380546549952954	0.9175078848884123	0.9750516487562308	0.9037037095107087	0.8754010822333609						0.0			0.0		0.0	0.0	0.0	0.0		F9	F9		52861		CCSBVarC030590		NC_000023.11:139561632:T:C		Ile316Thr																												F9_Ile316Thr	23	139561632	T	C	X	allele	947T>C	G10	527_CAVA_Array_P02	M20	B13A7A8P1_R1	B14A7A8P1_R2				X-139561632-T-C	-	0.71151	1.0	316	.	.	.	X	138643791	C	.	.	X	1_Pathogenic	NC_000023.11	.	Ile316Thr	.	25.6	.	0	.	D	.	3	1	.	.	.	.	.	0	0.99783	Select	0.9553	.	0.90580	.	.	D	D	.	1.84500378867	0	.	.	.	.	0.49171	.	.	.	.	0.80975	.	.	0.99336	0.989	.	10.0	0.935206	4.99	0.9	C	single nucleotide variant	NC_000023.11:g.139561632T>C	.	.	2	0.9520444	.	0	0.9802627	0		.	.	.	.	.	146	.	0	MedGen:CN169374|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	.	.	.	.	0.92786	D	0.99308	D	H	.	.	T/T	84	0	.	.	not specified|Hereditary factor IX deficiency disease;Thrombophilia, X-linked, due to factor 9 defect|not provided	.	0.99323	.	.	-	139561632	.	-	7.922000	.	0.99334	.	0	.	.	germline	.	Loss of catalytic residue at L321 (P = 0.0518)| Loss of stability (P = 0.0585)| Gain of ubiquitination at K311 (P = 0.1106)| Loss of sheet (P = 0.1501)| Gain of disorder (P = 0.184)	0.99639	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.947T>C	.	0.83999	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	.	NM_000133.4(F9):c.947T>C (p.Ile316Thr)	2	.	FA9_HUMAN	.	90.0	.	.	D	0.75544	0.98325217	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	.	.	.	.	p.Ile316Thr	.	0.74613	.	germline	.		T	Nov 13, 2023	.	T/T	.	.	1.0	N	Xq27.1	6962	.	.	SCV001158649|SCV004571525|SCV005413449	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	.	ENSP00000218099	ENST00000218099	.	0.001	.	.	0.609	T	.	4.529531	0.83643	.	D	-	.	.	0.99811	610	.	.	0.95690	0	139561632	Y	10	0	.	.	P00740	.	0.972778	0.93824		.	0.998	D	.	0.9668009	.	0.64309	2158	0.694692	.	-4.77	.	.	0.78662	.	.	.	.	.	.	0.98499	X	F9	.	0	Ile	10680	.	X-139561632-T-C	not_specified|Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	.	.	138471457	.	.	.	.	RCV001001414|RCV003769385|RCV004792605	D	.	.	c.947T>C	.	.	.	0.99926	T/T	rs1603267344	139561632	.	T	.	P00740	.	0.99114	.	0.68239		.	.	.	3.94	0	0	264690	5.57	0.99714	108	D	T	.	.	0	24	.	.	.	98879	811502	0.99925	0.92182	0.998964428901672	2294	.	0.71675	.	.	.	.	7.647	.	D	.	.	7.5560088E-6	0	306900|300807	0.82668	X	.	ENSG00000101981	.	0	.	0	0.9996498989908393	2	0.88579	0.18019	.	2	.	.	.	YES	.	0.969256	800240	HGNC:3551	A	.	simple_aae	0.981	.	139561632	ATT	1.000000	.	-	0	0.99921	.	0	.	Pathogenic/Likely pathogenic	0.85599	.	.	.	ClinGen:CA414444900	I	.	0.999203327797	-	0.964	-	0.98575	.	466	0.99964	0.573964655399	0.5673	.	0.99859680176771604	94	-	947T>C 	.	0	CN169374|C0008533|C2749016	.	.	.	.	NM_000133.4	-	.	.	1	0.78054	1603267344	.	0	0.99918	.	0.884	0.001	2210	0.99999190	5.57	.	.	.	0.7601	0.999656738398078	0.96320	D	84	.	.	1.0921	0.98549	p.Ile316Thr	0	.	-12.147	0.99409103	.	0.97351	811502	D	.	F9	.	D	0.976	.	I316T	D	0.89858	0.47831	T/T	principal1	169723	F9_Popp_2025_carboxy_gla_motif_var256353	No											I		947	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ile316Thr		true	c.947T>C						3551.0	139561632.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				Ile316Thr						T	Nov 13, 2023					missense_variant		316.0				0.0233977835246009		Pathogenic/Likely pathogenic	139561632.0	missense_variant		0.976					Reporter			F9_Ile316Thr
BRCA1_Glu455Lys	-0.7002018322598149	0.5063990015883388	-8.447337291706042	0.00006429500751423078	2025_01_Batch_13-14	0.8265669894377499	0.9153739121502169	0.9888722334786625	0.9392603930163101	0.9493802375316499	0.665053456627972	0.8656269708209633	0.9909752059810135	0.9331208421321344	0.9317151446696804	0.7458102230328609	0.8905004414855902	0.9899237197298381	0.9361906175742223	0.9405476911006652	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	BRCA1	BRCA1		14613		CCSBVarC011868		NC_000017.11:43074331:C:T		Glu455Lys																												BRCA1_Glu455Lys	17	43074331	C	T	17	allele	1363G>A	A10	527_CAVA_Array_P01	A19	B13A7A8P1_R1	B14A7A8P1_R2				17-43074331-C-T	-	0.95486	0.011	1559	.	0	.	17	41226348	T	1.239380e-06	.	17	1_Pathogenic	NC_000017.11	1	Glu1559Lys	.	35.0	.	0	.	D	0	16	1	.	.	.	.	.	0	0.92017	.	0.5963	.	0.43580	.	.	T	D	64026	.	0	0	.	.	.	0.17650	.	44886	0	.	0.37944	.	.	0.35225	0.995	.	.	.	3.53	.	T	single nucleotide variant	NC_000017.11:g.43074331C>T	0	.	2	0.16500245	.	0	0.16502066	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	.	.	0.000000e+00	0	0.99291	B	0.38009	B	L	3.256703	2	C/C	0	0	.	1613716	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	.	0.80692	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43074331	.	-	5.613000	.	0.90686	29604	0	64026	.	germline;unknown	91074	.	.	GRCh38	534	reviewed by expert panel	.	.	0.82883	2	.	.	.	.	.	.	0	0.000000e+00	NM_007294.4(BRCA1):c.4675G>A (p.Glu1559Lys)	3	.	BRCA1_HUMAN	.	.	0.189406980124867	.	.	0.39417	0.15768379	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99146	.	0	.	.	59978	.	0	0.49136	.	germline	.		c	Jun 18, 2019	.	C/C	.	.	0.985	N	17q21.31	20546	.	.	SCV001161548	Pathogenic	.	.	Lys	K	-	912	ENSP00000419274	ENST00000470026	.	.	.	.	0.591	C	.	6.609515	0.74454	D	.	-	3.957668	.	0.98855	0	.	.	0.50935	0	43074331	Y	9	0	.	0.000000e+00	P38398	.	0.166952	0.92321		.	0.006	D	.	0.16464907	.	0.73271	672	0.26768	1	.	.	1.561870e-05	0.68399	.	.	74882	.	6080	.	0.38072	17	BRCA1	0.000000e+00	0	Glu	21304	.	17-43074331-C-T	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	0	.	38479874	ClinGen:CA002963	0.733049	0.50447	0	RCV000031185|RCV000131823|RCV000496604|RCV000482921	.	0	.	c.4675G>A	.	0	1	0.80087	C/C	rs80356988	43074331	.	C	.	.	.	0.36448	.	0.68239		.	.	0.000000e+00	1.75	0	2	.	5.54	0.51091	44	D	T	.	.	0	0	.	.	.	140162|145|145	37604	0.79829	0.11248	0.861642837524414	426	.	0.36067	0.67845	.	.	1179808	3.38	.	.	.	.	.	0	604370	0.52274	17	.	ENSG00000012048	1.561870e-05	9.734254842791784E-5	.	0	.	1	0.35928	0.73376	.	.	.	0.000000e+00	0.339873231586349	.	0.000000e+00	0.851739	46160	HGNC:1100	.	.	.	0.831	.	43074331	GAG	1.000000	.	-	0	0.70725	8.475960e-07	0	0	Pathogenic	0.26211	.	0	0	ClinGen:CA002963	E	.	.	-	.	-	0.78942	.	288	0.33367	0.348278313875	.	0	0.9984248885113004	0	-	4675G>A 	.	0	C3661900|C0027672|C2676676|C0677776	.	.	.	.	NM_007294.4	-	.	.	1	0.48225	80356988	.	9.38790837401427E-5	0.80535	0.57676	.	.	426	0.99910450	5.54	.	.	.	0.146727	0.95000846091201	0.45271	T	44	.	.	-0.0701	0.85548	p.Glu1559Lys	0	0	-3.995	.	0	0.80446	37604	T	.	BRCA1	.	D	.	.	.	.	0.64053	0.32125	C/C	principal2																																																																																																				
RAD51D_Val66Leu	3.332290913702663	0.01255158257903223	1.740539247119287	0.1253102833057257	2025_01_Batch_13-14	0.7368980398348188	0.8389360038622496	0.7995719693817023	0.8769572018758964	0.6571225292527669	0.4735135380022462	0.6069124412868073	0.6694074919314468	0.6884580734740696	0.49921612075738153	0.6052057889185325	0.7229242225745285	0.7344897306565745	0.7827076376749831	0.5781693250050742	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024807		NC_000017.11:35118568:C:A		Val66Leu																												RAD51D_Val66Leu	17	35118568	C	A	17	allele	196G>T	H12	527_CAVA_Array_P04	P24	B13A7A8P1_R1	B14A7A8P1_R2				17-35118568-C-A	-	0.06924	0.0	66	.	0	.	17	33445587	A	1.239020e-06	.	17	3_Conflicting	NC_000017.11	1	Val66Leu	.	3.434	.	0	.	T	0	5	1	.	.	.	.	.	0	0.13183	Select	0.0520	.	0.02950	.	.	T	T	64024	.	0	0	.	.	.	.	.	44872	0	.	0.06455	.	.	0.19601	0.443	.	94.0	.	-5.85	0.06	A	single nucleotide variant	NC_000017.11:g.35118568C>A	0	.	2	0.0358917	.	0	0.08530245	0		.	.	.	.	.	442	.	0	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	0.000000e+00	0	0.18971	B	0.02939	B	N	0.1402777	2	C/C	176	0	.	1614178	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	.	0.14873	.	.	-	35118568	.	-	0.681000	.	0.00522	29608	0	75058	.	germline	91078	Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Loss of catalytic residue at V66 (P = 0.2378)| Gain of disorder (P = 0.3398)| Gain of loop (P = 0.3485)	0.61027	GRCh38	926	criteria provided, conflicting classifications	c.196G>T	.	0.12675	0	.	.	.	.	.	LB	0	0.000000e+00	NM_002878.4(RAD51D):c.196G>T (p.Val66Leu)	1	.	RA51D_HUMAN	.	6.0	-1.34751807488594	.	.	0.29891	0.08530245	-	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.87977	.	0	.	.	60016	p.Val66Leu	0	0.20762	.	germline	.		C	Oct 24, 2024	.	C/C	.	.	0.001	N	17q12	153016	.	.	SCV000567624|SCV001570603|SCV001734195|SCV002721596|SCV005641837	Conflicting_classifications_of_pathogenicity	.	.	Leu	L	-	912	ENSP00000338790	ENST00000345365	.	0.831	.	.	-1.926	C	.	0.314705	0.11871	N	T	-	0.2641167	.	0.23404	950	.	.	0.18410	0	35118568	Y	10	0	.	0.000000e+00	O75771	.	0.112411	0.14047		.	0.004	T	.	0.0358917	.	0.27788	5892	-0.25802	0	0.04	.	1.332300e-05	0.13644	.	.	75058	.	6062	.	0.02939	17	RAD51D	1.332300e-05	0	Val	177652	.	17-35118568-C-A	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	.	30469700	ClinGen:CA16620388	0.088102	0.03118	0	RCV000484401|RCV001373871|RCV001524373	T	0	.	c.196G>T	.	0	0	0.12873	C/C	rs56026142	35118568	.	C	.	O75771	.	0.19601	.	0.24998		.	.	0.000000e+00	-0.185	0	0	.	-0.163	0.42566	6346	T	.	.	.	0	1848	.	.	.	140162|145	419663	0.11857	.	0.170912176370621	4900	.	0.13799	0.17661	.	.	1180038	0.004	.	N	.	.	.	0	614291	0.13047	17	.	ENSG00000185379	0.000000e+00	0	.	0	.	1	0.10086	0.17784	.	.	.	0.000000e+00	-1.22328831331821	YES	0.000000e+00	0.008992	409903	HGNC:9823	N	.	simple_aae	0.009	.	35118568	GTG	0.444000	.	-	0	0.06602	0.000000e+00	0	0	Conflicting classifications of pathogenicity	0.26677	.	0	0	ClinGen:CA16620388	V	.	0.394990421082	-	0.513	-	0.17177	.	11718	.	.	0.1367	0	0.81722106588712895	280	-	196G>T 	.	0	C3661900|C0027672|C3280345	.	.	.	.	NM_002878.4	-	.	.	0	0.24645	56026142	.	0	0.38713	0.05450	0.164	0.486	4724	0.78514117	4.79	.	.	.	-0.608404	1.88384050960672e-05	0.04240	T	4498	.	.	-1.0483	0.21919	p.Val66Leu	0	0	-4.193	0.057495058	1	0.00991	419663	T	.	RAD51D	.	T	0.048	.	V66L	T	0.03264	0.00504	C/C	principal1	962163	RAD51D_unpublished_var156410	Yes						overall function		Cell survival			V		196	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Val66Leu		true	c.196G>T						9823.0	35118568.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		T									criteria provided, conflicting classifications				Val66Leu						L	Aug 10, 2023					missense_variant		66.0	G		1.2390207275e-6	0.0187496		Conflicting classifications of pathogenicity	35118568.0	missense_variant		0.048	functionally_normal				Cell viability			RAD51D_Val66Leu
RAD51D_Val66Leu	3.332290913702663	0.01255158257903223	1.740539247119287	0.1253102833057257	2025_01_Batch_13-14	0.7368980398348188	0.8389360038622496	0.7995719693817023	0.8769572018758964	0.6571225292527669	0.4735135380022462	0.6069124412868073	0.6694074919314468	0.6884580734740696	0.49921612075738153	0.6052057889185325	0.7229242225745285	0.7344897306565745	0.7827076376749831	0.5781693250050742	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024807	ALE00021596	NC_000017.11:35118568:C:A	196G>T	Val66Leu	CAVA																											RAD51D_Val66Leu	17	35118568	C	A	17								1	1	1	17-35118568-C-A	-	0.06924	0.0	66	.	0	.	17	33445587	A	1.239020e-06	.	17	3_Conflicting	NC_000017.11	1	Val66Leu	.	3.434	.	0	.	T	0	5	1	.	.	.	.	.	0	0.13183	Select	0.0520	.	0.02950	.	.	T	T	64024	.	0	0	.	.	.	.	.	44872	0	.	0.06455	.	.	0.19601	0.443	.	94.0	.	-5.85	0.06	A	single nucleotide variant	NC_000017.11:g.35118568C>A	0	.	2	0.0358917	.	0	0.08530245	0		.	.	.	.	.	442	.	0	MedGen:C3661900|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	.	.	0.000000e+00	0	0.18971	B	0.02939	B	N	0.1402777	2	C/C	176	0	.	1614178	not provided|Breast-ovarian cancer, familial, susceptibility to, 4|Hereditary cancer-predisposing syndrome	.	0.14873	.	.	-	35118568	.	-	0.681000	.	0.00522	29608	0	75058	.	germline	91078	Gain of helix (P = 0.1736)| Loss of sheet (P = 0.1907)| Loss of catalytic residue at V66 (P = 0.2378)| Gain of disorder (P = 0.3398)| Gain of loop (P = 0.3485)	0.61027	GRCh38	926	criteria provided, conflicting classifications	c.196G>T	.	0.12675	0	.	.	.	.	.	LB	0	0.000000e+00	NM_002878.4(RAD51D):c.196G>T (p.Val66Leu)	1	.	RA51D_HUMAN	.	6.0	-1.34751807488594	.	.	0.29891	0.08530245	-	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.87977	.	0	.	.	60016	p.Val66Leu	0	0.20762	.	germline	.		C	Oct 24, 2024	.	C/C	.	.	0.001	N	17q12	153016	.	.	SCV000567624|SCV001570603|SCV001734195|SCV002721596|SCV005641837	Conflicting_classifications_of_pathogenicity	.	.	Leu	L	-	912	ENSP00000338790	ENST00000345365	.	0.831	.	.	-1.926	C	.	0.314705	0.11871	N	T	-	0.2641167	.	0.23404	950	.	.	0.18410	0	35118568	Y	10	0	.	0.000000e+00	O75771	.	0.112411	0.14047		.	0.004	T	.	0.0358917	.	0.27788	5892	-0.25802	0	0.04	.	1.332300e-05	0.13644	.	.	75058	.	6062	.	0.02939	17	RAD51D	1.332300e-05	0	Val	177652	.	17-35118568-C-A	not_provided|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	0	.	30469700	ClinGen:CA16620388	0.088102	0.03118	0	RCV000484401|RCV001373871|RCV001524373	T	0	.	c.196G>T	.	0	0	0.12873	C/C	rs56026142	35118568	.	C	.	O75771	.	0.19601	.	0.24998		.	.	0.000000e+00	-0.185	0	0	.	-0.163	0.42566	6346	T	.	.	.	0	1848	.	.	.	140162|145	419663	0.11857	.	0.170912176370621	4900	.	0.13799	0.17661	.	.	1180038	0.004	.	N	.	.	.	0	614291	0.13047	17	.	ENSG00000185379	0.000000e+00	0	.	0	.	1	0.10086	0.17784	.	.	.	0.000000e+00	-1.22328831331821	YES	0.000000e+00	0.008992	409903	HGNC:9823	N	.	simple_aae	0.009	.	35118568	GTG	0.444000	.	-	0	0.06602	0.000000e+00	0	0	Conflicting classifications of pathogenicity	0.26677	.	0	0	ClinGen:CA16620388	V	.	0.394990421082	-	0.513	-	0.17177	.	11718	.	.	0.1367	0	0.81722106588712895	280	-	196G>T 	.	0	C3661900|C0027672|C3280345	.	.	.	.	NM_002878.4	-	.	.	0	0.24645	56026142	.	0	0.38713	0.05450	0.164	0.486	4724	0.78514117	4.79	.	.	.	-0.608404	1.88384050960672e-05	0.04240	T	4498	.	.	-1.0483	0.21919	p.Val66Leu	0	0	-4.193	0.057495058	1	0.00991	419663	T	.	RAD51D	.	T	0.048	.	V66L	T	0.03264	0.00504	C/C	principal1	962163	RAD51D_unpublished_var156410	Yes						overall function		Cell survival			V		196	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Val66Leu		true	c.196G>T						9823.0	35118568.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		T									criteria provided, conflicting classifications				Val66Leu						L	Aug 10, 2023					missense_variant		66.0	G		1.2390207275e-6	0.0187496		Conflicting classifications of pathogenicity	35118568.0	missense_variant		0.048	functionally_normal				Cell viability			RAD51D_Val66Leu
BRCA1_Lys502Glu	0.8105603126478718	0.44429777323077857	4.989655621459293	0.0015836344442593491	2025_01_Batch_13-14	0.8872472228434506	0.8853565853297606	0.883380119926835	0.940891248085023	0.7309200947844363	0.8760282906814945	0.834676051235093	0.8217419276734688	0.8994130753199278	0.762667311487012	0.8816377567624725	0.8600163182824268	0.8525610238001519	0.9201521617024754	0.7467937031357241	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1	ENSG00000012048	14613	218418	CCSBVarC003301	ALE00003301	NC_000017.11:43071098:T:C	1504A>G	Lys502Glu	CEGS2	CegsMutGDEh1026	D01	GDEhDisVCh_40059	H08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0		0			0			0			BRCA1_Lys502Glu	17	43071098	T	C	17											17-43071098-T-C	-	0.24404	0.0	1606	5	0	0	17	41223115	C	3.097920e-05	0	17	2_Benign	NC_000017.11	45	Lys1606Glu	0	16.37	0	1	6.817830e-05	T	0	16	1	42768	2.955230e-05	.	30526	0.000000e+00	0	0.75894	.	0.4017	102672	0.02950	0	.	T	D	64032	.	1.271617497456765E-4	0	0.000000e+00	0	0	0.04893	17112	44898	0	0.000000e+00	0.10767	3	.	0.22901	0.007	.	.	0.852615	3.03	.	C	single nucleotide variant	NC_000017.11:g.43071098T>C	0	16732	2	0.07730816	109406	0	0.096304744	0	C	5	236868	0	0	0.000000e+00	146	7.014590e-05	0	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	3	0	0.000000e+00	0	0.99291	B	0.22003	B	N	0.4834715	50	T/T	298	0	7164	1613986	Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	16218	0.66897	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43071098	7.014590e-05	-	6.225000	0	0.10339	29606	0	1180018	0	germline;unknown	91082	.	.	GRCh38	543	reviewed by expert panel	.	0.000000e+00	0.32534	2	0	0	.	0.000000e+00	9046	.	0	0.000000e+00	NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	3	0	BRCA1_HUMAN	0	.	-0.929974890242364	0	D	0.04993	0.09800102	-	0.000000e+00	.	0.0000321515	5	0.000000e+00	0	34260	reviewed_by_expert_panel	0.98290	2.742080e-05	0	0.000000e+00	0	59958	.	0	0.55234	.	germline	3	43071098	T	Jun 18, 2019	0	T/T	0	89554	0.492	N	17q21.31	19780	.	0.000000e+00	SCV001161595	Benign	0	0	Glu	E	-	912	ENSP00000478114	ENST00000618469	17692	.	13416	0	-0.114	T	0	1.918289	0.49207	N	.	-	0.6474283	.	0.88048	610	0	.	0.12918	0	43071098	Y	10	0	102672	0.000000e+00	P38398	0	0.098826	0.21378	T	0	0.0	D	89554	0.09333296	42768	0.07843	672	0.0938011	45	.	.	3.813500e-05	0.72322	0.000000e+00	0	74914	0.000000e+00	6084	0	0.17192	17	BRCA1	1.334860e-05	0	Lys	30890	5.583220e-05	17-43071098-T-C	BRCA1-related_disorder|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	0	7	38476641	ClinGen:CA003037|UniProtKB:P38398#VAR_007790	0.169829	0.10024	0	RCV000048668|RCV000436368|RCV000735492|RCV000130005|RCV004554630|RCV000031193|RCV001281714	.	0	0	c.4816A>G	0	0	0	0.63355	T/T	rs80356943	43071098	14902	T	.	.	15690	0.22477	0.000000e+00	0.68239	17	0	0	0.000000e+00	0	0	1	264690	2.88	0.40015	112	T	T	0	0.000000e+00	0	26	.	0	0	145|140162|145	37612	0.75211	0.12617	0.106747360008648	8162	.	0.26984	0.29455	0.000000e+00	5.583220e-05	1180018	2.465	2.402340e-05	.	13392	0	2.2668026E-5	0	604370	0.44835	17	0.000000e+00	ENSG00000012048	0.000000e+00	5.0556117290192114E-5	0	0	.	1	0.01384	0.72771	30608	6	6.817830e-05	0.000000e+00	-0.879878298600479	.	0.000000e+00	0.227152	46168	HGNC:1100	.	0	.	0.042	208130	43071098	AAA	1.000000	.	-	1.2251899044351874E-4	0.37017	3.813500e-05	1	0	Benign	0.10842	0	0	0	ClinGen:CA003037,UniProtKB:P38398#VAR_007790	K	0	.	-	.	-	0.28302	7	1982	0.16602	0.260015904903	.	0	0.91817812478712357	98	-	4816A>G 	7	0	CN169374|C0677776|CN221562|C0027672|C3661900|C2676676	0	0	0	0	NM_007294.4	-	.	.	0	0.53662	80356943	2320	6.474587245063128E-5	0.58443	0.12355	.	.	7864	0.99718000	4.92	.	.	0.000000e+00	0.0772584	0.00105470856972761	0.06502	T	86	6212	9572	-0.5432	0.75178	p.Lys1606Glu	0	0	-3.059	.	1	0.09785	37612	T	30524	BRCA1	0.000000e+00	D	.	21630	.	.	0.55386	0.14662	T/T	principal2																																																																																																				
BRCA1_Lys502Glu	0.8105603126478718	0.44429777323077857	4.989655621459293	0.0015836344442593491	2025_01_Batch_13-14	0.8872472228434506	0.8853565853297606	0.883380119926835	0.940891248085023	0.7309200947844363	0.8760282906814945	0.834676051235093	0.8217419276734688	0.8994130753199278	0.762667311487012	0.8816377567624725	0.8600163182824268	0.8525610238001519	0.9201521617024754	0.7467937031357241	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC003301		NC_000017.11:43071098:T:C		Lys502Glu																												BRCA1_Lys502Glu	17	43071098	T	C	17	allele	1504A>G	B07	527_CAVA_Array_P01	C13	B13A7A8P1_R1	B14A7A8P1_R2				17-43071098-T-C	-	0.24404	0.0	1606	5	0	0	17	41223115	C	3.097920e-05	0	17	2_Benign	NC_000017.11	45	Lys1606Glu	0	16.37	0	1	6.817830e-05	T	0	16	1	42768	2.955230e-05	.	30526	0.000000e+00	0	0.75894	.	0.4017	102672	0.02950	0	.	T	D	64032	.	1.271617497456765E-4	0	0.000000e+00	0	0	0.04893	17112	44898	0	0.000000e+00	0.10767	3	.	0.22901	0.007	.	.	0.852615	3.03	.	C	single nucleotide variant	NC_000017.11:g.43071098T>C	0	16732	2	0.07730816	109406	0	0.096304744	0	C	5	236868	0	0	0.000000e+00	146	7.014590e-05	0	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	3	0	0.000000e+00	0	0.99291	B	0.22003	B	N	0.4834715	50	T/T	298	0	7164	1613986	Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	16218	0.66897	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43071098	7.014590e-05	-	6.225000	0	0.10339	29606	0	1180018	0	germline;unknown	91082	.	.	GRCh38	543	reviewed by expert panel	.	0.000000e+00	0.32534	2	0	0	.	0.000000e+00	9046	.	0	0.000000e+00	NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	3	0	BRCA1_HUMAN	0	.	-0.929974890242364	0	D	0.04993	0.09800102	-	0.000000e+00	.	0.0000321515	5	0.000000e+00	0	34260	reviewed_by_expert_panel	0.98290	2.742080e-05	0	0.000000e+00	0	59958	.	0	0.55234	.	germline	3	43071098	T	Jun 18, 2019	0	T/T	0	89554	0.492	N	17q21.31	19780	.	0.000000e+00	SCV001161595	Benign	0	0	Glu	E	-	912	ENSP00000478114	ENST00000618469	17692	.	13416	0	-0.114	T	0	1.918289	0.49207	N	.	-	0.6474283	.	0.88048	610	0	.	0.12918	0	43071098	Y	10	0	102672	0.000000e+00	P38398	0	0.098826	0.21378	T	0	0.0	D	89554	0.09333296	42768	0.07843	672	0.0938011	45	.	.	3.813500e-05	0.72322	0.000000e+00	0	74914	0.000000e+00	6084	0	0.17192	17	BRCA1	1.334860e-05	0	Lys	30890	5.583220e-05	17-43071098-T-C	BRCA1-related_disorder|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	0	7	38476641	ClinGen:CA003037|UniProtKB:P38398#VAR_007790	0.169829	0.10024	0	RCV000048668|RCV000436368|RCV000735492|RCV000130005|RCV004554630|RCV000031193|RCV001281714	.	0	0	c.4816A>G	0	0	0	0.63355	T/T	rs80356943	43071098	14902	T	.	.	15690	0.22477	0.000000e+00	0.68239	17	0	0	0.000000e+00	0	0	1	264690	2.88	0.40015	112	T	T	0	0.000000e+00	0	26	.	0	0	145|140162|145	37612	0.75211	0.12617	0.106747360008648	8162	.	0.26984	0.29455	0.000000e+00	5.583220e-05	1180018	2.465	2.402340e-05	.	13392	0	2.2668026E-5	0	604370	0.44835	17	0.000000e+00	ENSG00000012048	0.000000e+00	5.0556117290192114E-5	0	0	.	1	0.01384	0.72771	30608	6	6.817830e-05	0.000000e+00	-0.879878298600479	.	0.000000e+00	0.227152	46168	HGNC:1100	.	0	.	0.042	208130	43071098	AAA	1.000000	.	-	1.2251899044351874E-4	0.37017	3.813500e-05	1	0	Benign	0.10842	0	0	0	ClinGen:CA003037,UniProtKB:P38398#VAR_007790	K	0	.	-	.	-	0.28302	7	1982	0.16602	0.260015904903	.	0	0.91817812478712357	98	-	4816A>G 	7	0	CN169374|C0677776|CN221562|C0027672|C3661900|C2676676	0	0	0	0	NM_007294.4	-	.	.	0	0.53662	80356943	2320	6.474587245063128E-5	0.58443	0.12355	.	.	7864	0.99718000	4.92	.	.	0.000000e+00	0.0772584	0.00105470856972761	0.06502	T	86	6212	9572	-0.5432	0.75178	p.Lys1606Glu	0	0	-3.059	.	1	0.09785	37612	T	30524	BRCA1	0.000000e+00	D	.	21630	.	.	0.55386	0.14662	T/T	principal2																																																																																																				
RHO_Asp190Gly	-2.929431263260496	0.022042111608632748	-16.30915772533287	7.936833693923803e-7	2025_01_Batch_13-14	0.7833410739468739	0.973871326723488	0.9993510763772249	0.9976678451985929	0.9739839064032518	0.7636426303341604	0.9795315278480028	0.9995586420580448	0.9983459299136886	0.98020196728197	0.7734918521405172	0.9767014272857454	0.9994548592176349	0.9980068875561408	0.9770929368426109	0.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	RHO	RHO		40080645		CCSBVarC013544		NC_000003.12:129532289:A:G		Asp190Gly																												RHO_Asp190Gly	3	129532289	A	G	3	allele	569A>G	F09	527_CAVA_Array_P05	K17	B13A7A8P2_R1	B14A7A8P2_R2				3-129532289-A-G	-	0.79269	0.754	190	.	.	.	3	129251132	G	.	.	3	1_Pathogenic	NC_000003.12	.	Asp190Gly	.	27.1	.	0	.	T	.	5	1	.	.	.	.	.	0	0.87421	Select	0.3223	.	0.43372	.	.	D	D	.	0.888851575013	0	.	.	.	.	0.75160	.	.	.	.	0.86945	.	.	0.99559	0.259	.	7.0	0.983802	.	0.93	G	single nucleotide variant	NC_000003.12:g.129532289A>G	.	.	3	0.97526824	.	0	0.9865587	0		.	.	.	.	.	0	.	0	MONDO:MONDO:0013395,MedGen:C3151001,OMIM:613731,Orphanet:791|MedGen:C3661900|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	.	.	.	.	0.93829	P	0.99667	P	H	4.438596	.	A/A	0	0	.	.	Retinitis pigmentosa 4|not provided|Retinal dystrophy	.	0.80024	.	.	-	129532289	.	-	11.251000	.	0.98360	.	0	.	.	germline	.	Loss of ubiquitination at K195 (P = 0.0596)| Gain of catalytic residue at G188 (P = 0.097)| Loss of stability (P = 0.1082)| Gain of sheet (P = 0.1208)| Gain of methylation at K195 (P = 0.1246)	0.99098	GRCh38	511	criteria provided, multiple submitters, no conflicts	c.569A>G	.	0.45905	0	.	.	GPCR, rhodopsin-like, 7TM	.	.	P	0	.	NM_000539.3(RHO):c.569A>G (p.Asp190Gly)	2	.	OPSD_HUMAN	.	93.0	0.415179912855261	.	D	0.92535	0.9865587	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99752	.	.	.	.	.	p.Asp190Gly	.	0.90759	.	germline	.		A	Oct 01, 2023	.	A/A	.	.	1.0	N	3q22.1	78	.	.	SCV001587465|SCV004705665	Pathogenic/Likely_pathogenic	.	.	Gly	G	-	.	ENSP00000296271	ENST00000296271	.	0.001	.	.	-0.083	A	.	4.848578	0.60067	D	D	-	3.822499	.	0.86214	0	.	.	0.88134	0	129532289	Y	9	0	.	.	P08100	.	0.836933	0.83425		.	0.826	D	.	0.97526824	.	0.23539	6010	0.326972	.	-5.64	.	.	0.78662	.	.	.	.	.	.	0.99668	3	RHO	.	0	Asp	658	.	3-129532289-A-G	not_provided|Retinitis_pigmentosa_4|Retinal_dystrophy	.	.	130733822	ClinGen:CA256673|OMIM:180380.0014|UniProtKB:P08100#VAR_004814	0.915171	0.62061	.	RCV000013900|RCV001386998|RCV003887863	D	.	.	c.569A>G	.	.	.	0.84848	A/A	rs104893777	129532289	.	A	.	P08100	.	0.99559	.	0.68239		.	.	.	3.785	0	0	.	4.02	0.96131	34	D	T	.	.	0	0	.	.	.	791|71862	13026	0.84650	0.69945	0.995872437953949	434	.	0.71675	0.87913	.	.	.	9.32	.	D	.	.	.	0	613731	0.95493	3	.	ENSG00000163914	.	0	.	0	0.9390784996612188	2	0.59366	0.75154	.	.	.	.	0.317870176801044	YES	.	0.192539	28065	HGNC:10012	A	.	simple_aae	0.961	.	129532289	GAC	1.000000	.	-	0	0.99365	.	0	.	Pathogenic/Likely pathogenic	0.91898	.	.	.	ClinGen:CA256673,UniProtKB:P08100#VAR_004814,OMIM:180380.0014	D	.	0.775995073384	-	0.937	-	0.99866	.	106	0.93850	0.75512355566	0.9863	.	0.99740077491250712	6	-	569A>G 	.	0	C3661900|C3151001|C0854723	.	.	.	.	NM_000539.3	-	.	.	1	0.94524	104893777	.	0	0.77216	0.56361	0.993	0.018	434	0.99981183	5.19	.	.	.	0.231896	0.999678264541609	0.95215	T	34	.	.	-0.0993	0.68995	p.Asp190Gly	0	.	-13.655	0.9891775	.	0.97434	13026	D	.	RHO	.	D	0.664	.	D190G	D	.	0.16243	A/A	principal1	999387	RHO_Wan_2019_var220594	No						cell surface expression		Fluorescence			D		569	RHO_Wan_2019		ENST00000296271.4							immortalized human cells					p.Asp190Gly		true	c.569A>G						10012.0	129532289.0	No		RHO				NM_000539.3		1.0	urn:mavedb:00000099-a-1		nucleotide		G									criteria provided, multiple submitters, no conflicts				Asp190Gly						G	Oct 01, 2023					missense_variant		190.0	A			0.2641042882582283		Pathogenic/Likely pathogenic	129532289.0	missense_variant		0.664					Reporter			RHO_Asp190Gly
BAP1_Pro12Thr	1.2327266947006599	0.2574688649083334	-4.423763667701538	0.0030672880820356166	2025_01_Batch_13-14	0.5225870430891271	0.6416290286580817	0.7147171308588358	0.6437854650790235	0.5746693073816628	0.6776572885689629	0.5555168145010463	0.7009330534809918	0.6351656876991867	0.685230249882894	0.600122165829045	0.598572921579564	0.7078250921699138	0.6394755763891051	0.6299497786322784	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BAP1	BAP1		3760		CCSBVarC009495		NC_000003.12:52409845:G:T		Pro12Thr																												BAP1_Pro12Thr	3	52409845	G	T	3	allele	34C>A	E02	527_CAVA_Array_P01	I03	B13A7A8P1_R1	B14A7A8P1_R2				3-52409845-G-T	-	0.88323	0.994	12	.	.	.	3	52443861	T	.	.	3	1_Pathogenic	NC_000003.12	.	Pro12Thr	.	29.5	.	.	.	D	.	2	1	.	.	.	.	.	.	0.94750	Select	0.6438	.	0.66535	.	.	D	D	.	2.47156410767	.	.	.	.	.	0.79237	.	.	.	.	0.95806	.	.	0.96420	0.974	.	.	0.89941	2.88	.	T	single nucleotide variant	NC_000003.12:g.52409845G>T	.	.	3	0.9296314	.	.	0.9520596	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0700092,MeSH:D065886,MedGen:C1535926|MONDO:MONDO:0859230,MedGen:C5676925,OMIM:619762	.	.	.	.	.	D	0.97027	D	M	12.63146	.	G/G	.	.	.	.	Neurodevelopmental disorder|Kury-Isidor syndrome	.	0.91592	.	.	-	52409845	.	-	11.420000	.	0.92474	.	.	.	.	de novo;germline	.	Gain of catalytic residue at F15 (P = 0.1611)| Loss of stability (P = 0.1989)| Loss of disorder (P = 0.2123)| Loss of glycosylation at P12 (P = 0.257)| Gain of phosphorylation at S10 (P = 0.4485)	0.93687	GRCh38	68	no assertion criteria provided	c.34C>A	.	0.64349	.	.	.	Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase|Peptidase C12, ubiquitin carboxyl-terminal hydrolase	.	.	P	.	.	NM_004656.4(BAP1):c.34C>A (p.Pro12Thr)		.	BAP1_HUMAN	.	.	0.957361183823445	.	D	0.97942	0.9520596	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.99714	.	.	.	.	.	p.Pro12Thr	.	0.92722	.	germline	.		G	Feb 24, 2022	.	G/G	.	.	1.0	N	3p21.1	.	.	.	SCV001572228|SCV002098941	Pathogenic	.	.	Thr	T	-	.	ENSP00000417132	ENST00000460680	.	0.001	.	.	0.676	G	.	5.259026	0.92967	D	D	-	12.2498	.	0.96627	.	.	.	0.95954	.	52409845	Y	10	.	.	.	Q92560	.	0.587622	0.84864		.	0.943	D	.	0.9296314	.	0.5568	8314	0.322782	.	-7.52	.	.	0.78662	.	.	.	.	.	.	0.97028	3	BAP1	.	.	Pro	.	.	3-52409845-G-T	Kury-Isidor_syndrome|Neurodevelopmental_disorder	.	.	52418901	OMIM:603089.0011	0.875323	0.94241	.	RCV001374940|RCV001839042	D	.	.	c.34C>A	.	.	.	0.84559	G/G	rs2153228682	52409845	.	G	.	Q92560	.	0.96419	.	0.68239		.	.	.	3.34	.	.	.	4.93	0.86468	.	D	T	.	.	.	.	.	.	.	.	1064792	0.84358	0.97481	0.99904853105545	.	.	0.71675	0.79793	.	.	.	6.576	.	D	.	.	.	.	619762	0.73975	3	.	ENSG00000163930	.	.	.	.	0.932184403075094	1	0.67917	0.97129	.	.	.	.	0.862850773711547	YES	.	0.613498	1053076	HGNC:950	.	.	.	0.862	.	52409845	CCA	1.000000	.	-	.	0.94626	.	.	.	Pathogenic	0.91007	.	.	.	OMIM:603089.0011,ClinGen:CA353115049	P	.	0.910963055978	-	0.826	-	0.76196	.	.	0.93154	0.78230202198	0.9986	.	0.99758718307023109	.	-	34C>A 	.	.	C5676925|C1535926	.	.	.	.	NM_004656.4	-	.	.	1	0.64684	2153228682	.	.	0.90939	0.93709	0.717	0.0	.	0.99978024	4.93	.	.	.	0.225878	0.938734357228053	0.90844	D	.	.	.	0.5791	0.87520	p.Pro12Thr	.	.	-13.412	0.9533975	.	0.79228	1064792	D	.	BAP1	.	D	0.834	.	P12T	D	0.52655	0.76753	G/G	principal1																																																																																																				
FH_Leu303Ser	4.116431421416617	0.006241164929272879	-6.345032355574454	0.00038706498420756636	2025_01_Batch_13-14	0.8505563411567993	0.859268928404852	0.8885463987713997	0.9118880825508586	0.7094237006526922	0.6280580150688557	0.8204002263080932	0.8932375913349474	0.7610136797967357	0.60468249164271	0.7393071781128275	0.8398345773564726	0.8908919950531735	0.8364508811737972	0.6570530961477011	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH	ENSG00000091483	3408	214596	CCSBVarC004051	ALE00004051	NC_000001.11:241504242:A:G	908T>C	Leu303Ser	CEGS2	CegsMutGDEh1040	C11	GDEhDisVCh_40065	F08	1	CegsMutGDDh1040	C11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_Leu303Ser	1	241504242	A	G	1											1-241504242-A-G	-	0.7991	1.0	303	2	0	0	1	241667542	G	4.027500e-05	0	1	3_Conflicting	NC_000001.11	65	Leu303Ser	0	27.2	0	0	9.796240e-06	D	0	8	1	42732	4.243730e-06	.	30490	0.000000e+00	0	0.98921	Select	0.9919	102080	0.90580	0	.	D	D	64028	0.74807911618	0	0	0.000000e+00	0	0	0.73213	17080	44900	0	0.000000e+00	0.79692	0	.	0.79432	0.992	.	1.0	0.970103	6.28	0.99	G	single nucleotide variant	NC_000001.11:g.241504242A>G	0	16720	2	0.67910284	109296	0	0.72908586	0	G	2	235642	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	0	0	0.000000e+00	0	0.97926	D	0.80933	D	M	14.65791	65	./.	84	0	7160	1613904	Hereditary cancer-predisposing syndrome|not specified|not provided|Fumarase deficiency	15810	0.96644	.	.	-	241504242	.	-	11.145000	0	0.88939	29600	0	1179950	0	germline	91074	Loss of stability (P = 0.0343)| Gain of glycosylation at L303 (P = 0.0808)| Gain of disorder (P = 0.2233)| Gain of phosphorylation at T301 (P = 0.2914)| Gain of MoRF binding (P = 0.2989)	0.87592	GRCh38	975	criteria provided, conflicting classifications	c.908T>C	0.000000e+00	0.89714	0	0	0	Fumarate lyase, N-terminal	0.000000e+00	9036	P	0	0.000000e+00	NM_000143.4(FH):c.908T>C (p.Leu303Ser)	1	0	FUMH_HUMAN	0	99.0	1.02294957323601	0	D	0.73810	0.72908586	-	0.000000e+00	.	0.0000437859	2	0.000000e+00	0	34174	criteria_provided,_conflicting_classifications	0.93050	0.000000e+00	0	0.000000e+00	0	59996	p.Leu303Ser	0	0.87201	.	germline	.	241504242	A	Jan 08, 2025	0	./.	0	89310	1.0	N	1q43	6962	.	0.000000e+00	SCV000544239|SCV000673377|SCV001986003|SCV002535579|SCV004224834|SCV005381789	Conflicting_classifications_of_pathogenicity	0	0	Ser	S	-	912	ENSP00000355518	ENST00000366560	17666	0.011	13406	0	0.756	A	0	4.874147	0.57446	D	D	-	15.70981	.	0.98810	610	0	.	0.73778	0	241504242	Y	10	0	102080	0.000000e+00	P07954	0	0.984249	0.92581	A	.	0.987	D	89310	0.67910284	.	0.67791	2271	0.547779	65	-4.68	.	5.508710e-05	0.55689	0.000000e+00	0	74938	0.000000e+00	6030	0	0.80934	1	FH	0.000000e+00	0	Leu	10680	2.239390e-05	1-241504242-A-G	not_provided|Hereditary_cancer-predisposing_syndrome|Fumarase_deficiency	0	1	239734165	ClinGen:CA215563	0.938010	0.96387	0	RCV000568576|RCV004767031|RCV000034486|RCV000471678	D	0	0	c.908T>C	0	0	0	0.95628	./.	rs201502246	241504242	14502	A	.	P07954	15672	0.79431	0.000000e+00	0.68239	1	0	0	0.000000e+00	3.44	0	0	264690	5.73	0.99894	108	D	T	0	0.000000e+00	0	24	segdup	0	0	140162|24	41584	0.95967	0.63377	0.981520354747772	2294	.	0.71675	0.93635	0.000000e+00	2.239390e-05	1179950	8.711	9.648500e-06	D	13390	0	3.7780044E-6	0	606812	0.91115	1	0.000000e+00	ENSG00000091483	0.000000e+00	0	0	0	0.9823634086207722	2	0.77493	0.05314	30572	1	9.796240e-06	0.000000e+00	0.942700215822651	YES	0.000000e+00	0.846144	50023	HGNC:3700	D	0	simple_aae	0.8	207286	241504242	TTG	1.000000	.	-	0	0.95552	5.508710e-05	0	0	Conflicting classifications of pathogenicity	0.80574	0	0	0	ClinGen:CA215563	L	0	0.993238567584	-	0.745	-	0.87133	1	466	0.98220	0.741951107979	0.7218	0	0.99846162936952287	94	-	908T>C 	1	0	C3661900|C0027672|C0342770	0	0	0	0	NM_000143.4	-	.	.	1	0.89232	201502246	2318	0	0.99308	0.97163	0.874	0.023	2210	0.94387890	5.73	.	.	0.000000e+00	0.564556	0.993515370856004	0.92016	D	84	6202	9556	0.9670	0.99799	p.Leu303Ser	0	0	-11.157	0.9618218	0	0.90091	41584	D	30442	FH	0.000000e+00	D	0.946	21616	L303S	D	0.98834	0.943	./.	principal1																																																																																																				
FH_Leu303Ser	4.116431421416617	0.006241164929272879	-6.345032355574454	0.00038706498420756636	2025_01_Batch_13-14	0.8505563411567993	0.859268928404852	0.8885463987713997	0.9118880825508586	0.7094237006526922	0.6280580150688557	0.8204002263080932	0.8932375913349474	0.7610136797967357	0.60468249164271	0.7393071781128275	0.8398345773564726	0.8908919950531735	0.8364508811737972	0.6570530961477011	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH		3408		CCSBVarC004051		NC_000001.11:241504242:A:G		Leu303Ser																												FH_Leu303Ser	1	241504242	A	G	1	allele	908T>C	F03	527_CAVA_Array_P03	L05	B13A7A8P1_R1	B14A7A8P1_R2				1-241504242-A-G	-	0.7991	1.0	303	2	0	0	1	241667542	G	4.027500e-05	0	1	3_Conflicting	NC_000001.11	65	Leu303Ser	0	27.2	0	0	9.796240e-06	D	0	8	1	42732	4.243730e-06	.	30490	0.000000e+00	0	0.98921	Select	0.9919	102080	0.90580	0	.	D	D	64028	0.74807911618	0	0	0.000000e+00	0	0	0.73213	17080	44900	0	0.000000e+00	0.79692	0	.	0.79432	0.992	.	1.0	0.970103	6.28	0.99	G	single nucleotide variant	NC_000001.11:g.241504242A>G	0	16720	2	0.67910284	109296	0	0.72908586	0	G	2	235642	0	0	0.000000e+00	146	0.000000e+00	0	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0011730,MedGen:C0342770,OMIM:606812,Orphanet:24	0	0	0.000000e+00	0	0.97926	D	0.80933	D	M	14.65791	65	./.	84	0	7160	1613904	Hereditary cancer-predisposing syndrome|not specified|not provided|Fumarase deficiency	15810	0.96644	.	.	-	241504242	.	-	11.145000	0	0.88939	29600	0	1179950	0	germline	91074	Loss of stability (P = 0.0343)| Gain of glycosylation at L303 (P = 0.0808)| Gain of disorder (P = 0.2233)| Gain of phosphorylation at T301 (P = 0.2914)| Gain of MoRF binding (P = 0.2989)	0.87592	GRCh38	975	criteria provided, conflicting classifications	c.908T>C	0.000000e+00	0.89714	0	0	0	Fumarate lyase, N-terminal	0.000000e+00	9036	P	0	0.000000e+00	NM_000143.4(FH):c.908T>C (p.Leu303Ser)	1	0	FUMH_HUMAN	0	99.0	1.02294957323601	0	D	0.73810	0.72908586	-	0.000000e+00	.	0.0000437859	2	0.000000e+00	0	34174	criteria_provided,_conflicting_classifications	0.93050	0.000000e+00	0	0.000000e+00	0	59996	p.Leu303Ser	0	0.87201	.	germline	.	241504242	A	Jan 08, 2025	0	./.	0	89310	1.0	N	1q43	6962	.	0.000000e+00	SCV000544239|SCV000673377|SCV001986003|SCV002535579|SCV004224834|SCV005381789	Conflicting_classifications_of_pathogenicity	0	0	Ser	S	-	912	ENSP00000355518	ENST00000366560	17666	0.011	13406	0	0.756	A	0	4.874147	0.57446	D	D	-	15.70981	.	0.98810	610	0	.	0.73778	0	241504242	Y	10	0	102080	0.000000e+00	P07954	0	0.984249	0.92581	A	.	0.987	D	89310	0.67910284	.	0.67791	2271	0.547779	65	-4.68	.	5.508710e-05	0.55689	0.000000e+00	0	74938	0.000000e+00	6030	0	0.80934	1	FH	0.000000e+00	0	Leu	10680	2.239390e-05	1-241504242-A-G	not_provided|Hereditary_cancer-predisposing_syndrome|Fumarase_deficiency	0	1	239734165	ClinGen:CA215563	0.938010	0.96387	0	RCV000568576|RCV004767031|RCV000034486|RCV000471678	D	0	0	c.908T>C	0	0	0	0.95628	./.	rs201502246	241504242	14502	A	.	P07954	15672	0.79431	0.000000e+00	0.68239	1	0	0	0.000000e+00	3.44	0	0	264690	5.73	0.99894	108	D	T	0	0.000000e+00	0	24	segdup	0	0	140162|24	41584	0.95967	0.63377	0.981520354747772	2294	.	0.71675	0.93635	0.000000e+00	2.239390e-05	1179950	8.711	9.648500e-06	D	13390	0	3.7780044E-6	0	606812	0.91115	1	0.000000e+00	ENSG00000091483	0.000000e+00	0	0	0	0.9823634086207722	2	0.77493	0.05314	30572	1	9.796240e-06	0.000000e+00	0.942700215822651	YES	0.000000e+00	0.846144	50023	HGNC:3700	D	0	simple_aae	0.8	207286	241504242	TTG	1.000000	.	-	0	0.95552	5.508710e-05	0	0	Conflicting classifications of pathogenicity	0.80574	0	0	0	ClinGen:CA215563	L	0	0.993238567584	-	0.745	-	0.87133	1	466	0.98220	0.741951107979	0.7218	0	0.99846162936952287	94	-	908T>C 	1	0	C3661900|C0027672|C0342770	0	0	0	0	NM_000143.4	-	.	.	1	0.89232	201502246	2318	0	0.99308	0.97163	0.874	0.023	2210	0.94387890	5.73	.	.	0.000000e+00	0.564556	0.993515370856004	0.92016	D	84	6202	9556	0.9670	0.99799	p.Leu303Ser	0	0	-11.157	0.9618218	0	0.90091	41584	D	30442	FH	0.000000e+00	D	0.946	21616	L303S	D	0.98834	0.943	./.	principal1																																																																																																				
F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	0.7006583857956397	0.6349475052381794	0.7446486183877772	0.7575240541543928	0.5895147161593801	0.5795383237608178	0.6254171119251482	0.7511562537806007	0.7363706289984878	0.5770519565396172	0.6400983547782287	0.6301823085816638	0.7479024360841889	0.7469473415764403	0.5832833363494987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C		Ile443Thr																												F9_Ile443Thr	23	139562013	T	C	X	allele	1328T>C	G05	527_CAVA_Array_P02	M10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562013-T-C	-	0.68492	0.973	443	.	0	.	X	138644172	C	8.258080e-07	.	X	1_Pathogenic	NC_000023.11	1	Ile443Thr	.	25.2	.	0	.	D	0	6	1	.	.	.	.	.	0	0.97394	Select	0.7847	.	0.57613	.	.	D	D	46791	1.8200784132	0	0	.	.	.	0.68313	.	33829	0	.	0.75007	.	.	0.93561	0.998	.	2.0	0.931207	5.23	0.98	C	single nucleotide variant	NC_000023.11:g.139562013T>C	0	.	3	0.8973755	.	0	0.9132074	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.97016	D	0.96661	D	M	.	1	T/T	114	0	.	1210935	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.93342	.	.	-	139562013	.	-	7.901000	.	0.99524	22027	0	895048	.	germline	56919	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.99464	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1328T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	0.000000e+00	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2	.	FA9_HUMAN	.	98.0	.	.	D	0.84877	0.92416036	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	0	.	.	45970	p.Ile443Thr	0	0.73593	.	germline	.		T	Aug 21, 2024	.	T/T	.	.	1.0	N	Xq27.1	9768	.	.	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	688	ENSP00000218099	ENST00000218099	.	0.003	.	.	0.665	T	.	4.4192	0.76775	.	D	-	.	.	0.99403	610	.	.	0.83514	0	139562013	Y	10	0	.	0.000000e+00	P00740	.	0.894511	0.93018		.	0.951	D	.	0.92443126	.	0.85369	2158	0.538835	1	-4.11	.	1.117260e-06	0.68399	.	.	57682	.	4350	.	0.94718	X	F9	0.000000e+00	0	Ile	14710	.	X-139562013-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	0	.	138471838	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	.	.	0	RCV000011371|RCV001810850|RCV005042032|RCV001382695	D	0	.	c.1328T>C	.	0	0	0.95331	T/T	rs137852268	139562013	.	T	.	P00740	.	0.92487	.	0.68239		.	.	0.000000e+00	2.195	0	0	.	5.59	0.97862	146	D	T	.	.	0	26	.	.	.	98879	10627	0.95261	0.91900	0.993006281329265	3332	.	0.71675	.	.	.	895048	7.991	.	D	.	.	.	0	306900|300807	0.87929	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9967505453949344	2	0.68937	0.18019	.	.	.	0.000000e+00	.	YES	0.000000e+00	0.919322	25666	HGNC:3551	A	.	simple_aae	0.986	.	139562013	ATA	1.000000	.	-	0	0.99241	1.117260e-06	0	0	Pathogenic/Likely pathogenic	0.79899	.	0	0	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	I	.	0.999526675672	-	0.953	-	0.93024	.	604	0.99673	0.708432018757	0.7773	0	0.9985035315891414	104	-	1328T>C 	.	0	C0008533|C2749016|C3661900	.	.	.	.	NM_000133.4	-	.	.	1	0.78302	137852268	.	0	0.99951	.	0.704	0.003	3218	0.99998903	5.59	.	.	.	0.536223	0.99926867450489	0.61650	D	120	.	.	0.7153	0.92672	p.Ile443Thr	0	0	-10.184	0.9883479	0	0.96103	10627	D	.	F9	.	D	0.905	.	I443T	D	0.92191	0.62996	T/T	principal1	177426	F9_Popp_2025_carboxy_gla_motif_var259020	No											I		1328	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Ile443Thr		true	c.1328T>C						3551.0	139562013.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, multiple submitters, no conflicts				Ile443Thr						T	Feb 27, 2024					missense_variant		443.0			8.258081565071619e-7	0.8460506942392463		Pathogenic/Likely pathogenic	139562013.0	missense_variant		0.905					Reporter			F9_Ile443Thr
F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	0.7006583857956397	0.6349475052381794	0.7446486183877772	0.7575240541543928	0.5895147161593801	0.5795383237608178	0.6254171119251482	0.7511562537806007	0.7363706289984878	0.5770519565396172	0.6400983547782287	0.6301823085816638	0.7479024360841889	0.7469473415764403	0.5832833363494987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C		Ile443Thr																												F9_Ile443Thr	23	139562013	T	C	X	allele	1328T>C	G05	527_CAVA_Array_P02	M10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562013-T-C	-	0.68492	0.973	443	.	0	.	X	138644172	C	8.258080e-07	.	X	1_Pathogenic	NC_000023.11	1	Ile443Thr	.	25.2	.	0	.	D	0	6	1	.	.	.	.	.	0	0.97394	Select	0.7847	.	0.57613	.	.	D	D	46791	1.8200784132	0	0	.	.	.	0.68313	.	33829	0	.	0.75007	.	.	0.93561	0.998	.	2.0	0.931207	5.23	0.98	C	single nucleotide variant	NC_000023.11:g.139562013T>C	0	.	3	0.8973755	.	0	0.9132074	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.97016	D	0.96661	D	M	.	1	T/T	114	0	.	1210935	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.93342	.	.	-	139562013	.	-	7.901000	.	0.99524	22027	0	895048	.	germline	56919	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.99464	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1328T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	0.000000e+00	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2	.	FA9_HUMAN	.	98.0	.	.	D	0.84877	0.92416036	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	0	.	.	45970	p.Ile443Thr	0	0.73593	.	germline	.		T	Aug 21, 2024	.	T/T	.	.	1.0	N	Xq27.1	9768	.	.	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	688	ENSP00000218099	ENST00000218099	.	0.003	.	.	0.665	T	.	4.4192	0.76775	.	D	-	.	.	0.99403	610	.	.	0.83514	0	139562013	Y	10	0	.	0.000000e+00	P00740	.	0.894511	0.93018		.	0.951	D	.	0.92443126	.	0.85369	2158	0.538835	1	-4.11	.	1.117260e-06	0.68399	.	.	57682	.	4350	.	0.94718	X	F9	0.000000e+00	0	Ile	14710	.	X-139562013-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	0	.	138471838	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	.	.	0	RCV000011371|RCV001810850|RCV005042032|RCV001382695	D	0	.	c.1328T>C	.	0	0	0.95331	T/T	rs137852268	139562013	.	T	.	P00740	.	0.92487	.	0.68239		.	.	0.000000e+00	2.195	0	0	.	5.59	0.97862	146	D	T	.	.	0	26	.	.	.	98879	10627	0.95261	0.91900	0.993006281329265	3332	.	0.71675	.	.	.	895048	7.991	.	D	.	.	.	0	306900|300807	0.87929	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9967505453949344	2	0.68937	0.18019	.	.	.	0.000000e+00	.	YES	0.000000e+00	0.919322	25666	HGNC:3551	A	.	simple_aae	0.986	.	139562013	ATA	1.000000	.	-	0	0.99241	1.117260e-06	0	0	Pathogenic/Likely pathogenic	0.79899	.	0	0	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	I	.	0.999526675672	-	0.953	-	0.93024	.	604	0.99673	0.708432018757	0.7773	0	0.9985035315891414	104	-	1328T>C 	.	0	C0008533|C2749016|C3661900	.	.	.	.	NM_000133.4	-	.	.	1	0.78302	137852268	.	0	0.99951	.	0.704	0.003	3218	0.99998903	5.59	.	.	.	0.536223	0.99926867450489	0.61650	D	120	.	.	0.7153	0.92672	p.Ile443Thr	0	0	-10.184	0.9883479	0	0.96103	10627	D	.	F9	.	D	0.905	.	I443T	D	0.92191	0.62996	T/T	principal1	232458	F9_Popp_2025_light_chain_var249339	No											I		1328	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Ile443Thr		true	c.1328T>C						3551.0	139562013.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, multiple submitters, no conflicts				Ile443Thr						T	Feb 27, 2024					missense_variant		443.0			8.258081565071619e-7	0.8181587757660991		Pathogenic/Likely pathogenic	139562013.0	missense_variant		0.905					Reporter			F9_Ile443Thr
F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	0.7006583857956397	0.6349475052381794	0.7446486183877772	0.7575240541543928	0.5895147161593801	0.5795383237608178	0.6254171119251482	0.7511562537806007	0.7363706289984878	0.5770519565396172	0.6400983547782287	0.6301823085816638	0.7479024360841889	0.7469473415764403	0.5832833363494987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C		Ile443Thr																												F9_Ile443Thr	23	139562013	T	C	X	allele	1328T>C	G05	527_CAVA_Array_P02	M10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562013-T-C	-	0.68492	0.973	443	.	0	.	X	138644172	C	8.258080e-07	.	X	1_Pathogenic	NC_000023.11	1	Ile443Thr	.	25.2	.	0	.	D	0	6	1	.	.	.	.	.	0	0.97394	Select	0.7847	.	0.57613	.	.	D	D	46791	1.8200784132	0	0	.	.	.	0.68313	.	33829	0	.	0.75007	.	.	0.93561	0.998	.	2.0	0.931207	5.23	0.98	C	single nucleotide variant	NC_000023.11:g.139562013T>C	0	.	3	0.8973755	.	0	0.9132074	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.97016	D	0.96661	D	M	.	1	T/T	114	0	.	1210935	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.93342	.	.	-	139562013	.	-	7.901000	.	0.99524	22027	0	895048	.	germline	56919	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.99464	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1328T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	0.000000e+00	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2	.	FA9_HUMAN	.	98.0	.	.	D	0.84877	0.92416036	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	0	.	.	45970	p.Ile443Thr	0	0.73593	.	germline	.		T	Aug 21, 2024	.	T/T	.	.	1.0	N	Xq27.1	9768	.	.	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	688	ENSP00000218099	ENST00000218099	.	0.003	.	.	0.665	T	.	4.4192	0.76775	.	D	-	.	.	0.99403	610	.	.	0.83514	0	139562013	Y	10	0	.	0.000000e+00	P00740	.	0.894511	0.93018		.	0.951	D	.	0.92443126	.	0.85369	2158	0.538835	1	-4.11	.	1.117260e-06	0.68399	.	.	57682	.	4350	.	0.94718	X	F9	0.000000e+00	0	Ile	14710	.	X-139562013-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	0	.	138471838	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	.	.	0	RCV000011371|RCV001810850|RCV005042032|RCV001382695	D	0	.	c.1328T>C	.	0	0	0.95331	T/T	rs137852268	139562013	.	T	.	P00740	.	0.92487	.	0.68239		.	.	0.000000e+00	2.195	0	0	.	5.59	0.97862	146	D	T	.	.	0	26	.	.	.	98879	10627	0.95261	0.91900	0.993006281329265	3332	.	0.71675	.	.	.	895048	7.991	.	D	.	.	.	0	306900|300807	0.87929	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9967505453949344	2	0.68937	0.18019	.	.	.	0.000000e+00	.	YES	0.000000e+00	0.919322	25666	HGNC:3551	A	.	simple_aae	0.986	.	139562013	ATA	1.000000	.	-	0	0.99241	1.117260e-06	0	0	Pathogenic/Likely pathogenic	0.79899	.	0	0	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	I	.	0.999526675672	-	0.953	-	0.93024	.	604	0.99673	0.708432018757	0.7773	0	0.9985035315891414	104	-	1328T>C 	.	0	C0008533|C2749016|C3661900	.	.	.	.	NM_000133.4	-	.	.	1	0.78302	137852268	.	0	0.99951	.	0.704	0.003	3218	0.99998903	5.59	.	.	.	0.536223	0.99926867450489	0.61650	D	120	.	.	0.7153	0.92672	p.Ile443Thr	0	0	-10.184	0.9883479	0	0.96103	10627	D	.	F9	.	D	0.905	.	I443T	D	0.92191	0.62996	T/T	principal1	149910	F9_Popp_2025_carboxy_F9_specific_var229977	No											I		1328	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Ile443Thr		true	c.1328T>C						3551.0	139562013.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, multiple submitters, no conflicts				Ile443Thr						T	Feb 27, 2024					missense_variant		443.0			8.258081565071619e-7	0.7664048975098552		Pathogenic/Likely pathogenic	139562013.0	missense_variant		0.905					Reporter			F9_Ile443Thr
F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	0.7006583857956397	0.6349475052381794	0.7446486183877772	0.7575240541543928	0.5895147161593801	0.5795383237608178	0.6254171119251482	0.7511562537806007	0.7363706289984878	0.5770519565396172	0.6400983547782287	0.6301823085816638	0.7479024360841889	0.7469473415764403	0.5832833363494987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C		Ile443Thr																												F9_Ile443Thr	23	139562013	T	C	X	allele	1328T>C	G05	527_CAVA_Array_P02	M10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562013-T-C	-	0.68492	0.973	443	.	0	.	X	138644172	C	8.258080e-07	.	X	1_Pathogenic	NC_000023.11	1	Ile443Thr	.	25.2	.	0	.	D	0	6	1	.	.	.	.	.	0	0.97394	Select	0.7847	.	0.57613	.	.	D	D	46791	1.8200784132	0	0	.	.	.	0.68313	.	33829	0	.	0.75007	.	.	0.93561	0.998	.	2.0	0.931207	5.23	0.98	C	single nucleotide variant	NC_000023.11:g.139562013T>C	0	.	3	0.8973755	.	0	0.9132074	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.97016	D	0.96661	D	M	.	1	T/T	114	0	.	1210935	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.93342	.	.	-	139562013	.	-	7.901000	.	0.99524	22027	0	895048	.	germline	56919	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.99464	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1328T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	0.000000e+00	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2	.	FA9_HUMAN	.	98.0	.	.	D	0.84877	0.92416036	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	0	.	.	45970	p.Ile443Thr	0	0.73593	.	germline	.		T	Aug 21, 2024	.	T/T	.	.	1.0	N	Xq27.1	9768	.	.	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	688	ENSP00000218099	ENST00000218099	.	0.003	.	.	0.665	T	.	4.4192	0.76775	.	D	-	.	.	0.99403	610	.	.	0.83514	0	139562013	Y	10	0	.	0.000000e+00	P00740	.	0.894511	0.93018		.	0.951	D	.	0.92443126	.	0.85369	2158	0.538835	1	-4.11	.	1.117260e-06	0.68399	.	.	57682	.	4350	.	0.94718	X	F9	0.000000e+00	0	Ile	14710	.	X-139562013-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	0	.	138471838	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	.	.	0	RCV000011371|RCV001810850|RCV005042032|RCV001382695	D	0	.	c.1328T>C	.	0	0	0.95331	T/T	rs137852268	139562013	.	T	.	P00740	.	0.92487	.	0.68239		.	.	0.000000e+00	2.195	0	0	.	5.59	0.97862	146	D	T	.	.	0	26	.	.	.	98879	10627	0.95261	0.91900	0.993006281329265	3332	.	0.71675	.	.	.	895048	7.991	.	D	.	.	.	0	306900|300807	0.87929	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9967505453949344	2	0.68937	0.18019	.	.	.	0.000000e+00	.	YES	0.000000e+00	0.919322	25666	HGNC:3551	A	.	simple_aae	0.986	.	139562013	ATA	1.000000	.	-	0	0.99241	1.117260e-06	0	0	Pathogenic/Likely pathogenic	0.79899	.	0	0	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	I	.	0.999526675672	-	0.953	-	0.93024	.	604	0.99673	0.708432018757	0.7773	0	0.9985035315891414	104	-	1328T>C 	.	0	C0008533|C2749016|C3661900	.	.	.	.	NM_000133.4	-	.	.	1	0.78302	137852268	.	0	0.99951	.	0.704	0.003	3218	0.99998903	5.59	.	.	.	0.536223	0.99926867450489	0.61650	D	120	.	.	0.7153	0.92672	p.Ile443Thr	0	0	-10.184	0.9883479	0	0.96103	10627	D	.	F9	.	D	0.905	.	I443T	D	0.92191	0.62996	T/T	principal1	259974	F9_Popp_2025_strep_2_var268701	No											I		1328	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Ile443Thr		true	c.1328T>C						3551.0	139562013.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, multiple submitters, no conflicts				Ile443Thr						T	Feb 27, 2024					missense_variant		443.0			8.258081565071619e-7	1.067409682132013		Pathogenic/Likely pathogenic	139562013.0	missense_variant		0.905					Reporter			F9_Ile443Thr
F9_Ile443Thr	-2.603126825347658	0.035264293228412145	0.8828856898637611	0.4065947210623251	2025_01_Batch_13-14	0.7006583857956397	0.6349475052381794	0.7446486183877772	0.7575240541543928	0.5895147161593801	0.5795383237608178	0.6254171119251482	0.7511562537806007	0.7363706289984878	0.5770519565396172	0.6400983547782287	0.6301823085816638	0.7479024360841889	0.7469473415764403	0.5832833363494987	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	F9	F9		52861		CCSBVarC030634		NC_000023.11:139562013:T:C		Ile443Thr																												F9_Ile443Thr	23	139562013	T	C	X	allele	1328T>C	G05	527_CAVA_Array_P02	M10	B13A7A8P1_R1	B14A7A8P1_R2				X-139562013-T-C	-	0.68492	0.973	443	.	0	.	X	138644172	C	8.258080e-07	.	X	1_Pathogenic	NC_000023.11	1	Ile443Thr	.	25.2	.	0	.	D	0	6	1	.	.	.	.	.	0	0.97394	Select	0.7847	.	0.57613	.	.	D	D	46791	1.8200784132	0	0	.	.	.	0.68313	.	33829	0	.	0.75007	.	.	0.93561	0.998	.	2.0	0.931207	5.23	0.98	C	single nucleotide variant	NC_000023.11:g.139562013T>C	0	.	3	0.8973755	.	0	0.9132074	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C3661900|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	.	.	0.000000e+00	0	0.97016	D	0.96661	D	M	.	1	T/T	114	0	.	1210935	Hereditary factor IX deficiency disease|not provided|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	.	0.93342	.	.	-	139562013	.	-	7.901000	.	0.99524	22027	0	895048	.	germline	56919	Loss of stability (P = 0.0048)| Loss of catalytic residue at I443 (P = 0.0223)| Gain of ubiquitination at K438 (P = 0.0415)| Gain of disorder (P = 0.0432)| Gain of phosphorylation at I443 (P = 0.0823)	0.99464	GRCh38	924	criteria provided, multiple submitters, no conflicts	c.1328T>C	.	0.84656	0	.	.	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	.	.	P	0	0.000000e+00	NM_000133.4(F9):c.1328T>C (p.Ile443Thr)	2	.	FA9_HUMAN	.	98.0	.	.	D	0.84877	0.92416036	+	.	.		.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.99996	.	0	.	.	45970	p.Ile443Thr	0	0.73593	.	germline	.		T	Aug 21, 2024	.	T/T	.	.	1.0	N	Xq27.1	9768	.	.	SCV001473253|SCV001581597|SCV002573773|SCV004813249|SCV005682979	Pathogenic/Likely_pathogenic	.	.	Thr	T	-	688	ENSP00000218099	ENST00000218099	.	0.003	.	.	0.665	T	.	4.4192	0.76775	.	D	-	.	.	0.99403	610	.	.	0.83514	0	139562013	Y	10	0	.	0.000000e+00	P00740	.	0.894511	0.93018		.	0.951	D	.	0.92443126	.	0.85369	2158	0.538835	1	-4.11	.	1.117260e-06	0.68399	.	.	57682	.	4350	.	0.94718	X	F9	0.000000e+00	0	Ile	14710	.	X-139562013-T-C	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_provided	0	.	138471838	ClinGen:CA255420|OMIM:300746.0069|UniProtKB:P00740#VAR_017323	.	.	0	RCV000011371|RCV001810850|RCV005042032|RCV001382695	D	0	.	c.1328T>C	.	0	0	0.95331	T/T	rs137852268	139562013	.	T	.	P00740	.	0.92487	.	0.68239		.	.	0.000000e+00	2.195	0	0	.	5.59	0.97862	146	D	T	.	.	0	26	.	.	.	98879	10627	0.95261	0.91900	0.993006281329265	3332	.	0.71675	.	.	.	895048	7.991	.	D	.	.	.	0	306900|300807	0.87929	X	.	ENSG00000101981	0.000000e+00	0	.	0	0.9967505453949344	2	0.68937	0.18019	.	.	.	0.000000e+00	.	YES	0.000000e+00	0.919322	25666	HGNC:3551	A	.	simple_aae	0.986	.	139562013	ATA	1.000000	.	-	0	0.99241	1.117260e-06	0	0	Pathogenic/Likely pathogenic	0.79899	.	0	0	ClinGen:CA255420,UniProtKB:P00740#VAR_017323,OMIM:300746.0069	I	.	0.999526675672	-	0.953	-	0.93024	.	604	0.99673	0.708432018757	0.7773	0	0.9985035315891414	104	-	1328T>C 	.	0	C0008533|C2749016|C3661900	.	.	.	.	NM_000133.4	-	.	.	1	0.78302	137852268	.	0	0.99951	.	0.704	0.003	3218	0.99998903	5.59	.	.	.	0.536223	0.99926867450489	0.61650	D	120	.	.	0.7153	0.92672	p.Ile443Thr	0	0	-10.184	0.9883479	0	0.96103	10627	D	.	F9	.	D	0.905	.	I443T	D	0.92191	0.62996	T/T	principal1	204942	F9_Popp_2025_heavy_chain_var239658	No											I		1328	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Ile443Thr		true	c.1328T>C						3551.0	139562013.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, multiple submitters, no conflicts				Ile443Thr						T	Feb 27, 2024					missense_variant		443.0			8.258081565071619e-7	0.9483916253669096		Pathogenic/Likely pathogenic	139562013.0	missense_variant		0.905					Reporter			F9_Ile443Thr
ZC4H2_Leu66His	-6.503081082564646	0.0003331667654269905	5.090199097323906	0.0014148589207405259	2025_01_Batch_13-14	0.8522655514090403	0.9633536275335962	0.9804984863300853	0.9752995486173831	0.9748941121269308	0.9542813202282818	0.9690505195896728	0.9833910565904622	0.9883638761388648	0.9641545542687115	0.903273435818661	0.9662020735616346	0.9819447714602738	0.9818317123781239	0.9695243331978212	0.0	1.0	1.0	1.0	1.0	0.0	0.0	0.0	0.0	1.0	ZC4H2	ZC4H2		4320		CCSBVarC009188		NC_000023.11:64921845:A:T		Leu66His																												ZC4H2_Leu66His	23	64921845	A	T	X	allele	197T>A	A05	527_CAVA_Array_P06	A10	B13A7A8P2_R1	B14A7A8P2_R2				X-64921845-A-T	-	0.67299	1.0	66	.	.	.	X	64141725	T	.	.	X	1_Pathogenic	NC_000023.11	.	Leu66His	.	25.1	.	.	.	T	.	1	1	.	.	.	.	.	.	0.87862	Select	0.3407	.	0.90580	.	.	D	D	.	2.23748090164	.	.	.	.	.	0.99245	.	.	.	.	0.90790	.	.	0.93903	0.995	.	6.0	0.950605	.	0.94	T	single nucleotide variant	NC_000023.11:g.64921845A>T	.	.	1	0.858151	.	.	0.9276844	.		.	.	.	.	.	.	.	.	Gene:4183,MONDO:MONDO:0010758,MedGen:C0796200,OMIM:314580,Orphanet:3454,Orphanet:85283	.	.	.	.	0.94378	D	0.91794	D	M	.	.	A/A	.	.	.	.	Wieacker-Wolff syndrome	.	0.71488	.	.	-	64921845	.	-	11.114000	.	0.99793	.	.	.	.	germline	.	Loss of stability (P = 0.0086)| Gain of disorder (P = 0.0553)| Loss of helix (P = 0.079)| Gain of catalytic residue at L68 (P = 0.0857)| Loss of MoRF binding (P = 0.5018)	0.93752	GRCh38	40	no assertion criteria provided	c.197T>A	.	0.55168	.	.	.	.	.	.	P	.	.	NM_018684.4(ZC4H2):c.197T>A (p.Leu66His)		.	ZC4H2_HUMAN	.	94.0	.	.	D	0.99952	0.9275634	-	.	.		.	.	0	.	no_assertion_criteria_provided	0.98531	.	.	.	.	.	p.Leu66His	.	0.86409	.	germline	.		A	Mar 02, 2017	.	A/A	.	.	1.0	N	Xq11.2	.	.	.	SCV000513395	Pathogenic	.	.	His	H	-	.	ENSP00000363972	ENST00000374839	.	0.0	.	.	0.756	A	.	4.36859	0.92967	.	D	-	.	.	0.78686	.	.	.	0.90862	.	64921845	Y	9	.	.	.	Q9NQZ6	.	0.857357	0.40650		.	0.998	D	.	0.8559096	.	0.73271	55906	0.55841	.	-6.17	.	.	0.91343	.	.	.	.	.	.	0.91947	X	ZC4H2	.	.	Leu	.	.	X-64921845-A-T	Wieacker-Wolff_syndrome	.	.	64058450	ClinGen:CA16609220|OMIM:300897.0005	.	.	.	RCV000425925	D	.	.	c.197T>A	.	.	.	0.96027	A/A	rs1057520297	64921845	.	A	.	Q9NQZ6	.	0.93915	.	0.68239		.	.	.	2.58	.	.	.	4.54	0.96779	.	D	D	.	.	.	.	.	.	.	3454|85283	378042	0.95964	0.95976	0.997178673744202	.	.	0.71675	.	.	.	.	9.008	.	D	.	.	.	.	314580	0.9315	X	.	ENSG00000126970	.	.	.	.	0.9684491553990456	2	0.88579	0.97963	.	.	.	.	.	YES	.	0.110217	380135	HGNC:24931	A	.	simple_aae	0.994	.	64921845	CTC	1.000000	.	-	.	0.91035	.	.	.	Pathogenic	0.85475	.	.	.	ClinGen:CA16609220,OMIM:300897.0005	L	.	0.958049427582	-	0.827	-	0.97658	.	.	0.96815	0.934989273548	1.0	.	0.98348546103222834	.	-	197T>A 	.	.	C0796200	.	.	.	.	NM_018684.4	-	.	.	1	0.87028	1057520297	.	.	0.95723	.	0.966	0.001	.	0.99785450	5.7	.	.	.	0.564341	0.99974676713688	0.75182	T	.	.	.	-0.4130	0.70541	p.Leu66His	.	.	-11.957	0.91775376	.	0.97751	378042	D	.	ZC4H2	.	D	0.673	.	L66H	D	.	0.943	A/A	principal1																																																																																																				
F9_Glu54Val	-4.798263563246736	0.004891134037280333	-9.969911056687636	0.0000218233869121902																											F9	F9		52861		CCSBVarC030495		NC_000023.11:139537082:A:T		Glu54Val																												F9_Glu54Val	23	139537082	A	T	X	allele	161A>T	A06	527_CAVA_Array_P02	A12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537082-A-T	-	0.81477	1.0	54	.	.	.	X	138619241	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu54Val	.	27.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98227	Select	0.9830	.	0.90580	.	.	D	D	.	0.432362513328	.	.	.	.	.	0.41100	.	.	.	.	0.89665	.	.	0.95485	0.985	.	2.0	0.886711	5.06	0.98	T	single nucleotide variant	NC_000023.11:g.139537082A>T	.	.	2	0.91379434	.	.	0.9502473	.		.	.	.	.	.	.	.	.	MedGen:CN517202	.	.	.	.	0.97016	D	0.97262	D	M	.	.	A/A	.	.	.	.	not provided	.	0.98185	.	.	-	139537082	.	-	11.053000	.	0.99892	.	.	.	.	germline	.	Loss of disorder (P = 0.0173)| Gain of MoRF binding (P = 0.0503)| Loss of methylation at K51 (P = 0.0736)| Loss of ubiquitination at K51 (P = 0.1106)| Loss of phosphorylation at S49 (P = 0.1843)	0.98831	GRCh38	924	criteria provided, single submitter	c.161A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.161A>T (p.Glu54Val)	1	.	FA9_HUMAN	.	98.0	.	.	D	0.75883	0.94300646	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Glu54Val	.	0.85349	.	germline	.		A	Dec 11, 2017	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000883848	Likely_pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.936893	0.92967	.	D	-	.	.	0.99342	.	.	.	0.92867	.	139537082	Y	10	.	.	.	P00740	.	0.989494	0.58071		.	0.992	D	.	0.9330192	.	0.61072	2158	0.347386	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.95902	X	F9	.	.	Glu	.	.	X-139537082-A-T	not_provided	.	.	138446907	.	.	.	.	RCV000756129	D	.	.	c.161A>T	.	.	.	0.86234	A/A	rs1569481966	139537082	.	A	.	P00740	.	0.96232	.	0.68239		.	.	.	3.39	.	.	.	5.19	0.99950	.	D	T	.	.	.	.	.	.	.	.	618117	0.86054	0.43127	0.997980773448944	.	.	0.71675	.	.	.	.	6.646	.	D	.	.	.	.	.	0.74266	X	.	ENSG00000101981	.	.	.	.	0.9863972613488678	2	0.80453	0.18019	.	.	.	.	.	YES	.	0.911935	610192	HGNC:3551	A	.	simple_aae	0.997	.	139537082	GAG	1.000000	.	-	.	0.99600	.	.	.	Likely pathogenic	0.87581	.	.	.	ClinGen:CA414435761	E	.	0.997881643828	-	0.928	-	0.71096	.	.	0.98628	0.516671419144	0.7702	.	0.99284327618253276	.	-	161A>T 	.	.	CN517202	.	.	.	.	NM_000133.4	-	.	.	1	0.61285	1569481966	.	.	0.99783	.	0.709	0.0	.	0.99998617	5.19	.	.	.	0.261219	0.999768326828511	0.91450	D	.	.	.	1.0533	0.99480	p.Glu54Val	.	.	-12.114	0.9908852	.	0.97851	618117	D	.	F9	.	D	0.927	.	E54V	D	0.90556	0.943	A/A	principal1	209245	F9_Popp_2025_light_chain_var241162	No											E		161	F9_Popp_2025_light_chain		ENST00000218099.7							immortalized human cells					p.Glu54Val		true	c.161A>T						3551.0	139537082.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-c-1		aa											criteria provided, single submitter				Glu54Val						V	Dec 11, 2017					missense_variant		54.0				0.6207238790209235		Likely pathogenic	139537082.0	missense_variant		0.927					Reporter			F9_Glu54Val
F9_Glu54Val	-4.798263563246736	0.004891134037280333	-9.969911056687636	0.0000218233869121902																											F9	F9		52861		CCSBVarC030495		NC_000023.11:139537082:A:T		Glu54Val																												F9_Glu54Val	23	139537082	A	T	X	allele	161A>T	A06	527_CAVA_Array_P02	A12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537082-A-T	-	0.81477	1.0	54	.	.	.	X	138619241	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu54Val	.	27.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98227	Select	0.9830	.	0.90580	.	.	D	D	.	0.432362513328	.	.	.	.	.	0.41100	.	.	.	.	0.89665	.	.	0.95485	0.985	.	2.0	0.886711	5.06	0.98	T	single nucleotide variant	NC_000023.11:g.139537082A>T	.	.	2	0.91379434	.	.	0.9502473	.		.	.	.	.	.	.	.	.	MedGen:CN517202	.	.	.	.	0.97016	D	0.97262	D	M	.	.	A/A	.	.	.	.	not provided	.	0.98185	.	.	-	139537082	.	-	11.053000	.	0.99892	.	.	.	.	germline	.	Loss of disorder (P = 0.0173)| Gain of MoRF binding (P = 0.0503)| Loss of methylation at K51 (P = 0.0736)| Loss of ubiquitination at K51 (P = 0.1106)| Loss of phosphorylation at S49 (P = 0.1843)	0.98831	GRCh38	924	criteria provided, single submitter	c.161A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.161A>T (p.Glu54Val)	1	.	FA9_HUMAN	.	98.0	.	.	D	0.75883	0.94300646	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Glu54Val	.	0.85349	.	germline	.		A	Dec 11, 2017	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000883848	Likely_pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.936893	0.92967	.	D	-	.	.	0.99342	.	.	.	0.92867	.	139537082	Y	10	.	.	.	P00740	.	0.989494	0.58071		.	0.992	D	.	0.9330192	.	0.61072	2158	0.347386	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.95902	X	F9	.	.	Glu	.	.	X-139537082-A-T	not_provided	.	.	138446907	.	.	.	.	RCV000756129	D	.	.	c.161A>T	.	.	.	0.86234	A/A	rs1569481966	139537082	.	A	.	P00740	.	0.96232	.	0.68239		.	.	.	3.39	.	.	.	5.19	0.99950	.	D	T	.	.	.	.	.	.	.	.	618117	0.86054	0.43127	0.997980773448944	.	.	0.71675	.	.	.	.	6.646	.	D	.	.	.	.	.	0.74266	X	.	ENSG00000101981	.	.	.	.	0.9863972613488678	2	0.80453	0.18019	.	.	.	.	.	YES	.	0.911935	610192	HGNC:3551	A	.	simple_aae	0.997	.	139537082	GAG	1.000000	.	-	.	0.99600	.	.	.	Likely pathogenic	0.87581	.	.	.	ClinGen:CA414435761	E	.	0.997881643828	-	0.928	-	0.71096	.	.	0.98628	0.516671419144	0.7702	.	0.99284327618253276	.	-	161A>T 	.	.	CN517202	.	.	.	.	NM_000133.4	-	.	.	1	0.61285	1569481966	.	.	0.99783	.	0.709	0.0	.	0.99998617	5.19	.	.	.	0.261219	0.999768326828511	0.91450	D	.	.	.	1.0533	0.99480	p.Glu54Val	.	.	-12.114	0.9908852	.	0.97851	618117	D	.	F9	.	D	0.927	.	E54V	D	0.90556	0.943	A/A	principal1	126697	F9_Popp_2025_carboxy_F9_specific_var221800	No											E		161	F9_Popp_2025_carboxy_F9_specific		ENST00000218099.7							immortalized human cells					p.Glu54Val		true	c.161A>T						3551.0	139537082.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-d-1		aa											criteria provided, single submitter				Glu54Val						V	Dec 11, 2017					missense_variant		54.0				0.0129022316852641		Likely pathogenic	139537082.0	missense_variant		0.927					Reporter			F9_Glu54Val
F9_Glu54Val	-4.798263563246736	0.004891134037280333	-9.969911056687636	0.0000218233869121902																											F9	F9		52861		CCSBVarC030495		NC_000023.11:139537082:A:T		Glu54Val																												F9_Glu54Val	23	139537082	A	T	X	allele	161A>T	A06	527_CAVA_Array_P02	A12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537082-A-T	-	0.81477	1.0	54	.	.	.	X	138619241	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu54Val	.	27.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98227	Select	0.9830	.	0.90580	.	.	D	D	.	0.432362513328	.	.	.	.	.	0.41100	.	.	.	.	0.89665	.	.	0.95485	0.985	.	2.0	0.886711	5.06	0.98	T	single nucleotide variant	NC_000023.11:g.139537082A>T	.	.	2	0.91379434	.	.	0.9502473	.		.	.	.	.	.	.	.	.	MedGen:CN517202	.	.	.	.	0.97016	D	0.97262	D	M	.	.	A/A	.	.	.	.	not provided	.	0.98185	.	.	-	139537082	.	-	11.053000	.	0.99892	.	.	.	.	germline	.	Loss of disorder (P = 0.0173)| Gain of MoRF binding (P = 0.0503)| Loss of methylation at K51 (P = 0.0736)| Loss of ubiquitination at K51 (P = 0.1106)| Loss of phosphorylation at S49 (P = 0.1843)	0.98831	GRCh38	924	criteria provided, single submitter	c.161A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.161A>T (p.Glu54Val)	1	.	FA9_HUMAN	.	98.0	.	.	D	0.75883	0.94300646	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Glu54Val	.	0.85349	.	germline	.		A	Dec 11, 2017	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000883848	Likely_pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.936893	0.92967	.	D	-	.	.	0.99342	.	.	.	0.92867	.	139537082	Y	10	.	.	.	P00740	.	0.989494	0.58071		.	0.992	D	.	0.9330192	.	0.61072	2158	0.347386	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.95902	X	F9	.	.	Glu	.	.	X-139537082-A-T	not_provided	.	.	138446907	.	.	.	.	RCV000756129	D	.	.	c.161A>T	.	.	.	0.86234	A/A	rs1569481966	139537082	.	A	.	P00740	.	0.96232	.	0.68239		.	.	.	3.39	.	.	.	5.19	0.99950	.	D	T	.	.	.	.	.	.	.	.	618117	0.86054	0.43127	0.997980773448944	.	.	0.71675	.	.	.	.	6.646	.	D	.	.	.	.	.	0.74266	X	.	ENSG00000101981	.	.	.	.	0.9863972613488678	2	0.80453	0.18019	.	.	.	.	.	YES	.	0.911935	610192	HGNC:3551	A	.	simple_aae	0.997	.	139537082	GAG	1.000000	.	-	.	0.99600	.	.	.	Likely pathogenic	0.87581	.	.	.	ClinGen:CA414435761	E	.	0.997881643828	-	0.928	-	0.71096	.	.	0.98628	0.516671419144	0.7702	.	0.99284327618253276	.	-	161A>T 	.	.	CN517202	.	.	.	.	NM_000133.4	-	.	.	1	0.61285	1569481966	.	.	0.99783	.	0.709	0.0	.	0.99998617	5.19	.	.	.	0.261219	0.999768326828511	0.91450	D	.	.	.	1.0533	0.99480	p.Glu54Val	.	.	-12.114	0.9908852	.	0.97851	618117	D	.	F9	.	D	0.927	.	E54V	D	0.90556	0.943	A/A	principal1	236761	F9_Popp_2025_strep_2_var260524	No											E		161	F9_Popp_2025_strep_2		ENST00000218099.7							immortalized human cells					p.Glu54Val		true	c.161A>T						3551.0	139537082.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-a-1		aa											criteria provided, single submitter				Glu54Val						V	Dec 11, 2017					missense_variant		54.0				0.477580849		Likely pathogenic	139537082.0	missense_variant		0.927					Reporter			F9_Glu54Val
F9_Glu54Val	-4.798263563246736	0.004891134037280333	-9.969911056687636	0.0000218233869121902																											F9	F9		52861		CCSBVarC030495		NC_000023.11:139537082:A:T		Glu54Val																												F9_Glu54Val	23	139537082	A	T	X	allele	161A>T	A06	527_CAVA_Array_P02	A12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537082-A-T	-	0.81477	1.0	54	.	.	.	X	138619241	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu54Val	.	27.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98227	Select	0.9830	.	0.90580	.	.	D	D	.	0.432362513328	.	.	.	.	.	0.41100	.	.	.	.	0.89665	.	.	0.95485	0.985	.	2.0	0.886711	5.06	0.98	T	single nucleotide variant	NC_000023.11:g.139537082A>T	.	.	2	0.91379434	.	.	0.9502473	.		.	.	.	.	.	.	.	.	MedGen:CN517202	.	.	.	.	0.97016	D	0.97262	D	M	.	.	A/A	.	.	.	.	not provided	.	0.98185	.	.	-	139537082	.	-	11.053000	.	0.99892	.	.	.	.	germline	.	Loss of disorder (P = 0.0173)| Gain of MoRF binding (P = 0.0503)| Loss of methylation at K51 (P = 0.0736)| Loss of ubiquitination at K51 (P = 0.1106)| Loss of phosphorylation at S49 (P = 0.1843)	0.98831	GRCh38	924	criteria provided, single submitter	c.161A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.161A>T (p.Glu54Val)	1	.	FA9_HUMAN	.	98.0	.	.	D	0.75883	0.94300646	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Glu54Val	.	0.85349	.	germline	.		A	Dec 11, 2017	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000883848	Likely_pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.936893	0.92967	.	D	-	.	.	0.99342	.	.	.	0.92867	.	139537082	Y	10	.	.	.	P00740	.	0.989494	0.58071		.	0.992	D	.	0.9330192	.	0.61072	2158	0.347386	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.95902	X	F9	.	.	Glu	.	.	X-139537082-A-T	not_provided	.	.	138446907	.	.	.	.	RCV000756129	D	.	.	c.161A>T	.	.	.	0.86234	A/A	rs1569481966	139537082	.	A	.	P00740	.	0.96232	.	0.68239		.	.	.	3.39	.	.	.	5.19	0.99950	.	D	T	.	.	.	.	.	.	.	.	618117	0.86054	0.43127	0.997980773448944	.	.	0.71675	.	.	.	.	6.646	.	D	.	.	.	.	.	0.74266	X	.	ENSG00000101981	.	.	.	.	0.9863972613488678	2	0.80453	0.18019	.	.	.	.	.	YES	.	0.911935	610192	HGNC:3551	A	.	simple_aae	0.997	.	139537082	GAG	1.000000	.	-	.	0.99600	.	.	.	Likely pathogenic	0.87581	.	.	.	ClinGen:CA414435761	E	.	0.997881643828	-	0.928	-	0.71096	.	.	0.98628	0.516671419144	0.7702	.	0.99284327618253276	.	-	161A>T 	.	.	CN517202	.	.	.	.	NM_000133.4	-	.	.	1	0.61285	1569481966	.	.	0.99783	.	0.709	0.0	.	0.99998617	5.19	.	.	.	0.261219	0.999768326828511	0.91450	D	.	.	.	1.0533	0.99480	p.Glu54Val	.	.	-12.114	0.9908852	.	0.97851	618117	D	.	F9	.	D	0.927	.	E54V	D	0.90556	0.943	A/A	principal1	181729	F9_Popp_2025_heavy_chain_var231481	No											E		161	F9_Popp_2025_heavy_chain		ENST00000218099.7							immortalized human cells					p.Glu54Val		true	c.161A>T						3551.0	139537082.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-b-1		aa											criteria provided, single submitter				Glu54Val						V	Dec 11, 2017					missense_variant		54.0				0.7034075113107217		Likely pathogenic	139537082.0	missense_variant		0.927					Reporter			F9_Glu54Val
F9_Glu54Val	-4.798263563246736	0.004891134037280333	-9.969911056687636	0.0000218233869121902																											F9	F9		52861		CCSBVarC030495		NC_000023.11:139537082:A:T		Glu54Val																												F9_Glu54Val	23	139537082	A	T	X	allele	161A>T	A06	527_CAVA_Array_P02	A12	B13A7A8P1_R1	B14A7A8P1_R2				X-139537082-A-T	-	0.81477	1.0	54	.	.	.	X	138619241	T	.	.	X	1_Pathogenic	NC_000023.11	.	Glu54Val	.	27.5	.	.	.	D	.	1	1	.	.	.	.	.	.	0.98227	Select	0.9830	.	0.90580	.	.	D	D	.	0.432362513328	.	.	.	.	.	0.41100	.	.	.	.	0.89665	.	.	0.95485	0.985	.	2.0	0.886711	5.06	0.98	T	single nucleotide variant	NC_000023.11:g.139537082A>T	.	.	2	0.91379434	.	.	0.9502473	.		.	.	.	.	.	.	.	.	MedGen:CN517202	.	.	.	.	0.97016	D	0.97262	D	M	.	.	A/A	.	.	.	.	not provided	.	0.98185	.	.	-	139537082	.	-	11.053000	.	0.99892	.	.	.	.	germline	.	Loss of disorder (P = 0.0173)| Gain of MoRF binding (P = 0.0503)| Loss of methylation at K51 (P = 0.0736)| Loss of ubiquitination at K51 (P = 0.1106)| Loss of phosphorylation at S49 (P = 0.1843)	0.98831	GRCh38	924	criteria provided, single submitter	c.161A>T	.	0.71389	.	.	.	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	.	.	P	.	.	NM_000133.4(F9):c.161A>T (p.Glu54Val)	1	.	FA9_HUMAN	.	98.0	.	.	D	0.75883	0.94300646	+	.	.		.	.	0	.	criteria_provided,_single_submitter	0.99996	.	.	.	.	.	p.Glu54Val	.	0.85349	.	germline	.		A	Dec 11, 2017	.	A/A	.	.	1.0	N	Xq27.1	.	.	.	SCV000883848	Likely_pathogenic	.	.	Val	V	-	.	ENSP00000218099	ENST00000218099	.	0.0	.	.	0.756	A	.	4.936893	0.92967	.	D	-	.	.	0.99342	.	.	.	0.92867	.	139537082	Y	10	.	.	.	P00740	.	0.989494	0.58071		.	0.992	D	.	0.9330192	.	0.61072	2158	0.347386	.	-5.93	.	.	0.91343	.	.	.	.	.	.	0.95902	X	F9	.	.	Glu	.	.	X-139537082-A-T	not_provided	.	.	138446907	.	.	.	.	RCV000756129	D	.	.	c.161A>T	.	.	.	0.86234	A/A	rs1569481966	139537082	.	A	.	P00740	.	0.96232	.	0.68239		.	.	.	3.39	.	.	.	5.19	0.99950	.	D	T	.	.	.	.	.	.	.	.	618117	0.86054	0.43127	0.997980773448944	.	.	0.71675	.	.	.	.	6.646	.	D	.	.	.	.	.	0.74266	X	.	ENSG00000101981	.	.	.	.	0.9863972613488678	2	0.80453	0.18019	.	.	.	.	.	YES	.	0.911935	610192	HGNC:3551	A	.	simple_aae	0.997	.	139537082	GAG	1.000000	.	-	.	0.99600	.	.	.	Likely pathogenic	0.87581	.	.	.	ClinGen:CA414435761	E	.	0.997881643828	-	0.928	-	0.71096	.	.	0.98628	0.516671419144	0.7702	.	0.99284327618253276	.	-	161A>T 	.	.	CN517202	.	.	.	.	NM_000133.4	-	.	.	1	0.61285	1569481966	.	.	0.99783	.	0.709	0.0	.	0.99998617	5.19	.	.	.	0.261219	0.999768326828511	0.91450	D	.	.	.	1.0533	0.99480	p.Glu54Val	.	.	-12.114	0.9908852	.	0.97851	618117	D	.	F9	.	D	0.927	.	E54V	D	0.90556	0.943	A/A	principal1	154213	F9_Popp_2025_carboxy_gla_motif_var250843	No											E		161	F9_Popp_2025_carboxy_gla_motif		ENST00000218099.7							immortalized human cells					p.Glu54Val		true	c.161A>T						3551.0	139537082.0	No		F9				NM_000133.4		1.0	urn:mavedb:00001200-e-1		aa											criteria provided, single submitter				Glu54Val						V	Dec 11, 2017					missense_variant		54.0				0.7650353777003946		Likely pathogenic	139537082.0	missense_variant		0.927					Reporter			F9_Glu54Val
RAD51D_Val28Leu	-0.90363915640805	0.3962182548910523	11.911894475594517	6.680577611790535e-6	2025_01_Batch_13-14	0.8519265761309345	0.8839725446363323	0.9382073875115703	0.9477089800607024	0.7668278317963809	0.9488692246219801	0.9229132976854257	0.9568895776594537	0.9680219306510565	0.8853726734734867	0.9003979003764573	0.903442921160879	0.947548482585512	0.9578654553558794	0.8261002526349338	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D		7201		CCSBVarC024750		NC_000017.11:35119532:C:G		Val28Leu																												RAD51D_Val28Leu	17	35119532	C	G	17	allele	82G>C	C02	527_CAVA_Array_P05	E03	B13A7A8P2_R1	B14A7A8P2_R2				17-35119532-C-G	-	0.96318	1.0	28	.	.	.	17	33446551	G	.	.	17	3_Conflicting	NC_000017.11	.	Val28Leu	.	36.0	.	.	.	T	.	2	5	.	.	.	.	.	.	0.52699	.	0.3608	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	.	.	.	.	.	0.56973	.	.	0.72070	0.947	.	.	0.90461	.	.	G	single nucleotide variant	NC_000017.11:g.35119532C>G	.	.	2	0.3945471	.	.	0.593787	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	.	.	.	.	.	D	0.63896	D	M	6.833586	.	C/C	.	.	.	.	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	.	0.73082	.	.	-	35119532	.	-	7.344000	.	0.82005	.	.	.	.	germline;unknown	.	Loss of sheet (P = 0.0126)| Gain of helix (P = 0.027)| Gain of loop (P = 0.0851)| Gain of ubiquitination at K26 (P = 0.1504)| Loss of phosphorylation at T27 (P = 0.2477)	0.53105	GRCh38	926	criteria provided, conflicting classifications	c.82G>C	.	0.54328	.	.	.	RAD51D, N-terminal domain	.	.	P	.	.	NM_002878.4(RAD51D):c.82G>C (p.Val28Leu)	1	.	RA51D_HUMAN	.	.	0.678883385112307	.	D	0.75430	0.593787	-	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.91550	.	.	.	.	.	p.Val28Leu	.	0.58328	.	germline	.		C	Nov 06, 2023	.	C/C	.	.	1.0	N	17q12	.	.	.	SCV002681932|SCV004189682	Conflicting_classifications_of_pathogenicity	.	.	Leu	L	-	.	ENSP00000378090	ENST00000394589	.	0.0	.	.	0.599	C	.	7.247327	0.92967	D	T	-	6.433988	.	0.88003	.	.	.	0.75431	.	35119532	Y	9	.	.	.	O75771	.	0.485341	0.88559		.	0.996	D	.	0.3945471	.	0.4917	5892	0.0746214	.	-2.45	.	.	0.91343	.	.	.	.	.	.	0.63896	17	RAD51D	.	.	Val	.	.	17-35119532-C-G	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	.	.	30470664	.	0.836844	0.78132	.	RCV002430340|RCV003454215	D	.	.	c.82G>C	.	.	.	0.61132	C/C	rs2142480064	35119532	.	C	.	O75771	.	0.72069	.	0.68239		.	.	.	2.71	.	.	.	4.5	0.81083	.	D	.	.	.	.	.	.	.	.	140162|145	1762829	0.60646	0.39860	0.984222710132599	.	.	0.71675	0.75365	.	.	.	3.379	.	N	.	.	.	.	614291	0.52266	17	.	ENSG00000185379	.	.	.	.	.	1	0.84488	0.17784	.	.	.	.	0.616344378564284	.	.	0.226204	1813922	HGNC:9823	.	.	.	0.676	.	35119532	GTG	1.000000	.	-	.	0.65335	.	.	.	Conflicting classifications of pathogenicity	0.67329	.	.	.	ClinGen:CA399092236	V	.	0.834963111294	-	0.463	-	0.55314	.	.	0.68920	.	0.7085	.	0.99800754297607808	.	-	82G>C 	.	.	C0027672|C3280345	.	.	.	.	NM_002878.4	-	.	.	1	0.67517	-1	.	.	0.83208	0.75995	0.495	0.106	.	0.90928640	4.5	.	.	.	-0.130588	0.00939506599652921	0.79120	T	.	.	.	-0.3621	0.72130	p.Val28Leu	.	.	-8.931	0.57687366	.	0.23451	1762829	D	.	RAD51D	.	T	0.229	.	V28L	D	.	0.40292	C/C	principal1	962965	RAD51D_unpublished_var157212	Yes						overall function		Cell survival			V		82	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Val28Leu		true	c.82G>C						9823.0	35119532.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		C									criteria provided, conflicting classifications				Val28Leu						L	Nov 06, 2023					missense_variant		28.0	G			-0.191517		Conflicting classifications of pathogenicity	35119532.0	missense_variant,splice_region_variant		0.229	functionally_abnormal				Cell viability			RAD51D_Val28Leu
RAD51D_Val28Leu	-0.90363915640805	0.3962182548910523	11.911894475594517	6.680577611790535e-6	2025_01_Batch_13-14	0.8519265761309345	0.8839725446363323	0.9382073875115703	0.9477089800607024	0.7668278317963809	0.9488692246219801	0.9229132976854257	0.9568895776594537	0.9680219306510565	0.8853726734734867	0.9003979003764573	0.903442921160879	0.947548482585512	0.9578654553558794	0.8261002526349338	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	RAD51D	RAD51D				CCSBVarC024750	ALE00036624	NC_000017.11:35119532:C:G	82G>C	Val28Leu	CAVA																											RAD51D_Val28Leu	17	35119532	C	G	17								1	1	1	17-35119532-C-G	-	0.96318	1.0	28	.	.	.	17	33446551	G	.	.	17	3_Conflicting	NC_000017.11	.	Val28Leu	.	36.0	.	.	.	T	.	2	5	.	.	.	.	.	.	0.52699	.	0.3608	.	0.90580	.	.	T	D	.	.	.	.	.	.	.	.	.	.	.	.	0.56973	.	.	0.72070	0.947	.	.	0.90461	.	.	G	single nucleotide variant	NC_000017.11:g.35119532C>G	.	.	2	0.3945471	.	.	0.593787	.		.	.	.	.	.	.	.	.	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145	.	.	.	.	.	D	0.63896	D	M	6.833586	.	C/C	.	.	.	.	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4	.	0.73082	.	.	-	35119532	.	-	7.344000	.	0.82005	.	.	.	.	germline;unknown	.	Loss of sheet (P = 0.0126)| Gain of helix (P = 0.027)| Gain of loop (P = 0.0851)| Gain of ubiquitination at K26 (P = 0.1504)| Loss of phosphorylation at T27 (P = 0.2477)	0.53105	GRCh38	926	criteria provided, conflicting classifications	c.82G>C	.	0.54328	.	.	.	RAD51D, N-terminal domain	.	.	P	.	.	NM_002878.4(RAD51D):c.82G>C (p.Val28Leu)	1	.	RA51D_HUMAN	.	.	0.678883385112307	.	D	0.75430	0.593787	-	.	.		.	.	0	.	criteria_provided,_conflicting_classifications	0.91550	.	.	.	.	.	p.Val28Leu	.	0.58328	.	germline	.		C	Nov 06, 2023	.	C/C	.	.	1.0	N	17q12	.	.	.	SCV002681932|SCV004189682	Conflicting_classifications_of_pathogenicity	.	.	Leu	L	-	.	ENSP00000378090	ENST00000394589	.	0.0	.	.	0.599	C	.	7.247327	0.92967	D	T	-	6.433988	.	0.88003	.	.	.	0.75431	.	35119532	Y	9	.	.	.	O75771	.	0.485341	0.88559		.	0.996	D	.	0.3945471	.	0.4917	5892	0.0746214	.	-2.45	.	.	0.91343	.	.	.	.	.	.	0.63896	17	RAD51D	.	.	Val	.	.	17-35119532-C-G	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4	.	.	30470664	.	0.836844	0.78132	.	RCV002430340|RCV003454215	D	.	.	c.82G>C	.	.	.	0.61132	C/C	rs2142480064	35119532	.	C	.	O75771	.	0.72069	.	0.68239		.	.	.	2.71	.	.	.	4.5	0.81083	.	D	.	.	.	.	.	.	.	.	140162|145	1762829	0.60646	0.39860	0.984222710132599	.	.	0.71675	0.75365	.	.	.	3.379	.	N	.	.	.	.	614291	0.52266	17	.	ENSG00000185379	.	.	.	.	.	1	0.84488	0.17784	.	.	.	.	0.616344378564284	.	.	0.226204	1813922	HGNC:9823	.	.	.	0.676	.	35119532	GTG	1.000000	.	-	.	0.65335	.	.	.	Conflicting classifications of pathogenicity	0.67329	.	.	.	ClinGen:CA399092236	V	.	0.834963111294	-	0.463	-	0.55314	.	.	0.68920	.	0.7085	.	0.99800754297607808	.	-	82G>C 	.	.	C0027672|C3280345	.	.	.	.	NM_002878.4	-	.	.	1	0.67517	-1	.	.	0.83208	0.75995	0.495	0.106	.	0.90928640	4.5	.	.	.	-0.130588	0.00939506599652921	0.79120	T	.	.	.	-0.3621	0.72130	p.Val28Leu	.	.	-8.931	0.57687366	.	0.23451	1762829	D	.	RAD51D	.	T	0.229	.	V28L	D	.	0.40292	C/C	principal1	962965	RAD51D_unpublished_var157212	Yes						overall function		Cell survival			V		82	RAD51D_unpublished		ENST00000345365.11							immortalized human cells					p.Val28Leu		true	c.82G>C						9823.0	35119532.0	Yes		RAD51D				NM_002878.4		-1.0			nucleotide		C									criteria provided, conflicting classifications				Val28Leu						L	Nov 06, 2023					missense_variant		28.0	G			-0.191517		Conflicting classifications of pathogenicity	35119532.0	missense_variant,splice_region_variant		0.229	functionally_abnormal				Cell viability			RAD51D_Val28Leu
FH_Ser419Pro	1.6917016548170403	0.14165291060128632	-6.746355577654343	0.0002658955188190891	2025_01_Batch_13-14	0.9213201043130436	0.8773370007239154	0.9050679469217979	0.8950052648966569	0.9097442483214611	0.8723439684984999	0.9018804115409382	0.9215463175573746	0.9176128966731075	0.7942962155237551	0.8968320364057718	0.8896087061324268	0.9133071322395863	0.9063090807848821	0.852020231922608	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH	ENSG00000091483	3408	214603	CCSBVarC004056	ALE00004056	NC_000001.11:241500572:A:G	1255T>C	Ser419Pro	CEGS2	CegsMutGDEh1042	E07	GDEhDisVCh_40065	C09	1	CegsMutGDDh1042	E07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0			0			0			FH_Ser419Pro	1	241500572	A	G	1											1-241500572-A-G	-	0.90245	1.0	419	.	0	.	1	241663872	G	1.876820e-06	.	1	1_Pathogenic	NC_000001.11	1	Ser419Pro	.	31.0	.	0	.	D	0	8	1	.	.	.	.	.	0	0.94297	Select	0.9643	.	0.90580	.	.	D	D	61956	1.10507444367	0	0	.	.	.	0.72276	.	44352	0	.	0.81865	.	.	0.95417	0.998	.	2.0	0.987601	5.93	0.98	G	single nucleotide variant	NC_000001.11:g.241500572A>G	0	.	2	0.89128804	.	0	0.94234765	0	G	.	.	.	.	.	146	.	0	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	.	.	0.000000e+00	0	0.97016	D	0.94281	D	H	14.9433	3	./.	114	0	.	1598452	not provided|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|FH-related disorder	.	0.99132	.	.	-	241500572	.	-	11.015000	.	0.99727	29280	0	72718	.	germline;unknown	90710	Loss of MoRF binding (P = 0.0866)| Gain of ubiquitination at K414 (P = 0.2044)| Loss of methylation at R421 (P = 0.225)| Loss of catalytic residue at S419 (P = 0.2816)| Loss of disorder (P = 0.2882)	0.54885	GRCh38	975	criteria provided, multiple submitters, no conflicts	c.1255T>C	.	0.89013	0	.	.	.	.	.	P	0	0.000000e+00	NM_000143.4(FH):c.1255T>C (p.Ser419Pro)	2	.	FUMH_HUMAN	.	98.0	1.0315813013022	.	D	0.94292	0.94234765	-	.	.	1.37695e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.94135	.	0	.	.	58902	p.Ser419Pro	0	0.84918	.	germline	.	241500572	A	Sep 23, 2024	.	./.	.	.	1.0	N	1q43	9690	.	.	SCV000109982|SCV000537264|SCV000544243|SCV000581641|SCV002535539|SCV004186966|SCV005414250	Pathogenic/Likely_pathogenic	.	.	Pro	P	-	886	ENSP00000355518	ENST00000366560	.	0.0	.	.	0.756	A	.	5.38469	0.83643	D	D	-	15.05383	.	0.95732	610	.	.	0.98285	0	241500572	Y	10	0	.	0.000000e+00	P07954	.	0.924582	0.96438	A	.	0.999	D	.	0.89128804	.	0.85369	2271	0.567543	1	-4.94	.	1.375180e-05	0.91343	.	.	72718	.	5882	.	0.94282	1	FH	1.375180e-05	0	Ser	14050	.	1-241500572-A-G	FH-related_disorder|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	0	.	239730495	ClinGen:CA285322	0.950240	0.96616	0	RCV000078144|RCV000445624|RCV000492881|RCV004555536	D	0	.	c.1255T>C	.	0	0	0.96347	./.	rs200004220	241500572	.	A	.	P07954	.	0.95416	.	0.68239	1	.	.	0.000000e+00	4.865	0	0	.	5.71	0.98660	112	D	T	.	.	0	26	.	.	.	523|140162	92451	0.96286	0.77742	0.999648451805115	2898	.	0.71675	0.96356	.	.	1171916	7.0	.	D	.	.	.	0	150800	0.76103	1	.	ENSG00000091483	0.000000e+00	0	.	0	0.9942181623254077	1	0.92348	0.05314	.	.	.	0.000000e+00	0.929047610943649	YES	0.000000e+00	0.541982	98360	HGNC:3700	A	.	simple_aae	0.992	.	241500572	TCA	1.000000	.	-	0	0.90156	8.533030e-07	0	0	Pathogenic/Likely pathogenic	0.93593	.	0	0	ClinGen:CA285322	S	.	0.988284473714	-	0.474	-	0.94916	.	496	0.99417	0.735592842102	0.9921	0	0.99890297198214184	98	-	1255T>C 	.	0	C1708350|C0027672|C3661900	.	.	.	.	NM_000143.4	-	.	.	1	0.95789	200004220	.	0	0.98802	0.96701	0.942	0.001	2784	0.96268230	5.71	.	.	.	0.57746	0.999992778285156	0.99733	D	86	.	.	1.0873	0.98856	p.Ser419Pro	0	0	-14.165	0.9089949	1	0.99831	92451	D	.	FH	.	D	0.822	.	S419P	D	0.96971	0.943	./.	principal1																																																																																																				
FH_Ser419Pro	1.6917016548170403	0.14165291060128632	-6.746355577654343	0.0002658955188190891	2025_01_Batch_13-14	0.9213201043130436	0.8773370007239154	0.9050679469217979	0.8950052648966569	0.9097442483214611	0.8723439684984999	0.9018804115409382	0.9215463175573746	0.9176128966731075	0.7942962155237551	0.8968320364057718	0.8896087061324268	0.9133071322395863	0.9063090807848821	0.852020231922608	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	FH	FH		3408		CCSBVarC004056		NC_000001.11:241500572:A:G		Ser419Pro																												FH_Ser419Pro	1	241500572	A	G	1	allele	1255T>C	B03	527_CAVA_Array_P03	D05	B13A7A8P1_R1	B14A7A8P1_R2				1-241500572-A-G	-	0.90245	1.0	419	.	0	.	1	241663872	G	1.876820e-06	.	1	1_Pathogenic	NC_000001.11	1	Ser419Pro	.	31.0	.	0	.	D	0	8	1	.	.	.	.	.	0	0.94297	Select	0.9643	.	0.90580	.	.	D	D	61956	1.10507444367	0	0	.	.	.	0.72276	.	44352	0	.	0.81865	.	.	0.95417	0.998	.	2.0	0.987601	5.93	0.98	G	single nucleotide variant	NC_000001.11:g.241500572A>G	0	.	2	0.89128804	.	0	0.94234765	0	G	.	.	.	.	.	146	.	0	MedGen:C3661900|Human Phenotype Ontology:HP:0007437,MONDO:MONDO:0007888,MedGen:C1708350,OMIM:150800,Orphanet:523|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|	.	.	0.000000e+00	0	0.97016	D	0.94281	D	H	14.9433	3	./.	114	0	.	1598452	not provided|Hereditary leiomyomatosis and renal cell cancer|Hereditary cancer-predisposing syndrome|FH-related disorder	.	0.99132	.	.	-	241500572	.	-	11.015000	.	0.99727	29280	0	72718	.	germline;unknown	90710	Loss of MoRF binding (P = 0.0866)| Gain of ubiquitination at K414 (P = 0.2044)| Loss of methylation at R421 (P = 0.225)| Loss of catalytic residue at S419 (P = 0.2816)| Loss of disorder (P = 0.2882)	0.54885	GRCh38	975	criteria provided, multiple submitters, no conflicts	c.1255T>C	.	0.89013	0	.	.	.	.	.	P	0	0.000000e+00	NM_000143.4(FH):c.1255T>C (p.Ser419Pro)	2	.	FUMH_HUMAN	.	98.0	1.0315813013022	.	D	0.94292	0.94234765	-	.	.	1.37695e-6	.	.	0	.	criteria_provided,_multiple_submitters,_no_conflicts	0.94135	.	0	.	.	58902	p.Ser419Pro	0	0.84918	.	germline	.	241500572	A	Sep 23, 2024	.	./.	.	.	1.0	N	1q43	9690	.	.	SCV000109982|SCV000537264|SCV000544243|SCV000581641|SCV002535539|SCV004186966|SCV005414250	Pathogenic/Likely_pathogenic	.	.	Pro	P	-	886	ENSP00000355518	ENST00000366560	.	0.0	.	.	0.756	A	.	5.38469	0.83643	D	D	-	15.05383	.	0.95732	610	.	.	0.98285	0	241500572	Y	10	0	.	0.000000e+00	P07954	.	0.924582	0.96438	A	.	0.999	D	.	0.89128804	.	0.85369	2271	0.567543	1	-4.94	.	1.375180e-05	0.91343	.	.	72718	.	5882	.	0.94282	1	FH	1.375180e-05	0	Ser	14050	.	1-241500572-A-G	FH-related_disorder|Hereditary_leiomyomatosis_and_renal_cell_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	0	.	239730495	ClinGen:CA285322	0.950240	0.96616	0	RCV000078144|RCV000445624|RCV000492881|RCV004555536	D	0	.	c.1255T>C	.	0	0	0.96347	./.	rs200004220	241500572	.	A	.	P07954	.	0.95416	.	0.68239	1	.	.	0.000000e+00	4.865	0	0	.	5.71	0.98660	112	D	T	.	.	0	26	.	.	.	523|140162	92451	0.96286	0.77742	0.999648451805115	2898	.	0.71675	0.96356	.	.	1171916	7.0	.	D	.	.	.	0	150800	0.76103	1	.	ENSG00000091483	0.000000e+00	0	.	0	0.9942181623254077	1	0.92348	0.05314	.	.	.	0.000000e+00	0.929047610943649	YES	0.000000e+00	0.541982	98360	HGNC:3700	A	.	simple_aae	0.992	.	241500572	TCA	1.000000	.	-	0	0.90156	8.533030e-07	0	0	Pathogenic/Likely pathogenic	0.93593	.	0	0	ClinGen:CA285322	S	.	0.988284473714	-	0.474	-	0.94916	.	496	0.99417	0.735592842102	0.9921	0	0.99890297198214184	98	-	1255T>C 	.	0	C1708350|C0027672|C3661900	.	.	.	.	NM_000143.4	-	.	.	1	0.95789	200004220	.	0	0.98802	0.96701	0.942	0.001	2784	0.96268230	5.71	.	.	.	0.57746	0.999992778285156	0.99733	D	86	.	.	1.0873	0.98856	p.Ser419Pro	0	0	-14.165	0.9089949	1	0.99831	92451	D	.	FH	.	D	0.822	.	S419P	D	0.96971	0.943	./.	principal1																																																																																																				
BRCA1_Cys64Tyr	-0.2411116846042154	0.8163785956912686	-2.2694527201623846	0.057523894319769224	2025_01_Batch_13-14	0.8767777326467615	0.9730828220329724	0.8770861220785622	0.7593569849355692	0.6491123281602564	0.984165069167112	0.9493837665828397	0.9688679226686315	0.9870125638742568	0.960958284831255	0.9304714009069368	0.961233294307906	0.9229770223735969	0.873184774404913	0.8050353064957557	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	BRCA1	BRCA1		14613		CCSBVarC011839		NC_000017.11:43106477:C:T		Cys64Tyr																												BRCA1_Cys64Tyr	17	43106477	C	T	17	allele	191G>A	H08	527_CAVA_Array_P01	O15	B13A7A8P1_R1	B14A7A8P1_R2				17-43106477-C-T	-	0.87099	0.999	64	.	0	.	17	41258494	T	1.248490e-06	.	17	1_Pathogenic	NC_000017.11	1	Cys64Tyr	.	29.1	.	0	.	D	0	27	1	.	.	.	.	.	0	0.99189	.	0.9922	.	0.77914	.	.	T	D	63954	.	0	0	.	.	.	0.82191	.	44730	0	.	0.99046	.	.	0.98562	0.997	.	.	.	.	.	T	single nucleotide variant	NC_000017.11:g.43106477C>T	0	.	2	0.9065188	.	0	0.98057026	0		.	.	.	.	.	146	.	0	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MONDO:MONDO:0700268,MedGen:CN377757	.	.	0.000000e+00	0	0.99291	D	0.96684	D	H	10.55451	2	C/C	114	0	.	1601934	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not provided|Pancreatic cancer, susceptibility to, 4|BRCA1-related cancer predisposition	.	0.96449	.	.	ACMG2013,ACMG2016,ACMG2021,ACMG2022	43106477	.	-	7.641000	.	0.98836	29512	0	1170064	.	germline;not applicable;paternal;unknown	90238	Loss of stability (P = 0.0601)| Loss of disorder (P = 0.0647)| Loss of methylation at K65 (P = 0.0701)| Gain of phosphorylation at T69 (P = 0.1857)| Loss of catalytic residue at L63 (P = 0.238)	0.99904	GRCh38	459	reviewed by expert panel	c.191G>A	.	0.57348	0	.	.	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type	.	.	LP	0	0.000000e+00	NM_007294.4(BRCA1):c.191G>A (p.Cys64Tyr)	3	.	BRCA1_HUMAN	.	.	0.880338828138272	.	.	0.96039	0.9736041	-	.	.		.	.	0	.	reviewed_by_expert_panel	0.99701	.	0	.	.	59914	p.Cys64Tyr	0	0.63257	.	germline	.		C	Jun 11, 2024	.	C/C	.	.	1.0	N	17q21.31	9690	.	.	SCV004101417	Pathogenic	.	.	Tyr	Y	-	912	ENSP00000419103	ENST00000494123	.	0.001	.	.	0.531	C	.	5.19196	0.92967	D	D	-	9.115097	.	0.99626	610	.	.	0.93754	0	43106477	Y	10	0	.	0.000000e+00	P38398	.	0.476203	0.54687		.	0.972	D	.	0.92475754	.	0.79771	672	0.553373	1	-2.59	.	8.546540e-07	0.91343	.	.	74760	.	5808	.	0.95378	17	BRCA1	0.000000e+00	0	Cys	14528	.	17-43106477-C-T	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|BRCA1-related_cancer_predisposition	0	.	38512020	ClinGen:CA001262|UniProtKB:P38398#VAR_007759	0.851286	0.90713	0	RCV000047641|RCV000077501|RCV000131896|RCV000236464|RCV003334380|RCV004566890	D	0	.	c.191G>A	.	0	0	0.95819	C/C	rs55851803	43106477	.	C	.	E9PFC7	.	0.99138	.	0.68239		.	.	0.000000e+00	4.34	0	0	264690	4.64	0.92995	112	D	T	.	.	0	26	.	.	.	145|1333|140162|145	54400	0.95755	0.52543	0.998311161994934	3324	.	0.71675	0.76729	.	.	1170064	4.108	.	D	.	.	3.7780044E-6	0	614320|604370	0.57643	17	.	ENSG00000012048	0.000000e+00	0	.	0	.	2	0.84488	0.78836	.	1	.	0.000000e+00	0.762986794469818	.	0.000000e+00	0.946477	69067	HGNC:1100	.	.	.	0.97	.	43106477	TGT	1.000000	.	-	0	0.99609	8.546540e-07	0	0	Pathogenic	0.94701	.	0	0	UniProtKB:P38398#VAR_007759,ClinGen:CA001262	C	.	0.999548998322	-	0.991	-	0.97441	.	548	0.88610	0.801703929901	0.9941	0	0.99179197590808121	98	-	191G>A 	.	0	C3661900|C0677776|C3280442|C0027672|C2676676|CN377757	.	.	.	.	NM_007294.4	-	.	.	1	0.87587	55851803	.	0	0.99953	0.87052	.	0.0	3210	0.99977249	4.64	.	.	.	0.557106	0.999711406740052	0.98393	D	86	.	.	0.9543	0.99809	p.Cys64Tyr	0	0	-12.677	0.9909615	0	0.97610	54400	D	.	BRCA1	.	D	0.954	.	C64Y	D	.	0.24877	C/C	principal2																																																																																																				
